PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sasaki, Y; Kamei, D; Ishikawa, Y; Ishii, T; Uematsu, S; Akira, S; Murakami, M; Hara, S				Sasaki, Y.; Kamei, D.; Ishikawa, Y.; Ishii, T.; Uematsu, S.; Akira, S.; Murakami, M.; Hara, S.			Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis	ONCOGENE			English	Article						mPGES-1; colon cancer; prostaglandin E-2; macrophage	HYPERPLASTIC GASTRIC TUMORS; CANCER; MICE; EXPRESSION; CYCLOOXYGENASE-2; AZOXYMETHANE; INFLAMMATION; PHYSIOLOGY; ROFECOXIB; DELETION	Accumulating evidence indicates that cyclooxygenase (COX)-2-derived prostaglandin (PG) E-2 is involved in the development of various tumors, including colorectal cancer. However, the precise contribution of microsomal PGE synthase (mPGES)-1, a terminal enzyme that acts downstream of COX-2 in the PGE(2)-biosynthetic pathway, to multiple processes of tumor development is not yet fully understood. Here, we show the pro-tumorigenic role of mPGES-1 in chemical carcinogen-induced colon carcinogenesis and intrasplenic tumor transplantation models. Genetic deletion of mPGES-1 significantly reduced both the total number and size of colorectal polyps at 18 weeks after azoxymethane administration with reduced nuclear translocation of beta-catenin, altered expression profiles of chemokines/cytokines and increased production of anti-tumorigenic PGs, prostaglandin D-2 and prostacyclin in tumor tissues. At an early stage (6 weeks), mPGES-1 deficiency significantly reduced the number of aberrant crypt foci, while its transgenic overexpression increased the number. Furthermore, the growth of intrasplenically transplanted tumor cells was suppressed in mPGES-1 knockout (KO) mice. Co-culture of tumor cells with bone marrow-derived macrophages (BM-M Phi s) isolated from wild-type (WT) mice resulted in the induction of mPGES-1 in BM-M Phi s and increased the growth of tumor cells in vitro, whereas mPGES-1-null BM-M Phi s failed to facilitate tumor growth. The adoptive transfer of WT BM-M Phi s into mPGES-1 KO mice restored the growth of transplanted tumor cells, indicating that mPGES-1 in M Phi s is important for the growth of adjacent tumor cells. Taken together, our findings suggest that the inhibition of mPGES-1 is an alternative therapeutic target for colorectal and possibly other cancers.	[Hara, S.] Showa Univ, Sch Pharm, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Kamei, D.] Showa Univ, Sch Pharm, Dept Res & Dev Innovat Med Needs, Tokyo 1428555, Japan; [Ishikawa, Y.; Ishii, T.] Toho Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Uematsu, S.; Akira, S.] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan; [Murakami, M.] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 113, Japan	Showa University; Showa University; Toho University; Osaka University; Tokyo Metropolitan Institute of Medical Science	Hara, S (corresponding author), Showa Univ, Sch Pharm, Dept Hlth Chem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	haras@pharm.showa-u.ac.jp	Akira, Shizuo/C-3134-2009		Ministry of Education, Sports, Science, Culture and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; PRESTO from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21689015, 22116005] Funding Source: KAKEN	Ministry of Education, Sports, Science, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research; by a Private University High Technology Research Center Project matching-fund subsidy from the Ministry of Education, Sports, Science, Culture and Technology of Japan; and by a Showa University Special Grant-in-Aid for Innovative Collaborative Research Projects. D Kamei was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists. M Murakami was supported by PRESTO from the Japan Science and Technology Agency.	Ban JO, 2010, CHEM-BIOL INTERACT, V188, P75, DOI 10.1016/j.cbi.2010.06.001; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Casos K, 2011, MICROVASC RES, V81, P261, DOI 10.1016/j.mvr.2011.01.006; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cathcart MC, 2010, BBA-REV CANCER, V1805, P153, DOI 10.1016/j.bbcan.2010.01.006; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Golijanin D, 2004, CLIN CANCER RES, V10, P1024, DOI 10.1158/1078-0432.CCR-1032-3; Guda K, 2004, ONCOGENE, V23, P3813, DOI 10.1038/sj.onc.1207489; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hembruff Stacey L, 2009, Cancer Ther, V7, P254; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamata H, 2010, BIOMED PHARMACOTHER, V64, P409, DOI 10.1016/j.biopha.2010.01.017; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Keith RL, 2004, CANCER RES, V64, P5897, DOI 10.1158/0008-5472.CAN-04-1070; Lavergne E, 2004, J IMMUNOL, V173, P3755, DOI 10.4049/jimmunol.173.6.3755; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Mansure JJ, 2009, CANCER BIOL THER, V8, P1; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nakanishi M, 2011, CANCER PREV RES, V4, P1198, DOI 10.1158/1940-6207.CAPR-11-0188; Nakatani Y, 2007, J HEALTH SCI, V53, P251, DOI 10.1248/jhs.53.251; Nambiar PR, 2003, INT J ONCOL, V22, P145; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima M, 2005, CANCER RES, V65, P9147, DOI 10.1158/0008-5472.CAN-05-1936; Park JM, 2007, CANCER RES, V67, P881, DOI 10.1158/0008-5472.CAN-05-3767; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Robinson SC, 2003, CANCER RES, V63, P8360; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Singh B, 2007, J SURG RES, V140, P220, DOI 10.1016/j.jss.2007.01.039; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Thompson EA, 2007, MOL CELLS, V24, P167; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809	47	48	50	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	24					2943	2952		10.1038/onc.2011.472	http://dx.doi.org/10.1038/onc.2011.472			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	21986945				2022-12-25	WOS:000305388400004
J	Purcell, DJ; Jeong, KW; Bittencourt, D; Gerke, DS; Stallcup, MR				Purcell, Daniel J.; Jeong, Kwang Won; Bittencourt, Danielle; Gerke, Daniel S.; Stallcup, Michael R.			A Distinct Mechanism for Coactivator versus Corepressor Function by Histone Methyltransferase G9a in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; PROTEIN METHYLTRANSFERASE; NUCLEAR RECEPTORS; DNA METHYLATION; H3; GENES; BETA; RECRUITMENT; PROMOTER; REPEATS	Histone methyltransferase G9a has been understood primarily as a corepressor of gene expression, but we showed previously that G9a positively regulates nuclear receptor-mediated transcription in reporter gene assays. Here, we show that endogenous G9a contributes to the estradiol (E-2)-dependent induction of some endogenous target genes of estrogen receptor (ER)alpha in MCF-7 breast cancer cells while simultaneously limiting the E-2-induced expression of other ER alpha target genes. Thus, G9a has a dual and selective role as a coregulator for ER alpha target genes. The ER alpha binding regions associated with the pS2 gene, which requires G9a for E-2-induced expression, are transiently occupied by G9a at 15 min after beginning E-2 treatment, suggesting that G9a coactivator function is by direct interaction with ER alpha target genes. Transient reporter gene assays with deletion mutants of G9a demonstrated that domains previously associated with the corepressor functions of G9a (C-terminal methyltransferase domain, ankyrin repeat domain, and cysteine-rich domain) were unnecessary for G9a coactivator function in ER alpha mediated transcription. In contrast, the N-terminal domain of G9a was necessary and sufficient for enhancement of ER alpha-mediated transcription and for E-2-induced occupancy of G9a on ER alpha binding sites associated with endogenous target genes of ER alpha. In addition to a previously identified activation domain, this region contains a previously uncharacterized ligand-dependent ER alpha binding function, indicating how G9a is recruited to the target genes. Therefore, the coactivator and corepressor functions of G9a involve different G9a domains and different molecular mechanisms.	[Purcell, Daniel J.; Jeong, Kwang Won; Bittencourt, Danielle; Gerke, Daniel S.; Stallcup, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, NOR 6316,1441 Eastlake Ave, Los Angeles, CA 90089 USA.	stallcup@usc.edu			National Institutes of Health [R01 DK055274]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK055274 (to M. R. S.).	Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Glass CK, 2000, GENE DEV, V14, P121; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Ma H, 1999, MOL CELL BIOL, V19, P6164; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MILNER CM, 1993, BIOCHEM J, V290, P811, DOI 10.1042/bj2900811; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451	28	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41963	41971		10.1074/jbc.M111.298463	http://dx.doi.org/10.1074/jbc.M111.298463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21984853	Green Published, hybrid			2022-12-25	WOS:000298180900007
J	Marbaix, AY; Noel, G; Detroux, AM; Vertommen, D; Van Schaftingen, E; Linster, CL				Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Vertommen, Didier; Van Schaftingen, Emile; Linster, Carole L.			Extremely Conserved ATP- or ADP-dependent Enzymatic System for Nicotinamide Nucleotide Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED DIPHOSPHOPYRIDINE NUCLEOTIDE; I BINDING-PROTEIN; ADENINE-DINUCLEOTIDE; SACCHAROMYCES-CEREVISIAE; NADH; DEHYDROGENASE; GENOME; ACID	The reduced forms of NAD and NADP, two major nucleotides playing a central role in metabolism, are continuously damaged by enzymatic or heat-dependent hydration. We report the molecular identification of the eukaryotic dehydratase that repairs these nucleotides and show that this enzyme (Carkd in mammals, YKL151C in yeast) catalyzes the dehydration of the S form of NADHX and NADPHX, at the expense of ATP, which is converted to ADP. Surprisingly, the Escherichia coli homolog, YjeF, a bidomain protein, catalyzes a similar reaction, but using ADP instead of ATP. The latter reaction is ascribable to the C-terminal domain of YjeF. This represents an unprecedented example of orthologous enzymes using either ADP or ATP as phosphoryl donor, We also show that eukaryotic proteins homologous to the N-terminal domain of YjeF (apolipoprotein A-1-binding protein (AIBP) in mammals, YNL200C in yeast) catalyze the epimerization of the S and R forms of NAD(P)HX, thereby allowing, in conjunction with the energy-dependent dehydratase, the repair of both epimers of NAD(P)HX. Both enzymes are very widespread in eukaryotes, prokaryotes, and archaea, which together with the ADP dependence of the dehydratase in some species indicates the ancient origin of this repair system.	[Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Van Schaftingen, Emile; Linster, Carole L.] Catholic Univ Louvain, Duve Inst, WELBIO, B-1200 Brussels, Belgium; [Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Van Schaftingen, Emile; Linster, Carole L.] Catholic Univ Louvain, Physiol Chem Lab, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Hormone & Metab Res Unit, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, WELBIO, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be; carole.linster@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Vertommen, Didier/0000-0001-7648-8282; Van Schaftingen, Emile/0000-0002-6199-7647; Linster, Carole/0000-0001-7143-0719	Fonds de la Recherche Scientifique (FRS-FNRS); European Union [276814]; Welbio (Walloon region)	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); Welbio (Walloon region)(WELBIO)	This work was supported by the Fonds de la Recherche Scientifique (FRS-FNRS), by the European Union Seventh Framework Programme (Grant FP7/2007-2013) under Grant Agreement 276814, and by Welbio (Walloon region).	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Linster CL, 2003, J BIOL CHEM, V278, P36328, DOI 10.1074/jbc.M306593200; MEINHART JO, 1956, J BIOL CHEM, V220, P821; MIKSIC JR, 1978, BIOCHEMISTRY-US, V17, P2234, DOI 10.1021/bi00604a034; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4675, DOI 10.1021/bi00720a001; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6	21	85	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41246	41252		10.1074/jbc.C111.310847	http://dx.doi.org/10.1074/jbc.C111.310847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994945	Green Published, hybrid			2022-12-25	WOS:000298057500012
J	Boichuk, S; Hu, L; Makielski, K; Pandolfi, PP; Gjoerup, OV				Boichuk, Sergei; Hu, Liang; Makielski, Kathleen; Pandolfi, Pier Paolo; Gjoerup, Ole V.			Functional Connection between Rad51 and PML in Homology-Directed Repair	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; LEUKEMIA NUCLEAR-BODIES; LARGE T-ANTIGEN; RECOMBINATIONAL REPAIR; SUMO MODIFICATION; END RESECTION; IN-VIVO; REPLICATION; PROTEIN; ND10	The promyelocytic leukemia protein (PML) is a tumor suppressor critical for formation of nuclear bodies (NBs) performing important functions in transcription, apoptosis, DNA repair and antiviral responses. Earlier studies demonstrated that simian virus 40 (SV40) initiates replication near PML NBs. Here we show that PML knockdown inhibits viral replication in vivo, thus indicating a positive role of PML early in infection. SV40 large T antigen (LT) induces DNA damage and, consequently, nuclear foci of the key homologous recombination repair protein Rad51 that colocalize with PML. PML depletion abrogates LT-induced Rad51 foci. LT may target PML NBs to gain access to DNA repair factors like Rad51 that are required for viral replication. We have used the SV40 model to gain insight to DNA repair events involving PML. Strikingly, even in normal cells devoid of viral oncoproteins, PML is found to be instrumental for foci of Rad51, Mre11 and BRCA1, as well as homology-directed repair after double-strand break (DSB) induction. Following LT expression or external DNA damage, PML associates with Rad51. PML depletion also causes a loss of RPA foci following gamma-irradiation, suggesting that PML is required for processing of DSBs. Immunofluorescent detection of incorporated BrdU without prior denaturation indicates a failure to generate ssDNA foci in PML knockdown cells upon gamma-irradiation. Consistent with the lack of RPA and BrdU foci, gamma-irradiation fails to induce Chk1 activation, when PML is depleted. Taken together, we have discovered a novel functional connection between PML and the homologous recombination-mediated repair machinery, which might contribute to PML tumor suppressor activity.	[Boichuk, Sergei; Hu, Liang; Makielski, Kathleen; Gjoerup, Ole V.] Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boichuk, S (corresponding author), Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA.	ogjoerup@tuftsmedicalcenter.org		Pandolfi, Pier Paolo/0000-0002-5352-5295; Boichuk, Sergei/0000-0003-2415-1084	NIH [AI078926]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant AI078926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Everett RD, 2006, CELL MICROBIOL, V8, P365, DOI 10.1111/j.1462-5822.2005.00677.x; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fradet-Turcotte A, 2010, VIROLOGY, V399, P65, DOI 10.1016/j.virol.2009.12.026; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jul-Larsen A, 2004, EXP CELL RES, V298, P58, DOI 10.1016/j.yexcr.2004.03.045; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wang ZG, 1998, SCIENCE, V279, P1547; Wimmer P, 2010, ONCOGENE; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003; Yeager TR, 1999, CANCER RES, V59, P4175; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	58	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25814	10.1371/journal.pone.0025814	http://dx.doi.org/10.1371/journal.pone.0025814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998700	Green Published, gold, Green Accepted			2022-12-25	WOS:000295966900057
J	Buck, M; Chojkier, M				Buck, Martina; Chojkier, Mario			C/EBP beta-Thr217 Phosphorylation Signaling Contributes to the Development of Lung Injury and Fibrosis in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY FIBROSIS; C/EBP-BETA PHOSPHORYLATION; RIBOSOMAL S-6 KINASE; TRANSCRIPTIONAL ACTIVATOR; OXIDATIVE STRESS; LIVER; PROTEIN; EXPRESSION; LAP; NF-IL6	Background: Although C/EBP beta(ko) mice are refractory to Bleomycin-induced lung fibrosis the molecular mechanisms remain unknown. Here we show that blocking the ribosomal S-6 kinase (RSK) phosphorylation of the CCAAT/Enhancer Binding Protein (C/EBP)-beta on Thr217 (a RSK phosphoacceptor) with either a single point mutation (Ala217), dominant negative transgene or a blocking peptide containing the mutated phosphoacceptor ameliorates the progression of lung injury and fibrosis induced by Bleomycin in mice. Methodology/Principal Findings: Mice expressing the non-phosphorylatable C/EBP beta-Ala217 transgene had a marked reduction in lung injury on day-13 after Bleomycin exposure, compared to C/EBP beta(wt) mice, judging by the decrease of CD68(+) activated monocytes/macrophages, bone marrow-derived CD45(+) cells and lung cytokines as well as by the normal surfactant protein-C expression by lung pneumocytes. On day-21 after Bleomycin treatment, C/EBPbwt mice but not mice expressing the dominant negative C/EBPb-Ala217 transgene developed severe lung fibrosis as determined by quantitative collagen assays. All mice were of identical genetic background and back-crossed to the parental wild-type inbreed FVB mice for at least ten generations. Treatment of C/EBPbwt mice with a cell permeant, C/EBP beta peptide that inhibits phosphorylation of C/EBP beta on Thr217 (40 mu g instilled intracheally on day-2 and day-6 after the single Bleomycin dose) also blocked the progression of lung injury and fibrosis induced by Bleomycin. Phosphorylation of human C/EBP beta on Thr266 (human homologue phosphoacceptor) was induced in collagen-activated human lung fibroblasts in culture as well as in activated lung fibroblasts in situ in lungs of patients with severe lung fibrosis but not in control lungs, suggesting that this signaling pathway may be also relevant in human lung injury and fibrosis. Conclusions/Significance: These data suggest that the RSK-C/EBP beta phosphorylation pathway may contribute to the development of lung injury and fibrosis.	[Buck, Martina; Chojkier, Mario] VA Healthcare Ctr, Dept Med, San Diego, CA USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), VA Healthcare Ctr, Dept Med, San Diego, CA USA.	mbuck@ucsd.edu			National Institutes of Health [RC1 Challenge-DK 087031, MERIT R37-DK-46071, R01-DK-38652, R01-DK084139, K-22-CA-96932]; Department of Veterans Affairs (Merit Review); National Cancer Institute; NATIONAL CANCER INSTITUTE [K01CA096932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087031, R01DK038652, R01DK084139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Merit Review)(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RC1 Challenge-DK 087031; MERIT R37-DK-46071; R01-DK-38652, R01-DK084139 and K-22-CA-96932), and the Department of Veterans Affairs (Merit Review). M.B. was a recipient of the Howard Temin Award from the National Cancer Institute during part of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; An MR, 1996, MOL CELL BIOL, V16, P2295; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Buck M, 2008, DRUG NEWS PERSPECT, V21, P301, DOI 10.1358/dnp.2008.21.6.1246796; Buck M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001372; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Chojkier M, 1995, Prog Liver Dis, V13, P37; Chojkier M, 1998, LIVER GROWTH REPAIR, P430; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Garantziotis S, 2004, J CLIN INVEST, V114, P319, DOI 10.1172/jci200422497; Gauldie J, 2008, AM J PHYSIOL-LUNG C, V294, pL151, DOI 10.1152/ajplung.00520.2007; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hilgendorff A, 2006, CRIT CARE MED, V34, P203, DOI 10.1097/01.CCM.0000190624.77908.E2; Hu B, 2007, J PATHOL, V211, P455, DOI 10.1002/path.2119; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Walther FJ, 2007, NEONATOLOGY, V91, P303, DOI 10.1159/000101346; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797	55	7	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25497	10.1371/journal.pone.0025497	http://dx.doi.org/10.1371/journal.pone.0025497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998664	Green Submitted, gold, Green Published			2022-12-25	WOS:000295966900031
J	David, GK; Condon, CH; Bywater, CL; Ortiz-Barrientos, D; Wilson, RS				David, Gwendolyn K.; Condon, Catriona H.; Bywater, Candice L.; Ortiz-Barrientos, Daniel; Wilson, Robbie S.			Receivers Limit the Prevalence of Deception in Humans: Evidence from Diving Behaviour in Soccer Players	PLOS ONE			English	Article							SIGNALS; COST; EVOLUTION; DISPLAYS; HONESTY	Deception remains a hotly debated topic in evolutionary and behavioural research. Our understanding of what impedes or facilitates the use and detection of deceptive signals in humans is still largely limited to studies of verbal deception under laboratory conditions. Recent theoretical models of non-human behaviour have suggested that the potential outcome for deceivers and the ability of receivers to discriminate signals can effectively maintain their honesty. In this paper, we empirically test these predictions in a real-world case of human deception, simulation in soccer. In support of theoretical predictions in signalling theory, we show that cost-free deceit by soccer players decreases as the potential outcome for the signaller becomes more costly. We further show that the ability of receivers (referees) to detect deceptive signals may limit the prevalence of deception by soccer players. Our study provides empirical support to recent theoretical models in signalling theory, and identifies conditions that may facilitate human deception and hinder its detection.	[David, Gwendolyn K.; Condon, Catriona H.; Bywater, Candice L.; Ortiz-Barrientos, Daniel; Wilson, Robbie S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	David, GK (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	g.david@uq.edu.au	David, Gwendolyn/M-1703-2018; Ortiz-Barrientos, Daniel/N-3294-2019; Ortiz-Barrientos, Daniel/B-2274-2010; Bywater, Candice L./AAW-5481-2021	David, Gwendolyn/0000-0002-8422-9093; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Bywater, Candice L./0000-0001-6270-0422; Wilson, Robbie/0000-0002-0116-5427	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This work was supported by the Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2011, NEUROSCIENTIST; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; Andrewartha D, 2008, PSYCHIAT PSYCHOL LAW, V15, P88, DOI 10.1080/13218710701873940; Backwell PRY, 2000, P ROY SOC B-BIOL SCI, V267, P719, DOI 10.1098/rspb.2000.1062; BOND CF, 1988, J NONVERBAL BEHAV, V12, P295, DOI 10.1007/BF00987597; Bond GD, 2008, LAW HUMAN BEHAV, V32, P339, DOI 10.1007/s10979-007-9110-z; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Daly M, 1999, ANIM BEHAV, V57, P509, DOI 10.1006/anbe.1998.1027; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hirschberg J, 2010, SPEECH TECHNOLOGY: THEORY AND APPLICATIONS, P79, DOI 10.1007/978-0-387-73819-2_5; Joron M, 2003, ENCY INSECTS; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Laidre ME, 2008, ANIM BEHAV, V75, P2041, DOI 10.1016/j.anbehav.2007.11.011; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mawby R, 1986, DECEPTION PERSPECTIV; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Morris PH, 2010, J NONVERBAL BEHAV, V34, P1, DOI 10.1007/s10919-009-0075-0; Peters RA, 2007, J EXP BIOL, V210, P395, DOI 10.1242/jeb.02676; Reddy V, 2007, PHILOS T R SOC B, V362, P621, DOI 10.1098/rstb.2006.1999; Santos E, 2010, IEEE T SYST MAN CY A, V40, P224, DOI 10.1109/TSMCA.2009.2034862; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; Wiley R. Haven, 1994, P157; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	29	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26017	10.1371/journal.pone.0026017	http://dx.doi.org/10.1371/journal.pone.0026017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998745	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900091
J	Ku, SW; Lee, U; Noh, GJ; Jun, IG; Mashour, GA				Ku, Seung-Woo; Lee, UnCheol; Noh, Gyu-Jeong; Jun, In-Gu; Mashour, George A.			Preferential Inhibition of Frontal-to-Parietal Feedback Connectivity Is a Neurophysiologic Correlate of General Anesthesia in Surgical Patients	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; CONSCIOUSNESS; AWARENESS; DIRECTIONALITY; FEEDFORWARD; BREAKDOWN; FLASH; MODEL	Background: The precise mechanism and optimal measure of anesthetic-induced unconsciousness has yet to be elucidated. Preferential inhibition of feedback connectivity from frontal to parietal brain networks is one potential neurophysiologic correlate, but has only been demonstrated in animals or under limited conditions in healthy volunteers. Methods and Findings: We recruited eighteen patients presenting for surgery under general anesthesia; electroencephalography of the frontal and parietal regions was acquired during (i) baseline consciousness, (ii) anesthetic induction with propofol or sevoflurane, (iii) general anesthesia, (iv) recovery of consciousness, and (v) post-recovery states. We used two measures of effective connectivity, evolutional map approach and symbolic transfer entropy, to analyze causal interactions of the frontal and parietal regions. The dominant feedback connectivity of the baseline conscious state was inhibited after anesthetic induction and during general anesthesia, resulting in reduced asymmetry of feedback and feedforward connections in the frontoparietal network. Dominant feedback connectivity returned when patients recovered from anesthesia. Both analytic techniques and both classes of anesthetics demonstrated similar results in this heterogeneous population of surgical patients. Conclusions: The disruption of dominant feedback connectivity in the frontoparietal network is a common neurophysiologic correlate of general anesthesia across two anesthetic classes and two analytic measures. This study represents a key translational step from the underlying cognitive neuroscience of consciousness to more sophisticated monitoring of anesthetic effects in human surgical patients.	[Ku, Seung-Woo; Noh, Gyu-Jeong; Jun, In-Gu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Ku, Seung-Woo; Lee, UnCheol; Mashour, George A.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA	University of Ulsan; Asan Medical Center; University of Michigan System; University of Michigan	Ku, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gmashour@umich.edu						[Anonymous], 1956, MODERN MATH ENG; Boehler CN, 2008, P NATL ACAD SCI USA, V105, P8742, DOI 10.1073/pnas.0801999105; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chicharro D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026217; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hudetz AG, 2009, CONSCIOUS COGN, V18, P1079, DOI 10.1016/j.concog.2009.08.004; Hudetz AG, 2009, ANESTHESIOLOGY, V111, P231, DOI 10.1097/ALN.0b013e3181ab671e; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Imas OA, 2006, NEUROSCI LETT, V402, P216, DOI 10.1016/j.neulet.2006.04.003; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Mrowka R, 2003, AM J PHYSIOL-REG I, V285, pR1395, DOI 10.1152/ajpregu.00373.2003; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Orser BA, 2008, CAN MED ASSOC J, V178, P185, DOI 10.1503/cmaj.071761; Palanca BA, 2009, CURR OPIN ANESTHESIO, V22, P553, DOI 10.1097/ACO.0b013e3283304032; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Quan MN, 2011, BRAIN RES BULL, V85, P109, DOI 10.1016/j.brainresbull.2011.03.002; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; Rosenblum MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041909; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Shao ZW, 1996, J NEUROSCI, V16, P7353; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Zheng CG, 2011, NEUROSCI LETT, V490, P52, DOI 10.1016/j.neulet.2010.12.024	43	154	158	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25155	10.1371/journal.pone.0025155	http://dx.doi.org/10.1371/journal.pone.0025155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998638	gold, Green Published, Green Submitted			2022-12-25	WOS:000295966900011
J	Salomon, R; Szpiro-Grinberg, S; Lamy, D				Salomon, Roy; Szpiro-Grinberg, Sarit; Lamy, Dominique			Self-Motion Holds a Special Status in Visual Processing	PLOS ONE			English	Article							AGENCY; AWARENESS; PERCEPTION; MOVEMENTS; SEARCH; HAND	Agency plays an important role in self-recognition from motion. Here, we investigated whether our own movements benefit from preferential processing even when the task is unrelated to self-recognition, and does not involve agency judgments. Participants searched for a moving target defined by its known shape among moving distractors, while continuously moving the computer mouse with one hand. They thereby controlled the motion of one item, which was randomly either the target or any of the distractors, while the other items followed pre-recorded motion pathways. Performance was more accurate and less prone to degradation as set size increased when the target was the self-controlled item. An additional experiment confirmed that participant-controlled motion was not physically more salient than motion recorded offline. We found no evidence that self-controlled items captured attention. Taken together, these results suggest that visual events are perceived more accurately when they are the consequences of our actions, even when self-motion is task irrelevant.	[Salomon, Roy; Lamy, Dominique] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel; [Szpiro-Grinberg, Sarit] NYU, Dept Psychol, New York, NY 10003 USA	Tel Aviv University; New York University	Salomon, R (corresponding author), Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel.	royesal@gmail.com	Salomon, Roy/N-8249-2015; Lamy, Dominique/L-5032-2013	Salomon, Roy/0000-0002-6688-617X; Szpiro, Sarit/0000-0001-7814-0757				Ahissar M, 1999, CURR DIR PSYCHOL SCI, V8, P124, DOI 10.1111/1467-8721.00029; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; de Vignemont F, 2004, CONSCIOUS COGN, V13, P1, DOI 10.1016/S1053-8100(03)00022-9; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; KAPTEIN NA, 1995, J EXP PSYCHOL HUMAN, V21, P1053, DOI 10.1037/0096-1523.21.5.1053; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Preston C, 2010, NEUROPSYCHOLOGIA, V48, P3443, DOI 10.1016/j.neuropsychologia.2010.07.027; Salomon R, 2009, INVOLVEMENT INTRINSI; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24347	10.1371/journal.pone.0024347	http://dx.doi.org/10.1371/journal.pone.0024347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998629	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900002
J	Chang, CW; Su, YC; Her, GM; Ken, CF; Hong, JR				Chang, Chih-Wei; Su, Yu-Chin; Her, Guor-Mour; Ken, Chuian-Fu; Hong, Jiann-Ruey			Betanodavirus Induces Oxidative Stress-Mediated Cell Death That Prevented by Anti-Oxidants and Zfcatalase in Fish Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL FISSION; HYDROGEN-PEROXIDE; MAMMALIAN-CELLS; MARINE FISH; VIRUS; NECROSIS; FUSION; REPLICATION; ZFBCL-X(L)	The role of oxidative stress in the pathogenesis of RNA nervous necrosis virus infection is still unknown. Red-spotted grouper nervous necrosis virus (RGNNV) induced free radical species (ROS) production at 12-24 h post-infection (pi; early replication stage) in fish GF-1 cells, and then at middle replication stage (24-48 h pi), this ROS signal may upregulate some expressions of the anti-oxidant enzymes Cu/Zn SOD and catalase, and eventually expression of the transcription factor Nrf2. Furthermore, both antioxidants diphenyliodonium and N-acetylcysteine or overexpression of zebrafish catalase in GF-1 cells also reduced ROS production and protected cells for enhancing host survival rate due to RGNNV infection. Furthermore, localization of ROS production using esterase activity and Mitotracker staining assays found that the ROS generated can affect mitochondrial morphology changes and causes Delta Psi loss, both of which can be reversed by antioxidant treatment. Taken together, our data suggest that RGNNV induced oxidative stress response for playing dual role that can initiate the host oxidative stress defense system to upregulate expression of antioxidant enzymes and induces cell death via disrupting the mitochondrial morphology and inducing DY loss, which can be reversed by anti-oxidants and zfcatalase, which provide new insight into betanodavirus-induced ROS-mediated pathogenesis.	[Chang, Chih-Wei; Su, Yu-Chin; Hong, Jiann-Ruey] Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan; [Her, Guor-Mour] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Ken, Chuian-Fu] Natl Changhua Univ Educ, Dept Biotechnol, Changhua, Taiwan	National Cheng Kung University; National Taiwan Ocean University; National Changhua University of Education	Chang, CW (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan.	jrhong@mail.ncku.edu.tw			National Science Council, Taiwan, Republic of China [NSC 98-2313-B-006-004-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC 98-2313-B-006-004-MY3) awarded to Dr. Jiann-Ruey Hong from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen LJ, 2009, VIROLOGY, V385, P444, DOI 10.1016/j.virol.2008.11.048; Chen SP, 2006, J FISH DIS, V29, P347, DOI 10.1111/j.1365-2761.2006.00725.x; Chen SP, 2007, APOPTOSIS, V12, P1043, DOI 10.1007/s10495-006-0032-x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Desagher S, 1996, J NEUROSCI, V16, P2553; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dringen R, 1997, BRAIN RES, V759, P67, DOI 10.1016/S0006-8993(97)00233-3; Gao N, 2005, ONCOGENE, V24, P3797, DOI 10.1038/sj.onc.1208530; Gou DM, 2003, FEBS LETT, V548, P113, DOI 10.1016/S0014-5793(03)00630-6; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Johnson KN, 2000, J VIROL, V74, P5123, DOI 10.1128/JVI.74.11.5123-5132.2000; KAIN SR, 1994, BIOTECHNIQUES, V17, P982; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kelly G S, 1998, Altern Med Rev, V3, P114; Ken CF, 2000, J AGR FOOD CHEM, V48, P2092, DOI 10.1021/jf990838+; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McClung CR, 1997, FREE RADICAL BIO MED, V23, P489, DOI 10.1016/S0891-5849(97)00109-3; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MULLEN OL, 1975, J NATL CANCER I, V54, P229, DOI 10.1093/jnci/54.1.229; MULLER F, 1992, FREE RADICAL BIO MED, V13, P651, DOI 10.1016/0891-5849(92)90039-J; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Peterhans E, 1987, Free Radic Res Commun, V3, P39, DOI 10.3109/10715768709069768; Qi XP, 1997, INVEST OPHTH VIS SCI, V38, P1203; SCHIAVONE JR, 1988, ANAL BIOCHEM, V168, P455, DOI 10.1016/0003-2697(88)90343-0; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Schroder K, 2010, CURR OPIN PHARMACOL, V10, P122, DOI 10.1016/j.coph.2010.01.002; SHULL S, 1991, J BIOL CHEM, V266, P24398; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Su YC, 2010, J BIOL CHEM, V285, P39801, DOI 10.1074/jbc.M110.164988; Su YC, 2009, VIROLOGY, V385, P143, DOI 10.1016/j.virol.2008.11.036; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Tanaka S, 2003, J FISH DIS, V26, P109, DOI 10.1046/j.1365-2761.2003.00440.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vassort G, 2010, CARDIOVASC TOXICOL, V10, P73, DOI 10.1007/s12012-010-9064-0; VIERUCCI A, 1983, PEDIATR RES, V17, P814, DOI 10.1203/00006450-198310000-00010; Wang M, 2003, J MED VIROL, V70, P470, DOI 10.1002/jmv.10419; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wu HC, 2008, FISH SHELLFISH IMMUN, V24, P436, DOI 10.1016/j.fsi.2008.01.001; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003	61	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25853	10.1371/journal.pone.0025853	http://dx.doi.org/10.1371/journal.pone.0025853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991373	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000086
J	Giannaki, CD; Sakkas, GK; Karatzaferi, C; Hadjigeorgiou, GM; Lavdas, E; Liakopoulos, V; Tsianas, N; Koukoulis, GN; Koutedakis, Y; Stefanidis, I				Giannaki, Christoforos D.; Sakkas, Giorgos K.; Karatzaferi, Christina; Hadjigeorgiou, Georgios M.; Lavdas, Eleftherios; Liakopoulos, Vassilios; Tsianas, Nikolaos; Koukoulis, Georgios N.; Koutedakis, Yiannis; Stefanidis, Ioannis			Evidence of Increased Muscle Atrophy and Impaired Quality of Life Parameters in Patients with Uremic Restless Legs Syndrome	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; HEMODIALYSIS-PATIENTS; PHYSICAL FUNCTION; SLEEP DISORDERS; RISK-FACTORS; MAINTENANCE DIALYSIS; FUNCTIONAL-CAPACITY; CARDIOVASCULAR RISK	Background: Restless Legs Syndrome is a very common disorder in hemodialysis patients. Restless Legs Syndrome negatively affects quality of life; however it is not clear whether this is due to mental or physical parameters and whether an association exists between the syndrome and parameters affecting survival. Methodology/Principal Findings: Using the Restless Legs Syndrome criteria and the presence of Periodic Limb Movements in Sleep (PLMS/h >15), 70 clinically stable hemodialysis patients were assessed and divided into the RLS (n = 30) and non-RLS (n = 40) groups. Physical performance was evaluated by a battery of tests: body composition by dual energy X ray absorptiometry, muscle size and composition by computer tomography, while depression symptoms, perception of sleep quality and quality of life were assessed through validated questionnaires. In this cross sectional analysis, the RLS group showed evidence of thigh muscle atrophy compared to the non-RLS group. Sleep quality and depression score were found to be significantly impaired in the RLS group. The mental component of the quality of life questionnaire appeared significantly diminished in the RLS group, reducing thus the overall quality of life score. In contrast, there were no significant differences between groups in any of the physical performance tests, body and muscle composition. Conclusions: The low level of quality of life reported by the HD patients with Restless Legs Syndrome seems to be due mainly to mental health and sleep related aspects. Increased evidence of muscle atrophy is also observed in the RLS group and possibly can be attributed to the lack of restorative sleep.	[Giannaki, Christoforos D.; Sakkas, Giorgos K.; Liakopoulos, Vassilios; Stefanidis, Ioannis] Univ Thessaly, Dept Nephrol, Larisa, Thessaly, Greece; [Hadjigeorgiou, Georgios M.] Univ Thessaly, Dept Neurol, Larisa, Thessaly, Greece; [Koukoulis, Georgios N.] Univ Thessaly, Dept Endocrinol, Sch Med, Larisa, Thessaly, Greece; [Lavdas, Eleftherios] Technol Educ Inst Athens, Dept Med Radiol Technologists, Athens, Attika, Greece; [Karatzaferi, Christina; Koutedakis, Yiannis] Univ Thessaly, Dept Sport Sci, Trikala, Thessaly, Greece; [Giannaki, Christoforos D.; Sakkas, Giorgos K.; Karatzaferi, Christina; Hadjigeorgiou, Georgios M.; Koutedakis, Yiannis; Stefanidis, Ioannis] Ctr Res & Technol Thessaly, Volos, Thessaly, Greece; [Tsianas, Nikolaos] Gen Hosp Trikala, Dept Nephrol, Trikala, Thessaly, Greece; [Giannaki, Christoforos D.] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus	University of Thessaly; University of Thessaly; University of Thessaly; University of West Attica; University of Thessaly; University of Nicosia	Giannaki, CD (corresponding author), Univ Thessaly, Dept Nephrol, Larisa, Thessaly, Greece.	gsakkas@med.uth.gr	Karatzaferi, Christina/AAM-7344-2021; Sakkas, Giorgos K./AAJ-4745-2021; Liakopoulos, Vassilios/AAN-1640-2020; Karatzaferi, Christina/ABA-9876-2020	Sakkas, Giorgos K./0000-0002-2462-995X; Liakopoulos, Vassilios/0000-0002-7564-2724; Karatzaferi, Christina/0000-0002-8266-5780; Stefanidis, Ioannis/0000-0002-5515-8089; Koutedakis, Yiannis/0000-0002-7065-9447; Giannaki, Christoforos/0000-0003-0029-1189	Greek Ministry of Development-General Secretariat of Research and Technology; E.U.;  [03ED375]	Greek Ministry of Development-General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); E.U.(European Commission); 	This study was supported by the 03ED375 research grant, implemented within the framework of the "Reinforcement Programme of Human Research Manpower'' (ENTER) and co-financed by National and Community Funds (25% from the Greek Ministry of Development-General Secretariat of Research and Technology and 75% from E.U. European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Benz RL, 2000, AM J KIDNEY DIS, V35, P1052, DOI 10.1016/S0272-6386(00)70039-4; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Gigli GL, 2004, SLEEP MED, V5, P309, DOI 10.1016/j.sleep.2004.01.014; Johansen KL, 2009, ADV CHRONIC KIDNEY D, V16, P501, DOI 10.1053/j.ackd.2009.07.007; Johansen KL, 2003, AM J CLIN NUTR, V77, P842, DOI 10.1093/ajcn/77.4.842; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Johansen KL, 2001, KIDNEY INT, V60, P1586, DOI 10.1046/j.1523-1755.2001.00972.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kavanagh D, 2004, AM J KIDNEY DIS, V43, P763, DOI 10.1053/j.ajkd.2004.01.007; Kawauchi A, 2006, CLIN NEPHROL, V66, P440; Kimmel PL, 2006, CLIN J AM SOC NEPHRO, V1, P349, DOI 10.2215/CJN.00890306; Kimmel PL, 2001, KIDNEY INT, V59, P1599, DOI 10.1046/j.1523-1755.2001.0590041599.x; Koufaki P, 2002, CLIN PHYSIOL FUNCT I, V22, P115, DOI 10.1046/j.1365-2281.2002.00405.x; Koufaki P, 2009, ADV CHRONIC KIDNEY D, V16, P410, DOI 10.1053/j.ackd.2009.08.010; La Manna G, 2011, NEPHROL DIAL TRANSPL, V26, P1976, DOI 10.1093/ndt/gfq681; Larsson BW, 2007, EUR NEUROL, V58, P133, DOI 10.1159/000104712; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; McIntyre CW, 2006, NEPHROL DIAL TRANSPL, V21, P2210, DOI 10.1093/ndt/gfl064; Mercer TH, 1998, NEPHROL DIAL TRANSPL, V13, P2023, DOI 10.1093/ndt/13.8.2023; Merlino G, 2006, NEPHROL DIAL TRANSPL, V21, P184, DOI 10.1093/ndt/gfi144; Merlino G, 2010, DIABETES EDUCATOR, V36, P79, DOI 10.1177/0145721709351252; Mucsi F, 2005, NEPHROL DIAL TRANSPL, V20, P571, DOI 10.1093/ndt/gfh654; Pai MF, 2007, RENAL FAILURE, V29, P673, DOI 10.1080/08860220701459642; Painter Patricia, 2005, Hemodial Int, V9, P218, DOI 10.1111/j.1492-7535.2005.01136.x; Parker KP, 2003, SLEEP MED REV, V7, P131, DOI 10.1053/smrv.2001.0240; Perl J, 2006, KIDNEY INT, V70, P1687, DOI 10.1038/sj.ki.5001791; Rijsman RM, 2004, NEPHROLOGY, V9, P353, DOI 10.1111/j.1440-1797.2004.00330.x; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; Sakkas GK, 2008, NEPHROL DIAL TRANSPL, V23, P336, DOI 10.1093/ndt/gfm559; Sakkas GK, 2008, AM J PHYSIOL-REG I, V295, pR1721, DOI 10.1152/ajpregu.00935.2007; Sakkas GK, 2003, NEPHROL DIAL TRANSPL, V18, P2074, DOI 10.1093/ndt/gfg325; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Sforza E, 2005, SLEEP MED, V6, P259, DOI 10.1016/j.sleep.2004.11.006; Siddiqui S, 2005, NEPHRON CLIN PRACT, V101, P155, DOI 10.1159/000087073; Suh MR, 2002, RENAL FAILURE, V24, P337; SVENDSEN OL, 1993, BASIC LIFE SCI, P381; Szentkiralyi A, 2009, J PSYCHOSOM RES, V67, P173, DOI 10.1016/j.jpsychores.2009.05.004; Tuncel D, RESTLESS LEGS SYNDRO; Unruh ML, 2004, AM J KIDNEY DIS, V43, P900, DOI 10.1053/j.ajkd.2004.01.013; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	50	40	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25180	10.1371/journal.pone.0025180	http://dx.doi.org/10.1371/journal.pone.0025180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984901	gold, Green Published			2022-12-25	WOS:000295943000012
J	Ishida, JK; Yoshida, S; Ito, M; Namba, S; Shirasu, K				Ishida, Juliane K.; Yoshida, Satoko; Ito, Masaki; Namba, Shigetou; Shirasu, Ken			Agrobacterium rhizogenes-Mediated Transformation of the Parasitic Plant Phtheirospermum japonicum	PLOS ONE			English	Article							TRIPHYSARIA-VERSICOLOR; GENETIC-TRANSFORMATION; PHENOLIC-COMPOUNDS; EFFICIENCY; TUMEFACIENS	Background: Plants within the Orobanchaceae are an agriculturally important group of parasites that attack economically important crops to obtain water and nutrients from their hosts. Despite their agricultural importance, molecular mechanisms of the parasitism are poorly understood. Methodology/Principal Findings: We developed transient and stable transformation systems for Phtheirospermum japonicum, a facultative parasitic plant in the Orobanchaceae. The transformation protocol was established by a combination of sonication and acetosyringone treatments using the hairy-root-inducing bacterium, Agrobacterium rhizogenes and young seedlings. Transgenic hairy roots of P. japonicum were obtained from cotyledons 2 to 3 weeks after A. rhizogenes inoculation. The presence and the expression of transgenes in P. japonicum were verified by genomic PCR, Southern blot and RT-PCR methods. Transgenic roots derived from A. rhizogenes-mediated transformation were able to develop haustoria on rice and maize roots. Transgenic roots also formed apparently competent haustoria in response to 2,6-dimethoxy-1,4-benzoquinone (DMBQ), a haustorium-inducing chemical. Using this system, we introduced a reporter gene with a Cyclin B1 promoter into P. japonicum, and visualized cell division during haustorium formation. Conclusions: We provide an easy and efficient method for hairy-root transformation of P. japonicum. Transgenic marker analysis revealed that cell divisions during haustorium development occur 24 h after DMBQ treatment. The protocols described here will allow functional analysis of genes involved in plant parasitism.	[Ishida, Juliane K.; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ishida, Juliane K.; Yoshida, Satoko; Shirasu, Ken] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Ito, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	University of Tokyo; RIKEN; Nagoya University	Ishida, JK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	ken.shirasu@psc.riken.jp	yoshida, satoko/AAO-4892-2020; Shirasu, Ken/ABF-5306-2020; Yoshida, Satoko/AAZ-4757-2021; Shirasu, Ken/A-4455-2010; ishida, juliane/O-9414-2015; Yoshida, Satoko/G-5003-2010; Ito, Masaki/G-4252-2013	yoshida, satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; ishida, juliane/0000-0002-0956-7578; Yoshida, Satoko/0000-0002-9999-7861; Ito, Masaki/0000-0002-9635-9709	Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan) [21780044, 19678001]; RIKEN President Fund; MEXT	Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN President Fund; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan, no. 21780044 to SY and no. 19678001 to KS) and the RIKEN President Fund. JKI is supported by the MEXT scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 1999, PLANT PHYSIOL, V119, P585, DOI 10.1104/pp.119.2.585; BAIRD WV, 1984, AM J BOT, V71, P803, DOI 10.2307/2443471; Bandaranayake PCG, 2010, PLANT CELL, V22, P1404, DOI 10.1105/tpc.110.074831; Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Beranova M, 2008, PLANT CELL TISS ORG, V94, P253, DOI 10.1007/s11240-007-9335-z; Cheng M, 2003, IN VITRO CELL DEV-PL, V39, P595, DOI 10.1079/IVP2003471; DIAZ CL, 1989, NATURE, V338, P579, DOI 10.1038/338579a0; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Ito M, 2000, PLANT MOL BIOL, V43, P677, DOI 10.1023/A:1006336005587; Krens FA, 1996, PLANT SCI, V116, P97, DOI 10.1016/0168-9452(96)04357-9; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LYNN DG, 1990, ANNU REV PLANT PHYS, V41, P497, DOI 10.1146/annurev.pp.41.060190.002433; MATERN U, 1988, PHYTOPARASITICA, V16, P153, DOI 10.1007/BF02980469; Matvienko M, 2001, PLANT PHYSIOL, V127, P272, DOI 10.1104/pp.127.1.272; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; OFFRINGA IA, 1986, P NATL ACAD SCI USA, V83, P6935, DOI 10.1073/pnas.83.18.6935; Parker A., 1993, PARASITIC WEEDS WORL; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Santarem ER, 1998, PLANT CELL REP, V17, P752, DOI 10.1007/s002990050478; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Tiwari RK, 2007, PLANT CELL REP, V26, P199, DOI 10.1007/s00299-006-0236-0; Tomilov AA, 2005, PLANT PHYSIOL, V138, P1469, DOI 10.1104/pp.104.057836; Tomilov A, 2007, PLANTA, V225, P1059, DOI 10.1007/s00425-006-0415-9; Torres MJ, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-24; Trick HN, 1997, TRANSGENIC RES, V6, P329, DOI 10.1023/A:1018470930944; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0; Yoshida S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-55; Yoshida S, 2009, NEW PHYTOL, V183, P180, DOI 10.1111/j.1469-8137.2009.02840.x	32	52	56	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25802	10.1371/journal.pone.0025802	http://dx.doi.org/10.1371/journal.pone.0025802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991355	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000073
J	Bushell, KN; Leeman, SE; Gillespie, E; Gower, AC; Reed, KL; Stucchi, AF; Becker, JM; Amar, S				Bushell, Kristen N.; Leeman, Susan E.; Gillespie, Earl; Gower, Adam C.; Reed, Karen L.; Stucchi, Arthur F.; Becker, James M.; Amar, Salomon			LITAF Mediation of Increased TNF-alpha Secretion from Inflamed Colonic Lamina Propria Macrophages	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NEUROKININ-1 RECEPTOR; MOLECULAR-CLONING; CROHNS-DISEASE; PROMOTER; LIPOPOLYSACCHARIDE; ACTIVATION	Dysregulation of TNF-alpha in lamina propria macrophages (LPM) is a feature of inflammatory bowel diseases (IBD). LPS-Induced-TNF-Alpha-Factor (LITAF) is a transcription factor that mediates TNF-alpha expression. To determine whether LITAF participates in the mediation of TNF-alpha expression in acutely inflamed colonic tissues, we first established the TNBS-induced colonic inflammation model in C57BL/6 mice. LPM were harvested from non-inflamed and inflamed colonic tissue and inflammatory parameters TNF-alpha and LITAF mRNA and protein levels were measured ex-vivo. LPM from TNBS-treated mice secreted significantly more TNF-alpha at basal state and in response to LPS than LPM from untreated mice (p<0.05). LITAF mRNA and protein levels were elevated in LPM from TNBS compared with untreated animals and LPS further increased LITAF protein levels in LPM from inflamed tissue (P<0.05). To further confirm the role of LITAF in acutely inflamed colonic tissues, TNBS-induced colonic inflammation was produced in LITAF macrophage specific knockout mice (LITAF mac-/-mice) and compared to wild type (WT) C57BL/6. Twenty four hours following TNBS administration, colonic tissue from LITAF mac-/-mice had less MPO activity and reduced colonic TNF-alpha mRNA then WT C57BL/6 mice (p<0.05). LPM harvested from LITAF mac-/-secreted significantly less TNF-alpha in response to LPS than wild type (WT) C57BL/6 (p<0.05). This study provides evidence that LITAF contributes to the regulation of TNF-alpha in LPM harvested following acute inflammation or LPS treatment paving the way for future work focusing on LITAF inhibitors in the treatment of TNF-alpha-mediated inflammatory conditions.	[Bushell, Kristen N.; Leeman, Susan E.; Gillespie, Earl] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Gower, Adam C.; Reed, Karen L.; Stucchi, Arthur F.; Becker, James M.] Boston Univ, Med Ctr, Dept Surg, Boston, MA 02118 USA; [Amar, Salomon] Boston Univ, Goldman Sch Dent Med, Ctr Antiinflammatory Therapeut, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Bushell, KN (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	samar@bu.edu		Amar, Salomon/0000-0002-0017-5930; Gower, Adam/0000-0002-6122-7511; Leeman, Susan/0000-0002-0951-5364; Stucchi, Arthur/0000-0002-9240-9844	Department of Surgery, Boston University Medical Center, NIH/NIDCR [R01 DE 014079 SA]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014079] Funding Source: NIH RePORTER	Department of Surgery, Boston University Medical Center, NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Smithwick and Tyler Endowment Fund, Department of Surgery, Boston University Medical Center, NIH/NIDCR grant # R01 DE 014079 SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud PA, 2008, EUR J PHARMACOL, V579, P411, DOI 10.1016/j.ejphar.2007.10.053; ALLISON MC, 1988, GUT, V29, P1531, DOI 10.1136/gut.29.11.1531; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P728, DOI 10.1006/bcmd.2001.0441; Bolcato-Bellemin AL, 2004, J ENDOTOXIN RES, V10, P15, DOI 10.1179/096805104225003780; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim HJ, 2006, TOXICOLOGY, V225, P36, DOI 10.1016/j.tox.2006.04.053; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; KRAMER B, 1995, J BIOL CHEM, V270, P6577; LEITMAN DC, 1991, J BIOL CHEM, V266, P9343; Lo CJ, 2003, J SURG RES, V113, P189, DOI 10.1016/S0022-4804(03)00186-0; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Mannel DN, 2000, CHEM IMMUNOL, V74, P141; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Pollastri MP, 2009, CHEM BIOL DRUG DES, V74, P121, DOI 10.1111/j.1747-0285.2009.00838.x; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; Reed KL, 2004, P NATL ACAD SCI USA, V101, P9115, DOI 10.1073/pnas.0403210101; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; Sandborn William J, 2005, Rev Gastroenterol Disord, V5, P10; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; SRINIVASAN S, 2008, THESIS BOSTON U, V17; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Stucchi A, 2006, INFLAMM BOWEL DIS, V12, P581, DOI 10.1097/01.MIB.0000225338.14356.d5; Su C, 2005, ADV DRUG DELIVER REV, V57, P237, DOI 10.1016/j.addr.2004.08.006; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Togashi H, 2003, GUT, V52, P1291, DOI 10.1136/gut.52.9.1291; UEDA Y, INT IMMUNOLOGY, V22, P953; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; ZHOU J, ONCOGENE, V30, P1892; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	41	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25849	10.1371/journal.pone.0025849	http://dx.doi.org/10.1371/journal.pone.0025849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984950	gold, Green Published			2022-12-25	WOS:000295941300061
J	Campbell, JJ; Davidenko, N; Caffarel, MM; Cameron, RE; Watson, CJ				Campbell, Jonathan J.; Davidenko, Natalia; Caffarel, Maria M.; Cameron, Ruth E.; Watson, Christine J.			A Multifunctional 3D Co-Culture System for Studies of Mammary Tissue Morphogenesis and Stem Cell Biology	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; HYALURONAN; CD44; EXPRESSION; GLYCOSAMINOGLYCANS; ORGANIZATION; ADHESION; KINASE	Studies on the stem cell niche and the efficacy of cancer therapeutics require complex multicellular structures and interactions between different cell types and extracellular matrix (ECM) in three dimensional (3D) space. We have engineered a 3D in vitro model of mammary gland that encompasses a defined, porous collagen/hyaluronic acid (HA) scaffold forming a physiologically relevant foundation for epithelial and adipocyte co-culture. Polarized ductal and acinar structures form within this scaffold recapitulating normal tissue morphology in the absence of reconstituted basement membrane (rBM) hydrogel. Furthermore, organoid developmental outcome can be controlled by the ratio of collagen to HA, with a higher HA concentration favouring acinar morphological development. Importantly, this culture system recapitulates the stem cell niche as primary mammary stem cells form complex organoids, emphasising the utility of this approach for developmental and tumorigenic studies using genetically altered animals or human biopsy material, and for screening cancer therapeutics for personalised medicine.	[Campbell, Jonathan J.; Caffarel, Maria M.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Davidenko, Natalia; Cameron, Ruth E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge; University of Cambridge	Campbell, JJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	jjc55@cam.ac.uk; cjw53@cam.ac.uk	watson, Christine J/B-1431-2012	Cameron, Ruth/0000-0003-1573-4923; Caffarel, Maria/0000-0002-7442-6827	Biotechnology and Biological Sciences Research Council [BB/F000871/1]; BBSRC [BB/F000871/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, BB/F000871/1 (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARATANI Y, 1988, J BIOL CHEM, V263, P16163; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Cabrera PV, 2004, INFLAMM RES, V53, P556, DOI 10.1007/s00011-004-1295-8; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162; Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Eheman CR, 2009, CANCER EPIDEM BIOMAR, V18, P1763, DOI 10.1158/1055-9965.EPI-08-1082; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Fujita Y, 2002, FEBS LETT, V528, P101, DOI 10.1016/S0014-5793(02)03262-3; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Gudjonsson T, 2002, J CELL SCI, V115, P39; He Y, 2008, AM J PHYSIOL-GASTR L, V295, pG305, DOI 10.1152/ajpgi.90229.2008; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; SILBERSTEIN GB, 1982, DEV BIOL, V90, P215, DOI 10.1016/0012-1606(82)90228-7; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Sunil N, 2000, ACTA PHYSIOL SCAND, V168, P385, DOI 10.1046/j.1365-201x.2000.00675.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WIENS D, 1987, DEV BIOL, V120, P245, DOI 10.1016/0012-1606(87)90122-9; Zangani D, 1999, EXP CELL RES, V247, P399, DOI 10.1006/excr.1998.4373; ZIMMERMAN E, 2008, BIOPHYS J, V82, P1848	38	78	78	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25661	10.1371/journal.pone.0025661	http://dx.doi.org/10.1371/journal.pone.0025661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984937	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300047
J	Osada, N				Osada, Naoki			Phylogenetic Inconsistency Caused by Ancient Sex-Biased Gene Migration	PLOS ONE			English	Article							NUCLEAR; FLOW; INTROGRESSION; HYBRIDIZATION; DIVERGENCE; DISPERSAL; MONKEYS; DNA; INCONGRUENCE; POPULATIONS	Inferences of ancient sex-biased migration patterns using sex-linked genetic markers are usually difficult because of a stochastic process of allele fixation. Nevertheless, incongruent phylogenetic trees between different sex-linked markers and between sex-linked and autosomal markers are frequently interpreted as a signature of sex-biased migration without further statistical evaluation. I investigated the types of incongruent phylogenetic trees from which past sex-biased migration events can be statistically supported under the coalescent model. In the case of mammals, detecting a sex-biased migration pattern is not guaranteed by comparing the phylogenetic pattern of mitochondrial and Y-chromosomal loci Likewise, evidence of introgression at a mitochondrial locus, but not at autosomal loci, does not support the hypothesis of an ancient female-biased migration pattern with statistical significance. In contrast, evidence of introgression at >= 5 unlinked autosomal loci, but not at a Y-chromosomal locus, would reject the null hypothesis of a sexually equal migration ate with statistical significance. A similar argument can be made to infer a male-biased migration pattern. Furthermore, the Investigation of many recombining sex-biased markers such as X-chromosomal loci in mammals has the potential to efficiently detect ancient sex-biased demographic patterns.	[Osada, Naoki] Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan; [Osada, Naoki] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Osada, N (corresponding author), Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan.	nosada@lab.nig.ac.jp	Osada, Naoki/B-2938-2009; Osada, Naoki/J-3790-2019	Osada, Naoki/0000-0003-0180-5372	Scientific Research (KAKENHI); Grant-in-Aid for Young Scientists [(A)(22687021)]	Scientific Research (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI), Grant-in-Aid for Young Scientists (A)(22687021). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KMA, 2005, EVOLUTION, V59, P720; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Evans BJ, 2010, GENETICS, V185, P923, DOI 10.1534/genetics.110.116228; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Osada N, 2010, MOL ECOL, V19, P2884, DOI 10.1111/j.1365-294X.2010.04687.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Rieseberg LH, 1996, ACTA BOT NEERL, V45, P243; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Schubert G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021514; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Yannic G, 2010, MOL PHYLOGENET EVOL, V57, P1062, DOI 10.1016/j.ympev.2010.09.015; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25549	10.1371/journal.pone.0025549	http://dx.doi.org/10.1371/journal.pone.0025549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980490	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600035
J	Clague, J; Wilhoite, G; Adamson, A; Bailis, A; Weitzel, JN; Neuhausen, SL				Clague, Jessica; Wilhoite, Greg; Adamson, Aaron; Bailis, Adam; Weitzel, Jeffrey N.; Neuhausen, Susan L.			RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; PROTEIN; INSTABILITY; BRCA2	BRCA1 and BRCA2 are the most well-known breast cancer susceptibility genes. Additional genes involved in DNA repair have been identified as predisposing to breast cancer. One such gene, RAD51C, is essential for homologous recombination repair. Several likely pathogenic RAD51C mutations have been identified in BRCA1- and BRCA2-negative breast and ovarian cancer families. We performed complete sequencing of RAD51C in germline DNA of 286 female breast and/or ovarian cancer cases with a family history of breast and ovarian cancers, who had previously tested negative for mutations in BRCA1 and BRCA2. We screened 133 breast cancer cases, 119 ovarian cancer cases, and 34 with both breast and ovarian cancers. Fifteen DNA sequence variants were identified; including four intronic, one 5' UTR, one promoter, three synonymous, and six non-synonymous variants. None were truncating. The in-silico SIFT and Polyphen programs were used to predict possible pathogenicity of the six non-synonomous variants based on sequence conservation. G153D and T287A were predicted to be likely pathogenic. Two additional variants, A126T and R214C alter amino acids in important domains of the protein such that they could be pathogenic. Two-hybrid screening and immunoblot analyses were performed to assess the functionality of these four non-synonomous variants in yeast. The RAD51C-G153D protein displayed no detectable interaction with either XRCC3 or RAD51B, and RAD51C-R214C displayed significantly decreased interaction with both XRCC3 and RAD51B (p<0.001). Immunoblots of RAD51C-Gal4 activation domain fusion peptides showed protein levels of RAD51C-G153D and RAD51C-R214C that were 50% and 60% of the wild-type, respectively. Based on these data, the RAD51C-G153D variant is likely to be pathogenic, while the RAD51C-R214C variant is hypomorphic of uncertain pathogenicity. These results provide further support that RAD51C is a rare breast and ovarian cancer susceptibility gene.	[Clague, Jessica; Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA; [Wilhoite, Greg; Adamson, Aaron; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bailis, Adam] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Clague, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA.	sneuhausen@coh.org		Bailis, Adam/0000-0001-5628-0468	National Cancer Institute [RC4A153828, R25 CA85771]; Office of the Director, National Institutes of Health; Morris and Horowitz Families Endowed Professorship; Markel/Friedman Peritoneal Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R25CA085771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris and Horowitz Families Endowed Professorship; Markel/Friedman Peritoneal Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The City of Hope Clinical Cancer Genetics Community Research Network is supported by Award Number RC4A153828 (PI : JNW) from the National Cancer Institute and the Office of the Director, National Institutes of Health. JC is supported by National Cancer Institute grant R25 CA85771. SLN is partially supported by the Morris and Horowitz Families Endowed Professorship. JNW is partially supported by Markel/Friedman Peritoneal Ovarian Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2619; Barlund M, 2000, CANCER RES, V60, P5340; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Jemal A, 2010, CA CANC J CLIN, V60; Kurumizaka H, 2003, NUCLEIC ACIDS RES, V31, P4041, DOI 10.1093/nar/gkg442; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Miller KA, 2004, NUCLEIC ACIDS RES, V32, P169, DOI 10.1093/nar/gkg925; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Pang Z., 2011, BREAST CANC RES TREA; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; ROMERO A, 2011, BREAST CANC RES TREA; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Smeenk G, 2010, MUTAT RES-FUND MOL M, V689, P50, DOI 10.1016/j.mrfmmm.2010.05.001; Sowter HM, 2005, CARCINOGENESIS, V26, P1651, DOI 10.1093/carcin/bgi136; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; VUORELA M, 2011, BREAST CANC RES TREA; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; ZHENG Y, 2010, BREAST CANC RES TREA	21	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25632	10.1371/journal.pone.0025632	http://dx.doi.org/10.1371/journal.pone.0025632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980511	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900083
J	Gaiser, AM; Kaiser, CJO; Haslbeck, V; Richter, K				Gaiser, Andreas M.; Kaiser, Christoph J. O.; Haslbeck, Veronika; Richter, Klaus			Downregulation of the Hsp90 System Causes Defects in Muscle Cells of Caenorhabditis Elegans	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGES; SKELETAL-MUSCLES; DAUER FORMATION; PROTEIN; UNC-45; MYOSIN; GENE; GELDANAMYCIN	The ATP-dependent molecular chaperone Hsp90 is required for the activation of a variety of client proteins involved in various cellular processes. Despite the abundance of known client proteins, functions of Hsp90 in the organismal context are not fully explored. In Caenorhabditis elegans, Hsp90 (DAF-21) has been implicated in the regulation of the stress-resistant dauer state, in chemosensing and in gonad formation. In a C. elegans strain carrying a DAF-21 mutation with a lower ATP turnover, we observed motility defects. Similarly, a reduction of DAF-21 levels in wild type nematodes leads to reduced motility and induction of the muscular stress response. Furthermore, aggregates of the myosin MYO-3 are visible in muscle cells, if DAF-21 is depleted, implying a role of Hsp90 in the maintenance of muscle cell functionality. Similar defects can also be observed upon knockdown of the Hsp90-cochaperone UNC-45. In life nematodes YFP-DAF-21 localizes to the I-band and the M-line of the muscular ultrastructure, but the protein is not stably attached there. The Hsp90-cofactor UNC-45-CFP contrarily can be found in all bands of the nematode muscle ultrastructure and stably associates with the UNC-54 containing A-band. Thus, despite the physical interaction between DAF-21 and UNC-45, apparently the two proteins are not always localized to the same muscular structures. While UNC-45 can stably bind to myofilaments in the muscular ultrastructure, Hsp90 (DAF-21) appears to participate in the maintenance of muscle structures as a transiently associated diffusible factor.	[Gaiser, Andreas M.] Dept Chem, Munich, Germany; CIPSM, Munich, Germany; Tech Univ Munich, Munich, Germany	University of Munich; Technical University of Munich	Gaiser, AM (corresponding author), Dept Chem, Munich, Germany.	klaus.richter@tum.de	Richter, Klaus/A-2673-2010; Kaiser, Christoph JO/C-5609-2013	Richter, Klaus/0000-0002-8952-9642; Kaiser, Christoph JO/0000-0002-8481-6845	Deutsche Forschungsgemeinschaft (DFG) [RI1873-1/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by grant no. RI1873-1/1 of Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/index.jsp) provided to Klaus Richter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Altun Z. F., 2009, MUSCLE SYSTEM SOMATI; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Birnby DA, 2000, GENETICS, V155, P85; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRENNER S, 1974, GENETICS, V77, P71; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chang YS, 2006, J CELL BIOCHEM, V97, P156, DOI 10.1002/jcb.20623; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Gillan V, 2009, INT J PARASITOL, V39, P1071, DOI 10.1016/j.ijpara.2009.02.024; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Haslbeck M, 2003, J CHROMATOGR B, V786, P127, DOI 10.1016/S1570-0232(02)00716-X; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mori I, 1993, WORM BREEDERS GAZETT; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SMITH DF, 1992, J BIOL CHEM, V267, P1350; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; THOMAS JH, 1993, GENETICS, V134, P1105; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; VENOLIA L, 1990, GENETICS, V126, P345; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voss AK, 2000, DEVELOPMENT, V127, P1; VOWELS JJ, 1992, GENETICS, V130, P105; Waterston R., 1988, NEMATODE C ELEGANS, P281; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043	69	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25485	10.1371/journal.pone.0025485	http://dx.doi.org/10.1371/journal.pone.0025485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980476	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900071
J	Brazzatti, JA; Klingler-Hoffmann, M; Haylock-Jacobs, S; Harata-Lee, Y; Niu, M; Higgins, MD; Kochetkova, M; Hoffmann, P; McColl, SR				Brazzatti, J. A.; Klingler-Hoffmann, M.; Haylock-Jacobs, S.; Harata-Lee, Y.; Niu, M.; Higgins, M. D.; Kochetkova, M.; Hoffmann, P.; McColl, S. R.			Differential roles for the p101 and p84 regulatory subunits of PI3K gamma in tumor growth and metastasis	ONCOGENE			English	Article						phosphoinositide 3-kinase gamma; p101; p84/p87(PIKAP); breast cancer; apoptosis	G-BETA-GAMMA; I PHOSPHOINOSITIDE 3-KINASE; BREAST-CANCER METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; ONCOGENIC TRANSFORMATION; GENETIC ALTERATIONS; EPITHELIAL-CELLS; PI 3-KINASE; CLASS IPI3K	Phosphoinositide 3-kinase gamma (PI3K gamma) consists of a catalytic subunit p110 gamma, which forms mutually exclusive dimers with one of the regulatory subunits called p101 and p84/p87(PIKAP). Recently, PI3K gamma emerged as being a potential oncogene because overexpression of the catalytic subunit p110 gamma or the regulatory subunit p101 leads to oncogenic cellular transformation and malignancy. However, the contribution of the individual subunits to tumor growth and metastasis and the mechanisms involved are not understood. We therefore individually knocked down the PI3K gamma subunits (p84, p101 and p110 gamma) in MDA-MB-231 cells, which reduced in vitro migration of the cell lines. Knockdown of p110 gamma or p101 inhibited apoptosis, Akt phosphorylation and lung colonization in SCID mice. Similarly, the knockdown of p110 gamma and p101 in murine epithelial carcinoma 4T1.2 cells inhibited primary tumor growth and spontaneous metastasis, as well as lung colonization. In contrast, knockdown of p84 in MDA-MB-231 cells enhanced Akt phosphorylation and lung colonization. These findings are the first to implicate differential functions of the two PI3K gamma regulatory subunits in the process of oncogenesis, and indicate that loss of p101 is sufficient to reduce in vivo tumor growth and metastasis to the same extent as that of p110 gamma. Oncogene (2012) 31, 2350-2361; doi:10.1038/onc.2011.414; published online 26 September 2011	[Brazzatti, J. A.; Klingler-Hoffmann, M.; Haylock-Jacobs, S.; Harata-Lee, Y.; Niu, M.; Higgins, M. D.; Kochetkova, M.; Hoffmann, P.; McColl, S. R.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Adelaide	McColl, SR (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	shaun.mccoll@adelaide.edu.au	Hoffmann, Peter/U-5996-2017; Kochetkova, Marina/ABE-9538-2021; Klingler-Hoffmann, Manuela/D-1934-2018	Hoffmann, Peter/0000-0001-8493-2208; Brazzatti, Julie/0000-0002-4015-9679; Klingler-Hoffmann, Manuela/0000-0003-2165-7813; Kochetkova, Marina/0000-0002-0599-7378	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Mark Bunting for assistance with animal experiments, John Brazzatti for assistance with statistical analysis and Francisco Olmo for assistance with apoptosis experiments. The work was supported by grants from the National Health and Medical Research Council of Australia.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Al-Aoukaty A, 1999, J IMMUNOL, V162, P3249; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Benistant C, 2000, ONCOGENE, V19, P5083, DOI 10.1038/sj.onc.1203871; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Ching TT, 1999, J BIOL CHEM, V274, P8611, DOI 10.1074/jbc.274.13.8611; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; Denley A, 2009, MOL CANCER RES, V7, P1132, DOI 10.1158/1541-7786.MCR-09-0068; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Edling CE, 2010, CLIN CANCER RES, V16, P4928, DOI 10.1158/1078-0432.CCR-10-1210; El Haibi CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-85; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Goldberg GS, 2001, CANCER RES, V61, P1334; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Johnson C, 2007, ONCOGENE, V26, P7049, DOI 10.1038/sj.onc.1210504; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kim JH, 2011, J CELL PHYSIOL, V226, P2881, DOI 10.1002/jcp.22631; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Krugmann S, 1999, J BIOL CHEM, V274, P17152, DOI 10.1074/jbc.274.24.17152; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Metjian A, 1999, J BIOL CHEM, V274, P27943, DOI 10.1074/jbc.274.39.27943; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; PONS S, 1995, MOL CELL BIOL, V15, P4453; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tang MKS, 2010, NEOPLASIA, V12, P128, DOI 10.1593/neo.91438; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang LH, 2004, MT SINAI J MED, V71, P361; Williams SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-250; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yamada M, 2004, BIOCHEM J, V378, P649, DOI 10.1042/BJ20031398; YU G, 1995, J BIOL CHEM, V270, P4792, DOI 10.1074/jbc.270.9.4792; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7; Zhong MG, 2003, BIOCHEM BIOPH RES CO, V302, P615, DOI 10.1016/S0006-291X(03)00229-8	69	42	43	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	18					2350	2361		10.1038/onc.2011.414	http://dx.doi.org/10.1038/onc.2011.414			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21996737				2022-12-25	WOS:000303610800009
J	Chang, CY; Lin, SC; Su, WH; Ho, CM; Jou, YS				Chang, C-Y; Lin, S-C; Su, W-H; Ho, C-M; Jou, Y-S			Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma	ONCOGENE			English	Article						somatic mutations; LMCD1; LIM domain; metastasis; hepatocellular carcinoma	FOCAL ADHESION PROTEIN; BREAST-CANCER CELLS; LIM DOMAIN GENE; LOCALIZATION; GROWTH; ACTIN; ONCOGENES; TES; HYPERMETHYLATION; IDENTIFICATION	Common genetic alteration in cancer genomes is implicated for embracing an aberrant cancer gene participated in tumor progression. In this study, we identified a somatic mutated LIM and cysteine-rich domains-1 (LMCD1) as a putative metastatic oncogene in human hepatocellular carcinoma (HCC) using integrated genomic approaches. In addition to revealing genomic amplification and gene upregulation, we identified recurrent E135K (3/48 cases) mutations in HCC tissues and K237R mutation in the PLC/PRF/5 HCC cell line. Expression of mutant LMCD1 E135K or K237R reduced the stress fiber assembly, increased cortical actin accumulation and induced lamellipodial extension. Consistently, these mutations enhanced cell migration and showed activation of the Rac1-signaling pathway. Inhibition of the LMCD1/Rac1 pathway by an LMCD1 short-hairpin RNA (shLMCD1) or the Rac1 inhibitor NSC23766 suppressed the mutation-mediated lamellipodial protrusion and cell migration. In PLC/PRF/5 cells with endogenous K237R mutation, cell migration was enhanced by estrogen-induced LMCD1 expression but reversed by shLMCD1 treatment. Moreover, overexpression of LMCD1 E135K mutation significantly promoted systemic lung metastasis in a murine tail vein injection model. Together, our results suggest that LMCD1 mutations are potential oncogenic events in HCC metastasis to promote cell migration through the Rac1-signaling pathway. Oncogene (2012) 31, 2640-2652; doi:10.1038/onc.2011.440; published online 26 September 2011	[Chang, C-Y; Lin, S-C; Jou, Y-S] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chang, C-Y; Jou, Y-S] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Su, W-H] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Grad Inst Biomed Sci, Dept Biomed Sci, Tao Yuan, Taiwan; [Ho, C-M] Natl Chiao Tung Univ, Inst Bioinformat, Hsinchu, Taiwan; [Ho, C-M; Jou, Y-S] Acad Sinica, Bioinformat Program, Taiwan Int Grad Program, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Jou, YS (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	jou@ibms.sinica.edu.tw	Jou, Yuh-Shan/O-5921-2018	Jou, Yuh-Shan/0000-0001-5090-3732; Su, Wen-Hui/0000-0003-1037-4615	National Science Council, Taiwan [NSC98-3112-B-001-004, NSC98-3112-B-001-031, NSC99-3112-B-001-019]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank Dr Pei-Jer Chen and Dr Ding-Shinn Chen at School of Medicine, National Taiwan University, for helpful discussions and advice on the work. We also thank the core facilities from National Research Program for Genomic Medicine, National Science Council, Taiwan, including the National Genotyping Center, for their service in SNP genotyping and the National RNAi Core facility for providing shRNAs. Financial Support: This work was funded by the National Research Program for Genomic Medicine of the National Science Council, Taiwan, through grant numbers NSC98-3112-B-001-004, NSC98-3112-B-001-031 and NSC99-3112-B-001-019.	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; Bespalova IN, 2000, GENOMICS, V63, P69, DOI 10.1006/geno.1999.6049; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; CHALLEN C, 1992, J HEPATOL, V14, P342, DOI 10.1016/0168-8278(92)90181-N; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Dudek P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001859; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Harvell DME, 2006, ENDOCRINOLOGY, V147, P700, DOI 10.1210/en.2005-0617; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Jou YS, 2004, CANCER RES, V64, P3030, DOI 10.1158/0008-5472.CAN-03-2320; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Kang SM, 2000, CANCER RES, V60, P5296; Khurana T, 2002, PROTOPLASMA, V219, P1, DOI 10.1007/s007090200000; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Liu CY, 2009, J PATHOL, V219, P222, DOI 10.1002/path.2589; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Murata H, 2004, LAB INVEST, V84, P1050, DOI 10.1038/labinvest.3700118; Niketeghad F, 2001, BRIT J CANCER, V85, P697, DOI 10.1054/bjoc.2001.1963; OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang G, 2001, GENE CHROMOSOME CANC, V31, P221, DOI 10.1002/gcc.1138; Yakicier MC, 1999, ONCOGENE, V18, P4879, DOI 10.1038/sj.onc.1202866; Yao YJ, 1999, ONCOGENE, V18, P3181, DOI 10.1038/sj.onc.1202659; Yoshida T, 2010, CANCER INFORM, V9, P147; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	48	31	31	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	21					2640	2652		10.1038/onc.2011.440	http://dx.doi.org/10.1038/onc.2011.440			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21996735				2022-12-25	WOS:000304523500004
J	Alalouf, O; Balazs, Y; Volkinshtein, M; Grimpel, Y; Shoham, G; Shoham, Y				Alalouf, Onit; Balazs, Yael; Volkinshtein, Margarita; Grimpel, Yael; Shoham, Gil; Shoham, Yuval			A New Family of Carbohydrate Esterases Is Represented by a GDSL Hydrolase/Acetylxylan Esterase from Geobacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; DETAILED KINETIC-ANALYSIS; ACETYLXYLAN ESTERASE; GLYCOSIDE HYDROLASE; CATALYTIC RESIDUES; CRYSTAL-STRUCTURE; BETA-XYLOSIDASE; BIOCHEMICAL-CHARACTERIZATION; THERMOSTABLE XYLANASE; SUBSTRATE-SPECIFICITY	Acetylxylan esterases hydrolyze the ester linkages of acetyl groups at positions 2 and/or 3 of the xylose moieties in xylan and play an important role in enhancing the accessibility of xylanases to the xylan backbone. The hemicellulolytic system of the thermophilic bacterium Geobacillus stearothermophilus T-6 comprises a putative acetylxylan esterase gene, axe2. The gene product belongs to the GDSL hydrolase family and does not share sequence homology with any of the carbohydrate esterases in the CAZy Database. The axe2 gene is induced by xylose, and the purified gene product completely deacetylates xylobiose peracetate (fully acetylated) and hydrolyzes the synthetic substrates 2-naphthyl acetate, 4-nitrophenyl acetate, 4-methylumbelliferyl acetate, and phenyl acetate. The pH profiles for k(cat) and k(cat)/K-m suggest the existence of two ionizable groups affecting the binding of the substrate to the enzyme. Using NMR spectroscopy, the regioselectivity of Axe2 was directly determined with the aid of one-dimensional selective total correlation spectroscopy. Methyl 2,3,4-tri-O-acetyl-beta-D-xylopyranoside was rapidly deacetylated at position 2 or at positions 3 and 4 to give either diacetyl or monoacetyl intermediates, respectively; methyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside was initially deacetylated at position 6. In both cases, the complete hydrolysis of the intermediates occurred at a much slower rate, suggesting that the preferred substrate is the peracetate sugar form. Site-directed mutagenesis of Ser-15, His-194, and Asp-191 resulted in complete inactivation of the enzyme, consistent with their role as the catalytic triad. Overall, our results show that Axe2 is a serine acetylxylan esterase representing a new carbohydrate esterase family.	[Alalouf, Onit; Volkinshtein, Margarita; Grimpel, Yael; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Balazs, Yael] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	yshoham@technion.ac.il	Shoham, Yuval/M-4409-2013; Balazs, Amber/AAO-5408-2021	Balazs, Amber/0000-0002-5556-6795	Israel Science Foundation [500/10]; United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel) [96-178]; Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel)(US-Israel Binational Science Foundation); Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology	This work was supported by Israel Science Foundation Grant 500/10 (to Y. S.), United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel) Grant 96-178 (to Y. S.), and the Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology, established by the Minerva Foundation (Munich, Germany).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Bakshy K, 2009, BBA-PROTEINS PROTEOM, V1794, P324, DOI 10.1016/j.bbapap.2008.10.007; Bar M, 2004, ACTA CRYSTALLOGR D, V60, P545, DOI 10.1107/S0907444903029305; Ben-David A, 2007, CHEMBIOCHEM, V8, P2145, DOI 10.1002/cbic.200700414; BENDER M L, 1973, Critical Reviews in Biochemistry, V1, P149, DOI 10.3109/10409237309102546; Biely P, 1996, FEBS LETT, V396, P257, DOI 10.1016/0014-5793(96)01080-0; Biely P, 1996, BBA-PROTEIN STRUCT M, V1298, P209, DOI 10.1016/S0167-4838(96)00132-X; Biely P, 2011, J BIOTECHNOL, V151, P137, DOI 10.1016/j.jbiotec.2010.10.074; Bravman T, 2003, BIOCHEMISTRY-US, V42, P10528, DOI 10.1021/bi034505o; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAT O, 1994, APPL ENVIRON MICROB, V60, P1889, DOI 10.1128/AEM.60.6.1889-1896.1994; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JOHNSON KG, 1988, HEMICELLULOSE; KESSLER H, 1986, J MAGN RESON, V70, P106, DOI 10.1016/0022-2364(86)90366-5; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; Lapidot A, 1996, J BIOTECHNOL, V51, P259, DOI 10.1016/S0168-1656(96)01604-5; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Shallom D, 2004, J BACTERIOL, V186, P6928, DOI 10.1128/JB.186.20.6928-6937.2004; Shallom D, 2002, FEBS LETT, V514, P163, DOI 10.1016/S0014-5793(02)02343-8; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Teplitsky A, 1997, ACTA CRYSTALLOGR D, V53, P608, DOI 10.1107/S0907444997002734; Topakas E, 2010, FEBS LETT, V584, P543, DOI 10.1016/j.febslet.2009.11.095; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; WHARTON CW, 1998, SERINE PROTEINASES; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x	46	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41993	42001		10.1074/jbc.M111.301051	http://dx.doi.org/10.1074/jbc.M111.301051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994937	Green Published, hybrid			2022-12-25	WOS:000298180900010
J	Bock, G; Gebhart, M; Scharinger, A; Jangsangthong, W; Busquet, P; Poggiani, C; Sartori, S; Mangoni, ME; Sinnegger-Brauns, MJ; Herzig, S; Striessnig, J; Koschak, A				Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Jangsangthong, Wanchana; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Mangoni, Matteo E.; Sinnegger-Brauns, Martina J.; Herzig, Stefan; Striessnig, Joerg; Koschak, Alexandra			Functional Properties of a Newly Identified C-terminal Splice Variant of Ca(v)1.3 L-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; CONGENITAL DEAFNESS; DOPAMINE NEURONS; DOMAIN; SUBUNITS; REVEALS; CELLS; MODULATION; MECHANISMS	An intramolecular interaction between a distal (DCRD) and a proximal regulatory domain (PCRD) within theCterminus of long Ca(v)1.3 L-type Ca2+ channels (Cav1.3(L)) is a major determinant of their voltage-and Ca2+-dependent gating kinetics. Removal of these regulatory domains by alternative splicing generates Ca(v)1.3(42A) channels that activate at a more negative voltage range and exhibit more pronounced Ca2+-dependent inactivation. Here we describe the discovery of a novel short splice variant (Ca(v)1.3(43S)) that is expressed at high levels in the brain but not in the heart. It lacks the DCRD but, in contrast to Ca(v)1.3(42A), still contains PCRD. When expressed together with alpha 2 delta 1 and beta 3 subunits in tsA-201 cells, Ca(v)1.3(43S) also activated at more negative voltages like Ca(v)1.3(42A) but Ca2+-dependent inactivation was less pronounced. Single channel recordings revealed much higher channel open probabilities for both short splice variants as compared with Ca(v)1.3(L). The presence of the proximal C terminus in Ca(v)1.3(43S) channels preserved their modulation by distal C terminus-containing Ca(v)1.3- and Ca(v)1.2-derived C-terminal peptides. Removal of the C-terminal modulation by alternative splicing also induced a faster decay of Ca2+ influx during electrical activities mimicking trains of neuronal action potentials. Our findings extend the spectrum of functionally diverse Ca(v)1.3 L-type channels produced by tissue-specific alternative splicing. This diversity may help to fine tune Ca2+ channel signaling and, in the case of short variants lacking a functional C-terminal modulation, prevent excessive Ca2+ accumulation during burst firing in neurons. This may be especially important in neurons that are affected by Ca2+-induced neurodegenerative processes.	[Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Sinnegger-Brauns, Martina J.; Striessnig, Joerg; Koschak, Alexandra] Inst Pharm Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Sinnegger-Brauns, Martina J.; Striessnig, Joerg; Koschak, Alexandra] Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Jangsangthong, Wanchana; Herzig, Stefan] Univ Cologne, Dept Pharmacol, D-50931 Cologne, Germany; [Jangsangthong, Wanchana; Herzig, Stefan] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Mangoni, Matteo E.] CNRS, Dept Physiol, Inst Genom Fonctionnelle, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] INSERM, U661, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] Univ Montpellier 1, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] Univ Montpellier 2, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] INSERM, U637, F-34000 Montpellier, France	University of Innsbruck; University of Cologne; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Striessnig, J (corresponding author), Inst Pharm Pharmacol & Toxicol, Peter Mayr Str 1-I, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at; alexandra.koschak@meduniwien.ac.at	Striessnig, Joerg/S-9334-2017; Tuluc, Petronel/C-2527-2011; Mangoni, Matteo E/E-6025-2015	Striessnig, Joerg/0000-0002-9406-7120; Mangoni, Matteo E/0000-0002-8892-3373; Sartori, Simone B./0000-0002-2396-1838; Herzig, Stefan/0000-0001-8107-5204; Brauns, Martina/0000-0002-0547-2731	National Institutes of Health [R01HL087120-A2]; Austrian Science Fund (FWF) [P-22528, P-20670, F4402]; European Community Research Training Network [MRTN-CT-2006-35367]; Center for Molecular Medicine Cologne [CMMC A5]; University of Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 22528, P 20670] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Community Research Training Network(European Commission); Center for Molecular Medicine Cologne; University of Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL087120-A2, Austrian Science Fund (FWF) Grants P-22528 (to A.K.) and P-20670 and F4402 (to J.S.), The European Community Research Training Network Cavnet Grant MRTN-CT-2006-35367), Center for Molecular Medicine Cologne Grant CMMC A5 (to S.H.), and the University of Innsbruck.	Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Berkefeld H, 2008, J NEUROSCI, V28, P8238, DOI 10.1523/JNEUROSCI.2274-08.2008; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cui GH, 2007, J NEUROSCI, V27, P4776, DOI 10.1523/JNEUROSCI.0139-07.2007; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liss B, 2008, BRAIN RES REV, V58, P314, DOI 10.1016/j.brainresrev.2007.10.004; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Soong TW, 2002, J NEUROSCI, V22, P10142; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	40	89	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42736	42748		10.1074/jbc.M111.269951	http://dx.doi.org/10.1074/jbc.M111.269951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998310	hybrid, Green Published			2022-12-25	WOS:000298180900080
J	Magliano, P; Flipphi, M; Arpat, BA; Delessert, S; Poirier, Y				Magliano, Pasqualina; Flipphi, Michel; Arpat, Bulak A.; Delessert, Syndie; Poirier, Yves			Contributions of the Peroxisome and beta-Oxidation Cycle to Biotin Synthesis in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA COLI K-12; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; 8-AMINO-7-OXONONANOATE SYNTHASE; BACILLUS-SUBTILIS; GENE-CLUSTER; FATTY-ACIDS; BIOSYNTHESIS; SEQUENCE; IDENTIFICATION	The first step in the synthesis of the bicyclic rings of D-biotin is mediated by 8-amino-7-oxononanoate (AON) synthase, which catalyzes the decarboxylative condensation of L-alanine and pimelate thioester. We found that the Aspergillus nidulans AON synthase, encoded by the bioF gene, is a peroxisomal enzyme with a type 1 peroxisomal targeting sequence (PTS1). Localization of AON to the peroxisome was essential for biotin synthesis because expression of a cytosolic AON variant or deletion of pexE, encoding the PTS1 receptor, rendered A. nidulans a biotin auxotroph. AON synthases with PTS1 are found throughout the fungal kingdom, in ascomycetes, basidiomycetes, and members of basal fungal lineages but not in representatives of the Saccharomyces species complex, including Saccharomyces cerevisiae. A. nidulans mutants defective in the peroxisomal acyl-CoA oxidase AoxA or the multifunctional protein FoxA showed a strong decrease in colonial growth rate in biotin-deficient medium, whereas partial growth recovery occurred with pimelic acid supplementation. These results indicate that pimeloyl-CoA is the in vivo substrate of AON synthase and that it is generated in the peroxisome via the beta-oxidation cycle in A. nidulans and probably in a broad range of fungi. However, the beta-oxidation cycle is not essential for biotin synthesis in S. cerevisiae or Escherichia coli. These results suggest that alternative pathways for synthesis of the pimelate intermediate exist in bacteria and eukaryotes and that Saccharomyces species use a pathway different from that used by the majority of fungi.	[Poirier, Yves] Univ Lausanne, DBMV, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Flipphi, Michel] CSIC, Inst Agroquim & Tecnol Alimentos, E-46100 Valencia, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Poirier, Y (corresponding author), Univ Lausanne, DBMV, Dept Plant Mol Biol, Biophore Bldg, CH-1015 Lausanne, Switzerland.	yves.poirier@unil.ch	Arpat, Alaaddin Bulak/C-1336-2008	Arpat, Alaaddin Bulak/0000-0002-7749-3793	Fonds National Suisse de la Recherche Scientifique [3100A0-122493]; Ministerio de Ciencia e Innovacion (MCINN) [BIO2008-00228]; Spanish Ministerio de Ciencia e Innovacion [RYC-2004-003005]	Fonds National Suisse de la Recherche Scientifique; Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Fonds National Suisse de la Recherche Scientifique Grant 3100A0-122493 (to Y. P.). Work at the Instituto de Agroquimica y Tecnologia de Alimentos was supported by Ministerio de Ciencia e Innovacion (MCINN) Grant BIO2008-00228.; Supported by Ramon y Cajal Postdoctoral Contract RYC-2004-003005 from the Spanish Ministerio de Ciencia e Innovacion.	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bower S, 1996, J BACTERIOL, V178, P4122, DOI 10.1128/jb.178.14.4122-4130.1996; CLEARY PP, 1972, J BACTERIOL, V112, P830, DOI 10.1128/JB.112.2.830-839.1972; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; DELCAMPI.A, 1967, J BACTERIOL, V94, P2065, DOI 10.1128/JB.94.6.2065-2066.1967; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Han KH, 2003, J MICROBIOL, V41, P34; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Magliano P, 2011, FUNGAL GENET BIOL, V48, P208, DOI 10.1016/j.fgb.2010.08.004; Magliano P, 2010, BBA-MOL CELL BIOL L, V1801, P1386, DOI 10.1016/j.bbalip.2010.08.008; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Phalip V, 1999, GENE, V232, P43, DOI 10.1016/S0378-1119(99)00117-1; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Pokorska A, 2000, J MOL BIOL, V298, P585, DOI 10.1006/jmbi.2000.3666; Reiser K, 2010, CURR GENET, V56, P139, DOI 10.1007/s00294-009-0286-2; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; ROLFE B, 1968, J BACTERIOL, V96, P515, DOI 10.1128/JB.96.2.515-524.1968; Ruprich-Robert G, 2002, GENETICS, V161, P1089; Stok JE, 2000, ARCH BIOCHEM BIOPHYS, V384, P351, DOI 10.1006/abbi.2000.2067; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Tanabe Y, 2011, J BIOL CHEM, V286, P30455, DOI 10.1074/jbc.M111.247338; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wu H, 2005, APPL ENVIRON MICROB, V71, P6845, DOI 10.1128/AEM.71.11.6845-6855.2005; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	38	27	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42133	42140		10.1074/jbc.M111.279687	http://dx.doi.org/10.1074/jbc.M111.279687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998305	hybrid, Green Published			2022-12-25	WOS:000298180900024
J	Wong, W; Wijeyewickrema, LC; Kennan, RM; Reeve, SB; Steer, DL; Reboul, C; Smith, AI; Pike, RN; Rood, JI; Whisstock, JC; Porter, CJ				Wong, Wilson; Wijeyewickrema, Lakshmi C.; Kennan, Ruth M.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Pike, Robert N.; Rood, Julian I.; Whisstock, James C.; Porter, Corrine J.			S1 Pocket of a Bacterially Derived Subtilisin-like Protease Underpins Effective Tissue Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN DICHELOBACTER-NODOSUS; MOLECULAR-GRAPHICS PROJECT; OVINE FOOTROT PATHOGEN; BACTEROIDES-NODOSUS; SERINE PROTEASES; BASIC PROTEASE; AMINO-ACID; IDENTIFICATION; ELASTASE; VIRULENT	The ovine footrot pathogen, Dichelobacter nodosus, secretes three subtilisin-like proteases that play an important role in the pathogenesis of footrot through their ability to mediate tissue destruction. Virulent and benign strains of D. nodosus secrete the basic proteases BprV and BprB, respectively, with the catalytic domain of these enzymes having 96% sequence identity. At present, it is not known how sequence variation between these two putative virulence factors influences their respective biological activity. We have determined the high resolution crystal structures of BprV and BprB. These data reveal that that the S1 pocket of BprV is more hydrophobic but smaller than that of BprB. We show that BprV is more effective than BprB in degrading extracellular matrix components of the host tissue. Mutation of two residues around the S1 pocket of BprB to the equivalent residues in BprV dramatically enhanced its proteolytic activity against elastin substrates. Application of a novel approach for profiling substrate specificity, the Rapid Endopeptidase Profiling Library (REPLi) method, revealed that both enzymes prefer cleaving after hydrophobic residues (and in particular P1 leucine) but that BprV has more restricted primary substrate specificity than BprB. Furthermore, for P1 Leu-containing substrates we found that BprV is a significantly more efficient enzyme than BprB. Collectively, these data illuminate how subtle changes in D. nodosus proteases may significantly influence tissue destruction as part of the ovine footrot pathogenesis process.	[Kennan, Ruth M.; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Wong, Wilson; Kennan, Ruth M.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Rood, Julian I.; Whisstock, James C.; Porter, Corrine J.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Wong, Wilson; Wijeyewickrema, Lakshmi C.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Pike, Robert N.; Whisstock, James C.; Porter, Corrine J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Rood, JI (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	julian.rood@monash.edu; james.whisstock@monash.edu	Rood, Julian I/A-4858-2008; Wijeyewickrema, Lakshmi/A-9676-2015	Rood, Julian I/0000-0003-2126-7209; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Smith, Ian/0000-0002-4143-2892; Reboul, Cyril/0000-0002-6258-2697; Pike, Robert/0000-0002-2083-0269; Wong, Wilson/0000-0003-1335-8047; Whisstock, James/0000-0003-4200-5611	Australian Research Council; Department of Biochemistry and Molecular Biology at Monash University; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics	Australian Research Council(Australian Research Council); Department of Biochemistry and Molecular Biology at Monash University; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council)	This research was supported by the Australian Research Council through funding to the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics.; Supported by a Faculty scholarship provided by the Department of Biochemistry and Molecular Biology at Monash University and previously supported by a scholarship from the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics.	Androulakis S, 2008, ACTA CRYSTALLOGR D, V64, P810, DOI 10.1107/S0907444908015540; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEPIAZZI LJ, 1979, AUST VET J, V55, P25, DOI 10.1111/j.1751-0813.1979.tb09541.x; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green LE, 2008, VET J, V175, P173, DOI 10.1016/j.tvjl.2007.01.014; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; KORTT AA, 1994, BIOCHEM J, V299, P521, DOI 10.1042/bj2990521; LILLEY GG, 1992, EUR J BIOCHEM, V210, P13, DOI 10.1111/j.1432-1033.1992.tb17385.x; LILLEY GG, 1995, BIOCHEM MOL BIOL INT, V36, P101; LIU D, 1993, RES VET SCI, V55, P124, DOI 10.1016/0034-5288(93)90046-I; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2007, NAT BIOTECHNOL, V25, P569, DOI 10.1038/nbt1302; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RIFFKIN MC, 1993, GENE, V137, P259, DOI 10.1016/0378-1119(93)90017-W; Riffkin MC, 1995, GENE, V167, P279, DOI 10.1016/0378-1119(95)00664-8; ROBERTS DS, 1969, J COMP PATHOL, V79, P217, DOI 10.1016/0021-9975(69)90008-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stewart D. J., 1989, Footrot and foot abscess of ruminants., P5; STEWART DJ, 1979, RES VET SCI, V27, P99, DOI 10.1016/S0034-5288(18)32866-2; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Wani SA, 2006, VET J, V171, P421, DOI 10.1016/j.tvjl.2005.02.017; Wong W, 2010, ACTA CRYSTALLOGR F, V66, P289, DOI 10.1107/S1744309110000333	33	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42180	42187		10.1074/jbc.M111.298711	http://dx.doi.org/10.1074/jbc.M111.298711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990366	Green Published, hybrid			2022-12-25	WOS:000298180900028
J	Barrantes-Reynolds, R; Wallace, SS; Bond, JP				Barrantes-Reynolds, Ramiro; Wallace, Susan S.; Bond, Jeffrey P.			Using Shifts in Amino Acid Frequency and Substitution Rate to Identify Latent Structural Characters in Base-Excision Repair Enzymes	PLOS ONE			English	Article							FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; FUNCTIONALLY IMPORTANT RESIDUES; COLI ENDONUCLEASE-VIII; LIKELIHOOD PHYLOGENETICS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; PREDICTION; DIVERGENCE; BINDING	Protein evolution includes the birth and death of structural motifs. For example, a zinc finger or a salt bridge may be present in some, but not all, members of a protein family. We propose that such transitions are manifest in sequence phylogenies as concerted shifts in substitution rates of amino acids that are neighbors in a representative structure. First, we identified rate shifts in a quartet from the Fpg/Nei family of base excision repair enzymes using a method developed by Xun Gu and coworkers. We found the shifts to be spatially correlated, more precisely, associated with a flexible loop involved in bacterial Fpg substrate specificity. Consistent with our result, sequences and structures provide convincing evidence that this loop plays a very different role in other family members. Second, then, we developed a method for identifying latent protein structural characters (LSC) given a set of homologous sequences based on Gu's method and proximity in a high-resolution structure. Third, we identified LSC and assigned states of LSC to clades within the Fpg/Nei family of base excision repair enzymes. We describe seven LSC; an accompanying Proteopedia page (http://proteopedia.org/wiki/index.php/Fpg_Nei_Protein_Family) describes these in greater detail and facilitates 3D viewing. The LSC we found provided a surprisingly complete picture of the interaction of the protein with the DNA capturing familiar examples, such as a Zn finger, as well as more subtle interactions. Their preponderance is consistent with an important role as phylogenetic characters. Phylogenetic inference based on LSC provided convincing evidence of independent losses of Zn fingers. Structural motifs may serve as important phylogenetic characters and modeling transitions involving structural motifs may provide a much deeper understanding of protein evolution.	[Barrantes-Reynolds, Ramiro; Wallace, Susan S.; Bond, Jeffrey P.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Barrantes-Reynolds, R (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	jeffrey.bond@uvm.edu		Wallace, Susan S./0000-0002-3906-0321	National Institutes of Health [P01 CA098993]; National Cancer Institute; NASA at the University of Vermont [NNX 06AC88G]; University of Vermont; Vermont Genetics Network [P20 RR16462]; National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NASA at the University of Vermont; University of Vermont; Vermont Genetics Network; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health [P01 CA098993], grant awarded by the National Cancer Institute; the Vermont Advanced Computing Center which is supported by NASA [NNX 06AC88G], at the University of Vermont for providing high-performance computing resources that have contributed to the research results reported within this paper; the Vermont Genetics Network [P20 RR16462] from the INBRE Program of the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2008, NUCLEIC ACIDS RES, V36, P5922, DOI 10.1093/nar/gkn573; Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amara P, 2006, DNA REPAIR, V5, P947, DOI 10.1016/j.dnarep.2006.05.042; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Burgess S, 2002, J BIOL CHEM, V277, P2938, DOI 10.1074/jbc.M110499200; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cheng Q, 2008, GENE; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; de Jesus KP, 2005, NUCLEIC ACIDS RES, V33, P5936, DOI 10.1093/nar/gki879; del Sol A, 2007, PLOS COMPUT BIOL, V3, P2446, DOI 10.1371/journal.pcbi.0030239; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deu E, 2002, PROTEIN SCI, V11, P1062, DOI 10.1110/ps.0200902; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hirano Hisashi, 2003, Methods Mol Biol, V211, P355; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Imamura K, 2009, J BIOL CHEM; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kathe SD, 2009, DNA REPAIR, V8, P643, DOI 10.1016/j.dnarep.2008.12.013; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ko J, 2005, BIOINFORMATICS, V21, pI258, DOI 10.1093/bioinformatics/bti1039; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Koshi J M, 2001, Pac Symp Biocomput, P191; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Kuznetsov SV, 1998, EUR J BIOCHEM, V253, P413, DOI 10.1046/j.1432-1327.1998.2530413.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Landgraf R, 2001, J MOL BIOL, V307, P1487, DOI 10.1006/jmbi.2001.4540; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Limbird LE, 2005, CELL SURFACE RECEPTO; Lio Pietro, 2008, V452, P255, DOI 10.1007/978-1-60327-159-2_13; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marttinen P, 2006, BIOINFORMATICS, V22, P2466, DOI 10.1093/bioinformatics/btl411; Martz E, 2009, BIOPOLYMERS, V92, P76, DOI 10.1002/bip.21126; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; MIYATAKE N, 1993, EUR J BIOCHEM, V212, P785, DOI 10.1111/j.1432-1033.1993.tb17719.x; Naylor GJP, 1997, NATURE, V388, P527, DOI 10.1038/41460; Nimrod G, 2005, BIOINFORMATICS, V21, pI328, DOI 10.1093/bioinformatics/bti1023; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pei JM, 2006, BIOINFORMATICS, V22, P164, DOI 10.1093/bioinformatics/bti766; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pumo DE, 2009, EPIGENETICS MECH FUN; Rabow L, 2001, PROG NUCLEIC ACID RE, V68, P223; Rahat O, 2008, PROTEINS, V71, P621, DOI 10.1002/prot.21749; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rogacheva M, 2006, J BIOL CHEM, V281, P32353, DOI 10.1074/jbc.M606217200; Ruano-Rubio V, 2007, SYST BIOL, V56, P68, DOI 10.1080/10635150601175578; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Saparbaev M, 2002, ENVIRON MOL MUTAGEN, V39, P10, DOI 10.1002/em.10041; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Wolfram S., 1999, MATH BOOK; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	102	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25246	10.1371/journal.pone.0025246	http://dx.doi.org/10.1371/journal.pone.0025246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998646	Green Submitted, gold, Green Published			2022-12-25	WOS:000295968700007
J	D'Alba, L; Van Hemert, C; Handel, CM; Shawkey, MD				D'Alba, Liliana; Van Hemert, Caroline; Handel, Colleen M.; Shawkey, Matthew D.			A Natural Experiment on the Condition-Dependence of Achromatic Plumage Reflectance in Black-Capped Chickadees	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BEAK DEFORMITIES; COLOR VARIATION; HONEST SIGNAL; QUALITY; TRAITS; BIRDS; PIGMENTATION; EXPRESSION; ORNAMENTS	Honest advertisement models posit that only individuals in good health can produce and/or maintain ornamental traits. Even though disease has profound effects on condition, few studies have experimentally tested its effects on trait expression and even fewer have identified a mechanistic basis for these effects. Recent evidence suggests that black and white, but not grey, plumage colors of black-capped chickadees (Poecile atricapillus) are sexually selected. We therefore hypothesized that birds afflicted with avian keratin disorder, a condition that affects the beak and other keratinized tissues, would show reduced expression of black and white, but not grey, color. UV-vis spectrometry of black-capped chickadees affected and unaffected by avian keratin disorder revealed spectral differences between them consistent with this hypothesis. To elucidate the mechanistic bases of these differences, we used scanning electron microscopy (SEM), electron-dispersive x-ray spectroscopy (EDX) and a feather cleaning experiment. SEM showed extreme feather soiling in affected birds, and EDX revealed that this was most likely from external sources. Experimentally cleaning the feathers increased color expression of ornamental feathers of affected, but not unaffected, birds. These data provide strong evidence that black and white color is an honest indicator in chickadees, and that variation in feather dirtiness, likely due to differences in preening behavior is a mechanism for this association.	[D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Van Hemert, Caroline; Handel, Colleen M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Van Hemert, Caroline] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	D'Alba, L (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	liliana@uakron.edu	D'Alba, Liliana/AAC-4969-2022	D'Alba, Liliana/0000-0002-2478-3455; Handel, Colleen/0000-0002-0267-7408; Shawkey, Matthew/0000-0002-5131-8209	U. S. Geological Survey; National Science Foundation; University of Alaska Foundation; AFOSR [FA9550-09-1-0159]	U. S. Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); University of Alaska Foundation; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Funding was provided by the U. S. Geological Survey, the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/) Program, the University of Alaska Foundation Angus Gavin Memorial Bird Research Grant (http://www.alaska.edu/foundation/donor_relations/grants-and-awards/), and the AFOSR (FA9550-09-1-0159)(http://www.wpafb.af.mil/library/factsheets/factsheet.asp?id=8973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Andersson S, 2006, BIRD COLOURATION MEC, P40; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2003, J AVIAN BIOL, V34, P237, DOI 10.1034/j.1600-048X.2003.03113.x; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; Fecchio RS, 2010, MAT SCI ENG C-MATER, V30, P460, DOI 10.1016/j.msec.2010.01.001; FRENKEL MJ, 1976, AUST J BIOL SCI, V29, P467, DOI 10.1071/BI9760467; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; Griggio M, 2011, ITAL J ZOOL, V78, P90, DOI 10.1080/11250003.2010.504238; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Griggio M, 2010, BEHAV PROCESS, V84, P739, DOI 10.1016/j.beproc.2010.05.003; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; Handel CM, 2010, AUK, V127, P882, DOI 10.1525/auk.2010.10111; Heindl M, 2003, BEHAV ECOL SOCIOBIOL, V53, P153, DOI 10.1007/s00265-002-0562-3; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Keyser AJ, 2000, BEHAV ECOL, V11, P202, DOI 10.1093/beheco/11.2.202; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Montgomerie Robert, 2006, P399; Nolan PM, 1998, P ROY SOC B-BIOL SCI, V265, P961, DOI 10.1098/rspb.1998.0384; Pearn SM, 2003, ETHOLOGY, V109, P961, DOI 10.1046/j.0179-1613.2003.00936.x; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Prum RO, 2006, BIRD COLORATION, V1, P295; Senar J.C., 2006, BIRD COLORATION, V2, P87; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Siefferman L, 2007, BEHAV ECOL SOCIOBIOL, V61, P1839, DOI 10.1007/s00265-007-0416-0; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 2002, ANIM BEHAV, V63, P97, DOI 10.1006/anbe.2001.1870; Surmacki A, 2007, NATURWISSENSCHAFTEN, V94, P829, DOI 10.1007/s00114-007-0263-x; Van Hemert C, 2010, AUK, V127, P746, DOI 10.1525/auk.2010.10132; Walther BA, 2005, BEHAV ECOL, V16, P89, DOI 10.1093/beheco/arh135; Wolfenbarger LL, 1999, BEHAV ECOL, V10, P80, DOI 10.1093/beheco/10.1.80; Woodcock EA, 2005, ETHOLOGY, V111, P891, DOI 10.1111/j.1439-0310.2005.01120.x; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339, DOI 10.1080/08927014.2004.9522625	54	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25877	10.1371/journal.pone.0025877	http://dx.doi.org/10.1371/journal.pone.0025877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991378	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000089
J	Gould, NS; Min, E; Day, BJ				Gould, Neal S.; Min, Elysia; Day, Brian J.			Macropinocytosis of Extracellular Glutathione Ameliorates Tumor Necrosis Factor alpha Release in Activated Macrophages	PLOS ONE			English	Article							RESPIRATORY BURST; TOBACCO-SMOKE; LUNG; FLUID; MECHANISMS; RESPONSES; GAMMA; PHAGOCYTOSIS; DEFENSE; STATE	A number of inflammatory lung diseases have abnormally low glutathione (GSH) levels in the airway fluids. Lung macrophages are common mediators of inflammation, make up the majority of cells that are found in the airway epithelial lining fluid (ELF), and are commonly elevated in many lung diseases. Several animal models with altered ELF GSH levels are associated with similar alterations in the intracellular GSH levels of bronchoalveolar lavage (BAL) cells. The possible mechanisms and outcomes for this association between ELF GSH levels and intracellular BAL cell GSH are unknown. To investigate these issues, macrophages were grown in media supplemented with 500 mu M GSH. GSH supplementation resulted in a 2-3 fold increase in macrophage intracellular GSH levels. The increase in macrophage intracellular GSH levels was associated with a significant reduction in NF-kappa B nuclear translocation and tumor necrosis factor alpha (TNF alpha) release upon LPS stimulation. Furthermore, co-treatment of macrophages with GSH and inhibitors of GSH breakdown or synthesis did not block GSH accumulation. In contrast, treatment with cytochalasin D, an inhibitor of actin dependent endocytosis, and amiloride, an inhibitor of macropinocytosis blocked, at least in part, GSH uptake. Furthermore, using two cigarette smoke exposure paradigms that result in two different GSH levels in the ELF and thus in the BAL cells resulted in modulation of cytokine release when stimulated with LPS ex vivo. These data suggest that macrophages are able to utilize extracellular GSH which can then modulate inflammatory signaling in response to proinflammatory stimuli. This data also suggests the lung can modulate inflammatory responses triggered by proinflammatory stimuli by altering ELF GSH levels and may help explain the dysregulated inflammation associated with lung diseases that have low ELF GSH levels.	[Gould, Neal S.; Min, Elysia; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gould, Neal S.; Day, Brian J.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO USA; [Day, Brian J.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Day, Brian J.] Univ Colorado Denver, Dept Immunol, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gould, NS (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	dayb@njhealth.org			National Institutes of Health [HL084469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part from National Institutes of Health grant HL084469 to BJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Allen TC, 2010, ARCH PATHOL LAB MED, V134, P702, DOI 10.1043/1543-2165-134.5.702; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Bishop C, 2005, CHEST, V127, P308, DOI 10.1378/chest.127.1.308; Brennan S, 2009, EUR RESPIR J, V34, P655, DOI 10.1183/09031936.00178508; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; BUHL R, 1990, P NATL ACAD SCI USA, V87, P4063, DOI 10.1073/pnas.87.11.4063; CANTIN AM, 1991, LUNG, V169, P123, DOI 10.1007/BF02714149; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Eun JS, 2000, ARCH PHARM RES, V23, P531, DOI 10.1007/BF02976585; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gosset P, 1999, EUR RESPIR J, V14, P98, DOI 10.1034/j.1399-3003.1999.14a17.x; Gould NS, 2011, BIOCHEM PHARMACOL, V81, P187, DOI 10.1016/j.bcp.2010.10.001; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; GOULD NS, 2010, AM J RESP CRIT CARE; Griese M, 2004, AM J RESP CRIT CARE, V169, P822, DOI 10.1164/rccm.200308-1104OC; Haddad JJ, 2001, EUR CYTOKINE NETW, V12, P614; Haddad JJ, 2002, BIOCHEM PHARMACOL, V63, P305, DOI 10.1016/S0006-2952(01)00870-X; Haddad JJ, 2000, CYTOKINES CELL MOL T, V6, P177, DOI 10.1080/mccm.6.4.177.187; Hashimoto S, 2001, CLIN EXP ALLERGY, V31, P144, DOI 10.1046/j.1365-2222.2001.00967.x; Iyer SS, 2009, AM J PHYSIOL-LUNG C, V296, pL37, DOI 10.1152/ajplung.90401.2008; Kariya C, 2008, INFECT IMMUN, V76, P4455, DOI 10.1128/IAI.00136-08; Kelly F J, 1996, Cent Eur J Public Health, V4 Suppl, P11; Kinnula VL, 2002, ANTIOXID REDOX SIGN, V4, P27, DOI 10.1089/152308602753625825; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; MORRIS PE, 1994, AM J MED SCI, V307, P119, DOI 10.1097/00000441-199402000-00010; Ng AW, 2004, LUNG, V182, P297, DOI 10.1007/s00408-004-2511-6; Pietarinen-Runtti P, 2000, AM J PHYSIOL-CELL PH, V278, pC118, DOI 10.1152/ajpcell.2000.278.1.C118; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Seres T, 2000, J IMMUNOL, V165, P3333, DOI 10.4049/jimmunol.165.6.3333; Sixt Stephan Urs, 2010, Proc Am Thorac Soc, V7, P91, DOI 10.1513/pats.200906-035JS; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; TERAMOTO S, 1994, LUNG, V172, P223, DOI 10.1007/BF00164439; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Willemse BWM, 2004, EUR RESPIR J, V24, P391, DOI 10.1183/09031936.04.00117603	46	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25704	10.1371/journal.pone.0025704	http://dx.doi.org/10.1371/journal.pone.0025704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991336	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000057
J	Tsuchiya, M; Ogawa, H; Suzuki, T; Sugiyama, N; Haraguchi, T; Hiraoka, Y				Tsuchiya, Megumi; Ogawa, Hidesato; Suzuki, Taiga; Sugiyama, Noriyuki; Haraguchi, Tokuko; Hiraoka, Yasushi			Exportin 4 Interacts with Sox9 through the HMG Box and Inhibits the DNA Binding of Sox9	PLOS ONE			English	Article							AUTOSOMAL SEX REVERSAL; NUCLEAR-LOCALIZATION SIGNALS; SRY-RELATED GENE; TRANSCRIPTION FACTORS; CAMPOMELIC DYSPLASIA; COLLAGEN GENE; ASSOCIATION; PROTEINS; CHONDROGENESIS; EXPRESSION	Sox9 is a transcription factor that is required for tissue development in mammals. In general, such transcription factors require co-regulators for precise temporal and spatial control of the activation and inactivation of the numerous genes necessary for precise development during embryogenesis. Here we identify a new Sox9 co-regulator: Using affinity chromatography with immobilized Sox9 protein, we identified exportin 4 (Exp4) as an interacting protein of Sox9 in human cultured cells. Interaction between endogenous Exp4 and Sox9 proteins was confirmed in the human osteosarcoma U2OS cells by immunoprecipitation experiments using anti-Sox9 antibody. siRNA depletion of Exp4 enhanced transcription of Sox9 target genes in U2OS cells, but did not affect nuclear localization of Sox9. These results suggest that Exp4 regulates Sox9 activity in the nucleus. Furthermore we found that the HMG box of Sox9 was responsible for binding to Exp4, and the HMG box was required for suppression of Sox9-mediated transcription. This contrasts with the known Sox9 co-regulators which bind to its transcriptional activation domain. Chromatin immunoprecipitation analyses revealed that Exp4 prevents Sox9 binding to the enhancers of its target genes. These results demonstrate that Exp4 acts as a Sox9 co-regulator that directly regulates binding of Sox9 to its target genes.	[Tsuchiya, Megumi; Ogawa, Hidesato; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tsuchiya, Megumi; Ogawa, Hidesato] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448585, Japan; [Ogawa, Hidesato; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan; [Suzuki, Taiga] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Sugiyama, Noriyuki] Kyoto Prefectural Univ Med, Kyoto, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Information & Communications Technology (NICT) - Japan; University of California System; University of California Santa Barbara; Kyoto Prefectural University of Medicine	Tsuchiya, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	hidesato@nict.go.jp; hiraoka@fbs.osaka-u.ac.jp	Hiraoka, Yasushi/B-5111-2009; Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016	Hiraoka, Yasushi/0000-0001-9407-8228; Ogawa, Hidesato/0000-0001-9740-9010; 	Japan Ministry of Education, Culture, Sports, Science and Technology [23570219, 21370094, 20114002, 23114724]; Grants-in-Aid for Scientific Research [23570219] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology (www.jsps.go.jp/english/e-grants/grants.html): a Grant-in-Aid for Scientific Research (C) #23570219 to HO, a Grant-in-Aid for Scientific Research (B) #21370094 to TH, a Grant-in-Aid for Scientific Research on Innovative Areas #20114002 to YH, and a Grant-in-Aid for Scientific Research on Innovative Areas #23114724 to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Chan CK, 1999, FEBS LETT, V462, P221, DOI 10.1016/S0014-5793(99)01515-X; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Malki S, 2009, INT J BIOCH CELL BIO; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ogawa H, 2009, MOL BIOL CELL, V20, P4235, DOI 10.1091/mbc.E08-12-1247; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25694	10.1371/journal.pone.0025694	http://dx.doi.org/10.1371/journal.pone.0025694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991335	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000056
J	Filippov, AA; Sergueev, KV; He, YX; Huang, XZ; Gnade, BT; Mueller, AJ; Fernandez-Prada, CM; Nikolich, MP				Filippov, Andrey A.; Sergueev, Kirill V.; He, Yunxiu; Huang, Xiao-Zhe; Gnade, Bryan T.; Mueller, Allen J.; Fernandez-Prada, Carmen M.; Nikolich, Mikeljon P.			Bacteriophage-Resistant Mutants in Yersinia pestis: Identification of Phage Receptors and Attenuation for Mice	PLOS ONE			English	Article							GENERALIZED TRANSDUCING PHAGE; LIPOPOLYSACCHARIDE OUTER CORE; ESCHERICHIA-COLI DIARRHEA; PASTEURELLA-PESTIS; GENOME SEQUENCE; ANTIMICROBIAL PEPTIDES; NUCLEOTIDE-SEQUENCE; BUBONIC PLAGUE; PLATING MEDIUM; MUTATION-RATE	Background: Bacteriophages specific for Yersinia pestis are routinely used for plague diagnostics and could be an alternative to antibiotics in case of drug-resistant plague. A major concern of bacteriophage therapy is the emergence of phage-resistant mutants. The use of phage cocktails can overcome this problem but only if the phages exploit different receptors. Some phage-resistant mutants lose virulence and therefore should not complicate bacteriophage therapy. Methodology/Principal Findings: The purpose of this work was to identify Y. pestis phage receptors using site-directed mutagenesis and trans-complementation and to determine potential attenuation of phage-resistant mutants for mice. Six receptors for eight phages were found in different parts of the lipopolysaccharide (LPS) inner and outer core. The receptor for R phage was localized beyond the LPS core. Most spontaneous and defined phage-resistant mutants of Y. pestis were attenuated, showing increase in LD50 and time to death. The loss of different LPS core biosynthesis enzymes resulted in the reduction of Y. pestis virulence and there was a correlation between the degree of core truncation and the impact on virulence. The yrbH and waaA mutants completely lost their virulence. Conclusions/Significance: We identified Y. pestis receptors for eight bacteriophages. Nine phages together use at least seven different Y. pestis receptors that makes some of them promising for formulation of plague therapeutic cocktails. Most phage-resistant Y. pestis mutants become attenuated and thus should not pose a serious problem for bacteriophage therapy of plague. LPS is a critical virulence factor of Y. pestis.	[Filippov, Andrey A.; Sergueev, Kirill V.; He, Yunxiu; Huang, Xiao-Zhe; Gnade, Bryan T.; Mueller, Allen J.; Fernandez-Prada, Carmen M.; Nikolich, Mikeljon P.] Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Dept Emerging Bacterial Infect, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Filippov, AA (corresponding author), Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Dept Emerging Bacterial Infect, Silver Spring, MD 20910 USA.	andrey.filippov@amedd.army.mil	Nikolich, Mikeljon P/ABC-9871-2021; Nikolich, Mikeljon/ABD-5270-2020	Nikolich, Mikeljon P/0000-0001-5770-8980; Filippov, Andrey/0000-0003-2256-861X	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division [2.10052_08_WR_B]	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the Defense Threat Reduction Agency, Joint Science and Technology Office, Medical S&T Division (http://www.dtra.mil/Research.aspx), grant #2.10052_08_WR_B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN.HW, 1969, REV CAN BIOL EXPTL, V28, P201; ADVIER M., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P94; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Anisimov AP, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P77, DOI 10.1007/978-90-481-9054-6_8; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; APPLEYARD RK, 1954, GENETICS, V39, P440; Arutyunov YI, 1970, ZH MIKROBIOL EPIDEMI, V8, P106; Batson HC, 1956, INTRO STAT MED SCI; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Begum YA, 2010, J MED MICROBIOL, V59, P266, DOI 10.1099/jmm.0.014795-0; BERTANI LE, 1957, VIROLOGY, V4, P53, DOI 10.1016/0042-6822(57)90043-0; BOBROV AG, 1999, PROBL PARTICULARLY D, V79, P138; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; BURROWS TW, 1960, BRIT J EXP PATHOL, V41, P38; Chu MC., 2000, LAB MANUAL PLAGUE DI; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deresinski S, 2009, CLIN INFECT DIS, V48, P1096, DOI 10.1086/597405; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Feodorova VA, 2007, VACCINE, V25, P7620, DOI 10.1016/j.vaccine.2007.08.055; Feodorova VA, 2009, VACCINE, V27, P2240, DOI 10.1016/j.vaccine.2009.02.020; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003; Garcia E, 2008, VIROLOGY, V372, P85, DOI 10.1016/j.virol.2007.10.032; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Goodridge LD, 2010, CURR PHARM BIOTECHNO, V11, P15, DOI 10.2174/138920110790725348; GUNNISON JB, 1951, J INFECT DIS, V88, P254, DOI 10.1093/infdis/88.3.254; Gurleva GG, 1981, ZH MIKROBIOL EPIDEMI, V5, P65; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HERTMAN I, 1964, J BACTERIOL, V88, P1002, DOI 10.1128/JB.88.4.1002-1005.1964; HIGUCHI K, 1961, J BACTERIOL, V81, P605, DOI 10.1128/JB.81.4.605-608.1961; Housby JN, 2009, DRUG DISCOV TODAY, V14, P536, DOI 10.1016/j.drudis.2009.03.006; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; JACKSON S, 1956, BRIT J EXP PATHOL, V37, P570; Jawetz E, 1943, J INFECT DIS, V73, P124, DOI 10.1093/infdis/73.2.124; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KERBY GP, 1949, J IMMUNOL, V63, P93; KNAPP W., 1964, ARCH GESAMTE VIRUSFORSCH, V14, P563, DOI 10.1007/BF01555086; KNAPP W, 1963, ZBL BAKT PARASIT, V190, P39; Kotlyarova RI, 1956, P RES ANT I CAUC TRA, P234; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kutyrev V V, 1989, Mol Gen Mikrobiol Virusol, P42; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larina VS, 1970, PROBL PARTICULARLY D, V11, P132; Lebedeva SA, 2000, ZH MIKROBIOL EPIDEMI, V3, P99; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; NAUMOV AV, 1992, MANUAL PROPHYLAXIS P; NOVOSELTSEV NN, 1990, ZH MIKROB EPID IMMUN, P9; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; OPULSKI A, 1992, JAMA-J AM MED ASSOC, V268, P2146; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Petty NK, 2007, MICROBIOL-SGM, V153, P2984, DOI 10.1099/mic.0.2007/008888-0; Petty NK, 2006, MICROBIOL-SGM, V152, P1701, DOI 10.1099/mic.0.28712-0; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Plotnikov OP, 1982, SELECTION GENETICS C, P56; POKROVSKAYA MP, 1929, GIGIENA EPIDEMIOL, V12, P31; PRUZZO C, 1983, INFECT IMMUN, V39, P520, DOI 10.1128/IAI.39.2.520-527.1983; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ricci V, 2010, APPL ENVIRON MICROB, V76, P1704, DOI 10.1128/AEM.02681-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schofield DA, 2009, J CLIN MICROBIOL, V47, P3887, DOI 10.1128/JCM.01533-09; SCHOONEJANS E, 1987, J BACTERIOL, V169, P4011, DOI 10.1128/jb.169.9.4011-4017.1987; Schwudke D, 2008, J BACTERIOL, V190, P332, DOI 10.1128/JB.01402-07; Sergueev KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011337; Shashaev MA, 1966, PRODUCTION BACTERIAL, P350; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; SMITH DA, 1962, NATURE, V193, P397, DOI 10.1038/193397a0; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; SUNSHINE MG, 1971, VIROLOGY, V46, P691, DOI 10.1016/0042-6822(71)90071-7; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Tan L, 2005, J BACTERIOL, V187, P6599, DOI 10.1128/JB.187.18.6599-6600.2005; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971; Yethon JA, 2000, INFECT IMMUN, V68, P4485, DOI 10.1128/IAI.68.8.4485-4491.2000; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994; Zhao XN, 2011, J GEN VIROL, V92, P216, DOI 10.1099/vir.0.026328-0; ZINDER ND, 1958, VIROLOGY, V5, P291, DOI 10.1016/0042-6822(58)90025-4	95	109	117	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25486	10.1371/journal.pone.0025486	http://dx.doi.org/10.1371/journal.pone.0025486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980477	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900072
J	Lackey, SWK; Wideman, JG; Kennedy, EK; Go, NE; Nargang, FE				Lackey, Sebastian W. K.; Wideman, Jeremy G.; Kennedy, Erin K.; Go, Nancy E.; Nargang, Frank E.			The Neurospora crassa TOB Complex: Analysis of the Topology and Function of Tob38 and Tob37	PLOS ONE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BETA-BARREL PROTEINS; BLUE NATIVE ELECTROPHORESIS; ASSEMBLY PATHWAY; ADP/ATP CARRIER; IMPORT CHANNEL; PREPROTEIN TRANSLOCASE; ESSENTIAL COMPONENT; SAM COMPLEX; BIOGENESIS	The TOB or SAM complex is responsible for assembling several proteins into the mitochondrial outer membrane, including all beta-barrel proteins. We have identified several forms of the complex in Neurospora crassa. One form contains Tob55, Tob38, and Tob37; another contains these three subunits plus the Mdm10 protein; while additional complexes contain only Tob55. As previously shown for Tob55, both Tob37 and Tob38 are essential for viability of the organism. Mitochondria deficient in Tob37 or Tob38 have reduced ability to assemble beta-barrel proteins. The function of two hydrophobic domains in the C-terminal region of the Tob37 protein was investigated. Mutant Tob37 proteins lacking either or both of these regions are able to restore viability to cells lacking the protein. One of the domains was found to anchor the protein to the outer mitochondrial membrane but was not necessary for targeting or association of the protein with mitochondria. Examination of the import properties of mitochondria containing Tob37 with deletions of the hydrophobic domains reveals that the topology of Tob37 may be important for interactions between specific classes of beta-barrel precursors and the TOB complex.	[Lackey, Sebastian W. K.; Wideman, Jeremy G.; Kennedy, Erin K.; Go, Nancy E.; Nargang, Frank E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Lackey, SWK (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	frank.nargang@ualberta.ca		Wideman, Jeremy/0000-0002-4426-9533	Canadian Institutes for Health Research [MOP84284]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant #MOP84284 to FEN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; AUSTIN B, 1990, GENE, V93, P157, DOI 10.1016/0378-1119(90)90152-H; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; BORKOVICH KA, 1987, J BACTERIOL, V169, P5510, DOI 10.1128/jb.169.12.5510-5517.1987; BORNSTEIN P, 1995, P NATL ACAD SCI USA, V92, P4547, DOI 10.1073/pnas.92.10.4547; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Grad LI, 1999, CURR GENET, V36, P137, DOI 10.1007/s002940050483; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; GROTELUESCHEN J, 1995, GENETICS, V139, P1545; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins SC, 2007, GENETICS, V177, P137, DOI 10.1534/genetics.107.075051; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Marathe S, 1998, J BIOL CHEM, V273, P29776, DOI 10.1074/jbc.273.45.29776; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; NARGANG FE, 1995, EMBO J, V14, P1099, DOI 10.1002/j.1460-2075.1995.tb07093.x; Nargang FE, 2007, MITOCHONDRIA PRACTIC; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2004, TOP CURR GENET, V8, P37; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schlossmann J, 1996, J BIOL CHEM, V271, P17890, DOI 10.1074/jbc.271.30.17890; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Stroud DA, 2011, MOL BIOL CELL, V22, P2823, DOI 10.1091/mbc.E11-02-0148; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283	71	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25650	10.1371/journal.pone.0025650	http://dx.doi.org/10.1371/journal.pone.0025650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980517	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900086
J	Tse, H; Tsoi, HW; Teng, JLL; Chen, XC; Liu, HY; Zhou, BP; Zheng, BJ; Woo, PCY; Lau, SKP; Yuen, KY				Tse, Herman; Tsoi, Hoi-Wah; Teng, Jade L. L.; Chen, Xin-Chun; Liu, Haiying; Zhou, Boping; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung			Discovery and Genomic Characterization of a Novel Ovine Partetravirus and a New Genotype of Bovine Partetravirus	PLOS ONE			English	Article							HUMAN PARVOVIRUS PARV4; HUMAN BOCAVIRUS; MOLECULAR EPIDEMIOLOGY; ADENOASSOCIATED VIRUS; BLOOD-DONORS; HUMAN PLASMA; IDENTIFICATION; B19; DNA; PERSISTENCE	Partetravirus is a recently described group of animal parvoviruses which include the human partetravirus, bovine partetravirus and porcine partetravirus (previously known as human parvovirus 4, bovine hokovirus and porcine hokovirus respectively). In this report, we describe the discovery and genomic characterization of partetraviruses in bovine and ovine samples from China. These partetraviruses were detected by PCR in 1.8% of bovine liver samples, 66.7% of ovine liver samples and 71.4% of ovine spleen samples. One of the bovine partetraviruses detected in the present samples is phylogenetically distinct from previously reported bovine partetraviruses and likely represents a novel genotype. The ovine partetravirus is a novel partetravirus and phylogenetically most related to the bovine partetraviruses. The genome organization is conserved amongst these viruses, including the presence of a putative transmembrane protein encoded by an overlapping reading frame in ORF2. Results from the present study provide further support to the classification of partetraviruses as a separate genus in Parvovirinae.	[Tse, Herman; Tsoi, Hoi-Wah; Teng, Jade L. L.; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immun, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Zheng, Bo-Jian; Woo, Patrick C. Y.; Lau, Susanna K. P.; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Chen, Xin-Chun; Zhou, Boping] Shenzhen Third Peoples Hosp, Shenzhen Inst Hepatol, Shenzhen Hong Kong Inst Infect Dis, Shenzhen, Peoples R China; [Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Tse, H (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	Lau, Susanna Kar Pui/0000-0002-1383-7374; Yuen, Kwok-yung/0000-0002-2083-1552; Woo, Patrick Chiu Yat/0000-0001-9401-1832	Health, Welfare and Food Bureau [08070712]; Research Grants Council; University of Hong Kong; Tung Wah Group of Hospitals; Providence Foundation Limited	Health, Welfare and Food Bureau; Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); Tung Wah Group of Hospitals; Providence Foundation Limited	This work is partly supported by the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau (project no.: 08070712) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html); Research Grants Council grant (http://www.ugc.edu.hk/eng/rgc/index.htm); University Development Fund, and Outstanding Young Researcher Award, The University of Hong Kong (http://www.hku.hk/rss/index4.htm); The Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; and the Providence Foundation Limited in memory of the late Dr. Lui Hac Minh. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlhoch C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-171; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Battilani M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-43; Besselsen DG, 2006, J GEN VIROL, V87, P1543, DOI 10.1099/vir.0.81547-0; BLOOM ME, 1988, J VIROL, V62, P2903, DOI 10.1128/JVI.62.8.2903-2915.1988; Burns K, 2007, FIELDS VIROLOGY, P2437; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Corcioli F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-272; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darriba D., 2011, BIOINFORMATICS; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, J GEN VIROL, V88, P2162, DOI 10.1099/vir.0.82620-0; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton H, 2004, J VIROL, V78, P7874, DOI 10.1128/JVI.78.15.7874-7882.2004; Hokynar K, 2002, VIROLOGY, V302, P224, DOI 10.1006/viro.2002.1673; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longhi E, 2007, AIDS, V21, P1481, DOI 10.1097/QAD.0b013e3281e38558; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Moriyama Y, 2010, EUR J PEDIATR, V169, P1087, DOI 10.1007/s00431-010-1183-x; Nguyen QT, 2002, VIROLOGY, V301, P374, DOI 10.1006/viro.2002.1585; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; Panning M, 2010, EMERG INFECT DIS, V16, P1143, DOI 10.3201/eid1607.100025; Parrish CR, 1999, VET MICROBIOL, V69, P29, DOI 10.1016/S0378-1135(99)00084-X; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Servant A, 2002, J VIROL, V76, P9124, DOI 10.1128/JVI.76.18.9124-9134.2002; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Simmonds P, 2008, J GEN VIROL, V89, P2299, DOI 10.1099/vir.0.2008/001180-0; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Soderlund M, 1997, LANCET, V349, P1063, DOI 10.1016/S0140-6736(96)09110-6; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3210/eid1603.090746, 10.3201/eid1603.090746]; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Tuke PW, 2010, J GEN VIROL, V91, P541, DOI 10.1099/vir.0.014852-0; YANG SJ, 2011, J CLIN VIROL; Zehender G, 2010, INFECT GENET EVOL, V10, P215, DOI 10.1016/j.meegid.2009.11.011; Zuo J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-124	60	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25619	10.1371/journal.pone.0025619	http://dx.doi.org/10.1371/journal.pone.0025619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980506	Green Submitted, Green Published, gold			2022-12-25	WOS:000295933700047
J	Renner, P; Roger, T; Bochud, PY; Sprong, T; Sweep, FCGJ; Bochud, M; Faust, SN; Haralambous, E; Betts, H; Chanson, AL; Reymond, MK; Mermel, E; Erard, V; van Deuren, M; Read, RC; Levin, M; Calandra, T				Renner, Pascal; Roger, Thierry; Bochud, Pierre-Yves; Sprong, Tom; Sweep, Fred C. G. J.; Bochud, Murielle; Faust, Saul N.; Haralambous, Elene; Betts, Helen; Chanson, Anne-Laure; Reymond, Marlies Knaup; Mermel, Elliot; Erard, Veronique; van Deuren, Marcel; Read, Robert C.; Levin, Michael; Calandra, Thierry			A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease	FASEB JOURNAL			English	Article						sepsis; Neisseria meningitidis; gene polymorphism; cytokine	JUVENILE IDIOPATHIC ARTHRITIS; INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTOR-4; P38 MAP KINASE; FACTOR MIF; PROMOTER POLYMORPHISM; REGULATORY ROLE; SEVERE SEPSIS; SEPTIC SHOCK; KAPPA-B	Macrophage migration inhibitory factor (MIF) is an abundantly expressed proinflammatory cytokine playing a critical role in innate immunity and sepsis and other inflammatory diseases. We examined whether functional MIF gene polymorphisms (-794 CATT5-8 microsatellite and -173 G/C SNP) were associated with the occurrence and outcome of meningococcal disease in children. The CATT5 allele was associated with the probability of death predicted by the Pediatric Index of Mortality 2 (P = 0.001), which increased in correlation with the CATT5 copy number (P = 0.04). The CATT5 allele, but not the -173 G/C alleles, was also associated with the actual mortality from meningoccal sepsis [OR 2.72 (1.2-6.4), P = 0.02]. A family-based association test (i.e., transmission disequilibrium test) performed in 240 trios with 1 afflicted offspring indicated that CATT5 was a protective allele (P = 0.02) for the occurrence of meningococcal disease. At baseline and after stimulation with Neisseria meningitidis in THP-1 monocytic cells or in a whole-blood assay, CATT5 was found to be a low-expression MIF allele (P = 0.005 and P = 0.04 for transcriptional activity; P = 0.09 and P = 0.09 for MIF production). Taken together, these data suggest that polymorphisms of the MIF gene affecting MIF expression are associated with the occurrence, severity, and outcome of meningococcal disease in children.-Renner, P., Roger, T., Bochud, P.-Y., Sprong, T., Sweep, F. C. G. J., Bochud, M., Faust, S. N., Haralambous, E., Betts, H., Chanson, A.-L., Reymond, M. K., Mermel, E., Erard, V., van Deuren, M., Read, R. C., Levin, M., Calandra, T. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J. 26, 907-916 (2012). www.fasebj.org	[Renner, Pascal; Roger, Thierry; Bochud, Pierre-Yves; Chanson, Anne-Laure; Reymond, Marlies Knaup; Mermel, Elliot; Erard, Veronique; Calandra, Thierry] CHU Vaudois, Infect Dis Serv, Dept Med, CH-1011 Lausanne, Switzerland; [Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Bochud, Murielle] Univ Lausanne, Lausanne, Switzerland; [Sprong, Tom; van Deuren, Marcel] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Sprong, Tom; van Deuren, Marcel] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun N4I, NL-6525 ED Nijmegen, Netherlands; [Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Ziekenhuis Nijmegen, Dept Internal Med, Nijmegen, Netherlands; [Faust, Saul N.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Sprong, Tom] Canisius Wilhelmina Ziekenhuis Nijmegen, Dept Med Microbiol, Nijmegen, Netherlands; [Faust, Saul N.] Southampton Univ Hosp, Natl Hlth Serv Fdn Trust, Southampton, Hants, England; [Faust, Saul N.] Wellcome Trust Res Labs, Clin Res Facil, Southampton, Hants, England; [Haralambous, Elene] Imperial Coll London St Marys Campus, Dept Pediat, London, England; [Betts, Helen; Levin, Michael] Imperial Coll London St Marys Campus, Div Infect Dis, Dept Med, London, England; [Read, Robert C.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Read, Robert C.] Sheffield Teaching Hosp Fdn Trust, Sheffield, S Yorkshire, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Southampton; Canisius-Wilhelmina Hospital; University of Southampton; Imperial College London; Imperial College London; University of Sheffield	Calandra, T (corresponding author), CHU Vaudois, Infect Dis Serv, Dept Med, BH 10-555,Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	thierry.calandra@chuv.ch	Bochud, Murielle/A-3981-2010; Deuren, Marcel/O-1846-2013; Sweep, C.G.J./H-8096-2014; Calandra, Thierry/D-9017-2015; Faust, Saul/J-9779-2014; Bochud, Pierre-Yves/ABE-5979-2020; Roger, Thierry/G-2007-2012	Bochud, Murielle/0000-0002-5727-0218; Sweep, C.G.J./0000-0003-1103-3070; Calandra, Thierry/0000-0003-3051-1285; Faust, Saul/0000-0003-3410-7642; Roger, Thierry/0000-0002-9358-0109; Bochud, Pierre-Yves/0000-0002-2208-4757; Levin, Michael/0000-0003-2767-6919	Swiss National Science Foundation [3100_066972, 310000_118266]; Leenaards Foundation; Santos-Suarez Foundation for Medical Research; Meningitis Research Foundation, UK; Baxter AG (Vienna); University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; Santos-Suarez Foundation for Medical Research; Meningitis Research Foundation, UK(Meningitis Research Foundation (MRF)); Baxter AG (Vienna); University of Lausanne	The authors thank Francisca Tilves Pazos for blood drawing. This work was supported by the Swiss National Science Foundation (grants 3100_066972 and 310000_118266 to T. C.), the Leenaards Foundation (T. R. and T. C.), the Santos-Suarez Foundation for Medical Research (T. C.), and the Meningitis Research Foundation, UK (M. L.). T. C. has received research funding from and has been a consultant for Baxter AG (Vienna). E. M. was supported by the Summer Undergraduate Research (SUR) program of the University of Lausanne.	Aeberli D, 2006, FEBS LETT, V580, P974, DOI 10.1016/j.febslet.2006.01.027; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Awandare GA, 2006, GENES IMMUN, V7, P568, DOI 10.1038/sj.gene.6364332; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Balding J, 2003, GENES IMMUN, V4, P533, DOI 10.1038/sj.gene.6364020; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Beishuizen A, 2001, J CLIN ENDOCR METAB, V86, P2811, DOI 10.1210/jc.86.6.2811; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Burger-Kentischer A, 2006, ATHEROSCLEROSIS, V184, P28, DOI 10.1016/j.atherosclerosis.2005.03.028; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Daun JM, 2000, AM J PHYSIOL-REG I, V279, pR1043, DOI 10.1152/ajpregu.2000.279.3.R1043; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Donn R, 2004, ARTHRITIS RHEUM-US, V50, P1604, DOI 10.1002/art.20178; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Endler G, 2006, CLIN CHEM, V52, P511, DOI 10.1373/clinchem.2005.058537; Filip AM, 2009, J BIOL CHEM, V284, P7977, DOI 10.1074/jbc.M808620200; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gando S, 2001, INTENS CARE MED, V27, P1187, DOI 10.1007/s001340000818; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Gregersen PK, 2003, ARTHRITIS RHEUM-US, V48, P1171, DOI 10.1002/art.10880; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Haralambous E, 2003, CRIT CARE MED, V31, P2788, DOI 10.1097/01.CCM.0000100122.57249.5D; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Le Roy D, 2001, J IMMUNOL, V167, P2759, DOI 10.4049/jimmunol.167.5.2759; Lehmann LE, 2001, INTENS CARE MED, V27, P1412, DOI 10.1007/s001340101022; Lehmann LE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-100; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2009, CYTOKINE, V48, P177, DOI 10.1016/j.cyto.2009.07.002; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lugrin J, 2009, BBA-MOL CELL RES, V1793, P1749, DOI 10.1016/j.bbamcr.2009.09.007; Martin RJL, 2010, DIABETIC MED, V27, P143, DOI 10.1111/j.1464-5491.2009.02916.x; Maxime V, 2005, J INFECT DIS, V191, P138, DOI 10.1086/426401; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Renner P, 2005, CLIN INFECT DIS, V41, pS513, DOI 10.1086/432009; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Roger T, 2007, EUR J IMMUNOL, V37, P3509, DOI 10.1002/eji.200737357; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Santos LL, 2004, J RHEUMATOL, V31, P1038; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sprong T, 2007, SHOCK, V27, P482, DOI 10.1097/01.shk.0000246898.65692.34; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Veillat V, 2009, FERTIL STERIL, V91, P2148, DOI 10.1016/j.fertnstert.2008.05.017; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Wright V, 2009, VACCINE, V27, pB90, DOI 10.1016/j.vaccine.2009.05.002; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445	79	42	42	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					907	916		10.1096/fj.11-195065	http://dx.doi.org/10.1096/fj.11-195065			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	21990375				2022-12-25	WOS:000300485700040
J	Yang, X; Teng, Y; Hou, N; Fan, XW; Cheng, X; Li, J; Wang, LJ; Wang, YL; Wu, XS; Yang, X				Yang, Xue; Teng, Yan; Hou, Ning; Fan, Xiongwei; Cheng, Xuan; Li, Jun; Wang, Lijuan; Wang, Youliang; Wu, Xiushan; Yang, Xiao			Delayed Re-epithelialization in Ppm1a Gene-deficient Mice Is Mediated by Enhanced Activation of Smad2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TRANSGENIC MICE; ACCELERATED REEPITHILIALIZATION; WOUND REPAIR; SKIN WOUNDS; PHOSPHATASE; MOUSE; TGF-BETA-1; INDUCTION; REEPITHELIALIZATION	Protein phosphatase magnesium-dependent 1A (PPM1A), a protein serine/threonine phosphatase, controls several signal pathways through cleavage of phosphate from its substrates. However, the in vivo function of Ppm1a in mammals remains unknown. Here we reported that mice lacking Ppm1a developed normally but were impaired in re-epithelialization process during cutaneous wound healing. Specifically, complete or keratinocyte-specific deletion of Ppm1a led to delayed re-epithelialization with reduced keratinocyte migration upon wounding. We showed that this effect was the result of an increase in Smad2/3 phosphorylation in keratinocytes. Keratinocyte-specific Smad2 deficient mice displayed accelerated re-epithelialization with enhanced keratinocyte migration. Importantly, Smad2 and Ppm1a double mutant mice also exhibited accelerated re-epithelialization, demonstrating that the effect of Ppm1a on promoting re-epithelialization is mediated by Smad2 signaling. Furthermore, the decreased expression of specific integrins and matrix metalloproteinases (MMPs) may contribute to the retarded re-epithelialization in Ppm1a mutant mice. These data indicate that Ppm1a, through suppressing Smad2 signaling, plays a critical role in re-epithelialization during wound healing.	[Yang, Xue; Teng, Yan; Hou, Ning; Fan, Xiongwei; Cheng, Xuan; Li, Jun; Wang, Lijuan; Wang, Youliang; Yang, Xiao] Inst Biotechnol, State Key Lab Prote Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Yang, Xue; Yang, Xiao] Shanghai Jiao Tong Univ, E Inst Shanghai Univ, Model Organism Div, Shanghai 200025, Peoples R China; [Wu, Xiushan] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China	Shanghai Jiao Tong University; Hunan Normal University	Teng, Y (corresponding author), Inst Biotechnol, State Key Lab Prote Genet Lab Dev & Dis, 20 Dongdajie, Beijing 100071, Peoples R China.	tengyan0919@tom.com; yangx@nic.bmi.ac.cn	Yang, xue/G-3626-2016; XIAO, YANG/GPW-5529-2022	Yang, Xiao/0000-0002-0298-9831	Chinese National Key Program on Basic Research [2011CB504200, 2012CB945100, 2011CB910601]; National Natural Science Foundation of China [31030040, 30871396, 31171249, 30700423]; Beijing Natural Science Foundation of China [5082018]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by Grants 2011CB504200, 2012CB945100, and 2011CB910601 from the Chinese National Key Program on Basic Research, Grants 31030040, 30871396, 31171249, and 30700423 from the National Natural Science Foundation of China, and Grant 5082018 from the Beijing Natural Science Foundation of China.	Amendt C, 2002, J CELL SCI, V115, P2189; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Chan T, 2002, WOUND REPAIR REGEN, V10, P177, DOI 10.1046/j.1524-475X.2002.11101.x; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Kaiser S, 1998, J INVEST DERMATOL, V111, P1145, DOI 10.1046/j.1523-1747.1998.00407.x; KOKABU S, J BONE MINER RES, V25, P653; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Owens P, 2010, AM J PATHOL, V176, P122, DOI 10.2353/ajpath.2010.090081; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Schilling SH, 2006, CELL, V125, P838, DOI 10.1016/j.cell.2006.05.015; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Teng Y, 2006, CANCER RES, V66, P6972, DOI 10.1158/0008-5472.CAN-06-0507; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhang BH, 2009, HISTOCHEM CELL BIOL, V132, P169, DOI 10.1007/s00418-009-0601-5; Zhou J, 2002, SCI CHINA SER C, V45, P129, DOI 10.1360/02yc9015	37	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42267	42273		10.1074/jbc.M111.292284	http://dx.doi.org/10.1074/jbc.M111.292284			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990361	Green Published, hybrid			2022-12-25	WOS:000298180900036
J	Ikushima, H; Todo, T; Ino, Y; Takahashi, M; Saito, N; Miyazawa, K; Miyazono, K				Ikushima, Hiroaki; Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Saito, Nobuhito; Miyazawa, Keiji; Miyazono, Kohei			Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; SELF-RENEWAL; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; MICE LACKING; GLIOBLASTOMA; COMPLEX; IDENTIFICATION; TUMORS; DIFFERENTIATION	Although the concept of cancer stem cells or cancer-initiating cells had created a new paradigm for the treatment of malignant tumors, it remains unclear how cancer-initiating cells can be eradicated. We have previously reported that the transforming growth factor-beta (TGF-beta)-Sox4-Sox2 pathway is essential for glioma-initiating cells to retain their sternness, and inhibition of TGF-beta signaling may lead to differentiation of glioma-initiating cells (Ikushima, H., Todo, T., Ino, Y., Takahashi, M., Miyazawa, K., and Miyazono, K. (2009) Cell Stem Cell 5, 504-514). Here we demonstrate that Oct4 plays essential roles in retention of the sternness properties of glioma-initiating cells through positive regulation of Sox2 expression. We also show that, in glioma-initiating cells, Oct4 is associated with Sox4 and that Oct4-Sox4 complexes cooperatively activate the enhancer activity of the SOX2 gene. In contrast, in fetal neural progenitor cells, Sox2 expression is enhanced by transcriptional complex containing Sox2 protein itself, and this self-reinforcing loop of Sox2 appears to be disrupted in glioma-initiating cells, suggesting that Sox2 expression in glioma-initiating cells is differently regulated from that in neural progenitor cells. Our findings reveal differences between glioma-initiating cells and fetal neural progenitor cells and may open the way to depriving glioma-initiating cells of tumorigenic activity without affecting normal tissues.	[Ikushima, Hiroaki; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi] Univ Tokyo, Grad Sch Med, Translat Res Ctr, Tokyo 1130033, Japan; [Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Yamanashi 4093898, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Yamanashi	Miyazono, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Takahashi, Masamichi/GRJ-2866-2022	Todo, Tomoki/0000-0003-0523-8010; Takahashi, Masamichi/0000-0001-8792-1993	KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan; University of Tokyo; Antisense Pharma GmbH (Germany); Grants-in-Aid for Scientific Research [21390404] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokyo; Antisense Pharma GmbH (Germany); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (grant-in-aid for scientific research) and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a grant-in-aid for Cancer Research for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour, and Welfare of Japan.; Supported by a Tetsumon scholarship for the Ph.D.-M.D. program of the University of Tokyo.; Supported by a research grant from Antisense Pharma GmbH (Germany).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Jones TD, 2004, CLIN CANCER RES, V10, P8544, DOI 10.1158/1078-0432.CCR-04-0688; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka M, 2005, LANCET ONCOL, V6, P953, DOI 10.1016/S1470-2045(05)70395-8; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	41	112	118	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41434	41441		10.1074/jbc.M111.300863	http://dx.doi.org/10.1074/jbc.M111.300863			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987575	hybrid, Green Published			2022-12-25	WOS:000298057500030
J	Kuang, ES; Fu, BS; Liang, QM; Myoung, J; Zhu, FX				Kuang, Ersheng; Fu, Bishi; Liang, Qiming; Myoung, Jinjong; Zhu, Fanxiu			Phosphorylation of Eukaryotic Translation Initiation Factor 4B (EIF4B) by Open Reading Frame 45/p90 Ribosomal S6 Kinase (ORF45/RSK) Signaling Axis Facilitates Protein Translation during Kaposi Sarcoma-associated Herpesvirus (KSHV) Lytic Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; PRIMARY EFFUSION LYMPHOMA; FACTOR EIF-4B; TUBEROUS SCLEROSIS; HELICASE ACTIVITY; GENE-EXPRESSION; VACCINIA VIRUS; MAPK PATHWAYS; ENTRY SITE; IN-VITRO	Open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus (KSHV) causes sustained activation of p90 ribosomal 56 kinase (RSK), which is crucial for KSHV lytic replication, but the exact functional roles remain to be determined. To characterize the biological consequence of persistent RSK activation by ORF45, we screened known cellular substrates of RSK. We found that ORF45 induced phosphorylation of eukaryotic translation initiation factor 4B (eIF4B), increased its assembly into translation initiation complex, and subsequently facilitated protein translation. The ORF45/RSK-mediated eIF4B phosphorylation was distinguishable from that caused by the canonical AKT/mammalian target of rapamycin/ribosomal S6 kinase and MEK/ERK/RSK pathways because it was resistant to both rapamycin (an mammalian target of rapamycin inhibitor) and U1026 (an MEK inhibitor). The rapamycin and U1026 doubly insensitive eIF4B phosphorylation was induced during KSHV reactivation but was abolished if either ORF45 or RSK1/2 were ablated by siRNA, a pattern that is correlated with reduced lytic gene expression as we observed previously. Ectopic expression of eIF4B but not its phosphorylation-deficient mutant form increased KSHV lytic gene expression and production of progeny viruses. Together, these results indicated that ORF45/RSK axis-induced eIF4B phosphorylation is involved in translational regulation and is required for optimal KSHV lytic replication.	[Kuang, Ersheng; Fu, Bishi; Liang, Qiming; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Myoung, Jinjong] Novartis Inst Biomed Res, Emeryville, CA 94608 USA	State University System of Florida; Florida State University; Novartis	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	fzhu@bio.fsu.edu			National Institutes of Health [R01DE016680]; Bankhead-Coley bridge; Florida State University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley bridge; Florida State University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE016680 (to F. Z.). This work was also supported by a Bankhead-Coley bridge grant, a Florida State University setup fund, and a Florida State University planning grant (to F. Z.).	Angenstein F, 1998, P NATL ACAD SCI USA, V95, P15078, DOI 10.1073/pnas.95.25.15078; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; BAGLIONI C, 1978, NATURE, V275, P240, DOI 10.1038/275240a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Boulanger E, 2008, AM J TRANSPLANT, V8, P707, DOI 10.1111/j.1600-6143.2007.02110.x; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Dioum EM, 2009, CELL, V139, P462, DOI 10.1016/j.cell.2009.10.007; Doepker RC, 2004, J VIROL, V78, P4684, DOI 10.1128/JVI.78.9.4684-4699.2004; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; KWONG AD, 1988, J VIROL, V62, P912, DOI 10.1128/JVI.62.3.912-921.1988; Lambert PJ, 2007, EXPERT OPIN THER TAR, V11, P589, DOI 10.1517/14728222.11.5.589; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Li XJ, 2009, J VIROL, V83, P2531, DOI 10.1128/JVI.02209-08; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; MEYER K, 1995, J VIROL, V69, P2819, DOI 10.1128/JVI.69.5.2819-2824.1995; Mizutani T, 2007, ANN NY ACAD SCI, V1102, P86, DOI 10.1196/annals.1408.006; MOHR IJ, 2007, TRANSLATIONAL CONTRO, P545; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; Ochs K, 1999, J VIROL, V73, P7505, DOI 10.1128/JVI.73.9.7505-7514.1999; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Panteva M, 2003, VIRUS RES, V92, P131, DOI 10.1016/S0168-1702(02)00356-8; Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Rust RC, 1999, J VIROL, V73, P6111, DOI 10.1128/JVI.73.7.6111-6113.1999; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Smith RWP, 2008, BIOCHEM SOC T, V36, P701, DOI 10.1042/BST0360701; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tominaga Y, 2005, MOL CELL BIOL, V25, P8465, DOI 10.1128/MCB.25.19.8465-8475.2005; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	83	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41171	41182		10.1074/jbc.M111.280982	http://dx.doi.org/10.1074/jbc.M111.280982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994950	Green Published, hybrid			2022-12-25	WOS:000298057500006
J	Fei, YR; Xiao, LP; Doetschman, T; Coffin, DJ; Hurley, MM				Fei, Yurong; Xiao, Liping; Doetschman, Thomas; Coffin, Douglas J.; Hurley, Marja M.			Fibroblast Growth Factor 2 Stimulation of Osteoblast Differentiation and Bone Formation Is Mediated by Modulation of the Wnt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIZZLED-RELATED PROTEIN-1; BETA-CATENIN; NEGATIVE REGULATOR; MISSENSE MUTATIONS; IN-VIVO; MASS; MICE; GENE; LRP5; RECEPTOR	Fibroblast growth factor 2 (FGT2) positively modulates osteoblast differentiation and bone formation. However, the mechanism(s) is not fully understood. Because the Wnt canonical pathway is important for bone homeostasis, this study focuses on modulation of Wnt/beta-catenin signaling using Fgf2(-/-) mice (FGF2 all isoforms ablated), both in the absence of endogenous FGF2 and in the presence of exogenous FGF2. This study demonstrates a role of endogenous FGF2 in bone formation through Wnt signaling. Specifically, mRNA expression for the canonical Wnt genes Wnt10b, Lrp6, and beta-catenin was decreased significantly in Fgf2(-/-) bone marrow stromal cells during osteoblast differentiation. In addition, a marked reduction of Wnt10b and p-catenin protein expression was observed in Fgf2(-/-) mice. Furthermore, Fgf2(-/-) osteoblasts displayed marked reduction of inactive phosphorylated glycogen synthase kinase-3 beta, a negative regulator of Wnt/beta-catenin pathway as well as a significant decrease of Dkk2 mRNA, which plays a role in terminal osteoblast differentiation. Addition of exogenous FGF2 promoted p-catenin nuclear accumulation and further partially rescued decreased mineralization in Fgf2(-/-) bone marrow stromal cell cultures, Collectively, our findings suggest that FGF2 stimulation of osteoblast differentiation and bone formation is mediated in part by modulating the Wnt pathway.	[Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Doetschman, Thomas] Univ Arizona, Tucson, AZ 85724 USA; [Coffin, Douglas J.] Univ Montana, Missoula, MT 59812 USA	University of Connecticut; University of Arizona; University of Montana System; University of Montana	Hurley, MM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@nso1.uchc.edu			National Institutes of Health [AG021189]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, National Institutes of Health Grant AG021189 (to M. M. H.).	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Cho HY, 2010, BONE, V47, P263, DOI 10.1016/j.bone.2010.05.010; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Fei YR, 2010, BIOCHEM BIOPH RES CO, V391, P335, DOI 10.1016/j.bbrc.2009.11.059; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Hurley M. M., 2002, PRINCIPLES BONE BIOL, P627; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; HURLEY MM, 1994, J BIOL CHEM, V269, P9392; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Karsenty G, 2008, HUM GENET, V9, P183; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawaguchi H, 2010, J BONE MINER RES, V25, P2459, DOI 10.1002/jbmr.146; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakamura K, 1998, INT ORTHOP, V22, P49, DOI 10.1007/s002640050207; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Okada Y, 2003, J BIOL CHEM, V278, P21258, DOI 10.1074/jbc.M302113200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Spellman PT, 2002, GENOME BIOL, V3; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	66	74	81	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40575	40583		10.1074/jbc.M111.274910	http://dx.doi.org/10.1074/jbc.M111.274910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21987573	Green Published, hybrid			2022-12-25	WOS:000297315400017
J	Jun, GG; Nicolaou, M; Morrison, MA; Buros, J; Morgan, DJ; Radeke, MJ; Yonekawa, Y; Tsironi, EE; Kotoula, MG; Zacharaki, F; Mollema, N; Yuan, Y; Miller, JW; Haider, NB; Hageman, GS; Kim, IK; Schaumberg, DA; Farrer, LA; DeAngelis, MM				Jun, Gyungah; Nicolaou, Michael; Morrison, Margaux A.; Buros, Jacqueline; Morgan, Denise J.; Radeke, Monte J.; Yonekawa, Yoshihiro; Tsironi, Evangelia E.; Kotoula, Maria G.; Zacharaki, Fani; Mollema, Nissa; Yuan, Yang; Miller, Joan W.; Haider, Neena B.; Hageman, Gregory S.; Kim, Ivana K.; Schaumberg, Debra A.; Farrer, Lindsay A.; DeAngelis, Margaret M.			Influence of ROBO1 and RORA on Risk of Age-Related Macular Degeneration Reveals Genetically Distinct Phenotypes in Disease Pathophysiology	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; GENE-EXPRESSION; AXON GUIDANCE; SMOKING; DRUSEN; ALPHA; SUSCEPTIBILITY; POLYMORPHISM; VARIANT; COMMON	ROBO1 is a strong candidate gene for age-related macular degeneration (AMD) based upon its location under a linkage peak on chromosome 3p12, its expression pattern, and its purported function in a pathway that includes RORA, a gene previously associated with risk for neovascular AMD. Previously, we observed that expression of ROBO1 and RORA is down-regulated among wet AMD cases, as compared to their unaffected siblings. Thus, we hypothesized that contribution of association signals in ROBO1, and interaction between these two genes may be important for both wet and dry AMD. We evaluated association of 19 single nucleotide polymorphisms (SNPs) in ROBO1 with wet and dry stages of AMD in a sibling cohort and a Greek case-control cohort containing 491 wet AMD cases, 174 dry AMD cases and 411 controls. Association signals and interaction results were replicated in an independent prospective cohort (1070 controls, 164 wet AMD cases, 293 dry AMD cases). The most significantly associated ROBO1 SNPs were rs1387665 under an additive model (meta P = 0.028) for wet AMD and rs9309833 under a recessive model (meta P = 6x10(-4)) for dry AMD. Further analyses revealed interaction between ROBO1 rs9309833 and RORA rs8034864 for both wet and dry AMD (interaction P<0.05). These studies were further supported by whole transcriptome expression profile studies from 66 human donor eyes and chromatin immunoprecipitation assays from mouse retinas. These findings suggest that distinct ROBO1 variants may influence the risk of wet and dry AMD, and the effects of ROBO1 on AMD risk may be modulated by RORA variants.	[Jun, Gyungah; Nicolaou, Michael; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Morrison, Margaux A.; Yonekawa, Yoshihiro; Miller, Joan W.; Kim, Ivana K.; DeAngelis, Margaret M.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Morrison, Margaux A.; Morgan, Denise J.; Hageman, Gregory S.; DeAngelis, Margaret M.] Univ Utah, Ctr Translat Med, John Moran Eye Ctr, Salt Lake City, UT USA; [Radeke, Monte J.] Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA; [Yonekawa, Yoshihiro] Weill Cornell Med Coll, New York, NY USA; [Tsironi, Evangelia E.; Kotoula, Maria G.; Zacharaki, Fani] Univ Thessaly, Larisa, Greece; [Mollema, Nissa; Yuan, Yang; Haider, Neena B.] Univ Nebraska Med Ctr, Omaha, NE USA; [Schaumberg, Debra A.] Brigham & Womens Hosp, Harvard Med Sch, Div Prevent Med, Boston, MA 02115 USA; [Jun, Gyungah; Nicolaou, Michael; Buros, Jacqueline; Schaumberg, Debra A.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Harvard University; Massachusetts Eye & Ear Infirmary; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Barbara; Cornell University; University of Thessaly; University of Nebraska System; University of Nebraska Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Jun, GG (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	Margaret.DeAngelis@utah.edu	Kotoula, Maria/Y-6539-2019; Farrer, Lindsay/AAS-1035-2020; DeAngelis, e/J-7863-2015; Nicolaou, Michael/AAU-1054-2021	Jun, Gyungah/0000-0002-3230-8697; Kim, Ivana/0000-0003-0310-6129; Buros, Jacqueline/0000-0001-9588-4889; Farrer, Lindsay/0000-0001-5533-4225	Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Research to Prevent Blindness; Hope for Vision; National Institutes of Health [EY014458, EY14104, EY017362, EY017404]; Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE [R01EY014458, R01EY017362, P30EY014800, R24EY017404, P30EY014104] Funding Source: NIH RePORTER	Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hope for Vision; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; the Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, University of Utah; Hope for Vision; and the National Institutes of Health (EY014458, EY14104, EY017362, EY017404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anitha A, 2008, AM J MED GENET B, V147B, P1019, DOI 10.1002/ajmg.b.30697; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen HY, 2010, ADV EXP MED BIOL, V664, P457, DOI 10.1007/978-1-4419-1399-9_52; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; CHEN W, 2010, P NATL ACAD SCI US; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Cong RH, 2008, ANN EPIDEMIOL, V18, P647, DOI 10.1016/j.annepidem.2008.04.002; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Erskine L, 2000, J NEUROSCI, V20, P4975; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hamdi HK, 2003, FRONT BIOSCI-LANDMRK, V8, pE305, DOI 10.2741/1019; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, CURR EYE RES, V34, P1019, DOI 10.3109/02713680903308495; Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jun G, 2005, INVEST OPHTH VIS SCI, V46, P3081, DOI 10.1167/iovs.04-1360; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Plachez C, 2008, MOL CELL NEUROSCI, V37, P719, DOI 10.1016/j.mcn.2007.12.017; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SanGiovanni JP, 2009, AM J CLIN NUTR, V90, P1601, DOI 10.3945/ajcn.2009.27594; Schaumberg DA, 2010, ARCH OPHTHALMOL-CHIC, V128, P1462, DOI 10.1001/archophthalmol.2010.261; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Silveira AC, 2010, VISION RES, V50, P698, DOI 10.1016/j.visres.2009.09.016; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836	49	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25775	10.1371/journal.pone.0025775	http://dx.doi.org/10.1371/journal.pone.0025775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998696	gold, Green Published, Green Submitted			2022-12-25	WOS:000295968700018
J	Park, MT; Song, MJ; Lee, H; Oh, ET; Choi, BH; Jeong, SY; Choi, EK; Park, HJ				Park, Moon-Taek; Song, Min-Jeong; Lee, Hyemi; Oh, Eun-Taex; Choi, Bo-Hwa; Jeong, Seong-Yun; Choi, Eun-Kyung; Park, Heon Joo			beta-Lapachone Significantly Increases the Effect of Ionizing Radiation to Cause Mitochondrial Apoptosis via JNK Activation in Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MAP KINASES; NAD(P)H-QUINONE OXIDOREDUCTASE; CASPASE-8 ACTIVATION; MEDIATED APOPTOSIS; ARSENIC TRIOXIDE; DEATH PATHWAY; UP-REGULATION; BID CLEAVAGE	Background: beta-lapachone (beta-lap), has been known to cause NQO1-dependnet death in cancer cells and sensitize cancer cells to ionizing radiation (IR). We investigated the mechanisms underlying the radiosensitization caused by beta-lap. Methodology/Principal Findings: beta-lap enhanced the effect of IR to cause clonogenic cells in NQO1(+)-MDA-MB-231 cells but not in NQO1(-)-MDA-MB-231 cells. beta-lap caused apoptosis only in NQO1(+) cells and not in NQO1(-) cells and it markedly increased IR-induced apoptosis only in NQO1(+) cells. Combined treatment of NQO1(+) cells induced ROS generation, triggered ER stress and stimulated activation of ERK and JNK. Inhibition of ROS generation by NAC effectively attenuated the activation of ERK and JNK, induction of ER stress, and subsequent apoptosis. Importantly, inhibition of ERK abolished ROS generation and ER stress, whereas inhibition of JNK did not, indicating that positive feedback regulation between ERK activation and ROS generation triggers ER stress in response to combined treatment. Furthermore, prevention of ER stress completely blocked combination treatment-induced JNK activation and subsequent apoptotic cell death. In addition, combined treatment efficiently induced the mitochondrial translocation of cleaved Bax, disrupted mitochondrial membrane potential, and the nuclear translocation of AIF, all of which were efficiently blocked by a JNK inhibitor. Caspases 3, 8 and 9 were activated by combined treatment but inhibition of these caspases did not abolish apoptosis indicating caspase activation played a minor role in the induction of apoptosis. Conclusions/Significance: beta-lap causes NQO1-dependent radiosensitization of cancer cells. When NQO1(+) cells are treated with combination of IR and beta-lap, positive feedback regulation between ERK and ROS leads to ER stress causing JNK activation and mitochondrial translocation of cleaved Bax. The resultant decrease in mitochondrial membrane leads to translocation of AIF and apoptosis.	[Park, Moon-Taek; Song, Min-Jeong; Lee, Hyemi; Oh, Eun-Taex; Choi, Bo-Hwa; Park, Heon Joo] Inha Univ, Dept Microbiol, Ctr Adv Med Educ, BK21 Project,Coll Med, Inchon, South Korea; [Jeong, Seong-Yun; Choi, Eun-Kyung] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea	Inha University; University of Ulsan; Asan Medical Center	Park, MT (corresponding author), Inha Univ, Dept Microbiol, Ctr Adv Med Educ, BK21 Project,Coll Med, Inchon, South Korea.	park001@inha.ac.kr			Korea Health 21 RD Project [A062254]; Korea Science and Engineering Foundation [2009-0093747]; National Research Foundation of Korea; Korea government (MEST) [20110018954]	Korea Health 21 RD Project; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Health 21 R&D Project (A062254), the nuclear research and development program of the Korea Science and Engineering Foundation (2009-0093747), and by the National Research Foundation of Korea grant funded by the Korea government (MEST) (20110018954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; BOORSTEIN RJ, 1984, BIOCHEM BIOPH RES CO, V118, P828, DOI 10.1016/0006-291X(84)91469-4; BOOTHMAN DA, 1989, CANCER RES, V49, P605; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camacho-Leal P, 2008, ONCOGENE, V27, P1545, DOI 10.1038/sj.onc.1210789; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Choi EK, 2007, NEOPLASIA, V9, P634, DOI 10.1593/neo.07397; Dang PMC, 2006, FASEB J, V20, P1504, DOI 10.1096/fj.05-5395fje; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Dong Y, 2010, CANCER RES, V70, P8088, DOI 10.1158/0008-5472.CAN-10-1418; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Karlsson J, 2004, CLIN CANCER RES, V10, P3179, DOI 10.1158/1078-0432.CCR-03-0309; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Kumi-Diaka J, 2002, BIOL CELL, V94, P37, DOI 10.1016/S0248-4900(01)01175-3; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Li CJ, 1999, P NATL ACAD SCI USA, V96, P13369, DOI 10.1073/pnas.96.23.13369; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Park HJ, 2005, INT J RADIAT ONCOL, V61, P212, DOI 10.1016/j.ijrobp.2004.09.018; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Terai K, 2009, ANTI-CANCER DRUG, V20, P901, DOI 10.1097/CAD.0b013e328330098d; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	56	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25976	10.1371/journal.pone.0025976	http://dx.doi.org/10.1371/journal.pone.0025976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998736	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700028
J	Petty, E; Laughlin, E; Csankovszki, G				Petty, Emily; Laughlin, Emily; Csankovszki, Gyoergyi			Regulation of DCC Localization by HTZ-1/H2A. Z and DPY-30 Does not Correlate with H3K4 Methylation Levels	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOMES; HISTONE H3; MOLECULAR REGULATION; GENOME-WIDE; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; ESSENTIAL COMPONENT; DNA METHYLATION; SET1 COMPLEX	Dosage compensation is a specialized form of gene regulation that balances sex-chromosome linked gene expression between the sexes. In C. elegans, dosage compensation is achieved by the activity of the dosage compensation complex (DCC). The DCC binds along both X chromosomes in hermaphrodites to down-regulate gene expression by half, limiting X-linked gene products to levels produced in XO males. Sequence motifs enriched on the X chromosome play an important role in targeting the DCC to the X. However, these motifs are not strictly X-specific and therefore other factors, such as the chromatin environment of the X chromosome, are likely to aid in DCC targeting. Previously, we found that loss of HTZ-1 results in partial disruption of dosage compensation localization to the X chromosomes. We wanted to know whether other chromatin components coordinated with HTZ-1 to regulate DCC localization. One candidate is DPY-30, a protein known to play a role in DCC localization. DPY-30 homologs in yeast, flies, and mammals are highly conserved members of histone H3 lysine 4 (H3K4) methyltransferase Set1/MLL complexes. Therefore, we investigated the hypothesis that the dosage compensation function of DPY-30 involves H3K4 methylation. We found that in dpy-30 animals the DCC fails to stably bind chromatin. Interestingly, of all the C. elegans homologs of Set1/MLL complex subunits, only DPY-30 is required for stable DCC binding to chromatin. Additionally, loss of H3K4 methylation does not enhance DCC mislocalization in htz-1 animals. We conclude that DPY-30 and HTZ-1 have unique functions in DCC localization, both of which are largely independent of H3K4 methylation.	[Petty, Emily; Laughlin, Emily; Csankovszki, Gyoergyi] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Petty, E (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	gyorgyi@umich.edu		Csankovszki, Gyorgyi/0000-0001-5918-034X	NIH [R01 GM079533]; University of Michigan; Genetics Predoctoral Training Program [NIH T32 GM07544]; Center for Organogenesis Predoctoral Training Program [NIH 5 T32 HD007505]; NIH Center for Research Resources (NCRR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079533, T32GM007544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Genetics Predoctoral Training Program; Center for Organogenesis Predoctoral Training Program; NIH Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM079533 to GC, funding from the Biological Sciences Scholar Program at the University of Michigan to GC, and Genetics Predoctoral Training Program, NIH T32 GM07544 and Center for Organogenesis Predoctoral Training Program, NIH 5 T32 HD007505, to ELP. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Ahringer J, 2005, REVERSE GENETICS WOR; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; ALLIS CD, 1986, J BIOL CHEM, V261, P1941; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blauwkamp TA, 2009, MOL CELL BIOL, V29, P2023, DOI 10.1128/MCB.01448-08; BRENNER S, 1974, GENETICS, V77, P71; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Csankovszki G, 2009, CHROMOSOME RES, V17, P621, DOI 10.1007/s10577-009-9061-y; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Davis TL, 1997, DEVELOPMENT, V124, P1019; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Ercan S, 2009, CURR BIOL, V19, P1777, DOI 10.1016/j.cub.2009.09.047; Ercan S, 2009, CHROMOSOME RES, V17, P215, DOI 10.1007/s10577-008-9011-0; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Fisher K, 2010, DEV BIOL, V341, P142, DOI 10.1016/j.ydbio.2010.02.023; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Gladden JM, 2007, GENETICS, V177, P1639, DOI 10.1534/genetics.107.078071; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; HODGKIN J, 1979, GENETICS, V91, P67; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Larschan E, 2006, COLD SPRING HARB SYM, V71, P385, DOI 10.1101/sqb.2006.71.026; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li TG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001349; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Li XG, 2011, BLOOD, V118, P1386, DOI 10.1182/blood-2010-11-319111; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu XW, 1996, MOL CELL BIOL, V16, P4305; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2011, MOL CELLULAR BIOL; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Petty EL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000699; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Straub T, 2011, CURR OPIN GENET DEV, V21, P147, DOI 10.1016/j.gde.2011.01.012; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang XP, 2009, J MOL BIOL, V390, P530, DOI 10.1016/j.jmb.2009.05.061; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xiao Y, 2011, P NATL ACAD SCI USA, V108, P8305, DOI 10.1073/pnas.1019290108; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yonker SA, 2003, DEVELOPMENT, V130, P6519, DOI 10.1242/dev.00886; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	91	4	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25973	10.1371/journal.pone.0025973	http://dx.doi.org/10.1371/journal.pone.0025973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998734	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900084
J	van Doremalen, N; Shelton, H; Roberts, KL; Jones, IM; Pickles, RJ; Thompson, CI; Barclay, WS				van Doremalen, Neeltje; Shelton, Holly; Roberts, Kim L.; Jones, Ian M.; Pickles, Ray J.; Thompson, Catherine I.; Barclay, Wendy S.			A Single Amino Acid in the HA of pH1N1 2009 Influenza Virus Affects Cell Tropism in Human Airway Epithelium, but Not Transmission in Ferrets	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; LOWER RESPIRATORY-TRACT; A VIRUSES; UNITED-STATES; HEMAGGLUTININ; ORIGIN; INFECTION; H1; PATHOGENESIS; REPLICATION	The first pandemic of the 21(st) century, pandemic H1N1 2009 (pH1N1 2009), emerged from a swine-origin source. Although human infections with swine-origin influenza have been reported previously, none went on to cause a pandemic or indeed any sustained human transmission. In previous pandemics, specific residues in the receptor binding site of the haemagglutinin (HA) protein of influenza have been associated with the ability of the virus to transmit between humans. In the present study we investigated the effect of residue 227 in HA on cell tropism and transmission of pH1N1 2009. In pH1N1 2009 and recent seasonal H1N1 viruses this residue is glutamic acid, whereas in swine influenza it is alanine. Using human airway epithelium, we show a differential cell tropism of pH1N1 2009 compared to pH1N1 2009 E227A and swine influenza suggesting this residue may alter the sialic acid conformer binding preference of the HA. Furthermore, both pH1N1 2009 E227A and swine influenza multi-cycle viral growth was found to be attenuated in comparison to pH1N1 2009 in human airway epithelium. However this altered tropism and viral growth in human airway epithelium did not abrogate respiratory droplet transmission of pH1N1 2009 E227A in ferrets. Thus, acquisition of E at residue 227 was not solely responsible for the ability of pH1N1 2009 to transmit between humans.	[van Doremalen, Neeltje; Shelton, Holly; Roberts, Kim L.; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Virol, London, England; [van Doremalen, Neeltje; Thompson, Catherine I.] Hlth Protect Agcy Microbiol Serv Colindale, Virus Reference Dept, London, England; [Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Pickles, Ray J.] Univ N Carolina, Dept Microbiol & Immunol, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA	Imperial College London; University of Reading; University of North Carolina; University of North Carolina Chapel Hill	van Doremalen, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Virol, St Marys Campus, London, England.	w.barclay@imperial.ac.uk	Jones, Ian/AAF-4986-2019; van Doremalen, Neeltje/AAD-2315-2021	Jones, Ian/0000-0002-7738-2516; Van Doremalen, Neeltje/0000-0003-4368-6359; Barclay, Wendy/0000-0002-3948-0895; shelton, Holly/0000-0002-5776-0735	Health Protection Agency; Society for General Microbiology; Medical Research Council [G0600504]; Medical Research Council [G0500597] Funding Source: researchfish; MRC [G0600504, G0500597] Funding Source: UKRI	Health Protection Agency; Society for General Microbiology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a PhD studentship awarded to NvD by the Health Protection Agency, and a Society for General Microbiology Presidents Fund award to NvD, and a Medical Research Council project grant G0600504 awarded to WSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Chen LM, 2011, VIROLOGY, V412, P401, DOI 10.1016/j.virol.2011.01.015; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Galiano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023779; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Langlois Isabelle, 2005, Vet Clin North Am Exot Anim Pract, V8, P139, DOI 10.1016/j.cvex.2004.09.008; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martin J, 1998, VIROLOGY, V241, P101, DOI 10.1006/viro.1997.8958; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 1999, ADV VIRUS RES, V53, P265, DOI 10.1016/S0065-3527(08)60352-8; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; ROBERTS KL, 2011, J GEN VIROLOGY; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; VINCENT AL, 2009, VIRUS GENES; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; World Health Organization, 2010, PAND H1N1 2009 UPD 1; 2009, MMWR MORBIDITY MORTA, V58, P400	49	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25755	10.1371/journal.pone.0025755	http://dx.doi.org/10.1371/journal.pone.0025755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998692	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900052
J	Davies, MJ; Marino, JL; Willson, KJ; March, WA; Moore, VM				Davies, Michael J.; Marino, Jennifer L.; Willson, Kristyn J.; March, Wendy A.; Moore, Vivienne M.			Intergenerational Associations of Chronic Disease and Polycystic Ovary Syndrome	PLOS ONE			English	Article							II DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC FEATURES; FAMILY-HISTORY; RISK-FACTORS; WOMEN; PREVALENCE; ENDOCRINE; RELATIVES	Background: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder of heterogeneous clinical presentation, high disease burden, and unknown aetiology. The disease and associated conditions cluster in families, suggesting that PCOS may be the reproductive consequence of underlying chronic disease susceptibility. Objective: To determine whether parents of young women with PCOS were more likely to have a history of diabetes or cardiovascular disease in later adult life. Design, Setting and Participants: Structured interviews with 715 members of a cohort constructed by tracing female infants born at a single general hospital in Adelaide between 1973 and 1975. Participants were asked whether they had a pre-existing medical diagnosis of PCOS, and whether each parent had ever had high blood pressure, high cholesterol, diabetes, stroke, or heart disease. Maternal high blood pressure during pregnancy was taken from the medical record of the pregnancy with the study participant. Results and Conclusions: Mothers of women with PCOS were more likely than mothers of other women to have any cardiovascular disease (RR 1.78, 95% CI 1.29, 2.47), and nearly twice as likely to have high blood pressure (RR 1.95, 95% CI 1.38, 2.76). Fathers of women with PCOS were more than twice as likely to have heart disease (RR 2.36, 95% CI 1.44, 3.88) and over four times as likely to have had a stroke (RR 4.37, 95% CI 1.97, 9.70). Occurrence of cardiovascular disease in both mother and father are associated with the risk of PCOS in daughters. Further detailed study is required to elucidate the precise pathways that may be causally related to the observations.	[Davies, Michael J.; Marino, Jennifer L.; March, Wendy A.] Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Inst, Adelaide, SA, Australia; [Marino, Jennifer L.; Willson, Kristyn J.; March, Wendy A.; Moore, Vivienne M.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide	Davies, MJ (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Inst, Adelaide, SA, Australia.	michael.davies@adelaide.edu.au	Davies, Michael John/Y-3542-2018; Marino, Jennifer L/O-2909-2017; Davies, Michael/GWV-2527-2022	Davies, Michael John/0000-0003-1526-0801; Marino, Jennifer L/0000-0001-6742-1940; 	National Health and Medical Research Council of Australia (NHMRC) [465455]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a grant from the National Health and Medical Research Council of Australia (NHMRC) Strategic Award No. 465455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SOC IND AR SEIFA; Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Cheang Kai I, 2008, Endocr Pract, V14, P1084; DAHLGREN E, 1992, ACTA OBSTET GYN SCAN, V71, P599, DOI 10.3109/00016349209006227; Escobar-Morreale HF, 2005, ENDOCR REV, V26, P251, DOI 10.1210/er.2004-0004; Holte J, 1998, J CLIN ENDOCR METAB, V83, P1143, DOI 10.1210/jc.83.4.1143; Hunter A, 2007, J OBSTET GYNAECOL, V27, P591, DOI 10.1080/01443610701497520; JAHANFAR S, 1995, FERTIL STERIL, V63, P478, DOI 10.1016/S0015-0282(16)57412-3; Kahsar-Miller M, 1998, TRENDS ENDOCRIN MET, V9, P55, DOI 10.1016/S1043-2760(98)00021-6; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Lesser K B, 1997, J Matern Fetal Med, V6, P303, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<303::AID-MFM14>3.0.CO;2-L; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Moini A, 2009, J ASSIST REPROD GEN, V26, P123, DOI 10.1007/s10815-009-9297-7; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Paradisi G, 1998, HUM REPROD, V13, P542, DOI 10.1093/humrep/13.3.542; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Sam S, 2006, P NATL ACAD SCI USA, V103, P7030, DOI 10.1073/pnas.0602025103; SHEAR CL, 1985, AM J EPIDEMIOL, V122, P762, DOI 10.1093/oxfordjournals.aje.a114159; Sir-Petermann T, 2002, DIABETOLOGIA, V45, P959, DOI 10.1007/s00125-002-0836-3; Yilmaz M, 2005, HUM REPROD, V20, P2414, DOI 10.1093/humrep/dei070	21	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25947	10.1371/journal.pone.0025947	http://dx.doi.org/10.1371/journal.pone.0025947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991389	Green Published, gold			2022-12-25	WOS:000295963300031
J	Wijenayaka, AR; Kogawa, M; Lim, HP; Bonewald, LF; Findlay, DM; Atkins, GJ				Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Bonewald, Lynda F.; Findlay, David M.; Atkins, Gerald J.			Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; KAPPA-B LIGAND; HUMAN PRIMARY OSTEOBLASTS; RECEPTOR ACTIVATOR; MECHANICAL STIMULATION; CELL-DIFFERENTIATION; PARATHYROID-HORMONE; MESSENGER-RNA; EXPRESSION; WNT	Sclerostin is a product of mature osteocytes embedded in mineralised bone and is a negative regulator of bone mass and osteoblast differentiation. While evidence suggests that sclerostin has an anti-anabolic role, the possibility also exists that sclerostin has catabolic activity. To test this we treated human primary pre-osteocyte cultures, cells we have found are exquisitely sensitive to sclerostin, or mouse osteocyte-like MLO-Y4 cells, with recombinant human sclerostin (rhSCL) and measured effects on pro-catabolic gene expression. Sclerostin dose-dependently up-regulated the expression of receptor activator of nuclear factor kappa B (RANKL) mRNA and down-regulated that of osteoprotegerin (OPG) mRNA, causing an increase in the RANKL: OPG mRNA ratio. To examine the effects of rhSCL on resulting osteoclastic activity, MLO-Y4 cells plated onto a bone-like substrate were primed with rhSCL for 3 days and then either mouse splenocytes or human peripheral blood mononuclear cells (PBMC) were added. This resulted in cultures with elevated osteoclastic resorption (approximately 7-fold) compared to untreated co-cultures. The increased resorption was abolished by co-addition of recombinant OPG. In co-cultures of MLO-Y4 cells with PBMC, SCL also increased the number and size of the TRAP-positive multinucleated cells formed. Importantly, rhSCL had no effect on TRAP-positive cell formation from monocultures of either splenocytes or PBMC. Further, rhSCL did not induce apoptosis of MLO-Y4 cells, as determined by caspase activity assays, demonstrating that the osteoclastic response was not driven by dying osteocytes. Together, these results suggest that sclerostin may have a catabolic action through promotion of osteoclast formation and activity by osteocytes, in a RANKL-dependent manner.	[Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Findlay, David M.; Atkins, Gerald J.] Univ Adelaide, Bone Cell Biol Grp, Discipline Orthopaed & Trauma, Adelaide, SA, Australia; [Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Findlay, David M.; Atkins, Gerald J.] Hanson Inst, Adelaide, SA, Australia; [Bonewald, Lynda F.] Univ Missouri, Kansas City Sch Dent, Dept Oral Biol, Kansas City, MO 64110 USA	University of Adelaide; Hanson Institute; University of Missouri System; University of Missouri Kansas City	Wijenayaka, AR (corresponding author), Univ Adelaide, Bone Cell Biol Grp, Discipline Orthopaed & Trauma, Adelaide, SA, Australia.	Gerald.atkins@adelaide.edu.au	Bonewald, Lynda/Q-3638-2019	Atkins, Gerald/0000-0002-3123-9861	National Health and Medical Research Council of Australia (NHMRC) [ID565372]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a Project Grant (ID565372) from the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Atkins GJ, 2006, J BONE MINER RES, V21, P1339, DOI 10.1359/JBMR.060604; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Atkins GJ, 2009, BIOMATERIALS, V30, P3672, DOI 10.1016/j.biomaterials.2009.03.035; Atkins GJ, 2002, BONE, V31, P448, DOI 10.1016/S8756-3282(02)00858-X; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Chandrasegaran AL, 2007, CHEM EDUC RES PRACT, V8, P293; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Drake MT, 2010, J CLIN ENDOCRINOL ME; Findlay DM, 2011, ADV EXP MED BIOL, V691, P337, DOI 10.1007/978-1-4419-6612-4_34; Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Jager A, 2010, J PERIODONTAL RES, V45, P246, DOI 10.1111/j.1600-0765.2009.01227.x; Kaneuji T, 2011, BIOCHEM BIOPH RES CO, V408, P103, DOI 10.1016/j.bbrc.2011.03.128; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kogawa M, 2010, ENDOCRINOLOGY, V151, P4613, DOI 10.1210/en.2010-0334; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Kurata K, 2006, J BONE MINER RES, V21, P616, DOI 10.1359/JBMR.060106; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Medina V, 1997, CANCER RES, V57, P3697; Modder UI, 2010, J BONE MINER RES; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Nakashima T, NAT MED IN PRESS, DOI nm.2452; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Robling A. G., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P354; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Shiotani A, 2001, J ELECTRON MICROSC, V50, P365, DOI 10.1093/jmicro/50.4.365; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Sutherland MK, 2004, BONE, V35, P448, DOI 10.1016/j.bone.2004.04.019; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Tian XY, 2010, BONE, V47, P529, DOI 10.1016/j.bone.2010.05.032; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; van Bezooijen RL, 2009, J DENT RES, V88, P569, DOI 10.1177/0022034509338340; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xiong J, NAT MED IN PRESS, DOI nm.2448; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	63	330	348	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25900	10.1371/journal.pone.0025900	http://dx.doi.org/10.1371/journal.pone.0025900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991382	Green Published, gold, Green Submitted			2022-12-25	WOS:000295963300028
J	Charge, R; Sorci, G; Hingrat, Y; Lacroix, F; Saint Jalme, M				Charge, Remi; Sorci, Gabriele; Hingrat, Yves; Lacroix, Frederic; Saint Jalme, Michel			Immune-Mediated Change in the Expression of a Sexual Trait Predicts Offspring Survival in the Wild	PLOS ONE			English	Article							CHLAMYDOTIS-UNDULATA-UNDULATA; HOUBARA BUSTARD; INDIRECT SELECTION; JUVENILE SURVIVAL; HATCHING SUCCESS; GENETIC QUALITY; HEALTH-STATUS; MATE CHOICE; BENEFITS; FITNESS	Background: The "good genes'' theory of sexual selection postulates that females choose mates that will improve their offspring's fitness through the inheritance of paternal genes. In spite of the attention that this hypothesis has given rise to, the empirical evidence remains sparse, mostly because of the difficulties of controlling for the many environmental factors that may covary with both the paternal phenotype and offspring fitness. Here, we tested the hypothesis that offspring sired by males of a preferred phenotype should have better survival in an endangered bird, the houbara bustard (Chlamydotis undulata undulata). Methodology/Principal Findings: We tested if natural and experimentally-induced variation in courtship display (following an inflammatory challenge) predicts the survival of offspring. Chicks were produced by artificial insemination of females, ensuring that any effect on survival could only arise from the transfer of paternal genes. One hundred and twenty offspring were equipped with radio transmitters, and their survival monitored in the wild for a year. This allowed assessment of the potential benefits of paternal genes in a natural setting, where birds experience the whole range of environmental hazards. Although natural variation in sire courtship display did not predict offspring survival, sires that withstood the inflammatory insult and maintained their courtship activity sired offspring with the best survival upon release. Conclusions: This finding is relevant both to enlighten the debate on "good genes'' sexual selection and the management of supportive breeding programs.	[Charge, Remi; Saint Jalme, Michel] Museum Natl Hist Nat, F-75231 Paris, France; [Charge, Remi; Hingrat, Yves; Lacroix, Frederic] Emirates Ctr Wildlife Propagat, Missour, Morocco; [Sorci, Gabriele] Univ Bourgogne, Unite Mixte Rech, Ctr Natl Rech Sci, Dijon, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Charge, R (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	gabriele.sorci@u-bourgogne.fr	Hingrat, Yves/AAR-3275-2021	Sorci, Gabriele/0000-0002-0799-3995; Hingrat, Yves/0000-0003-2388-8826	Emirates Center for Wildlife Propagation; International Fund for Houbara Conservation (IFHC)	Emirates Center for Wildlife Propagation; International Fund for Houbara Conservation (IFHC)	The study has been funded by the Emirates Center for Wildlife Propagation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to H. H. Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the International Fund for Houbara Conservation (IFHC), and H. E. Mohammed Al Bowardi, Deputy Chairman of IFHC, for their support. We are very grateful to Gwenaelle Leveque, Pierre-Marie Beranger and Stephane Hemon for the breeding and rearing management and to Pierrick Rautureau and the Ecology staff involved in bird survey. Brian Preston greatly improved a previous version of the manuscript.	Anderson WW, 2007, P NATL ACAD SCI USA, V104, P4484, DOI 10.1073/pnas.0611152104; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Charge R, 2010, J ANIM ECOL, V79, P843, DOI 10.1111/j.1365-2656.2010.01696.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Evans JP, 2004, P ROY SOC B-BIOL SCI, V271, P2035, DOI 10.1098/rspb.2004.2815; Fiumera AC, 2000, CONSERV BIOL, V14, P886, DOI 10.1046/j.1523-1739.2000.97337.x; FOESTER K, 2003, NATURE, V425, P714; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grahn M, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P341; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; Hingrat Y, 2005, ARDEOLA, V52, P91; Hingrat Y, 2008, J AVIAN BIOL, V39, P393, DOI 10.1111/j.0908-8857.2008.03994.x; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; JALME MS, 1994, J REPROD FERTIL, V100, P93, DOI 10.1530/jrf.0.1000093; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kotiaho JS, 2007, FUNCT ECOL, V21, P638, DOI 10.1111/j.1365-2435.2007.01286.x; Lesobre L, 2010, CONSERV GENET, V11, P1489, DOI 10.1007/s10592-009-9979-9; Loyau A, 2005, BEHAV ECOL SOCIOBIOL, V58, P552, DOI 10.1007/s00265-005-0958-y; Loyau A, 2010, P ROY SOC B-BIOL SCI, V277, P3453, DOI 10.1098/rspb.2010.0473; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Maklakov AA, 2009, CURR BIOL, V19, P1903, DOI 10.1016/j.cub.2009.08.058; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Pitcher TE, 2007, CONSERV GENET, V8, P607, DOI 10.1007/s10592-006-9204-z; PRESTON BT, 2011, ECOL LETT IN PRESS; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Quader S, 2005, CURR SCI INDIA, V89, P1220; SaintJalme M, 1996, GEN COMP ENDOCR, V102, P102, DOI 10.1006/gcen.1996.0051; Saura M, 2008, CONSERV BIOL, V22, P1277, DOI 10.1111/j.1523-1739.2008.00992.x; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Wedekind C, 2002, CONSERV BIOL, V16, P1204, DOI 10.1046/j.1523-1739.2002.01217.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	42	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25305	10.1371/journal.pone.0025305	http://dx.doi.org/10.1371/journal.pone.0025305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984912	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000023
J	Dahl, CD; Logothetis, NK; Bulthoff, HH; Wallraven, C				Dahl, Christoph D.; Logothetis, Nikos K.; Buelthoff, Heinrich H.; Wallraven, Christian			Second-Order Relational Manipulations Affect Both Humans and Monkeys	PLOS ONE			English	Article							FEATURE DISPLACEMENT; PERCEPTION; INVERSION; FACES; CONFIGURATION; FEATURES	Recognition and individuation of conspecifics by their face is essential for primate social cognition. This ability is driven by a mechanism that integrates the appearance of facial features with subtle variations in their configuration (i.e., second-order relational properties) into a holistic representation. So far, there is little evidence of whether our evolutionary ancestors show sensitivity to featural spatial relations and hence holistic processing of faces as shown in humans. Here, we directly compared macaques with humans in their sensitivity to configurally altered faces in upright and inverted orientations using a habituation paradigm and eye tracking technologies. In addition, we tested for differences in processing of conspecific faces (human faces for humans, macaque faces for macaques) and non-conspecific faces, addressing aspects of perceptual expertise. In both species, we found sensitivity to second-order relational properties for conspecific (expert) faces, when presented in upright, not in inverted, orientation. This shows that macaques possess the requirements for holistic processing, and thus show similar face processing to that of humans.	[Dahl, Christoph D.; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, Physiol Cognit Proc Dept, Tubingen, Germany; [Dahl, Christoph D.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Human Percept Cognit & Act Dept, Tubingen, Germany; [Dahl, Christoph D.] Kyoto Univ, Language & Intelligence Sect, Aichi, Japan; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester, Lancs, England; [Buelthoff, Heinrich H.; Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Max Planck Society; Kyoto University; University of Manchester; Korea University	Dahl, CD (corresponding author), Max Planck Inst Biol Cybernet, Physiol Cognit Proc Dept, Tubingen, Germany.	wallraven@korea.ac.kr	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Logothetis, Nikos/U-9282-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Wallraven, Christian/0000-0002-2604-9115; Dahl, Christoph D/0000-0002-4296-1526	Max Planck Society; Swiss National Science Foundation; Japan Society for the Promotion of Science; World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-000-10008-0]; Grants-in-Aid for Scientific Research [10F00312] Funding Source: KAKEN	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Max Planck Society, a fellowship for Prospective Researchers by the Swiss National Science Foundation (CDD), a fellowship by the Japan Society for the Promotion of Science (CDD), and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10008-0) (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared	Adachi I, 2009, CURR BIOL, V19, P1270, DOI 10.1016/j.cub.2009.05.067; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BRUCE V, 1991, COGNITION, V38, P109, DOI 10.1016/0010-0277(91)90049-A; Dahl CD, 2007, P R SOC B, V274, P2069, DOI 10.1098/rspb.2007.0477; Dahl CD, 2010, P ROY SOC B-BIOL SCI, V277, P2973, DOI 10.1098/rspb.2010.0438; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; HAIG ND, 1984, PERCEPTION, V13, P505, DOI 10.1068/p130505; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; KEMP R, 1990, PERCEPTION, V19, P531, DOI 10.1068/p190531; Lewis MB, 2003, PERCEPTION, V32, P903, DOI 10.1068/p5007; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Parr LA, 2008, J COMP PSYCHOL, V122, P390, DOI 10.1037/0735-7036.122.4.390; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Schwaninger A, 2006, PROG BRAIN RES, V156, P321, DOI 10.1016/S0079-6123(06)56018-2; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25793	10.1371/journal.pone.0025793	http://dx.doi.org/10.1371/journal.pone.0025793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991354	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000072
J	De Barro, P; Ahmed, MZ				De Barro, Paul; Ahmed, Muhammad Z.			Genetic Networking of the Bemisia tabaci Cryptic Species Complex Reveals Pattern of Biological Invasions	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DELIMITATION; TREES; POPULATIONS; HEMIPTERA; HAPLOTYPES; LIKELIHOOD; DIVERSITY; ALIEN; LIFE	Background: A challenge within the context of cryptic species is the delimitation of individual species within the complex. Statistical parsimony network analytics offers the opportunity to explore limits in situations where there are insufficient species-specific morphological characters to separate taxa. The results also enable us to explore the spread in taxa that have invaded globally. Methodology/Principal Findings: Using a 657 bp portion of mitochondrial cytochrome oxidase 1 from 352 unique haplotypes belonging to the Bemisia tabaci cryptic species complex, the analysis revealed 28 networks plus 7 unconnected individual haplotypes. Of the networks, 24 corresponded to the putative species identified using the rule set devised by Dinsdale et al. (2010). Only two species proposed in Dinsdale et al. (2010) departed substantially from the structure suggested by the analysis. The analysis of the two invasive members of the complex, Mediterranean (MED) and Middle East - Asia Minor 1 (MEAM1), showed that in both cases only a small number of haplotypes represent the majority that have spread beyond the home range; one MEAM1 and three MED haplotypes account for >80% of the GenBank records. Israel is a possible source of the globally invasive MEAM1 whereas MED has two possible sources. The first is the eastern Mediterranean which has invaded only the USA, primarily Florida and to a lesser extent California. The second are western Mediterranean haplotypes that have spread to the USA, Asia and South America. The structure for MED supports two home range distributions, a Sub-Saharan range and a Mediterranean range. The MEAM1 network supports the Middle East - Asia Minor region. Conclusion/Significance: The network analyses show a high level of congruence with the species identified in a previous phylogenetic analysis. The analysis of the two globally invasive members of the complex support the view that global invasion often involve very small portions of the available genetic diversity.	[De Barro, Paul] CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Ahmed, Muhammad Z.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Pretoria	De Barro, P (corresponding author), CSIRO Ecosyst Sci, Brisbane, Qld, Australia.	paul.debarro@csiro.au	De Barro, Paul J/C-1724-2008; Ahmed, Muhammad Z/E-5735-2011	Ahmed, Muhammad Z/0000-0003-2486-157X	University of Pretoria	University of Pretoria	M.Z. Ahmed thanks University of Pretoria for awarding him a Commonwealth scholarship to support his doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Ahmed MZ, 2009, J APPL ENTOMOL, V133, P733, DOI 10.1111/j.1439-0418.2009.01442.x; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cracraft J., 1983, Current Ornithology, V1, P159; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Queiroz K, 1999, SPECIES, P49; DIDAY E, 1986, PATTERN RECOGN, P411; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; EIGEN M, 1988, P NATL ACAD SCI USA, V85, P5913, DOI 10.1073/pnas.85.16.5913; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; EXCOFFIER L, 1994, GENETICS, V136, P343; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Gentile G, 2002, GENETICS, V161, P1561; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Lee PLM, 2004, INT J PLANT SCI, V165, P833, DOI 10.1086/422043; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Makarenkov V, 2000, ST CLASS DAT ANAL, P35; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Pilgrim EM, 2010, DIVERS DISTRIB, V16, P827, DOI 10.1111/j.1472-4642.2010.00681.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Seal JN, 2011, J BIOGEOGR, V38, P868, DOI 10.1111/j.1365-2699.2010.02447.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Strimmer K, 2000, MOL BIOL EVOL, V17, P875, DOI 10.1093/oxfordjournals.molbev.a026367; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Xavier R, 2009, MOL ECOL, V18, P3283, DOI 10.1111/j.1365-294X.2009.04260.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xu SZ, 2000, MOL BIOL EVOL, V17, P897, DOI 10.1093/oxfordjournals.molbev.a026370; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	70	73	78	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25579	10.1371/journal.pone.0025579	http://dx.doi.org/10.1371/journal.pone.0025579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21998669	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000042
J	Etcoff, NL; Stock, S; Haley, LE; Vickery, SA; House, DM				Etcoff, Nancy L.; Stock, Shannon; Haley, Lauren E.; Vickery, Sarah A.; House, David M.			Cosmetics as a Feature of the Extended Human Phenotype: Modulation of the Perception of Biologically Important Facial Signals	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; FACES; BEAUTY; COLOR; SEX; AGE; RATIONALITY; IMPRESSIONS; COMPETENCE; STEREOTYPE	Research on the perception of faces has focused on the size, shape, and configuration of inherited features or the biological phenotype, and largely ignored the effects of adornment, or the extended phenotype. Research on the evolution of signaling has shown that animals frequently alter visual features, including color cues, to attract, intimidate or protect themselves from conspecifics. Humans engage in conscious manipulation of visual signals using cultural tools in real time rather than genetic changes over evolutionary time. Here, we investigate one tool, the use of color cosmetics. In two studies, we asked viewers to rate the same female faces with or without color cosmetics, and we varied the style of makeup from minimal (natural), to moderate (professional), to dramatic (glamorous). Each look provided increasing luminance contrast between the facial features and surrounding skin. Faces were shown for 250 ms or for unlimited inspection time, and subjects rated them for attractiveness, competence, likeability and trustworthiness. At 250 ms, cosmetics had significant positive effects on all outcomes. Length of inspection time did not change the effect for competence or attractiveness. However, with longer inspection time, the effect of cosmetics on likability and trust varied by specific makeup looks, indicating that cosmetics could impact automatic and deliberative judgments differently. The results suggest that cosmetics can create supernormal facial stimuli, and that one way they may do so is by exaggerating cues to sexual dimorphism. Our results provide evidence that judgments of facial trustworthiness and attractiveness are at least partially separable, that beauty has a significant positive effect on judgment of competence, a universal dimension of social cognition, but has a more nuanced effect on the other universal dimension of social warmth, and that the extended phenotype significantly influences perception of biologically important signals at first glance and at longer inspection.	[Etcoff, Nancy L.; Haley, Lauren E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Etcoff, Nancy L.; Haley, Lauren E.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Stock, Shannon] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Vickery, Sarah A.] Procter & Gamble Cosmet, Procter & Gamble Beauty & Grooming, Hunt Valley, MD USA; [House, David M.] Boston Univ, Dept Comp Sci, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Procter & Gamble; Boston University	Etcoff, NL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	netcoff@partners.org			P&G Beauty and Grooming	P&G Beauty and Grooming	This study was funded by P&G Beauty and Grooming, where Sarah A. Vickery is employed as a Principal Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; CORSON R, 1972, FASHIONS MAKCUP ANCI; Dawkins R., 1989, EXTENDED PHENOTYPE; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Etcoff N., 1999, SURVIVAL PRETTIEST S; ETCOFF NL, 1994, NATURE, V368, P186, DOI 10.1038/368186a0; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; FRIEZE IH, 1991, J APPL SOC PSYCHOL, V21, P1039, DOI 10.1111/j.1559-1816.1991.tb00458.x; FRIEZE IH, 1990, J APPL SOC PSYCHOL, V20, P46, DOI 10.1111/j.1559-1816.1990.tb00377.x; *GLOB IND AN INC, 2010, COL COSM GLOB STRAT; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kyle DJ, 1996, PSYCHOL WOMEN QUART, V20, P447, DOI 10.1111/j.1471-6402.1996.tb00311.x; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; *NPD GROUP INC, 2010, MAK IN DEPTH CONS RE; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Riordan T., 2004, INVENTING BEAUTY; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Symons D., 1995, SEXUAL NATURE SEXUAL; Tinbergen N., 1953, HERRING GULLS WORLD; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Trivers R. L., 1985, SOCIAL EVOLUTION; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Walter P, 1999, NATURE, V397, P483, DOI 10.1038/17240; WEBSTER M, 1983, AM J SOCIOL, V89, P140, DOI 10.1086/227836; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	41	118	118	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25656	10.1371/journal.pone.0025656	http://dx.doi.org/10.1371/journal.pone.0025656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991328	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000052
J	Martel, V; Schlyter, F; Ignell, R; Hansson, BS; Anderson, P				Martel, Veronique; Schlyter, Fredrik; Ignell, Rickard; Hansson, Bill S.; Anderson, Peter			Mosquito Feeding Affects Larval Behaviour and Development in a Moth	PLOS ONE			English	Article							GNATHIID ISOPODS; AEDES-AEGYPTI; GROWTH; SIZE; FECUNDITY; SURVIVAL; MICROPREDATORS; PATTERNS; DEFENSES; INSECTS	Organisms are attacked by different natural enemies present in their habitat. While enemies such as parasitoids and predators will kill their hosts/preys when they successfully attack them, enemies such as micropredators will not entirely consume their prey. However, they can still have important consequences on the performance and ecology of the prey, such as reduced growth, increased emigration, disease transmission. In this paper, we investigated the impact of a terrestrial micropredator, the yellow fever mosquito Aedes aegypti, on its unusual invertebrate host, the Egyptian cotton leaf worm, Spodoptera littoralis. Larvae developing in presence of mosquitoes showed a slower development and reached a smaller pupal weight when compared to a control without mosquitoes, apparently because of a reduced feeding time for larvae. In addition, larvae tended to leave the plant in presence of mosquitoes. These results suggest that mosquitoes act as micropredators and affects lepidopteran larvae behaviour and development. Ecological impacts such as higher risks of food depletion and longer exposure to natural enemies are likely to be costly consequences. The importance of this phenomenon in nature - the possible function as last resort when vertebrates are unavailable - and the evolutionary aspects are discussed.	[Martel, Veronique; Schlyter, Fredrik; Ignell, Rickard; Anderson, Peter] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Swedish University of Agricultural Sciences; Max Planck Society	Martel, V (corresponding author), Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France.	veronique.martel@mail.mcgill.ca	Martel, Véronique/Q-5127-2019; Hansson, Bill S/G-2774-2013; Schlyter, Fredrik/F-8567-2015	Martel, Véronique/0000-0001-8111-5931; Hansson, Bill S/0000-0002-4811-1223; Schlyter, Fredrik/0000-0002-1244-0308	Formas; Fonds Quebecois de Recherche sur la Nature et les Technologies	Formas(Swedish Research Council Formas); Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT)	This research was funded as a part of the Linnaeus-program Insect Chemical Ecology, Ethology and Evolution IC-E3 funded by Formas. VM was supported by a postdoctoral fellowship from the Fonds Quebecois de Recherche sur la Nature et les Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashov YS., 2006, ENTOMOL REV, V86, P957, DOI [10.1134/S0013873806080112, DOI 10.1134/S0013873806080112]; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; BUTLIN RK, 1985, HEREDITY, V54, P107, DOI 10.1038/hdy.1985.14; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Gordon AS, 2005, HARMFUL ALGAE, V4, P423, DOI 10.1016/j.hal.2004.07.003; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Grutter AS, 2008, CORAL REEFS, V27, P655, DOI 10.1007/s00338-008-0377-4; Hagen H, 1883, ENTOMOL MON MAG, V19, P254; HARDY ICW, 1992, J ANIM ECOL, V61, P121, DOI 10.2307/5515; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; HARRIS P, 1969, NATURE, V222, P1264, DOI 10.1038/2221264a0; HINKS CF, 1976, CAN ENTOMOL, V108, P1345, DOI 10.4039/Ent1081345-12; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Howard L. O., 1912, MOSQUITOES N CENTRAL, V1; Jones CM, 2008, CORAL REEFS, V27, P677, DOI 10.1007/s00338-008-0383-6; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Loxdale HD, 1999, PHILOS T R SOC B, V354, P1479, DOI 10.1098/rstb.1999.0492; MCIVER SB, 1968, J MED ENTOMOL, V5, P422, DOI 10.1093/jmedent/5.4.422; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; OSMAN RW, 1992, MAR ECOL PROG SER, V83, P35, DOI 10.3354/meps083035; Penfold R, 2008, MAR ECOL PROG SER, V357, P111, DOI 10.3354/meps07312; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Quicke D. L. J., 1997, PARASITIC WASPS; Ramos JA, 2001, AUK, V118, P709, DOI 10.1642/0004-8038(2001)118[0709:APAEOT]2.0.CO;2; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; *SERV MW, 1993, MOSQ EC FIELD SAMPL; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; WAAGE JK, 1979, BIOL J LINN SOC, V12, P187, DOI 10.1111/j.1095-8312.1979.tb00055.x; Weisser Wolfgang W., 2001, P180	35	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25658	10.1371/journal.pone.0025658	http://dx.doi.org/10.1371/journal.pone.0025658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991329	gold, Green Published			2022-12-25	WOS:000295943000053
J	Viscosi, V; Cardini, A				Viscosi, Vincenzo; Cardini, Andrea			Leaf Morphology, Taxonomy and Geometric Morphometrics: A Simplified Protocol for Beginners	PLOS ONE			English	Article							COROLLA SHAPE; QUERCUS; EVOLUTION; GROWTH; PLANT; HYBRIDIZATION; HETEROCHRONY; DIVERGENCE; SELECTION; PATTERNS	Taxonomy relies greatly on morphology to discriminate groups. Computerized geometric morphometric methods for quantitative shape analysis measure, test and visualize differences in form in a highly effective, reproducible, accurate and statistically powerful way. Plant leaves are commonly used in taxonomic analyses and are particularly suitable to landmark based geometric morphometrics. However, botanists do not yet seem to have taken advantage of this set of methods in their studies as much as zoologists have done. Using free software and an example dataset from two geographical populations of sessile oak leaves, we describe in detailed but simple terms how to: a) compute size and shape variables using Procrustes methods; b) test measurement error and the main levels of variation (population and trees) using a hierachical design; c) estimate the accuracy of group discrimination; d) repeat this estimate after controlling for the effect of size differences on shape (i.e., allometry). Measurement error was completely negligible; individual variation in leaf morphology was large and differences between trees were generally bigger than within trees; differences between the two geographic populations were small in both size and shape; despite a weak allometric trend, controlling for the effect of size on shape slighly increased discrimination accuracy. Procrustes based methods for the analysis of landmarks were highly efficient in measuring the hierarchical structure of differences in leaves and in revealing very small-scale variation. In taxonomy and many other fields of botany and biology, the application of geometric morphometrics contributes to increase scientific rigour in the description of important aspects of the phenotypic dimension of biodiversity. Easy to follow but detailed step by step example studies can promote a more extensive use of these numerical methods, as they provide an introduction to the discipline which, for many biologists, is less intimidating than the often inaccessible specialistic literature.	[Viscosi, Vincenzo] Univ Molise, Museo Erbario Molise, Dipartimento Sci & Tecnol Ambiente & Terr, Pesche, Italy; [Cardini, Andrea] Univ Modena & Reggio Emilia, Dipartimento Biol, Modena, Italy; [Cardini, Andrea] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Cardini, Andrea] Univ Western Australia, Ctr Forens Sci, Crawley, WA, Australia	University of Molise; Universita di Modena e Reggio Emilia; University of Hull; University of York - UK; University of Western Australia	Viscosi, V (corresponding author), Univ Molise, Museo Erbario Molise, Dipartimento Sci & Tecnol Ambiente & Terr, Pesche, Italy.	vincenzo.viscosi@unimol.it	cardini, andrea/G-9951-2011	cardini, andrea/0000-0003-2910-632X				Adams DC, 2011, J HUM EVOL, V60, P240, DOI 10.1016/j.jhevol.2010.02.003; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Albrecht G.H., 1992, Human Evolution, V7, P49, DOI 10.1007/BF02436412; ANTONECCHIA G, 2011, THESIS U MOLISE PESC; Bell A. D., 2008, PLANT FORM ILLUSTRAT; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Cardini A, 2009, ETHOL ECOL EVOL, V21, P209, DOI 10.1080/08927014.2009.9522476; Cardini A, 2008, J HUM EVOL, V54, P615, DOI 10.1016/j.jhevol.2007.09.022; Cardini A, 2011, INT J PRIMATOL, V32, P377, DOI 10.1007/s10764-010-9475-6; Cardini A, 2009, GLOBAL ECOL BIOGEOGR, V18, P248, DOI 10.1111/j.1466-8238.2008.00432.x; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Claude J, 2008, MORPHOMETRICS R; Debat V, 2009, EVOLUTION, V63, P2864, DOI 10.1111/j.1558-5646.2009.00774.x; deQueiroz K, 1997, Q REV BIOL, V72, P3, DOI 10.1086/419656; Dryden I., 1998, STAT ANAL SHAPE; Elton S, 2010, BIOL J LINN SOC, V101, P823, DOI 10.1111/j.1095-8312.2010.01504.x; Fadda C, 2001, J ZOOL SYST EVOL RES, V39, P235, DOI 10.1046/j.1439-0469.2001.00169.x; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Gomez JM, 2009, EVOLUTION, V63, P1820, DOI 10.1111/j.1558-5646.2009.00667.x; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; Hammer O, 2011, PAST VER 2 09; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Howell D, 2002, STAT METHODS PSYCHOL; Huttegger SM, 2011, EVOL BIOL, V38, P335, DOI 10.1007/s11692-011-9123-x; JENSEN RJ, 1990, AM J BOT, V77, P1279, DOI 10.2307/2444589; Jensen RJ, 2003, TAXON, V52, P663, DOI 10.2307/3647340; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; JENSEN RJ, 1993, AM J BOT, V80, P1358, DOI 10.2307/2445721; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; KOVAROVIC K, J ARCHAEOL IN PRESS; KOVAROVIC K, 2011, J ARCHAEOL IN PRESS; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Albarran-Lara AL, 2010, INT J PLANT SCI, V171, P310, DOI 10.1086/650317; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Manly BFJ, 1997, RANDOMISATION BOOTST; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Marcus Leslie F., 2000, Hystrix, V11, P27; MARCUS LF, 1990, P MICH MORPH WORKSH; McDonald J.H., 2009, HDB BIOL STAT; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Neff N. A., 1980, SURVEY MULTIVARIATE; OHIGGINS P, 2007, FOURIER DESCRIPTORS; Oxnard Charles, 2009, Biology Theory, V4, P84, DOI 10.1162/biot.2009.4.1.84; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; ROHLF FJ, 1981, SYST ZOOL, V30, P459, DOI 10.2307/2413054; Rohlf FJ, 2010, TPS SERIES; Rohlf FJ, 2000, HYSTRIX, V11, P8; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sanfilippo PG, 2009, PROG RETIN EYE RES, V28, P227, DOI 10.1016/j.preteyeres.2009.05.004; SHEETS HD, 2006, FRONT ZOOL, V3, P2; Sokal R. R., 2012, BIOMETRY; STANLEY SM, 1987, PALEOBIOLOGY, V13, P113; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; THOMPSON DW, 1917, GROWTH FORMS; Tsukaya H, 1995, J PLANT RES, V108, P407, DOI 10.1007/BF02344229; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Viscosi V, 2009, PLANT BIOSYST, V143, P575, DOI 10.1080/11263500902775277; VISCOSI V, 2011, NORD J BOT IN PRESS; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x	81	247	266	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25630	10.1371/journal.pone.0025630	http://dx.doi.org/10.1371/journal.pone.0025630			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991324	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000048
J	Lackner, P; Beer, R; Broessner, G; Helbok, R; Dallago, K; Hess, MW; Pfaller, K; Bandtlow, C; Schmutzhard, E				Lackner, Peter; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Dallago, Karolin; Hess, Michael W.; Pfaller, Kristian; Bandtlow, Christine; Schmutzhard, Erich			Nogo-A Expression in the Brain of Mice with Cerebral Malaria	PLOS ONE			English	Article							NEURITE OUTGROWTH INHIBITOR; FALCIPARUM-MALARIA; INJURY; IDENTIFICATION; REGENERATION; APOPTOSIS; CHILDREN; SURVIVAL; SEQUELAE; PROFILE	Cerebral malaria (CM) is associated with a high rate of transient or persistent neurological sequelae. Nogo-A, a protein that is highly expressed in the endoplasmic reticulum (ER) of the mammalian central nervous system (CNS), is involved in neuronal regeneration and synaptic plasticity in the injured CNS. The current study investigates the role of Nogo-A in the course of experimental CM. C57BL/6J mice were infected with Plasmodium berghei ANKA blood stages. Brain homogenates of mice with different clinical severity levels of CM, infected animals without CM and control animals were analyzed for Nogo-A up-regulation by Western blotting and immunohistochemistry. Brain regions with Nogo-A upregulation were evaluated by tansmission electron microscopy. Densitometric analysis of Western blots yielded a statistically significant upregulation of Nogo-A in mice showing moderate to severe CM. The number of neurons and oligodendrocytes positive for Nogo-A did not differ significantly between the studied groups. However, mice with severe CM showed a significantly higher number of cells with intense Nogo-A staining in the brain stem. In this region ultrastructural alterations of the ER were regularly observed. Nogo-A is upregulated during the early course of experimental CM. In the brain stem of severely affected animals increased Nogo-A expression and ultrastructural changes of the ER were observed. These data indicate a role of Nogo-A in neuronal stress response during experimental CM.	[Lackner, Peter; Beer, Ronny; Broessner, Gregor; Helbok, Raimund; Dallago, Karolin; Schmutzhard, Erich] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Hess, Michael W.; Pfaller, Kristian] Innsbruck Med Univ, Div Histol & Embryol, Innsbruck, Austria; [Bandtlow, Christine] Innsbruck Med Univ, Div Neurobiochem, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Lackner, P (corresponding author), Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria.	peter.lackner@i-med.ac.at	Helbok, Raimund/AAA-8361-2021; Hess, Michael/AAE-1985-2019	Hess, Michael/0000-0002-5154-3553; Schmutzhard, Erich/0000-0003-3295-7491	Asia-European University Network	Asia-European University Network	This study was supported by the Asia-European University Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baka ID, 1996, MOL CELL NEUROSCI, V7, P289, DOI 10.1006/mcne.1996.0022; Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F; Bandtlow CE, 2004, EUR J NEUROSCI, V20, P195, DOI 10.1111/j.1460-9568.2004.03470.x; Buchli AD, 2007, NEURODEGENER DIS, V4, P51, DOI 10.1159/000100359; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Carter JA, 2003, BRAIN INJURY, V17, P217, DOI 10.1080/0269905021000038447; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Clark H, 1945, MALARIOLOGY, P874; Clausen F, 2010, J NEUROTRAUMA; Delekate A, 2011, P NATL ACAD SCI US; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hens J, 1998, CELL TISSUE RES, V292, P229, DOI 10.1007/s004410051054; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Lackner P, 2007, NEUROPATH APPL NEURO, V33, P560, DOI 10.1111/j.1365-2990.2007.00833.x; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lackner P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-116; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liu HP, 2002, NEUROSCI LETT, V328, P257, DOI 10.1016/S0304-3940(02)00528-1; Ma N, 1997, J INFECT DIS, V175, P1480, DOI 10.1086/516483; Marchiafava E., 1894, MALARIA PARASITES MA, V15, P1; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Medana IM, 2007, NEUROPATH APPL NEURO, V33, P179, DOI 10.1111/j.1365-2990.2006.00777.x; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Sasaki S, 2010, J NEUROPATH EXP NEUR, V69, P346, DOI 10.1097/NEN.0b013e3181d44992; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; SCHMUTZHARD E, 1984, T ROY SOC TROP MED H, V78, P351, DOI 10.1016/0035-9203(84)90118-4; Teng FYH, 2008, J CELL PHYSIOL, V216, P303, DOI 10.1002/jcp.21434; Villalobos V, 2009, BIOCELL, V33, P187; Wang H, 2006, BRAIN RES, V1114, P212, DOI 10.1016/j.brainres.2006.07.056; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Yang YS, 2009, J NEUROSCI, V29, P13850, DOI 10.1523/JNEUROSCI.2312-09.2009; Zhang F, 2006, J NEUROCHEM, V98, P102, DOI 10.1111/j.1471-4159.2006.03838.x	46	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25728	10.1371/journal.pone.0025728	http://dx.doi.org/10.1371/journal.pone.0025728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980529	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600050
J	Turnbaugh, JA; Westergard, L; Unterberger, U; Biasini, E; Harris, DA				Turnbaugh, Jessie A.; Westergard, Laura; Unterberger, Ursula; Biasini, Emiliano; Harris, David A.			The N-Terminal, Polybasic Region Is Critical for Prion Protein Neuroprotective Activity	PLOS ONE			English	Article							INDUCED CELL-DEATH; TRANSGENIC MICE; HUMAN NEURONS; PRP; STRESS; DOMAIN; IDENTIFICATION; ENDOCYTOSIS; ATAXIA; EXPRESSION	Several lines of evidence suggest that the normal form of the prion protein, PrP(C) exerts a neuroprotective activity against cellular stress or toxicity. One of the clearest examples of such activity is the ability of wild-type PrP(C) to suppress the spontaneous neurodegenerative phenotype of transgenic mice expressing a deleted form of PrP (Delta 32-134, called F35). To define domains of PrP involved in its neuroprotective activity, we have analyzed the ability of several deletion mutants of PrP (Delta 23-31, Delta 23-111, and Delta 23-134) to rescue the phenotype of Tg(F35) mice. Surprisingly, all of these mutants displayed greatly diminished rescue activity, although Delta 23-31 PrP partially suppressed neuronal loss when expressed at very high levels. Our results pinpoint the N-terminal, polybasic domain as a critical determinant of PrP(C) neuroprotective activity, and suggest that identification of molecules interacting with this region will provide important clues regarding the normal function of the protein. Small molecule ligands targeting this region may also represent useful therapeutic agents for treatment of prion diseases.	[Turnbaugh, Jessie A.; Unterberger, Ursula; Biasini, Emiliano; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Turnbaugh, Jessie A.; Westergard, Laura] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Turnbaugh, JA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	daharris@bu.edu	Biasini, Emiliano/A-3147-2011	Biasini, Emiliano/0000-0002-3927-6341; Harris, David/0000-0002-6985-5790	N.I.H [NS040975, NS052526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040975, R01NS052526, R01NS065244] Funding Source: NIH RePORTER	N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the N.I.H. to D.A.H. (NS040975 and NS052526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Boland MP, 2010, J BIOL CHEM, V285, P32282, DOI 10.1074/jbc.M110.123398; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christensen HM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-11; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P2777, DOI 10.1038/sj.emboj.7601726; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Oglecka K, 2008, BBA-BIOMEMBRANES, V1778, P206, DOI 10.1016/j.bbamem.2007.09.034; Osiecka KM, 2009, PROTEINS, V77, P279, DOI 10.1002/prot.22435; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger U.K., 2011, EMBO J; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; SOLOMON IH, 2011, J BIOL CHEM; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taubner LM, 2010, J MOL BIOL, V395, P475, DOI 10.1016/j.jmb.2009.10.075; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vincent B, 2001, J BIOL CHEM, V276, P37743; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200	49	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25675	10.1371/journal.pone.0025675	http://dx.doi.org/10.1371/journal.pone.0025675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980526	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600049
J	Koning, H; Sayers, I; Stewart, CE; de Jong, D; ten Hacken, NHT; Postma, DS; van Oosterhout, AJM; Nawijn, MC; Koppelman, GH				Koning, Henk; Sayers, Ian; Stewart, Ceri E.; de Jong, Debora; ten Hacken, Nick H. T.; Postma, Dirkje S.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.; Koppelman, Gerard H.			Characterization of protocadherin-1 expression in primary bronchial epithelial cells: association with epithelial cell differentiation	FASEB JOURNAL			English	Article						asthma; brush; rapid amplification of cDNA ends; air-liquid interface; splice variants	MUCOCILIARY DIFFERENTIATION; DELTA-PROTOCADHERINS; DYSREGULATED REPAIR; LARGE FAMILY; ORGANIZATION; EVOLUTION; ISOFORMS; ALPHA(+); ADHESION; GROWTH	Protocadherin-1 (PCDH1) is a novel susceptibility gene for asthma that is expressed in airway epithelium. We aimed to characterize PCDH1 mRNA transcripts and protein expression in primary bronchial epithelial cells and to determine regulation of PCDH1 during mucociliary differentiation. Total RNA and protein were isolated from human primary bronchial epithelial cells. PCDH1 transcripts were characterized by rapid amplification of cDNA ends in bronchial epithelial cells of 4 subjects. PCDH1 expression was quantified by quantitative RT-PCR and Western blotting in bronchial epithelial cells directly ex vivo and after air liquid interface (ALI) or submerged culture. We identified 5 novel exons on the 5' end and 1 exon on the 3' end of PCDH1. Novel transcripts showed major variation in expression of intracellular conserved motifs. Expression levels of PCDH1 transcripts encoding exon 1-2 were 4-fold higher, and transcripts encoding exon 3-4 were 15-fold higher in freshly isolated bronchial epithelial cells than in submerged cultures. PCDH1 mRNA (3 to 8-fold) and protein levels (2- to 3-fold) were strongly up-regulated during mucociliary differentiation of primary bronchial epithelial cells in ALI cultures. In summary, PCDH1 transcripts display remarkable variability in expression of conserved intracellular signaling domains. Enhanced PCDH1 expression levels strongly correlate with differentiation of bronchial epithelial cells.-Koning, H., Sayers, I., Stewart, C. E., de Jong, D., ten Hacken, N. H. T., Postma, D. S., van Oosterhout, A. J. M., Nawijn, M. C., Koppelman, G. H. Characterization of protocadherin-1 expression in primary bronchial epithelial cells: association with epithelial cell differentiation. FASEB J. 26, 439-448 (2012). www.fasebj.org	[Koppelman, Gerard H.] Univ Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Koning, Henk; de Jong, Debora; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Lab Allergol & Pulm Dis, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands; [ten Hacken, Nick H. T.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 RB Groningen, Netherlands; [Sayers, Ian; Stewart, Ceri E.] Univ Nottingham, Div Therapeut & Mol Med, Nottingham Resp Biomed Res Unit, Queens Med Ctr, Nottingham NG7 2RD, England	University of Groningen; University of Groningen; University of Groningen; University of Nottingham	Koppelman, GH (corresponding author), Univ Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	g.h.koppelman@umcg.nl	Koppelman, Gerard/AAG-9187-2020	Stewart, Ceri/0000-0002-6214-2237; Nawijn, Martijn/0000-0003-3372-6521; Sayers, Ian/0000-0001-5601-5410; Koppelman, Gerard/0000-0001-8567-3252	Jan Kornelis de Cock Stichting; GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community); European Commission; Stichting Astma Bestrijding; Netherlands Asthma Foundation [3.2.09.055]; ZonMW Veni Koppelman [916.56.091]	Jan Kornelis de Cock Stichting; GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community); European Commission(European CommissionEuropean Commission Joint Research Centre); Stichting Astma Bestrijding; Netherlands Asthma Foundation; ZonMW Veni Koppelman	The authors thank Dr. C. van Kooten (Leiden University Hospital, Leiden, The Netherlands) for providing mouse L-cell fibroblasts, and D. C. Gruenert (Department of Medicine, University of Vermont, Burlington, VT, USA, and University of California, San Francisco, CA, USA) for providing the bronchial epithelial cell-line 16HBE14o<SUP>-</SUP>. Furthermore, the authors thank all subjects who contributed to this study and J. Noordhoek for technical assistance. This work was supported by Jan Kornelis de Cock Stichting, GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community), a European Commission FP6 grant, Stichting Astma Bestrijding, Netherlands Asthma Foundation Grant 3.2.09.055, and ZonMW Veni Koppelman (916.56.091).	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blanco-Arias P, 2004, MAMM GENOME, V15, P41, DOI 10.1007/s00335-003-3028-7; Borger P, 2002, J HEART LUNG TRANSPL, V21, P567, DOI 10.1016/S1053-2498(01)00418-1; Bouillot S, 2011, J BIOL CHEM, V286, P15195, DOI 10.1074/jbc.M111.230045; Broekema M, 2009, AM J RESP CRIT CARE, V180, P1170, DOI 10.1164/rccm.200906-0828OC; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Ciana A, 2010, CELL BIOL INT, V34, P669, DOI 10.1042/CBI20090067; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; DEJONG PM, 1993, IN VITRO CELL DEV-AN, V29A, P379, DOI 10.1007/BF02633985; Demontis F, 2006, DEV GENES EVOL, V216, P737, DOI 10.1007/s00427-006-0097-0; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Frank M, 2002, CURR OPIN CELL BIOL, V14, P557, DOI 10.1016/S0955-0674(02)00365-4; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Hormi-Carver KK, 2004, DEV DYNAM, V229, P791, DOI 10.1002/dvdy.10497; Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906; Hulpiau P, 2011, MOL BIOL EVOL, V28, P647, DOI 10.1093/molbev/msq233; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Krahn MP, 2010, J BIOL CHEM, V285, P13193, DOI 10.1074/jbc.M109.080051; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Romagnoli M, 1999, RESP MED, V93, P461, DOI 10.1016/S0954-6111(99)90088-4; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheth B, 1997, DEVELOPMENT, V124, P2027; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; VIGNOLA AM, 1993, ALLERGY, V48, P32, DOI 10.1111/j.1398-9995.1993.tb04696.x; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5; Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003	45	25	26	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					439	448		10.1096/fj.11-185207	http://dx.doi.org/10.1096/fj.11-185207			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21982948				2022-12-25	WOS:000299202200043
J	Cao, JS; Zhou, YJ; Peng, HB; Huang, XY; Stahler, S; Suri, V; Qadri, A; Gareski, T; Jones, J; Hahm, S; Perreault, M; Mckew, J; Shi, MX; Xu, X; Tobin, JF; Gimeno, RE				Cao, Jingsong; Zhou, Yingjiang; Peng, Haibing; Huang, Xinyi; Stahler, Shannon; Suri, Vipin; Qadri, Ariful; Gareski, Tiffany; Jones, Juli; Hahm, Seung; Perreault, Mylene; McKew, John; Shi, Mengxiao; Xu, Xin; Tobin, James F.; Gimeno, Ruth E.			Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME ADIACYLGLYCEROL ACYLTRANSFERASE; COA-DIACYLGLYCEROL ACYLTRANSFERASE-1; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; HEPATIC STEATOSIS; ADIPOSE-TISSUE; KEY ENZYME; MICE	Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. Findings from genetically modified mice as well as pharmacological studies suggest that inhibition of DGAT1 is a promising strategy for the treatment of obesity and type 2 diabetes. Here we characterize a tool DGAT1 inhibitor compound, T863. We found that T863 is a potent inhibitor for both human and mouse DGAT1 in vitro, which acts on the acyl-CoA binding site of DGAT1 and inhibits DGAT1-mediated triacylglycerol formation in cells. In an acute lipid challenge model, oral administration of 1863 significantly delayed fat absorption and resulted in lipid accumulation in the distal small intestine of mice, mimicking the effects of genetic ablation of DGAT1. In diet-induced obese mice, oral administration of T863 for 2 weeks caused weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity. In addition to the expected triglyceride-lowering activity, T863 also lowered serum cholesterol. Hepatic IRS2 protein was dramatically up-regulated in mice treated with T863, possibly contributing to improved insulin sensitivity. In differentiated 3T3-L1 adipocytes, T863 enhanced insulin-stimulated glucose uptake, suggesting a possible role for adipocytes to improve insulin sensitivity upon DGAT1 inhibition. These results reveal novel mechanistic insights into the insulin-sensitizing effects of DGAT1 inhibition in mouse models. Taken together, our study provides a comprehensive evaluation of a small molecule inhibitor for DGAT1 and suggests that pharmacological inhibition of DGAT1 holds promise in treating diverse metabolic disorders.	[Cao, Jingsong; Zhou, Yingjiang; Peng, Haibing; Suri, Vipin; Qadri, Ariful; Gareski, Tiffany; Jones, Juli; Hahm, Seung; Perreault, Mylene; Tobin, James F.; Gimeno, Ruth E.] Pfizer, Biocorrect Res Unit, Cambridge, MA 02140 USA; [McKew, John] Pfizer, Exploratory Med Chem, Cambridge, MA 02140 USA; [Huang, Xinyi; Stahler, Shannon] Pfizer, Screening Sci, Collegeville, PA 19426 USA; [Shi, Mengxiao; Xu, Xin] Pfizer, Discovery Pharmacokinet, Andover, MA 01810 USA	Pfizer; Pfizer; Pfizer; Pfizer	Cao, JS (corresponding author), Pfizer, Biocorrect Res Unit, Cambridge, MA 02140 USA.	jingsong.cao@novartis.com; gimeno_ruth@lilly.com						Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Bello AA, 1996, BIOCHEM PHARMACOL, V51, P413, DOI 10.1016/0006-2952(95)02186-8; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chiari A, 1995, PHARMACOL RES, V32, P189, DOI 10.1016/S1043-6618(05)80022-2; Chung CC, 2008, ASSAY DRUG DEV TECHN, V6, P361, DOI 10.1089/adt.2007.105; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fox B.M., 2004, U.S. Patent, Patent No. [US 2004/0209871 A1, 20040209871, 2004/0209871 A1]; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Kohjima M, 2007, INT J MOL MED, V20, P351; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Ramharack R.R., 2002, Diacylglycerol acyltransferase (DGAT) assay, Patent No. [US20020127627, 20020127627]; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seethala R, 2008, ANAL BIOCHEM, V383, P144, DOI 10.1016/j.ab.2008.09.013; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Tan CH, 2010, ANAL BIOCHEM, V401, P144, DOI 10.1016/j.ab.2010.02.021; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zhang JH, 2010, J BIOMOL SCREEN, V15, P695, DOI 10.1177/1087057110370210; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	36	105	108	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41838	41851		10.1074/jbc.M111.245456	http://dx.doi.org/10.1074/jbc.M111.245456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990351	Green Published, hybrid			2022-12-25	WOS:000298057500066
J	Geng, Z; Xu, FY; Huang, SH; Chen, ZY				Geng, Zhao; Xu, Feng-Yi; Huang, Shu-Hong; Chen, Zhe-Yu			Sorting Protein-related Receptor SorLA Controls Regulated Secretion of Glial Cell Line-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; INTRACELLULAR TRAFFICKING; DOPAMINERGIC-NEURONS; CYTOPLASMIC DOMAIN; PARKINSON-DISEASE; VPS10P DOMAIN; LIVING CELLS; GOLGI PH; GDNF	Ghat cell line-derived neurotrophic factor (GDNF), after secreted from cells, plays a critical role in central and peripheral neuron survival and function. The secretion of GDNF can be either constitutive or regulated by physiological stimuli; however, the detailed mechanism driving GDNF secretion is still unknown. Here, we report that sorting protein-related receptor with A-type repeats (SorLA), a member of the mammal Vps10p domain receptor, interacts with GDNF and is localized to GDNF-containing vesicles. Overexpression of SorLA significantly increases, and knockdown of SorLA by siRNA decreases, the regulated secretion of GDNF in PC12 and MN9D cells but has no effect on GDNF constitutive secretion. In addition, overexpression of a truncated form of SorLA also impairs GDNF-regulated secretion. Finally, we found that the prodomain of GDNF mediates the interaction of GDNF with SorLA under acidic conditions. Moreover, overexpression of SorLA could enhance the regulated secretion of the GDNF prodomain-GFP fusion protein, suggesting that the prodomain of GDNF is responsible for its regulated secretion. Together, these findings will advance our understanding of the molecular mechanism underlying GDNF-regulated secretion.	[Geng, Zhao; Xu, Feng-Yi; Huang, Shu-Hong; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Huang, Shuhong/AAI-4151-2021		National Natural Science Foundation of China [30725020, 30900717, 31071254, 31130026]; National 973 Basic Research Program of China [2012CB911004, 2009CB941403]; National Natural Science Foundation of China for Innovative Research Group [81021001]; Foundation for Excellent Young Scientists of Shandong Province [BS2010SW022]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; Independent Innovation Foundation of Shandong University [2011DX001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong Province; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University	This study was supported by the National Natural Science Foundation of China (No. 30725020, 30900717, 31071254, 31130026), the National 973 Basic Research Program of China (No. 2012CB911004, 2009CB941403), the State Program of National Natural Science Foundation of China for Innovative Research Group (No.81021001), the Foundation for Excellent Young Scientists of Shandong Province (BS2010SW022), Research Fund for the Doctoral Program of Higher Education of China (200804221070), and Independent Innovation Foundation of Shandong University (2011DX001).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kawamoto Y, 2000, NEUROSCIENCE, V100, P701, DOI 10.1016/S0306-4522(00)00326-2; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lonka-Nevalaita L, 2010, J NEUROSCI, V30, P11403, DOI 10.1523/JNEUROSCI.5888-09.2010; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oh-hashi K, 2009, MOL CELL BIOCHEM, V323, P1, DOI 10.1007/s11010-008-9958-3; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Soderstrom K, 2006, CELL TRANSPLANT, V15, P251, DOI 10.3727/000000006783982025; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Verity AN, 1998, J NEUROCHEM, V70, P531; Wang Y, 2008, BRAIN RES, V1226, P1, DOI 10.1016/j.brainres.2008.05.087; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761	41	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41871	41882		10.1074/jbc.M111.246413	http://dx.doi.org/10.1074/jbc.M111.246413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994944	Green Published, hybrid			2022-12-25	WOS:000298057500069
J	Mao, YF; Shang, YL; Pham, VC; Ernst, JA; Lill, JR; Scales, SJ; Zha, JP				Mao, Yifan; Shang, Yonglei; Pham, Victoria C.; Ernst, James A.; Lill, Jennie R.; Scales, Suzie J.; Zha, Jiping			Polyubiquitination of Insulin-like Growth Factor I Receptor (IGF-IR) Activation Loop Promotes Antibody-induced Receptor Internalization and Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; MULTIUBIQUITIN CHAIN; ANTITUMOR-ACTIVITY; UBIQUITIN CHAINS; KINASE DOMAIN; TUMOR-GROWTH; DEGRADATION; PROTEIN; CANCER	Ubiquitination has been implicated in negatively regulating insulin-like growth factor I receptor (IGF-IR) activity. Because of the relative stability of IGF-IR in the presence of ligand stimulation, IGF-IR ubiquitination sites have yet to be mapped and characterized, thus preventing a direct demonstration of how the receptor ubiquitination contributes to downstream molecular cascades. We took advantage of an anti-IGF-IR antibody (h10H5) that induces more efficient receptor down-regulation to show that IGF-IR is promptly and robustly ubiquitinated. The ubiquitination sites were mapped to the two lysine residues in the IGF-IR activation loop (Lys-1138 and Lys-1141) and consisted of polyubiquitin chains formed through both Lys-48 and Lys-29 linkages. Mutation of these ubiquitinated lysine residues resulted in decreased h10H5-induced IGF-IR internalization and down-regulation as well as a reduced cellular response to h10H5 treatment. We have therefore demonstrated that IGF-IR ubiquitination contributes critically to the down-regulating and antiproliferative activity of h10H5. This finding is physiologically relevant because insulin-like growth factor I appears to mediate ubiquitination of the same major sites as h10H5 (albeit to a lesser extent), and ubiquitination is facilitated by pre-existing phosphorylation of the receptor in both cases. Furthermore, identification of a breast cancer cell line with a defect in IGF-IR ubiquitination suggests that this could be an important tumor resistance mechanism to evade down-regulation-mediated negative regulation of IGF-IR activity in cancer.	[Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Mao, Yifan; Shang, Yonglei; Zha, Jiping] Genentech Inc, Dept Pathol Res, San Francisco, CA 94080 USA; [Pham, Victoria C.; Ernst, James A.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Scales, SJ (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sscales@gene.com; jzha@crownbio.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Broussas M, 2009, INT J CANCER, V124, P2281, DOI 10.1002/ijc.24186; Burtrum D, 2003, CANCER RES, V63, P8912; Carelli S, 2006, J CELL PHYSIOL, V208, P354, DOI 10.1002/jcp.20670; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI SW, 1994, J BIOL CHEM, V269, P32558; Maloney EK, 2003, CANCER RES, V63, P5073; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	43	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41852	41861		10.1074/jbc.M111.288514	http://dx.doi.org/10.1074/jbc.M111.288514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994939	hybrid, Green Published			2022-12-25	WOS:000298057500067
J	Timm, T; von Kries, JP; Li, XY; Zennpel, H; Mandelkow, E; Mandelkow, EM				Timm, Thomas; von Kries, Jens Peter; Li, Xiaoyu; Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria			Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor INHIBITORS WITH THERAPEUTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE MOUSE MODELS; DETERMINES AGGREGATION; TAU-PHOSPHORYLATION; REPEAT DOMAIN; PAR PROTEINS; POLARITY; MARK; ESTABLISHMENT; DOUBLECORTIN; MARK/PAR-1	Protein kinases of the microtubule affinity regulating kinase (MARK)/Par-1 family play important roles in the establishment of cellular polarity, cell cycle control, and intracellular signal transduction. Disturbance of their function is linked to cancer and brain diseases, e.g. lissencephaly and Alzheimer disease. To understand the biological role of MARK family kinases, we searched for specific inhibitors and a biosensor for MARK activity. A screen of the ChemBioNet library containing similar to 18,000 substances yielded several compounds with inhibitory activity in the low micromolar range and capable of inhibiting MARK activity in cultured cells and primary neurons, as judged by MARK-dependent phosphorylation of microtubule-associated proteins and its consequences for microtubule integrity. Four of the compounds share a 9-oxo-9H-acridin-10-yl structure as a basis that will serve as a lead for optimization of inhibition efficiency. To test these inhibitors, we developed a cellular biosensor for MARK activity based on a MARK target sequence attached to the 14-3-3 scaffold protein and linked to enhanced cyan or teal and yellow fluorescent protein as FRET donor and acceptor pairs. Transfection of the teal/yellow fluorescent protein sensor into neurons and imaging by fluorescence lifetime imaging revealed that MARK was particularly active in the axons and growth cones of differentiating neurons.	[Timm, Thomas; Li, Xiaoyu; Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [von Kries, Jens Peter] Forschungsinst Fuer Mol Pharmakol, FMP, D-13125 Berlin, Germany; [Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DZNE German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] CAESAR, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Mandelkow, EM (corresponding author), DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mandelkow@dzne.de			Institute for the Study of Aging (ISOA, New York); Deutsche Forschungsgemeinschaft; EU	Institute for the Study of Aging (ISOA, New York); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported by grants from the Institute for the Study of Aging (ISOA, New York), the Deutsche Forschungsgemeinschaft, and the EU-FP7 (Memosad project).	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Buee L, 2010, BIOCHEM SOC T, V38, P967, DOI 10.1042/BST0380967; Chin JY, 2000, J NEUROPATH EXP NEUR, V59, P966, DOI 10.1093/jnen/59.11.966; Clegg RM, 2003, METHOD ENZYMOL, V360, P509; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Esterman AL, 2006, GENET ENG NEWS, V26, P26; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	44	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41711	41722		10.1074/jbc.M111.257865	http://dx.doi.org/10.1074/jbc.M111.257865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984823	Green Published, hybrid			2022-12-25	WOS:000298057500055
J	Lai, JN; Wu, CT; Chen, PC; Huang, CS; Chow, SN; Wang, JD				Lai, Jung-Nien; Wu, Chien-Tung; Chen, Pau-Chung; Huang, Chiun-Sheng; Chow, Song-Nan; Wang, Jung-Der			Increased Risk for Invasive Breast Cancer Associated with Hormonal Therapy: A Nation-Wide Random Sample of 65,723 Women Followed from 1997 to 2008	PLOS ONE			English	Article							PROGESTIN-REPLACEMENT THERAPY; HEALTH INITIATIVE WHI; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; ESTROGEN; TAIWAN; COHORT; CELLS	Background: Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by dietary phytoestrogens intake and low prevalence of contraceptive pills prescription. Methodology: A total of 65,723 women (20-79 years of age) without cancer or the use of Chinese herbal products were recruited from a nation-wide one-million representative sample of the National Health Insurance of Taiwan and followed from 1997 to 2008. Seven hundred and eighty incidents of invasive breast cancer were diagnosed. Using a reference group that comprised 40,052 women who had never received a hormone prescription, Cox proportional hazard models were constructed to determine the hazard ratios for receiving different types of HT and the occurrence of breast cancer. Conclusions: 5,156 (20%) women ever used E+P, 2,798 (10.8%) ever used E-alone, and 17,717 (69%) ever used other preparation types. The Cox model revealed adjusted hazard ratios (HRs) of 2.05 (95% CI 1.37-3.07) for current users of E-alone and 8.65 (95% CI 5.45-13.70) for current users of E+P. Using women who had ceased to take hormonal medication for 6 years or more as the reference group, the adjusted HRs were significantly elevated and greater than current users and women who had discontinued hormonal medication for less than 6 years. Current users of either E-alone or E+P have an increased risk for invasive breast cancer in Taiwan, and precautions should be taken when such agents are prescribed.	[Lai, Jung-Nien] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Lai, Jung-Nien] Taipei City Hosp, Yangming Branch, Dept Obstet & Gynecol, Taipei, Taiwan; [Wu, Chien-Tung] Taipei City Hosp, Dept Chinese Med, Taipei, Taiwan; [Chen, Pau-Chung; Wang, Jung-Der] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Huang, Chiun-Sheng] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Huang, Chiun-Sheng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chow, Song-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Lai, JN (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	jdwang121@gmail.com	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974; Huang, Chiun-Sheng/0000-0002-6557-211X	National Health Research Institute; National Research Institute of Chinese Medicine	National Health Research Institute(National Health Research Institutes - Taiwan); National Research Institute of Chinese Medicine	This study was funded by the National Health Research Institute and National Research Institute of Chinese Medicine. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. And no additional external funding was received for this study. The database was kindly provided by the Bureau of National Health Insurance, the Department of Health, and the National Health Research Institutes.	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Amato P, 2002, MENOPAUSE, V9, P145, DOI 10.1097/00042192-200203000-00010; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bush TM, 2007, J GEN INTERN MED, V22, P1311, DOI 10.1007/s11606-007-0296-z; Centers for Disease Control and Prevention, 1979, INT CLASS DIS 9 REV; Chen SB, 2006, J CHROMATOGR A, V1121, P114, DOI 10.1016/j.chroma.2006.04.082; Chlebowski RT, 2010, J CLIN ONCOL, V28, P2690, DOI 10.1200/JCO.2009.24.8799; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Cust Michael P, 2007, Menopause Int, V13, P141, DOI 10.1258/175404507783004285; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; Government Information Office, 2004, TAIW YB 2004; Haines CJ, 2005, MATURITAS, V52, P264, DOI 10.1016/j.maturitas.2005.03.012; Hines LM, 2010, CANCER-AM CANCER SOC, V116, P3215, DOI 10.1002/cncr.25154; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Hu CY, 2009, J STEROID BIOCHEM, V113, P209, DOI 10.1016/j.jsbmb.2008.12.019; Kuo DJ, 2007, MATURITAS, V58, P259, DOI 10.1016/j.maturitas.2007.08.013; Lau WS, 2009, BRIT J PHARMACOL, V156, P1136, DOI 10.1111/j.1476-5381.2009.00123.x; Lee SH, 2004, J NUTR BIOCHEM, V15, P452, DOI 10.1016/j.jnutbio.2004.01.007; Lyytinen H, 2006, OBSTET GYNECOL, V108, P1354, DOI 10.1097/01.AOG.0000241091.86268.6e; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; National Health Research Institutes, 2003, NAT HLTH INS RES DAT; Pedersen AT, 2003, HUM REPROD, V18, P2241, DOI 10.1093/humrep/deg435; Piersen Colleen E, 2003, Integr Cancer Ther, V2, P120, DOI 10.1177/1534735403002002004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; Tjonneland A, 2004, CANCER-AM CANCER SOC, V100, P2328, DOI 10.1002/cncr.20250; Weissmann-Brenner A, 2010, MED SCI MONITOR, V16, pPH35	30	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25183	10.1371/journal.pone.0025183	http://dx.doi.org/10.1371/journal.pone.0025183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998640	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700006
J	Arola-Arnal, A; Blade, C				Arola-Arnal, Anna; Blade, Cinta			Proanthocyanidins Modulate MicroRNA Expression in Human HepG2 Cells	PLOS ONE			English	Article							GRAPE SEED PROCYANIDINS; ANTIOXIDANT ACTIVITY; TEA POLYPHENOLS; IN-VITRO; CANCER; BIOAVAILABILITY; MECHANISMS; PREVENTION; TANNINS; DISEASE	Mi(cro)RNAs are small non-coding RNAs of 18-25 nucleotides in length that modulate gene expression at the post-transcriptional level. These RNAs have been shown to be involved in a several biological processes, human diseases and metabolic disorders. Proanthocyanidins, which are the most abundant polyphenol class in the human diet, have positive health effects on a variety of metabolic disorders such as inflammation, obesity, diabetes and insulin resistance. The present study aimed to evaluate whether proanthocyanidin-rich natural extracts modulate miRNA expression. Using microarray analysis and Q-PCR, we investigated miRNA expression in HepG2 cells treated with proanthocyanidins. Our results showed that when HepG2 cells were treated with grape seed proanthocyanidin extract (GSPE), cocoa proanthocyanidin extract (CPE) or pure epigallocatechin gallate isolated from green tea (EGCG), fifteen, six and five differentially expressed miRNAs, respectively, were identified out of 904 mRNAs. Specifically, miR-30b* was downregulated by the three treatments, and treatment with GSPE or CPE upregulated miR-1224-3p, miR-197 and miR-532-3p. Therefore, these results provide evidence of the capacity of dietary proanthocyanidins to influence microRNA expression, suggesting a new mechanism of action of proanthocyanidins.	[Arola-Arnal, Anna; Blade, Cinta] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain; [Arola-Arnal, Anna] CTNS, Reus, Spain	Universitat Rovira i Virgili	Arola-Arnal, A (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain.	anna.arola@urv.cat	Arola-Arnal, Anna/C-2087-2015	Arola-Arnal, Anna/0000-0001-6529-1345; Blade, Cinta/0000-0003-2838-2402	Spanish Government [AGL 2008-00387/ALI]; European Union [244995]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	This work was supported by grant number AGL 2008-00387/ALI from the Spanish Government. The research leading to these results has received funding from the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Chen J, 2010, ADV GENET, V71, P237, DOI [10.1016/B978-0-12-380864-6.00008-0, 10.1016/S0065-2660(10)71009-9]; Chiba Y, 2010, J PHARMACOL SCI, V114, P262, DOI 10.1254/jphs.10R09FM; Counet C, 2003, J AGR FOOD CHEM, V51, P6816, DOI 10.1021/jf030349g; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; De Bruyne T, 1999, BIOCHEM SYST ECOL, V27, P445, DOI 10.1016/S0305-1978(98)00101-X; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Garcia-Ramirez B, 2006, J AGR FOOD CHEM, V54, P2543, DOI 10.1021/jf0527753; Iglesias J, 2010, J AGR FOOD CHEM, V58, P7423, DOI 10.1021/jf100832z; Kobayashi M, 2009, J AGR FOOD CHEM, V57, P7131, DOI 10.1021/jf900855v; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Montagut G, 2010, J NUTR BIOCHEM, V21, P476, DOI 10.1016/j.jnutbio.2009.02.003; Montagut G, 2009, FOOD CHEM, V116, P265, DOI 10.1016/j.foodchem.2009.02.044; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Ortega N, 2008, J AGR FOOD CHEM, V56, P9621, DOI 10.1021/jf8014415; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Puiggros F, 2005, J AGR FOOD CHEM, V53, P6080, DOI 10.1021/jf050343m; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Terra X, 2011, FREE RADICAL RES, V45, P611, DOI 10.3109/10715762.2011.564165; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; United States Department of Agriculture, 2014, USDA DATABASE FLAVON	37	79	87	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25982	10.1371/journal.pone.0025982	http://dx.doi.org/10.1371/journal.pone.0025982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998738	gold, Green Published			2022-12-25	WOS:000295966900086
J	Fre, S; Hannezo, E; Sale, S; Huyghe, M; Lafkas, D; Kissel, H; Louvi, A; Greve, J; Louvard, D; Artavanis-Tsakonas, S				Fre, Silvia; Hannezo, Edouard; Sale, Sanja; Huyghe, Mathilde; Lafkas, Daniel; Kissel, Holger; Louvi, Angeliki; Greve, Jeffrey; Louvard, Daniel; Artavanis-Tsakonas, Spyros			Notch Lineages and Activity in Intestinal Stem Cells Determined by a New Set of Knock-In Mice	PLOS ONE			English	Article							PROGENITOR CELLS; RECEPTOR EXPRESSION; MUTATION; SIGNALS; BRAIN; FATE; RENEWAL; CRYPTS; COLON; VIVO	The conserved role of Notch signaling in controlling intestinal cell fate specification and homeostasis has been extensively studied. Nevertheless, the precise identity of the cells in which Notch signaling is active and the role of different Notch receptor paralogues in the intestine remain ambiguous, due to the lack of reliable tools to investigate Notch expression and function in vivo. We generated a new series of transgenic mice that allowed us, by lineage analysis, to formally prove that Notch1 and Notch2 are specifically expressed in crypt stem cells. In addition, a novel Notch reporter mouse, Hes1-EmGFP(SAT), demonstrated exclusive Notch activity in crypt stem cells and absorptive progenitors. This roster of knock-in and reporter mice represents a valuable resource to functionally explore the Notch pathway in vivo in virtually all tissues.	[Fre, Silvia; Huyghe, Mathilde; Louvard, Daniel] Inst Curie, CNRS, UMR144, F-75231 Paris, France; [Hannezo, Edouard] UPMC, CNRS, Inst Curie, UMR 168, Paris, France; [Sale, Sanja; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Lafkas, Daniel; Artavanis-Tsakonas, Spyros] INSERM, Dept Dev Biol & Genet, Inst Curie, CNRS,U934,UMR3215, Paris, France; [Kissel, Holger] TaconicArtemis GmbH, Cologne, Germany; [Louvi, Angeliki] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Greve, Jeffrey] Exelixis Inc, San Francisco, CA USA; [Artavanis-Tsakonas, Spyros] Coll France, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; Yale University; Yale University; Exelixis, Inc.; UDICE-French Research Universities; PSL Research University Paris; College de France	Fre, S (corresponding author), Inst Curie, CNRS, UMR144, F-75231 Paris, France.	artavanis@hms.harvard.edu	Lafkas, Daniel/AAI-8718-2021; Fre, Silvia/C-7540-2017	Lafkas, Daniel/0000-0001-7395-476X; Fre, Silvia/0000-0002-7209-7636; huyghe, mathilde/0000-0002-8473-2924; Hannezo, Edouard/0000-0001-6005-1561	Institut National du Cancer [2009-175]; Ligue Nationale contre le Cancer [EL2008.LNCC/SR1]; NIH [NS26084, CA098402]; Exelixis, Inc.; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026084, R37NS026084] Funding Source: NIH RePORTER	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Exelixis, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from "Institut National du Cancer" (2009-175) (http://www.e-cancer.fr/) and "Ligue Nationale contre le Cancer" (EL2008.LNCC/SR1) (http://www.ligue-cancer.net/) to SF and DL and by the NIH (NS26084, CA098402) (http://www.nih.gov/) to SAT. Exelixis, Inc. funded the construction of the Notch transgenic mice used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Murphy PA, 2009, LAB INVEST, V89, P971, DOI 10.1038/labinvest.2009.62; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; PARK HS, 1995, AM J PATHOL, V147, P1416; Pellegrinet L, 2011, GASTROENTEROLOGY; Prakash N, 2002, EXP CELL RES, V278, P31, DOI 10.1006/excr.2002.5544; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	40	99	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25785	10.1371/journal.pone.0025785	http://dx.doi.org/10.1371/journal.pone.0025785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991352	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000070
J	Qiu, LL; Tian, L; Pan, C; Zhu, RS; Liu, Q; Yan, J; Zhao, Q; Yuan, HS; Han, YH; Yue, WH; Yan, H; Zhang, D				Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Zhao, Qiang; Yuan, Huishu; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai			Neuroanatomical Circuitry Associated with Exploratory Eye Movement in Schizophrenia: A Voxel-Based Morphometric Study	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; SMOOTH-PURSUIT; VISUAL-OBJECT; FUNCTIONAL NEUROANATOMY; TRACKING DYSFUNCTION; CORTICAL CONTROL; RECOGNITION; DEFICITS; LESIONS; FIELD	Schizophrenic patients present abnormalities in a variety of eye movement tasks. Exploratory eye movement (EEM) dysfunction appears to be particularly specific to schizophrenia. However, the underlying mechanisms of EEM dysfunction in schizophrenia are not clearly understood. To assess the potential neuroanatomical substrates of EEM, we recorded EEM performance and conducted a voxel-based morphometric analysis of gray matter in 33 schizophrenic patients and 29 well matched healthy controls. In schizophrenic patients, decreased responsive search score (RSS) and widespread gray matter density (GMD) reductions were observed. Moreover, the RSS was positively correlated with GMD in distributed brain regions in schizophrenic patients. Furthermore, in schizophrenic patients, some brain regions with neuroanatomical deficits overlapped with some ones associated with RSS. These brain regions constituted an occipito-tempro-frontal circuitry involved in visual information processing and eye movement control, including the left calcarine cortex [ Brodmann area (BA) 17], the left cuneus (BA 18), the left superior occipital cortex (BA 18/19), the left superior frontal gyrus (BA 6), the left cerebellum, the right lingual cortex (BA 17/18), the right middle occipital cortex (BA19), the right inferior temporal cortex (BA 37), the right dorsolateral prefrontal cortex (BA 46) and bilateral precentral gyri (BA 6) extending to the frontal eye fields (FEF, BA 8). To our knowledge, we firstly reported empirical evidence that gray matter loss in the occipito-tempro-frontal neuroanatomical circuitry of visual processing system was associated with EEM performance in schizophrenia, which may be helpful for the future effort to reveal the underlying neural mechanisms for EEM disturbances in schizophrenia.	[Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhao, Qiang; Yuan, Huishu] Peking Univ, Dept Radiol, Hosp 3, Beijing 100871, Peoples R China	Peking University; Peking University	Qiu, LL (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	hao_y@hsc.pku.edu.cn; daizhang@hsc.pku.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037	National Basic Research Program of China [2011CB707805, 2007CB512301]; National Natural Science Foundation of China [81071088, 81000580]; Capital Foundation of Medical Developments [2007-1001]; International Science and Technology Cooperation Program of China [2010DFB30820]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Foundation of Medical Developments; International Science and Technology Cooperation Program of China	This work was supported by grants from National Basic Research Program of China (2011CB707805, 2007CB512301), National Natural Science Foundation of China (81071088 and 81000580), Capital Foundation of Medical Developments (2007-1001) and International Science and Technology Cooperation Program of China (2010DFB30820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1990, BEHAV BRAIN RES, V39, P262, DOI 10.1016/0166-4328(90)90032-A; Bagary MS, 2004, BIOL PSYCHIAT, V56, P620, DOI 10.1016/j.biopsych.2004.08.017; Bai YM, 2007, J CLIN PSYCHIAT, V68, P1218, DOI 10.4088/JCP.v68n0808; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Barton JJS, 1996, ANN NEUROL, V40, P387, DOI 10.1002/ana.410400308; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Blumberg J, 2010, J CLIN INVEST, V120, P3054, DOI 10.1172/JCI42161; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Cadenhead KS, 1997, SCHIZOPHR RES, V28, P51, DOI 10.1016/S0920-9964(97)00085-6; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; COFFMAN JA, 1981, LANCET, V1, P666; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Gegeshidze K, 2004, WORLD J BIOL PSYCHIA, V5, P26, DOI 10.1080/15622970410029904; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; KATSANIS J, 1991, J ABNORM PSYCHOL, V100, P526, DOI 10.1037/0021-843X.100.4.526; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; KOJIMA T, 1989, PSYCHIAT RES, V28, P307, DOI 10.1016/0165-1781(89)90211-4; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Kojima T, 2001, SCHIZOPHR RES, V52, P203, DOI 10.1016/S0920-9964(00)00181-X; KOJIMA T, 1990, BIOL PSYCHIAT, V27, P975, DOI 10.1016/0006-3223(90)90035-Z; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; MATSUE Y, 1986, BIOL PSYCHIAT, V21, P382, DOI 10.1016/0006-3223(86)90166-6; MATSUSHIMA E, 1992, EUR ARCH PSY CLIN N, V241, P210, DOI 10.1007/BF02190255; Matsushima E, 1998, J PSYCHIAT RES, V32, P289, DOI 10.1016/S0022-3956(98)00019-3; Meisenzahl EM, 2008, SCHIZOPHR RES, V102, P150, DOI 10.1016/j.schres.2008.02.023; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P187, DOI 10.1037/h0057551; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; Obayashi S, 2001, EUR ARCH PSY CLIN N, V251, P211, DOI 10.1007/s004060170029; ODonnell BF, 1996, AM J PSYCHIAT, V153, P687; Oliveri M, 2001, CEREB CORTEX, V11, P606, DOI 10.1093/cercor/11.7.606; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C, 2002, ANN NEUROL, V52, P10, DOI 10.1002/ana.10273; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; Straube A, 1997, ANN NEUROL, V42, P891, DOI 10.1002/ana.410420611; Suzuki M, 2009, EUR ARCH PSY CLIN N, V259, P186, DOI 10.1007/s00406-008-0850-7; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takahashi S, 2003, AM J MED GENET B, V123B, P27, DOI 10.1002/ajmg.b.10046; Takahashi S, 2008, PSYCHIAT CLIN NEUROS, V62, P487, DOI 10.1111/j.1440-1819.2008.01840.x; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tregellas JR, 2004, AM J PSYCHIAT, V161, P315, DOI 10.1176/appi.ajp.161.2.315; Tsunoda M, 2005, EUR ARCH PSY CLIN N, V255, P104, DOI 10.1007/s00406-004-0540-z; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organization, 1993, ICD 10 ICD 10 CLASSI, pxiii; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010931; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	72	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25805	10.1371/journal.pone.0025805	http://dx.doi.org/10.1371/journal.pone.0025805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991357	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000074
J	Boll, H; Nittka, S; Doyon, F; Neumaier, M; Marx, A; Kramer, M; Groden, C; Brockmann, MA				Boll, Hanne; Nittka, Stefanie; Doyon, Fabian; Neumaier, Michael; Marx, Alexander; Kramer, Martin; Groden, Christoph; Brockmann, Marc A.			Micro-CT Based Experimental Liver Imaging Using a Nanoparticulate Contrast Agent: A Longitudinal Study in Mice	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ENHANCEMENT; TUMORS; PHEOCHROMOCYTOMA; INTUBATION; RABBITS; TIME	Background: Micro-CT imaging of liver disease in mice relies on high soft tissue contrast to detect small lesions like liver metastases. Purpose of this study was to characterize the localization and time course of contrast enhancement of a nanoparticular alkaline earth metal-based contrast agent (VISCOVER ExiTron nano) developed for small animal liver CT imaging. Methodology: ExiTron nano 6000 and ExiTron nano 12000, formulated for liver/spleen imaging and angiography, respectively, were intravenously injected in C57BL/6J-mice. The distribution and time course of contrast enhancement were analysed by repeated micro-CT up to 6 months. Finally, mice developing liver metastases after intrasplenic injection of colon carcinoma cells underwent longitudinal micro-CT imaging after a single injection of ExiTron nano. Principal Findings: After a single injection of ExiTron nano the contrast of liver and spleen peaked after 4-8 hours, lasted up to several months and was tolerated well by all mice. In addition, strong contrast enhancement of abdominal and mediastinal lymph nodes and the adrenal glands was observed. Within the first two hours after injection, particularly ExiTron nano 12000 provided pronounced contrast for imaging of vascular structures. ExiTron nano facilitated detection of liver metastases and provided sufficient contrast for longitudinal observation of tumor development over weeks. Conclusions: The nanoparticulate contrast agents ExiTron nano 6000 and 12000 provide strong contrast of the liver, spleen, lymph nodes and adrenal glands up to weeks, hereby allowing longitudinal monitoring of pathological processes of these organs in small animals, with ExiTron nano 12000 being particularly optimized for angiography due to its very high initial vessel contrast.	[Boll, Hanne; Groden, Christoph; Brockmann, Marc A.] Univ Heidelberg, Dept Neuroradiol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Nittka, Stefanie; Neumaier, Michael] Univ Heidelberg, Dept Clin Chem, Med Fac Mannheim, D-6800 Mannheim, Germany; [Doyon, Fabian] Univ Heidelberg, Dept Surg, Med Fac Mannheim, D-6800 Mannheim, Germany; [Marx, Alexander] Univ Heidelberg, Dept Pathol, Med Fac Mannheim, D-6800 Mannheim, Germany; [Kramer, Martin] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Boll, H (corresponding author), Univ Heidelberg, Dept Neuroradiol, Med Fac Mannheim, D-6800 Mannheim, Germany.	brockmann@gmx.de			Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg; German Federal Ministry of Economics and Technology [KF2725101]; Federal Ministry of Education and Research; Land Baden-Wuerttemberg [125-648]	Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg; German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wuerttemberg	This work was supported by a fellowship granted to Hanne Boll by the Forschungsschwerpunkt Onkologie of the Medical Faculty Mannheim, University of Heidelberg and by the German Federal Ministry of Economics and Technology (ZIM-KOOP grant # KF2725101). The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wuerttemberg (HBFG grant # 125-648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Bakan D A, 2001, Am J Ther, V8, P359, DOI 10.1097/00045391-200109000-00009; Bakan DA, 1996, J PHARM SCI, V85, P908, DOI 10.1021/js960119z; Bakan DA, 2000, INVEST RADIOL, V35, P158, DOI 10.1097/00004424-200003000-00002; Boll H, 2011, INT J COLORECTAL DIS, V26, P721, DOI 10.1007/s00384-011-1181-0; Boll H, 2010, J COMPUT ASSIST TOMO, V34, P783, DOI 10.1097/RCT.0b013e3181e1050a; Chouker A, 2008, INVEST RADIOL, V43, P77, DOI 10.1097/RLI.0b013e318155aa2e; Ford NL, 2006, INVEST RADIOL, V41, P384, DOI 10.1097/01.rli.0000197981.66537.48; Graham KC, 2008, INVEST RADIOL, V43, P488, DOI 10.1097/RLI.0b013e318172f5b5; Kerl HU, 2011, J COMPUT ASSIST TOMO, V35, P517, DOI 10.1097/RCT.0b013e31821c662b; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; MacDonald KD, 2009, J APPL PHYSIOL, V106, P984, DOI 10.1152/japplphysiol.91376.2008; Martiniova L, 2010, METHODS, V50, P20, DOI 10.1016/j.ymeth.2009.05.016; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; Montet X, 2007, INVEST RADIOL, V42, P652, DOI 10.1097/RLI.0b013e31805f445b; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Ohta S, 2006, INT J CANCER, V119, P2236, DOI 10.1002/ijc.22127; Rupp K, 2002, INVEST RADIOL, V37, P241; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Suckow CE, 2008, MOL IMAGING BIOL, V10, P114, DOI 10.1007/s11307-007-0128-x; Weber SM, 2004, J SURG RES, V119, P41, DOI 10.1016/S0022-4804(03)00357-3; WEICHERT JP, 1995, J MED CHEM, V38, P636, DOI 10.1021/jm00004a010; Weichert JP, 2000, RADIOLOGY, V216, P865, DOI 10.1148/radiology.216.3.r00se43865; Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7; Willekens I, 2009, MOL IMAGING BIOL, V11, P128, DOI 10.1007/s11307-008-0186-8	26	66	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25692	10.1371/journal.pone.0025692	http://dx.doi.org/10.1371/journal.pone.0025692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984939	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300049
J	Glennie, SJ; Sepako, E; Mzinza, D; Harawa, V; Miles, DJC; Jambo, KC; Gordon, SB; Williams, NA; Heyderman, RS				Glennie, Sarah J.; Sepako, Enoch; Mzinza, David; Harawa, Visopo; Miles, David J. C.; Jambo, Kondwani C.; Gordon, Stephen B.; Williams, Neil A.; Heyderman, Robert S.			Impaired CD4 T Cell Memory Response to Streptococcus pneumoniae Precedes CD4 T Cell Depletion in HIV-Infected Malawian Adults	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCOCCAL PROTEIN ANTIGENS; SURFACE ADHESIN-A; GAMMA-INTERFERON; OTITIS-MEDIA; B-CELL; DISEASE; CHILDREN; MUCOSAL; PNEUMOLYSIN	Objective: Invasive pneumococcal disease (IPD) is a leading cause of morbidity and mortality in HIV-infected African adults. CD4 T cell depletion may partially explain this high disease burden but those with relatively preserved T cell numbers are still at increased risk of IPD. This study evaluated the extent of pneumococcal-specific T cell memory dysfunction in asymptomatic HIV infection early on in the evolution of the disease. Methods: Peripheral blood mononuclear cells were isolated from asymptomatic HIV-infected and HIV-uninfected Malawian adults and stained to characterize the underlying degree of CD4 T cell immune activation, senescence and regulation. Pneumococcal-specific T cell proliferation, IFN-gamma, IL-17 production and CD154 expression was assessed using flow cytometry and ELISpot. Results: We find that in asymptomatic HIV-infected Malawian adults, there is considerable immune disruption with an increase in activated and senescent CD4(+) CD38(+) PD-1(+) and CD4(+) CD25(high)Foxp3(+) Treg cells. In the context of high pneumococcal exposure and therefore immune stimulation, show a failure in pneumococcal-specific memory T cell proliferation, skewing of T cell cytokine production with preservation of interleukin-17 but decreased interferon-gamma responses, and failure of activated T cells to express the co-stimulatory molecule CD154. Conclusion: Asymptomatic HIV-infected Malawian adults show early signs of pneumococcal-specific immune dysregulation with a shift in the balance of CD4 memory, T helper 17 cells and Treg. Together these data offer a mechanistic understanding of how antigen-specific T cell dysfunction occurs prior to T cell depletion and may explain the early susceptibility to IPD in those with relatively preserved CD4 T cell numbers.	[Glennie, Sarah J.; Sepako, Enoch; Mzinza, David; Harawa, Visopo; Miles, David J. C.; Jambo, Kondwani C.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Miles, David J. C.] Univ Cape Town, S African TB Vaccine Inst, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Jambo, Kondwani C.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England; [Williams, Neil A.; Heyderman, Robert S.] Univ Bristol, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Malawi; University of Cape Town; Liverpool School of Tropical Medicine; University of Liverpool; University of Bristol	Glennie, SJ (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	sarah.glennie@liverpool.ac.uk		Jambo, Kondwani/0000-0002-3195-2210; Mzinza, David/0000-0002-5999-8616; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]; Commonwealth Scholarship Commission (United Kingdom) [MWCS-2007-477]	Wellcome Trust (United Kingdom)(Wellcome Trust); Commonwealth Scholarship Commission (United Kingdom)	This work was supported by a grant to NAW and RSH by the Wellcome Trust "083603/A/07/Z" (United Kingdom), a core programme grant to RSH by the Wellcome Trust "084679/Z/08/Z" (United Kingdom) and a grant to KCJ from the Commonwealth Scholarship Commission "MWCS-2007-477" (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDAHL BM, 1995, AM J RESP CRIT CARE, V152, P2000, DOI 10.1164/ajrccm.152.6.8520768; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; CLOT J, 1975, IMMUNOLOGY, V29, P445; Davenport V, 2007, CELL MICROBIOL, V9, P1050, DOI 10.1111/j.1462-5822.2006.00851.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Glennie SJ, 2010, TRENDS MICROBIOL, V18, P487, DOI 10.1016/j.tim.2010.08.002; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Kelly P, 2004, CLIN EXP IMMUNOL, V135, P303, DOI 10.1111/j.1365-2249.2004.02374.x; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PIDO J, 2010, TEL AVIV; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Rutjens E, 2008, EUR J IMMUNOL, V38, P1164, DOI 10.1002/eji.200737792; SAID EA, NAT MED; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Simell B, 2001, J INFECT DIS, V183, P887, DOI 10.1086/319246; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Sun K, 2007, INFECT IMMUN, V75, P1196, DOI 10.1128/IAI.01403-06; SUTHERLAND JS, J IMMUNOL, P6537; WHO, 2009, NEW HIV REC IMPR HLT; Zhang QB, 2006, INFECT IMMUN, V74, P4735, DOI 10.1128/IAI.00165-06; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678	49	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25610	10.1371/journal.pone.0025610	http://dx.doi.org/10.1371/journal.pone.0025610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980502	Green Published, Green Accepted, gold			2022-12-25	WOS:000295933700046
J	Chen, PH; Chang, H; Chang, JT; Lin, P				Chen, P-H; Chang, H.; Chang, J. T.; Lin, P.			Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer	ONCOGENE			English	Article						AhR; NF kappa B; IL-6; non-smokers; lung adeno carcinoma	NF-KAPPA-B; NEVER-SMOKERS; CONSTITUTIVE ACTIVATION; PROSTATE-CANCER; AH RECEPTOR; IN-VIVO; CELLS; OVEREXPRESSION; INTERLEUKIN-6; RISK	Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is activated by cigarette smoke. Previously, we demonstrated that AhR is overexpressed in lung adenocarcinomas (ADs). In this study we observed that AhR expression is significantly correlated with nuclear RelA (a nuclear factor-kappa B (NF kappa B) subunit) and cytosolic interleukin-6 (IL-6) in 200 non-small cell lung cancer patients, especially among never smokers. Overexpression of AhR increased IL-6 expression in H1355 cells and immortalized human bronchial epithelial cells BEAS-2B. As NF kappa B inhibitor and knockdown RelA expression greatly reduced constitutive AhR-induced IL-6 expression, we hypothesized that AhR expression, in the absence of exogenous ligand, is able to modulate NF kappa B activity and subsequently upregulate IL-6 expression, thus promoting the development of lung AD. Specifically, AhR overexpression significantly increased NF kappa B activity, whereas interference with AhR expression significantly reduced NF kappa B activity and IL-6 expression in H1355 cells. We demonstrated that AhR associates with RelA in the cytosol and nucleus of human lung cells. Furthermore, AhR overexpression enhanced nuclear localization of AhR and RelA, and increased the association of AhR-RelA with the NF kappa B response element of the IL-6 promoter. However, p50 was not involved. Our results indicate that AhR, without exposure to a ligand, associates with RelA, which then positively modulates NF kappa B activity and then upregulates IL-6 expression in human lung cells. Thus we have identified a new mechanism for lung tumorigenesis in non-smokers. Oncogene (2012) 31, 2555-2565; doi:10.1038/onc.2011.438; published online 26 September 2011	[Chen, P-H; Chang, J. T.; Lin, P.] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, P-H; Chang, J. T.; Lin, P.] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan; [Chen, P-H; Lin, P.] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan 350, Miaoli County, Taiwan; [Chang, H.] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Chang, H.] China Med Univ, Sch Med, Taichung, Taiwan; [Chang, J. T.] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Chang, JT (corresponding author), Chung Shan Med Univ, Inst Med, 110,Sect 1,Jianguo N Rd, Taichung, Taiwan.	jinghuat@csmu.edu.tw; pplin@nhri.org.tw	Lin, Pinpin/B-2668-2010; Lin, PinPin/A-2006-2019; Chang, Jinghua/AAV-5620-2021	Lin, Pinpin/0000-0001-5459-907X; Lin, PinPin/0000-0001-5459-907X; 	National Health Research Institutes [99A1-EOPP02-014]; National Science Council of Taiwan [NSC 97-2320-B-040-016, NSC 97-2314-B-400-010]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Health Research Institutes (99A1-EOPP02-014) and the National Science Council (NSC 97-2320-B-040-016 and NSC 97-2314-B-400-010) of Taiwan.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ando M, 2003, INT J CANCER, V105, P249, DOI 10.1002/ijc.11043; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bryant A, 2007, CHEST, V132, P185, DOI 10.1378/chest.07-0442; Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90; Carolan BJ, 2008, J IMMUNOL, V181, P5760, DOI 10.4049/jimmunol.181.8.5760; Chang JHT, 2007, CLIN CANCER RES, V13, P38, DOI 10.1158/1078-0432.CCR-06-1166; Chang LW, 2007, CARCINOGENESIS, V28, P1606, DOI 10.1093/carcin/bgm013; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen JY, 2005, CARCINOGENESIS, V26, P1035, DOI 10.1093/carcin/bgi052; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen YC, 2004, CANCER-AM CANCER SOC, V101, P1428, DOI 10.1002/cncr.20538; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Dhar A, 2002, MOL CELL BIOCHEM, V234, P185, DOI 10.1023/A:1015948505117; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; Dijsselbloem N, 2004, BIOCHEM PHARMACOL, V68, P1171, DOI 10.1016/j.bcp.2004.05.036; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Fukuda I, 2007, BIOCHEM BIOPH RES CO, V359, P822, DOI 10.1016/j.bbrc.2007.05.199; Gao Shu-geng, 2007, Zhonghua Yi Xue Za Zhi, V87, P1701; Hayashibara T, 2003, BIOCHEM BIOPH RES CO, V300, P128, DOI 10.1016/S0006-291X(02)02793-6; Ishida M, 2010, CARCINOGENESIS, V31, P287, DOI 10.1093/carcin/bgp222; Izawa H, 2008, BIOSCI BIOTECH BIOCH, V72, P1235, DOI 10.1271/bbb.70705; Jensen Brenda A, 2003, Environ Health, V2, P16, DOI 10.1186/1476-069X-2-16; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Liaw YP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-22; Lin PH, 2007, TOXICOL LETT, V172, P146, DOI 10.1016/j.toxlet.2007.06.003; Lin PP, 2003, TOXICOL PATHOL, V31, P22, DOI 10.1080/01926230309746; Lu F, 2008, CANCER PREV RES, V1, P135, DOI 10.1158/1940-6207.CAPR-08-0037; Matsumoto Y, 2007, ENVIRON SCI TECHNOL, V41, P3775, DOI 10.1021/es062793g; Mukai M, 2007, TOXICOL SCI, V95, P172, DOI 10.1093/toxsci/kfl126; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Peng TL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-27; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Puga A, 2000, BIOCHEM PHARMACOL, V59, P997, DOI 10.1016/S0006-2952(99)00406-2; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Su JM, 2009, ANTICANCER RES, V29, P509; Subramanian J, 2007, J THORAC ONCOL, V2, P827, DOI 10.1097/JTO.0b013e318145af79; Tan XL, 2009, CLIN CANCER RES, V15, P7562, DOI 10.1158/1078-0432.CCR-09-1694; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Tse LA, 2009, AM J EPIDEMIOL, V169, P533, DOI 10.1093/aje/kwn385; Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957; Wang CK, 2009, INT J CANCER, V125, P807, DOI 10.1002/ijc.24348; Wang XR, 2009, CANCER CAUSE CONTROL, V20, P757, DOI 10.1007/s10552-008-9289-4; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Zerbini LF, 2003, CANCER RES, V63, P2206	57	41	44	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2555	2565		10.1038/onc.2011.438	http://dx.doi.org/10.1038/onc.2011.438			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21996739				2022-12-25	WOS:000304191800006
J	Ward, PS; Cross, JR; Lu, C; Weigert, O; Abel-Wahab, O; Levine, RL; Weinstock, DM; Sharp, KA; Thompson, CB				Ward, P. S.; Cross, J. R.; Lu, C.; Weigert, O.; Abel-Wahab, O.; Levine, R. L.; Weinstock, D. M.; Sharp, K. A.; Thompson, C. B.			Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production	ONCOGENE			English	Article						IDH1; IDH2; 2-hydroxyglutarate; oncometabolite; NADPH	ACUTE MYELOID-LEUKEMIA; HIGH-GRADE GLIOMAS; ISOCITRATE; MECHANISM; DISEASE	Mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) or its mitochondrial homolog IDH2 can lead to R(-)-2-hydroxyglutarate (2HG) production. To date, mutations in three active site arginine residues, IDH1 R132, IDH2 R172 and IDH2 R140, have been shown to result in the neomorphic production of 2HG. Here we report on three additional 2HG-producing IDH1 mutations: IDH1 R100, which is affected in adult glioma, IDH1 G97, which is mutated in colon cancer cell lines and pediatric glioblastoma, and IDH1 Y139. All these new mutants stereospecifically produced 2HG's (R) enantiomer. In contrast, we find that the IDH1 SNPs V71I and V178I, as well as a number of other single-sample reports of IDH non-synonymous mutation, did not elevate cellular 2HG levels in cells and retained the wild-type ability for isocitrate-dependent NADPH production. Finally, we report the existence of additional rare, but recurring mutations found in lymphoma and thyroid cancer, which while failing to elevate 2HG nonetheless displayed loss of function, indicating a possible tumorigenic mechanism for a non-2HG-producing subset of IDH mutations in some malignancies. These data broaden our understanding of how IDH mutations may contribute to cancer through either neomorphic R(-)-2HG production or reduced wildtype enzymatic activity, and highlight the potential value of metabolite screening in identifying IDH-mutated tumors associated with elevated oncometabolite levels. Oncogene (2012) 31, 2491-2498; doi: 10.1038/onc.2011.416; published online 26 September 2011	[Ward, P. S.; Cross, J. R.; Lu, C.; Thompson, C. B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Ward, P. S.; Lu, C.] Univ Penn, Abramson Canc Ctr, Dept Canc Biol, Philadelphia, PA 19104 USA; [Weigert, O.; Weinstock, D. M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Abel-Wahab, O.; Levine, R. L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Abel-Wahab, O.; Levine, R. L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Sharp, K. A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave,Room M110, New York, NY 10065 USA.	thompsonc@mskcc.org	levine, ross/AAE-7658-2019; Lu, Chao/E-8047-2012; Ward, Patrick/H-2361-2014	Ward, Patrick/0000-0001-6437-8174; Abdel-Wahab, Omar/0000-0002-3907-6171; Lu, Chao/0000-0003-0982-8122; Cross, Justin/0000-0002-6356-057X	NCI; NIH; HHMI; Stand Up To Cancer Innovative Research Grant; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA092660, R01CA105463] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Stand Up To Cancer Innovative Research Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the NCI and NIH. RL Levine is a HHMI Early Career Award Recipient and Geoffrey Beene Junior Faculty Chair at MSKCC. DM Weinstock is supported by a Stand Up To Cancer Innovative Research Grant and American Cancer Society Research Scholar Grant.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeLano W., 2006, PYMOL MOL GRAPHICS S; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Ho PA, 2010, LEUKEMIA, V24, P909, DOI 10.1038/leu.2010.56; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; KAMERLING JP, 1981, J CHROMATOGR, V222, P276, DOI 10.1016/S0378-4347(00)81061-0; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pusch S, 2011, NEUROPATH APPL NEURO, V37, P428, DOI 10.1111/j.1365-2990.2010.01127.x; Rakheja D, 2011, PEDIATR BLOOD CANCER, V56, P379, DOI 10.1002/pbc.22697; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zou Y, 2010, BIOCHEM BIOPH RES CO, V402, P378, DOI 10.1016/j.bbrc.2010.10.038	27	144	150	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	19					2491	2498		10.1038/onc.2011.416	http://dx.doi.org/10.1038/onc.2011.416			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996744	Green Accepted			2022-12-25	WOS:000303985300011
J	Afshar, Y; Jeong, JW; Roqueiro, D; DeMayo, F; Lydon, J; Radtke, F; Radnor, R; Miele, L; Fazleabas, A				Afshar, Yalda; Jeong, Jae-Wook; Roqueiro, Damian; DeMayo, Franco; Lydon, John; Radtke, Freddy; Radnor, Rachel; Miele, Lucio; Fazleabas, Asgerally			Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse	FASEB JOURNAL			English	Article						implantation; endometrium; reproduction	PAPIO-ANUBIS UTERUS; CHORIONIC-GONADOTROPIN; ESTROGEN-RECEPTOR; CROSS-TALK; IN-VIVO; EXPRESSION; APOPTOSIS; PATHWAY; ACTIVATION; MECHANISMS	Uterine receptivity implies a dialogue between the hormonally primed maternal endometrium and the free-floating blastocyst. Endometrial stromal cells proliferate, avert apoptosis, and undergo decidualization in preparation for implantation; however, the molecular mechanisms that underlie differentiation into the decidual phenotype remain largely undefined. The Notch family of transmembrane receptors transduce extracellular signals responsible for cell survival, cell-to-cell communication, and differentiation, all fundamental processes for decidualization and pregnancy. Using a murine artificial decidualization model, pharmacological inhibition of Notch signaling by gamma-secretase inhibition resulted in a significantly decreased deciduoma. Furthermore, a progesterone receptor (PR)-Cre Notch1 bigenic (Notch1d/d) confirmed a Notch1-dependent hypomorphic decidual phenotype. Microarray and pathway analysis, following Notch1 ablation, demonstrated significantly altered signaling repertoire. Concomitantly, hierarchical clustering demonstrated Notch1-dependent differences in gene expression. Uteri deprived of Notch1 signaling demonstrated decreased cellular proliferation; namely, reduced proliferation-specific antigen, Ki67, altered p21, cdk6, and cyclinD activity and an increased apoptotic-profile, cleaved caspase-3, Bad, and attenuated Bcl2. The results demonstrate that the preimplantation uterus relies on Notch signaling to inhibit apoptosis of stromal fibroblasts and regulate cell cycle progression, which together promotes successful decidualization. In summary, Notch1 signaling modulates multiple signaling mechanisms crucial for decidualization and these studies provide additional perspectives to the coordination of multiple signaling modalities required during decidualization.-Afshar, Y., Jeong, J.-W., Roqueiro, D., DeMayo, F., Lydon, J., Radtke, F., Radnor, R., Miele, L., Fazleabas, A. Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J. 26, 282-294 (2012). www.fasebj.org	[Fazleabas, Asgerally] Michigan State Univ, Ctr Womens Hlth, Van Andel Inst, Dept Obstet & Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA; [Afshar, Yalda] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Roqueiro, Damian] Univ Illinois, Dept Bioengn, Chicago, IL USA; [DeMayo, Franco; Lydon, John] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Miele, Lucio] Univ Mississippi, Inst Canc, Jackson, MS 39216 USA	Michigan State University; Van Andel Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Baylor College of Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Mississippi	Fazleabas, A (corresponding author), Michigan State Univ, Ctr Womens Hlth, Van Andel Inst, Dept Obstet & Gynecol & Reprod Biol, 333 Bostwick Ave NE,Rm 4027, Grand Rapids, MI 49503 USA.	asgi@hc.msu.edu	Roqueiro, Damian/AAE-2240-2020; Radtke, Freddy/Q-3198-2017; DeMayo, Francesco/C-6255-2019	Radtke, Freddy/0000-0003-4315-4045; Afshar, Yalda/0000-0003-3807-7022; DeMayo, Francesco/0000-0002-9480-7336; Miele, Lucio/0000-0002-5853-7287; Roqueiro, Damian/0000-0002-9195-5915	U.S. National Institutes of Health [RO1HD42280, TL1RR029879, R01HD057873, R01HD042311, U54HD0077495];  [RO1CA077530]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD077495, R01HD057873, R01HD042311, R01HD042280] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Patty Mavrogianis and Zuzana Harrison (University of Illinois) for technical assistance; Barbara Osborn (University of Massachusetts, Amherst, MA, USA) for the GSI chow; and the University of Illinois at Chicago Biological Research Laboratory for wild-type pregnant mice. Funding support was provided by grants from the U.S. National Institutes of Health: RO1HD42280 (A. T. F.), TL1RR029879 (Y.A.), R01HD057873 (J.J.), R01HD042311 and U54HD0077495 (F. D.), and RO1CA077530 (J.L.). All gene expression data, cluster groups, and functional categories have been placed on the National Center for Biotechnology Information Gene Expression Omnibus (GEO) under accession number GSE31244 and are available online in their entirety (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31244).	Akcali KC, 1996, ENDOCRINOLOGY, V137, P3123, DOI 10.1210/en.137.7.3123; Aoyama K, 2007, STEM CELLS, V25, P2488, DOI 10.1634/stemcells.2007-0102; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1988, TRENDS GENET, V4, P95, DOI 10.1016/0168-9525(88)90096-0; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Banaszak S, 2000, BIOL REPROD, V63, P820, DOI 10.1095/biolreprod63.3.820; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Fazleabas AT, 1999, P NATL ACAD SCI USA, V96, P2543, DOI 10.1073/pnas.96.5.2543; FINN CA, 1971, ADV REPROD PHYSIOL, V5, P1; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hao L, 2010, ONCOGENE, V29, P201, DOI 10.1038/onc.2009.323; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jabbour HN, 2001, REPRODUCTION, V121, P197, DOI 10.1530/rep.0.1210197; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Jasinska A, 2006, ENDOCRINOLOGY, V147, P4112, DOI 10.1210/en.2005-1577; JAYATILAK PG, 1984, BIOL REPROD, V31, P556, DOI 10.1095/biolreprod31.3.556; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; Lee K, 2006, J STEROID BIOCHEM, V102, P41, DOI 10.1016/j.jsbmb.2006.09.006; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukherjee A, 2006, J STEROID BIOCHEM, V102, P22, DOI 10.1016/j.jsbmb.2006.09.007; Nickoloff BJ, 2005, J INVEST DERM SYMP P, V10, P95, DOI 10.1111/j.1087-0024.2005.200404.x; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rangarajan A, 2001, VIROLOGY, V286, P23, DOI 10.1006/viro.2001.0867; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rizzo P, 2009, ADV ENZYME REGUL, V49, P134, DOI 10.1016/j.advenzreg.2009.01.008; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shiozawa T, 1998, MOL HUM REPROD, V4, P899, DOI 10.1093/molehr/4.9.899; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Suarez-Huerta N, 2000, CELL PROLIFERAT, V33, P101, DOI 10.1046/j.1365-2184.2000.00169.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TARANTINO S, 1992, ENDOCRINOLOGY, V130, P2354, DOI 10.1210/en.130.4.2354; Tong W, 1999, MOL CELL BIOL, V19, P2251; Vaskivuo TE, 2000, MOL CELL ENDOCRINOL, V165, P75, DOI 10.1016/S0303-7207(00)00261-6; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wu Xia, 2004, Zhonghua Yi Xue Za Zhi, V84, P1018; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339	79	75	80	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					282	294		10.1096/fj.11-184663	http://dx.doi.org/10.1096/fj.11-184663			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21990372	Green Published			2022-12-25	WOS:000299202200029
J	Benosman, S; Meng, XJ; Von Grabowiecki, Y; Palamiuc, L; Hritcu, L; Gross, I; Mellitzer, G; Taya, Y; Loeffler, JP; Gaiddon, C				Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Palamiuc, Lavinia; Hritcu, Lucian; Gross, Isabelle; Mellitzer, Georg; Taya, Yoichi; Loeffler, Jean-Philippe; Gaiddon, Christian			Complex Regulation of p73 Isoforms after Alteration of Amyloid Precursor Polypeptide (APP) Function and DNA Damage in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CELL-DEATH; SIGNALING PATHWAY; P53 FAMILY; PROTEIN STABILITY; CORTICAL-NEURONS; GENE; APOPTOSIS	Background: Alterations of the APP pathway or DNA damage induce neuronal cell death. Results: Alterations of the APP pathway or DNA damage increase TAp73 expression and reduce Delta Np73 protein levels. Conclusion: A tight control of the expression of p73 isoforms participates in neuronal cell death. Significance: p73 isoforms may play a role in neurodegenerative diseases such as Alzheimer and in the neurotoxicity of anticancer drug therapies.	[Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Loeffler, Jean-Philippe; Gaiddon, Christian] INSERM, U692, F-67000 Strasbourg, France; [Gross, Isabelle; Mellitzer, Georg; Gaiddon, Christian] INSERM, U682, F-67000 Strasbourg, France; [Benosman, Samir; Meng, Xiangjun; Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Benosman, Samir; Meng, Xiangjun; Taya, Yoichi] Natl Univ Singapore, Dept Biochem, Singapore 117456, Singapore; [Palamiuc, Lavinia; Hritcu, Lucian] Alexandru Ioan Cuza Univ, Fac Biol, Physiol Anim Lab, Iasi 700506, Romania; [Von Grabowiecki, Yannick; Gross, Isabelle; Mellitzer, Georg; Loeffler, Jean-Philippe; Gaiddon, Christian] Strasbourg Univ, F-67000 Strasbourg, France; [Meng, Xiangjun] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200087, Peoples R China; [Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Loeffler, Jean-Philippe; Gaiddon, Christian] INSERM, U682, F-67200 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National University of Singapore; National University of Singapore; Alexandru Ioan Cuza University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg		gaiddon@unistra.fr	Hritcu, Lucian/G-5378-2010; Gaiddon, Christian/F-7321-2012; Georg, Mellitzer/R-4180-2016; Gross, Isabelle/I-4972-2016; LOEFFLER, Jean-Philippe/AAS-4401-2020; Gross, Isabelle/P-9859-2019	Hritcu, Lucian/0000-0001-6981-4174; Gaiddon, Christian/0000-0003-4315-3851; Georg, Mellitzer/0000-0003-4467-0789; Gross, Isabelle/0000-0002-2783-8773; Gross, Isabelle/0000-0002-2783-8773; von Grabowiecki, Yannick/0000-0003-2189-6953	CNRS; Universite de Strasbourg; Association pour la Recherche Contre le Cancer [3288]; La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle); ANR; Institut National du Cancer; CONECTUS Alsace; Fond National pour la Recherche (Luxembourg, FNR)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle); ANR(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); CONECTUS Alsace(Region Grand-Est); Fond National pour la Recherche (Luxembourg, FNR)(Luxembourg National Research Fund)	This work was supported by CNRS, Universite de Strasbourg, Association pour la Recherche Contre le Cancer Grant 3288, La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle), ANR, Institut National du Cancer, and CONECTUS Alsace, Fond National pour la Recherche (Luxembourg, FNR).	Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Benosman S, 2007, CELL DEATH DIFFER, V14, P2047, DOI 10.1038/sj.cdd.4402216; Billon N, 2004, DEVELOPMENT, V131, P1211, DOI 10.1242/dev.01035; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Bui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004373; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Casciano I, 1999, CELL DEATH DIFFER, V6, P391, DOI 10.1038/sj.cdd.4400522; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Ding Y, 1999, DNA Res, V6, P347, DOI 10.1093/dnares/6.5.347; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Ferreira A, 1996, J CELL SCI, V109, P1509; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gaiddon C, 1999, MOL ENDOCRINOL, V13, P742, DOI 10.1210/me.13.5.742; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Garden GA, 2004, FASEB J, V18, P1141, DOI 10.1096/fj.04-1676fje; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Huttinger-Kirchhof N, 2006, CELL DEATH DIFFER, V13, P174, DOI 10.1038/sj.cdd.4401809; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Jacobs WB, 2004, NEUROSCIENTIST, V10, P443, DOI 10.1177/1073858404263456; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan J, 1997, J NEUROSCI, V17, P1397; KEDAR A, 1978, CANCER TREAT REP, V62, P819; Kiryu-Seo S, 2005, J NEUROSCI, V25, P1442, DOI 10.1523/JNEUROSCI.4041-04.2005; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Li Quanyi, 2004, BMC Med Genet, V5, P14, DOI 10.1186/1471-2350-5-14; Lokshin M, 2007, NUCLEIC ACIDS RES, V35, P340, DOI 10.1093/nar/gkl1047; Lunghi P, 2009, CLIN CANCER RES, V15, P6495, DOI 10.1158/1078-0432.CCR-09-1229; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mbebi C, 2005, NEUROBIOL DIS, V19, P129, DOI 10.1016/j.nbd.2004.11.010; Mbebi C, 2002, J BIOL CHEM, V277, P20979, DOI 10.1074/jbc.M107948200; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meng XJ, 2009, CANCER RES, V69, P5458, DOI 10.1158/0008-5472.CAN-08-4408; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Monaco EA, 2005, FRONT BIOSCI-LANDMRK, V10, P143, DOI 10.2741/1516; Morrison RS, 1996, J NEUROSCI, V16, P1337; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pardo LM, 2005, MUTAT RES-FUND MOL M, V592, P89, DOI 10.1016/j.mrfmmm.2005.06.006; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Prives C, 1999, J PATHOL, V187, P112; Rene F, 1996, NEUROENDOCRINOLOGY, V64, P2, DOI 10.1159/000127091; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Seidl R, 1999, NEUROSCI LETT, V260, P9, DOI 10.1016/S0304-3940(98)00945-8; Sohm F, 1999, ONCOGENE, V18, P2762, DOI 10.1038/sj.onc.1202634; Steeghs N, 2003, ANTI-CANCER DRUG, V14, P443, DOI 10.1097/00001813-200307000-00009; Trimmer PA, 1996, NEURODEGENERATION, V5, P233, DOI 10.1006/neur.1996.0031; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vogel Michael W, 2002, Cerebellum, V1, P277, DOI 10.1080/147342202320883588; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wilson C, 2004, NEUROPATH APPL NEURO, V30, P19, DOI 10.1046/j.0305-1846.2003.00496.x; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	75	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43013	43025		10.1074/jbc.M111.261271	http://dx.doi.org/10.1074/jbc.M111.261271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002055	Green Published, hybrid			2022-12-25	WOS:000298351300022
J	Hinds, TD; Stechschulte, LA; Cash, HA; Whisler, D; Banerjee, A; Yong, WD; Khuder, SS; Kaw, MK; Shou, WN; Najjar, SM; Sanchez, ER				Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Yong, Weidong; Khuder, Saja S.; Kaw, Meenakshi K.; Shou, Weinian; Najjar, Sonia M.; Sanchez, Edwin R.			Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; HEAT-SHOCK-PROTEIN; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; ADIPOSE-TISSUE; SERINE/THREONINE PHOSPHATASE; IMMUNOPHILIN FKBP51; STEROID-RECEPTORS; SQUIRREL-MONKEY; MESSENGER-RNA	Background: The glucocorticoid (GR) and peroxisome proliferator-activated (PPAR gamma) receptors are antagonists of lipid metabolism. Results: Protein phosphatase 5 (PP5) dephosphorylates GR and PPAR gamma to reciprocally control their activities. Conclusion: PP5 is a switch point in nuclear receptor control of lipid metabolism. Significance: PP5 is a potential new drug target in the treatment of obesity.	[Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Khuder, Saja S.; Kaw, Meenakshi K.; Najjar, Sonia M.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Khuder, Saja S.; Kaw, Meenakshi K.; Najjar, Sonia M.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Yong, Weidong; Shou, Weinian] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Pediat Cardiol Sect, Indianapolis, IN 46202 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Indiana University System; Indiana University Bloomington	Sanchez, ER (corresponding author), Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, 3035 Arlington Ave, Toledo, OH 43614 USA.	edwin.sanchez@utoledo.edu	Najjar, Sonia M/GXW-2217-2022; Hinds, Terry/B-8495-2015	Stechschulte, Lance/0000-0001-9783-6194; Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK70127, DK73402, DK054254, DK083850, F31DK84958]; national research service award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK084958, R01DK073402, R01DK054254, R01DK070127, R01DK083850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national research service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK70127 (to E. R. S.), DK73402 (to W. S.), DK054254 and DK083850 (to S. M. N.), and F31DK84958, a national research service award (to T. D. H.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; BECKER W, 1994, J BIOL CHEM, V269, P22586; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Campbell JE, 2009, METABOLISM, V58, P651, DOI 10.1016/j.metabol.2009.01.002; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Heuvel JPV, 2003, TOXICOL APPL PHARM, V188, P185, DOI 10.1016/S0041-008X(03)00015-2; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Jan HJ, 2009, CANCER LETT, V277, P141, DOI 10.1016/j.canlet.2008.11.033; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Nye C, 2008, TRENDS ENDOCRIN MET, V19, P356, DOI 10.1016/j.tem.2008.08.003; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; SLAVIN BG, 1994, J LIPID RES, V35, P1535; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sumanasekera WK, 2003, BIOCHEMISTRY-US, V42, P10726, DOI 10.1021/bi0347353; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Swingle Mark, 2007, V365, P23; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wolf IM, 2009, J STEROID BIOCHEM, V113, P36, DOI 10.1016/j.jsbmb.2008.11.006; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	75	66	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42911	42922		10.1074/jbc.M111.311662	http://dx.doi.org/10.1074/jbc.M111.311662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21994940	hybrid, Green Published			2022-12-25	WOS:000298351300013
J	Schmidt, J; Guillaume, P; Irving, M; Baunngaertner, P; Speiser, D; Luescher, IF				Schmidt, Julien; Guillaume, Philippe; Irving, Melita; Baunngaertner, Petra; Speiser, Daniel; Luescher, Immanuel F.			Reversible Major Histocompatibility Complex I-Peptide Multimers Containing Ni2+-Nitrilotriacetic Acid Peptides and Histidine Tags Improve Analysis and Sorting of CD8(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLED LIPID INTERFACES; TAGGED PROTEINS; MHC-PEPTIDE; CHELATOR-LIPIDS; CD8+T CELLS; AFFINITY; BINDING; MOLECULES; TCR; IMMOBILIZATION	MHC-peptide multimers containing biotinylated MHC-peptide complexes bound to phycoerythrin (PE) streptavidin (SA) are widely used for analyzing and sorting antigen-specific T cells. Here we describe alternative T cell-staining reagents that are superior to conventional reagents. They are built on reversible chelate complexes of Ni2+-nitrilotriacetic acid (NTA) with oligohistidines. We synthesized biotinylated linear mono-, di-, and tetra-NTA compounds using conventional solid phase peptide chemistry and studied their interaction with HLA-A 0201-peptide complexes containing a His(6), His(12), or 2 x His(6) tag by surface plasmon resonance on SA-coated sensor chips and equilibrium dialysis. The binding avidity increased in the order His(6) < His(12) < 2 x His(6) and NTA(1) < NTA(2) < NTA(4), respectively, depending on the configuration of the NTA moieties and increased to picomolar K-D for the combination of a 2 x His(6) tag and a 2 x Ni2+-NTA(2). We demonstrate that HLA-A2-2 x His(6)-peptide multimers containing either Ni2+-NTA(4)-biotin and PE-SA- or PE-NTA(4)-stained influenza and Melan A-specific CD8+ T cells equal or better than conventional multimers. Although these complexes were highly stable, they very rapidly dissociated in the presence of imidazole, which allowed sorting of bona fide antigen-specific CD8+ T cells without inducing T cell death as well as assessment of HLA-A2-peptide monomer dissociation kinetics on CD8+ T cells.	[Schmidt, Julien; Guillaume, Philippe; Luescher, Immanuel F.] Univ Lausanne, Ludwig Ctr, CH-1066 Epalinges, Switzerland; [Irving, Melita] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Baunngaertner, Petra; Speiser, Daniel] Univ Lausanne, Div Clin Oncoimmunol, Ludwig Ctr, CH-7011 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Luescher, IF (corresponding author), 155 Chemin Boveresses, CH-1066 Epalinges, Switzerland.	immanuel.luescher@unil.ch	Speiser, Daniel E./F-2173-2013		Swiss National Science Foundation [310030_12533/1]; Cancer Research Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Institute	This work was supported by grants from the Swiss National Science Foundation (310030_12533/1) and from the Cancer Research Institute.	Andre T, 2009, CHEMBIOCHEM, V10, P1878, DOI 10.1002/cbic.200900001; Angelov GS, 2006, J IMMUNOL, V176, P3356, DOI 10.4049/jimmunol.176.6.3356; Brellier M, 2009, CHEM-EUR J, V15, P12689, DOI 10.1002/chem.200901213; Cao HP, 2009, BIOTECHNOL PROGR, V25, P461, DOI 10.1002/btpr.121; Cebecauer M, 2005, J IMMUNOL, V174, P6809, DOI 10.4049/jimmunol.174.11.6809; DIETRICH C, 1995, P NATL ACAD SCI USA, V92, P9014, DOI 10.1073/pnas.92.20.9014; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Dutoit V, 2002, EUR J IMMUNOL, V32, P3285, DOI 10.1002/1521-4141(200211)32:11<3285::AID-IMMU3285>3.0.CO;2-9; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Guillaume P, 2003, J BIOL CHEM, V278, P4500, DOI 10.1074/jbc.M208863200; Guillaume P, 2006, J IMMUNOL, V177, P3903, DOI 10.4049/jimmunol.177.6.3903; Guillaume P, 2010, INT J CANCER, V127, P910, DOI 10.1002/ijc.25099; Guillaume Philippe, 2009, Cancer Immun, V9, P7; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huang ZH, 2006, BIOCONJUGATE CHEM, V17, P1592, DOI 10.1021/bc0602228; Huang ZH, 2009, BIOCONJUGATE CHEM, V20, P1667, DOI 10.1021/bc900309n; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Steinhauer C, 2006, PROTEOMICS, V6, P4227, DOI 10.1002/pmic.200600036; Tareste D, 2005, J AM CHEM SOC, V127, P3879, DOI 10.1021/ja043525q; Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9	37	24	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41723	41735		10.1074/jbc.M111.283127	http://dx.doi.org/10.1074/jbc.M111.283127			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990358	Green Published, hybrid			2022-12-25	WOS:000298057500056
J	Wycisk, AI; Lin, JC; Loch, S; Hobohm, K; Funke, J; Wieneke, R; Koch, J; Skach, WR; Mayerhofer, PU; Tampe, R				Wycisk, Agnes I.; Lin, Jiacheng; Loch, Sandra; Hobohm, Kathleen; Funke, Jessica; Wieneke, Ralph; Koch, Joachim; Skach, William R.; Mayerhofer, Peter U.; Tampe, Robert			Epstein-Barr Viral BNLF2a Protein Hijacks the Tail-anchored Protein Insertion Machinery to Block Antigen Processing by the Transport Complex TAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PEPTIDE-LOADING COMPLEX; MOLECULAR-MECHANISM; ER MEMBRANE; VIRUS; GLYCOPROTEIN; INTEGRATION; TRANSLOCATION; BINDING; ICP47	Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein. We demonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.	[Wycisk, Agnes I.; Lin, Jiacheng; Loch, Sandra; Hobohm, Kathleen; Funke, Jessica; Wieneke, Ralph; Koch, Joachim; Mayerhofer, Peter U.; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Goethe University Frankfurt; Oregon Health & Science University	Tampe, R (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Hartmann, Jessica/AAL-8849-2021; Tampé, Robert/H-2953-2015	Hartmann, Jessica/0000-0001-9372-8954; Tampé, Robert/0000-0002-0403-2160; Wieneke, Ralph/0000-0002-0767-4679	German Research Foundation [SFB 807]; Transport and Communication across Biological Membranes; European Drug Initiative on Channels and Transporters (EDICT) [TA157/7]; European Commission; National Institutes of Health [GM53457, DK51818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Transport and Communication across Biological Membranes; European Drug Initiative on Channels and Transporters (EDICT); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by German Research Foundation Grants SFB 807, Transport and Communication across Biological Membranes, and TA157/7 (to R.T.), by a grant from the European Drug Initiative on Channels and Transporters (EDICT) funded by the European Commission Seventh Framework Program to R. T.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM53457 and DK51818 (to W. R. S.).	Abele R, 2009, CURR OPIN CELL BIOL, V21, P508, DOI 10.1016/j.ceb.2009.04.008; Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Horst D, 2011, J IMMUNOL, V186, P3594, DOI 10.4049/jimmunol.1002656; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Horst D, 2009, J IMMUNOL, V182, P2313, DOI 10.4049/jimmunol.0803218; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Loch S, 2008, J BIOL CHEM, V283, P13428, DOI 10.1074/jbc.M800226200; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; SKACH WR, 1993, J BIOL CHEM, V268, P23552; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	49	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41402	41412		10.1074/jbc.M111.237784	http://dx.doi.org/10.1074/jbc.M111.237784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984826	Green Published, hybrid			2022-12-25	WOS:000298057500027
J	Xu, D; Young, J; Song, DY; Esko, JD				Xu, Ding; Young, Jeffrey; Song, Danyin; Esko, Jeffrey D.			Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; GROUP BOX-1 PROTEIN; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; IN-VIVO; BINDING; DANGER; ANGIOGENESIS; DOMAIN	In a proteomic search for heparan sulfate-binding proteins on monocytes, we identified HMGB1 (high mobility group protein B1). The extracellular role of HMGB1 as a cytokine has been studied intensively and shown to be important as a danger-associated molecular pattern protein. Here, we report that the activity of HMGB1 depends on heparan sulfate. Binding and competition studies demonstrate that HMGB1 interacts with CHO and endothelial cell heparan sulfate. By site-directed mutagenesis, we identified a loop region that connects the A-box and B-box domains of HMGB1 as responsible for heparan sulfate binding. HMGB1-induced Erk1/2 and p38 phosphorylation is abolished when endothelial heparan sulfate is removed or blocked pharmacologically, resulting in decreased HMGB1-induced endothelial sprouting. However, mutated HMGB1 that lacks the heparan sulfate-binding site retained its signaling activity. We show the major receptor for HMGB1, receptor for advanced glycation end products (RAGE), also binds to heparan sulfate and that RAGE and heparan sulfate forms a complex. Our data establishes that the functional receptor for HMGB1 consists of a complex of RAGE and cell surface heparan sulfate.	[Xu, Ding; Young, Jeffrey; Song, Danyin; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dxu@ucsd.edu; jesko@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712	National Institutes of Health [HL57345]; American Heart Association [0825274F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 (to J. D. E.). This work was also supported by Postdoctoral Fellowship 0825274F from the American Heart Association (to D. X.).	Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Brandt R, 2004, BBA-GEN SUBJECTS, V1670, P132, DOI 10.1016/j.bbagen.2003.11.003; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; JORDAN P, 1994, BIOCHEMISTRY-US, V33, P14696, DOI 10.1021/bi00253a007; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McArthur C, 2002, ARCH ORAL BIOL, V47, P443, DOI 10.1016/S0003-9969(02)00025-0; Menoret A, 2000, J IMMUNOL METHODS, V237, P119, DOI 10.1016/S0022-1759(00)00137-X; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H., 2011, BIOCHIM BIOPHYS ACTA, V1799, P164; SALMIVIRTA M, 1992, EXP CELL RES, V200, P444, DOI 10.1016/0014-4827(92)90194-D; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Taudte S, 2000, BIOCHEM J, V347, P807, DOI 10.1042/0264-6021:3470807; Wang CH, 2011, BIOCHEM J, V433, P127, DOI 10.1042/BJ20100589; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	39	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41736	41744		10.1074/jbc.M111.299685	http://dx.doi.org/10.1074/jbc.M111.299685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990362	Green Published, hybrid			2022-12-25	WOS:000298057500057
J	Begriche, K; Levasseur, PR; Zhang, JY; Rossi, J; Skorupa, D; Solt, LA; Young, B; Burris, TP; Marks, DL; Mynatt, RL; Butler, AA				Begriche, Karima; Levasseur, Peter R.; Zhang, Jingying; Rossi, Jari; Skorupa, Danielle; Solt, Laura A.; Young, Brandon; Burris, Thomas P.; Marks, Daniel L.; Mynatt, Randall L.; Butler, Andrew A.			Genetic Dissection of the Functions of the Melanocortin-3 Receptor, a Seven-transmembrane G-protein-coupled Receptor, Suggests Roles for Central and Peripheral Receptors in Energy Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C57BL/6J MICE LACKING; FOOD-INTAKE; METABOLIC DISEASE; BODY-WEIGHT; SYSTEM; LEPTIN; BALANCE; OBESITY; EXPENDITURE; NEURONS	The melanocortin-3 receptor (MC3R) gene is pleiotropic, influencing body composition, natriuresis, immune function, and entrainment of circadian rhythms to nutrient intake. MC3Rs are expressed in hypothalamic and limbic regions of the brain and in peripheral tissues. To investigate the roles of central MC3Rs, we inserted a "lox-stop-lox" (LoxTB) 5' of the translation initiation codon of the mouse Mc3r gene and reactivated transcription using neuron-specific Cre transgenic mice. As predicted based on earlier observations of Mc3r knock-out mice, Mc3r(TB/TB) mice displayed reduced lean mass, increased fat mass, and accelerated diet-induced obesity. Surprisingly, rescuing Mc3r expression in the nervous system using the Nestin-Cre transgene only partially rescued obesity in chow-fed conditions and had no impact on the accelerated diet-induced obesity phenotype. The ventromedial hypothalamus (VMH), a critical node in the neural networks regulating feeding-related behaviors and metabolic homeostasis, exhibits dense Mc3r expression relative to other brain regions. To target VMH MC3R expression, we used the steroidogenic factor-1 Cre transgenic mouse. Although restoring VMH MC3R signaling also had a modest impact on obesity, marked improvements in metabolic homeostasis were observed. VMH MC3R signaling was not sufficient to rescue the lean mass phenotype or the regulation of behaviors anticipating food anticipation. These results suggest that actions of MC3Rs impacting on energy homeostasis involve both central and peripheral sites of action. The impact of central MC3Rs on behavior and metabolism involves divergent pathways; VMH MC3R signaling improves metabolic homeostasis but does not significantly impact on the expression of behaviors anticipating nutrient availability.	[Begriche, Karima; Rossi, Jari; Skorupa, Danielle; Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Solt, Laura A.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Young, Brandon] Scripps Res Inst, Dept Genom Core, Jupiter, FL 33458 USA; [Levasseur, Peter R.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Zhang, Jingying; Mynatt, Randall L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Oregon Health & Science University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Butler, AA (corresponding author), 130 Scripps Way, Jupiter, FL 33458 USA.	AButler@Scripps.edu	Marks, Daniel/C-3712-2009; Begriche, Karima/Y-9444-2019; zhang, jingying R/R-4262-2018; Burris, Thomas/H-5078-2011; Mynatt, Randall L/N-1980-2017; Burris, Thomas P/B-3886-2016	Mynatt, Randall L/0000-0003-4399-0019; Burris, Thomas P/0000-0003-2922-4449; Begriche, Karima/0000-0002-6378-3861; Butler, Andrew/0000-0001-7196-0170; Rossi, Jari/0000-0002-3728-9800	National Institutes of Health [DK073189]; Pennington Biomedical Research Foundation; Clinical Nutrition Research Unit Center [1P30 DK072476]; National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073189, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennington Biomedical Research Foundation; Clinical Nutrition Research Unit Center; National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK073189 (to A. A. B.). This work was also supported by a grant from the Pennington Biomedical Research Foundation (to A. A. B. and R. L. M.).; Supported by the Clinical Nutrition Research Unit Center Grant 1P30 DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions" sponsored by the National Institutes of Health through the NIDDK (Eric Ravussin, principal investigator).	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Begriche K, 2011, PHYSIOL BEHAV, V104, P546, DOI 10.1016/j.physbeh.2011.04.007; Blum I.D., 2011, NEUROSCI BI IN PRESS; Briancon N, 2010, DIABETES, V59, P3074, DOI 10.2337/db10-0481; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; ELIA M, 1988, AM J CLIN NUTR, V47, P591, DOI 10.1093/ajcn/47.4.591; Ellacott KLJ, 2007, ENDOCRINOLOGY, V148, P6186, DOI 10.1210/en.2007-0699; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Getting SJ, 2006, PHARMACOL THERAPEUT, V111, P1, DOI 10.1016/j.pharmthera.2005.06.022; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; Hatzileremia S, 2007, RAPID COMMUN MASS SP, V21, P2431, DOI 10.1002/rcm.3106; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Humphreys MH, 2011, EUR J PHARMACOL, V660, P43, DOI 10.1016/j.ejphar.2010.10.102; Irani BG, 2011, EUR J PHARMACOL, V660, P80, DOI 10.1016/j.ejphar.2010.10.101; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kim KW, 2011, P NATL ACAD SCI USA, V108, P10673, DOI 10.1073/pnas.1102364108; Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kumar KG, 2009, PEPTIDES, V30, P1892, DOI 10.1016/j.peptides.2009.07.012; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee M, 2008, PEPTIDES, V29, P440, DOI 10.1016/j.peptides.2007.11.005; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; Marsh DJ, 1999, BRAIN RES, V848, P66, DOI 10.1016/S0006-8993(99)01962-9; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Navarro M, 2011, ALCOHOL CLIN EXP RES, V35, P1058, DOI 10.1111/j.1530-0277.2011.01438.x; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Perez-Tilve D, 2010, NAT NEUROSCI, V13, P877, DOI 10.1038/nn.2569; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scarlett JM, 2007, ENDOCRINOLOGY, V148, P4217, DOI 10.1210/en.2007-0017; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Sutton GM, 2010, FASEB J, V24, P862, DOI 10.1096/fj.09-142000; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Trivedi P, 2003, BRAIN RES, V977, P221, DOI 10.1016/S0006-8993(03)02683-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com	57	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40771	40781		10.1074/jbc.M111.278374	http://dx.doi.org/10.1074/jbc.M111.278374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984834	Green Published, hybrid			2022-12-25	WOS:000297315400038
J	Gutierrez, A; Arendt, BK; Tschumper, RC; Kay, NE; Zent, CS; Jelinek, DF				Gutierrez, Albert, Jr.; Arendt, Bonnie K.; Tschumper, Renee C.; Kay, Neil E.; Zent, Clive S.; Jelinek, Diane F.			Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR AGONISTS; SIGNALING PATHWAY; ACTIVATION; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDE; PROLIFERATION; PHENOTYPE; MECHANISM; APOPTOSIS	Lymphocyte enhancer binding factor 1 (LEF-1) plays a crucial role in B lineage development and is only expressed in B cell precursors as B cell differentiation into mature B and plasma cells silences its expression. Chronic lymphocytic leukemia (CLL) cells aberrantly express LEF-1 and its expression is required for cellular survival. We hypothesized that modification of the differentiation status of CLL cells would result in loss of LEF-1 expression and eliminate the survival advantage provided by its aberrant expression. In this study, we first established a methodology that induces CLL cells to differentiate into immunoglobulin (Ig) secreting cells (ISC) using the TLR9 agonist, CpG, together with cytokines (CpG/c). CpG/c stimulation resulted in dramatic CLL cell phenotypic and morphologic changes, expression of cytoplasmic Ig, and secretion of light chain restricted Ig. CpG/c stimulation also resulted in decreased CLL cell LEF-1 expression and increased Blimp-1 expression, which is crucial for plasma cell differentiation. Further, Wnt pathway activation and cellular survival were impaired in differentiated CLL cells compared to undifferentiated CLL cells. These data support the notion that CLL can differentiate into ISC and that this triggers decreased leukemic cell survival secondary to the down regulation of LEF-1 and decreased Wnt pathway activation.	[Gutierrez, Albert, Jr.; Arendt, Bonnie K.; Tschumper, Renee C.; Jelinek, Diane F.] Mayo Clin, Dept Immunol, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA; [Kay, Neil E.; Zent, Clive S.] Mayo Clin, Dept Internal Med, Mayo Grad Sch, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Gutierrez, A (corresponding author), Mayo Clin, Dept Immunol, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA.	jelinek.diane@mayo.edu			National Cancer Institute (NCI); National Institutes of Health [R01CA136591, R01CA95241, R01CA111953, F31CA142310]; NATIONAL CANCER INSTITUTE [R01CA095241, R01CA136591, R01CA111953, F31CA142310] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (NCI), National Institutes of Health (R01CA136591 awarded to DFJ, R01CA95241 and R01CA111953 awarded to NEK, and F31CA142310 awarded to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSSON M, 1988, LEUKEMIA, V2, P734; COSSMAN J, 1984, J CLIN INVEST, V73, P587, DOI 10.1172/JCI111247; Darce JR, 2007, J IMMUNOL, V178, P5612, DOI 10.4049/jimmunol.178.9.5612; Decker T, 2000, BLOOD, V95, P999, DOI 10.1182/blood.V95.3.999.003k10_999_1006; Dicker F, 2006, BLOOD, V108, P3152, DOI 10.1182/blood-2006-02-005322; FU SM, 1978, J EXP MED, V148, P1570, DOI 10.1084/jem.148.6.1570; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Holtick U, 2011, EXPERT OPIN INV DRUG, V20, P361, DOI 10.1517/13543784.2011.553187; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Jahrsdorfer B, 2005, CLIN CANCER RES, V11, P1490, DOI 10.1158/1078-0432.CCR-04-1890; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Longo PG, 2007, LEUKEMIA, V21, P110, DOI 10.1038/sj.leu.2404417; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Meyer T, 2008, EXPERT OPIN INV DRUG, V17, P1051, DOI [10.1517/13543784.17.7.1051, 10.1517/13543784.17.7.1051 ]; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Puissant A, 2010, CELL CYCLE, V9, P3470, DOI 10.4161/cc.9.17.13048; Put N, 2009, GENE CHROMOSOME CANC, V48, P843, DOI 10.1002/gcc.20691; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Schnaiter A, 2010, ONCOTARGET, V1, P472; Sherborne AL, 2010, ONCOTARGET, V1, P367; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Spaner DE, 2007, LEUKEMIA, V21, P53, DOI 10.1038/sj.leu.2404456; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; TOTTERMAN TH, 1987, LEUKEMIA, V1, P667; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VEDANTHAM S, 1992, CANCER RES, V52, P1056; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Zupo S, 2000, BLOOD, V95, P1199, DOI 10.1182/blood.V95.4.1199.004k21_1199_1206	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26056	10.1371/journal.pone.0026056	http://dx.doi.org/10.1371/journal.pone.0026056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998751	Green Submitted, Green Published, gold			2022-12-25	WOS:000295968700036
J	Bhat, A; Boyadjiev, SA; Senders, CW; Leach, JK				Bhat, Archana; Boyadjiev, Simeon A.; Senders, Craig W.; Leach, J. Kent			Differential Growth Factor Adsorption to Calvarial Osteoblast-Secreted Extracellular Matrices Instructs Osteoblastic Behavior	PLOS ONE			English	Article							CRANIAL SUTURE FUSION; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; FACTOR-BETA; MESSENGER-RNA; OSTEOGENIC DIFFERENTIATION; DEFICIENT MICE; STEM-CELLS; CRANIOSYNOSTOSIS; BIOLOGY	Craniosynostosis (CS), the premature ossification of cranial sutures, is attributed to increased osteogenic potential of resident osteoblasts, yet the contribution of the surrounding extracellular matrix (ECM) on osteogenic differentiation is unclear. The osteoblast-secreted ECM provides binding sites for cellular adhesion and regulates the transport and signaling of osteoinductive factors secreted by the underlying dura mater. The binding affinity of each osteoinductive factor for the ECM may amplify or mute its relative effect, thus contributing to the rate of suture fusion. The purpose of this paper was to examine the role of ECM composition derived from calvarial osteoblasts on protein binding and its resultant effect on cell phenotype. We hypothesized that potent osteoinductive proteins present during sutural fusion (e.g., bone morphogenetic protein-2 (BMP-2) and transforming growth factor beta-1 (TGF-beta 1)) would exhibit distinct differences in binding when exposed to ECMs generated by human calvarial osteoblasts from unaffected control individuals (CI) or CS patients. Decellularized ECMs produced by osteoblasts from CI or CS patients were incubated in the presence of BMP-2 or TGF-beta 1, and the affinity of each protein was analyzed. The contribution of ECM composition to protein binding was interrogated by enzymatically modulating proteoglycan content within the ECM. BMP-2 had a similar binding affinity for each ECM, while TGF-beta 1 had a greater affinity for ECMs produced by osteoblasts from CI compared to CS patients. Enzymatic treatment of ECMs reduced protein binding. CS osteoblasts cultured on enzymatically-treated ECMs secreted by osteoblasts from CI patients in the presence of BMP-2 exhibited impaired osteogenic differentiation compared to cells on untreated ECMs. These data demonstrate the importance of protein binding to cell-secreted ECMs and confirm that protein-ECM interactions have an important role in directing osteoblastic differentiation of calvarial osteoblasts.	[Bhat, Archana; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Boyadjiev, Simeon A.] Univ Calif Davis, Sch Med, Genet Sect, Dept Pediat, Sacramento, CA 95817 USA; [Senders, Craig W.] Univ Calif Davis, Sch Med, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bhat, A (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jkleach@ucdavis.edu			The Hartwell Foundation; National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) [K23DE00462, R03 DE016342, R01 DE016886]; National Center for Research Resources (NCRR)/NIH [M01-RR00052]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE000462, R03DE016342] Funding Source: NIH RePORTER	The Hartwell Foundation; National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (NCRR)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors are thankful to The Hartwell Foundation for their generous financial support of this work (to KL). SAB is partially funded through a Children's Miracle Network Endowed Chair and through grants K23DE00462, R03 DE016342, and R01 DE016886 from National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) and M01-RR00052 from the National Center for Research Resources (NCRR)/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Boyadjiev SA, 2007, ORTHOD CRANIOFAC RES, V10, P129, DOI 10.1111/j.1601-6343.2007.00393.x; Carinci P, 2000, INT J DEV BIOL, V44, P715; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; COHEN MM, 1993, AM J MED GENET, V47, P581, DOI 10.1002/ajmg.1320470507; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; Davis HE, 2009, J BIOMED MATER RES A, V90A, P1021, DOI 10.1002/jbm.a.32169; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; DePollack C, 1996, J BONE MINER RES, V11, P401; Foster KA, 2008, PLAST RECONSTR SURG, V121, p70E, DOI 10.1097/01.prs.0000299393.36063.de; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Gosain AK, 2004, PLAST RECONSTR SURG, V113, P1675, DOI 10.1097/01.PRS.0000117362.33347.43; Gutierrez J, 2006, J CELL PHYSIOL, V206, P58, DOI 10.1002/jcp.20428; HARRIS SE, 1994, J BONE MINER RES, V9, P855; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132; Most D, 1998, PLAST RECONSTR SURG, V101, P1431, DOI 10.1097/00006534-199805000-00001; Nishigaki F, 2002, EUR J PHARMACOL, V437, P123, DOI 10.1016/S0014-2999(02)01269-4; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Robin NH, 1999, PLAST RECONSTR SURG, V103, P1060, DOI 10.1097/00006534-199903000-00053; Roth DA, 1996, PLAST RECONSTR SURG, V97, P693, DOI 10.1097/00006534-199604000-00001; Roth DA, 1997, PLAST RECONSTR SURG, V99, P300, DOI 10.1097/00006534-199702000-00002; Roth DA, 1997, J BONE MINER RES, V12, P311, DOI 10.1359/jbmr.1997.12.3.311; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wadhwa S, 2007, BONE, V40, P861, DOI 10.1016/j.bone.2006.11.003; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Xu Y, 2007, PLAST RECONSTR SURG, V119, P819, DOI 10.1097/01.prs.0000255540.91987.a0	41	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25990	10.1371/journal.pone.0025990	http://dx.doi.org/10.1371/journal.pone.0025990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998741	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900087
J	Cui, Y; Su, WY; Xing, J; Wang, YC; Wang, P; Chen, XY; Shen, ZY; Cao, H; Lu, YY; Fang, JY				Cui, Yun; Su, Wen-Yu; Xing, Jing; Wang, Ying-Chao; Wang, Ping; Chen, Xiao-Yu; Shen, Zhi-Yong; Cao, Hui; Lu, You-Yong; Fang, Jing-Yuan			MiR-29a Inhibits Cell Proliferation and Induces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer	PLOS ONE			English	Article								As a newly identified and characterized gene, p42.3 is associated with cell proliferation and tumorigenicity. The expression of p42.3 is upregulated in human gastric cancer (GC), but its underlying mechanisms of action are not well understood. MicroRNAs (miRNAs) are known to play vital regulatory roles in many cellular processes. Here we utilized bioinformatics and experimental approaches to investigate the regulatory relationship between miRNAs and the p42.3 gene. We showed that miR-29a could repress p42.3 expression at both the mRNA and protein levels via directly binding to its 3'UTR. Furthermore, an inverse relationship was observed between miR-29a and p42.3 expression in gastric cancer cell lines and GC tissue samples, especially in cases where p42.3 was downregulated. Taken together, we have elucidated previously unrecognized roles of miR-29a and indicated that miR-29a may function, at least partially, by targeting the p42.3 gene in human GC.	[Cui, Yun; Su, Wen-Yu; Xing, Jing; Wang, Ying-Chao; Chen, Xiao-Yu; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Sch Med,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China; [Wang, Ping] Shanghai Jiao Tong Univ, GI Div, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Shen, Zhi-Yong; Cao, Hui] Shanghai Jiao Tong Univ, GI Surg Div, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Lu, You-Yong] Peking Univ, Mol Oncol Lab, Beijing Inst Canc Res, Sch Oncol, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University	Cui, Y (corresponding author), Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Sch Med,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China.	jingyuanfang@yahoo.com	wang, yingying/GRS-3058-2022		National Basic Research Program of China 973 program [2010CB5293]; National High Technology Research and Development Program of China (863 Program) [2006AA02A402]; National Natural Science Foundation [30830055]; Ministry of Public Health, China [200802094]	National Basic Research Program of China 973 program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Public Health, China	This work was supported by grants from the National Basic Research Program of China 973 program (2010CB5293, the National High Technology Research and Development Program of China (863 Program)(2006AA02A402, the National Natural Science Foundation of Key Program (No. 30830055) and the Ministry of Public Health, China (No. 200802094) to FJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chiang YP, 2011, J GASTROINTEST SURG, V15, P63, DOI 10.1007/s11605-010-1367-8; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Golan A, 2010, CELL CYCLE, V13; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; KONG L, 2010, ACTA DIABETOL; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Meng XZ, 2011, J GASTROEN HEPATOL, V26, P186, DOI 10.1111/j.1440-1746.2010.06317.x; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Mutallip M, 2011, INT J MOL MED, V27, P345, DOI 10.3892/ijmm.2010.589; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Pandey AK, 2011, MOL CELL ENDOCRINOL, V332, P125, DOI 10.1016/j.mce.2010.10.004; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Xu X, 2007, ONCOGENE, V26, P7371, DOI 10.1038/sj.onc.1210538; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	34	87	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25872	10.1371/journal.pone.0025872	http://dx.doi.org/10.1371/journal.pone.0025872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998710	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900065
J	Heidary, F; Gharebaghi, R; Hitam, WHW; Naing, NN; Wan-Arfah, N; Shatriah, I				Heidary, Fatemah; Gharebaghi, Reza; Hitam, Wan Hazabbah Wan; Naing, Nyi Nyi; Wan-Arfah, Nadiah; Shatriah, Ismail			Central Corneal Thickness and Intraocular Pressure in Malay Children	PLOS ONE			English	Article							TONO-PEN; SPECULAR MICROSCOPE; NONCONTACT; CURVATURE; TONOMETER; JAPANESE; CHINESE; WHITE; AGE	Background: To determine the mean values for central corneal thickness (CCT) and intraocular pressure (IOP) and the relationship between these values, in healthy Malay children to serve as reference values in diagnosis and treatment. Design: A cross-sectional study. Methodology/Principal Findings: One hundred and eight eyes (54 subjects) of Malay children without diagnosis of ocular abnormality or disease meeting our inclusion and exclusion criteria were selected. The CCT and IOP were measured by specular microscopy and non-contact air-puff tonometry respectively, for analysis and comparison with the values obtained in previous studies. Mean CCT and IOP was found to be 530.87630.79 mm and 15.6563.05 mm Hg respectively. CCT was found not to vary with age. A positive relationship was found between CCT and IOP; specifically, with every 100-mm increase in CCT, IOP increased by 3.5 mm Hg. Conclusions/Significance: CCT and IOP are strongly related in healthy Malay children aged 8 to 16. The mean CCT of Malay children is lower than that of majority children of other ethnic groups, supporting the existence of CCT variation among different populations and that ethnicity should be a key consideration when applying CCT data to the general pediatric population.	[Heidary, Fatemah; Gharebaghi, Reza; Hitam, Wan Hazabbah Wan; Shatriah, Ismail] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia; [Naing, Nyi Nyi; Wan-Arfah, Nadiah] Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Heidary, F (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia.	shatriah@kck.usm.my	Naing, Nyi Nyi/AAB-3851-2021; Nadiah, Wan Arfah/H-8553-2016; Shatriah, Ismail/D-3637-2016; Naing, Nyi Nyi/M-3455-2015; Wan Hitam, Wan Hazabbah/M-3262-2016; Wan-Arfah, Nadiah/AAZ-1317-2021	Nadiah, Wan Arfah/0000-0002-4265-442X; Shatriah, Ismail/0000-0002-4753-4814; Naing, Nyi Nyi/0000-0001-8308-5625; Heidary, A/Prof. Fatemeh/0000-0002-6558-6132; Wan Hitam, Wan Hazabbah/0000-0002-3737-1820				Aghaian E, 2004, OPHTHALMOLOGY, V111, P2211, DOI 10.1016/j.ophtha.2004.06.013; Bovelle R, 1999, ARCH OPHTHALMOL-CHIC, V117, P868; Coste R, 2008, J FR OPHTALMOL, V31, P273, DOI 10.1016/S0181-5512(08)74804-6; Dai E, 2006, J AAPOS, V10, P22, DOI 10.1016/j.jaapos.2005.12.007; Dohadwala AA, 1998, OPHTHALMOLOGY, V105, P1849, DOI 10.1016/S0161-6420(98)91029-6; Doughty MJ, 2002, OPHTHAL PHYSL OPT, V22, P491, DOI 10.1046/j.1475-1313.2002.00053.x; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Gharebaghi R, 2010, CLIN OPTOM, V2, P119, DOI 10.2147/OPTO.S15290; Haider KM, 2008, J PEDIAT OPHTH STRAB, V45, P227, DOI 10.3928/01913913-20080701-07; HANSEN FK, 1971, ACTA OPHTHALMOL, V49, P82; Heidary F, 2010, OPHTHALMOLOGY, V117, P1861, DOI 10.1016/j.ophtha.2010.05.024; Heidary F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003705; HERSE P, 1993, ACTA OPHTHALMOL, V71, P360; Hikoya A, 2009, JPN J OPHTHALMOL, V53, P7, DOI 10.1007/s10384-008-0619-6; Husni MA, 2004, THESIS U SAINS MALAY; Hussein MAW, 2004, AM J OPHTHALMOL, V138, P744, DOI 10.1016/j.ajo.2004.06.030; Kim HY, 2008, AM J OPHTHALMOL, V145, P228, DOI 10.1016/j.ajo.2007.09.030; Kohli Poonam G., 2010, Journal of Medical Engineering & Technology, V34, P1, DOI 10.3109/03091900903247919; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Lim L, 2009, INVEST OPHTH VIS SCI, V50, P121, DOI 10.1167/iovs.08-2352; Muir KW, 2006, J GLAUCOMA, V15, P520, DOI 10.1097/01.ijg.0000212284.78045.45; Muir KW, 2004, OPHTHALMOLOGY, V111, P2220, DOI 10.1016/j.ophtha.2004.06.020; Muller A, 2000, BRIT J OPHTHALMOL, V84, P692, DOI 10.1136/bjo.84.7.692; Naing NN, 2010, PRACTICAL GUIDE DETE; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Osmera J, 2009, Cesk Slov Oftalmol, V65, P19; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Recep OF, 2001, J CATARACT REFR SURG, V27, P1787, DOI 10.1016/S0886-3350(01)00900-2; Sahin A, 2008, J GLAUCOMA, V17, P57, DOI 10.1097/IJG.0b013e31806ab33e; Sauer A, 2011, J FR OPHTALMOL, V34, P238, DOI 10.1016/j.jfo.2011.01.010; Shih CY, 2004, ARCH OPHTHALMOL-CHIC, V122, P1270, DOI 10.1001/archopht.122.9.1270; Suzuki S, 2003, J CATARACT REFR SURG, V29, P1313, DOI 10.1016/S0886-3350(03)00123-8; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P4004, DOI 10.1167/iovs.04-0121; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Yip JLY, 2007, BRIT J OPHTHALMOL, V91, P56, DOI 10.1136/bjo.2006.099549; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934	37	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25208	10.1371/journal.pone.0025208	http://dx.doi.org/10.1371/journal.pone.0025208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998644	Green Submitted, gold, Green Published			2022-12-25	WOS:000295966900015
J	Heining, E; Bhushan, R; Paarmann, P; Henis, YI; Knaus, P				Heining, Eva; Bhushan, Raghu; Paarmann, Pia; Henis, Yoav I.; Knaus, Petra			Spatial Segregation of BMP/Smad Signaling Affects Osteoblast Differentiation in C2C12 Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; LARGE GENE LISTS; BONE-FORMATION; OSTEOGENIC DIFFERENTIATION; RECEPTOR ENDOCYTOSIS; MESENCHYMAL CELLS; CAUSES OSTEOPENIA; COMPLEX-FORMATION; SMAD ANCHOR; PROTEIN	Background: Bone morphogenetic proteins (BMPs) are involved in a plethora of cellular processes in embryonic development and adult tissue homeostasis. Signaling specificity is achieved by dynamic processes involving BMP receptor oligomerization and endocytosis. This allows for spatiotemporal control of Smad dependent and non-Smad pathways. In this study, we investigate the spatiotemporal regulation within the BMP-induced Smad transcriptional pathway. Methodology/Principal Findings: Here we discriminate between Smad signaling events that are dynamin-dependent (i.e., require an intact endocytic pathway) and dynamin-independent. Inhibition of dynamin-dependent endocytosis in fluorescence microscopy and fractionation studies revealed a delay in Smad1/5/8 phosphorylation and nuclear translocation after BMP-2 stimulation of C2C12 cells. Using whole genome microarray and qPCR analysis, we identified two classes of BMP-2 induced genes that are differentially affected by inhibition of endocytosis. Thus, BMP-2 induced gene expression of Id1, Id3, Dlx2 and Hey1 is endocytosis-dependent, whereas BMP-2 induced expression of Id2, Dlx3, Zbtb2 and Krt16 is endocytosis-independent. Furthermore, we demonstrate that short term inhibition of endocytosis interferes with osteoblast differentiation as measured by alkaline phosphatase (ALP) production and qPCR analysis of osteoblast marker gene expression. Conclusions/Significance: Our study demonstrates that dynamin-dependent endocytosis is crucial for the concise spatial activation of the BMP-2 induced signaling cascade. Inhibition of endocytic processes during BMP-2 stimulation leads to altered Smad1/5/8 signaling kinetics and results in differential target gene expression. We show that interfering with the BMP-2 induced transcriptional network by endocytosis inhibition results in an attenuation of osteoblast differentiation. This implies that selective sensitivity of gene expression to endocytosis provides an additional mechanism for the cell to respond to BMP in a context specific manner. Moreover, we suggest a novel Smad dependent signal cascade induced by BMP-2, which does not require endocytosis.	[Heining, Eva; Bhushan, Raghu; Paarmann, Pia; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany; [Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Free University of Berlin; Tel Aviv University	Heining, E (corresponding author), Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany.	knaus@chemie.fu-berlin.de		Henis, Yoav/0000-0002-1408-3877; Bhushan, Raghu/0000-0001-6960-6025	German-Israeli Foundation for Scientific Research and Development (GIF) [932-244.13/2006]	German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the German-Israeli Foundation for Scientific Research and Development (GIF, grant number 932-244.13/2006 to PK and YIH). EH is a member of the Berlin-Brandenburg School for Regenerative Therapies (GSC 203). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bragdon B, 2009, BIOPHYS J, V97, P1428, DOI 10.1016/j.bpj.2009.05.061; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Genetos DC, 2010, CELL TISSUE RES, V340, P81, DOI 10.1007/s00441-010-0929-0; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Karner E, 2009, J CELL PHYSIOL, V218, P323, DOI 10.1002/jcp.21605; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Luan Y, 2008, MOL BIOL CELL, V19, P2113, DOI 10.1091/mbc.E07-10-1057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Merlo GR, 2000, INT J DEV BIOL, V44, P619; MIYAZONO K, 2002, SCI STKE, pPE40; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Rosen V, 1996, ANN NY ACAD SCI, V785, P59, DOI 10.1111/j.1749-6632.1996.tb56244.x; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto K, 2008, J CELL SCI, V121, P1613, DOI 10.1242/jcs.023119; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silvestris F, 2008, CLIN CANCER RES, V14, P6081, DOI 10.1158/1078-0432.CCR-08-0219; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Trost A, 2010, MECH AGEING DEV, V131, P346, DOI 10.1016/j.mad.2010.04.002; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zhou YL, 2004, MOL ENDOCRINOL, V18, P1818, DOI 10.1210/me.2004-0079	64	37	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25163	10.1371/journal.pone.0025163	http://dx.doi.org/10.1371/journal.pone.0025163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998639	gold, Green Published, Green Submitted			2022-12-25	WOS:000295966900012
J	Nguyen, HV; Legras, JL; Neuveglise, C; Gaillardin, C				Huu-Vang Nguyen; Legras, Jean-Luc; Neuveglise, Cecile; Gaillardin, Claude			Deciphering the Hybridisation History Leading to the Lager Lineage Based on the Mosaic Genomes of Saccharomyces bayanus Strains NBRC1948 and CBS380(T)	PLOS ONE			English	Article							INTERSPECIES HYBRIDIZATION; MALTOTRIOSE UTILIZATION; EVOLUTIONARY GENETICS; GENUS SACCHAROMYCES; NATURAL HYBRIDS; BREWING YEAST; CEREVISIAE; SEQUENCE; WINE; CARLSBERGENSIS	Saccharomyces bayanus is a yeast species described as one of the two parents of the hybrid brewing yeast S. pastorianus. Strains CBS380(T) and NBRC1948 have been retained successively as pure-line representatives of S. bayanus. In the present study, sequence analyses confirmed and upgraded our previous finding: S. bayanus type strain CBS380(T) harbours a mosaic genome. The genome of strain NBRC1948 was also revealed to be mosaic. Both genomes were characterized by amplification and sequencing of different markers, including genes involved in maltotriose utilization or genes detected by array-CGH mapping. Sequence comparisons with public Saccharomyces spp. nucleotide sequences revealed that the CBS380(T) and NBRC1948 genomes are composed of: a predominant non-cerevisiae genetic background belonging to S. uvarum, a second unidentified species provisionally named S. lagerae, and several introgressed S. cerevisiae fragments. The largest cerevisiae-introgressed DNA common to both genomes totals 70kb in length and is distributed in three contigs, cA, cB and cC. These vary in terms of length and presence of MAL31 or MTY1 (maltotriose-transporter gene). In NBRC1948, two additional cerevisiae-contigs, cD and cE, totaling 12kb in length, as well as several smaller cerevisiae fragments were identified. All of these contigs were partially detected in the genomes of S. pastorianus lager strains CBS1503 (S. monacensis) and CBS1513 (S. carlsbergensis) explaining the noticeable common ability of S. bayanus and S. pastorianus to metabolize maltotriose. NBRC1948 was shown to be inter-fertile with S. uvarum CBS7001. The cross involving these two strains produced F1 segregants resembling the strains CBS380(T) or NRRLY-1551. This demonstrates that these S. bayanus strains were the offspring of a cross between S. uvarum and a strain similar to NBRC1948. Phylogenies established with selected cerevisiae and non-cerevisiae genes allowed us to decipher the complex hybridisation events linking S. lagerae/S. uvarum/S. cerevisiae with their hybrid species, S. bayanus/pastorianus.	[Huu-Vang Nguyen; Neuveglise, Cecile; Gaillardin, Claude] INRA, Micalis UMR1319, Jouy En Josas, France; [Huu-Vang Nguyen; Neuveglise, Cecile; Gaillardin, Claude] AgroParisTech, Micalis, Jouy En Josas, France; [Legras, Jean-Luc] INRA, Sci CEnol UMR1083, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Nguyen, HV (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	Huu-Vang.Nguyen@grignon.inra.fr	Legras, Jean-Luc/A-7589-2008	Legras, Jean-Luc/0000-0002-4006-4389; Neuveglise, Cecile/0000-0001-5017-7830	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was only supported by the proper funds of the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SL, 2008, APPL ENVIRON MICROB, V74, P1494, DOI 10.1128/AEM.02570-07; BANNO I, 1989, YEAST, V5, P373; BARNETT JA, 1992, YEAST, V8, P1, DOI 10.1002/yea.320080102; Bon E, 2000, FEBS LETT, V487, P37, DOI 10.1016/S0014-5793(00)02276-6; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; CORRAN H. S., 1975, HIST BREWING; D Anderson B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-91; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dietvorst J, 2005, YEAST, V22, P775, DOI 10.1002/yea.1279; Dietvorst J, 2010, FEMS MICROBIOL LETT, V310, P152, DOI 10.1111/j.1574-6968.2010.02056.x; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Galeote V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017872; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; HANSEN J, 1994, GENE, V140, P33, DOI 10.1016/0378-1119(94)90727-7; Hinchliffe E, 1989, MOL CELL BIOL YEAST, P281; Joubert R, 2000, YEAST, V16, P511, DOI 10.1002/(SICI)1097-0061(200004)16:6<511::AID-YEA544>3.0.CO;2-I; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodama Y, 2001, APPL ENVIRON MICROB, V67, P3455, DOI 10.1128/AEM.67.8.3455-3462.2001; LACHANCE MA, 1985, MICROBIOL SCI, V2, P122; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; MARTINI AV, 1985, INT J SYST BACTERIOL, V35, P508; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Muller-Wille S, 2007, STUD HIST PHI PART C, V38, P796, DOI 10.1016/j.shpsc.2007.09.012; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; NAUMOV G, 1993, SYST APPL MICROBIOL, V16, P274; Naumov G. I., 2000, Mikrobiologiya, V69, P410; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; NESS F, 1995, GENETICS, V140, P945; Nguyen HV, 2000, SYST APPL MICROBIOL, V23, P71, DOI 10.1016/S0723-2020(00)80048-X; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; PEDERSEN MB, 1986, CARLSBERG RES COMMUN, V51, P185, DOI 10.1007/BF02907323; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rozpedowska E, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P145; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salema-Oom M, 2005, APPL ENVIRON MICROB, V71, P5044, DOI 10.1128/AEM.71.9.5044-5049.2005; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Stewart GG, 1983, YEAST GENETICS FUNDA, P461; Tamai Y, 2000, YEAST, V16, P1335, DOI 10.1002/1097-0061(200010)16:14<1335::AID-YEA623>3.0.CO;2-P; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teste MA, 2010, J BIOL CHEM, V285, P26815, DOI 10.1074/jbc.M110.145946; TURAKAINEN H, 1991, GENE, V101, P97, DOI 10.1016/0378-1119(91)90229-5; van der Walt J.P., 1970, YEASTS TAXONOMIC STU, P555; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Zhang HY, 2010, FEMS YEAST RES, V10, P941, DOI 10.1111/j.1567-1364.2010.00681.x	61	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25821	10.1371/journal.pone.0025821	http://dx.doi.org/10.1371/journal.pone.0025821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998701	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900058
J	Mehrbod, M; Mofrad, MRK				Mehrbod, Mehrdad; Mofrad, Mohammad R. K.			On the Significance of Microtubule Flexural Behavior in Cytoskeletal Mechanics	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; LIVING CELLS; RIGIDITY; KINESIN; FORCE; MODEL	Quantitative description of cell mechanics has challenged biological scientists for the past two decades. Various structural models have been attempted to analyze the structure of the cytoskeleton. One important aspect that has been largely ignored in all these modeling approaches is related to the flexural and buckling behavior of microtubular filaments. The objective of this paper is to explore the influence of this flexural and buckling behavior in cytoskeletal mechanics. In vitro the microtubules are observed to buckle in the first mode, reminiscent of a free, simply-supported beam. In vivo images of microtubules, however, indicate that the buckling mostly occurs in higher modes. This buckling mode switch takes place mostly because of the lateral support of microtubules via their connections to actin and intermediate filaments. These lateral loads are exerted throughout the microtubule length and yield a considerable bending behavior that, unless properly accounted for, would produce erroneous results in the modeling and analysis of the cytoskeletal mechanics. One of the promising attempts towards mechanical modeling of the cytoskeleton is the tensegrity model, which simplifies the complex network of cytoskeletal filaments into a combination merely of tension-bearing actin filaments and compression-bearing microtubules. Interestingly, this discrete model can qualitatively explain many experimental observations in cell mechanics. However, evidence suggests that the simplicity of this model may undermine the accuracy of its predictions, given the model's underlying assumption that "every single member bears solely either tensile or compressive behavior,'' i.e. neglecting the flexural behavior of the microtubule filaments. We invoke an anisotropic continuum model for microtubules and compare the bending energy stored in a single microtubule with its axial strain energy at the verge of buckling. Our results suggest that the bending energy can exceed the axial energy of microtubules by 40 folds. A modification to tensegrity model is, therefore, proved necessary in order to take into account the flexural response of microtubules. The concept of "bendo-tensegrity'' is proposed as a modification to contemporary cytoskeletal tensegrity models.	[Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mehrbod, M (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859				Baudriller H, 2006, CR MECANIQUE, V334, P662, DOI 10.1016/j.crme.2006.08.004; Blundell JR, 2009, SOFT MATTER, V5, P4015, DOI 10.1039/b903583d; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BRUNELLE EJ, 1970, J COMPOS MATER, V4, P404, DOI 10.1177/002199837000400311; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Gao Y, 2010, PHYSICA E; Gregory MS, 1967, ELASTIC INSTABILITY, Vxii; Guilak F, 2006, CYTOSKELETAL MECH MO, P256; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Hibbeler R. C., 2010, ENG MECH STATICS; Howard J., 2001, MECH MOTOR PROTEINS; Ingber D, 1994, CELLULAR TENSEGRITY; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jiang HQ, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2966216; Karimi R, 2011, PHYS REV L UNPUB; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Kiss B, 2006, J STRUCT BIOL, V155, P327, DOI 10.1016/j.jsb.2006.03.020; Li C, 2006, BIOCHEM BIOPH RES CO, V349, P1145, DOI 10.1016/j.bbrc.2006.08.153; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Pirentis A, 2009, INT J SOLIDS STRUCTU; Pirentis AP, 2010, INT J SOLIDS STRUCT, V47, P759, DOI 10.1016/j.ijsolstr.2009.11.010; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Shen HS, 2010, J THEOR BIOL, V264, P386, DOI 10.1016/j.jtbi.2010.02.014; Shi YJ, 2008, PHYSICA E, V41, P213, DOI 10.1016/j.physe.2008.06.025; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Li T, 2008, J BIOMECH, V41, P1722, DOI 10.1016/j.jbiomech.2008.03.003; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598	38	36	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25627	10.1371/journal.pone.0025627	http://dx.doi.org/10.1371/journal.pone.0025627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998675	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900038
J	Meissner, CS; Koppen-Rung, P; Dittmer, A; Lapp, S; Bogner, E				Meissner, Christina Sylvia; Koeppen-Rung, Panja; Dittmer, Alexandra; Lapp, Sara; Bogner, Elke			A "Coiled-Coil" Motif Is Important for Oligomerization and DNA Binding Properties of Human Cytomegalovirus Protein UL77	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TERMINASE SUBUNIT PUL56; OPEN READING FRAME; UL25 GENE-PRODUCT; PACKAGING PROTEIN; PSEUDORABIES VIRUS; UL6 GENE; TYPE-1; CLEAVAGE; IDENTIFICATION	Human cytomegalovirus (HCMV) UL77 gene encodes the essential protein UL77, its function is characterized in the present study. Immunoprecipitation identified monomeric and oligomeric pUL77 in HCMV infected cells. Immunostaining of purified virions and subviral fractions showed that pUL77 is a structural protein associated with capsids. In silico analysis revealed the presence of a coiled-coil motif (CCM) at the N-terminus of pUL77. Chemical cross-linking of either wild-type pUL77 or CCM deletion mutant (pUL77 Delta CCM) implicated that CCM is critical for oligomerization of pUL77. Furthermore, co-immunoprecipitations of infected and transfected cells demonstrated that pUL77 interacts with the capsid-associated DNA packaging motor components, pUL56 and pUL104, as well as the major capsid protein. The ability of pUL77 to bind dsDNA was shown by an in vitro assay. Binding to certain DNA was further confirmed by an assay using biotinylated 36-, 250-, 500-, 1000-meric dsDNA and 966-meric HCMV-specific dsDNA designed for this study. The binding efficiency (BE) was determined by image processing program defining values above 1.0 as positive. While the BE of the pUL56 binding to the 36-mer bio-pac1 containing a packaging signal was 10.0+/-0.63, the one for pUL77 was only 0.2+/-0.03. In contrast to this observation the BE of pUL77 binding to bio-500 bp or bio-1000 bp was 2.2+/-0.41 and 4.9+/-0.71, respectively. By using pUL77 Delta CCM it was demonstrated that this protein could not bind to dsDNA. These data indicated that pUL77 (i) could form homodimers, (ii) CCM of pUL77 is crucial for oligomerization and (iii) could bind to dsDNA in a sequence independent manner.	[Meissner, Christina Sylvia; Koeppen-Rung, Panja; Dittmer, Alexandra; Lapp, Sara; Bogner, Elke] Charite, Inst Virol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meissner, CS (corresponding author), Charite, Inst Virol, D-13353 Berlin, Germany.	elke.bogner@charite.de	Bogner, Elke/AAG-2207-2019	Bogner, Elke/0000-0001-7622-2900	Deutsche Forschungsgesellschaft [Bo 1214/15-1]; DFG [Graduiertenkolleg 1121, A9]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The work was funded by the Deutsche Forschungsgesellschaft (Bo 1214/15-1) and DFG Graduiertenkolleg 1121 (Project Bogner A9)(http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKOBAISI MF, 1991, VIROLOGY, V180, P380, DOI 10.1016/0042-6822(91)90043-B; Baines JD, 1997, J VIROL, V71, P2666, DOI 10.1128/JVI.71.4.2666-2673.1997; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BOGNER E, 1993, VIROLOGY, V196, P290, DOI 10.1006/viro.1993.1477; Bogner E, 1998, J VIROL, V72, P2259, DOI 10.1128/JVI.72.3.2259-2264.1998; Bogner E, 2002, REV MED VIROL, V12, P115, DOI 10.1002/rmv.344; Borst EM, 2008, J VIROL, V82, P2065, DOI 10.1128/JVI.01967-07; Bowman BR, 2006, J VIROL, V80, P2309, DOI 10.1128/JVI.80.5.2309-2317.2006; Brown J, 2002, STRUCTURE FUNCTION R, P111; CASJENS S, 1982, J MOL BIOL, V157, P287, DOI 10.1016/0022-2836(82)90235-2; Chang YJE, 1996, J VIROL, V70, P3938, DOI 10.1128/JVI.70.6.3938-3946.1996; Cockrell SK, 2011, J VIROL, V85, P4875, DOI 10.1128/JVI.00242-11; Cockrell SK, 2009, J VIROL, V83, P47, DOI 10.1128/JVI.01889-08; Dittmer A, 2005, J VIROL, V79, P14660, DOI 10.1128/JVI.79.23.14660-14667.2005; Dittmer A, 2005, BIOCHEMISTRY-US, V44, P759, DOI 10.1021/bi047911w; Dong Y, 2003, P NATL ACAD SCI USA, V100, P12396; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; FLECKENSTEIN B, 1982, GENE, V18, P39, DOI 10.1016/0378-1119(82)90054-3; Giesen K, 2000, J GEN VIROL, V81, P2231, DOI 10.1099/0022-1317-81-9-2231; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Guo PX, 2007, MOL MICROBIOL, V64, P886, DOI 10.1111/j.1365-2958.2007.05706.x; Holzenburg A, 2009, J GEN VIROL, V90, P2381, DOI 10.1099/vir.0.013292-0; Hwang JS, 2002, J BIOL CHEM, V277, P6943, DOI 10.1074/jbc.M108984200; Klupp BG, 2006, J VIROL, V80, P6235, DOI 10.1128/JVI.02662-05; Kuhn J, 2008, J VIROL, V82, P5725, DOI 10.1128/JVI.02441-07; Lamberti C, 1996, VIROLOGY, V226, P403, DOI 10.1006/viro.1996.0668; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McNab AR, 1998, J VIROL, V72, P1060, DOI 10.1128/JVI.72.2.1060-1070.1998; Newcomb WW, 2006, J VIROL, V80, P6286, DOI 10.1128/JVI.02648-05; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Ogasawara M, 2001, J VIROL, V75, P1427, DOI 10.1128/JVI.75.3.1427-1436.2001; PATEL AH, 1995, VIROLOGY, V206, P465, DOI 10.1016/S0042-6822(95)80062-X; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; Preston VG, 2008, J VIROL, V82, P6654, DOI 10.1128/JVI.00257-08; Salmon B, 1998, J VIROL, V72, P3779, DOI 10.1128/JVI.72.5.3779-3788.1998; Savva CGW, 2004, FEBS LETT, V563, P135, DOI 10.1016/S0014-5793(04)00283-2; Scheffczik H, 2002, NUCLEIC ACIDS RES, V30, P1695, DOI 10.1093/nar/30.7.1695; Scholz B, 2003, NUCLEIC ACIDS RES, V31, P1426, DOI 10.1093/nar/gkg229; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Stow ND, 2001, J VIROL, V75, P10755, DOI 10.1128/JVI.75.22.10755-10765.2001; TALBOT P, 1977, J GEN VIROL, V36, P345, DOI 10.1099/0022-1317-36-2-345; TENGELSEN LA, 1993, J VIROL, V67, P3470, DOI 10.1128/JVI.67.6.3470-3480.1993; Thurlow JK, 2006, J VIROL, V80, P2118, DOI 10.1128/JVI.80.5.2118-2126.2006; Thurlow JK, 2005, J VIROL, V79, P150, DOI 10.1128/JVI.79.1.150-158.2005; To A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017796; Trus BL, 2007, MOL CELL, V26, P479, DOI 10.1016/j.molcel.2007.04.010; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Yu D, 1998, J VIROL, V72, P7428, DOI 10.1128/JVI.72.9.7428-7439.1998	50	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25115	10.1371/journal.pone.0025115	http://dx.doi.org/10.1371/journal.pone.0025115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998635	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900007
J	Pitino, M; Coleman, AD; Maffei, ME; Ridout, CJ; Hogenhout, SA				Pitino, Marco; Coleman, Alexander D.; Maffei, Massimo E.; Ridout, Christopher J.; Hogenhout, Saskia A.			Silencing of Aphid Genes by dsRNA Feeding from Plants	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE-C; MYZUS-PERSICAE; EXPRESSION; RACK1; IDENTIFICATION; INTERFERENCE; COMPONENTS; PATHWAY; HOST	Background: RNA interference (RNAi) is a valuable reverse genetics tool to study gene function in various organisms, including hemipteran insects such as aphids. Previous work has shown that RNAi-mediated knockdown of pea aphid (Acyrthosiphon pisum) genes can be achieved through direct injection of double-stranded RNA (dsRNA) or small-interfering RNAs (siRNA) into the pea aphid hemolymph or by feeding these insects on artificial diets containing the small RNAs. Methodology/Principal Findings: In this study, we have developed the plant-mediated RNAi technology for aphids to allow for gene silencing in the aphid natural environment and minimize handling of these insects during experiments. The green peach aphid M. persicae was selected because it has a broad plant host range that includes the model plants Nicotiana benthamiana and Arabidopsis thaliana for which transgenic materials can relatively quickly be generated. We targeted M. persicae Rack1, which is predominantly expressed in the gut, and M. persicae C002 (MpC002), which is predominantly expressed in the salivary glands. The aphids were fed on N. benthamiana leaf disks transiently producing dsRNA corresponding to these genes and on A. thaliana plants stably producing the dsRNAs. MpC002 and Rack-1 expression were knocked down by up to 60% on transgenic N. benthamiana and A. thaliana. Moreover, silenced M. persicae produced less progeny consistent with these genes having essential functions. Conclusions/Significance: Similar levels of gene silencing were achieved in our plant-mediated RNAi approach and published silencing methods for aphids. Furthermore, the N. benthamiana leaf disk assay can be developed into a screen to assess which genes are essential for aphid survival on plants. Our results also demonstrate the feasibility of the plant-mediated RNAi approach for aphid control.	[Pitino, Marco; Coleman, Alexander D.; Ridout, Christopher J.; Hogenhout, Saskia A.] John Innes Ctr, Dept Dis & Stress Biol, Norwich, Norfolk, England; [Pitino, Marco; Maffei, Massimo E.] Univ Turin, Innovat Ctr, Dept Plant Biol, Plant Physiol Unit, Turin, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Turin	Pitino, M (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich Res Pk, Norwich, Norfolk, England.	saskia.hogenhout@jic.ac.uk	Hogenhout, Saskia A/D-9266-2012; Maffei, Massimo E/K-9593-2015	Hogenhout, Saskia A/0000-0003-1371-5606; Maffei, Massimo E/0000-0001-6814-2353; Coleman, Alexander/0000-0001-7771-2290; Ridout, Christopher/0000-0001-9287-938X	The John Innes Centre; The Gatsby Charitable Foundation in the UK; Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy; Biotechnology and Biological Sciences Research Council (BBSRC); Home Grown Cereals Authority; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0623] Funding Source: researchfish; BBSRC [BBS/E/J/000C0623] Funding Source: UKRI	The John Innes Centre; The Gatsby Charitable Foundation in the UK; Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Home Grown Cereals Authority; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by The John Innes Centre and The Gatsby Charitable Foundation in the UK, and a grant from the Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy. The John Innes Centre is grant-aided by the Biotechnology and Biological Sciences Research Council (BBSRC). A.C. is funded from a studentship co-funded by the BBSRC and the Home Grown Cereals Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson B, 1999, VIRUS RES, V64, P125, DOI 10.1016/S0168-1702(99)00087-8; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brault V, 2007, MICRON, V38, P302, DOI 10.1016/j.micron.2006.04.005; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chen T, 2002, J AM SOC NEPHROL, V13, p501A; Ciche TA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-101; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HANLEY BA, 1991, NUCLEIC ACIDS RES, V19, P6319, DOI 10.1093/nar/19.22.6319; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Gomollon S, 2011, DETECTING SRNAS NO B, P25; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; VANEMDEN HF, 1969, ANNU REV ENTOMOL, V14, P197, DOI 10.1146/annurev.en.14.010169.001213; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG NS, 1990, DEV GENET, V11, P289, DOI 10.1002/dvg.1020110407; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	45	269	306	1	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25709	10.1371/journal.pone.0025709	http://dx.doi.org/10.1371/journal.pone.0025709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998682	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900045
J	Schleicher, TR; Nyholm, SV				Schleicher, Tyler R.; Nyholm, Spencer V.			Characterizing the Host and Symbiont Proteomes in the Association between the Bobtail Squid, Euprymna scolopes, and the Bacterium, Vibrio fischeri	PLOS ONE			English	Article							NF-KAPPA-B; THIOESTER-CONTAINING PROTEINS; LIGHT-ORGAN COLONIZATION; MASS-SPECTROMETRY; NITRIC-OXIDE; BENEFICIAL ASSOCIATION; STATIONARY-PHASE; OXIDATIVE STRESS; GENE-EXPRESSION; SCALE ANALYSIS	The beneficial symbiosis between the Hawaiian bobtail squid, Euprymna scolopes, and the bioluminescent bacterium, Vibrio fischeri, provides a unique opportunity to study host/microbe interactions within a natural microenvironment. Colonization of the squid light organ by V. fischeri begins a lifelong association with a regulated daily rhythm. Each morning the host expels an exudate from the light organ consisting of 95% of the symbiont population in addition to host hemocytes and shed epithelial cells. We analyzed the host and symbiont proteomes of adult squid exudate and surrounding light organ epithelial tissue using 1D- and 2D-polyacrylamide gel electrophoresis and multidimensional protein identification technology (MudPIT) in an effort to understand the contribution of both partners to the maintenance of this association. These proteomic analyses putatively identified 1581 unique proteins, 870 proteins originating from the symbiont and 711 from the host. Identified host proteins indicate a role of the innate immune system and reactive oxygen species (ROS) in regulating the symbiosis. Symbiont proteins detected enhance our understanding of the role of quorum sensing, two-component signaling, motility, and detoxification of ROS and reactive nitrogen species (RNS) inside the light organ. This study offers the first proteomic analysis of the symbiotic microenvironment of the adult light organ and provides the identification of proteins important to the regulation of this beneficial association.	[Schleicher, Tyler R.; Nyholm, Spencer V.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Schleicher, TR (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	spencer.nyholm@uconn.edu			National Science Foundation [IOS-0958006]; University of Connecticut Research Foundation; Direct For Biological Sciences [0958006] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation IOS-0958006 (nsf.gov) and the University of Connecticut Research Foundation (research.uconn.edu) to SVN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2008, IMMUNOBIOLOGY, V213, P815, DOI 10.1016/j.imbio.2008.07.029; Aeckersberg F, 2001, J BACTERIOL, V183, P6590, DOI 10.1128/JB.183.22.6590-6597.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunes LCM, 2007, J BACTERIOL, V189, P8387, DOI 10.1128/JB.00736-07; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Balhesteros H, 2010, ARCH MICROBIOL, V192, P747, DOI 10.1007/s00203-010-0602-8; Barth KR, 2009, MICROBIOL-SGM, V155, P2532, DOI 10.1099/mic.0.028092-0; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Boettcher KJ, 1996, J COMP PHYSIOL A, V179, P65; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Callahan SM, 2000, J BACTERIOL, V182, P2811, DOI 10.1128/JB.182.10.2811-2822.2000; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; Cerliani JP, 2011, J CLIN IMMUNOL, V31, P10, DOI 10.1007/s10875-010-9494-2; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Dunn AK, 2008, J BACTERIOL, V190, P5814, DOI 10.1128/JB.00227-08; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Froese N, 2006, MOL CELL BIOL, V26, P293, DOI 10.1128/MCB.26.1.293-302.2006; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Graf J, 2000, MOL MICROBIOL, V37, P168, DOI 10.1046/j.1365-2958.2000.01984.x; Graf J, 1998, P NATL ACAD SCI USA, V95, P1818, DOI 10.1073/pnas.95.4.1818; Guerrero-Ferreira RC, 2010, ENV MICROBIOL REP, V2, P514, DOI 10.1111/j.1758-2229.2009.00077.x; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Ho YP, 2002, J CHROMATOGR A, V976, P103, DOI 10.1016/S0021-9673(02)00939-1; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jones BW, 2006, CAN J MICROBIOL, V52, P1218, DOI 10.1139/W06-088; Jones BM, 2011, MAR BIOTECHNOL, V13, P496, DOI 10.1007/s10126-010-9320-0; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; LEE KH, 1994, APPL ENVIRON MICROB, V60, P1565, DOI 10.1128/AEM.60.5.1565-1571.1994; Lemus JD, 2000, APPL ENVIRON MICROB, V66, P4091, DOI 10.1128/AEM.66.9.4091-4097.2000; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lupp C, 2004, J BACTERIOL, V186, P3873, DOI 10.1128/JB.186.12.3873-3881.2004; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Mandel MJ, 2010, TRENDS MICROBIOL, V18, P504, DOI 10.1016/j.tim.2010.07.005; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Mastronunzio JE, 2010, SYMBIOSIS, V50, P13, DOI 10.1007/s13199-009-0030-1; McFall-Ngai M, 2008, ADV EXP MED BIOL, V635, P102, DOI 10.1007/978-0-387-09550-9_9; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; Millikan DS, 2003, J BACTERIOL, V185, P3547, DOI 10.1128/JB.185.12.3547-3557.2003; Millikan DS, 2004, J BACTERIOL, V186, P4315, DOI 10.1128/JB.186.13.4315-4325.2004; NEALSON KH, 1977, ARCH MICROBIOL, V112, P73, DOI 10.1007/BF00446657; Nguyen DT, 2009, FEMS MICROBIOL LETT, V298, P37, DOI 10.1111/j.1574-6968.2009.01693.x; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Nyholm SV, 1998, BIOL BULL, V195, P89, DOI 10.2307/1542815; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Nyholm SV, 2002, APPL ENVIRON MICROB, V68, P5113, DOI 10.1128/AEM.68.10.5113-5122.2002; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Robinson MW, 2010, PARASITE IMMUNOL, V32, P305, DOI 10.1111/j.1365-3024.2010.01201.x; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Small AL, 1999, J CELL BIOCHEM, V72, P445, DOI 10.1002/(SICI)1097-4644(19990315)72:4<445::AID-JCB1>3.0.CO;2-P; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tian Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1063, DOI 10.1271/bbb.70812; TOMAREV SI, 1993, GENE, V132, P219, DOI 10.1016/0378-1119(93)90199-D; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Visick KL, 1998, J BACTERIOL, V180, P2087, DOI 10.1128/JB.180.8.2087-2092.1998; Wang YL, 2011, CELL MICROBIOL, V13, P518, DOI 10.1111/j.1462-5822.2011.01576.x; Wang YL, 2010, MOL MICROBIOL, V78, P903, DOI 10.1111/j.1365-2958.2010.07376.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Whistler CA, 2003, J BACTERIOL, V185, P7202, DOI 10.1128/JB.185.24.7202-7212.2003; Whistler CA, 2007, CELL MICROBIOL, V9, P766, DOI 10.1111/j.1462-5822.2006.00826.x; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Yamanaka K, 2001, MOL MICROBIOL, V39, P1572, DOI 10.1046/j.1365-2958.2001.02345.x; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934	89	40	41	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25649	10.1371/journal.pone.0025649	http://dx.doi.org/10.1371/journal.pone.0025649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998678	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900041
J	Wang, DZ; Jiang, ZW; Shen, ZY; Wang, H; Wang, BL; Shou, WH; Zheng, H; Chu, X; Shi, JX; Huang, W				Wang, Dazhi; Jiang, Zhengwen; Shen, Zhongyang; Wang, Hui; Wang, Beilan; Shou, Weihua; Zheng, Hong; Chu, Xun; Shi, Jinxiu; Huang, Wei			Functional Evaluation of Genetic and Environmental Regulators of P450 mRNA Levels	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATIC NUCLEAR FACTOR-4-ALPHA; ARYL-HYDROCARBON RECEPTOR; HUMAN LIVER; INTERINDIVIDUAL VARIABILITY; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; CYP2C9; SEQUENCE; CYP1A2	Variations in the activities of Cytochrome P450s are one of the major factors responsible for inter-individual differences in drug clearance rates, which may cause serious toxicity or inefficacy of therapeutic drugs. Various mRNA level is one of the key factors for different activity of the major P450 genes. Although both genetic and environmental regulators of P450 gene expression have been widely investigated, few studies have evaluated the functional importance of cis- and trans-regulatory factors and environmental factors in the modulation of inter-individual expression variations of the P450 genes. In this study, we measured the mRNA levels of seven major P450 genes (CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 and CYP3A5) in 96 liver biopsy samples from Chinese population. Both trans-acting (mRNA levels and non-synonymous SNPs of putative regulator genes) and cis-acting (gene copy number and functional SNPs) factors were investigated to identify the determinants of the expression variations of these seven P450 genes. We found that expression variations of most P450 genes, regulator genes and housekeeping genes were positively correlated at the mRNA level. After partial correlation analysis using ACTB and GAPDH expression to eliminate the effect of global regulators, a UPGMA (Unweighted Pair Group Method with Arithmetic Mean) tree was constructed to reveal the effects of specific regulation networks potentially masked by global regulators. Combined with the functional analysis of regulators, our results suggested that expression variation at the mRNA level was mediated by several factors in a gene-specific manner. Cis-acting genetic variants might play key roles in the expression variation of CYP2D6 and CYP3A5, environmental inducers might play key roles in CYP1A1 and CYP1A2 variation and global regulators might play key roles in CYP2C9 variation. In addition, the functions of regulators that play less important roles in controlling expression variation for each P450 gene were determined.	[Wang, Dazhi; Shou, Weihua; Chu, Xun; Huang, Wei] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Dazhi; Jiang, Zhengwen; Wang, Beilan; Shou, Weihua; Chu, Xun; Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Dept Genet, Shanghai, Peoples R China; [Shen, Zhongyang; Wang, Hui; Zheng, Hong] Tianjin First Cent Hosp, Organ Transplant Ctr, Tianjin, Peoples R China	Shanghai Jiao Tong University; Tianjin Medical University	Wang, DZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China.	weihuangsh@gmail.com			Chinese High-Tech Program [2009AA022709]; Chinese National Natural Science Fund for Distinguished Young Scholars [30625019]; Chinese National Natural Science Fund for Youth [30900828]	Chinese High-Tech Program; Chinese National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National Natural Science Fund for Youth	This work was supported by the grants from Chinese High-Tech Program (2009AA022709), Chinese National Natural Science Fund for Distinguished Young Scholars (30625019) and Chinese National Natural Science Fund for Youth (30900828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516; Gaedigk A, 2005, PHARMACOGENOMICS J, V5, P173, DOI 10.1038/sj.tpj.6500305; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; IKEYA K, 1989, MOL ENDOCRINOL, V3, P1399, DOI 10.1210/mend-3-9-1399; Jiang Zhengwen, 2005, Nucleic Acids Res, V33, pe91, DOI 10.1093/nar/gni089; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Jung D, 2003, HEPATOLOGY, V37, P622, DOI 10.1053/jhep.2003.50100; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lasker JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P16, DOI 10.1006/abbi.1998.0615; Lee CR, 2003, J CLIN PHARMACOL, V43, P84, DOI 10.1177/0091270002239710; Li W, 1998, BIOCHEM PHARMACOL, V56, P599, DOI 10.1016/S0006-2952(98)00208-1; Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nebert DW, 2004, EUR J PHARMACOL, V500, P267, DOI 10.1016/j.ejphar.2004.07.031; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; Rebbeck TR, 2000, J NATL CANCER I, V92, P76, DOI 10.1093/jnci/92.1.76; Rodriguez-Antona C, 2001, ARCH BIOCHEM BIOPHYS, V393, P308, DOI 10.1006/abbi.2001.2499; Sachse C, 1997, AM J HUM GENET, V60, P284; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ueda R, 2006, MOL PHARMACOL, V69, P1924, DOI 10.1124/mol.105.021220; Uno Y, 2003, J HUM GENET, V48, P594, DOI 10.1007/s10038-003-0076-5; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109	33	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24900	10.1371/journal.pone.0024900	http://dx.doi.org/10.1371/journal.pone.0024900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998633	Green Submitted, gold, Green Published			2022-12-25	WOS:000295966900005
J	Hars, M; Hars, M; Stam, CJ; Calmels, C				Hars, Magaly; Hars, Melany; Stam, Cornelis J.; Calmels, Claire			Effects of Visual Context upon Functional Connectivity during Observation of Biological Motions	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; NONLINEAR EEG SYNCHRONIZATION; ATTENTIONAL MODULATION; PERCEPTION; MEMORY; ALPHA; MOTOR; BRAIN; AREAS; OSCILLATIONS	The aim of this study was to examine brain responses, in particular functional connectivity, to different visual stimuli depicting familiar biological motions. Ten subjects actively observed familiar biological motions embedded in point-light and video displays. Electroencephalograms were recorded from 64 electrodes. Activity was considered in three frequency bands (4-8 Hz, 8-10 Hz, and 10-13 Hz) using a non-linear measure of functional connectivity. In the 4-8 Hz and 8-10 Hz frequency bands, functional connectivity for the SMA was greater during the observation of biological motions presented in a point-light display compared to the observation of motions presented in a video display. The reverse was observed for the 4-8 Hz frequency band for the left temporal area. Explanations related to: (i) the task demands (i. e., attention and mental effort), (ii) the role(s) of theta and alpha oscillations in cognitive processes, and (iii) the function(s) of cortical areas are discussed. It has been suggested that attention was required to process human biological motions under unfamiliar viewing conditions such as point-light display.	[Hars, Magaly; Calmels, Claire] Inst Natl Sport, INSEP, Paris, France; [Hars, Magaly] Univ Reims, Reims, France; [Hars, Melany] Univ Hosp Geneva, Dept Rehabil & Geriatr, Geneva, Switzerland; [Hars, Melany] Univ Valenciennes & Hainaut Cambresis, LAMIH UMR CNRS 8530, Valenciennes, France; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Universite de Reims Champagne-Ardenne; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Hars, M (corresponding author), Inst Natl Sport, INSEP, Paris, France.	claire.calmels@insep.fr	Hars, Mélany/AAI-1125-2021; Hars, Magaly/H-1879-2012	HARS, MELANY/0000-0002-5108-0528; Stam, Cornelis/0000-0001-9163-7274	French Ministry of Sport	French Ministry of Sport	This study was supported by a grant from the French Ministry of Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROSCI LETT, V461, P240, DOI 10.1016/j.neulet.2009.06.055; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Babiloni C, 2009, NEUROIMAGE, V45, P512, DOI 10.1016/j.neuroimage.2008.11.035; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; BOITEN F, 1992, ELECTROEN CLIN NEURO, V82, P302, DOI 10.1016/0013-4694(92)90110-4; Calmels C, 2009, NEUROPHYSIOL CLIN, V39, P303, DOI 10.1016/j.neucli.2009.09.003; Calmels C, 2008, EXP BRAIN RES, V190, P389, DOI 10.1007/s00221-008-1480-z; Calmels C, 2010, PSYCHOPHYSIOLOGY, V47, P799, DOI 10.1111/j.1469-8986.2010.00985.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chandrasekaran C, 2005, 139 M PLANCK I BIOL; Chandrasekaran C, 2010, PSIHOLOGIJA, V43, P5, DOI 10.2298/PSI1001005C; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Fingelkurts AA, 2005, NEUROSCI BIOBEHAV R, V28, P827, DOI 10.1016/j.neubiorev.2004.10.009; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Krause CM, 2000, CLIN NEUROPHYSIOL, V111, P2071, DOI 10.1016/S1388-2457(00)00429-6; Lagerlund TD, 2005, ELECTROENCEPHALOGRAP, P829; LONG BC, 1995, J APPL SPORT PSYCHOL, V7, P167, DOI 10.1080/10413209508406963; Manganotti P, 1998, ELECTROMYOGR MOTOR C, V109, P50, DOI 10.1016/S0924-980X(97)00074-X; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nuwer MR, 1999, EEG CL N SU, V50, P150; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Parasuraman R, 2009, J EXP PSYCHOL-APPL, V15, P275, DOI 10.1037/a0017132; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; PFURTSCHELLER G, 1988, ELECTROEN CLIN NEURO, V70, P190, DOI 10.1016/0013-4694(88)90119-8; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Safford AS, 2010, J NEUROSCI, V30, P9064, DOI 10.1523/JNEUROSCI.1779-10.2010; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Stam CJ, 2002, INT J PSYCHOPHYSIOL, V46, P53, DOI 10.1016/S0167-8760(02)00041-7; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Zentgraf K, 2005, NEUROIMAGE, V26, P662, DOI 10.1016/j.neuroimage.2005.02.015	78	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25903	10.1371/journal.pone.0025903	http://dx.doi.org/10.1371/journal.pone.0025903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991384	gold, Green Published, Green Submitted			2022-12-25	WOS:000295963300029
J	Hussain, R; Ansari, A; Talat, N; Hasan, Z; Dawood, G				Hussain, Rabia; Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra; Dawood, Ghaffar			CCL2/MCP-I Genotype-Phenotype Relationship in Latent Tuberculosis Infection	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; HOUSEHOLD CONTACTS; MCP-1 GENE; EXPRESSION; CHEMOKINES; SUSCEPTIBILITY; ASSOCIATION; RESPONSES	Among the known biomarkers, chemokines, secreted by activated macrophages and T cells, attract groups of immune cells to the site of infection and may determine the clinical outcome. Association studies of CCL-2/MCP-1 -2518 A/G functional SNP linked to high and low phenotypes with tuberculosis disease susceptibility have shown conflicting results in tuberculosis. Some of these differences could be due the variability of latent infection and recent exposure in the control groups. We have therefore carried out a detailed analysis of CCL-2 genotype SNP -2518 (A/G transition) with plasma CCL-2 levels and related these levels to tuberculin skin test positivity in asymptomatic community controls with no known exposure to tuberculosis and in recently exposed household contacts of pulmonary tuberculosis patients. TST positivity was linked to higher concentrations of plasma CCL2 (Mann Whitney U test; p = 0.004) and was more marked when the G allele was present in TST+ asymptomatic controls (A/G; p = 0.01). Recent exposure also had a significant effect on CCL-2 levels and was linked to the G allele (p = 0.007). Therefore association studies for susceptibility or protection from disease should take into consideration the PPD status as well as recent exposure of the controls group used for comparison. Our results also suggest a role for CCL-2 in maintaining the integrity of granuloma in asymptomatic individuals with latent infection in high TB burden settings. Therefore additional studies into the role of CCL-2 in disease reactivation and progression are warranted.	[Hussain, Rabia; Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Trust Hosp, Karachi, Pakistan	Aga Khan University	Hussain, R (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/F-5111-2015; Hussain, Rabia/M-6649-2015; Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015	Hussain, Rabia/0000-0001-9995-8742; Hasan, Zahra/0000-0001-7580-372X; 	Pakistan Academy of Sciences, Government of Pakistan [5/9/PAS/3031]	Pakistan Academy of Sciences, Government of Pakistan	The authors acknowledge the Pakistan Academy of Sciences, Government of Pakistan for providing financial support for this project through Grant No. 5/9/PAS/3031. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gale LM, 1999, BIOESSAYS, V21, P17, DOI 10.1002/(SICI)1521-1878(199901)21:1<17::AID-BIES3>3.0.CO;2-4; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mendez A, 2011, TUBERCULOSIS, V91, P140, DOI 10.1016/j.tube.2010.12.008; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Rathi SK, 2002, INT J TUBERC LUNG D, V6, P851; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Siveke JT, 1998, J IMMUNOL, V160, P550; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Talat N, 2009, SCAND J IMMUNOL, V69, P537, DOI 10.1111/j.1365-3083.2009.02250.x; Tapaninen P, 2010, INT J TUBERC LUNG D, V14, P347; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200	36	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25803	10.1371/journal.pone.0025803	http://dx.doi.org/10.1371/journal.pone.0025803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991356	Green Published, gold, Green Submitted			2022-12-25	WOS:000295963300021
J	Lussiana, C; Clemente, SVL; Tarquino, IAP; Paulo, I				Lussiana, Cristina; Loa Clemente, Sofia Vanda; Pulido Tarquino, Ivan Alejandro; Paulo, Isabel			Predictors of Bacterial Meningitis in Resource-Limited Contexts: An Angolan Case	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; HAEMOPHILUS-INFLUENZAE; CLINICAL PRESENTATION; CHILDREN; CHILDHOOD; DIAGNOSIS; AFRICA; BURDEN	Background: Despite the great morbidity and mortality that childhood bacterial meningitis (BM) is experiencing in Africa, diagnosis of BM in resource-limited contexts is still a challenge. Several algorithms and clinical predictors have been proposed to help physicians in decision-making but a lot of these markers used variables that are calculable only in well-equipped laboratories. Predictors or algorithm based on parameters that can be easily performed in basic laboratories can help significantly in BM diagnosis, even in resource-limited settings, rural hospitals or health centers. Results: This retrospective study examined 145 cerebral-spinal fluid (CSF) specimens from children from 2 months to 14 years. CSF specimens were divided into two groups, according to the presence or not of a clinical diagnosis of BM. For each specimen, CSF aspect, CSF white blood cells (WBC) count, CSF glucose and protein concentration were analyzed and statistical analysis were performed. CSF WBC count >= 10/mu l is no more a valuable predictor of BM. CSF protein concentration >= 50 mg/dl has a better sensitivity for BM diagnosis and when used with CSF glucose concentration <= 40 mg/dl, can help to diagnose correctly almost all the BM cases. An algorithm including CSF protein concentration, glucose concentration and WBC count has been proposed to rule out BM and to correctly diagnose it. Conclusions: In resource-limited health centers, the availability of a combination of easy-to-obtain parameters can significantly help physicians in BM diagnosis. The prompt identification of a BM case can be rapid treated or transferred to adequate structures and can modify the outcome in the patient.	[Lussiana, Cristina; Pulido Tarquino, Ivan Alejandro] Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola		Lussiana, C (corresponding author), Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola.	cristinaelle@hotmail.it	Pulido Tarquino, Ivan Alejandro/GPS-7553-2022	Pulido Tarquino, Ivan Alejandro/0000-0002-1448-8268				Armitage P., 2001, STAT METHODS MED RES; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Bernardino L, 2003, LANCET, V361, P1564, DOI 10.1016/S0140-6736(03)13204-7; Bogaerts J, 1999, J INFECTION, V39, P32, DOI 10.1016/S0163-4453(99)90099-3; BURG F, 1996, CURRENT PEDIATR THER; Chavanet P, 2007, J INFECTION, V54, P328, DOI 10.1016/j.jinf.2006.06.009; Daoud AS, 1995, J TROP PEDIATRICS, V41, P308, DOI 10.1093/tropej/41.5.308; DONALD PR, 1983, J PEDIATR-US, V103, P413, DOI 10.1016/S0022-3476(83)80416-8; Forbes B. E., 2002, BAILEY SCOTTS DIAGNO; Freedman SB, 2001, ARCH PEDIAT ADOL MED, V155, P1301, DOI 10.1001/archpedi.155.12.1301; KACICA MA, 1994, PEDIATR ANN, V23, P69, DOI 10.3928/0090-4481-19940201-06; Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x; MURRAY CJ, 1996, GLOBAL HLTH STAT, V285; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; Pelkonen T, 2008, SCAND J INFECT DIS, V40, P859, DOI 10.1080/00365540802262091; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saez-Llorens X, 1990, Infect Dis Clin North Am, V4, P623; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; WALLACH J, 2000, INTERPRETATION DIAGN; WRIGHT JP, 1995, TROP DOCT, V25, P5, DOI 10.1177/004947559502500102	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25706	10.1371/journal.pone.0025706	http://dx.doi.org/10.1371/journal.pone.0025706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991337	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300018
J	Mech, LD; Cluff, HD				Mech, L. David; Cluff, H. Dean			Movements of Wolves at the Northern Extreme of the Species' Range, Including during Four Months of Darkness	PLOS ONE			English	Article							WOLF	Information about wolf (Canis lupus) movements anywhere near the northern extreme of the species' range in the High Arctic (>75 degrees N latitude) are lacking. There, wolves prey primarily on muskoxen (Ovibos moschatus) and must survive 4 months of 24 hr/day winter darkness and temperatures reaching -53 C. The extent to which wolves remain active and prey on muskoxen during the dark period are unknown, for the closest area where information is available about winter wolf movements is >2,250 km south. We studied a pack of >= 20 wolves on Ellesmere Island, Nunavut, Canada (80 degrees N latitude) from July 2009 through mid-April 2010 by collaring a lead wolf with a Global Positioning System (GPS)/Argos radio collar. The collar recorded the wolf's precise locations at 6:00 a.m. and 6:00 p.m. daily and transmitted the locations by satellite to our email. Straight-line distances between consecutive 12-hr locations varied between 0 and 76 km. Mean (SE) linear distance between consecutive locations (n = 554) was 11 (0.5) km. Total minimum distance traveled was 5,979 km, and total area covered was 6,640 km(2), the largest wolf range reported. The wolf and presumably his pack once made a 263-km (straight-line distance) foray to the southeast during 19-28 January 2010, returning 29 January to 1 February at an average of 41 km/day straight-line distances between 12-hr locations. This study produced the first detailed movement information about any large mammal in the High Arctic, and the average movements during the dark period did not differ from those afterwards. Wolf movements during the dark period in the highest latitudes match those of the other seasons and generally those of wolves in lower latitudes, and, at least with the gross movements measurable by our methods, the 4-month period without direct sunlight produced little change in movements.	[Mech, L. David] US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA; [Cluff, H. Dean] Govt NW Terr, Dept Environm & Nat Resources, Yellowknife, NT, Canada	United States Department of the Interior; United States Geological Survey	Mech, LD (corresponding author), Univ Minnesota, Raptor Ctr, St Paul, MN 55108 USA.	mechx002@umn.edu	Cluff, Howard D/B-3808-2009		U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	This work was supported by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOLDER BOB L., 1959, JOUR WILDLIFE MANAGEMENT, V23, P1, DOI 10.2307/3797740; Fuller T.K, 2003, WOLVES BEHAV ECOLOGY; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Goldman EA., 1944, WOLVES N AM 1; GRACE E S, 1976, Canadian Field-Naturalist, V90, P149; Gray DR, 1987, MUSKOXEN POLAR BEAR; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Lau MK, 2011, DTK DUNNETT TUKEY KR; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mech L. David, 2003, P1; Mech LD, 2005, ARCTIC, V58, P305; Mech LD, 2000, ARCTIC, V53, P69; MECH LD, 1993, J MAMMAL, V74, P485, DOI 10.2307/1382407; MECH LD, 1990, CAN FIELD NAT, V104, P484; Mech LD, 1995, ARCTIC, V48, P329; Mech LD, 1988, ARCTOC WOLF LIVING P; Mech LD, 2010, CAN FIELD NAT, V124; Musiani M, 1998, ACTA THERIOL, V43, P409, DOI 10.4098/AT.arch.98-51; Parmelee D.F, 1964, BEAVER, P4; PULLIAINEN ERKKI, 1965, ANN ZOOL FENNICI, V2, P215; R Development Core Team, 2010, R LANG ENV STAT COMP; Tener JS, 1954, WILDL MANAGE B 1, V1; Turchin Peter, 1998; Walton LR, 2001, J MAMMAL, V82, P867, DOI 10.1644/1545-1542(2001)082<0867:MPOBGW>2.0.CO;2	25	15	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25328	10.1371/journal.pone.0025328	http://dx.doi.org/10.1371/journal.pone.0025328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991308	Green Published, gold			2022-12-25	WOS:000295963300010
J	Pfister, CA; McCoy, SJ; Wootton, JT; Martin, PA; Colman, AS; Archer, D				Pfister, Catherine A.; McCoy, Sophie J.; Wootton, J. Timothy; Martin, Pamela A.; Colman, Albert S.; Archer, David			Rapid Environmental Change over the Past Decade Revealed by Isotopic Analysis of the California Mussel in the Northeast Pacific	PLOS ONE			English	Article							METABOLIC CARBON CONTRIBUTION; OCEAN ACIDIFICATION; CO2; COASTAL; C-13; PH; TEMPERATURE; PATTERNS; IMPACTS; RECORD	The anthropogenic input of fossil fuel carbon into the atmosphere results in increased carbon dioxide (CO2) into the oceans, a process that lowers seawater pH, decreases alkalinity and can inhibit the production of shell material. Corrosive water has recently been documented in the northeast Pacific, along with a rapid decline in seawater pH over the past decade. A lack of instrumentation prior to the 1990s means that we have no indication whether these carbon cycle changes have precedence or are a response to recent anthropogenic CO2 inputs. We analyzed stable carbon and oxygen isotopes (delta C-13, delta O-18) of decade-old California mussel shells (Mytilus californianus) in the context of an instrumental seawater record of the same length. We further compared modern shells to shells from 1000 to 1340 years BP and from the 1960s to the present and show declines in the delta C-13 of modern shells that have no historical precedent. Our finding of decline in another shelled mollusk (limpet) and our extensive environmental data show that these delta C-13 declines are unexplained by changes to the coastal food web, upwelling regime, or local circulation. Our observed decline in shell delta C-13 parallels other signs of rapid changes to the nearshore carbon cycle in the Pacific, including a decline in pH that is an order of magnitude greater than predicted by an equilibrium response to rising atmospheric CO2, the presence of low pH water throughout the region, and a record of a similarly steep decline in delta C-13 in algae in the Gulf of Alaska. These unprecedented changes and the lack of a clear causal variable underscores the need for better quantifying carbon dynamics in nearshore environments.	[Pfister, Catherine A.; McCoy, Sophie J.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Martin, Pamela A.; Colman, Albert S.; Archer, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Pfister, CA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	cpfister@uchicago.edu	Martin, Pamela A/C-3678-2012; McCoy, Sophie/H-9877-2019; Wootton, J. Timothy/F-3191-2015; Archer, David/K-7371-2012	McCoy, Sophie/0000-0003-1324-1578; Wootton, J. Timothy/0000-0002-7715-0344; Archer, David/0000-0002-4523-7912	SeaDoc Foundation; Department of Defense (DoD) NDSEG; National Science Foundation (NSF); Direct For Biological Sciences [0919420] Funding Source: National Science Foundation; Directorate For Geosciences [0928232] Funding Source: National Science Foundation	SeaDoc Foundation; Department of Defense (DoD) NDSEG(United States Department of Defense); National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The SeaDoc Foundation provided funding for this study. SJM was supported by Department of Defense (DoD) NDSEG and National Science Foundation (NSF) GRFP Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CANE MA, 1983, SCIENCE, V222, P1189, DOI 10.1126/science.222.4629.1189; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Coe WR, 1944, BIOL BULL-US, V87, P59, DOI 10.2307/1538129; DODD JR, 1964, J PALEONTOL, V38, P1065; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DRUFFEL ERM, 1986, NATURE, V321, P58, DOI 10.1038/321058a0; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Ford HL, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001677; Gillikin DP, 2007, GEOCHIM COSMOCHIM AC, V71, P2936, DOI 10.1016/j.gca.2007.04.003; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; KILLINGLEY JS, 1979, SCIENCE, V205, P186, DOI 10.1126/science.205.4402.186; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Klein RT, 1996, GEOLOGY, V24, P415, DOI 10.1130/0091-7613(1996)024<0415:BSRSST>2.3.CO;2; Lorrain A, 2004, GEOCHIM COSMOCHIM AC, V68, P3509, DOI 10.1016/j.gca.2004.01.025; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; McMillan AD, 1999, SCI TIME TRANSFORMER; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Ortiz JD, 2000, GLOBAL BIOGEOCHEM CY, V14, P917, DOI 10.1029/1999GB001155; Paine RT, 2004, ECOL LETT, V7, P441, DOI 10.1111/j.1461-0248.2004.00601.x; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; QUAY PD, 1992, SCIENCE, V256, P74, DOI 10.1126/science.256.5053.74; Schell DM, 2001, LIMNOL OCEANOGR, V46, P999; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Ullmann CV, 2010, CHEM GEOL, V277, P160, DOI 10.1016/j.chemgeo.2010.07.019; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	34	19	19	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25766	10.1371/journal.pone.0025766	http://dx.doi.org/10.1371/journal.pone.0025766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991348	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000067
J	Valentin-Acevedo, A; Sinquett, FL; Covey, LR				Valentin-Acevedo, Anibal; Sinquett, Frank L.; Covey, Lori R.			c-Rel Deficiency Increases Caspase-4 Expression and Leads to ER Stress and Necrosis in EBV-Transformed Cells	PLOS ONE			English	Article							NF-KAPPA-B; CHICKEN SPLEEN-CELLS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; LATENT MEMBRANE-PROTEIN-1; LYMPHOCYTE DEVELOPMENT; SURVIVAL PATHWAYS; CYCLE PROGRESSION; INDUCED APOPTOSIS; MARGINAL ZONE	LMP1-mediated activation of nuclear factor of kappaB (NF-kappa B) is critical for the ligand independent proliferation and cell survival of in vitro EBV-transformed lymphoblastoid cell lines (LCLs). Previous experiments revealed that a majority of LMP1-dependent responses are regulated by NF-kappa B. However, the extent that individual NF-kappa B family members are required for these responses, in particular, c-Rel, whose expression is restricted to mature hematopoietic cells, remains unclear. Here we report that low c-Rel expression in LCLs derived from a patient with hyper-IgM syndrome (Pt1), resulted in defects in proliferation and cell survival. In contrast to studies that associated loss of NF-kappa B with increased apoptosis, Pt1 LCLs failed to initiate apoptosis and alternatively underwent autophagy and necrotic cell death. Whereas the proliferation defect appeared linked to a c-Rel-associated decrease in c-myc expression, identified pro-survival and pro-apoptotic targets were expressed at or near control levels consistent with the absence of apoptosis. Ultrastructural examination of Pt1 LCLs revealed a high level of cellular and ER stress that was further supported by gene expression profiling showing the upregulation of several genes involved in stress and inflammation. Apoptosis-independent cell death was accompanied by increased expression of the inflammatory marker, caspase-4. Using gene overexpression and siRNA knockdown we demonstrated that levels of c-Rel directly modulated expression of caspase-4 as well as other ER stress genes. Overall, these findings reveal the importance of c-Rel in maintaining LCL viability and that decreased expression results in ER stress and a default response leading to necrotic cell death.	[Valentin-Acevedo, Anibal; Sinquett, Frank L.; Covey, Lori R.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Valentin-Acevedo, A (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	covey@biology.rutgers.edu			National Institutes of Health [R56AI037081]; New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI037081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L. C. was supported by R56AI037081 from the National Institutes of Health and A. V-A. was supported by a pre-doctoral fellowship from the New Jersey Commission on Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Barth TFE, 2001, GENE CHROMOSOME CANC, V31, P316, DOI 10.1002/gcc.1150; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Bhushan A, 2000, J IMMUNOL, V164, P2871, DOI 10.4049/jimmunol.164.6.2871; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; CHAN MA, 1986, J IMMUNOL, V136, P106; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Darzynkiewicz Z, 2011, METHODS MOL BIOL, V682, P103, DOI 10.1007/978-1-60327-409-8_9; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Feuillard J, 2000, BLOOD, V95, P2068, DOI 10.1182/blood.V95.6.2068.2068; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; HIBI T, 1986, J IMMUNOL, V136, P3211; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Houldsworth J, 1996, BLOOD, V87, P25; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Lu KT, 2005, J LEUKOCYTE BIOL, V78, P620, DOI 10.1189/jlb.0305159; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Oh SH, 2009, J PHARMACOL EXP THER, V329, P112, DOI 10.1124/jpet.108.144113; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Paoluzzi L, 2010, ADV EXP MED BIOL, V687, P79; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Purchase H G, 1975, Curr Top Microbiol Immunol, V71, P103; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; WEIH F, 1994, ONCOGENE, V9, P3289; White E, 2008, AUTOPHAGY, V4, P399, DOI 10.4161/auto.5907; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	58	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25467	10.1371/journal.pone.0025467	http://dx.doi.org/10.1371/journal.pone.0025467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984918	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000031
J	Weis, E; Schoen, H; Victor, A; Spix, C; Ludwig, M; Schneider-Raetzke, B; Kohlschmidt, N; Bartsch, O; Gerhold-Ay, A; Boehm, N; Grus, F; Haaf, T; Galetzka, D				Weis, Eva; Schoen, Holger; Victor, Anja; Spix, Claudia; Ludwig, Marco; Schneider-Raetzke, Brigitte; Kohlschmidt, Nicolai; Bartsch, Oliver; Gerhold-Ay, Aslihan; Boehm, Nils; Grus, Franz; Haaf, Thomas; Galetzka, Danuta			Reduced mRNA and Protein Expression of the Genomic Caretaker RAD9A in Primary Fibroblasts of Individuals with Childhood and Independent Second Cancer	PLOS ONE			English	Article							DNA METHYLATION; MALIGNANT NEOPLASMS; GENES; SUSCEPTIBILITY; CHECKPOINTS; INSTABILITY; STABILITY; DAMAGE	Background: The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer. Methodology/Findings: To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to one-cancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the two-cancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy gamma-irradiated cells of two-cancer patients. Conclusions/Significance: Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.	[Weis, Eva; Schoen, Holger; Ludwig, Marco; Schneider-Raetzke, Brigitte; Kohlschmidt, Nicolai; Bartsch, Oliver; Galetzka, Danuta] Univ Med Ctr, Inst Human Genet, Mainz, Germany; [Victor, Anja; Spix, Claudia; Gerhold-Ay, Aslihan] Univ Med Ctr, Inst Med Biometry Epidemiol & Informat, Mainz, Germany; [Boehm, Nils; Grus, Franz] Univ Med Ctr, Expt Ophthalmol Ocular Prote & Immunol Ctr, Mainz, Germany; [Haaf, Thomas] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Wurzburg	Weis, E (corresponding author), Univ Med Ctr, Inst Human Genet, Mainz, Germany.	thomas.haaf@uni-wuerzburg.de	Galetzka, Danuta/D-2199-2012; Bartsch, Oliver/ABE-2681-2020		Stiftung Rheinland-Pfalz fur Innovation [698]; FAZIT-Stiftung	Stiftung Rheinland-Pfalz fur Innovation; FAZIT-Stiftung	This study was supported by the Stiftung Rheinland-Pfalz fur Innovation (project no. 698) and the FAZIT-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodairy Fahad M, 2004, Asian Pac J Cancer Prev, V5, P139; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Boulton E, 2001, INT J RADIAT BIOL, V77, P21, DOI 10.1080/0955300010001880; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng CK, 2005, CANCER RES, V65, P8646, DOI 10.1158/0008-5472.CAN-04-4243; Chuang EY, 2006, CANCER RES, V66, P3428, DOI 10.1158/0008-5472.CAN-05-2847; Dang TY, 2005, GENES CELLS, V10, P287, DOI 10.1111/j.1365-2443.2005.00840.x; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P1; Infante-Rivard C, 2000, ENVIRON HEALTH PERSP, V108, P495, DOI 10.2307/3454609; Kaatsch P, 2009, CANCER CAUSE CONTROL, V20, P965, DOI 10.1007/s10552-009-9315-1; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kebebew E, 2006, WORLD J SURG, V30, P767, DOI 10.1007/s00268-005-0308-2; Klein G, 2003, EUR J CANCER, V39, P808, DOI 10.1016/S0959-8049(02)00875-4; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; MacDonald D, 2001, INT J RADIAT BIOL, V77, P1023, DOI 10.1080/09553000110073411; Maniwa Y, 2005, CANCER, V103, P1261; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nomura T, 2004, CYTOGENET GENOME RES, V104, P252, DOI 10.1159/000077499; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Plon SE, 2005, CANCER J, V11, P255, DOI 10.1097/00130404-200507000-00002; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Sontag LB, 2006, J THEOR BIOL, V242, P890, DOI 10.1016/j.jtbi.2006.05.012; Strahm B, 2006, INT J CANCER, V119, P2001, DOI 10.1002/ijc.21962; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25750	10.1371/journal.pone.0025750	http://dx.doi.org/10.1371/journal.pone.0025750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991345	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000064
J	Ahmad, F; Mani, J; Kumar, P; Haridas, S; Upadhyay, P; Bhaskar, S				Ahmad, Faiz; Mani, Jiju; Kumar, Pawan; Haridas, Seenu; Upadhyay, Pramod; Bhaskar, Sangeeta			Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BCG IMMUNOTHERAPY; CALMETTE-GUERIN; BLADDER-CANCER; NKT CELLS; CARCINOMA; PATHOGENICITY; TUBERCULOSIS; REJECTION; SURVIVAL	Background: Role of immune system in protecting the host from cancer is well established. Growing cancer however subverts immune response towards Th2 type and escape from antitumor mechanism of the host. Activation of both innate and Th1 type response is crucial for host antitumor activity. In our previous study it was found, that Mycobacterium indicus pranii (MIP) also known as M. w induces Th1 type response and activates macrophages in animal model of tuberculosis. Hence, we studied the immunotherapeutic potential of MIP in mouse tumor model and the underlying mechanisms for its antitumor activity. Methodology and Principal Findings: Tumors were implanted by injecting B16F10 melanoma cells subcutaneously into C57BL/6 mice. Using the optimized dose and treatment regimes, anti-tumor efficacy of heat killed MIP was evaluated. In MIP treated group, tumor appeared in only 50-60% of mice, tumor growth was delayed and tumor volume was less as compared to control. MIP mediated immune activation was analysed in the tumor microenvironment, tumor draining lymph node and spleen. Induction of Th1 response and higher infiltration of immune cells in the tumor microenvironment was observed in MIP treated mice. A large fraction of these immune cells were in activated state as confirmed by phenotypic and functional analysis. Interestingly, percentage of Treg cells in the tumor milieu of treated mice was less. We also evaluated efficacy of MIP along with chemotherapy and found a better response as compared to chemotherapy alone. Conclusion: MIP therapy is effective in protecting mice from tumor. It activates the immune cells, increases their infiltration in tumor, and abrogates tumor mediated immune suppression.	[Ahmad, Faiz; Mani, Jiju; Kumar, Pawan; Haridas, Seenu; Upadhyay, Pramod; Bhaskar, Sangeeta] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Ahmad, F (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	sangeeta@nii.res.in	Kumar, Pawan/GXF-7072-2022	Ahmad, Faiz/0000-0002-0450-042X; Bhaskar, Sangeeta/0000-0001-7902-5267	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR8239/Med/14/1243/2006]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by a research grant (BT/PR8239/Med/14/1243/2006) from the Department of Biotechnology, Ministry of Science and Technology, Government of India (FA, JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Baxevanis CN, 2003, J IMMUNOL, V171, P2953, DOI 10.4049/jimmunol.171.6.2953; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Cheadle EJ, 2005, INFECT IMMUN, V73, P784, DOI 10.1128/IAI.73.2.784-794.2005; CLEVENGER CV, 2001, CURRENT PROTOCOLS IM; Copier J, 2009, EUR J CANCER, V45, P1424, DOI 10.1016/j.ejca.2008.12.017; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dalgleish AG, 2006, CANCER IMMUNOL IMMUN, V55, P1025, DOI 10.1007/s00262-006-0128-8; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Hayashi A, 1998, P JPN ACAD B-PHYS, V74, P50, DOI 10.2183/pjab.74.50; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Johns DG, 1998, AM J PHYSIOL-HEART C, V275, pH1592, DOI 10.1152/ajpheart.1998.275.5.H1592; Katoch K, 2008, VACCINE, V26, P1228, DOI 10.1016/j.vaccine.2007.12.025; LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; LANEELLE G, 1991, RES MICROBIOL, V142, P433, DOI 10.1016/0923-2508(91)90116-R; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; Malmstrom PU, 2000, EUR UROL, V37, P16, DOI 10.1159/000052377; Park SH, 2003, J IMMUNOL, V170, P1197, DOI 10.4049/jimmunol.170.3.1197; Patel Naresh, 2003, J Indian Med Assoc, V101, P682; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; Stanford JL, 2008, EUR J CANCER, V44, P224, DOI 10.1016/j.ejca.2007.08.021; Sur Prabir Kumar, 2003, J Indian Med Assoc, V101, P120; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	32	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25424	10.1371/journal.pone.0025424	http://dx.doi.org/10.1371/journal.pone.0025424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984926	gold, Green Published, Green Submitted			2022-12-25	WOS:000295941300030
J	Hirbod, T; Kaldensjo, T; Broliden, K				Hirbod, Taha; Kaldensjo, Tove; Broliden, Kristina			In Situ Distribution of HIV-Binding CCR5 and C-Type Lectin Receptors in the Human Endocervical Mucosa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORMAL UTERINE CERVIX; FEMALE GENITAL-TRACT; LANGERHANS CELLS; DENDRITIC CELLS; INTRAVAGINAL INOCULATION; NK CELLS; DC-SIGN; INFECTION; EXPRESSION	The endocervical mucosa is believed to be a primary site of HIV transmission. However, to date there is little known about the distribution of the HIV co-receptor CCR5 and the HIV-binding C-type lectin receptors, including Langerin, dendritic cell (DC)-specific intercellular adhesion molecule-grabbing non-integrin (DC-SIGN) and mannose receptor (MR) at this site. We therefore characterized the expression of these molecules in the endocervix of HIV seronegative women by computerized image analysis. Endocervical tissue biopsies were collected from women (n = 6) undergoing hysterectomy. All study individuals were diagnosed with benign and non-inflammatory diseases. CCR5+ CD4+ CD3+ T cells were found within or adjacent to the endocervical epithelium. The C-type lectin Langerin was expressed by intraepithelial CD1a+ CD4+ and CD11c+ CD4+ Langerhans cells, whereas DC-SIGN+ MR+ CD11c myeloid dendritic cells and MR+ CD68+ macrophages were localized in the submucosa of the endocervix. The previously defined immune effector cells including CD8+, CD56+, CD19+ and IgD+ cells were also found in the submucosa as well as occasional CD123+ BDCA-2+ plasmacytoid dendritic cells. Understanding the spatial distribution of potential HIV target cells and immune effector cells in relation to the endocervical canal forms a basis for deciphering the routes of HIV transmission events in humans as well as designing HIV-inhibiting compounds.	[Hirbod, Taha; Kaldensjo, Tove; Broliden, Kristina] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Div Infect Dis,Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Hirbod, T (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Div Infect Dis,Dept Med, Stockholm, Sweden.	tove.kaldensjo@ki.se			Vetenskapsradet; SIDA; Stiftelsen Lakare mot AIDS	Vetenskapsradet(Swedish Research Council); SIDA; Stiftelsen Lakare mot AIDS	This study was supported by grants from Vetenskapsradet, SIDA and Stiftelsen Lakare mot AIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel CE, 2007, INT IMMUNOL, V19, P1271, DOI 10.1093/intimm/dxm096; Bouhlal H, 2007, J IMMUNOL, V178, P1086, DOI 10.4049/jimmunol.178.2.1086; CROWLEYNOWICK PA, 1995, AM J REPROD IMMUNOL, V34, P241, DOI 10.1111/j.1600-0897.1995.tb00948.x; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Donaghy H, 2009, J VIROL, V83, P1952, DOI 10.1128/JVI.01578-08; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Harada H, 2007, EUR J IMMUNOL, V37, P2148, DOI 10.1002/eji.200737217; Hirbod T, 2006, JAIDS-J ACQ IMM DEF, V43, P137, DOI 10.1097/01.qai.0000229016.85192.60; Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jacobson DL, 2000, SEX TRANSM DIS, V27, P252, DOI 10.1097/00007435-200005000-00003; Kaldensjo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021344; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; KUTTEH WH, 1994, AM J REPROD IMMUNOL, V31, P40, DOI 10.1111/j.1600-0897.1994.tb00845.x; LARKIN M, 1989, AIDS, V3, P793, DOI 10.1097/00002030-198912000-00003; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lore K., 2004, METH MOL B, V249, P201; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; MILLER CJ, 1992, LAB INVEST, V67, P628; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Mselle TF, 2007, CLIN IMMUNOL, V124, P69, DOI 10.1016/j.clim.2007.04.008; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Poonia B, 2006, J REPROD IMMUNOL, V72, P74, DOI 10.1016/j.jri.2006.02.004; Poppe WAJ, 1998, EUR J OBSTET GYN R B, V81, P277, DOI 10.1016/S0301-2115(98)00202-4; Prakash M, 2004, BJOG-INT J OBSTET GY, V111, P1468, DOI 10.1111/j.1471-0528.2004.00283.x; Prakash M, 2004, J INFECT DIS, V190, P246, DOI 10.1086/422034; Prakash M, 2001, J REPROD IMMUNOL, V52, P101, DOI 10.1016/S0165-0378(01)00114-0; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Quayle AJ, 2007, JAIDS-J ACQ IMM DEF, V44, P292, DOI 10.1097/QAI.0b013e31802c5b3a; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Zhang LB, 1998, J SOC GYNECOL INVEST, V5, P72, DOI 10.1016/S1071-5576(97)00107-X; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	45	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25551	10.1371/journal.pone.0025551	http://dx.doi.org/10.1371/journal.pone.0025551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984929	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300039
J	Russ, HA; Sintov, E; Anker-Kitai, L; Friedman, O; Lenz, A; Toren, G; Farhy, C; Pasmanik-Chor, M; Oron-Karni, V; Ravassard, P; Efrat, S				Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Friedman, Orr; Lenz, Ayelet; Toren, Ginat; Farhy, Chen; Pasmanik-Chor, Metsada; Oron-Karni, Varda; Ravassard, Philippe; Efrat, Shimon			Insulin-Producing Cells Generated from Dedifferentiated Human Pancreatic Beta Cells Expanded In Vitro	PLOS ONE			English	Article							STEM-CELLS; MESENCHYMAL TRANSITION; PRECURSOR CELLS; PROLIFERATION; DIFFERENTIATION; EXPANSION; GROWTH; RATS; MASS; REDIFFERENTIATION	Background: Expansion of beta cells from the limited number of adult human islet donors is an attractive prospect for increasing cell availability for cell therapy of diabetes. However, attempts at expanding human islet cells in tissue culture result in loss of beta-cell phenotype. Using a lineage-tracing approach we provided evidence for massive proliferation of beta-cell-derived (BCD) cells within these cultures. Expansion involves dedifferentiation resembling epithelial-mesenchymal transition (EMT). Epigenetic analyses indicate that key beta-cell genes maintain open chromatin structure in expanded BCD cells, although they are not transcribed. Here we investigated whether BCD cells can be redifferentiated into beta-like cells. Methodology/Principal Finding: Redifferentiation conditions were screened by following activation of an insulin-DsRed2 reporter gene. Redifferentiated cells were characterized for gene expression, insulin content and secretion assays, and presence of secretory vesicles by electron microscopy. BCD cells were induced to redifferentiate by a combination of soluble factors. The redifferentiated cells expressed beta-cell genes, stored insulin in typical secretory vesicles, and released it in response to glucose. The redifferentiation process involved mesenchymal-epithelial transition, as judged by changes in gene expression. Moreover, inhibition of the EMT effector SLUG (SNAI2) using shRNA resulted in stimulation of redifferentiation. Lineage-traced cells also gave rise at a low rate to cells expressing other islet hormones, suggesting transition of BCD cells through an islet progenitor-like stage during redifferentiation. Conclusions/Significance: These findings demonstrate for the first time that expanded dedifferentiated beta cells can be induced to redifferentiate in culture. The findings suggest that ex-vivo expansion of adult human islet cells is a promising approach for generation of insulin-producing cells for transplantation, as well as basic research, toxicology studies, and drug screening.	[Russ, Holger A.; Sintov, Elad; Anker-Kitai, Leeat; Friedman, Orr; Lenz, Ayelet; Toren, Ginat; Farhy, Chen; Efrat, Shimon] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Pasmanik-Chor, Metsada; Oron-Karni, Varda] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; [Ravassard, Philippe] Hop La Pitie Salpetriere, Dept Biotechnol & Biotherapy, Paris, France	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Russ, HA (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X; ravassard, philippe/0000-0002-0393-9262	Juvenile Diabetes Research Foundation [31-2008-413]; Israel Science Foundation; Integrated Islet Distribution Program	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Integrated Islet Distribution Program	This work was funded by grants from the Juvenile Diabetes Research Foundation and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human islets were provided through the JDRF award 31-2008-413 (ECIT Islets for Basic Research Program) and the Integrated Islet Distribution Program. We thank Yael Bar, Tel Aviv University, for helpful discussions, Sarah Knoller, Tel Aviv University, for technical assistance, Palle Serup, Hagedorn Research Institute, for NKX6.1 antibody, Julie Kerr-Conte, University Lille-Nord de France, for human pancreas sections, Alberto Hayek, UC San Diego, and John Hutton, University of Colorado Health Sciences Center, for fetal pancreas sections, Ran Elkon, Tel Aviv University, for assistance with statistical analysis, and Yuval Dor, Hebrew University, for comments on the manuscript. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of HAR.	Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; ROBERTSON RP, 1994, DIABETES, V43, P1085, DOI 10.2337/diabetes.43.9.1085; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311	26	60	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25566	10.1371/journal.pone.0025566	http://dx.doi.org/10.1371/journal.pone.0025566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984932	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300042
J	Bottari, D; Caclin, A; Giard, MH; Pavani, F				Bottari, Davide; Caclin, Anne; Giard, Marie-Helene; Pavani, Francesco			Changes in Early Cortical Visual Processing Predict Enhanced Reactivity in Deaf Individuals	PLOS ONE			English	Article							CONGENITALLY DEAF; AUDITORY DEPRIVATION; EXOGENOUS ATTENTION; SIGN-LANGUAGE; HEARING; DISSOCIATION; POTENTIALS; COMPONENTS; STIMULI; MOTION	Individuals with profound deafness rely critically on vision to interact with their environment. Improvement of visual performance as a consequence of auditory deprivation is assumed to result from cross-model changes occurring in late stages of visual processing. Here we measured reaction times and event-related potentials (ERPs) in profoundly deaf adults and hearing controls during a speeded visual detection task, to assess to what extent the enhanced reactivity of deaf indivisuals could reflect plastic changes in the early cortical processing of the stimulus. We found that deaf subjects were faster than hearing controls at detecting the visual targets, regardless of their location in the visual field (peripheral or perifoveal). The behavioural facilitation was associated with ERP changes starting from the first detectable response in the striate cortex (C1 component) at about 80 ms after stimulus onset, in the P1 complex (100-150 ms). In addition, we found that P1 peak amplitudes predicted the response times in deaf subjects, whereas in hearing individuals visual reactivity and ERP amplitudes predicted the response times in deaf subjects, whereas in hearing individuals visual reactivity and ERP amplitudes correlated only at later stages of processing. These findings show that long-term auditory deprivation can profoundly alter visual processing from the earliest cortical stages. Furthermore, our results provide the first evidence of a co-variation between modified brain activity (cortical plasticity) and behavioural enhancement in this sensory deprived population.	[Bottari, Davide; Pavani, Francesco] Univ Trento, Dept Cognit Sci & Educ, Trento, Italy; [Bottari, Davide; Pavani, Francesco] Univ Trento, Ctr Mind Brain Sci, Trento, Italy; [Caclin, Anne; Giard, Marie-Helene] INSERM, U1028, F-69008 Lyon, France; [Caclin, Anne; Giard, Marie-Helene] CNRS, UMR5292, Lyon, France; [Caclin, Anne; Giard, Marie-Helene] Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Caclin, Anne; Giard, Marie-Helene] Univ Lyon 1, F-69365 Lyon, France	University of Trento; University of Trento; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bottari, D (corresponding author), Univ Trento, Dept Cognit Sci & Educ, Trento, Italy.	davidebottari@gmail.com	Pavani, Francesco/B-4836-2010; Giard, Marie-Helene/AAH-1048-2019; Bottari, Davide/H-1694-2018; Caclin, Anne/K-1682-2017	Pavani, Francesco/0000-0003-0426-5578; Bottari, Davide/0000-0001-6843-1569; Caclin, Anne/0000-0003-1367-5923	MIUR (Italy) [Prot. 2006118540_004]; Italian University; French University; University of Trento (Italy)	MIUR (Italy)(Ministry of Education, Universities and Research (MIUR)); Italian University; French University; University of Trento (Italy)	This work was supported by a PRIN 2006 grant (Prot. 2006118540_004) from MIUR (Italy), a Galileo grant from Italian and French Universities, and a PAT-CRS grant from University of Trento (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Armstrong BA, 2002, COGNITIVE BRAIN RES, V14, P422, DOI 10.1016/S0926-6410(02)00211-2; Bavelier D, 2000, PERCEPT PSYCHOPHYS, V62, P100, DOI 10.3758/BF03212064; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bottari D, 2010, RESTOR NEUROL NEUROS, V28, P167, DOI 10.3233/RNN-2010-0502; Chica AB, 2009, BRAIN RES, V1278, P75, DOI 10.1016/j.brainres.2009.04.011; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Colmenero JM, 2004, EUR J COGN PSYCHOL, V16, P791, DOI 10.1080/09541440340000312; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Foxe JJ, 2008, BRAIN TOPOGR, V21, P11, DOI 10.1007/s10548-008-0063-4; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Hunt DL, 2005, ANAT REC PART A, V287A, P1051, DOI 10.1002/ar.a.20251; Karns CM, 2009, J COGNITIVE NEUROSCI, V21, P669, DOI 10.1162/jocn.2009.21037; Kim DJ, 2009, NEUROREPORT, V20, P1032, DOI 10.1097/WNR.0b013e32832e0cdd; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Mennes M, 2010, PSYCHOPHYSIOLOGY, V47, P1142, DOI 10.1111/j.1469-8986.2010.01015.x; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pavani F., FRONTIERS N IN PRESS; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Proverbio AM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-59; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; REYNOLDS HN, 1993, AM J PSYCHOL, V106, P523, DOI 10.2307/1422967; SAARINEN J, 1989, INVEST OPHTH VIS SCI, V30, P293; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Talsma D, 2007, BRAIN RES, V1178, P92, DOI 10.1016/j.brainres.2007.07.099; Trillenberg P, 2000, CLIN NEUROPHYSIOL, V111, P1216, DOI 10.1016/S1388-2457(00)00274-1	38	56	57	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25607	10.1371/journal.pone.0025607	http://dx.doi.org/10.1371/journal.pone.0025607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834DM	21980501	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600039
J	Castilla-Ortega, E; Hoyo-Becerra, C; Pedraza, C; Chun, J; De Fonseca, FR; Estivill-Torrus, G; Santin, LJ				Castilla-Ortega, Estela; Hoyo-Becerra, Carolina; Pedraza, Carmen; Chun, Jerold; Rodriguez De Fonseca, Fernando; Estivill-Torrus, Guillermo; Santin, Luis J.			Aggravation of Chronic Stress Effects on Hippocampal Neurogenesis and Spatial Memory in LPA(1) Receptor Knockout Mice	PLOS ONE			English	Article							PRECURSOR CELL-PROLIFERATION; ANXIETY-RELATED BEHAVIORS; ADULT DENTATE GYRUS; LYSOPHOSPHATIDIC ACID; GRANULE CELLS; LYSOPHOSPHOLIPID RECEPTORS; NEURONAL DIFFERENTIATION; PREFRONTAL CORTEX; CHRONIC RESTRAINT; PROGENITOR CELLS	Background: The lysophosphatidic acid LPA(1), receptor regulates plasticity and neurogenesis in the adult hippocampus. Here, we studied whether absence of the LPA(1) receptor modulated the detrimental effects of chronic stress on hippocampal neurogenesis and spatial memory. Methodology/Principal Findings:Male LPA(1)-null (NULL) and wild-type (WT) mice were assigned to control or chronic stress conditions (21 days of restraint, 3 h/day). Immunohistochemistry for bromodeoxyuridine and endogenous markers was performed to examine hippocampal cell proliferation, survival, number and maturation of young neurons, hippocampal structure and apoptosis in the hippocampus. Corticosterone levels were measured in another a separate cohort of mice. Finally, the hole-board test assessed spatial reference and working memory. Under control conditions, NULL mice showed reduced cell proliferation, a defective population of young neurons, reduced hippocampal volume and moderate spatial memory deficits. However, the primary result is that chronic stress impaired hippocampal neurogenesis in NULLs more severely than in WT mice in terms of cell proliferation; apoptosis; the number and maturation of young neurons; and both the volume and neuronal density in the granular zone. Only stressed NULLs presented hypocortisolemia. Moreover, a dramatic deficit in spatial reference memory consolidation was observed in chronically stressed NULL mice, which was in contrast to the minor effect observed in stressed WT mice. Conclusions/Significance:These results reveal that the absence of the LPA(1), receptor aggravates the chronic stress-induced impairment to hippocampal neurogenesis and its dependent functions. Thus, modulation of the LPA(1) receptor pathway may be of interest with respect to the treatment of stress-induced hippocampal pathology.	[Castilla-Ortega, Estela; Pedraza, Carmen; Santin, Luis J.] Univ Malaga, Dept Psicobiol & Metodol CC, E-29071 Malaga, Spain; [Hoyo-Becerra, Carolina; Rodriguez De Fonseca, Fernando; Estivill-Torrus, Guillermo] Hosp Reg Univ Carlos Haya, Fdn IMABIS, Unidad Invest, Malaga, Spain; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Universidad de Malaga; FIMABIS; Hospital Carlos Haya; Scripps Research Institute	Castilla-Ortega, E (corresponding author), Univ Malaga, Dept Psicobiol & Metodol CC, Campus Teatinos, E-29071 Malaga, Spain.	luis@uma.es	Benitez, Carmen Pedraza/K-2328-2017; Torrús, Guillermo Estivill/L-5157-2015; Chun, Jerold/Y-4670-2019; Santin, Luis Javier LJ/G-4364-2011; Castilla-Ortega, Estela/K-2811-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Santin, Luis Javier/G-4364-2011	Benitez, Carmen Pedraza/0000-0002-0011-2817; Torrús, Guillermo Estivill/0000-0002-7124-2678; Santin, Luis Javier LJ/0000-0003-0894-8536; Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier/0000-0003-1755-6497	Spanish Ministry of Education and Science [MEC SEJ2007-61187]; Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System; Human Frontier Science Programme; Carlos III Health Institute [FIS 02/1643, FIS PI07/0629]; Red de Trastornos Adictivos RTA [RD06/001]; Fund for Health Research; Andalusian Ministry of Health and of Innovation, Science and Enterprise [CTS065, CTS433]; National Institutes of Health (USA) [MH051699, MH01723]; Spanish Ministry of Education [AP-2006-02582]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723, R01MH051699, R29MH051699] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System; Human Frontier Science Programme(Human Frontier Science Program); Carlos III Health Institute(Instituto de Salud Carlos III); Red de Trastornos Adictivos RTA; Fund for Health Research; Andalusian Ministry of Health and of Innovation, Science and Enterprise; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Spanish Ministry of Education and Science (MEC SEJ2007-61187; to US), Programme for Stabilization of Researchers and Research Technician and Intensification of Research Activity in the National Health System (I3SNS Programme; to GET), the Human Frontier Science Programme (to JC, FRDF), Fund for Health Research, Carlos III Health Institute (FIS 02/1643, FIS PI07/0629; to GET), Red de Trastornos Adictivos RTA (RD06/001; to FRDF), Andalusian Ministry of Health and of Innovation, Science and Enterprise (CTS065, to GET, and CTS433 to FRDF) and the National Institutes of Health (USA) MH051699 and MH01723 (to JC). The author E. Castilla-Ortega has a FPU Grant from the Spanish Ministry of Education (AP-2006-02582). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; ARMARIO A, 1990, PSYCHONEUROENDOCRINO, V15, P341, DOI 10.1016/0306-4530(90)90059-I; Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Bland ST, 2006, NEUROREPORT, V17, P593, DOI 10.1097/00001756-200604240-00008; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Castilla-Ortega E, 2011, REV NEUROSCIENCE, V22, P267, DOI 10.1515/RNS.2011.027; Castilla-Ortega E, 2010, NEUROBIOL LEARN MEM, V94, P73, DOI 10.1016/j.nlm.2010.04.003; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2005, PROSTAG OTH LIPID M, V77, P46, DOI 10.1016/j.prostaglandins.2004.09.009; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Douma BRK, 1998, PSYCHONEUROENDOCRINO, V23, P33, DOI 10.1016/S0306-4530(97)00091-7; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Dwivedi Y, 2005, NEUROPSYCHOPHARMACOL, V30, P473, DOI 10.1038/sj.npp.1300605; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hayashi F, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-22; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ito H, 2010, NEUROPHARMACOLOGY, V58, P746, DOI 10.1016/j.neuropharm.2009.12.011; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; KORBO L, 1990, J NEUROSCI METH, V31, P93, DOI 10.1016/0165-0270(90)90153-7; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Musazzi L, 2010, INT J NEUROPSYCHOPH, P1; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pilpel Y, 2006, J NEUROCHEM, V97, P1379, DOI 10.1111/j.1471-4159.2006.03825.x; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rhee HJ, 2006, NEUROREPORT, V17, P523; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Roberts C, 2005, NEUROCHEM RES, V30, P371, DOI 10.1007/s11064-005-2611-6; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Schloesser RJ, 2009, NEUROREPORT, V20, P553, DOI 10.1097/WNR.0b013e3283293e59; Schoenfeld T.J., 2011, EXP NEUROL IN PRESS; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Strekalova T, 2005, BEHAV PHARMACOL, V16, P171, DOI 10.1097/00008877-200505000-00006; Swinny JD, 2006, EUR J NEUROSCI, V24, P2481, DOI 10.1111/j.1460-9568.2006.05129.x; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; van der Beek EM, 2004, HIPPOCAMPUS, V14, P688, DOI 10.1002/hipo.10213; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x	104	60	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25522	10.1371/journal.pone.0025522	http://dx.doi.org/10.1371/journal.pone.0025522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980482	gold, Green Published			2022-12-25	WOS:000295939600033
J	Chamberlain, G; Smith, H; Rainger, GE; Middleton, J				Chamberlain, Giselle; Smith, Helen; Rainger, G. Ed; Middleton, Jim			Mesenchymal Stem Cells Exhibit Firm Adhesion, Crawling, Spreading and Transmigration across Aortic Endothelial Cells: Effects of Chemokines and Shear	PLOS ONE			English	Article							HUMAN BONE-MARROW; INFARCTED MYOCARDIUM; T-CELLS; MIGRATION; RECEPTORS; EXPRESS; TRAFFICKING; MECHANISMS; CAPACITY; BEHAVIOR	Mesenchymal stem cells (MSCs) have anti-inflammatory and immunosuppressive properties and may be useful in the therapy of diseases such as arteriosclerosis. MSCs have some ability to traffic into inflamed tissues, however to exploit this therapeutically their migratory mechanisms need to be elucidated. This study examines the interaction of murine MSCs (mMSCs) with, and their migration across, murine aortic endothelial cells (MAECs), and the effects of chemokines and shear stress. The interaction of mMSCs with MAECs was examined under physiological flow conditions. mMSCs showed lack of interaction with MAECs under continuous flow. However, when the flow was stopped (for 10min) and then started, mMSCs adhered and crawled on the endothelial surface, extending fine microvillous processes (filopodia). They then spread extending pseudopodia in multiple directions. CXCL9 significantly enhanced the percentage of mMSCs adhering, crawling and spreading and shear forces markedly stimulated crawling and spreading. CXCL9, CXCL16, CCL20 and CCL25 significantly enhanced transendothelial migration across MAECs. The transmigrated mMSCs had down-regulated receptors CXCR3, CXCR6, CCR6 and CCR9. This study furthers the knowledge of MSC transendothelial migration and the effects of chemokines and shear stress which is of relevance to inflammatory diseases such as arteriosclerosis.	[Chamberlain, Giselle; Smith, Helen; Middleton, Jim] Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Rainger, G. Ed] Univ Birmingham, Coll Med & Dent, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Middleton, Jim] Univ Bristol, Fac Med & Dent, Sch Oral & Dent Sci, Bristol, Avon, England	Keele University; University of Birmingham; University of Bristol	Chamberlain, G (corresponding author), Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England.	Jim.Middleton@bristol.ac.uk			Biotechnology and Biological Sciences Research Council (UK); Keele University; BBSRC [BB/D014905/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014905/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Keele University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Biotechnology and Biological Sciences Research Council (UK) and Keele University funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bajada S, 2007, J BONE JOINT SURG BR, V89B, P1382, DOI 10.1302/0301-620X.89B10.19103; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Dewitt S, 2007, J LEUKOCYTE BIOL, V81, P1160, DOI 10.1189/jlb.1106710; GOETZ DJ, 1994, BIOPHYS J, V66, P2202, DOI 10.1016/S0006-3495(94)81016-1; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Koenen RR, 2010, NAT REV DRUG DISCOV, V9, P141, DOI 10.1038/nrd3048; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luu NT, 1999, J VASC RES, V36, P477, DOI 10.1159/000025690; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nishiyama T, 2007, J VASC RES, V44, P138, DOI 10.1159/000098520; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Semont A, 2006, ADV EXP MED BIOL, V585, P19; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Xu YL, 2010, INT J CARDIOL, V138, P182, DOI 10.1016/j.ijcard.2009.03.071; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	80	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25663	10.1371/journal.pone.0025663	http://dx.doi.org/10.1371/journal.pone.0025663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980522	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900088
J	Charmandari, E; Chrousos, GP; Lambrou, GI; Pavlaki, A; Koide, H; Sinnie, SMN; Kino, T				Charmandari, Evangelia; Chrousos, George P.; Lambrou, George I.; Pavlaki, Aikaterini; Koide, Hisashi; Sinnie Sin Man Ng; Kino, Tomoshige			Peripheral CLOCK Regulates Target-Tissue Glucocorticoid Receptor Transcriptional Activity in a Circadian Fashion in Man	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATION; MONONUCLEAR; RHYTHMS; STRESS; SYSTEM; CELLS	Context and Objective: Circulating cortisol fluctuates diurnally under the control of the "master'' circadian CLOCK, while the peripheral "slave'' counterpart of the latter regulates the transcriptional activity of the glucocorticoid receptor (GR) at local glucocorticoid target tissues through acetylation. In this manuscript, we studied the effect of CLOCK-mediated GR acetylation on the sensitivity of peripheral tissues to glucocorticoids in humans. Design and Participants: We examined GR acetylation and mRNA expression of GR, CLOCK-related and glucocorticoid-responsive genes in peripheral blood mononuclear cells (PBMCs) obtained at 8 am and 8 pm from 10 healthy subjects, as well as in PBMCs obtained in the morning and cultured for 24 hours with exposure to 3-hour hydrocortisone pulses every 6 hours. We used EBV-transformed lymphocytes (EBVLs) as non-synchronized controls. Results: GR acetylation was higher in the morning than in the evening in PBMCs, mirroring the fluctuations of circulating cortisol in reverse phase. All known glucocorticoid-responsive genes tested responded as expected to hydrocortisone in non-synchronized EBVLs, however, some of these genes did not show the expected diurnal mRNA fluctuations in PBMCs in vivo. Instead, their mRNA oscillated in a Clock-and a GR acetylation-dependent fashion in naturally synchronized PBMCs cultured ex vivo in the absence of the endogenous glucocorticoid, suggesting that circulating cortisol might prevent circadian GR acetylation-dependent effects in some glucocorticoid-responsive genes in vivo. Conclusions: Peripheral CLOCK-mediated circadian acetylation of the human GR may function as a target-tissue, gene-specific counter regulatory mechanism to the actions of diurnally fluctuating cortisol, effectively decreasing tissue sensitivity to glucocorticoids in the morning and increasing it at night.	[Charmandari, Evangelia; Chrousos, George P.; Lambrou, George I.; Pavlaki, Aikaterini] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Pediat 1, GR-11527 Athens, Greece; [Charmandari, Evangelia; Chrousos, George P.] Acad Athens, Div Endocrinol & Metab, Biomed Res Fdn, Athens, Greece; [Koide, Hisashi] Eunice Kennedy Shriver Inst Child Hlth & Human De, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sinnie Sin Man Ng; Kino, Tomoshige] Eunice Kennedy Shriver Inst Child Hlth & Human De, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sinnie Sin Man Ng] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Academy of Athens; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong	Charmandari, E (corresponding author), Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Dept Pediat 1, GR-11527 Athens, Greece.	kinot@mail.nih.gov	Charmandari, Evangelia/B-6701-2011; Charmandari, Evangelia/AAF-2038-2019; Lambrou, George/F-9674-2011	Lambrou, George/0000-0001-8389-1360; Charmandari, Evangelia/0000-0002-0851-6998; Koide, Hisashi/0000-0002-8545-7530	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; National and Kapodistrian University of Athens; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000618, ZIAHD008732] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National and Kapodistrian University of Athens; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, and the National and Kapodistrian University of Athens. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Charmandari E, 2005, J CLIN ENDOCR METAB, V90, P3696, DOI 10.1210/jc.2004-1920; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Ekstrand K, 1996, ANGIOLOGY, V47, P1089, DOI 10.1177/000331979604701109; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Henley D. E., 2009, Journal of Medical Engineering & Technology, V33, P199, DOI 10.1080/03091900802185970; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kusanagi H, 2004, NEUROSCI LETT, V365, P124, DOI 10.1016/j.neulet.2004.04.065; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; RIVEST RW, 1989, J CLIN ENDOCR METAB, V68, P721, DOI 10.1210/jcem-68-4-721; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430	28	90	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25612	10.1371/journal.pone.0025612	http://dx.doi.org/10.1371/journal.pone.0025612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980503	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900080
J	Haddow, AD; Bixler, D; Schuh, AJ				Haddow, Andrew D.; Bixler, Danae; Schuh, Amy J.			The Demographic and Socioeconomic Factors Predictive for Populations at High-Risk for La Crosse Virus Infection in West Virginia	PLOS ONE			English	Article							CALIFORNIA ENCEPHALITIS GROUP; CENTRAL-NERVOUS-SYSTEM; NILE-VIRUS; AEDES-TRISERIATUS; LACROSSE VIRUS; EASTERN TENNESSEE; SPATIAL-ANALYSIS; SOCIAL IMPACTS; NORTH-CAROLINA; UNITED-STATES	Although a large body of literature exists for the environmental risk factors for La Crosse virus (LACV) transmission, the demographic and socioeconomic risk factors for developing LACV infection have not been investigated. Therefore, this study investigated the demographic and socioeconomic risk factors for LACV infection in West Virginia from 2003 to 2007, using two forward stepwise discriminant analyses. The discriminant analyses were used to evaluate a number of demographic and socioeconomic factors for their ability to predict: 1) those census tracts with at least one reported case of LACV infection versus those census tracts with no reported cases of LACV infection and 2) to evaluate significantly high-risk clusters for LACV infection versus significantly low-risk clusters for LACV infection. In the first model, a high school education diploma or a general education diploma or less and a lower housing density were found to be predictive of those census tracts with at least one case of LACV infection. A high school or a general education diploma or less, lower housing density, and housing built in 1969 and earlier were all found to be predictive of those census tracts displaying high-risk clusters versus census tracts displaying low-risk clusters in the second model. The cluster discriminant analysis was found to be more predictive than the census tract discriminant analysis as indicated by the Eigenvalues, canonical correlation, and grouping accuracy. The results of this study indicate that socioeconomically disadvantaged populations are at the highest risk for LACV infection and should be a focus of LACV infection prevention efforts.	[Haddow, Andrew D.; Schuh, Amy J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Schuh, Amy J.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX USA; [Haddow, Andrew D.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Bixler, Danae] W Virginia Bur Publ Hlth, Charleston, WV USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	adhaddow@gmail.com	Haddow, Andrew/C-5902-2008	Haddow, Andrew/0000-0002-8957-2608				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2003, GEODA VERSION 0 95I; BALFOUR HH, 1973, PEDIATRICS, V52, P680; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; BEATY BJ, 1991, CURR TOP MICROBIOL, V169, P27; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; CDC, 2011, NAT NOT INF DIS; *CDC, 2004, NEUR NONN DOM ARB DI; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P79; Chun R W, 1983, Prog Clin Biol Res, V123, P193; CHUN RWM, 1968, NEUROLOGY, V18, P369; DeGroote JP, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-19; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; ESRI, 2006, ARCVIEW GIS VERS 9 2; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; Haddow AD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-29; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006954; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Hardin SG, 2003, AM J INFECT CONTROL, V31, P508, DOI 10.1016/S0196-6553(03)00084-1; IBM, 2009, PASW STAT; JOHNSON KP, 1968, NEUROLOGY, V18, P250, DOI 10.1212/WNL.18.3.250; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kitron U, 1997, AM J TROP MED HYG, V57, P469, DOI 10.4269/ajtmh.1997.57.469; KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815, DOI 10.4269/ajtmh.1977.26.815; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; MOULTON DW, 1971, AM J TROP MED HYG, V20, P474, DOI 10.4269/ajtmh.1971.20.474; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; Odoi Agricola, 2003, Int J Health Geogr, V2, P5, DOI 10.1186/1476-072X-2-5; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Parry J.E., 1983, Progress in Clinical and Biological Research, V123, P355; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; Thompson W H, 1983, Prog Clin Biol Res, V123, P225; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tsai T F, 1991, Infect Dis Clin North Am, V5, P73; US Census Bureau, 2008, CART BOUND FIL; Utz JT, 2005, HUM ORGAN, V64, P135, DOI 10.17730/humo.64.2.xa6yqcmf13qnu2k9; Utz JT, 2003, AM J TROP MED HYG, V69, P509, DOI 10.4269/ajtmh.2003.69.509; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; WATTS DM, 1972, J MED ENTOMOL, V9, P125, DOI 10.1093/jmedent/9.2.125; Winters AM, 2010, AM J TROP MED HYG, V82, P945, DOI 10.4269/ajtmh.2010.09-0648; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497	52	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25739	10.1371/journal.pone.0025739	http://dx.doi.org/10.1371/journal.pone.0025739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980533	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900094
J	Yang, CY; Tai, MF; Lin, CP; Lu, CW; Wang, JL; Hsiao, JK; Liu, HM				Yang, Chung-Yi; Tai, Ming-Fong; Lin, Chih-Peng; Lu, Chen-Wen; Wang, Jaw-Lin; Hsiao, Jong-Kai; Liu, Hon-Man			Mechanism of Cellular Uptake and Impact of Ferucarbotran on Macrophage Physiology	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MR CONTRAST AGENTS; MESENCHYMAL STEM-CELLS; MAGNETIC-RESONANCE; ATHEROSCLEROTIC PLAQUES; ENHANCED MRI; NANOPARTICLES; TRACKING; INFLAMMATION; FERUMOXIDES	Superparamagnetic iron oxide (SPIO) nanoparticles are contrast agents used for magnetic resonance imaging. Ferucarbotran is a clinically approved SPIO-coated carboxydextran with a diameter of about 45-60 nm. We investigated the mechanism of cellular uptake of Ferucarbotran with a cell model using the murine macrophage cell line Raw 264.7. We observed a dose-dependent uptake of these SPIO particles by spectrophotometer analysis and also a dose-dependent increase in the granularity of the macrophages as determined by flow cytometry. There was a linear correlation between the side scattering mean value and iron content (P<0.001, R(2) = 0.8048). For evaluation of the endocytotic pathway of these ingested SPIO particles, different inhibitors of the endocytotic pathways were employed. There was a significant decrease of side scattering counts in the cells and a less significant change in signal intensity based on magnetic resonance in the phenylarsine oxide-treated macrophages. After labeling with SPIO particles, the macrophages showed an increase in the production of reactive oxygen species at 2, 24, and 48 h; a decrease in mitochondrial membrane potential at 24 h; and an increase in cell proliferation at 24 h. We concluded that Ferucarbotran was internalized into macrophages via the clathrin-mediated pathway and can change the cellular behavior of these cells after labeling.	[Yang, Chung-Yi; Wang, Jaw-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Yang, Chung-Yi; Lu, Chen-Wen; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi; Lin, Chih-Peng; Lu, Chen-Wen; Liu, Hon-Man] Coll Med, Taipei, Taiwan; [Tai, Ming-Fong] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Lin, Chih-Peng] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Hsiao, Jong-Kai] Buddhist Tzu Chi Gen Hosp, Dept Med Imaging, Taipei Branch, New Taipei City, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital	Yang, CY (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	hmliu@ntu.edu.tw	Liu, Hon-Man/B-1352-2012; Lin, Chih-Peng/H-5979-2019	Lin, Chih-Peng/0000-0003-2928-3203; WANG, JAW-LIN/0000-0002-5734-9276; LIU, HON-MAN/0000-0001-6715-6366	National Science Council, Taiwan [NSC 98-2218-E-002-035, NSC 99-2314-B-303-012-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (grants NSC 98-2218-E-002-035, NSC 99-2314-B-303-012-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bishop NE, 1997, REV MED VIROL, V7, P199, DOI 10.1002/(SICI)1099-1654(199712)7:4<199::AID-RMV203>3.0.CO;2-F; Bogdanov A, 2002, MOL IMAGING, V1, P16, DOI 10.1162/153535002753395671; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chang Y, 2005, TOXICOL APPL PHARM, V204, P27, DOI 10.1016/j.taap.2004.08.011; Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011; Daldrup-Link HE, 2003, RADIOLOGY, V228, P760, DOI 10.1148/radiol.2283020322; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Dubey P, 2003, P NATL ACAD SCI USA, V100, P1232, DOI 10.1073/pnas.0337418100; GANDHI SN, 2006, MR CONTRAST AGENTS L, P1621; HSIAO JK, 2008, NMR BIOMED; Hsiao JK, 2007, IEEE T MAGN, V43, P2421, DOI 10.1109/TMAG.2007.893860; Hsiao JK, 2007, MAGN RESON MED, V58, P717, DOI 10.1002/mrm.21377; Hsiao JK, 2006, J MAGN MAGN MATER, V304, pE4, DOI 10.1016/j.jmmm.2006.01.134; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Huth US, 2006, J CONTROL RELEASE, V110, P490, DOI 10.1016/j.jconrel.2005.10.018; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Kircher MF, 2003, CANCER RES, V63, P6838; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003; Lunov O, 2010, BIOMATERIALS, V31, P5063, DOI 10.1016/j.biomaterials.2010.03.023; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Metz S, 2004, EUR RADIOL, V14, P1851, DOI 10.1007/s00330-004-2405-2; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Schmitz SA, 2002, INVEST RADIOL, V37, P405, DOI 10.1097/00004424-200207000-00008; Schmitz SA, 2000, INVEST RADIOL, V35, P460, DOI 10.1097/00004424-200008000-00002; Simon GH, 2006, EUR J NUCL MED MOL I, V33, P998, DOI 10.1007/s00259-006-0081-y; Sista AK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-94; Turvey SE, 2005, J CLIN INVEST, V115, P2454, DOI 10.1172/JCI25048; Valable S, 2008, NEUROIMAGE, V40, P973, DOI 10.1016/j.neuroimage.2008.01.005; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; YANG CY, 2010, DIRECT LABELING HMSC; YEH TC, 1993, MAGN RESON MED, V30, P617, DOI 10.1002/mrm.1910300513	38	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25524	10.1371/journal.pone.0025524	http://dx.doi.org/10.1371/journal.pone.0025524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21991395	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900074
J	Sasse, C; Schillig, R; Dierolf, F; Weyler, M; Schneider, S; Mogavero, S; Rogers, PD; Morschhauser, J				Sasse, Christoph; Schillig, Rebecca; Dierolf, Franziska; Weyler, Michael; Schneider, Sabrina; Mogavero, Selene; Rogers, P. David; Morschhaeuser, Joachim			The Transcription Factor Ndt80 Does Not Contribute to Mrr1-, Tac1-, and Upc2-Mediated Fluconazole Resistance in Candida albicans	PLOS ONE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; ABC TRANSPORTERS CDR1; AZOLE RESISTANCE; STEROL-METABOLISM; EFFLUX PUMP; MULTIDRUG-RESISTANCE; CONFERS RESISTANCE; MAJOR FACILITATOR; REGULATING CDR1; UP-REGULATION	The pathogenic yeast Candida albicans can develop resistance to the widely used antifungal agent fluconazole, which inhibits ergosterol biosynthesis, by the overexpression of genes encoding multidrug efflux pumps or ergosterol biosynthesis enzymes. Zinc cluster transcription factors play a central role in the transcriptional regulation of drug resistance. Mrr1 regulates the expression of the major facilitator MDR1, Tac1 controls the expression of the ABC transporters CDR1 and CDR2, and Upc2 regulates ergosterol biosynthesis (ERG) genes. Gain-of-function mutations in these transcription factors result in constitutive overexpression of their target genes and are responsible for fluconazole resistance in many clinical C. albicans isolates. The transcription factor Ndt80 contributes to the drug-induced upregulation of CDR1 and ERG genes and also binds to the MDR1 and CDR2 promoters, suggesting that it is an important component of all major transcriptional mechanisms of fluconazole resistance. However, we found that Ndt80 is not required for the induction of MDR1 and CDR2 expression by inducing chemicals. CDR2 was even partially derepressed in ndt80D mutants, indicating that Ndt80 is a repressor of CDR2 expression. Hyperactive forms of Mrr1, Tac1, and Upc2 promoted overexpression of MDR1, CDR1/CDR2, and ERG11, respectively, with the same efficiency in the presence and absence of Ndt80. Mrr1- and Tac1-mediated fluconazole resistance was even slightly enhanced in ndt80D mutants compared to wild-type cells. These results demonstrate that Ndt80 is dispensable for the constitutive overexpression of Mrr1, Tac1, and Upc2 target genes and the increased fluconazole resistance of strains that have acquired activating mutations in these transcription factors.	[Sasse, Christoph; Schillig, Rebecca; Dierolf, Franziska; Weyler, Michael; Schneider, Sabrina; Mogavero, Selene; Morschhaeuser, Joachim] Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany; [Mogavero, Selene] Univ Pisa, Dept Biol, Pisa, Italy; [Rogers, P. David] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Clin Pharm, Memphis, TN 38163 USA; [Rogers, P. David] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pediat, Memphis, TN 38163 USA	University of Wurzburg; University of Pisa; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Sasse, C (corresponding author), Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany.	joachim.morschhaeuser@uni-wuerzburg.de	Morschhäuser, Joachim/AFS-2547-2022; Mogavero, Selene/L-8432-2017; Morschhäuser, Joachim/E-2918-2013	Morschhäuser, Joachim/0000-0003-4227-8687; Mogavero, Selene/0000-0003-0642-0068; Morschhäuser, Joachim/0000-0003-4227-8687	Deutsche Forschungsgemeinschaft (DFG) [MO 846/3, SFB 630]; National Institutes of Health (NIH) [AI058145]; University of Pisa; University of Wurzburg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058145, R21AI058145] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pisa; University of Wurzburg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG grant MO 846/3 and SFB 630) and the National Institutes of Health (NIH grant AI058145). Selene Mogavero was supported by the University of Pisa. Publication of the work was funded by the DFG and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chen CG, 2004, ANTIMICROB AGENTS CH, V48, P4505, DOI 10.1128/AAC.48.12.4505-4512.2004; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; De Backer MD, 2001, ANTIMICROB AGENTS CH, V45, P1660, DOI 10.1128/AAC.45.6.1660-1670.2001; de Micheli M, 2002, MOL MICROBIOL, V43, P1197, DOI 10.1046/j.1365-2958.2002.02814.x; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Goffeau A, 2008, NATURE, V452, P541, DOI 10.1038/452541a; Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385; Heilmann CJ, 2010, ANTIMICROB AGENTS CH, V54, P353, DOI 10.1128/AAC.01102-09; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Kohler GA, 1997, J BACTERIOL, V179, P2331; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; MacPherson S, 2005, ANTIMICROB AGENTS CH, V49, P1745, DOI 10.1128/AAC.49.5.1745-1752.2005; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Morschhauser J, 1998, MOL GEN GENET, V257, P412, DOI 10.1007/s004380050665; Ramirez-Zavala B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000089; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rognon B, 2006, MICROBIOL-SGM, V152, P3701, DOI 10.1099/mic.0.29277-0; RUHNKE M, 1994, J CLIN MICROBIOL, V32, P2092, DOI 10.1128/JCM.32.9.2092-2098.1994; Schubert S, 2008, ANTIMICROB AGENTS CH, V52, P4274, DOI 10.1128/AAC.00740-08; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Sellam A, 2010, EUKARYOT CELL, V9, P634, DOI 10.1128/EC.00325-09; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004; Staib P, 2002, INFECT IMMUN, V70, P921, DOI 10.1128/IAI.70.2.921-927.2002; Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08; Yang YL, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-22; Znaidi S, 2008, EUKARYOT CELL, V7, P836, DOI 10.1128/EC.00070-08; Znaidi S, 2007, MOL MICROBIOL, V66, P440, DOI 10.1111/j.1365-2958.2007.05931.x	36	43	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25623	10.1371/journal.pone.0025623	http://dx.doi.org/10.1371/journal.pone.0025623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980509	Green Submitted, Green Published, gold			2022-12-25	WOS:000295933700048
J	Rao, VH; Kandel, A; Lynch, D; Pena, Z; Marwaha, N; Deng, C; Watson, P; Hansen, LA				Rao, V. H.; Kandel, A.; Lynch, D.; Pena, Z.; Marwaha, N.; Deng, C.; Watson, P.; Hansen, L. A.			A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion	ONCOGENE			English	Article						HER2; ADAM12; head and neck cancer; oral cancer; migration; invasion	GROWTH-FACTOR-RECEPTOR; HUMAN-BREAST-CANCER; GENE-EXPRESSION; PROTEIN EXPRESSION; FAMILY-MEMBERS; CARCINOMA; OVEREXPRESSION; AMPLIFICATION; ERBB2; EGFR	Increased activation of epidermal growth factor receptor (EGFR) family members such as HER2/Erbb2 can result in more aggressive disease, resistance to chemotherapy and reduced survival of head and neck squamous cell carcinoma (HNSCC) patients. In order to identify mechanisms through which these receptor tyrosine kinases accelerate tumor progression, the regulation of metalloprotease expression by EGFR family members was investigated in 11 squamous cell carcinoma (SCC) cell lines. HER2 expression was significantly correlated with ADAM12 (A Disintegrin And Metalloprotease 12) expression in these cell lines and was co-expressed in human head and neck cancers. Inhibition of HER2 or EGFR decreased ADAM12 transcripts whereas HER2 transfection upregulated ADAM12 expression. To understand the molecular mechanisms underlying HER2 regulation of ADAM12, we investigated the signaling pathways directing ADAM12 production in SCC cells. Inhibition of phosphatidyl inositol-3-kinase or mammalian target of rapamycin decreased ADAM12 transcripts in HER2-expressing SCC cells, whereas transfection with AKT increased ADAM12 mRNA. Experiments utilizing ADAM12 transfection or siRNA targeting of ADAM12 revealed that the protease increased both the migration and invasiveness of oral SCC cells. Surprisingly, ADAM12 also increased HER2 message, protein levels and activity through an Ets1-dependent mechanism. Collectively, these results reveal a novel positive activation loop between ADAM12 and HER2 that may contribute to HNSCC progression. Oncogene (2012) 31, 2888-2898; doi:10.1038/onc.2011.460; published online 10 October 2011	[Rao, V. H.; Kandel, A.; Lynch, D.; Pena, Z.; Marwaha, N.; Hansen, L. A.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Deng, C.] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE 68178 USA; [Watson, P.] Creighton Univ, Sch Med, Dept Prevent Hlth, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University	Hansen, LA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, 2500 Calif Plaza,Criss 2,Room 431, Omaha, NE 68178 USA.	LHansen@creighton.edu			NIH; Nebraska Cancer and Smoking-Related Diseases Research Program; Dobleman Institute for Head and Neck Cancer Research; National Institutes of Health [1RO1ES015585]; State of Nebraska [LB595]; Dobleman Head and Neck Cancer Institute; National Center for Research Resources, National Institutes of Health [1CO6RR17417-01, G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001, C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015585] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Cancer and Smoking-Related Diseases Research Program; Dobleman Institute for Head and Neck Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska; Dobleman Head and Neck Cancer Institute; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr Hansen's work has been funded by the NIH, the Nebraska Cancer and Smoking-Related Diseases Research Program and the Dobleman Institute for Head and Neck Cancer Research. The other authors declare no conflict of interest.; The cell lines used in this study were gifts from Drs Greg Oakley (University of Nebraska, Lincoln) and Thomas Carey (University of Michigan). We also thank Drs U. Wewer and C. Frohlich (University of Copenhagen, Denmark) for the gifts of ADAM12 plasmids. This research was supported by the National Institutes of Health (1RO1ES015585), the State of Nebraska LB595 and The Dobleman Head and Neck Cancer Institute. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Numbers 1CO6RR17417-01 and G20RR024001 from the National Center for Research Resources, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Akervall J, 2004, ACTA OTO-LARYNGOL, V124, P851, DOI 10.1080/00016480410017323; Ang KK, 2002, CANCER RES, V62, P7350; Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brunner K, 2010, ANAL QUANT CYTOL, V32, P78; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; Coutant A, 2005, J HEPATOL, V43, P1038; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Ettl T, 2008, HISTOPATHOLOGY, V53, P567, DOI 10.1111/j.1365-2559.2008.03159.x; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; GRENMAN R, 1991, CANCER, V67, P2741, DOI 10.1002/1097-0142(19910601)67:11<2741::AID-CNCR2820671105>3.0.CO;2-S; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Ibrahim SO, 1997, ANTICANCER RES, V17, P4539; Jacobsen J, 2009, CURR PHARM DESIGN, V15, P2300, DOI 10.2174/138161209788682389; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kong A, 2006, CANCER RES, V66, P2834, DOI 10.1158/0008-5472.CAN-05-2994; Kornberg LJ, 2005, LARYNGOSCOPE, V115, P690, DOI 10.1097/01.mlg.0000161333.67977.93; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liu F, 2001, EUR J BIOCHEM, V268, P3501, DOI 10.1046/j.1432-1327.2001.02254.x; Madson JG, 2006, AM J PATHOL, V169, P1402, DOI 10.2353/ajpath.2006.060082; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Moon C, 2010, EXP BIOL MED, V235, P907, DOI 10.1258/ebm.2009.009181; O-Charoenrat P, 2000, INT J CANCER, V86, P307, DOI 10.1002/(SICI)1097-0215(20000501)86:3<307::AID-IJC2>3.0.CO;2-I; Ou CC, 2008, CARCINOGENESIS, V29, P299, DOI 10.1093/carcin/bgm263; Pande P, 1999, J PATHOL, V189, P40, DOI 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#; Pande P, 2001, CANCER DETECT PREV, V25, P496; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Ragin CCR, 2007, J DENT RES, V86, P104, DOI 10.1177/154405910708600202; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Rohatgi N, 2005, ORAL ONCOL, V41, P806, DOI 10.1016/j.oraloncology.2005.04.010; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Sato-Kuwabara Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-6; Scott GK, 2000, ONCOGENE, V19, P6490, DOI 10.1038/sj.onc.1204041; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Squire JA, 2002, HEAD NECK-J SCI SPEC, V24, P874, DOI 10.1002/hed.10122; Thodeti CK, 2005, EXP CELL RES, V309, P438, DOI 10.1016/j.yexcr.2005.06.020; Worsham MJ, 1999, J CLIN PATHOL-MOL PA, V52, P42, DOI 10.1136/mp.52.1.42; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294	52	37	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	23					2888	2898		10.1038/onc.2011.460	http://dx.doi.org/10.1038/onc.2011.460			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	21986939	Green Accepted			2022-12-25	WOS:000305277900008
J	Okumoto, K; Kametani, Y; Fujiki, Y				Okumoto, Kanji; Kametani, Yukari; Fujiki, Yukio			Two Proteases, Trypsin Domain-containing 1 (Tysnd1) and Peroxisomal Lon Protease (PsLon), Cooperatively Regulate Fatty Acid beta-Oxidation in Peroxisomal Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID TRANSFER PROTEIN; ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE; INSULIN-DEGRADING ENZYME; TARGETING SIGNAL TYPE-2; RAT-LIVER PEROXISOMES; OVARY CELL MUTANT; ACYL-COA OXIDASE; STEROL CARRIER; PTS1 RECEPTOR; FUNCTIONAL COMPLEMENTATION	The molecular mechanisms underlying protein turnover and enzyme regulation in the peroxisomal matrix remain largely unknown. Trypsin domain-containing 1 (Tysnd1) and peroxisomal Lon protease (PsLon) are newly identified peroxisomal matrix proteins that harbor both a serine protease-like domain and a peroxisome-targeting signal 1 (PTS1) sequence. Tysnd1 processes several PTS1-containing proteins and cleaves N-terminal presequences from PTS2-containing protein precursors. Here we report that knockdown of Tysnd1, but not PsLon, resulted in accumulation of endogenous beta-oxidation enzymes in their premature form. The protease activity of Tysnd1 was inactivated by intermolecular self-conversion of the 60-kDa form to 15- and 45-kDa chains, which were preferentially degraded by PsLon. Peroxisomal beta-oxidation of a very long fatty acid was significantly decreased by knockdown of Tysnd1 and partially lowered by PsLon knockdown. Taken together, these data suggest that Tysnd1 is a key regulator of the peroxisomal beta-oxidation pathway via proteolytic processing of beta-oxidation enzymes. The proteolytic activity of oligomeric Tysnd1 is in turn controlled by self-cleavage of Tysnd1 and degradation of Tysnd1 cleavage products by PsLon.	[Okumoto, Kanji; Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; [Okumoto, Kanji; Kametani, Yukari; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Grad Sch, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] Core Res Evolut Sci & Technol CREST, Japan Sci & Technol Agcy JST, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp			Science and Technology Agency of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology	Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported in part by a CREST grant (to Y. F.) from the Science and Technology Agency of Japan; by grants-in-aid for scientific research (to Y. F.) and The Global Center of Excellence Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; and a grant (to Y. F.) from the Japan Foundation for Applied Enzymology.	ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Aksam EB, 2007, AUTOPHAGY, V3, P96, DOI 10.4161/auto.3534; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Chang CC, 1999, J CELL SCI, V112, P1579; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; deVet ECJM, 1997, J BIOL CHEM, V272, P798, DOI 10.1074/jbc.272.2.798; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1374, DOI 10.1016/j.bbamcr.2006.09.012; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; LEENDERS F, 1994, MOL CELL ENDOCRINOL, V104, P127, DOI 10.1016/0303-7207(94)90114-7; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Mukai S, 2006, J BIOL CHEM, V281, P37311, DOI 10.1074/jbc.M607178200; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2001, J BIOL CHEM, V276, P2858, DOI 10.1074/jbc.M007730200; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179; Yokota S, 2008, HISTOCHEM CELL BIOL, V129, P73, DOI 10.1007/s00418-007-0328-0	71	41	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44367	44379		10.1074/jbc.M111.285197	http://dx.doi.org/10.1074/jbc.M111.285197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22002062	hybrid, Green Published			2022-12-25	WOS:000298645500009
J	Nakane, S; Wakamatsu, T; Masui, R; Kuramitsu, S; Fukui, K				Nakane, Shuhei; Wakamatsu, Taisuke; Masui, Ryoji; Kuramitsu, Seiki; Fukui, Kenji			In Vivo, in Vitro, and X-ray Crystallographic Analyses Suggest the Involvement of an Uncharacterized Triose-phosphate Isomerase (TIM) Barrel Protein in Protection against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS HB8; SINGLE-STRANDED-DNA; OLD YELLOW ENZYME; CRYSTAL-STRUCTURE; ENDONUCLEASE-IV; DEINOCOCCUS-RADIODURANS; HELICOBACTER-PYLORI; EXCISION-REPAIR; DAMAGE; EXONUCLEASE	Accumulating genome sequences have revealed the existence of a large number of conserved hypothetical proteins. Characterization of these proteins is considered essential in the elucidation of intracellular biological pathways. Our previous transcriptomic analysis suggested that, in Thermus thermophilus HB8, loss of an oxidized DNA-repairing activity leads to the up-regulation of a function-unknown gene, tthb071, which is conserved in a wide range of bacteria. Interestingly, the tthb071 gene product, TTHB071, showed a significant primary structure similarity to apurinic/apyrimidinic (AP) endonucleases, which are required for the repair of oxidized DNA. In the present study, we observed that disruption of tthb071 increases the H2O2 sensitivity in T. thermophilus HB8, suggesting the involvement of tthb071 in a protection mechanism against oxidative stress. However, purified TTHB071 exhibited no AP endonuclease or DNA-binding activities, indicating that TTHB071 plays no major role in repairing oxidative DNA damage. Then we determined the three-dimensional structure of TTHB071 complexed with zinc ions by x-ray crystallography. In addition to the overall structural similarity, the zinc-binding fashion was almost identical to that of the phosphatase active site of an AP endonuclease, implying that TTHB071 possesses a phosphatase activity. Based on the structural information around the zinc-binding site, we investigated the binding of TTHB071 to 14 different compounds. As a result, TTHB071 favorably bound FMN and pyridoxal phosphate in a zinc ion-mediated manner. Our results suggest that TTHB071 protects the cell from oxidative stress, through controlling the metabolism of FMN, pyridoxal phosphate, or an analogous compound.	[Masui, Ryoji; Kuramitsu, Seiki; Fukui, Kenji] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakane, Shuhei; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Wakamatsu, Taisuke; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; Osaka University	Fukui, K (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	k.fukui@spring8.or.jp	Wakamatsu, Taisuke/AAD-8007-2022	Fukui, Kenji/0000-0003-2463-7578	Japan Society for the Promotion of Science [22-37]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Recipient of a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (Grant 22-37).	Adalbjornsson BV, 2010, CHEMBIOCHEM, V11, P197, DOI 10.1002/cbic.200900570; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2010, FEMS MICROBIOL LETT, V313, P127, DOI 10.1111/j.1574-6968.2010.02133.x; Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Asano R, 2011, ACTA CRYSTALLOGR D, V67, P149, DOI 10.1107/S0907444910052479; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BONNY C, 1991, BIOCHIM BIOPHYS ACTA, V1089, P213, DOI 10.1016/0167-4781(91)90010-J; Cortial S, 2010, FEBS LETT, V584, P3916, DOI 10.1016/j.febslet.2010.08.019; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DISCHE Z, 1951, J BIOL CHEM, V192, P583; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Iino H, 2008, ACTA CRYSTALLOGR F, V64, P487, DOI 10.1107/S1744309108013572; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Iwasaki W, 2007, J MOL BIOL, V371, P123, DOI 10.1016/j.jmb.2007.05.007; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Leulliot N, 2009, J BIOL CHEM, V284, P11992, DOI 10.1074/jbc.M809342200; Liao RZ, 2010, J PHYS CHEM B, V114, P2533, DOI 10.1021/jp910992f; Luria SE, 1943, GENETICS, V28, P491; Mega R, 2010, BIOCHEM BIOPH RES CO, V399, P336, DOI 10.1016/j.bbrc.2010.07.065; Monds RD, 2010, J BACTERIOL, V192, P3011, DOI 10.1128/JB.01571-09; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Nakane S, 2009, NUCLEIC ACIDS RES, V37, P2037, DOI 10.1093/nar/gkp064; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Ooga T, 2009, J BIOL CHEM, V284, P15549, DOI 10.1074/jbc.M900582200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paspaleva K, 2007, STRUCTURE, V15, P1316, DOI 10.1016/j.str.2007.05.010; PINARD R, 1993, FASEB J, V7, P173, DOI 10.1096/fasebj.7.1.7678560; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Sakamoto K, 2008, GENE, V423, P153, DOI 10.1016/j.gene.2008.07.012; Shimada A, 2010, NUCLEIC ACIDS RES, V38, P5692, DOI 10.1093/nar/gkq350; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Tazoe M, 2005, BIOSCI BIOTECH BIOCH, V69, P2277, DOI 10.1271/bbb.69.2277; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tirrell IM, 2006, BIOCHEM J, V394, P665, DOI 10.1042/BJ20051172; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	57	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41636	41646		10.1074/jbc.M111.293886	http://dx.doi.org/10.1074/jbc.M111.293886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984829	Green Published, hybrid			2022-12-25	WOS:000298057500048
J	Aimon, S; Manzi, J; Schmidt, D; Larrosa, JAP; Bassereau, P; Toombes, GES				Aimon, Sophie; Manzi, John; Schmidt, Daniel; Poveda Larrosa, Jose Antonio; Bassereau, Patricia; Toombes, Gilman E. S.			Functional Reconstitution of a Voltage-Gated Potassium Channel in Giant Unilamellar Vesicles	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; ION CHANNELS; PATCH; CELL; ELECTROFORMATION; CONDUCTANCE; CURVATURE; MOBILITY; KCSA	Voltage-gated ion channels are key players in cellular excitability. Recent studies suggest that their behavior can depend strongly on the membrane lipid composition and physical state. In vivo studies of membrane/channel and channel/channel interactions are challenging as membrane properties are actively regulated in living cells, and are difficult to control in experimental settings. We developed a method to reconstitute functional voltage-gated ion channels into cell-sized Giant Unilamellar Vesicles (GUVs) in which membrane composition, tension and geometry can be controlled. First, a voltage-gated potassium channel, KvAP, was purified, fluorescently labeled and reconstituted into small proteoliposomes. Small proteoliposomes were then converted into GUVs via electroformation. GUVs could be formed using different lipid compositions and buffers containing low (5 mM) or near-physiological (100 mM) salt concentrations. Protein incorporation into GUVs was characterized with quantitative confocal microscopy, and the protein density of GUVs was comparable to the small proteoliposomes from which they were formed. Furthermore, patch-clamp measurements confirmed that the reconstituted channels retained potassium selectivity and voltage-gated activation. GUVs containing functional voltage-gated ion channels will allow the study of channel activity, distribution and diffusion while controlling membrane state, and should prove a powerful tool for understanding how the membrane modulates cellular excitability.	[Aimon, Sophie; Manzi, John; Bassereau, Patricia; Toombes, Gilman E. S.] Univ Paris 06, CNRS, Inst Curie, Ctr Rech,Unite Mixte Rech UMR 168, Paris, France; [Schmidt, Daniel] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; [Poveda Larrosa, Jose Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Howard Hughes Medical Institute; Rockefeller University; Universidad Miguel Hernandez de Elche	Aimon, S (corresponding author), Univ Paris 06, CNRS, Inst Curie, Ctr Rech,Unite Mixte Rech UMR 168, Paris, France.	Patricia.Bassereau@curie.fr	Manzi, John/AAI-8253-2021; Poveda Larrosa, Jose Antonio/H-5925-2015; Bassereau, Patricia/P-8657-2018	Manzi, John/0000-0003-2574-4260; Poveda Larrosa, Jose Antonio/0000-0003-0722-3752; Toombes, Gilman/0000-0001-8346-1790; Bassereau, Patricia/0000-0002-8544-6778	Agence Nationale de la Recherche by the European Commission (NoE SoftComp) [BLAN-0057-01]; Universite Pierre et Marie Curie (FED21, Dynamique des Systemes Complexes); Fondation pour la Recherche Medicale; European Commission; Universite Pierre et Marie Curie	Agence Nationale de la Recherche by the European Commission (NoE SoftComp)(French National Research Agency (ANR)); Universite Pierre et Marie Curie (FED21, Dynamique des Systemes Complexes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Commission(European CommissionEuropean Commission Joint Research Centre); Universite Pierre et Marie Curie	The project was funded by the Agence Nationale de la Recherche (grant BLAN-0057-01) by the European Commission (NoE SoftComp) and by the Universite Pierre et Marie Curie (grant from the FED21, Dynamique des Systemes Complexes). Dr. Aimon was supported by a fellowship from the Fondation pour la Recherche Medicale. Dr. Toombes was supported by a Marie Curie Incoming International Fellowship from the European Commission and a grant from the Universite Pierre et Marie Curie. Dr. Bassereau's group belongs to the French research consortium "CellTiss''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ANR Website: http://www.agence-nationale-recherche.fr/. NoE SoftComp Website: http://www.eu-softcomp.net/. UPMC Website: http://www.upmc.fr/. EU FP7 Marie Curie Website: http://cordis.europa.eu/fp7/home_en.html. Fondation pour la Recherche Medicale Website: http://www.frm.org/.	Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Bezanilla F, 2008, NEURON, V60, P456, DOI 10.1016/j.neuron.2008.10.035; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Davidson M, 2003, J AM CHEM SOC, V125, P374, DOI 10.1021/ja027699o; DILGER JP, 1985, J MEMBRANE BIOL, V85, P181, DOI 10.1007/BF01871270; Doeven MK, 2005, BIOPHYS J, V88, P1134, DOI 10.1529/biophysj.104.053413; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; ELALAOUI F, 2009, PHYS REV LETT, V102; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heinrich V, 1999, BIOPHYS J, V76, P2056, DOI 10.1016/S0006-3495(99)77362-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kahya N, 2002, J BIOL CHEM, V277, P39304, DOI 10.1074/jbc.M202635200; Kahya N, 2001, BIOPHYS J, V81, P1464, DOI 10.1016/S0006-3495(01)75801-8; Kahya N, 2010, BBA-BIOMEMBRANES, V1798, P1392, DOI 10.1016/j.bbamem.2010.02.028; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LEE SY, 2005, STRUCTURE, V102, P15441; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mahendran KR, 2010, J BIOMOL SCREEN, V15, P302, DOI 10.1177/1087057109357791; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Miller C., 1986, ION CHANNEL RECONSTI; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Reeves D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041901; REQUENA J, 1975, J COLLOID INTERF SCI, V51, P315, DOI 10.1016/0021-9797(75)90119-8; Rodriguez N, 2005, COLLOID SURFACE B, V42, P125, DOI 10.1016/j.colsurfb.2005.01.010; RUTA V, 2003, FUNCTIONAL ANAL, V422, P180; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; SCHMIDT D, 2008, CELL, V105, P19276; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Shimanouchi T, 2009, LANGMUIR, V25, P4835, DOI 10.1021/la8040488; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Varnier A, 2010, J MEMBRANE BIOL, V233, P85, DOI 10.1007/s00232-010-9227-8; Veatch SL, 2006, BIOPHYS J, V90, P4428, DOI 10.1529/biophysj.105.080283; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wang A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018598; WAUGH RE, 1992, BIOPHYS J, V61, P974, DOI 10.1016/S0006-3495(92)81904-5; Yanagisawa M, 2011, J AM CHEM SOC, V133, P11774, DOI 10.1021/ja2040859; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P101, DOI 10.1111/j.1469-7793.2000.00101.x	61	86	87	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25529	10.1371/journal.pone.0025529	http://dx.doi.org/10.1371/journal.pone.0025529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998666	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700012
J	Brody, JP				Brody, James P.			Age-Specific Incidence Data Indicate Four Mutations Are Required for Human Testicular Cancers	PLOS ONE			English	Article							GERM-CELL TUMORS; MULTISTAGE CARCINOGENESIS; TEMPORAL VARIATION; BREAST-CANCER; COHORT MODELS; IN-UTERO; DISEASE; GENOME; TRENDS; PERIOD	Normal human cells require a series of genetic alterations to undergo malignant transformation. Direct sequencing of human tumors has identified hundreds of mutations in tumors, but many of these are thought to be unnecessary and a result of, rather than a cause of, the tumor. The exact number of mutations to transform a normal human cell into a tumor cell is unknown. Here I show that male gonadal germ cell tumors, the most common form of testicular cancers, occur after four mutations. I infer this by constructing a mathematical model based upon the multi-hit hypothesis and comparing it to the age-specific incidence data. This result is consistent with the multi-hit hypothesis, and implies that these cancers are genetically or epigenetically predetermined at birth or an early age.	Univ Calif Irvine, Dept Biomed Engn, Ctr Complex Biol Syst, Irvine, CA 92717 USA	University of California System; University of California Irvine	Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	University of California	University of California(University of California System)	This research was supported by the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Brody JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007053; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frank S. A., 2007, Dynamics of cancer: incidence, inheritance and evolution; Frank SA, 2004, CURR BIOL, V14, P242, DOI 10.1016/j.cub.2003.12.026; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding C, 2008, CANCER RES, V68, P4465, DOI 10.1158/0008-5472.CAN-07-1670; Houldsworth J, 2006, J CLIN ONCOL, V24, P5512, DOI 10.1200/JCO.2006.08.4285; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Looijenga LHJ, 1999, REV REPROD, V4, P90, DOI 10.1530/ror.0.0040090; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manecksha RP, 2009, BJU INT, V104, P1329, DOI 10.1111/j.1464-410X.2009.08854.x; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moger TA, 2004, BIOSTATISTICS, V5, P1, DOI 10.1093/biostatistics/5.1.1; Moolgavkar SH, 2004, INT J EPIDEMIOL, V33, P1182, DOI 10.1093/ije/dyh288; Moolgavkar SH, 2003, GENE CHROMOSOME CANC, V38, P302, DOI 10.1002/gcc.10264; Myrup C, 2007, NEW ENGL J MED, V357, P825; National Cancer Institute, SEER STAT SOFTW VERS; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Pettersson A, 2007, NEW ENGL J MED, V356, P1835, DOI 10.1056/NEJMoa067588; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rothman N, 2001, BBA-REV CANCER, V1471, pC1, DOI 10.1016/S0304-419X(00)00021-4; Shah MN, 2007, INT J ANDROL, V30, P206, DOI 10.1111/j.1365-2605.2007.00795.x; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT INC SE; Thilly WG, 2003, NAT GENET, V34, P255, DOI 10.1038/ng1205; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Westergaard T, 1996, INT J CANCER, V66, P627, DOI 10.1002/(SICI)1097-0215(19960529)66:5<627::AID-IJC8>3.3.CO;2-Y; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang XN, 2005, BREAST CANCER RES TR, V91, P121, DOI 10.1007/s10549-004-5782-y	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25978	10.1371/journal.pone.0025978	http://dx.doi.org/10.1371/journal.pone.0025978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998737	gold, Green Published			2022-12-25	WOS:000295968700029
J	Garabedian, M; Jarnik, M; Kotova, E; Tulin, AV				Garabedian, Mikael; Jarnik, Michael; Kotova, Elena; Tulin, Alexei V.			Generating a Knockdown Transgene against Drosophila Heterochromatic Tim17b Gene Encoding Mitochondrial Translocase Subunit	PLOS ONE			English	Article							MELANOGASTER HETEROCHROMATIN; MOLECULAR EVOLUTION; CHROMATIN-STRUCTURE; P-ELEMENTS; RAT-LIVER; MUTAGENESIS; PROTEINS; GENOME; RECOMBINATION; ORGANIZATION	Heterochromatic regions of eukaryotic genomes contain multiple functional elements involved in chromosomal dynamics, as well as multiple housekeeping genes. Cytological and molecular peculiarities of heterochromatic loci complicate genetic studies based on standard approaches developed using euchromatic genes. Here, we report the development of an RNAi-based knockdown transgenic construct and red fluorescent reporter transgene for a small gene, Tim17b, which localizes in constitutive heterochromatin of Drosophila melanogaster third chromosome and encodes a mitochondrial translocase subunit. We demonstrate that Tim17b protein is required strictly for protein delivery to mitochondrial matrix. Knockdown of Tim17b completely disrupts functions of the mitochondrial translocase complex. Using fluorescent recovery after photobleaching assay, we show that Tim17b protein has a very stable localization in the membranes of the mitochondrial network and that its exchange rate is close to zero when compared with soluble proteins of mitochondrial matrix. These results confirm that we have developed comprehensive tools to study functions of heterochromatic Tim17b gene.	[Garabedian, Mikael; Jarnik, Michael; Kotova, Elena; Tulin, Alexei V.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Garabedian, M (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Alexei.Tulin@fccc.edu	Kotova, Elena/V-3767-2019	Garabedian, Mikael/0000-0001-7826-7491	National Institutes of Health [R01 GM077452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the National Institutes of Health (R01 GM077452) to AVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; CARAFOLI E, 1980, MOL ASPECTS MED, V3, P295, DOI 10.1016/0098-2997(80)90005-9; CHANG LO, 1971, CANCER RES, V31, P108; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Coulthard AB, 2010, GENETICS, V185, P479, DOI 10.1534/genetics.110.117259; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Ellermeier C, 2010, P NATL ACAD SCI USA, V107, P8701, DOI 10.1073/pnas.0914160107; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; GATTI M, 1983, CHROMOSOMA, V88, P593; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Giordano E, 2002, GENETICS, V160, P637; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HEITZ E, 1933, J JH WISS, V69, P762; HILLIKER AJ, 1980, CELL, V21, P607, DOI 10.1016/0092-8674(80)90424-9; IRWIN CC, 1978, CANCER RES, V38, P1584; Kotova E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000387; LOHE AR, 1993, GENETICS, V134, P1149; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Modica-Napolitano Josephine S, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004453; NURMINSKY DI, 1994, CHROMOSOMA, V103, P277, DOI 10.1007/BF00352252; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Peluso G, 2000, J CELL PHYSIOL, V182, P339, DOI 10.1002/(SICI)1097-4652(200003)182:3<339::AID-JCP4>3.3.CO;2-2; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; PROKHOROVA AV, 1994, GENETIKA+, V30, P874; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rossi F, 2007, GENETICS, V175, P595, DOI 10.1534/genetics.106.065441; Schulze S, 2001, MOL GEN GENET, V264, P782, DOI 10.1007/s004380000367; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sinclair DAR, 2000, GENETICA, V109, P9, DOI 10.1023/A:1026500620158; SONDEK J, 1992, P NATL ACAD SCI USA, V89, P3581, DOI 10.1073/pnas.89.8.3581; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Tulin AV, 1997, GENETICS, V146, P253; WEINHOUSE S, 1955, ADV CANCER RES, V3, P269, DOI 10.1016/S0065-230X(08)60922-7; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113	47	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25945	10.1371/journal.pone.0025945	http://dx.doi.org/10.1371/journal.pone.0025945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998726	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700026
J	Tenuta, T; Monopoli, MP; Kim, J; Salvati, A; Dawson, KA; Sandin, P; Lynch, I				Tenuta, Tiziana; Monopoli, Marco P.; Kim, JongAh; Salvati, Anna; Dawson, Kenneth A.; Sandin, Peter; Lynch, Iseult			Elution of Labile Fluorescent Dye from Nanoparticles during Biological Use	PLOS ONE			English	Article							PROTEINS	Cells act as extremely efficient filters for elution of unbound fluorescent tags or impurities associated with nanoparticles, including those that cannot be removed by extensive cleaning. This has consequences for quantification of nanoparticle uptake and sub-cellular localization in vitro and in vivo as a result of the presence of significant amount of labile dye even following extensive cleaning by dialysis. Polyacrylamide gel electrophoresis (PAGE) can be used to monitor the elution of unbound fluorescent probes from nanoparticles, either commercially available or synthesized in-house, and to ensure their complete purification for biological studies, including cellular uptake and sub-cellular localisation. Very different fluorescence distribution within cells is observed after short dialysis times versus following extensive dialysis against a solvent in which the free dye is more soluble, due to the contribution from free dye. In the absence of an understanding of the presence of residual free dye in (most) labeled nanoparticle solutions, the total fluorescence intensity in cells following exposure to nanoparticle solutions could be mis-ascribed to the presence of nanoparticles through the cell, rather than correctly assigned to either a combination of free-dye and nanoparticle-bound dye, or even entirely to free dye depending on the exposure conditions (i.e. aggregation of the particles etc). Where all of the dye is nanoparticle-bound, the particles are highly localized in sub-cellular organelles, likely lysosomes, whereas in a system containing significant amounts of free dye, the fluorescence is distributed through the cell due to the free diffusion of the molecule dye across all cellular barriers and into the cytoplasm.	[Tenuta, Tiziana; Monopoli, Marco P.; Kim, JongAh; Salvati, Anna; Dawson, Kenneth A.; Sandin, Peter; Lynch, Iseult] Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 2, Ireland	University College Dublin	Tenuta, T (corresponding author), Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 2, Ireland.	Iseult.Lynch@cbni.ucd.ie	Monopoli, Marco P./AAM-6527-2021; Monopoli, Marco P/I-7060-2018; Dawson, Kenneth A. A/L-2540-2016; Lynch, Iseult/I-3915-2014	Monopoli, Marco P./0000-0002-2035-6894; Monopoli, Marco P/0000-0002-2035-6894; Dawson, Kenneth A. A/0000-0002-0568-6588; Lynch, Iseult/0000-0003-4250-4584; Salvati, Anna/0000-0002-9339-0161	Irish Government; EPA [2006-PhD-RCA-19]; EU [NMP4-CT-2006-033231]; Knut and Alice Wallenberg foundation; SFI SRC BioNanoInteract [07 SRC B1155]	Irish Government; EPA(United States Environmental Protection Agency); EU(European Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); SFI SRC BioNanoInteract(Science Foundation Ireland)	This work was conducted under the framework of the INSPIRE programme, funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013 (J-AK, MM). Additional funding from EPA (2006-PhD-RCA-19, TT), EU FP6 STREP project NanoInteract (NMP4-CT-2006-033231, IL, AS), the Knut and Alice Wallenberg foundation (PS) and SFI SRC BioNanoInteract (07 SRC B1155) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Lynch I, 2003, J PHYS CHEM B, V107, P9629, DOI 10.1021/jp022008w; Pietzonka P, 2002, PHARMACEUT RES, V19, P595, DOI 10.1023/A:1015393710253; PRESTON RA, 1987, J CELL BIOL, V105, P1981, DOI 10.1083/jcb.105.5.1981; SALVATI A, 2011, NANOMEDICIN IN PRESS; TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113	7	70	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25556	10.1371/journal.pone.0025556	http://dx.doi.org/10.1371/journal.pone.0025556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998668	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700013
J	Romero, Y; Meikar, O; Papaioannou, MD; Conne, B; Grey, C; Weier, M; Pralong, F; De Massy, B; Kaessmann, H; Vassalli, JD; Kotaja, N; Nef, S				Romero, Yannick; Meikar, Oliver; Papaioannou, Marilena D.; Conne, Beatrice; Grey, Corinne; Weier, Manuela; Pralong, Francois; De Massy, Bernard; Kaessmann, Henrik; Vassalli, Jean-Dominique; Kotaja, Noora; Nef, Serge			Dicer1 Depletion in Male Germ Cells Leads to Infertility Due to Cumulative Meiotic and Spermiogenic Defects	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMALL RNAS; ENDOGENOUS SIRNAS; GENE-EXPRESSION; MOUSE; SPERMATOGENESIS; MICRORNAS; FERTILITY; RETROTRANSPOSONS; DIFFERENTIATION	Background: Spermatogenesis is a complex biological process that requires a highly specialized control of gene expression. In the past decade, small non-coding RNAs have emerged as critical regulators of gene expression both at the transcriptional and post-transcriptional level. DICER1, an RNAse III endonuclease, is essential for the biogenesis of several classes of small RNAs, including microRNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs), but is also critical for the degradation of toxic transposable elements. In this study, we investigated to which extent DICER1 is required for germ cell development and the progress of spermatogenesis in mice. Principal Findings: We show that the selective ablation of Dicer1 at the early onset of male germ cell development leads to infertility, due to multiple cumulative defects at the meiotic and post-meiotic stages culminating with the absence of functional spermatozoa. Alterations were observed in the first spermatogenic wave and include delayed progression of spermatocytes to prophase I and increased apoptosis, resulting in a reduced number of round spermatids. The transition from round to mature spermatozoa was also severely affected, since the few spermatozoa formed in mutant animals were immobile and misshapen, exhibiting morphological defects of the head and flagellum. We also found evidence that the expression of transposable elements of the SINE family is up-regulated in Dicer1-depleted spermatocytes. Conclusions/Significance: Our findings indicate that DICER1 is dispensable for spermatogonial stem cell renewal and mitotic proliferation, but is required for germ cell differentiation through the meiotic and haploid phases of spermatogenesis.	[Romero, Yannick; Papaioannou, Marilena D.; Conne, Beatrice; Vassalli, Jean-Dominique; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Meikar, Oliver; Kotaja, Noora] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Grey, Corinne; De Massy, Bernard] CNRS, IGH, Montpellier, France; [Weier, Manuela; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Pralong, Francois] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland	University of Geneva; University of Turku; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Romero, Y (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	serge.nef@unige.ch	Nef, Serge/AAV-6445-2020; Kaessmann, Henrik/B-4989-2013	Nef, Serge/0000-0001-5462-0676; Kaessmann, Henrik/0000-0001-7563-839X; Kotaja, Noora/0000-0003-1503-9170	Swiss National Science Foundation [3100A0-119862]; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-09-BLAN-0269-01]; Academy of Finland; Emil Aaltonen Foundation; Turku Graduate School of Biomedical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Turku Graduate School of Biomedical Sciences	This project is supported by grant no. 3100A0-119862 to SN from the Swiss National Science Foundation. CG and BdM are supported by grants from the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (ANR-09-BLAN-0269-01). NK and OM are supported by the Academy of Finland, Emil Aaltonen Foundation and Turku Graduate School of Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Barchi M, 2009, METHODS MOL BIOL, V558, P299, DOI 10.1007/978-1-60761-103-5_18; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Gonzalez-Gonzalez E, 2008, BIOCH BIOPHYS ACTA; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Huang CCJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-66; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; KOBAYASHI T, 2008, P NATL ACAD SCI US; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mattiske DM, 2009, REPRODUCTION, V137, P625, DOI 10.1530/REP-08-0475; Meikar O, 2010, EXP CELL RES, V316, P1567, DOI 10.1016/j.yexcr.2010.02.023; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Siomi MC, 2009, CURR OPIN CELL BIOL, V21, P426, DOI 10.1016/j.ceb.2009.02.003; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suh N, 2010, CURR BIOL; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Swetloff A, 2009, MOL CELL BI IN PRESS; Tam W, 2008, J MOL DIAGN, V10, P411, DOI 10.2353/jmoldx.2008.080067; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706	54	102	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25241	10.1371/journal.pone.0025241	http://dx.doi.org/10.1371/journal.pone.0025241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998645	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900016
J	Schafer, MG; Ross, AA; Londo, JP; Burdick, CA; Lee, EH; Travers, SE; Van de Water, PK; Sagers, CL				Schafer, Meredith G.; Ross, Andrew A.; Londo, Jason P.; Burdick, Connie A.; Lee, E. Henry; Travers, Steven E.; Van de Water, Peter K.; Sagers, Cynthia L.			The Establishment of Genetically Engineered Canola Populations in the US	PLOS ONE			English	Article							BENTGRASS AGROSTIS-STOLONIFERA; BRASSICA-NAPUS L.; GENE FLOW; CREEPING BENTGRASS; HERBICIDE RESISTANCE; HYBRIDIZATION; PERSISTENCE	Concerns regarding the commercial release of genetically engineered (GE) crops include naturalization, introgression to sexually compatible relatives and the transfer of beneficial traits to native and weedy species through hybridization. To date there have been few documented reports of escape leading some researchers to question the environmental risks of biotech products. In this study we conducted a systematic roadside survey of canola (Brassica napus) populations growing outside of cultivation in North Dakota, USA, the dominant canola growing region in the U.S. We document the presence of two escaped, transgenic genotypes, as well as non-GE canola, and provide evidence of novel combinations of transgenic forms in the wild. Our results demonstrate that feral populations are large and widespread. Moreover, flowering times of escaped populations, as well as the fertile condition of the majority of collections suggest that these populations are established and persistent outside of cultivation.	[Schafer, Meredith G.; Londo, Jason P.; Sagers, Cynthia L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Ross, Andrew A.; Travers, Steven E.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Burdick, Connie A.; Lee, E. Henry] US EPA, Western Ecol Div, Natl Hlth & Environm Effects Res Lab, Corvallis, OR USA; [Van de Water, Peter K.] Calif State Univ Fresno, Earth & Environm Sci Dept, Fresno, CA 93740 USA	University of Arkansas System; University of Arkansas Fayetteville; North Dakota State University Fargo; United States Environmental Protection Agency; California State University System; California State University Fresno	Schafer, MG (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	csagers@uark.edu		Londo, Jason/0000-0003-0535-4820	USDA CREES [NRI 35615-19216]	USDA CREES(United States Department of Agriculture (USDA))	Provided by: USDA CREES NRI 35615-19216, "Ecological Impacts from the Interactions of Climate Change, Land-Use Change and Invasive Species.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Gulden RH, 2003, WEED SCI, V51, P904, DOI 10.1614/P2002-170; Gulden RH, 2003, WEED SCI, V51, P83, DOI 10.1614/0043-1745(2003)051[0083:HLOCBN]2.0.CO;2; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Reichman JR, 2006, MOL ECOL, V15, P4243, DOI 10.1111/j.1365-294X.2006.03072.x; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; Sinemus K, 2009, EUROPEAN COMMISSION; USDA NRCS, 2011, PLANTS DAT; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x	24	58	61	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25736	10.1371/journal.pone.0025736	http://dx.doi.org/10.1371/journal.pone.0025736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998689	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900050
J	Zhang, XB; Zhang, SC; Sun, DJ; Hu, J; Wali, A; Pass, H; Fernandez-Madrid, F; Harbut, MR; Tang, NM				Zhang, Xinbo; Zhang, Siyu Crystal; Sun, Dejun; Hu, Jiang; Wali, Anil; Pass, Harvey; Fernandez-Madrid, Felix; Harbut, Michael R.; Tang, Naimei			New Insight into the Molecular Mechanisms of the Biological Effects of DNA Minor Groove Binders	PLOS ONE			English	Article							HOECHST 33342-INDUCED APOPTOSIS; 33342 INDUCES APOPTOSIS; BOX-BINDING PROTEIN; I IN-VIVO; BC3H-1 MYOCYTES; TOPOISOMERASE-I; HL-60 CELLS; AGENTS; 33258-HOECHST; CONDENSATION	Background: Bisbenzimides, or Hoechst 33258 (H258), and its derivative Hoechst 33342 (H342) are archetypal molecules for designing minor groove binders, and widely used as tools for staining DNA and analyzing side population cells. They are supravital DNA minor groove binders with AT selectivity. H342 and H258 share similar biological effects based on the similarity of their chemical structures, but also have their unique biological effects. For example, H342, but not H258, is a potent apoptotic inducer and both H342 and H258 can induce transgene overexpression in in vitro studies. However, the molecular mechanisms by which Hoechst dyes induce apoptosis and enhance transgene overexpression are unclear. Methodology/Principal Findings: To determine the molecular mechanisms underlying different biological effects between H342 and H258, microarray technique coupled with bioinformatics analyses and multiple other techniques has been utilized to detect differential global gene expression profiles, Hoechst dye-specific gene expression signatures, and changes in cell morphology and levels of apoptosis-associated proteins in malignant mesothelioma cells. H342-induced apoptosis occurs in a dose-dependent fashion and is associated with morphological changes, caspase-3 activation, cytochrome c mitochondrial translocation, and cleavage of apoptosis-associated proteins. The antagonistic effect of H258 on H342-induced apoptosis indicates a pharmacokinetic basis for the two dyes' different biological effects. Differential global gene expression profiles induced by H258 and H342 are accompanied by unique gene expression signatures determined by DNA microarray and bioinformatics software, indicating a genetic basis for their different biological effects. Conclusions/Significance: A unique gene expression signature associated with H342-induced apoptosis provides a new avenue to predict and classify the therapeutic class of minor groove binders in the drug development process. Further analysis of H258-upregulated genes of transcription regulation may identify the genes that enhance transgene overexpression in gene therapy and promote recombinant protein products in biopharmaceutical companies. Data Deposition: The microarray data reported in this article have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no.GSE28616).	[Zhang, Xinbo; Zhang, Siyu Crystal] Wayne State Univ, MedStart Program, Detroit, MI 48202 USA; [Harbut, Michael R.; Tang, Naimei] Karmanos Canc Inst, Environm Canc Initiat, Natl Ctr Vermiculite & Asbestos Related Canc, Detroit, MI USA; [Sun, Dejun] Res Inst Resp & Crit Care Med, Baotou, Inner Mongolia, Peoples R China; [Hu, Jiang] Cent Hosp, Dept Surg, Baotou, Inner Mongolia, Peoples R China; [Wali, Anil] NCI, Ctr Reduce Canc Hlth Dispar, Rockville, MD USA; [Pass, Harvey] NYU, Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Harbut, Michael R.] Providence Hosp, Ctr Occupat & Environm Med, Southfield, MI 48037 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Zhang, XB (corresponding author), Wayne State Univ, MedStart Program, Detroit, MI 48202 USA.	ntang@med.wayne.edu		Pass, Harvey/0000-0003-3222-3471				Athar M, 2011, MOL CELL BIOCHEM, V352, P281, DOI 10.1007/s11010-011-0764-y; Athar M, 2010, FREE RADICAL RES, V44, P936, DOI 10.3109/10715762.2010.492829; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; BEERMAN TA, 1992, BIOCHIM BIOPHYS ACTA, V1131, P53, DOI 10.1016/0167-4781(92)90098-K; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Ceresoli GL, 2010, CANCER TREAT REV, V36, P24, DOI 10.1016/j.ctrv.2009.09.003; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chen JC, 2004, ANN CLIN LAB SCI, V34, P458; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; HIRSCHBERG J, 1980, EXP CELL RES, V130, P63, DOI 10.1016/0014-4827(80)90042-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jerome KR, 2000, ARCH PATHOL LAB MED, V124, P802; Jia Y, 2010, J BIOL CHEM, V285, P1726, DOI 10.1074/jbc.M109.046847; Karagiannis TC, 2006, J PHOTOCH PHOTOBIO B, V83, P195, DOI 10.1016/j.jphotobiol.2005.12.013; Kiechle FL, 2002, CLIN CHIM ACTA, V326, P27, DOI 10.1016/S0009-8981(02)00297-8; KRAUT EH, 1991, INVEST NEW DRUG, V9, P95; KUSYK CJ, 1979, CYTOGENET CELL GENET, V23, P39, DOI 10.1159/000131300; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; Li LN, 2005, J GENE MED, V7, P420, DOI 10.1002/jgm.681; MARCUS M, 1979, EXP CELL RES, V123, P406, DOI 10.1016/0014-4827(79)90488-9; Marquis JF, 2003, PARASITOLOGY, V126, P21, DOI 10.1017/S0031182002002524; Morandi E, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-66; Nautiyal J, 2010, MOL CANCER THER, V9, P1503, DOI 10.1158/1535-7163.MCT-10-0019; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; PATEL SR, 1991, INVEST NEW DRUG, V9, P53; Puckowska A, 2004, EUR J MED CHEM, V39, P99, DOI 10.1016/j.ejmech.2003.11.005; Reddy BSP, 2001, CURR MED CHEM, V8, P475; Rishi AK, 2010, CURR CANCER THER REV, V6, P262, DOI 10.2174/157339410793358075; Sacconi S, 2005, BIOCHEM BIOPH RES CO, V337, P832, DOI 10.1016/j.bbrc.2005.09.127; SMITH PJ, 1990, CARCINOGENESIS, V11, P659, DOI 10.1093/carcin/11.4.659; Soderlind KJ, 1999, ANTI-CANCER DRUG DES, V14, P19; SRIRAM M, 1992, EMBO J, V11, P225, DOI 10.1002/j.1460-2075.1992.tb05045.x; Tawar U, 2007, MOL CELL BIOCHEM, V305, P221, DOI 10.1007/s11010-007-9546-y; TOBEY RA, 1990, P NATL ACAD SCI USA, V87, P5104, DOI 10.1073/pnas.87.13.5104; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Turner P. R., 2000, Current Drug Targets, V1, P1, DOI 10.2174/1389450003349407; Van Dang Chi, 2010, Genes Cancer, V1, P560; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Welsenfeld RB, 2007, BIOORGAN MED CHEM, V15, P6361, DOI 10.1016/j.bme.2007.06.061; WOYNAROWSKI JM, 1989, MOL PHARMACOL, V35, P177; Zhang XB, 1999, ARCH PATHOL LAB MED, V123, P921; Zhang XB, 1998, BIOCHEM BIOPH RES CO, V248, P18, DOI 10.1006/bbrc.1998.8906; Zhang XB, 1998, ANN CLIN LAB SCI, V28, P104; Zhang XB, 2003, ARCH PATHOL LAB MED, V127, P1124; Zhang XB, 1997, ANN CLIN LAB SCI, V27, P260; Zhang XB, 2001, BIOCHEM BIOPH RES CO, V287, P865, DOI 10.1006/bbrc.2001.5676; Zhang XB, 2001, ARCH PATHOL LAB MED, V125, P99; Zhang XB, 2001, ANN CLIN LAB SCI, V31, P187; Zhang XB, 2006, ANN CLIN LAB SCI, V36, P185	58	72	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25822	10.1371/journal.pone.0025822	http://dx.doi.org/10.1371/journal.pone.0025822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998702	gold, Green Submitted, Green Published			2022-12-25	WOS:000295966900059
J	Harvey, SC; Orbidans, HE				Harvey, Simon C.; Orbidans, Helen E.			All Eggs Are Not Equal: The Maternal Environment Affects Progeny Reproduction and Developmental Fate in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-HISTORY; DAUER LARVA; EVOLUTION; GROWTH; CYCLE; GENE; FOOD	Background: Maternal effects on progeny traits are common and these can profoundly alter progeny life history. Maternal effects can be adaptive, representing attempts to appropriately match offspring phenotype to the expected environment and are often mediated via trade-offs between progeny number and quality. Here we have investigated the effect of maternal food availability on progeny life history in the free-living nematode Caenorhabditis elegans. Methodology/Principal Findings: The maternal environment affects both reproductive traits and progeny development. Comparisons of the progeny of worms from high and low maternal food environments indicates that low maternal food availability reduces progeny reproduction in good environments, increases progeny reproduction in poor environments and decreases the likelihood that progeny will develop as dauer larvae. These analyses also indicate that the effects on progeny are not a simple consequence of changes in maternal body size, but are associated with an increase in the size of eggs produced by worms at low maternal food availabilities. Conclusions/Significance: These results indicate that the maternal environment affects both progeny reproduction and development in C. elegans and therefore that all progeny are not equal. The observed effects are consistent with changes to egg provisioning, which are beneficial in harsh environments, and of changes to progeny development, which are beneficial in harsh environments and detrimental in benign environments. These changes in progeny life history suggest that mothers in poor quality environments may be producing larger eggs that are better suited to poor conditions.	[Harvey, Simon C.; Orbidans, Helen E.] Canterbury Christ Church Univ, Ecol Res Grp, Dept Geog & Life Sci, Canterbury, Kent, England	Canterbury Christ Church University	Harvey, SC (corresponding author), Canterbury Christ Church Univ, Ecol Res Grp, Dept Geog & Life Sci, Canterbury, Kent, England.	simon.harvey@canterbury.ac.uk	Harvey, Simon/A-1263-2011	Harvey, Simon/0000-0002-7504-2227				Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere Antoine, 2005, P1; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Bernardo J, 1996, AM ZOOL, V36, P83; Bonte D, 2009, J EVOLUTION BIOL, V22, P1242, DOI 10.1111/j.1420-9101.2009.01737.x; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cleuvers M, 1997, OECOLOGIA, V110, P337, DOI 10.1007/s004420050167; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Fitzsimmons JM, 2006, HYDROBIOLOGIA, V568, P187, DOI 10.1007/s10750-006-0104-5; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hu PJ, 2007, DAUER WORMBOOK; LYNCH M, 1983, EXP GERONTOL, V18, P147, DOI 10.1016/0531-5565(83)90008-6; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Muschiol Daniel, 2009, BMC Ecol, V9, P14, DOI 10.1186/1472-6785-9-14; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasband WS, 1997, IMAGEJ; Roff Derek, 2002, pi; SKORPING A, 1991, OIKOS, V60, P365, DOI 10.2307/3545079; Stiernagle Theresa, 2006, WormBook, P1; Van Voorhies WA, 2005, BIOL LETTERS, V1, P247, DOI 10.1098/rsbl.2004.0278; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; WONG A, 1995, GENETICS, V139, P1247; Zhang TY, 2006, BIOL PSYCHOL, V73, P72, DOI 10.1016/j.biopsycho.2006.01.009	34	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25840	10.1371/journal.pone.0025840	http://dx.doi.org/10.1371/journal.pone.0025840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991370	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300025
J	Quental, TB; Marshall, CR				Quental, Tiago B.; Marshall, Charles R.			The Molecular Phylogenetic Signature of Clades in Decline	PLOS ONE			English	Article							DIVERSIFICATION RATES; EVOLUTIONARY RADIATIONS; EXTINCTION RATES; FOSSIL RECORD; MACROEVOLUTIONARY; MODELS	Molecular phylogenies have been used to study the diversification of many clades. However, current methods for inferring diversification dynamics from molecular phylogenies ignore the possibility that clades may be decreasing in diversity, despite the fact that the fossil record shows this to be the case for many groups. Here we investigate the molecular phylogenetic signature of decreasing diversity using the most widely used statistic for inferring diversity dynamics from molecular phylogenies, the gamma statistic. We show that if a clade is in decline its molecular phylogeny may show evidence of the decrease in the diversification rate that occurred between its diversification and decline phases. The ability to detect the change in diversification rate depends largely on the ratio of the speciation rates of the diversification and decline phases, the higher the ratio the stronger the signal of the change in diversification rate. Consequently, molecular phylogenies of clades in relative rapid decline do not carry a signature of their decreasing diversification. Further, the signal of the change in diversification rate, if present, declines as the diversity drop. Unfortunately, the molecular signature of clades in decline is the same as the signature produced by diversity dependent diversification. Given this similarity, and the inability of current methods to detect declining diversity, it is likely that some of the extant clades that show a decrease in diversification rate, currently interpreted as evidence for diversity dependent diversification, are in fact in decline. Unless methods can be developed that can discriminate between the different modes of diversification, specifically diversity dependent diversification and declining diversity, we will need the fossil record, or data from some other source, to distinguish between these very different diversity trajectories.	[Quental, Tiago B.] Univ Estadual Sao Paulo USP, Dept Ecol, Sao Paulo, Brazil; [Marshall, Charles R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Marshall, Charles R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Quental, TB (corresponding author), Univ Estadual Sao Paulo USP, Dept Ecol, Sao Paulo, Brazil.	tbquental@usp.br	Quental, Tiago B/C-7077-2013		University of California, Berkeley; Universidade de Sao Paulo, Brazil	University of California, Berkeley(University of California System); Universidade de Sao Paulo, Brazil	University of California, Berkeley and Universidade de Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Ezard THG, 2009, PALEOBIOLOGY, V35, P460, DOI 10.1666/0094-8373-35.3.460; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pyron RA, EVOLUTION  IN PRESS, DOI [10.1111/j.1558-5646.2011.01437.x, DOI 10.1111/J.1558-5646.2011.01437.X]; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2009, P ROY SOC B-BIOL SCI, V276, P995, DOI 10.1098/rspb.2008.1584; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Stadler T., 2010, TREESIM R SIMULATING; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Turgeon J, 2005, AM NAT, V165, pE78, DOI 10.1086/428682	30	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25780	10.1371/journal.pone.0025780	http://dx.doi.org/10.1371/journal.pone.0025780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991349	Green Submitted, gold, Green Published			2022-12-25	WOS:000295963300020
J	Boeglin, E; Smulski, CR; Brun, S; Milosevic, S; Schneider, P; Fournel, S				Boeglin, Emmanuelle; Smulski, Cristian R.; Brun, Susana; Milosevic, Sara; Schneider, Pascal; Fournel, Sylvie			Toll-Like Receptor Agonists Synergize with CD40L to Induce Either Proliferation or Plasma Cell Differentiation of Mouse B Cells	PLOS ONE			English	Article							IMMUNE-RESPONSE MODIFIERS; DENDRITIC CELLS; INNATE IMMUNITY; INFECTED MICE; CUTTING EDGE; T-CELLS; IN-VIVO; ACTIVATION; LYMPHOCYTES; EXPRESSION	In a classical dogma, pathogens are sensed (via recognition of Pathogen Associated Molecular Patterns (PAMPs)) by innate immune cells that in turn activate adaptive immune cells. However, recent data showed that TLRs (Toll Like Receptors), the most characterized class of Pattern Recognition Receptors, are also expressed by adaptive immune B cells. B cells play an important role in protective immunity essentially by differentiating into antibody-secreting cells (ASC). This differentiation requires at least two signals: the recognition of an antigen by the B cell specific receptor (BCR) and a T cell co-stimulatory signal provided mainly by CD154/CD40L acting on CD40. In order to better understand interactions of innate and adaptive B cell stimulatory signals, we evaluated the outcome of combinations of TLRs, BCR and/or CD40 stimulation. For this purpose, mouse spleen B cells were activated with synthetic TLR agonists, recombinant mouse CD40L and agonist anti-BCR antibodies. As expected, TLR agonists induced mouse B cell proliferation and activation or differentiation into ASC. Interestingly, addition of CD40 signal to TLR agonists stimulated either B cell proliferation and activation (TLR3, TLR4, and TLR9) or differentiation into ASC (TLR1/2, TLR2/6, TLR4 and TLR7). Addition of a BCR signal to CD40L and either TLR3 or TLR9 agonists did not induce differentiation into ASC, which could be interpreted as an entrance into the memory pathway. In conclusion, our results suggest that PAMPs synergize with signals from adaptive immunity to regulate B lymphocyte fate during humoral immune response.	[Boeglin, Emmanuelle; Smulski, Cristian R.; Brun, Susana; Milosevic, Sara; Fournel, Sylvie] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Boeglin, E (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France.	s.fournel@unistra.fr	Fournel, Sylvie/C-1195-2014; Brun, Susana/J-9865-2016	Fournel, Sylvie/0000-0003-3583-6548; Brun, Susana/0000-0002-7031-9733; Schneider, Pascal/0000-0003-0677-9409; Smulski, Cristian/0000-0003-4186-8116	Centre National de la Recherche Scientifique; Swiss National Research Fundation; French "Ministere de la Recherche"; Agence Nationale Recherche; Strasbourg University; foundation "Fundayacucho"; Fondation de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Swiss National Research Fundation; French "Ministere de la Recherche"(Ministry of Research, France); Agence Nationale Recherche(French National Research Agency (ANR)); Strasbourg University; foundation "Fundayacucho"; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	The authors gratefully acknowledge financial support from Centre National de la Recherche Scientifique (to SF) and of the Swiss National Research Fundation (to PS). EB was granted by the French "Ministere de la Recherche", CS by Agence Nationale Recherche and Strasbourg University and SB by the foundation "Fundayacucho" and by Fondation de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Casadevall A, 2006, ADV IMMUNOL, V91, P1, DOI 10.1016/S0065-2776(06)91001-3; COUTELIER JP, 1990, J VIROL, V64, P5383, DOI 10.1128/JVI.64.11.5383-5388.1990; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Durandy A, 2003, EUR J IMMUNOL, V33, P2069, DOI 10.1002/eji.200324133; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Gantner F, 2003, EUR J IMMUNOL, V33, P1576, DOI 10.1002/eji.200323444; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Knodel M, 2001, EUR J IMMUNOL, V31, P1972; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Marshall JD, 2005, DNA CELL BIOL, V24, P63, DOI 10.1089/dna.2005.24.63; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; OLDSTONE MB, 1969, J EXP MED, V129, P483, DOI 10.1084/jem.129.3.483; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Silverstein AM, 2003, NAT IMMUNOL, V4, P931, DOI 10.1038/ni1003-931; Soulas P, 2005, J CLIN INVEST, V115, P2257, DOI 10.1172/JCI24646; Spanedda MV, 2010, BIOORG MED CHEM LETT, V20, P1869, DOI 10.1016/j.bmcl.2010.01.146; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Underhill GH, 2002, BLOOD, V99, P2905, DOI 10.1182/blood.V99.8.2905; YANG LM, 1992, INFECT IMMUN, V60, P3033, DOI 10.1128/IAI.60.8.3033-3041.1992	49	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25542	10.1371/journal.pone.0025542	http://dx.doi.org/10.1371/journal.pone.0025542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991317	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000036
J	Kay, P; Schlossmacher, G; Matthews, L; Sommer, P; Singh, D; White, A; Ray, D				Kay, Paul; Schlossmacher, George; Matthews, Laura; Sommer, Paula; Singh, Dave; White, Anne; Ray, David			Loss of Glucocorticoid Receptor Expression by DNA Methylation Prevents Glucocorticoid Induced Apoptosis in Human Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE; CARCINOMA; LINES; SENSITIVITY; MECHANISMS	Human small cell lung cancer (SCLC) is highly aggressive, and quickly develops resistance to therapy. SCLC cells are typically insensitive to glucocorticoids due to impaired glucocorticoid receptor (GR) expression. This is important as we have previously shown that expression of a GR transgene induces cell death in-vitro, and inhibits tumor growth in-vivo. However, the underlying mechanism for loss of GR expression is unknown. The SCLC cell line, DMS79, has low GR expression, compared to non-SCLC cell lines and normal bronchial epithelial cells. Retroviral GR expression in DMS79 cells caused activation of the apoptotic pathway as evidenced by marked induction of caspase-3 activity. Methylation analysis of the GR promoter revealed some methylation in the 1D, and 1E promoters of the GR gene, however the ubiquitous constitutively active 1C promoter was heavily methylated. In the 1C promoter there was a highly significant increase in DNA methylation in a panel of 14 human SCLC cell lines compared to a mixed panel of GR expressing, and non-expressing cell lines, and to peripheral blood mononuclear cells. Furthermore, within the panel of SCLC cell lines there was a significant negative correlation seen between methylation of the 1C promoter, and GR protein expression. Reversal of GR gene methylation with DNA methyltransferase inhibition caused increased GR mRNA and protein expression in SCLC but not non-SCLC cells. This resulted in increased Gc sensitivity, decreased Bcl-2 expression and increased caspase-3 activity in SCLC cells. These data suggest that DNA methylation decreases GR gene expression in human SCLC cells, in a similar manner to that for conventional tumor suppressor genes.	[Kay, Paul; Matthews, Laura; Sommer, Paula; Singh, Dave; White, Anne; Ray, David] Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Schlossmacher, George; White, Anne] Univ Manchester, Fac Life Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Sommer, Paula] Univ KwaZulu Natal, Sch Biol Sci, Durban, South Africa	University of Manchester; University of Manchester; University of Kwazulu Natal	Kay, P (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	awhite@manchester.ac.uk; david.w.ray@manchester.ac.uk	Singh, Dave/AAH-4342-2020; Sommer, Paula/E-9454-2010; White, Anne/G-7717-2015	Singh, Dave/0000-0001-8918-7075; White, Anne/0000-0002-7686-2884; Ray, David/0000-0002-4739-6773; Sommer, Paula/0000-0001-6810-5587; Schlossmacher, George/0000-0001-7713-5729	NIHR Manchester Biomedical Research Centre; University of Manchester Alumni association; BBSRC; Barbara Mawer endowed studentship	NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); University of Manchester Alumni association; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Barbara Mawer endowed studentship	This work was supported by the NIHR Manchester Biomedical Research Centre and University of Manchester Alumni association. PK and GS have received a BBSRC studentship award (http://www.bbsrc.ac.uk). GS also has a Barbara Mawer endowed studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLIEJOHNSON H, 1985, BRIT J CANCER, V52, P495, DOI 10.1038/bjc.1985.220; Berry A, 2010, FASEB J, V24, P1700, DOI 10.1096/fj.09-139998; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Kayahara M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1047, DOI 10.1152/ajpendo.90429.2008; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Matthews L, 2009, ENDOCRINOLOGY, V150, P75, DOI 10.1210/en.2008-0196; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Piperi C, 2008, J CELL MOL MED, V12, P1495, DOI 10.1111/j.1582-4934.2008.00309.x; RAY DW, 1994, J CLIN INVEST, V93, P1625, DOI 10.1172/JCI117143; Ray DW, 1996, CANCER RES, V56, P3276; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Sommer P, 2010, ENDOCR-RELAT CANCER, V17, P203, DOI 10.1677/ERC-09-0241; Stevens A, 2004, J CLIN ENDOCR METAB, V89, P892, DOI 10.1210/jc.2003-031235; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	24	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24839	10.1371/journal.pone.0024839	http://dx.doi.org/10.1371/journal.pone.0024839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984896	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000006
J	Rajakannan, V; Lee, HS; Chong, SH; Ryu, HB; Bae, JY; Whang, EY; Huh, JW; Cho, SW; Kang, LW; Choe, H; Robinson, RC				Rajakannan, Venkatachalam; Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Whang, Eun-Young; Huh, Jae-Wan; Cho, Sung-Woo; Kang, Lin-Woo; Choe, Han; Robinson, Robert C.			Structural Basis of Cooperativity in Human UDP-Glucose Dehydrogenase	PLOS ONE			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; GROUP-A STREPTOCOCCI; BOVINE LIVER; MOLECULAR CHARACTERIZATION; CDNA CLONING; EXPRESSION; HYALURONAN; BINDING; GENE; PURIFICATION	Background: UDP-glucose dehydrogenase (UGDH) is the sole enzyme that catalyzes the conversion of UDP-glucose to UDP-glucuronic acid. The product is used in xenobiotic glucuronidation in hepatocytes and in the production of proteoglycans that are involved in promoting normal cellular growth and migration. Overproduction of proteoglycans has been implicated in the progression of certain epithelial cancers, while inhibition of UGDH diminished tumor angiogenesis in vivo. A better understanding of the conformational changes occurring during the UGDH reaction cycle will pave the way for inhibitor design and potential cancer therapeutics. Methodology: Previously, the substrate-bound of UGDH was determined to be a symmetrical hexamer and this regular symmetry is disrupted on binding the inhibitor, UDP-alpha-D-xylose. Here, we have solved an alternate crystal structure of human UGDH (hUGDH) in complex with UDP-glucose at 2.8 angstrom resolution. Surprisingly, the quaternary structure of this substrate-bound protein complex consists of the open homohexamer that was previously observed for inhibitor-bound hUGDH, indicating that this conformation is relevant for deciphering elements of the normal reaction cycle. Conclusion: In all subunits of the present open structure, Thr131 has translocated into the active site occupying the volume vacated by the absent active water and partially disordered NAD(+) molecule. This conformation suggests a mechanism by which the enzyme may exchange NADH for NAD(+) and repolarize the catalytic water bound to Asp280 while protecting the reaction intermediates. The structure also indicates how the subunits may communicate with each other through two reaction state sensors in this highly cooperative enzyme.	[Rajakannan, Venkatachalam; Robinson, Robert C.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Choe, Han] Univ Ulsan, Dept Physiol, Coll Med, Seoul, South Korea; [Lee, Hui-Sun; Chong, Seon-Ha; Ryu, Han-Bong; Bae, Ji-Young; Choe, Han] Univ Ulsan, Biomed Inst Technol, Coll Med, Seoul, South Korea; [Whang, Eun-Young; Huh, Jae-Wan; Cho, Sung-Woo] Univ Ulsan, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Kang, Lin-Woo] Kunkuk Univ, Dept Adv Technol Fus, Seoul, South Korea	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Ulsan; University of Ulsan; University of Ulsan; Konkuk University	Rajakannan, V (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	hchoe@amc.seoul.kr	VENKATACHALAM, RAJAKANNAN/G-3684-2017; choe, han/A-5679-2010; Robinson, Robert/G-9702-2011	VENKATACHALAM, RAJAKANNAN/0000-0002-4129-9227; choe, han/0000-0003-4604-647X; Robinson, Robert/0000-0001-6367-6903	Korea Research Foundation [NRF-2010-R13-0029522]; Brain Research Center of the 21st Century Frontier Research Program [2011K000279]; Biomedical Research Council of A*STAR	Korea Research Foundation(National Research Foundation of Korea); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was funded by the Korea Research Foundation (http://www.krf.or.kr/KHPapp/eng/mainc.jsp) (NRF-2010-R13-0029522), the Brain Research Center of the 21st Century Frontier Research Program (http://english.mest.go.kr/enMain.do) (2011K000279), and the Biomedical Research Council of A*STAR (http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARRECUBIETA C, 1994, J BACTERIOL, V176, P6375, DOI 10.1128/jb.176.20.6375-6383.1994; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CHEN A, 1974, CARBOHYD RES, V37, P155, DOI 10.1016/S0008-6215(00)87071-8; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2011, J BIOL CHEM IN PRESS; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1981, TRENDS BIOCHEM SCI, V6, P103, DOI 10.1016/0968-0004(81)90038-4; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; HEMPEL J, 1994, PROTEIN SCI, V3, P1074, DOI 10.1002/pro.5560030710; Huh JW, 2006, PROTEIN PEPTIDE LETT, V13, P859; Huh JW, 2007, J BIOCHEM MOL BIOL, V40, P690; Huh JW, 2004, J BIOL CHEM, V279, P37491, DOI 10.1074/jbc.M404234200; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; JANSEN PLM, 1992, HEPATOLOGY, V15, P532, DOI 10.1002/hep.1840150328; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Lind T, 1999, GLYCOBIOLOGY, V9, P595, DOI 10.1093/glycob/9.6.595; Lokeshwar VB, 1996, CANCER RES, V56, P651; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLZ RJ, 1971, BIOCHIM BIOPHYS ACTA, V250, P6, DOI 10.1016/0005-2744(71)90114-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RIDLEY WP, 1975, J BIOL CHEM, V250, P8761; Ropponen K, 1998, CANCER RES, V58, P342; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wegrowski Y, 1998, BIOCHEM BIOPH RES CO, V250, P206, DOI 10.1006/bbrc.1998.9262; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; ZALITIS J, 1969, ARCH BIOCHEM BIOPHYS, V132, P457, DOI 10.1016/0003-9861(69)90389-0; ZEMEL E, 1989, J RHEUMATOL, V16, P825	49	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25226	10.1371/journal.pone.0025226	http://dx.doi.org/10.1371/journal.pone.0025226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984906	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000017
J	Taneja, N; Nato, F; Dartevelle, S; Sire, JM; Garin, B; Lan, NTP; Diep, TT; Shako, JC; Bimet, F; Filliol, I; Muyembe, JJ; Ungeheuer, MN; Ottone, C; Sansonetti, P; Germani, Y				Taneja, Neelam; Nato, Faridabano; Dartevelle, Sylvie; Sire, Jean Marie; Garin, Benoit; Lan Nguyen Thi Phuong; Tai The Diep; Shako, Jean Christophe; Bimet, Francois; Filliol, Ingrid; Muyembe, Jean-Jacques; Ungeheuer, Marie Noelle; Ottone, Catherine; Sansonetti, Philippe; Germani, Yves			Dipstick Test for Rapid Diagnosis of Shigella dysenteriae 1 in Bacterial Cultures and Its Potential Use on Stool Samples	PLOS ONE			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; SHIGA-BACILLUS DYSENTERY; ANTIMICROBIAL RESISTANCE; CONJUGATE VACCINES; VIBRIO-CHOLERAE; CENTRAL-AMERICA; EPIDEMIC; TYPE-1; IDENTIFICATION; INVASION	Background: We describe a test for rapid detection of S. dysenteriae 1 in bacterial cultures and in stools, at the bedside of patients. Methodology/Principal Findings: The test is based on the detection of S. dysenteriae 1 lipopolysaccharide (LPS) using serotype 1-specific monoclonal antibodies coupled to gold particles and displayed on a one-step immunochromatographic dipstick. A concentration as low as 15 ng/ml of LPS was detected in distilled water and in reconstituted stools in 10 minutes. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 1.6x10(6) CFU/ml and 4.9x10(6) CFU/ml of S. dysenteriae 1, respectively. Optimal conditions to read the test have been determined to limit the risk of ambiguous results due to appearance of a faint yellow test band in some negative samples. The specificity was 100% when tested with a battery of Shigella and unrelated strains in culture. When tested on 328 clinical samples in India, Vietnam, Senegal and France by laboratory technicians and in Democratic Republic of Congo by a field technician, the specificity (312/316) was 98.7% (95% CI: 96.6-99.6%) and the sensitivity (11/12) was 91.7% (95% CI: 59.8-99.6%). Stool cultures and the immunochromatographic test showed concordant results in 98.4 % of cases (323/328) in comparative studies. Positive and negative predictive values were 73.3% (95% CI: 44.8-91.1%) and 99.7% (95% CI: 98-100%). Conclusion: The initial findings presented here for a simple dipstick-based test to diagnose S. dysenteriae 1 demonstrates its promising potential to become a powerful tool for case management and epidemiological surveys.	[Taneja, Neelam] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Sire, Jean Marie; Garin, Benoit] Inst Pasteur, Med Biol Lab, Dakar, Senegal; [Lan Nguyen Thi Phuong; Tai The Diep] Pasteur Inst Ho Chi Minh City, Dept Immunol & Microbiol, Ho Chi Minh City, Vietnam; [Bimet, Francois] Inst Pasteur, Ctr Ressources Biol, Paris, France; [Shako, Jean Christophe] Antenne Med Bunia, Bunia, DEM REP CONGO; [Filliol, Ingrid] Inst Pasteur, Ctr Natl Reference Escherichia Coli & Shigella, Unite Rech & Expertise Bacteries Pathogenes Enter, Paris, France; [Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Sansonetti, Philippe; Germani, Yves] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Germani, Yves] BioSpeedia Soc Act Simplifee, Orsay, France	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute Nacional de Recherche Biomedical; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Taneja, N (corresponding author), Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India.	ygermani@pasteur.fr	Diep, Tai/ABG-9477-2021	Diep, Tai/0000-0001-7166-6369; TANEJA, NEELAM/0000-0003-1198-6138	Institute Pasteur [PTR 179]; TOTAL Societe Anonyme	Institute Pasteur; TOTAL Societe Anonyme	This work was supported by the Institute Pasteur (grant PTR 179). Additionally, part of the work was supported by a grant from TOTAL Societe Anonyme (http://www.total.com/en/home-page-940596.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agtini MD, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-89; [Anonymous], 1995, Lancet, V345, P339; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; BENNISH ML, 1991, REV INFECT DIS, V13, pS245; BLACK RE, 1986, DEV VACCINES DRUGS D, P23; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dutta P, 1995, Indian Pediatr, V32, P313; Dykman LA, 2000, FEMS IMMUNOL MED MIC, V27, P135, DOI 10.1111/j.1574-695X.2000.tb01423.x; ECHEVERRIA P, 1991, REV INFECT DIS, V13, pS220; Engels D, 1995, B WORLD HEALTH ORGAN, V73, P787; Feng L, 2007, MICROBIOL-SGM, V153, P139, DOI 10.1099/mic.0.2006/001107-0; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guerin PJ, 2003, LANCET, V362, P705, DOI 10.1016/S0140-6736(03)14227-4; IIJIMA Y, 1995, LANCET, V345, P69, DOI 10.1016/S0140-6736(95)91197-9; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; LINDBERG AA, 1999, REV INFECT DIS S4, V13, pS279; MATA LJ, 1970, J INFECT DIS, V122, P170, DOI 10.1093/infdis/122.3.170; MENDIZAB.CA, 1971, AM J TROP MED HYG, V20, P927, DOI 10.4269/ajtmh.1971.20.927; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Nato F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000361; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niyogi SK, 2003, JPN J INFECT DIS, V56, P33; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Passwell JH, 2001, INFECT IMMUN, V69, P1351, DOI 10.1128/IAI.69.3.1351-1357.2001; Pazhani GP, 2004, ANTIMICROB AGENTS CH, V48, P681, DOI 10.1128/AAC.48.2.681-684.2004; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; RICCI KA, 2006, NATURE S1, V23, P29; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; Rollins NC, 1995, J TROP PEDIATRICS, V41, P281, DOI 10.1093/tropej/41.5.281; RONSMANS C, 1988, LANCET, V2, P552; Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Szakal D, 2003, DIAGN MICR INFEC DIS, V45, P165, DOI 10.1016/S0732-8893(02)00512-6; Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06; TAYLOR DN, 1993, INFECT IMMUN, V61, P3678, DOI 10.1128/IAI.61.9.3678-3687.1993; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17; Wang XY, 2005, AM J TROP MED HYG, V73, P416, DOI 10.4269/ajtmh.2005.73.416; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; 2005, WHO WEEKLY EPIDEMIOL, V80, P93; 1994, MMWR MORB MORTAL WKL, V43, P701	55	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24830	10.1371/journal.pone.0024830	http://dx.doi.org/10.1371/journal.pone.0024830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984895	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000005
J	Yahata, N; Asai, M; Kitaoka, S; Takahashi, K; Asaka, I; Hioki, H; Kaneko, T; Maruyama, K; Saido, TC; Nakahata, T; Asada, T; Yamanaka, S; Iwata, N; Inoue, H				Yahata, Naoki; Asai, Masashi; Kitaoka, Shiho; Takahashi, Kazutoshi; Asaka, Isao; Hioki, Hiroyuki; Kaneko, Takeshi; Maruyama, Kei; Saido, Takaomi C.; Nakahata, Tatsutoshi; Asada, Takashi; Yamanaka, Shinya; Iwata, Nobuhisa; Inoue, Haruhisa			Anti-A beta Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TRANSGENIC MOUSE MODEL; AMYLOID-BETA; GAMMA-SECRETASE; A-BETA-42; PROTEIN; DIFFERENTIATION; FIBROBLASTS; GLUTAMINASE; DEPOSITION	Background: Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive memory and cognitive decline during middle to late adult life. The AD brain is characterized by deposition of amyloid beta peptide (A beta), which is produced from amyloid precursor protein by beta- and gamma-secretase (presenilin complex)-mediated sequential cleavage. Induced pluripotent stem (iPS) cells potentially provide an opportunity to generate a human cell-based model of AD that would be crucial for drug discovery as well as for investigating mechanisms of the disease. Methodology/Principal Findings: We differentiated human iPS (hiPS) cells into neuronal cells expressing the forebrain marker, Foxg1, and the neocortical markers, Cux1, Satb2, Ctip2, and Tbr1. The iPS cell-derived neuronal cells also expressed amyloid precursor protein, beta-secretase, and gamma-secretase components, and were capable of secreting A beta into the conditioned media. A beta production was inhibited by beta-secretase inhibitor, gamma-secretase inhibitor (GSI), and an NSAID; however, there were different susceptibilities to all three drugs between early and late differentiation stages. At the early differentiation stage, GSI treatment caused a fast increase at lower dose (A beta surge) and drastic decline of A beta production. Conclusions/Significance: These results indicate that the hiPS cell-derived neuronal cells express functional beta- and gamma-secretases involved in A beta production; however, anti-A beta drug screening using these hiPS cell-derived neuronal cells requires sufficient neuronal differentiation.	[Yahata, Naoki; Kitaoka, Shiho; Takahashi, Kazutoshi; Asaka, Isao; Nakahata, Tatsutoshi; Yamanaka, Shinya; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Yamanaka, Shinya; Inoue, Haruhisa] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Saitama, Japan; [Asai, Masashi; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Saitama, Japan; [Asai, Masashi; Saido, Takaomi C.; Iwata, Nobuhisa] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto, Japan; [Asada, Takashi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Tsukuba, Ibaraki 305, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Kyoto University; Japan Science & Technology Agency (JST); Saitama Medical University; RIKEN; Kyoto University; University of Tsukuba; Nagasaki University	Yahata, N (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	iwata-n@nagasaki-u.ac.jp; haruhisa@cira.kyoto-u.ac.jp	Asai, Masashi/AAB-7672-2022; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Takahashi, Kazutoshi/ABE-5504-2020; Hioki, Hiroyuki/J-9412-2017	Asai, Masashi/0000-0001-6392-0910; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Takahashi, Kazutoshi/0000-0002-5329-8395; Hioki, Hiroyuki/0000-0002-0152-7854; Inoue, Haruhisa/0000-0003-4736-9537	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; NOVARTIS Foundation for Gerontological Research	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NOVARTIS Foundation for Gerontological Research(Novartis Foundation for Gerontological Research)	This study was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (HI & NI), and a research grant from the NOVARTIS Foundation for Gerontological Research (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J COMP NEUROL, V297, P239, DOI 10.1002/cne.902970207; Asai M, 2010, J NEUROSCI RES, V88, P3588, DOI 10.1002/jnr.22503; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KANEKO T, 1987, J NEUROSCI, V7, P302; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lazarov O, 2002, J NEUROSCI, V22, P9785; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853	47	126	145	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25788	10.1371/journal.pone.0025788	http://dx.doi.org/10.1371/journal.pone.0025788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984949	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300059
J	Sun, HY; Ou, NY; Wang, SW; Liu, WC; Cheng, TF; Shr, SJ; Sun, KT; Chang, TT; Young, KC				Sun, Hung-Yu; Ou, Nai-Ying; Wang, Shainn-Wei; Liu, Wen-Chun; Cheng, Ting-Fang; Shr, Shiou-Jiuan; Sun, Koun-Tem; Chang, Ting-Tsung; Young, Kung-Chia			Novel Nucleotide and Amino Acid Covariation between the 5 ' UTR and the NS2/NS3 Proteins of Hepatitis C Virus: Bioinformatic and Functional Analyses	PLOS ONE			English	Article							5' NONTRANSLATED REGION; RIBOSOME ENTRY SITE; STEM-LOOP STRUCTURE; RNA-RNA INTERACTION; ANTIVIRAL THERAPY; CRYSTAL-STRUCTURE; REPLICATION; NS2; TRANSLATION; MUTATIONS	Molecular covariation of highly polymorphic viruses is thought to have crucial effects on viral replication and fitness. This study employs association rule data mining of hepatitis C virus (HCV) sequences to search for specific evolutionary covariation and then tests functional relevance on HCV replication. Data mining is performed between nucleotides in the untranslated regions 5' and 3'UTR, and the amino acid residues in the non-structural proteins NS2, NS3 and NS5B. Results indicate covariance of the 243(rd) nucleotide of the 5'UTR with the 14(th), 41(st), 76(th), 110(th), 211(th) and 212(th) residues of NS2 and with the 71(st), 175(th) and 621(st) residues of NS3. Real-time experiments using an HCV subgenomic system to quantify viral replication confirm replication regulation for each covariant pair between 5'UTR243 and NS2-41, -76, -110, -211, and NS3-71, -175. The HCV subgenomic system with/without the NS2 region shows that regulatory effects vanish without NS2, so replicative modulation mediated by HCV 5'UTR243 depends on NS2. Strong binding of the NS2 variants to HCV RNA correlates with reduced HCV replication whereas weak binding correlates with restoration of HCV replication efficiency, as determined by RNA-protein immunoprecipitation assay band intensity. The dominant haplotype 5'UTR243-NS2-41-76-110-211-NS3-71-175 differs according to the HCV genotype: G-Ile-Ile-Ile-Gly-Ile-Met for genotype 1b and A-Leu-Val-Leu-Ser-Val-Leu for genotypes 1a, 2a and 2b. In conclusion, 5'UTR243 co-varies with specific NS2/3 protein amino acid residues, which may have significant structural and functional consequences for HCV replication. This unreported mechanism involving HCV replication possibly can be exploited in the development of advanced anti-HCV medication.	[Sun, Hung-Yu; Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Ou, Nai-Ying; Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Wang, Shainn-Wei; Cheng, Ting-Fang] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Liu, Wen-Chun] MingDao Univ, Coll Appl Sci, Dept Biotechnol, Changhua, Taiwan; [Shr, Shiou-Jiuan; Sun, Koun-Tem] Natl Univ Tainan, Dept Informat & Learning Technol, Sci & Engn Coll, Tainan, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Chang, Ting-Tsung; Young, Kung-Chia] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Mingdao University; National University Tainan; National Cheng Kung University; National Cheng Kung University	Sun, HY (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	t7908077@mail.ncku.edu.tw	Wang, Shainn-Wei/B-9644-2009; Young, Kung-Chia/G-1529-2011		National Science Council of Taiwan [NSC 96-2628-B-006-007-MY3, NSC 99-2320-B-006-015-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan under grant numbers NSC 96-2628-B-006-007-MY3 and NSC 99-2320-B-006-015MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Diviney S, 2008, J VIROL, V82, P9008, DOI 10.1128/JVI.02326-07; Dutkiewicz M, 2008, BIOCHEMISTRY-US, V47, P12197, DOI 10.1021/bi800348g; Edelstein HA, 1999, INTRO DATA MINING KN; El Awady MK, 2009, WORLD J GASTROENTERO, V15, P1480, DOI 10.3748/wjg.15.1480; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Han J, 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Honda M, 1999, J VIROL, V73, P4941, DOI 10.1128/JVI.73.6.4941-4951.1999; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Laporte J, 2003, BLOOD, V101, P52, DOI 10.1182/blood-2002-03-0818; Lerat H, 2000, J VIROL, V74, P7024, DOI 10.1128/JVI.74.15.7024-7031.2000; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Luo GX, 2003, J VIROL, V77, P3312, DOI 10.1128/JVI.77.5.3312-3318.2003; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nakajima N, 1996, J VIROL, V70, P3325, DOI 10.1128/JVI.70.5.3325-3329.1996; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Paul S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-62; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pelemans H, 2001, VIROLOGY, V287, P143, DOI 10.1006/viro.2001.1032; She YL, 2008, ARCH VIROL, V153, P1991, DOI 10.1007/s00705-008-0198-3; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Tan SH, 2004, NUCLEIC ACIDS RES, V32, pW69, DOI 10.1093/nar/gkh471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Witten I. H., 2005, DATA MINING PRACTICA; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Xu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	53	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25530	10.1371/journal.pone.0025530	http://dx.doi.org/10.1371/journal.pone.0025530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980483	Green Published, gold			2022-12-25	WOS:000295936900075
J	Diaz-Vera, J; Camacho, M; Machado, JD; Dominguez, N; Montesinos, MS; Hernandez-Fernaud, JR; Lujan, R; Borges, R				Diaz-Vera, Jesica; Camacho, Marcial; David Machado, Jose; Dominguez, Natalia; Montesinos, Monica S.; Hernandez-Fernaud, Juan R.; Lujan, Rafael; Borges, Ricardo			Chromogranins A and B are key proteins in amine accumulation, but the catecholamine secretory pathway is conserved without them	FASEB JOURNAL			English	Article						adrenal; amperometry; chromaffin cells	GRANULE BIOGENESIS; TARGETED ABLATION; CHROMAFFIN CELLS; EXOCYTOSIS; FIBRINOGEN; AMPEROMETRY; ASSAY; GENE	Chromogranins are the main soluble proteins in the large dense core secretory vesicles (LDCVs) found in aminergic neurons and chromaffin cells. We recently demonstrated that chromogranins A and B each regulate the concentration of adrenaline in chromaffin granules and its exocytosis. Here we have further studied the role played by these proteins by generating mice lacking both chromogranins. Surprisingly, these animals are both viable and fertile. Although chromogranins are thought to be essential for their biogenesis, LDCVs were evident in these mice. These vesicles do have a somewhat atypical appearance and larger size. Despite their increased size, single-cell amperometry recordings from chromaffin cells showed that the amine content in these vesicles is reduced by half. These data demonstrate that although chromogranins regulate the amine concentration in LDCVs, they are not completely essential, and other proteins unrelated to neurosecretion, such as fibrinogen, might compensate for their loss to ensure that vesicles are generated and the secretory pathway conserved.-DiazVera, J., Camacho, M., Machado, J. D., Dominguez, N., Montesinos, M. S., Hernandez-Fernaud, J. R., Lujan, R., Borges, R. Chromogranins A and B are key proteins in amine accumulation, but the catecholamine secretory pathway is conserved without them. FASEB J. 26, 430-438 (2012). www.fasebj.org	[Diaz-Vera, Jesica; Camacho, Marcial; David Machado, Jose; Dominguez, Natalia; Montesinos, Monica S.; Hernandez-Fernaud, Juan R.; Borges, Ricardo] Univ La Laguna, Fac Med, Unidad Farmacol, ES-38071 Tenerife, Spain; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain	Universidad de la Laguna; Universidad de Castilla-La Mancha	Borges, R (corresponding author), Univ La Laguna, Fac Med, Unidad Farmacol, ES-38071 Tenerife, Spain.	rborges@ull.es	Diaz Vera, Jesica/N-3082-2015; Fernaud, Juan Ramon Hernandez/H-9190-2015; Lujan, Rafael/G-2555-2015; Borges, Ricardo/N-3250-2014; Machado, José David/N-5210-2014; Dominguez, Natalia/ABG-7769-2020	Diaz Vera, Jesica/0000-0002-0750-8267; Fernaud, Juan Ramon Hernandez/0000-0003-2807-0601; Borges, Ricardo/0000-0003-3413-4392; Machado, José David/0000-0003-3531-7051; Camacho Perez, Marcial/0000-0002-2367-1259; Lujan Miras, Rafael/0000-0003-2001-9545; Dominguez, Natalia/0000-0002-2615-3414	Spanish Ministry of Science and Innovation (MICINN); Consolider contract [CSD2008-00005]; Spanish Ministry of Science and Innovation [BFU2010-15822]; Canary Islands Agency for Research, Innovation and Information Society [PI2007/017]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider contract; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Canary Islands Agency for Research, Innovation and Information Society	J.D.V. and N.D. are the recipients of a FPU fellowship from the Spanish Ministry of Science and Innovation (MICINN). J.D.M. holds a Consolider contract (CSD2008-00005). This work was supported by the Spanish Ministry of Science and Innovation (BFU2010-15822) and Consolider (R. B.), and the Canary Islands Agency for Research, Innovation and Information Society PI2007/017 (J.D.M.). The authors are grateful to Daniel O'Connor and Sushil Mahata (University of California, San Diego, CA, USA) for providing the CgA<SUP>-/-</SUP> mice, and to Wieland Huttner and Federico Callegari (Max Planck Institute of Molecular Biology and Genetics, Dresden, Germany) for providing the CgB<SUP>-/-</SUP> mice. Agustin Castaneyra and Emilia Carmona helped to obtain the immunocytochemistry images. The authors also thank the personnel of the animal house of the University of La Laguna for maintaining the mouse strains. Discussions with Humberto Viveros, Lucio Diaz-Flores, Reiner Fischer-Colbrie, and Mark Sefton were whole-heartedly appreciated. The authors declare no conflicts of interest.	BORGES R, 1986, J NEUROSCI METH, V16, P289, DOI 10.1016/0165-0270(86)90054-3; Borges R, 1997, J BIOL CHEM, V272, P8325, DOI 10.1074/jbc.272.13.8325; Borges R, 2010, J NEUROCHEM, V114, P335, DOI 10.1111/j.1471-4159.2010.06786.x; Colliver TL, 2001, J NEUROSCI METH, V105, P95, DOI 10.1016/S0165-0270(00)00359-9; Courel M, 2010, J BIOL CHEM, V285, P10030, DOI 10.1074/jbc.M109.064196; Crivellato E, 2003, ANAT REC PART A, V270A, P103, DOI 10.1002/ar.a.10013; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Diaz-Vera J, 2010, J NEUROSCI, V30, P950, DOI 10.1523/JNEUROSCI.2894-09.2010; Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; Helle KB, 2000, ADV EXP MED BIOL, V482, P3; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Machado David J., 2008, V440, P297, DOI 10.1007/978-1-59745-178-9_23; Machado JD, 2000, J BIOL CHEM, V275, P20274, DOI 10.1074/jbc.M000930200; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Martini S, 2007, BIOMACROMOLECULES, V8, P2689, DOI 10.1021/bm070273n; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Mosharov EV, 2003, J NEUROSCI, V23, P5835; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; NAGATSU T, 1979, ANAL BIOCHEM, V93, P82, DOI 10.1016/S0003-2697(79)80119-0; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; SantoDomingo J, 2008, EUR J NEUROSCI, V28, P1265, DOI 10.1111/j.1460-9568.2008.06440.x; Segura F, 2000, J NEUROSCI METH, V103, P151, DOI 10.1016/S0165-0270(00)00309-5; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; Zhang JZ, 1996, J BIOL CHEM, V271, P12674, DOI 10.1074/jbc.271.21.12674; Zhang JZ, 1996, J BIOL CHEM, V271, P30083, DOI 10.1074/jbc.271.47.30083	35	38	38	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					430	438		10.1096/fj.11-181941	http://dx.doi.org/10.1096/fj.11-181941			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21990378				2022-12-25	WOS:000299202200042
J	Kang, HJ; Kwak, HI; Kaunas, R; Bayless, KJ				Kang, Hojin; Kwak, Hyeong-Il; Kaunas, Roland; Bayless, Kayla J.			Fluid Shear Stress and Sphingosine 1-Phosphate Activate Calpain to Promote Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Membrane Translocation and Endothelial Invasion into Three-dimensional Collagen Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-VESSELS; CELL INVASION; GROWTH-FACTOR; CALPAIN/CALPASTATIN NETWORK; MOLECULAR-BASIS; ANGIOGENESIS; FLOW; MORPHOGENESIS; ADHESION; LUMEN	The vascular endothelium continually senses and responds to biochemical and mechanical stimuli to appropriately initiate angiogenesis. We have shown previously that fluid wall shear stress (WSS) and sphingosine 1-phosphate (S1P) cooperatively initiate the invasion of human umbilical vein endothelial cells into collagen matrices (Kang, H., Bayless, K. J., and Kaunas, R. (2008) Am. J. Physiol. Heart Circ. Physiol. 295, H2087-2097). Here, we investigated the role of calpains in the regulation of endothelial cell invasion in response to WSS and S1P. Calpain inhibition significantly decreased S1P- and WSS-induced invasion. Short hairpin RNA-mediated gene silencing demonstrated that calpain 1 and 2 were required for WSS and S1P-induced invasion. Also, S1P synergized with WSS to induce invasion and to activate calpains and promote calpain membrane localization. Calpain inhibition results in a cell morphology consistent with reduced matrix proteolysis. Membrane type 1-matrix metalloproteinase (MT1-MMP) has been shown by others to regulate endothelial cell invasion, prompting us to test whether calpain acted upstream of MT1-MMP. S1P and WSS synergistically activated MT1-MMP and induced cell membrane localization of MT1-MMP in a calpain-dependent manner. Calpain activation, MT1-MMP activation and MT1-MMP membrane localization were all maximal with 5.3 dynes/cm(2) WSS and S1P treatment, which correlated with maximal invasion responses. Our data show for the first time that 5.3 dynes/cm(2) WSS in the presence of S1P combine to activate calpains, which direct MT1-MMP membrane localization to initiate endothelial sprouting into three-dimensional collagen matrices.	[Kwak, Hyeong-Il; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Kang, Hojin; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu			National Institutes of Health [R01 HL09576]; American Heart Association [0530020N, 0730238N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL09576 (to K. J. B.). This work was also supported by American Heart Association Scientist Development Grants 0530020N (to K. J. B.) and 0730238N (to R. K.).	Ariyoshi H, 2001, J CELL BIOCHEM, V81, P184, DOI 10.1002/1097-4644(20010401)81:1<184::AID-JCB1034>3.3.CO;2-7; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Boisseau MR, 2005, CLIN HEMORHEOL MICRO, V33, P201; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Clark ER, 1931, ANAT REC, V50, P129, DOI 10.1002/ar.1090500203; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hoang MV, 2011, BBA-MOL BASIS DIS, V1812, P549, DOI 10.1016/j.bbadis.2010.08.008; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Kang HJ, 2008, AM J PHYSIOL-HEART C, V295, pH2087, DOI 10.1152/ajpheart.00281.2008; KAUNAS R, 2011, CELL MOL BI IN PRESS; Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182; Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Langlois S, 2007, MOL CANCER RES, V5, P569, DOI 10.1158/1541-7786.MCR-06-0267; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martyre MC, 1997, BRIT J HAEMATOL, V97, P441, DOI 10.1046/j.1365-2141.1997.292671.x; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Nasu R, 1999, BRIT J CANCER, V79, P780, DOI 10.1038/sj.bjc.6690125; NEREM RM, 1993, J BIOMECH ENG-T ASME, V115, P510, DOI 10.1115/1.2895532; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Su SC, 2008, AM J PHYSIOL-CELL PH, V295, pC1215, DOI 10.1152/ajpcell.00336.2008; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Tamada Y, 2000, J OCUL PHARMACOL TH, V16, P271, DOI 10.1089/jop.2000.16.271; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yatomi Y, 1997, J BIOCHEM, V121, P969; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	66	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42017	42026		10.1074/jbc.M111.290841	http://dx.doi.org/10.1074/jbc.M111.290841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002053	Green Published, hybrid			2022-12-25	WOS:000298180900012
J	Clarke, BR; Richards, MR; Greenfield, LK; Hou, DJ; Lowary, TL; Whitfield, C				Clarke, Bradley R.; Richards, Michele R.; Greenfield, Laura K.; Hou, Dianjie; Lowary, Todd L.; Whitfield, Chris			In Vitro Reconstruction of the Chain Termination Reaction in Biosynthesis of the Escherichia coli O9a O-Polysaccharide THE CHAIN-LENGTH REGULATOR, WbdD, CATALYZES THE ADDITION OF METHYL PHOSPHATE TO THE NON-REDUCING TERMINUS OF THE GROWING GLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; SERUM RESISTANCE; LIPOPOLYSACCHARIDE; ANTIGEN; EXPRESSION; MUTANTS; SYSTEM; EXPORT; GENE; PROTEINS	The Escherichia coli O9a O-polysaccharide (O-PS) represents a model system for glycan biosynthesis and export by the ATP-binding cassette (ABC) transporter-dependent pathway. The polymannose O9a O-PS is synthesized using an undecaprenol-diphosphate-linked acceptor by mannosyltransferases located at the cytoplasmic membrane. An ABC-transporter subsequently exports the polymer to the periplasm where it is assembled onto lipopolysaccharide prior to translocation to the cell surface. The chain length of the O9a O-PS is regulated by the dual kinase/methyltransferase activity of the WbdD enzyme and modification of the polymer is crucial for binding and export by the ABC-transporter. Previous biochemical data provided evidence for phosphorylation/methylation at the non-reducing end of the O9a O-PS but the structure of the terminus has not been determined. Here, we describe the exploitation of a synthetic O9a O-PS repeating unit carrying a fluorescent tag as an acceptor for in vitro phosphorylation and methylation by a purified soluble form of WbdD. Phosphorylation of the acceptor was evident by both a mobility shift in thin layer chromatography and radiolabeling of the acceptor using [gamma-P-33]ATP. Methylation of the acceptor was dependent on phosphorylation and was demonstrated by radiolabeling using S-[methyl-H-3]adenosylmethionine as a substrate, in the presence of ATP. NMR spectroscopic and mass spectrometric methods were used to determine the precise structure of the terminal modification, leading to the conclusion that WbdD catalyzes the addition of a novel methyl phosphate group to the 3-position of the non-reducing terminal mannose of the O9a O-PS repeating unit.	[Clarke, Bradley R.; Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Hou, Dianjie; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Hou, Dianjie; Lowary, Todd L.] Univ Alberta, Alberta Innovates Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; Alberta Innovates; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011; Hou, Dianjie/G-4214-2013	Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Hou, Dianjie/0000-0002-6555-5993	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Alberta Innovates Centre for Carbohydrate Science	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Centre for Carbohydrate Science	This work was supported by the Canadian Institutes of Health Research (to C.W.), the Natural Sciences and Engineering Research Council (to T.L.L), and by the Alberta Innovates Centre for Carbohydrate Science (to T.L.L.).	BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Burns SM, 1998, INFECT IMMUN, V66, P4244; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOLDMAN RC, 1980, EUR J BIOCHEM, V107, P145, DOI 10.1111/j.1432-1033.1980.tb04635.x; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HASEGAWA T, 1985, CHEM PHARM BULL, V33, P333; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Kahlig H, 2005, J BIOL CHEM, V280, P20292, DOI 10.1074/jbc.M501724200; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Miller J. H., 1972, EXPT MOL GENETICS, P432; Najdenski H, 2003, FEMS IMMUNOL MED MIC, V38, P97, DOI 10.1016/S0928-8244(03)00183-4; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEUHARD J, 1976, J BACTERIOL, V126, P999, DOI 10.1128/JB.126.2.999-1001.1976; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rasband WS, 2011, IMAGEJ; ROBERTS IS, 1988, J BACTERIOL, V170, P1305, DOI 10.1128/jb.170.3.1305-1310.1988; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1989, J GEN MICROBIOL, V135, P2589	39	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41391	41401		10.1074/jbc.M111.295857	http://dx.doi.org/10.1074/jbc.M111.295857			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990359	hybrid, Green Published			2022-12-25	WOS:000298057500026
J	Desai, PR; Thakur, A; Ganguli, D; Paul, S; Morschhauser, J; Bachhawat, AK				Desai, Prashant Ramesh; Thakur, Anil; Ganguli, Dwaipayan; Paul, Sanjoy; Morschhaeuser, Joachim; Bachhawat, Anand K.			Glutathione Utilization by Candida albicans Requires a Functional Glutathione Degradation (DUG) Pathway and OPT7, an Unusual Member of the Oligopeptide Transporter Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN 9; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; SUBSTRATE RECOGNITION; YEAST PATHOGENS; GROWTH; GENE; THIOREDOXIN; INFECTION; VIRULENCE	Candida albicans lacks the ability to survive within its mammalian host in the absence of endogenous glutathione biosynthesis. To examine the ability of this yeast to utilize exogenous glutathione, we exploited the organic sulfur auxotrophy of C. albicans met15 Delta strains. We observed that glutathione is utilized efficiently by the alternative pathway of glutathione degradation (DUG pathway). The major oligopeptide transporters OPT1-OPT5 of C. albicans that were most similar to the known yeast glutathione transporters were not found to contribute to glutathione transport to any significant extent. A genomic library approach to identify the glutathione transporter of C. albicans yielded OPT7 as the primary glutathione transporter. Biochemical studies on OPT7 using radiolabeled GSH uptake revealed a K-m of 205 mu M indicating that it was a high affinity glutathione transporter. OPT7 is unusual in several aspects. It is the most remote member to known yeast glutathione transporters, lacks the two highly conserved cysteines in the family that are known to be crucial in trafficking, and also has the ability to take up tripeptides. The transporter was regulated by sulfur sources in the medium. OPT7 orthologues were prevalent among many pathogenic yeasts and fungi and formed a distinct cluster quite remote from the Saccharomyces cerevisiae HGT1 glutathione transporter duster. In vivo experiments using a systemic model of candidiasis failed to detect expression of OPT7 in vivo, and strains disrupted either in the degradation (dug3 Delta) or transport (opt7 Delta) of glutathione failed to show a defect in virulence.	[Bachhawat, Anand K.] Indian Inst Sci Educ & Res Mohali, Sas Nagar 140306, Punjab, India; [Desai, Prashant Ramesh; Thakur, Anil; Ganguli, Dwaipayan; Paul, Sanjoy; Bachhawat, Anand K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Morschhaeuser, Joachim] Univ Wurzburg, Inst Mol Infekt Biol, D-97080 Wurzburg, Germany	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Wurzburg	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Sas Nagar 140306, Punjab, India.	anand@iisermohali.ac.in	Morschhäuser, Joachim/AFS-2547-2022; Morschhäuser, Joachim/E-2918-2013	Morschhäuser, Joachim/0000-0003-4227-8687; Morschhäuser, Joachim/0000-0003-4227-8687	Council of Scientific and Industrial Research, Government of India; Deutsche Forschungsgemeinschaft [MO 846/4]; Department of Science and Technology; Department of Biotechnology	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology	Recipients of a Research Fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by Deutsche Forschungsgemeinschaft Grant MO 846/4.; Supported by grant-in-aid projects from the Department of Science and Technology, the Department of Biotechnology, and the Council of Scientific and Industrial Research, Government of India. To whom correspondence should be addressed: Indian Institute of Science Education & Research, Knowledge City, S.A.S. Nagar, Punjab-140306, India.Tel.: 91-172-2240119; Fax: 91-172-2790188; E-mail: anand@iisermohali.ac.in.	Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Biswas K, 2003, GENE, V323, P43, DOI 10.1016/j.gene.2003.09.005; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kaur J, 2009, J BIOL CHEM, V284, P23872, DOI 10.1074/jbc.M109.029728; Kaur J, 2009, FEMS YEAST RES, V9, P849, DOI 10.1111/j.1567-1364.2009.00529.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; Michan C, 2009, FEMS YEAST RES, V9, P1078, DOI 10.1111/j.1567-1364.2009.00558.x; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma KG, 2000, CURR GENET, V38, P71, DOI 10.1007/s002940000137; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x; Thakur A, 2010, BIOCHEM J, V429, P593, DOI 10.1042/BJ20100240; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viaene J, 2000, YEAST, V16, P1205, DOI 10.1002/1097-0061(20000930)16:13&lt;1205::AID-YEA615&gt;3.0.CO;2-C; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0	34	16	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41183	41194		10.1074/jbc.M111.272377	http://dx.doi.org/10.1074/jbc.M111.272377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994941	Green Published, hybrid			2022-12-25	WOS:000298057500007
J	Muhlenhoff, U; Richter, N; Pines, O; Pierik, AJ; Lill, R				Muehlenhoff, Ulrich; Richter, Nadine; Pines, Ophry; Pierik, Antonio J.; Lill, Roland			Specialized Function of Yeast Isa1 and Isa2 Proteins in the Maturation of Mitochondrial [4Fe-4S] Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; ASSEMBLY PROTEIN; OXIDATIVE STRESS; BINDING ACTIVITY; ISCA; BIOGENESIS; SUFA; BIOSYNTHESIS; MECHANISMS	Most eukaryotes contain iron-sulfur cluster (ISC) assembly proteins related to Saccharomyces cerevisiae Isa1 and Isa2. We show here that Isa1 but not Isa2 can be functionally replaced by the bacterial relatives IscA, SufA, and ErpA. The specific function of these "A-type" ISC proteins within the framework of mitochondrial and bacterial Fe/S protein biogenesis is still unresolved. In a comprehensive in vivo analysis, we show that S. cerevisiae Isa1 and Isa2 form a complex that is required for maturation of mitochondrial [4Fe-4S] proteins, including aconitase and homoaconitase. In contrast, Isa1-Isa2 were dispensable for the generation of mitochondrial [2Fe-2S] proteins and cytosolic [4Fe-4S] proteins. Targeting of bacterial [2Fe-2S] and [4Fe-4S] ferredoxins to yeast mitochondria further supported this specificity. Isa1 and Isa2 proteins are shown to bind iron in vivo, yet the Isa1-Isa2-bound iron was not needed as a donor for de novo assembly of the [2Fe-2S] cluster on the general Fe/S scaffold proteins Isu1-Isu2. Upon depletion of the ISC assembly factor Iba57, which specifically interacts with Isa1 and Isa2, or in the absence of the major mitochondrial [4Fe-4S] protein aconitase, iron accumulated on the Isa proteins. These results suggest that the iron bound to the Isa proteins is required for the de novo synthesis of [4Fe-4S] clusters in mitochondria and for their insertion into apoproteins in a reaction mediated by Iba57. Taken together, these findings define Isa1, Isa2, and Iba57 as a specialized, late-acting ISC assembly subsystem that is specifically dedicated to the maturation of mitochondrial [4Fe-4S] proteins.	[Muehlenhoff, Ulrich; Richter, Nadine; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Philipps University Marburg; Hebrew University of Jerusalem	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	Lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010; pines, ophry/C-4086-2011	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; pines, ophry/0000-0001-7126-2575	Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft; German-Israeli Foundation; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft(Max Planck Society); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 593, Gottfried-Wilhelm Leibniz program, and GRK 1216), von Behring-Rontgen Stiftung, the LOEWE program of state Hessen, Max-Planck Gesellschaft, the German-Israeli Foundation, and Fonds der Chemischen Industrie.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; FLINT DH, 1988, J BIOL CHEM, V263, P3558; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Harlow E., 1988, ANTIBODIES LAB MANUA; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Long SJ, 2011, MOL MICROBIOL, V81, P1403, DOI 10.1111/j.1365-2958.2011.07769.x; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lu JX, 2010, BIOCHEM J, V428, P125, DOI 10.1042/BJ20100122; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel AD, 2009, ANN MED, V41, P82, DOI 10.1080/07853890802322229; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; SULO P, 1993, J BIOL CHEM, V268, P17634; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang W, 2010, BIOCHEM J, V432, P429, DOI 10.1042/BJ20101507; Wu G, 2002, J BIOL INORG CHEM, V7, P526, DOI 10.1007/s00775-001-0330-2; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; ZHENG LM, 1994, J BIOL CHEM, V269, P18723	65	119	120	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41205	41216		10.1074/jbc.M111.296152	http://dx.doi.org/10.1074/jbc.M111.296152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987576	Green Published, hybrid			2022-12-25	WOS:000298057500009
J	Feng, Y; Zhao, WH; Feng, YM; Dai, JJ; Li, Z; Zhang, XY; Liu, L; Bai, J; Zhang, HT; Lu, L; Xia, XS				Feng, Yue; Zhao, Wenhua; Feng, Yuemei; Dai, Jiejie; Li, Zheng; Zhang, Xiaoyan; Liu, Li; Bai, Jie; Zhang, Huatang; Lu, Ling; Xia, Xueshan			A Novel Genotype of GB Virus C: Its Identification and Predominance among Injecting Drug Users in Yunnan, China	PLOS ONE			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G-VIRUS; PHYLOGENETIC ANALYSIS; SYNTHETIC PEPTIDES; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; 5'-UNTRANSLATED REGION; BLOOD-DONORS; HIV; INFECTION	GB virus C (GBV-C) is prevalent globally and particularly among individuals at risk of parental exposures. Based on genetic diversity, this virus is now classified into six genotypes and many subtypes with distinct geographical distribution. In this study, 120 Injecting Drug Users (IDUs) were recruited from Yunnan province, China. Among them, 43 (35.8%) were positive for GBV-C RNA, 70 (58.3%) and 103 (85.8%) sero-positive for HIV-1 and HCV respectively. This revealed 18.3% of IDUs having GBV-C/HIV/HCV triple infection, which is significantly higher than 7.5% of GBV-C/HIV-1 and 10% of GBV-C/HCV dual infection rates (P<0.05). Based on 5'UTR sequences, the identified 43 viral isolates can be classified into three phylogenetic groups: one (2.3%) and two (4.7%) belonged to genotype 3 and 4, respectively, and the remaining 40 (93%) formed a new group with 97% of bootstrap support. This new GBV-C group was further confirmed by characterizing the E2 region and full-length genome sequences. Analysis of 187 nt 5'UTR sequence showed three previous reported isolates from Southeast Asia were re-classified into this new group. It implies they have the same origin with strains from Yunnan. Although we provisionally assigned this new group as GBV-C genotype 7, a simpler five groups of GBV-C nomenclature is recommended. Genotype 4, 6 and the newly designated genotype 7 could be reclassified as one group, which may represent a single GBV-C genotype. The classification of the other four groups was corresponding to that of previous reported genotype 1, 2, 3 and 5. Furthermore, the diversity of amino acid sequence in the E2 region was analyzed. The inhibitory effect of GBV-C genotype 7 on HIV-1 cell entry could be deduced. Since GBV-C may have a beneficial effect on AIDS disease progression and interact with HCV during co-infection, this finding may raise interests in future studies on this virus that was previously thought to be a "non-pathogenic virus''.	[Feng, Yue; Liu, Li; Bai, Jie; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China; [Feng, Yue; Liu, Li; Bai, Jie; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Zhao, Wenhua] Key Lab Trop & Subtrop Anim Viral Dis Yunnan Prov, Kunming, Yunnan, Peoples R China; [Feng, Yuemei; Zhang, Huatang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Dai, Jiejie] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Dai, Jiejie] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Li, Zheng] Kunming Med Coll, Affiliated Kunhua Hosp, Clin Lab, Ctr Yunnan Prov, Kunming, Peoples R China; [Zhang, Xiaoyan] Fudan Univ, Res Ctr Shanghai Publ Hlth Clin Ctr, Inst Biomed Sci, Shanghai, Peoples R China; [Lu, Ling] Univ Kansas, Med Ctr, Dept Pathol, Viral Oncol Ctr, Kansas City, KS 66103 USA; Sun Yat Sen Univ, Affiliated Hosp 3, Lab Hepatol, Guangzhou 510275, Guangdong, Peoples R China	Kunming University of Science & Technology; Kunming University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kunming Medical University; Fudan University; University of Kansas; University of Kansas Medical Center; Sun Yat Sen University	Feng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China.	oliverxia2000@yahoo.com.cn		zhao, wenhua/0000-0003-0811-7978	Natural Science Foundation of China (NSFC) [30960346, 30960005]; National Basic Research Program of China (973 Program) [2009CB522502]; Chinese Key Projects in the National Science & Technology Pillar Program [2009BAI83B02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Key Projects in the National Science & Technology Pillar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by grants from the Natural Science Foundation of China (NSFC) (No. 30960346 and No. 30960005) and the National Basic Research Program of China (973 Program, 2009CB522502), and partially supported by Chinese Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period (2009BAI83B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2007, INDIAN J MED RES, V125, P717; Alcalde R, 2010, VIRUS RES, V151, P148, DOI 10.1016/j.virusres.2010.04.008; An P, 1997, J GEN VIROL, V78, P2477, DOI 10.1099/0022-1317-78-10-2477; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Beyrer C, 2005, AIDS, V19, P1535, DOI 10.1097/01.aids.0000183122.01583.c7; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x; Branco C, 2010, J MED VIROL, V82, P452, DOI 10.1002/jmv.21703; Fukushi S, 1996, BIOCHEM BIOPH RES CO, V226, P314, DOI 10.1006/bbrc.1996.1353; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; George Sarah L, 2005, Curr Gastroenterol Rep, V7, P54, DOI 10.1007/s11894-005-0067-0; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Hekmat S, 2008, J MED VIROL, V80, P1941, DOI 10.1002/jmv.21314; Herrera E, 2010, J MED CHEM, V53, P6054, DOI 10.1021/jm100452c; Herrera E, 2009, J PHYS CHEM B, V113, P7383, DOI 10.1021/jp900707t; Hwang SJ, 1999, J MED VIROL, V57, P85, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;85::AID-JMV13&gt;3.0.CO;2-2; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lai S, 2001, J ACQ IMMUN DEF SYND, V26, P365, DOI 10.1097/00126334-200104010-00014; Larios C, 2005, LUMINESCENCE, V20, P279, DOI 10.1002/bio.850; Larios C, 2005, ARCH BIOCHEM BIOPHYS, V442, P149, DOI 10.1016/j.abb.2005.06.027; Li G, 2002, WORLD J GASTROENTERO, V8, P1081, DOI 10.3748/wjg.v8.i6.1081; LI G, 2002, WORLD J GASTROENTERO, V9, P1739; Liu HF, 2003, J MED VIROL, V71, P385, DOI 10.1002/jmv.10491; Lu L, 2001, VIRUS RES, V73, P131, DOI 10.1016/S0168-1702(00)00231-8; Mphahlele MJ, 1998, LIVER, V18, P143; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Petrik J, 1998, GUT, V42, P103, DOI 10.1136/gut.42.1.103; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; Schleicher SB, 2003, J MED VIROL, V71, P226, DOI 10.1002/jmv.10474; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shankar EM, 2008, T ROY SOC TROP MED H, V102, P1176, DOI 10.1016/j.trstmh.2008.04.034; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2000, J GEN VIROL, V81, P769, DOI 10.1099/0022-1317-81-3-769; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Stark K, 1996, J INFECT DIS, V174, P1320, DOI 10.1093/infdis/174.6.1320; Takebe Y, 2004, PEDIATR INT, V46, P236, DOI 10.1046/j.1442-200x.2004.01869.x; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Zhou YQ, 2010, J CLIN VIROL, V49, P272, DOI 10.1016/j.jcv.2010.08.007	46	45	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e21151	10.1371/journal.pone.0021151	http://dx.doi.org/10.1371/journal.pone.0021151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998624	gold, Green Submitted, Green Published			2022-12-25	WOS:000295968700001
J	Zheng, HX; Yan, S; Qin, ZD; Wang, Y; Tan, JZ; Li, H; Jin, L				Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li			Major Population Expansion of East Asians Began before Neolithic Time: Evidence of mtDNA Genomes	PLOS ONE			English	Article							AGRICULTURAL ORIGINS; NORTH CHINA; DOMESTICATION; JOMON; EVOLUTION; SELECTION; INSIGHTS; REVEALS; HUMANS; SIZE	It is a major question in archaeology and anthropology whether human populations started to grow primarily after the advent of agriculture, i.e., the Neolithic time, especially in East Asia, which was one of the centers of ancient agricultural civilization. To answer this question requires an accurate estimation of the time of lineage expansion as well as that of population expansion in a population sample without ascertainment bias. In this study, we analyzed all available mtDNA genomes of East Asians ascertained by random sampling, a total of 367 complete mtDNA sequences generated by the 1000 Genome Project, including 249 Chinese (CHB, CHD, and CHS) and 118 Japanese (JPT). We found that major mtDNA lineages underwent expansions, all of which, except for two JPT-specific lineages, including D4, D4b2b, D4a, D4j, D5a2a, A, N9a, F1a1'4, F2, B4, B4a, G2a1 and M7b1'2'4, occurred before 10 kya, i.e., before the Neolithic time (symbolized by Dadiwan Culture at 7.9 kya) in East Asia. Consistent to this observation, the further analysis showed that the population expansion in East Asia started at 13 kya and lasted until 4 kya. The results suggest that the population growth in East Asia constituted a need for the introduction of agriculture and might be one of the driving forces that led to the further development of agriculture.	[Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Chinese Acad Sci, Max Planck Soc, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yan, Shi; Jin, Li] Chinese Acad Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wang, Yi] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Baylor College of Medicine	Zheng, HX (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com	Jin, Li/C-1468-2009; Li, Hui/A-2014-2010; Jin, Li/M-5063-2019; Yan, Shi/GYR-3441-2022	Jin, Li/0000-0002-4546-2415; Yan, Shi/0000-0001-8304-8445	National Science Foundation of China [30890034, 31071098, 31071102]; National Outstanding Youth Science Foundation of China [30625016]; Shanghai Leading Academic Discipline Project [B111]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Outstanding Youth Science Foundation of China; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was supported by grants from the National Science Foundation of China (30890034, 31071098, 31071102), and National Outstanding Youth Science Foundation of China (30625016). LJ is also supported by Shanghai Leading Academic Discipline Project (B111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; Crawford GW, 2009, P NATL ACAD SCI USA, V106, P7271, DOI 10.1073/pnas.0903375106; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Forster P, 1996, AM J HUM GENET, V59, P935; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Matsui A, 2006, WORLD ARCHAEOL, V38, P259, DOI 10.1080/00438240600708295; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pearson R, 2006, WORLD ARCHAEOL, V38, P239, DOI 10.1080/00438240600693976; Peng MS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-46; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; SHI WT, MOL BIOL EVOLUTION, V27, P385; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; UNDERHILL AP, 2008, EARLY COMMUNITIES E, P121; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wall JD, 2000, GENETICS, V155, P1865; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Xue FH, 2008, EUR J HUM GENET, V16, P705, DOI 10.1038/sj.ejhg.5201998; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	49	58	64	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25835	10.1371/journal.pone.0025835	http://dx.doi.org/10.1371/journal.pone.0025835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998705	gold, Green Published, Green Submitted			2022-12-25	WOS:000295968700021
J	Cai, KL; Hua, GH; Ahmad, S; Liang, AX; Han, L; Wu, CJ; Yang, FF; Yang, LG				Cai, Kailai; Hua, Guohua; Ahmad, Sibtain; Liang, Aaixin; Han, Li; Wu, Canjie; Yang, Feifei; Yang, Liguo			Action Mechanism of Inhibin alpha-Subunit on the Development of Sertoli Cells and First Wave of Spermatogenesis in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RNA INTERFERENCE; SPERM PRODUCTION; POSTNATAL-DEVELOPMENT; SIGNALING PATHWAYS; TESTIS; EXPRESSION; MOUSE; GERM; GENE	Inhibin is an important marker of Sertoli cell (SC) activity in animals with impaired spermatogenesis. However, the precise relationship between inhibin and SC activity is unknown. To investigate this relationship, we partially silenced both the transcription and translation of the gene for the alpha-subunit of inhibin, Inha, using recombinant pshRNA vectors developed with RNAi-Ready pSIREN-RetroQ-ZsGreen Vector (Clontech Laboratories, Mountain View, Calif). We found that Inha silencing suppresses the cell-cycle regulators Cyclin D1 and Cyclin E and up-regulates the cell-cycle inhibitor P21 (as detected by Western blot analysis), thereby increasing the number of SCs in the G1 phase of the cell cycle and decreasing the amount in the S-phase of the cell cycle (as detected by flow cytometry). Inha silencing also suppressed Pdgfa, Igf1, and Kitl mRNA levels and up-regulated Tgfbrs, Inhba, Inhbb, Cyp11a1, Dhh, and Tjp1 mRNA levels (as indicated by real-time polymerase chain reaction [PCR] analysis). These findings indicate that Inha has the potential to influence the availability of the ligand inhibin and its antagonist activin in the SC in an autocrine manner and inhibit the progression of SC from G1 to S. It may also participate in the development of the blood-testis barrier, Leydig cells, and spermatogenesis through its effect on Dhh, Tjp1, Kitl, and Pdgfa. Real-time PCR and Western blot analyses of Inha, Inhba, and Inhbb mRNA and Inha levels over time show that Inha plays an important role in the formation of round spermatid during the first wave of spermatogenesis in mice.	[Cai, Kailai; Hua, Guohua; Ahmad, Sibtain; Liang, Aaixin; Han, Li; Wu, Canjie; Yang, Feifei; Yang, Liguo] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Educ Minist China, Wuhan, Peoples R China; [Ahmad, Sibtain] Univ Agr Faisalabad, Dept Livestock Management, Faisalabad, Pakistan	Huazhong Agricultural University; University of Agriculture Faisalabad	Cai, KL (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Educ Minist China, Wuhan, Peoples R China.	yangliguo2006@yahoo.com.cn			Special Fund for Agro-scientific Research in the Public Interest [201003060]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-37-04B]	Special Fund for Agro-scientific Research in the Public Interest; Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201003060) and the Earmarked Fund for Modern Agro-industry Technology Research System (No. CARS-37-04B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2006, MOL CANCER, V5, P11; Anawalt BD, 1996, J CLIN ENDOCR METAB, V81, P3341, DOI 10.1210/jc.81.9.3341; Bame JH, 1999, BIOL REPROD, V60, P1360, DOI 10.1095/biolreprod60.6.1360; Barakat B, 2008, REPRODUCTION, V136, P345, DOI 10.1530/REP-08-0140; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; BYERS S, 1991, AM J ANAT, V191, P35, DOI 10.1002/aja.1001910104; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Findlay JK, 2000, MOL CELL ENDOCRINOL, V163, P81, DOI 10.1016/S0303-7207(99)00243-9; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Greep RO, 1937, ENDOCRINOLOGY, V21, P611, DOI 10.1210/endo-21-5-611; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HARPER JW, 1993, CELL, V75, P805; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; JOYCE KL, 1993, J ANDROL, V14, P448; Kananen K, 1996, MOL ENDOCRINOL, V10, P1667, DOI 10.1210/me.10.12.1667; Kawai Y, 2011, REPRODUCTION, V141, P217, DOI 10.1530/REP-10-0006; KERR JB, 1992, CELL TISSUE RES, V268, P179, DOI 10.1007/BF00338067; Knight PG, 1996, FRONT NEUROENDOCRIN, V17, P476, DOI 10.1006/frne.1996.0013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looyenga BD, 2010, MOL ENDOCRINOL, V24, P608, DOI 10.1210/me.2008-0374; Loveland KL, 2007, INT J ANDROL, V30, P377, DOI 10.1111/j.1365-2605.2007.00785.x; Luisi S, 2005, HUM REPROD UPDATE, V11, P123, DOI 10.1093/humupd/dmh057; Mackay S, 2000, INT REV CYTOL, V200, P47, DOI 10.1016/S0074-7696(00)00002-4; Majdic G, 1997, ENDOCRINOLOGY, V138, P2136, DOI 10.1210/en.138.5.2136; MANN GE, 1992, J ENDOCRINOL, V133, P381, DOI 10.1677/joe.0.1330381; MANOVA K, 1993, DEV BIOL, V157, P85, DOI 10.1006/dbio.1993.1114; MARTIN TL, 1991, BIOL REPROD, V45, P73, DOI 10.1095/biolreprod45.1.73; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Medras M, 2010, ENDOKRYNOL POL, V61, P695; Mehta MN, 2003, AM J REPROD IMMUNOL, V49, P42, DOI 10.1034/j.1600-0897.2003.01042.x; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; ROBERTS V, 1989, ENDOCRINOLOGY, V125, P2350, DOI 10.1210/endo-125-5-2350; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; SCHANBACHER BD, 1991, J ANIM SCI, V69, P252; Shen WG, 2004, CHINESE MED J-PEKING, V117, P1084; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Spiliotis M, 2010, MOL BIOCHEM PARASIT, V174, P83, DOI 10.1016/j.molbiopara.2010.07.001; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Voge JL, 2007, J ANIM SCI, V85, P3249, DOI 10.2527/jas.2007-0506; Yan W, 2000, J CELL SCI, V113, P161; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yomgogida K, 2008, DEV GROWTH DIFFER, V50, P513, DOI [10.1111/j.1440-169x.2008.01042.x, 10.1111/j.1440-169X.2008.01042.x]; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2	57	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25585	10.1371/journal.pone.0025585	http://dx.doi.org/10.1371/journal.pone.0025585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998670	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900034
J	Cheng, S; Scigalla, FP; di Fenizio, PS; Zhang, ZG; Stolzenburg, JU; Neuhaus, J				Cheng, Sheng; Scigalla, Frank Peter; di Fenizio, Pietro Speroni; Zhang, Zhi Geng; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			ATP Enhances Spontaneous Calcium Activity in Cultured Suburothelial Myofibroblasts of the Human Bladder	PLOS ONE			English	Article							URINARY-BLADDER; SMOOTH-MUSCLE; CONNEXIN EXPRESSION; RECEPTOR; CELLS; CONTRACTIONS; OSCILLATIONS	Background: Suburothelial myofibroblasts (sMF) are located underneath the urothelium in close proximity to afferent nerves. They express purinergic receptors and show calcium transients in response to ATP. Therefore they are supposed to be involved in afferent signaling of the bladder fullness. Since ATP concentration is likely to be very low during the initial filling phase, we hypothesized that sMF Ca2+ activity is affected even at very low ATP concentrations. We investigated ATP induced modulation of spontaneous activity, intracellular calcium response and purinergic signaling in cultured sMF. Methodology/Principal Findings: Myofibroblast cultures, established from cystectomies, were challenged by exogenous ATP in presence or absence of purinergic antagonist. Fura-2 calcium imaging was used to monitor ATP (10(-16) to 10(-4) mol/l) induced alterations of calcium activity. Purinergic receptors (P2X1, P2X2, P2X3) were analysed by confocal immunofluorescence. We found spontaneous calcium activity in 55.18% +/- 61.65 of the sMF (N = 48 experiments). ATP significantly increased calcium activity even at 10(-16) mol/l. The calcium transients were partially attenuated by subtype selective antagonist (TNP-ATP, 1 mu M; A-317491, 1 mu M), and were mimicked by the P2X1, P2X3 selective agonist alpha,beta-methylene ATP. The expression of purinergic receptor subtypes in sMF was confirmed by immunofluorescence. Conclusions/Significance: Our experiments demonstrate for the first time that ATP can modulate spontaneous activity and induce intracellular Ca2+ response in cultured sMF at very low concentrations, most likely involving P2X receptors. These findings support the notion that sMF are able to register bladder fullness very sensitively, which predestines them for the modulation of the afferent bladder signaling in normal and pathological conditions.	[Cheng, Sheng; Scigalla, Frank Peter; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany; [Cheng, Sheng; Zhang, Zhi Geng] Zhejiang Univ, Dept Urol, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [di Fenizio, Pietro Speroni] Univ Coimbra, CISUC, Dept Informat Engn, Coimbra, Portugal	Leipzig University; Zhejiang University; Universidade de Coimbra	Cheng, S (corresponding author), Univ Leipzig, Dept Urol, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de	cheng, sheng/HHD-0386-2022	Speroni di Fenizio, Pietro/0000-0001-9909-8068	Deutsche Forschungsgemeinschaft (DFG) [NE425/4-4]; Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (JN:NE425/4-4) and Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino H, 2008, BJU INT, V102, P1168, DOI 10.1111/j.1464-410X.2008.07782.x; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Drake MJ, 2003, EXP PHYSIOL, V88, P19, DOI 10.1113/eph8802473; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Ikeda Y, 2007, AM J PHYSIOL-RENAL, pF1018; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Liu F, 2009, INT J UROL, V16, P570, DOI 10.1111/j.1442-2042.2009.02307.x; Mahoney MG, 1998, BIOPHYS J, V75, P2050, DOI 10.1016/S0006-3495(98)77647-7; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Meng F, 2007, J CELL PHYSIOL, V213, P79, DOI 10.1002/jcp.21092; Mills IW, 2000, J UROLOGY, V163, P646, DOI 10.1016/S0022-5347(05)67951-7; Neuhaus J, 2008, UROLOGE, V47, P1085, DOI 10.1007/s00120-008-1817-z; Neuhaus J, 2007, UROLOGE, V46, P1197, DOI 10.1007/s00120-007-1480-9; Neuhaus J, 2005, BJU INT, V96, P670, DOI 10.1111/j.1464-410X.2005.05703.x; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Oger S, 2010, BJU INT; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roosen A, 2009, EUR UROL, V55, P1440, DOI 10.1016/j.eururo.2008.11.009; Streng T, 2006, BJU INT, V97, P1094, DOI 10.1111/j.1464-410X.2006.06137.x; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Sui GP, 2006, BJU INT, V97, P1327, DOI 10.1111/j.1464-410X.2006.06200.x; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934	31	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25769	10.1371/journal.pone.0025769	http://dx.doi.org/10.1371/journal.pone.0025769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998694	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900054
J	Danilov, SM; Gordon, K; Nesterovitch, AB; Lunsdorf, H; Chen, ZL; Castellon, M; Popova, IA; Kalinin, S; Mendonca, E; Petukhov, PA; Schwartz, DE; Minshall, RD; Sturrock, ED				Danilov, Sergei M.; Gordon, Kerry; Nesterovitch, Andrew B.; Luensdorf, Heinrich; Chen, Zhenlong; Castellon, Maricela; Popova, Isolda A.; Kalinin, Sergey; Mendonca, Emma; Petukhov, Pavel A.; Schwartz, David E.; Minshall, Richard D.; Sturrock, Edward D.			An Angiotensin I-Converting Enzyme Mutation (Y465D) Causes a Dramatic Increase in Blood ACE via Accelerated ACE Shedding	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; N-DOMAIN; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; SERUM; SARCOIDOSIS; LOCALIZATION; ELEVATION	Background: Angiotensin I-converting enzyme (ACE) metabolizes a range of peptidic substrates and plays a key role in blood pressure regulation and vascular remodeling. Thus, elevated ACE levels may be associated with an increased risk for different cardiovascular or respiratory diseases. Previously, a striking familial elevation in blood ACE was explained by mutations in the ACE juxtamembrane region that enhanced the cleavage-secretion process. Recently, we found a family whose affected members had a 6-fold increase in blood ACE and a Tyr465Asp (Y465D) substitution, distal to the stalk region, in the N domain of ACE. Methodology/Principal Findings: HEK and CHO cells expressing mutant (Tyr465Asp) ACE demonstrate a 3- and 8-fold increase, respectively, in the rate of ACE shedding compared to wild-type ACE. Conformational fingerprinting of mutant ACE demonstrated dramatic changes in ACE conformation in several different epitopes of ACE. Cell ELISA carried out on CHO-ACE cells also demonstrated significant changes in local ACE conformation, particularly proximal to the stalk region. However, the cleavage site of the mutant ACE - between Arg1203 and Ser1204 - was the same as that of WT ACE. The Y465D substitution is localized in the interface of the N-domain dimer (from the crystal structure) and abolishes a hydrogen bond between Tyr465 in one monomer and Asp462 in another. Conclusions/Significance: The Y465D substitution results in dramatic increase in the rate of ACE shedding and is associated with significant local conformational changes in ACE. These changes could result in increased ACE dimerization and accessibility of the stalk region or the entire sACE, thus increasing the rate of cleavage by the putative ACE secretase (sheddase).	[Danilov, Sergei M.; Castellon, Maricela; Kalinin, Sergey; Schwartz, David E.; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA; [Danilov, Sergei M.] Univ Illinois, Inst Personalized Med, Chicago, IL USA; [Gordon, Kerry; Sturrock, Edward D.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Nesterovitch, Andrew B.] Rush Univ, Dept Dermatol, Chicago, IL 60612 USA; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Chen, Zhenlong; Castellon, Maricela; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Popova, Isolda A.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Mendonca, Emma] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Petukhov, Pavel A.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Cape Town; Rush University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA.	danilov@uic.edu	Nesterovitch, Andrew/K-7286-2014; Chen, Zhenlong/AAQ-9578-2021	Nesterovitch, Andrew/0000-0002-9508-5363; 	South African National Research Foundation; German Academic Exchange; National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	South African National Research Foundation(National Research Foundation - South Africa); German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Partial funding was provided by South African National Research Foundation, the German Academic Exchange. Molecular graphics images were produced using the University of California San Francisco Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health P41 RR001081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; Balyasnikova IV, 2002, BIOCHEM J, V362, P585, DOI 10.1042/0264-6021:3620585; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Balyasnikova IV, 1998, IN VITRO CELL DEV-AN, V34, P545; BENETEAUBURNAT B, 1991, CRIT REV CL LAB SCI, V28, P337, DOI 10.3109/10408369109106868; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Chen HL, 2010, MICRON, V41, P674, DOI 10.1016/j.micron.2010.01.005; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; Corvol P., 2004, HDB PROTEOLYTIC ENZY, V1, P332, DOI DOI 10.1016/B978-0-12-079611-3.50090-2; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; JASPARD E, 1995, BIOCHEM BIOPH RES CO, V211, P528, DOI 10.1006/bbrc.1995.1845; Kishimoto, 1997, LEUCOCYTE TYPING, P746; Kohlstedt K, 2006, MOL PHARMACOL, V69, P1725, DOI 10.1124/mol.105.020636; Kost OA, 2003, BIOCHEMISTRY-US, V42, P6965, DOI 10.1021/bi034645y; Kramers C, 2003, Ned Tijdschr Geneeskd, V147, P473; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1989, CLIN LAB MED, V9, P745, DOI 10.1016/S0272-2712(18)30602-4; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; RYAN US, 1976, TISSUE CELL, V8, P125, DOI 10.1016/0040-8166(76)90025-2; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; SIBONY M, 1993, HYPERTENSION, V21, P827, DOI 10.1161/01.HYP.21.6.827; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; SKIDGEL RA, 1993, RENIN ANGIOTENSIN SY; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1991, J BIOL CHEM, V266, P5540; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711	63	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25952	10.1371/journal.pone.0025952	http://dx.doi.org/10.1371/journal.pone.0025952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998728	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900079
J	Xiong, Y; Zhang, L; Holloway, AK; Wu, XL; Su, L; Kebebew, E				Xiong, Yin; Zhang, Lisa; Holloway, Alisha K.; Wu, Xiaolin; Su, Ling; Kebebew, Electron			MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer	PLOS ONE			English	Article							CDNA MICROARRAY DATA; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; EXPRESSION; CARCINOMA; ZYXIN; TUMORS; PREDISPOSITION; NORMALIZATION; REPLICATION	Background: The molecular basis and characteristics of familial non-medullary thyroid cancer are poorly understood. In this study, we performed microRNA (miRNA) profiling of familial and sporadic papillary thyroid cancer tumor samples. Methodology/Principal Findings: Genome wide miRNA profiling of sporadic and familial papillary thyroid cancer was performed. Differentially expressed miRNAs were validated by quantitative RT-PCR. Ectopic expression of miR-886-3p in thyroid cancer lines was performed to identify pathways targeted by the miRNA, as well as, to determine its effect on tumor cell biology. We found four differentially expressed miRNAs between familial and sporadic papillary thyroid cancer tumor samples. MiR-886-3p and miR-20a were validated to be differentially expressed by 3- and 4-fold, respectively. Pathway analysis of genome-wide expression data on cells overexpressing miR-886-3p and target prediction analysis showed genes involved in DNA replication and focal adhesion pathways were regulated by miR-886-3p. Overexpression of miR-886-3p in thyroid cancer cell lines significantly inhibited cellular proliferation, the number and size of spheroids and cellular migration. Additionally, overexpression of miR-886-3p increased the number of cells in S phase. Conclusions/Significance: Our findings for the first time suggest that miR-886-3p plays an important role in thyroid cancer tumor cell biology and regulates genes involved in DNA replication and focal adhesion. Thus, miR-886-3p may play a role in the initiation and or progression of papillary thyroid cancer.	[Xiong, Yin; Zhang, Lisa; Kebebew, Electron] NCI, Endocrine Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Holloway, Alisha K.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Wu, Xiaolin; Su, Ling] NCI, Lab Mol Technol, Sci Applicat Int Coorporat Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Xiong, Y (corresponding author), NCI, Endocrine Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X	National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011275, ZIABC011287] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcinas A, 2009, J PROTEOME RES, V8, P3958, DOI 10.1021/pr900278c; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Cattaruzza M, 2004, HYPERTENSION, V43, P726, DOI 10.1161/01.HYP.0000119189.82659.52; Cavaco BM, 2008, ENDOCR-RELAT CANCER, V15, P207, DOI 10.1677/ERC-07-0214; Cavaco BM, 2008, J CLIN ENDOCR METAB, V93, P4426, DOI 10.1210/jc.2008-0449; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Decraene C, 2004, BIOCHEM BIOPH RES CO, V318, P439, DOI 10.1016/j.bbrc.2004.04.047; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Frich L, 2001, CANCER EPIDEM BIOMAR, V10, P113; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hemminki K, 2004, INT J CANCER, V108, P109, DOI 10.1002/ijc.11478; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ito Y, 2009, SURGERY, V145, P100, DOI 10.1016/j.surg.2008.08.004; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kebebew E, 1999, J CLIN ENDOCR METAB, V84, P2840, DOI 10.1210/jc.84.8.2840; Lupoli G, 1999, LANCET, V353, P637, DOI 10.1016/S0140-6736(98)08004-0; McKay JD, 2004, J MED GENET, V41, P407, DOI 10.1136/jmg.2003.017350; Menon MP, 2009, J CLIN PATHOL, V62, P978, DOI 10.1136/jcp.2008.063909; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Moses W, 2011, THYROID, V21, P367, DOI 10.1089/thy.2010.0256; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Pesta M, 2010, ANTICANCER RES, V30, P3579; Prazeres HJ, 2008, FAM CANCER, V7, P141, DOI 10.1007/s10689-007-9160-x; Robenshtok E, 2011, THYROID, V21, P43, DOI 10.1089/thy.2009.0406; RON E, 1991, ONCOLOGY, V48, P309; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Sheu SY, 2010, BRIT J CANCER, V102, P376, DOI 10.1038/sj.bjc.6605493; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Suh I, 2009, SURGERY, V146, P1073, DOI 10.1016/j.surg.2009.09.012; Theodore SC, 2010, ETHN DIS, V20; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Vriens MR, 2009, THYROID, V19, P1343, DOI 10.1089/thy.2009.1607; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	49	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24717	10.1371/journal.pone.0024717	http://dx.doi.org/10.1371/journal.pone.0024717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998631	Green Submitted, gold, Green Published			2022-12-25	WOS:000295966900004
J	Balabanova, Y; Gilsdorf, A; Buda, S; Burger, R; Eckmanns, T; Gartner, B; Gross, U; Haas, W; Hamouda, O; Hubner, J; Janisch, T; Kist, M; Kramer, MH; Ledig, T; Mielke, M; Pulz, M; Stark, K; Suttorp, N; Ulbrich, U; Wichmann, O; Krause, G				Balabanova, Yanina; Gilsdorf, Andreas; Buda, Silke; Burger, Reinhard; Eckmanns, Tim; Gaertner, Barbara; Gross, Uwe; Haas, Walter; Hamouda, Osamah; Huebner, Johannes; Jaenisch, Thomas; Kist, Manfred; Kramer, Michael H.; Ledig, Thomas; Mielke, Martin; Pulz, Matthias; Stark, Klaus; Suttorp, Norbert; Ulbrich, Uta; Wichmann, Ole; Krause, Gerard			Communicable Diseases Prioritized for Surveillance and Epidemiological Research: Results of a Standardized Prioritization Procedure in Germany, 2011	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; SETTING PRIORITIES; HELICOBACTER-PYLORI; MATRIX	Introduction: To establish strategic priorities for the German national public health institute (RKI) and guide the institute's mid-term strategic decisions, we prioritized infectious pathogens in accordance with their importance for national surveillance and epidemiological research. Methods: We used the Delphi process with internal (RKI) and external experts and a metric-consensus approach to score pathogens according to ten three-tiered criteria. Additional experts were invited to weight each criterion, leading to the calculation of a median weight by which each score was multiplied. We ranked the pathogens according to the total weighted score and divided them into four priority groups. Results: 127 pathogens were scored. Eighty-six experts participated in the weighting; "Case fatality rate" was rated as the most important criterion. Twenty-six pathogens were ranked in the highest priority group; among those were pathogens with internationally recognised importance (e.g., Human Immunodeficiency Virus, Mycobacterium tuberculosis, Influenza virus, Hepatitis C virus, Neisseria meningitides), pathogens frequently causing large outbreaks (e. g., Campylobacter spp.), and nosocomial pathogens associated with antimicrobial resistance. Other pathogens in the highest priority group included Helicobacter pylori, Respiratory Syncytial Virus, Varicella zoster virus and Hantavirus. Discussion: While several pathogens from the highest priority group already have a high profile in national and international health policy documents, high scores for other pathogens (e.g., Helicobacter pylori, Respiratory syncytial virus or Hantavirus) indicate a possible under-recognised importance within the current German public health framework. A process to strengthen respective surveillance systems and research has been started. The prioritization methodology has worked well; its modular structure makes it potentially useful for other settings.	[Balabanova, Yanina; Gilsdorf, Andreas; Buda, Silke; Burger, Reinhard; Eckmanns, Tim; Haas, Walter; Hamouda, Osamah; Mielke, Martin; Stark, Klaus; Wichmann, Ole; Krause, Gerard] Robert Koch Inst, D-1000 Berlin, Germany; [Gaertner, Barbara] Univ Saarland, Inst Microbiol & Hyg, D-6650 Homburg, Germany; [Gross, Uwe] Univ Gottingen, Dept Med Microbiol, Gottingen, Germany; [Huebner, Johannes] Univ Med Ctr Freiburg, Div Infect Dis, Freiburg, Germany; [Jaenisch, Thomas] Univ Heidelberg, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany; [Kist, Manfred] Univ Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Kramer, Michael H.] Fed Minist Hlth, Div Communicable Dis AIDS & Prevent Epidem, Berlin, Germany; [Pulz, Matthias] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany; [Suttorp, Norbert] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Ulbrich, Uta] Dortmund Reg Hlth Author, Dortmund, Germany	Robert Koch Institute; Saarland University; University of Gottingen; University of Freiburg; Ruprecht Karls University Heidelberg; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Balabanova, Y (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	lenzy@rki.de	Jaenisch, Thomas/H-3473-2017	Suttorp, Norbert/0000-0002-3958-1151; Krause, Gerard/0000-0003-3328-8808; Wichmann, Ole/0000-0003-2353-7188; Gilsdorf, Andreas/0000-0001-8572-2798; Huebner, Johannes/0000-0003-1232-4646	Robert Koch Institute	Robert Koch Institute	The study was funded internally by Robert Koch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2008, INT HLTH REG; Berra S, 2010, INT J TECHNOL ASSESS, V26, P217, DOI 10.1017/S0266462310000012; Carter Anne O., 1992, Morbidity and Mortality Weekly Report, V41, P79; *COMM EUR COMM, 2009, OFF J EUR UN; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Doherty J A, 2000, Can J Infect Dis, V11, P21; *ECDC, 2011, ECEDC ANN WORK PROGR, V2011; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Ghaffar A, 2009, INDIAN J MED RES, V129, P368; Gilsdorf A, 2011, EURO SURVEILL, V16; Gooberman-Hill R, 2008, HEALTH EXPECT, V11, P272, DOI 10.1111/j.1369-7625.2008.00502.x; Heymann DL, 2008, CONTROL COMMUNICABLE; Kapiriri L, 2007, CROAT MED J, V48, P618; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; Miller S, 2010, J PEDIATR NURS, V25, P551, DOI 10.1016/j.pedn.2010.06.011; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Remme JHF, 2002, TRENDS MICROBIOL, V10, P435, DOI 10.1016/S0966-842X(02)02431-9; Sibbald SL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-43; Siedler A, 2010, EURO SURVEILL, V15, P19530; Tan VPY, 2011, J GASTROEN HEPATOL, V26, P42, DOI 10.1111/j.1440-1746.2010.06593.x; Tegnell A, 2006, CELL MOL LIFE SCI, V63, P2223, DOI 10.1007/s00018-006-6310-5; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; World Health Organization, 2010, WHOHTMTB20107; Wueppenhorst N, 2009, J ANTIMICROB CHEMOTH, V63, P648, DOI 10.1093/jac/dkp003; 2008, PRIOR SETT METH HLTH; 2008, GERM STRAT ANT RES; 2010, MED TERM STAT PLAN 2; 2000, BUNDESGEZETZBLATT, V33, P1045	31	65	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25691	10.1371/journal.pone.0025691	http://dx.doi.org/10.1371/journal.pone.0025691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991334	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300017
J	Bourgeois, MA; Denslow, ND; Seino, KS; Barber, DS; Long, MT				Bourgeois, Melissa A.; Denslow, Nancy D.; Seino, Kathy S.; Barber, David S.; Long, Maureen T.			Gene Expression Analysis in the Thalamus and Cerebrum of Horses Experimentally Infected with West Nile Virus	PLOS ONE			English	Article							LIVE FLAVIVIRUS CHIMERA; DENGUE VIRUS; MICROARRAY; IDENTIFICATION; MECHANISMS; DURATION; VACCINES; STRAINS; BRAIN; DEATH	Gene expression associated with West Nile virus (WNV) infection was profiled in the central nervous system of horses. Pyrosequencing and library annotation was performed on pooled RNA from the CNS and lymphoid tissues on horses experimentally infected with WNV (vaccinated and naive) and non-exposed controls. These sequences were used to create a custom microarray enriched for neurological and immunological sequences to quantitate gene expression in the thalamus and cerebrum of three experimentally infected groups of horses (naive/WNV exposed, vaccinated/WNV exposed, and normal). From the sequenced transcriptome, 41,040 sequences were identified by alignment against five databases. 31,357 good sequence hits (e < 10(-4)) were obtained with 3.1% of the sequences novel to the equine genome project. Sequences were compared to human expressed sequence tag database, with 31,473 equine sequences aligning to human sequences (69.27% contigs, 78.13% seed contigs, 80.17% singlets). This indicated a high degree of sequence homology between human and equine transcriptome (average identity 90.17%). Significant differences (p < 0.05) in gene expression were seen due to virus exposure (9,020), survival (7,395), and location (7,649). Pathways analysis revealed many genes that mapped to neurological and immunological categories. Involvement of both innate and adaptive components of immunity was seen, with higher levels of expression correlating with survival. This was highlighted by increased expression of suppressor of cytokine signaling 3 in horses exposed to WNV which functions to suppress innate immunity. Pentraxin 3 was most increased in expression for all horses exposed to WNV. Neurological pathways that demonstrated the greatest changes in gene expression included neurotransmitter and signaling pathways. Decreased expression of transcripts in both the glutamate and dopamine signaling pathways was seen in horses exposed to WNV, providing evidence of possible glutamate excitotoxicity and clinical signs associated with decreased dopamine. Many transcripts mapped to non-infectious neurological disease functions, including mental disorders and degenerative neuropathies.	[Bourgeois, Melissa A.; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Denslow, Nancy D.; Barber, David S.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Seino, Kathy S.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington State University	Bourgeois, MA (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	MBourgeois@cdc.gov			University of South Florida Centers for Biological Defense	University of South Florida Centers for Biological Defense	This work was supported by the University of South Florida Centers for Biological Defense research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Bene R, 2009, ACTA CLIN CROAT, V48, P377; Blakely PK, 2009, J NEUROPATH EXP NEUR, V68, P1061, DOI 10.1097/NEN.0b013e3181b8ba14; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Bozza S, 2006, BLOOD, V108, P3387, DOI 10.1182/blood-2006-03-009266; Center for Disease Control and Prevention (CDC), 2011, CDC W NIL VIR STAT S; Darman J, 2004, J NEUROSCI, V24, P7566, DOI 10.1523/JNEUROSCI.2002-04.2004; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Erdmann NB, 2006, CLIN NEUROSCI RES, V6, P315, DOI 10.1016/j.cnr.2006.09.009; Glaser KE, 2009, EQUINE VET J, V41, P663, DOI 10.2746/042516409X412381; Grinev A, 2008, J VIROL METHODS, V154, P27, DOI 10.1016/j.jviromet.2008.09.015; Gupta N, 2010, VIRUS RES, V147, P107, DOI 10.1016/j.virusres.2009.10.018; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Lefeuvre A, 2006, MICROBES INFECT, V8, P1530, DOI 10.1016/j.micinf.2006.01.013; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Long MT, 2007, EQUINE VET J, V39, P491, DOI 10.2746/042516407X217416; Long MT, 2007, EQUINE VET J, V39, P486, DOI 10.2746/042516407X214473; Mansfield KL, 2010, VECTOR-BORNE ZOONOT, V10, P649, DOI 10.1089/vbz.2009.0259; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Moreno-Altamirano MMB, 2004, SCAND J IMMUNOL, V60, P631, DOI 10.1111/j.0300-9475.2004.01519.x; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nordstrom H, 2005, J MED VIROL, V77, P528, DOI 10.1002/jmv.20489; Porter MB, 2003, J AM VET MED ASSOC, V222, P1241, DOI 10.2460/javma.2003.222.1241; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Rodrigues L, 2009, EXPERT REV VACCINES, V8, P167, DOI 10.1586/14760584.8.2.167; Rodrigues L, 2009, MOL IMMUNOL, V46, P1494, DOI 10.1016/j.molimm.2008.12.033; Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07; Sellon D, EQUINE INFECT DIS; U.S. Department of Agriculture (USDA), 2011, USDA APHIS AN HLTH M; Ubol S, 2008, VIROLOGY, V376, P290, DOI 10.1016/j.virol.2008.03.030; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Xiao Wei-wei, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P905; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633	39	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e24371	10.1371/journal.pone.0024371	http://dx.doi.org/10.1371/journal.pone.0024371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991302	gold, Green Published, Green Submitted			2022-12-25	WOS:000295963300003
J	Broderick, MP; Hansen, CJ; Russell, KL; Kaplan, EL; Blumer, JL; Faix, DJ				Broderick, Michael P.; Hansen, Christian J.; Russell, Kevin L.; Kaplan, Edward L.; Blumer, Jeffrey L.; Faix, Dennis J.			Serum Penicillin G Levels Are Lower Than Expected in Adults within Two Weeks of Administration of 1.2 Million Units	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; RHEUMATIC-FEVER; BENZATHINE; PHARYNGITIS; PREVENTION	When introduced in the 1950s, benzathine penicillin G (BPG) was shown to be effective in eradicating group A beta-hemolytic streptococcus (GAS) for at least 3 weeks after administration. Several studies since the 1990s suggest that at 3-4 weeks serum penicillin G levels are less than adequate (below MIC 90 of 0.016 mg/ml). We studied these levels for 4 weeks after the recommended dose of BPG in military recruits, for whom it is used as prophylaxis against GAS. The 329 subjects (mean age 20 years) each received 1.2 million units BPG IM and gave sera 1 day post injection and twice more at staggered time points over 4 weeks. Serum penicillin G levels were measured by liquid chromatography/tandem mass spectometry. The half-life of serum penicillin G was 4.1 days. By day 11, mean levels were, <0.02 mu g/ml, and by day 15<0.01 mu g/ml. Levels in more than 50% of the subjects were below 0.02 mu g/ml on day 9, and, <.01 mg/ml on day 16. There was no demonstrable effect of subject body-surface area nor of the four different lots of BPG used. These data indicate that in healthy young adults serum penicillin G levels become less than protective <21/2 weeks after injection of 1.2 million units of BPG. The findings require serious consideration in future medical and public health recommendations for treatment and prophylaxis of GAS upper respiratory tract infections.	[Broderick, Michael P.; Hansen, Christian J.] USN, Henry M Jackson Fdn Adv Mil Med, Hlth Res Ctr, San Diego, CA 92152 USA; [Russell, Kevin L.] US Dept Def Global Emerging Infect Surveillance &, Silver Spring, MD USA; [Kaplan, Edward L.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Blumer, Jeffrey L.] Case Western Reserve Univ, Sch Med, Dept Pediat & Pharmacol, Cleveland, OH USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University	Broderick, MP (corresponding author), USN, Henry M Jackson Fdn Adv Mil Med, Hlth Res Ctr, San Diego, CA 92152 USA.	michael.broderick@med.navy.mil			Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [60501]	Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center(United States Department of Defense)	This work was supported by the Department of Defense Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, WU# 60501, http://afhsc.mil/geis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass JW, 1996, CLIN INFECT DIS, V22, P727, DOI 10.1093/clinids/22.4.727; Carapetis JR, 2006, DIAGNOSIS MANAGEMENT; Crum NF, 2005, CLIN INFECT DIS, V40, P511, DOI 10.1086/427502; CURRIE BJ, 1994, ANTIMICROB AGENTS CH, V38, P1203, DOI 10.1128/AAC.38.5.1203; Decourt L V, 1983, Arq Bras Cardiol, V40, P3; ELIAS W, 1951, ANTIBIOT CHEMOTHER, V1, P491; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; Kaplan EL, 2006, CLIN INFECT DIS, V43, P1398, DOI 10.1086/508773; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; Kaplan EL, 2001, PEDIATRICS, V108, P1180, DOI 10.1542/peds.108.5.1180; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Ndiaye AG, 2009, J INFECT DEV COUNTR, V3, P660, DOI 10.3855/jidc.20; Raghuram T C, 1979, Indian Heart J, V31, P333; STOLLERMAN GH, 1952, JAMA-J AM MED ASSOC, V150, P1571, DOI 10.1001/jama.1952.03680160021005; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, WHO TECHN REP SER, V923; WRIGHT WILLIAM W., 1959, ANTIBIOT MED AND CLIN THER, V6, P232; ZAHER SR, 1992, J PHARM MED, V2, P17	17	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25308	10.1371/journal.pone.0025308	http://dx.doi.org/10.1371/journal.pone.0025308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991307	Green Published, gold, Green Submitted			2022-12-25	WOS:000295963300009
J	Pavan, G; Dalmaso, M; Galfano, G; Castelli, L				Pavan, Giulia; Dalmaso, Mario; Galfano, Giovanni; Castelli, Luigi			Racial Group Membership Is Associated to Gaze-Mediated Orienting in Italy	PLOS ONE			English	Article							STEREOTYPE CONTENT; VISUAL-ATTENTION; SOCIAL ATTENTION; REFLEXIVE; ATTITUDES; MONKEYS; COMPETENCE; PERCEPTION; ACTIVATION; COGNITION	Viewing a face with averted gaze results in a spatial shift of attention in the corresponding direction, a phenomenon defined as gaze-mediated orienting. In the present paper, we investigated whether this effect is influenced by social factors. Across three experiments, White and Black participants were presented with faces of White and Black individuals. A modified spatial cueing paradigm was used in which a peripheral target stimulus requiring a discrimination response was preceded by a noninformative gaze cue. Results showed that Black participants shifted attention to the averted gaze of both ingroup and outgroup faces, whereas White participants selectively shifted attention only in response to individuals of their same group. Interestingly, the modulatory effect of social factors was context-dependent and emerged only when group membership was situationally salient to participants. It was hypothesized that differences in the relative social status of the two groups might account for the observed asymmetry between White and Black participants. A final experiment ruled out an alternative explanation based on differences in perceptual familiarity with the face stimuli. Overall, these findings strengthen the idea that gaze-mediated orienting is a socially-connoted phenomenon.	[Pavan, Giulia; Dalmaso, Mario; Galfano, Giovanni; Castelli, Luigi] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy	University of Padua	Pavan, G (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	giovanni.galfano@unipd.it	Dalmaso, Mario/F-6507-2011; GALFANO, GIOVANNI/AAI-6142-2020; Galfano, Giovanni/B-7582-2008	Dalmaso, Mario/0000-0003-0199-7861; GALFANO, GIOVANNI/0000-0001-5327-4062; Castelli, Luigi/0000-0002-1472-4507	University of Padova [60A17-8231, 60A17-1159]	University of Padova	The research was funded by the University of Padova (grants 60A17-8231 and 60A17-1159 awarded to GG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLI STRAN NEL MERC L; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Castelli L, 2008, J EXP SOC PSYCHOL, V44, P679, DOI 10.1016/j.jesp.2007.04.006; Castelli L, 2011, J EXP SOC PSYCHOL, V47, P1013, DOI 10.1016/j.jesp.2011.03.016; Castelli L, 2009, DEV PSYCHOL, V45, P586, DOI 10.1037/a0014619; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DEVINE PG, 1995, PERS SOC PSYCHOL B, V21, P1139, DOI 10.1177/01461672952111002; Dovidio J. F., 2006, SAGE HDB NONVERBAL C, V25, P481, DOI DOI 10.4135/9781412976152.N25; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Dunham Y, 2006, CHILD DEV, V77, P1268, DOI 10.1111/j.1467-8624.2006.00933.x; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Hosie JA, 1996, MEMORY, V4, P175, DOI 10.1080/096582196389031; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; KEVERNE EB, 1978, ANIM BEHAV, V26, P933, DOI 10.1016/0003-3472(78)90157-4; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Macrae CN, 2009, J EXP SOC PSYCHOL, V45, P1012, DOI 10.1016/j.jesp.2009.04.021; McNelis Nicole L., 1998, Animal Cognition, V1, P65, DOI 10.1007/s100710050008; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Ristic J, 2007, PSYCHON B REV, V14, P964, DOI 10.3758/BF03194129; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Sidanius J., 1999, SOCIAL DOMINANCE INT; Sniderman Paul M., 2000, OUTSIDER PREJUDICE P; Stevens SA, 2008, PSYCHON B REV, V15, P1148, DOI 10.3758/PBR.15.6.1148; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	45	70	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25608	10.1371/journal.pone.0025608	http://dx.doi.org/10.1371/journal.pone.0025608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991323	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300014
J	Chassot, AA; Gregoire, EP; Lavery, R; Taketo, MM; de Rooij, DG; Adams, IR; Chaboissier, MC				Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Taketo, Makoto M.; de Rooij, Dirk G.; Adams, Ian R.; Chaboissier, Marie-Christine			RSPO1/beta-Catenin Signaling Pathway Regulates Oogonia Differentiation and Entry into Meiosis in the Mouse Fetal Ovary	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; RETINOIC ACID; BETA-CATENIN; SEX DETERMINATION; SUPPRESSES MEIOSIS; MEIOTIC INITIATION; CONSERVED ROLE; ENTER MEIOSIS; R-SPONDIN1; EXPRESSION	Differentiation of germ cells into male gonocytes or female oocytes is a central event in sexual reproduction. Proliferation and differentiation of fetal germ cells depend on the sex of the embryo. In male mouse embryos, germ cell proliferation is regulated by the RNA helicase Mouse Vasa homolog gene and factors synthesized by the somatic Sertoli cells promote gonocyte differentiation. In the female, ovarian differentiation requires activation of the WNT/beta-catenin signaling pathway in the somatic cells by the secreted protein RSPO1. Using mouse models, we now show that Rspo1 also activates the WNT/beta-catenin signaling pathway in germ cells. In XX Rspo1(-/-) gonads, germ cell proliferation, expression of the early meiotic marker Stra8, and entry into meiosis are all impaired. In these gonads, impaired entry into meiosis and germ cell sex reversal occur prior to detectable Sertoli cell differentiation, suggesting that beta-catenin signaling acts within the germ cells to promote oogonial differentiation and entry into meiosis. Our results demonstrate that RSPO1/beta-catenin signaling is involved in meiosis in fetal germ cells and contributes to the cellular decision of germ cells to differentiate into oocyte or sperm.	[Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Chaboissier, Marie-Christine] Fac Med Nice, INSERM, U636, F-06034 Nice, France; [Chassot, Anne-Amandine; Gregoire, Elodie P.; Lavery, Rowena; Chaboissier, Marie-Christine] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France; [Taketo, Makoto M.] Kyoto Univ Yoshida Konoe Cho, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto, Japan; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [de Rooij, Dirk G.] Univ Utrecht, Dept Endocrinol & Metab, Fac Sci, Utrecht, Netherlands; [Adams, Ian R.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Kyoto University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; University of Edinburgh	Chassot, AA (corresponding author), Fac Med Nice, INSERM, U636, U210, F-06034 Nice, France.	Marie-Christine.Chaboissier@unice.fr	Adams, Ian R/AAU-1231-2021; CHABOISSIER, Marie-Christine/F-6166-2019; Chassot, Anne-Amandine/O-2102-2016; CHABOISSIER, Marie-Christine/AAZ-5905-2021; de Rooij, D.G./AAW-1195-2021; Grégoire, Elodie P./CAG-7541-2022; Adams, Ian/P-9862-2016	Adams, Ian R/0000-0001-8838-1271; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Chassot, Anne-Amandine/0000-0003-1242-9456; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Grégoire, Elodie P./0000-0001-7614-4754; Adams, Ian/0000-0001-8838-1271; de Rooij, Dirk/0000-0003-3932-4419	Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche [ANR-09-GENM-009-03, ANR-10-Blanc]; La Fondation pour la Recherche Medicale; MRC [MC_U127580973] Funding Source: UKRI; Medical Research Council [MC_U127580973] Funding Source: researchfish	Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche (ANR-09-GENM-009-03 and ANR-10-Blanc SVSE2-Molmechmeiosis). A.A.C. was financed by La Fondation pour la Recherche Medicale (post-doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Allard S, 2000, DEVELOPMENT, V127, P3349; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Gregoire EP, 2011, DEV BIOL, V349, P65, DOI 10.1016/j.ydbio.2010.10.006; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim B, 2011, DEV BIOL, V349, P417, DOI 10.1016/j.ydbio.2010.10.010; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kimble J, 2007, SCIENCE, V316, P400, DOI 10.1126/science.1142109; Kocer A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-36; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Li H, 2004, BIOL REPROD, V70, P687, DOI 10.1095/biolreprod.103.023135; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Li H, 2009, BIOL REPROD, V81, P996, DOI 10.1095/biolreprod.109.078808; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Nagamine CM, 1996, DEVELOPMENT, V122, P3597; Naillat F, 2010, HUM MOL GENET; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Tanaka SS, 2000, GENE DEV, V14, P841; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622	73	91	93	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25641	10.1371/journal.pone.0025641	http://dx.doi.org/10.1371/journal.pone.0025641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991325	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000049
J	Frenzel, J; Gessner, C; Sandvoss, T; Hammerschmidt, S; Schellenberger, W; Sack, U; Eschrich, K; Wirtz, H				Frenzel, Jochen; Gessner, Christian; Sandvoss, Torsten; Hammerschmidt, Stefan; Schellenberger, Wolfgang; Sack, Ulrich; Eschrich, Klaus; Wirtz, Hubert			Outcome Prediction in Pneumonia Induced ALI/ARDS by Clinical Features and Peptide Patterns of BALF Determined by Mass Spectrometry	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; OBSTRUCTIVE PULMONARY-DISEASE; SUPPORT VECTOR MACHINES; PROTEOMIC ANALYSIS; SAMPLE PREPARATION; CANCER-PATIENTS; TIDAL VOLUME; CLASSIFICATION	Background: Peptide patterns of bronchoalveolar lavage fluid (BALF) were assumed to reflect the complex pathology of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) better than clinical and inflammatory parameters and may be superior for outcome prediction. Methodology/Principal Findings: A training group of patients suffering from ALI/ARDS was compiled from equal numbers of survivors and nonsurvivors. Clinical history, ventilation parameters, Murray's lung injury severity score (Murray's LISS) and interleukins in BALF were gathered. In addition, samples of bronchoalveolar lavage fluid were analyzed by means of hydrophobic chromatography and MALDI-ToF mass spectrometry (MALDI-ToF MS). Receiver operating characteristic (ROC) analysis for each clinical and cytokine parameter revealed interleukin-6>interleukin-8>diabetes mellitus>Murray's LISS as the best outcome predictors. Outcome predicted on the basis of BALF levels of interleukin-6 resulted in 79.4% accuracy, 82.7% sensitivity and 76.1% specificity (area under the ROC curve, AUC, 0.853). Both clinical parameters and cytokines as well as peptide patterns determined by MALDI-ToF MS were analyzed by classification and regression tree (CART) analysis and support vector machine (SVM) algorithms. CART analysis including Murray's LISS, interleukin-6 and interleukin-8 in combination was correct in 78.0%. MALDI-ToF MS of BALF peptides did not reveal a single identifiable biomarker for ARDS. However, classification of patients was successfully achieved based on the entire peptide pattern analyzed using SVM. This method resulted in 90% accuracy, 93.3% sensitivity and 86.7% specificity following a 10-fold cross validation (AUC = 0.953). Subsequent validation of the optimized SVM algorithm with a test group of patients with unknown prognosis yielded 87.5% accuracy, 83.3% sensitivity and 90.0% specificity. Conclusions/Significance: MALDI-ToF MS peptide patterns of BALF, evaluated by appropriate mathematical methods can be of value in predicting outcome in pneumonia induced ALI/ARDS.	[Frenzel, Jochen; Schellenberger, Wolfgang; Eschrich, Klaus] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Gessner, Christian; Sandvoss, Torsten; Hammerschmidt, Stefan; Wirtz, Hubert] Univ Leipzig, Dept Resp Med, Leipzig, Germany; [Sack, Ulrich] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Frenzel, J (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	Jochen.Frenzel@medizin.uni-leipzig.de	Sack, Ulrich/J-6301-2015	Sack, Ulrich/0000-0002-7813-0492	University of Leipzig	University of Leipzig	This work was supported by the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JH, 2008, STAT APPL GENET MOL, V7; Ben-David A, 2008, ENG APPL ARTIF INTEL, V21, P874, DOI 10.1016/j.engappai.2007.09.009; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bowler RP, 2004, AM J PHYSIOL-LUNG C, V286, pL1095, DOI 10.1152/ajplung.00304.2003; Bowler RP, 2006, CHEST, V130, P567, DOI 10.1378/chest.130.2.567; Bowler Russell P, 2006, COPD, V3, P41, DOI 10.1080/15412550500493394; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Candiano G, 2007, AM J PHYSIOL-LUNG C, V292, pL185, DOI 10.1152/ajplung.00085.2006; Chang DW, 2008, AM J RESP CRIT CARE, V178, P701, DOI 10.1164/rccm.200712-1895OC; Chaurand P, 2004, J PROTEOME RES, V3, P245, DOI 10.1021/pr0341282; Craig TR, 2010, CRIT CARE MED, V38, P114, DOI 10.1097/CCM.0b013e3181b43050; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gessner C, 2003, CHEST, V124, P1046, DOI 10.1378/chest.124.3.1046; Girard TD, 2007, CHEST, V131, P921, DOI 10.1378/chest.06-1515; Grassi M, 2001, EUR J EPIDEMIOL, V17, P19, DOI 10.1023/A:1010987521885; Hirsch J, 2004, AM J PHYSIOL-LUNG C, V287, pL1, DOI 10.1152/ajplung.00301.2003; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; Ichikado K, 2006, RADIOLOGY, V238, P321, DOI 10.1148/radiol.2373041515; Jayasurya K, 2010, MED PHYS, V37, P1401, DOI 10.1118/1.3352709; KIPNIS E, 2009, INTENS CARE MED, P23; Kriegova E, 2006, AM J RESP CRIT CARE, V173, P1145, DOI 10.1164/rccm.200507-1126OC; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lee Y, 2009, COMPUT METH PROG BIO, V93, P206, DOI 10.1016/j.cmpb.2008.10.008; Leroy Baptiste, 2008, V425, P67, DOI 10.1007/978-1-60327-210-0_6; Lin WC, 2010, EXP BIOL MED, V235, P57, DOI 10.1258/ebm.2009.009256; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Noel-Georis I, 2002, J CHROMATOGR B, V771, P221, DOI 10.1016/S1570-0232(02)00114-9; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Plymoth A, 2003, PROTEOMICS, V3, P962, DOI 10.1002/pmic.200300387; Rocco TR, 2001, ANN SURG, V233, P414, DOI 10.1097/00000658-200103000-00017; Rose AS, 2007, SEMIN RESP CRIT CARE, V28, P561, DOI 10.1055/s-2007-991528; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Rupf S, 2005, ORAL MICROBIOL IMMUN, V20, P267, DOI 10.1111/j.1399-302X.2005.00223.x; Scholkopf B, 2001, LEARNING KERNELS SUP; Seeley E, 2008, THORAX, V63, P994, DOI 10.1136/thx.2007.093658; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware Lorraine B, 2005, Crit Care Med, V33, pS217, DOI 10.1097/01.CCM.0000155788.39101.7E; Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; WESTON J, MATLAB MACHINE LEARN; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	56	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25544	10.1371/journal.pone.0025544	http://dx.doi.org/10.1371/journal.pone.0025544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991318	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000038
J	Haider, AJ; Briggs, D; Self, TJ; Chilvers, HL; Holliday, ND; Kerr, ID				Haider, Ameena J.; Briggs, Deborah; Self, Tim J.; Chilvers, Hannah L.; Holliday, Nicholas D.; Kerr, Ian D.			Dimerization of ABCG2 Analysed by Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; ATP-BINDING; MULTIDRUG-RESISTANCE; TRANSPORTER ABCG2; MUTATIONAL ANALYSIS; DISULFIDE BOND; BCRP/ABCG2; DOMAIN; IDENTIFICATION; LOCALIZATION	ABCG2 is one of three human ATP binding cassette transporters that are functionally capable of exporting a diverse range of substrates from cells. The physiological consequence of ABCG2 multidrug transport activity in leukaemia, and some solid tumours is the acquisition of cancer multidrug resistance. ABCG2 has a primary structure that infers that a minimal functional transporting unit would be a homodimer. Here we investigated the ability of a bimolecular fluorescence complementation approach to examine ABCG2 dimers, and to probe the role of individual amino acid substitutions in dimer formation. ABCG2 was tagged with fragments of venus fluorescent protein (vYFP), and this tagging did not perturb trafficking or function. Co-expression of two proteins bearing N-terminal and C-terminal fragments of YFP resulted in their association and detection of dimerization by fluorescence microscopy and flow cytometry. Point mutations in ABCG2 which may affect dimer formation were examined for alterations in the magnitude of fluorescence complementation signal. Bimolecular fluorescence complementation (BiFC) demonstrated specific ABCG2 dimer formation, but no changes in dimer formation, resulting from single amino acid substitutions, were detected by BiFC analysis.	[Haider, Ameena J.; Briggs, Deborah; Self, Tim J.; Chilvers, Hannah L.; Holliday, Nicholas D.; Kerr, Ian D.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham	Haider, AJ (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	Ian.kerr@nottingham.ac.uk	Kerr, Ian D/B-3803-2015	Kerr, Ian D/0000-0002-7544-8454; Holliday, Nicholas/0000-0002-2900-828X	Government of Kuwait; BBSRC; Biochemical Society; Medical Research Council [G0700049] Funding Source: researchfish; MRC [G0700049] Funding Source: UKRI	Government of Kuwait; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biochemical Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study came from a PhD scholarship award from the Government of Kuwait to AJH, a BBSRC summer vacation bursary to HLC, and a Biochemical Society Guildford Bench Methodology Fund award to IDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Clark R, 2006, BRIT J PHARMACOL, V149, P506, DOI 10.1038/sj.bjp.0706904; Cooray HC, 2002, NEUROREPORT, V13, P2059, DOI 10.1097/00001756-200211150-00014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Hegedus C, 2008, ADV DRUG DELIV REV; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kerr ID, 2011, BR J PHARM; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lawson J, 2008, BBA-BIOMEMBRANES, V1778, P376, DOI 10.1016/j.bbamem.2007.10.021; Liu Y, 2008, J PHARMACOL EXP THER, V326, P33, DOI 10.1124/jpet.108.138115; Maliepaard M, 2001, CANCER RES, V61, P3458; McDevitt CA, 2008, FEBS J, V275, P4354, DOI 10.1111/j.1742-4658.2008.06578.x; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ni Zhanglin, 2010, Int J Biochem Mol Biol, V1, P1; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Polgar O, 2006, BIOCHEMISTRY-US, V45, P5251, DOI 10.1021/bi0521590; Polgar O, 2010, BIOCHEMISTRY-US, V49, P2235, DOI 10.1021/bi902085q; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2001, BBA-BIOMEMBRANES, V1512, P171, DOI 10.1016/S0005-2736(01)00308-X; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Wang HG, 2008, BIOCHEMISTRY-US, V47, P13778, DOI 10.1021/bi801644v; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	48	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25818	10.1371/journal.pone.0025818	http://dx.doi.org/10.1371/journal.pone.0025818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991363	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000079
J	Hibert, F; Sabatier, D; Andrivot, J; Scotti-Saintagne, C; Gonzalez, S; Prevost, MF; Grenand, P; Chave, J; Caron, H; Richard-Hansen, C				Hibert, Fabrice; Sabatier, Daniel; Andrivot, Judith; Scotti-Saintagne, Caroline; Gonzalez, Sophie; Prevost, Marie-Francoise; Grenand, Pierre; Chave, Jerome; Caron, Henri; Richard-Hansen, Cecile			Botany, Genetics and Ethnobotany: A Crossed Investigation on the Elusive Tapir's Diet in French Guiana	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; SEED-DISPERSAL; TROPICAL FORESTS; DNA-SEQUENCES; HABITAT USE; CONSERVATION; RECRUITMENT; TERRESTRIS; STRATEGIES; COMMUNITY	While the populations of large herbivores are being depleted in many tropical rainforests, the importance of their trophic role in the ecological functioning and biodiversity of these ecosystems is still not well evaluated. This is due to the outstanding plant diversity that they feed upon and the inherent difficulties involved in observing their elusive behaviour. Classically, the diet of elusive tropical herbivores is studied through the observation of browsing signs and macroscopic analysis of faeces or stomach contents. In this study, we illustrate that the original coupling of classic methods with genetic and ethnobotanical approaches yields information both about the diet diversity, the foraging modalities and the potential impact on vegetation of the largest terrestrial mammal of Amazonia, the lowland tapir. The study was conducted in the Guianan shield, where the ecology of tapirs has been less investigated. We identified 92 new species, 51 new genera and 13 new families of plants eaten by tapirs. We discuss the relative contribution of our different approaches, notably the contribution of genetic barcoding, used for the first time to investigate the diet of a large tropical mammal, and how local traditional ecological knowledge is accredited and valuable for research on the ecology of elusive animals.	[Hibert, Fabrice; Andrivot, Judith; Richard-Hansen, Cecile] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech Guyane, Kourou, French Guiana; [Sabatier, Daniel; Gonzalez, Sophie; Prevost, Marie-Francoise] IRD, UMR AMAP, Herbier Guyane, Cayenne, French Guiana; [Sabatier, Daniel] IRD, UMR AMAP, Montpellier, France; [Grenand, Pierre] OHM Oyapock CNRS, UPS IRD 3188, Cayenne, French Guiana; [Andrivot, Judith; Scotti-Saintagne, Caroline] INRA, UMR EcoFoG 0745, Kourou, French Guiana; [Chave, Jerome] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Caron, Henri] Univ Bordeaux, INRA, BIOGECO UMR1202, Cestas, France	Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Hibert, F (corresponding author), Off Natl Chasse & Faune Sauvage, Direct Etud & Rech Guyane, Kourou, French Guiana.	fabricenz@gmail.com	Scotti-Saintagne, Caroline/C-3119-2009; Gonzalez, Sophie/U-1674-2017; Sabatier, Daniel/D-9117-2011; Scotti-Saintagne, Caroline/AAC-1938-2020	Gonzalez, Sophie/0000-0003-4109-2004; Scotti-Saintagne, Caroline/0000-0001-6891-7315; Richard-Hansen, Cecile/0000-0002-9353-791X; Sabatier, Daniel/0000-0003-0883-1530				AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Aublet JBCF, 1775, HIST PLANTES GUYANE, P327; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.2307/2641280; Biegert A, 2010, NUCLEIC ACIDS RES, V34, pW335; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BODMER RE, 1990, J ZOOL, V222, P121, DOI 10.1111/j.1469-7998.1990.tb04034.x; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; BONGERS F, 2001, NOURAGUES DYNAMICS P; Bradford MG, 2008, BIOTROPICA, V40, P338, DOI 10.1111/j.1744-7429.2007.00372.x; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; C?lix M., 2018, EUROPEAN RED LIST SA; Campos-Arceiz A, 2008, ECOL RES, V23, P1057, DOI 10.1007/s11284-008-0466-4; Coley PD, 2005, ECOLOGY, V86, P2633, DOI 10.1890/04-1283; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Costa-Neto EM, 2000, INTERCIENCIA, V25, P423; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DIRZO R, 1990, CONSERV BIOL, V4, P444, DOI 10.1111/j.1523-1739.1990.tb00320.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; FEER F, 1995, J TROP ECOL, V11, P683, DOI 10.1017/S0266467400009238; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Forget PM, 2007, CONSERV BIOL, V21, P106, DOI 10.1111/j.1523-1739.2006.00590.x; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Freeman M.M., 1992, N PERSPECT, V20, P9; Funk V.A., 2007, CONTRIB U S NATL HER, V55, P1; GADGIL M, 1993, AMBIO, V22, P151; Galetti M, 2001, BIOTROPICA, V33, P723, DOI 10.1111/j.1744-7429.2001.tb00232.x; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Giombini MI, 2009, BIOTROPICA, V41, P408, DOI 10.1111/j.1744-7429.2009.00526.x; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Grenand F, 2008, PEUT ON CLASSER VIVA, P119; GRENAND P, 1993, MAN BIOSPH, V13, P425; GRENAND P, 1992, SUSTAINABLE HARVEST, P28; GUILLOTIN M, 1994, J ZOOL, V233, P551, DOI 10.1111/j.1469-7998.1994.tb05365.x; Henry O, 2000, BIOTROPICA, V32, P364, DOI 10.1646/0006-3606(2000)032[0364:DOTLTT]2.0.CO;2; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huntington HP, 1999, ARCTIC, V52, P49; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Keuroghlian A, 2009, BIODIVERS CONSERV, V18, P1733, DOI 10.1007/s10531-008-9554-6; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Montenegro O, 2004, THESIS U FLORIDA FLO; MORI SA, 2002, GUIDE VASCULAR PLA 2; Mueller JG, 2010, CONSERV BIOL, V24, P140, DOI 10.1111/j.1523-1739.2009.01392.x; Norden N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001079; Olmos F, 1999, BIOTROPICA, V31, P375, DOI 10.1111/j.1744-7429.1999.tb00151.x; Poncy O, 2001, MONOG BIOL, V80, P31; Quiroga-Castro VD, 2001, BIOTROPICA, V33, P472, DOI 10.1111/j.1744-7429.2001.tb00200.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rist L, 2010, ECOL SOC, V15; Roldan AI, 2001, CONSERV BIOL, V15, P617, DOI 10.1046/j.1523-1739.2001.015003617.x; Royo AA, 2005, OECOLOGIA, V145, P66, DOI 10.1007/s00442-005-0079-3; Russo SE, 2005, INT J PRIMATOL, V26, P1017, DOI 10.1007/s10764-005-6456-2; SABATIER D, 1985, REV ECOL-TERRE VIE, V40, P289; Salas LA, 1996, CAN J ZOOL, V74, P1444, DOI 10.1139/z96-159; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Santos LGRO, 2005, TAPIR CONSERV, V14, P22; SHARMA AD, 2002, PLANT MOL BIOL REP, V20, pA415, DOI [10.1007/BF02772129, DOI 10.1007/BF02772129]; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Taber A, 2008, DESTINO ARQUITECTOS; Talamoni SA, 2009, ZOOLOGIA-CURITIBA, V26, P251, DOI 10.1590/S1984-46702009000200007; Tate JA, 2003, SYST BOT, V28, P723; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Timm RM, 2009, FOREST ECOL MANAG, V258, P997, DOI 10.1016/j.foreco.2008.10.027; Tobler M, 2008, THESIS TEXAS A M U; Tobler MW, 2010, BIOTROPICA, V42, P215, DOI 10.1111/j.1744-7429.2009.00549.x; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wright SJ, 2003, PERSPECT PLANT ECOL, V6, P73, DOI 10.1078/1433-8319-00043; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x	90	32	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25850	10.1371/journal.pone.0025850	http://dx.doi.org/10.1371/journal.pone.0025850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991372	Green Published, gold			2022-12-25	WOS:000295943000085
J	Otsuka, A; Kubo, M; Honda, T; Egawa, G; Nakajima, S; Tanizaki, H; Kim, B; Matsuoka, S; Watanabe, T; Nakae, S; Miyachi, Y; Kabashima, K				Otsuka, Atsushi; Kubo, Masato; Honda, Tetsuya; Egawa, Gyohei; Nakajima, Saeko; Tanizaki, Hideaki; Kim, Bongju; Matsuoka, Satoshi; Watanabe, Takeshi; Nakae, Susumu; Miyachi, Yoshiki; Kabashima, Kenji			Requirement of Interaction between Mast Cells and Skin Dendritic Cells to Establish Contact Hypersensitivity	PLOS ONE			English	Article							CUTANEOUS IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; T-CELLS; ACTIVATION; MIGRATION; MICE; TNF; IGE; EXPRESSION; RECEPTOR	The role of mast cells (MCs) in contact hypersensitivity (CHS) remains controversial. This is due in part to the use of the MC-deficient Kit(W/Wv) mouse model, since Kit(W/Wv) mice congenitally lack other types of cells as a result of a point mutation in c-kit. A recent study indicated that the intronic enhancer (IE) for Il4 gene transcription is essential for MCs but not in other cell types. The aim of this study is to re-evaluate the roles of MCs in CHS using mice in which MCs can be conditionally and specifically depleted. Transgenic Mas-TRECK mice in which MCs are depleted conditionally were newly generated using cell-type specific gene regulation by IE. Using this mouse, CHS and FITC-induced cutaneous DC migration were analyzed. Chemotaxis assay and cytoplasmic Ca(2+) imaging were performed by co-culture of bone marrow-derived MCs (BMMCs) and bone marrow-derived dendritic cells (BMDCs). In Mas-TRECK mice, CHS was attenuated when MCs were depleted during the sensitization phase. In addition, both maturation and migration of skin DCs were abrogated by MC depletion. Consistently, BMMCs enhanced maturation and chemotaxis of BMDC in ICAM-1 and TNF-alpha dependent manners Furthermore, stimulated BMDCs increased intracellular Ca(2+) of MC upon direct interaction and up-regulated membrane-bound TNF-alpha on BMMCs. These results suggest that MCs enhance DC functions by interacting with DCs in the skin to establish the sensitization phase of CHS.	[Otsuka, Atsushi; Honda, Tetsuya; Egawa, Gyohei; Nakajima, Saeko; Tanizaki, Hideaki; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Otsuka, Atsushi; Kim, Bongju; Matsuoka, Satoshi; Watanabe, Takeshi] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Kanagawa, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Minato Ku, Tokyo, Japan	Kyoto University; Kyoto University; RIKEN; University of Tokyo	Otsuka, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	matsuoka, satoshi/GWD-0440-2022; Nakajima, Saeko/AAB-1577-2021; Kim, Bongju/M-2016-2019; Kubo, Masato/A-5918-2016; Kabashima, Kenji/G-2521-2014	matsuoka, satoshi/0000-0003-3321-9749; Kim, Bongju/0000-0001-7309-5977; Egawa, Gyohei/0000-0002-6101-4719; Otsuka, Atsushi/0000-0001-7365-947X; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23650258] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; EGAWA G, 2011, J INVEST DERMATOL; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hammad H, 2003, J IMMUNOL, V171, P3936, DOI 10.4049/jimmunol.171.8.3936; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Inamura N, 1998, J IMMUNOL, V160, P4026; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Kabashima K, 2004, J DERMATOL SCI, V34, P177, DOI 10.1016/j.jdermsci.2003.11.008; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kitawaki T, 2006, INT IMMUNOL, V18, P1789, DOI 10.1093/intimm/dxl113; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Maurer M, 1997, LAB INVEST, V77, P319; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; RA CS, 1994, J ALLERGY CLIN IMMUN, V94, P625, DOI 10.1016/0091-6749(94)90139-2; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; SWOPE VB, 1994, J INVEST DERMATOL, V102, P749, DOI 10.1111/1523-1747.ep12376970; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003	30	102	107	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25538	10.1371/journal.pone.0025538	http://dx.doi.org/10.1371/journal.pone.0025538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21980488	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300038
J	Yin, JK; Lu, KR; Lin, J; Wu, L; Hildebrandt, MAT; Chang, DW; Meyer, L; Wu, XF; Liang, D				Yin, Jikai; Lu, Karen; Lin, Jie; Wu, Lei; Hildebrandt, Michelle A. T.; Chang, David W.; Meyer, Larissa; Wu, Xifeng; Liang, Dong			Genetic Variants in TGF-beta Pathway Are Associated with Ovarian Cancer Risk	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SUSCEPTIBILITY; EXPRESSION; HYPOTHESIS; MUTATIONS; RECEPTORS; CELLS	The transforming growth factor-beta (TGF-beta) signaling pathway is involved in a diverse array of cellular processes responsible for tumorigenesis. In this case-control study, we applied a pathway-based approach to evaluate single-nucleotide polymorphisms (SNPs) in the TGF-beta signaling pathway as predictors of ovarian cancer risk. We systematically genotyped 218 SNPs from 21 genes in the TGF-beta signaling pathway in 417 ovarian cancer cases and 417 matched control subjects. We analyzed the associations of these SNPs with ovarian cancer risk, performed haplotype analysis and identified potential cumulative effects of genetic variants. We also performed analysis to identify higher-order gene-gene interactions influencing ovarian cancer risk. Individual SNP analysis showed that the most significant SNP was SMAD6:rs4147407, with an adjusted odds ratio (OR) of 1.60 (95% confidence interval [CI], 1.14-2.24, P = 0.0066). Cumulative genotype analysis of 13 SNPs with significant main effects exhibited a clear dose-response trend of escalating risk with increasing number of unfavorable genotypes. In gene-based analysis, SMAD6 was identified as the most significant gene associated with ovarian cancer risk. Haplotype analysis further revealed that two haplotype blocks within SMAD6 were significantly associated with decreased ovarian cancer risk, as compared to the most common haplotype. Gene-gene interaction analysis further categorized the study population into subgroups with different ovarian cancer risk. Our findings suggest that genetic variants in the TGF-beta signaling pathway are associated with ovarian cancer risk and may facilitate the identification of high-risk subgroups in the general population.	[Yin, Jikai; Lin, Jie; Hildebrandt, Michelle A. T.; Chang, David W.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lu, Karen; Meyer, Larissa] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Wu, Lei] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA; [Liang, Dong] Texas So Univ, Coll Pharm, Houston, TX 77004 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; Texas Southern University	Yin, JK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	liang_dx@tsu.edu			Department of Defense [W81XWH-07-0449]; National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions [5G12RR003045-21]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003045] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported in part by the Department of Defense Ovarian Cancer Research Program under award number W81XWH-07-0449, and National Institutes of Health/National Center for Research Resources/Research Centers in Minority Institutions grant 5G12RR003045-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony ML, 2010, J CANCER RES CLIN, V136, P351, DOI 10.1007/s00432-009-0703-4; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Chen T, 2001, CANCER RES, V61, P4679; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hu W, 2000, ANTICANCER RES, V20, P729; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Martinek I, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007929.pub2; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Notaridou M, 2011, INT J CANCER, V128, P2063, DOI 10.1002/ijc.25554; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Wang D, 2000, INT J ONCOL, V17, P1087; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535	30	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25559	10.1371/journal.pone.0025559	http://dx.doi.org/10.1371/journal.pone.0025559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984931	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300041
J	Shola, DTN; Wang, H; Wahdan-Alaswad, R; Danielpour, D				Shola, D. T. N.; Wang, H.; Wahdan-Alaswad, R.; Danielpour, D.			Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8	ONCOGENE			English	Article						Hic-5; BMP; Smad1; Smad; apoptosis; prostate	BONE MORPHOGENETIC PROTEINS; ANDROGEN RECEPTOR; OXIDATIVE STRESS; METASTATIC PROSTATE; UP-REGULATION; LIM PROTEIN; EXPRESSION; IDENTIFICATION; GROWTH; DEATH	Hydrogen peroxide-inducible clone-5 (Hic-5, or androgen receptor-associated protein 55) is a transforming growth factor-beta-inducible LIM protein whose deregulation is implicated in the progression of prostate cancer. Here, we report that Hic-5 binds to Smads 1, 5 and 8, and represses bone morphogenetic protein (BMP) signaling responses. Myc-Hic-5 but not Myc-paxillin was specifically immunoprecipitated with anti-FLAG IgG1 from lysates of HEK293 co-transfected with either Myc-Hic-5 or Myc-paxillin and FLAG-tagged Smads 1, 5 or 8. We showed that such interactions require the LIM3 domain of Hic-5 and the MH2 domain of those Smads. Anti-Hic-5 antibody specifically pulled down endogenous Smad1 in both the PC3 human prostate cell line and primary cultures of rat prostate fibroblasts, supporting that Hic-5 binds to Smad1 at the endogenous level. Bacterially expressed glutathione S-transferase (GST)-Smads 1, 5 or 8, but not GST alone, pulled down in vitro transcribed and translated Hic-5, implicating that Hic-5 binds directly to Smads 1, 5 and 8. Significantly, using Hic-5 small hairpin RNA silencing and overexpression systems, we show that Hic-5 (at both the endogenous and exogenous levels) represses the ability of BMP4 to induce expression of the inhibitor of differentiation-1 (Id1; a downstream target gene of BMP), activate the Id1 gene promoter and induce apoptosis in human and rat prostate epithelial cells. Moreover, silencing of Hic-5 in PC3 cells as well as in the WPMY-1 human prostate stroma cell line greatly enhances the levels of endogenous phospho-Smad1/5/8. Finally, we provide fluorescent microscopic imaging to support that Smad1 and Hic-5 mutually interact also at the level of their nuclear export mechanisms. Collectively, these results provide the first evidence for a physical and mutual functional interaction between Hic-5 and the BMP signaling pathway. Oncogene (2012) 31, 2480-2490; doi: 10.1038/onc.2011.422; published online 26 September 2011	[Danielpour, D.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Case Comprehens Canc Ctr Res Labs, Cleveland, OH 44106 USA; [Shola, D. T. N.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Wang, H.; Wahdan-Alaswad, R.; Danielpour, D.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Danielpour, D.] Univ Hosp Cleveland, Dept Urol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Danielpour, D (corresponding author), Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Case Comprehens Canc Ctr Res Labs, Wolstein Res Bldg,Room 3-532V,2103 Cornell Rd, Cleveland, OH 44106 USA.	dxd49@case.edu	Shola, Dorjee/AAE-1443-2019; Wahdan-alaswad, Reema/AAA-5604-2021	Shola, Dorjee/0000-0001-7236-5912; 	NIH [R01CA102074, R01CA134878]; Case Comprehensive Cancer Center [5T32CA059366-15, P30CA43703]; National Research Service [1F31CA142311]; NATIONAL CANCER INSTITUTE [R01CA102074, F31CA142311, P30CA043703, R01CA134878, T32CA059366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; National Research Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grants R01CA102074 and R01CA134878 (D Danielpour), a pre-doctoral fellowship (R Wahdan-Alaswad) from Case Comprehensive Cancer Center's Research Oncology Training Grant 5T32CA059366-15 and National Research Service Award Individual Fellowship Application 1F31CA142311, and the Case Comprehensive Cancer Center P30CA43703 (for the Cytometry Core facility).	Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Barnes J, 1995, WORLD J UROL, V13, P337; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bobinac D, 2005, CROAT MED J, V46, P389; Chipuk JE, 2002, J BIOL CHEM, V277, P26412, DOI 10.1074/jbc.M201244200; Corey E, 2007, J UROLOGY, V178, P750, DOI 10.1016/j.juro.2007.06.007; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH569, DOI 10.1152/ajpheart.00180.2008; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; DANIELPOUR D, 1994, CANCER RES, V54, P3413; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; Gao ZL, 2007, EXP CELL RES, V313, P4000, DOI 10.1016/j.yexcr.2007.05.023; Gao ZL, 2005, FEBS LETT, V579, P5651, DOI 10.1016/j.febslet.2005.08.086; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Heitzer MD, 2007, STEROIDS, V72, P218, DOI 10.1016/j.steroids.2006.11.010; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Hornigold N, 2010, KIDNEY INT, V77, P329, DOI 10.1038/ki.2009.417; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Hsu MY, 2005, CANCER METAST REV, V24, P251, DOI 10.1007/s10555-005-1575-y; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Li Z. L, 2006, ZHONGHUA NAN KE XUE, V12, P132; Li Ze-Liang, 2006, Zhonghua Nan Ke Xue, V12, P126; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Miyoshi Y, 2003, PROSTATE, V56, P280, DOI 10.1002/pros.10262; Mori K, 2009, MOL BIOL CELL, V20, P218, DOI 10.1091/mbc.E08-04-0428; Przybyszewski WM, 2009, POSTEP HIG MED DOSW, V63, P340; Rahman MM, 2003, P NATL ACAD SCI USA, V100, P5124, DOI 10.1073/pnas.0530097100; SCHIMENTI KJ, 1992, CYTOMETRY, V13, P48, DOI 10.1002/cyto.990130109; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; Song K, 2003, CANCER RES, V63, P4358; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Thomas SM, 1999, J CELL SCI, V112, P181; Trousse F, 2001, J NEUROSCI, V21, P1292; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Wahdan-Alaswad RS, 2010, CANCER RES, V70, P9106, DOI 10.1158/0008-5472.CAN-10-1119; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Ye L, 2007, J UROLOGY, V178, P1086, DOI 10.1016/j.juro.2007.05.003; Yeh Shuyuan, 1999, Keio Journal of Medicine, V48, P87; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817	48	17	17	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2480	2490		10.1038/onc.2011.422	http://dx.doi.org/10.1038/onc.2011.422			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996749	Green Accepted			2022-12-25	WOS:000303985300010
J	Aulagnier, M; Janssens, W; De Beer, I; van Rooy, G; Gaeb, E; Hesp, C; van der Gaag, J; de Wit, TFR				Aulagnier, Marielle; Janssens, Wendy; De Beer, Ingrid; van Rooy, Gert; Gaeb, Esegiel; Hesp, Cees; van der Gaag, Jacques; de Wit, Tobias F. Rinke			Incidence of HIV in Windhoek, Namibia: Demographic and Socio-Economic Associations	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIAL DETERMINANTS; URBAN HEALTH; PREVALENCE; POVERTY; WOMEN; POPULATION; PREVENTION; BEHAVIOR; SEROSTATUS	Objective: To estimate HIV incidence and prevalence in Windhoek, Namibia and to analyze socio-economic factors related to HIV infection. Method: In 2006/7, baseline surveys were performed with 1,753 private households living in the greater Windhoek area; follow-up visits took place in 2008 and 2009. Face-to-face socio-economic questionnaires were administrated by trained interviewers; biomedical markers were collected by nurses; GPS codes of household residences were recorded. Results: The HIV prevalence in the population (aged>12 years) was 11.8% in 2006/7 and 14.6% in 2009. HIV incidence between 2007 and 2009 was 2.4 per 100 person year (95%CI = 1.9-2.9). HIV incidence and prevalence were higher in female populations. HIV incidence appeared non-associated with any socioeconomic factor, indicating universal risk for the population. For women a positive trend was found between low per-capita consumption and HIV acquisition. A HIV knowledge score was strongly associated with HIV incidence for both men and women. High HIV prevalence and incidence was concentrated in the north-western part of the city, an area with lower HIV knowledge, higher HIV risk perception and lower per-capita consumption. Discussion: The HIV incidence and prevalence figures do not suggest a declining epidemic in Windhoek. Higher vulnerability of women is recorded, most likely related to economic dependency and increasing transactional sex in Namibia. The lack of relation between HIV incidence and socio-economic factors confirms HIV risks for the overall urban community. Appropriate knowledge is strongly associated to lower HIV incidence and prevalence, underscoring the importance of continuous information and education activities for prevention of infection. Geographical areas were identified that would require prioritized HIV campaigning.	[Aulagnier, Marielle; Hesp, Cees; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands; [Janssens, Wendy; van der Gaag, Jacques] Vrije Univ Amsterdam, Dept Dev Econ, Amsterdam, Netherlands; [De Beer, Ingrid] PharmAccess Fdn Namibia, Windhoek, Namibia; [van Rooy, Gert] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia; [Gaeb, Esegiel] Namibia Inst Pathol, Windhoek, Namibia; [Janssens, Wendy; van der Gaag, Jacques] Amsterdam Inst Int Dev, Amsterdam, Netherlands; [van der Gaag, Jacques] Brookings Inst, Washington, DC 20036 USA; [de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Namibia; Brookings Institution; University of Amsterdam; Academic Medical Center Amsterdam	Aulagnier, M (corresponding author), PharmAccess Fdn, Amsterdam, Netherlands.	m_aulagnier@yahoo.fr	de Wit, Tobias TF Rinke/A-1224-2013; Van Rooy, Gert/Q-6636-2019	Van Rooy, Gert/0000-0002-8013-8768; Janssens, Wendy/0000-0002-2085-8608	Netherlands Ministry of Foreign Affairs (DSI/SB) [13298]	Netherlands Ministry of Foreign Affairs (DSI/SB)	This work was supported by a grant from the Netherlands Ministry of Foreign Affairs (DSI/SB, project number 13298). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, World Health Statistics 2010; [Anonymous], NAM HLTH RES TRACK 2; [Anonymous], 2008, NAM DEM HLTH SURV 20; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Braunstein SL, 2009, AIDS REV, V11, P140; Daniels N, 1999, DAEDALUS, V128, P215; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Frayne B, 2004, GEOFORUM, V35, P489, DOI 10.1016/j.geoforum.2004.01.003; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Grosh M., 2000, DESIGNING HOUSEHOLD; Gustafsson-Wright E, 2011, HEALTH POLICY PLANN, V26, P142, DOI 10.1093/heapol/czq029; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Homers RL, 2008, JAIDS-J ACQ IMM DEF, V48, P116, DOI 10.1097/QAI.0b013e31816bcdcf; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Janssens W, 2008, NONRESPONSE BIAS MEA; Janssens W, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6323; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Kumwenda N, 2006, SEX TRANSM DIS, V33, P646, DOI 10.1097/01.olq.0000223283.27142.9f; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; MoHSS, 2009, 2008 9 EST PROJ IMP; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Schellekens O, 2009, HEALTH AFFAIR, V28, P6; Schmidt M, 2009, POVERTY INEQUALITY N; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; Stringer EM, 2004, JAIDS-J ACQ IMM DEF, V35, P60, DOI 10.1097/00126334-200401010-00009; UNAIDS, 2010, REP GLOB AIDS EP; [USAID MOHSS], 2009, HIV AIDS NAM BEHAV C; Vearey J, 2010, HEALTH PLACE, V16, P694, DOI 10.1016/j.healthplace.2010.02.007; Vlahov David, 2005, Cad. Saúde Pública, V21, P949, DOI 10.1590/S0102-311X2005000300031; Voeten HA, 2009, SEX TRANSM DIS, V2; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	43	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25860	10.1371/journal.pone.0025860	http://dx.doi.org/10.1371/journal.pone.0025860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991374	Green Published, gold, Green Submitted			2022-12-25	WOS:000295963300026
J	Bartels, SJJ; Spruijt, CG; Brinkman, AB; Jansen, PWTC; Vermeulen, M; Stunnenberg, HG				Bartels, Stefanie J. J.; Spruijt, Cornelia G.; Brinkman, Arie B.; Jansen, Pascal W. T. C.; Vermeulen, Michiel; Stunnenberg, Hendrik G.			A SILAC-Based Screen for Methyl-CpG Binding Proteins Identifies RBP-J as a DNA Methylation and Sequence-Specific Binding Protein	PLOS ONE			English	Article							B-VIRUS ENHANCER; ZINC-FINGER PROTEINS; HUMAN FMR1 GENE; TRANSCRIPTIONAL REPRESSOR; HUMAN CYTOMEGALOVIRUS; CHROMOSOMAL PROTEIN; SRA DOMAIN; PROMOTER; MECP2; COMPLEX	Background: DNA methylation is an epigenetic modification that plays a crucial role in a variety of biological processes. Methylated DNA is specifically bound by Methyl-CpG Binding Proteins (MBPs). Three different types of MBPs have been identified so far: the Methyl-CpG Binding Domain (MBD) family proteins, three BTB/POZ-Zn-finger proteins, and UHRF1. Most of the known MBPs have been identified via homology with the MBD and Zn-finger domains as present in MeCP2 and Kaiso, respectively. It is conceivable that other proteins are capable of recognizing methylated DNA. Methodology/Principal Findings: For the purpose of identifying novel 'readers' we set up a methyl-CpG pull-down assay combined with stable-isotope labeling by amino acids in cell culture (SILAC). In a methyl-CpG pull-down with U937 nuclear extracts, we recovered several known MBPs and almost all subunits of the MBD2/NuRD complex as methylation specific binders, providing proof-of-principle. Interestingly, RBP-J, the transcription factor downstream of Notch receptors, also bound the DNA in a methylation dependent manner. Follow-up pull-downs and electrophoretic mobility shift assays (EMSAs) showed that RBP-J binds methylated DNA in the context of a mutated RBP-J consensus motif. Conclusions/Significance: The here described SILAC/methyl-CpG pull-down constitutes a new approach to identify potential novel DNAme readers and will advance unraveling of the complete methyl-DNA interactome.	[Bartels, Stefanie J. J.; Brinkman, Arie B.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Spruijt, Cornelia G.; Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Bartels, SJJ (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Brinkman, Arie/V-1533-2018; Stunnenberg, Hendrik G./D-6875-2012; Vermeulen, Michiel/C-8883-2013	Brinkman, Arie/0000-0002-9875-1835; Stunnenberg, Hendrik G./0000-0002-0066-1576; Vermeulen, Michiel/0000-0003-0836-6894; Spruijt, Cornelia/0000-0002-1789-670X	Netherlands Organisation for Scientific Research (NWO) [VIDI 864-05-002]; Dutch Cancer Foundation (KWF) [KUN 2008-4130]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding)	This work was supported by the Netherlands Organisation for Scientific Research (NWO) grant VIDI 864-05-002 and the Dutch Cancer Foundation (KWF) grant KUN 2008-4130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deissler H, 1997, J BIOL CHEM, V272, P16761, DOI 10.1074/jbc.272.27.16761; Deissler H, 1996, J BIOL CHEM, V271, P4327; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberl HC, 2011, CHEMBIOCHEM, V12, P224, DOI 10.1002/cbic.201000429; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; GHAZAL P, 1987, P NATL ACAD SCI USA, V84, P3658, DOI 10.1073/pnas.84.11.3658; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; HUANG LH, 1984, NATURE, V308, P293, DOI 10.1038/308293a0; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; KARPEN S, 1988, MOL CELL BIOL, V8, P5159, DOI 10.1128/MCB.8.12.5159; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rauch Tibor A., 2009, V507, P65, DOI 10.1007/978-1-59745-522-0_6; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; WANG RYH, 1986, NUCLEIC ACIDS RES, V14, P1599, DOI 10.1093/nar/14.4.1599; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; ZHANG XY, 1991, VIROLOGY, V182, P865, DOI 10.1016/0042-6822(91)90631-K; ZHANG XY, 1990, CANCER RES, V50, P6865; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810; ZHANG XY, 1989, NUCLEIC ACIDS RES, V17, P1459, DOI 10.1093/nar/17.4.1459; ZHANG XY, 1990, NUCLEIC ACIDS RES, V18, P6253, DOI 10.1093/nar/18.21.6253	58	38	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25884	10.1371/journal.pone.0025884	http://dx.doi.org/10.1371/journal.pone.0025884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991380	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000091
J	Coultrap, SJ; Bayer, KU				Coultrap, Steven J.; Bayer, K. Ulrich			Improving a Natural CaMKII Inhibitor by Random and Rational Design	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NR2B SUBUNIT; CALMODULIN; CALCIUM/CALMODULIN; AUTOPHOSPHORYLATION; RECEPTOR; EXPRESSION; BINDING	Background: CaM-KIIN has evolved to inhibit stimulated and autonomous activity of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) efficiently, selectively, and potently (IC50 similar to 100 nM). The CN class of peptides, derived from the inhibitory region of CaM-KIIN, provides powerful new tools to study CaMKII functions. The goal of this study was to identify the residues required for CaMKII inhibition, and to assess if artificial mutations could further improve the potency achieved during evolution. Methodology/Principal Findings: First, the minimal region with full inhibitory potency was identified (CN19) by determining the effect of truncated peptides on CaMKII activity in biochemical assays. Then, individual residues of CN19 were mutated. Most individual Ala substitutions decreased potency of CaMKII inhibition, however, P3A, K13A, and R14A increased potency. Importantly, this initial Ala scan suggested a specific interaction of the region around R11 with the CaMKII substrate binding site, which was exploited for further rational mutagenesis to generate an optimized pseudo-substrate sequence. Indeed, the potency of the optimized peptide CN19o was >250fold improved (IC50 <0.4 nM), and CN19o has characteristics of a tight-binding inhibitor. The selectivity for CaMKII versus CaMKI was similarly improved (to almost 100,000fold for CN19o). A phospho-mimetic S12D mutation decreased potency, indicating potential for regulation by cellular signaling. Consistent with importance of this residue in inhibition, most other S12 mutations also significantly decreased potency, however, mutation to V or Q did not. Conlusions/Significance: These results provide improved research tools for studying CaMKII function, and indicate that evolution fine-tuned CaM-KIIN not for maximal potency of CaMKII inhibition, but for lower potency that may be optimal for dynamic regulation of signal transduction.	[Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu			National Institutes of Health [R01NS052644]; State of Colorado/University of Colorado; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Colorado/University of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health grant R01NS052644 and by a State of Colorado/University of Colorado TTO Bioscience Discovery and Evaluation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; ILLARIO M, 2003, J BIOL CHEM; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lepicard EM, 2006, EUR J NEUROSCI, V23, P3063, DOI 10.1111/j.1460-9568.2006.04830.x; LI GD, 1992, MOL PHARMACOL, V42, P489; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Radwanska K, 2010, GENES BRAIN BEHAV, V9, P648, DOI 10.1111/j.1601-183X.2010.00595.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	57	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25245	10.1371/journal.pone.0025245	http://dx.doi.org/10.1371/journal.pone.0025245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984908	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000019
J	Eacker, SM; Keuss, MJ; Berezikov, E; Dawson, VL; Dawson, TM				Eacker, Stephen M.; Keuss, Matthew J.; Berezikov, Eugene; Dawson, Valina L.; Dawson, Ted M.			Neuronal Activity Regulates Hippocampal miRNA Expression	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; INDUCED MICRORNA; IN-VIVO; PROTEIN; CREB; IDENTIFICATION; TRANSCRIPTION; DROSOPHILA; REVEALS; MEMORY	Neuronal activity regulates a broad range of processes in the hippocampus, including the precise regulation of translation. Disruptions in proper translational control in the nervous system are associated with a variety of disorders that fall in the autistic spectrum. MicroRNA (miRNA) represent a relatively recently discovered player in the regulation of translation in the nervous system. We have conducted an in depth analysis of how neuronal activity regulates miRNA expression in the hippocampus. Using deep sequencing we exhaustively identify all miRNAs, including 15 novel miRNAs, expressed in hippocampus of the adult mouse. We identified 119 miRNAs documented in miRBase but less than half of these miRNA were expressed at a level greater than 0.1% of total miRNA. Expression profiling following induction of neuronal activity by electroconvulsive shock demonstrates that most miRNA show a biphasic pattern of expression: rapid induction of specific mature miRNA expression followed by a decline in expression. These results have important implications into how miRNAs influence activity-dependent translational control.	[Eacker, Stephen M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA; [Eacker, Stephen M.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Keuss, Matthew J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr, Utrecht, Netherlands; [Berezikov, Eugene] InteRNA Genom BV, Bilthoven, Netherlands; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins University	Eacker, SM (corresponding author), Johns Hopkins Univ, Sch Med, Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Berezikov, Eugene/D-3363-2013	Berezikov, Eugene/0000-0002-1145-2884; Dawson, Valina/0000-0002-2915-3970	National Institute for Drug Abuse [DA00266]; Foundation for Advance Research in the Medical Sciences; Howard Hughes Medical Institute; National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Foundation for Advance Research in the Medical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a grant from the National Institute for Drug Abuse (DA00266). SME was supported by a fellowship from the Foundation for Advance Research in the Medical Sciences. MJK was supported by the Howard Hughes Medical Institute training grant for nanotechnology for biology and medicine and an IGERT Fellowship from the National Science Foundation. TMD is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; BEREZIKOV E, 2006, NAT GENET; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x	31	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25068	10.1371/journal.pone.0025068	http://dx.doi.org/10.1371/journal.pone.0025068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984899	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000010
J	Freche, D; Pannasch, U; Rouach, N; Holcman, D				Freche, Dominik; Pannasch, Ulrike; Rouach, Nathalie; Holcman, David			Synapse Geometry and Receptor Dynamics Modulate Synaptic Strength	PLOS ONE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; MAGUK SCAFFOLDING PROTEINS; AMPA RECEPTORS; EXCITATORY SYNAPSES; DENDRITIC SPINES; HIPPOCAMPAL SYNAPSES; QUANTAL TRANSMISSION; RECYCLING ENDOSOMES; LATERAL DIFFUSION; VESICLE CYCLE	Synaptic transmission relies on several processes, such as the location of a released vesicle, the number and type of receptors, trafficking between the postsynaptic density (PSD) and extrasynaptic compartment, as well as the synapse organization. To study the impact of these parameters on excitatory synaptic transmission, we present a computational model for the fast AMPA-receptor mediated synaptic current. We show that in addition to the vesicular release probability, due to variations in their release locations and the AMPAR distribution, the postsynaptic current amplitude has a large variance, making a synapse an intrinsic unreliable device. We use our model to examine our experimental data recorded from CA1 mice hippocampal slices to study the differences between mEPSC and evoked EPSC variance. The synaptic current but not the coefficient of variation is maximal when the active zone where vesicles are released is apposed to the PSD. Moreover, we find that for certain type of synapses, receptor trafficking can affect the magnitude of synaptic depression. Finally, we demonstrate that perisynaptic microdomains located outside the PSD impacts synaptic transmission by regulating the number of desensitized receptors and their trafficking to the PSD. We conclude that geometrical modifications, reorganization of the PSD or perisynaptic microdomains modulate synaptic strength, as the mechanisms underlying long-term plasticity.	[Freche, Dominik] Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel; [Freche, Dominik] Weizmann Inst Sci, Dept Neurosci, IL-76100 Rehovot, Israel; [Pannasch, Ulrike; Rouach, Nathalie] CIRB CNRS UMR 7241 INSERM U1050 Coll France, Team Neuroglial Interact Cerebral Physiopathol, Paris, France; [Holcman, David] IBENS Ecole Normale Super, Dept Math & Computat Biol, Paris, France; [Holcman, David] Tel Aviv Univ, Dept Appl Math, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Tel Aviv University	Freche, D (corresponding author), Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel.	david.holcman@ens.fr	Rouach, Nathalie/L-4767-2017; Holcman, David/L-9243-2013	Rouach, Nathalie/0000-0002-5574-888X; holcman, david/0000-0001-9854-5014	Max Planck Society; Deutsche Forschungsgemeinschaft; Human Frontier Science Program CDA; Human Frontier Science Program	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program CDA(Human Frontier Science Program); Human Frontier Science Program(Human Frontier Science Program)	DF was supported by a Minerva fellowship of the Max Planck Society, UP by a Deutsche Forschungsgemeinschaft fellowship of Deutsche Forschungsgemeinschaft, NR by a Human Frontier Science Program CDA grant, DH by a Human Frontier Science Program research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Biess A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021922; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Gerrow K., 2007, SCI STKE, V2007, P56; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Jiang Ma-Li, 2003, Shengli Xuebao, V55, P705; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Korkotian E, 2004, EUR J NEUROSCI, V20, P2649, DOI 10.1111/j.1460-9568.2004.03691.x; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKUS EJ, 1987, DEV BRAIN RES, V35, P239, DOI 10.1016/0165-3806(87)90048-4; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taia A, 2007, J CHEM PHYS, V126; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ventriglia F, 2002, BIOSYSTEMS, V67, P287, DOI 10.1016/S0303-2647(02)00086-2; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2005, NEURON, V45, P482, DOI 10.1016/j.neuron.2005.02.003	62	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25122	10.1371/journal.pone.0025122	http://dx.doi.org/10.1371/journal.pone.0025122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984900	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000011
J	Guillen-Ahlers, H; Tan, JN; Castellino, FJ; Ploplis, VA				Guillen-Ahlers, Hector; Tan, Jiangning; Castellino, Francis J.; Ploplis, Victoria A.			Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; METALLOPROTEINASE MATRILYSIN; APC(MIN/+) MICE; EXPRESSION; GROWTH; CARCINOMAS; HYDROLASE; APOPTOSIS; POLYPOSIS	Matrix metalloproteinase 7 (MMP7), a metallohydrolase involved in the development of several cancers, is downregulated in the Apc(Min/+) colon cancer mouse model following sulindac treatment. To determine whether this effect is relevant to the human condition, HT-29 human colon cancer cells were treated with sulindac and its metabolites, and compared to results obtained from in vivo mouse studies. The expression of MMP7 was monitored. The results demonstrated that sulindac sulfide effectively downregulated both MMP7 expression and activity. Furthermore, activity-based proteomics demonstrated that sulindac sulfide dramatically decreased the activity of leukotriene A4 hydrolase in HT-29 cells as reflected by a decrease in the level of its product, leukotriene B4. This study demonstrates that the effect of sulindac treatment in a mouse model of colon cancer may be relevant to the human counterpart and highlights the effect of sulindac treatment on metallohydrolases.	[Guillen-Ahlers, Hector; Tan, Jiangning; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Guillen-Ahlers, H (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	vploplis@nd.edu	Tan, Jiangning/B-9069-2014	Guillen Ahlers, Hector/0000-0001-6077-3425	National Institutes of Health (National Heart, Lung, and Blood Institute) [PO1HL07375]	National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (National Heart, Lung, and Blood Institute) grant PO1HL07375 (to FJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004728; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Boolbol SK, 1996, CANCER RES, V56, P2556; Bortuzzo C, 1996, BBA-LIPID LIPID MET, V1300, P240, DOI 10.1016/0005-2760(96)00003-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; FRIEND WG, 1990, AM FAM PHYSICIAN, V41, P891; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Guillen-Ahlers H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009070; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; HIXSON LJ, 1994, CANCER EPIDEM BIOMAR, V3, P433; HIXSON LJ, 1993, AM J GASTROENTEROL, V88, P1652; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Larrinaga G, 2007, REGUL PEPTIDES, V144, P56, DOI 10.1016/j.regpep.2007.06.002; Mannello F, 2006, RECENT PAT ANTI-CANC, V1, P91, DOI 10.2174/157489206775246421; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; WADDELL WR, 1983, J SURG ONCOL, V24, P83, DOI 10.1002/jso.2930240119; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	25	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25725	10.1371/journal.pone.0025725	http://dx.doi.org/10.1371/journal.pone.0025725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991341	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000060
J	Maatallah, M; Cheriaa, J; Backhrouf, A; Iversen, A; Grundmann, H; Do, T; Lanotte, P; Mastouri, M; Elghmati, MS; Rojo, F; Mejdi, S; Giske, CG				Maatallah, Makaoui; Cheriaa, Jihane; Backhrouf, Amina; Iversen, Aina; Grundmann, Hajo; Thuy Do; Lanotte, Philippe; Mastouri, Maha; Elghmati, Mohamed Salem; Rojo, Fernando; Mejdi, Snoussi; Giske, Christian G.			Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; FIELD GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS PATIENTS; SINGLE-NUCLEOTIDE-POLYMORPHISM; III PROTEIN SECRETION; ESCHERICHIA-COLI; GENOME SEQUENCE; VIRULENCE; INFECTIONS; RESISTANCE	Several studies in recent years have provided evidence that Pseudomonas aeruginosa has a non-clonal population structure punctuated by highly successful epidemic clones or clonal complexes. The role of recombination in the diversification of P. aeruginosa clones has been suggested, but not yet demonstrated using multi-locus sequence typing (MLST). Isolates of P. aeruginosa from five Mediterranean countries (n = 141) were subjected to pulsed-field gel electrophoresis (PFGE), serotyping and PCR targeting the virulence genes exoS and exoU. The occurrence of multi-resistance (>= 3 antipseudomonal drugs) was analyzed with disk diffusion according to EUCAST. MLST was performed on a subset of strains (n = 110) most of them had a distinct PFGE variant. MLST data were analyzed with Bionumerics 6.0, using minimal spanning tree (MST) as well as eBURST. Measurement of clonality was assessed by the standardized index of association (IAS). Evidence of recombination was estimated by ClonalFrame as well as SplitsTree4.0. The MST analysis connected 70 sequence types, among which ST235 was by far the most common. ST235 was very frequently associated with the O11 serotype, and frequently displayed multiresistance and the virulence genotype exoS(-)/exoU(+). ClonalFrame linked several groups previously identified by eBURST and MST, and provided insight to the evolutionary events occurring in the population; the recombination/mutation ratio was found to be 8.4. A Neighbor-Net analysis based on the concatenated sequences revealed a complex network, providing evidence of frequent recombination. The index of association when all the strains were considered indicated a freely recombining population. P. aeruginosa isolates from the Mediterranean countries display an epidemic population structure, particularly dominated by ST235-O11, which has earlier also been coupled to the spread of beta-lactamases in many countries.	[Maatallah, Makaoui; Cheriaa, Jihane; Backhrouf, Amina; Mejdi, Snoussi] Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia; [Iversen, Aina; Giske, Christian G.] Karolinska Inst, Karolinska Univ Hosp Solna, MTC, Stockholm, Sweden; [Grundmann, Hajo] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Grundmann, Hajo] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Thuy Do] Kings Coll London, Infect Res Grp, Inst Dent, London WC2R 2LS, England; [Thuy Do] Guys & St Thomas NHS & Fdn Trust, Biomed Res Ctr, London, England; [Lanotte, Philippe] Hop Bretonneau, CHRU Tours, Serv Bacteriol Virol, Tours, France; [Lanotte, Philippe] Univ Tours, Tours, France; [Mastouri, Maha] Lab Microbiol CHU Fattouma Bourguiba, Monastir, Tunisia; [Elghmati, Mohamed Salem] Univ Alfateh Tripoli, Fac Pharm, Dept Microbiol & Immunol, Tripoli, Libya; [Rojo, Fernando] CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Madrid, Spain	Universite de Monastir; Karolinska Institutet; Karolinska University Hospital; University of Groningen; Netherlands National Institute for Public Health & the Environment; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; CHU Tours; Universite de Tours; Universite de Monastir; Hopital Fattouma Bourguiba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Maatallah, M (corresponding author), Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.	christian.giske@karolinska.se	Snoussi, Mejdi/AAE-4486-2020; Rojo, Fernando/A-7038-2008; Snoussi, Mejdi/AAR-7495-2021	Snoussi, Mejdi/0000-0002-2309-2601; Rojo, Fernando/0000-0003-1848-7745; Snoussi, Mejdi/0000-0002-2309-2601	Karolinska University Hospital; Ministry of Higher Education and Scientific Research in Tunisia	Karolinska University Hospital(Karolinska Institutet); Ministry of Higher Education and Scientific Research in Tunisia	Internal funding at the Karolinska University Hospital and funding from the Ministry of Higher Education and Scientific Research in Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Ajayi T, 2003, J CLIN MICROBIOL, V41, P3526, DOI 10.1128/JCM.41.8.3526-3531.2003; Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527; Berthelot P, 2003, J INFECT DIS, V188, P512, DOI 10.1086/377000; Bingen E, 1996, J CLIN MICROBIOL, V34, P3226, DOI 10.1128/JCM.34.12.3226-3229.1996; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; DeVos D, 1997, J CLIN MICROBIOL, V35, P1295, DOI 10.1128/JCM.35.6.1295-1299.1997; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Doring G, 1987, Antibiot Chemother (1971), V39, P136; Duljasz W, 2009, ANTIMICROB AGENTS CH, V53, P2221, DOI 10.1128/AAC.01573-08; Edalucci E, 2008, CLIN MICROBIOL INFEC, V14, P88, DOI 10.1111/j.1469-0691.2007.01874.x; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Faure K, 2003, J CLIN MICROBIOL, V41, P2158, DOI 10.1128/JCM.41.5.2158-2160.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Foght JM, 1996, MICROBIOL-UK, V142, P2333, DOI 10.1099/00221287-142-9-2333; FONSECA EL, ANTIMICROB AGENTS CH, V54, P2743; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Giske CG, 2006, J CLIN MICROBIOL, V44, P4309, DOI 10.1128/JCM.00817-06; Glupczynski Y, 2010, J ANTIMICROB CHEMOTH, V65, P866, DOI 10.1093/jac/dkq048; GRATTARD F, 1993, EUR J CLIN MICROBIOL, V12, P57, DOI 10.1007/BF01997061; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Holder IA, 2001, BURNS, V27, P129, DOI 10.1016/S0305-4179(00)00142-X; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491; Kettner M, 1995, INFECTION, V23, P380, DOI 10.1007/BF01713571; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Koh TH, 2010, J CLIN MICROBIOL, V48, P2563, DOI 10.1128/JCM.01905-09; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Lepsanovic Z, 2008, ACTA MICROBIOL IMM H, V55, P447, DOI 10.1556/AMicr.55.2008.4.9; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIU PV, 1983, INT J SYST BACTERIOL, V33, P256, DOI 10.1099/00207713-33-2-256; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin C, 1999, MICROBIOL-UK, V145, P2587, DOI 10.1099/00221287-145-9-2587; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; MUSSER JM, 1987, J BACTERIOL, V169, P2793, DOI 10.1128/jb.169.6.2793-2803.1987; MUSSER JM, 1988, INFECT IMMUN, V56, P1837, DOI 10.1128/IAI.56.8.1837-1845.1988; Nemec A, 2010, RES MICROBIOL, V161, P234, DOI 10.1016/j.resmic.2010.02.002; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; PITT TL, 1989, EPIDEMIOL INFECT, V103, P565, DOI 10.1017/S095026880003096X; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; SELANDER RK, 1985, J BACTERIOL, V163, P1021, DOI 10.1128/JB.163.3.1021-1037.1985; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; SELANDER RK, 1987, MICROB PATHOGENESIS, V3, P1, DOI 10.1016/0882-4010(87)90032-5; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Silva FM, 2011, MICROB DRUG RESIST, V17, P215, DOI 10.1089/mdr.2010.0140; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	97	98	105	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25617	10.1371/journal.pone.0025617	http://dx.doi.org/10.1371/journal.pone.0025617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984923	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000047
J	Martinic, M; Hoare, A; Contreras, I; Alvarez, SA				Martinic, Mara; Hoare, Anilei; Contreras, Ines; Alvarez, Sergio A.			Contribution of the Lipopolysaccharide to Resistance of Shigella flexneri 2a to Extreme Acidity	PLOS ONE			English	Article							ANTIGEN CHAIN-LENGTH; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; LIPID-A; PHOSPHOETHANOLAMINE MODIFICATION; TOLERANCE RESPONSE; GENOME SEQUENCE; GENE-EXPRESSION; REGULATED LOCUS; PH	Shigella flexneri is endemic in most underdeveloped countries, causing diarrheal disease and dysentery among young children. In order to reach its target site, the colon, Shigella must overcome the acid environment of the stomach. Shigella is able to persist in this stressful environment and, because of this ability it can initiate infection following the ingestion of very small inocula. Thus, acid resistance is considered an important virulence trait of this bacterium. It has been reported that moderate acid conditions regulate the expression of numerous components of the bacterial envelope. Because the lipopolysaccharide (LPS) is the major component of the bacterial surface, here we have addressed the role of LPS in acid resistance of S. flexneri 2a. Defined deletion mutants in genes encoding proteins involved in the synthesis, assembly and length regulation of the LPS O antigen were constructed and assayed for resistance to pH 2.5 after adaptation to pH 5.5. The results showed that a mutant lacking O antigen was significantly more sensitive to extreme acid conditions than the wild type. Not only the presence of polymerized O antigen, but also a particular polymer length (S-OAg) was required for acid resistance. Glucosylation of the O antigen also contributed to this property. In addition, a moderate acidic pH induced changes in the composition of the lipid A domain of LPS. The main modification was the addition of phosphoethanolamine to the 19 phosphate of lipid A. This modification increased resistance of S. flexneri to extreme acid conditions, provide that O antigen was produced. Overall, the results of this work point out to an important role of LPS in resistance of Shigella flexneri to acid stress.	[Martinic, Mara; Hoare, Anilei; Contreras, Ines; Alvarez, Sergio A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile	Universidad de Chile	Martinic, M (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	salvarez@uchile.cl	Álvarez, Sergio A/J-6814-2017		Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Chile) [ADI-08/2006]; World Bank; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100092]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); World Bank(The World Bank India); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grant ADI-08/2006 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT; www.conicyt.cl)(Chile) and The World Bank and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grant 1100092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Budin-Verneuil A, 2007, PROTEOMICS, V7, P2038, DOI 10.1002/pmic.200600773; Carter JA, 2007, MICROBIOL-SGM, V153, P3499, DOI 10.1099/mic.0.2007/010066-0; Carter JA, 2009, MICROBIOL-SGM, V155, P3260, DOI 10.1099/mic.0.028944-0; CHEN HC, 1993, APPL ENVIRON MICROB, V59, P1058, DOI 10.1128/AEM.59.4.1058-1064.1993; Cheng F, 2007, FEMS MICROBIOL LETT, V270, P12, DOI 10.1111/j.1574-6968.2007.00647.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Huang YJ, 2007, J AGR FOOD CHEM, V55, P7182, DOI 10.1021/jf071014s; Jennison AV, 2007, MICROBIOL-SGM, V153, P2593, DOI 10.1099/mic.0.2007/006718-0; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Quivey RG, 2000, FEMS MICROBIOL LETT, V189, P89, DOI 10.1111/j.1574-6968.2000.tb09211.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Sandlin RC, 1996, MOL MICROBIOL, V22, P63, DOI 10.1111/j.1365-2958.1996.tb02656.x; Sato M, 2000, APPL ENVIRON MICROB, V66, P943, DOI 10.1128/AEM.66.3.943-947.2000; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sinnott ML, 2007, CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY: STRUCTURE AND MECHANISM, pV; STEVENSON G, 1995, FEMS MICROBIOL LETT, V125, P23, DOI 10.1016/0378-1097(94)00485-A; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Thomsen LE, 2003, FEMS MICROBIOL LETT, V228, P225, DOI 10.1016/S0378-1097(03)00762-6; Touze T, 2008, MOL MICROBIOL, V67, P264, DOI 10.1111/j.1365-2958.2007.06044.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503	64	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25557	10.1371/journal.pone.0025557	http://dx.doi.org/10.1371/journal.pone.0025557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984920	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000039
J	Restrepo-Montoya, D; Becerra, D; Carvajal-Patino, JG; Mongui, A; Nino, LF; Patarroyo, ME; Patarroyo, MA				Restrepo-Montoya, Daniel; Becerra, David; Carvajal-Patino, Juan G.; Mongui, Alvaro; Nino, Luis F.; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Identification of Plasmodium vivax Proteins with Potential Role in Invasion Using Sequence Redundancy Reduction and Profile Hidden Markov Models	PLOS ONE			English	Article							IN-SILICO; SUBCELLULAR-LOCALIZATION; APICOMPLEXAN PARASITES; AOTUS MONKEYS; PREDICTION; FALCIPARUM; MEMBRANES; PEPTIDES; HOMOLOGY; DATABASE	Background: This study describes a bioinformatics approach designed to identify Plasmodium vivax proteins potentially involved in reticulocyte invasion. Specifically, different protein training sets were built and tuned based on different biological parameters, such as experimental evidence of secretion and/or involvement in invasion-related processes. A profile-based sequence method supported by hidden Markov models (HMMs) was then used to build classifiers to search for biologically-related proteins. The transcriptional profile of the P. vivax intra-erythrocyte developmental cycle was then screened using these classifiers. Results: A bioinformatics methodology for identifying potentially secreted P. vivax proteins was designed using sequence redundancy reduction and probabilistic profiles. This methodology led to identifying a set of 45 proteins that are potentially secreted during the P. vivax intra-erythrocyte development cycle and could be involved in cell invasion. Thirteen of the 45 proteins have already been described as vaccine candidates; there is experimental evidence of protein expression for 7 of the 32 remaining ones, while no previous studies of expression, function or immunology have been carried out for the additional 25. Conclusions: The results support the idea that probabilistic techniques like profile HMMs improve similarity searches. Also, different adjustments such as sequence redundancy reduction using Pisces or Cd-Hit allowed data clustering based on rational reproducible measurements. This kind of approach for selecting proteins with specific functions is highly important for supporting large-scale analyses that could aid in the identification of genes encoding potential new target antigens for vaccine development and drug design. The present study has led to targeting 32 proteins for further testing regarding their ability to induce protective immune responses against P. vivax malaria.	[Restrepo-Montoya, Daniel; Becerra, David; Carvajal-Patino, Juan G.; Nino, Luis F.] Univ Nacl Colombia, Bioinformat & Intelligent Syst Res Lab BIOLISI, Bogota, Colombia; [Restrepo-Montoya, Daniel; Becerra, David; Nino, Luis F.] Univ Nacl Colombia, Res Grp Combinatorial Algorithms ALGOS UN, Bogota, Colombia; [Restrepo-Montoya, Daniel; Carvajal-Patino, Juan G.; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Restrepo-Montoya, Daniel; Carvajal-Patino, Juan G.; Mongui, Alvaro; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad del Rosario; Universidad Nacional de Colombia	Restrepo-Montoya, D (corresponding author), Univ Nacl Colombia, Bioinformat & Intelligent Syst Res Lab BIOLISI, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Mongui, Alvaro/0000-0002-4834-2865; Restrepo-Montoya, Daniel/0000-0003-4910-7880	Asociacion de Investigacion Solidaria (SADAR); Caja Navarra (Navarra, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo	Asociacion de Investigacion Solidaria (SADAR); Caja Navarra (Navarra, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo	The authors would like to extend their sincerest gratitude to Asociacion de Investigacion Solidaria (SADAR), Caja Navarra (Navarra, Spain) and Agencia Espanola de Cooperacion Internacional para el Desarrollo for supporting and financing this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari FA, 2008, PROTEINS, V70, P659, DOI 10.1002/prot.21568; Arevalo-Pinzon G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-60; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bischoff E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-34; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; De Fonzo V, 2007, CURR BIOINFORM, V2, P49, DOI 10.2174/157489307779314348; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Farid Arenas Aylan, 2010, Genomics Proteomics & Bioinformatics, V8, P103, DOI 10.1016/S1672-0229(10)60011-3; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-503; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Ghouila A, 2011, INFECT GENET EVOL, V11, P698, DOI 10.1016/j.meegid.2010.09.008; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Isokpehi RD, 2007, METHODS OF MICROARRAY DATA ANALYSIS V, P1, DOI 10.1007/978-0-387-34569-7_1; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Llinas M, 2005, TRENDS PARASITOL, V21, P350, DOI 10.1016/j.pt.2005.06.009; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Mittra P, 2010, MICROBES INFECT, V12, P1019, DOI 10.1016/j.micinf.2010.07.004; Mongui A, 2006, BIOCHEM BIOPH RES CO, V351, P639, DOI 10.1016/j.bbrc.2006.10.082; Perez-Leal O, 2006, BIOCHEM BIOPH RES CO, V341, P1053, DOI 10.1016/j.bbrc.2006.01.061; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Rojas-Caraballo J, 2009, VACCINE, V27, P2870, DOI 10.1016/j.vaccine.2009.02.083; ROOBSOONG W, 2011, J PROTEOMICS; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sierra AY, 2003, VACCINE, V21, P4133, DOI 10.1016/S0264-410X(03)00455-9; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P171, DOI 10.3347/kjp.2001.39.2.171; Sugiyama T, 1996, VACCINE, V14, P1069, DOI 10.1016/0264-410X(95)00238-V; Terrapon N, 2009, BIOINFORMATICS, V25, P3077, DOI 10.1093/bioinformatics/btp560; Tonhosolo R, 2009, J BIOL CHEM, V284, P9974, DOI 10.1074/jbc.M807464200; Urquiza M, 2002, PEPTIDES, V23, P2265, DOI 10.1016/S0196-9781(02)00267-X; Wakaguri H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-312; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	59	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25189	10.1371/journal.pone.0025189	http://dx.doi.org/10.1371/journal.pone.0025189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984903	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000014
J	Knowlton, WM; Daniels, RL; Palkar, R; Mccoy, DD; McKemy, DD				Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McCoy, Daniel D.; McKemy, David D.			Pharmacological Blockade of TRPM8 Ion Channels Alters Cold and Cold Pain Responses in Mice	PLOS ONE			English	Article							MENTHOL RECEPTOR TRPM8; BODY-TEMPERATURE; SENSORY NEURONS; HEAT; CAPSAZEPINE; ANTAGONIST; ACTIVATION; CALCIUM; VOLTAGE; TRPV1	TRPM8 (Transient Receptor Potential Melastatin-8) is a cold-and menthol-gated ion channel necessary for the detection of cold temperatures in the mammalian peripheral nervous system. Functioning TRPM8 channels are required for behavioral responses to innocuous cool, noxious cold, injury-evoked cold hypersensitivity, cooling-mediated analgesia, and thermoregulation. Because of these various roles, the ability to pharmacologically manipulate TRPM8 function to alter the excitability of cold-sensing neurons may have broad impact clinically. Here we examined a novel compound, PBMC (1-phenylethyl-4-(benzyloxy)-3-methoxybenzyl(2-aminoethyl) carbamate) which robustly and selectively inhibited TRPM8 channels in vitro with sub-nanomolar affinity, as determined by calcium microfluorimetry and electrophysiology. The actions of PBMC were selective for TRPM8, with no functional effects observed for the sensory ion channels TRPV1 and TRPA1. PBMC altered TRPM8 gating by shifting the voltage-dependence of menthol-evoked currents towards positive membrane potentials. When administered systemically to mice, PBMC treatment produced a dose-dependent hypothermia in wildtype animals while TRPM8-knockout mice remained unaffected. This hypothermic response was reduced at lower doses, whereas responses to evaporative cooling were still significantly attenuated. Lastly, systemic PBMC also diminished cold hypersensitivity in inflammatory and nerve-injury pain models, but was ineffective against oxaliplatin-induced neuropathic cold hypersensitivity, despite our findings that TRPM8 is required for the cold-related symptoms of this pathology. Thus PBMC is an attractive compound that serves as a template for the formulation of highly specific and potent TRPM8 antagonists that will have utility both in vitro and in vivo.	[Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McCoy, Daniel D.; McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA; [McCoy, Daniel D.; McKemy, David D.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Knowlton, Wendy M.; Daniels, Richard L.; Palkar, Radhika; McKemy, David D.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Knowlton, WM (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	mckemy@usc.edu		Daniels, Richard/0000-0003-2477-6025	National Institutes of Health [NS054069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health Grant NS054069 to DDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Benedikt J, 2007, J NEUROCHEM, V100, P211, DOI 10.1111/j.1471-4159.2006.04192.x; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P7076, DOI 10.1016/j.bmcl.2010.09.099; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Ding Z, 2008, EUR J PHARMACOL, V578, P201, DOI 10.1016/j.ejphar.2007.09.030; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Iida T, 2005, NEUROSCI LETT, V378, P28, DOI 10.1016/j.neulet.2004.12.007; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Knowlton WM, 2011, CURR PHARM BIOTECHNO, V12, P68; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Montell C, 2007, CURR BIOL, V17, pR885, DOI 10.1016/j.cub.2007.08.016; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nomoto S, 2004, INT J BIOMETEOROL, V49, P67, DOI 10.1007/s00484-004-0220-8; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Ruskin DN, 2007, EUR J PHARMACOL, V559, P161, DOI 10.1016/j.ejphar.2007.01.006; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Tajino K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017504; Valenzano KJ, 2004, CURR MED CHEM, V11, P3185, DOI 10.2174/0929867043363686; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007	48	140	144	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25894	10.1371/journal.pone.0025894	http://dx.doi.org/10.1371/journal.pone.0025894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984952	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300063
J	Dziallas, C; Grossart, HP				Dziallas, Claudia; Grossart, Hans-Peter			Increasing Oxygen Radicals and Water Temperature Select for Toxic Microcystis sp.	PLOS ONE			English	Article							CYANOBACTERIAL BLOOMS; BACTERIA; GROWTH; LAKE; QUANTIFICATION; EXTRACTION; CLIMATE; SAMPLES; LIGHT	Pronounced rises in frequency of toxic cyanobacterial blooms are recently observed worldwide, particularly when temperatures increase. Different strains of cyanobacterial species vary in their potential to produce toxins but driving forces are still obscure. Our study examines effects of hydrogen peroxide on toxic and non-toxic (including a non-toxic mutant) strains of M. aeruginosa. Here we show that hydrogen peroxide diminishes chlorophyll a content and growth of cyanobacteria and that this reduction is significantly lower for toxic than for non-toxic strains. This indicates that microcystins protect from detrimental effects of oxygen radicals. Incubation of toxic and non-toxic strains of M. aeruginosa with other bacteria or without (axenic) at three temperatures (20, 26 and 32 degrees C) reveals a shift toward toxic strains at higher temperatures. In parallel to increases in abundance of toxic (i.e. toxin gene possessing) strains and their actual toxin expression, concentrations of microcystins rise with temperature, when amounts of radicals are expected to be enhanced. Field samples from three continents support the influence of radicals and temperature on toxic potential of M. aeruginosa. Our results imply that global warming will significantly increase toxic potential and toxicity of cyanobacterial blooms which has strong implications for socio-economical assessments of global change.	[Dziallas, Claudia; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Limnol Stratified Lakes, Stechlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Dziallas, C (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Limnol Stratified Lakes, Stechlin, Germany.	hgrossart@igb-berlin.de			German Science Foundation (DFG) [GR1540/11-1, GR1540/11-2]	German Science Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Science Foundation (DFG, grant GR1540/11-1,2 to HPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom JF, 2005, TOXICON, V46, P465, DOI 10.1016/j.toxicon.2005.06.013; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dittmann E, 2001, MICROBIOL-SGM, V147, P3113, DOI 10.1099/00221287-147-11-3113; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Dziallas C, 2011, LIMNOL OCEANOGR-METH, V9, P67, DOI 10.4319/lom.2011.9.67; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Erhard M, 1997, NAT BIOTECHNOL, V15, P906, DOI 10.1038/nbt0997-906; Fastner J, 1998, WATER RES, V32, P3177, DOI 10.1016/S0043-1354(98)00073-6; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Ho LN, 2007, TOXICON, V50, P438, DOI 10.1016/j.toxicon.2007.03.021; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; Kieber D, 2003, UV EFFECTS AQUATIC O, V575; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; Kononen K, 1996, LIMNOL OCEANOGR, V41, P98, DOI 10.4319/lo.1996.41.1.0098; LAWTON LA, 1994, ANALYST, V119, P1525, DOI 10.1039/an9941901525; Lehtimaki J, 1997, APPL ENVIRON MICROB, V63, P1647, DOI 10.1128/AEM.63.5.1647-1656.1997; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Schone K, 2010, HARMFUL ALGAE, V9, P494, DOI 10.1016/j.hal.2010.03.005; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Surono IS, 2008, FOOD CHEM TOXICOL, V46, P502, DOI 10.1016/j.fct.2007.08.017; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077; Zhou J., 1996, APPL ENVIRON MICROB, V62, P695; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	33	98	100	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25569	10.1371/journal.pone.0025569	http://dx.doi.org/10.1371/journal.pone.0025569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980492	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900076
J	Kunst, M; Pfortner, R; Aschenbrenner, K; Heinrich, R				Kunst, Michael; Pfoertner, Ramona; Aschenbrenner, Katja; Heinrich, Ralf			Neurochemical Architecture of the Central Complex Related to Its Function in the Control of Grasshopper Acoustic Communication	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; MUSCARINIC ACETYLCHOLINE-RECEPTOR; GABA-LIKE IMMUNOREACTIVITY; NITRIC-OXIDE; STRIDULATORY BEHAVIOR; NERVOUS-SYSTEM; CYCLIC-GMP; GUANOSINE-MONOPHOSPHATE; BRAIN; INSECT	The central complex selects and coordinates the species-and situation-specific song production in acoustically communicating grasshoppers. Control of sound production is mediated by several neurotransmitters and modulators, their receptors and intracellular signaling pathways. It has previously been shown that muscarinic cholinergic excitation in the central complex promotes sound production whereas both GABA and nitric oxide/cyclic GMP signaling suppress its performance. The present immunocytochemical and pharmacological study investigates the question whether GABA and nitric oxide mediate inhibition of sound production independently. Muscarinic ACh receptors are expressed by columnar output neurons of the central complex that innervate the lower division of the central body and terminate in the lateral accessory lobes. GABAergic tangential neurons that innervate the lower division of the central body arborize in close proximity of columnar neurons and thus may directly inhibit these central complex output neurons. A subset of these GABAergic tangential neurons accumulates cyclic GMP following the release of nitric oxide from neurites in the upper division of the central body. While sound production stimulated by muscarine injection into the central complex is suppressed by co-application of sodium nitroprusside, picrotoxin-stimulated singing was not affected by co-application of this nitric oxide donor, indicating that nitric oxide mediated inhibition requires functional GABA signaling. Hence, grasshopper sound production is controlled by processing of information in the lower division of the central body which is subject to modulation by nitric oxide released from neurons in the upper division.	[Kunst, Michael; Pfoertner, Ramona; Aschenbrenner, Katja; Heinrich, Ralf] Univ Gottingen, Dept Cellular Neurobiol, Inst Zool, Gottingen, Germany	University of Gottingen	Kunst, M (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	rheinri1@gwdg.de		Kunst, Michael/0000-0003-4159-8056	Deutsche Forschungsgemeinschaft [HE 33301]; Georg-Christoph-Lichtenberg scholarship; Hertie PostDoc scholarship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-Christoph-Lichtenberg scholarship; Hertie PostDoc scholarship	This work was supported by Deutsche Forschungsgemeinschaft, Grant HE 33301 (to RH) and a Georg-Christoph-Lichtenberg scholarship and a Hertie PostDoc scholarship (both to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 2004, ACTA BIOL HUNG, V55, P65, DOI 10.1556/ABiol.55.2004.1-4.8; Becker M, 1993, GENE BRAIN BEHAV; Bicker G, 1996, EUR J NEUROSCI, V8, P2635, DOI 10.1111/j.1460-9568.1996.tb01558.x; Bicker G, 1997, EUR J NEUROSCI, V9, P189, DOI 10.1111/j.1460-9568.1997.tb01366.x; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; BLAKE AD, 1993, MOL PHARMACOL, V44, P716; BLECHSCHMIDT K, 1990, J CHEM NEUROANAT, V3, P323; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOYAN G, 1993, J COMP NEUROL, V332, P358, DOI 10.1002/cne.903320308; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; CLEMENTS AN, 1974, J EXP BIOL, V60, P673; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Elsner Norbert, 1994, Progress in Zoology, V39, P167; Gonzalez-Zulueta M, 1997, BIF FUTURA, V12, P1; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heck C, 2009, J NEUROSCI METH, V183, P202, DOI 10.1016/j.jneumeth.2009.06.032; HEDWIG B, 1994, J NEUROPHYSIOL, V72, P2015, DOI 10.1152/jn.1994.72.4.2015; Hedwig B, 1997, J COMP PHYSIOL A, V180, P285, DOI 10.1007/s003590050048; HEDWIG B, 1992, J NEUROSCI METH, V45, P135, DOI 10.1016/0165-0270(92)90051-E; Hedwig B, 1995, VERH DT ZOOL GES, V72, P2015; Heinrich R, 1997, J EXP BIOL, V200, P1327; Heinrich R, 1998, J COMP PHYSIOL A, V183, P389, DOI 10.1007/s003590050265; Heinrich R, 2001, P NATL ACAD SCI USA, V98, P9919, DOI 10.1073/pnas.151131998; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; Heinrich R, 2007, ADV EXP BIOL, V1, P107, DOI 10.1016/S1872-2423(07)01005-8; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Helversen Dvon, 1983, NEUROETHOLOGY BEHAV, P9; Hoffmann K, 2007, ZOOL SCI, V24, P1028, DOI 10.2108/zsj.24.1028; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; HOMBERG U, 1991, J COMP NEUROL, V303, P245, DOI 10.1002/cne.903030207; Homberg U., 1987, P347; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Jones IW, 1999, P ROY SOC B-BIOL SCI, V266, P413, DOI 10.1098/rspb.1999.0653; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KNIPPER M, 1989, COMP BIOCHEM PHYS C, V93, P287, DOI 10.1016/0742-8413(89)90235-1; Kurylas AE, 2005, J COMP NEUROL, V484, P206, DOI 10.1002/cne.20467; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Madison D V, 1995, Curr Top Microbiol Immunol, V196, P5; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Martinelli GPT, 2002, NEUROSCIENCE, V114, P111, DOI 10.1016/S0306-4522(02)00238-5; McLean DL, 2002, J NEUROSCI, V22, P4175, DOI 10.1523/JNEUROSCI.22-10-04175.2002; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; MILLAR NS, 1995, J EXP BIOL, V198, P1843; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nugent FS, 2009, NEUROPSYCHOPHARMACOL, V34, P1829, DOI 10.1038/npp.2009.5; Ott SR, 2004, EUR J NEUROSCI, V20, P1231, DOI 10.1111/j.1460-9568.2004.03588.x; Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Popov A V, 2005, Neurosci Behav Physiol, V35, P741, DOI 10.1007/s11055-005-0118-x; Ridgel AL, 2007, J COMP PHYSIOL A, V193, P385, DOI 10.1007/s00359-006-0193-7; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Siegl T, 2009, CELL TISSUE RES, V337, P327, DOI 10.1007/s00441-009-0820-z; Stern M, 2008, DEV NEUROBIOL, V68, P295, DOI 10.1002/dneu.20585; Stern M, 2010, J COMP NEUROL, V518, P1157, DOI 10.1002/cne.22303; Strambi C, 1998, LEARN MEMORY, V5, P78; Strausfeld NJ, 1999, PROG BRAIN RES, V123, P273, DOI 10.1016/S0079-6123(08)62863-0; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka J, 1997, GLIA, V19, P286; Vitzthum H, 1996, J COMP NEUROL, V369, P419, DOI 10.1002/(SICI)1096-9861(19960603)369:3&lt;419::AID-CNE7&gt;3.0.CO;2-8; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; von Helversen D., 1972, Journal Comp Physiol, V81, P381; Wang S, 2006, FASEB J, V20, P1537, DOI 10.1096/fj.05-5547fje; WEGERHOFF R, 1992, CELL TISSUE RES, V268, P341, DOI 10.1007/BF00318803; Weinrich A, 2008, J COMP PHYSIOL A, V194, P763, DOI 10.1007/s00359-008-0347-x; Wenzel B, 2005, J COMP NEUROL, V488, P129, DOI 10.1002/cne.20600; Wenzel B, 2002, J NEUROPHYSIOL, V87, P876, DOI 10.1152/jn.00312.2001; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; Wicher D, 2004, J BIOL CHEM, V279, P50410, DOI 10.1074/jbc.M405800200; WILLIAMS JLD, 1975, J ZOOL, V176, P67; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Xing JH, 2008, NEUROPHARMACOLOGY, V54, P734, DOI 10.1016/j.neuropharm.2007.12.008; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416	79	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25613	10.1371/journal.pone.0025613	http://dx.doi.org/10.1371/journal.pone.0025613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980504	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900081
J	Deblon, N; Veyrat-Durebex, C; Bourgoin, L; Caillon, A; Bussier, AL; Petrosino, S; Piscitelli, F; Legros, JJ; Geenen, V; Foti, M; Wahli, W; Di Marzo, V; Rohner-Jeanrenaud, F				Deblon, Nicolas; Veyrat-Durebex, Christelle; Bourgoin, Lucie; Caillon, Aurelie; Bussier, Anne-Lise; Petrosino, Stefania; Piscitelli, Fabiana; Legros, Jean-Jacques; Geenen, Vincent; Foti, Michelangelo; Wahli, Walter; Di Marzo, Vincenzo; Rohner-Jeanrenaud, Francoise			Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; BODY-WEIGHT; TARGETED DISRUPTION; MAMMARY-GLAND; PPAR-ALPHA; PLASMA; FAT; OLEOYLETHANOLAMIDE; GLUCOSE; BRAIN	Apart from its role during labor and lactation, oxytocin is involved in several other functions. Interestingly, oxytocin-and oxytocin receptor-deficient mice develop late-onset obesity with normal food intake, suggesting that the hormone might exert a series of beneficial metabolic effects. This was recently confirmed by data showing that central oxytocin infusion causes weight loss in diet-induced obese mice. The aim of the present study was to unravel the mechanisms underlying such beneficial effects of oxytocin. Chronic central oxytocin infusion was carried out in high fat diet-induced obese rats. Its impact on body weight, lipid metabolism and insulin sensitivity was determined. We observed a dose-dependent decrease in body weight gain, increased adipose tissue lipolysis and fatty acid beta-oxidation, as well as reduced glucose intolerance and insulin resistance. The additional observation that plasma oxytocin levels increased upon central infusion suggested that the hormone might affect adipose tissue metabolism by direct action. This was demonstrated using in vitro, ex vivo, as well as in vivo experiments. With regard to its mechanism of action in adipose tissue, oxytocin increased the expression of stearoyl-coenzyme A desaturase 1, as well as the tissue content of the phospholipid precursor, N-oleoyl-phosphatidyl-ethanolamine, the biosynthetic precursor of the oleic acid-derived PPAR-alpha activator, oleoylethanolamide. Because PPAR-alpha regulates fatty acid beta-oxidation, we hypothesized that this transcription factor might mediate the oxytocin effects. This was substantiated by the observation that, in contrast to its effects in wild-type mice, oxytocin infusion failed to induce weight loss and fat oxidation in PPAR-alpha-deficient animals. Altogether, these results suggest that oxytocin administration could represent a promising therapeutic approach for the treatment of human obesity and type 2 diabetes.	[Deblon, Nicolas; Veyrat-Durebex, Christelle; Caillon, Aurelie; Bussier, Anne-Lise; Rohner-Jeanrenaud, Francoise] Univ Geneva, Fac Med, Dept Internal Med, Div Endocrinol Diabetol & Nutr, Geneva, Switzerland; [Bourgoin, Lucie; Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Petrosino, Stefania; Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, I-80125 Naples, Italy; [Legros, Jean-Jacques] Univ Liege, Ctr Hosp Reg Citadelle, Liege, Belgium; [Di Marzo, Vincenzo] Univ Liege, Ctr Immunol, CHU B23, Liege, Belgium; [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland	University of Geneva; University of Geneva; Consiglio Nazionale delle Ricerche (CNR); University of Liege; University of Liege; University of Lausanne	Deblon, N (corresponding author), Univ Geneva, Fac Med, Dept Internal Med, Div Endocrinol Diabetol & Nutr, Geneva, Switzerland.	francoise.jeanrenaud@unige.ch	Di Marzo, Vincenzo/AAD-7742-2019; Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; Piscitelli, Fabiana/A-7100-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; Wahli, Walter/0000-0002-5966-9089; Piscitelli, Fabiana/0000-0001-9343-4622; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Geenen, Vincent/0000-0002-8733-7284; Foti, Michelangelo/0000-0001-7199-4135	Swiss National Science Foundation, Bern, Switzerland [310000-120147/1, 31003A-134919/1, 310030-135727, 3100A0-128660/1]; National Institutes of Health (NIH) [DA009789]	Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants N<SUP>o</SUP> 310000-120147/1 (Dr. Rohner-Jeanrenaud), N<SUP>o</SUP> 31003A-134919/1 (Dr. Rohner-Jeanrenaud), N<SUP>o</SUP> 310030-135727 (Dr. Foti) and N<SUP>o</SUP> 3100A0-128660/1 (Dr. Wahli) from the Swiss National Science Foundation, Bern, Switzerland. Dr. Petrosino, Dr. Piscitelli and Dr. Di Marzo are grateful to the National Institutes of Health (NIH) for partly funding this study (grant N<SUP>o</SUP> DA009789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama H, 2010, J BIOL CHEM; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; BJORKSTRAND E, 1992, ACTA PHYSIOL SCAND, V144, P355, DOI 10.1111/j.1748-1716.1992.tb09305.x; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Dobrzyn P, 2010, J APPL PHYSL; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Gaetani S, 2010, J NEUROSCI, V30, P8096, DOI 10.1523/JNEUROSCI.0036-10.2010; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gonzalez-Yanes C, 2005, AM J PHYSIOL-ENDOC M, V289, pE923, DOI 10.1152/ajpendo.00555.2004; Gould BR, 2003, NEUROSCIENCE, V122, P155, DOI 10.1016/S0306-4522(03)00283-5; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; JENSEN DR, 1994, BIOCHEM J, V298, P321, DOI 10.1042/bj2980321; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kusui C, 2001, BIOCHEM BIOPH RES CO, V289, P681, DOI 10.1006/bbrc.2001.6024; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; MUCHMORE DB, 1981, J BIOL CHEM, V256, P365; Murata T, 2000, J ENDOCRINOL, V166, P45, DOI 10.1677/joe.0.1660045; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pequeux C, 2001, SCAND J CLIN LAB INV, V61, P407, DOI 10.1080/003655101316911468; Popeijus HE, 2008, INT J OBESITY, V32, P1076, DOI 10.1038/ijo.2008.55; ROHNERJEANRENAUD F, 1989, ENDOCRINOLOGY, V124, P733, DOI 10.1210/endo-124-2-733; Schaffler A, 2005, NEUROPEPTIDES, V39, P363, DOI 10.1016/j.npep.2005.06.003; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Tsuda T, 2006, BIOCHEM PHARMACOL, V71, P1184, DOI 10.1016/j.bcp.2005.12.042; VETTOR R, 1994, DIABETOLOGIA, V37, P1202, DOI 10.1007/s001250050236; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P77, DOI 10.1016/j.siny.2008.09.002; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036	42	183	193	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25565	10.1371/journal.pone.0025565	http://dx.doi.org/10.1371/journal.pone.0025565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980491	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700043
J	Garcia, CB; Shaffer, CM; Alfaro, MP; Smith, AL; Sun, J; Zhao, Z; Young, PP; VanSaun, MN; Eid, JE				Garcia, C. B.; Shaffer, C. M.; Alfaro, M. P.; Smith, A. L.; Sun, J.; Zhao, Z.; Young, P. P.; VanSaun, M. N.; Eid, J. E.			Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2	ONCOGENE			English	Article						cancer; differentiation; gene expression	GENE-EXPRESSION; DIFFERENTIATION; POLYCOMB; GROWTH; ADULT; PROTEINS; NEUROGENESIS; PROGENITORS; ACTIVATION; INHIBITORS	Cell identity is determined by its gene expression programs. The ability of a cell to change its identity and produce cell types outside its lineage is achieved by the activity of transcription controllers capable of reprogramming differentiation gene networks. The synovial sarcoma (SS)-associated protein, SYT-SSX2, reprograms myogenic progenitors and human bone marrow-derived mesenchymal stem cells (BMMSCs) by dictating their commitment to a pro-neural lineage. It fulfills this function by directly targeting an extensive array of neural-specific genes as well as genes of developmental pathway mediators. Concomitantly, the ability of both myoblasts and BMMSCs to differentiate into their normal myogenic and adipogenic lineages was compromised. SS is believed to arise in mesenchymal stem cells where formation of the t(X/18) translocation product, SYT-SSX, constitutes the primary event in the cancer. SYT-SSX is therefore believed to initiate tumorigenesis in its target stem cell. The data presented here allow a glimpse at the initial events that likely occur when SYT-SSX2 is first expressed, and its dominant function in subverting the nuclear program of the stem cell, leading to its aberrant differentiation, as a first step toward transformation. In addition, we identified the fibroblast growth factor receptor gene, Fgfr2, as one occupied and upregulated by SYT-SSX2. Knockdown of FGFR2 in both BMMSCs and SS cells abrogated their growth and attenuated their neural phenotype. These results support the notion that the SYT-SSX2 nuclear function and differentiation effects are conserved throughout sarcoma development and are required for its maintenance beyond the initial phase. They also provide the stem cell regulator, FGFR2, as a promising candidate target for future SS therapy. Oncogene (2012) 31, 2323-2334; doi:10.1038/onc.2011.418; published online 26 September 2011	[Garcia, C. B.; Smith, A. L.; Zhao, Z.; VanSaun, M. N.; Eid, J. E.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Shaffer, C. M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Alfaro, M. P.; Young, P. P.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Sun, J.; Zhao, Z.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Young, P. P.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Eid, JE (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 740 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	josiane.eid@vanderbilt.edu		Garcia, Christina/0000-0001-7892-0120	Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; NCRR of the NIH [P40RR017447]; NATIONAL CANCER INSTITUTE [T32CA009592, P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; NCRR of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Alex's Lemonade Stand Foundation (Innovation Award) and the Sarcoma Foundation of America. Microarrays were performed at the Vanderbilt Functional Genomics Shared Resource core supported by the VICC (P30 CA68485), the VDCC (P30 DK58404) and the Vanderbilt Vision Center (P30 EY08126). Some of the materials used in this work were provided by the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White through a grant from NCRR of the NIH (grant no. P40RR017447). We thank BV Mary and H Trinity for assistance; T Ito and M Ladanyi for SYO-1 cells and A Sandelin and S Wilhite for technical support.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barco R, 2007, MOL BIOL CELL, V18, P4003, DOI 10.1091/mbc.E07-05-0496; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Chadashvili T, 2006, J COMP NEUROL, V498, P1, DOI 10.1002/cne.21009; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ever L, 2005, CURR OPIN NEUROBIOL, V15, P29, DOI 10.1016/j.conb.2005.01.005; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2009, CANCER RES, V69, P3657, DOI 10.1158/0008-5472.CAN-08-4127; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ishibe T, 2008, CLIN ORTHOP RELAT R, V466, P2147, DOI 10.1007/s11999-008-0343-z; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Ladanyi M, 2001, ONCOGENE, V20, P5755, DOI 10.1038/sj.onc.1204601; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Mackall CL, 2002, CANCER CELL, V2, P175, DOI 10.1016/S1535-6108(02)00132-0; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mateos-Langerak J, 2008, ADV GENET, V61, P45, DOI 10.1016/S0065-2660(07)00002-8; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Villegas SN, 2010, J CELL BIOCHEM, V110, P10, DOI 10.1002/jcb.22536; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	50	51	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	18					2323	2334		10.1038/onc.2011.418	http://dx.doi.org/10.1038/onc.2011.418			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21996728	Green Accepted			2022-12-25	WOS:000303610800007
J	Peeters, A; Fraisl, P; van den Berg, S; van Themaat, EVL; Van Kampen, A; Rider, MH; Takemori, H; van Dijk, KW; Van Veldhoven, PP; Carmeliet, P; Baes, M				Peeters, Annelies; Fraisl, Peter; van den Berg, Sjoerd; van Themaat, Emiel Ver Loren; Van Kampen, Antoine; Rider, Mark H.; Takemori, Hiroshi; van Dijk, Ko Willems; Van Veldhoven, Paul P.; Carmeliet, Peter; Baes, Myriam			Carbohydrate Metabolism Is Perturbed in Peroxisome-deficient Hepatocytes Due to Mitochondrial Dysfunction, AMP-activated Protein Kinase (AMPK) Activation, and Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; CEREBROHEPATORENAL SYNDROME; INSULIN-RESISTANCE; RAT-LIVER; MULTIFUNCTIONAL PROTEIN-2; HEPATIC GLUCONEOGENESIS; GLYCOGEN-SYNTHASE; OXIDATIVE STRESS; TRIBBLES HOMOLOG; GENE-EXPRESSION	Hepatic peroxisomes are essential for lipid conversions that include the formation of mature conjugated bile acids, the degradation of branched chain fatty acids, and the synthesis of docosahexaenoic acid. Through unresolved mechanisms, deletion of functional peroxisomes from mouse hepatocytes (L-Pex5(-/-) mice) causes severe structural and functional abnormalities at the inner mitochondrial membrane. We now demonstrate that the peroxisomal and mitochondrial anomalies trigger energy deficits, as shown by increased AMP/ATP and decreased NAD(+)/NADH ratios. This causes suppression of gluconeogenesis and glycogen synthesis and up-regulation of glycolysis. As a consequence, L-Pex5(-/-) mice combust more carbohydrates resulting in lower body weights despite increased food intake. The perturbation of carbohydrate metabolism does not require a long term adaptation to the absence of functional peroxisomes as similar metabolic changes were also rapidly induced by acute elimination of Pex5 via adenoviral administration of Cre. Despite its marked activation, peroxisome proliferator-activated receptor alpha (PPAR alpha) was not causally involved in these metabolic perturbations, because all abnormalities still manifested when peroxisomes were eliminated in a peroxisome proliferator-activated receptor alpha null background. Instead, AMP-activated kinase activation was responsible for the down-regulation of glycogen synthesis and induction of glycolysis. Remarkably, PGC-1 alpha was suppressed despite AMP-activated kinase activation, a paradigm not previously reported, and they jointly contributed to impaired gluconeogenesis. In conclusion, lack of functional peroxisomes from hepatocytes results in marked disturbances of carbohydrate homeostasis, which are consistent with adaptations to an energy deficit. Because this is primarily due to impaired mitochondrial ATP production, these L-Pex5-deficient livers can also be considered as a model for secondary mitochondrial hepatopathies.	[Baes, Myriam] Univ Leuven, Fac Pharmaceut Sci, Lab Cell Metab, Dept Pharmaceut Sci, B-3000 Louvain, Belgium; [Carmeliet, Peter] Univ Leuven, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van Veldhoven, Paul P.] Univ Leuven, Lab Lipid Biochem & Prot Interact, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Fraisl, Peter; Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Fraisl, Peter; van den Berg, Sjoerd; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [van Themaat, Emiel Ver Loren; Van Kampen, Antoine] Acad Med Ctr, Lab Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Rider, Mark H.] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Rider, Mark H.] Duve Inst, B-1200 Brussels, Belgium; [Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Universite Catholique Louvain; National Institute of Health Sciences - Japan	Baes, M (corresponding author), Univ Leuven, Fac Pharmaceut Sci, Lab Cell Metab, Dept Pharmaceut Sci, Campus Gasthuisberg O-N2,Herestr 49,Box 823, B-3000 Louvain, Belgium.	myriam.baes@pharm.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; van Dijk, Ko Willems/A-1798-2008; van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018; Ver Loren van Themaat, Emiel/F-2564-2012; , Van Veldhoven Paul/U-6359-2019; van Dijk, Ko Willems/AAT-4681-2021	Carmeliet, Peter/0000-0001-7961-1821; van Dijk, Ko Willems/0000-0002-2172-7394; , Van Veldhoven Paul/0000-0002-4478-2564; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505; Baes, Myriam/0000-0002-2525-2269	Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0760.09]; Geconcerteerde Onderzoeksacties [2004/08]; OT [08/40]; European Union [LSHG-CT-2004-512018]; Center of Medical Systems Biology; Netherlands Consortium for Systems Biology	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksacties; OT; European Union(European Commission); Center of Medical Systems Biology; Netherlands Consortium for Systems Biology	This work was funded by Fonds Wetenschappelijk Onderzoek Vlaanderen Grant G.0760.09, Geconcerteerde Onderzoeksacties Grant 2004/08, OT Grant 08/40, European Union Grant LSHG-CT-2004-512018, FP6, the Center of Medical Systems Biology, and the Netherlands Consortium for Systems Biology (established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Baes M, 2002, GENESIS, V32, P177, DOI 10.1002/gene.10047; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Dirkx R, 2007, BIOCHEM BIOPH RES CO, V357, P718, DOI 10.1016/j.bbrc.2007.03.198; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; HUGHES JL, 1990, VIRCHOWS ARCH A, V416, P255, DOI 10.1007/BF01678985; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Jevon GP, 1998, PEDIATR DEVEL PATHOL, V1, P179, DOI 10.1007/s100249900026; JOMAINBAUM M, 1978, J BIOL CHEM, V253, P3648; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Martens K, 2008, BBA-MOL CELL BIOL L, V1781, P694, DOI 10.1016/j.bbalip.2008.07.010; MATHIS RK, 1980, GASTROENTEROLOGY, V79, P1311; MOOI WJ, 1983, ULTRASTRUCT PATHOL, V5, P135, DOI 10.3109/01913128309141833; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peeters A, 2011, BIOCHIMIE, V93, P1828, DOI 10.1016/j.biochi.2011.06.034; Peeters A, 2010, PPAR RES, V2010, DOI 10.1155/2010/572405; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PFEIFER U, 1979, VIRCHOWS ARCH A, V384, P269, DOI 10.1007/BF00428229; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; TRIJBELS JMF, 1983, PEDIATR RES, V17, P514, DOI 10.1203/00006450-198306000-00018; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; van den Berg SAA, 2010, METABOLISM, V59, P1612, DOI 10.1016/j.metabol.2010.03.008; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; VANVELDHOVEN P, 1984, BIOCHEM PHARMACOL, V33, P1153, DOI 10.1016/0006-2952(84)90531-8; VanVeldhoven PP, 1996, ANAL BIOCHEM, V237, P17, DOI 10.1006/abio.1996.0194; Viana AYI, 2006, DIABETES RES CLIN PR, V73, P135, DOI 10.1016/j.diabres.2005.12.011; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang YG, 2009, WORLD J GASTROENTERO, V15, P2329, DOI 10.3748/wjg.15.2329; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	66	29	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42162	42179		10.1074/jbc.M111.299727	http://dx.doi.org/10.1074/jbc.M111.299727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002056	Green Published, hybrid			2022-12-25	WOS:000298180900027
J	Lee, KA; Hammerle, LP; Andrews, PS; Stokes, MP; Mustelin, T; Silva, JC; Black, RA; Doedens, JR				Lee, Kimberly A.; Hammerle, Lisa P.; Andrews, Paul S.; Stokes, Matthew P.; Mustelin, Tomas; Silva, Jeffrey C.; Black, Roy A.; Doedens, John R.			Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CULTURE; AMINO-ACIDS; HUMAN HRD1; SYNOVIOLIN; EXPRESSION; SILAC	Protein ubiquitination is a key regulatory process essential to life at a cellular level; significant efforts have been made to identify ubiquitinated proteins through proteomics studies, but the level of success has not reached that of heavily studied post-translational modifications, such as phosphorylation. HRD1 an E3 ubiquitin ligase, has been implicated in rheumatoid arthritis, but no disease-relevant substrates have been identified. To identify these substrates, we have taken both peptide and protein level approaches to enrich for ubiquitinated proteins in the presence and absence of HRD1. At the protein level, a two-step strategy was taken using cells expressing His(6)-tagged ubiquitin, enriching proteins first based on their ubiquitination and second based on the His tag with protein identification by LC-MS/MS. Application of this method resulted in identification and quantification of more than 400 ubiquitinated proteins, a fraction of which were found to be sensitive to HRD1 and were therefore deemed candidate substrates. In a second approach, ubiquitinated peptides were enriched after tryptic digestion by peptide immunoprecipitation using an antibody specific for the diglycine-labeled internal lysine residue indicative of protein ubiquitination, with peptides and ubiquitination sites identified by LC-MS/MS. Peptide immunoprecipitation resulted in identification of over 1800 ubiquitinated peptides on over 900 proteins in each study, with several proteins emerging as sensitive to HRD1 levels. Notably, significant overlap exists between the HRD1 substrates identified by the protein-based and the peptide-based strategies, with clear cross-validation apparent both qualitatively and quantitatively, demonstrating the effectiveness of both strategies and furthering our understanding of HRD1 biology.	[Lee, Kimberly A.] Amgen Inc, Dept Mol Sci, Seattle, WA 98119 USA; [Hammerle, Lisa P.; Mustelin, Tomas; Black, Roy A.; Doedens, John R.] Amgen Inc, Dept Inflammat, Seattle, WA 98119 USA; [Andrews, Paul S.] Amgen Inc, Dept Lead Discovery, Cambridge, MA 02142 USA; [Stokes, Matthew P.; Silva, Jeffrey C.] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Amgen; Amgen; Amgen	Doedens, JR (corresponding author), 119 NW 50th St, Seattle, WA 98107 USA.	jdoedens@yahoo.com		Mustelin, Tomas/0000-0001-5912-8840				Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ehinger M, 2001, IMMUNOLOGY, V103, P291, DOI 10.1046/j.1365-2567.2001.01257.x; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lossner C, 2011, ANAL BIOCHEM, V412, P123, DOI 10.1016/j.ab.2011.01.011; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Notley CA, 2010, ARTHRITIS RHEUM-US, V62, P171, DOI 10.1002/art.25058; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pirila L, 2001, J RHEUMATOL, V28, P478; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654	28	66	70	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41530	41538		10.1074/jbc.M111.248856	http://dx.doi.org/10.1074/jbc.M111.248856			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987572	hybrid, Green Published			2022-12-25	WOS:000298057500039
J	Hu, M; Wang, Y; Wang, Y				Hu, Ming; Wang, Yong; Wang, Yi			Rapid Dynamics of Contrast Responses in the Cat Primary Visual Cortex	PLOS ONE			English	Article							STRIATE CORTEX; GAIN-CONTROL; TEMPORAL DYNAMICS; SPATIAL-FREQUENCY; STIMULUS CONTRAST; CORTICAL-NEURONS; EYE-MOVEMENTS; SINGLE CELLS; ADAPTATION; INFORMATION	The visual information we receive during natural vision changes rapidly and continuously. The visual system must adapt to the spatiotemporal contents of the environment in order to efficiently process the dynamic signals. However, neuronal responses to luminance contrast are usually measured using drifting or stationary gratings presented for a prolonged duration. Since motion in our visual field is continuous, the signals received by the visual system contain an abundance of transient components in the contrast domain. Here using a modified reverse correlation method, we studied the properties of responses of neurons in the cat primary visual cortex to different contrasts of grating stimuli presented statically and transiently for 40 ms, and showed that neurons can effectively discriminate the rapidly changing contrasts. The change in the contrast response function (CRF) over time mainly consisted of an increment in contrast gain (CRF shifts to left) in the developing phase of temporal responses and a decrement in response gain (CRF shifts downward) in the decay phase. When the distribution range of stimulus contrasts was increased, neurons demonstrated decrement in contrast gain and response gain. Our results suggest that contrast gain control (contrast adaptation) and response gain control mechanisms are well established during the first tens of milliseconds after stimulus onset and may cooperatively mediate the rapid dynamic responses of visual cortical neurons to the continuously changing contrast. This fast contrast adaptation may play a role in detecting contrast contours in the context of visual scenes that are varying rapidly.	[Hu, Ming; Wang, Yong; Wang, Yi] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Hu, Ming; Wang, Yong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, M (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	yiwang@ibp.ac.cn			National Natural Science Foundation of China [30570587, 30623004, 30870831]; Ministry of Science and Technology [2007AA02Z313]; Chinese Academy of Sciences [KSCX1-YW-R-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants to Yi Wang from the National Natural Science Foundation of China (30570587, 30623004, 30870831), by National High-Tech Research & Development Program (2007AA02Z313 of 863 Program) from Ministry of Science and Technology, by the Knowledge Innovation Program from Chinese Academy of Sciences (KSCX1-YW-R-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Chelaru MI, 2008, CEREB CORTEX, V18, P771, DOI 10.1093/cercor/bhm119; Crowder NA, 2008, J PHYSIOL-LONDON, V586, P4107, DOI 10.1113/jphysiol.2008.156273; Dai J, 2012, CEREB CORTEX, V22, P776, DOI 10.1093/cercor/bhr133; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLean J, 1996, VISUAL NEUROSCI, V13, P1069, DOI 10.1017/S0952523800007720; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nishimoto S, 2005, J NEUROPHYSIOL, V93, P3524, DOI 10.1152/jn.01169.2004; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Samonds JM, 2005, J NEUROPHYSIOL, V93, P223, DOI 10.1152/jn.00548.2004; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Sit YF, 2009, NEURON, V64, P943, DOI 10.1016/j.neuron.2009.08.041; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stanley GB, 2008, NEURON, V58, P467, DOI 10.1016/j.neuron.2008.05.003; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P19, DOI 10.1017/S0952523800008725; Varela JA, 1997, J NEUROSCI, V17, P7926; von der Malsburg C, 1981, CORRELATION THEORY B; WANG Y, 1995, NEUROREPORT, V6, P1969, DOI 10.1097/00001756-199510010-00005; Webb BS, 2003, VISUAL NEUROSCI, V20, P221, DOI 10.1017/S0952523803203011; Williams PE, 2007, J NEUROSCI, V27, P5706, DOI 10.1523/JNEUROSCI.4743-06.2007; Yarbus AL, 1967, EYE MOVEMENTS VISION, Vxiii	54	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25410	10.1371/journal.pone.0025410	http://dx.doi.org/10.1371/journal.pone.0025410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998655	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900024
J	Nardo, G; Pozzi, S; Pignataro, M; Lauranzano, E; Spano, G; Garbelli, S; Mantovani, S; Marinou, K; Papetti, L; Monteforte, M; Torri, V; Paris, L; Bazzoni, G; Lunetta, C; Corbo, M; Mora, G; Bendotti, C; Bonetto, V				Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Spano, Giorgia; Garbelli, Silvia; Mantovani, Stefania; Marinou, Kalliopi; Papetti, Laura; Monteforte, Marta; Torri, Valter; Paris, Luca; Bazzoni, Gianfranco; Lunetta, Christian; Corbo, Massimo; Mora, Gabriele; Bendotti, Caterina; Bonetto, Valentina			Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN CEREBROSPINAL-FLUID; INCREASED 3-NITROTYROSINE; PROTEOMIC ANALYSIS; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; TRANSGENIC MICE; EXTEND SURVIVAL; MOTOR-NEURONS	Background: Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease, for which there are still no diagnostic/prognostic test and therapy. Specific molecular biomarkers are urgently needed to facilitate clinical studies and speed up the development of effective treatments. Methodology/Principal Findings: We used a two-dimensional difference in gel electrophoresis approach to identify in easily accessible clinical samples, peripheral blood mononuclear cells (PBMC), a panel of protein biomarkers that are closely associated with ALS. Validations and a longitudinal study were performed by immunoassays on a selected number of proteins. The same proteins were also measured in PBMC and spinal cord of a G93A SOD1 transgenic rat model. We identified combinations of protein biomarkers that can distinguish, with high discriminatory power, ALS patients from healthy controls (98%), and from patients with neurological disorders that may resemble ALS (91%), between two levels of disease severity (90%), and a number of translational biomarkers, that link responses between human and animal model. We demonstrated that TDP-43, cyclophilin A and ERp57 associate with disease progression in a longitudinal study. Moreover, the protein profile changes detected in peripheral blood mononuclear cells of ALS patients are suggestive of possible intracellular pathogenic mechanisms such as endoplasmic reticulum stress, nitrative stress, disturbances in redox regulation and RNA processing. Conclusions/Significance: Our results indicate that PBMC multiprotein biomarkers could contribute to determine amyotrophic lateral sclerosis diagnosis, differential diagnosis, disease severity and progression, and may help to elucidate pathogenic mechanisms.	[Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Spano, Giorgia; Bonetto, Valentina] Dulbecco Telethon Inst, Milan, Italy; [Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Paris, Luca; Bazzoni, Gianfranco; Bonetto, Valentina] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, Milan, Italy; [Spano, Giorgia; Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy; [Garbelli, Silvia; Mantovani, Stefania] Ist Ricovero & Cura Carattere Sci IRCCS Fdn Salva, Pavia, Italy; [Garbelli, Silvia; Mantovani, Stefania] IRCCS Fdn Salvato Maugeri, Natl Inst Occupat Safety & Prevent ISPESL, Res Ctr, Pavia, Italy; [Monteforte, Marta; Torri, Valter] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Lunetta, Christian; Corbo, Massimo] Osped Niguarda Ca Granda, NEuroMuscular Omnictr NEMO, Milan, Italy; [Marinou, Kalliopi; Papetti, Laura; Mora, Gabriele] IRCCS Fdn Salvatore Maugeri, Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Istituti Clinici Scientifici Maugeri IRCCS	Nardo, G (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	valentina.bonetto@marionegri.it	MANTOVANI, STEFANIA/K-4634-2016; Bonetto, Valentina/I-4694-2018; Mora, Gabriele/Z-2346-2019; Bonetto, Valentina/ABB-6383-2020; Lunetta, Christian/K-9214-2016; Torri, Valter/H-7550-2015; Marinou Aktipi, Kalliopi/AAB-8246-2020; Monteforte, Marta/ABG-1301-2020; Bendotti, Caterina/AAB-2273-2020; Papetti, Laura/B-1262-2013; Nardo, Giovanni/C-1406-2014; Silvia, Pozzi/AAF-9396-2019	MANTOVANI, STEFANIA/0000-0002-5885-2842; Bonetto, Valentina/0000-0003-0456-2054; Mora, Gabriele/0000-0002-8388-2373; Bonetto, Valentina/0000-0003-0456-2054; Lunetta, Christian/0000-0002-4788-1875; Torri, Valter/0000-0001-9541-9354; Marinou Aktipi, Kalliopi/0000-0003-3384-0367; Monteforte, Marta/0000-0002-1591-7810; Bendotti, Caterina/0000-0003-1055-1271; Papetti, Laura/0000-0002-3336-9205; Nardo, Giovanni/0000-0002-1803-1484; Silvia, Pozzi/0000-0002-1500-8158; Corbo, Massimo/0000-0003-0793-9830; Lauranzano, Eliana/0000-0002-9297-3242	Telethon Foundation [S01010, TCR08002]; Cariplo Foundation; Compagnia San Paolo Foundation; Fondazione Aldo e Cele Dacco per la ricerca scientifica; Vialli and Mauro Foundation for Research and Sport; European Community [FP7/2007-2013, 259867]	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Compagnia San Paolo Foundation(Compagnia di San Paolo); Fondazione Aldo e Cele Dacco per la ricerca scientifica; Vialli and Mauro Foundation for Research and Sport; European Community(European Commission)	This work was supported by Telethon Foundation (S01010 and TCR08002 to V. B.), Cariplo Foundation (to V.B. and C.B.), Compagnia San Paolo Foundation (to V.B.), Fondazione Aldo e Cele Dacco per la ricerca scientifica (to V. B.), Vialli and Mauro Foundation for Research and Sport (to S.P. and V.B.), and the European Community's Seventh Framework Programme (FP7/2007-2013) under the Health Cooperation Programme, grant agreement no 259867 (to V.B. and C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2006, AUTOIMMUN REV, V5, P517, DOI 10.1016/j.autrev.2006.02.009; Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Carpi D, 2009, TOXICOL SCI, V108, P330, DOI 10.1093/toxsci/kfp021; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060; Davenport RJ, 1996, J NEUROL NEUROSUR PS, V60, P147, DOI 10.1136/jnnp.60.2.147; De Giessen EV, 2008, AMYOTROPH LATERAL SC, V9, P81, DOI 10.1080/17482960701702553; De Marco G, 2011, ACTA NEUROPATHOL, V121, P611, DOI 10.1007/s00401-010-0786-7; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ganesalingam J, 2010, J NEUROCHEM; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kraemer M, 2010, CLIN NEUROL NEUROSUR, V112, P103, DOI 10.1016/j.clineuro.2009.10.014; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lemmens R, 2010, TRENDS NEUROSCI, V33, P249, DOI 10.1016/j.tins.2010.02.003; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Massignan T, 2007, BIOCHEM BIOPH RES CO, V353, P719, DOI 10.1016/j.bbrc.2006.12.075; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ono S, 2000, AMYOTROPH LATERAL SC, V1, P191, DOI 10.1080/14660820050515188; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Poulopoulou C, 2005, ANN NEUROL, V58, P946, DOI 10.1002/ana.20675; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Srinivasan J, 2006, MUSCLE NERVE, V34, P359, DOI 10.1002/mus.20555; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P109, DOI 10.1001/archneur.57.1.109; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang J, 2007, PROTEOM CLIN APPL, V1, P805, DOI 10.1002/prca.200700081	56	94	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25545	10.1371/journal.pone.0025545	http://dx.doi.org/10.1371/journal.pone.0025545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998667	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900033
J	Zinn, PO; Majadan, B; Sathyan, P; Singh, SK; Majumder, S; Jolesz, FA; Colen, RR				Zinn, Pascal O.; Majadan, Bhanu; Sathyan, Pratheesh; Singh, Sanjay K.; Majumder, Sadhan; Jolesz, Ferenc A.; Colen, Rivka R.			Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; CELL-MIGRATION; HIGH-GRADE; TUMOR; BRAIN; GLIOMAS; CANCER; CLASSIFICATION; TEMOZOLOMIDE	Background: Despite recent discoveries of new molecular targets and pathways, the search for an effective therapy for Glioblastoma Multiforme (GBM) continues. A newly emerged field, radiogenomics, links gene expression profiles with MRI phenotypes. MRI-FLAIR is a noninvasive diagnostic modality and was previously found to correlate with cellular invasion in GBM. Thus, our radiogenomic screen has the potential to reveal novel molecular determinants of invasion. Here, we present the first comprehensive radiogenomic analysis using quantitative MRI volumetrics and large-scale gene- and microRNA expression profiling in GBM. Methods: Based on The Cancer Genome Atlas (TCGA), discovery and validation sets with gene, microRNA, and quantitative MR-imaging data were created. Top concordant genes and microRNAs correlated with high FLAIR volumes from both sets were further characterized by Kaplan Meier survival statistics, microRNA-gene correlation analyses, and GBM molecular subtype-specific distribution. Results: The top upregulated gene in both the discovery (4 fold) and validation (11 fold) sets was PERIOSTIN (POSTN). The top downregulated microRNA in both sets was miR-219, which is predicted to bind to POSTN. Kaplan Meier analysis demonstrated that above median expression of POSTN resulted in significantly decreased survival and shorter time to disease progression (P<0.001). High POSTN and low miR-219 expression were significantly associated with the mesenchymal GBM subtype (P<0.0001). Conclusion: Here, we propose a novel diagnostic method to screen for molecular cancer subtypes and genomic correlates of cellular invasion. Our findings also have potential therapeutic significance since successful molecular inhibition of invasion will improve therapy and patient survival in GBM.	[Zinn, Pascal O.; Sathyan, Pratheesh; Singh, Sanjay K.; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Zinn, Pascal O.] Univ Hosp CHUV BH19 110, Dept Clin Neurosci, Lausanne, Switzerland; [Majadan, Bhanu; Jolesz, Ferenc A.; Colen, Rivka R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zinn, PO (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	pozinn@mdanderson.org; rrcolen@partners.org	Colen, Rivka/Y-4062-2019		National Institute of Health [P41-RR019703, R25 CA089017-06A2]; NATIONAL CANCER INSTITUTE [R25CA089017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703, U41RR019703] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institute of Health grants: P41-RR019703 (FAJ) and R25 CA089017-06A2 (RRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archip N, 2007, ACAD RADIOL, V14, P1242, DOI 10.1016/j.acra.2007.05.025; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Delic S, 2011, NEUROPATHOL APPL NEU; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; DWEEP H, 2011, J BIOMED INFORM; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; George A, 2011, BRIT J BIOMED SCI, V68, P100, DOI 10.1080/09674845.2011.11730334; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Gottlieb A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-300; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; McMillan KM, 2009, J MAGN RESON IMAGING, V29, P251, DOI 10.1002/jmri.21659; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Nagashima G, 1999, SURG NEUROL, V51, P292, DOI 10.1016/S0090-3019(98)00056-1; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Nutt CL, 2003, CANCER RES, V63, P1602; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pavlisa G, 2009, CLIN IMAG, V33, P96, DOI 10.1016/j.clinimag.2008.06.035; Pichon E, 2004, MED IMAGE ANAL, V8, P267, DOI 10.1016/j.media.2004.06.006; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Quant EC, 2010, NEUROIMAG CLIN N AM, V20, P425, DOI 10.1016/j.nic.2010.04.007; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Rickman DS, 2001, CANCER RES, V61, P6885; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Stevenson CB, 2008, NEUROSURGERY, V63, P560, DOI 10.1227/01.NEU.0000324896.26088.EF; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Van Meter T, 2006, DIAGN MOL PATHOL, V15, P195, DOI 10.1097/01.pdm.0000213464.06387.36; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200	50	198	211	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25451	10.1371/journal.pone.0025451	http://dx.doi.org/10.1371/journal.pone.0025451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998659	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900028
J	Barrett, AN; Zimmermann, BG; Wang, D; Holloway, A; Chitty, LS				Barrett, Angela N.; Zimmermann, Bernhard G.; Wang, Darrell; Holloway, Andrew; Chitty, Lyn S.			Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield	PLOS ONE			English	Article							MATERNAL PLASMA; FORMALDEHYDE; PROPORTION; IMPACT; BLOOD; SIZE; PCR	Objective: Cell-free fetal DNA is a source of fetal genetic material that can be used for non-invasive prenatal diagnosis. Usually constituting less than 10% of the total cell free DNA in maternal plasma, the majority is maternal in origin. Optimizing conditions for maximizing yield of cell-free fetal DNA will be crucial for effective implementation of testing. We explore factors influencing yield of fetal DNA from maternal blood samples, including assessment of collection tubes containing cell-stabilizing agents, storage temperature, interval to sample processing and DNA extraction method used. Methods: Microfluidic digital PCR was performed to precisely quantify male (fetal) DNA, total DNA and long DNA fragments (indicative of maternal cellular DNA). Real-time qPCR was used to assay for the presence of male SRY signal in samples. Results: Total cell-free DNA quantity increased significantly with time in samples stored in K(3)EDTA tubes, but only minimally in cell stabilizing tubes. This increase was solely due to the presence of additional long fragment DNA, with no change in quantity of fetal or short DNA, resulting in a significant decrease in proportion of cell-free fetal DNA over time. Storage at 4 degrees C did not prevent these changes. Conclusion: When samples can be processed within eight hours of blood draw, K(3)EDTA tubes can be used. Prolonged transfer times in K(3)EDTA tubes should be avoided as the proportion of fetal DNA present decreases significantly; in these situations the use of cell stabilising tubes is preferable. The DNA extraction kit used may influence success rate of diagnostic tests.	[Barrett, Angela N.] Great Ormond St Hosp Sick Children, NE Thames Reg Mol Genet Labs, London WC1N 3JH, England; [Zimmermann, Bernhard G.] Fluidigm Corp, San Francisco, CA USA; [Barrett, Angela N.; Wang, Darrell; Chitty, Lyn S.] UCL, Inst Child Hlth, London, England; [Holloway, Andrew; Chitty, Lyn S.] Univ Coll Hosp NHS Fdn Trust, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London	Barrett, AN (corresponding author), Great Ormond St Hosp Sick Children, NE Thames Reg Mol Genet Labs, Great Ormond St, London WC1N 3JH, England.	l.chitty@ich.ucl.ac.uk	Barrett, Angela/H-8181-2019	Barrett, Angela/0000-0002-4529-0940; chitty, lyn/0000-0002-4857-7138	European Commission [LSHCT-2004-503241]; NIHR; NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust; UCL Institute of Child Health; Great Ormond Street Hospital Children's Charity; NIHR Central and East London Comprehensive Local Research Network; National Institute for Health Research [RP-PG-0707-10107] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); NIHR(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust; UCL Institute of Child Health; Great Ormond Street Hospital Children's Charity; NIHR Central and East London Comprehensive Local Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID" project). The authors acknowledge the support from the European Commission (Framework 6) Special Non-Invasive Advances in Fetal and Neonatal Evaluation (SAFE) Network of Excellence (LSHCT-2004-503241), the NIHR Programme Grants for Applied Research scheme and the NIHR Central and East London Comprehensive Local Research Network. LSC receives some funding from the NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust and UCL Institute of Child Health and the Great Ormond Street Hospital Children's Charity. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert RM, 2003, CLIN CHEM, V49, P195, DOI 10.1373/49.1.195; Benachi A, 2005, CLIN CHEM, V51, P242; Chan KCA, 2005, CLIN CHEM, V51, P781, DOI 10.1373/clinchem.2004.046219; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chinnapapagari SKR, 2005, CLIN CHEM, V51, P652, DOI 10.1373/clinchem.2004.042119; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chung GTY, 2005, CLIN CHEM, V51, P655, DOI 10.1373/clinchem.2004.042168; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Galbiati S, 2011, CLIN CHEM, V57, P136, DOI 10.1373/clinchem.2010.155671; Hill M, 2010, CLIN GENET      0819; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Picchiassi E, 2008, PRENATAL DIAG, V28, P525, DOI 10.1002/pd.2018; Raymond FL, 2010, PRENATAL DIAG, V30, P674, DOI 10.1002/pd.2575; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Sikora A, 2010, CLIN CHEM, V56, P136, DOI 10.1373/clinchem.2009.132951; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van der Schoot CE, 2008, SEMIN FETAL NEONAT M, V13, P63, DOI 10.1016/j.siny.2007.12.012; Zhang Y, 2008, CLIN CHIM ACTA, V397, P60, DOI 10.1016/j.cca.2008.07.017; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	29	26	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25202	10.1371/journal.pone.0025202	http://dx.doi.org/10.1371/journal.pone.0025202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21998643	Green Submitted, Green Published, gold			2022-12-25	WOS:000295963300005
J	Gibb, EA; Vucic, EA; Enfield, KSS; Stewart, GL; Lonergan, KM; Kennett, JY; Becker-Santos, DD; MacAulay, CE; Lam, S; Brown, CJ; Lam, WL				Gibb, Ewan A.; Vucic, Emily A.; Enfield, Katey S. S.; Stewart, Greg L.; Lonergan, Kim M.; Kennett, Jennifer Y.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Stephen; Brown, Carolyn J.; Lam, Wan L.			Human Cancer Long Non-Coding RNA Transcriptomes	PLOS ONE			English	Article							HOUSEKEEPING GENES; FUNCTIONAL-ROLE; CELL; EXPRESSION; IDENTIFICATION; INACTIVATION; CHROMATIN; MEG3; ASSOCIATION; CARCINOMA	Once thought to be a part of the 'dark matter' of the genome, long non-coding RNAs (lncRNAs) are emerging as an integral functional component of the mammalian transcriptome. LncRNAs are a novel class of mRNA-like transcripts which, despite no known protein-coding potential, demonstrate a wide range of structural and functional roles in cellular biology. However, the magnitude of the contribution of lncRNA expression to normal human tissues and cancers has not been investigated in a comprehensive manner. In this study, we compiled 272 human serial analysis of gene expression (SAGE) libraries to delineate lncRNA transcription patterns across a broad spectrum of normal human tissues and cancers. Using a novel lncRNA discovery pipeline we parsed over 24 million SAGE tags and report lncRNA expression profiles across a panel of 26 different normal human tissues and 19 human cancers. Our findings show extensive, tissue-specific lncRNA expression in normal tissues and highly aberrant lncRNA expression in human cancers. Here, we present a first generation atlas for lncRNA profiling in cancer.	[Gibb, Ewan A.; Vucic, Emily A.; Enfield, Katey S. S.; Stewart, Greg L.; Lonergan, Kim M.; Kennett, Jennifer Y.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Stephen; Brown, Carolyn J.; Lam, Wan L.] British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada; [Gibb, Ewan A.; Vucic, Emily A.; Kennett, Jennifer Y.; MacAulay, Calum E.; Lam, Wan L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Enfield, Katey S. S.; Stewart, Greg L.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Wan L.] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC V5Z 1M9, Canada; [Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Gibb, EA (corresponding author), British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada.	egibb@bccrc.ca	Brown, Carolyn J/A-5159-2014; MacAulay, Calum/K-1795-2016	Brown, Carolyn J/0000-0002-8959-0101; Vucic, Emily/0000-0002-2728-8708; MacAulay, Calum/0000-0003-4440-2792	Canadian Institutes for Health Research (CIHR) [MOP 86731, MOP 77903, MOP 13690]; National Institutes of Health [NIH] [2R01 CA103830 - 6A1]; Department of Defense [CDMRP W81XWH-10-1-0634]; Michael Smith Foundation for Health Research (MSFHR); CIHR, Canada; NATIONAL CANCER INSTITUTE [R01CA103830] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR, Canada(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) [MOP 86731, MOP 77903 to W.L.L., MOP 13690 to C.J.B.]; National Institutes of Health [NIH 2R01 CA103830 - 6A1]; Department of Defense [CDMRP W81XWH-10-1-0634]; CIHR and Michael Smith Foundation for Health Research (MSFHR) Postdoctoral Fellowships [to E.A.G.]; and CIHR Frederick Banting and Charles Best Canada Graduate Scholarship [to E.A.V.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Benetatos L, 2011, INT J CANC; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Buschges R, 1999, BRAIN PATHOL, V9, P435; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kanduri C, 2011, SEMIN CELL DEV BIOL; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; MARUYAMA R, 2010, P NATL ACAD SCI US; Mattick JS, 2011, SCIENCE, V331, P874, DOI 10.1126/science.1203703; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mestdagh P, 2010, ONCOGENE, V29, P3583, DOI 10.1038/onc.2010.106; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Morris KV, 2009, OLIGONUCLEOTIDES, V19, P299, DOI 10.1089/oli.2009.0212; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Steele BK, 2002, ANAL BIOCHEM, V307, P341, DOI 10.1016/S0003-2697(02)00045-3; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Takeuchi S, 2007, BRIT J HAEMATOL, V137, P380, DOI 10.1111/j.1365-2141.2007.06581.x; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Leeuwen S, 2010, DIFFERENTIATION, V80, P175, DOI 10.1016/j.diff.2010.07.003; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yu W, 2009, CANCER GENET CYTOGEN, V193, P29, DOI 10.1016/j.cancergencyto.2009.03.017; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222	71	299	329	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25915	10.1371/journal.pone.0025915	http://dx.doi.org/10.1371/journal.pone.0025915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991387	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000095
J	Nori, J; Urbina-Cardona, JN; Loyola, RD; Lescano, JN; Leynaud, GC				Nori, Javier; Nicolas Urbina-Cardona, J.; Loyola, Rafael D.; Lescano, Julian N.; Leynaud, Gerardo C.			Climate Change and American Bullfrog Invasion: What Could We Expect in South America?	PLOS ONE			English	Article							LITHOBATES-CATESBEIANUS; BIOLOGICAL INVASIONS; SPECIES DISTRIBUTIONS; NICHE; PREDICTION; POPULATIONS; AMPHIBIANS; IMPACTS; RANGES; SHIFTS	Background: Biological invasion and climate change pose challenges to biodiversity conservation in the 21(st) century. Invasive species modify ecosystem structure and functioning and climatic changes are likely to produce invasive species' range shifts pushing some populations into protected areas. The American Bullfrog (Lithobates catesbeianus) is one of the hundred worst invasive species in the world. Native from the southeast of USA, it has colonized more than 75% of South America where it has been reported as a highly effective predator, competitor and vector of amphibian diseases. Methodology/Principal Findings: We modeled the potential distribution of the bullfrog in its native range based on different climate models and green-house gases emission scenarios, and projected the results onto South America for the years of 2050 and 2080. We also overlaid projected models onto the South American network of protected areas. Our results indicate a slight decrease in potential suitable area for bullfrog invasion, although protected areas will become more climatically suitable. Therefore, invasion of these sites is forecasted. Conclusion/Significance: We provide new evidence supporting the vulnerability of the Atlantic Forest Biodiversity Hotspot to bullfrog invasion and call attention to optimal future climatic conditions of the Andean-Patagonian forest, eastern Paraguay, and northwestern Bolivia, where invasive populations have not been found yet. We recommend several management and policy strategies to control bullfrog invasion and argue that these would be possible if based on appropriate articulation among government agencies, NGOs, research institutions and civil society.	[Nori, Javier; Lescano, Julian N.; Leynaud, Gerardo C.] Univ Nacl Cordoba, Ctr Zool Aplicada, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Nicolas Urbina-Cardona, J.] Pontificia Univ Javeriana, Dept Ecol & Terr, Fac Estudios Ambientales & Rurales, Bogota, Colombia; [Loyola, Rafael D.] Univ Fed Goias, Dept Ecol, Goias, Brazil; [Lescano, Julian N.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	National University of Cordoba; Pontificia Universidad Javeriana; Universidade Federal de Goias; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Nori, J (corresponding author), Univ Nacl Cordoba, Ctr Zool Aplicada, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina.	javiernori@gmail.com	Loyola, Rafael/A-4425-2008; Urbina-Cardona, J. Nicolas/B-5447-2008; Loyola, Rafael/S-3978-2019	Loyola, Rafael/0000-0001-5323-2735; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Loyola, Rafael/0000-0001-5323-2735; Lescano, Julian Norberto/0000-0002-8776-012X; Nori, Javier/0000-0002-7127-7934	MINCyT [000113/2011]; CNPq [475886/2009-7]; CAPES-FCT [12/2009]; Brazilian Research Network on Global Climate Change; Consejo Nacional de Investigaciones Cientificas y Tecnicas	MINCyT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FCT(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Portuguese Foundation for Science and Technology); Brazilian Research Network on Global Climate Change; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	JN, JNL and GCL research is supported by MINCyT - PID 2010 (project #000113/2011). RDL research is supported by CNPq (project #475886/2009-7), CAPES-FCT Program (project #12/2009) and the Brazilian Research Network on Global Climate Change. JNL has a doctoral fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; C?lix M., 2018, EUROPEAN RED LIST SA; Coutts-Smith A., 2006, TECHNICAL SERIES CRC, V11; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Environmental Systems Research Institute (ESRI), 2005, ARCMAP GIS VER 9 3 1; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2007, CLIM CHANG 2007 SCI; ISSG (Invasive Species Specialist Group), 2009, GLOB INV SPEC DAT; Jamsranjav J, 2008, WORLDS PROTECTED ARE, P88; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Lever C, 2003, NATURALIZED REPTILES; Loyola RD, 2011, CLIMATE CHA IN PRESS; Lutz C.G., 1999, SO REGIONAL AQUACULT, V436; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Matthews S., 2005, SUDAMERICA INVADIDA; McNeely Jeffrey A., 2005, SCOPE, V63, P332; Nori J, 2011, BIODIVERS CONSERV, V20, P1125, DOI 10.1007/s10531-011-0014-3; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; Reaser JK, 2005, ESPECIES ALIENIGENAS; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanabria E, 2011, REV MEX BIODIVERS, V82, P311; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Akmentins MS, 2010, BIOL INVASIONS, V12, P735, DOI 10.1007/s10530-009-9515-3; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Simberloff D, 1997, STRANGERS PARADISE I; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Thuiller Wilfried, 2007, V193, P197; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Urbina-Cardona J. N., 2010, BIODIVERSIDAD CAMBIO, P65; Urbina-Cardona JN, 2011, BIOTA COLOM IN PRESS; USHER MB, 1988, BIOL CONSERV, V44, P1, DOI 10.1016/0006-3207(88)90002-X; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wilcove David S., 2000, P239	54	47	53	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25718	10.1371/journal.pone.0025718	http://dx.doi.org/10.1371/journal.pone.0025718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991339	gold, Green Submitted, Green Published			2022-12-25	WOS:000295943000059
J	Kraehling, JR; Busker, M; Haase, T; Haase, N; Koglin, M; Linnenbaum, M; Behrends, S				Kraehling, Jan R.; Busker, Mareike; Haase, Tobias; Haase, Nadine; Koglin, Markus; Linnenbaum, Monika; Behrends, Soenke			The Amino-Terminus of Nitric Oxide Sensitive Guanylyl Cyclase alpha(1) Does Not Affect Dimerization but Influences Subcellular Localization	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; IN-VIVO; ACTIVATION; GLUTATHIONE; SUBUNIT; DOMAINS	Background: Nitric oxide sensitive guanylyl cyclase (NOsGC) is a heterodimeric enzyme formed by an alpha- and a beta(1)-subunit. A splice variant (C-alpha(1)) of the alpha(1)-subunit, lacking at least the first 236 amino acids has been described by Sharina et al. 2008 and has been shown to be expressed in differentiating human embryonic cells. Wagner et al. 2005 have shown that the amino acids 61-128 of the alpha(1)-subunit are mandatory for quantitative heterodimerization implying that the C-alpha(1)-splice variant should lose its capacity to dimerize quantitatively. Methodology/Principal Findings: In the current study we demonstrate preserved quantitative dimerization of the C-alpha(1)-splice by co-purification with the beta(1)-subunit. In addition we used fluorescence resonance energy transfer (FRET) based on fluorescence lifetime imaging (FLIM) using fusion proteins of the beta(1)-subunit and the alpha(1)-subunit or the C-alpha(1) variant with ECFP or EYFP. Analysis of the respective combinations in HEK-293 cells showed that the fluorescence lifetime was significantly shorter (approximate to 0.3 ns) for alpha(1)/beta(1) and C-alpha(1)/beta(1) than the negative control. In addition we show that lack of the amino-terminus in the alpha(1) splice variant directs it to a more oxidized subcellular compartment. Significance: We conclude that the amino-terminus of the alpha(1)-subunit is dispensable for dimerization in-vivo and ex-vivo, but influences the subcellular trafficking.	[Kraehling, Jan R.; Busker, Mareike; Linnenbaum, Monika; Behrends, Soenke] Univ Brunswick, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany; [Haase, Tobias] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Haase, Nadine] Expt & Clin Res Ctr, Berlin, Germany; [Haase, Nadine] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kraehling, JR (corresponding author), Univ Brunswick, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010; Kraehling, Jan/D-5327-2009	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan/0000-0002-0979-2900; Haase, Nadine/0000-0003-0727-1738; Haase, Tobias/0000-0002-7220-602X	Deutsche Forschungsgemeinschaft [INST 188/286-1, BE 1865/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (INST 188/286-1; BE 1865/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Baltrons MA, 2008, MOL CELL NEUROSCI, V37, P494, DOI 10.1016/j.mcn.2007.11.004; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Haase N, 2010, BIOCHEM PHARMACOL, V80, P1676, DOI 10.1016/j.bcp.2010.08.007; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Schultz G., 1984, METHOD ENZYMAT AN, P379; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; SEEANNER M, 2010, BASIC CLIN PHARMACOL, V107, P162; Sharin VG, 2011, STEM CELLS DEV, V20, P1287, DOI 10.1089/scd.2010.0411; SHARINA IG, 2011, NITRIC OXIDE; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Wagner C, 2005, J BIOL CHEM, V280, P17687, DOI 10.1074/jbc.M412099200; Warburg O, 1942, BIOCHEM Z, V310, P384; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; ZHONG F, 2011, J BIOL INORG CHEM	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25772	10.1371/journal.pone.0025772	http://dx.doi.org/10.1371/journal.pone.0025772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984946	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295941300056
J	Malone, BM; Tan, F; Bridges, SM; Peng, ZH				Malone, Brandon M.; Tan, Feng; Bridges, Susan M.; Peng, Zhaohua			Comparison of Four ChIP-Seq Analytical Algorithms Using Rice Endosperm H3K27 Trimethylation Profiling Data	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POLYCOMB GROUP; DEVELOPMENTAL REGULATORS; SEED DEVELOPMENT; GENOME; ARABIDOPSIS; MEDEA; PROTEINS; SEQUENCE; BINDING	Chromatin immunoprecipitation coupled with high throughput DNA Sequencing (ChIP-Seq) has emerged as a powerful tool for genome wide profiling of the binding sites of proteins associated with DNA such as histones and transcription factors. However, no peak calling program has gained consensus acceptance by the scientific community as the preferred tool for ChIP-Seq data analysis. Analyzing the large data sets generated by ChIP-Seq studies remains highly challenging for most molecular biology laboratories. Here we profile H3K27me3 enrichment sites in rice young endospermusing the ChIP-Seq approach and analyze the data using four peak calling algorithms (FindPeaks, PeakSeq, USeq, and MACS). Comparison of the four algorithms reveals that these programs produce very different peaks in terms of peak size, number, and position relative to genes. We verify the peak predictions using ChIP-PCR to evaluate the accuracy of peak prediction of the four algorithms. We discuss the approach of each algorithm and compare similarities and differences in the results. Despite their differences in the peaks identified, all of the programs reach similar conclusions about the effect of H3K27me3 on gene expression. Its presence either upstream or downstream of a gene is predominately associated with repression of the gene. Additionally, GO analysis finds that a substantially higher ratio of genes associated with H3K27me3 were involved in multicellular organism development, signal transduction, response to external and endogenous stimuli, and secondary metabolic pathways than the rest of the rice genome.	[Malone, Brandon M.; Bridges, Susan M.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Malone, Brandon M.; Bridges, Susan M.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Tan, Feng; Peng, Zhaohua] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University	Malone, BM (corresponding author), Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA.	bridges@cse.msstate.edu; zp7@BCH.msstate.edu			USDA [2005-35604-15357, 2011-67013-30125]; DOE [DE-FG02-07ER64459]; National Science Foundation [EPS 0903787]	USDA(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This project is supported by USDA Grants (2005-35604-15357 and 2011-67013-30125) and DOE grant (DE-FG02-07ER64459) to Zhaohua Peng, and by the National Science Foundation under award number EPS 0903787 to Susan Bridges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 2001, CONTROL FALSE DISCOV, P29; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; COX A, 2001, ELAND EFFICIENT LOCA; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FELLER W, 1968, HYPERGEOMETRIC SERIE; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H., 2008, MAQ MAPPING ASSEMBLY; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; PAPOULIS A, 1984, CONDITIONAL PROBABIL, P33; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; R Development Core Team, 2006, R LANG ENV STAT COMP; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	37	46	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25260	10.1371/journal.pone.0025260	http://dx.doi.org/10.1371/journal.pone.0025260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984925	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300022
J	Stackley, KD; Beeson, CC; Rahn, JJ; Chan, SSL				Stackley, Krista D.; Beeson, Craig C.; Rahn, Jennifer J.; Chan, Sherine S. L.			Bioenergetic Profiling of Zebrafish Embryonic Development	PLOS ONE			English	Article							MITOCHONDRIAL TOXICITY; MIDBLASTULA TRANSITION; OXYGEN-CONSUMPTION; ENERGY-METABOLISM; MODEL; EMBRYOGENESIS; CELLS; ASSAY; EFFICIENCY; DISCOVERY	Many debilitating conditions are linked to bioenergetic defects. Developing screens to probe the genetic and/or chemical basic for such links has proved intractable. Furthermore, there is a need for a physiologically relevant assay of bioenergetics in whole organisms, especially for early stages in life where perturbations could increase disease susceptibility with aging. Thus, we asked whether we could screen bioenergetics and mitochondrial function in the developing zebrafish embryo. We present a multiplexed method to assay bioenergetics in zebrafish embryos from the blastula period (3 hours post-fertilization, hpf) through to hatching (48 hpf). In proof of principle experiments, we measured respiration and acid extrusion of developing zebrafish embryos. We quantified respiratory coupling to various bioenergetic functions by using specific pharmacological inhibitors of bioenergetic pathways. We demonstrate that change in the coupling to ATP turnover and proton leak are correlated with developmental stage. The multiwell format of this assay enables the user to screen for the effects of drugs and environmental agents on bioenergetics in the zebrafish embryo with high sensitivity and reproducibility.	[Stackley, Krista D.; Beeson, Craig C.; Rahn, Jennifer J.; Chan, Sherine S. L.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina	Stackley, KD (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA.	chans@musc.edu			National Institutes of Health [R00ES015555, P20RR024485]; MUSC; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR [UL1RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882, P20RR024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Chan lab is supported by National Institutes of Health awards R00ES015555 and P20RR024485, startup funds provided by MUSC, and the South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, NIH/NCRR Grant Number UL1RR029882. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bang A, 2004, J FISH BIOL, V64, P1285, DOI 10.1111/j.0022-1112.2004.00391.x; Barker DJP, 1992, FETAL INFANT ORIGINS; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bishop T, 2000, J EXP BIOL, V203, P3603; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; DAWID IB, 1985, J EMBRYOL EXP MORPH, V89, P113; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; FINN RN, 1993, FISH FARMING TECHNOLOGY, P117; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; HEMING TA, 1988, YOLK ABSORPTION EMBR, P407; Herst PM, 2004, BBA-BIOENERGETICS, V1656, P79, DOI 10.1016/j.bbabio.2004.01.008; Holtta-Vuori M., BIOCH J, V429, P235; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kamler E., 1992, EARLY LIFE HIST FISH; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lahnsteiner F, 2005, COMP BIOCHEM PHYS B, V142, P46, DOI 10.1016/j.cbpc.2005.05.015; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Mendelsohn BA, 2008, DEV DYNAM, V237, P1789, DOI 10.1002/dvdy.21584; Moran D, 2007, AQUACULTURE, V265, P359, DOI 10.1016/j.aquaculture.2007.02.003; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Rolfe VE, 1997, J PHYSIOL-LONDON, V503, P347, DOI 10.1111/j.1469-7793.1997.347bh.x; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schnellmann Rick G., 1994, V1 PART B, P128; Schuh RA, 2011, J NEUROSCI RES; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zamir E, 1997, MOL CELL BIOL, V17, P529, DOI 10.1128/MCB.17.2.529; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	48	92	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25652	10.1371/journal.pone.0025652	http://dx.doi.org/10.1371/journal.pone.0025652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980518	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600045
J	Tan, XJ; Huang, XY; Zhu, SL; Chen, H; Yu, QL; Wang, HY; Huo, XX; Zhou, JH; Wu, Y; Yan, DM; Zhang, Y; Wang, DY; Cui, AL; An, HQ; Xu, WB				Tan, Xiaojuan; Huang, Xueyong; Zhu, Shuangli; Chen, Hui; Yu, Qiuli; Wang, Haiyan; Huo, Xixiang; Zhou, Jianhui; Wu, Yan; Yan, Dongmei; Zhang, Yong; Wang, Dongyan; Cui, Aili; An, Hongqiu; Xu, Wenbo			The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; PACIFIC REGION; EVOLUTION; TAIWAN; HAND; FOOT; INFECTION; OUTBREAK	Emerging epidemics of hand-foot-and-mouth disease (HFMD) associated with enterovirus 71 (EV71) has become a serious concern in mainland China. It caused 126 and 353 fatalities in 2008 and 2009, respectively. The epidemiologic and pathogenic data of the outbreak collected from national laboratory network and notifiable disease surveillance system. To understand the virological evolution of this emerging outbreak, 326 VP1 gene sequences of EV71 detected in China from 1987 to 2009 were collected for genetic analyses. Evidence from both traditional and molecular epidemiology confirmed that the recent HFMD outbreak was an emerging one caused by EV71 of subgenotype C4. This emerging HFMD outbreak is associated with EV71 of subgenotype C4, circulating persistently in mainland China since 1998, but not attributed to the importation of new genotype. Originating from 1992, subgenotype C4 has been the predominant genotype since 1998 in mainland China, with an evolutionary rate of 4.6 similar to 4.8 x 10(-3) nucleotide substitutions/site/year. The phylogenetic analysis revealed that the majority of the virus during this epidemic was the most recent descendant of subgenotype C4 (clade C4a). It suggests that the evolution might be one of the potential reasons for this native virus to cause the emerging outbreak in China. However, strong negative selective pressure on VP1 protein of EV71 suggested that immune escape might not be the evolving strategy of EV71, predicting a light future for vaccine development. Nonetheless, long-term antigenic and genetic surveillance is still necessary for further understanding.	[Tan, Xiaojuan; Zhu, Shuangli; Yan, Dongmei; Zhang, Yong; Wang, Dongyan; Cui, Aili; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Chen, Hui] Ningxia Prov Ctr Dis Control & Prevent, Ningxia, Peoples R China; [Yu, Qiuli] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Wang, Haiyan] Shandong Prov Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Huo, Xixiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Wu, Yan] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tan, XJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	Ministry of Science and Technology of the People's Republic of China [2011CB504902, 2009ZX10004-201, 2008BAI69D00, 2009ZX10004-202]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology of the People's Republic of China, grant number 2011CB504902, 2009ZX10004-201, 2008BAI69D00, and 2009ZX10004-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; BLOMBERG J, 1974, LANCET, V2, P112; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; CRAINIC R, 1993, BIOLOGICALS, V21, P379, DOI 10.1006/biol.1993.1099; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; MELNICK JL, 1979, INTERVIROLOGY, V12, P297, DOI 10.1159/000149088; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi Wei-feng, 2009, Virologica Sinica, V24, P59, DOI 10.1007/s12250-009-2976-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang Qi, 2010, Disease Surveillance, V25, P181; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; ZHENG Z-M, 1989, Virologica Sinica, V4, P375; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	49	128	161	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25662	10.1371/journal.pone.0025662	http://dx.doi.org/10.1371/journal.pone.0025662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980521	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900087
J	Papadimitriou, E; Vasilaki, E; Vorvis, C; Iliopoulos, D; Moustakas, A; Kardassis, D; Stournaras, C				Papadimitriou, E.; Vasilaki, E.; Vorvis, C.; Iliopoulos, D.; Moustakas, A.; Kardassis, D.; Stournaras, C.			Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-beta and miR-24: role in epithelial-to-mesenchymal transition	ONCOGENE			English	Article						TGF-beta; Net1A; RhoA; EMT; miR-24	EXCHANGE FACTOR NET1; SMAD PROTEINS; ADHERENS JUNCTIONS; TUMOR-SUPPRESSOR; FAMILY; DYNAMICS; DOWNSTREAM; MECHANISMS; PLASTICITY; RECEPTORS	In the present study we analyzed the regulation of the two isoforms of the RhoA-specific guanine nucleotide exchange factor Net1 by transforming growth factor-beta (TGF-beta) in keratinocytes. We report that short-term TGF-beta treatment selectively induced Net1 isoform2 (Net1A) but not Net1 isoform1. This led to upregulation of cytoplasmic Net1A protein levels that were necessary for TGF-beta-mediated RhoA activation. Smad signaling and the MAPK/ERK kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway were involved in Net1A upregulation by TGF-beta. Interestingly, long-term TGF-beta treatment resulted in Net1 mRNA downregulation and Net1A protein degradation by the proteasome. Furthermore, we identified the microRNA miR-24 as a novel post-transcriptional regulator of Net1A expression. Silencing of Net1A resulted in disruption of E-cadherin-and zonula occludens-1 (ZO-1)-mediated junctions, as well as expression of the transcriptional repressor of E-cadherin, Slug and the mesenchymal markers N-cadherin, plasminogen activator inhibitor-1 (PAI-1) and fibronectin, indicating that late TGF-beta-induced downregulation of Net1A is involved in epithelial-to-mesenchymal transition (EMT). Finally, miR-24 was found to be implicated in the regulation of the EMT program in response to TGF-beta and was shown to be directly involved in the TGF-beta-induced breast cancer cell invasiveness through Net1A regulation. Our results emphasize the importance of Net1 isoform2 in the short-and long-term TGF-beta-mediated regulation of EMT. Oncogene (2012) 31, 2862-2875; doi:10.1038/onc.2011.457; published online 10 October 2011	[Papadimitriou, E.; Vasilaki, E.; Kardassis, D.; Stournaras, C.] Univ Crete, Dept Biochem, Sch Med, Iraklion 71003, Crete, Greece; [Vorvis, C.; Iliopoulos, D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Vorvis, C.; Iliopoulos, D.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Vasilaki, E.; Moustakas, A.] Uppsala Univ, Ludwig Inst Canc Res, Uppsala, Sweden; [Moustakas, A.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	University of Crete; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Stournaras, C (corresponding author), Univ Crete, Dept Biochem, Sch Med, POB 2208, Iraklion 71003, Crete, Greece.	cstourn@med.uoc.gr	Vasilaki, Eleftheria/AAY-6392-2020; Iliopoulos, Dimitrios/AAE-9106-2019		PENED program of the Greek Secretariat for Research and Technology [PENED03-688]	PENED program of the Greek Secretariat for Research and Technology	This work was supported by the PENED program of the Greek Secretariat for Research and Technology (Grant no. PENED03-688). We thank Dr EA Papakonstanti for valuable comments.	Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Carr HS, 2009, J BIOL CHEM, V284, P24269, DOI 10.1074/jbc.M109.029439; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Lin SC, 2011, ORAL ONCOL, V46, P204; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Piek E, 1999, J CELL SCI, V112, P4557; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Xie L, 2011, CLIN BIOCHEM, V44, P216, DOI 10.1016/j.clinbiochem.2010.11.002; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	44	78	80	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	23					2862	2875		10.1038/onc.2011.457	http://dx.doi.org/10.1038/onc.2011.457			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	21986943				2022-12-25	WOS:000305277900006
J	Feng, H; Liu, KW; Guo, P; Zhang, P; Cheng, T; McNiven, MA; Johnson, GR; Hu, B; Cheng, SY				Feng, H.; Liu, K. W.; Guo, P.; Zhang, P.; Cheng, T.; McNiven, M. A.; Johnson, G. R.; Hu, B.; Cheng, S. Y.			Dynamin 2 mediates PDGFR alpha-SHP-2-promoted glioblastoma growth and invasion	ONCOGENE			English	Article						Dyn2; PDGFR alpha; SHP-2; Src; glioma tumor growth; invasion	TYROSINE-PHOSPHATASE SHP-2; CELL-MIGRATION; MALIGNANT GLIOMAS; ACTIVATION; SRC; PHOSPHORYLATION; FAMILY; CYTOSKELETON; PROTEINS; BINDING	Dynamin 2 (Dyn2), a large GTPase, is involved in receptor tyrosine kinase (RTK)-promoted cell migration. However, the molecular mechanisms by which Dyn2 regulates RTK-induced cell migration have not been established. Recently, we reported that tyrosine-protein phosphatase non-receptor type 11 (SHP-2) and phosphatidylinositol 3-kinase (PI3K) mediate platelet-derived growth factor receptor-alpha (PDGFR alpha)-promoted glioma tumor growth and invasion. Here, we show that Dyn2 is an effector downstream of the PDGFR alpha-PI3K/SHP-2 signaling in glioma cells. Depletion of endogenous Dyn2 by short hairpin RNAs (shRNAs) inhibited PDGFR alpha-stimulated phosphorylation of Akt, Erk1/2, Rac1 and Cdc42 activities, glioma cell migration and survival in vitro and tumor growth and invasion in the brains of mice. Dyn2 binds to SHP-2 and PI3K and colocalizes with PDGFR alpha at the invasive fronts in PDGF-A-stimulated glioma cells. Inhibition of SHP-2 by siRNA knockdown abrogated Dyn2 association with activated PDGFR alpha and PDGFR alpha activation of Rac1 and Cdc42, and glioma cell migration, thereby establishing a link between SHP-2 interaction with Dyn2 and the PDGFR alpha signaling. Furthermore, a dominant-negative SHP-2 C459S mutant inhibited PDGF-A-stimulated glioma cell migration, phosphorylation of Dyn2 and concomitantly blocked PDGFR alpha-induced Src activation. Inhibition of Src by Src inhibitors attenuated PDGF-A-stimulated phosphorylation of Akt and Dyn2 and glioma cell migration. Additionally, mutations of binding sites to PI3K, SHP-2 or Src of PDGFR alpha impaired PDGFR alpha-stimulated phosphorylation of Akt and Dyn2, and Dyn2 association with activated PDGFR alpha. Taken together, this study identifies Dyn2 as an effector that mediates PDGFR alpha-SHP-2-induced glioma tumor growth and invasion, suggesting that targeting the PDGFR alpha-SHP-2-Dyn2 pathway may be beneficial to patients with malignant glioblastomas. Oncogene (2012) 31, 2691-2702; doi:10.1038/onc.2011.436; published online 26 September 2011	[Hu, B.] Univ Pittsburgh, Dept Med, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Feng, H.; Liu, K. W.; Guo, P.; Cheng, S. Y.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Guo, P.] Childrens Hosp, Div Pediat Gen & Thorac Surg, Pittsburgh, PA 15213 USA; [Zhang, P.; Cheng, T.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Cheng, T.] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China; [Cheng, T.] Chinese Acad Med Sci, Blood Dis Hosp, Ctr Stem Cell Med, Tianjin, Peoples R China; [Cheng, T.] Peking Union Med Coll, Tianjin, Peoples R China; [McNiven, M. A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [McNiven, M. A.] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN USA; [Johnson, G. R.] US FDA, Chem Lab, Div Therapeut Prot, Bethesda, MD 20014 USA; [Johnson, G. R.] US FDA, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Mayo Clinic; Mayo Clinic; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Hu, B (corresponding author), Univ Pittsburgh, Dept Med, Inst Canc, Hillman Canc Ctr, Suite 2-26,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	hub@upmc.edu; chengs@upmc.edu	Zhang, Peng/B-6898-2014; Feng, Haizhong/E-5795-2017; Liu, Kun-Wei/A-9370-2013	Zhang, Peng/0000-0001-5574-0899; Feng, Haizhong/0000-0003-3552-6865; 	ACS (RSG) [CSM-107144]; NIH [CA130966]; Pennsylvania Department of Health; Hillman Foundation; James S McDonnell Foundation; NATIONAL CANCER INSTITUTE [R01CA130966, R01CA104125] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	ACS (RSG)(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Hillman Foundation; James S McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs Y Zhou and E Van Meir for providing glioma cell lines and Dr H Damke and L Vance for proofreading of this manuscript. This work was supported in part by a grant from ACS (RSG CSM-107144), grants from NIH (CA130966), a grant with the Pennsylvania Department of Health, and Innovative Research Scholar Awards of the Hillman Foundation to SY Cheng and B Hu, and a James S McDonnell Foundation Researching Award in Brain Cancer to B Hu.	Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Carver KC, 2010, J BIOL CHEM, V285, P8003, DOI 10.1074/jbc.M109.066480; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Haberler C, 2006, J NEURO-ONCOL, V76, P105, DOI 10.1007/s11060-005-4570-9; Imanishi Y, 2007, CANCER RES, V67, P4254; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Liu KW, 2011, J CLIN INVEST, V121, P905, DOI 10.1172/JCI43690; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mitola S, 2006, CIRC RES, V98, P45, DOI 10.1161/01.RES.0000199355.32422.7b; Navis AC, 2010, ACTA NEUROPATHOL, V119, P157, DOI 10.1007/s00401-009-0614-0; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; SCAIFE R, 1994, EMBO J, V13, P2574, DOI 10.1002/j.1460-2075.1994.tb06547.x; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	42	58	58	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	21					2691	2702		10.1038/onc.2011.436	http://dx.doi.org/10.1038/onc.2011.436			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21996738	Green Accepted, Green Submitted			2022-12-25	WOS:000304523500008
J	Hands, S; Sajjad, MU; Newton, MJ; Wyttenbach, A				Hands, Sarah; Sajjad, Mohammad U.; Newton, Michael J.; Wyttenbach, Andreas			In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CYTOCHROME-C RELEASE; MUTANT HUNTINGTIN; OXIDATIVE DAMAGE; HYDROGEN-PEROXIDE; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION; TRANSGENIC MOUSE; CELL-DEATH; HEAT-SHOCK	Neurodegenerative diseases are characterized by intra- and/or extracellular protein aggregation and oxidative stress. Intense attention has been paid to whether protein aggregation itself contributes to abnormal production of free radicals and ensuing cellular oxidative damage. Although this question has been investigated in the context of extracellular protein aggregation, it remains unclear whether protein aggregation inside cells alters the redox homeostasis. To address this, we have used in vitro and in vivo (cellular) models of Huntington disease, one of nine polyglutamine (poly(Q)) disorders, and examined the causal relationship among intracellular protein aggregation, reactive oxygen species (ROS) production, and toxicity. Live imaging of cells expressing a fragment of huntingtin (httExon1) with a poly(Q) expansion shows increased ROS production preceding cell death. ROS production is poly(Q) length-dependent and not due to the httExon 1 flanking sequence. Aggregation inhibition by the MW7 intrabody and Pgl-135 treatment abolishes ROS production, showing that increased ROS is caused by poly(Q) aggregation itself. To examine this hypothesis further, we determined whether aggregation of poly(Q) peptides in vitro generated free radicals. Monitoring poly(Q) protein aggregation using atomic force microscopy and hydrogen peroxide (H2O2) production over time in parallel we show that oligomerization of httEx1Q53 results in early generation of H2O2. Inhibition of poly(Q) oligomerization by the single chain antibody MW7 abrogates H2O2 formation. These results demonstrate that intracellular protein aggregation directly causes free radical production, and targeting potentially toxic poly(Q) oligomers may constitute a therapeutic target to counteract oxidative stress in poly(Q) diseases.	[Hands, Sarah; Sajjad, Mohammad U.; Newton, Michael J.; Wyttenbach, Andreas] Univ Southampton, Southampton Neurosci Grp, Sch Biol Sci, Southampton SO17 1BJ, Hants, England	University of Southampton	Wyttenbach, A (corresponding author), Univ Southampton, Southampton Neurosci Grp, Sch Biol Sci, Southampton SO17 1BJ, Hants, England.	aw3@soton.ac.uk			Medical Research Council; Gerald Kerkut Trust; Bestway Foundation; University of Southampton; Medical Research Council [G120/881] Funding Source: researchfish; MRC [G120/881] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gerald Kerkut Trust; Bestway Foundation; University of Southampton; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to S. H. and A. W.).; Supported by the Gerald Kerkut Trust, Bestway Foundation, and the University of Southampton.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bertoni A, 2011, J BIOL CHEM, V286, P4727, DOI 10.1074/jbc.M110.156521; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 1999, BRAIN PATHOL, V9, P147; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Firdaus WJJ, 2006, FEBS J, V273, P3076, DOI 10.1111/j.1742-4658.2006.05318.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Halliwell B., 2007, FREE RADICALS BIOL M; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hands SL, 2010, BIOCHEM SOC T, V38, P552, DOI 10.1042/BST0380552; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Puranam KL, 2006, BIOCHEM BIOPH RES CO, V341, P607, DOI 10.1016/j.bbrc.2006.01.007; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Turnbull S, 2003, BIOCHEMISTRY-US, V42, P7675, DOI 10.1021/bi030036e; van Roon-Mom WMC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-84; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137	48	80	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44512	44520		10.1074/jbc.M111.307587	http://dx.doi.org/10.1074/jbc.M111.307587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21984825	hybrid, Green Published			2022-12-25	WOS:000298645500023
J	Singarapu, KK; Tonelli, M; Chow, DC; Frederick, RO; Westler, WM; Markley, JL				Singarapu, Kiran K.; Tonelli, Marco; Chow, Darius C.; Frederick, Ronnie O.; Westler, William M.; Markley, John L.			Structural Characterization of Hsp12, the Heat Shock Protein from Saccharomyces cerevisiae, in Aqueous Solution Where It Is Intrinsically Disordered and in Detergent Micelles Where It Is Locally alpha-Helical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEA-LIKE PROTEIN; TREHALOSE; GENE; SPECTROSCOPY; DESICCATION; TOLERANCE; PROGRAM; STRESS; CELLS	Hsp12 (heat shock protein 12) belongs to the small heat shock protein family, partially characterized as a stress response, stationary phase entry, late embryonic abundant-like protein located at the plasma membrane to protect membrane from desiccation. Here, we report the structural characterization of Hsp12 by NMR and biophysical techniques. The protein was labeled uniformly with nitrogen-15 and carbon-13 so that its conformation could be determined in detail both in aqueous solution and in two membrane-mimetic environments, SDS and dodecylphosphocholine (DPC) micelles. Secondary structural elements determined from assigned chemical shifts indicated that Hsp12 is dynamically disordered in aqueous solution, whereas it gains four helical stretches in the presence of SDS micelles and a single helix in presence of DPC. These conclusions were reinforced by circular dichroism spectra of the protein in all three environments. The lack of long range interactions in NOESY spectra indicated that the helices present in SDS micelles do not pack together. R-1 and R-2, relaxation and heteronuclear NOE measurements showed that the protein is disordered in aqueous solution but becomes more ordered in presence of detergent micelles. NMR spectra collected in presence of paramagnetic spin relaxation agents (5DSA, 16DSA, and Gd(DTPA-BMA)) indicated that the amphipathic alpha-helices of Hsp12 in SDS micelles lie on the membrane surface. These observations are in agreement with studies suggesting that Hsp12 functions to protect the membrane from desiccation.	[Singarapu, Kiran K.; Tonelli, Marco; Westler, William M.; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA; [Chow, Darius C.; Frederick, Ronnie O.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Gen, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), 433 Babcock Dr, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health [P41 RR02301, P41 GM66326, 1U54 GM074901]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 RR02301, P41 GM66326, and 1U54 GM074901 (to J. L. M.).	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Motshwene P, 2004, BIOCHEM J, V377, P769, DOI 10.1042/bj20031301; Mtwisha L, 1998, PLANT MOL BIOL, V37, P513, DOI 10.1023/A:1005904219201; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Park JI, 1997, APPL ENVIRON MICROB, V63, P3818, DOI 10.1128/AEM.63.10.3818-3824.1997; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Sano F, 1999, CRYOBIOLOGY, V39, P80, DOI 10.1006/cryo.1999.2188; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Shamrock VJ, 2008, CAN J MICROBIOL, V54, P559, DOI [10.1139/W08-044, 10.1139/w08-044]; Sharma SC, 1997, FEMS MICROBIOL LETT, V152, P11, DOI 10.1111/j.1574-6968.1997.tb10402.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STONE RL, 1990, GENE, V96, P171, DOI 10.1016/0378-1119(90)90249-Q; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Zara S, 2002, YEAST, V19, P269, DOI 10.1002/yea.831	35	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43447	43453		10.1074/jbc.M111.306464	http://dx.doi.org/10.1074/jbc.M111.306464			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998307	Green Published, hybrid			2022-12-25	WOS:000298351300064
J	Brodersen, J; Rodriguez-Gil, JL; Jonsson, M; Hansson, LA; Bronmark, C; Nilsson, PA; Nicolle, A; Berglund, O				Brodersen, Jakob; Rodriguez-Gil, Jose Luis; Jonsson, Mikael; Hansson, Lars-Anders; Bronmark, Christer; Nilsson, P. Anders; Nicolle, Alice; Berglund, Olof			Temperature and Resource Availability May Interactively Affect Over-Wintering Success of Juvenile Fish in a Changing Climate	PLOS ONE			English	Article							COMPENSATORY GROWTH; WATER TEMPERATURE; ENERGY RESERVES; SEASONAL SUCCESSION; LAKE; MORTALITY; SIZE; CONSEQUENCES; ZOOPLANKTON; MIGRATION	The predicted global warming may affect freshwater systems at several organizational levels, from organism to ecosystem. Specifically, in temperate regions, the projected increase of winter temperatures may have important effects on the over-winter biology of a range of organisms and especially for fish and other ectothermic animals. However, temperature effects on organisms may be directed strongly by resource availability. Here, we investigated whether over-winter loss of biomass and lipid content of juvenile roach (Rutilus rutilus) was affected by the physiologically relatively small (2-5 degrees C) changes of winter temperatures predicted by the Intergovernmental Panel on Climate Change (IPCC), under both natural and experimental conditions. This was investigated in combination with the effects of food availability. Finally, we explored the potential for a correlation between lake temperature and resource levels for planktivorous fish, i.e., zooplankton biomass, during five consecutive winters in a south Swedish lake. We show that small increases in temperature (+2 degrees C) affected fish biomass loss in both presence and absence of food, but negatively and positively respectively. Temperature alone explained only a minor part of the variation when food availability was not taken into account. In contrast to other studies, lipid analyses of experimental fish suggest that critical somatic condition rather than critical lipid content determined starvation induced mortality. Our results illustrate the importance of considering not only changes in temperature when predicting organism response to climate change but also food-web interactions, such as resource availability and predation. However, as exemplified by our finding that zooplankton over-winter biomass in the lake was not related to over-winter temperature, this may not be a straightforward task.	[Brodersen, Jakob; Rodriguez-Gil, Jose Luis; Jonsson, Mikael; Hansson, Lars-Anders; Bronmark, Christer; Nilsson, P. Anders; Nicolle, Alice; Berglund, Olof] Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden	Lund University	Brodersen, J (corresponding author), EAWAG Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Ctr Ecol Evolut & Biochem, Kastanienbaum, Switzerland.	jakob.brodersen@eawag.ch	Hansson, Lars-Anders/HCI-2735-2022; Nilsson, Anders/H-6836-2014; Rodriguez Gil, Jose Luis/B-3479-2010; Jönsson, Mikael/M-7449-2013	Nilsson, Anders/0000-0002-3541-9835; Rodriguez Gil, Jose Luis/0000-0001-9325-9131; Jönsson, Mikael/0000-0002-9799-6435; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Physiographic Society in Lund	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Physiographic Society in Lund	The work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Swedish Research Council (VR) and the Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 1999, FRESHWATER BIOL, V41, P621, DOI 10.1046/j.1365-2427.1999.00411.x; Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; ARTS MT, 1991, LIMNOL OCEANOGR, V36, P289, DOI 10.4319/lo.1991.36.2.0289; Berger SA, 2007, OECOLOGIA, V150, P643, DOI 10.1007/s00442-006-0550-9; Biro PA, 2004, CAN J FISH AQUAT SCI, V61, P1513, DOI 10.1139/F04-083; Biro PA, 2007, P NATL ACAD SCI USA, V104, P9715, DOI 10.1073/pnas.0701638104; Blenckner T, 2007, GLOBAL CHANGE BIOL, V13, P1314, DOI 10.1111/j.1365-2486.2007.01364.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOHL E, 1980, OECOLOGIA, V44, P368, DOI 10.1007/BF00545241; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Bystrom P, 2006, OIKOS, V115, P43, DOI 10.1111/j.2006.0030-1299.15014.x; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; COSTANZO JP, 1995, ECOLOGY, V76, P1772, DOI 10.2307/1940709; CRYER M, 1986, LIMNOL OCEANOGR, V31, P1022, DOI 10.4319/lo.1986.31.5.1022; CUNJAK RA, 1987, T AM FISH SOC, V116, P817, DOI 10.1577/1548-8659(1987)116<817:SEBOBT>2.0.CO;2; DERICKSON WK, 1976, AM ZOOL, V16, P711; DRATNAL E, 1993, FUNCT ECOL, V7, P91, DOI 10.2307/2389871; FITZPATRICK LC, 1976, AM ZOOL, V16, P725; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fry F.E.J., 1971, P1; Garvey JE, 2004, ECOLOGY, V85, P2860, DOI 10.1890/03-0329; Garvey JE, 1998, CAN J FISH AQUAT SCI, V55, P2414, DOI 10.1139/cjfas-55-11-2414; GEORGE DG, 1985, NATURE, V316, P536, DOI 10.1038/316536a0; George G, 2007, FRESHWATER BIOL, V52, P1647, DOI 10.1111/j.1365-2427.2007.01773.x; Gerten D, 2000, LIMNOL OCEANOGR, V45, P1058, DOI 10.4319/lo.2000.45.5.1058; Graeb BDS, 2004, T AM FISH SOC, V133, P504, DOI 10.1577/T03-050.1; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Henen BT, 1997, ECOLOGY, V78, P283; Hoxmeier RJH, 2004, T AM FISH SOC, V133, P45, DOI 10.1577/T01-082; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Hurst TP, 2003, ECOLOGY, V84, P3360, DOI 10.1890/02-0562; Huss M, 2008, CAN J FISH AQUAT SCI, V65, P2149, DOI 10.1139/F08-115; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; JOHNSON M. G., 1960, PROGR FISH CULTURIST, V22, P155, DOI 10.1577/1548-8659(1960)22[155:SEOTOT]2.0.CO;2; Johnsson JI, 2006, P ROY SOC B-BIOL SCI, V273, P1281, DOI 10.1098/rspb.2005.3437; Lehtonen H., 1996, Fisheries Management and Ecology, V3, P59, DOI 10.1111/j.1365-2400.1996.tb00130.x; MACCULLOCH RD, 1983, CAN J ZOOL, V61, P1499, DOI 10.1139/z83-202; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MullerNavarra DC, 1997, GLOB CHANGE BIOL, V3, P429, DOI 10.1046/j.1365-2486.1997.00080.x; Nielsen T, 2008, THESIS AAHUS U; Raisanen J, 2004, CLIM DYNAM, V22, P13, DOI 10.1007/s00382-003-0365-x; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; REZNICK DN, 1987, OECOLOGIA, V73, P401, DOI 10.1007/BF00385257; Rummukainen M, 2001, CLIM DYNAM, V17, P339, DOI 10.1007/s003820000109; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SCHULTZ ET, 1991, AM NAT, V138, P1408, DOI 10.1086/285294; Schultz ET, 1999, OECOLOGIA, V119, P474, DOI 10.1007/s004420050810; Seebens H, 2007, LIMNOL OCEANOGR, V52, P2364, DOI 10.4319/lo.2007.52.6.2364; SHUTER BJ, 1990, T AM FISH SOC, V119, P314, DOI 10.1577/1548-8659(1990)119<0314:CPVATZ>2.3.CO;2; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; Skov C, 2008, ECOL FRESHW FISH, V17, P406, DOI 10.1111/j.1600-0633.2008.00291.x; Sogard SM, 2000, J FISH BIOL, V56, P1; SOMERO GN, 1971, AM ZOOL, V11, P157; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stefan HG, 1995, SPEC PUBL FISH AQUAT, V121, P57; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Van Dijk PLM, 2005, J FISH BIOL, V66, P167, DOI 10.1111/j.0022-1112.2005.00590.x; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weatherley AH, 1987, BIOL FISH GROWTH; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	70	24	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24022	10.1371/journal.pone.0024022	http://dx.doi.org/10.1371/journal.pone.0024022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998627	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700003
J	Clark, LC; Hoskisson, PA				Clark, Laura C.; Hoskisson, Paul A.			Duplication and Evolution of devA-Like Genes in Streptomyces Has Resulted in Distinct Developmental Roles	PLOS ONE			English	Article							AERIAL MYCELIUM FORMATION; ANTIBIOTIC PRODUCTION; TRANSCRIPTIONAL REGULATOR; ADAPTIVE EVOLUTION; COELICOLOR A3(2); SP-NOV; FAMILY; MORPHOGENESIS; SPORULATION; PROTEINS	Understanding morphological transformations is essential to elucidating the evolution and developmental biology of many organisms. The Gram-positive soil bacterium, Streptomyces coelicolor has a complex lifecycle which lends itself well to such studies. We recently identified a transcriptional regulator, devA, which is required for correct sporulation in this organism, with mutants forming short, mis-septate aerial hyphae. devA is highly conserved within the Streptomyces genus along with a duplicate copy, devE. Disruption of devE indicates this gene also plays a role in sporulation; however the phenotype of a devE mutant differs from a devA mutant, forming long un-septate aerial hyphae. Transcriptional analysis of devA and devE indicates that they are expressed at different stages of the lifecycle. This suggests that following duplication they have diverged in regulation and function. Analysis of fully sequenced actinomycete genomes shows that devA is found in a single copy in morphologically simpler actinobacteria, suggesting that duplication has lead to increased morphological complexity. Complementation studies with devA from Salinispora, which sporulates but does not form aerial hyphae, indicates the ancestral gene cannot complement devA or devE, suggesting neo-functionalisation has occurred. Analysis of the synonymous and non-synonymous nucleotide changes within the devA paralogues suggest subfunctionalisation has occurred as both copies have diverged from the ancestral sequences. Divergence is also asymmetric with a higher level of functional constraint observed in the DNA binding domain compared with the effector binding/oligomerisation domain, suggesting diversification in the substrate specificity of these paralogues has contributed to their evolution.	[Clark, Laura C.; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde	Clark, LC (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	Paul.hoskisson@strath.ac.uk		Hoskisson, Paul/0000-0003-4332-1640; Clark, Laura/0000-0001-9471-2743				Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; Campanaro S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-313; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Claessen D, 2002, MOL MICROBIOL, V44, P1483, DOI 10.1046/j.1365-2958.2002.02980.x; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; GOODFELLOW M, 1983, BIOL ACTINOMYCETES; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HASEGAWA T, 1978, INT J SYST BACTERIOL, V28, P304, DOI 10.1099/00207713-28-2-304; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; He XL, 2005, CURR BIOL, V15, P1016, DOI 10.1016/j.cub.2005.04.035; Hillerich B, 2006, J BACTERIOL, V188, P7477, DOI 10.1128/JB.00898-06; HOBBS G, 1989, APPL MICROBIOL BIOT, V31, P272; Hoskisson PA, 2006, J BACTERIOL, V188, P5014, DOI 10.1128/JB.00307-06; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Johnson DA, 2007, MOL BIOL EVOL, V24, P2412, DOI 10.1093/molbev/msm184; Karandikar A, 1997, MICROBIOL-SGM, V143, P3581, DOI 10.1099/00221287-143-11-3581; Kelemen GH, 1996, MOL MICROBIOL, V21, P593, DOI 10.1111/j.1365-2958.1996.tb02567.x; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Labeda DP, 2005, INT J SYST EVOL MICR, V55, P1687, DOI 10.1099/ijs.0.63496-0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nodwell JR, 1999, GENETICS, V151, P569; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Park YH, 1999, INT J SYST BACTERIOL, V49, P743, DOI 10.1099/00207713-49-2-743; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Ryding NJ, 1998, MOL MICROBIOL, V29, P343, DOI 10.1046/j.1365-2958.1998.00939.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skamnioti P, 2008, NEW PHYTOL, V180, P711, DOI 10.1111/j.1469-8137.2008.02598.x; Skamnioti Pari, 2008, Commun Integr Biol, V1, P196; Sprusansky O, 2003, J BACTERIOL, V185, P6147, DOI 10.1128/JB.185.20.6147-6157.2003; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thomaides HB, 2007, J BACTERIOL, V189, P591, DOI 10.1128/JB.01381-06; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Traag BA, 2008, ANTON LEEUW INT J G, V94, P85, DOI 10.1007/s10482-008-9225-3; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25049	10.1371/journal.pone.0025049	http://dx.doi.org/10.1371/journal.pone.0025049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998634	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295966900006
J	Scully, S; Yan, W; Bentley, B; Cao, QJ; Shao, R				Scully, Steve; Yan, Wei; Bentley, Brooke; Cao, Qing Jackie; Shao, Rong			Inhibitory Activity of YKL-40 in Mammary Epithelial Cell Differentiation and Polarization Induced by Lactogenic Hormones: A Role in Mammary Tissue Involution	PLOS ONE			English	Article							CHITINASE PROTEIN FAMILY; HUMAN CARTILAGE GLYCOPROTEIN-39; BREAST-CANCER; SERUM YKL-40; GENE-EXPRESSION; STIMULATES PROLIFERATION; BRANCHING MORPHOGENESIS; DUCTAL MORPHOGENESIS; NONLACTATING PERIOD; SIGNALING PATHWAYS	We previously reported that a secreted glycoprotein YKL-40 acts as an angiogenic factor to promote breast cancer angiogenesis. However, its functional role in normal mammary gland development is poorly understood. Here we investigated its biophysiological activity in mammary epithelial development and mammary tissue morphogenesis. YKL-40 was expressed exclusively by ductal epithelial cells of parous and non-parous mammary tissue, but was dramatically up-regulated at the beginning of involution. To mimic ductal development and explore activity of elevated YKL-40 during mammary tissue regression in vivo, we grew a mammary epithelial cell line 76N MECs in a 3-D Matrigel system in the presence of lactogenic hormones including prolactin, hydrocortisone, and insulin. Treatment of 76N MECs with recombinant YKL-40 significantly inhibited acinar formation, luminal polarization, and secretion. YKL-40 also suppressed expression of E-cadherin but increased MMP-9 and cell motility, the crucial mechanisms that mediate mammary tissue remodeling during involution. In addition, engineering of 76N MECs with YKL-40 gene to express ectopic YKL-40 recapitulated the same activities as recombinant YKL-40 in the inhibition of cell differentiation. These results suggest that YKL-40-mediated inhibition of cell differentiation and polarization in the presence of lactogenic hormones may represent its important function during mammary tissue involution. Identification of this biophysiological property will enhance our understanding of its pathologic role in the later stage of breast cancer that is developed from poorly differentiated and highly invasive cells.	[Scully, Steve; Yan, Wei; Bentley, Brooke; Shao, Rong] Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA USA; [Scully, Steve; Shao, Rong] Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA; [Cao, Qing Jackie] Tufts Univ, Dept Pathol, Baystate Med Ctr, Springfield, MA USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Scully, S (corresponding author), Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA USA.	rong.shao@bhs.org			National Institutes of Health (National Cancer Institutes) [RO1 CA120659]; Department Of Defense [W81XWH-06-1-0563]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institutes)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Department Of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (National Cancer Institutes) RO1 CA120659 "Role of a novel angiogenic factor YKL-40 in breast cancer development" and Department Of Defense W81XWH-06-1-0563 "PVLSI Breast Cancer Research Program: Biomarkers and Chemoprevention." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brill B, 2008, LAB ANIM-UK, V42, P104, DOI 10.1258/la.2007.06003e; Cao YA, 1997, CANCER RES, V57, P5584; Chen CC, 2011, CLIN IMMUNOL, V140, P268, DOI 10.1016/j.clim.2011.04.007; Chen CC, 2011, AM J PATHOL, V179, P1494, DOI 10.1016/j.ajpath.2011.05.038; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; El-Sabban ME, 2003, J CELL SCI, V116, P3531, DOI 10.1242/jcs.00656; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Helguero LA, 2008, CANCER RES, V68, P8695, DOI 10.1158/0008-5472.CAN-08-0788; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kronborg G, 2002, SCAND J INFECT DIS, V34, P323, DOI 10.1080/00365540110080233; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lian ZL, 2006, J CELL PHYSIOL, V208, P255, DOI 10.1002/jcp.20681; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Qin WY, 2007, INT J CANCER, V121, P1536, DOI 10.1002/ijc.22881; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; Vind I, 2003, SCAND J GASTROENTERO, V38, P599, DOI 10.1080/00365520310000537; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yamac D, 2008, ADV THER, V25, P801, DOI 10.1007/s12325-008-0082-2; Yamada M, 2002, ELECTROPHORESIS, V23, P1153, DOI 10.1002/1522-2683(200204)23:7/8&lt;1153::AID-ELPS1153&gt;3.0.CO;2-Y; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; ZHAO X, 2006, P NATL ACAD SCI USA, V107, P14146	62	30	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25819	10.1371/journal.pone.0025819	http://dx.doi.org/10.1371/journal.pone.0025819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991364	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000080
J	Yanagihara, S; Hessler, NA				Yanagihara, Shin; Hessler, Neal A.			Common Features of Neural Activity during Singing and Sleep Periods in a Basal Ganglia Nucleus Critical for Vocal Learning in a Juvenile Songbird	PLOS ONE			English	Article							ZEBRA FINCH; SOCIAL-CONTEXT; AUDITORY RESPONSES; ANTERIOR FOREBRAIN; BEHAVIORAL STATE; CIRCUIT; SYSTEM; NEURONS; MODULATION; BIRDSONG	Reactivations of waking experiences during sleep have been considered fundamental neural processes for memory consolidation. In songbirds, evidence suggests the importance of sleep-related neuronal activity in song system motor pathway nuclei for both juvenile vocal learning and maintenance of adult song. Like those in singing motor nuclei, neurons in the basal ganglia nucleus Area X, part of the basal ganglia-thalamocortical circuit essential for vocal plasticity, exhibit singing-related activity. It is unclear, however, whether Area X neurons show any distinctive spiking activity during sleep similar to that during singing. Here we demonstrate that, during sleep, Area X pallidal neurons exhibit phasic spiking activity, which shares some firing properties with activity during singing. Shorter interspike intervals that almost exclusively occurred during singing in awake periods were also observed during sleep. The level of firing variability was consistently higher during singing and sleep than during awake non-singing states. Moreover, deceleration of firing rate, which is considered to be an important firing property for transmitting signals from Area X to the thalamic nucleus DLM, was observed mainly during sleep as well as during singing. These results suggest that songbird basal ganglia circuitry may be involved in the off-line processing potentially critical for vocal learning during sensorimotor learning phase.	[Yanagihara, Shin; Hessler, Neal A.] RIKEN Brain Sci Inst, Wako, Saitama, Japan	RIKEN	Yanagihara, S (corresponding author), RIKEN Brain Sci Inst, Wako, Saitama, Japan.	syanagihara@brain.riken.jp	Yanagihara, Shin/G-4998-2015		RIKEN BSI; Sound Technology Promotion Foundation; Japan Society for the Promotion of Science [20700306, 23700396]	RIKEN BSI; Sound Technology Promotion Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by RIKEN BSI and grants to Dr. Yanagihara from The Sound Technology Promotion Foundation and Japan Society for the Promotion of Science (Grant-in-aid-for Young Scientists (B), 20700306, 23700396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Goldberg JH, 2010, J NEUROSCI, V30, P7088, DOI 10.1523/JNEUROSCI.0168-10.2010; Goldberg JH, 2010, J NEUROPHYSIOL; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Leblois A, 2009, J NEUROSCI, V29, P15420, DOI 10.1523/JNEUROSCI.3060-09.2009; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; Luo MM, 1999, J COMP NEUROL, V403, P68; Margoliash D, 2005, NAT NEUROSCI, V8, P546, DOI 10.1038/nn0505-546; Margoliash D, 2010, BRAIN LANG, V115, P45, DOI 10.1016/j.bandl.2009.09.005; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Person AL, 2007, J NEUROSCI, V27, P8687, DOI 10.1523/JNEUROSCI.2045-07.2007; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1997, J NEUROSCI, V17, P6447; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25879	10.1371/journal.pone.0025879	http://dx.doi.org/10.1371/journal.pone.0025879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991379	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000090
J	Guan, JS; Su, SC; Gao, J; Joseph, N; Xie, ZG; Zhou, Y; Durak, O; Zhang, L; Zhu, JJ; Clauser, KR; Carr, SA; Tsai, LH				Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Zhang, Lei; Zhu, J. Julius; Clauser, Karl R.; Carr, Steven A.; Tsai, Li-Huei			Cdk5 Is Required for Memory Function and Hippocampal Plasticity via the cAMP Signaling Pathway	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; LONG-TERM-MEMORY; BIDIRECTIONAL SYNAPTIC PLASTICITY; RUBINSTEIN-TAYBI-SYNDROME; RESTRICTED GENE KNOCKOUT; CA3 NMDA RECEPTORS; ADENYLYL-CYCLASE; MOUSE-BRAIN; PHOSPHORYLATION SITES; TRANSGENIC MICE	Memory formation is modulated by pre- and post-synaptic signaling events in neurons. The neuronal protein kinase Cyclin-Dependent Kinase 5 (Cdk5) phosphorylates a variety of synaptic substrates and is implicated in memory formation. It has also been shown to play a role in homeostatic regulation of synaptic plasticity in cultured neurons. Surprisingly, we found that Cdk5 loss of function in hippocampal circuits results in severe impairments in memory formation and retrieval. Moreover, Cdk5 loss of function in the hippocampus disrupts cAMP signaling due to an aberrant increase in phosphodiesterase (PDE) proteins. Dysregulation of cAMP is associated with defective CREB phosphorylation and disrupted composition of synaptic proteins in Cdk5-deficient mice. Rolipram, a PDE4 inhibitor that prevents cAMP depletion, restores synaptic plasticity and memory formation in Cdk5-deficient mice. Collectively, our results demonstrate a critical role for Cdk5 in the regulation of cAMP-mediated hippocampal functions essential for synaptic plasticity and memory formation.	[Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Xie, Zhigang; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Zhou, Ying; Durak, Omer; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Guan, Ji-Song; Su, Susan C.; Gao, Jun; Joseph, Nadine; Zhou, Ying; Durak, Omer; Clauser, Karl R.; Carr, Steven A.; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Zhang, Lei; Zhu, J. Julius] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Virginia	Guan, JS (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	lhtsai@mit.edu	Zhang, Lei/F-2603-2011; Carr, Steven A./AAH-8366-2019	Durak, Omer/0000-0001-8426-6188; Clauser, Karl/0000-0002-1052-9456; Guan, Ji-Song/0000-0001-5219-0289; Xie, Zhigang/0000-0002-5794-2977	NIH [T32 MH074249, RO1 NS051874]; Norman B. Leventhal fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH074249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman B. Leventhal fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.C.S. was supported by NIH T32 MH074249 and a Norman B. Leventhal fellowship. This work is supported by NIH RO1 NS051874 (L.-H.T.). L.-H.T. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boy J, 2006, NEUROIMAGE, V33, P449, DOI 10.1016/j.neuroimage.2006.05.055; Calabresi P, 1999, J NEUROSCI, V19, P2489; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hawasli AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005808; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Radulovic J, 1999, J NEUROSCI, V19, P5016; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L. R., 1987, MEMORY BRAIN; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1998, PATHOL BIOL, V46, P699; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	67	47	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25735	10.1371/journal.pone.0025735	http://dx.doi.org/10.1371/journal.pone.0025735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984943	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300053
J	Chen, M; Zeng, GM; Tan, ZY; Jiang, M; Li, H; Liu, LF; Zhu, Y; Yu, Z; Wei, Z; Liu, YY; Xie, GX				Chen, Ming; Zeng, Guangming; Tan, Zhongyang; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin			Understanding Lignin-Degrading Reactions of Ligninolytic Enzymes: Binding Affinity and Interactional Profile	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; MANGANESE PEROXIDASE; CRYSTAL-STRUCTURE; MOLECULAR DOCKING; LIGNOCELLULOSIC WASTE; RESOLUTION; SYSTEMS; DEGRADATION; COMPLEXES; SEQUENCE	Previous works have demonstrated that ligninolytic enzymes mediated effective degradation of ligand wastes. The degrading ability greatly relied on the interactions of ligninolytic enzymes with lignin. Ligninolytic enzymes mainly contain laccase (Lac), lignin peroxidase (LiP) and manganese peroxidase (MnP). In the present study, the binding modes of lignin to Lac, LiP and MnP were systematically determined, respectively. Robustness of these modes was further verified by molecular dynamics (MD) simulations. Residues GLU460, PRO346 and SER113 in Lac, residues ARG43, ALA180 and ASP183 in LiP and residues ARG42, HIS173 and ARG177 in MnP were most crucial in binding of lignin, respectively. Interactional analyses showed hydrophobic contacts were most abundant, playing an important role in the determination of substrate specificity. This information is an important contribution to the details of enzyme-catalyzed reactions in the process of lignin biodegradation, which can be used as references for designing enzyme mutants with a better lignin-degrading activity	[Chen, Ming; Zeng, Guangming; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Chen, Ming; Zeng, Guangming; Jiang, Min; Li, Hui; Liu, Lifeng; Zhu, Yi; Yu, Zhen; Wei, Zhen; Liu, Yuanyuan; Xie, Gengxin] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha 410082, Hunan, Peoples R China; [Tan, Zhongyang] Hunan Univ, Coll Biol, State Key Lab Chem Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China	Hunan University; Hunan University; Hunan University	Chen, M (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.	zgming@hnu.cn	WEI, ZHEN/K-4123-2015	Wei, Zhen/0000-0002-9625-6574	National Natural Science Foundation of China [50608029, 50978088, 50808073, 51039001]; Hunan Provincial Natural Science Foundation of China [10JJ7005]; Hunan Key Scientific Research Project [2009FJ1010]; Hunan Provincial Innovation Foundation For Postgraduate [CX2009B078, CX2010B157]; Program for New Century Excellent Talents in University [NCET-08-0181]; Research Fund for the Doctoral Program of Higher Education of China [20100161110012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan Key Scientific Research Project; Hunan Provincial Innovation Foundation For Postgraduate; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The study was financially supported by the National Natural Science Foundation of China (No. 50608029, No. 50978088, No. 50808073, No. 51039001), the Hunan Provincial Natural Science Foundation of China (10JJ7005), the Hunan Key Scientific Research Project (2009FJ1010), the Hunan Provincial Innovation Foundation For Postgraduate (CX2009B078, CX2010B157), the Program for New Century Excellent Talents in University (NCET-08-0181) and the Research Fund for the Doctoral Program of Higher Education of China (20100161110012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha CM, 2010, J MOL MODEL, V16, P77, DOI 10.1007/s00894-009-0521-2; Araujo JQ, 2011, J MOL MODEL, V17, P1401, DOI 10.1007/s00894-010-0841-2; Aristilde L, 2010, ENVIRON SCI TECHNOL, V44, P7839, DOI 10.1021/es102136y; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bonagura CA, 2003, BIOCHEMISTRY-US, V42, P5600, DOI 10.1021/bi034058c; Cassidy CE, 2010, J MOL MODEL, V16, P311, DOI 10.1007/s00894-009-0547-5; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Christenson A, 2004, ELECTROANAL, V16, P1074, DOI 10.1002/elan.200403004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong BL, 2011, J MOL MODEL, V17, P1727, DOI 10.1007/s00894-010-0881-7; Gelpke MDS, 1999, BIOCHEMISTRY-US, V38, P11482, DOI 10.1021/bi990943c; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Huang DL, 2008, ENVIRON SCI TECHNOL, V42, P4946, DOI 10.1021/es800072c; Huang DL, 2010, BIORESOURCE TECHNOL, V101, P4062, DOI 10.1016/j.biortech.2009.12.145; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Park JC, 2011, BIORESOURCE TECHNOL, V102, P4901, DOI 10.1016/j.biortech.2010.12.021; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shleev S, 2006, ENZYME MICROB TECH, V39, P841, DOI 10.1016/j.enzmictec.2006.01.010; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sundaramoorthy M, 2005, BIOCHEMISTRY-US, V44, P6463, DOI 10.1021/bi047318e; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Sundaramoorthy M, 2010, J INORG BIOCHEM, V104, P683, DOI 10.1016/j.jinorgbio.2010.02.011; Tang L, 2005, ENZYME MICROB TECH, V36, P960, DOI 10.1016/j.enzmictec.2005.02.009; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wu B, 2010, CHEMOSPHERE, V80, P535, DOI 10.1016/j.chemosphere.2010.04.043; Zeng GM, 2010, BIORESOURCE TECHNOL, V101, P222, DOI 10.1016/j.biortech.2009.08.013	35	21	22	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25647	10.1371/journal.pone.0025647	http://dx.doi.org/10.1371/journal.pone.0025647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980516	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600044
J	Noll, JE; Jeffery, J; Al-Ejeh, F; Kumar, R; Khanna, KK; Callen, DF; Neilsen, PM				Noll, J. E.; Jeffery, J.; Al-Ejeh, F.; Kumar, R.; Khanna, K. K.; Callen, D. F.; Neilsen, P. M.			Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11	ONCOGENE			English	Article						ANKRD11; centrosome aberrations; gain of function; invasion; mutant p53	GAIN-OF-FUNCTION; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; CORE DOMAIN; GENETIC INSTABILITY; KAPPA-B; CELLS; COMPLEX; MUTATIONS; PROTEIN	Mutations of p53 in cancer can result in a gain of function associated with tumour progression and metastasis. We show that inducible expression of several p53 'hotspot' mutants promote a range of centrosome abnormalities, including centrosome amplification, increased centrosome size and loss of cohesion, which lead to mitotic defects and multinucleation. These mutant p53-expressing cells also show a change in morphology and enhanced invasive capabilities. Consequently, we sought for a means to specifically target the function of mutant p53 in cancer cells. This study has identified ANKRD11 as a key regulator of the oncogenic potential of mutant p53. Loss of ANKRD11 expression with p53 mutation defines breast cancer patients with poor prognosis. ANKRD11 alleviates the mitotic defects driven by mutant p53 and suppresses mutant p53-mediated mesenchymal-like transformation and invasion. Mechanistically, we show that ANKRD11 restores a native conformation to the mutant p53 protein and causes dissociation of the mutant p53-p63 complex. This represents the first evidence of an endogenous protein with the capacity to suppress the oncogenic properties of mutant p53. Oncogene (2012) 31, 2836-2848; doi:10.1038/onc.2011.456; published online 10 October 2011	[Noll, J. E.; Kumar, R.; Callen, D. F.; Neilsen, P. M.] Univ Adelaide, Canc Therapeut Lab, Discipline Med, Adelaide, SA 5000, Australia; [Jeffery, J.; Al-Ejeh, F.; Khanna, K. K.] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4006, Australia; [Neilsen, P. M.] Univ Adelaide, Discipline Med, Sarcoma Res Grp, Adelaide, SA, Australia; [Neilsen, P. M.] Hanson Inst, Adelaide, SA, Australia	University of Adelaide; QIMR Berghofer Medical Research Institute; University of Adelaide; Hanson Institute	Noll, JE (corresponding author), Univ Adelaide, Canc Therapeut Lab, Discipline Med, Frome Rd, Adelaide, SA 5000, Australia.	jacqueline.noll@adelaide.edu.au	Kumar, Raman/AHE-0538-2022; Al-Ejeh, Fares/M-7032-2016; Callen, David F/G-1975-2012; Khanna, Kum Kum/I-1747-2013	Kumar, Raman/0000-0001-7976-8386; Al-Ejeh, Fares/0000-0002-1553-0077; Noll, Jacqueline/0000-0001-7375-635X; Neilsen, Paul/0000-0001-7937-3675; Callen, David/0000-0002-6189-9991; Khanna, Kum Kum/0000-0001-8650-5381	Cancer Council of South Australia and San Remo; NHMRC Program grant; Cancer Council NSW; Cure Cancer Foundation Australia; Cancer Council SA	Cancer Council of South Australia and San Remo(Cancer Council South Australia); NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cure Cancer Foundation Australia; Cancer Council SA(Cancer Council South Australia)	We thank Vivek Mittal for the ecdysone-inducible constructs; Karen Vousden and Patricia Muller for the p63 and p73 constructs; Maria Lung, Sumitra Deb and Chikashi Ishioka for the mutant p53 constructs; Jeffrey Salisbury for the anti-centrin antibody; Anne-Marie Cleton-Jansen for providing patient material; and Darryl Russell and Kira Height for technical assistance. We acknowledge the Cancer Council of South Australia and San Remo for financial support. KKK is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow, and this work is supported by an NHMRC Program grant to KKK. FA is supported by the Cancer Council NSW, the Cure Cancer Foundation Australia and the Cancer Council SA.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Di Agostino S, 2008, CELL CYCLE, V7, P3440, DOI 10.4161/cc.7.21.6995; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dong PX, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-103; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Hansen LL, 1998, CANCER RES, V58, P2166; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MILNER J, 1987, ONCOGENE, V1, P453; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy KL, 2000, FASEB J, V14, P2291, DOI 10.1096/fj.00-0128com; Neilsen PM, 2008, J CELL SCI, V121, P3541, DOI 10.1242/jcs.026351; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059	48	47	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	23					2836	2848		10.1038/onc.2011.456	http://dx.doi.org/10.1038/onc.2011.456			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	958YW	21986947	Green Published			2022-12-25	WOS:000305277900004
J	Wang, Y; Sheng, Q; Spillman, MA; Behbakht, K; Gu, H				Wang, Y.; Sheng, Q.; Spillman, M. A.; Behbakht, K.; Gu, H.			Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells	ONCOGENE			English	Article						Gab2; PI3K; Zeb1; E-cadherin; EMT; ovarian cancer	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; SIGNAL-TRANSDUCTION; DOCKING PROTEIN; HIGH-FREQUENCY; PIK3CA GENE; METASTASIS; PROLIFERATION; TUMORIGENESIS; AMPLIFICATION	Ovarian cancer, the most deadly gynecologic malignancy, is often diagnosed late and at the advanced stage when the cancer cells have already migrated and invaded into other tissues and organs. Better understanding of the mechanism of metastasis in ovarian cancer cells is essential to the design of effective therapy. In this study, we investigated the function of scaffolding adaptor protein Gab2 in ovarian cancer cells. Gab2 is found to be overexpressed in a subset of ovarian tumors and cancer cell lines. Gab2 expression mainly regulates the migratory behaviors of ovarian cancer cells. Overexpression of Gab2 promotes the migration and invasion, and downregulates E-cadherin expression in ovarian cancer cells with low-Gab2 expression. Conversely, knockdown of Gab2 expression inhibits the migration and invasion, and promotes E-cadherin expression in ovarian cancer cells with high-Gab2 expression. By expressing Gab2 wild-type and Gab2 mutants that are defective in activation of the PI3K and Shp2-Erk pathways, we find that Gab2 inhibits E-cadherin expression and enhances the expression of Zeb1, a transcription factor involved in epithelial-to-mesenchymal transition (EMT), and cell migration and invasion through the activation of the PI3K pathway. Knockdown of Zeb1 expression blocks Gab2-induced suppression of E-cadherin expression and increase in cell invasion. LY294002 and GDC-0941, inhibitors of PI3K, or Rapamycin, an inhibitor of PI3K downstream target mTOR, can reverse the effects of Gab2 on migration and invasion. Overall, our studies reveal that Gab2 overexpression, via activation of the PI3K-Zeb1 pathway, promotes characteristics of EMT in ovarian cancer cells. Oncogene (2012) 31, 2512-2520; doi:10.1038/onc.2011.435; published online 26 September 2011	[Wang, Y.; Gu, H.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Sheng, Q.] Univ Colorado Denver, Div Bas Reprod Sci & Gynecol Oncol, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Spillman, M. A.; Behbakht, K.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Spillman, M. A.; Behbakht, K.] Harvard Univ, Sch Med, Boston, MA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Gu, H (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus,Mail Stop 8104,POB 6511, Aurora, CO 80045 USA.	haihua.gu@ucdenver.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Behbakht, Kian/0000-0003-4793-9958	Department of Pathology, University of Colorado, Anschutz Medical Campus; National Institutes of Health [R01-AI51612]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051612] Funding Source: NIH RePORTER	Department of Pathology, University of Colorado, Anschutz Medical Campus; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr Sam Mok for the HOSE lines. This work is supported by the Department of Pathology, University of Colorado, Anschutz Medical Campus and in part by the National Institutes of Health grant R01-AI51612 (to HG).	Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Agarwal R, 2010, CURR OPIN INVEST DR, V11, P615; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Cheng JC, 2011, ONCOGENE, V30, P1020, DOI 10.1038/onc.2010.486; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Kolasa IK, 2009, CANCER BIOL THER, V8, P21, DOI 10.4161/cbt.8.1.7209; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ries LAG, 2007, SEER SURVIVAL MONOGR, P133; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tan DSP, 2008, ADV EXP MED BIOL, V622, P153, DOI 10.1007/978-0-387-68969-2_13; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	40	63	73	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2512	2520		10.1038/onc.2011.435	http://dx.doi.org/10.1038/onc.2011.435			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21996746	Green Accepted			2022-12-25	WOS:000304191800002
J	Iliev, DB; Sobhkhez, M; Fremmerlid, K; Jorgensen, JB				Iliev, Dimitar B.; Sobhkhez, Mehrdad; Fremmerlid, Kjersti; Jorgensen, Jorunn B.			MyD88 Interacts with Interferon Regulatory Factor (IRF) 3 and IRF7 in Atlantic Salmon (Salmo salar) TRANSGENIC SsMyD88 MODULATES THE IRF-INDUCED TYPE I INTERFERON RESPONSE AND ACCUMULATES IN AGGRESOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; GENE INDUCTION-PROGRAM; I INTERFERON; RAINBOW-TROUT; CPG OLIGODEOXYNUCLEOTIDES; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; SIGNALING PATHWAY; DENDRITIC CELLS	MyD88 is an intracellular adaptor protein that transmits signals downstream of immune receptors such as the IL-1 receptor and the majority of the known mammalian toll-like receptors. Homologs of MyD88 have been identified in many vertebrate species; however, the adaptor has been studied mostly in mammals, and little is known about its function in lower vertebrates. The results presented in the current paper demonstrate, for the first time, that the teleost MyD88, through its Toll/Interleukin-1 receptor domain, interacts with SsIRF3 and two SsIRF7 paralogs: transcription factors that are critically involved in the virus-induced IFN responses. The data further highlight the potential of transgenic SsMyD88 to modulate the IRF-induced type I IFN response as the adaptor synergized with SsIRF3 to activate IRF-E/ IFN-stimulated response element-containing reporter gene constructs and endogenous myxovirus resistance homolog expression. Microscopy analyses demonstrated that, similar to mammalian MyD88, both endogenous and transgenic SsMyD88 accumulated in intracellular aggregates. However, unlike the endogenous SsMyD88 clusters, which co-localized with endocytosed CpGs and probably represented myddosomes, overexpressed SsMyD88 accumulated in aggresomes. Although these structures accumulated ubiquitinated proteins, they did not associate with the autophagosome markers p62 and light chain 3-like protein, indicating that they are most likely classical aggresomes rather than aggresome-like induced structures, aggregates of ubiquitinated proteins induced by toll-like receptor/ MyD88 signaling in antigen-presenting cells. The significance of the accumulation of transgenic MyD88 in aggresomes is currently unknown; nevertheless it is tempting to speculate that it might represent a defense mechanism against the potentially harmful effects of excessive MyD88 signaling.	[Iliev, Dimitar B.; Sobhkhez, Mehrdad; Fremmerlid, Kjersti; Jorgensen, Jorunn B.] Univ Tromso, Fac Biosci Fisheries & Econ, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Jorgensen, JB (corresponding author), Univ Tromso, Fac Biosci Fisheries & Econ, N-9037 Tromso, Norway.			jorgensen, jorunn/0000-0002-8163-6777	Research Council of Norway [183196/S40 InNoVacc, 183217/S40 Platform]	Research Council of Norway(Research Council of Norway)	This work was supported by Aquaculture Program of the Research Council of Norway Grants 183196/S40 InNoVacc and 183217/S40 Platform for Viral Aquamedicine.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bergan V, 2006, FEBS J, V273, P3893, DOI 10.1111/j.1742-4658.2006.05382.x; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fan S, 2008, J IMMUNOL, V180, P5373, DOI 10.4049/jimmunol.180.8.5373; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Holland JW, 2008, MOL IMMUNOL, V46, P269, DOI 10.1016/j.molimm.2008.08.265; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Iliev DB, 2010, DEV COMP IMMUNOL, V34, P29, DOI 10.1016/j.dci.2009.07.009; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Johansen A, 2004, FISH SHELLFISH IMMUN, V16, P173, DOI 10.1016/S1050-4648(03)00060-3; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jorgensen JB, 2001, DEV COMP IMMUNOL, V25, P313, DOI 10.1016/S0145-305X(00)00068-9; Jorgensen JB, 2001, FISH SHELLFISH IMMUN, V11, P673, DOI 10.1006/fsim.2001.0344; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Rebl A, 2011, DEV COMP IMMUNOL, V35, P81, DOI 10.1016/j.dci.2010.08.012; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Skjaeveland I, 2009, DEV COMP IMMUNOL, V33, P1011, DOI 10.1016/j.dci.2009.04.007; Skjesol A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-17; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Strandskog G, 2007, DEV COMP IMMUNOL, V31, P39, DOI 10.1016/j.dci.2006.05.004; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	67	43	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42715	42724		10.1074/jbc.M111.293969	http://dx.doi.org/10.1074/jbc.M111.293969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990356	Green Published, hybrid			2022-12-25	WOS:000298180900078
J	Reiss, K; Kirchner, E; Gijzen, M; Zocher, G; Loffelhardt, B; Nurnberger, T; Stehle, T; Brunner, F				Reiss, Kerstin; Kirchner, Eva; Gijzen, Mark; Zocher, Georg; Loeffelhardt, Birgit; Nuernberger, Thorsten; Stehle, Thilo; Brunner, Frederic			Structural and Phylogenetic Analyses of the GP42 Transglutaminase from Phytophthora sojae Reveal an Evolutionary Relationship between Oomycetes and Marine Vibrio Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING ENZYMES; OLIGOPEPTIDE ELICITOR; CRYSTAL-STRUCTURE; PLANT DEFENSE; BINDING; ACTIVATION; PROTEINS; PATHOGEN; HARVEYI; PEP-13	Transglutaminases (TGases) are ubiquitous enzymes that catalyze selective cross-linking between protein-bound glutamine and lysine residues; the resulting isopeptide bond confers high resistance to proteolysis. Phytophthora sojae, a pathogen of soybean, secretes a Ca2+-dependent TGase (GP42) that is activating defense responses in both host and non-host plants. A GP42 fragment of 13 amino acids, termed Pep-13, was shown to be absolutely indispensable for both TGase and elicitor activity. GP42 does not share significant primary sequence similarity with known TGases from mammals or bacteria. This suggests that GP42 has evolved novel structural and catalytic features to support enzymatic activity. We have solved the crystal structure of the catalytically inactive point mutant GP42 (C290S) at 2.95 angstrom resolution and identified residues involved in catalysis by mutational analysis. The protein comprises three domains that assemble into an elongated structure. Although GP42 has no structural homolog, its core region displays significant similarity to the catalytic core of the Mac-1 cysteine protease from Group A Streptococcus, a member of the papain-like superfamily of cysteine proteases. Proteins that are taxonomically related to GP42 are only present in plant pathogenic oomycetes belonging to the order of the Peronosporales (e. g. Phytophthora, Hyaloperonospora, and Pythium spp.) and in marine Vibrio bacteria. This suggests that a lateral gene transfer event may have occurred between bacteria and oomycetes. Our results offer a basis to design and use highly specific inhibitors of the GP42-like TGase family that may impair the growth of important oomycete and bacterial pathogens.	[Loeffelhardt, Birgit; Brunner, Frederic] Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; [Reiss, Kerstin; Kirchner, Eva; Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; Agri Food Canada, London, ON N5V 4T3, Canada; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Vanderbilt University	Brunner, F (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 5, D-72076 Tubingen, Germany.	frederic.brunner@zmbp.uni-tuebingen.de	Gijzen, Mark/C-6284-2011	Gijzen, Mark/0000-0002-3715-6389	German Research Foundation (DFG) [Br 3875/2-1, SFB766]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG) Grants Br 3875/2-1 (to F. B.) and SFB766 (to T. S.)	Agniswamy J, 2006, STRUCTURE, V14, P225, DOI 10.1016/j.str.2005.10.012; Ahvazi B, 2004, J STRUCT BIOL, V147, P200, DOI 10.1016/j.jsb.2004.03.009; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Cheng S, 2010, VACCINE, V28, P2716, DOI 10.1016/j.vaccine.2010.01.023; Chica RA, 2004, PROTEIN SCI, V13, P979, DOI 10.1110/ps.03433304; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAHLBROCK K, 1995, P NATL ACAD SCI USA, V92, P4150, DOI 10.1073/pnas.92.10.4150; Halim VA, 2004, PHYSIOL MOL PLANT P, V64, P311, DOI 10.1016/j.pmpp.2004.10.003; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu PC, 1997, CURR MICROBIOL, V35, P32, DOI 10.1007/s002849900207; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; NURNBERGER T, 1994, CELL, V78, P449, DOI 10.1016/0092-8674(94)90423-5; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5	35	14	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42585	42593		10.1074/jbc.M111.290544	http://dx.doi.org/10.1074/jbc.M111.290544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994936	hybrid, Green Published			2022-12-25	WOS:000298180900066
J	Scott, DA; Richardson, AD; Filipp, FV; Knutzen, CA; Chiang, GG; Ronai, ZA; Osterman, AL; Smith, JW				Scott, David A.; Richardson, Adam D.; Filipp, Fabian V.; Knutzen, Christine A.; Chiang, Gary G.; Ronai, Ze'ev A.; Osterman, Andrei L.; Smith, Jeffrey W.			Comparative Metabolic Flux Profiling of Melanoma Cell Lines BEYOND THE WARBURG EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-METABOLISM; CANCER; HYPOXIA; ADAPTATION; SENESCENCE; EXPRESSION; KINASE; TARGET; GROWTH	Metabolic rewiring is an established hallmark of cancer, but the details of this rewiring at a systems level are not well characterized. Here we acquire this insight in a melanoma cell line panel by tracking metabolic flux using isotopically labeled nutrients. Metabolic profiling and flux balance analysis were used to compare normal melanocytes to melanoma cell lines in both normoxic and hypoxic conditions. All melanoma cells exhibited the Warburg phenomenon; they used more glucose and produced more lactate than melanocytes. Other changes were observed in melanoma cells that are not described by the Warburg phenomenon. Hypoxic conditions increased fermentation of glucose to lactate in both melanocytes and melanoma cells (the Pasteur effect). However, metabolism was not strictly glycolytic, as the tricarboxylic acid (TCA) cycle was functional in all melanoma lines, even under hypoxia. Furthermore, glutamine was also a key nutrient providing a substantial anaplerotic contribution to the TCA cycle. In the WM35 melanoma line glutamine was metabolized in the "reverse" (reductive) direction in the TCA cycle, particularly under hypoxia. This reverse flux allowed the melanoma cells to synthesize fatty acids from glutamine while glucose was primarily converted to lactate. Altogether, this study, which is the first comprehensive comparative analysis of metabolism in melanoma cells, provides a foundation for targeting metabolism for therapeutic benefit in melanoma.	[Scott, David A.; Richardson, Adam D.; Filipp, Fabian V.; Knutzen, Christine A.; Chiang, Gary G.; Ronai, Ze'ev A.; Osterman, Andrei L.; Smith, Jeffrey W.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org	Filipp, Fabian Volker/X-5425-2018; Richardson, Adam D/N-7845-2014	Filipp, Fabian Volker/0000-0001-9889-5727; Richardson, Adam D/0000-0003-3646-2584; Scott, David/0000-0002-8668-2449; Chiang, Gary/0000-0003-3004-7400; RONAI, ZEEV/0000-0002-3859-0400	National Institutes of Health [CA-128814, CA-147978, CA-154887]; NATIONAL CANCER INSTITUTE [P01CA128814, R21CA147978, R00CA154887, K99CA154887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-128814 (to Z. A. R.), CA-147978 (to A. D. R.), and CA-154887 (to F. V. F.).	Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chen Y, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P181; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Meadows AL, 2008, BIOTECHNOL PROGR, V24, P334, DOI 10.1021/bp070301d; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	45	235	239	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42626	42634		10.1074/jbc.M111.282046	http://dx.doi.org/10.1074/jbc.M111.282046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998308	Green Published, hybrid			2022-12-25	WOS:000298180900070
J	Murray, DC; Bunce, M; Cannell, BL; Oliver, R; Houston, J; White, NE; Barrero, RA; Bellgard, MI; Haile, J				Murray, Daithi C.; Bunce, Michael; Cannell, Belinda L.; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Barrero, Roberto A.; Bellgard, Matthew I.; Haile, James			DNA-Based Faecal Dietary Analysis: A Comparison of qPCR and High Throughput Sequencing Approaches	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; PREY DNA; MOLECULAR ANALYSIS; FECES; PREDATOR; PCR; VICTORIA; PRIMERS; ECOLOGY; ISLAND	The genetic analysis of faecal material represents a relatively non-invasive way to study animal diet and has been widely adopted in ecological research. Due to the heterogeneous nature of faecal material the primary obstacle, common to all genetic approaches, is a means to dissect the constituent DNA sequences. Traditionally, bacterial cloning of PCR amplified products was employed; less common has been the use of species-specific quantitative PCR (qPCR) assays. Currently, with the advent of High-Throughput Sequencing (HTS) technologies and indexed primers it has become possible to conduct genetic audits of faecal material to a much greater depth than previously possible. To date, no studies have systematically compared the estimates obtained by HTS with that of qPCR. What are the relative strengths and weaknesses of each technique and how quantitative are deep-sequencing approaches that employ universal primers? Using the locally threatened Little Penguin (Eudyptula minor) as a model organism, it is shown here that both qPCR and HTS techniques are highly correlated and produce strikingly similar quantitative estimates of fish DNA in faecal material, with no statistical difference. By designing four species-specific fish qPCR assays and comparing the data to the same four fish in the HTS data it was possible to directly compare the strengths and weaknesses of both techniques. To obtain reproducible quantitative data one of the key, and often overlooked, steps common to both approaches is ensuring that efficient DNA isolation methods are employed and that extracts are free of inhibitors. Taken together, the methodology chosen for long-term faecal monitoring programs is largely dependent on the complexity of the prey species present and the level of accuracy that is desired. Importantly, these methods should not be thought of as mutually exclusive, as the use of both HTS and qPCR in tandem will generate datasets with the highest fidelity.	[Murray, Daithi C.; Bunce, Michael; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Haile, James] Murdoch Univ, Australian Wildlife Forens Serv, Murdoch, WA 6150, Australia; [Murray, Daithi C.; Bunce, Michael; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Haile, James] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Murdoch, WA 6150, Australia; [Barrero, Roberto A.; Bellgard, Matthew I.] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia	Murdoch University; Murdoch University; Murdoch University	Murray, DC (corresponding author), Murdoch Univ, Australian Wildlife Forens Serv, Murdoch, WA 6150, Australia.	m.bunce@murdoch.edu.au		White, Nicole/0000-0002-0068-6693; Cannell, Belinda/0000-0001-9214-8958; Bellgard, Matthew/0000-0002-6303-9469; Bunce, Michael/0000-0002-0302-4206; Barrero, Roberto/0000-0002-7735-665X	Foundation for National Parks and Wildlife; Department of Environment and Conservation; Centre for Fish and Fisheries Research at Murdoch University; Robert Hammond Research Studentship; Australian Research Council [FT0991741]	Foundation for National Parks and Wildlife; Department of Environment and Conservation; Centre for Fish and Fisheries Research at Murdoch University; Robert Hammond Research Studentship; Australian Research Council(Australian Research Council)	Funding was obtained from the Foundation for National Parks and Wildlife, the Department of Environment and Conservation, and the Centre for Fish and Fisheries Research at Murdoch University. NEW received support from the Robert Hammond Research Studentship and MB from the Australian Research Council grant FT0991741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2009, ECOL MONOGR, V79, P59, DOI 10.1890/06-0419.1; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Bradley J. S., 1997, RADIO TRACKING STUDY; CANNELL BL, 2001, MMSLNESIS402001 DEP; CASPER RM, 1997, J EXP MAR BIOL ECOL, V347, P144; CHAPE S, 1984, PENGUIN ISLAND DRAFT; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Dann P., 2009, CLIMATE CHANGE LITTL; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, FRONT ZOOL, V3, P10; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; *DEP WAF, 2008, STAT FISH REP; Drummond A., 2011, GENEIOUS V5 5; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; HARRIGAN KE, 1992, EMU, V91, P273, DOI 10.1071/MU9910273; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kim BJ, 2011, CONSERV GENET, V12, P851, DOI 10.1007/s10592-011-0192-2; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KLOMP NI, 1988, AUST J MAR FRESH RES, V39, P633; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Mallory ML, 2010, MAR POLLUT BULL, V60, P7, DOI 10.1016/j.marpolbul.2009.08.024; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Matejusova I, 2008, J APPL ECOL, V45, P632, DOI 10.1111/j.1365-2664.2007.01429.x; MILLER KM, 1995, J FIELD ORNITHOL, V66, P152; MONTAGUE TL, 1985, AUST WILDLIFE RES, V12, P327; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; *ROCH, 2009, TECHN B TCB; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Vila AR, 2011, FOREST ECOL MANAG, V261, P1306, DOI 10.1016/j.foreco.2011.01.009; WHITEHEAD PJP., 1985, Clupeoid fishes of the world (suborder Clupeoidei), P125; Wienecke BC, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P440; WIENECKE BC, 1989, THESIS MURDOCH U; WIENECKE BC, 1993, THESIS MURODCH U; Williams CT, 2010, J ORNITHOL, V151, P531, DOI 10.1007/s10336-010-0513-0; WOOLLER R D, 1991, Journal of the Royal Society of Western Australia, V74, P129	59	93	100	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25776	10.1371/journal.pone.0025776	http://dx.doi.org/10.1371/journal.pone.0025776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998697	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700019
J	Park, B; Iwase, T; Liu, GY				Park, Bonggoo; Iwase, Tadayuki; Liu, George Y.			Intranasal Application of S. epidermidis Prevents Colonization by Methicillin-Resistant Staphylococcus aureus in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BACTERIAL INTERFERENCE; NASAL COLONIZATION; MUPIROCIN; IMPLANTATION; COMPETITION; INFECTIONS; CARRIAGE; CAVITIES; CHILDREN	Methicillin-resistant S. aureus emerged in recent decades to become a leading cause of infection worldwide. Colonization with MRSA predisposes to infection and facilitates transmission of the pathogen; however, available regimens are ineffective at preventing MRSA colonization. Studies of human nasal flora suggest that resident bacteria play a critical role in limiting S. aureus growth, and prompted us to query whether application of commensal resident bacteria could prevent nasal colonization with MRSA. We established a murine model system to study this question, and showed that mice nasally pre-colonized with S. epidermidis became more resistant to colonization with MRSA. Our study suggests that application of commensal bacteria with antibiotics could represent a more effective strategy to prevent MRSA colonization.	[Park, Bonggoo; Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Res Div Immunol,Dept Biomed Sci, Los Angeles, CA 90048 USA; [Park, Bonggoo; Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Iwase, Tadayuki] Jikei Univ, Sch Med, Dept Bacteriol, Tokyo, Japan	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Jikei University	Park, B (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Res Div Immunol,Dept Biomed Sci, Los Angeles, CA 90048 USA.	george.liu@cshs.org		Iwase, Tadayuki/0000-0003-4915-3983	Burroughs Wellcome; National Institute of Health [AI074832]; Uehara Memorial Foundation; The Promotion and Mutual Aid Corporation for Private Schools of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590521, 22770241] Funding Source: KAKEN	Burroughs Wellcome(Burroughs Wellcome Fund); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); The Promotion and Mutual Aid Corporation for Private Schools of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Burroughs Wellcome Career Award in Biomedical Sciences (GYL), a National Institute of Health Grant AI074832 (GYL), and Grants from the Uehara Memorial Foundation (TI) and from the Science Research Promotion Fund of The Promotion and Mutual Aid Corporation for Private Schools of Japan (TI). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; DRUTZ DJ, 1966, NEW ENGL J MED, V275, P1161, DOI 10.1056/NEJM196611242752104; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; SHINEFIE.HR, 1974, ANN NY ACAD SCI, V236, P444, DOI 10.1111/j.1749-6632.1974.tb41509.x; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Uehara Y, 2001, CLIN INFECT DIS, V32, P1399, DOI 10.1086/320147; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; WARD A, 1986, DRUGS, V32, P425, DOI 10.2165/00003495-198632050-00002; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	18	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25880	10.1371/journal.pone.0025880	http://dx.doi.org/10.1371/journal.pone.0025880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998712	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900066
J	Rydstrom, A; Deshayes, S; Konate, K; Crombez, L; Padari, K; Boukhaddaoui, H; Aldrian, G; Pooga, M; Divita, G				Rydstroem, Anna; Deshayes, Sebastien; Konate, Karidia; Crombez, Laurence; Padari, Kaert; Boukhaddaoui, Hassan; Aldrian, Gudrun; Pooga, Margus; Divita, Gilles			Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles	PLOS ONE			English	Article							PENETRATING PEPTIDES; MOLECULAR-MECHANISMS; SIRNA DELIVERY; INTERNALIZATION; PATHWAYS; INSIGHT; STRATEGIES; PROTEINS; CARRIER; REPAIR	Cell penetrating peptides constitute a potent approach to overcome the limitations of in vivo siRNA delivery. We recently proposed a peptide-based nanoparticle system, CADY, for efficient delivery of siRNA into numerous cell lines. CADY is a secondary amphipathic peptide that forms stable complexes with siRNA thereby improving both their cellular uptake and biological response. With the aim of understanding the cellular uptake mechanism of CADY: siRNA complexes, we have combined biochemical, confocal and electron microscopy approaches. In the present work, we provide evidence that the major route for CADY: siRNA cellular uptake involves direct translocation through the membrane but not the endosomal pathway. We have demonstrated that CADY: siRNA complexes do not colocalize with most endosomal markers and remain fully active in the presence of inhibitors of the endosomal pathway. Moreover, neither electrostatic interactions with cell surface heparan sulphates nor membrane potential are essential for CADY: siRNA cell entry. In contrast, we have shown that CADY: siRNA complexes clearly induce a transient cell membrane permeabilization, which is rapidly restored by cell membrane fluidity. Therefore, we propose that direct translocation is the major gate for cell entry of CADY: siRNA complexes. Membrane perturbation and uptake are driven mainly by the ability of CADY to interact with phospholipids within the cell membrane, followed by rapid localization of the complex in the cytoplasm, without affecting cell integrity or viability.	[Rydstroem, Anna; Deshayes, Sebastien; Konate, Karidia; Crombez, Laurence; Aldrian, Gudrun; Divita, Gilles] Univ Montpellier, Ctr Rech Biochim Macromol, Dept Mol Biophys & Therapeut, UMR 5237,UM1 UM2,CRBM,CNRS, F-34059 Montpellier, France; [Padari, Kaert; Pooga, Margus] Univ Tartu, Dept Dev Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Boukhaddaoui, Hassan] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Rydstrom, A (corresponding author), Univ Montpellier, Ctr Rech Biochim Macromol, Dept Mol Biophys & Therapeut, UMR 5237,UM1 UM2,CRBM,CNRS, F-34059 Montpellier, France.	gilles.divita@crbm.cnrs.fr	DIVITA, GILLES/AAV-9214-2021; Deshayes, Sebastien/J-9228-2018; Pooga, Margus/A-8575-2011	Deshayes, Sebastien/0000-0002-4684-9152; Pooga, Margus/0000-0003-4532-4087; BOUKHADDAOUI, HASSAN/0000-0003-1808-7901; Aldrian, Gudrun/0000-0002-7899-0572; Rydstrom, Anna/0000-0002-3404-7195	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR- ANR-06-BLAN-0071]; Estonian Science Foundation [ESF8705]; Estonian Ministry of Education and Research [180019s11]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Centre National de la Recherche Scientifique and grants from the Agence Nationale de la Recherche (ANR- ANR-06-BLAN-0071), the Estonian Science Foundation (ESF8705) and the Estonian Ministry of Education and Research (180019s11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009; Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Brasseur R, 2010, BBA-BIOMEMBRANES, V1798, P2177, DOI 10.1016/j.bbamem.2010.09.001; Broeck DV, 2007, ACTA BIOCHIM POL, V54, P757, DOI 10.18388/abp.2007_3154; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crombez L, 2009, NUCLEIC ACIDS RES, V37, P4559, DOI 10.1093/nar/gkp451; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Deshayes S, 2004, BBA-BIOMEMBRANES, V1667, P141, DOI 10.1016/j.bbamem.2004.09.010; Deshayes S, 2010, BBA-BIOMEMBRANES, V1798, P2304, DOI 10.1016/j.bbamem.2010.06.005; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Eguchi A, 2009, TRENDS PHARMACOL SCI, V30, P341, DOI 10.1016/j.tips.2009.04.009; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Gao K, 2009, MOL PHARMACEUT, V6, P651, DOI 10.1021/mp800134q; Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hassane FS, 2010, CELL MOL LIFE SCI, V67, P715, DOI 10.1007/s00018-009-0186-0; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Konate K, 2010, BIOCHEMISTRY-US, V49, P3393, DOI 10.1021/bi901791x; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Torgersen ML, 2001, J CELL SCI, V114, P3737; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Via LE, 1998, J CELL SCI, V111, P897; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watkins CL, 2009, BIOCHEM J, V420, P179, DOI 10.1042/BJ20090042; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	49	85	90	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25924	10.1371/journal.pone.0025924	http://dx.doi.org/10.1371/journal.pone.0025924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998722	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900074
J	Shimmura, C; Suda, S; Tsuchiya, KJ; Hashimoto, K; Ohno, K; Matsuzaki, H; Iwata, K; Matsumoto, K; Wakuda, T; Kameno, Y; Suzuki, K; Tsujii, M; Nakamura, K; Takei, N; Mori, N				Shimmura, Chie; Suda, Shiro; Tsuchiya, Kenji J.; Hashimoto, Kenji; Ohno, Koji; Matsuzaki, Hideo; Iwata, Keiko; Matsumoto, Kaori; Wakuda, Tomoyasu; Kameno, Yosuke; Suzuki, Katsuaki; Tsujii, Masatsugu; Nakamura, Kazuhiko; Takei, Nori; Mori, Norio			Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; AMINO-ACIDS; CENTRAL MECHANISM; SEX-DIFFERENCES; PARIETAL; INDUCTION; TRANSPORT; SERUM	Background: It has recently been hypothesized that hyperglutamatergia in the brain is involved in the pathophysiology of autism. However, there is no conclusive evidence of the validity of this hypothesis. As peripheral glutamate/glutamine levels have been reported to be correlated with those of the central nervous system, the authors examined whether the levels of 25 amino acids, including glutamate and glutamine, in the platelet-poor plasma of drug-naive, male children with high-functioning autism (HFA) would be altered compared with those of normal controls. Methodology/Principal Findings: Plasma levels of 25 amino acids in male children (N = 23) with HFA and normally developed healthy male controls (N = 22) were determined using high-performance liquid chromatography. Multiple testing was allowed for in the analyses. Compared with the normal control group, the HFA group had higher levels of plasma glutamate and lower levels of plasma glutamine. No significant group difference was found in the remaining 23 amino acids. The effect size (Cohen's d) for glutamate and glutamine was large: 1.13 and 1.36, respectively. Using discriminant analysis with logistic regression, the two values of plasma glutamate and glutamine were shown to well-differentiate the HFA group from the control group; the rate of correct classification was 91%. Conclusions/Significance: The present study suggests that plasma glutamate and glutamine levels can serve as a diagnostic tool for the early detection of autism, especially normal IQ autism. These findings indicate that glutamatergic abnormalities in the brain may be associated with the pathobiology of autism.	[Shimmura, Chie; Wakuda, Tomoyasu; Kameno, Yosuke; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Suda, Shiro; Tsuchiya, Kenji J.; Matsuzaki, Hideo; Iwata, Keiko; Matsumoto, Kaori; Suzuki, Katsuaki; Tsujii, Masatsugu; Takei, Nori; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Ohno, Koji] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan; [Tsujii, Masatsugu] Chukyo Univ, Fac Sociol, Nagoya, Aichi, Japan; [Takei, Nori] Inst Psychiat, Div Psychol Med, London, England	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chiba University; Chukyo University; University of London; King's College London	Shimmura, C (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan.	sudash@jichi.ac.jp	Takei, Nori/AAC-8578-2019; MATSUZAKI, HIDEO/AAE-5246-2020; Tsuchiya, Kenji J./I-9123-2019; Takei, Nori/GWZ-7464-2022; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tsuchiya, Kenji J./0000-0002-1314-4199; Suzuki, Katsuaki/0000-0003-0446-3355; Hashimoto, Kenji/0000-0002-8892-0439; Wakuda, Tomoyasu/0000-0002-1924-8167	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Takeda Science Foundation; Mitsubishi Pharma Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (CS, SS); by the Takeda Science Foundation (SS); and by the Mitsubishi Pharma Research Foundation (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; ALFREDSSON G, 1988, BIOL PSYCHIAT, V23, P689, DOI 10.1016/0006-3223(88)90052-2; Arnold GL, 2003, J AUTISM DEV DISORD, V33, P449, DOI 10.1023/A:1025071014191; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Blaylock RL, 2009, CURR MED CHEM, V16, P157, DOI 10.2174/092986709787002745; Blaylock RL, 2008, ALTERN THER HEALTH M, V14, P46; Brune CW, 2008, AUTISM RES, V1, P108, DOI 10.1002/aur.11; Croonenburghs J, 2002, ACTA NEUROPSYCHIATR, V14, P93, DOI 10.1034/j.1601-5215.2002.140209.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Fatemi SH, 2008, PROG NEURO-PSYCHOPH, V32, P911, DOI 10.1016/j.pnpbp.2007.11.004; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hosoya K, 1999, J NEUROCHEM, V73, P1206, DOI 10.1046/j.1471-4159.1999.0731206.x; Howlin P, 1999, DEV MED CHILD NEUROL, V41, P834, DOI 10.1017/S0012162299001656; Ilzecka J, 2003, AMINO ACIDS, V25, P69, DOI 10.1007/s00726-002-0352-2; Kantojarvi K, 2010, PSYCHIAT GENET, V20, P102, DOI 10.1097/YPG.0b013e32833a2080; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; LORD CRM, 1994, J AUTISM DEV DISORD, V24, P27; MANEV H, 1989, MOL PHARMACOL, V36, P106; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Miulli Dan E., 1993, Journal of the American Osteopathic Association, V93, P670; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; OHSAWA S, 1998, MED TECHNOLOGY, V26, P7; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Rainesalo S, 2004, NEUROCHEM RES, V29, P319, DOI 10.1023/B:NERE.0000010461.34920.0c; ROLF LH, 1993, ACTA PSYCHIAT SCAND, V87, P312, DOI 10.1111/j.1600-0447.1993.tb03378.x; SCHWARZ E, 2010, MOL PSYCHIAT; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; 2007, MMWR SURVEILL SUMM, V56, P11	41	116	123	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25340	10.1371/journal.pone.0025340	http://dx.doi.org/10.1371/journal.pone.0025340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998651	gold, Green Submitted, Green Published			2022-12-25	WOS:000295966900020
J	Zhu, L; Hu, W; Liu, DT; Tian, WH; Yu, G; Liu, XK; Wang, J; Feng, E; Zhang, XM; Chen, B; Zeng, M; Wang, HL				Zhu, Li; Hu, Wei; Liu, Datao; Tian, Wanhong; Yu, Gang; Liu, Xiankai; Wang, Jie; Feng, Erling; Zhang, Xuemin; Chen, Bei; Zeng, Ming; Wang, Hengliang			A Reference Proteomic Database of Lactobacillus plantarum CMCC-P0002	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; KEY PROTEINS; BIFIDOBACTERIUM; ADHESION; 2-DE; ACID	Lactobacillus plantarum is a widespread probiotic bacteria found in many fermented food products. In this study, the wholecell proteins and secretory proteins of L. plantarum were separated by two-dimensional electrophoresis method. A total of 434 proteins were identified by tandem mass spectrometry, including a plasmid-encoded hypothetical protein pLP9000_05. The information of first 20 highest abundance proteins was listed for the further genetic manipulation of L. plantarum, such as construction of high-level expressions system. Furthermore, the first interaction map of L. plantarum was established by Blue-Native/SDS-PAGE technique. A heterodimeric complex composed of maltose phosphorylase Map3 and Map2, and two homodimeric complexes composed of Map3 and Map2 respectively, were identified at the same time, indicating the important roles of these proteins. These findings provided valuable information for the further proteomic researches of L. plantarum.	[Zhu, Li; Hu, Wei; Liu, Xiankai; Feng, Erling; Wang, Hengliang] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Hu, Wei; Tian, Wanhong; Yu, Gang; Zeng, Ming] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; [Liu, Datao; Chen, Bei] Sine Pharmaceut Corp Ltd, Shanghai, Peoples R China; [Wang, Jie; Zhang, Xuemin] Natl Ctr Biomed Anal, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Zhu, L (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zengming@nicpbp.org.cn; wanghl@nic.bmi.ac.cn	Wang, Hengliang/AAL-5340-2021; wang, hengliang/AAA-8300-2020; Wang, Hengliang/AAT-4586-2021; Zhu, Li/Q-7499-2017	Wang, Hengliang/0000-0001-8476-4320; Zhu, Li/0000-0001-9975-8978	National Key Basic Research Program of China (973 Program) [2011CB504900]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2011CB504900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck HC, 2009, FEMS MICROBIOL LETT, V297, P61, DOI 10.1111/j.1574-6968.2009.01662.x; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; Curiel JA, 2011, MOL NUTR FOOD RES; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; Guillot A, 2003, PROTEOMICS, V3, P337, DOI 10.1002/pmic.200390047; Hamon E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-63; Izquierdo E, 2009, ELECTROPHORESIS, V30, P949, DOI 10.1002/elps.200800399; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lee K, 2011, J BIOTECHNOL, V153, P1, DOI 10.1016/j.jbiotec.2011.02.008; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Swamy M, 2006, SCI STKE, P14; Wang YY, 2011, J BACTERIOL, V193, P313, DOI 10.1128/JB.01159-10; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zhang ZY, 2009, J BACTERIOL, V191, P5020, DOI 10.1128/JB.00587-09	18	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25596	10.1371/journal.pone.0025596	http://dx.doi.org/10.1371/journal.pone.0025596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998671	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900035
J	Jakubowski, AR; Casler, MD; Jackson, RD				Jakubowski, Andrew R.; Casler, Michael D.; Jackson, Randall D.			Has Selection for Improved Agronomic Traits Made Reed Canarygrass Invasive?	PLOS ONE			English	Article							GRASS PHALARIS-ARUNDINACEA; ECONOMIC COSTS; PLANT; BIOENERGY; PROGRESS; BIOMASS; ESTABLISHMENT; ADAPTATION; STABILITY; BIOFUELS	Plant breeders have played an essential role in improving agricultural crops, and their efforts will be critical to meet the increasing demand for cellulosic bioenergy feedstocks. However, a major concern is the potential development of novel invasive species that result from breeders' efforts to improve agronomic traits in a crop. We use reed canarygrass as a case study to evaluate the potential of plant breeding to give rise to invasive species. Reed canarygrass has been improved by breeders for use as a forage crop, but it is unclear whether breeding efforts have given rise to more vigorous populations of the species. We evaluated cultivars, European wild, and North American invader populations in upland and wetland environments to identify differences in vigor between the groups of populations. While cultivars were among the most vigorous populations in an agricultural environment (upland soils with nitrogen addition), there were no differences in above-or below-ground production between any populations in wetland environments. These results suggest that breeding has only marginally increased vigor in upland environments and that these gains are not maintained in wetland environments. Breeding focuses on selection for improvements of a specific target population of environments, and stability across a wide range of environments has proved elusive for even the most intensively bred crops. We conclude that breeding efforts are not responsible for wetland invasion by reed canarygrass and offer guidelines that will help reduce the possibility of breeding programs releasing cultivars that will become invasive.	[Jakubowski, Andrew R.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Casler, Michael D.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA; [Casler, Michael D.; Jackson, Randall D.] Univ Wisconsin, US Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Jakubowski, AR (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	Jakubowski@wisc.edu	Jackson, Randall/AAE-5573-2022		Grazing Lands Conservation Initiative [941-3]; United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]	Grazing Lands Conservation Initiative; United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE))	This work was funded in part by Grazing Lands Conservation Initiative grant 941-3 and by the United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; ALWAY FREDERICK J., 1931, JOUR AMER SOC AGRON, V23, P64; Baeten L, 2010, OECOLOGIA, V163, P1021, DOI 10.1007/s00442-010-1599-z; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Burvall J, 1997, BIOMASS BIOENERG, V12, P149, DOI 10.1016/S0961-9534(96)00064-5; Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; BYERS RA, 1979, ENVIRON ENTOMOL, V8, P408, DOI 10.1093/ee/8.3.408; Carlson I. T., 1996, COOL SEASON FORAGE G, V34, P569, DOI [10.2134/agronmonogr34.c18, DOI 10.2134/AGRONMONOGR34.C18]; Casler MD, 2009, CROP SCI, V49, P2139, DOI 10.2135/cropsci2009.02.0055; Casler M.D., 1996, COOL SEASON FORAGE G, V34, P413, DOI DOI 10.2134/AGR0NM0N0GR34.C14; Casler M.D., 2010, INT J PLANT BREEDING, V4, P30; Casler MD, 2004, CROP SCI, V44, P1601, DOI 10.2135/cropsci2004.1601; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; Casler MD, 2009, BIOENERG RES, V2, P165, DOI 10.1007/s12155-009-9043-0; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; Coops H, 1996, AQUAT BOT, V54, P11, DOI 10.1016/0304-3770(96)01025-X; Crawley MJ., 2007, R BOOK; Cully AC, 2003, CONSERV BIOL, V17, P990, DOI 10.1046/j.1523-1739.2003.02107.x; Davis AS, 2010, FRONT ECOL ENVIRON, V8, P533, DOI 10.1890/090030; Dore W, 1980, GRASSES ONTARIO AGR; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Green EK, 2002, J APPL ECOL, V39, P134, DOI 10.1046/j.1365-2664.2002.00702.x; Green EK, 2001, CAN J BOT, V79, P170, DOI 10.1139/cjb-79-2-170; GROSS MF, 1991, ESTUARIES, V14, P180, DOI 10.2307/1351692; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; HEICHEL GH, 1980, CROP SCI, V20, P683, DOI 10.2135/cropsci1980.0011183X002000060002x; Jakubowski AR, 2010, RESTOR ECOL, V18, P789, DOI 10.1111/j.1526-100X.2010.00738.x; Jakubowski AR, 2010, WETLANDS, V30, P685, DOI 10.1007/s13157-010-0078-y; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Keeney D, 2006, FORAGES SCI GRASSLAN, P167; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Koonin SE, 2006, SCIENCE, V311, P435, DOI 10.1126/science.1124886; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Lavergne S, 2004, CRIT REV PLANT SCI, V23, P415, DOI 10.1080/07352680490505934; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Li JZ, 2011, MOL BREEDING, V28, P611, DOI 10.1007/s11032-010-9513-2; Marten G.C., 1989, CSSA SPEC PUBL, V15, P71; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Merigliano MF, 1998, NAT AREA J, V18, P223; Miller RC, 2003, PLANT ECOL, V167, P57, DOI 10.1023/A:1023918619073; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sahramaa M, 2003, AGR FOOD SCI FINLAND, V12, P227, DOI 10.23986/afsci.5751; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salehi H, 2005, J PLANT PHYSIOL, V162, P711, DOI 10.1016/j.jplph.2004.12.002; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sharp W.C., 1994, GRASS VARIETIES US, DOI 10.5962/bhl.title.97052; SIMMONDS NW, 1991, THEOR APPL GENET, V82, P363, DOI 10.1007/BF02190624; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058	63	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25757	10.1371/journal.pone.0025757	http://dx.doi.org/10.1371/journal.pone.0025757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991347	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000066
J	Kelly, S; Wickstead, B; Maini, PK; Gull, K				Kelly, Steven; Wickstead, Bill; Maini, Philip K.; Gull, Keith			Ab Initio Identification of Novel Regulatory Elements in the Genome of Trypanosoma brucei by Bayesian Inference on Sequence Segmentation	PLOS ONE			English	Article							3 UNTRANSLATED REGION; PROTEIN-CODING GENES; FACTOR-BINDING SITES; SPLICED LEADER RNA; PRE-MESSENGER-RNA; LEISHMANIA-MAJOR; DISCONTINUOUS TRANSCRIPTION; ANTIGENIC VARIATION; RIBOSOMAL-RNA; POLYMERASE-I	Background: The rapid increase in the availability of genome information has created considerable demand for both comparative and ab initio predictive bioinformatic analyses. The biology laid bare in the genomes of many organisms is often novel, presenting new challenges for bioinformatic interrogation. A paradigm for this is the collected genomes of the kinetoplastid parasites, a group which includes Trypanosoma brucei the causative agent of human African trypanosomiasis. These genomes, though outwardly simple in organisation and gene content, have historically challenged many theories for gene expression regulation in eukaryotes. Methodology/Principle Findings: Here we utilise a Bayesian approach to identify local changes in nucleotide composition in the genome of T. brucei. We show that there are several elements which are found at the starts and ends of multicopy gene arrays and that there are compositional elements that are common to all intergenic regions. We also show that there is a composition-inversion element that occurs at the position of the trans-splice site. Conclusions/Significance: The nature of the elements discovered reinforces the hypothesis that context dependant RNA secondary structure has an important influence on gene expression regulation in Trypanosoma brucei.	[Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; [Kelly, Steven; Maini, Philip K.; Gull, Keith] Univ Oxford, Dept Biochem, Oxford Ctr Interact Syst Biol, Oxford OX1 3QU, England; [Wickstead, Bill; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Wickstead, Bill] Univ Nottingham, Ctr Genet & Genom, Queens Med Ctr, Nottingham NG7 2RD, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Nottingham	Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	steven.kelly@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362; Wickstead, Bill/0000-0002-4620-9091	Biotechnology and Biological Sciences Research Council; Wellcome Trust; Royal Society	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), the Wellcome Trust (http://www.wellcome.ac.uk/) and the Royal Society (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOTHROYD JC, 1985, ANNU REV MICROBIOL, V39, P475, DOI 10.1146/annurev.mi.39.100185.002355; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; Boys RJ, 2004, BIOMETRICS, V60, P585; Boys RJ, 2004, BIOMETRICS, V60, P573, DOI 10.1111/j.0006-341X.2004.00206.x; BROWN SD, 1992, MOL CELL BIOL, V12, P2644, DOI 10.1128/MCB.12.6.2644; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cora D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-57; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Gopal S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r95; Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hoare CA, 1929, T ROY SOC TROP MED H, V23, P18; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; HUG M, 1994, MOL CELL BIOL, V14, P7428, DOI 10.1128/MCB.14.11.7428; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JANZ L, 1994, MOL CELL BIOL, V14, P5804, DOI 10.1128/MCB.14.9.5804; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee MGS, 1997, ANNU REV MICROBIOL, V51, P463, DOI 10.1146/annurev.micro.51.1.463; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; McDonagh PD, 2000, NUCLEIC ACIDS RES, V28, P2800, DOI 10.1093/nar/28.14.2800; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Pham VP, 1996, MOL BIOCHEM PARASIT, V75, P241, DOI 10.1016/0166-6851(95)02513-8; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schurch N, 1997, MOL BIOCHEM PARASIT, V89, P109, DOI 10.1016/S0166-6851(97)00107-2; SHERMAN DR, 1991, EMBO J, V10, P3379, DOI 10.1002/j.1460-2075.1991.tb04902.x; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Siegel TN, 2004, MOL BIOCHEM PARASIT, V172, P141; Siegel TN, 2010, NUCL ACIDS RES; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; VANDERPLOEG LHT, 1986, CELL, V47, P479, DOI 10.1016/0092-8674(86)90608-2; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; VANHAMME L, 1995, MOL CELL BIOL, V15, P5598; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25666	10.1371/journal.pone.0025666	http://dx.doi.org/10.1371/journal.pone.0025666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991330	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000054
J	Dong, YL; Li, JL; Zhang, FX; Li, YQ				Dong, Yulin; Li, Jinlian; Zhang, Fuxing; Li, Yunqing			Nociceptive Afferents to the Premotor Neurons That Send Axons Simultaneously to the Facial and Hypoglossal Motoneurons by Means of Axon Collaterals	PLOS ONE			English	Article							BRAIN-STEM PROJECTIONS; MEDULLARY DORSAL-HORN; ORAL MOTOR NUCLEI; SUBSTANCE-P; RETICULAR-FORMATION; TRIGEMINAL MOTOR; TONGUE MOVEMENT; REFLEX; RAT; STIMULATION	It is well known that the brainstem premotor neurons of the facial nucleus and hypoglossal nucleus coordinate orofacial nociceptive reflex (ONR) responses. However, whether the brainstem PNs receive the nociceptive projection directly from the caudal spinal trigeminal nucleus is still kept unclear. Our present study focuses on the distribution of premotor neurons in the ONR pathways of rats and the collateral projection of the premotor neurons which are involved in the brainstem local pathways of the orofacial nociceptive reflexes of rat. Retrograde tracer Fluoro-gold (FG) or FG/tetramethylrhodamine-dextran amine (TMR-DA) were injected into the VII or/and XII, and anterograde tracer biotinylated dextran amine (BDA) was injected into the caudal spinal trigeminal nucleus (Vc). The tracing studies indicated that FG-labeled neurons receiving BDA-labeled fibers from the Vc were mainly distributed bilaterally in the parvicellular reticular formation (PCRt), dorsal and ventral medullary reticular formation (MdD, MdV), supratrigeminal nucleus (Vsup) and parabrachial nucleus (PBN) with an ipsilateral dominance. Some FG/TMR-DA double-labeled premotor neurons, which were observed bilaterally in the PCRt, MdD, dorsal part of the MdV, peri-motor nucleus regions, contacted with BDA-labeled axonal terminals and expressed c-fos protein-like immunoreactivity which induced by subcutaneous injection of formalin into the lip. After retrograde tracer wheat germ agglutinated horseradish peroxidase (WGA-HRP) was injected into VII or XII and BDA into Vc, electron microscopic study revealed that some BDA-labeled axonal terminals made mainly asymmetric synapses on the dendritic and somatic profiles of WGA-HRP-labeled premotor neurons. These data indicate that some premotor neurons could integrate the orofacial nociceptive input from the Vc and transfer these signals simultaneously to different brainstem motonuclei by axonal collaterals.	[Dong, Yulin] Fourth Mil Med Univ, Dept Anat & Histol & Embryol, Xian 710032, Peoples R China; Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, YL (corresponding author), Fourth Mil Med Univ, Dept Anat & Histol & Embryol, Xian 710032, Peoples R China.	jinlian@fmmu.edu.cn; deptanat@fmmu.edu.cn			Nature Science Foundation of China [31010103909, 81070900, 81171050]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants-in-Aid from the Nature Science Foundation of China (Grant Nos: 31010103909, 81070900, 81171050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDES LD, 1990, J COMP NEUROL, V302, P643, DOI 10.1002/cne.903020318; ANDERSEN OK, 1995, ACTA PHYSIOL SCAND, V155, P87, DOI 10.1111/j.1748-1716.1995.tb09951.x; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; BORKE RC, 1983, BRAIN RES, V269, P47, DOI 10.1016/0006-8993(83)90961-7; CLARKE RW, 1985, BRAIN RES, V332, P231, DOI 10.1016/0006-8993(85)90592-X; CONNAUGHTON M, 1986, NEUROSCIENCE, V17, P205, DOI 10.1016/0306-4522(86)90237-X; Dauvergne C, 2001, NEUROSCI LETT, V311, P109, DOI 10.1016/S0304-3940(01)02150-4; Ellrich J, 1999, PAIN, V82, P229, DOI 10.1016/S0304-3959(99)00063-9; Ellrich J, 2002, MOVEMENT DISORD, V17, pS41, DOI 10.1002/mds.10057; Esser MJ, 1998, J COMP NEUROL, V391, P526, DOI 10.1002/(SICI)1096-9861(19980222)391:4<526::AID-CNE8>3.0.CO;2-2; Fay RA, 1997, BRAIN RES REV, V25, P255, DOI 10.1016/S0165-0173(97)00026-X; Gatti PJ, 1996, EXP BRAIN RES, V110, P175; GERMAN RZ, 1991, J EXP ZOOL, V257, P34, DOI 10.1002/jez.1402570105; GU YM, 1992, J NEUROSCI METH, V42, P1, DOI 10.1016/0165-0270(92)90129-2; Henriquez VM, 2005, EXP BRAIN RES, V163, P445, DOI 10.1007/s00221-004-2200-y; HINRICHSEN CFL, 1983, BRAIN BEHAV EVOLUT, V22, P153, DOI 10.1159/000121514; ISOKAWAAKESSON M, 1987, EXP BRAIN RES, V65, P385; Kaneko T, 1996, J NEUROSCI METH, V65, P157, DOI 10.1016/0165-0270(95)00162-X; KATOH ME, 1982, NEUROSCI LETT, V33, P141, DOI 10.1016/0304-3940(82)90241-5; Li JL, 2005, NEUROSCI RES, V51, P81, DOI 10.1016/j.neures.2004.10.005; Li JL, 2000, J COMP NEUROL, V418, P156; LI YQ, 1993, BRAIN RES, V611, P160, DOI 10.1016/0006-8993(93)91789-U; LI YQ, 1995, J COMP NEUROL, V356, P563, DOI 10.1002/cne.903560407; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; LI YQ, 1993, NEUROSCI LETT, V152, P29, DOI 10.1016/0304-3940(93)90475-Z; LOWE AA, 1984, BRAIN BEHAV EVOLUT, V25, P128, DOI 10.1159/000118858; Luccarini P, 1998, BRAIN RES, V803, P79, DOI 10.1016/S0006-8993(98)00624-6; MARTIN MR, 1977, Q J EXP PHYSIOL CMS, V62, P209, DOI 10.1113/expphysiol.1977.sp002393; NOZAKI S, 1993, J NEUROPHYSIOL, V69, P595, DOI 10.1152/jn.1993.69.2.595; PANNETON WM, 1983, BRAIN RES, V267, P19, DOI 10.1016/0006-8993(83)91036-3; Pellegrini JJ, 1995, EXP BRAIN RES, V107, P166, DOI 10.1007/BF00230039; Popratiloff AS, 2001, J COMP NEUROL, V433, P364, DOI 10.1002/cne.1145; RYE DB, 1984, J HISTOCHEM CYTOCHEM, V32, P1145, DOI 10.1177/32.11.6548485; Streppel M, 2000, HNO, V48, P911, DOI 10.1007/s001060050687; TAKASU N, 1988, J COMP NEUROL, V271, P461, DOI 10.1002/cne.902710313; THEXTON AJ, 1989, ARCH ORAL BIOL, V34, P239, DOI 10.1016/0003-9969(89)90064-2; THEXTON AJ, 1988, ARCH ORAL BIOL, V33, P331, DOI 10.1016/0003-9969(88)90066-0; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Tsai CM, 1999, PAIN, V81, P115, DOI 10.1016/S0304-3959(99)00009-3; Tsai CM, 1999, BRAIN RES, V826, P293, DOI 10.1016/S0006-8993(99)01248-2; Westberg KG, 1997, PAIN, V73, P295, DOI 10.1016/S0304-3959(97)00103-6; Zerari-Mailly F, 2001, J COMP NEUROL, V429, P80, DOI 10.1002/1096-9861(20000101)429:1<80::AID-CNE7>3.0.CO;2-L; ZHANG GX, 1990, BRAIN RES BULL, V24, P221, DOI 10.1016/0361-9230(90)90209-I	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25615	10.1371/journal.pone.0025615	http://dx.doi.org/10.1371/journal.pone.0025615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980505	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600040
J	Chiam, K; Centenera, MM; Butler, LM; Tilley, WD; Bianco-Miotto, T				Chiam, Karen; Centenera, Margaret M.; Butler, Lisa M.; Tilley, Wayne D.; Bianco-Miotto, Tina			GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2 '-Deoxycytidine Efficacy in Human Prostate Cancer Cells	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; RISK MYELODYSPLASTIC SYNDROME; PROMOTER METHYLATION; BREAST-CANCER; GENE-EXPRESSION; PHASE-I; HYPOMETHYLATING AGENT; ANTINEOPLASTIC ACTION; L1210 LEUKEMIA; MOUSE MODEL	DNA methylation plays an important role in carcinogenesis and the reversibility of this epigenetic modification makes it a potential therapeutic target. To date, DNA methyltransferase inhibitors (DNMTi) have not demonstrated clinical efficacy in prostate cancer, with one of the major obstacles being the inability to monitor drug activity during the trial. Given the high frequency and specificity of GSTP1 DNA methylation in prostate cancer, we investigated whether GSTP1 is a useful marker of DNMTi treatment efficacy. LNCaP prostate cancer cells were treated with 5-aza-2'-deoxycytidine (5-aza-CdR) either with a single high dose (5-20 mu M), every alternate day (0.1-10 mu M) or daily (0.005-2.5 mu M). A daily treatment regimen with 5-aza-CdR was optimal, with significant suppression of cell proliferation achieved with doses of 0.05 mu M or greater (p<0.0001) and induction of cell death from 0.5 mu M (p<0.0001). In contrast, treatment with a single high dose of 20 mu M 5-aza-CdR inhibited cell proliferation but was not able to induce cell death. Demethylation of GSTP1 was observed with doses of 5-aza-CdR that induced significant suppression of cell proliferation (>= 0.05 mu M). Re-expression of the GSTP1 protein was observed only at doses of 5-aza-CdR (>= 0.5 mu M) associated with induction of cell death. Treatment of LNCaP cells with a more stable DNMTi, Zebularine required at least a 100-fold higher dose (>= 50 mu M) to inhibit proliferation and was less potent in inducing cell death, which corresponded to a lack of GSTP1 protein re-expression. We have shown that GSTP1 DNA methylation and protein expression status is correlated with DNMTi treatment response in prostate cancer cells. Since GSTP1 is methylated in nearly all prostate cancers, our results warrant its testing as a marker of epigenetic therapy response in future clinical trials. We conclude that the DNA methylation and protein expression status of GSTP1 are good indicators of DNMTi efficacy.	[Chiam, Karen; Centenera, Margaret M.; Butler, Lisa M.; Tilley, Wayne D.; Bianco-Miotto, Tina] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Discipline Med, Hanson Inst, Adelaide, SA, Australia	Hanson Institute; University of Adelaide	Chiam, K (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	tina.bianco@adelaide.edu.au	Butler, Lisa/AAP-9088-2020; Butler, Lisa M/C-9843-2010; Bianco-Miotto, Tina/C-4808-2008	Butler, Lisa/0000-0003-2698-3220; Bianco-Miotto, Tina/0000-0002-8431-5338; centenera, margaret/0000-0002-2206-0632; Chiam, Karen/0000-0001-8154-6731; Tilley, Wayne/0000-0003-1893-2626	National Health and Medical Research Council [627185]; U.S. Department of Defense [W81XWH-04-1-0017]; Cancer Australia/Prostate Cancer Foundation of Australia [627229]; Prostate Cancer Foundation of Australia [EG0809]; W. Bruce Hall Cancer Council of SA; Cancer Council SA	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. Department of Defense(United States Department of Defense); Cancer Australia/Prostate Cancer Foundation of Australia; Prostate Cancer Foundation of Australia; W. Bruce Hall Cancer Council of SA; Cancer Council SA(Cancer Council South Australia)	This work was supported by grants from the National Health and Medical Research Council (627185; WDT, LMB, TBM), the U.S. Department of Defense (W81XWH-04-1-0017; WDT, LMB), Cancer Australia/Prostate Cancer Foundation of Australia (627229; LMB, WDT), Prostate Cancer Foundation of Australia Equipment Grant (EG0809; WDT, LMB, TBM), W. Bruce Hall Cancer Council of SA Research Fellowship (TBM), and a Cancer Council SA Senior Research Fellowship (LMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian PJ, 2005, CLIN CANCER RES, V11, P4037, DOI 10.1158/1078-0432.CCR-04-2446; Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bender CM, 1998, CANCER RES, V58, P95; Bianco-Miotto T, 2010, CANCER EPIDEM BIOMAR, V19, P2611, DOI 10.1158/1055-9965.EPI-10-0555; Bott SRJ, 2005, PROSTATE CANCER P D, V8, P321, DOI 10.1038/sj.pcan.4500822; Brothman AR, 2005, CANCER GENET CYTOGEN, V156, P31, DOI 10.1016/j.cancergencyto.2004.04.004; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Hurtubise A, 2004, ANTI-CANCER DRUG, V15, P161, DOI 10.1097/01.cad.0000113334.52071.97; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Lemaire M, 2005, ANTI-CANCER DRUG, V16, P301, DOI 10.1097/00001813-200503000-00009; Lin XH, 2001, CANCER RES, V61, P8611; Lin XH, 2001, AM J PATHOL, V159, P1815, DOI 10.1016/S0002-9440(10)63028-3; Lubbert M, 2001, BRIT J HAEMATOL, V114, P349, DOI 10.1046/j.1365-2141.2001.02933.x; Marrocco DL, 2007, MOL CANCER THER, V6, P51, DOI 10.1158/1535-7163.MCT-06-0144; McCabe MT, 2006, CANCER RES, V66, P385, DOI 10.1158/0008-5472.CAN-05-2020; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P277, DOI 10.1016/0163-7258(85)90052-X; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; MOMPARLER RL, 1984, LEUKEMIA RES, V8, P1043, DOI 10.1016/0145-2126(84)90059-6; Nakayama T, 2000, LAB INVEST, V80, P1789, DOI 10.1038/labinvest.3780190; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Patra SK, 2001, BIOCHEM BIOPH RES CO, V287, P705, DOI 10.1006/bbrc.2001.5639; Perry AS, 2006, ENDOCR-RELAT CANCER, V13, P357, DOI 10.1677/erc.1.01184; Pulukuri SMK, 2005, INT J ONCOL, V26, P863; Richter E, 2007, EPIGENETICS-US, V2, P100, DOI 10.4161/epi.2.2.4611; RIVARD GE, 1981, LEUKEMIA RES, V5, P453, DOI 10.1016/0145-2126(81)90116-8; Santourlidis S, 1999, PROSTATE, V39, P166; Shang DH, 2009, CANCER LETT, V278, P82, DOI 10.1016/j.canlet.2008.12.034; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Singal R, 2001, CANCER RES, V61, P4820; SORM F, 1968, NEOPLASMA, V15, P339; Steiner MS, 2000, ONCOGENE, V19, P1297, DOI 10.1038/sj.onc.1203428; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; Tan LW, 2002, CARCINOGENESIS, V23, P231, DOI 10.1093/carcin/23.2.231; Thibault A, 1998, TUMORI, V84, P87, DOI 10.1177/030089169808400120; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; XIANG N, 2008, CARCINOGENESIS; Xiong JB, 2009, MOL CANCER THER, V8, P779, DOI 10.1158/1535-7163.MCT-08-0926; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang Q, 2005, MOL ENDOCRINOL, V19, P2390, DOI 10.1210/me.2005-0096; Zorn CS, 2007, CLIN CANCER RES, V13, P2136, DOI 10.1158/1078-0432.CCR-06-2381	60	34	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25634	10.1371/journal.pone.0025634	http://dx.doi.org/10.1371/journal.pone.0025634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980513	Green Published, gold, Green Submitted			2022-12-25	WOS:000295936900085
J	Naudin, C; Joulin-Giet, A; Couetdic, G; Plesiat, P; Szymanska, A; Gorna, E; Gauthier, F; Kasprzykowski, F; Lecaille, F; Lalmanach, G				Naudin, Clement; Joulin-Giet, Alix; Couetdic, Gerard; Plesiat, Patrick; Szymanska, Aneta; Gorna, Emilia; Gauthier, Francis; Kasprzykowski, Franciszek; Lecaille, Fabien; Lalmanach, Gilles			Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUIDS; NEUTROPHIL ELASTASE; LUNG-DISEASE; HYDROGEN-PEROXIDE; HUMAN SPUTUM; CYSTATIN-C; PROTEASES; INFLAMMATION; PROTEINASES; INHIBITORS	Cysteine cathepsins have emerged as new players in inflammatory lung disorders. Their activities are dramatically increased in the sputum of cystic fibrosis (CF) patients, suggesting that they are involved in the pathophysiology of CF. We have characterized the cathepsins in CF expectorations and evaluated their use as markers of colonization by Pseudomonas aeruginosa. The concentrations of active cathepsins B, H, K, L and S were the same in P. aeruginosa-positive (19 Ps+) and P. aeruginosa-negative (6 Ps-) samples, unlike those of human neutrophil elastase. Also the cathepsin inhibitory potential and the cathepsins/cathepsin inhibitors imbalance remained unchanged and similar (similar to 2-fold) in the Ps+ and Ps- groups (p<0.001), which correlated with the breakdown of their circulating cystatin-like inhibitors (kininogens). Procathepsins, which may be activated autocatalytically, are a potential proteolytic reservoir. Immunoblotting and active-site labeling identified the double-chain cathepsin B, the major cathepsin in CF sputum, as the main molecular form in both Ps+ and Ps- samples, despite the possible release of the similar to 31 kDa single-chain form from procathepsin B by sputum elastase. Thus, the hydrolytic activity of cysteine cathepsins was not correlated with bacterial colonization, indicating that cathepsins, unlike human neutrophil elastase, are not suitable markers of P. aeruginosa infection.	[Naudin, Clement; Joulin-Giet, Alix; Gauthier, Francis; Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, INSERM, U618, Tours, France; [Couetdic, Gerard; Plesiat, Patrick] CHU Jean Minjoz, Bacteriol Lab, Besancon, France; [Szymanska, Aneta; Gorna, Emilia; Kasprzykowski, Franciszek] Univ Gdansk, Dept Med Chem, Fac Chem, PL-80952 Gdansk, Poland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universite de Franche-Comte; CHU Besancon; Fahrenheit Universities; University of Gdansk	Naudin, C (corresponding author), Univ Tours, INSERM, U618, Tours, France.	gilles.lalmanach@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022; Szymanska, Aneta/AAZ-2783-2021	Szymanska, Aneta/0000-0002-8664-2041; Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821; Ilowska, Emilia/0000-0002-5774-3644	French cystic fibrosis association "Vaincre la Mucoviscidose'' (VLM, France) [IC0810]; VLM; Institut National de la Sante et de la Recherche Medicale (INSERM)	French cystic fibrosis association "Vaincre la Mucoviscidose'' (VLM, France); VLM; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The French cystic fibrosis association "Vaincre la Mucoviscidose'' provided financial support (VLM, France, Grant IC0810). CN is a recipient of a doctoral fellowship from VLM. This work was also supported by institutional funding from the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg-Machleidt I, 1992, Agents Actions Suppl, V38 ( Pt 1), P312; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BROMME D, 1993, J BIOL CHEM, V268, P4832; Buhling F, 2004, EUR RESPIR J, V23, P620, DOI 10.1183/09031936.04.00105304; BUTTLE DJ, 1990, SCAND J CLIN LAB INV, V50, P509, DOI 10.3109/00365519009089165; BUTTLE DJ, 1991, BIOCHEM J, V276, P325, DOI 10.1042/bj2760325; Florent I, 2005, BIOL CHEM, V386, P401, DOI 10.1515/BC.2005.048; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gilligan PH, 2006, CYSTIC FIBROSIS MICR; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Grasemann H, 2010, EXPERT OPIN EMERG DR, V15, P653, DOI 10.1517/14728214.2010.517746; Grasemann H, 2010, PEDIATR PULM, V45, P845, DOI 10.1002/ppul.21298; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; Kasabova M, 2011, CLIN REV BONE MINER, V9, P148, DOI 10.1007/s12018-011-9094-6; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; LALMANACH G, 1992, J IMMUNOL METHODS, V149, P197, DOI 10.1016/0022-1759(92)90251-N; Lalmanach G, 1996, BIOCHEM J, V318, P395, DOI 10.1042/bj3180395; Lalmanach G, 2006, BIOL CHEM, V387, P863, DOI 10.1515/BC.2006.109; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; MACH L, 1994, J BIOL CHEM, V269, P13036; Majerle A, 2003, ARCH BIOCHEM BIOPHYS, V417, P53, DOI 10.1016/S0003-9861(03)00319-9; Martin SL, 2010, PEDIATR PULM, V45, P860, DOI 10.1002/ppul.21274; MAY TB, 1991, CLIN MICROBIOL REV, V4, P191, DOI 10.1128/CMR.4.2.191-206.1991; Naudin C, 2010, J MOL BIOL, V400, P1022, DOI 10.1016/j.jmb.2010.06.006; Owen Caroline A, 2005, Proc Am Thorac Soc, V2, P373, DOI 10.1513/pats.200504-029SR; Perdereau C, 2006, BBA-MOL BASIS DIS, V1762, P351, DOI 10.1016/j.bbadis.2005.10.005; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Quinn Derek J, 2010, Open Respir Med J, V4, P20, DOI 10.2174/1874306401004020020; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Takeyabu K, 1998, EUR RESPIR J, V12, P1033, DOI 10.1183/09031936.98.12051033; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Veillard F, 2008, INT J BIOCHEM CELL B, V40, P1079, DOI 10.1016/j.biocel.2007.10.030; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691	44	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25577	10.1371/journal.pone.0025577	http://dx.doi.org/10.1371/journal.pone.0025577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980493	Green Submitted, gold, Green Published			2022-12-25	WOS:000295936900077
J	Caino, MC; Lopez-Haber, C; Kim, J; Mochly-Rosen, D; Kazanietz, MG				Caino, M. C.; Lopez-Haber, C.; Kim, J.; Mochly-Rosen, D.; Kazanietz, M. G.			Proteins kinase C epsilon is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes	ONCOGENE			English	Article						PKC epsilon; non-small cell lung carcinoma; tumorigenesis; cell survival; apoptotic genes	CANCER CELLS; PKC-EPSILON; INHIBITORS; DEATH; OVEREXPRESSION; ACTIVATION; RECEPTOR; DELTA; SENESCENCE; MUTATIONS	Protein kinase C (PKC)epsilon, a member of the novel PKC family, has key roles in mitogenesis and survival in normal and cancer cells. PKC epsilon is frequently overexpressed in epithelial cancers, particularly in lung cancer. Using a short-hairpin RNA approach, here we established that PKCe is required for non-small cell lung carcinoma (NSCLC) growth in vitro as well as tumor growth when inoculated into athymic mice. Moreover, sustained delivery of a PKC epsilon-selective inhibitor peptide, epsilon V1-2, reduced xenograft growth in mice. Both RNA interference depletion and pharmacological inhibition of PKCe caused a marked elevation in the number of apoptotic cells in NSCLC tumors. PKC epsilon-depleted NSCLC cells show elevated expression of pro-apoptotic proteins of the Bcl2 family, caspase recruitment domain-containing proteins and tumor necrosis factor ligands/receptor superfamily members. Moreover, a Gene Set Enrichment Analysis revealed that a vast majority of the genes changed in PKC epsilon-depleted cells were also deregulated in human NSCLC. Our results strongly suggest that PKC epsilon is required for NSCLC cell survival and maintenance of NSCLC tumor growth. Therefore, PKC epsilon may represent an attractive therapeutic target for NSCLC. Oncogene (2012) 31, 2593-2600; doi:10.1038/onc.2011.428; published online 26 September 2011	[Caino, M. C.; Lopez-Haber, C.; Kazanietz, M. G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Kim, J.] Stanford Sch Med, Stanford Comprehens Canc Ctr, Stanford, CA USA; [Mochly-Rosen, D.] Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA USA	University of Pennsylvania; Stanford University; Stanford University	Kazanietz, MG (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 1256 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Kim, Jeewon/0000-0002-1063-0239; Caino, M. Cecilia/0000-0001-8294-8070; Mochly-Rosen, Daria/0000-0002-6691-8733; Lopez Haber, Cynthia/0000-0001-9106-543X	NCI NIH HHS [R01 CA074197] Funding Source: Medline; NHLBI NIH HHS [R01 HL052141] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BARR LF, 1991, CANCER RES, V51, P5514; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Felber M, 2007, PATHOL ONCOL RES, V13, P295, DOI 10.1007/BF02940308; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; Goekjian PG, 2001, EXPERT OPIN INV DRUG, V10, P2117; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HAN EKH, 1995, CARCINOGENESIS, V16, P2423, DOI 10.1093/carcin/16.10.2423; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Jansen AP, 2001, CANCER RES, V61, P808; Koyanagi T, 2007, J MOL CELL CARDIOL, V43, P517, DOI 10.1016/j.yjmcc.2007.06.003; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MATYAS GR, 1989, CELL SIGNAL, V1, P395, DOI 10.1016/0898-6568(89)90058-2; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mochly-Rosen D, 1998, ADV PHARMACOL, V44, P91, DOI 10.1016/S1054-3589(08)60126-X; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Perletti GP, 1996, ONCOGENE, V12, P847; PREISS J, 1986, J BIOL CHEM, V261, P8597; RUSCH V, 1993, CANCER RES, V53, P2379; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Slupsky JR, 2007, AM J PATHOL, V170, P745, DOI 10.2353/ajpath.2007.060557; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134	47	32	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	20					2593	2600		10.1038/onc.2011.428	http://dx.doi.org/10.1038/onc.2011.428			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21996750	Green Accepted			2022-12-25	WOS:000304191800009
J	Zagorodna, O; Martin, SM; Rutkowski, DT; Kuwana, T; Spitz, DR; Knudson, CM				Zagorodna, O.; Martin, S. M.; Rutkowski, D. T.; Kuwana, T.; Spitz, D. R.; Knudson, C. M.			2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines	ONCOGENE			English	Article						2-deoxyglucose (2DG); apoptosis; Bcl-2; Bax; BH3 mimetics; oncogenesis	MOUSE B-CELL; MITOCHONDRIAL APOPTOSIS; BH3-ONLY PROTEINS; BH3 DOMAINS; IN-VITRO; 2-DEOXY-D-GLUCOSE; STRESS; BAX; METABOLISM; ACTIVATION	Targeting altered cancer cell metabolism with the glycolysis inhibitor, 2-deoxyglucose (2DG), is a viable therapeutic strategy, but the effects of 2DG on lymphoma cells and the mechanism of action are unknown. Five T-cell lymphoma lines and two B-cell lymphoma lines were shown to be highly sensitive to 2DG. Examination of the cell death pathway demonstrated pro-apoptotic protein Bax 'activation' and caspase cleavage in 2DG-treated cells. However, Q-VD-OPh, a potent inhibitor of caspase activity provided minimal protection from death. In contrast, overexpressing the anti-apoptotic protein Bcl-2 dramatically enhanced the survival of 2DG-treated cells that was negated by a Bcl-2 antagonist. BH3-only members, Bim and Bmf, were upregulated by 2DG, and shRNAs targeting Bim protected from 2DG toxicity demonstrating that Bim is a critical mediator of 2DG toxicity. 2DG also induced GADD153/CHOP expression, a marker of endoplasmic reticulum (ER) stress and a known activator of Bim. Mannose, a reagent known to alleviate ER stress, transiently protected from 2DG-induced cell death. Examination of the effects of 2DG on energy metabolism showed a drop in ATP levels by 30 min that was not affected by either Bcl-2 or mannose. These results demonstrate that ER stress appears to be rate limiting in 2DG-induced cell death in lymphoma cells, and this cell killing is regulated by the Bcl-2 family of proteins. Bcl-2 inhibition combined with 2DG may be an effective therapeutic strategy for lymphoma. Oncogene (2012) 31, 2738-2749; doi: 10.1038/onc.2011.454; published online 10 October 2011	[Zagorodna, O.; Martin, S. M.; Kuwana, T.; Knudson, C. M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Zagorodna, O.; Spitz, D. R.; Knudson, C. M.] Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Rutkowski, D. T.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Knudson, CM (corresponding author), Univ Iowa, Dept Pathol, 200 Hawkins Dr,1171 ML, Iowa City, IA 52242 USA.	c-knudson@uiowa.edu		Knudson, Charles Michael/0000-0003-3964-5466; Spitz, Douglas/0000-0002-1254-8765; Rutkowski, Thomas/0000-0001-6586-4449	 [CA104695];  [CA133114];  [DK084058];  [GM086389.]; NATIONAL CANCER INSTITUTE [R01CA104695, R01CA133114, P50CA097274, T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086389] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by RO1 no. CA104695, RO1 no. CA133114, R01 no. DK084058, and R01 no. GM086389. We thank Dr Chris van de Wetering for assistance in generating lymphoma cell lines, Dr Siegfried Janz and Dr SS Han for B-cell neoplasms, Dr Agshin Taghiyev and Dr Van Tompkins for their advice and assistance with TCL transduction experiments, Dr Craig Kuder and Dr Ray Hohl for antibodies and assistance with ER-stress markers, Heather Tyra for assistance with RT-PCR, Han Du for advice with the Bcl-2 IP experiments, Rebecca Glover and Jacob Wolf for their technical advice on western blotting and Dr Craig Thompson (The Sloan-Kettering Cancer Center) for Bax/Bak double-knockout cells.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; CRANE RK, 1954, J BIOL CHEM, V210, P597; Dasmahapatra G, 2009, CANCER BIOL THER, V8, P808, DOI 10.4161/cbt.8.9.8131; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Han SS, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-22; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Raden D, 2005, IEE P SYST BIOL, V152, P285, DOI 10.1049/ip-syb:20050048; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; TOWER DB, 1958, J NEUROCHEM, V3, P185, DOI 10.1111/j.1471-4159.1958.tb12625.x; van de Wetering CI, 2007, CANCER RES, V67, P8081, DOI 10.1158/0008-5472.CAN-07-1666; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Zhang XD, 2006, ANTICANCER RES, V26, P3561	43	45	48	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	22					2738	2749		10.1038/onc.2011.454	http://dx.doi.org/10.1038/onc.2011.454			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	952DB	21986940	Green Accepted			2022-12-25	WOS:000304769000004
J	Salcedo-Sora, JE; Ochong, E; Beveridge, S; Johnson, D; Nzila, A; Biagini, GA; Stocks, PA; O'Neill, PM; Krishna, S; Bray, PG; Ward, SA				Salcedo-Sora, J. Enrique; Ochong, Edwin; Beveridge, Susan; Johnson, David; Nzila, Alexis; Biagini, Giancarlo A.; Stocks, Paul A.; O'Neill, Paul M.; Krishna, Sanjeev; Bray, Patrick G.; Ward, Stephen A.			The Molecular Basis of Folate Salvage in Plasmodium falciparum CHARACTERIZATION OF TWO FOLATE TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA PARASITE; MENSCHEN PL FALCIPARUM; PARA-AMINOBENZOIC ACID; DIE IMMUNITAT BEI; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; EXOGENOUS FOLATE; TRANSPORTER; SULFADOXINE; RESISTANCE	Tetrahydrofolates are essential cofactors for DNA synthesis and methionine metabolism. Malaria parasites are capable both of synthesizing tetrahydrofolates and precursors de novo and of salvaging them from the environment. The biosynthetic route has been studied in some detail over decades, whereas the molecular mechanisms that underpin the salvage pathway lag behind. Here we identify two functional folate transporters (named PfFT1 and PfFT2) and delineate unexpected substrate preferences of the folate salvage pathway in Plasmodium falciparum. Both proteins are localized in the plasma membrane and internal membranes of the parasite intra-erythrocytic stages. Transport substrates include folic acid, folinic acid, the folate precursor p-amino benzoic acid (pABA), and the human folate catabolite pABAG(n). Intriguingly, the major circulating plasma folate, 5-methyltetrahydrofolate, was a poor substrate for transport via PfFT2 and was not transported by PfFT1. Transport of all folates studied was inhibited by probenecid and methotrexate. Growth rescue in Escherichia coli and antifolate antagonism experiments in P. falciparum indicate that functional salvage of 5-methyltetrahydrofolate is detectable but trivial. In fact pABA was the only effective salvage substrate at normal physiological levels. Because pABA is neither synthesized nor required by the human host, pABA metabolism may offer opportunities for chemotherapeutic intervention.	[O'Neill, Paul M.; Bray, Patrick G.; Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QA, Merseyside, England; [O'Neill, Paul M.] Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Krishna, Sanjeev] St Georges Univ London, London SW17 0RE, England; [Nzila, Alexis] Wellcome Trust Collaborat Res Programme, Kenya Med Res Inst, Kilifi 801808, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; St Georges University London; Kenya Medical Research Institute	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	saward@liverpool.ac.uk	Ward, Steve/G-6003-2015; Biagini, Giancarlo A/F-3449-2011	Ward, Steve/0000-0003-2331-3192; Biagini, Giancarlo A/0000-0001-6356-6595; Krishna, Sanjeev/0000-0003-0066-0634	Medical Research Council [G0400173]; Bill and Melinda Gates Foundation; Wellcome Trust; MRC [G0400173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400173 (to P. G. B.), the Bill and Melinda Gates Foundation, and the Wellcome Trust (open access publishing grant).	ARFMAN N, 1992, J BACTERIOL, V174, P7370, DOI 10.1128/jb.174.22.7370-7378.1992; ASAWAMAHASAKDA W, 1993, PARASITOLOGY, V107, P1, DOI 10.1017/S0031182000079348; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; BRAY RS, 1953, BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.4821.1200; BROCKELMAN CR, 1982, B WORLD HEALTH ORGAN, V60, P423; Carter EL, 2007, J BACTERIOL, V189, P3329, DOI 10.1128/JB.01940-06; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eudes A, 2010, J BIOL CHEM, V285, P2867, DOI 10.1074/jbc.M109.063651; FERONE R, 1973, J PROTOZOOL, V20, P459, DOI 10.1111/j.1550-7408.1973.tb00926.x; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hannisdal R, 2009, CLIN CHEM, V55, P1147, DOI 10.1373/clinchem.2008.114389; HAWKING F, 1954, BMJ-BRIT MED J, V1, P425, DOI 10.1136/bmj.1.4859.425; Hondorp ER, 2009, J BACTERIOL, V191, P3407, DOI 10.1128/JB.01722-08; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Hyde JE, 2005, ACTA TROP, V94, P191, DOI 10.1016/j.actatropica.2005.04.002; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kicska GA, 2003, J INFECT DIS, V188, P1776, DOI 10.1086/379373; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; KRETSCHM.W, 1966, Z TROPENMED PARASIT, V17, P369; KRETSCHMAR W, 1966, Z TROPENMED PARASIT, V17, P301; KRETSCHMAR W, 1966, Z TROPENMED PARASIT, V17, P375; KRUNGKRAI J, 1989, MOL BIOCHEM PARASIT, V32, P25, DOI 10.1016/0166-6851(89)90126-6; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lin YM, 2004, AM J CLIN NUTR, V80, P680; LO RS, 1991, P ROY SOC B-BIOL SCI, V246, P161, DOI 10.1098/rspb.1991.0139; MAEGRAITH BG, 1952, BRIT MED J, V2, P1382, DOI 10.1136/bmj.2.4799.1382; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; MCCONKEY GA, 1994, P NATL ACAD SCI USA, V91, P4244, DOI 10.1073/pnas.91.10.4244; McDowell Margaret A, 2008, NCHS Data Brief, P1; MILHOUS WK, 1985, ANTIMICROB AGENTS CH, V27, P525, DOI 10.1128/AAC.27.4.525; Nduati E, 2008, PARASITOL RES, V102, P1227, DOI 10.1007/s00436-008-0897-4; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Nzila A, 2003, ANTIMICROB AGENTS CH, V47, P2108, DOI 10.1128/AAC.47.7.2108-2112.2003; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAPIRA A, 1986, AM J TROP MED HYG, V35, P239, DOI 10.4269/ajtmh.1986.35.239; Sowunmi A, 2004, TROP MED INT HEALTH, V9, P606, DOI 10.1111/j.1365-3156.2004.01233.x; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; TANARIYA P, 1983, J PARASITOL, V69, P353, DOI 10.2307/3281233; TANARIYA P, 1983, EXP PARASITOL, V55, P364, DOI 10.1016/0014-4894(83)90033-4; TANARIYA P, 1987, AM J TROP MED HYG, V37, P42, DOI 10.4269/ajtmh.1987.37.42; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Virkki LV, 2001, AM J PHYSIOL-REG I, V281, pR1994, DOI 10.1152/ajpregu.2001.281.6.R1994; Wang P, 2004, MOL BIOCHEM PARASIT, V135, P77, DOI 10.1016/j.molbiopara.2004.01.008; Wang P, 1999, MOL MICROBIOL, V32, P1254, DOI 10.1046/j.1365-2958.1999.01437.x; Wang P, 1997, PARASITOLOGY, V115, P223, DOI 10.1017/S0031182097001431; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8; WATKINS WM, 1985, MOL BIOCHEM PARASIT, V14, P55, DOI 10.1016/0166-6851(85)90105-7; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099	69	32	32	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44659	44668		10.1074/jbc.M111.286054	http://dx.doi.org/10.1074/jbc.M111.286054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21998306	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000298645500036
J	Bar-Lev, DD; Degani-Katzav, N; Perelman, A; Paas, Y				Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Perelman, Alexander; Paas, Yoav			Molecular Dissection of Cl- -selective Cys-loop Receptor Points to Components That Are Dispensable or Essential for Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; CELL-SURFACE EXPRESSION; AGONIST BINDING-SITES; ALPHA-BUNGAROTOXIN; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; CAENORHABDITIS-ELEGANS; GABA(A) RECEPTORS	Cys-loop receptors are pentameric ligand-gated ion channels (pLGICs) that bind neurotransmitters to open an intrinsic transmembrane ion channel pore. The recent crystal structure of a prokaryotic pLGIC from the cyanobacterium Gloeobacter violaceus (GLIC) revealed that it naturally lacks an N-terminal extracellular alpha helix and an intracellular domain that are typical of eukaryotic pLGICs. GLIC does not respond to neurotransmitters acting at eukaryotic pLGICs but is activated by protons. To determine whether the structural differences account for functional differences, we used a eukaryotic chimeric acetylcholine-glutamate pLGIC that was modified to carry deletions corresponding to the sequences missing in the prokaryotic homolog GLIC. Deletions made in the N-terminal extracellular alpha helix did not prevent the expression of receptor subunits and the appearance of receptor assemblies on the cell surface but abolished the capability of the receptor to bind alpha -bungarotoxin (a competitive antagonist) and to respond to the neurotransmitter. Other truncated chimeric receptors that lacked the intracellular domain did bind ligands; displayed robust acetylcholine-elicited responses; and shared with the full-length chimeric receptor similar anionic selectivity, effective open pore diameter, and unitary conductance. We suggest that the integrity of the N-terminal alpha helix is crucial for ligand accommodation because it stabilizes the intersubunit interfaces adjacent to the neurotransmitter-binding pocket(s). We also conclude that the intracellular domain of the chimeric acetylcholine-glutamate receptor does not modulate the ion channel conductance and is not involved in positioning of the pore-lining helices in the conformation necessary for coordinating a Cl- ion within the intracellular vestibule of the ion channel pore.	[Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Lab Ion Channels, IL-52900 Ramat Gan, Israel; [Perelman, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sci Equipment Unit, IL-52900 Ramat Gan, Israel; [Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University; Bar Ilan University	Paas, Y (corresponding author), Bar Ilan Univ, Lab Ion Channels, IL-52900 Ramat Gan, Israel.	yoav.paas@biu.ac.il			Wolfson Family Foundation; Israel Science Foundation [812/07, 1645/07]	Wolfson Family Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the Wolfson Family Foundation and Israel Science Foundation Grants 812/07 and 1645/07.	Adelsberger H, 1997, NEUROSCI LETT, V230, P183, DOI 10.1016/S0304-3940(97)00512-0; ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANG CC, 1966, BRIT J PHARM CHEMOTH, V28, P172, DOI 10.1111/j.1476-5381.1966.tb01883.x; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2009, MOL PHARMACOL, V75, P1084, DOI 10.1124/mol.108.054353; COHEN BN, 1992, J GEN PHYSIOL, V99, P545, DOI 10.1085/jgp.99.4.545; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; Connolly CN, 2008, MOL MEMBR BIOL, V25, P293, DOI 10.1080/09687680801898503; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2011, NATURE, V474, P526, DOI 10.1038/nature10015; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LESTER HA, 1970, NATURE, V227, P727, DOI 10.1038/227727a0; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; MacInnes D.A., 1961, PRINCIPLES ELECTROCH; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Nashmi R, 2003, J NEUROSCI, V23, P11554; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Pittel I, 2010, J BIOL CHEM, V285, P26519, DOI 10.1074/jbc.M110.102327; Pitzer K.S, 1991, ION INTERACTION APPR, Vsecond; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; SINE SM, 1991, J BIOL CHEM, V266, P19369; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2010, J MOL NEUROSCI, V40, P70, DOI 10.1007/s12031-009-9260-1; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; SUKHNO IV, 2005, CHEM INT, V27; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; YU XM, 1994, J NEUROSCI, V14, P785; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	97	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43830	43841		10.1074/jbc.M111.282715	http://dx.doi.org/10.1074/jbc.M111.282715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21987577	Green Published, hybrid			2022-12-25	WOS:000298402300025
J	Cao, ZB; Tavender, TJ; Roszak, AW; Cogdell, RJ; Bulleid, NJ				Cao, Zhenbo; Tavender, Timothy J.; Roszak, Aleksander W.; Cogdell, Richard J.; Bulleid, Neil J.			Crystal Structure of Reduced and of Oxidized Peroxiredoxin IV Enzyme Reveals a Stable Oxidized Decamer and a Non-disulfide-bonded Intermediate in the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; 2-CYS PEROXIREDOXINS; DIFFRACTION DATA; PATHWAY; STATE; PEROXIDASE; REFINEMENT; MECHANISMS; REDUCTION	Peroxiredoxin IV (PrxIV) is an endoplasmic reticulum-localized enzyme that metabolizes the hydrogen peroxide produced by endoplasmic reticulum oxidase 1 (Ero1). It has been shown to play a role in de novo disulfide formation, oxidizing members of the protein disulfide isomerase family of enzymes, and is a member of the typical 2-Cys peroxiredoxin family. We have determined the crystal structure of both reduced and disulfide-bonded, as well as a resolving cysteine mutant of human PrxIV. We show that PrxIV has a similar structure to other typical 2-Cys peroxiredoxins and undergoes a conformational change from a fully folded to a locally unfolded form following the formation of a disulfide between the peroxidatic and resolving cysteine residues. Unlike other mammalian typical 2-Cys peroxiredoxins, we show that human PrxIV forms a stable decameric structure even in its disulfide-bonded state. In addition, the structure of a resolving cysteine mutant reveals an intermediate in the reaction cycle that adopts the locally unfolded conformation. Interestingly the peroxidatic cysteine in the crystal structure is sulfenylated rather than sulfinylated or sulfonylated. In addition, the peroxidatic cysteine in the resolving cysteine mutant is resistant to hyper-oxidation following incubation with high concentrations of hydrogen peroxide. These results high-light some unique properties of PrxIV and suggest that the equilibrium between the fully folded and locally unfolded forms favors the locally unfolded conformation upon sulfenylation of the peroxidatic cysteine residue.	[Cao, Zhenbo; Tavender, Timothy J.; Cogdell, Richard J.; Bulleid, Neil J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Roszak, Aleksander W.] Univ Glasgow, WestCHEM, Sch Chem, Coll Sci & Engn, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [88053]; Scottish University Life Science Alliance	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Science Alliance	The work was supported by grants from the Wellcome Trust (Grant 88053) and the Scottish University Life Science Alliance (to N. J. B.).	Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Ikeda Y, 2010, PROTEIN EXPRES PURIF, V72, P1, DOI 10.1016/j.pep.2010.02.001; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MACER DRJ, 1988, J CELL SCI, V91, P61; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	37	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42257	42266		10.1074/jbc.M111.298810	http://dx.doi.org/10.1074/jbc.M111.298810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994946	hybrid, Green Published			2022-12-25	WOS:000298180900035
J	Sheng, ZT; Xu, JJ; Bai, H; Zhu, F; Palli, SR				Sheng, Zhentao; Xu, Jingjing; Bai, Hua; Zhu, Fang; Palli, Subba R.			Juvenile Hormone Regulates Vitellogenin Gene Expression through Insulin-like Peptide Signaling Pathway in the Red Flour Beetle, Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSQUITO AEDES-AEGYPTI; LOCUST FAT-BODY; DROSOPHILA-MELANOGASTER; BLATTELLA-GERMANICA; MOLECULAR ACTIONS; MESSENGER-RNA; C-ELEGANS; LIFE-SPAN; INDUCTION; TARGET	Our recent studies identified juvenile hormone (JH) and nutrition as the two key signals that regulate vitellogenin (Vg) gene expression in the red flour beetle, Tribolium castaneum. Juvenile hormone regulation of Vg synthesis has been known for a long time in several insects, but the mechanism of JH action is not known. Experiments were conducted to determine the mechanism of action of these two signals in regulation of Vg gene expression. Injection of bovine insulin or FOXO double-stranded RNA into the previtellogenic, starved, or JH-deficient female adults increased Vg mRNA and protein levels, thereby implicating the pivotal role for insulin-like peptide signaling in the regulation of Vg gene expression and possible cross-talk between JH and insulin-like peptide signaling pathways. Reduction in JH synthesis or its action by RNAi-mediated silencing of genes coding for acid methyltransferase or methoprene-tolerant decreased expression of genes coding for insulin-like peptides (ILPs) and influenced FOXO subcellular localization, resulting in the down-regulation of Vg gene expression. Furthermore, JH application to previtellogenic female beetles induced the expression of genes coding for ILP2 and ILP3, and induced Vg gene expression. FOXO protein expressed in baculovirus system binds to FOXO response element present in the Vg gene promoter. These data suggest that JH functions through insulin-like peptide signaling pathway to regulate Vg gene expression.	[Sheng, Zhentao; Xu, Jingjing; Bai, Hua; Zhu, Fang; Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA	University of Kentucky	Palli, SR (corresponding author), Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA.	rpalli@uky.edu	PALLI, SUBBA REDDY/AAU-8289-2020; Xu, Jingjing/H-2267-2013; sheng, Zhentao Sheng/E-8962-2017; Bai, Hua/A-6665-2012	PALLI, SUBBA REDDY/0000-0002-0873-3247; Bai, Hua/0000-0003-2221-7545; Xu, Jingjing/0000-0003-1976-3721	National Institutes of Health [GM070559-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070559-07). This is contribution number 11-08-057 from the Kentucky Agricultural Experimental Station.	Ashrafi Kaveh, 2007, WormBook, P1; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Carnevali O, 1998, ANN NY ACAD SCI, V839, P556, DOI 10.1111/j.1749-6632.1998.tb10871.x; CHINZEI Y, 1982, CAN J BIOCHEM CELL B, V60, P243, DOI 10.1139/o82-029; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Comas D, 1999, INSECT BIOCHEM MOLEC, V29, P821, DOI 10.1016/S0965-1748(99)00058-2; Comas D, 2001, MOL CELL ENDOCRINOL, V183, P93, DOI 10.1016/S0303-7207(01)00589-5; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DHADIALLA TS, 1983, DEV BIOL, V96, P436, DOI 10.1016/0012-1606(83)90181-1; DHADIALLA TS, 1987, DEV BIOL, V123, P108, DOI 10.1016/0012-1606(87)90432-5; Fronstin RB, 2008, J EXP BIOL, V211, P79, DOI 10.1242/jeb.009530; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; KEELEY LL, 1985, COMP BIOCHEM PHYS A, V80, P115, DOI 10.1016/0300-9629(85)90688-7; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wuertz S, 2007, GEN COMP ENDOCR, V150, P140, DOI 10.1016/j.ygcen.2006.07.005; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	42	140	147	8	111	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41924	41936		10.1074/jbc.M111.269845	http://dx.doi.org/10.1074/jbc.M111.269845			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002054	hybrid, Green Published			2022-12-25	WOS:000298180900004
J	Buurman, ET; Andrews, B; Gao, N; Hu, J; Keating, TA; Lahiri, S; Otterbein, LR; Patten, AD; Stokes, SS; Shapiro, AB				Buurman, Ed T.; Andrews, Beth; Gao, Ning; Hu, Jun; Keating, Thomas A.; Lahiri, Sushmita; Otterbein, Ludovic R.; Patten, Arthur D.; Stokes, Suzanne S.; Shapiro, Adam B.			In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GENE; CHALLENGES; INHIBITORS; PROTEIN; SITE	GlmU is a bifunctional enzyme that is essential for bacterial growth, converting D-glucosamine 1-phosphate into UDP-GlicNAc via acetylation and subsequent uridyl transfer. A biochemical screen of AstraZeneca's compound library using GlmU of Escherichia coli identified novel sulfonamide inhibitors of the acetyltransferase reaction. Steady-state kinetics, ligand-observe NMR, isothermal titration calorimetry, and x-ray crystallography showed that the inhibitors were competitive with acetyl-CoA substrate. Iterative chemistry efforts improved biochemical potency against Gram-negative isozymes 300-fold and afforded antimicrobial activity against a strain of Haemophilus influenzae lacking its major efflux pump. Inhibition of precursor incorporation into bacterial macromolecules was consistent with the antimicrobial activity being caused by disruption of peptidoglycan and fatty acid biosyntheses. Isolation and characterization of two different resistant mutant strains identified the GlmU acetyltransferase domain as the molecular target. These data, along with x-ray co-crystal structures, confirmed the binding mode of the inhibitors and explained their relative lack of potency against Gram-positive GlmU isozymes. This is the first example of antimicrobial compounds mediating their growth inhibitory effects specifically via Glut U.	[Buurman, Ed T.; Andrews, Beth; Gao, Ning; Hu, Jun; Keating, Thomas A.; Lahiri, Sushmita; Patten, Arthur D.; Stokes, Suzanne S.; Shapiro, Adam B.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA 02451 USA; [Otterbein, Ludovic R.] AstraZeneca, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England	AstraZeneca; AstraZeneca	Buurman, ET (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	Ed.Buurman@astrazeneca.com	Fan, Jianqing/B-2115-2008	Shapiro, Adam/0000-0002-2662-6146; Gao, Ning/0000-0003-1605-4137				ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Bazan JA, 2010, DRUG TODAY, V46, P743, DOI 10.1358/dot.2010.46.10.1519172; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Buurman ET, 2006, ANTIMICROB AGENTS CH, V50, P385, DOI 10.1128/AAC.50.1.385-387.2006; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Mochalkin I, 2008, PROTEIN SCI, V17, P577, DOI 10.1110/ps.073271408; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Pioli D., 1999, WIPO Pat., Patent No. [W0/1999/005297, 1999005297]; Saeed-Kothe A, 2004, APPL ENVIRON MICROB, V70, P4136, DOI 10.1128/AEM.70.7.4136-4143.2004; Sanchez L, 1997, J BACTERIOL, V179, P6855, DOI 10.1128/jb.179.21.6855-6857.1997; Scott K. S., 1995, J AM CHEM SOC, V117, P4199; Segel I. H., 1993, ENZYME KINETICS BEHA; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799	24	34	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40734	40742		10.1074/jbc.M111.274068	http://dx.doi.org/10.1074/jbc.M111.274068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984832	Green Published, hybrid			2022-12-25	WOS:000297315400034
J	Fan, YB; Guo, YH; Hamblin, M; Chang, L; Zhang, JF; Chen, YE				Fan, Yanbo; Guo, Yanhong; Hamblin, Milton; Chang, Lin; Zhang, Jifeng; Chen, Y. Eugene			Inhibition of Gluconeogenic Genes by Calcium-regulated Heat-stable Protein 1 via Repression of Peroxisome Proliferator-activated Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; FREE FATTY-ACIDS; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; TRANSCRIPTIONAL COACTIVATOR; PHYSIOLOGICAL SUBSTRATE; HEPATIC GLUCONEOGENESIS; PPAR; IDENTIFICATION; PHOSPHORYLATION	Gluconeogenesis contributes to insulin resistance in type 1 and type 2 diabetes, but its regulation and the underlying molecular mechanisms remain unclear. Recently, calcium-regulated heat-stable protein 1 (CARHSP1) was identified as a biomarker for diabetic complications. In this study, we investigated the role of CARHSP1 in hepatic gluconeogenesis. We assessed the regulation of hepatic CARHSP1 expression under conditions of fasting and refeeding. Adenovirus-mediated CARHSP1 overexpression and siRNA-mediated knockdown experiments were performed to characterize the role of CARHSP1 in the regulation of gluconeogenic gene expression. Here, we document for the first time that CARHSP1 is regulated by nutrient status in the liver and functions at the transcriptional level to negatively regulate gluconeogenic genes, including the glucose-6-phosphatase catalytic subunit (G6Pc) and phosphoenolpyruvate carboxykinase 1 (PEPCK1). In addition, we found that CARHSP1 can physically interact with peroxisome proliferator-activated receptor-alpha (PPAR alpha) and inhibit its transcriptional activity. Both pharmacological and genetic ablations of PPAR alpha attenuate the inhibitory effect of CARHSP1 on gluconeogenic gene expression in hepatocytes. Our data suggest that CARHSP1 inhibits hepatic gluconeogenic gene expression via repression of PPARa and that CARHSP1 may be a molecular target for the treatment of diabetes.	[Fan, Yanbo; Guo, Yanhong; Hamblin, Milton; Chang, Lin; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Cardiovasc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Cardiovasc Ctr, Dept Internal Med, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	Fan, Yanbo/C-6360-2013; Fan, Yanbo/AAD-4710-2020; Guo, Yanhong/D-9764-2012; GUO, Yanhong/B-5325-2012	Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562; 	National Institutes of Health [HL068878, HL105114, HL089544]; American Heart Association [10POST3270008, 09SDG2230270, 0835237N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R01HL068878, R01HL105114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068878, HL105114, and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grants 10POST3270008 (Y. F.), 09SDG2230270 (L. C.), and 0835237N (J. Z.).	Aoyama H, 2006, INT J MOL MED, V18, P433; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Auld GC, 2005, BIOCHEM J, V389, P775, DOI 10.1042/BJ20050733; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479; Dietrich CG, 2007, AM J PHYSIOL-GASTR L, V293, pG585, DOI 10.1152/ajpgi.00175.2007; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hou H, 2011, J BIOL CHEM, V286, P9623, DOI 10.1074/jbc.M110.177436; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kaestner KH, 2008, CELL METAB, V8, P449, DOI 10.1016/j.cmet.2008.11.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Lee SH, 2009, BIOCHEM BIOPH RES CO, V385, P413, DOI 10.1016/j.bbrc.2009.05.096; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Perriello G, 1997, DIABETES, V46, P1010, DOI 10.2337/diabetes.46.6.1010; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zeeb M, 2003, PROTEIN SCI, V12, P112, DOI 10.1110/ps.0219703	47	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40584	40594		10.1074/jbc.M111.232918	http://dx.doi.org/10.1074/jbc.M111.232918			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990353	hybrid, Green Published			2022-12-25	WOS:000297315400018
J	Lachance, V; Cartier, A; Genier, S; Munger, S; Germain, P; Labrecque, P; Parent, JL				Lachance, Veronik; Cartier, Andreane; Genier, Samuel; Munger, Sandra; Germain, Pascale; Labrecque, Pascale; Parent, Jean-Luc			Regulation of beta(2)-Adrenergic Receptor Maturation and Anterograde Trafficking by an Interaction with Rab Geranylgeranyltransferase MODULATION OF Rab GERANYLGERANYLATION BY THE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTACYCLIN RECEPTOR; TRANS-GOLGI NETWORK; GTP-BINDING; GTPASES; ASSOCIATION; PROTEINS; COMPLEX; DISSOCIATION; TRANSFERASE; INTERNALIZATION	Previous reports by us and others demonstrated that G protein-coupled receptors interact functionally with Rab GTPases. Here, we show that the beta(2)-adrenergic receptor (beta(2)AR) interacts with the Rab geranylgeranyltransferase alpha-subunit (RGGTA). Confocal microscopy showed that beta(2)AR co-localizes with RGGTA in intracellular compartments and at the plasma membrane. Site-directed mutagenesis revealed that RGGTA binds to the (LL340)-L-339 motif in the beta(2)AR C terminus known to be involved in the transport of the receptor from the endoplasmic reticulum to the cell surface. Modulation of the cellular levels of RGGTA protein by overexpression or siRNA-mediated knockdown of the endogenous protein demonstrated that RGGTA has a positive role in the maturation and anterograde trafficking of the beta(2)AR, which requires the interaction of RGGTA with the beta(2)AR (LL340)-L-339 motif. Furthermore, the beta(2)AR modulates the geranylgeranylation of Rab6a, Rab8a, and Rab Ha, but not of other Rab proteins tested in this study. Regulation of Rab geranylgeranylation by the beta(2)AR was dependent on the RGGTA-interacting (LL340)-L-339 motif. Interestingly, a RGGTA-Y107F mutant was unable to regulate Rab geranylgeranylation but still promoted beta(2)AR maturation, suggesting that RGGTA may have functions independent of Rab geranylgeranylation. We demonstrate for the first time an interaction between a transmembrane receptor and RGGTA which regulates the maturation and anterograde transport of the receptor, as well as geranylgeranylation of Rab GTPases.	[Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Fac Med, Inst Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Serv Rhumatol, Fac Med & Sci Sante, Ctr Rech Clin Etienne Le Bel,Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Parent, JL (corresponding author), Univ Sherbrooke, Serv Rhumatol, Fac Med, Inst Pharmacol, 3001,12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	jean-luc.parent@usherbrooke.ca			Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes of Health Research (to J.-L. P).; Recipient of a Chercheur boursier-Senior salary award from the Fonds de la Recherche en Sante du Quebec and holder of the Andre-Lussier Research Chair during this work. To whom correspondence should be addressed: Service de Rhumatologie, Faculte de Medecine, 3001, 12<SUP>e</SUP> Avenue Nord, Sherbrooke, QC, Canada J1H 5N4. Tel.: 1-819-564-5264; Fax: 1-819-564-5265; E-mail: jean-luc.parent@usherbrooke.ca.	Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goalstone ML, 2001, J BIOL CHEM, V276, P12805, DOI 10.1074/jbc.M009443200; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Gromov P, 1998, ELECTROPHORESIS, V19, P1803, DOI 10.1002/elps.1150191043; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Kametaka S, 2010, J CELL SCI, V123, P460, DOI 10.1242/jcs.055103; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Smythe E, 2002, MOL CELL, V9, P205, DOI 10.1016/S1097-2765(02)00462-8; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; Theriault C, 2004, BIOCHEMISTRY-US, V43, P5600, DOI 10.1021/bi036268v; Thoma NH, 2001, J BIOL CHEM, V276, P48637, DOI 10.1074/jbc.M108241200; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460	53	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40802	40813		10.1074/jbc.M111.267815	http://dx.doi.org/10.1074/jbc.M111.267815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990357	hybrid, Green Published			2022-12-25	WOS:000297315400041
J	Marsh, AA; Crowe, SL; Yu, HH; Gorodetsky, EK; Goldman, D; Blair, RJR				Marsh, Abigail A.; Crowe, Samantha L.; Yu, Henry H.; Gorodetsky, Elena K.; Goldman, David; Blair, R. J. R.			Serotonin Transporter Genotype (5-HTTLPR) Predicts Utilitarian Moral Judgments	PLOS ONE			English	Article							NEGATIVE AFFECTIVITY; PREFRONTAL CORTEX; SUSCEPTIBILITY; POLYMORPHISM; PSYCHOPATHY; DEPRESSION; AMYGDALA; RISK; GENE	Background: The psychological and neurobiological processes underlying moral judgment have been the focus of extensive recent research. Here we show that serotonin transporter (5-HTTLPR) genotype predicts responses to moral dilemmas featuring foreseen harm to an innocent. Methodology/Principal Findings: Participants in this study judged the acceptability of actions that would unintentionally or intentionally harm an innocent victim in order to save others' lives. An analysis of variance revealed a genotype 6 scenario interaction, F(2, 63)=4.52, p=.02. Results showed that, relative to long allele homozygotes (LL), carriers of the short (S) allele showed particular reluctance to endorse utilitarian actions resulting in foreseen harm to an innocent individual. LL genotype participants rated perpetrating unintentional harm as more acceptable (M=4.98, SEM=0.20) than did SL genotype participants (M=4.65, SEM=0.20) or SS genotype participants (M=4.29, SEM=0.30). No group differences in moral judgments were observed in response to scenarios featuring intentional harm. Conclusions/Significance: The results indicate that inherited variants in a genetic polymorphism that influences serotonin neurotransmission influence utilitarian moral judgments as well. This finding is interpreted in light of evidence that the S allele is associated with elevated emotional responsiveness.	[Marsh, Abigail A.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Marsh, Abigail A.; Crowe, Samantha L.; Yu, Henry H.; Blair, R. J. R.] NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA; [Gorodetsky, Elena K.; Goldman, David] NIAAA, Sect Human Neurogenet, Bethesda, MD 90034 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Marsh, AA (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	aam72@georgetown.edu	Majid, Salma/AAT-2616-2020; Blair, Robert James/ABH-7982-2020; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Blair, Robert James/0000-0002-6377-2361; Yu, Henry/0000-0003-3789-5250	National Institute of Mental Health/Nathional Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	National Institute of Mental Health/Nathional Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program at the National Institute of Mental Health/Nathional Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Harmon A, 2010, NY TIMES        0918; Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465	18	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25148	10.1371/journal.pone.0025148	http://dx.doi.org/10.1371/journal.pone.0025148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998637	gold, Green Published, Green Submitted			2022-12-25	WOS:000295966900010
J	Oosting, M; ter Hofstede, H; Sturm, P; Adema, GJ; Kullberg, BJ; van der Meer, JWM; Netea, MG; Joosten, LAB				Oosting, Marije; ter Hofstede, Hadewych; Sturm, Patrick; Adema, Gosse J.; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.			TLR1/TLR2 Heterodimers Play an Important Role in the Recognition of Borrelia Spirochetes	PLOS ONE			English	Article							RECEPTOR SIGNALING PATHWAY; TOLL-LIKE RECEPTOR-6; LYME-DISEASE; CUTTING EDGE; HUMAN MONOCYTES; ERYTHEMA MIGRANS; IMMUNE-RESPONSE; HOST-DEFENSE; BURGDORFERI; TLR1	After infection with Borrelia species, the risk for developing Lyme disease varies significantly between individuals. Recognition of Borrelia by the immune system is mediated by pattern recognition receptors (PRRs), such as TLRs. While TLR2 is the main recognition receptor for Borrelia spp., little is known about the role of TLR1 and TLR6, which both can form functionally active heterodimers with TLR2. Here we investigated the recognition of Borrelia by both murine and human TLR1 and TLR6. Peritoneal macrophages from TLR1- and TLR6- gene deficient mice were isolated and exposed to Borrelia. Human PBMCs were stimulated with Borrelia with or without specific TLR1 and TLR6 blocking using specific antibodies. Finally, the functional consequences of TLR polymorphisms on Borrelia-induced cytokine production were assessed. Splenocytes isolated from both TLR1-/- and TLR-/- mice displayed a distorted Th1/Th2 cytokine balance after stimulation with B. burgdorferi, while no differences in pro-inflammatory cytokine production were observed. In contrast, blockade of TLR1 with specific neutralizing antibodies led to decreased cytokine production by human PBMCs after exposure to B. burgdorferi. Blockade of human TLR6 did not lead to suppression of cytokine production. When PBMCs from healthy individuals bearing polymorphisms in TLR1 were exposed to B. burgdorferi, a remarkably decreased in vitro cytokine production was observed in comparison to wild-type controls. TLR6 polymorphisms lead to a minor modified cytokine production. This study indicates a dominant role for TLR1/TLR2 heterodimers in the induction of the early inflammatory response by Borrelia spirochetes in humans.	[Oosting, Marije; ter Hofstede, Hadewych; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Oosting, Marije; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Sturm, Patrick] Radboud Univ Nijmegen, Med Ctr, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Oosting, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Joosten, Leo AB/H-3138-2015; Oosting, Marije/H-7437-2015; Kullberg, BJ/C-8520-2013; Hofstede, Hadewych ter/AAD-1118-2019; Adema, G.J./H-8007-2014; Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013	Joosten, Leo AB/0000-0001-6166-9830; Kullberg, BJ/0000-0002-6813-8167; van der Meer, Jos W.M./0000-0001-5120-3690	Dutch Arthritis Association [NR 10-1-303]; Netherlands Organization for Scientific Research	Dutch Arthritis Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Arthritis Association (NR 10-1-303). M.G.N. was supported by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; BALMELLI T, 1995, RES MICROBIOL, V146, P329, DOI 10.1016/0923-2508(96)81056-4; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; Fikrig E, 2009, J INFECT DIS, V200, P1331, DOI 10.1086/605950; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Glickstein L, 2003, INFECT IMMUN, V71, P6051, DOI 10.1128/IAI.71.10.6051-6053.2003; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoshino K, 1999, J IMMUNOL, V162, P3749; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; Netea MG, 2008, FEMS IMMUNOL MED MIC, V52, P118, DOI 10.1111/j.1574-695X.2007.00353.x; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Wang XH, 2008, FEMS IMMUNOL MED MIC, V52, P124, DOI 10.1111/j.1574-695X.2007.00356.x; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348	31	44	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25998	10.1371/journal.pone.0025998	http://dx.doi.org/10.1371/journal.pone.0025998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998742	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900088
J	Necchi, F; Nardi-Dei, V; Biagini, M; Assfalg, M; Nuccitelli, A; Cozzi, R; Norais, N; Telford, JL; Rinaudo, CD; Grandi, G; Maione, D				Necchi, Francesca; Nardi-Dei, Vincenzo; Biagini, Massimiliano; Assfalg, Michael; Nuccitelli, Annalisa; Cozzi, Roberta; Norais, Nathalie; Telford, John L.; Rinaudo, C. Daniela; Grandi, Guido; Maione, Domenico			Sortase A Substrate Specificity in GBS Pilus 2a Cell Wall Anchoring	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; ACTINOMYCES-NAESLUNDII; EPITHELIAL-CELLS; SURFACE-PROTEINS; LPXTG MOTIF; TRANSPEPTIDASE; COLONIZATION; INVOLVEMENT	Streptococcus agalactiae, also referred to as Group B Streptococcus (GBS), is one of the most common causes of life-threatening bacterial infections in infants. In recent years cell surface pili have been identified in several Gram-positive bacteria, including GBS, as important virulence factors and promising vaccine candidates. In GBS, three structurally distinct types of pili have been discovered (pilus 1, 2a and 2b), whose structural subunits are assembled in high-molecular weight polymers by specific class C sortases. In addition, the highly conserved housekeeping sortase A (SrtA), whose main role is to link surface proteins to bacterial cell wall peptidoglycan by a transpeptidation reaction, is also involved in pili cell wall anchoring in many bacteria. Through in vivo mutagenesis, we demonstrate that the LPXTG sorting signal of the minor ancillary protein (AP2) is essential for pilus 2a anchoring. We successfully produced a highly purified recombinant SrtA (SrtA(Delta N40)) able to specifically hydrolyze the sorting signal of pilus 2a minor ancillary protein (AP2-2a) and catalyze in vitro the transpeptidation reaction between peptidoglycan analogues and the LPXTG motif, using both synthetic fluorescent peptides and recombinant proteins. By contrast, SrtADN40 does not catalyze the transpeptidation reaction with substrate-peptides mimicking sorting signals of the other pilus 2a subunits (the backbone protein and the major ancillary protein). Thus, our results add further insight into the proposed model of GBS pilus 2a assembly, in which SrtA is required for pili cell wall covalent attachment, acting exclusively on the minor accessory pilin, representing the terminal subunit located at the base of the pilus.	[Necchi, Francesca; Nardi-Dei, Vincenzo; Biagini, Massimiliano; Nuccitelli, Annalisa; Cozzi, Roberta; Norais, Nathalie; Telford, John L.; Rinaudo, C. Daniela; Grandi, Guido; Maione, Domenico] Novartis Vaccines & Diagnost, Siena, Italy; [Assfalg, Michael] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Novartis; University of Verona	Necchi, F (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185; Assfalg, Michael/0000-0001-9331-3169	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics, whose role, through the employment of Francesca Necchi, Vincenzo Nardi-Dei, Massimiliano Biagini, Annalisa Nuccitelli, Roberta Cozzi, Nathalie Norais, John L. Telford, C. Daniela Rinaudo, Guido Grandi and Domenico Maione, involved conceiving, designing and performing the experiments and analyzing the data.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; CHANG C, 2001, MOL MICROBIOL, V79, P1236; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Reinscheid DJ, 2003, FEMS MICROBIOL LETT, V221, P73, DOI 10.1016/S0378-1097(03)00167-8; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yeung MK, 1997, INFECT IMMUN, V65, P2629, DOI 10.1128/IAI.65.7.2629-2639.1997	37	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25300	10.1371/journal.pone.0025300	http://dx.doi.org/10.1371/journal.pone.0025300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991306	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300008
J	Conte, E; Fruciano, M; Fagone, E; Gili, E; Caraci, F; Iemmolo, M; Crimi, N; Vancheri, C				Conte, Enrico; Fruciano, Mary; Fagone, Evelina; Gili, Elisa; Caraci, Filippo; Iemmolo, Maria; Crimi, Nunzio; Vancheri, Carlo			Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-PROLIFERATION; PULMONARY-FIBROSIS; P38 MAPK; PHOSPHOINOSITIDE; ACTIVATION; EXPRESSION	Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-beta (TGF-beta)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-beta signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-beta: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-beta-induced increase in cell proliferation, in alpha-smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110 delta and p110 gamma are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110 alpha and beta. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110 gamma and p110 alpha in both TGF-beta-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.	[Conte, Enrico; Fruciano, Mary; Fagone, Evelina; Gili, Elisa; Caraci, Filippo; Iemmolo, Maria; Crimi, Nunzio; Vancheri, Carlo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy	University of Catania	Conte, E (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	econte@unict.it	Fruciano, Mary/K-8102-2016; Crimi, Nunzio/AAL-2994-2020; Caraci, Filippo/K-2262-2016; Conte, Enrico/AAD-4597-2019; VANCHERI, Carlo/K-9417-2016	Fruciano, Mary/0000-0002-6201-8092; Crimi, Nunzio/0000-0002-8591-4535; Caraci, Filippo/0000-0002-9867-6054; Conte, Enrico/0000-0002-5780-8735; Fagone, Evelina/0000-0001-8413-7300; VANCHERI, Carlo/0000-0002-5120-9926	European Community [HEALTH-F2-2007-202224 eurIPFnet]	European Community(European Commission)	The research has been funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> HEALTH-F2-2007-202224 eurIPFnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; FINE A, 1987, J BIOL CHEM, V262, P3897; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; RAGHU G, 1989, AM REV RESPIR DIS, V140, P95, DOI 10.1164/ajrccm/140.1.95; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Wei X, 2010, BIOCHEM BIOPH RES CO, V397, P311, DOI 10.1016/j.bbrc.2010.05.109; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117	23	89	104	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24663	10.1371/journal.pone.0024663	http://dx.doi.org/10.1371/journal.pone.0024663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984893	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000003
J	Wulfken, LM; Moritz, R; Ohlmann, C; Holdenrieder, S; Jung, V; Becker, F; Herrmann, E; Walgenbach-Brunagel, G; von Ruecker, A; Muller, SC; Ellinger, J				Wulfken, Lena M.; Moritz, Rudolf; Ohlmann, Carsten; Holdenrieder, Stefan; Jung, Volker; Becker, Frank; Herrmann, Edwin; Walgenbach-Bruenagel, Gisela; von Ruecker, Alexander; Mueller, Stefan C.; Ellinger, Joerg			MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CANCER; BIOMARKERS; EXPRESSION; KIDNEY; PLASMA; HYPERMETHYLATION; IDENTIFICATION	Background: MicroRNA expression is altered in cancer cells, and microRNAs could serve as diagnostic/prognostic biomarker for cancer patients. Our study was designed to analyze circulating serum microRNAs in patients with renal cell carcinoma (RCC). Methodology/Principal Findings: We first explored microRNA expression profiles in tissue and serum using TaqMan Low Density Arrays in each six malignant and benign samples: Although 109 microRNAs were circulating at higher levels in cancer patients' serum, we identified only 36 microRNAs with up-regulation in RCC tissue and serum of RCC patients. Seven candidate microRNAs were selected for verification based on the finding of up-regulation in serum and tissue of RCC patients: miR-7-1*, miR-93, miR-106b*, miR-210, miR-320b, miR-1233 and miR-1290 levels in serum of healthy controls (n = 30) and RCC (n = 33) patients were determined using quantitative real-time PCR (TaqMan MicroRNA Assays). miR-1233 was increased in RCC patients, and thus validated in a multicentre cohort of 84 RCC patients and 93 healthy controls using quantitative real-time PCR (sensitivity 77.4%, specificity 37.6%, AUC 0.588). We also studied 13 samples of patients with angiomyolipoma or oncocytoma, whose serum miR-1233 levels were similar to RCC patients. Circulating microRNAs were not correlated with clinical-pathological parameters. Conclusions/Significance: MicroRNA levels are distinctly increased in cancer patients, although only a small subset of circulating microRNAs has a tumor-specific origin. We identify circulating miR-1233 as a potential biomarker for RCC patients. Larger-scaled studies are warranted to fully explore the role of circulating microRNAs in RCC.	[Wulfken, Lena M.; Mueller, Stefan C.; Ellinger, Joerg] Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany; [Moritz, Rudolf; Herrmann, Edwin] Univ Klinikum Munster, Klin & Poliklin Urol, Munster, Germany; [Ohlmann, Carsten; Jung, Volker; Becker, Frank] Univ Klinikum Saarlandes, Klin & Poliklin Urol, Homburg, Germany; [Holdenrieder, Stefan] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [von Ruecker, Alexander] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Universitatsklinikum des Saarlandes; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Bonn	Wulfken, LM (corresponding author), Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany.	joerg.ellinger@ukb.uni-bonn.de	Ellinger, Jörg/D-8389-2011	Ellinger, Jörg/0000-0002-7526-0857	Deutsche Forschungsgemeinschaft [EL-623/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a research grant to Jorg Ellinger from the Deutsche Forschungsgemeinschaft (EL-623/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; DWEEP H, 2011, J BIOMED INFORM; Ellinger J, 2008, PROSTATE, V68, P42, DOI 10.1002/pros.20651; Ellinger J, 2008, J UROLOGY, V179, P346, DOI 10.1016/j.juro.2007.08.091; Ellinger J, 2008, INT J CANCER, V122, P138, DOI 10.1002/ijc.23057; Ellinger J, 2009, J UROLOGY, V182, P324, DOI 10.1016/j.juro.2009.02.106; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004	32	185	192	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25787	10.1371/journal.pone.0025787	http://dx.doi.org/10.1371/journal.pone.0025787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984948	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300058
J	Varady, G; Sarkadi, B; Fatyol, K				Varady, Gyoergy; Sarkadi, Balazs; Fatyol, Karoly			TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-beta Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; 5'-TYROSYL DNA PHOSPHODIESTERASE; RECEPTOR-ASSOCIATED FACTORS; BREAST-CANCER PROGRESSION; P38 MAP KINASE; ACTIVATED KINASE-1; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSIENT ACTIVATION; CELL-PROLIFERATION; INDUCED APOPTOSIS	Transforming growth factor-beta (TGF-beta) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signaling routes are also employed by this pleiotropic cytokine. For instance recently, we have demonstrated that ligand occupied TGF-beta receptors can directly trigger the TRAF6-TAK1 signaling module, resulting in MAP kinase activation. Here we report identification of the adaptor molecule T TRAP as a novel component of this non-canonical TGF-beta pathway. We show that the protein associates with TGF-beta receptors and components of the TRAF6-TAK1 signaling module, resulting in differential regulation of TGF-beta activated p38 and NF-kappa B responses. Modulation of cellular TTRAP level affects cell viability in the presence of TGF-beta, suggesting that the protein is an important component of the TGF-beta induced apoptotic process.	[Varady, Gyoergy; Sarkadi, Balazs; Fatyol, Karoly] Hungarian Acad Sci, Membrane Res Grp, Budapest, Hungary	Hungarian Academy of Sciences	Varady, G (corresponding author), Hungarian Acad Sci, Membrane Res Grp, Budapest, Hungary.	kfatyol@gmail.com	Sarkadi, Balazs/I-5024-2013; György, Várady/J-8118-2017		Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism [NNF78805]; Janos Bolyai fellowship	Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai fellowship(Hungarian Academy of Sciences)	This research was supported by a Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism joint grant (NNF78805). KF was supported by a Janos Bolyai fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Davies CC, 2005, MOL CELL BIOL, V25, P9806, DOI 10.1128/MCB.25.22.9806-9819.2005; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Sung I, 2009, J BIOL CHEM, V284, P22285, DOI 10.1074/jbc.M109.007146; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Li C., 2011, ONCOGENE IN PRESS; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; PARVANI JG, 2011, J MAMMARY G IN PRESS; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Resch U, 2009, J CELL SCI, V122, P2651, DOI 10.1242/jcs.049940; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Watkins SJ, 2006, CARDIOVASC RES, V69, P432, DOI 10.1016/j.cardiores.2005.11.007; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	61	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25548	10.1371/journal.pone.0025548	http://dx.doi.org/10.1371/journal.pone.0025548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980489	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700042
J	Harma, V; Knuuttila, M; Virtanen, J; Mirtti, T; Kohonen, P; Kovanen, P; Happonen, A; Kaewphan, S; Ahonen, I; Kallioniemi, O; Grafstrom, R; Lotjonen, J; Nees, M				Harma, V.; Knuuttila, M.; Virtanen, J.; Mirtti, T.; Kohonen, P.; Kovanen, P.; Happonen, A.; Kaewphan, S.; Ahonen, I.; Kallioniemi, O.; Grafstrom, R.; Lotjonen, J.; Nees, M.			Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models	ONCOGENE			English	Article						prostate cancer; epithelial plasticity; bioactive lipids; G-protein coupled receptors; lysophosphatidic acid; sphingosine-1-phosphate	SMALL-MOLECULE INHIBITOR; HUMAN OVARIAN-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; SPHINGOSINE 1-PHOSPHATE; PHOSPHOLIPASE A(2); GENE-EXPRESSION; KINASE PATHWAY; RECEPTOR 2; LPA; ACTIVATION	Normal prostate and some malignant prostate cancer (PrCa) cell lines undergo acinar differentiation and form spheroids in three-dimensional (3-D) organotypic culture. Acini formed by PC-3 and PC-3M, less pronounced also in other PrCa cell lines, spontaneously undergo an invasive switch, leading to the disintegration of epithelial structures and the basal lamina, and formation of invadopodia. This demonstrates the highly dynamic nature of epithelial plasticity, balancing epithelial-to-mesenchymal transition against metastable acinar differentiation. This study assessed the role of lipid metabolites on epithelial maturation. PC-3 cells completely failed to form acinar structures in delipidated serum. Adding back lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) rescued acinar morphogenesis and repressed invasion effectively. Blocking LPA receptor 1 (LPAR1) functions by siRNA (small interference RNA) or the specific LPAR1 inhibitor Ki16425 promoted invasion, while silencing of other G-protein-coupled receptors responsive to LPA or S1P mainly caused growth arrest or had no effects. The G-proteins G alpha(12/13) and G alpha(i) were identified as key mediators of LPA signalling via stimulation of RhoA and Rho kinases ROCK1 and 2, activating Rac1, while inhibition of adenylate cyclase and accumulation of cAMP may be secondary. Interfering with these pathways specifically impeded epithelial polarization in transformed cells. In contrast, blocking the same pathways in non-transformed, normal cells promoted differentiation. We conclude that LPA and LPAR1 effectively promote epithelial maturation and block invasion of PrCa cells in 3-D culture. The analysis of clinical transcriptome data confirmed reduced expression of LPAR1 in a subset of PrCa's. Our study demonstrates a metastasis-suppressor function for LPAR1 and G alpha(12/13) signalling, regulating cell motility and invasion versus epithelial maturation. Oncogene (2012) 31, 2075-2089; doi: 10.1038/onc.2011.396; published online 26 September 2011	[Harma, V.; Virtanen, J.; Grafstrom, R.; Nees, M.] VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, FI-20520 Turku, Finland; [Knuuttila, M.; Virtanen, J.; Kohonen, P.; Ahonen, I.] Univ Turku, Ctr Biotechnol, Turku, Finland; [Mirtti, T.; Kallioniemi, O.] Univ Helsinki, FIMM, Helsinki, Finland; [Mirtti, T.; Kovanen, P.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Mirtti, T.; Kovanen, P.] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Happonen, A.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Kaewphan, S.] Univ Turku, Dept Informat Technol, Turku, Finland; [Grafstrom, R.] Karolinska Inst, Toxicol Lab, Stockholm, Sweden; [Lotjonen, J.] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Tampere, Finland	VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; University of Turku; Karolinska Institutet; VTT Technical Research Center Finland	Nees, M (corresponding author), VTT Tech Res Ctr Finland, Med Biotechnol Knowledge Ctr, POB 106, FI-20520 Turku, Finland.	matthias.nees@vtt.fi	Kohonen, Pekka/F-9596-2011; Happonen, Antti/M-7644-2014; Nees, Matthias/W-6596-2018; Kallioniemi, Olli P/H-5111-2011; Nees, Matthias/AAT-5577-2020; Grafström, Roland C/N-7217-2016	Kohonen, Pekka/0000-0002-7845-3611; Nees, Matthias/0000-0002-9034-301X; Kallioniemi, Olli P/0000-0002-3231-0332; Knuuttila, Matias/0000-0002-9953-5755; Mirtti, Tuomas/0000-0003-0455-9891; Harma, Ville/0000-0001-5767-5226	Academy of Finland [134472]	Academy of Finland(Academy of Finland)	We would like to thank Leena Saikko for expert technical assistance. This work was funded by the Academy of Finland (grant to MN), number 134472.	Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Brizuela L, 2010, FASEB J, V24, P3882, DOI 10.1096/fj.10-160838; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Daaka Y, 2002, BBA-MOL CELL BIOL L, V1582, P265, DOI 10.1016/S1388-1981(02)00180-4; Deng WL, 2002, GASTROENTEROLOGY, V123, P206, DOI 10.1053/gast.2002.34209; Devine KM, 2008, GYNECOL ONCOL, V110, P237, DOI 10.1016/j.ygyno.2008.04.013; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fishman DA, 2001, CANCER RES, V61, P3194; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Gibbs TC, 2009, PROSTATE, V69, P1493, DOI 10.1002/pros.20994; Gobeil F, 2003, J BIOL CHEM, V278, P38875, DOI 10.1074/jbc.M212481200; Goetzl EJ, 1999, CANCER RES, V59, P4732; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Groves-Kirkby N, 2010, NAT REV UROL, V7, P420; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Hasegawa Y, 2008, MOL ONCOL, V2, P54, DOI 10.1016/j.molonc.2008.03.009; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Hong GY, 1999, FEBS LETT, V460, P513, DOI 10.1016/S0014-5793(99)01400-3; Hope JM, 2009, GYNECOL ONCOL, V112, P215, DOI 10.1016/j.ygyno.2008.09.019; Hwang YS, 2006, MOL CARCINOGEN, V45, P518, DOI 10.1002/mc.20183; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kim EK, 2008, EXP MOL MED, V40, P445, DOI 10.3858/emm.2008.40.4.445; Kim J, 2002, CANCER RES, V62, P1549; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Li SY, 2005, INT J ONCOL, V27, P1329; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin P, 2011, EUR J CELL BIOL, V90, P13, DOI 10.1016/j.ejcb.2010.09.009; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nouh MAAM, 2009, CANCER SCI, V100, P1631, DOI 10.1111/j.1349-7006.2009.01234.x; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pchejetski D, 2010, CANCER RES, V70, P8651, DOI 10.1158/0008-5472.CAN-10-1388; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Shida D, 2003, CANCER RES, V63, P1706; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Smicun Y, 2007, GYNECOL ONCOL, V107, P298, DOI 10.1016/j.ygyno.2007.06.024; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Snider AJ, 2010, AM J PHYSIOL-CELL PH, V298, pC163, DOI 10.1152/ajpcell.00001.2009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; van Dijk MCM, 1998, CURR BIOL, V8, P386, DOI 10.1016/S0960-9822(98)70157-5; van Golen KL, 2008, J CELL BIOCHEM, V104, P1587, DOI 10.1002/jcb.21652; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Wang FQ, 2010, GYNECOL ONCOL, V117, P88, DOI 10.1016/j.ygyno.2009.12.012; Waters CM, 2006, BIOCHEM J, V398, P55, DOI 10.1042/BJ20060155; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Yamaguchi H, 2003, BIOCHEM J, V374, P715, DOI 10.1042/BJ20030381; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	83	35	40	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2075	2089		10.1038/onc.2011.396	http://dx.doi.org/10.1038/onc.2011.396			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21996742	Green Published, hybrid			2022-12-25	WOS:000303008600008
J	Swant, J; Goodwin, JS; North, A; Ali, AA; Gamble-George, J; Chirwa, S; Khoshbouei, H				Swant, Jarod; Goodwin, J. Shawn; North, Ashley; Ali, Ahmad Abdul; Gamble-George, Joyonna; Chirwa, Sanika; Khoshbouei, Habibeh			alpha-Synuclein Stimulates a Dopamine Transporter-dependent Chloride Current and Modulates the Activity of the Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; PARKINSONS-DISEASE; MICE LACKING; AMPHETAMINE; COCAINE; RECEPTOR; KINETICS; NEURONS; CHANNEL; BINDING	Dysregulation of dopamine (DA) homeostasis is implicated in neurodegenerative diseases, drug addiction, and neuropsychiatric disorders. The neuronal plasma membrane dopamine transporter (DAT) is essential for the maintenance of DA homeostasis in the brain. alpha-Synuclein is a 140-amino acid protein that forms a stable complex with DAT and is linked to the pathogenesis of neurodegenerative disease. To elucidate the potential functional consequences of DAT/alpha-synuclein interaction, we explored alpha-synuclein modulation of DAT activity in midbrain dopaminergic neurons obtained from TH::RFP mice, immortalized DA neurons, and a heterologous system expressing DAT. We used dual pipette whole cell patch clamp recording to measure the DAT-mediated current before and after dialysis of recombinant alpha-synuclein into immortalized DA neurons. Our data suggest that intracellular alpha-synuclein induces a Na+ independent but Cl--sensitive inward current in DAT-expressing cells. This current is blocked by DAT blocker GBR12935 and is absent when heat-inactivated alpha-synuclein is dialyzed into these cells. The functional consequence of this interaction on DAT activity was further examined with real-time monitoring of transport function using a fluorescent substrate of DAT, 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP(+)). Overexpression of alpha-synucleinin DAT-positive immortalized DA neurons and CHO cells expressing DAT decreased the magnitude and rate of DAT-mediated substrate uptake without a decrease in the initial binding of the substrate at the plasma membrane. Taken together our findings are consistent with the interpretation that DAT/alpha-synuclein interaction at the cell surface results in a DAT-dependent, Na+-insensitive, Cl-sensitive inward current with a decrease in substrate uptake, suggesting that DAT/alpha-synuclein interaction can modulate dopamine transmission and thus neuronal function.	[Swant, Jarod; Goodwin, J. Shawn; North, Ashley; Gamble-George, Joyonna; Chirwa, Sanika; Khoshbouei, Habibeh] Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA; [Ali, Ahmad Abdul] James Madison Univ, Harrisonburg, VA 22807 USA	Meharry Medical College; James Madison University	Khoshbouei, H (corresponding author), Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA.	hkhoshbouei@mmc.edu	Gamble-George, Joyonna C/Q-2075-2017; Gamble-George, Joyonna Carrie/GQA-7423-2022; Gamble-George, Joyonna/AAM-7598-2021	Gamble-George, Joyonna C/0000-0002-5492-9216; Gamble-George, Joyonna/0000-0002-5492-9216; Khoshbouei, Habibeh/0000-0002-1533-8771	National Institutes of Health [DA026947, DA021471, NS071122, U01NS041071, U54RR026140, S10RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071, R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA026947, DA021471, and NS071122.; Microscopy experiments were performed using the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grants U01NS041071, U54RR026140, and S10RR0254970. We thank Drs. Lee Limbird and Louis DeFelice for helpful suggestions and critical review of this manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Blakely RD, 2007, MOL PHARMACOL, V71, P1206, DOI 10.1124/mol.107.035493; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Felix K, 2005, J BIOCHEM MOL TOXIC, V19, P67, DOI 10.1002/jbt.20062; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Gwinn-Hardy K, 2000, ACTA NEUROPATHOL, V99, P663, DOI 10.1007/s004010051177; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Ingram SL, 2000, J NEUROSCI, V20, P550, DOI 10.1523/JNEUROSCI.20-02-00550.2000; IVERSEN L, 1992, NATURE, V358, P109, DOI 10.1038/358109a0; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Lute BJ, 2008, BIOCHEM BIOPH RES CO, V372, P656, DOI 10.1016/j.bbrc.2008.05.091; Mash DC, 2003, J NEUROSCI, V23, P2564; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; MAZZANTI M, 1987, BIOPHYS J, V52, P95, DOI 10.1016/S0006-3495(87)83192-2; MAZZANTI M, 1987, BIOPHYS J, V51, P115, DOI 10.1016/S0006-3495(87)83316-7; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oz M, 2010, J NEUROCHEM, V112, P1454, DOI 10.1111/j.1471-4159.2009.06557.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prasad KN, 1998, MOL GENET METAB, V65, P1, DOI 10.1006/mgme.1998.2726; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Schwartz JW, 2006, HANDB EXP PHARM, V175, P23; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2003, FASEB J, V17, P2151, DOI 10.1096/fj.03-0152fje; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zarranz J, 2004, REV NEUROLOGIA, V39, P576, DOI 10.33588/rn.3906.2004278; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	72	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43933	43943		10.1074/jbc.M111.241232	http://dx.doi.org/10.1074/jbc.M111.241232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21990355	hybrid, Green Published			2022-12-25	WOS:000298402300034
J	Rosental, N; Gameiro, A; Grewer, C; Kanner, BI				Rosental, Noa; Gameiro, Armanda; Grewer, Christof; Kanner, Baruch I.			A Conserved Aspartate Residue Located at the Extracellular End of the Binding Pocket Controls Cation Interactions in Brain Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; SUBSTRATE INTERACTIONS; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; MEMBRANE-VESICLES; CHLORIDE CHANNEL; MAMMALIAN-CELLS; REENTRANT LOOP; EAAC1	In the brain, transporters of the major excitatory neurotransmitter glutamate remove their substrate from the synaptic cleft to allow optimal glutamatergic neurotransmission. Their transport cycle consists of two sequential translocation steps, namely cotransport of glutamic acid with three Na+ ions, followed by countertransport of K+ Recent studies, based on several crystal structures of the archeal homologue Glt(ph), indicate that glutamate translocation occurs by an elevator-like mechanism. The resolution of these structures was not sufficiently high to unambiguously identify the sites of Na+ binding, but functional and computational studies suggest some candidate sites. In the Gltph structure, a conserved aspartate residue (Asp-390) is located adjacent to a conserved tyrosine residue, previously shown to be a molecular determinant of ion selectivity in the brain glutamate transporter GET-1. In this study, we characterize mutants of Asp-440 of the neuronal transporter EAAC1, which is the counterpart of Asp-390 of Glt(ph). Except for substitution by glutamate, this residue is functionally irreplaceable. Using biochemical and electrophysiological approaches, we conclude that although D440E is intrinsically capable of net flux, this mutant behaves as an exchanger under physiological conditions, due to increased and decreased apparent affinities for Na+ and K+ respectively. Our present and previous data are compatible with the idea that the conserved tyrosine and aspartate residues, located at the external end of the binding pocket, may serve as a transient or stable cation binding site in the glutamate transporters.	[Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA	Hebrew University of Jerusalem; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Kanner, BI (corresponding author), POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il	Albers, Thomas/A-9082-2012		National Institutes of Health [NS16708, 2R01NS049335-06A1]; Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708, R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS16708 and 2R01NS049335-06A1 (to B. I. K. and C. G.) and Binational Science Foundation Grant 2007051 (to C. G. and B. I. K.).	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lowry O. H., 1951, BIOL CHEM, V193, P265; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41381	41390		10.1074/jbc.M111.291021	http://dx.doi.org/10.1074/jbc.M111.291021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984827	Green Published, hybrid			2022-12-25	WOS:000298057500025
J	Guo, XL; Pace, RG; Stonebraker, JR; Commander, CW; Dang, AT; Drumm, ML; Harris, A; Zou, F; Swallow, DM; Wright, FA; O'Neal, WK; Knowles, MR				Guo, XueLiang; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Commander, Clayton W.; Dang, Anthony T.; Drumm, Mitchell L.; Harris, Ann; Zou, Fei; Swallow, Dallas M.; Wright, Fred A.; O'Neal, Wanda K.; Knowles, Michael R.			Mucin Variable Number Tandem Repeat Polymorphisms and Severity of Cystic Fibrosis Lung Disease: Significant Association with MUC5AC	PLOS ONE			English	Article							ALLELIC ASSOCIATION; GENE; IDENTIFICATION; EXPRESSION; COMPLEX; MUCUS	Variability in cystic fibrosis (CF) lung disease is partially due to non-CFTR genetic modifiers. Mucin genes are very polymorphic, and mucins play a key role in the pathogenesis of CF lung disease; therefore, mucin genes are strong candidates as genetic modifiers. DNA from CF patients recruited for extremes of lung phenotype was analyzed by Southern blot or PCR to define variable number tandem repeat (VNTR) length polymorphisms for MUC1, MUC2, MUC5AC, and MUC7. VNTR length polymorphisms were tested for association with lung disease severity and for linkage disequilibrium (LD) with flanking single nucleotide polymorphisms (SNPs). No strong associations were found for MUC1, MUC2, or MUC7. A significant association was found between the overall distribution of MUC5AC VNTR length and CF lung disease severity (p = 0.025; n = 468 patients); plus, there was robust association of the specific 6.4 kb HinfI VNTR fragment with severity of lung disease (p = 6.2 x 10(-4) after Bonferroni correction). There was strong LD between MUC5AC VNTR length modes and flanking SNPs. The severity-associated 6.4 kb VNTR allele of MUC5AC was confirmed to be genetically distinct from the 6.3 kb allele, as it showed significantly stronger association with nearby SNPs. These data provide detailed respiratory mucin gene VNTR allele distributions in CF patients. Our data also show a novel link between the MUC5AC 6.4 kb VNTR allele and severity of CF lung disease. The LD pattern with surrounding SNPs suggests that the 6.4 kb allele contains, or is linked to, important functional genetic variation.	[Guo, XueLiang; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Commander, Clayton W.; Dang, Anthony T.; O'Neal, Wanda K.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Zou, Fei; Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London, England; [Knowles, Michael R.] Gene Modifier Study Grp, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; Case Western Reserve University	Guo, XL (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA.	knowles@med.unc.edu		Commander, Clayton/0000-0001-8477-932X; Pace, Rhonda/0000-0001-8606-0327	United States Cystic Fibrosis Foundation [STONEB08G0, KNOWLE00A0, DRUMM00A0, R026-CR02]; National Institutes of Health [CTRC RR00046, CTSA UL1RR025747, HL068890, HL094585]; British Lung Foundation [P96/14]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747, M01RR000046] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585, R01HL068890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Lung Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the United States Cystic Fibrosis Foundation: STONEB08G0 (J.R.S.), KNOWLE00A0 (M.R.K.), DRUMM00A0 (M.L.D.), R026-CR02 (W.K.O.); the National Institutes of Health: CTRC RR00046, CTSA UL1RR025747, HL068890 (M.R.K.) and HL094585 (A.H.); and the British Lung Foundation P96/14 (D.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du J., 2002, COMBINED ALGORITHMS; Engelmann K, 2001, J BIOL CHEM, V276, P27764, DOI 10.1074/jbc.M103187200; Escande F, 2001, BIOCHEM J, V358, P763, DOI 10.1042/0264-6021:3580763; Fowler J, 2001, FRONT BIOSCI-LANDMRK, V6, pD1207, DOI 10.2741/Fowler; Fowler JC, 2003, HUM GENET, V113, P473, DOI 10.1007/s00439-003-1011-8; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Henke MO, 2007, AM J RESP CRIT CARE, V175, P816, DOI 10.1164/rccm.200607-1011OC; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Mitsuta K, 2005, ONCOL REP, V14, P185; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Pratt WS, 1996, ANN HUM GENET, V60, P21, DOI 10.1111/j.1469-1809.1996.tb01168.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rousseau K, 2007, ANN HUM GENET, V71, P561, DOI 10.1111/j.1469-1809.2007.00374.x; Rousseau K, 2006, ANN HUM GENET, V70, P417, DOI 10.1111/j.1469-1809.2006.00250.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Silva F, 2001, EUR J HUM GENET, V9, P548, DOI 10.1038/sj.ejhg.5200677; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Vinall LE, 2002, GASTROENTEROLOGY, V123, P41, DOI 10.1053/gast.2002.34157; Vinall LE, 2000, METH MOL B, V125, P337; Vinall LE, 2000, AM J RESP CELL MOL, V23, P678, DOI 10.1165/ajrcmb.23.5.4176; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Watson AM, 2009, J INVEST MED, V57, P882, DOI 10.2310/JIM.0b013e3181c0466d; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838	36	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25452	10.1371/journal.pone.0025452	http://dx.doi.org/10.1371/journal.pone.0025452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998660	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700010
J	Lougheed, R; Turnbull, J				Lougheed, Rosamond; Turnbull, John			Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; INCREASED 3-NITROTYROSINE; OXIDATIVE DAMAGE; PROTEIN; MUTATIONS; GENE; MICE; ALS; IMPAIRMENT; INCLUSIONS	Background: Methylene blue (MB) is a drug with a long history and good safety profile, and with recently-described features desirable in a treatment for ALS. Methodology/Principal Findings: We tested oral MB in inbred high-copy number SOD1 G93A mice, at 25 mg/kg/day beginning at 45 days of age. We measured disease onset, progression, and survival. There was no difference in disease onset between MB-treated mice and controls, although subgroup analysis showed a modest but statistically significant delay in disease onset in MB-treated female mice only (control 122 +/- 10.2 versus MB 129 +/- 10.0 days). MB-treated mice of both sexes spent more time in less severe stages of disease, and less time in later, more severe stages of disease. There was a nonsignificant trend to longer survival in MB-treated animals (control males reached endpoint at 161 +/- 14.1 days, versus 166 +/- 10.0 days for MB-treated animals, and control females reached endpoint at 171 +/- 6.2 days versus 173 +/- 13.4 days for MB-treated animals). Conclusions/Significance: In spite of a strong theoretical rationale, MB had no significant effects on onset or survival in the inbred SOD1 G93A mouse model of ALS.	[Lougheed, Rosamond; Turnbull, John] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University	Lougheed, R (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	turnbull@mcmaster.ca			Andrew Bruce Douglas Endowed Chair in Neurology	Andrew Bruce Douglas Endowed Chair in Neurology	This work was supported by the Andrew Bruce Douglas Endowed Chair in Neurology and Mr. David Hunt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harrington C., 2008, ALZHEIMERS DEMENT, V4, pT120, DOI DOI 10.1016/J.JALZ.2008.05.259; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; MacGowan DJL, 2001, NEUROLOGY, V57, P1094, DOI 10.1212/WNL.57.6.1094; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MCCOMAS AJ, 1973, LANCET, V2, P1477; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; National Toxicology Program, 2008, NATL TOXICOL PROGRAM, V540, P1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Silva MTT, 2005, NEUROLOGY, V65, P1332, DOI 10.1212/01.wnl.0000180962.47653.5e; Strong MJ, 2006, NEUROLOGY, V66, P1770, DOI 10.1212/01.wnl.0000218161.15834.db; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2; Wiklund L, 2007, ANN NY ACAD SCI, V1122, P231, DOI 10.1196/annals.1403.016; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yang WC, 2003, NEUROLOGY, V61, P1766, DOI 10.1212/01.WNL.0000099372.75786.F8; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	41	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e23141	10.1371/journal.pone.0023141	http://dx.doi.org/10.1371/journal.pone.0023141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998625	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700002
J	Fu, S; Guo, Y; Chen, H; Xu, ZM; Qiu, GB; Zhong, M; Sun, KL; Fu, WN				Fu, Shuang; Guo, Yan; Chen, Hong; Xu, Zhen-Ming; Qiu, Guang-Bin; Zhong, Ming; Sun, Kai-Lai; Fu, Wei-Neng			MYCT1-TV, A Novel MYCT1 Transcript, Is Regulated by c-Myc and May Participate in Laryngeal Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BINDING-SITES; TARGET; EXPRESSION; GENE; P53; IDENTIFICATION; METASTASIS; MICRORNAS; MIGRATION	Background: MYCT1, a putative target of c-Myc, is a novel candidate tumor suppressor gene cloned from laryngeal squamous cell carcinoma (LSCC). Its transcriptional regulation and biological effects on LSCC have not been clarified. Methodology/Principal Findings: Using RACE assay, we cloned a 1106 bp transcript named Myc target 1 transcript variant 1 (MYCT1-TV) and confirmed its transcriptional start site was located at 140 bp upstream of the ATG start codon of MYCT1-TV. Luciferase, electrophoretic mobility shift and chromatin immunoprecipitation assays confirmed c-Myc could regulate the promoter activity of MYCT1-TV by specifically binding to the E-box elements within 2886 to 2655 bp region. These results were further verified by site-directed mutagenesis and RNA interference (RNAi) assays. MYCT1-TV and MYCT1 expressed lower in LSCC than those in paired adjacent normal laryngeal tissues, and overexpression of MYCT1-TV and MYCT1 could inhibit cell proliferation and invasion and promote apoptosis in LSCC cells. Conclusions/Significance: Our data indicate that MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and downregulation of MYCT1-TV/MYCT1 could contribute to LSCC development and function.	[Fu, Shuang; Chen, Hong; Sun, Kai-Lai; Fu, Wei-Neng] China Med Univ, Dept Med Genet, Shenyang, Peoples R China; [Guo, Yan; Zhong, Ming] China Med Univ, Dept Cent Lab, Sch Stomatol, Shenyang, Peoples R China; [Xu, Zhen-Ming] 463 Hosp PLA, Dept Otolaryngol, Shenyang, Peoples R China; [Qiu, Guang-Bin] 202 Hosp PLA, Dept Clin Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Fu, WN (corresponding author), China Med Univ, Dept Med Genet, Shenyang, Peoples R China.	wnfu@mail.cmu.edu.cn			National Nature Science Foundation of China [30700980]; National 863 Project of China [2002BA711A08-18]; Natural Science Foundation of Liaoning Province [20092110]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Project of China(National High Technology Research and Development Program of China); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Nature Science Foundation of China (30700980), the National 863 Project (2002BA711A08-18) of China and the Natural Science Foundation of Liaoning Province (20092110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2006, Acta Otorhinolaryngol Ital, V26, P326; Ashraf MJ, 2010, INDIAN J PATHOL MICR, V53, P661, DOI 10.4103/0377-4929.72019; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chou ST, 2010, J BIOL CHEM, V285, P17833, DOI 10.1074/jbc.M109.078386; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Cretu Alexandra, 2009, Cancer Ther, V7, P268; Cripps C, 2010, CURR ONCOL, V17, P37; Dang CV, 1999, MOL CELL BIOL, V19, P1; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Graf F, 2009, J ONCOL, V2009, DOI 10.1155/2009/106378; Guo Y, 2008, ONCOL REP, V19, P1453; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Krecicki T, 2004, ACTA OTO-LARYNGOL, V124, P634, DOI 10.1080/00016480310016064; Kuznetsov VA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S12; Le Devedec SE, 2010, CELL MOL LIFE SCI, V67, P3219, DOI 10.1007/s00018-010-0419-2; Lewis BC, 2000, CANCER RES, V60, P6178; Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06; Li N, 2011, PATHOL ONCOL RES, V10, pe1007; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Liu Tingyan, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P648; Mareel M, 2009, VIRCHOWS ARCH, V454, P599, DOI 10.1007/s00428-009-0784-0; Morshed K, 2008, EUR ARCH OTO-RHINO-L, V265, pS89, DOI 10.1007/s00405-007-0569-5; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozdek A, 2004, OTOLARYNG HEAD NECK, V131, P77, DOI 10.1016/j.otohns.2004.02.015; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Pietruszewska Wioletta, 2007, Otolaryngol Pol, V61, P951, DOI 10.1016/S0030-6657(07)70559-0; Qiu GB, 2003, WORLD J GASTROENTERO, V9, P2160; Qiu Guangbin, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P94; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; Ross J, 2009, NUCLEIC ACIDS RES, V37, P5295, DOI 10.1093/nar/gkp545; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x; Wang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-60; Wang YY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-174; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200	43	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25648	10.1371/journal.pone.0025648	http://dx.doi.org/10.1371/journal.pone.0025648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998677	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900040
J	Jia, ZW; Wang, L; Chen, RY; Li, DM; Wang, L; Qin, QQ; Ding, ZW; Ding, GW; Zang, CP; Wang, N				Jia, Zhongwei; Wang, Lu; Chen, Ray Y.; Li, Dongmin; Wang, Lan; Qin, Qianqian; Ding, Zhengwei; Ding, Guowei; Zang, Chunpeng; Wang, Ning			Tracking the Evolution of HIV/AIDS in China from 1989-2009 to Inform Future Prevention and Control Efforts	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MIGRANT WORKERS; HIV; EPIDEMIOLOGY; SHANGHAI; PROGRAM	Background: To determine policy implications, this analysis tracks the evolution of HIV/AIDS infection across China to understand current trends and potential risk factors. Methods and Principal Findings: A retrospective study with spatial analytical model and multilevel spatial models was conducted among 326,157 HIV/AIDS cases reported from 1989-2009. The results indicate that the distribution of HIV/AIDS was clustered at the county level with different directional distributions across China from 2003 to 2009. Compared to 2003, by 2009 there was a 122% increase in HIV cases among rural residents, 294% increase among urban residents, 211% increase among migrants, and 237% increase among permanent residents. The overall proportion of HIV by different routes of transmission showed dramatic changes with a 504% increase in sexual transmission of HIV, 90% decrease in blood/plasma transmission, and 35% decrease in injecting drug user transmission. Sexual transmission was the major transmission route among women (44%) and the elderly (59% in men, 44% in women) as well as among permanent (36%) and urban residents (33%). Among those < 65 years old, women increased more than men, but among those >= 65 years, men increased more than women. Migrants contributed to the variance of HIV infection between counties but not within counties. The length of highway and urbanization combined with illiteracy were risk factors for HIV/AIDS. Conclusions/Significance: Rates of HIV/AIDS among permanent urban residents, particularly women and elderly men, have increased significantly in recent years. To prevent HIV from spreading further among the general population, additional attention should be paid to these populations as well as to migrants.	[Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Jia, Zhongwei; Wang, Lu; Li, Dongmin; Wang, Lan; Qin, Qianqian; Ding, Zhengwei; Ding, Guowei; Zang, Chunpeng; Wang, Ning] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Chen, Ray Y.] US Embassy, NIAID, US Natl Inst Hlth, Beijing, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jia, ZW (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	wangnbj@163.com	Qin, Qin/GVT-5910-2022; qin, qin x/GXG-6164-2022; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019	Chen, Ray/0000-0001-6344-1442	Eleventh Five-year Plan [2008ZX100 (01-003), 03-008]; National Natural Science Foundation [30973981]; U.S. NIH Fogarty [R24 TW007988]; Beijing Municipal Commission of Education [KM201010025010]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Eleventh Five-year Plan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); U.S. NIH Fogarty; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Eleventh Five-year Plan (No. 2008ZX100 (01-003), (03-008)), National Natural Science Foundation (No. 30973981), and U.S. NIH Fogarty R24 TW007988, and Beijing Municipal Commission of Education (No. KM201010025010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, CHIN STAT YB 2004 20; Cao HJ, 2010, AIDS EDUC PREV, V22, P445, DOI 10.1521/aeap.2010.22.5.445; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Li S, 2010, INT J STD AIDS, V21, P82, DOI 10.1258/ijsa.2009.008514; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; Li XJ, 2005, AIDS RES HUM RETROV, V21, P977, DOI 10.1089/aid.2005.21.977; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; LU Z, 2004, GERIATRICS HLTH CARE, V10, P206; Mardia V., 2000, DIRECTIONAL STAT, V2nd; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; *NAT POP FAM PLANN, 2009, REP CHIN MIGR POP DE; PAN SM, 1994, J PSYCHOL HUMAN SEXU, V6, P1; Ruan Fang Fu, 1991, SEX CHINA STUDIES SE; SHAO YM, 1998, INT C AIDS, V12, P111; *STAT COUNC AIDS W, 2010, JOINT ASS HIV AIDS P; WU JP, 1986, SEXUAL MED; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; YUAN FF, 1985, SEXUAL KNOWLEDGE MAN; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803	28	30	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25671	10.1371/journal.pone.0025671	http://dx.doi.org/10.1371/journal.pone.0025671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998679	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900042
J	Lindsay, WR; Webster, MS; Schwabl, H				Lindsay, Willow R.; Webster, Michael S.; Schwabl, Hubert			Sexually Selected Male Plumage Color Is Testosterone Dependent in a Tropical Passerine Bird, the Red-Backed Fairy-Wren (Malurus melanocephalus)	PLOS ONE			English	Article							MALE HOUSE SPARROWS; ELEVATED TESTOSTERONE; EUROPEAN STONECHATS; SOCIAL-DOMINANCE; LIFE-HISTORIES; MOLT; CAROTENOIDS; ORNAMENTS; YOLK; REPRODUCTION	Background: Sexual signals, such as bright plumage coloration in passerine birds, reflect individual quality, and testosterone (T) may play a critical role in maintaining signal honesty. Manipulations of T during molt have yielded mixed effects on passerine plumage color, in most cases delaying molt or leading to production of drab plumage. However, the majority of these studies have been conducted on species that undergo a post-nuptial molt when T is low; the role of T in species that acquire breeding plumage during a pre-nuptial molt remains largely unexplored. Methodology/Principal Findings: We experimentally tested the effects of increased T on plumage color in second-year male red-backed fairy-wrens (Malurus melanocephalus), a species in which after-second-year males undergo a pre-nuptial molt into red/black (carotenoid and melanin-based) plumage and second-year males either assume red/black or brown breeding plumage. T treatment stimulated a rapid and early onset pre-nuptial molt and resulted in red/black plumage acquisition, bill darkening, and growth of the sperm storage organ, but had no effect on body condition or corticosterone concentrations. Control males molted later and assumed brown plumage. T treated males produced feathers with similar but not identical reflectance parameters to those of unmanipulated after-second-year red/black males; while reflectance spectra of red back and black crown feathers were similar, black breast feathers differed in UV chroma, hue and brightness, indicating a potentially age and plumage patch-dependent response to T for melanin-vs. carotenoid-pigmentation. Conclusions/Significance: We show that testosterone is the primary mechanism functioning during the pre-nuptial molt to regulate intrasexually variable plumage color and breeding phenotype in male red-backed fairy-wrens. Our results suggest that the effects of T on plumage coloration may vary with timing of molt (pre- vs. post-nuptial), and that the role of T in mediating plumage signal production may differ across age classes, plumage patches, and between pigment-types.	[Lindsay, Willow R.; Schwabl, Hubert] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Lindsay, Willow R.; Schwabl, Hubert] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Webster, Michael S.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Webster, Michael S.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Washington State University; Washington State University; Cornell University; Cornell University	Lindsay, WR (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	willowlindsay@gmail.com	Webster, Michael/AAB-7151-2020	Webster, Michael/0000-0001-7585-4578	National Science Foundation (United States of America) [0213075, 0818962, 0750540]; Direct For Biological Sciences [0964826] Funding Source: National Science Foundation	National Science Foundation (United States of America)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grants 0213075 and 0818962 to MW, and 0750540 to John Wingfield from the National Science Foundation (United States of America; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Andersson Malte, 1994; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Bokony V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1229, DOI 10.1007/s00265-008-0551-2; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Casagrande S, 2011, J COMP PHYSIOL A, V197, P1, DOI 10.1007/s00359-010-0579-4; Chard T., 1995, INTRO RADIOIMMUNOASS; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; COLLIS K, 1992, AUK, V109, P422; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; DAWSON A, 1994, IBIS, V136, P335, DOI 10.1111/j.1474-919X.1994.tb01104.x; Day LB, 2006, HORM BEHAV, V49, P223, DOI 10.1016/j.yhbeh.2005.07.006; Duckworth RA, 2004, BEHAV ECOL, V15, P779, DOI 10.1093/beheco/arh079; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; Fair J., 2010, ORNITHOLOGICAL COUNC; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galvan I, 2010, J EXP BIOL, V213, P3127, DOI 10.1242/jeb.045096; Gonzalez G, 2001, BEHAV ECOL SOCIOBIOL, V50, P557; Goymann W, 2004, AM NAT, V164, P327, DOI 10.1086/422856; Goymann W, 2002, AUK, V119, P1167, DOI 10.1642/0004-8038(2002)119[1167:CMCBMN]2.0.CO;2; Goymann W, 2002, GEN COMP ENDOCR, V129, P80, DOI 10.1016/S0016-6480(02)00520-8; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Karubian J, 2002, EVOLUTION, V56, P1673; Karubian J, 2008, BEHAV ECOL, V19, P508, DOI 10.1093/beheco/arm159; Karubian J, 2008, J AVIAN BIOL, V39, P81, DOI 10.1111/j.0908-8857.2008.04161.x; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; Kimball Rebecca T., 2006, P431; Kurvers RHJM, 2008, HORM BEHAV, V54, P263, DOI 10.1016/j.yhbeh.2008.03.011; Lindsay WR, 2009, ANIM BEHAV, V77, P1525, DOI 10.1016/j.anbehav.2009.02.027; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Montgomerie, 2008, CLR VERSION 1 05; MULDER RA, 1993, AUK, V110, P588, DOI 10.2307/4088422; NOLAN V, 1992, CONDOR, V94, P364, DOI 10.2307/1369209; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; Peters A, 2006, BEHAV ECOL SOCIOBIOL, V59, P666, DOI 10.1007/s00265-005-0095-7; Peters A, 2000, P ROY SOC B-BIOL SCI, V267, P883, DOI 10.1098/rspb.2000.1085; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, BIOESSAYS, V29, P427, DOI 10.1002/bies.20563; Peters A, 2007, IBIS, V149, P121; Pyle P, 1987, IDENTIFICATION GUIDE, P273; Roberts M, 2009, J EXP BIOL, V212, P1811, DOI 10.1242/jeb.031047; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rowe M, 2008, CONDOR, V110, P694, DOI 10.1525/cond.2008.8604; RUNFELDT S, 1985, ANIM BEHAV, V33, P403, DOI 10.1016/S0003-3472(85)80064-6; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; SCHLEUSSNER G, 1985, PHYSIOL ZOOL, V58, P597, DOI 10.1086/physzool.58.5.30158586; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Sokal R. R., 2012, BIOMETRY; Stoehr AM, 2001, J AVIAN BIOL, V32, P153, DOI 10.1034/j.1600-048X.2001.320208.x; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Varian-Ramos CW, 2010, BEHAV ECOL SOCIOBIOL, V64, P967, DOI 10.1007/s00265-010-0912-5; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; Webster MS, 2008, BEHAV ECOL, V19, P517, DOI 10.1093/beheco/arn015; Wikelski M, 2003, CONDOR, V105, P683, DOI 10.1650/7251; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P406, DOI 10.1016/0016-6480(84)90083-2; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Witschi E., 1961, BIOL COMP PHYSL BIRD, P115; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	68	50	51	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26067	10.1371/journal.pone.0026067	http://dx.doi.org/10.1371/journal.pone.0026067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998753	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900094
J	Rentsch, MB; Zimmer, G				Rentsch, Marianne Berger; Zimmer, Gert			A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon	PLOS ONE			English	Article							HEPATITIS-C; V-PROTEIN; ALPHA; INFECTION; RESPONSES; CELLS; GAMMA; EFFECTORS; DEFENSE; CANCER	Type I interferons (IFN) comprise a family of cytokines that signal through a common cellular receptor to induce a plethora of genes with antiviral and other activities. Recombinant IFNs are used for the treatment of hepatitis C virus infection, multiple sclerosis, and certain malignancies. The capability of type I IFN to suppress virus replication and resultant cytopathic effects is frequently used to measure their bioactivity. However, these assays are time-consuming and require appropriate biosafety containment. In this study, an improved IFN assay is presented which is based on a recombinant vesicular stomatitis virus (VSV) replicon encoding two reporter proteins, firefly luciferase and green fluorescent protein. The vector lacks the essential envelope glycoprotein (G) gene of VSV and is propagated on a G protein-expressing transgenic cell line. Several mammalian and avian cells turned out to be susceptible to infection with the complemented replicon particles. Infected cells readily expressed the reporter proteins at high levels five hours post infection. When human fibroblasts were treated with serial dilutions of human IFN-beta prior to infection, reporter expression was accordingly suppressed. This method was more sensitive and faster than a classical IFN bioassay based on VSV cytopathic effects. In addition, the antiviral activity of human IFN-lambda (interleukin-29), a type III IFN, was determined on Calu-3 cells. Both IFN-beta and IFN-lambda were acid-stable, but only IFN-beta was resistant to alkaline treatment. The antiviral activities of canine, porcine, and avian type I IFN were analysed with cell lines derived from the corresponding species. This safe bioassay will be useful for the rapid and sensitive quantification of multi-species type I IFN and potentially other antiviral cytokines.	[Rentsch, Marianne Berger; Zimmer, Gert] Inst Viruskrankheiten & Immunprophylaxe, Mittelhausern, Switzerland		Rentsch, MB (corresponding author), Inst Viruskrankheiten & Immunprophylaxe, Mittelhausern, Switzerland.	gert.zimmer@ivi.admin.ch		Zimmer, Gert/0000-0002-2708-2507	Wilhelm Sander Foundation [2007.101.1]; Swiss National Science Foundation [310030_129669]	Wilhelm Sander Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Wilhelm Sander Foundation (www.sanst.de) (grant no. 2007.101.1); Swiss National Science Foundation (www.snf.ch), grant no. 310030_129669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmelli C, 2005, EUR J IMMUNOL, V35, P2406, DOI 10.1002/eji.200525998; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JARIWALLA R, 1975, ARCH VIROL, V49, P261, DOI 10.1007/BF01317544; Kalhoro NH, 2009, VACCINE, V27, P1174, DOI 10.1016/j.vaccine.2008.12.019; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Larocque L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174615; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Malucchi S, 2011, J NEUROL, V258, P895, DOI 10.1007/s00415-010-5844-5; Meager A, 2002, J IMMUNOL METHODS, V261, P21, DOI 10.1016/S0022-1759(01)00570-1; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Perler L, 1999, J IMMUNOL METHODS, V222, P189, DOI 10.1016/S0022-1759(98)00198-7; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCHULTZ U, 1995, EUR J BIOCHEM, V229, P73, DOI 10.1111/j.1432-1033.1995.tb20439.x; Schwarz H, 2004, J INTERF CYTOK RES, V24, P179, DOI 10.1089/107999004322917025; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; TAYLORPA.J, 1971, NATURE-NEW BIOL, V230, P114, DOI 10.1038/newbio230114a0; Tsubota A, 2011, WORLD J GASTROENTERO, V17, P419, DOI 10.3748/wjg.v17.i4.419; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; VIRELIZIER JL, 1977, INFECT IMMUN, V17, P282, DOI 10.1128/IAI.17.2.282-285.1977; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4	36	127	129	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25858	10.1371/journal.pone.0025858	http://dx.doi.org/10.1371/journal.pone.0025858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998709	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900064
J	Ljungdahl, A; Hanrieder, J; Falth, M; Bergquist, J; Andersson, M				Ljungdahl, Anna; Hanrieder, Jorg; Faelth, Maria; Bergquist, Jonas; Andersson, Malin			Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIAS; KAPPA-OPIOID RECEPTOR; LONG-DURATION RESPONSE; MESSENGER-RNA; DOPAMINERGIC AGENTS; BASAL GANGLIA; IMMUNOHISTOCHEMICAL DISTRIBUTION; ENDOGENOUS LIGANDS; SUBSTANTIA-NIGRA; PRIMATE MODEL	L-DOPA-induced dyskinesia is a troublesome complication of L-DOPA pharmacotherapy of Parkinson's disease and has been associated with disturbed brain opioid transmission. However, so far the results of clinical and preclinical studies on the effects of opioids agonists and antagonists have been contradictory at best. Prodynorphin mRNA levels correlate well with the severity of dyskinesia in animal models of Parkinson's disease; however the identities of the actual neuroactive opioid effectors in their target basal ganglia output structures have not yet been determined. For the first time MALDI-TOF imaging mass spectrometry (IMS) was used for unbiased assessment and topographical elucidation of prodynorphin-derived peptides in the substantia nigra of a unilateral rat model of Parkinson's disease and L-DOPA induced dyskinesia. Nigral levels of dynorphin B and alpha-neoendorphin strongly correlated with the severity of dyskinesia. Even if dynorphin peptide levels were elevated in both the medial and lateral part of the substantia nigra, MALDI IMS analysis revealed that the most prominent changes were localized to the lateral part of the substantia nigra. MALDI IMS is advantageous compared with traditional molecular methods, such as radioimmunoassay, in that neither the molecular identity analyzed, nor the specific localization needs to be predetermined. Indeed, MALDI IMS revealed that the bioconverted metabolite leu-enkephalin-arg also correlated positively with severity of dyskinesia. Multiplexing DynB and leu-enkephalin-arg ion images revealed small (0.25 by 0.5 mm) nigral subregions with complementing ion intensities, indicating localized peptide release followed by bioconversion. The nigral dynorphins associated with L-DOPA-induced dyskinesia were not those with high affinity to kappa opioid receptors, but consisted of shorter peptides, mainly dynorphin B and alpha-neoendorphin that are known to bind and activate mu and delta opioid receptors. This suggests that mu and/or delta subtype-selective opioid receptor antagonists may be clinically relevant for reducing L-DOPA-induced dyskinesia in Parkinson's disease.	[Ljungdahl, Anna; Hanrieder, Jorg; Andersson, Malin] Uppsala Univ, Dept Pharmaceut Biosci Drug Safety & Toxicol, Uppsala, Sweden; [Hanrieder, Jorg; Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, Uppsala, Sweden; [Faelth, Maria] German Canc Res Ctr, Div Mol Genet, Unit Canc Genome Res, Heidelberg, Germany	Uppsala University; Uppsala University; Helmholtz Association; German Cancer Research Center (DKFZ)	Ljungdahl, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci Drug Safety & Toxicol, Uppsala, Sweden.	malin.andersson@farmbio.uu.se	Andersson, Malin/A-9930-2009; Bergquist, Jonas/C-5894-2015; Hanrieder, Jörg/E-9706-2011	Andersson, Malin/0000-0002-1450-8046; Bergquist, Jonas/0000-0002-4597-041X	Swedish Research Council [522-2006-6414, 521-2007-5407, 342-2004-3944, 621-2008-3562]; Swedish Parkinson Foundation; Swedish Royal Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Royal Academy of Sciences	This work was funded by the Swedish Research Council grant #522-2006-6414 (MA), 521-2007-5407 (MA), Swedish Parkinson Foundation (MA), Swedish Royal Academy of Sciences (MA), Swedish Research Council grant #342-2004-3944 (JB), 621-2008-3562 (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Aubert I, 2007, BIOL PSYCHIAT, V61, P836, DOI 10.1016/j.biopsych.2006.06.038; BENJAMINI Y, 1995, J R STAT SOC B, V57, P125; BERGSTROM L, 1983, LIFE SCI, V33, P1613, DOI 10.1016/0024-3205(83)90703-8; Brotchie J, 2009, NEUROLOGY, V72, pS32, DOI 10.1212/WNL.0b013e318198e0e9; Calon F, 2002, J NEUROPATH EXP NEUR, V61, P186, DOI 10.1093/jnen/61.2.186; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Chan PLS, 2007, PHARM RES-DORDR, V24, P791, DOI 10.1007/s11095-006-9202-3; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; CHRISTENSSONNYLANDER I, 1986, EXP BRAIN RES, V64, P169; CHRISTENSSONNYLANDER I, 1985, NEUROPEPTIDES, V6, P391, DOI 10.1016/0143-4179(85)90137-4; Cox H, 2007, EXP NEUROL, V205, P101, DOI 10.1016/j.expneurol.2007.01.024; El Atifi-Borel M, 2009, NEUROBIOL DIS, V34, P340, DOI 10.1016/j.nbd.2009.02.002; Fox S, 2004, MOVEMENT DISORD, V19, P554, DOI 10.1002/mds.10693; FOX SH, 2009, EFFECTS OPIOID ANTAG, P569; Fox Susan H., 2009, P569, DOI 10.1007/978-1-59745-197-0_30; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; HANRIEDER J, 2011, MOL CELL PR IN PRESS; Henry B, 2003, EXP NEUROL, V183, P458, DOI 10.1016/S0014-4886(03)00064-5; Henry B, 2001, EXP NEUROL, V171, P139, DOI 10.1006/exnr.2001.7727; Johansson PA, 2001, NEUROBIOL DIS, V8, P220, DOI 10.1006/nbdi.2000.0372; Klintenberg R, 2005, J MASS SPECTROM, V40, P261, DOI 10.1002/jms.754; Klintenberg R, 2002, J NEURAL TRANSM, V109, P1295, DOI 10.1007/s00702-002-0715-6; LI H, MASS SPECTROMETRY BI; Liu B, 2001, J PHARMACOL EXP THER, V298, P1133; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Marin C, 2003, EXP NEUROL, V183, P66, DOI 10.1016/S0014-4886(03)00107-9; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; NUTT JG, 1995, NEUROLOGY, V45, P1613, DOI 10.1212/WNL.45.8.1613; Nyberg F, 2007, CURR DRUG TARGETS, V8, P147, DOI 10.2174/138945007779315597; Nylander I, 1997, NEUROPEPTIDES, V31, P357, DOI 10.1016/S0143-4179(97)90072-X; Obeso JA, 2000, ANN NEUROL, V47, pS22; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piccini P, 1997, ANN NEUROL, V42, P720, DOI 10.1002/ana.410420508; QUATTRONE A, 1995, ANN NEUROL, V38, P389, DOI 10.1002/ana.410380308; RASCOL O, 1994, MOVEMENT DISORD, V9, P437, DOI 10.1002/mds.870090410; Samadi P, 2004, NEUROBIOL DIS, V16, P246, DOI 10.1016/j.nbd.2004.02.002; Samadi P, 2003, NEUROPHARMACOLOGY, V45, P954, DOI 10.1016/S0028-3908(03)00249-1; Sandin J, 1997, PEPTIDES, V18, P949, DOI 10.1016/S0196-9781(97)00025-9; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schapira AHV, 2009, EUR J NEUROL, V16, P982, DOI 10.1111/j.1468-1331.2009.02697.x; SCHULZ R, 1982, PEPTIDES, V3, P973, DOI 10.1016/0196-9781(82)90067-5; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; SILBERRING J, 1989, J BIOL CHEM, V264, P11082; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stocchi F, 2010, EUR NEUROL, V63, P257, DOI 10.1159/000300647; Team RDC, 2008, LANGUAGE ENV STAT CO; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; TRUJILLO KA, 1990, BRAIN RES, V518, P244, DOI 10.1016/0006-8993(90)90977-J; VINCENT S, 1982, EUR J PHARMACOL, V85, P251, DOI 10.1016/0014-2999(82)90477-0; WALKER JM, 1982, EUR J PHARMACOL, V85, P121, DOI 10.1016/0014-2999(82)90433-2; WEBER E, 1982, P NATL ACAD SCI-BIOL, V79, P3062, DOI 10.1073/pnas.79.9.3062; WEBER E, 1983, P NATL ACAD SCI-BIOL, V80, P1125, DOI 10.1073/pnas.80.4.1125; ZAMIR N, 1984, BRAIN RES, V322, P356, DOI 10.1016/0006-8993(84)90133-1	59	49	49	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25653	10.1371/journal.pone.0025653	http://dx.doi.org/10.1371/journal.pone.0025653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984936	Green Published, gold			2022-12-25	WOS:000295941300046
J	Ding, YY; Zhang, L; Wang, YH; Huang, W; Tang, Y; Bai, L; Ross, CJD; Hayden, MR; Liu, G				Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Ross, Colin J. D.; Hayden, Michael R.; Liu, George			Amelioration of Hypertriglyceridemia with Hypo-Alpha-Cholesterolemia in LPL Deficient Mice by Hematopoietic Cell-Derived LPL	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; LPLS447X BENEFICIAL MUTATION; PLASMA TRIGLYCERIDE; KNOCKOUT MICE; GENE-TRANSFER; BONE-MARROW; LIPASE; ATHEROSCLEROSIS; EXPRESSION; METABOLISM	Background: Macrophage-derived lipoprotein lipase (LPL) has been shown uniformly to promote atherosclerotic lesion formation while the extent to which it affects plasma lipid and lipoprotein levels varies in wild-type and hypercholesterolemic mice. It is known that high levels of LPL in the bulk of adipose tissue and skeletal muscle would certainly mask the contribution of macrophage LPL to metabolism of plasma lipoprotein. Therefore, we chose LPL deficient (LPL(-/-)) mice with severe hypertriglyceridemia as an alternative model to assess the role of macrophage LPL in plasma lipoprotein metabolism via bone marrow transplant, through which LPL will be produced mainly by hematopoietic cell-derived macrophages. Methods and Results: Hypertriglyceridemic LPL(-/-) mice were lethally irradiated, then transplanted with bone marrow from wild-type (LPL(+/+)) or LPL(-/-) mice, respectively. Sixteen weeks later, LPL(+/+) -> LPL(-/-) mice displayed significant reduction in plasma levels of triglyceride and cholesterol (408 +/- 44.9 vs. 2.7 +/- 0.5 x10(3) and 82.9 +/- 7.1 vs. 229.1 +/- 30.6 mg/dl, p<0.05, respectively), while a 2.7-fold increase in plasma high density lipoprotein-cholesterol (p<0.01) was observed, compared with LPL(-/-) -> LPL(-/-) control mice. The clearance rate for the oral fat load test in LPL(+/+) -> LPL(-/-) mice was faster than that in LPL(-/-) -> LPL(-/-) mice, but slower than that in wild-type mice. Liver triglyceride content in LPL(+/+) -> LPL(-/-) mice was also significantly increased, compared with LPL(-/-) -> LPL(-/-) mice (6.8 +/- 0.7 vs. 4.6 +/- 0.5 mg/g wet tissue, p<0.05, n = 6). However, no significant change was observed in the expression levels of genes involved in hepatic lipid metabolism between the two groups. Conclusions: Hematopoietic cell-derived LPL could efficiently ameliorate severe hypertriglyceridemia and hypo-alpha-cholesterolemia at the compensation of increased triglyceride content of liver in LPL(-/-) mice.	[Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Liu, George] Peking Univ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China; [Ding, Yinyuan; Zhang, Ling; Wang, Yuhui; Huang, Wei; Tang, Yin; Bai, Lu; Liu, George] Peking Univ, Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Ross, Colin J. D.; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada	Peking University; Peking University; University of British Columbia	Ding, YY (corresponding author), Peking Univ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China.	vangeorgeliu@gmail.com	Hayden, Michael R/D-8581-2011; 王, 宇慧/GXZ-7548-2022	Hayden, Michael R/0000-0001-5159-1419; Ross, Colin/0000-0003-1476-7037	Major National Basic Research Program of the People's Republic of China [2011CB503900]; National Natural Science Foundation of the People's Republic of China [30821001, 30870994, 30930037]	Major National Basic Research Program of the People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This project was supported in part by Major National Basic Research Program of the People's Republic of China (2011CB503900) (http://www.nsfc.gov. cn/Portal0/default124.htm), grants from the National Natural Science Foundation of the People's Republic of China (No. 30821001; No. 30870994 and No. 30930037) (http://www.nsfc.gov.cn/Portal0/default124.htm) awarded to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; EISENBERG S, 1984, J LIPID RES, V25, P1017; Huang W, 2006, BIOCHEM BIOPH RES CO, V346, P14, DOI 10.1016/j.bbrc.2006.05.072; HUSSAIN MM, 1989, J BIOL CHEM, V264, P9571; HUSSAIN MM, 1989, J BIOL CHEM, V264, P17931; Levak-Frank S, 1999, P NATL ACAD SCI USA, V96, P3165, DOI 10.1073/pnas.96.6.3165; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; MATTSSON L, 1993, J CLIN INVEST, V92, P1759, DOI 10.1172/JCI116764; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Nordestgaard Borge G, 2007, Ugeskr Laeger, V169, P3865; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Ross CJD, 2005, ARTERIOSCL THROM VAS, V25, P2143, DOI 10.1161/01.ATV.0000176971.27302.b0; Ross CJD, 2004, HUM GENE THER, V15, P906, DOI 10.1089/hum.2004.15.906; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P20, DOI 10.1161/ATVBAHA.109.196329; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Wu XJ, 2006, ATHEROSCLEROSIS, V187, P65, DOI 10.1016/j.atherosclerosis.2005.08.032; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554	27	4	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25620	10.1371/journal.pone.0025620	http://dx.doi.org/10.1371/journal.pone.0025620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980507	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600041
J	Takeuchi, H; Taki, Y; Hashizume, H; Sassa, Y; Nagase, T; Nouchi, R; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Nagase, Tomomi; Nouchi, Rui; Kawashima, Ryuta			Cerebral Blood Flow during Rest Associates with General Intelligence and Creativity	PLOS ONE			English	Article							SUBCORTICAL VASCULAR ENCEPHALOPATHY; POSITRON-EMISSION-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; WHITE-MATTER; DEFAULT NETWORK; SEX-DIFFERENCES; BINSWANGER TYPE; BRAIN; FMRI; MRI	Recently, much scientific attention has been focused on resting brain activity and its investigation through such methods as the analysis of functional connectivity during rest (the temporal correlation of brain activities in different regions). However, investigation of the magnitude of brain activity during rest has focused on the relative decrease of brain activity during a task, rather than on the absolute resting brain activity. It is thus necessary to investigate the association between cognitive factors and measures of absolute resting brain activity, such as cerebral blood flow (CBF), during rest (rest-CBF). In this study, we examined this association using multiple regression analyses. Rest-CBF was the dependent variable and the independent variables included two essential components of cognitive functions, psychometric general intelligence and creativity. CBF was measured using arterial spin labeling and there were three analyses for rest-CBF; namely mean gray matter rest-CBF, mean white matter rest-CBF, and regional rest-CBF. The results showed that mean gray and white matter rest-CBF were significantly and positively correlated with individual psychometric intelligence. Furthermore, mean white matter rest-CBF was significantly and positively correlated with creativity. After correcting the effect of mean gray matter rest-CBF the significant and positive correlation between regional rest-CBF in the perisylvian anatomical cluster that includes the left superior temporal gyrus and insula and individual psychometric intelligence was found. Also, regional rest-CBF in the precuneus was significantly and negatively correlated with individual creativity. Significance of these results of regional rest-CBF did not change when the effect of regional gray matter density was corrected. The findings showed mean and regional rest-CBF in healthy young subjects to be correlated with cognitive functions. The findings also suggest that, even in young cognitively intact subjects, resting brain activity (possibly underlain by default cognitive activity or metabolic demand from developed brain structures) is associated with cognitive functions.	[Takeuchi, Hikaru; Nouchi, Rui; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Nagase, Tomomi; Kawashima, Ryuta] Tohoku Univ, Fac Med, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011; Nouchi, Rui/GQH-1608-2022	Takeuchi, Hikaru/0000-0002-8022-9694; Nouchi, Rui/0000-0002-2078-9518	JST/RISTEX, JST/CREST	JST/RISTEX, JST/CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST/RISTEX, JST/CREST (there are no particular numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Colom R, 2007, INTELLIGENCE, V35, P183, DOI 10.1016/j.intell.2006.06.003; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Fisher JE, 2004, J RES PERS, V38, P24, DOI 10.1016/j.jrp.2003.09.014; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; GUILFORD JP, 1973, J CREATIVE BEHAV, V7, P247, DOI 10.1002/j.2162-6057.1973.tb01096.x; Guilford JP, 1967, NAT HUM INTELL; HAGBERG BO, 1976, BRIT J PSYCHIAT, V128, P209, DOI 10.1192/bjp.128.3.209; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HEAUSLER NL, 1988, EDUC PSYCHOL MEAS, V48, P463, DOI 10.1177/0013164488482021; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; HSU YY, 2007, P INT SOC MAGN RESON, V15, P1860; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McNair D. M, 1992, PROFILE MOOD STATES; Minds Society For Creative, 1969, MAN S A CREAT TEST; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raven J.C., 1998, ADV PROGR MATRICES; RUSHTON JP, 1983, SCIENTOMETRICS, V5, P93, DOI 10.1007/BF02072856; Sabri O, 1999, STROKE, V30, P556, DOI 10.1161/01.STR.30.3.556; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schmithorst VJ, 2006, NEUROIMAGE, V31, P1366, DOI 10.1016/j.neuroimage.2006.01.010; SCHNEIDER F, 1994, PSYCHIAT RES, V52, P215, DOI 10.1016/0165-1781(94)90089-2; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; TAKI Y, 2011, HUMAN BRAIN MAPPING; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Torrance E. P., 1966, TORRANCE TESTS CREAT; Treffinger D. J., 1985, 9 MENTAL MEASUREMENT, P1632; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; YAMANOUCHI H, 1989, J NEUROL, V236, P382, DOI 10.1007/BF00314894; YAMANOUCHI H, 1991, ACTA NEUROL SCAND, V83, P301, DOI 10.1111/j.1600-0404.1991.tb04706.x; Yokoyama K., 2005, POMS SHORTENED VERSI; Yoshiura T, 2009, AM J NEURORADIOL, V30, P1388, DOI 10.3174/ajnr.A1562	58	46	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25532	10.1371/journal.pone.0025532	http://dx.doi.org/10.1371/journal.pone.0025532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980485	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600034
J	de Meijer, VE; Le, HD; Meisel, JA; Sharma, AK; Popov, Y; Puder, M				de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Sharma, Anisha K.; Popov, Yury; Puder, Mark			Tumor Necrosis Factor alpha-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; RESISTANCE; INFLAMMATION; METALLOPROTEINASE; CANCER; TRANSPLANTATION; PATHOGENESIS; DISINTEGRIN; PROGRESSION	Background: Hepatic steatosis is an established risk factor for complications following major hepatic resection. Pharmacological options to reverse steatosis prior to surgery, however, are lacking. We hypothesized that treatment with the pharmacologic tumor necrosis factor-alpha converting enzyme (TACE)-inhibitor Marimastat would reverse established steatosis, leading to improved outcome following hepatectomy. Methodology/Principal Findings: C57BL/6 male mice were fed a high fat diet for 9 weeks to establish obesity, hepatic steatosis and insulin resistance, and were administered either Marimastat or vehicle for an additional 2 or 4 weeks. Leptin deficient, hyperinsulinemic ob/ob mice were treated with Marimastat for 4 weeks. Hepatic steatosis was quantified by magnetic resonance spectroscopy and confirmed by histology. After two weeks, Marimastat-treated animals significantly improved surrogate markers for insulin sensitivity and liver histology, and experienced a 66% decrease in steatosis (P = 0.010). These findings were confirmed in ob/ob mice. Transcripts related to fatty acid synthesis were significantly downregulated in Marimastat-treated animals. Following pre-treatment with Marimastat or vehicle for two weeks, high fat fed C57BL/6 mice were subjected to two-thirds hepatectomy. Post-operative liver injury as quantified by serum aspartate aminotransferase levels and alanine aminotransferase levels was significantly decreased by 57% (P = 0.020) and 44% (P = 0.032) respectively, compared to controls. Conclusion/Significance: Treatment with the TACE-inhibitor Marimastat improved surrogate markers for insulin sensitivity and reversed steatosis in mouse models of diet-induced obesity and leptin deficiency, thereby attenuating post-operative injury following hepatectomy. This may suggest a potential therapeutic role in patients with fatty liver disease; especially those who need to undergo hepatic resection.	[de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Vasc Biol Program, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Surg, Rotterdam, Netherlands; [Le, Hau D.; Meisel, Jonathan A.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Sharma, Anisha K.; Popov, Yury] Harvard Univ, Sch Med, Div Gastroenterol & Hepatol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	de Meijer, VE (corresponding author), Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA.	vdemeijer@hotmail.com	Popov, Yury V./A-7781-2008; de Meijer, Vincent Erwin/H-6610-2019	Popov, Yury V./0000-0001-7973-942X; de Meijer, Vincent Erwin/0000-0002-7900-5917	Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands); VSBfonds (Utrecht, The Netherlands); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands); Children's Hospital Boston Surgical Foundation; Vascular Biology Program (Boston, Massachusetts); National Institutes of Health [DK069621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK069621] Funding Source: NIH RePORTER	Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands)(Netherlands Government); VSBfonds (Utrecht, The Netherlands)(Netherlands Government); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands)(Netherlands Government); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands)(Netherlands Government); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)(Netherlands Government); Children's Hospital Boston Surgical Foundation; Vascular Biology Program (Boston, Massachusetts); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	VdM was recipient of fellowships from the foundations Stichting Profesor Michael-van Vloten Fonds (Venray, The Netherlands), VSBfonds (Utrecht, The Netherlands), Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands), Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands), and Dr Saal van Zwanenberg Stichting (Oss, The Netherlands). MP was supported by the Children's Hospital Boston Surgical Foundation and The Vascular Biology Program (Boston, Massachusetts), and the National Institutes of Health (grant DK069621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2009, SEMIN LIVER DIS, V29, P3, DOI 10.1055/s-0029-1192052; Alwayn IPJ, 2008, J SURG RES, V145, P192, DOI 10.1016/j.jss.2007.04.002; Alwayn IPJ, 2006, AM J PHYSIOL-GASTR L, V291, pG1011, DOI 10.1152/ajpgi.00047.2006; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bramhall SR, 2002, BRIT J CANCER, V86, P1864, DOI 10.1038/sj.bjc.6600310; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; de Meijer VE, 2010, METABOLISM, V59, P1092, DOI 10.1016/j.metabol.2009.11.006; de Meijer VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011256; de Meijer VE, 2010, PHYSIOL BEHAV, V100, P387, DOI 10.1016/j.physbeh.2010.04.001; Doggrell SA, 2002, EXPERT OPIN INV DRUG, V11, P1003, DOI 10.1517/13543784.11.7.1003; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; OTWAY S, 1967, J PHYSIOL-LONDON, V190, P321, DOI 10.1113/jphysiol.1967.sp008211; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rosenbaum E, 2005, CLIN CANCER RES, V11, P4437, DOI 10.1158/1078-0432.CCR-04-2252; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Togashi N, 2002, HYPERTENSION, V39, P578, DOI 10.1161/hy0202.103290; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25587	10.1371/journal.pone.0025587	http://dx.doi.org/10.1371/journal.pone.0025587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980496	Green Published, Green Submitted, gold			2022-12-25	WOS:000295933700045
J	Plum, M; Michel, Y; Wallach, K; Raiber, T; Blank, S; Bantleon, FI; Diethers, A; Greunke, K; Braren, I; Hackl, T; Meyer, B; Spillner, E				Plum, Melanie; Michel, Yvonne; Wallach, Katharina; Raiber, Tim; Blank, Simon; Bantleon, Frank I.; Diethers, Andrea; Greunke, Kerstin; Braren, Ingke; Hackl, Thomas; Meyer, Bernd; Spillner, Edzard			Close-up of the Immunogenic alpha 1,3-Galactose Epitope as Defined by a Monoclonal Chimeric Immunoglobulin E and Human Serum Using Saturation Transfer Difference (STD) NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CARBOHYDRATE DETERMINANTS; HYMENOPTERA-VENOM ALLERGY; CRYSTAL-STRUCTURE; IGE ANTIBODIES; FAB FRAGMENT; XENOREACTIVE ANTIBODIES; BINDING-SPECIFICITY; CLINICAL-RELEVANCE; MARASMIUS-OREADES; CROSS-REACTIVITY	Anaphylaxis mediated by carbohydrate structures is a controversially discussed phenomenon. Nevertheless, IgE with specificity for the xenotransplantation antigen alpha 1,3-Gal (alpha-Gal) are associated with a delayed type of anaphylaxis, providing evidence for the clinical relevance of carbohydrate epitopes in allergy. The aim of this study was to dissect immunoreactivity, interaction, and fine epitope of alpha-Gal-specific antibodies to obtain insights into the recognition of carbohydrate epitopes by IgE antibodies and their consequences on a molecular and cellular level. The antigen binding moiety of an alpha-Gal-specific murine IgM antibody was employed to construct chimeric IgE and IgG antibodies. Reactivity and specificity of the resulting antibodies were assessed by means of ELISA and receptor binding studies. Using defined carbohydrates, interaction of the IgE and human serum was assessed by mediator release assays, surface plasmon resonance (SPR), and saturation transfer difference NMR analyses. The alpha-Gal-specific chimeric IgE and IgG antibodies were proven functional regarding interaction with antigen and Fc receptors. SPR measurements demonstrated affinities in the micromolar range. In contrast to a reference antibody, anti-Gal IgE did not induce mediator release, potentially reflecting the delayed type of anaphylaxis. The alpha 1,3-Gal epitope fine structures of both the recombinant IgE and affinity-purified serum were defined by saturation transfer difference NMR, revealing similar contributions of carbohydrate residues and participation of both galactose residues in interaction. The antibodies generated here constitute the principle underlying alpha 1,3-Gal-mediated anaphylaxis. The complementary data of affinity and fine specificity may help to elucidate the recognition of carbohydrates by the adaptive immune response and the molecular requirements of carbohydrate-based anaphylaxis.	[Spillner, Edzard] Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, D-20146 Hamburg, Germany; [Wallach, Katharina; Hackl, Thomas; Meyer, Bernd] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; [Braren, Ingke] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Expt Therapy Res, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Spillner, E (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	spillner@chemie.uni-hamburg.de	Hackl, Thomas/B-6447-2009; Meyer, Bernd/A-8828-2008; Blank, Simon/M-7708-2013	Hackl, Thomas/0000-0002-9875-9415; spillner, edzard/0000-0003-0999-5254				AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Agostino M, 2010, GLYCOBIOLOGY, V20, P724, DOI 10.1093/glycob/cwq022; Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bencurova M, 2004, GLYCOBIOLOGY, V14, P457, DOI 10.1093/glycob/cwh058; Braren I, 2007, CLIN CHEM, V53, P837, DOI 10.1373/clinchem.2006.078360; Braren I, 2011, ANAL BIOCHEM, V412, P134, DOI 10.1016/j.ab.2010.12.013; Chiang TR, 2000, TRANSPLANTATION, V69, P2593, DOI 10.1097/00007890-200006270-00020; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Clement MJ, 2006, J BIOL CHEM, V281, P2317, DOI 10.1074/jbc.M510172200; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Diswall M, 2011, XENOTRANSPLANTATION, V18, P28, DOI 10.1111/j.1399-3089.2011.00623.x; Enriquez-Navas PM, 2011, CHEM-EUR J, V17, P1547, DOI 10.1002/chem.201002519; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Fromberg J, 2006, ALLERGY, V61, P1234, DOI 10.1111/j.1398-9995.2006.01222.x; Gehlhar K, 2005, INT ARCH ALLERGY IMM, V136, P311, DOI 10.1159/000083976; Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Greunke K, 2006, J BIOTECHNOL, V124, P446, DOI 10.1016/j.jbiotec.2005.12.032; Gronlund H, 2009, J ALLERGY CLIN IMMUN, V123, P1189, DOI 10.1016/j.jaci.2009.03.011; Hantusch B, 2004, J ALLERGY CLIN IMMUN, V114, P1294, DOI 10.1016/j.jaci.2004.06.048; Herfurth L, 2005, J MED CHEM, V48, P6879, DOI 10.1021/jm0502687; Houliston RS, 2009, BIOCHEMISTRY-US, V48, P220, DOI 10.1021/bi802100u; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kooistra O, 2002, EUR J BIOCHEM, V269, P573, DOI 10.1046/j.0014-2956.2001.02684.x; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Maaheimo H, 2000, BIOCHEMISTRY-US, V39, P12778, DOI 10.1021/bi000780o; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Malandain H, 2005, Eur Ann Allergy Clin Immunol, V37, P122; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; Martin-Santamaria S, 2011, ORG BIOMOL CHEM, V9, P5445, DOI 10.1039/c0ob01235a; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McKenzie IFC, 1999, TRANSPLANTATION, V67, P864, DOI 10.1097/00007890-199903270-00013; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mikeska R, 2005, ACTA CRYSTALLOGR F, V61, P17, DOI 10.1107/S1744309104031501; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; MILLER MC, 2011, GLYCOBIOLOG IN PRESS; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Niedziela T, 2005, INFECT IMMUN, V73, P7381, DOI 10.1128/IAI.73.11.7381-7389.2005; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Oberli MA, 2010, J AM CHEM SOC, V132, P10239, DOI 10.1021/ja104027w; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Steinberger P, 1996, J BIOL CHEM, V271, P10967, DOI 10.1074/jbc.271.18.10967; Tempel W, 2002, J BIOL CHEM, V277, P6615, DOI 10.1074/jbc.M109919200; van Roon AMM, 2004, STRUCTURE, V12, P1227, DOI 10.1016/j.str.2004.05.008; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044; Yu PB, 1996, J IMMUNOL, V157, P5163; Zakhour M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000504	60	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43103	43111		10.1074/jbc.M111.291823	http://dx.doi.org/10.1074/jbc.M111.291823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21990360	Green Published, hybrid			2022-12-25	WOS:000298351300031
J	Majumdar, A; Petrescu, AD; Xiong, Y; Noy, N				Majumdar, Avijit; Petrescu, Anca D.; Xiong, Yin; Noy, Noa			Nuclear Translocation of Cellular Retinoic Acid-binding Protein II Is Regulated by Retinoic Acid-controlled SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR; BETA/DELTA; LIGAND; LOCALIZATION; RESISTANCE; SUMO; RAR	Cellular retinoic acid-binding protein II (CRABP-II) undergoes nuclear translocation upon binding of retinoic acid (RA). In the nucleus, CRABP-II directly binds to the nuclear receptor RAR to form a complex through which RA is "channeled" from the binding protein to the receptor. CRABP-II thus facilitates the ligation of RAR and markedly enhances its transcriptional activity. The primary sequence of CRABP-II contains three putative SUMOylation sites, centered at K45, K87, and K102. We show here that RA induces interactions of CRABP-II with the E2 SUMO ligase Ubc9 and triggers SUMOylation of the protein both in vitro and in cultured cells. Mutagenesis analyses demonstrate that K102 is the sole CRABP-II residue to be SUMOylated in response to RA. Mutation of this residue abolishes the ability of CRABP-II to undergo nuclear translocation in response RA and thus impairs CRABP-II-mediated activation of RAR. Additional observations demonstrate that apo-CRABP-II is associated with endoplasmic reticulum (ER), and that RA triggers the dissociation of CRABP-II from this location. Furthermore, we show that RA-induced dissociation of CRABP-II from the ER requires SUMOylation of K102. Hence, SUMOylation of K102 in response to RA binding is critical for dissociation of CRABP-II from ER and, consequently, for mobilization of the protein to nucleus and for its cooperation with RAR.	[Majumdar, Avijit; Petrescu, Anca D.; Xiong, Yin; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave,W333, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health (NIH) [R01 DK060684, T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK060684 (to N.N.) and by NIH Training Grant T32 CA059366 (to A.D.P.).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Donato LJ, 2006, ANAL BIOCHEM, V357, P249, DOI 10.1016/j.ab.2006.07.020; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Manor D, 2003, CANCER RES, V63, P4426; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Vaezeslami S, 2006, J MOL BIOL, V363, P687, DOI 10.1016/j.jmb.2006.08.059	17	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42749	42757		10.1074/jbc.M111.293464	http://dx.doi.org/10.1074/jbc.M111.293464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998312	Green Published, hybrid			2022-12-25	WOS:000298180900081
J	Rao, JN; Warren, GZL; Estolt-Povedano, S; Zammit, VA; Ulmer, TS				Rao, Jampani N.; Warren, Gemma Z. L.; Estolt-Povedano, Sara; Zammit, Victor A.; Ulmer, Tobias S.			An Environment-dependent Structural Switch Underlies the Regulation of Carnitine Palmitoyltransferase 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; MALONYL-COA SENSITIVITY; RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; NMR CHEMICAL-SHIFTS; CONTACT SITES; INTRAMOLECULAR INTERACTIONS; MOLECULAR-STRUCTURE; DIPOLAR COUPLINGS; CPT I	The enzyme carnitine palmitoyltransferase 1 (CPT1), which is anchored in the outer mitochondrial membrane (OMM), controls the rate-limiting step in fatty acid beta-oxidation in mammalian tissues. It is inhibited by malonyl-CoA, the first intermediate of fatty acid synthesis, and it responds to OMM curvature and lipid characteristics, which reflect long term nutrient/hormone availability. Here, we show that the N-terminal regulatory domain (N) of CPT1A can adopt two complex amphiphilic structural states, termed N alpha and N beta, that interchange in a switch-like manner in response to offered binding surface curvature. Structure-based site-directed mutageneses of native CPT1A suggest N alpha to be inhibitory and N beta to be noninhibitory, with the relative N alpha/N beta ratio setting the prevalent malonyl-CoA sensitivity of the enzyme. Based on the amphiphilic nature of N and molecular modeling, we propose malonyl-CoA sensitivity to be coupled to the properties of the OMM by N alpha-OMM associations that alter the N alpha/N beta ratio. For enzymes residing at the membrane-water interface, this constitutes an integrative regulatory mechanism of exceptional sophistication.	[Rao, Jampani N.; Ulmer, Tobias S.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Rao, Jampani N.; Ulmer, Tobias S.] Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Warren, Gemma Z. L.; Estolt-Povedano, Sara; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Metab & Vasc Hlth Div, Coventry CV4 7AL, W Midlands, England	University of Southern California; University of Southern California; University of Warwick	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			National Institutes of Health [HL089726]; John Douglas French Alzheimer's Foundation; British Heart Foundation; University of Southern California Liver Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer's Foundation; British Heart Foundation(British Heart Foundation); University of Southern California Liver Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL089726 (to T. S. U.). This work was also supported by The John Douglas French Alzheimer's Foundation.; Supported by the British Heart Foundation.; Supported by the University of Southern California Liver Center.	Akkaoui M, 2009, BIOCHEM J, V420, P429, DOI 10.1042/BJ20081932; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIRD MI, 1985, BIOCHEM J, V230, P161, DOI 10.1042/bj2300161; BOCKER J, 1994, J PHYS CHEM-US, V98, P712; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Decatur SM, 2000, BIOPOLYMERS, V54, P180, DOI 10.1002/1097-0282(200009)54:3<180::AID-BIP40>3.3.CO;2-0; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; Gobin S, 2003, J BIOL CHEM, V278, P50428, DOI 10.1074/jbc.M310130200; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Gunasekaran K, 1997, PROTEIN ENG, V10, P1131, DOI 10.1093/protein/10.10.1131; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; IMAE T, 1986, J PHYS CHEM-US, V90, P5216, DOI 10.1021/j100412a065; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; JENEI ZA, 2011, FASEB J IN PRESS; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; ONTKO JA, 1980, BIOCHEM J, V192, P959, DOI 10.1042/bj1920959; Pan Y, 2002, J BIOL CHEM, V277, P47184, DOI 10.1074/jbc.M208055200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rufer AC, 2007, FEBS LETT, V581, P3247, DOI 10.1016/j.febslet.2007.05.080; SAGGERSON ED, 1982, BIOCHEM J, V202, P397, DOI 10.1042/bj2020397; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2007, PROTEINS, V69, P734, DOI 10.1002/prot.21754; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi JY, 1999, J BIOL CHEM, V274, P9421, DOI 10.1074/jbc.274.14.9421; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Woldegiorgis G, 2005, MONATSH CHEM, V136, P1325, DOI 10.1007/s00706-005-0334-7; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5; ZAMMIT VA, 1983, BIOCHEM J, V214, P1027, DOI 10.1042/bj2141027; Zammit VA, 2001, BIOCHEM SOC T, V29, P287, DOI 10.1042/BST0290287; Zammit VA, 2009, ADV DRUG DELIVER REV, V61, P1353, DOI 10.1016/j.addr.2009.04.024	63	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42545	42554		10.1074/jbc.M111.306951	http://dx.doi.org/10.1074/jbc.M111.306951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990363	Green Published, hybrid			2022-12-25	WOS:000298180900062
J	von Stockum, S; Basso, E; Petronilli, V; Sabatelli, P; Forte, MA; Bernardi, P				von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Sabatelli, Patrizia; Forte, Michael A.; Bernardi, Paolo			Properties of Ca2+ Transport in Mitochondria of Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; HEART-MITOCHONDRIA; CYCLOSPORINE-A; RUTHENIUM RED; ESSENTIAL COMPONENT; INNER MEMBRANE; STEADY-STATE; CELL-DEATH; CALCIUM; LIVER	We have studied the pathways for Ca2+ transport in mitochondria of the fruit fly Drosophila rnelanogaster. We demonstrate the presence of ruthenium red (RR)-sensitive Ca2+ uptake, of RR-insensitive Ca2+ release, and of Na+-stimulated Ca2+ release in energized mitochondria, which match well characterized Ca2+ transport pathways of mammalian mitochondria. Following larger matrix Ca2+ loading Drosophila mitochondria underwent spontaneous RR-insensitive Ca2+ release, an event that in mammals is due to opening of the permeability transition pore (PTP). Like the PIP of mammals, Drosophila Ca2+-induced Ca2+ release could be triggered by uncoupler, diamide, and N-ethylmaleimide, indicating the existence of regulatory voltage- and redox-sensitive sites and was inhibited by tetracaine. Unlike PTP-mediated Ca2+ release in mammals, however, it was (i) insensitive to cyclosporin A, ubiquinone 0, and ADP; (ii) inhibited by P-i, as is the PTP of yeast mitochondria; and (iii) not accompanied by matrix swelling and cytochrome c release even in KCl-based medium. We conclude that Drosophila mitochondria possess a selective Ca2+ release channel with features intermediate between the PTP of yeast and mammals.	[von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy; [Sabatelli, Patrizia] Ist Ortoped Rizzoli, Inst Mol Genet, I-40126 Bologna, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Ortopedico Rizzoli; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Basso, Emy/F-7687-2015; Sabatelli, Patrizia/C-7479-2019; Petronilli, Valeria/C-3558-2015; Bernardi, Paolo/C-3656-2008	Basso, Emy/0000-0003-2962-7213; Sabatelli, Patrizia/0000-0003-2345-5094; Petronilli, Valeria/0000-0003-4026-6404; Bernardi, Paolo/0000-0001-9187-3736	National Institutes of Health [GM069883]; Fondazione Cariparo; University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Cariparo(Fondazione Cariparo); University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069883. This work was also supported in part by grants from the Fondazione Cariparo and the University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases.	ALTSCHULD RA, 1992, AM J PHYSIOL, V262, pH1699, DOI 10.1152/ajpheart.1992.262.6.H1699; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Azzolin L, 2010, BBA-BIOENERGETICS, V1797, P1775, DOI 10.1016/j.bbabio.2010.07.002; Azzolin L, 2010, FEBS LETT, V584, P2504, DOI 10.1016/j.febslet.2010.04.023; AZZONE GF, 1977, FEBS LETT, V78, P21, DOI 10.1016/0014-5793(77)80264-0; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CARAFOLI E, 1972, BIOCHEM BIOPH RES CO, V49, P1498, DOI 10.1016/0006-291X(72)90509-8; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DAWSON AP, 1979, NATURE, V277, P484, DOI 10.1038/277484a0; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Friel DD, 2000, CELL CALCIUM, V28, P307, DOI 10.1054/ceca.2000.0172; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; GUERIN B, 1994, J BIOL CHEM, V269, P25406; Gunter TE, 2001, IUBMB LIFE, V52, P197, DOI 10.1080/15216540152846000; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krieser RJ, 2009, APOPTOSIS, V14, P961, DOI 10.1007/s10495-009-0362-6; Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; Prieto S, 1996, ARCH BIOCHEM BIOPHYS, V334, P43, DOI 10.1006/abbi.1996.0427; PRIETO S, 1992, EUR J BIOCHEM, V208, P487, DOI 10.1111/j.1432-1033.1992.tb17212.x; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Roucou X, 1997, BBA-BIOMEMBRANES, V1324, P120, DOI 10.1016/S0005-2736(96)00215-5; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; STUCKI JW, 1974, EUR J BIOCHEM, V48, P365, DOI 10.1111/j.1432-1033.1974.tb03778.x; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Taupin P, 2008, EUR J HISTOCHEM, V52, P135; Uribe-Carvajal S, 2011, MITOCHONDRION, V11, P382, DOI 10.1016/j.mito.2011.02.004; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; Yamada A, 2009, BBA-BIOENERGETICS, V1787, P1486, DOI 10.1016/j.bbabio.2009.07.001; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	80	46	46	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41163	41170		10.1074/jbc.M111.268375	http://dx.doi.org/10.1074/jbc.M111.268375			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984833	hybrid, Green Published			2022-12-25	WOS:000298057500005
J	Wang, XB; Hu, GQ; Betts, C; Harmon, EY; Keller, RS; Van De Water, L; Zhou, JL				Wang, Xiaobo; Hu, Guoqing; Betts, Courtney; Harmon, Erin Yund; Keller, Rebecca S.; Van De Water, Livingston; Zhou, Jiliang			Transforming Growth Factor-beta 1-induced Transcript 1 Protein, a Novel Marker for Smooth Muscle Contractile Phenotype, Is Regulated by Serum Response Factor/Myocardin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION PROTEIN; LIM PROTEIN; CELL-LINES; TGF-BETA; HIC-5; DIFFERENTIATION; EXPRESSION; GENE; CONTRIBUTES; COACTIVATOR	Serum response factor (SRF) plays a central role in regulating expression of smooth muscle-specific genes partly by associating with the potent tissue-specific cofactor myocardin. Previous studies have shown that transforming growth factor-beta 1-induced transcript 1 (TGFB1I1, also known as Hic-5) is a TGF-beta-responsive gene and is involved in the cellular response to vascular injury, but the regulation of TGFB1I1 expression remains elusive. In this report, we demonstrated that TGFB1I1 is a novel marker for the smooth muscle contractile phenotype and is regulated by SRF/myocardin. We found that TGFB1I1 is specifically expressed in smooth muscle cells (SMCs) and in smooth muscle-rich tissues. Furthermore, TGFB1I1 expression is significantly down-regulated in a variety of models for smooth muscle phenotypic modulation. The TGFB1I1 promoter contains an evolutionarily conserved CArG element, and this element is indispensible for myocardin-induced transactivation of TGFB1I1 promoter. By oligonucleotide pulldown and chromatin immunoprecipitation assays, we found that SRI binds to this CArG element in vitro and in vivo. Ectopic expression of myocardin is sufficient to induce endogenous TGFB1I1 expression in multiple cell lines whereas knocking-down myocardin or SRF significantly attenuated TGFB1I1 expression in SMCs. Furthermore, our data demonstrated that SRF is essential for TGF-beta-mediated induction of TGFB1I1. Finally, silencing of TGFB1I1 expression significantly promotes SMC proliferation. Collectively, this study provides the first evidence that TGFB1I1 is not only an SRF/myocardin-regulated smooth muscle marker but also critical for maintaining smooth muscle contractile phenotype by inhibiting smooth muscle proliferation.	[Wang, Xiaobo; Hu, Guoqing; Harmon, Erin Yund; Keller, Rebecca S.; Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Betts, Courtney; Van De Water, Livingston] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Zhou, JL (corresponding author), 47 New Scotland Ave,Mail Code 8, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/J-4312-2014; Wang, Xiaobo/S-2476-2019	Wang, Xiaobo/0000-0001-6044-914X; Van De Water, Livingston/0000-0002-3825-9224	National Institutes of Health [GM56442]; NIGMS, National Institutes of Health; Albany Medical College and Scientist Development; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Albany Medical College and Scientist Development; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56442 and by American Recovery and Reinvestment Act funds from the NIGMS, National Institutes of Health (to L. V. D. W.). This work was also supported by a start-up fund from Albany Medical College and Scientist Development Grant from the American Heart Association (to J. Z.).	Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Brunskill EW, 2001, DEV BIOL, V235, P507, DOI 10.1006/dbio.2001.0313; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kim-Kaneyama JR, 2008, BIOCHEM BIOPH RES CO, V376, P682, DOI 10.1016/j.bbrc.2008.09.051; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; KUROO M, 1991, J BIOL CHEM, V266, P3768; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413; Yund EE, 2009, J MOL CELL CARDIOL, V47, P520, DOI 10.1016/j.yjmcc.2009.06.006; Zheng JP, 2010, EXP MOL PATHOL, V88, P52, DOI 10.1016/j.yexmp.2009.10.006; Zhou JL, 2010, J BIOL CHEM, V285, P23175, DOI 10.1074/jbc.M110.109868	49	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41589	41599		10.1074/jbc.M111.250878	http://dx.doi.org/10.1074/jbc.M111.250878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984848	hybrid, Green Published			2022-12-25	WOS:000298057500044
J	Rebuffo-Scheer, C; Bose, M; He, J; Khaja, S; Ulatowski, M; Beck, ET; Fan, J; Kumar, S; Nelson, MI; Henrickson, KJ				Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Nelson, Martha I.; Henrickson, Kelly J.			Whole Genome Sequencing and Evolutionary Analysis of Human Respiratory Syncytial Virus A and B from Milwaukee, WI 1998-2010	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SUBGROUP-B; GROUP-A; GENETIC-VARIABILITY; G-PROTEIN; TRANSCRIPTION TERMINATION; CIRCULATION PATTERNS; G-GLYCOPROTEIN; CONSECUTIVE SEASONS; SOUTH-AFRICA	Background: Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory-tract infections in infants and young children worldwide. Despite this, only six complete genome sequences of original strains have been previously published, the most recent of which dates back 35 and 26 years for RSV group A and group B respectively. Methodology/Principal Findings: We present a semi-automated sequencing method allowing for the sequencing of four RSV whole genomes simultaneously. We were able to sequence the complete coding sequences of 13 RSV A and 4 RSV B strains from Milwaukee collected from 1998-2010. Another 12 RSV A and 5 RSV B strains sequenced in this study cover the majority of the genome. All RSV A and RSV B sequences were analyzed by neighbor-joining, maximum parsimony and Bayesian phylogeny methods. Genetic diversity was high among RSV A viruses in Milwaukee including the circulation of multiple genotypes (GA1, GA2, GA5, GA7) with GA2 persisting throughout the 13 years of the study. However, RSV B genomes showed little variation with all belonging to the BA genotype. For RSV A, the same evolutionary patterns and clades were seen consistently across the whole genome including all intergenic, coding, and non-coding regions sequences. Conclusions/Significance: The sequencing strategy presented in this work allows for RSV A and B genomes to be sequenced simultaneously in two working days and with a low cost. We have significantly increased the amount of genomic data that is available for both RSV A and B, providing the basic molecular characteristics of RSV strains circulating in Milwaukee over the last 13 years. This information can be used for comparative analysis with strains circulating in other communities around the world which should also help with the development of new strategies for control of RSV, specifically vaccine development and improvement of RSV diagnostics.	[Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Midwest Resp Virus Program, Milwaukee, WI 53214 USA; [Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Henrickson, Kelly J.] Childrens Res Inst, Milwaukee, WI USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD USA	Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Rebuffo-Scheer, C (corresponding author), Midwest Resp Virus Program, Milwaukee, WI 53214 USA.	Khenrick@mcw.edu			National Institute of Allergy and Infectious Diseases (NIAID) from the National Institutes of Health (NIH) [U01-AI-066584, U01-AI-070428, U01-AI-077988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077988, U01AI070428, U01AI066584] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funds from the National Institute of Allergy and Infectious Diseases (NIAID) grants U01-AI-066584, U01-AI-070428, and U01-AI-077988 from the National Institutes of Health (NIH) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Beck ET, 2010, J MOL DIAGN, V12, P74, DOI 10.2353/jmoldx.2010.090095; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Collins PL, 2007, FIELDS VIROLOGY, P1601; Crowe JE, 1996, J INFECT DIS, V173, P829, DOI 10.1093/infdis/173.4.829; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Deng Jie, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P1; Fields B. N, 1996, FIELDS VIROLOGY, V1, P1177; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Harmon SB, 2002, VIROLOGY, V300, P304, DOI 10.1006/viro.2002.1541; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; JOHNSON PR, 1988, J GEN VIROL, V69, P2901, DOI 10.1099/0022-1317-69-11-2901; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KAWANO M, 1991, NUCLEIC ACIDS RES, V19, P2739, DOI 10.1093/nar/19.10.2739; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kuo L, 1997, J VIROL, V71, P4944, DOI 10.1128/JVI.71.7.4944-4953.1997; Kuo LL, 1996, J VIROL, V70, P6143, DOI 10.1128/JVI.70.9.6143-6150.1996; Kuroiwa Y, 2005, J MED VIROL, V76, P241, DOI 10.1002/jmv.20348; Lazar I, 2006, J CLIN VIROL, V37, P168, DOI 10.1016/j.jcv.2006.07.006; Matheson JW, 2006, J MED VIROL, V78, P1354, DOI 10.1002/jmv.20702; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Moudy RM, 2004, VIROLOGY, V327, P121, DOI 10.1016/j.virol.2004.06.013; Moudy RM, 2003, VIROLOGY, V313, P250, DOI 10.1016/S0042-6822(03)00299-X; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Nair H, 2010, LANCET; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; Ostlund MR, 2008, J MED VIROL, V80, P159, DOI 10.1002/jmv.21066; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Salter A, 2011, J MED VIROL, V83, P337, DOI 10.1002/jmv.21957; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Swofford DL, 1998, PHYLOGENETIC ANAL US; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tolley KP, 1996, VACCINE, V14, P1637, DOI 10.1016/S0264-410X(96)00136-3; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; United Nations Population Division, WORLD POP PROSP 2008; Venter M, 2002, J MED VIROL, V68, P452, DOI 10.1002/jmv.10225; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	57	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25468	10.1371/journal.pone.0025468	http://dx.doi.org/10.1371/journal.pone.0025468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998661	Green Submitted, Green Published, gold			2022-12-25	WOS:000295968700011
J	Cavallo, M; Adenzato, M; MacPherson, SE; Karwig, G; Enrici, I; Abrahams, S				Cavallo, Marco; Adenzato, Mauro; MacPherson, Sarah E.; Karwig, Gillian; Enrici, Ivan; Abrahams, Sharon			Evidence of Social Understanding Impairment in Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; EPWORTH SLEEPINESS SCALE; ASPERGER-SYNDROME; COGNITIVE IMPAIRMENT; COMPUTED-TOMOGRAPHY; SCORE DIFFERENCES; NORMAL ADULTS; DEMENTIA; MIND	The present study aims at clarifying the nature of the Theory of Mind (ToM) deficits associated with Amyotrophic Lateral Sclerosis (ALS). ToM is the ability to attribute mental states such as intentions and beliefs to others in order to understand and predict their behaviour and to behave accordingly. Several neuroimaging studies reported the prefrontal cortices as the brain region underlying a key ToM ability, i.e. the comprehension of social intentions. Dysfunction of the prefrontal cortices in patients with ALS has been indicated by a range of neuroimaging studies. The frontal syndrome that appears to characterize up to 50% of ALS has been noted to be similar to the profile that characterizes patients with frontotemporal dementia (FTD), a neurodegenerative condition characterised by ToM deficits. In the present paper, we hypothesize that the performance of patients with ALS is significantly worse than healthy controls' performance on tasks requiring the comprehension of social contexts, whereas patients' performance is comparable to healthy controls' performance on tasks not requiring the comprehension of social contexts. To this end, we tested 15 patients with ALS with an experimental protocol that distinguishes between private (non-social) intentions and social intentions. The pattern of results followed the experimental hypothesis: the performance of patients with ALS and healthy controls significantly differed on the comprehension of social context only, with an impairment in patients with ALS. Single case analysis confirmed the findings at an individual level. The present study is the first which has examined and compared the understanding of social and non-social contexts in patients with ALS and shown a specific and selective deficit in the former only. The current findings further support the notion of a continuum of cognitive dysfunction ranging from ALS to FTD, with parallel cognitive profiles in both disorders.	[Cavallo, Marco] Univ Turin, Dept Mental Hlth, San Luigi Gonzaga Hosp Med Sch, Turin, Italy; [Cavallo, Marco] Amedeo Avogadro Univ Eastern Piedmont, Dept Med Sci, Novara, Italy; [Adenzato, Mauro; Enrici, Ivan] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Adenzato, Mauro] Neurosci Inst Turin, Turin, Italy; [MacPherson, Sarah E.; Karwig, Gillian; Abrahams, Sharon] Univ Edinburgh, Human Cognit Neurosci Psychol, Edinburgh, Midlothian, Scotland; [MacPherson, Sarah E.; Abrahams, Sharon] Univ Edinburgh, Ctr Cognit Aging & Epidemiol, Edinburgh, Midlothian, Scotland; [Abrahams, Sharon] Univ Edinburgh, Euan MacDonald Ctr, Edinburgh, Midlothian, Scotland	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Edinburgh; University of Edinburgh; University of Edinburgh	Cavallo, M (corresponding author), Univ Turin, Dept Mental Hlth, San Luigi Gonzaga Hosp Med Sch, Turin, Italy.	mauro.adenzato@unito.it	Enrici, Ivan/C-3810-2018; MacPherson, Sarah E/G-8524-2013; Adenzato, Mauro/I-5127-2012; Adenzato, Mauro/AFQ-8675-2022	Enrici, Ivan/0000-0002-1289-5855; MacPherson, Sarah E/0000-0001-8676-6514; Adenzato, Mauro/0000-0002-6997-9283; Adenzato, Mauro/0000-0002-6997-9283; Cavallo, Marco/0000-0002-4784-0803	University of Turin (Ricerca scientifica finanziata dall'Universita); Medical Research Council [G0700704B] Funding Source: researchfish	University of Turin (Ricerca scientifica finanziata dall'Universita); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University of Turin (Ricerca scientifica finanziata dall'Universita 2007 e 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, J NEUROL NEUROSUR PS, V62, P464, DOI 10.1136/jnnp.62.5.464; Abrahams S, 2005, NEUROLOGY, V64, P1222, DOI 10.1212/01.WNL.0000156519.41681.27; Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Adenzato M, 2006, THEOR PSYCHOL, V16, P747, DOI 10.1177/0959354306070515; Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Bara BG, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00007; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bigio EH, 2003, NEUROPATH APPL NEURO, V29, P239, DOI 10.1046/j.1365-2990.2003.00466.x; Boersma P., 2016, PRAAT DOING PHONETIC; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cavallo M, 2011, ACTA NEUROPSYCHOL, V9, P167; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Chervin RD, 1997, J PSYCHOSOM RES, V42, P145, DOI 10.1016/S0022-3999(96)00239-5; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P898, DOI 10.1076/jcen.20.6.898.1112; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Enrici I, 2011, J COGNITIVE NEUROSCI, V23, P2415, DOI 10.1162/jocn.2010.21594; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Jeong Y, 2005, NEUROLOGY, V64, P734, DOI 10.1212/01.WNL.0000152047.58767.9D; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KATO S, 1993, J NEUROL SCI, V116, P52, DOI 10.1016/0022-510X(93)90089-H; Kipps CM, 2006, SOC NEUROSCI-UK, V1, P235, DOI 10.1080/17470910600989847; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; McKenna P., 1983, GRADED NAMING TEST; Meier SL, 2010, BRAIN, V133, P3444, DOI 10.1093/brain/awq254; Murphy J, 2007, ARCH NEUROL-CHICAGO, V64, P330, DOI 10.1001/archneur.64.3.330; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; NEARY D, 1990, J NEUROL NEUROSUR PS, V53, P23, DOI 10.1136/jnnp.53.1.23; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; Shi J, 2005, ACTA NEUROPATHOL, V110, P501, DOI 10.1007/s00401-005-1079-4; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Strong MJ, 1999, NEUROLOGY, V53, P1665, DOI 10.1212/WNL.53.8.1665; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; TALBOT PR, 1995, J NEUROL NEUROSUR PS, V58, P541, DOI 10.1136/jnnp.58.5.541; Tsiakiri A., 2022, APPL NEUROPSYCH-ADUL, DOI [10.1080/23279095.2022.2074850, DOI 10.1080/23279095.2022.2074850]; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Warrington EK., 1991, VISUAL OBJECT SPACE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	69	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25948	10.1371/journal.pone.0025948	http://dx.doi.org/10.1371/journal.pone.0025948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998727	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900078
J	Hempel, CM; Sivula, M; Levenson, JM; Rose, DM; Li, B; Sirianni, AC; Xia, E; Ryan, TA; Gerber, DJ; Cottrell, JR				Hempel, Chris M.; Sivula, Michael; Levenson, Jonathan M.; Rose, David M.; Li, Bing; Sirianni, Ana C.; Xia, Eva; Ryan, Timothy A.; Gerber, David J.; Cottrell, Jeffrey R.			A System for Performing High Throughput Assays of Synaptic Function	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; CALCIUM-CHANNELS; GENE-EXPRESSION; TRANSMISSION; STIMULATION; ASSOCIATION; SECRETION; MEMBRANE; DISORDER; SCREENS	Unbiased, high-throughput screening has proven invaluable for dissecting complex biological processes. Application of this general approach to synaptic function would have a major impact on neuroscience research and drug discovery. However, existing techniques for studying synaptic physiology are labor intensive and low-throughput. Here, we describe a new high-throughput technology for performing assays of synaptic function in primary neurons cultured in microtiter plates. We show that this system can perform 96 synaptic vesicle cycling assays in parallel with high sensitivity, precision, uniformity, and reproducibility and can detect modulators of presynaptic function. By screening libraries of pharmacologically defined compounds on rat forebrain cultures, we have used this system to identify novel effects of compounds on specific aspects of presynaptic function. As a system for unbiased compound as well as genomic screening, this technology has significant applications for basic neuroscience research and for the discovery of novel, mechanism-based treatments for central nervous system disorders.	[Hempel, Chris M.; Sivula, Michael; Levenson, Jonathan M.; Rose, David M.; Li, Bing; Sirianni, Ana C.; Xia, Eva; Gerber, David J.; Cottrell, Jeffrey R.] Galenea Corp, Cambridge, MA USA; [Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Cornell University	Hempel, CM (corresponding author), Galenea Corp, Cambridge, MA USA.	jcottrell@galenea.com	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	Otsuka Pharmaceutical Co., Ltd.; NIMH [1RC4MH092889-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783, RC4MH092889] Funding Source: NIH RePORTER	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a research and development collaboration with Otsuka Pharmaceutical Co., Ltd. and by NIMH grant 1RC4MH092889-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; Bugianesi RM, 2006, ASSAY DRUG DEV TECHN, V4, P21, DOI 10.1089/adt.2006.4.21; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Carbone E, 2006, PFLUG ARCH EUR J PHY, V453, P373, DOI 10.1007/s00424-006-0100-7; CUERVO LA, 1970, J GEN PHYSIOL, V55, P309, DOI 10.1085/jgp.55.3.309; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Enna SJ, 2009, J PHARMACOL EXP THER, V329, P404, DOI 10.1124/jpet.108.143420; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Huang CJ, 2006, NAT BIOTECHNOL, V24, P439, DOI 10.1038/nbt1194; Huang KS, 2006, METHOD ENZYMOL, V414, P589, DOI 10.1016/S0076-6879(06)14030-6; Jensen K, 1999, J NEUROPHYSIOL, V81, P1225, DOI 10.1152/jn.1999.81.3.1225; Kugler S, 2003, VIROLOGY, V311, P89, DOI 10.1016/S0042-6822(03)00162-4; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McCown TJ, 2005, CURR GENE THER, V5, P333, DOI 10.2174/1566523054064995; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Persidis A, 1998, NAT BIOTECHNOL, V16, P488, DOI 10.1038/nbt0598-488; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Royle Stephen J., 2008, V457, P293, DOI 10.1007/978-1-59745-261-8_22; Rozas JL, 2010, BIOCHEM SOC T, V38, P488, DOI 10.1042/BST0380488; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	45	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25999	10.1371/journal.pone.0025999	http://dx.doi.org/10.1371/journal.pone.0025999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998743	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900089
J	Li, HL; Lei, GC; Zhi, YB; An, SQ; Huang, HP; Ouyang, Y; Zhao, L; Deng, ZF; Liu, YH				Li, Hong-li; Lei, Guang-chun; Zhi, Ying-biao; An, Shu-qing; Huang, He-ping; Ouyang, Yan; Zhao, Lei; Deng, Zi-fa; Liu, Yu-hong			Nitrogen Level Changes the Interactions between a Native (Scirpus triqueter) and an Exotic Species (Spartina anglica) in Coastal China	PLOS ONE			English	Article							INTER-SPECIFIC COMPETITION; SALT-MARSH PLANTS; HYDRILLA-VERTICILLATA; ENVIRONMENTAL-FACTORS; INVASIVE PLANT; SALINITY; ZONATION; GROWTH; ALTERNIFLORA; PLANTATIONS	The exotic species Spartina anglica, introduced from Europe in 1963, has been experiencing a decline in the past decade in coastal China, but the reasons for the decline are still not clear. It is hypothesized that competition with the native species Scirpus triqueter may have played an important role in the decline due to niche overlap in the field. We measured biomass, leaf number and area, asexual reproduction and relative neighborhood effect (RNE) of the two species in both monoculture and mixture under three nitrogen levels (control, low and high). S. anglica showed significantly lower biomass accumulation, leaf number and asexual reproduction in mixture than in monoculture. The inter- and intra-specific RNE of S. anglica were all positive, and the inter- specific RNE was significantly higher than the intra-specific RNE in the control. For S. triqueter, interand intra-specific RNE were negative at the high nitrogen level but positive in the control and at the low nitrogen level. This indicates that S. triqueter exerted an asymmetric competitive advantage over S. anglica in the control and low nitrogen conditions; however, S. anglica facilitated growth of S. triqueter in high nitrogen conditions. Nitrogen level changed the interactions between the two species because S. triqueter better tolerated low nitrogen. Since S. anglica is increasingly confined to upper, more nitrogen-limited marsh areas in coastal China, increased competition from S. triqueter may help explain its decline.	[Li, Hong-li; Lei, Guang-chun] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Li, Hong-li; Zhi, Ying-biao; An, Shu-qing; Ouyang, Yan; Zhao, Lei; Deng, Zi-fa] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Life Sci, Nanjing 210008, Peoples R China; [An, Shu-qing] Nanjing Univ, Inst Wetland Ecol, Sch Life Sci, Nanjing 210008, Peoples R China; [Huang, He-ping] Jiangxi Univ Finance & Econ, Sch Tourism & Urban Management, Nanchang, Peoples R China; [Liu, Yu-hong] Chinese Acad Sci, Yantai Inst Coastal Zone Res Sustainable Dev, Yantai, Peoples R China	Beijing Forestry University; Nanjing University; Nanjing University; Jiangxi University of Finance & Economics; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Li, HL (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	anshq@nju.edu.cn	Guangchun, Lei/ABC-8081-2021		National Forestry Special Public Foundation of China [200804005]; Beijing Forestry University [BLX2009-;021]; Fundamental Research Funds for the Central Universities [2011-34]; Forestry Soft-Science Research Project [2008-R02]	National Forestry Special Public Foundation of China; Beijing Forestry University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Soft-Science Research Project	This research was supported by the National Forestry Special Public Foundation of China (No. 200804005), the Research Funds for the New Teacher of Beijing Forestry University (BLX2009-;021), the Fundamental Research Funds for the Central Universities (2011-34) and the Forestry Soft-Science Research Project (2008-R02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Boyer KE, 1999, RESTOR ECOL, V7, P74, DOI 10.1046/j.1526-100X.1999.07109.x; Brewer JS, 2003, PLANT ECOL, V168, P93, DOI 10.1023/A:1024478714291; Callaway JC, 1998, WETLANDS ECOLOGY MAN, V5, P179, DOI 10.1023/A:1008224204102; Charpentier A, 1999, PLANT ECOL, V141, P129, DOI 10.1023/A:1009825905117; Chen ZY, 2004, HYDROBIOLOGIA, V528, P99, DOI 10.1007/s10750-004-1888-9; Chung C., 1985, BRIEF HIST SPARTINA, P30; Chung CH, 2004, ECOL ENG, V23, P135, DOI 10.1016/j.ecoleng.2004.07.004; CHUNG CH, 1993, ECOL ENG, V2, P261, DOI 10.1016/0925-8574(93)90019-C; Daehler CC, 1996, BIOL CONSERV, V78, P51, DOI 10.1016/0006-3207(96)00017-1; Dormann CF, 2000, J ECOL, V88, P571, DOI 10.1046/j.1365-2745.2000.00469.x; Doyle RD, 2003, AQUAT BOT, V77, P223, DOI 10.1016/S0304-3770(03)00104-9; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Ferris C, 1997, MOL ECOL, V6, P185, DOI 10.1046/j.1365-294X.1997.00165.x; Fetene M, 2003, J ARID ENVIRON, V55, P441, DOI 10.1016/S0140-1963(03)00052-1; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Grace JB, 1997, AM NAT, V149, P436, DOI 10.1086/285999; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; Greenwood ME, 2009, AQUAT BOT, V90, P23, DOI 10.1016/j.aquabot.2008.05.001; Hofstra DE, 1999, AQUAT BOT, V63, P305, DOI 10.1016/S0304-3770(98)00125-9; Huckle JM, 2002, OIKOS, V96, P307, DOI 10.1034/j.1600-0706.2002.960213.x; Huckle JM, 2000, J ECOL, V88, P492, DOI 10.1046/j.1365-2745.2000.00464.x; Ikegami M, 2007, PLANT ECOL, V189, P247, DOI 10.1007/s11258-006-9181-9; Kiehl K, 1997, OECOLOGIA, V111, P325, DOI 10.1007/s004420050242; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kool A, 2009, PLANT ECOL, V204, P125, DOI 10.1007/s11258-009-9574-7; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Li HL, 2008, PLANT SCI, V174, P299, DOI 10.1016/j.plantsci.2007.11.015; Lillebo AI, 2003, AQUAT BOT, V77, P111, DOI 10.1016/S0304-3770(03)00088-3; PARTRIDGE TR, 1987, NEW ZEAL J BOT, V25, P567, DOI 10.1080/0028825X.1987.10410087; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Pennings SC, 2001, OECOLOGIA, V126, P587, DOI 10.1007/s004420000548; Perry LG, 2009, PLANT ECOL, V204, P247, DOI 10.1007/s11258-009-9588-1; Rossell IM, 1995, ENVIRON EXP BOT, V35, P507, DOI 10.1016/0098-8472(95)00027-5; THOMPSON JD, 1991, BIOSCIENCE, V41, P393, DOI 10.2307/1311746; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; van Wijnen HJ, 1999, J ECOL, V87, P265, DOI 10.1046/j.1365-2745.1999.00349.x; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426; Zhang JY, 2008, J INTEGR PLANT BIOL, V50, P1570, DOI 10.1111/j.1744-7909.2008.00699.x; Zhi YB, 2007, ESTUAR COAST SHELF S, V74, P437, DOI 10.1016/j.ecss.2007.04.026	42	9	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25629	10.1371/journal.pone.0025629	http://dx.doi.org/10.1371/journal.pone.0025629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998676	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900039
J	Sanchez-Garcia, C; Alsius, A; Enns, JT; Soto-Faraco, S				Sanchez-Garcia, Carolina; Alsius, Agnes; Enns, James T.; Soto-Faraco, Salvador			Cross-Modal Prediction in Speech Perception	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; HEARING LIPS; SEEING VOICES; COMPREHENSION; COMPETITION; ACTIVATION; EVENTS; BRAIN	Speech perception often benefits from vision of the speaker's lip movements when they are available. One potential mechanism underlying this reported gain in perception arising from audio-visual integration is on-line prediction. In this study we address whether the preceding speech context in a single modality can improve audiovisual processing and whether this improvement is based on on-line information-transfer across sensory modalities. In the experiments presented here, during each trial, a speech fragment (context) presented in a single sensory modality (voice or lips) was immediately continued by an audiovisual target fragment. Participants made speeded judgments about whether voice and lips were in agreement in the target fragment. The leading single sensory context and the subsequent audiovisual target fragment could be continuous in either one modality only, both (context in one modality continues into both modalities in the target fragment) or neither modalities (i.e., discontinuous). The results showed quicker audiovisual matching responses when context was continuous with the target within either the visual or auditory channel (Experiment 1). Critically, prior visual context also provided an advantage when it was cross-modally continuous (with the auditory channel in the target), but auditory to visual cross-modal continuity resulted in no advantage (Experiment 2). This suggests that visual speech information can provide an on-line benefit for processing the upcoming auditory input through the use of predictive mechanisms. We hypothesize that this benefit is expressed at an early level of speech analysis.	[Sanchez-Garcia, Carolina; Soto-Faraco, Salvador] Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain; [Alsius, Agnes] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Enns, James T.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Soto-Faraco, Salvador] ICREA, Barcelona, Spain	Pompeu Fabra University; Queens University - Canada; University of British Columbia; ICREA	Sanchez-Garcia, C (corresponding author), Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain.	Salvador.Soto@icrea.es	Enns, James T/O-7583-2017; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; SOTO-FARACO, SALVADOR/B-8400-2011	Enns, James T/0000-0002-3676-8316; SOTO-FARACO, SALVADOR/0000-0002-4799-3762	Spanish Ministry of Science and Innovation [PSI2010-15426, CSD2007-00012]; Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya [SRG2009-092, PIV2009-00122]; European Research Council [StG-2010 263145]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya(Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This research was supported by the Spanish Ministry of Science and Innovation (PSI2010-15426 and Consolider INGENIO CSD2007-00012), Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya (SRG2009-092 and PIV2009-00122), and the European Research Council (StG-2010 263145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Arnold P, 2001, BRIT J PSYCHOL, V92, P339, DOI 10.1348/000712601162220; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Calvert G., 2004, HDB MULTISENSORY PRO; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Dambacher M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005047; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Enns JT, 2008, TRENDS COGN SCI, V12, P327, DOI 10.1016/j.tics.2008.06.001; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fowler CA, 2004, HDB MULTISENSORY PRO, P189; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; Keller PE, 2008, Q J EXP PSYCHOL, V61, P275, DOI 10.1080/17470210601160864; LAMME VAF, 1995, J NEUROSCI, V15, P1605; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Navarra J, 2007, PSYCHOL RES-PSYCH FO, V71, P4, DOI 10.1007/s00426-005-0031-5; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rosenblum LD, 2007, PSYCHOL SCI, V18, P392, DOI 10.1111/j.1467-9280.2007.01911.x; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schwartz J.-L., 1998, HEARING EYE, P85; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Soto-Faraco S, 2007, PERCEPT PSYCHOPHYS, V69, P218, DOI 10.3758/BF03193744; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Stein BE, 1993, MERGING SENSES; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevens KN, 1967, MODELS PERCEPTION SP, P88; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Summerfield A.Q., 1987, HEARING EYE PSYCHOL, P3, DOI DOI 10.2307/1423237; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	40	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25198	10.1371/journal.pone.0025198	http://dx.doi.org/10.1371/journal.pone.0025198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998642	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900014
J	Martin, J; Jenkins, RH; Bennagi, R; Krupa, A; Phillips, AO; Bowen, T; Fraser, DJ				Martin, John; Jenkins, Robert H.; Bennagi, Rasha; Krupa, Aleksandra; Phillips, Aled O.; Bowen, Timothy; Fraser, Donald J.			Post-Transcriptional Regulation of Transforming Growth Factor Beta-1 by MicroRNA-744	PLOS ONE			English	Article							SIGNALING PATHWAYS; GROWTH-FACTOR-BETA-1; TRANSLATION; CELLS; EXPRESSION; CLEAVAGE; GLUCOSE; RNA	Transforming Growth Factor Beta-1 (TGF-beta 1) is a pleiotropic cytokine that is of central importance in wound healing, inflammation, and in key pathological processes including cancer and progressive tissue fibrosis. TGF-beta 1 is post-transcriptionally regulated, but the underlying mechanisms remain incompletely defined. Previously, we have extensively delineated post-transcriptional regulation of TGF-beta 1 synthesis in the kidney, with evidence for relief of translational repression in proximal tubular cells in the context of diabetic nephropathy. In this study, we have investigated the role of the TGF-beta 1 3'Untranslated Region (3'UTR). Two different 3'UTR lengths have been reported for TGF-beta 1, of 543 and 137 nucleotides. Absolute quantification showed that, while both UTR lengths were detectable in various human cell types and in a broad range of tissues, the short form predominated in the kidney and elsewhere. Expression of both forms was up-regulated following auto-induction by TGF-beta 1, but the short: long UTR ratio remained constant. Incorporation of the short UTR into a luciferase reporter vector significantly reduced reporter protein synthesis without major effect on RNA amount, suggesting post-transcriptional inhibition. In silico approaches identified multiple binding sites for miR-744 located in the proximal TGF-beta 1 3'UTR. A screen in RNA from human tissues showed widespread miR-744 expression. miR-744 transfection inhibited endogenous TGF-beta 1 synthesis, while direct targeting of TGF-beta 1 was shown in separate experiments, in which miR-744 decreased TGF-beta 1 3'UTR reporter activity. This work identifies miR-744-directed post-transcriptional regulation of TGF-beta 1 which, given the pleiotropic nature of cellular responses to TGF-beta 1, is potentially widely significant.	[Martin, John; Jenkins, Robert H.; Bennagi, Rasha; Krupa, Aleksandra; Phillips, Aled O.; Bowen, Timothy; Fraser, Donald J.] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales	Cardiff University	Martin, J (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales.	fraserdj@cf.ac.uk		Fraser, Donald/0000-0003-0102-9342; Jenkins, Robert/0000-0001-8500-9044	Kidney Research UK [RP24/2009]	Kidney Research UK(Kidney Research UK (KRUK))	This study was funded by Kidney Research UK, grant number RP24/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RSH, 1998, GROWTH FACTORS, V16, P89, DOI 10.3109/08977199809002120; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fraser D, 2002, AM J PATHOL, V161, P1039, DOI 10.1016/S0002-9440(10)64265-4; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jenkins RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012283; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Mangone M, 2010, SCIENCE; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; ROMEO DS, 1993, MOL ENDOCRINOL, V7, P759, DOI 10.1210/me.7.6.759; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SCOTTO L, 1993, MOL CELL BIOL, V13, P3588, DOI 10.1128/MCB.13.6.3588; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921	27	54	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25044	10.1371/journal.pone.0025044	http://dx.doi.org/10.1371/journal.pone.0025044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991303	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300004
J	Aguzzi, MS; D'Arcangelo, D; Giampietri, C; Capogrossi, MC; Facchiano, A				Aguzzi, Maria Simona; D'Arcangelo, Daniela; Giampietri, Claudia; Capogrossi, Maurizio C.; Facchiano, Antonio			RAM, an RGDS Analog, Exerts Potent Anti-Melanoma Effects In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; MELANOMA-CELLS; CASPASE-3 ACTIVATION; EXTRACELLULAR-MATRIX; INDUCE APOPTOSIS; TUMOR-CELLS; PEPTIDE; INTEGRIN; ANGIOGENESIS; METASTASIS	Peptides containing the RGD sequence are under continuous investigation given their ability to control cell adhesion and apoptosis. Since small peptides are quickly metabolized and degraded in vivo, developing analogs resistant to serum-induced degradation is a challenging task. RGD analogs developed so far are known as molecules mostly inhibiting cell adhesion; this feature may reduce cell proliferation and tumor development but may not induce regression of tumors or metastases already formed. In the current study, carried out in melanoma in vitro and in vivo models, we show that RAM, an RGD-non-peptide Analog-Molecule, strongly inhibits cells adhesion onto plastic, vitronectin, fibronectin, laminin and von Willebrand Factor while it does not inhibit cell adhesion onto collagen IV, similarly to the RGDS template peptide. It also strongly inhibits in vitro cell proliferation, migration and DNA-synthesis, increases melanoma cells apoptosis and reduces survivin expression. All such effects were observed in collagen IV seeded cells, therefore are most likely independent from the anti adhesive properties. Further, RAM is more stable than the template RGDS; in fact it maintains its anti-proliferation and anti-adhesion effects after long serum exposure while RGDS almost completely loses its effects upon serum exposure. In a mouse metastatic melanoma in vivo model, increasing doses of RAM significantly reduce up to about 80% lung metastases development, while comparable doses of RGDS are less potent. In conclusion these data show that RAM is a potent inhibitor of melanoma growth in vitro, strongly reduces melanoma metastases development in vivo and represents a novel candidate for further in vivo investigations in the cancer treatment field.	[Aguzzi, Maria Simona; D'Arcangelo, Daniela; Capogrossi, Maurizio C.; Facchiano, Antonio] IDI IRCCS, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy; [Giampietri, Claudia] Univ Roma La Sapienza, DAHFMO Sect Histol & Med Embryol, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome	Aguzzi, MS (corresponding author), IDI IRCCS, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy.	a.facchiano@idi.it	D'Arcangelo, Daniela/K-6533-2016; Facchiano, Antonio/J-4744-2012; Facchiano, Antonio/K-5984-2016	D'Arcangelo, Daniela/0000-0002-7862-3289; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Antonio/0000-0002-4243-2392; Giampietri, Claudia/0000-0002-5025-5365	Italian Ministry of Health [RF07 Onc-25/3, RC2008-2009]; Progetto Oncoproteomica Italia-USA [527B/2A/5]; Progetto Oncologico Ordinario Ministero della salute [Onc_ord 25/07]; Progetto integrato-Ministero della salute, Ricerca oncologica [RFPS-2006-7-342220]	Italian Ministry of Health(Ministry of Health, Italy); Progetto Oncoproteomica Italia-USA; Progetto Oncologico Ordinario Ministero della salute; Progetto integrato-Ministero della salute, Ricerca oncologica	This study was supported in part by grants from the Italian Ministry of Health Contract (RF07 Onc-25/3; RC2008-2009 to AF), by Progetto Oncoproteomica Italia-USA 527B/2A/5 to AF, by Progetto Oncologico Ordinario Ministero della salute (Onc_ord 25/07) to AF, and by Progetto integrato-Ministero della salute, Ricerca oncologica (RFPS-2006-7-342220) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 2000, J BIOL CHEM, V275, P5760, DOI 10.1074/jbc.275.8.5760; Aguzzi MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-84; Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144; Aguzzi MS, 2004, BIOCHEM BIOPH RES CO, V321, P809, DOI 10.1016/j.bbrc.2004.07.036; AHMADI M, 2008, CANCER BIOTHER RADI, V27, P27; Bruck R, 2000, ISRAEL MED ASSOC J, V2, P74; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Casadio R, 2002, SAR QSAR ENVIRON RES, V13, P473, DOI 10.1080/10629360290015961; CHEN W, 2010, FASEB J; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Faraone D, 2009, NEOPLASIA, V11, P732, DOI 10.1593/neo.09408; Fujii H, 1998, CLIN EXP METASTAS, V16, P94; Garanger E, 2007, ANTI-CANCER AGENT ME, V7, P552, DOI 10.2174/187152007781668706; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; GUARNIERI D, 2010, ACTA BIOMATER; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Haubner R, 2009, FRONT BIOSCI-LANDMRK, V14, P872, DOI 10.2741/3283; Huang GF, 2008, BIOMATERIALS, V29, P1676, DOI 10.1016/j.biomaterials.2007.12.015; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kurihara H, 2005, J BIOSCI BIOENG, V100, P82, DOI 10.1263/jbb.100.82; Kurohane K, 2000, LIFE SCI, V68, P273, DOI 10.1016/S0024-3205(00)00938-3; Laurens N, 2009, ANGIOGENESIS, V12, P275, DOI 10.1007/s10456-009-9150-8; Li PC, 2010, MOL THER, V18, P921, DOI 10.1038/mt.2010.5; Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Oku N, 1996, LIFE SCI, V58, P2263, DOI 10.1016/0024-3205(96)00221-4; Perlot RL, 2002, J BONE MINER RES, V17, P66, DOI 10.1359/jbmr.2002.17.1.66; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Popkov M, 2006, INT J CANCER, V119, P1194, DOI 10.1002/ijc.21924; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Rerat V, 2009, J MED CHEM, V52, P7029, DOI 10.1021/jm901133z; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; SRINIVASAN R, 2009, J BIOMED MAT RES A; Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838; Susuki Y, 2002, CHEM PHARM BULL, V50, P1229, DOI 10.1248/cpb.50.1229; Tai BCU, 2010, BIOMATERIALS, V31, P48, DOI 10.1016/j.biomaterials.2009.09.022; Wang YG, 2009, J DRUG TARGET, V17, P459, DOI 10.1080/10611860902974085; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25352	10.1371/journal.pone.0025352	http://dx.doi.org/10.1371/journal.pone.0025352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984914	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000025
J	Carrero, ZI; Velma, V; Douglas, HE; Hebert, MD				Carrero, Zunamys I.; Velma, Venkatramreddy; Douglas, Heather E.; Hebert, Michael D.			Coilin Phosphomutants Disrupt Cajal Body Formation, Reduce Cell Proliferation and Produce a Distinct Coilin Degradation Product	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; BODIES; SMN; PHOSPHORYLATION; LOCALIZATION; PROTEINS; SNRNPS; METHYLATION; INTERPHASE; INTERACTS	Coilin is a nuclear phosphoprotein that accumulates in Cajal bodies (CBs). CBs participate in ribonucleoprotein and telomerase biogenesis, and are often found in cells with high transcriptional demands such as neuronal and cancer cells, but can also be observed less frequently in other cell types such as fibroblasts. Many proteins enriched within the CB are phosphorylated, but it is not clear what role this modification has on the activity of these proteins in the CB. Coilin is considered to be the CB marker protein and is essential for proper CB formation and composition in mammalian cells. In order to characterize the role of coilin phosphorylation on CB formation, we evaluated various coilin phosphomutants using transient expression. Additionally, we generated inducible coilin phosphomutant cell lines that, when used in combination with endogenous coilin knockdown, allow for the expression of the phosphomutants at physiological levels. Transient expression of all coilin phosphomutants except the phosphonull mutant (OFF) significantly reduces proliferation. Interestingly, a stable cell line induced to express the coilin S489D phosphomutant displays nucleolar accumulation of the mutant and generates a N-terminal degradation product; neither of which is observed upon transient expression. A N-terminal degradation product and nucleolar localization are also observed in a stable cell line induced to express a coilin phosphonull mutant (OFF). The nucleolar localization of the S489D and OFF coilin mutants observed in the stable cell lines is decreased when endogenous coilin is reduced. Furthermore, all the phosphomutant cells lines show a significant reduction in CB formation when compared to wild-type after endogenous coilin knockdown. Cell proliferation studies on these lines reveal that only wild-type coilin and the OFF mutant are sufficient to rescue the reduction in proliferation associated with endogenous coilin depletion. These results emphasize the role of coilin phosphorylation in the formation and activity of CBs.	[Carrero, Zunamys I.; Velma, Venkatramreddy; Douglas, Heather E.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Carrero, ZI (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu		Carrero, Zunamys/0000-0001-8501-1566	National Institutes of Health [R01GM081448]; University of Mississippi Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM081448. Heather E. Douglas was supported in part by the Medical Student Research Program of The University of Mississippi Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Clelland AK, 2009, TRAFFIC, V10, P1585, DOI 10.1111/j.1600-0854.2009.00972.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fuentes JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015769; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2000, J CELL SCI, V113, P1543; Lyon CE, 1997, EXP CELL RES, V230, P84, DOI 10.1006/excr.1996.3380; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Shababi M, 2010, DRUG NEWS PERSPECT, V23, P475, DOI 10.1358/dnp.2010.23.8.1507295; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Strzelecka M, 2010, NUCLEUS IN PRESS; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Tapia O, 2010, CHROMOSOMA, V119, P527, DOI 10.1007/s00412-010-0276-7; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y	37	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25743	10.1371/journal.pone.0025743	http://dx.doi.org/10.1371/journal.pone.0025743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991343	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000062
J	Dumortier, O; Theys, N; Ahn, MT; Remacle, C; Reusens, B				Dumortier, Olivier; Theys, Nicolas; Ahn, Marie-Therese; Remacle, Claude; Reusens, Brigitte			Impairment of Rat Fetal Beta-Cell Development by Maternal Exposure to Dexamethasone during Different Time-Windows	PLOS ONE			English	Article							GLUCOCORTICOIDS INHIBIT PROLIFERATION; GENE-EXPRESSION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PRENATAL EXPOSURE; LOW-PROTEIN; GROWTH; RECEPTOR; ISLETS; PANCREAS; GLUCOSE	Aim: Glucocorticoids (GCs) take part in the direct control of cell lineage during the late phase of pancreas development when endocrine and exocrine cell differentiation occurs. However, other tissues such as the vasculature exert a critical role before that phase. This study aims to investigate the consequences of overexposure to exogenous glucocorticoids during different time-windows of gestation for the development of the fetal endocrine pancreas. Methods: Pregnant Wistar rats received dexamethasone acetate in their drinking water (1 mg/ml) during the last week or throughout gestation. Fetuses and their pancreases were analyzed at day 15 and 21 of gestation. Morphometrical analysis was performed on pancreatic sections after immunohistochemistry techniques and insulin secretion was evaluated on fetal islets collected in vitro. Results: Dexamethasone given the last week or throughout gestation reduced the beta-cell mass in 21-day-old fetuses by respectively 18% or 62%. This was accompanied by a defect in insulin secretion. The alpha-cell mass was reduced similarly. Neither islet vascularization nor beta-cell proliferation was affected when dexamethasone was administered during the last week, which was however the case when given throughout gestation. When given from the beginning of gestation, dexamethasone reduced the number of cells expressing the early marker of endocrine lineage neurogenin-3 when analyzed at 15 days of fetal age. Conclusions: GCs reduce the beta-and alpha-cell mass by different mechanisms according to the stage of development during which the treatment was applied. In fetuses exposed to glucocorticoids the last week of gestation only, beta-cell mass is reduced due to impairment of beta-cell commitment, whereas in fetuses exposed throughout gestation, islet vascularization and lower beta-cell proliferation are involved as well, amplifying the reduction of the endocrine mass.	[Dumortier, Olivier; Theys, Nicolas; Ahn, Marie-Therese; Remacle, Claude; Reusens, Brigitte] Catholic Univ Louvain, Inst Sci Vie, Biol Cellulaire Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain	Dumortier, O (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Biol Cellulaire Lab, B-3000 Louvain, Belgium.	brigitte.reusens@uclouvain.be			European Commission [NUTRIX/QLK1-200-00083, EARNEST/FOOD-CT-2005-007036]; Parthenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique; Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship	European Commission(European CommissionEuropean Commission Joint Research Centre); Parthenon Trust (London, UK); Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Commission (NUTRIX/QLK1-200-00083, 5th FP and EARNEST/FOOD-CT-2005-007036, 6th FP), the Parthenon Trust (London, UK), and the Belgian Fonds National de la Recherche Scientifique. O. Dumortier was a recipient of a Fonds pour la Recherche dans l'Industrie et l'Agriculture fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Crocker IC, 1998, ANN ALLERG ASTHMA IM, V80, P509, DOI 10.1016/S1081-1206(10)63075-X; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Ham JN, 2009, PEDIATR RES, V66, P42, DOI 10.1203/PDR.0b013e3181a282a5; HAMAMDZIC D, 1995, AM J PHYSIOL-ENDOC M, V269, pE162, DOI 10.1152/ajpendo.1995.269.1.E162; Hewitt DP, 2006, ENDOCRINOLOGY, V147, P5568, DOI 10.1210/en.2006-0825; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; JAMAL H, 1991, ENDOCRINOLOGY, V129, P3372, DOI 10.1210/endo-129-6-3372; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; KHAN A, 1992, AM J PHYSIOL, V263, pE663, DOI 10.1152/ajpendo.1992.263.4.E663; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Komatsu S, 1998, J ANAT, V193, P551, DOI 10.1046/j.1469-7580.1998.19340551.x; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Langdown ML, 2001, MOL CELL ENDOCRINOL, V185, P109, DOI 10.1016/S0303-7207(01)00629-3; Langley-Evans SC, 2009, J ANAT, V215, P36, DOI 10.1111/j.1469-7580.2008.00977.x; Li MQ, 2007, IMMUNOL LETT, V109, P129, DOI 10.1016/j.imlet.2007.02.002; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; MOURMEAUX JL, 1985, MOL CELL ENDOCRINOL, V39, P237, DOI 10.1016/0303-7207(85)90067-X; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; NOVY MJ, 1983, AM J OBSTET GYNECOL, V145, P920, DOI 10.1016/0002-9378(83)90841-4; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; PRICE WA, 1992, ENDOCRINOLOGY, V130, P1424, DOI 10.1210/en.130.3.1424; REINISCH JM, 1978, SCIENCE, V202, P436, DOI 10.1126/science.705336; Rojas A, 2010, ADV EXP MED BIOL, V654, P59, DOI 10.1007/978-90-481-3271-3_4; *ROYAL COLL OBST G, 2010, ANT CORT RED NEON MO, V7; Sakai H, 1999, ARCH DERMATOL RES, V291, P224, DOI 10.1007/s004030050398; Scutt N, 2006, J ORTHOP RES, V24, P173, DOI 10.1002/jor.20030; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Shen CN, 2003, BIOCHEM J, V375, P41, DOI 10.1042/BJ20030140; Smith JT, 2003, ENDOCRINOLOGY, V144, P3024, DOI 10.1210/en.2003-0145; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Ward JW, 2002, PLACENTA, V23, P451, DOI 10.1053/plac.2002.0834; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x	51	29	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25576	10.1371/journal.pone.0025576	http://dx.doi.org/10.1371/journal.pone.0025576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991320	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000041
J	Lippolis, JD; Reinhardt, TA; Sacco, RA; Nonnecke, BJ; Nelson, CD				Lippolis, John D.; Reinhardt, Timothy A.; Sacco, Randy A.; Nonnecke, Brian J.; Nelson, Corwin D.			Treatment of an Intramammary Bacterial Infection with 25-Hydroxyvitamin D-3	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INNATE IMMUNE-RESPONSE; VITAMIN-D; MYCOBACTERIUM-TUBERCULOSIS; MULTIPLE-SCLEROSIS; MONOCYTES; 1-ALPHA,25-DIHYDROXYVITAMIN-D3; 1,25-DIHYDROXYVITAMIN-D3; PROLIFERATION; SARCOIDOSIS	Deficiency of serum levels of 25-hydroxyvitamin D-3 has been correlated with increased risk of infectious diseases such as tuberculosis and influenza. A plausible reason for this association is that expression of genes encoding important antimicrobial proteins depends on concentrations of 1,25-dihydroxyvitamin D-3 produced by activated immune cells at sites of infection, and that synthesis of 1,25-dihydroxyvitamin D-3 is dependent on the availability of 25-hydroxyvitamin D-3. Thus, increasing the availability of 25(OH) D-3 for immune cell synthesis of 1,25-dihydroxyvitamin D-3 at sites of infection has been hypothesized to aid in clearance of the infection. This report details the treatment of an acute intramammary infection with infusion of 25-hydroxyvitamin D-3 to the site of infection. Ten lactating cows were infected with in one quarter of their mammary glands. Half of the animals were treated intramammary with 25-hydroxyvitamin D-3. The 25-hydroxyvitamin D-3 treated animal showed significantly lower bacterial counts in milk and showed reduced symptomatic affects of the mastitis. It is significant that treatment with 25-hydroxyvitamin D-3 reduced the severity of an acute bacterial infection. This finding suggested a significant non-antibiotic complimentary role for 25-hydroxyvitamin D-3 in the treatment of infections in compartments naturally low in 25-hydroxyvitamin D-3 such as the mammary gland and by extension, possibly upper respiratory tract infections.	[Lippolis, John D.; Reinhardt, Timothy A.; Sacco, Randy A.; Nonnecke, Brian J.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Nelson, Corwin D.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Lippolis, JD (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Lippolis, John/0000-0003-2314-4384; Nelson, Corwin/0000-0003-0195-5610	United States Department of Agriculture (USDA)	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	United States Department of Agriculture (USDA) was the sole funder for this research. USDA determines the research priorities of all research that it funds. Publication of research is subject to review of USDA officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; Bannerman DD, 2004, VET RES, V35, P681, DOI 10.1051/vetres:2004040; BARBOUR GL, 1981, NEW ENGL J MED, V305, P440, DOI 10.1056/NEJM198108203050807; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; GIRASOLE G, 1990, J IMMUNOL, V145, P2459; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; HOLLIS BW, 1981, J NUTR, V111, P1240, DOI 10.1093/jn/111.7.1240; HOLLIS BW, 1993, CLIN CHEM, V39, P529; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021674; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REINHARDT TA, 1982, BIOCHEM BIOPH RES CO, V106, P1012, DOI 10.1016/0006-291X(82)91812-5; Reinhardt TA, 1999, J DAIRY SCI, V82, P1904, DOI 10.3168/jds.S0022-0302(99)75425-1; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094	32	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25479	10.1371/journal.pone.0025479	http://dx.doi.org/10.1371/journal.pone.0025479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991312	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000032
J	Martinez, O; Ecochard, V; Maheo, S; Gross, G; Bodin, P; Teissie, J; Escudier, JM; Paquereau, L				Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Escudier, Jean-Marc; Paquereau, Laurent			alpha,beta-D-Constrained Nucleic Acids Are Strong Terminators of Thermostable DNA Polymerases in Polymerase Chain Reaction	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CONFORMATIONALLY RESTRICTED DINUCLEOTIDE; ENZYMATIC INCORPORATION; REPLICATION SLIPPAGE; TEMPLATES; SITE; PCR; FIDELITY; POLYMERIZATION; NUCLEOTIDES	(S-C5', R-P) alpha,beta-D-Constrained Nucleic Acids (CNA) are dinucleotide building blocks that can feature either B-type torsional angle values or non-canonical values, depending on their 5'C and P absolute stereochemistry. These CNA are modified neither on the nucleobase nor on the sugar structure and therefore represent a new class of nucleotide with specific chemical and structural characteristics. They promote marked bending in a single stranded DNA so as to preorganize it into a loop-like structure, and they have been shown to induce rigidity within oligonucleotides. Following their synthesis, studies performed on CNA have only focused on the constraints that this family of nucleotides introduced into DNA. On the assumption that bending in a DNA template may produce a terminator structure, we investigated whether CNA could be used as a new strong terminator of polymerization in PCR. We therefore assessed the efficiency of CNA as a terminator in PCR, using triethylene glycol phosphate units as a control. Analyses were performed by denaturing gel electrophoresis and several PCR products were further analysed by sequencing. The results showed that the incorporation of only one CNA was always skipped by the polymerases tested. On the other hand, two CNA units always stopped proofreading polymerases, such as Pfu DNA polymerase, as expected for a strong replication terminator. Non-proofreading enzymes, e.g. Taq DNA polymerase, did not recognize this modification as a strong terminator although it was predominantly stopped by this structure. In conclusion, this first functional use of CNA units shows that these modified nucleotides can be used as novel polymerization terminators of proofreading polymerases. Furthermore, our results lead us to propose that CNA and their derivatives could be useful tools for investigating the behaviour of different classes of polymerases.	[Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Paquereau, Laurent] CNRS, Unite Mixte Rech 5089, Inst Pharmacol & Biol Struct, Toulouse, France; [Martinez, Olivier; Ecochard, Vincent; Maheo, Sabrina; Gross, Gregori; Bodin, Pierre; Teissie, Justin; Paquereau, Laurent] Univ Toulouse 3, Fac Sci & Ingn, F-31062 Toulouse, France; [Escudier, Jean-Marc] CNRS, Unite Mixte Rech 5068, Lab Synth & Physicochim Mol Interet Biol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Martinez, O (corresponding author), CNRS, Unite Mixte Rech 5089, Inst Pharmacol & Biol Struct, Toulouse, France.	Laurent.Paquereau@ipbs.fr	Teissie, Justin/AAA-5697-2019	Teissie, Justin/0000-0002-7588-8062; MARTINEZ, OLIVIER/0000-0002-3950-5458; PAQUEREAU, Laurent/0000-0002-6158-0155	Conseil Regional de la Region Midi-Pyrenees [08004695]	Conseil Regional de la Region Midi-Pyrenees(Region Occitanie)	Financial support for this project was provided by the Conseil Regional de la Region Midi-Pyrenees under grant number 08004695. The authors are grateful to Plateforme de synthese d oligonucleotides modifies de l'Interface Chimie Biologie de l'ITAV de Toulouse for providing facilities for oligonucleotides synthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMERMAN N, 1976, J MOL BIOL, V107, P601, DOI 10.1016/S0022-2836(76)80086-1; CARIELLO NF, 1991, GENE, V99, P105, DOI 10.1016/0378-1119(91)90040-I; Chen JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004949; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COSTA GL, 1994, NUCLEIC ACIDS RES, V22, P2423, DOI 10.1093/nar/22.12.2423; Dupouy C, 2008, ORG BIOMOL CHEM, V6, P2849, DOI 10.1039/b809775e; Dupouy C, 2006, ANGEW CHEM INT EDIT, V45, P3623, DOI 10.1002/anie.200504475; Dupouy C, 2010, CHEM COMMUN, V46, P5142, DOI 10.1039/c0cc00244e; Dupouy C, 2006, EUR J ORG CHEM, V2006, P5515, DOI 10.1002/ejoc.200600593; Dupouy C, 2008, TARG HETEROCYCL SYST, V12, P185; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; Feschenko VV, 1998, J MOL BIOL, V276, P559, DOI 10.1006/jmbi.1997.1566; Garcia-Diaz M, 2006, TRENDS BIOCHEM SCI, V31, P206, DOI 10.1016/j.tibs.2006.02.004; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; Horhota A, 2005, J AM CHEM SOC, V127, P7427, DOI 10.1021/ja0428255; Kempeneers V, 2005, NUCLEIC ACIDS RES, V33, P3828, DOI 10.1093/nar/gki695; Kempeneers V, 2003, NUCLEIC ACIDS RES, V31, P6221, DOI 10.1093/nar/gkg833; Kim TW, 2006, J BIOL CHEM, V281, P2289, DOI 10.1074/jbc.M510744200; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Kuwahara M, 2009, BIOORG MED CHEM LETT, V19, P2941, DOI 10.1016/j.bmcl.2009.04.064; Le Clezio I, 2005, J ORG CHEM, V70, P1620, DOI 10.1021/jo048136t; Le Clezio I, 2003, ORG LETT, V5, P161, DOI 10.1021/ol027222h; Le Clezio I, 2007, EUR J ORG CHEM, V2007, P3894, DOI 10.1002/ejoc.200700229; Marx A, 1999, CHEM BIOL, V6, P111, DOI 10.1016/S1074-5521(99)80007-6; Potapova O, 2006, BIOCHEMISTRY-US, V45, P890, DOI 10.1021/bi051792i; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tanaka K, 2008, CHEMBIOCHEM, V9, P2120, DOI 10.1002/cbic.200800285; Tanaka K, 2008, CHEM LETT, V37, P584, DOI 10.1246/cl.2008.584; TRAN HT, 1995, MOL CELL BIOL, V15, P5607; Tsai CH, 2007, P NATL ACAD SCI USA, V104, P14598, DOI 10.1073/pnas.0704211104; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vastmans K, 2000, BIOCHEMISTRY-US, V39, P12757, DOI 10.1021/bi001297g; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Viguera E, 2001, J MOL BIOL, V312, P323, DOI 10.1006/jmbi.2001.4943; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25510	10.1371/journal.pone.0025510	http://dx.doi.org/10.1371/journal.pone.0025510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991314	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000033
J	Phua, SLC; Sivakamasundari, V; Shao, Y; Cai, XH; Zhang, LF; Lufkin, T; Featherstone, M				Phua, Sze Lynn Calista; Sivakamasundari, V.; Shao, Yu; Cai, Xiaohan; Zhang, Li-Feng; Lufkin, Thomas; Featherstone, Mark			Nuclear Accumulation of an Uncapped RNA Produced by Drosha Cleavage of a Transcript Encoding miR-10b and HOXD4	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; EXPRESSION PATTERNS; MICRORNA EXPRESSION; HOMEOTIC TRANSFORMATIONS; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; AXIAL SKELETON; BREAST-CANCER; HOST GENES; MOUSE	Patterning of the animal embryo's antero-posterior (AP) axis is dependent on spatially and temporally regulated Hox gene expression. The murine Hoxd4 gene has been proposed to harbour two promoters, an upstream promoter P2, and a downstream promoter P1, that lie 5.2 and 1.1 kilobase pairs (kb) upstream of the coding region respectively. The evolutionarily conserved microRNA-10b (miR-10b) gene lies in the Hoxd4 genomic locus in the intron separating the non-coding exons 4 and 5 of the P2 transcript and directly adjacent to the proposed P1 promoter. Hoxd4 transcription is regulated by a 3' neural enhancer that harbours a retinoic acid response element (RARE). Here, we show that the expression profiles of Hoxd4 and miR-10b transcripts during neural differentiation of mouse embryonal carcinoma (EC) P19 cells are coordinately regulated, suggesting that both Hoxd4 and miR-10b expression is governed by the neural enhancer. Our observation that P1 transcripts are uncapped, together with the mapping of their 5' ends, strongly suggests that they are generated by Drosha cleavage of P2 transcripts rather than by transcriptional initiation. This is supported by the colocalization of P1 and P2 transcripts to the same posterior expression domain in the mouse embryo. These uncapped P1 transcripts do not appear to possess an Internal Ribosomal Entry Site (IRES), but accumulate within multiple punctate bodies within the nucleus suggesting that they play a functional role. Finally, similar uncapped Drosha-cleaved P1-like transcripts originating from the paralogous Hoxb4/miR-10a locus were also identified. We propose that these transcripts may belong to a novel class of regulatory RNAs.	[Phua, Sze Lynn Calista; Shao, Yu; Cai, Xiaohan; Zhang, Li-Feng; Featherstone, Mark] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sivakamasundari, V.; Lufkin, Thomas] Genome Inst Singapore, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Phua, SLC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	msfeatherstone@ntu.edu.sg	Featherstone, Mark/E-8057-2010; Lufkin, Thomas/B-5352-2011; Lufkin, Thomas/AAG-7476-2019; Zhang, Li-Feng/A-2209-2011	Featherstone, Mark/0000-0003-1576-046X; Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771; Zhang, Li-Feng/0000-0003-0917-0017	Biomedical Research Council (Singapore) [07/1/22/19/5]; Agency for Science, Technology and Research (A*STAR) of Singapore; Singapore Stem Cell Consortium [SSCC-09-015]	Biomedical Research Council (Singapore)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium	This work was supported by Biomedical Research Council (Singapore) grant number 07/1/22/19/5 (MF), the Agency for Science, Technology and Research (A*STAR) of Singapore (TL), and Singapore Stem Cell Consortium grant number SSCC-09-015 (LFZ). The Biomedical Research Council (BMRC, Singapore) vetted the manuscript for potentially patentable material. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Durston AJ, 2010, GENOMICS, V95, P250, DOI 10.1016/j.ygeno.2009.11.002; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Folberg A, 1997, J BIOL CHEM, V272, P29151, DOI 10.1074/jbc.272.46.29151; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; GAUNT SJ, 1989, DEVELOPMENT, V107, P131; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hadrys T, 2004, J EXP ZOOL PART B, V302B, P147, DOI 10.1002/jez.b.20012; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Morrison A, 1996, DEVELOPMENT, V122, P1895; Morrison A, 1997, DEVELOPMENT, V124, P3135; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nolte C, 2003, MECH DEVELOP, V120, P325, DOI 10.1016/S0925-4773(02)00442-2; Nolte C, 2006, DEV BIOL, V299, P582, DOI 10.1016/j.ydbio.2006.08.061; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wei Y, 2002, DIFFERENTIATION, V70, P204, DOI 10.1046/j.1432-0436.2002.700409.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zhang F, 2000, MECH DEVELOP, V96, P79, DOI 10.1016/S0925-4773(00)00377-4; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	60	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25689	10.1371/journal.pone.0025689	http://dx.doi.org/10.1371/journal.pone.0025689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991333	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000055
J	Rajasekaran, M; Abirami, S; Chen, CP				Rajasekaran, M.; Abirami, Santhanam; Chen, Chinpan			Effects of Single Nucleotide Polymorphisms on Human N-Acetyltransferase 2 Structure and Dynamics by Molecular Dynamics Simulation	PLOS ONE			English	Article							HAMSTER ARYLAMINE N-ACETYLTRANSFERASE-2; SLOW ACETYLATOR PHENOTYPE; SITE-DIRECTED MUTAGENESIS; BREAST-CANCER RISK; FUNCTIONAL-CHARACTERIZATION; METABOLIC-ACTIVATION; CATALYTIC MECHANISM; COLORECTAL-CANCER; NAT2 ALLOZYMES; O-ACETYLATION	Background: Arylamine N-acetyltransferase 2 (NAT2) is an important catalytic enzyme that metabolizes the carcinogenic arylamines, hydrazine drugs and chemicals. This enzyme is highly polymorphic in different human populations. Several polymorphisms of NAT2, including the single amino acid substitutions R64Q, 1114T, D122N, L137F, Q145P, R197Q, and G286E, are classified as slow acetylators, whereas the wild-type NAT2 is classified as a fast acetylator. The slow acetylators are often associated with drug toxicity and efficacy as well as cancer susceptibility. The biological functions of these 7 mutations have previously been characterized, but the structural basis behind the reduced catalytic activity and reduced protein level is not clear. Methodology/Principal Findings: We performed multiple molecular dynamics simulations of these mutants as well as NAT2 to investigate the structural and dynamical effects throughout the protein structure, specifically the catalytic triad, cofactor binding site, and the substrate binding pocket. None of these mutations induced unfolding; instead, their effects were confined to the inter-domain, domain 3 and 17-residue insert region, where the flexibility was significantly reduced relative to the wild-type. Structural effects of these mutations propagate through space and cause a change in catalytic triad conformation, cofactor binding site, substrate binding pocket size/shape and electrostatic potential. Conclusions/Significance: Our results showed that the dynamical properties of all the mutant structures, especially in inter-domain, domain 3 and 17-residue insert region were affected in the same manner. Similarly, the electrostatic potential of all the mutants were altered and also the functionally important regions such as catalytic triad, cofactor binding site, and substrate binding pocket adopted different orientation and/or conformation relative to the wild-type that may affect the functions of the mutants. Overall, our study may provide the structural basis for reduced catalytic activity and protein level, as was experimentally observed for these polymorphisms.	[Rajasekaran, M.; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Rajasekaran, M.] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Rajasekaran, M.; Abirami, Santhanam] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Taipei, Taiwan; [Abirami, Santhanam] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan University	Rajasekaran, M (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmchinp@ibms.sinica.edu.tw	Santhanam, Abirami/J-6314-2019; Chen, Chinpan/O-4202-2018; Mahalingam, Rajasekaran/E-2065-2013	Santhanam, Abirami/0000-0002-1952-431X; Mahalingam, Rajasekaran/0000-0003-2228-5628				Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Alberg AJ, 2004, CANCER DETECT PREV, V28, P187, DOI 10.1016/j.cdp.2004.04.001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boukouvala S, 2005, DRUG METAB REV, V37, P511, DOI 10.1080/03602530500251204; Brockton N, 2000, AM J EPIDEMIOL, V151, P846; Cascorbi I, 1996, PHARMACOGENETICS, V6, P257, DOI 10.1097/00008571-199606000-00009; Costa I, 2005, PROSTATE, V64, P246, DOI 10.1002/pros.20241; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEGUCHI T, 1992, J BIOL CHEM, V267, P18140; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; EVANS DAP, 1964, J LAB CLIN MED, V63, P394; Fretland AJ, 2001, PHARMACOGENETICS, V11, P207, DOI 10.1097/00008571-200104000-00004; Goodfellow GH, 2000, BIOCHEM J, V348, P159, DOI 10.1042/0264-6021:3480159; Grant DM, 1997, MUTAT RES-FUND MOL M, V376, P61, DOI 10.1016/S0027-5107(97)00026-2; Hein DW, 2006, INT J CANCER, V119, P1208, DOI 10.1002/ijc.21957; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; HEIN DW, 1994, HUM MOL GENET, V3, P729; HEIN DW, 1995, CANCER RES, V55, P3531; Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29; Hein DW, 2002, ENVIRON MOL MUTAGEN, V40, P161, DOI 10.1002/em.10103; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; Hubbard S. J., 1993, NACCESS; Lau EY, 2006, CHEM RES TOXICOL, V19, P1182, DOI 10.1021/tx0600999; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oda A, 2010, BIOL PHARM BULL, V33, P1639, DOI 10.1248/bpb.33.1639; Pompeo F, 2002, PHARMACOGENOMICS, V3, P19, DOI 10.1517/14622416.3.1.19; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; RIDDLE B, 1971, J BIOL CHEM, V246, P3250; RISCH A, 1995, HUM MOL GENET, V4, P231, DOI 10.1093/hmg/4.2.231; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V291, P116, DOI 10.1006/bbrc.2002.6414; Sillanpaa P, 2005, INT J CANCER, V114, P579, DOI 10.1002/ijc.20677; Teixeira RLF, 2010, MUTAT RES-FUND MOL M, V683, P43, DOI 10.1016/j.mrfmmm.2009.10.009; van der Hel OL, 2003, PHARMACOGENETICS, V13, P399, DOI 10.1097/00008571-200307000-00005; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Walraven JM, 2008, CURR DRUG METAB, V9, P471, DOI 10.2174/138920008784892065; Walraven JM, 2007, DRUG METAB DISPOS, V35, P1001, DOI 10.1124/dmd.107.015040; Wang HQ, 2005, BIOCHEMISTRY-US, V44, P11295, DOI 10.1021/bi047564q; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; WEBER WW, 1985, PHARMACOL REV, V37, P25; Windmill KF, 2000, TOXICOL SCI, V54, P19, DOI 10.1093/toxsci/54.1.19; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Zang Y, 2004, PHARMACOGENETICS, V14, P717, DOI 10.1097/00008571-200411000-00002; Zang Y, 2007, CARCINOGENESIS, V28, P1665, DOI 10.1093/carcin/bgm085; Zang Y, 2007, PHARMACOGENET GENOM, V17, P37, DOI 10.1097/01.fpc.0000236325.73186.2c; Zhu JJ, 2003, CANCER EPIDEM BIOMAR, V12, P830	50	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25801	10.1371/journal.pone.0025801	http://dx.doi.org/10.1371/journal.pone.0025801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980537	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600055
J	Tran, HT; Sanchez, L; Esparza, TJ; Brody, DL				Tran, Hien T.; Sanchez, Laura; Esparza, Thomas J.; Brody, David L.			Distinct Temporal and Anatomical Distributions of Amyloid-beta and Tau Abnormalities following Controlled Cortical Impact in Transgenic Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRANEURONAL A-BETA-42 ACCUMULATION; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR-PROTEIN; HEAD-INJURY; PLAQUE-FORMATION; GAMMA-SECRETASE; DOWN-SYNDROME; MOUSE MODEL	Traumatic brain injury TBI is a major environmental risk factor for Alzheimer's disease. Intracellular accumulations of amyloid-beta and tau proteins have been observed within hours following severe TBI in humans. Similar abnormalities have been recapitulated in young 3xTg-AD mice subjected to the controlled cortical impact model (CCI) of TBI and sacrificed at 24 h and 7 days post injury. This study investigated the temporal and anatomical distributions of amyloid-beta and tau abnormalities from 1 h to 24 h post injury in the same model. Intra-axonal amyloid-beta accumulation in the fimbria was detected as early as 1 hour and increased monotonically over 24 hours following injury. Tau immunoreactivity in the fimbria and amygdala had a biphasic time course with peaks at 1 hour and 24 hours, while tau immunoreactivity in the contralateral CA1 rose in a delayed fashion starting at 12 hours after Injury Furthermore, rapid intra-axonal amyloid-beta accumulation was similarly observed post controlled cortical injury in APP/PS1 mice, another transgenic Alzheimer's disease mouse model. Acute increases in total and phospho-tau imunoreactivity were also evident in single transgenic Tau(p301L) mice subjected to controlled cortical injury. These data provide further evidence for the causal effects of moderately severe contusional TBI on acceleration of acute Alzheimer-related abnormalities and the independent la on hip between a amyloid-beta and tau in this setting.	[Tran, Hien T.; Sanchez, Laura; Esparza, Thomas J.; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Tran, HT (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	brodyd@neuro.wustl.edu			NIH [R01 NS065069 (Brody), K08 NS049237 (Brody)]; Burroughs Wellcome Career Award; Biomedical Sciences (Brody); Thrasher Research Fund (Brody); Washington University Office of Undergraduate Research Award (Sanchez); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065069, K08NS049237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Biomedical Sciences (Brody); Thrasher Research Fund (Brody); Washington University Office of Undergraduate Research Award (Sanchez); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 NS065069 (Brody), NIH K08 NS049237 (Brody), a Burroughs Wellcome Career Award in the Biomedical Sciences (Brody), the Thrasher Research Fund (Brody), and a Washington University Office of Undergraduate Research Award (Sanchez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	46	71	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25475	10.1371/journal.pone.0025475	http://dx.doi.org/10.1371/journal.pone.0025475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980472	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600028
J	Morin, A; Fritsch, L; Mathieu, JRR; Gilbert, C; Guarmit, B; Firlej, V; Gallou-Kabani, C; Vieillefond, A; Delongchamps, NB; Cabon, F				Morin, Aurelie; Fritsch, Lauriane; Mathieu, Jacques R. R.; Gilbert, Cristele; Guarmit, Basma; Firlej, Virginie; Gallou-Kabani, Catherine; Vieillefond, Annick; Delongchamps, Nicolas Barry; Cabon, Florence			Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence	FASEB JOURNAL			English	Article						pyrimidine biosynthesis; nuclear translocation	PYRIMIDINE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; EXPRESSION; PURIFICATION; URIDINE	Markers of prostate tumor recurrence after radical prostatectomy are lacking and highly demanded. The androgen receptor (AR) is a nuclear receptor that plays a pivotal role in normal and cancerous prostate tissue. AR interacts with a number of proteins modulating its stability, localization, and activity. To test the hypothesis that an increased expression of AR partners might foster tumor development, we immunopurified AR partners in human tumors xeno-grafted into mice. One of the identified AR partners was the multifunctional enzyme carbamoyl-phosphate synthetase II, aspartate transcarbamylase, and dihydro-orotase (CAD), which catalyzes the 3 initial steps of pyrimidine biosynthesis. We combined experiments in C4-2, LNCaP, 22RV1, and PC3 human prostate cell lines and analysis of frozen radical prostatectomy samples to study the CAD-AR interaction. We show here that in prostate tumor cells, CAD fosters AR translocation into the nucleus and stimulates its transcriptional activity. Notably, in radical prostatectomy specimens, CAD expression was not correlated with proliferation markers, but a higher CAD mRNA level was associated with local tumor extension (P=0.049) and cancer relapse (P=0.017). These results demonstrate an unsuspected function for a key metabolic enzyme and identify CAD as a potential predictive marker of cancer relapse.-Morin, A., Fritsch, L., Mathieu, J. R. R., Gilbert, C., Guarmit, B., Firlej, V., Gallou-Kabani, C., Vieillefond, A., Delongchamps, N. B., Cabon, F. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB J. 26, 460-467 (2012). www.fasebj.org	[Morin, Aurelie; Mathieu, Jacques R. R.; Gilbert, Cristele; Firlej, Virginie; Delongchamps, Nicolas Barry; Cabon, Florence] Univ Paris 11, FRE3239, CNRS, Villejuif, France; [Fritsch, Lauriane] Univ Paris Diderot, CNRS, Unite Mixte Rech UMR 7216, Paris, France; [Guarmit, Basma] Ctr Mediterraneen Med Mol, INSERM, U895, Nice, France; [Gallou-Kabani, Catherine; Cabon, Florence] SeleXel, Toulouse, France; [Vieillefond, Annick; Delongchamps, Nicolas Barry] Paris Descartes Univ, Cochin Hosp, Dept Urol & Pathol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Cabon, F (corresponding author), INSERM, UMR1037, 1 Ave Jean Poulhes, F-31403 Toulouse 4, France.	florence.cabon@inserm.fr	Firlej, Virginie/R-2065-2018; Firlej, Virginie/AFQ-6362-2022; Delongchamps, Nicolas Barry/AAE-8651-2020; Cabon, Florence/B-3284-2013	Firlej, Virginie/0000-0003-4132-0695; Cabon, Florence/0000-0002-6149-082X				Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; Bettoun D. J., 2005, J BIOL CHEM; Borley N, 2009, ASIAN J ANDROL, V11, P74, DOI 10.1038/aja.2008.19; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; CHAPARIAN MG, 1988, FASEB J, V2, P2982, DOI 10.1096/fasebj.2.14.2903106; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chi KN, 2009, EUR UROL, V56, P594, DOI 10.1016/j.eururo.2009.06.027; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; Colombel M, 2005, CANCER RES, V65, P300; Culig Z, 2005, ENDOCR-RELAT CANCER, V12, P229, DOI 10.1677/erc.1.00775a; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; KARLE JM, 1984, J BIOL CHEM, V259, P67; Khan S, 2003, ENDOCRINOLOGY, V144, P2325, DOI 10.1210/en.2002-0149; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; Miyamoto H, 1998, P NATL ACAD SCI USA, V95, P7379, DOI 10.1073/pnas.95.13.7379; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Qiu YQ, 2008, ASIAN J ANDROL, V10, P855, DOI 10.1111/j.1745-7262.2008.00428.x; REARDON MA, 1987, BIOCHEM BIOPH RES CO, V147, P494, DOI 10.1016/S0006-291X(87)80148-1; Sigoillot FD, 2005, J BIOL CHEM, V280, P25611, DOI 10.1074/jbc.M504581200; Sigoillot FD, 2004, INT J CANCER, V109, P491, DOI 10.1002/ijc.11717; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; TESSERA L, 1995, ANTICANCER RES, V15, P189; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441	25	15	15	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					460	467		10.1096/fj.11-191296	http://dx.doi.org/10.1096/fj.11-191296			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21982950				2022-12-25	WOS:000299202200045
J	Antonelou, MH; Kriebardis, AG; Stamoulis, KE; Trougakos, IP; Papassideri, IS				Antonelou, Marianna H.; Kriebardis, Anastasios G.; Stamoulis, Konstantinos E.; Trougakos, Ioannis P.; Papassideri, Issidora S.			Apolipoprotein J/Clusterin Is a Novel Structural Component of Human Erythrocytes and a Biomarker of Cellular Stress and Senescence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IN-VIVO; CLUSTERIN/APOLIPOPROTEIN-J; HEREDITARY SPHEROCYTOSIS; IDENTIFIES VARIANTS; OXIDATIVE STRESS; CLUSTERIN; PROTEIN; MEMBRANE; PROGRESSION	Background: Secretory Apolipoprotein J/Clusterin (sCLU) is a ubiquitously expressed chaperone that has been functionally implicated in several pathological conditions of increased oxidative injury, including aging. Nevertheless, the biological role of sCLU in red blood cells (RBCs) remained largely unknown. In the current study we identified sCLU as a component of human RBCs and we undertook a detailed analysis of its cellular topology. Moreover, we studied the erythrocytic membrane sCLU content during organismal aging, in conditions of increased organismal stress and accelerated RBCs senescence, as well as during physiological in vivo cellular senescence. Methodology/Principal Findings: By using a combination of molecular, biochemical and high resolution microscopical methods we found that sCLU is a novel structural component of RBCs extra-and intracellular plasma membrane and cytosol. We observed that the RBCs membrane-associated sCLU decreases during organismal aging or exposure to acute stress (e.g. smoking), in patients with congenital hemolytic anemia, as well as during RBCs in vivo senescence. In all cases, sCLU reduction paralleled the expression of typical cellular senescence, redox imbalance and erythrophagocytosis markers which are also indicative of the senescence-and oxidative stress-mediated RBCs membrane vesiculation. Conclusions/Significance: We propose that sCLU at the mature RBCs is not a silent remnant of the erythroid precursors, but an active component being functionally implicated in the signalling mechanisms of cellular senescence and oxidative stress-responses in both healthy and diseased organism. The reduced sCLU protein levels in the RBCs membrane following cell exposure to various endogenous or exogenous stressors closely correlates to the levels of cellular senescence and redox imbalance markers, suggesting the usefulness of sCLU as a sensitive biomarker of senescence and cellular stress.	[Antonelou, Marianna H.; Kriebardis, Anastasios G.; Trougakos, Ioannis P.; Papassideri, Issidora S.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece; [Kriebardis, Anastasios G.] Technol & Educ Inst Athens, Dept Med Labs, Fac Hlth & Caring Profess, Athens, Greece; [Stamoulis, Konstantinos E.] Ctr Blood Transfus, Nikea, Piraeus, Greece	National & Kapodistrian University of Athens; University of West Attica	Antonelou, MH (corresponding author), Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece.	itrougakos@biol.uoa.gr; ipapasid@biol.uoa.gr	Trougakos, Ioannis/R-6149-2018; Antonelou, Marianna H/C-1267-2011	Trougakos, Ioannis/0000-0002-6179-2772; Antonelou, Marianna H/0000-0003-3787-3596; Kriebardis, Anastasios/0000-0003-3915-1829	Hellenic General Secretariat for Research and Technology [2009 - 09FR-56]; ISP of the University of Athens Special Account for Research	Hellenic General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); ISP of the University of Athens Special Account for Research	IPT was partially supported by a "Greece-France R&T Cooperation Grant, 2009 - 09FR-56'' of the Hellenic General Secretariat for Research and Technology and ISP by a "Kapodistrias" Grant of the University of Athens Special Account for Research Grants. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Antonelou MH, 2011, J PROTEOMIC IN PRESS; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; BOSCH FH, 1992, BLOOD, V79, P254; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Bosman GJCGM, 2005, CELL PHYSIOL BIOCHEM, V16, P1, DOI 10.1159/000087725; Bratosin D, 2009, CYTOM PART A, V75A, P236, DOI 10.1002/cyto.a.20693; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Catalgol B, 2009, CURR PHARM DESIGN, V15, P3043, DOI 10.2174/138161209789058129; Chi KN, 2008, EXPERT OPIN INV DRUG, V17, P1955, DOI [10.1517/13543780802528609, 10.1517/13543780802528609 ]; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; CRESPO P, 1993, LEUKEMIA RES, V17, P771, DOI 10.1016/0145-2126(93)90111-W; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; GUDI T, 1993, J BIOL CHEM, V268, P21344; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hulea S. A., 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P173; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kay M, 2005, ANN NY ACAD SCI, V1057, P85, DOI 10.1196/annals.1356.005; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEONARD MB, 1995, DIABETIC MED, V12, P46, DOI 10.1111/j.1464-5491.1995.tb02061.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Margetis P, 2007, BLOOD CELL MOL DIS, V38, P210, DOI 10.1016/j.bcmd.2006.10.163; Mazzanti L, 1997, METABOLISM, V46, P59, DOI 10.1016/S0026-0495(97)90168-2; MCKENNEY J, 1990, BLOOD, V76, P206; MOHANDAS N, 1989, ANN NY ACAD SCI, V554, P217, DOI 10.1111/j.1749-6632.1989.tb22423.x; MUELLER TJ, 1987, J CLIN INVEST, V79, P492, DOI 10.1172/JCI112839; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Saha S, 2011, EUR J HAEMATOL, V87, P259, DOI 10.1111/j.1600-0609.2011.01648.x; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trougakos IP, 2006, BIOGERONTOLOGY, V7, P375, DOI 10.1007/s10522-006-9052-8; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	48	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26032	10.1371/journal.pone.0026032	http://dx.doi.org/10.1371/journal.pone.0026032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998749	Green Submitted, Green Published, gold			2022-12-25	WOS:000295968700034
J	Goodman, AG; Heinen, PP; Guerra, S; Vijayan, A; Sorzano, COS; Gomez, CE; Esteban, M				Goodman, Alan G.; Heinen, Paul P.; Guerra, Susana; Vijayan, Aneesh; Sorzano, Carlos Oscar S.; Gomez, Carmen E.; Esteban, Mariano			A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; PANDEMIC INFLUENZA; INFECTED-CELLS; UNITED-STATES; NUCLEOPROTEIN; MICE; HEMAGGLUTININ; IMMUNIZATION; DNA; IMMUNOGENICITY	There is a need to develop a universal vaccine against influenza virus infection to avoid developing new formulations of a seasonal vaccine each year. Many of the vaccine strategies for a universal vaccine target strain-conserved influenza virus proteins, such as the matrix, polymerase, and nucleoproteins, rather than the surface hemagglutinin and neuraminidase proteins. In addition, non-disease-causing viral vectors are a popular choice as a delivery system for the influenza virus antigens. As a proof-of-concept, we have designed a novel influenza virus immunogen based on the NP backbone containing human T cell epitopes for M1, NS1, NP, PB1 and PA proteins (referred as NPmix) as well as a construct containing the conserved regions of influenza virus neuraminidase (N-terminal) and hemagglutinin (C-terminal) (referred as NA-HA). DNA vectors and vaccinia virus recombinants expressing NPmix (WR-NP) or both NPmix plus NA-HA (WR-flu) in the cytosol were tested in a heterologous DNA-prime/vaccinia virus-boost vaccine regimen in mice. We observed an increase in the number of influenza virus-specific IFN gamma-secreting splenocytes, composed of populations marked by CD4(+) and CD8(+) T cells producing IFN gamma or TNF alpha. Upon challenge with influenza virus, the vaccinated mice exhibited decreased viral load in the lungs and a delay in mortality. These findings suggest that DNA prime/poxvirus boost with human multi-epitope recombinant influenza virus proteins is a valid approach for a general T-cell vaccine to protect against influenza virus infection.	[Goodman, Alan G.; Heinen, Paul P.; Guerra, Susana; Vijayan, Aneesh; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Cellular & Mol Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Preventat Med & Publ Hlth, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Comp Unit, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Goodman, AG (corresponding author), Univ Miami, Sch Med, Sylvester Comprehens Canc Inst, Miami, FL USA.	mesteban@cnb.csic.es	Gomez, Carmen Elena/K-1940-2014; Esteban, Mariano/ABG-5375-2020; Sorzano, Carlos Oscar S S./F-2639-2016; VIJAYAN, ANEESH/K-1961-2014; Goodman, Alan/AAQ-1108-2020; Vijayan, Aneesh/AAH-5640-2019; S. Sorzano, Carlos Oscar/ABE-4884-2021; guerra, susana/K-5972-2014	Gomez, Carmen Elena/0000-0002-5414-7935; Esteban, Mariano/0000-0003-0846-2827; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; VIJAYAN, ANEESH/0000-0002-2828-5285; Goodman, Alan/0000-0001-6394-332X; Vijayan, Aneesh/0000-0002-2828-5285; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; guerra, susana/0000-0001-9067-2991	Ministry of Science and Education of Spain [CSIC-FSE]; Spanish Ministry of Health Ramon y Cajal Program [FIS 2009-80145]; La Caixa Foundation; Marcelino Botin Foundation;  [SAF-2008-02036]	Ministry of Science and Education of Spain(Spanish Government); Spanish Ministry of Health Ramon y Cajal Program; La Caixa Foundation(La Caixa Foundation); Marcelino Botin Foundation; 	This work was supported by Ministry of Science and Education of Spain Program JAE-DOC (CSIC-FSE) (to A.G.G), Spanish Ministry of Health Ramon y Cajal Program (FIS 2009-80145) (to S.G.), La Caixa Foundation International PhD Program Fellowship (to A.V.), and SAF-2008-02036 and the Marcelino Botin Foundation (to M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstein AD, 2006, ARCH VIROL, V151, P921, DOI 10.1007/s00705-005-0676-9; ANDREW ME, 1987, SCAND J IMMUNOL, V25, P21, DOI 10.1111/j.1365-3083.1987.tb01042.x; ANDREW ME, 1986, MICROB PATHOGENESIS, V1, P443, DOI 10.1016/0882-4010(86)90006-9; ANDREW ME, 1988, SCAND J IMMUNOL, V28, P81, DOI 10.1111/j.1365-3083.1988.tb02418.x; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; DiazGuerra M, 1997, VIROLOGY, V227, P220, DOI 10.1006/viro.1996.8294; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Epstein SL, 1998, TXB INFLUENZA, P324; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JAKEMAN KJ, 1989, J GEN VIROL, V70, P1523, DOI 10.1099/0022-1317-70-6-1523; Jamali A, 2010, CLIN VACCINE IMMUNOL, V17, P683, DOI 10.1128/CVI.00445-09; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Ohba K, 2007, VACCINE, V25, P4291, DOI 10.1016/j.vaccine.2007.02.074; Otvos L, 2008, SYNTHESIS MULTIVALEN, P263; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saha S, 2006, VIROLOGY, V354, P48, DOI 10.1016/j.virol.2006.04.015; STITZ L, 1990, J GEN VIROL, V71, P1169, DOI 10.1099/0022-1317-71-5-1169; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Wei JC, 2010, BIOCHEM BIOPH RES CO, V396, P787, DOI 10.1016/j.bbrc.2010.04.133	42	37	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25938	10.1371/journal.pone.0025938	http://dx.doi.org/10.1371/journal.pone.0025938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998725	gold, Green Published			2022-12-25	WOS:000295966900077
J	Stratton, P; Milford, M; Wyeth, G; Wiles, J				Stratton, Peter; Milford, Michael; Wyeth, Gordon; Wiles, Janet			Using Strategic Movement to Calibrate a Neural Compass: A Spiking Network for Tracking Head Direction in Rats and Robots	PLOS ONE			English	Article							PATH-INTEGRATION; RECURRENT EXCITATION; MODEL; MOTOR; CELLS; MAP	The head direction (HD) system in mammals contains neurons that fire to represent the direction the animal is facing in its environment. The ability of these cells to reliably track head direction even after the removal of external sensory cues implies that the HD system is calibrated to function effectively using just internal (proprioceptive and vestibular) inputs. Rat pups and other infant mammals display stereotypical warm-up movements prior to locomotion in novel environments, and similar warm-up movements are seen in adult mammals with certain brain lesion-induced motor impairments. In this study we propose that synaptic learning mechanisms, in conjunction with appropriate movement strategies based on warm-up movements, can calibrate the HD system so that it functions effectively even in darkness. To examine the link between physical embodiment and neural control, and to determine that the system is robust to real-world phenomena, we implemented the synaptic mechanisms in a spiking neural network and tested it on a mobile robot platform. Results show that the combination of the synaptic learning mechanisms and warm-up movements are able to reliably calibrate the HD system so that it accurately tracks real-world head direction, and that calibration breaks down in systematic ways if certain movements are omitted. This work confirms that targeted, embodied behaviour can be used to calibrate neural systems, demonstrates that 'grounding' of modelled biological processes in the real world can reveal underlying functional principles (supporting the importance of robotics to biology), and proposes a functional role for stereotypical behaviours seen in infant mammals and those animals with certain motor deficits. We conjecture that these calibration principles may extend to the calibration of other neural systems involved in motion tracking and the representation of space, such as grid cells in entorhinal cortex.	[Stratton, Peter] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Stratton, Peter; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Milford, Michael; Wyeth, Gordon] Queensland Univ Technol, Sch Engn Syst, Brisbane, Qld 4001, Australia	University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Stratton, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	stratton@itee.uq.edu.au	Milford, Michael/J-1304-2012; Wiles, Janet/C-1989-2008	Milford, Michael/0000-0002-5162-1793; Stratton, Peter/0000-0002-3312-7505; Wiles, Janet/0000-0002-4051-4116; Wyeth, Gordon/0000-0002-4996-3612	Australian Research Council; National Health and Medical Research Council [TS0669699]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (www.arc.gov.au) and National Health and Medical Research Council (www.nhmrc.gov.au) Thinking Systems Grant (Special Research Initiative: Thinking Systems; grant number: TS0669699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Arleo A, 2001, NEUROCOMPUTING, V38, P1059, DOI 10.1016/S0925-2312(01)00572-0; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Beer RD, 2009, ADAPT BEHAV, V17, P296, DOI 10.1177/1059712309340844; Boucheny C, 2005, J COMPUT NEUROSCI, V18, P205, DOI 10.1007/s10827-005-6559-y; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Daney D, 2005, INT J ROBOT RES, V24, P501, DOI 10.1177/0278364905053185; Daney D, 2001, ROBUST PARALLEL ROBO, P3262; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; GOLANI I, 1981, P NATL ACAD SCI-BIOL, V78, P7226, DOI 10.1073/pnas.78.11.7226; GOLANI I, 1979, BRAIN RES, V164, P237, DOI 10.1016/0006-8993(79)90019-2; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; Goodridge JP, 2000, J NEUROPHYSIOL, V83, P3402, DOI 10.1152/jn.2000.83.6.3402; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahnloser RHR, 2003, NEUROSCIENCE, V120, P877, DOI 10.1016/S0306-4522(03)00201-X; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Korner AF, 1972, P 3 S OR SENS PERC, P335; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; LORDEN JF, 1984, J NEUROSCI, V4, P1925; Meng Y, 2007, ROBOT CIM-INT MANUF, V23, P436, DOI 10.1016/j.rcim.2006.05.002; Milford M, ROBOT NAVIGATION NAT; Milford M, 2010, INT J ROBOT RES, V29, P1131, DOI 10.1177/0278364909340592; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Milford MJ, 2004, IEEE INT CONF ROBOT, P403, DOI 10.1109/ROBOT.2004.1307183; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Olsson LA, 2006, CONNECT SCI, V18, P121, DOI 10.1080/09540090600768542; Piaget Jean, 1952, ORIGINS INTELLIGENCE; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Roy N, 1999, ONLINE SELF CALIBRAT, P2292; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Skaggs WE, 1995, ADV NEURAL INFORM PR, V7, P51; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; STEIN RB, 1967, PROC R SOC SER B-BIO, V167, P64, DOI 10.1098/rspb.1967.0013; Stratton P, 2010, J COMPUT NEUROSCI, V28, P527, DOI 10.1007/s10827-010-0234-7; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; Takeichi N, 2005, J NEUROPHYSIOL, V94, P1938, DOI 10.1152/jn.00113.2005; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; TAUBE JS, 1990, J NEUROSCI, V10, P420; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Walters DM, 2010, BIOL CYBERN, V103, P21, DOI 10.1007/s00422-009-0355-0; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Zugaro MB, 2003, J NEUROSCI, V23, P3478	49	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25687	10.1371/journal.pone.0025687	http://dx.doi.org/10.1371/journal.pone.0025687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991332	Green Published, gold, Green Submitted			2022-12-25	WOS:000295963300016
J	Cai, W; Kramarova, TV; Berg, P; Korbonits, M; Pongratz, I				Cai, Wen; Kramarova, Tatiana V.; Berg, Petra; Korbonits, Marta; Pongratz, Ingemar			The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor alpha	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; RESPONSIVE BREAST-CANCER; INDUCED PITUITARY-TUMOR; X-ASSOCIATED PROTEIN-2; HEAT-SHOCK-PROTEIN; CORE COMPLEX; AH RECEPTOR; IN-VIVO; BETA; TRANSCRIPTION	XAP2 (also known as aryl hydrocarbon receptor interacting protein, AIP) is originally identified as a negative regulator of the hepatitis B virus X-associated protein. Recent studies have expanded the range of XAP2 client proteins to include the nuclear receptor family of transcription factors. In this study, we show that XAP2 is recruited to the promoter of ER alpha regulated genes like the breast cancer marker gene pS2 or GREB1 and negatively regulate the expression of these genes in MCF-7 cells. Interestingly, we show that XAP2 downregulates the E(2)-dependent transcriptional activation in an estrogen receptor (ER) isoform-specific manner: XAP2 inhibits ER alpha but not ER beta-mediated transcription. Thus, knockdown of intracellular XAP2 levels leads to increased ER alpha activity. XAP2 proteins, carrying mutations in their primary structures, loose the ability of interacting with ER alpha and can no longer regulate ER target gene transcription. Taken together, this study shows that XAP2 exerts a negative effect on ER alpha transcriptional activity and may thus prevent ER alpha-dependent events.	[Cai, Wen; Kramarova, Tatiana V.; Berg, Petra; Pongratz, Ingemar] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, London, England	Karolinska Institutet; University of London; Queen Mary University London	Cai, W (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	Ingemar.Pongratz@ki.se		Korbonits, Marta/0000-0002-4101-9432	Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project [LSHM-CT-2005-018652]; CASCADE Network of Excellence [FOOD-CT-2004-506319 CASCADE]	Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project; CASCADE Network of Excellence	This work is supported by the Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project (LSHM-CT-2005-018652) and the CASCADE Network of Excellence (FOOD-CT-2004-506319 CASCADE). URL: www.cordis.lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Berg P, 2002, J BIOL CHEM, V277, P32310, DOI 10.1074/jbc.M203351200; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Faulds MH, 2004, MOL ENDOCRINOL, V18, P412, DOI 10.1210/me.2003-0290; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; Ghosh MG, 2000, CANCER RES, V60, P6367; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Greiser CM, 2007, HUM REPROD UPDATE, V13, P453, DOI 10.1093/humupd/dmm012; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heaney AP, 2007, HORM RES, V68, P132, DOI 10.1159/000110608; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Levenson AS, 1997, CANCER RES, V57, P3071; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Nakata A, 2009, EMBO REP, V10, P622, DOI 10.1038/embor.2009.35; Naves LA, 2007, EUR J ENDOCRINOL, V157, P383, DOI 10.1530/EJE-07-0533; Persson I, 1999, CANCER CAUSE CONTROL, V10, P253, DOI 10.1023/A:1008909128110; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Swedenborg E, 2008, MOL PHARMACOL, V73, P575, DOI 10.1124/mol.107.036384; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Swedenborg E, 2009, J MOL ENDOCRINOL, V43, P1, DOI 10.1677/JME-08-0132; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Zeng Q, 2008, J PATHOL, V214, P425, DOI 10.1002/path.2297	44	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25201	10.1371/journal.pone.0025201	http://dx.doi.org/10.1371/journal.pone.0025201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984905	Green Submitted, gold, Green Published			2022-12-25	WOS:000295943000016
J	Kim, E; Yoon, SJ; Kim, EY; Kim, Y; Lee, HS; Kim, KH; Lee, KA				Kim, Eunju; Yoon, Se-Jin; Kim, Eun-Young; Kim, Yunna; Lee, Hyun-Seo; Kim, Kyeoung-Hwa; Lee, Kyung-Ah			Function of COP9 Signalosome in Regulation of Mouse Oocytes Meiosis by Regulating MPF Activity and Securing Degradation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; HUMAN CYCLIN-A; CELL-CYCLE; PROTEIN-KINASE; COP9/SIGNALOSOME SUBUNITS; DROSOPHILA-MELANOGASTER; DEPENDENT PROTEOLYSIS; TRANSCRIPTION FACTORS; PROLIFERATION	The COP9 (constitutive photomorphogenic) signalosome (CSN), composed of eight subunits, is a highly conserved protein complex that regulates processes such as cell cycle progression and kinase signalling. Previously, we found the expression of the COP9 constitutive photomorphogenic homolog subunit 3 (CSN3) and subunit 5 (CSN5) changes as oocytes mature for the first time, and there is no report regarding roles of COP9 in the mammalian oocytes. Therefore, in the present study, we examined the effects of RNA interference (RNAi)-mediated transient knockdown of each subunit on the meiotic cell cycle in mice oocytes. Following knockdown of either CSN3 or CSN5, oocytes failed to complete meiosis I. These arrested oocytes exhibited a disrupted meiotic spindle and misarranged chromosomes. Moreover, down-regulation of each subunit disrupted the activity of maturation-promoting factor (MPF) and concurrently reduced degradation of the anaphase-promoting complex/cyclosome (APC/C) substrates Cyclin B1 and Securin. Our data suggest that the CSN3 and CSN5 are involved in oocyte meiosis by regulating degradation of Cyclin B1 and Securin via APC/C.	[Kim, Eunju; Kim, Yunna; Lee, Hyun-Seo; Kim, Kyeoung-Hwa; Lee, Kyung-Ah] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea; [Yoon, Se-Jin] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kim, Eun-Young; Lee, Kyung-Ah] CHA Gen Hosp, Fertil Ctr, CHA Res Inst, Seoul, South Korea	Pochon Cha University; Stanford University; Pochon Cha University	Kim, E (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	leeka@ovary.co.kr		Yoon, Se-Jin/0000-0001-8412-5991	National Research Foundation of Korea (NRF); Korean Government (Ministry of Education, Science and Technology [2009-0068363]; Priority Research Centers through the National Research Foundation of Korea (NRF) [2009-0093821]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Priority Research Centers through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Government (Ministry of Education, Science and Technology, 2009-0068363) and by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dohmann EMN, 2008, DEVELOPMENT, V135, P2013, DOI 10.1242/dev.020743; Doronkin S, 2002, DEVELOPMENT, V129, P5053; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Henke W, 1999, MOL BIOL REP, V26, P29, DOI 10.1023/A:1006991419464; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Kob R, 2009, CELL CYCLE, V8, P2041, DOI 10.4161/cc.8.13.8850; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Oren-Giladi P, 2008, GENES CELLS, V13, P221, DOI 10.1111/j.1365-2443.2008.01164.x; Oron E, 2002, DEVELOPMENT, V129, P4399; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Sun Y, 2002, J BIOL CHEM, V277, P45759, DOI 10.1074/jbc.M208709200; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang XP, 2009, PLANT J, V58, P655, DOI 10.1111/j.1365-313X.2009.03805.x; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wilson MP, 2001, J BIOL CHEM, V276, P40998, DOI 10.1074/jbc.M106605200; Winston N, 2000, DEV BIOL, V223, P139, DOI 10.1006/dbio.2000.9721; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037	53	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25870	10.1371/journal.pone.0025870	http://dx.doi.org/10.1371/journal.pone.0025870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991377	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000088
J	Li, TS; Ikeda, S; Kubo, M; Ohshima, M; Kurazumi, H; Takemoto, Y; Ueda, K; Hamano, K				Li, Tao-Sheng; Ikeda, Satoshi; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ueda, Kazuhiro; Hamano, Kimikazu			Diabetic Impairment of C-Kit(+) Bone Marrow Stem Cells Involves the Disorders of Inflammatory Factors, Cell Adhesion and Extracellular Matrix Molecules	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; PROGENITOR CELLS; THERAPEUTIC ANGIOGENESIS; MONONUCLEAR-CELLS; REPAIR; NEOVASCULARIZATION; IMPLANTATION; TRANSPLANTATION; COMPLICATIONS	Bone marrow stem cells from diabetes mellitus patients exhibit functional impairment, but the relative molecular mechanisms responsible for this impairment are poorly understood. We investigated the mechanisms responsible for diabetes-related functional impairment of bone marrow stem cells by extensively screening the expression levels of inflammatory factors, cell cycle regulating molecules, extracellular matrix molecules and adhesion molecules. Bone marrow cells were collected from type 2 diabetic (db/db) and healthy control (db/m+) mice, and c-kit(+) stem cells were purified (purity>85%) for experiments. Compared with the healthy control mice, diabetic mice had significantly fewer c-kit(+) stem cells, and these cells had a lower potency of endothelial differentiation; however, the production of the angiogenic growth factor VEGF did not differ between groups. A pathway-focused array showed that the c-kit(+) stem cells from diabetic mice had up-regulated expression levels of many inflammatory factors, including Tlr4, Cxcl9, Il9, Tgfb1, Il4, and Tnfsf5, but no obvious change in the expression levels of cell cycle molecules. Interestingly, diabetes-related alterations of the extracellular matrix and adhesion molecules were varied; Pecam, Mmp10, Lamc1, Itgb7, Mmp9, and Timp4 were up-regulated, but Col11a1, Fn1, Admts2, and Itgav were down-regulated. Some of these changes were also confirmed at the protein level by flow cytometry analysis. In conclusion, c-kit(+) bone marrow stem cells from diabetic mice exhibited an extensive enhancement of inflammatory factors and disorders of the extracellular matrix and adhesion molecules. Further intervention studies are required to determine the precise role of each molecule in the diabetes-related functional impairment of c-kit(+) bone marrow stem cells.	[Li, Tao-Sheng] Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Li, Tao-Sheng; Ikeda, Satoshi; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Takemoto, Yoshihiro; Ueda, Kazuhiro; Hamano, Kimikazu] Yamaguchi Univ, Dept Surg & Clin Sci, Grad Sch Med, Yamaguchi, Japan	Nagasaki University; Yamaguchi University	Li, TS (corresponding author), Nagasaki Univ, Dept Stem Cell Biol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; CLARK CM, 1995, NEW ENGL J MED, V332, P1210, DOI 10.1056/NEJM199505043321807; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Esato K, 2002, CELL TRANSPLANT, V11, P747; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Kempf K, 2006, ANN NY ACAD SCI, V1084, P30, DOI 10.1196/annals.1372.012; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Li TS, 2008, BIOCHEM BIOPH RES CO, V366, P1074, DOI 10.1016/j.bbrc.2007.12.095; Li TS, 2007, J THORAC CARDIOV SUR, V134, P1347, DOI 10.1016/j.jtcvs.2007.07.016; Li TS, 2007, STEM CELLS, V25, P911, DOI 10.1634/stemcells.2006-0497; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Li TS, 2009, CIRCULATION, V120, pS255, DOI 10.1161/CIRCULATIONAHA.108.837039; Li TS, 2006, AM J PHYSIOL-HEART C, V290, pH1362, DOI 10.1152/ajpheart.00766.2005; Li TS, 2005, CARDIOVASC RES, V65, P64, DOI 10.1016/j.cardiores.2004.08.019; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McClellan KA, 2009, MOL CELL BIOL, V29, P4701, DOI 10.1128/MCB.01767-08; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Ohshima M, 2009, CIRC J, V73, P162, DOI 10.1253/circj.CJ-08-0123; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81; Spees JL, 2008, FASEB J, V22, P1226, DOI 10.1096/fj.07-8076com; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25543	10.1371/journal.pone.0025543	http://dx.doi.org/10.1371/journal.pone.0025543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984919	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000037
J	Yang, YL; Zhu, YC; Ottea, J; Husseneder, C; Leonard, BR; Abel, C; Luttrell, R; Huang, FN				Yang, Yunlong; Zhu, Yu Cheng; Ottea, James; Husseneder, Claudia; Leonard, B. Rogers; Abel, Craig; Luttrell, Randall; Huang, Fangneng			Down Regulation of a Gene for Cadherin, but Not Alkaline Phosphatase, Associated with Cry1Ab Resistance in the Sugarcane Borer Diatraea saccharalis	PLOS ONE			English	Article							MIDGUT AMINOPEPTIDASE N; EUROPEAN CORN-BORER; BACILLUS-THURINGIENSIS; MANDUCA-SEXTA; TOXIN-BINDING; HELIOTHIS-VIRESCENS; RNA INTERFERENCE; FIELD-RESISTANCE; CLONING; RECEPTOR	The sugarcane borer, Diatraea saccharalis, is a major target pest of transgenic corn expressing Bacillus thuringiensis (Bt) proteins (i.e., Cry1Ab) in South America and the mid-southern region of the United States. Evolution of insecticide resistance in such target pests is a major threat to the durability of transgenic Bt crops. Understanding the pests' resistance mechanisms will facilitate development of effective strategies for delaying or countering resistance. Alterations in expression of cadherin-and alkaline phosphatase (ALP) have been associated with Bt resistance in several species of pest insects. In this study, neither the activity nor gene regulation of ALP was associated with Cry1Ab resistance in D. saccharalis. Total ALP enzymatic activity was similar between Cry1Ab-susceptible (Cry1Ab-SS) and -resistant (Cry1Ab-RR) strains of D. saccharalis. In addition, expression levels of three ALP genes were also similar between Cry1Ab-SS and -RR, and cDNA sequences did not differ between susceptible and resistant larvae. In contrast, altered expression of a midgut cadherin (DsCAD1) was associated with the Cry1Ab resistance. Whereas cDNA sequences of DsCAD1 were identical between the two strains, the transcript abundance of DsCAD1 was significantly lower in Cry1Ab-RR. To verify the involvement of DsCAD1 in susceptibility to Cry1Ab, RNA interference (RNAi) was employed to knock-down DsCAD1 expression in the susceptible larvae. Down-regulation of DsCAD1 expression by RNAi was functionally correlated with a decrease in Cry1Ab susceptibility. These results suggest that down-regulation of DsCAD1 is associated with resistance to Cry1Ab in D. saccharalis.	[Yang, Yunlong; Ottea, James; Husseneder, Claudia; Leonard, B. Rogers; Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Zhu, Yu Cheng; Abel, Craig; Luttrell, Randall] ARS, So Insect Management Res Unit, USDA, Stoneville, MS USA; [Abel, Craig] ARS, Corn Insects & Crop Genet Res Unit, USDA, Ames, IA USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Yang, YL (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	yc.zhu@ars.usda.gov		Husseneder, Claudia/0000-0001-5962-9354	Board of Regents of the State of Louisiana, United States of America [LEQSF 2006-09-RD-A-0]	Board of Regents of the State of Louisiana, United States of America	This work was supported by the Board of Regents of the State of Louisiana, United States of America, under contract no. LEQSF 2006-09-RD-A-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Castro BA., 2004, LOUISIANA AGR, V47, P4; CHANG WS, 1993, DEVELOPMENT, V118, P651; Denolf P, 1997, EUR J BIOCHEM, V248, P748, DOI 10.1111/j.1432-1033.1997.t01-1-00748.x; Dhurua S, 2011, PEST MANAG SCI, DOI [10.1002/ps.2127, DOI 10.1002/PS.2127]; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, ENTOMOL EXP APPL, V124, P117, DOI 10.1111/j.1570-7458.2007.00560.x; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Huang FN, 2006, J ECON ENTOMOL, V99, P194, DOI 10.1603/0022-0493(2006)099[0194:CSOECB]2.0.CO;2; Itoh M, 1999, INSECT BIOCHEM MOLEC, V29, P121, DOI 10.1016/S0965-1748(98)00115-5; ITOH M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P135, DOI 10.1016/0167-4781(91)90229-F; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; National Agricultural Statistics Service (NASS), 2010, ACR; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; OKADA N, 1989, J COMP PHYSIOL B, V159, P123, DOI 10.1007/BF00691732; Oltean DI, 1999, APPL ENVIRON MICROB, V65, P4760; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WOLFERSBERGER MG, 1984, AM ZOOL, V24, P187; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Yaoi K, 1999, BBA-GENE STRUCT EXPR, V1444, P131, DOI 10.1016/S0167-4781(98)00250-4; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008	51	41	43	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25783	10.1371/journal.pone.0025783	http://dx.doi.org/10.1371/journal.pone.0025783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991350	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000068
J	Kotas, ME; Lee, HY; Gillum, MP; Annicelli, C; Guigni, BA; Shulman, GI; Medzhitov, R				Kotas, Maya E.; Lee, Hui-Young; Gillum, Matthew P.; Annicelli, Charles; Guigni, Blas A.; Shulman, Gerald I.; Medzhitov, Ruslan			Impact of CD1d Deficiency on Metabolism	PLOS ONE			English	Article							KILLER T-CELLS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; NKT CELLS; IMMUNE-SYSTEM; GLUCOSE-INTOLERANCE; INKT CELLS; MICE; OBESITY; ACTIVATION	Invariant natural killer T cells (iNKTs) are innate-like T cells that are highly concentrated in the liver and recognize lipids presented on the MHC-like molecule CD1d. Although capable of a myriad of responses, few essential functions have been described for iNKTs. Among the many cell types of the immune system implicated in metabolic control and disease, iNKTs seem ideally poised for such a role, yet little has been done to elucidate such a possible function. We hypothesized that lipid presentation by CD1d could report on metabolic status and engage iNKts to regulate cellular lipid content through their various effector mechanisms. To test this hypothesis, we examined CD1d deficient mice in a variety of metabolically stressed paradigms including high fat feeding, choline-deficient feeding, fasting, and acute inflammation. CD1d deficiency led to a mild exacerbation of steatosis during high fat or choline-deficient feeding, accompained by impaired hepatic glucose tolerance. Surprisingly, however, this phenotype was not observed in J alpha 18(-/-) mice, which are deficient in iNKTs but express CD1d. Thus, CD1d appears to modulate some metabolic functions through an iNKT-independent mechanism.	[Kotas, Maya E.; Annicelli, Charles; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lee, Hui-Young; Guigni, Blas A.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Lee, Hui-Young; Shulman, Gerald I.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Gillum, Matthew P.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Iowa	Kotas, ME (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	maya.kotas@gmail.com	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Lee, Hui-Young/0000-0002-3464-6382; Gillum, Matthew/0000-0003-4893-012X; Guigni, Blas/0000-0002-9667-8195	National stitutes of Health [AI046688, AI055502, AI089771, DK 045735, DK R01 40936, U24 DK 059635, NIH MSTP TG 2T32GM07205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R01AI046688, R37AI046688, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National stitutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National stitutes of Health (AI046688, AI055502, AI089771 and DK 045735 to Dr. Medzhitov; DK R01 40936, U24 DK 059635 to Dr. Shulman; and NIH MSTP TG 2T32GM07205 for Dr. Kotas). Dr. Medzhitov and Dr. Sulman are investigators of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.In	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bezbradica JS, 2006, CURR PROTOC IMMUNOL; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; Matarese G, 2004, TRENDS IMMUNOL, V25, P193, DOI 10.1016/j.it.2004.02.009; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; TO K, 2009, ARTERIOSCLER THROMB; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wang JX, 2009, J IMMUNOL, V182, P6644, DOI 10.4049/jimmunol.0804050; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zeng J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-142	55	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25478	10.1371/journal.pone.0025478	http://dx.doi.org/10.1371/journal.pone.0025478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980475	Green Submitted, gold, Green Published			2022-12-25	WOS:000295939600030
J	Bekkers, MBM; Brunekreef, B; Smit, HA; Kerkhof, M; Koppelman, GH; Oldenwening, M; Wijga, AH				Bekkers, Marga B. M.; Brunekreef, Bert; Smit, Henriette A.; Kerkhof, Marjan; Koppelman, Gerard H.; Oldenwening, Marieke; Wijga, Alet H.			Early-Life Determinants of Total and HDL Cholesterol Concentrations in 8-Year-Old Children; The PIAMA Birth Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD CHOLESTEROL; SERUM-CHOLESTEROL; EARLY ADULTHOOD; IN-UTERO; GROWTH; WEIGHT; RISK; AGE; BORN	Background: Adult cholesterol concentrations might be influenced by early-life factors, such as breastfeeding and birth weight, referred to as "early programming". How such early factors exert their influence over the life course is still poorly understood. Evidence from studies in children and adolescents is scarce and conflicting. We investigated the influence of 6 different perinatal risk factors on childhood total and HDL cholesterol concentrations and total-to-HDL cholesterol ratio measured at 8 years of age, and additionally we studied the role of the child's current Body Mass Index (BMI). Methods: Anthropometric measures and blood plasma samples were collected during a medical examination in 751 8-year-old children participating in the prospective Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study. Linear and logistic regression were performed to estimate associations of total and HDL cholesterol concentrations with breastfeeding, birth weight, infant weight gain, maternal overweight before pregnancy, gestational diabetes and maternal smoking during pregnancy, taking into account the child's current BMI. Results: Linear regressions showed an association between total-to-HDL cholesterol ratio and maternal pre-pregnancy overweight (beta = 0.15, Confidence Interval 95% (CI): 0.02, 0.28), rapid infant weight gain (beta = 0.13, 95% CI: 0.01, 0.26), and maternal smoking during pregnancy (beta = 0.14, 95% CI: 0.00, 0.29). These associations were partly mediated by the child's BMI. Conclusion: Total-to-HDL cholesterol ratio in 8-year-old children was positively associated with maternal pre-pregnancy overweight, maternal smoking during pregnancy and rapid infant weight gain.	[Bekkers, Marga B. M.; Brunekreef, Bert; Oldenwening, Marieke] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Bekkers, Marga B. M.; Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kerkhof, Marjan] Univ Groningen, Dept Epidemiol & Bioinformat, Groningen, Netherlands; [Koppelman, Gerard H.] Beatrix Childrens Hosp, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Bekkers, MBM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	marga.bekkers@rivm.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252; brunekreef, bert/0000-0001-9908-0060	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing, and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing, and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing, and the Environment; and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Bell R., 1986, CHILDREN EXERCISE, P19; BERGSTROM E, 1995, ATHEROSCLEROSIS, V117, P1, DOI 10.1016/0021-9150(95)05549-C; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; CLOEY T, 1990, JAMA-J AM MED ASSOC, V263, P2788, DOI 10.1001/jama.263.20.2788; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; FOMON SJ, 1984, PEDIATR RES, V18, P1233, DOI 10.1203/00006450-198412000-00001; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Frontini Maria G, 2004, BMC Pediatr, V4, P22, DOI 10.1186/1471-2431-4-22; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Huxley R, 2004, JAMA-J AM MED ASSOC, V292, P2755, DOI 10.1001/jama.292.22.2755; Lawlor DA, 2006, ANN EPIDEMIOL, V16, P19, DOI 10.1016/j.annepidem.2005.04.006; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Leunissen RWJ, 2008, J CLIN ENDOCR METAB, V93, P4307, DOI 10.1210/jc.2008-0621; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; Mogren I, 2001, INT J EPIDEMIOL, V30, P853, DOI 10.1093/ije/30.4.853; Mortaz M, 2001, ARCH DIS CHILD, V84, P212, DOI 10.1136/adc.84.3.212; Owen CG, 2003, PEDIATRICS, V111, P1081, DOI 10.1542/peds.111.5.1081; Owen CG, 2008, AM J CLIN NUTR, V88, P305, DOI 10.1093/ajcn/88.2.305; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; Tam WH, 2008, PEDIATRICS, V122, P1229, DOI 10.1542/peds.2008-0158; Tenhola S, 2000, PEDIATR RES, V48, P623, DOI 10.1203/00006450-200011000-00012; Thorsdottir I, 2003, NUTR METAB CARDIOVAS, V13, P267, DOI 10.1016/S0939-4753(03)80030-3; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25533	10.1371/journal.pone.0025533	http://dx.doi.org/10.1371/journal.pone.0025533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980486	gold, Green Published, Green Submitted			2022-12-25	WOS:000295933700041
J	He, P; Liu, Q; Wu, J; Shen, Y				He, Ping; Liu, Qiang; Wu, Jie; Shen, Yong			Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons	FASEB JOURNAL			English	Article						clustering; inflammation; neurodysfunction; neurodegeneration; excitotoxicity	TUMOR-NECROSIS-FACTOR; LONG-TERM POTENTIATION; IONOTROPIC GLUTAMATE RECEPTORS; ACTIVITY-DEPENDENT REGULATION; CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE	The distribution of postsynaptic glutamate receptors has been shown to be regulated by proimmunocytokine tumor necrosis factor alpha (TNF-alpha) signaling. The role of TNF-alpha receptor subtypes in mediating glutamate receptor expression, trafficking, and function still remains unclear. Here, we report that TNF receptor subtypes (TNFR1 and TNFR2) differentially modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) clustering and function in cultured cortical neurons. We find that genetic deletion of TNFR1 decreases surface expression and synaptic localization of the AMPAR GluA1 subunit, reduces the frequency of miniature excitatory postsynaptic current (mEPSC), and reduces AMPA-induced maximal whole-cell current. In addition, these results are not observed in TNFR2-deleted neurons. The decreased AMPAR expression and function in TNFR1-deleted cells are not significantly restored by short (2 h) or long (24 h) term exposure to TNF-alpha. In TNFR2-deleted cells, TNF-alpha promotes AMPAR trafficking to the synapse and increases mEPSC frequency. In the present study, we find no significant change in the GluN1 subunit of NMDAR clusters, location, and mEPSC. This includes applying or withholding the TNF-alpha treatment in both TNFR1- and TNFR2-deleted neurons. Our results indicate that TNF receptor subtype 1 but not 2 plays a critical role in modulating AMPAR clustering, suggesting that targeting TNFR1 gene might be a novel approach to preventing neuronal AMPAR-mediated excitotoxicity.-He, P., Liu, Q., Wu, J., Shen, Y. Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. FASEB J. 26, 334-345 (2012). www.fasebj.org	[He, Ping; Shen, Yong] Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL 34243 USA; [He, Ping; Shen, Yong] Sun Hlth Res Inst, Haldeman Lab Mol & Cellular Neurobiol, Sun City, AZ USA; [Liu, Qiang; Wu, Jie] St Josephs Hosp, Div Neurol, Barrow Neurol Inst, Phoenix, AZ 85013 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Shen, Y (corresponding author), Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	jie.wu@chw.edu; yshen@rfdn.org	Liu, Qiang/HHZ-3181-2022		U.S. National Institutes of Health [NIH NIAAG025888]; Alzheimer's Association; Arizona Biomedical Research Commission	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Arizona Biomedical Research Commission	This work is supported by the U.S. National Institutes of Health, grant NIH NIAAG025888 (Y.S.); an Alzheimer's Association Zenith Award (Y.S.); and a grant from the Arizona Biomedical Research Commission (Y.S.). The authors thank Harrison Stratton for his editorial assistance.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Akassoglou K, 1997, J IMMUNOL, V158, P438; Allison DW, 1998, J NEUROSCI, V18, P2423; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bessler H, 1999, BIOMED PHARMACOTHER, V53, P141, DOI 10.1016/S0753-3322(99)80079-1; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cheng X, 2010, J ALZHEIMERS DIS, V19, P621, DOI 10.3233/JAD-2010-1253; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Diem R, 2001, J NEUROSCI, V21, P2058, DOI 10.1523/JNEUROSCI.21-06-02058.2001; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Grell M, 1996, J INFLAMM, V47, P8; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kobayashi T, 1998, EUR J PHARMACOL, V363, P1, DOI 10.1016/S0014-2999(98)00774-2; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Leonoudakis D, 2004, NEURON GLIA BIOL, V1, P263, DOI 10.1017/S1740925X05000608; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lissin DV, 1999, J NEUROSCI, V19, P1263; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Patel JR, 2008, J NEUROSCI RES, V86, P2303, DOI 10.1002/jnr.21663; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Raine CS, 1998, REV NEUROL-FRANCE, V154, P577; Rao A, 1998, J NEUROSCI, V18, P1217; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; RIECKMANN P, 1995, ANN NEUROL, V37, P82, DOI 10.1002/ana.410370115; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shen Y, 1997, J BIOL CHEM, V272, P3550, DOI 10.1074/jbc.272.6.3550; Shen Y, 2006, TRENDS MOL MED, V12, P574, DOI 10.1016/j.molmed.2006.10.002; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Wu LJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-40; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002; Youn DH, 2008, J NEUROSCI RES, V86, P2867, DOI 10.1002/jnr.21726; Yu ZF, 2002, NEUROBIOL DIS, V11, P199, DOI 10.1006/nbdi.2002.0530; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	82	62	65	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					334	345		10.1096/fj.11-192716	http://dx.doi.org/10.1096/fj.11-192716			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21982949	Green Published			2022-12-25	WOS:000299202200033
J	Takemoto, K; Borjigin, S				Takemoto, Kazuhiro; Borjigin, Suritalatu			Metabolic Network Modularity in Archaea Depends on Growth Conditions	PLOS ONE			English	Article							CELL BIOLOGY; EVOLUTION; ORGANIZATION; TEMPERATURE; ORGANISMS; LIFE	Network modularity is an important structural feature in metabolic networks. A previous study suggested that the variability in natural habitat promotes metabolic network modularity in bacteria. However, since many factors influence the structure of the metabolic network, this phenomenon might be limited and there may be other explanations for the change in metabolic network modularity. Therefore, we focus on archaea because they belong to another domain of prokaryotes and show variability in growth conditions (e.g., trophic requirement and optimal growth temperature), but not in habitats because of their specialized growth conditions (e.g., high growth temperature). The relationship between biological features and metabolic network modularity is examined in detail. We first show the absence of a relationship between network modularity and habitat variability in archaea, as archaeal habitats are more limited than bacterial habitats. Although this finding implies the need for further studies regarding the differences in network modularity, it does not contradict previous work. Further investigations reveal alternative explanations. Specifically, growth conditions, trophic requirement, and optimal growth temperature, in particular, affect metabolic network modularity. We have discussed the mechanisms for the growth condition-dependant changes in network modularity. Our findings suggest different explanations for the changes in network modularity and provide new insights into adaptation and evolution in metabolic networks, despite several limitations of data analysis.	[Takemoto, Kazuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Takemoto, Kazuhiro; Borjigin, Suritalatu] Univ Tokyo, Dept Biophys & Biochem, Bunkyo Ku, Tokyo, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Takemoto, K (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	takemoto@cb.k.u-tokyo.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366	JST PRESTO	JST PRESTO(Japan Science & Technology Agency (JST))	This work was supported by the JST PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Diaz-Mejia JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r26; Doworkin M., 2006, PROKARYOTES, V3; Ebenhoh Oliver, 2005, Genome Inform, V16, P203; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Kristjansson J. K., 1991, THERMOPHILIC BACTERI; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazurie A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-59; Nam H, 2011, CURR OPIN BIOTECH, V22, P595, DOI 10.1016/j.copbio.2011.03.006; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Papp B, 2009, HFSP J, V3, P24, DOI 10.2976/1.3020599; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; Takemoto K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-82; Takemoto K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-303; Wang HC, 2002, NUCLEIC ACIDS RES, V30, P2501, DOI 10.1093/nar/30.11.2501; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25874	10.1371/journal.pone.0025874	http://dx.doi.org/10.1371/journal.pone.0025874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998711	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700023
J	Gril, B; Palmieri, D; Qian, Y; Anwar, T; Ileva, L; Bernardo, M; Choyke, P; Liewehr, DJ; Steinberg, SM; Steeg, PS				Gril, Brunilde; Palmieri, Diane; Qian, Yong; Anwar, Talha; Ileva, Lilia; Bernardo, Marcelino; Choyke, Peter; Liewehr, David J.; Steinberg, Seth M.; Steeg, Patricia S.			The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; P42/P44 MAP KINASE; PHASE-II; MUTATION ANALYSIS; OPEN-LABEL; HA-RAS; BRAF; INHIBITOR; PROGRESSION	Pazopanib is an FDA approved Vascular Endothelial Growth Factor Receptor inhibitor. We previously reported that it also inhibits tumor cell B-Raf activity in an experimental brain metastatic setting. Here, we determine the effects of different B-Raf genotypes on pazopanib efficacy, in terms of primary tumor growth and anti-angiogenesis. A panel of seven human breast cancer and melanoma cell lines harboring different mutations in the Ras-Raf pathway was implanted orthotopically in mice, and tumor growth, ERK1/2, MEK1/2 and AKT activation, and blood vessel density and permeability were analyzed. Pazopanib was significantly inhibitory to xenografts expressing either exon 11 mutations of B-Raf, or HER2 activated wild type B-Raf; no significant inhibition of a xenograft expressing the common V600E B-Raf mutation was observed. Decreased pMEK staining in the responsive tumors confirmed that B-Raf was targeted by pazopanib. Interestingly, pazopanib inhibition of tumor cell B-Raf also correlated with its anti-angiogenic activity, as quantified by vessel density and area. In conclusion, using pazopanib, tumor B-Raf status was identified as a significant determinant of both tumor growth and angiogenesis.	[Gril, Brunilde; Palmieri, Diane; Qian, Yong; Anwar, Talha; Steeg, Patricia S.] NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Ileva, Lilia; Bernardo, Marcelino] NCI, Lab Anim Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA; [Bernardo, Marcelino; Choyke, Peter] NCI, Mol Imaging Program, Ctr Canc Res, Frederick, MD 21701 USA; [Liewehr, David J.; Steinberg, Seth M.] NIH, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gril, B (corresponding author), NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	grilbrun@mail.nih.gov	Palmieri, Diane/B-4258-2015; Liewehr, David J/GWV-3570-2022		National Cancer Institute; Department of Defense [W81XWH-062-0033]; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [ZIABC010538] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the National Cancer Institute, by grant W81XWH-062-0033 from the Department of Defense Breast Cancer Research Program, and by funding from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonio LV, 2003, J CLIN VIROL, V27, P263, DOI 10.1016/S1386-6532(02)00181-6; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; Auner V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-111; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brose MS, 2002, CANCER RES, V62, P6997; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Chiosea S, 2010, HUM PATHOL, V41, P1053, DOI 10.1016/j.humpath.2010.01.008; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Friedlander M, 2010, GYNECOL ONCOL, V119, P32, DOI 10.1016/j.ygyno.2010.05.033; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; GRUGEL S, 1995, J BIOL CHEM, V270, P25915, DOI 10.1074/jbc.270.43.25915; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hurwitz HI, 2009, CLIN CANCER RES, V15, P4220, DOI 10.1158/1078-0432.CCR-08-2740; Hutson TE, 2010, J CLIN ONCOL, V28, P475, DOI 10.1200/JCO.2008.21.6994; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kozma L, 1997, CANCER LETT, V111, P127, DOI 10.1016/S0304-3835(96)04527-2; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Kusters B, 2002, CANCER RES, V62, P341; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Monk BJ, 2010, J CLIN ONCOL, V28, P3562, DOI 10.1200/JCO.2009.26.9571; Olaussen KA, 2009, ONCOGENE, V28, P4249, DOI 10.1038/onc.2009.277; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rak J, 2000, CANCER RES, V60, P490; Slamon D, 2008, J CLIN ONCOL, V26; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Smalley KSM, 2009, FUTURE ONCOL, V5, P775, DOI [10.2217/fon.09.56, 10.2217/FON.09.56]; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Waldmann V, 1996, J CANCER RES CLIN, V122, P207, DOI 10.1007/BF01209647; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	48	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25625	10.1371/journal.pone.0025625	http://dx.doi.org/10.1371/journal.pone.0025625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998674	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900037
J	Li, QS; Bian, S; Hong, J; Kawase-Koga, Y; Zhu, E; Zheng, YR; Yang, LZ; Sun, T				Li, Qingsong; Bian, Shan; Hong, Janet; Kawase-Koga, Yoko; Zhu, Edwin; Zheng, Yongri; Yang, Lizhuang; Sun, Tao			Timing Specific Requirement of microRNA Function is Essential for Embryonic and Postnatal Hippocampal Development	PLOS ONE			English	Article							DENTATE GYRUS; NERVOUS-SYSTEM; STEM-CELLS; DORSAL TELENCEPHALON; CONDITIONAL LOSS; CEREBRAL-CORTEX; GRANULE CELLS; SMALL RNAS; C-ELEGANS; DICER	The adult hippocampus consists of the dentate gyrus (DG) and the CA1, CA2 and CA3 regions and is essential for learning and memory functions. During embryonic development, hippocampal neurons are derived from hippocampal neuroepithelial cells and dentate granular progenitors. The molecular mechanisms that control hippocampal progenitor proliferation and differentiation are not well understood. Here we show that noncoding microRNAs (miRNAs) are essential for early hippocampal development in mice. Conditionally ablating the RNAase III enzyme Dicer at different embryonic time points utilizing three Cre mouse lines causes abnormal hippocampal morphology and affects the number of hippocampal progenitors due to altered proliferation and increased apoptosis. Lack of miRNAs at earlier stages causes early differentiation of hippocampal neurons, in particular in the CA1 and DG regions. Lack of miRNAs at a later stage specifically affects neuronal production in the CA3 region. Our results reveal a timing requirement of miRNAs for the formation of specific hippocampal regions, with the CA1 and DG developmentally hindered by an early loss of miRNAs and the CA3 region to a late loss of miRNAs. Collectively, our studies indicate the importance of the Dicer-mediated miRNA pathway in hippocampal development and functions.	[Li, Qingsong; Bian, Shan; Hong, Janet; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Li, Qingsong; Zheng, Yongri; Yang, Lizhuang] Harbin Med Coll, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Kawase-Koga, Yoko] Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan; [Zhu, Edwin] NYU, Dept Biol, New York, NY 10003 USA	Cornell University; Harbin Medical University; University of Tokyo; New York University	Li, QS (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	tas2009@med.cornell.edu			Ellison Medical Foundation; Hirschl/Weill-Caulier Trust; National Institute of Mental Health (NIMH) [R01MH083680]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Hirschl/Weill-Caulier Trust; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Ellison Medical Foundation (Dr. Sun), an award from the Hirschl/Weill-Caulier Trust (Dr. Sun) and an R01MH083680 grant from the National Institute of Mental Health (NIMH)(Dr. Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galceran J, 2000, DEVELOPMENT, V127, P469; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Sun T, 2000, DEVELOPMENT, V127, P4519; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	38	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26000	10.1371/journal.pone.0026000	http://dx.doi.org/10.1371/journal.pone.0026000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991391	Green Submitted, Green Published, gold			2022-12-25	WOS:000295963300032
J	Li, HD; Huang, C; Huang, KJ; Wu, WD; Jiang, T; Cao, J; Feng, ZZ; Qiu, ZJ				Li, Hai Dong; Huang, Chen; Huang, Ke Jian; Wu, Wei Dong; Jiang, Tao; Cao, Jun; Feng, Zhen Zhong; Qiu, Zheng Jun			STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; SIGNAL TRANSDUCERS; MMP-7 EXPRESSION; TISSUE INHIBITOR; TUMOR INVASION; METASTASIS; ACTIVATION; INDUCTION	Aims: Transducer and activator of transcription-3 (STAT3) plays an important role in tumor cell invasion and metastasis. The aim of the present study was to investigate the effects of STAT3 knockdown in nude mouse xenografts of pancreatic cancer cells and underlying gene expression. Methods: A STAT3 shRNA lentiviral vector was constructed and infected into SW1990 cells. qRT-PCR and western immunoblot were performed to detect gene expression. Nude mouse xenograft assays were used to assess changes in phenotypes of these stable cells in vivo. HE staining was utilized to evaluate tumor cell invasion and immunohistochemistry was performed to analyze gene expression. Results: STAT3 shRNA successfully silenced expression of STAT3 mRNA and protein in SW1990 cells compared to control cells. Growth rate of the STAT3-silenced tumor cells in nude mice was significantly reduced compared to in the control vector tumors and parental cells-generated tumors. Tumor invasion into the vessel and muscle were also suppressed in the STAT3-silenced tumors compared to controls. Collagen IV expression was complete and continuous surrounding the tumors of STAT3-silenced SW1990 cells, whereas collagen IV expression was incomplete and discontinuous surrounding the control tumors. Moreover, microvessel density was significantly lower in STAT3-silenced tumors than parental or control tumors of SW1990 cells. In addition, MMP-7 expression was reduced in STAT3-silenced tumors compared to parental SW1990 xenografts and controls. In contrast, expression of IL-1 beta and IgT7 alpha was not altered. Conclusion: These data clearly demonstrate that STAT3 plays an important role in regulation of tumor growth, invasion, and angiogenesis, which could be act by reducing MMP-7 expression in pancreatic cancer cells.	[Li, Hai Dong; Huang, Chen; Huang, Ke Jian; Wu, Wei Dong; Jiang, Tao; Cao, Jun; Qiu, Zheng Jun] Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Li, Hai Dong; Huang, Chen; Qiu, Zheng Jun] Shanghai Key Lab Pancreas Dis, Shanghai, Peoples R China; [Li, Hai Dong; Huang, Chen; Qiu, Zheng Jun] Shanghai Jiao Tong Univ, Pancreat Canc Ctr, Shanghai 200030, Peoples R China; [Feng, Zhen Zhong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	qiuwryb@gmail.com			Science and Technology Commission of Shanghai Municipality [09QA1404600]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by a grant (No. 09QA1404600) awarded by fund for scientific research of Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara R, 2005, BRIT J SURG, V92, P454, DOI 10.1002/bjs.4868; Beeghly-Fadiel A, 2008, CANCER RES, V68, P6453, DOI 10.1158/0008-5472.CAN-08-0636; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Caldera V, 2008, J ONCOL, V2008, DOI 10.1155/2008/219241; Christine R, 2005, CANCER RES, V65, P195; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Glienke W, 2011, PANCREAS, V40, P323, DOI 10.1097/MPA.0b013e318204ea7b; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; HAYASHI Y, 2011, CANC SCI; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Huang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-51; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Li J, 2009, WORLD J GASTROENTERO, V15, P2602, DOI 10.3748/wjg.15.2602; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lopez MA, 2005, AM J PHYSIOL-CELL PH, V288, pC282, DOI 10.1152/ajpcell.00362.2003; Mukhopadhyay UK, 2010, MOL CELL BIOL, V30, P4980, DOI 10.1128/MCB.00004-10; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Qu P, 2009, CANCER RES, V69, P7252, DOI 10.1158/0008-5472.CAN-09-0577; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Tan X, 2005, INT J ONCOL, V26, P1283; Tsunoda S, 2007, CANCER SCI, V98, P541, DOI 10.1111/j.1349-7006.2007.00432.x; Wang L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-14; Wang L, 2009, CANCER EPIDEM BIOMAR, V18, P2829, DOI 10.1158/1055-9965.EPI-09-0557; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yakata Y, 2007, INT J ONCOL, V30, P437; Yang G, 2009, WORLD J GASTROENTERO, V15, P3757, DOI 10.3748/wjg.15.3757; Yokoyama Y, 2008, CLIN CANCER RES, V14, P5503, DOI 10.1158/1078-0432.CCR-07-4041; Yuan GG, 2008, CELL SIGNAL, V20, P1284, DOI 10.1016/j.cellsig.2008.02.017; ZHAO M, 2011, LUNG CANC; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhou DH, 2008, HEPATOB PANCREAT DIS, V7, P201	44	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25941	10.1371/journal.pone.0025941	http://dx.doi.org/10.1371/journal.pone.0025941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991388	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000096
J	Marella, M; Seo, BB; Flotte, TR; Matsuno-Yagi, A; Yagi, T				Marella, Mathieu; Seo, Byoung Boo; Flotte, Terence R.; Matsuno-Yagi, Akemi; Yagi, Takao			No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; COMPLEX-I DEFECTS; GENE-THERAPY; ADENOASSOCIATED VIRUS; DEHYDROGENASE NDI1; SUBUNIT; DISEASE; CELLS; VIVO; TRANSDUCTION	Background: The rotenone-insensitive internal NADH-quinone oxidoreductase from yeast, Ndi1, has been shown to work as a replacement molecule for complex I in the respiratory chain of mammalian mitochondria. In the so-called transkingdom gene therapy, one major concern is the fact that the yeast protein is foreign in mammals. Long term expression of Ndi1 observed in rodents with no apparent damage to the target tissue was indicative of no action by the host's immune system. Methodology/Principal Findings: In the present study, we examined rat skeletal muscles expressing Ndi1 for possible signs of inflammatory or immune response. In parallel, we carried out delivery of the GFP gene using the same viral vector that was used for the NDI1 gene. The tissues were subjected to H&E staining and immunohistochemical analyses using antibodies specific for markers, CD11b, CD3, CD4, and CD8. The data showed no detectable signs of an immune response with the tissues expressing Ndi1. In contrast, mild but distinctive positive reactions were observed in the tissues expressing GFP. This clear difference most likely comes from the difference in the location of the expressed protein. Ndi1 was localized to the mitochondria whereas GFP was in the cytosol. Conclusions/Significance: We demonstrated that Ndi1 expression did not trigger any inflammatory or immune response in rats. These results push forward the Ndi1-based molecular therapy and also expand the possibility of using foreign proteins that are directed to subcellular organelle such as mitochondria.	[Marella, Mathieu; Seo, Byoung Boo; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Flotte, Terence R.] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Flotte, Terence R.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA	Scripps Research Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Marella, M (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu			United States Public Health Service [R01EY020796, R01DK053244, R01HL069877]; NATIONAL EYE INSTITUTE [R01EY020796] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053244] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01EY020796 and R01DK053244 (to TY and AM-Y) and R01HL069877 (to TRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Barber-Singh J., 2010, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011.438370; Barber-Singh J, 2009, REJUV RES, V12, P259, DOI 10.1089/rej.2009.0854; Christ M, 2002, TOXICOLOGY, V174, P13, DOI 10.1016/S0300-483X(02)00052-5; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; FREGEAU DR, 1990, J IMMUNOL, V144, P1671; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; LINDAHL KF, 1989, COLD SH Q B, V54, P563; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Perry CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016288; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Simpson E, 2006, IMMUNOL REV, V213, P12, DOI 10.1111/j.1600-065X.2006.00434.x; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25910	10.1371/journal.pone.0025910	http://dx.doi.org/10.1371/journal.pone.0025910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991386	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000094
J	Nilvebrant, J; Alm, T; Hober, S; Lofblom, J				Nilvebrant, Johan; Alm, Tove; Hober, Sophia; Lofblom, John			Engineering Bispecificity into a Single Albumin-Binding Domain	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; STREPTOCOCCAL PROTEIN-G; ANTIBODY FRAGMENTS; SURFACE DISPLAY; MOLECULAR-SIZE; AFFINITY; BUNDLE; THERAPEUTICS; PURIFICATION; GENERATION	Bispecific antibodies as well as non-immunoglobulin based bispecific affinity proteins are considered to have a very high potential in future biotherapeutic applications. In this study, we report on a novel approach for generation of extremely small bispecific proteins comprised of only a single structural domain. Binding to tumor necrosis factor-alpha (TNF-alpha) was engineered into an albumin-binding domain while still retaining the original affinity for albumin, resulting in a bispecific protein composed of merely 46 amino acids. By diversification of the non albumin-binding side of the three-helix bundle domain, followed by display of the resulting library on phage particles, bispecific single-domain proteins were isolated using selections with TNF-alpha as target. Moreover, based on the obtained sequences from the phage selection, a second-generation library was designed in order to further increase the affinity of the bispecific candidates. Staphylococcal surface display was employed for the affinity maturation, enabling efficient isolation of improved binders as well as multiparameter-based sortings with both TNF-alpha and albumin as targets in the same selection cycle. Isolated variants were sequenced and the binding to albumin and TNF-alpha was analyzed. This analysis revealed an affinity for TNF-alpha below 5 nM for the strongest binders. From the multiparameter sorting that simultaneously targeted TNF-alpha and albumin, several bispecific candidates were isolated with high affinity to both antigens, suggesting that cell display in combination with fluorescence activated cell sorting is a suitable technology for engineering of bispecificity. To our knowledge, the new binders represent the smallest engineered bispecific proteins reported so far. Possibilities and challenges as well as potential future applications of this novel strategy are discussed.	[Nilvebrant, Johan; Alm, Tove; Hober, Sophia] AlbaNova Univ Ctr, Dept Prote, Sch Biotechnol, Stockholm, Sweden; [Lofblom, John] AlbaNova Univ Ctr, Dept Mol Biotechnol, Sch Biotechnol, Royal Inst Technol, Stockholm, Sweden	Royal Institute of Technology	Nilvebrant, J (corresponding author), AlbaNova Univ Ctr, Dept Prote, Sch Biotechnol, Stockholm, Sweden.	sophia@biotech.kth.se	Lofblom, John/A-6805-2012	Lofblom, John/0000-0001-9423-0541	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm T, 2010, BIOTECHNOL J, V5, P605, DOI 10.1002/biot.201000041; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Engfeldt T, 2005, CHEMBIOCHEM, V6, P1043, DOI 10.1002/cbic.200400388; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Gulich S, 2000, J BIOTECHNOL, V80, P169, DOI 10.1016/S0168-1656(00)00259-5; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOPP J, PROTEIN ENG DES SEL, V23, P827; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Jonsson A, 2009, BIOTECHNOL APPL BIOC, V54, P93, DOI 10.1042/BA20090085; Kraulis PJ, 1996, FEBS LETT, V378, P190, DOI 10.1016/0014-5793(95)01452-7; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist Nina, 2010, Recent Pat Biotechnol, V4, P171, DOI 10.2174/187220810793611536; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Linhult M, 2002, PROTEIN SCI, V11, P206, DOI 10.1110/ps.02802; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lofblom J, 2011, CURR OPIN BIOTECH, V022, P1; Miao Z., 2010, AMINO ACIDS, P1; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Roopenian DC, 2010, J CLIN IMMUNOL, V30, P790, DOI 10.1007/s10875-010-9458-6; RUTHER U, 1982, NUCLEIC ACIDS RES, V10, P5765, DOI 10.1093/nar/10.19.5765; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; STAHL S, 1989, J IMMUNOL METHODS, V124, P43, DOI 10.1016/0022-1759(89)90184-1; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	30	30	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25791	10.1371/journal.pone.0025791	http://dx.doi.org/10.1371/journal.pone.0025791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991353	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000071
J	Hopf, PS; Ford, RS; Zebian, N; Merkx-Jacques, A; Vijayakumar, S; Ratnayake, D; Hayworth, J; Creuzenet, C				Hopf, Patrick S.; Ford, Rachel S.; Zebian, Najwa; Merkx-Jacques, Alexandra; Vijayakumar, Somalinga; Ratnayake, Dinath; Hayworth, Jacqueline; Creuzenet, Carole			Protein Glycosylation in Helicobacter pylori: Beyond the Flagellins?	PLOS ONE			English	Article							ANION-EXCHANGE CHROMATOGRAPHY; OUTER-MEMBRANE PROTEIN; HUMAN EPITHELIAL-CELLS; CAMPYLOBACTER-JEJUNI; FUNCTIONAL-CHARACTERIZATION; POSTTRANSLATIONAL MODIFICATION; GENETIC-CHARACTERIZATION; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; POLYACRYLAMIDE GELS	Glycosylation of flagellins by pseudaminic acid is required for virulence in Helicobacter pylori. We demonstrate that, in H. pylori, glycosylation extends to proteins other than flagellins and to sugars other than pseudaminic acid. Several candidate glycoproteins distinct from the flagellins were detected via ProQ-emerald staining and DIG-or biotin-hydrazide labeling of the soluble and outer membrane fractions of wild-type H. pylori, suggesting that protein glycosylation is not limited to the flagellins. DIG-hydrazide labeling of proteins from pseudaminic acid biosynthesis pathway mutants showed that the glycosylation of some glycoproteins is not dependent on the pseudaminic acid glycosylation pathway, indicating the existence of a novel glycosylation pathway. Fractions enriched in glycoprotein candidates by ion exchange chromatography were used to extract the sugars by acid hydrolysis. High performance anion exchange chromatography with pulsed amperometric detection revealed characteristic monosaccharide peaks in these extracts. The monosaccharides were then identified by LC-ESI-MS/MS. The spectra are consistent with sugars such as 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Ac7Ac) previously described on flagellins, 5-acetamidino-7-acetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Am7Ac), bacillosamine derivatives and a potential legionaminic acid derivative (Leg5AmNMe7Ac) which were not previously identified in H. pylori. These data open the way to the study of the mechanism and role of protein glycosylation on protein function and virulence in H. pylori.	[Hopf, Patrick S.; Ford, Rachel S.; Zebian, Najwa; Merkx-Jacques, Alexandra; Vijayakumar, Somalinga; Ratnayake, Dinath; Hayworth, Jacqueline; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON, Canada	Western University (University of Western Ontario)	Hopf, PS (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON, Canada.	ccreuzen@uwo.ca			Canadian Institutes of Health Research (CIHR) [MOP-62775]; Schulich School of Medicine and Dentistry of the University of Western Ontario; Natural Sciences and Engineering Research Council of Canada; Canadian Association of Gastroenterologists; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Schulich School of Medicine and Dentistry of the University of Western Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Association of Gastroenterologists; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by operating grant MOP-62775 from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca) and in part by funding from the Schulich School of Medicine and Dentistry of the University of Western Ontario (http://www.schulich.uwo.ca/) to Dr. Creuzenet. Dr. Creuzenet was the recipient of a University Faculty Award from the Natural Sciences and Engineering Research Council of Canada, and of a Premier's Research Excellence Award (Ontario). A. Merkx-Jacques was the recipient of a Canadian Digestive Health Foundation/CIHR Doctoral Research Award. J. Hayworth was the recipient of a summer scholarship from the Canadian Association of Gastroenterologists, and P. Hopf was the recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Baik SC, 2004, J BACTERIOL, V186, P949, DOI 10.1128/JB.186.4.949-955.2004; Carlsohn E, 2006, J PROTEOME RES, V5, P3197, DOI 10.1021/pr060181p; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Censini S, 2001, CURR OPIN MICROBIOL, V4, P41, DOI 10.1016/S1369-5274(00)00162-4; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLYNE M, 1995, INFECT IMMUN, V63, P1669, DOI 10.1128/IAI.63.5.1669-1673.1995; COOPER GA, 1995, ANAL BIOCHEM, V226, P182, DOI 10.1006/abio.1995.1207; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2004, FEBS LETT, V559, P136, DOI 10.1016/S0014-5793(04)00057-2; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Demendi M, 2009, BIOCHEM CELL BIOL, V87, P469, DOI [10.1139/O09-002, 10.1139/o09-002]; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; DOIG P, 1994, INFECT IMMUN, V62, P4526, DOI 10.1128/IAI.62.10.4526-4533.1994; EGGERT FM, 1985, J CHROMATOGR, V333, P123; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; FLETCHER CM, 2010, J BIOL CHEM; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; GEIS G, 1993, J MED MICROBIOL, V38, P371, DOI 10.1099/00222615-38-5-371; GOODWIN CS, 1989, INT J SYST BACTERIOL, V39, P397, DOI 10.1099/00207713-39-4-397; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Josenhans C, 1999, MOL MICROBIOL, V33, P350, DOI 10.1046/j.1365-2958.1999.01478.x; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kakuda T, 2006, INFECT IMMUN, V74, P4715, DOI 10.1128/IAI.00033-06; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Koenigs MB, 2009, MOL BIOSYST, V5, P909, DOI 10.1039/b902178g; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwon DH, 1998, CURR MICROBIOL, V37, P144, DOI 10.1007/s002849900354; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Logan SM, 2002, MOL MICROBIOL, V46, P587, DOI 10.1046/j.1365-2958.2002.03185.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARSHALL B J, 1984, Microbios Letters, V25, P83; McGee DJ, 2002, J MED MICROBIOL, V51, P958, DOI 10.1099/0022-1317-51-11-958; McGee DJ, 1999, J BACTERIOL, V181, P2477, DOI 10.1128/JB.181.8.2477-2484.1999; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; McNally DJ, 2006, J BIOL CHEM, V281, P18489, DOI 10.1074/jbc.M603777200; Merkx-Jacques A, 2004, J BACTERIOL, V186, P2253, DOI 10.1128/JB.186.8.2253-2265.2004; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; NEESER JR, 1984, ANAL BIOCHEM, V142, P58, DOI 10.1016/0003-2697(84)90516-5; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Obhi RK, 2005, J BIOL CHEM, V280, P20902, DOI 10.1074/jbc.M413832200; Odenbreit S, 1996, J BACTERIOL, V178, P6960, DOI 10.1128/jb.178.23.6960-6967.1996; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Raymond J, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2009.00737.x; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; SCHOENHOFEN IC, 2006, GLYCOBIOLOGY; SOMALINGA V, 2005, P 105 GEN M AM SOC M, P53; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; STEAD CM, 2010, MOL MICROBIOL; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vijayakumar S, 2006, J BIOL CHEM, V281, P27733, DOI 10.1074/jbc.M511714200; Wang G, 1999, MICROBIOL-SGM, V145, P3245, DOI 10.1099/00221287-145-11-3245; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; WARREN JR, 1983, LANCET, V1, P1273; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Zhang CJ, 2004, PHYTOCHEMISTRY, V65, P1575, DOI 10.1016/j.phytochem.2004.03.031	92	39	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25722	10.1371/journal.pone.0025722	http://dx.doi.org/10.1371/journal.pone.0025722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984942	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300052
J	Shao, HY; Lin, YW; Yu, SL; Lin, HY; Chitra, E; Chang, YC; Sia, C; Chong, PL; Hsu, MT; Wei, OL; Chow, YH				Shao, Hsiao-Yun; Lin, Yi-Wen; Yu, Shu-Ling; Lin, Hsiang-Yin; Chitra, Ebenezer; Chang, Yung-Chen; Sia, Charles; Chong, Pele; Hsu, Ming-Tao; Wei, Olivia L.; Chow, Yen-Hung			Immunoprotectivity of HLA-A2 CTL Peptides Derived from Respiratory Syncytial Virus Fusion Protein in HLA-A2 Transgenic Mouse	PLOS ONE			English	Article							T-LYMPHOCYTE EPITOPE; VACCINE-ENHANCED DISEASE; PULMONARY EOSINOPHILIA; CELL RESPONSES; GLYCOPROTEIN-G; PRIMARY INFECTION; DENDRITIC CELLS; RSV INFECTION; IN-VIVO; MICE	Identification of HLA-restricted CD8(+) T cell epitopes is important to study RSV-induced immunity and illness. We algorthmically analyzed the sequence of the fusion protein (F) of respiratory syncytial virus (RSV) and generated synthetic peptides that can potentially bind to HLA-A*0201. Four out of the twenty-five 9-mer peptides tested: peptides 3 (F33-41), 13 (F214-222), 14 (F273-281), and 23 (F559-567), were found to bind to HLA-A*0201 with moderate to high affinity and were capable of inducing and IFN-gamma and IL-2 secretion in lymphocytes from HLA-A*0201 transgenic (HLA-Tg) mice pre-immunized with RSV or recombinant adenovirus expressing RSV F. HLA-Tg mice were immunized with these four peptides and were found to induce both Th1 and CD8(+) T cell responses in in vitro secondary recall. Effector responses induced by these peptides were observed to confer differential protection against live RSV challenge. These peptides also caused better recovery of body weight loss induced by RSV. A significant reduction of lung viral load was observed in mice immunized with peptide 23, which appeared to enhance the levels of inflammatory chemokines (CCL17, CCL22, and IL-18) but did not increase eosinophil infiltration in the lungs. Whereas significant reduction of infiltrated eosinophils induced by RSV infection was found in mice pre-immunized with peptide 13. Our results suggest that HLA-A2-restricted epitopes of RSV F protein could be useful for the development of epitope-based RSV vaccine.	[Shao, Hsiao-Yun; Lin, Yi-Wen; Yu, Shu-Ling; Lin, Hsiang-Yin; Chitra, Ebenezer; Chang, Yung-Chen; Sia, Charles; Chong, Pele; Hsu, Ming-Tao; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Wei, Olivia L.] Emory Univ, GDBBS, Atlanta, GA 30322 USA	National Health Research Institutes - Taiwan; National Tsing Hua University; Emory University	Shao, HY (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan.	choeyenh@nhri.org.tw	Chong, Pele/E-3855-2010; Chow, Yen-Hung/E-3863-2010; Sia, Dwo-Yuan/E-3860-2010; Chitra, Ebenezer/F-5984-2019	Chitra, Ebenezer/0000-0002-5818-6587	National Health Research Institutes [VC-99PP04]; National Science Council [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural funding, VC-99PP04 and National Science Council's funding, 99-2323-B-400-014-. (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do) (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; ALWAN WH, 1993, J IMMUNOL, V150, P5211; Aung S, 1999, J VIROL, V73, P8944, DOI 10.1128/JVI.73.11.8944-8949.1999; BANGHAM CRM, 1986, J IMMUNOL, V137, P3973; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Brandenburg AH, 2000, J VIROL, V74, P10240, DOI 10.1128/JVI.74.21.10240-10244.2000; Bukreyev A, 2005, J VIROL, V79, P9515, DOI 10.1128/JVI.79.15.9515-9526.2005; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; Chang J, 2004, J IMMUNOL, V172, P503, DOI 10.4049/jimmunol.172.1.503; Chang J, 2001, J IMMUNOL, V167, P4254, DOI 10.4049/jimmunol.167.8.4254; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; CHIBA Y, 1989, J MED VIROL, V28, P133, DOI 10.1002/jmv.1890280304; Colleton BA, 2009, J VIROL, V83, P6288, DOI 10.1128/JVI.02611-08; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; DING EX, 2009, HEPATOLOGY; Doherty P C, 1994, Trends Microbiol, V2, P148, DOI 10.1016/0966-842X(94)90662-9; DOHERTY PC, 1994, TRENDS MICROBIOL, V2, P149; EHLENFIELD DR, 2000, PEDIATRICS, V79, P83; Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Graham BS, 2002, VIROLOGY, V297, P1, DOI 10.1006/viro.2002.1431; Hancock GE, 2003, J MED VIROL, V70, P301, DOI 10.1002/jmv.10395; Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; HOLZEL A, 1963, LANCET, V1, P295; Huang YH, 2004, J GEN VIROL, V85, P3089, DOI 10.1099/vir.0.80183-0; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Hussell T, 1998, J IMMUNOL, V161, P6215; ISAACS D, 1991, LANCET, V337, P1223, DOI 10.1016/0140-6736(91)92893-7; Jiang SS, 2002, J GEN VIROL, V83, P429, DOI 10.1099/0022-1317-83-2-429; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Johnstone C, 2004, J GEN VIROL, V85, P3229, DOI 10.1099/vir.0.80219-0; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Krishnan A, 2008, IMMUNOL LETT, V120, P108, DOI 10.1016/j.imlet.2008.07.010; Kruijsen D, 2011, VACCINE, V29, P2730, DOI 10.1016/j.vaccine.2011.01.087; KULKARNI AB, 1993, J VIROL, V67, P1044, DOI 10.1128/JVI.67.2.1044-1049.1993; La Rosa C, 2002, BLOOD, V100, P3681, DOI 10.1182/blood-2002-03-0926; Matthews SP, 2005, J VIROL, V79, P2050, DOI 10.1128/JVI.79.4.2050-2057.2005; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; MOTT KR, 2009, INVEST OPHTHALMOL VI; NICHOLAS JA, 1990, J VIROL, V64, P4232, DOI 10.1128/JVI.64.9.4232-4241.1990; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; OPENSHAW PJM, 1990, J VIROL, V64, P1683, DOI 10.1128/JVI.64.4.1683-1689.1990; Partidos CD, 1996, IMMUNOLOGY, V87, P179, DOI 10.1046/j.1365-2567.1996.462527.x; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; PEMBERTON RM, 1987, J GEN VIROL, V68, P2177, DOI 10.1099/0022-1317-68-8-2177; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Rock MT, 2003, IMMUNOLOGY, V108, P474, DOI 10.1046/j.1365-2567.2003.01619.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Rutigliano JA, 2005, VIROLOGY, V337, P335, DOI 10.1016/j.virol.2005.04.032; Shao H. Y., 2009, VACCINE; Srikiatkhachorn A, 1997, J VIROL, V71, P678, DOI 10.1128/JVI.71.1.678-685.1997; Tekkanat KK, 2002, EUR J IMMUNOL, V32, P3276, DOI 10.1002/1521-4141(200211)32:11<3276::AID-IMMU3276>3.0.CO;2-5; Terrosi C, 2007, VIRAL IMMUNOL, V20, P399, DOI 10.1089/vim.2007.0041; Tregoning JS, 2008, J VIROL, V82, P4115, DOI 10.1128/JVI.02313-07; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Wahl A, 2009, P NATL ACAD SCI USA, V106, P540, DOI 10.1073/pnas.0811271106; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	74	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25500	10.1371/journal.pone.0025500	http://dx.doi.org/10.1371/journal.pone.0025500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980478	Green Submitted, Green Published, gold			2022-12-25	WOS:000295939600031
J	Domingues, I; Rino, J; Demmers, JAA; de Lanerolle, P; Santos, SCR				Domingues, Ines; Rino, Jose; Demmers, Jeroen A. A.; de Lanerolle, Primal; Rosa Santos, Susana Constantino			VEGFR2 Translocates to the Nucleus to Regulate Its Own Transcription	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE PROGRESSION; FACTOR RECEPTOR-2; TUMOR ANGIOGENESIS; THERAPEUTIC IMPLICATIONS; PHOSPHORYLATED KDR; PANCREATIC-CANCER; EXPRESSION; PROTEINS; GENE	Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is the major mediator of the angiogenic effects of VEGF. In addition to its well known role as a membrane receptor that activates multiple signaling pathways, VEGFR2 also has a nuclear localization. However, what VEGFR2 does in the nucleus is still unknown. In the present report we show that, in endothelial cells, nuclear VEGFR2 interacts with several nuclear proteins, including the Sp1, a transcription factor that has been implicated in the regulation of genes needed for angiogenesis. By in vivo chromatin immunoprecipitation (ChIP) assays, we found that VEGFR2 binds to the Sp1-responsive region of the VEGFR2 proximal promoter. These results were confirmed by EMSA assays, using the same region of the VEGFR2 promoter. Importantly, we show that the VEGFR2 DNA binding is directly linked to the transcriptional activation of the VEGFR2 promoter. By reporter assays, we found that the region between -300/-116 relative to the transcription start site is essential to confer VEGFR2-dependent transcriptional activity. It was previously described that nuclear translocation of the VEGFR2 is dependent on its activation by VEGF. In agreement, we observed that the binding of VEGFR2 to DNA requires VEGF activation, being blocked by Bevacizumab and Sunitinib, two anti-angiogenic agents that inhibit VEGFR2 activation. Our findings demonstrate a new mechanism by which VEGFR2 activates its own promoter that could be involved in amplifying the angiogenic response.	[Domingues, Ines; Rino, Jose; Rosa Santos, Susana Constantino] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands; [de Lanerolle, Primal] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	Universidade de Lisboa; Erasmus University Rotterdam; Erasmus MC; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Domingues, I (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	sconstantino@fm.ul.pt	Demmers, Jeroen AA/F-4046-2016; Rino, José/I-2990-2013; Santos, Susana/AAM-8902-2021	Demmers, Jeroen AA/0000-0002-8757-9611; Rino, José/0000-0002-0637-4527; Constantino Rosa Santos, Susana/0000-0002-5711-1292; Domingues, Ines/0000-0002-5535-619X	Fundacao para a Ciencia e Tecnologia (FCT) [POCTI\BIA-BCM 58929\2004]; NIH [R01GM080587]; FCT [SFRH/BD/27505/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080587] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was founded by Fundacao para a Ciencia e Tecnologia (FCT) POCTI\BIA-BCM 58929\2004 to SCRS and NIH R01GM080587 to PdeL. I. D. is the recipient of FCT PhD Fellowship SFRH/BD/27505/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blazquez C, 2006, CELL RES, V16, P93, DOI 10.1038/sj.cr.7310012; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chen DH, 2000, ARTERIOSCL THROM VAS, V20, P629, DOI 10.1161/01.ATV.20.3.629; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; DYER RB, 1995, NUCLEIC ACIDS RES, V23, P3345; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fernandez SL, 2007, BIOL PROCED ONLINE, V9, P84, DOI 10.1251/bpo136; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2004, J PATHOL, V202, P313, DOI 10.1002/path.1520; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Huang S, 2000, CANCER RES, V60, P5334; Huang S, 2000, CLIN CANCER RES, V6, P2573; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052, DOI 10.1128/MCB.13.10.6052; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li WL, 2000, J CELL SCI, V113, P1525; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Liu J, 2010, J IMMUNOL, V185, P1215, DOI 10.4049/jimmunol.0903660; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Stewart M, 2003, HISTOPATHOLOGY, V43, P33, DOI 10.1046/j.1365-2559.2003.01644.x; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yu HG, 2004, INT J COLORECTAL DIS, V19, P18, DOI 10.1007/s00384-003-0494-z; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhang YY, 2005, HUM PATHOL, V36, P797, DOI 10.1016/j.humpath.2005.05.015	59	69	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25668	10.1371/journal.pone.0025668	http://dx.doi.org/10.1371/journal.pone.0025668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980525	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900090
J	Buijs, JT; van der Horst, G; van den Hoogen, C; Cheung, H; de Rooij, B; Kroon, J; Petersen, M; van Overveld, PGM; Pelger, RCM; van der Pluijm, G				Buijs, J. T.; van der Horst, G.; van den Hoogen, C.; Cheung, H.; de Rooij, B.; Kroon, J.; Petersen, M.; van Overveld, P. G. M.; Pelger, R. C. M.; van der Pluijm, G.			The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation	ONCOGENE			English	Article						cancer stem cell; bone morphogenetic protein; heterodimer; breast cancer; bone metastasis; transforming growth factor-beta	ALDEHYDE DEHYDROGENASE-ACTIVITY; COMBINATORIAL GENE-THERAPY; MESENCHYMAL TRANSITION; PROSPECTIVE IDENTIFICATION; MORPHOGENETIC PROTEIN-7; INITIATING CELLS; HUMAN PROSTATE; TGF-BETA; RESISTANCE; BMP7	Accumulating evidence suggests that a subpopulation of breast cancer cells, referred to as cancer stem cells (CSCs), have the ability to propagate a tumor and potentially seed new metastases. Furthermore, stimulation of an epithelialto-mesenchymal transition by factors like transforming growth factor-beta (GF beta) is accompanied with the generation of breast CSCs. Previous observations indicated that bone morphogenetic protein-7 (BMP7) antagonizes the protumorigenic and prometastatic actions of TGF beta, but whether BMP7 action is mechanistically linked to breast CSCs has remained elusive. Here, we have studied the effects of BMP7, BMP2 and a BMP2/7 heterodimer on the formation of human breast CSCs (ALDH(hi)/CD44(hi)/CD24(-/low)) and bone metastases formation in a preclinical model of intra-cardiac injection of MDA-MB-231 cells in athymic nude (Balb/c nu/nu) mice. The BMP2/7 heterodimer was the most efficient stimulator of BMP signaling and very effectively reduced TGF beta-driven Smad signaling and cancer cell invasiveness. The tested BMPs-particularly the heterodimeric BMP2/7-srongly reduced the size of the ALDH(hi)/CD44(hi)/CD24(-/low) CSC subpopulation. In keeping with these in vitro observations, pretreatment of cancer cells with BMPs for 72 h prior to systemic inoculation of the cancer cells inhibited the formation of bone metastases. Collectively, our data support the notion that breast CSCs are involved in bone metastasis formation and describe heterodimeric BMP2/7 as a powerful TGFb antagonist with anti-metastatic potency. Oncogene (2012) 31, 2164-2174; doi:10.1038/onc.2011.400; published online 26 September 2011	[Buijs, J. T.; van der Horst, G.; van den Hoogen, C.; Cheung, H.; de Rooij, B.; Kroon, J.; Petersen, M.; van Overveld, P. G. M.; Pelger, R. C. M.; van der Pluijm, G.] Leiden Univ, Med Ctr, Dept Urol, NL-2333 ZA Leiden, Zuid Holland, Netherlands; [van der Pluijm, G.] Leiden Univ, Med Ctr, Dept Endocrinol, NL-2333 ZA Leiden, Zuid Holland, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Pluijm, G (corresponding author), Leiden Univ, Med Ctr, Dept Urol, J3-100,Albinusdreef 2, NL-2333 ZA Leiden, Zuid Holland, Netherlands.	G.van_der_Pluijm@lumc.nl	Buijs, Jeroen/E-6082-2011; Pelger, Rob/ABF-9029-2021	Buijs, Jeroen/0000-0001-5816-9739; Pelger, Rob/0000-0001-6328-6462; van der Horst, Geertje/0000-0003-1696-160X; van Overveld, Petra GM/0000-0003-0216-5004; de Rooij, Bob/0000-0002-6424-0025	PRIMA; PROMET; BRECOSM; Dutch Cancer Society (KWF) [UL-2004-3028]	PRIMA; PROMET; BRECOSM; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	We are grateful to Professor Dr P ten Dijke for providing the reporter constructs. JTB and GvdH were sponsored by the European Sixth Framework Programme PRIMA; CvdH and HC were sponsored by the European Sixth Framework Programme PROMET; MP was sponsored by the European Sixth Framework Programme BRECOSM and PGMvO was sponsored by a grant from Dutch Cancer Society (KWF project UL-2004-3028).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2010, J PATHOL, V222, P335, DOI 10.1002/path.2772; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Cheung AMS, 2007, LEUKEMIA, V21, P1423, DOI 10.1038/sj.leu.2404721; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cook C, 2007, DEV BIOL, V312, P217, DOI 10.1016/j.ydbio.2007.09.038; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; HAZAMA M, 1995, BIOCHEM BIOPH RES CO, V209, P859, DOI 10.1006/bbrc.1995.1578; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Klose A, 2011, NEOPLASIA, V13, P276, DOI 10.1593/neo.101540; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Notting IC, 2005, INVEST OPHTH VIS SCI, V46, P1581, DOI 10.1167/iovs.04-0245; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Uchino M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-414; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; van der Pluijm G, 2011, BONE, V48, P37, DOI 10.1016/j.bone.2010.07.023; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Winquist RJ, 2009, BIOCHEM PHARMACOL, V78, P326, DOI 10.1016/j.bcp.2009.03.020; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821	49	89	92	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2164	2174		10.1038/onc.2011.400	http://dx.doi.org/10.1038/onc.2011.400			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21996751				2022-12-25	WOS:000303415900005
J	Williams, KC; Coppolino, MG				Williams, Karla C.; Coppolino, Marc G.			Phosphorylation of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) and Its Vesicle-associated Membrane Protein 7 (VAMP7)-dependent Trafficking Facilitate Cell Invasion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-MATRIX-METALLOPROTEINASE; HUMAN ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; PERICELLULAR PROTEOLYSIS; CANCER INVASION; TUMOR-CELLS; KINASE-C; ACTIVATION; DEGRADATION; PROGRESSION	In multicellular organisms, uncontrolled movement of cells can contribute to pathological conditions, such as multiple sclerosis and cancer. In highly aggressive tumors, the expression of matrix metalloproteinases (MMPs) is linked to the capacity of tumor cells to invade surrounding tissue and current research indicates that the membrane-anchored membrane type 1-matrix metalloproteinase (MT1-MMP) has a central role in this process. Endocytosis and trafficking of MT1-MMP are essential for its proper function, and here we examine the phosphorylation, internalization, and recycling of this enzyme, and the associated biochemical signaling in HeLa and HT-1080 fibrosarcoma cells. Activation of protein kinase C with phorbol 12-myristate 13-acetate resulted in phosphorylation of endogenous MT1-MMP at Thr(567) in vivo. Mutation of Thr(567) to alanine (to mimic non-phosphorylated MT1-MMP) reduced internalization of MT1-MMP, whereas mutation of Thr(567) to glutamic acid (to mimic phosphorylation) resulted in decreased levels of MT1-MMP on the cell surface. The endosomal trafficking and recycling of MT1-MMP was found to be dependent upon Rab7 and VAMP7, and blocking the function of these proteins reduced cell migration and invasion. Intracellular trafficking of MT1-MMP was observed to be coupled to the trafficking of integrin alpha 5 and phosphorylation of ERK that coincided with this was dependent on phosphorylation of MT1-MMP. Together, these results reveal important roles for MT1-MMP phosphorylation and trafficking in both cell signaling and cell invasion.	[Williams, Karla C.; Coppolino, Marc G.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Coppolino, MG (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mcoppoli@uoguelph.ca		Williams, Karla/0000-0003-2954-2869	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Ontario Ministry of Research and Innovation.; Recipent of an NSERC scholarship.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Langlois S, 2007, MOL CANCER RES, V5, P569, DOI 10.1158/1541-7786.MCR-06-0267; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Miyata T, 2004, BIOCHEM BIOPH RES CO, V323, P118, DOI 10.1016/j.bbrc.2004.08.064; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Nyalendo C, 2010, ANTICANCER RES, V30, P1887; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seftor REB, 2001, CANCER RES, V61, P6322; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zucker S, 1999, ANN NY ACAD SCI, V878, P212, DOI 10.1111/j.1749-6632.1999.tb07687.x; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	49	88	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43405	43416		10.1074/jbc.M111.297069	http://dx.doi.org/10.1074/jbc.M111.297069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002060	hybrid, Green Published			2022-12-25	WOS:000298351300060
J	Inanobe, A; Nakagawa, A; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Kurachi, Yoshihisa			Interactions of Cations with the Cytoplasmic Pores of Inward Rectifier K+ Channels in the Closed State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; ACTIVATION GATE; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; RECTIFICATION; MECHANISM; RESIDUES; KIR2.1; PIP2	Ion channels gate at membrane-embedded domains by changing their conformation along the ion conduction pathway. Inward rectifier K+ (Kir) channels possess a unique extramembrane cytoplasmic domain that extends this pathway. However, the relevance and contribution of this domain to ion permeation remain unclear. By qualitative x-ray crystallographic analysis, we found that the pore in the cytoplasmic domain of Kir3.2 binds cations in a valency-dependent manner and does not allow the displacement of Mg2+ by monovalent cations or spermine Electrophysiological analyses revealed that the cytoplasmic pore of Kir3.2 selectively binds positively charged molecules and has a higher affinity for Mg2+ when it has a low probability of being open. The selective blocking of chemical modification of the side chain of pore-facing residues by Mg2+ indicates that the mode of binding of Mg2+ is likely to be similar to that observed in the crystal structure. These results indicate that the Kir3.2 crystal structure has a closed conformation with a negative electrostatic field potential at the cytoplasmic pore, the potential of which may be controlled by conformational changes in the cytoplasmic domain to regulate ion diffusion along the pore.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Dept Pharmacol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Dept Pharmacol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science and Technology of Japan [22136002];  [23590301]; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grant-in-Aid for Scientific Research (C) 23590301.; Supported by Grant-in-Aid for Scientific Research on Innovative Areas 22136002 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo Y, 2002, J BIOL CHEM, V277, P48289, DOI 10.1074/jbc.M207987200; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hansen SG, 2011, NATURE; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A., 1999, J PHYSL, V521, P19; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Inanobe A, 2010, J BIOL CHEM, V285, P38517, DOI 10.1074/jbc.M110.161703; ITO H, 1991, J GEN PHYSIOL, V98, P517, DOI 10.1085/jgp.98.3.517; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Xie LH, 2004, J PHYSIOL-LONDON, V561, P159, DOI 10.1113/jphysiol.2004.072330; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; Yamashita T, 1996, J PHYSIOL-LONDON, V493, P143, DOI 10.1113/jphysiol.1996.sp021370; Yan DH, 2005, J PHYSIOL-LONDON, V563, P725, DOI 10.1113/jphysiol.2004.079186; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zeidner G, 2001, J BIOL CHEM, V276, P35564, DOI 10.1074/jbc.M105189200; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	53	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41801	41811		10.1074/jbc.M111.278531	http://dx.doi.org/10.1074/jbc.M111.278531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21982822	Green Published, hybrid			2022-12-25	WOS:000298057500063
J	Lee, M; Kang, Y; Suk, K; Schwab, C; Yu, S; McGeer, PL				Lee, Moonhee; Kang, Yunhee; Suk, Kyoungho; Schwab, Claudia; Yu, Sheng; McGeer, Patrick L.			Acidic Fibroblast Growth Factor (FGF) Potentiates Glial-mediated Neurotoxicity by Activating FGFR2 IIIb Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CELLS; ASTROCYTES; MECHANISMS; RECEPTORS; NEURONS; FAMILY	Previous studies indicate that astrocytes are the brain cells that express acidic fibroblast growth factor (aFGF) and that the expression is increased upon activation. However, there has been no study investigating the significance of this phenomenon. Here we report that aFGF treatment of IFN gamma-stimulated human astrocytes, and LPS/IFN gamma-stimulated human microglia, enhances their secretion of inflammatory cytokines and other materials toxic to human neuroblastoma SH-SY5Y cells. The mechanism of aFGF enhancement involves stimulation of the receptor FGFR2 IIIb. We show by RT-PCR that this receptor, but not other FGF receptors, is robustly expressed by astrocytes and microglia. We establish by Western blotting, and immunohistochemistry on postmortem human brain tissue that the FGFR2 IIIb protein is expressed by both of these glial cell types. We blocked the inflammatory stimulant action of aFGF by transfecting microglia and astrocytes with a small inhibitory RNA (siRNA) to FGFR2 IIIb as well as by removal of aFGF using an anti-aFGF antibody. Treatment with bFGF in combination with the stimulants was without effect, but together with aFGF, it partially counteracted the action of aFGF, indicating that it may be a weak antagonist of FGFR2 IIIb. The inflammatory effect was also attenuated by treatment with inhibitors of protein kinase C, Src tyrosine kinase, and MEK-1/2 indicating the involvement of these intracellular pathways. Our data suggest that inhibition of expression or release of aFGF could have therapeutic potential by inhibiting inflammation in neurodegenerative diseases such as Alzheimer disease where many neuroinflammatory molecules are prominently expressed.	[Lee, Moonhee; Schwab, Claudia; Yu, Sheng; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Kang, Yunhee] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 700422, South Korea	University of British Columbia; University of British Columbia; Kyungpook National University	McGeer, PL (corresponding author), 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	mcgeerpl@interchange.ubc.ca			Pacific Alzheimer Research Foundation	Pacific Alzheimer Research Foundation	This work was supported by the Pacific Alzheimer Research Foundation.	BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; CASPER D, 1994, J NEUROCHEM, V62, P2166; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Galzie Z, 1997, BIOCHEM CELL BIOL, V75, P669, DOI 10.1139/bcb-75-6-669; Hashioka S, 2009, NEUROBIOL AGING, V30, P1924, DOI 10.1016/j.neurobiolaging.2008.02.019; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Kim HJ, 2006, ACTA OTO-LARYNGOL, V126, P600, DOI 10.1080/00016480500452533; KIMURA H, 1994, TOHOKU J EXP MED, V174, P279, DOI 10.1620/tjem.174.279; Klegeris A, 2000, J LEUKOCYTE BIOL, V67, P127, DOI 10.1002/jlb.67.1.127; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; MATTSON MP, 1993, J NEUROSCI, V13, P4575; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; ZHAO XM, 1994, J CLIN INVEST, V94, P992, DOI 10.1172/JCI117466	21	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41230	41245		10.1074/jbc.M111.270470	http://dx.doi.org/10.1074/jbc.M111.270470			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990352	Green Published, hybrid			2022-12-25	WOS:000298057500011
J	Kapeller, K; Milman, N; Yaffe, N; Shlomai, J				Kapeller, Kit; Milman, Neta; Yaffe, Nurit; Shlomai, Joseph			Interactions of a Replication Initiator with Histone H1-like Proteins Remodel the Condensed Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL MINICIRCLE SEQUENCE; KINETOPLAST DNA-REPLICATION; ZINC-FINGER PROTEIN; BINDING-PROTEIN; CELL-GROWTH; ORIGIN; CHROMATIN; ORGANIZATION; TOPOISOMERASE; NUCLEOSOMES	Kinetoplast DNA (kDNA), the mitochondrial genome of trypanosomatids, consists of several thousand topologically interlocked DNA circles. Mitochondrial histone H1-like proteins were implicated in the condensation of kDNA into a nucleoid structure in the mitochondrial matrix. However, the mechanism that remodels kDNA, promoting its accessibility to the replication machinery, has not yet been described. Analyses, using yeast two hybrid system, co-immunoprecipitation, and protein-protein cross-linking, revealed specific protein-protein interactions between the kDNA replication initiator protein universal minicircle sequence-binding protein (UMSBP) and two mitochondrial histone H1-like proteins. Fluorescence and electron microscopy, as well as biochemical analyses, demonstrated that these protein-protein interactions result in the decondensation of kDNA. UMSBP-mediated decondensation rendered the kDNA network accessible to topological decatenation by topoisomerase II, yielding free kDNA minicircle monomers. Hence, UMSBP has the potential capacity to function in vivo in the activation of the prereplication release of minicircles from the network, a key step in kDNA replication, which precedes and enables its replication initiation. These observations demonstrate the prereplication remodeling of a condensed mitochondrial DNA, which is mediated via specific interactions of histone-like proteins with a replication initiator, rather than through their posttranslational covalent modifications.	[Kapeller, Kit; Milman, Neta; Yaffe, Nurit; Shlomai, Joseph] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,Inst Med Res Is, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Shlomai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,Inst Med Res Is, IL-91120 Jerusalem, Israel.	josephs@ekmd.huji.ac.il			United States-Israel Binational Science Foundation, Jerusalem, Israel [2005023]; Israel Science Foundation [54/06, 1127]	United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported by United States-Israel Binational Science Foundation, Jerusalem, Israel Grant 2005023 and by Israel Science Foundation Grants 54/06 and 1127.	ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; Abu-Elneel K, 1999, J BIOL CHEM, V274, P13419, DOI 10.1074/jbc.274.19.13419; Avliyakulov NK, 2004, EUKARYOT CELL, V3, P518, DOI 10.1128/EC.3.2.518-526.2004; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; ENGLUND PT, 1979, J BIOL CHEM, V254, P4895; HAJDUK SL, 1984, CELL, V36, P483, DOI 10.1016/0092-8674(84)90241-1; Hines JC, 2011, EUKARYOT CELL, V10, P445, DOI 10.1128/EC.00308-10; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lukes J, 2001, MOL BIOCHEM PARASIT, V117, P179, DOI 10.1016/S0166-6851(01)00348-6; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Sasaki N, 2003, MOL BIOL CELL, V14, P4758, DOI 10.1091/mbc.E03-02-0099; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; SAUCIER JM, 1981, BIOCHEM BIOPH RES CO, V101, P988, DOI 10.1016/0006-291X(81)91846-5; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sela D, 2008, J BIOL CHEM, V283, P32034, DOI 10.1074/jbc.M804417200; Sela D, 2009, NUCLEIC ACIDS RES, V37, P279, DOI 10.1093/nar/gkn927; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Studitsky VM, 2004, TRENDS BIOCHEM SCI, V29, P127, DOI 10.1016/j.tibs.2004.01.003; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Swindle CS, 1998, J VIROL, V72, P1994, DOI 10.1128/JVI.72.3.1994-2001.1998; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; TZFATI Y, 1992, P NATL ACAD SCI USA, V89, P6891, DOI 10.1073/pnas.89.15.6891; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Xu CW, 1996, MOL CELL BIOL, V16, P564; XU CX, 1993, P NATL ACAD SCI USA, V90, P1786, DOI 10.1073/pnas.90.5.1786	47	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40566	40574		10.1074/jbc.M111.270322	http://dx.doi.org/10.1074/jbc.M111.270322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984849	hybrid, Green Published			2022-12-25	WOS:000297315400016
J	Chiarelli, V; El Yagoubi, R; Mondini, S; Bisiacchi, P; Semenza, C				Chiarelli, Valentina; El Yagoubi, Radouane; Mondini, Sara; Bisiacchi, Patrizia; Semenza, Carlo			The Syntactic and Semantic Processing of Mass and Count Nouns: An ERP Study	PLOS ONE			English	Article							BRAIN POTENTIALS; MASS/COUNT INFORMATION; ALZHEIMERS-DISEASE; LEXICAL ACCESS; WORD; COMPREHENSION; CONCRETE; APHASIA; OBJECTS; ACTIVATION	The present study addressed the question of whether count and mass nouns are differentially processed in the brain. In two different ERP (Event-Related Potentials) tasks we explored the semantic and syntactic levels of such distinction. Mass and count nouns typically differ in concreteness, hence the effect of this important variable was factorially examined in each task. Thus the stimuli presented were: count concrete, count abstract, mass concrete or mass abstract. The first experiment (concrete/abstract semantic judgment task) involved the interaction between the N400 concreteness effect and the Mass/Count condition, revealing a substantial effect between mass and count nouns at the semantic level. The second experiment (sentence syntactic violation task) showed a Mass/Count distinction on left anterior negativity (LAN) and on P600 components, confirming the difference at the syntactic level. This study suggests that the brain differentiates between count and mass nouns not only at the syntactic level but also at the semantic level. Implications for our understanding of the brain mechanisms underlying the Mass/Count distinction are discussed.	[Chiarelli, Valentina] Univ Trieste, Dept Psychol, Trieste, Italy; [El Yagoubi, Radouane] Univ Toulouse 2, CNRS, Lab CLLE LTC, UMR 5263, Toulouse, France; [Mondini, Sara; Bisiacchi, Patrizia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Semenza, Carlo] Univ Padua, Dept Neurosci, Padua, Italy; [Semenza, Carlo] IRCCS Osped S Camillo, Lido Di Venezia, Italy; [Chiarelli, Valentina] Osped Civile, SOC Neurol, Gorizia, Italy	University of Trieste; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Bordeaux-Montaigne; University of Padua; University of Padua	Chiarelli, V (corresponding author), Univ Trieste, Dept Psychol, Trieste, Italy.	patrizia.bisiacchi@unipd.it		bisiacchi, patrizia/0000-0003-2760-8000; MONDINI, SARA/0000-0002-2144-9435	Ministero dell'Istruzione, dell'Universita e della Ricerca [prot. 200879EB93_002]; Bial Foundation [146/2008]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Bial Foundation(Bial Foundation)	PB and SM were funded by Ministero dell'Istruzione, dell'Universita e della Ricerca prot. 200879EB93_002. The study was partially supported by a grant of the Bial Foundation (146/2008) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barner D, 2005, COGNITION, V97, P41, DOI 10.1016/j.cognition.2004.06.009; Bentin S, 1985, ELECTROENCEPHALOGRAP, V60, P345; Bisiacchi P, 2005, BRAIN LANG, V95, P98, DOI 10.1016/j.bandl.2005.07.054; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Borgo F, 2003, COGN NEUROPSYCHOL, V20, P327, DOI 10.1080/02643290244000310; Bunt H, 2006, ENCY LANGUAGE LIGUIS, P5757; Burani C., 2001, GIORNALE ITALIANO PS, V4, P839, DOI DOI 10.1421/379; Chiang WC, 2000, COGNITION, V77, P169, DOI 10.1016/S0010-0277(00)00091-3; Chierchia G, 1998, STUD LINGUIST PHILOS, V70, P53; Coltheart M, 1980, DEEP DYSLEXIA, P326; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Gillon B, 1999, BRAIN LANG, V68, P205, DOI 10.1006/brln.1999.2081; GILLON BS, 1992, LINGUIST PHILOS, V15, P597, DOI 10.1007/BF00628112; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GROSSMAN M, 1995, NEUROLOGY, V45, P85, DOI 10.1212/WNL.45.1.85; GROSSMAN M, 1993, BRAIN LANG, V44, P351, DOI 10.1006/brln.1993.1022; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Huntley-Fenner G, 2002, COGNITION, V85, P203, DOI 10.1016/S0010-0277(02)00088-4; JACKENDOFF R, 1991, COGNITION, V41, P9, DOI 10.1016/0010-0277(91)90031-X; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KATZ RB, 1990, BRAIN LANG, V39, P153, DOI 10.1016/0093-934X(90)90009-6; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kovacevic N, 2007, NEUROIMAGE, V35, P1103, DOI 10.1016/j.neuroimage.2007.01.016; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; Laycock H, 2006, ENCY LANGUAGE LINGUI, P530; MACNAMARA J, 1994, LOGICAL FDN COGNITIO; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Mondini S, 2004, BRAIN LANG, V91, P138, DOI 10.1016/j.bandl.2004.06.072; Mondini S, 2008, NEUROSCI LETT, V430, P48, DOI 10.1016/j.neulet.2007.10.020; Mondini S, 2009, MENT LEX, V4, P354, DOI 10.1075/ml.4.3.03mon; Munte TF, 1997, J COGNITIVE NEUROSCI, V9, P318, DOI 10.1162/jocn.1997.9.3.318; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A, 1971, IMAGERY VERBAL PROCE; Pelletier F, 1979, MASS TERMS SOME PHIL; Prasada S, 2002, COGNITION, V83, P141, DOI 10.1016/S0010-0277(01)00173-1; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Rothstein S, 2010, J SEMANT, V27, P343, DOI 10.1093/jos/ffq007; Schneider W., 2002, E PRIME VERSION 20 C; SCHWANENFLUGEL PJ, 1991, PSYCHOLOGY OF WORD MEANINGS, P223; Semenza C, 1997, NEUROPSYCHOLOGIA, V35, P669, DOI 10.1016/S0028-3932(96)00124-8; Semenza C, 2000, BRAIN LANG, V74, P428; Semenza C, 2005, BRAIN LANG, V95, P88, DOI 10.1016/j.bandl.2005.07.049; Semenza C, 1999, MANUALE NEUROPSICOLO, P288; Semlitsch HV, 1986, PSYCHOPHYSIOLOGY, V20, P168; Shapiro K, 2003, TRENDS COGN SCI, V7, P201, DOI 10.1016/S1364-6613(03)00060-3; SHAPIRO LP, 1989, J SPEECH HEAR RES, V32, P481, DOI 10.1044/jshr.3203.481; SOJA NN, 1991, COGNITION, V38, P179, DOI 10.1016/0010-0277(91)90051-5; Steinhauer K, 2001, NEUROREPORT, V12, P999, DOI 10.1097/00001756-200104170-00027; Swaab TY, 2002, COGNITIVE BRAIN RES, V15, P99, DOI 10.1016/S0926-6410(02)00219-7; Taler V, 2006, J NEUROLINGUIST, V19, P38, DOI 10.1016/j.jneuroling.2005.07.002; Taler V, 2005, BRAIN LANG, V95, P92, DOI 10.1016/j.bandl.2005.07.051; Taler V, 2004, BRAIN LANG, V90, P262, DOI 10.1016/S0093-934X(03)00439-5; Thorton A, 1994, BASE DATI VOCABOLARI; van Berkum JJA, 1999, J MEM LANG, V41, P147, DOI 10.1006/jmla.1999.2641; Vigliocco G, 1999, J MEM LANG, V40, P534, DOI 10.1006/jmla.1998.2626; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Weyerts H, 1996, NEUROSCI LETT, V206, P125, DOI 10.1016/S0304-3940(96)12442-3; Zhang Q, 2006, BRAIN LANG, V96, P59, DOI 10.1016/j.bandl.2005.04.004	74	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25885	10.1371/journal.pone.0025885	http://dx.doi.org/10.1371/journal.pone.0025885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998715	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900068
J	Dalsgaard, B; Magard, E; Fjeldsa, J; Gonzalez, AMM; Rahbek, C; Olesen, JM; Ollerton, J; Alarcon, R; Araujo, AC; Cotton, PA; Lara, C; Machado, CG; Sazima, I; Sazima, M; Timmermann, A; Watts, S; Sandel, B; Sutherland, WJ; Svenning, JC				Dalsgaard, Bo; Magard, Else; Fjeldsa, Jon; Gonzalez, Ana M. Martin; Rahbek, Carsten; Olesen, Jens M.; Ollerton, Jeff; Alarcon, Ruben; Araujo, Andrea Cardoso; Cotton, Peter A.; Lara, Carlos; Machado, Caio Graco; Sazima, Ivan; Sazima, Marlies; Timmermann, Allan; Watts, Stella; Sandel, Brody; Sutherland, William J.; Svenning, Jens-Christian			Specialization in Plant-Hummingbird Networks Is Associated with Species Richness, Contemporary Precipitation and Quaternary Climate-Change Velocity	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; LATITUDINAL GRADIENT; POLLINATION NETWORKS; ECOLOGICAL NETWORKS; GEOGRAPHIC PATTERNS; BIRD; EVOLUTIONARY; DISTRIBUTIONS; COINCIDENCE; COEVOLUTION	Large-scale geographical patterns of biotic specialization and the underlying drivers are poorly understood, but it is widely believed that climate plays an important role in determining specialization. As climate-driven range dynamics should diminish local adaptations and favor generalization, one hypothesis is that contemporary biotic specialization is determined by the degree of past climatic instability, primarily Quaternary climate-change velocity. Other prominent hypotheses predict that either contemporary climate or species richness affect biotic specialization. To gain insight into geographical patterns of contemporary biotic specialization and its drivers, we use network analysis to determine the degree of specialization in plant-hummingbird mutualistic networks sampled at 31 localities, spanning a wide range of climate regimes across the Americas. We found greater biotic specialization at lower latitudes, with latitude explaining 20-22% of the spatial variation in plant-hummingbird specialization. Potential drivers of specialization - contemporary climate, Quaternary climate-change velocity, and species richness -had superior explanatory power, together explaining 53-64% of the variation in specialization. Notably, our data provides empirical evidence for the hypothesized roles of species richness, contemporary precipitation and Quaternary climate-change velocity as key predictors of biotic specialization, whereas contemporary temperature and seasonality seem unimportant in determining specialization. These results suggest that both ecological and evolutionary processes at Quaternary time scales can be important in driving large-scale geographical patterns of contemporary biotic specialization, at least for co-evolved systems such as plant-hummingbird networks.	[Dalsgaard, Bo; Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Dalsgaard, Bo; Rahbek, Carsten] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Dalsgaard, Bo; Olesen, Jens M.; Timmermann, Allan; Sandel, Brody; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Magard, Else; Sandel, Brody] Aarhus Univ, Dept Comp Sci, Ctr Mass Data Algorithm, DK-8000 Aarhus, Denmark; [Fjeldsa, Jon] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Gonzalez, Ana M. Martin] Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA USA; [Ollerton, Jeff; Watts, Stella] Univ Northampton, Sch Sci & Technol, Landscape & Biodivers Res Grp, Northampton, England; [Alarcon, Ruben] Calif State Univ, Biol Program, Camarillo, CA USA; [Araujo, Andrea Cardoso] Univ Fed Mato Grosso do Sul, Dept Biol, Campo Grande, Brazil; [Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Lara, Carlos] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Tlaxcala, Mexico; [Machado, Caio Graco] Univ Estadual Feira de Santana, Lab Ornitol, Dept Ciencias Biol, Feira De Santana, BA, Brazil; [Sazima, Ivan] Univ Estadual Campinas, Museu Zool, IB, Campinas, SP, Brazil; [Sazima, Marlies] Univ Estadual Campinas, IB, Dept Biol Vegetal, Campinias, Brazil; [Watts, Stella] Univ Haifa, Lab Pollinat Ecol, Inst Evolut, IL-31999 Haifa, Israel	University of Cambridge; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; University of Northampton; Universidade Federal de Mato Grosso do Sul; University of Plymouth; Universidade Estadual de Feira de Santana; Universidade Estadual de Campinas; Universidade Estadual de Campinas; University of Haifa	Dalsgaard, B (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge, England.	b.dalsgaard@zoo.cam.ac.uk	Fjeldså, Jon/A-9699-2013; Machado, Caio G./I-1400-2012; Rahbek, Carsten/D-9372-2013; Araujo, Andréa Cardoso/D-9439-2013; Olesen, Jens M/A-3011-2009; Sazima, Marlies/B-6973-2013; Svenning, Jens-Christian/C-8977-2012; Sandel, Brody/I-8009-2013; Rahbek, Carsten/L-1129-2013; Gonzalez, Ana M. Martin/A-7827-2010; Sutherland, William/B-1291-2013; Ollerton, Jeff/AAE-3946-2020; Ollerton, Jeff/I-3946-2012	Fjeldså, Jon/0000-0003-0790-3600; Machado, Caio G./0000-0002-8070-8601; Araujo, Andréa Cardoso/0000-0003-0394-2012; Olesen, Jens M/0000-0003-1998-1083; Svenning, Jens-Christian/0000-0002-3415-0862; Rahbek, Carsten/0000-0003-4585-0300; Gonzalez, Ana M. Martin/0000-0001-9429-7180; Ollerton, Jeff/0000-0002-0887-8235; Ollerton, Jeff/0000-0002-0887-8235; Olesen, Jes/0000-0002-6712-2702; Sutherland, William/0000-0002-6498-0437; Dalsgaard, Bo/0000-0003-2867-2805; Lara, Carlos/0000-0001-6037-0327; Cotton, Peter/0000-0002-4830-0868	Frimodt-Heineke Foundation; Augustinus Foundation; Knud Hojgaard Foundation; Aarhus University; Department of Zoology, University of Cambridge; The Danish Council for Independent Research verbar Natural Sciences; Center for Massive Data Algorithmics; Danish National Research Foundation Center of Excellence; Center for Macroecology, Evolution and Climate; Svend Fiedler & Wife Foundation; Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark; British Ecological Society; Idea Wild; The Biodiversity Trust; The Anglo Peruvian Society; The Leslie Church Bursary Fund; The United States National Science Foundation; The California Alliance for Minority Participation; The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP); The National Council for Scientific and Technological Development (CNPq); British Ornithologists' Union; Consejo Nacional de Ciencia y Tecnologia; FAPESB; Danish Council for Independent Research - Natural Sciences [272-07-0242]; World Wildlife Foundation; Novozymes; CEA; CNRS; EU [EVK2-CT-2002-00153]; Programme National d'Etude de la Dynamique du Climat (PNEDC)	Frimodt-Heineke Foundation; Augustinus Foundation; Knud Hojgaard Foundation; Aarhus University; Department of Zoology, University of Cambridge(University of Cambridge); The Danish Council for Independent Research verbar Natural Sciences; Center for Massive Data Algorithmics; Danish National Research Foundation Center of Excellence; Center for Macroecology, Evolution and Climate; Svend Fiedler & Wife Foundation; Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark; British Ecological Society; Idea Wild; The Biodiversity Trust; The Anglo Peruvian Society; The Leslie Church Bursary Fund; The United States National Science Foundation; The California Alliance for Minority Participation; The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP); The National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); British Ornithologists' Union; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); World Wildlife Foundation; Novozymes; CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); Programme National d'Etude de la Dynamique du Climat (PNEDC)	Funding for BD was supported by Frimodt-Heineke Foundation, Augustinus Foundation, Knud Hojgaard Foundation, a PhD fellowship by Aarhus University, Weis-Fogh Fund at Department of Zoology, University of Cambridge, and The Danish Council for Independent Research vertical bar Natural Sciences. EM was supported by the Center for Massive Data Algorithmics, a Danish National Research Foundation Center of Excellence. JF and CR thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution and Climate. AMG was supported by Svend Fiedler & Wife Foundation, J.Olesen by the Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark, J.Ollerton and SW by the British Ecological Society, Idea Wild, The Biodiversity Trust, The Anglo Peruvian Society and The Leslie Church Bursary Fund, RA by The United States National Science Foundation's Predoctoral Fellowship Program and The California Alliance for Minority Participation, ACA by The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP) and The National Council for Scientific and Technological Development (CNPq), PC by the British Ornithologists' Union, CL by the Consejo Nacional de Ciencia y Tecnologia, CM by FAPESB and CNPq, IS and MS by FAPESP and CNPq, AT by Aarhus University, and J-CS by the Danish Council for Independent Research - Natural Sciences (grant 272-07-0242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.Olesen was awarded a grant jointly by the World Wildlife Foundation and Novozymes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; Thanks to Nico Bluthgen and Thiago Fernando Rangel for their advice regarding calculation of specialization indices and the use of SAM, respectively. Thanks to Anders H Madsen for helping with the figures, to Silvana Buzato for providing data and insight, and to Anna Traveset, Christopher Kaiser-Bunbury and two anonymous reviewers providing useful comments improving the manuscript. The PMIP2 Data Archive is supported by CEA, CNRS, the EU project MOTIF (EVK2-CT-2002-00153) and the Programme National d'Etude de la Dynamique du Climat (PNEDC). The analysis was using version 05-26-2010 of the database. More information is available on http://pmip2.lsce.ipsl.fr/. RA thanks the US Forest Service and The Wildlands Conservancy and the Rocky Mountain Biological Laboratory for access to the field sites in CA and CO, respectively, and SW thanks the National Institute of Natural Resources (INRENA) for research permits (permit numbers: 008799 and 0001982) in Peru	Abrahamczyk S, 2010, J ORNITHOL, V151, P615, DOI 10.1007/s10336-010-0496-x; Aizen MA, 2003, TAXON, V52, P675, DOI 10.2307/3647342; Aizen Marcelo A., 1998, Ecologia Austral, V8, P217; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; [Anonymous], 2005, REV BRAS ZOOL, V22, P51, DOI 10.1590/S0101-81752005000100007; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Buzato S, 2000, BIOTROPICA, V32, P824, DOI 10.1111/j.1744-7429.2000.tb00621.x; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Cotton PA, 1998, IBIS, V140, P639, DOI 10.1111/j.1474-919X.1998.tb04709.x; CRUDEN RW, 1972, SCIENCE, V176, P1439, DOI 10.1126/science.176.4042.1439; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dalsgaard B, 2009, OECOLOGIA, V159, P757, DOI 10.1007/s00442-008-1255-z; Dobzhansky T., 1950, American Scientist, V38, P209; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; FEINSINGER P, 1978, AM ZOOL, V18, P779; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Gonzalez AMM, 2009, J TROP ECOL, V25, P493, DOI 10.1017/S0266467409990034; Memmott J, 2010, PHILOS T R SOC B, V365, P2071, DOI 10.1098/rstb.2010.0015; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ollerton J, 2002, OIKOS, V98, P340, DOI 10.1034/j.1600-0706.2002.980215.x; Ollerton J, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P283; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; SCHEMSKE DW, 2002, FDN TROPICAL FOREST, P163; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; STILES FG, 1981, ANN MO BOT GARD, V68, P323, DOI 10.2307/2398801; STILES FG, 1978, AM ZOOL, V18, P715; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2004, AM NAT, V164, pE1, DOI 10.1086/421445; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4	65	120	120	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25891	10.1371/journal.pone.0025891	http://dx.doi.org/10.1371/journal.pone.0025891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998716	Green Published, Green Accepted, gold			2022-12-25	WOS:000295966900069
J	Dong, C; Qin, L; Liu, YC; Zhang, XN; Sato, Y				Dong, Chao; Qin, Ling; Liu, Yongchun; Zhang, Xinan; Sato, Yu			Neural Responses in the Primary Auditory Cortex of Freely Behaving Cats While Discriminating Fast and Slow Click-Trains	PLOS ONE			English	Article							AMPLITUDE-MODULATED SOUNDS; CORTICAL DISCRIMINATION; SOMATOSENSORY CORTEX; TEMPORAL INFORMATION; ACOUSTIC FLUTTER; NATURAL SOUNDS; PATTERN CODES; PERIODICITY; PERCEPTION; STIMULI	Repeated acoustic events are ubiquitous temporal features of natural sounds. To reveal the neural representation of the sound repetition rate, a number of electrophysiological studies have been conducted on various mammals and it has been proposed that both the spike-time and firing rate of primary auditory cortex (A1) neurons encode the repetition rate. However, previous studies rarely examined how the experimental animals perceive the difference in the sound repetition rate, and a caveat to these experiments is that they compared physiological data obtained from animals with psychophysical data obtained from humans. In this study, for the first time, we directly investigated acoustic perception and the underlying neural mechanisms in the same experimental animal by examining spike activities in the A1 of free-moving cats while performing a Go/No-go task to discriminate the click-trains at different repetition rates (12.5-200 Hz). As reported by previous studies on passively listening animals, A1 neurons showed both synchronized and non-synchronized responses to the click-trains. We further found that the neural performance estimated from the precise temporal information of synchronized units was good enough to distinguish all 16.7-200 Hz from the 12.5 Hz repetition rate; however, the cats showed declining behavioral performance with the decrease of the target repetition rate, indicating an increase of difficulty in discriminating two slower click-trains. Such behavioral performance was well explained by the firing rate of some synchronized and non-synchronized units. Trial-by-trial analysis indicated that A1 activity was not affected by the cat's judgment of behavioral response. Our results suggest that the main function of A1 is to effectively represent temporal signals using both spike timing and firing rate, while the cats may read out the rate-coding information to perform the task in this experiment.	[Dong, Chao; Qin, Ling; Liu, Yongchun; Zhang, Xinan; Sato, Yu] Univ Yamanashi, Dept Physiol, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Dong, Chao] Inner Mongolia Med Coll, Clin Med Res Ctr, Hohhot, Peoples R China; [Qin, Ling] China Med Univ, Dept Physiol, Shenyang, Peoples R China	University of Yamanashi; Inner Mongolia Medical University; China Medical University	Dong, C (corresponding author), Univ Yamanashi, Dept Physiol, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	qinlingling@yahoo.com		zhang, xin an/0000-0002-7854-4134	Japan Ministry of Education, Culture, Sports, Science and Technology [08038015, 23700377]; National Nature Science Foundation of China [30970979]	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Strategic Research Program for Brain Sciences 08038015 and No. 23700377 from the Japan Ministry of Education, Culture, Sports, Science and Technology (Y.S. and L.Q.), and the National Nature Science Foundation of China under grant 30970979 (L.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Bieser A, 1996, EXP BRAIN RES, V108, P273; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Fritz JB, 2010, NAT NEUROSCI, V13, P1011, DOI 10.1038/nn.2598; Gaese BH, 2003, EUR J NEUROSCI, V18, P2638, DOI 10.1046/j.1460-9568.2003.03007.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Green DM, 1966, SIGNAL DETECTION THE; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Imaizumi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011531; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KAY RH, 1982, PHYSIOL REV, V62, P894, DOI 10.1152/physrev.1982.62.3.894; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Lemus L, 2009, P NATL ACAD SCI USA, V106, P9471, DOI 10.1073/pnas.0904066106; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu YC, 2010, BEHAV BRAIN RES, V215, P28, DOI 10.1016/j.bbr.2010.06.013; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Macmillan N. A., 1991, DETECTION THEORY USE; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mardia K. V., 2000, DIRECTIONAL STAT; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PHILLIPS DP, 1989, HEARING RES, V40, P137, DOI 10.1016/0378-5955(89)90107-X; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Qin L, 2009, J NEUROSCI, V29, P15650, DOI 10.1523/JNEUROSCI.2442-09.2009; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Walker KMM, 2008, J COGNITIVE NEUROSCI, V20, P135, DOI 10.1162/jocn.2008.20012; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010; Zhang XN, 2011, BEHAV BRAIN RES, V217, P315, DOI 10.1016/j.bbr.2010.10.034	51	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25895	10.1371/journal.pone.0025895	http://dx.doi.org/10.1371/journal.pone.0025895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998717	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900070
J	Fingelkurts, AA; Fingelkurts, AA; Bagnato, S; Boccagni, C; Galardi, G				Fingelkurts, Alexander A.; Fingelkurts, Andrew A.; Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe			Life or Death: Prognostic Value of a Resting EEG with Regards to Survival in Patients in Vegetative and Minimally Conscious States	PLOS ONE			English	Article							COMPRESSED SPECTRAL ARRAY; ELECTROENCEPHALOGRAPHY; VARIABILITY; FREQUENCIES; DISABILITY; RECOVERY; SCALE; COMA	Objective: To investigate the potentially prognostic value of a resting state electroencephalogram (EEG) with regards to the clinical outcome from vegetative and minimally conscious states (VS and MCS) in terms of survival six months after a brain injury. Methods: We quantified a dynamic repertoire of EEG oscillations in resting condition with eyes closed in patients in VS and MCS. The exact composition of EEG oscillations was assessed by analysing the probability-classification of short-term EEG spectral patterns. Results: Results demonstrated that (a) the diversity and the variability of EEG for Non-Survivors were significantly lower than for Survivors; and (b) a higher probability of mostly delta and slow-theta oscillations occurring either alone or in combination were found during the first assessment for patients with a bad outcome (i.e., those who died) within six months of an injury compared to patients who survived. At the same time, patients with a good outcome (i.e., those who survived) after six months post-injury had a higher probability of mostly fast-theta and alpha oscillations occurring either alone or in combination during the first assessment when compared to patients who died within six months of an injury. Conclusions: Resting state EEGs properly analysed may have a potentially prognostic value with regards to the outcome from VS or MCS in terms of survival six months after a brain injury. Significance: This work may have implications for clinical care, rehabilitative programmes and medical-legal decisions for patients with impaired consciousness states after being in a coma due to acute brain injuries.	[Fingelkurts, Alexander A.; Fingelkurts, Andrew A.] BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland; [Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Neurorehabil Unit, Rehabil Dept, Palermo, Italy; [Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Neurophysiol Unit, Palermo, Italy		Fingelkurts, AA (corresponding author), BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland.	alexander.fingelkurts@bm-science.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Boccagni, Cristina/0000-0002-6317-015X				Achimowicz JZ, 1992, EVALUATION PILOT PSY; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Basar E, 2010, BRAIN BODY MIND NEBU, P523; Bates D, 2003, CLIN MED, V3, P249; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Beridze M, 2010, Georgian Med News, P28; BIRMANNS B, 1990, J NEUROL SCI, V100, P22, DOI 10.1016/0022-510X(90)90007-A; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; CANT BR, 1984, NEUROLOGY, V34, P35, DOI 10.1212/WNL.34.1.35; CELESIA, 1993, ANN NEUROL, V33, P386; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Claus JJ, 1998, ARCH NEUROL-CHICAGO, V55, P1105, DOI 10.1001/archneur.55.8.1105; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; Da Silva F.H.L., 1996, COMPREHENSIVE HUMAN, VVolume 1, P509; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; Donnelly E.M., 2007, CLIN NEUROPHYSIOLOGY, P127; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Ferrer R, 2011, CRIT CARE CLIN, V27, P229, DOI 10.1016/j.ccc.2010.12.008; Fingelkurts AA, 2003, INT J PSYCHOPHYSIOL, V47, P23, DOI 10.1016/S0167-8760(02)00089-2; Fingelkurts Al A, 2010, Open Neuroimag J, V4, P130, DOI 10.2174/1874440001004010130; Fingelkurts AA, 2010, NEUROSCI RES, V68, P207, DOI 10.1016/j.neures.2010.07.2031; Freeman Walter J, 2003, J Integr Neurosci, V2, P3, DOI 10.1142/S0219635203000214; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gohberg I.C., 1969, INTRO THEORY LINEAR, P1; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 2002, VEGETATIVE STATE MED; Jennings J. R., 1991, HDB COGNITIVE PSYCHO; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; KANG DH, 1991, BEHAV NEUROSCI, V105, P860, DOI 10.1037/0735-7044.105.6.860; Kaplan A. Ya, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P35; LEVY WJ, 1987, ANESTHESIOLOGY, V66, P489, DOI 10.1097/00000542-198704000-00007; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Muller UA, 1993, 19930618 OLS ASS; Niedermeye E., 1999, ELECTROENCEPHALOGRAP, P149; Norris PR, 2009, ANN SURG, V250, P524, DOI [10.1097/SLA.0b013e181b8fb1f, 10.1097/SLA.0b013e3181b8fb1f]; Oransky I, 2003, LANCET NEUROL, V2, P715, DOI 10.1016/S1474-4422(03)00600-8; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PULVERMULLER F, 1995, NEUROREPORT, V6, P2059, DOI 10.1097/00001756-199510010-00025; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robinson PA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021903; Rodriguez G, 1996, ELECTROEN CLIN NEURO, V99, P123, DOI 10.1016/0013-4694(96)95723-5; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAPHIER D, 1990, YALE J BIOL MED, V63, P109; Sara M, 2008, BRIT J NUTR, P1, DOI DOI 10.1017/S0007114508116270; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Sironi VA, 1982, ADV NEUROTRAUMATOLOG, P328; SOININEN H, 1991, ELECTROEN CLIN NEURO, V79, P342, DOI 10.1016/0013-4694(91)90198-D; Ssang-Hee Seo, 2010, Convergence and Hybrid Information Technologies, P413; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; Thatcher RW., 2001, J NEUROTHER, V3, P1; Tirsch W., 1988, PROGR COMPUTER ASSIS, P109; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; WALKER B B, 1983, International Journal of Psychophysiology, V1, P65, DOI 10.1016/0167-8760(83)90025-9; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; WINSLADE WJ, 1998, CONFRONTING TRAUMATI; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; [No title captured]	72	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25967	10.1371/journal.pone.0025967	http://dx.doi.org/10.1371/journal.pone.0025967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998732	Green Published, gold			2022-12-25	WOS:000295966900082
J	Huang, CW; Chen, HY; Yen, MH; Chen, JJW; Young, TH; Cheng, JY				Huang, Ching-Wen; Chen, Huai-Yi; Yen, Meng-Hua; Chen, Jeremy J. W.; Young, Tai-Horng; Cheng, Ji-Yen			Gene Expression of Human Lung Cancer Cell Line CL1-5 in Response to a Direct Current Electric Field	PLOS ONE			English	Article							IN-VITRO; HUMAN KERATINOCYTES; ADHESION MOLECULES; DERMAL FIBROBLASTS; KINASE-ACTIVITY; TGF-BETA; MIGRATION; RECEPTOR; GROWTH; PROTEIN	Background: Electrotaxis is the movement of adherent living cells in response to a direct current (dc) electric field (EF) of physiological strength. Highly metastatic human lung cancer cells, CL1-5, exhibit directional migration and orientation under dcEFs. To understand the transcriptional response of CL1-5 cells to a dcEF, microarray analysis was performed in this study. Methodology/Principal Findings: A large electric-field chip (LEFC) was designed, fabricated, and used in this study. CL1-5 cells were treated with the EF strength of 0mV/mm (the control group) and 300mV/mm (the EF-treated group) for two hours. Signaling pathways involving the genes that expressed differently between the two groups were revealed. It was shown that the EF-regulated genes highly correlated to adherens junction, telomerase RNA component gene regulation, and tight junction. Some up-regulated genes such as ACVR1B and CTTN, and some down-regulated genes such as PTEN, are known to be positively and negatively correlated to cell migration, respectively. The protein-protein interactions of adherens junction-associated EF-regulated genes suggested that platelet-derived growth factor (PDGF) receptors and ephrin receptors may participate in sensing extracellular electrical stimuli. We further observed a high percentage of significantly regulated genes which encode cell membrane proteins, suggesting that dcEF may directly influence the activity of cell membrane proteins in signal transduction. Conclusions/Significance: In this study, some of the EF-regulated genes have been reported to be essential whereas others are novel for electrotaxis. Our result confirms that the regulation of gene expression is involved in the mechanism of electrotactic response.	[Huang, Ching-Wen; Yen, Meng-Hua; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Huang, Ching-Wen; Chen, Huai-Yi; Yen, Meng-Hua; Cheng, Ji-Yen] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Chen, Huai-Yi] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu, Taiwan; [Chen, Huai-Yi] Acad Sinica, TIGP, Nano Sci & Technol Program, Taipei, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci & Mol Biol, Taichung 40227, Taiwan; [Cheng, Ji-Yen] Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Tsing Hua University; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan Ocean University; National Yang Ming Chiao Tung University	Huang, CW (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jycheng@gate.sinica.edu.tw	Cheng, Ji-Yen/D-7272-2011	Cheng, Ji-Yen/0000-0001-7623-7555; Chen, Jeremy J.W./0000-0003-1049-3825; Huang, Ching-Wen/0000-0001-9233-3002	National Science Council of Taiwan [98-2113-M-001-013-MY2, 100-2113-M-001-014-MY3]; National Taiwan University; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Academia Sinica(Academia Sinica - Taiwan)	This work is partially funded by National Science Council of Taiwan (http://web1.nsc.gov.tw/) (Contract no. 98-2113-M-001-013-MY2 and 100-2113-M-001 -014 -MY3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. Hsieh-Fu Tsai and Shih-Wei Peng for the assistance in chip fabrication and data analysis, respectively. We thank the Microarray Core of Institute of NTU Center for Genomic Medicine, supported by National Taiwan University, for performing the Affymetrix GeneChip assay. We also thank the Affymetrix Gene Expression Service Lab (http://ipmb.sinica.edu.tw/affy/), supported by Academia Sinica, for performing the Affymetrix GeneChip assay. We thank Dr. Tzu-Hung Hsiao of Institute of Biomedical Sciences, Academia Sinica, for the data analysis of membrane protein percentage.	Avrov K, 2003, EXP CELL RES, V291, P426, DOI 10.1016/j.yexcr.2003.08.001; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Cheng JY, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2952290; Cheng JY, 2004, SENSOR ACTUAT B-CHEM, V99, P186, DOI 10.1016/j.snb.2003.10.022; Chiarugi P, 1996, BIOCHEM BIOPH RES CO, V219, P21, DOI 10.1006/bbrc.1996.0174; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cuzick J, 1998, LANCET, V352, P359, DOI 10.1016/S0140-6736(97)10002-2; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; GRIEPP EB, 1983, J CELL BIOL, V96, P693, DOI 10.1083/jcb.96.3.693; GRULER H, 1991, CELL MOTIL CYTOSKEL, V19, P121, DOI 10.1002/cm.970190207; Hammerick KE, 2010, BIOCHEM BIOPH RES CO, V397, P12, DOI 10.1016/j.bbrc.2010.05.003; Hart FX, 2008, BIOELECTROMAGNETICS, V29, P447, DOI 10.1002/bem.20411; Hock B, 1998, ONCOGENE, V17, P255, DOI 10.1038/sj.onc.1201907; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Huang CW, 2009, BIOSENS BIOELECTRON, V24, P3510, DOI 10.1016/j.bios.2009.05.001; Huang HD, 2006, J CELL PHYSIOL, V209, P122, DOI 10.1002/jcp.20712; Ito H, 1998, CLIN CANCER RES, V4, P1603; Jennings J, 2008, BIOELECTROMAGNETICS, V29, P394, DOI 10.1002/bem.20408; Jennings JA, 2010, ARCH DERMATOL RES, V302, P211, DOI 10.1007/s00403-009-0995-x; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Kaur S, 2010, ARTERIOSCLEROSIS THR; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Lawrence DA, 2001, MOL CELL BIOCHEM, V219, P163, DOI 10.1023/A:1010819716023; Lewin B, 2010, ANTICANCER RES, V30, P2591; Liu CC, 2006, NUCLEIC ACIDS RES, V34, pW571, DOI 10.1093/nar/gkl279; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mruk DD, 2009, BIOL REPROD, V80, P590, DOI 10.1095/biolreprod.108.071647; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2011, PHYSL BIOELECTRICITY, V1, P1; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Pu J, 2005, J CELL SCI, V118, P1117, DOI 10.1242/jcs.01646; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Pullar CE, 2001, CELL MOTIL CYTOSKEL, V50, P207, DOI 10.1002/cm.10009; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Schulz WA, 2010, BMC CANCER, V10, P9; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Sillman AL, 2003, EXP DERMATOL, V12, P396, DOI 10.1034/j.1600-0625.2002.120406.x; Simon DP, 2009, NEOPLASIA, V11, P365, DOI 10.1593/neo.81544; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Szatkowski M, 2000, BJU INT, V86, P1068, DOI 10.1046/j.1464-410x.2000.00889.x; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TWAMLEY GM, 1992, ONCOGENE, V7, P1893; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Wang CC, 2007, BIOMATERIALS, V28, P625, DOI 10.1016/j.biomaterials.2006.09.025; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Yan XL, 2009, BIOELECTROMAGNETICS, V30, P29, DOI 10.1002/bem.20436; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	71	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25928	10.1371/journal.pone.0025928	http://dx.doi.org/10.1371/journal.pone.0025928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998723	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900075
J	Manrao, EA; Derrington, IM; Pavlenok, M; Niederweis, M; Gundlach, JH				Manrao, Elizabeth A.; Derrington, Ian M.; Pavlenok, Mikhail; Niederweis, Michael; Gundlach, Jens H.			Nucleotide Discrimination with DNA Immobilized in the MspA Nanopore	PLOS ONE			English	Article							PROTEIN NANOPORE; POLYNUCLEOTIDE MOLECULES; ELECTRONIC CONTROL; MEMBRANE CHANNEL; PROSTATE-CANCER; POLYMERASE; METHYLATION; REPLICATION; ASSOCIATION; CHALLENGES	Nanopore sequencing has the potential to become a fast and low-cost DNA sequencing platform. An ionic current passing through a small pore would directly map the sequence of single stranded DNA (ssDNA) driven through the constriction. The pore protein, MspA, derived from Mycobacterium smegmatis, has a short and narrow channel constriction ideally suited for nanopore sequencing. To study MspA's ability to resolve nucleotides, we held ssDNA within the pore using a biotin-NeutrAvidin complex. We show that homopolymers of adenine, cytosine, thymine, and guanine in MspA exhibit much larger current differences than in alpha-hemolysin. Additionally, methylated cytosine is distinguishable from unmethylated cytosine. We establish that single nucleotide substitutions within homopolymer ssDNA can be detected when held in MspA's constriction. Using genomic single nucleotide polymorphisms, we demonstrate that single nucleotides within random DNA can be identified. Our results indicate that MspA has high signal-to-noise ratio and the single nucleotide sensitivity desired for nanopore sequencing devices.	[Manrao, Elizabeth A.; Derrington, Ian M.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Pavlenok, Mikhail; Niederweis, Michael] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Manrao, EA (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Niederweis, Michael/0000-0003-4068-8092; Gundlach, Jens Horst/0000-0002-0773-8038	National Institutes of Health, National Human Genome Research Institute [5R21HG004145, R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115, R21HG004145] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health, National Human Genome Research Institute $1000 Genome Program Grant 5R21HG004145 and R01HG005115 (http://www.genome.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Mitchell N, 2008, ANGEW CHEM INT EDIT, V47, P5565, DOI 10.1002/anie.200800183; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Purnell RF, 2008, NANO LETT, V8, P3029, DOI 10.1021/nl802312f; Purnell RF, 2009, ACS NANO, V3, P2533, DOI 10.1021/nn900441x; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	29	115	148	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25723	10.1371/journal.pone.0025723	http://dx.doi.org/10.1371/journal.pone.0025723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991340	Green Submitted, Green Published, gold			2022-12-25	WOS:000295963300019
J	Pan, LT; Wu, X; Zhao, D; Hessari, NM; Lee, I; Zhang, XZ; Xu, JJ				Pan, Leiting; Wu, Xian; Zhao, Dan; Hessari, Nason Ma'ani; Lee, Imshik; Zhang, Xinzheng; Xu, Jingjun			Sulfhydryl Modification Induces Calcium Entry through IP3-Sensitive Store-Operated Pathway in Activation-Dependent Human Neutrophils	PLOS ONE			English	Article							2-AMINOETHOXYDIPHENYL BORATE 2-APB; INOSITOL TRISPHOSPHATE RECEPTOR; STIMULATES CA2+ ENTRY; PROTEIN-KINASE-C; S-NITROSYLATION; RESPIRATORY BURST; NITRIC-OXIDE; N-ETHYLMALEIMIDE; RELEASE; INFLUX	As the first line of host defense, neutrophils are stimulated by pro-inflammatory cytokines from resting state, facilitating the execution of immunomodulatory functions in activation state. Sulfhydryl modification has a regulatory role in a wide variety of physiological functions through mediation of signaling transductions in various cell types. Recent research suggested that two kinds of sulfhydryl modification, S-nitrosylation by exogenous nitric oxide (NO) and alkylation by N-ethylmaleimide (NEM), could induce calcium entry through a non-store-operated pathway in resting rat neutrophils and DDT1MF-2 cells, while in active human neutrophils a different process has been observed by us. In the present work, data showed that NEM induced a sharp rising of cytosolic calcium concentration ([Ca2+](c)) without external calcium, followed by a second [Ca2+](c) increase with readdition of external calcium in phorbol 12-myristate 13-acetate (PMA)-activated human neutrophils. Meanwhile, addition of external calcium did not cause [Ca2+](c) change of Ca2+-free PMA-activated neutrophils before application of NEM. These data indicated that NEM could induce believable store-operated calcium entry (SOCE) in PMA-activated neutrophils. Besides, we found that sodium nitroprusside (SNP), a donor of exogenous NO, resulted in believable SOCE in PMA-activated human neutrophils via S-nitrosylation modification. In contrast, NEM and SNP have no effect on [Ca2+](c) of resting neutrophils which were performed in suspension. Furthermore, 2-Aminoethoxydiphenyl borate, a reliable blocker of SOCE and an inhibitor of inositol 1,4,5-trisphosphate (IP3) receptor, evidently abolished SNP and NEM-induced calcium entry at 75 mu M, while preventing calcium release in a concentration-dependent manner. Considered together, these results demonstrated that NEM and SNP induced calcium entry through an IP3-sensitive store-operated pathway of human neutrophils via sulfhydryl modification in a PMA-induced activation-dependent manner.	[Pan, Leiting] Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, TEDA Appl Phys Sch, Tianjin 300071, Peoples R China; Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Pan, LT (corresponding author), Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, TEDA Appl Phys Sch, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn	Pan, Leiting/F-5001-2010; Lee, Imshik/G-6129-2010; xu, jing/GRR-8698-2022; Zhang, Xinzheng/C-5703-2009; Jingjun, Xu/A-1282-2010	Lee, Imshik/0000-0002-0098-392X; Zhang, Xinzheng/0000-0001-8128-3273; Maani, Nason/0000-0002-3398-0688	Fundamental Research Funds for the Central Universities [65010861]; National Basic Research Program of China [2007CB307002, 2010CB934101]; 111 Project [B07013]; National Natural Science Foundation of China [11074133]; Oversea Famous Teacher Project [MS2010NKDX023]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oversea Famous Teacher Project	This work was supported by the Fundamental Research Funds for the Central Universities (No. 65010861), the National Basic Research Program of China (Nos. 2007CB307002, 2010CB934101), 111 Project (No. B07013) and National Natural Science Foundation of China (No. 11074133), Oversea Famous Teacher Project (No. MS2010NKDX023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1997, CLIN EXP IMMUNOL, V110, P132, DOI 10.1046/j.1365-2249.1997.5051403.x; Anderson R, 2005, BIOCHEM PHARMACOL, V69, P1567, DOI 10.1016/j.bcp.2005.03.004; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Berton G, 1996, INT J CLIN LAB RES, V26, P160, DOI 10.1007/BF02592978; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; DIVIRGILIO F, 1984, NATURE, V310, P691, DOI 10.1038/310691a0; DIVIRGILIO F, 1985, BIOCHEM J, V229, P361, DOI 10.1042/bj2290361; Favre CJ, 1998, J BIOL CHEM, V273, P30855, DOI 10.1074/jbc.273.47.30855; FODER B, 1989, CELL CALCIUM, V10, P477, DOI 10.1016/0143-4160(89)90025-0; FRYER MW, 1992, NEUROSCI LETT, V146, P84, DOI 10.1016/0304-3940(92)90178-A; Gibon J, 2010, CELL CALCIUM, V48, P37, DOI 10.1016/j.ceca.2010.06.004; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hsu MF, 2006, EUR J PHARMACOL, V535, P43, DOI 10.1016/j.ejphar.2006.02.013; Hsu MF, 2005, BIOCHEM PHARMACOL, V70, P1320, DOI 10.1016/j.bcp.2005.07.029; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Klink M, 2009, IMMUNOBIOLOGY, V214, P692, DOI 10.1016/j.imbio.2008.12.001; LEW DP, 1989, EUR J CLIN INVEST, V19, P338, DOI 10.1111/j.1365-2362.1989.tb00240.x; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 1999, J BIOL CHEM, V274, P35318, DOI 10.1074/jbc.274.50.35318; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; MONTERO M, 1993, J BIOL CHEM, V268, P13055; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pan LT, 2008, BIOCHEM BIOPH RES CO, V377, P1320, DOI 10.1016/j.bbrc.2008.11.001; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Petty HR, 2000, PHYS REV LETT, V84, P2754, DOI 10.1103/PhysRevLett.84.2754; Petty HR, 2001, P NATL ACAD SCI USA, V98, P3145, DOI 10.1073/pnas.061014298; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; SAVAGE COS, 1992, AM J PATHOL, V141, P335; SEEDS MC, 1985, BLOOD, V65, P233; SHAAFI RI, 1983, BIOCHEM BIOPH RES CO, V114, P638, DOI 10.1016/0006-291X(83)90828-8; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Smith RJ, 1996, J PHARMACOL EXP THER, V278, P320; Smyth DG, 1960, J AM CHEM SOC, V82, P4600, DOI 10.1021/ja01502a039; Soulsby MD, 2002, CELL CALCIUM, V32, P175, DOI 10.1016/S0143416002001525; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; TAUBER AI, 1987, BLOOD, V69, P711; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wang JP, 2003, EUR J PHARMACOL, V458, P243, DOI 10.1016/S0014-2999(02)02790-5; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; YULE DI, 1992, J BIOL CHEM, V267, P13830	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25262	10.1371/journal.pone.0025262	http://dx.doi.org/10.1371/journal.pone.0025262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984909	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000020
J	Facey, PD; Sevcikova, B; Novakova, R; Hitchings, MD; Crack, JC; Kormanec, J; Dyson, PJ; Del Sol, R				Facey, Paul D.; Sevcikova, Beatrica; Novakova, Renata; Hitchings, Matthew D.; Crack, Jason C.; Kormanec, Jan; Dyson, Paul J.; Del Sol, Ricardo			The dpsA Gene of Streptomyces coelicolor: Induction of Expression from a Single Promoter in Response to Environmental Stress or during Development	PLOS ONE			English	Article							SIGMA-FACTOR SIGMA(H); ESCHERICHIA-COLI; ANTIBIOTIC PRODUCTION; BACILLUS-SUBTILIS; NITRIC-OXIDE; A3(2); IDENTIFICATION; DIFFERENTIATION; TRANSCRIPTION; PROTEIN	The DpsA protein plays a dual role in Streptomyces coelicolor, both as part of the stress response and contributing to nucleoid condensation during sporulation. Promoter mapping experiments indicated that dpsA is transcribed from a single, sigB-like dependent promoter. Expression studies implicate SigH and SigB as the sigma factors responsible for dpsA expression while the contribution of other SigB-like factors is indirect by means of controlling sigH expression. The promoter is massively induced in response to osmotic stress, in part due to its sensitivity to changes in DNA supercoiling. In addition, we determined that WhiB is required for dpsA expression, particularly during development. Gel retardation experiments revealed direct interaction between apoWhiB and the dpsA promoter region, providing the first evidence for a direct WhiB target in S. coelicolor.	[Facey, Paul D.; Hitchings, Matthew D.; Dyson, Paul J.; Del Sol, Ricardo] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Sevcikova, Beatrica; Novakova, Renata; Kormanec, Jan] Slovak Acad Sci, Inst Mol Biol, Bratislava 84251, Slovakia; [Crack, Jason C.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	Swansea University; Slovak Academy of Sciences; University of East Anglia	Facey, PD (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	e.r.abascal@swansea.ac.uk	Facey, Paul/AAK-3265-2021; Kormanec, Jan/AAA-7446-2019; Del Sol, Ricardo/L-3171-2015; Dyson, Paul/S-7312-2019	Del Sol, Ricardo/0000-0003-0015-3843; Facey, Paul/0000-0002-3229-0255; Kormanec, Jan/0000-0003-0377-6413; Dyson, Paul/0000-0002-0558-2666; Hitchings, Matthew/0000-0002-5527-4709; Crack, Jason C./0000-0002-4979-1910	Slovak Academy of Sciences [2/0104/09]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E019242/1] Funding Source: researchfish; BBSRC [BB/E019242/1] Funding Source: UKRI	Slovak Academy of Sciences(Slovak Academy of Sciences); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a VEGA grant 2/0104/09 from Slovak Academy of Sciences. MDH is supported by a Biotechnology and Biological Sciences Research Council Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Cho YH, 2001, MOL MICROBIOL, V42, P205, DOI 10.1046/j.1365-2958.2001.02622.x; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; Dalton KA, 2007, MOL MICROBIOL, V64, P719, DOI 10.1111/j.1365-2958.2007.05684.x; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fernandez-Martinez L, 2009, MOL MICROBIOL, V71, P1250, DOI 10.1111/j.1365-2958.2009.06599.x; Flardh K, 1999, MICROBIOL-SGM, V145, P2229, DOI 10.1099/00221287-145-9-2229; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Karoonuthaisiri N, 2005, GENE, V353, P53, DOI 10.1016/j.gene.2005.03.042; Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998; Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kormanec J, 2002, BBA-GENE STRUCT EXPR, V1577, P149, DOI 10.1016/S0167-4781(02)00409-8; Kormanec J, 2002, MOL GENET GENOMICS, V267, P536, DOI 10.1007/200438-002-0687-0; Kormanec J, 2000, FEMS MICROBIOL LETT, V189, P31, DOI 10.1111/j.1574-6968.2000.tb09202.x; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Lee EJ, 2004, J MICROBIOL, V42, P147; Mao XM, 2009, J BACTERIOL, V191, P6473, DOI 10.1128/JB.00875-09; Maxam A M, 1980, Methods Enzymol, V65, P499; Mazurakova V, 2006, ARCH MICROBIOL, V186, P435, DOI 10.1007/s00203-006-0158-9; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sevcikova B, 2001, ARCH MICROBIOL, V177, P98, DOI 10.1007/s00203-001-0367-1; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; SOLIVERI J, 1992, J BACTERIOL, V174, P6215, DOI 10.1128/JB.174.19.6215-6220.1992; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25593	10.1371/journal.pone.0025593	http://dx.doi.org/10.1371/journal.pone.0025593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984935	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300045
J	Hollister, JW; Milstead, WB; Urrutia, MA				Hollister, Jeffrey W.; Milstead, W. Bryan; Urrutia, M. Andrea			Predicting Maximum Lake Depth from Surrounding Topography	PLOS ONE			English	Article							MODELS	Information about lake morphometry (e. g., depth, volume, size, etc.) aids understanding of the physical and ecological dynamics of lakes, yet is often not readily available. The data needed to calculate measures of lake morphometry, particularly lake depth, are usually collected on a lake-by-lake basis and are difficult to obtain across broad regions. To span the gap between studies of individual lakes where detailed data exist and regional studies where access to useful data on lake depth is unavailable, we developed a method to predict maximum lake depth from the slope of the topography surrounding a lake. We use the National Elevation Dataset and the National Hydrography Dataset - Plus to estimate the percent slope of surrounding lakes and use this information to predict maximum lake depth. We also use field measured maximum lake depths from the US EPA's National Lakes Assessment to empirically adjust and cross-validate our predictions. We were able to predict maximum depth for similar to 28,000 lakes in the Northeastern United States with an average cross-validated RMSE of 5.95 m and 5.09 m and average correlation of 0.82 and 0.69 for Hydrological Unit Code Regions 01 and 02, respectively. The depth predictions and the scripts are openly available as supplements to this manuscript.	[Hollister, Jeffrey W.; Milstead, W. Bryan] US EPA, Off Res & Dev, Atlantic Ecol Div, Narragansett, RI USA; [Urrutia, M. Andrea] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	United States Environmental Protection Agency; University of Rhode Island	Hollister, JW (corresponding author), US EPA, Off Res & Dev, Atlantic Ecol Div, Narragansett, RI USA.	hollister.jeff@epa.gov	Hollister, Jeffrey/J-9920-2013	Hollister, Jeffrey/0000-0002-9254-9740	United States Environmental Protection Agency	United States Environmental Protection Agency(United States Environmental Protection Agency)	The research described in this paper has been funded by the United States Environmental Protection Agency. This paper has not been subjected to Agency review. Therefore, it does not necessarily reflect the views of the Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This is contribution number AED-11-013 of the Atlantic Ecology Division, Office of Research and Development, National Health and Environmental Effects Research Laboratory. The funding agency employs Dr. Hollister and Dr. Milstead, but beyond salary support for the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Carrara A, 1997, INT J GEOGR INF SCI, V11, P451, DOI 10.1080/136588197242257; Chaplot V, 2006, GEOMORPHOLOGY, V77, P126, DOI 10.1016/j.geomorph.2005.12.010; *ENV SYST RES INC, 2011, ARCGIS 10 0 ENV SYST; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Gesch D, 2009, NATL MAP ELEVATION; Hamilton L. C., 1992, REGRESSION GRAPHICS; Hollister J, 2010, LAKE RESERV MANAGE, V26, P194, DOI 10.1080/07438141.2010.504321; Hutchinson GE, 1957, TREATISE LIMNOLOGY, P1015; Kalff J, 2002, LIMNOLOGY INLAND WAT; Moore RB, 2011, J AM WATER RESOUR AS, V47, P965, DOI 10.1111/j.1752-1688.2011.00582.x; R Development Core Team, 2009, R FDN STAT COMP; Shary P.A., 2008, ADV DIGITAL TERRAIN; Smith RA, 1997, WATER RESOUR RES, V33, P2781, DOI 10.1029/97WR02171; U.S. ENVIRONMENTAL PROTECTION AGENCY, 2009, 841R09001 US EPA OFF; *US EPA, 2009, EPA600R09091 US EPA	17	43	44	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25764	10.1371/journal.pone.0025764	http://dx.doi.org/10.1371/journal.pone.0025764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984945	Green Published, Green Submitted, gold			2022-12-25	WOS:000295941300055
J	Stamataki, Z; Tilakaratne, S; Adams, DH; McKeating, JA				Stamataki, Zania; Tilakaratne, Samantha; Adams, David H.; McKeating, Jane A.			Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity	PLOS ONE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; CULTURE; LYMPHOCYTES; MECHANISMS; LYMPHOMA	Hepatitis C virus (HCV) infected patients with vasculitis are often treated with the B-cell-depleting anti-CD20 antibody rituximab. Treatment reduces the cryoglobulins that cause vasculitis, yet it also leads to a transient increase in liver enzymes and HCV genomic RNA in the periphery. The mechanism underlying the increased viral load is unclear and both direct and indirect roles have been proposed for B cells in HCV infection. We previously reported that HCV can associate with B cells and can trans-infect hepatocytes. We established an in vitro assay to study the effect(s) of rituximab on B cell-associated HCV infectivity. Rituximab-mediated lysis of B cells in vitro increases the level of infectious HCV released from B cells. Our results, using a model where virus does not replicate in B cells, recapitulate observations seen in patients and may explain in part the rapid increase in blood HCV RNA observed after rituximab treatment.	[Stamataki, Zania; Tilakaratne, Samantha; Adams, David H.; McKeating, Jane A.] Univ Birmingham, Ctr Immune Regulat, MRC, Birmingham, W Midlands, England; [Stamataki, Zania; Adams, David H.] Univ Birmingham, Natl Inst Hlth Res, Biomed Res Unit, Birmingham, W Midlands, England; [Stamataki, Zania; Adams, David H.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Stamataki, Z (corresponding author), Univ Birmingham, Ctr Immune Regulat, MRC, Birmingham, W Midlands, England.	z.stamataki@bham.ac.uk	Adams, David H/C-9092-2009; Stamataki, Zania/P-4681-2019; Stamataki, Zania/H-6541-2011	Adams, David H/0000-0001-6776-0336; Stamataki, Zania/0000-0003-3823-4497; McKeating, Jane/0000-0002-7229-5886	Medical Research Council, United Kingdom [G0400802]; National Institute for Health Research Biomedical Research Unit for the study of Liver Disease; Wellcome Trust; Medical Research Council [G9818340B, G0801976, G0400802] Funding Source: researchfish; MRC [G0801976, G0400802] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Unit for the study of Liver Disease; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council, United Kingdom (no. G0400802). ZS is currently funded by a Research Fellowship from the National Institute for Health Research Biomedical Research Unit for the study of Liver Disease. Funding from the Wellcome Trust to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cragg MS, 2004, BLOOD, V103, P2738, DOI 10.1182/blood-2003-06-2031; Galossi A, 2007, J GASTROINTEST LIVER, V16, P65; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; HOOFNAGLE JH, 1997, HEPATOLOGY, V26, P20; Lake-Bakaar G, 2007, BLOOD, V109, P845, DOI 10.1182/blood-2006-08-041525; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maloney DG, 1997, J CLIN ONCOL, V15, P3266, DOI 10.1200/JCO.1997.15.10.3266; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Sansonno D, 2003, BLOOD, V101, P3818, DOI 10.1182/blood-2002-10-3162; Stamataki Z, 2010, EXPERT REV ANTI-INFE, V8, P977, DOI 10.1586/ERI.10.86; Stamataki Z, 2009, BLOOD, V113, P585, DOI 10.1182/blood-2008-05-158824; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25789	10.1371/journal.pone.0025789	http://dx.doi.org/10.1371/journal.pone.0025789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21991396	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300060
J	Wang, LY; Kung, HJ				Wang, L-Y; Kung, H-J			Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/C-CDH1	ONCOGENE			English	Article						APC/C complex; CDH1/FZR1; MAK; mitosis; prostate cancer	ANAPHASE-PROMOTING COMPLEX; CHROMOSOMAL INSTABILITY; CENTROSOME AMPLIFICATION; PHOSPHORYLATION SITES; GENOMIC INSTABILITY; ANDROGEN RECEPTOR; PHOSPHATASE CDC14; ACTIVATING KINASE; MECHANISM; CDH1	Male germ cell-associated kinase (MAK), a direct transcriptional target of androgen receptor (AR), is a co-activator of AR. In this study, we determined the activating mechanism of MAK and identified a previously unknown AR-independent role of MAK in mitosis. We found that MAK kinase activity requires dual phosphorylation of the conserved TDY motif and that the phosphorylation is dynamic during cell cycle. MAK associates with CDH1 (FZR1, fizzy/cell division cycle 20 related 1) and phosphorylates CDH1 at sites phosphorylated by cyclin-dependent kinases. When MAK is overexpressed, the binding of CDH1 to anaphase promoting complex/cyclosome decreased, resulting in an attenuation of anaphase-promoting complex/C ubiquitin ligase activity and the consequential stabilization of the CDH1 targets such as Aurora kinase A and Polo-like kinase 1. As such, overexpression of MAK leads to mitotic defects such as centrosome amplification and lagging chromosomes. Our immunohistochemistry result showed that MAK is overexpressed in prostate tumor tissues, suggesting a role of MAK in prostate carcinogenesis. Taken with our previous results, our data implicate MAK in both AR activation and chromosomal instability, acting in both early and late prostate cancer development.	[Kung, H-J] Univ Calif Davis, Ctr Canc, Dept Biochem & Mol Med, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Kung, HJ (corresponding author), Univ Calif Davis, Ctr Canc, Dept Biochem & Mol Med, Sch Med, UCDMC Res 3,95 Room 2400B,4645 2nd Ave, Sacramento, CA 95817 USA.	hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Wang, Ling-Yu/0000-0002-1413-817X	NCI NIH HHS [R01 CA150197, CA150197] Funding Source: Medline; NIDDK NIH HHS [R01 DK052659, R01 DK078243, DK078243, DK526529] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA150197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078243, R01DK052659] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beheshti B, 2001, NEOPLASIA, V3, P62, DOI 10.1038/sj.neo.7900125; Bolte M, 2002, P NATL ACAD SCI USA, V99, P4385, DOI 10.1073/pnas.072385099; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GIBAS Z, 1984, CANCER GENET CYTOGEN, V11, P399, DOI 10.1016/0165-4608(84)90020-7; Gregory CW, 2001, CANCER RES, V61, P4315; Holt LJ, 2007, MOL CELL, V25, P689, DOI 10.1016/j.molcel.2007.02.012; Honigberg SM, 2004, J CELL BIOCHEM, V92, P1025, DOI 10.1002/jcb.20131; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; KOJI T, 1992, CELL BIOCHEM FUNCT, V10, P273, DOI 10.1002/cbf.290100411; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Ouyang XS, 2001, BBA-MOL CELL RES, V1541, P212, DOI 10.1016/S0167-4889(01)00157-4; Pan Y, 1999, CYTOGENET CELL GENET, V87, P225, DOI 10.1159/000015432; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Pihan GA, 2001, CANCER RES, V61, P2212; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Roh M, 2003, CANCER RES, V63, P8079; Ross KE, 2003, GENETICS, V165, P489; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; TRIBUKAIT B, 1991, ACTA ONCOL, V30, P187, DOI 10.3109/02841869109092348; Wang X, 2008, ONCOGENE, V27, P4456, DOI 10.1038/onc.2008.87; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	43	16	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					2907	2918		10.1038/onc.2011.464	http://dx.doi.org/10.1038/onc.2011.464			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	21986944	Green Accepted			2022-12-25	WOS:000305388400001
J	Li, WG; Yu, Y; Huang, C; Cao, H; Xu, TL				Li, Wei-Guang; Yu, Ye; Huang, Chen; Cao, Hui; Xu, Tian-Le			Nonproton Ligand Sensing Domain Is Required for Paradoxical Stimulation of Acid-sensing Ion Channel 3 (ASIC3) Channels by Amiloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CATION CHANNEL; NA+ CHANNEL; INFLAMMATORY PAIN; MOLECULAR-CLONING; SENSORY NEURONS; CONTRIBUTES; CALCIUM; MODULATION; ISCHEMIA; LINKER	Acid-sensing ion channels (ASICs), which belong to the epithelial sodium channel/degenerin family, are activated by extracellular protons and are inhibited by amiloride (AMI), an important pharmacological tool for studying all known members of epithelial sodium channel/degenerin. In this study, we reported that AMI paradoxically opened homomeric ASIC3 and heteromeric ASIC3 plus ASIC1b channels at neutral pH and synergistically enhanced channel activation induced by mild acidosis (pH 7.2 to 6.8). The characteristic profile of AMI stimulation of ASIC3 channels was reminiscent of the channel activation by the newly identified nonproton ligand, 2-guanidine-4-methylquinazoline. Using site-directed mutagenesis, we showed that ASIC3 activation by AMI, but not its inhibitory effect, was dependent on the integrity of the nonproton ligand sensing domain in ASIC3 channels. Moreover, the structure-activity relationship study demonstrated the differential requirement of the 5-amino group in AMI for the stimulation or inhibition effect, strengthening the different interactions within ASIC3 channels that confer the paradoxical actions of AMI. Furthermore, using covalent modification analyses, we provided strong evidence supporting the nonproton ligand sensing domain is required for the stimulation of ASIC3 channels by AMI. Finally, we showed that AMI causes pain-related behaviors in an ASIC3-dependent manner. These data reinforce the idea that ASICs can sense nonproton ligands in addition to protons. The results also indicate caution in the use of AMI for studying ASIC physiology and in the development of AMI-derived ASIC inhibitors for treating pain syndromes.	[Li, Wei-Guang; Yu, Ye; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Wei-Guang; Yu, Ye; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Inst Med Sci, Shanghai 200025, Peoples R China; [Li, Wei-Guang; Huang, Chen; Cao, Hui; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, TL (corresponding author), 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	xu-happiness@shsmu.edu.cn			National Natural Science Foundation of China [30830035]; National Basic Research Program of China [2011CBA00408]; Shanghai Municipal Government [09XD1404900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government	This work was supported by National Natural Science Foundation of China Grant 30830035, National Basic Research Program of China Grant 2011CBA00408, and Shanghai Municipal Government Grant 09XD1404900.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bagriantsev SN, 2010, NEURON, V68, P1, DOI 10.1016/j.neuron.2010.09.038; Catarsi S, 2001, NEUROPHARMACOLOGY, V41, P592, DOI 10.1016/S0028-3908(01)00107-1; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; FRELIN C, 1988, BIOCHIMIE, V70, P1285, DOI 10.1016/0300-9084(88)90196-4; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kuduk SD, 2009, BIOORG MED CHEM LETT, V19, P2514, DOI 10.1016/j.bmcl.2009.03.029; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Li YF, 2003, NEUROSCI LETT, V345, P173, DOI 10.1016/S0304-3940(03)00541-X; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Qadri YJ, 2010, J BIOL CHEM, V285, P9627, DOI 10.1074/jbc.M109.082735; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	47	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42635	42646		10.1074/jbc.M111.289058	http://dx.doi.org/10.1074/jbc.M111.289058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998313	Green Published, hybrid			2022-12-25	WOS:000298180900071
J	Rawat, R; Sandoval, FJ; Wei, ZY; Winkler, R; Roje, S				Rawat, Renu; Sandoval, Francisco J.; Wei, Zhaoyang; Winkler, Robert; Roje, Sanja			An FMN Hydrolase of the Haloacid Dehalogenase Superfamily Is Active in Plant Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-ADENINE-DINUCLEOTIDE; WEIGHT ACID-PHOSPHATASE; PARTIAL-PURIFICATION; FAD PYROPHOSPHATASE; PHASEOLUS RADIATUS; RIBOFLAVIN KINASE; MASS-SPECTROMETRY; STATISTICAL-MODEL; RAT-LIVER; BIOSYNTHESIS	FMN hydrolases catalyze dephosphorylation of FMN to riboflavin. Although these enzymes have been described in many organisms, few had their corresponding genes cloned and their recombinant proteins biochemically characterized, and none had their physiological roles determined. We found previously that FMN hydrolase activity in pea chloroplasts is Mg2+-dependent, suggesting an enzyme of the haloacid dehalogenase (HAD) superfamily. In this study, a new FMN hydrolase was purified by multistep chromatography after ammonium sulfate precipitation. The molecular weight of the native protein was estimated at similar to 59,400, a dimer of about twice the predicted molecular weight of most HAD superfamily phosphatases. After SDS-PAGE of the partially purified material, two separate protein bands within 25-30 kDa were extracted from the gel and analyzed by nanoLC-MS/MS. Peptide sequence matching to the protein samples suggested the presence of three HAD-like hydrolases. cDNAs for sequence homologs from Arabidopsis thaliana of these proteins were expressed in Escherichia coli. Activity screening of the encoded proteins showed that the At1g79790 gene encodes an FMN hydrolase (AtcpFHy1). Plastid localization of AtcpFHy1 was confirmed using fluorescence microscopy of A. thaliana protoplasts transiently expressing the N-terminal fusion of AtcpFHy1 to enhanced green fluorescent protein. Phosphatase activity of AtcpFHy1 is FMN-specific, as assayed with 19 potential substrates. Kinetic parameters and pH and temperature optima for AtcpFHy1 were determined. A phylogenetic analysis of putative phosphatases of the HAD superfamily suggested distinct evolutionary origins for the plastid AtcpFHy1 and the cytosolic FMN hydrolase characterized previously.	[Rawat, Renu; Sandoval, Francisco J.; Wei, Zhaoyang; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Winkler, Robert] Inst Tecnol & Estudios Super Monterrey, Dept Biotecnol & Tecnol Alimentos, Monterrey 64849, Nuevo Leon, Mexico	Washington State University; Tecnologico de Monterrey	Roje, S (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	sanja@wsu.edu	Winkler, Robert/A-1500-2009	Winkler, Robert/0000-0001-6732-1958; Roje, Sanja/0000-0002-6302-5382	United States National Institute of Food and Agriculture [2007-35318-18438]; National Science Foundation [MCB-1052492]; Murdoch Foundation; Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico) [CAT 161]	United States National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); Murdoch Foundation; Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico)	This work was supported by the United States National Institute of Food and Agriculture under National Research Initiative Competitive Grant 2007-35318-18438 (to S. R.), the National Science Foundation Grant MCB-1052492 (to S. R.), the Murdoch Foundation, and the Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico) under Bioengineering and Nano-particles Research Chair Grant CAT 161 (to R. W.).	Bacher A, 2001, VITAM HORM, V61, P1; Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYRD JC, 1985, J BIOL CHEM, V260, P7474; Caparros-Martin JA, 2007, PLANT MOL BIOL, V63, P505, DOI 10.1007/s11103-006-9104-0; CLINE K, 1986, J BIOL CHEM, V261, P4804; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; DOUCE R, 1987, METHOD ENZYMOL, V148, P403; FUCHS KR, 1992, BIOCHEM BIOPH RES CO, V189, P1598, DOI 10.1016/0006-291X(92)90259-N; Garcia NAT, 2004, PLANT PHYSIOL BIOCH, V42, P585, DOI 10.1016/j.plaphy.2004.04.004; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Granjeiro JM, 1997, BIOCHEM MOL BIOL INT, V41, P1201; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KUMAR SA, 1963, BIOCHIM BIOPHYS ACTA, V73, P98; KUMAR SA, 1965, ARCH BIOCHEM BIOPHYS, V111, P646, DOI 10.1016/0003-9861(65)90246-8; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; MCCORMICK DB, 1962, COMP BIOCHEM PHYSIOL, V5, P113, DOI 10.1016/0010-406X(62)90123-8; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; MITSUDA H, 1970, J VITAMINOL, V16, P52, DOI 10.5925/jnsv1954.16.52; MITSUDA H, 1965, J VITAMINOL, V11, P20, DOI 10.5925/jnsv1954.11.20; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Sandoval FJ, 2005, J BIOL CHEM, V280, P38337, DOI 10.1074/jbc.M500350200; Sandoval FJ, 2008, J BIOL CHEM, V283, P30890, DOI 10.1074/jbc.M803416200; SENSABAUGH GF, 1978, AM J HUM GENET, V30, P553; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; SHIN H, 1988, ARCH BIOCHEM BIOPHYS, V267, P95, DOI 10.1016/0003-9861(88)90012-4; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C	40	16	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42091	42098		10.1074/jbc.M111.260885	http://dx.doi.org/10.1074/jbc.M111.260885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002057	hybrid, Green Published			2022-12-25	WOS:000298180900019
J	Eun, C; Lorkovic, ZJ; Naumann, U; Long, Q; Havecker, ER; Simon, SA; Meyers, BC; Matzke, AJM; Matzke, M				Eun, Changho; Lorkovic, Zdravko J.; Naumann, Ulf; Long, Quan; Havecker, Ericka R.; Simon, Stacey A.; Meyers, Blake C.; Matzke, Antonius J. M.; Matzke, Marjori			AGO6 Functions in RNA-Mediated Transcriptional Gene Silencing in Shoot and Root Meristems in Arabidopsis thaliana	PLOS ONE			English	Article							DNA-METHYLATION; SIRNA ACCUMULATION; RETROTRANSPOSITION; ARGONAUTE4; PATHWAY; PROTEIN; PLANTS	RNA-directed DNA methylation (RdDM) is a small interfering RNA (siRNA)-mediated epigenetic modification that contributes to transposon silencing in plants. RdDM requires a complex transcriptional machinery that includes specialized RNA polymerases, named Pol IV and Pol V, as well as chromatin remodelling proteins, transcription factors, RNA binding proteins, and other plant-specific proteins whose functions are not yet clarified. In Arabidopsis thaliana, DICER-LIKE3 and members of the ARGONAUTE4 group of ARGONAUTE (AGO) proteins are involved, respectively, in generating and using 24-nt siRNAs that trigger methylation and transcriptional gene silencing of homologous promoter sequences. AGO4 is the main AGO protein implicated in the RdDM pathway. Here we report the identification of the related AGO6 in a forward genetic screen for mutants defective in RdDM and transcriptional gene silencing in shoot and root apical meristems in Arabidopsis thaliana. The identification of AGO6, and not AGO4, in our screen is consistent with the primary expression of AGO6 in shoot and root growing points.	[Eun, Changho; Lorkovic, Zdravko J.; Naumann, Ulf; Long, Quan; Matzke, Antonius J. M.; Matzke, Marjori] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria; [Havecker, Ericka R.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Simon, Stacey A.; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Simon, Stacey A.; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Cambridge; University of Delaware; University of Delaware	Eun, C (corresponding author), Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Matzke, Antonius/H-8698-2015; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Lorkovic, Zdravko/0000-0002-3074-7258	Fonds zur Forderung der wissenschaftlichen Forschung [P20702-B03]; Austrian Academy of Sciences; National Science Foundation (NSF) [0701745]	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Academy of Sciences; National Science Foundation (NSF)(National Science Foundation (NSF))	Work in the Matzke lab is supported by grant nr. P20702-B03 from the Fonds zur Forderung der wissenschaftlichen Forschung (www.fwf.ac.at) and the Austrian Academy of Sciences (www.oeaw.ac.at). Work in the Meyers lab is supported by National Science Foundation (NSF) Plant Genome Research Program (PGRP) award #0701745 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calarco JP, 2011, CURR OPIN GENET DEV, V21, P134, DOI 10.1016/j.gde.2011.01.014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Greenberg MVC, 2011, EPIGENETICS-US, V6, P344, DOI 10.4161/epi.6.3.14242; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Naumann U, 2011, GENETICS, V187, P977, DOI 10.1534/genetics.110.125401; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Stangeland B, 2002, PLANT MOL BIOL REP, V20, P107, DOI 10.1007/BF02799426; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Taylor B., 1982, FOCUS, V4, P4; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	34	40	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25730	10.1371/journal.pone.0025730	http://dx.doi.org/10.1371/journal.pone.0025730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998686	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900047
J	Lan, AP; Liao, XX; Mo, LQ; Yang, CT; Yang, ZL; Wang, XY; Hu, F; Chen, PX; Feng, JQ; Zheng, DD; Xiao, LC				Lan, Aiping; Liao, Xinxue; Mo, Liqiu; Yang, Chuntao; Yang, Zhanli; Wang, Xiuyu; Hu, Fen; Chen, Peixi; Feng, Jianqiang; Zheng, Dongdan; Xiao, Liangcan			Hydrogen Sulfide Protects against Chemical Hypoxia-Induced Injury by Inhibiting ROS-Activated ERK1/2 and p38MAPK Signaling Pathways in PC12 Cells	PLOS ONE			English	Article							P38 MAP KINASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; COBALT CHLORIDE; INVOLVEMENT; NEURONS; DAMAGE; NEUROMODULATOR; JNK; PHOSPHORYLATION	Hydrogen sulfide (H2S) has been proposed as a novel neuromodulator and neuroprotective agent. Cobalt chloride (CoCl2) is a well-known hypoxia mimetic agent. We have demonstrated that H2S protects against CoCl2-induced injuries in PC12 cells. However, whether the members of mitogen-activated protein kinases (MAPK), in particular, extracellular signal-regulated kinase1/2(ERK1/2) and p38MAPK are involved in the neuroprotection of H2S against chemical hypoxia-induced injuries of PC12 cells is not understood. We observed that CoCl2 induced expression of transcriptional factor hypoxia-inducible factor-1 alpha (HIF-1 alpha), decreased cystathionine-beta synthase (CBS, a synthase of H2S) expression, and increased generation of reactive oxygen species (ROS), leading to injuries of the cells, evidenced by decrease in cell viability, dissipation of mitochondrial membrane potential (MMP), caspase-3 activation and apoptosis, which were attenuated by pretreatment with NaHS (a donor of H2S) or N-acetyl-L cystein (NAC), a ROS scavenger. CoCl2 rapidly activated ERK1/2, p38MAPK and C-Jun N-terminal kinase (JNK). Inhibition of ERK1/2 or p38MAPK or JNK with kinase inhibitors (U0126 or SB203580 or SP600125, respectively) or genetic silencing of ERK1/2 or p38MAPK by RNAi (Si-ERK1/2 or Si-p38MAPK) significantly prevented CoCl2-induced injuries. Pretreatment with NaHS or NAC inhibited not only CoCl2-induced ROS production, but also phosphorylation of ERK1/2 and p38MAPK. Thus, we demonstrated that a concurrent activation of ERK1/2, p38MAPK and JNK participates in CoCl2-induced injuries and that H2S protects PC12 cells against chemical hypoxia-induced injuries by inhibition of ROS-activated ERK1/2 and p38MAPK pathways. Our results suggest that inhibitors of ERK1/2, p38MAPK and JNK or antioxidants may be useful for preventing and treating hypoxia-induced neuronal injury.	[Lan, Aiping; Yang, Chuntao; Yang, Zhanli; Wang, Xiuyu; Hu, Fen; Chen, Peixi; Feng, Jianqiang] Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Xinxue; Zheng, Dongdan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiovasol, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Liqiu; Xiao, Liangcan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lan, AP (corresponding author), Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	xiaoliangcan@hotmail.com	Yang, Chuntao/AAF-7687-2019; Zhuang, xiaodong/GPW-7235-2022; Yang, Zhan/GQG-9995-2022; lan, A/HHZ-6588-2022	Yang, Chuntao/0000-0002-5640-0930; Zhuang, xiaodong/0000-0001-6508-8507; 	Science and Technology Planning Project of Guangdong Province in China [2010B080701035, 2008B080703053]	Science and Technology Planning Project of Guangdong Province in China	This work was supported by Science and Technology Planning Project of Guangdong Province in China (2010B080701035, 2008B080703053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Banno Y, 2001, NEUROREPORT, V12, P2271, DOI 10.1097/00001756-200107200-00045; Cao YJ, 2001, GENE THER, V8, P1357, DOI 10.1038/sj.gt.3301536; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Eto K, 2002, J NEUROSCI, V22, P3386; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gaitanaki C, 2007, J EXP BIOL, V210, P2267, DOI 10.1242/jeb.003178; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Laggner H, 2007, FREE RADICAL RES, V41, P741, DOI 10.1080/10715760701263265; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu AL, 2009, EXP TOXICOL PATHOL, V61, P137, DOI 10.1016/j.etp.2008.06.004; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Nusuetrong P, 2005, EUR J PHARMACOL, V507, P239, DOI 10.1016/j.ejphar.2004.11.046; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Tang XQ, 2011, NEUROTOX RES, V19, P403, DOI 10.1007/s12640-010-9180-4; Uehara T, 1999, BRAIN RES, V823, P226, DOI 10.1016/S0006-8993(99)01178-6; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; WANG XY, 1993, ARCH BIOCHEM BIOPHYS, V306, P402, DOI 10.1006/abbi.1993.1529; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168	44	97	111	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25921	10.1371/journal.pone.0025921	http://dx.doi.org/10.1371/journal.pone.0025921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998720	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900072
J	Watson, ML; Macrae, K; Marley, AE; Hundal, HS				Watson, Maria L.; Macrae, Katherine; Marley, Anna E.; Hundal, Harinder S.			Chronic Effects of Palmitate Overload on Nutrient-Induced Insulin Secretion and Autocrine Signalling in Pancreatic MIN6 Beta Cells	PLOS ONE			English	Article							FREE FATTY-ACIDS; SKELETAL-MUSCLE CELLS; LONG-TERM EXPOSURE; PROTEIN-KINASE-C; GENE-EXPRESSION; CERAMIDE SYNTHESIS; REGULATED KINASES; COA PATHWAY; MALONYL-COA; LINE INS-1	Background: Sustained exposure of pancreatic beta cells to an increase in saturated fatty acids induces pleiotropic effects on beta-cell function, including a reduction in stimulus-induced insulin secretion. The objective of this study was to investigate the effects of chronic over supply of palmitate upon glucose- and amino acid-stimulated insulin secretion (GSIS and AASIS, respectively) and autocrine-dependent insulin signalling with particular focus on the importance of ceramide, ERK and CaMKII signalling. Principal Findings: GSIS and AASIS were both stimulated by >7-fold resulting in autocrine-dependent activation of protein kinase B (PKB, also known as Akt). Insulin release was dependent upon nutrient-induced activation of calcium/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated kinase (ERK) as their pharmacological inhibition suppressed GSIS/AASIS significantly. Chronic (48 h, 0.4 mM) palmitate treatment blunted glucose/AA-induced activation of CaMKII and ERK and caused a concomitant reduction (similar to 75%) in GSIS/AASIS and autocrine-dependent activation of PKB. This inhibition could not be attributed to enhanced mitochondrial fatty acid uptake/oxidation or ceramide synthesis, which were unaffected by palmitate. In contrast, diacylglycerol synthesis was elevated suggesting increased palmitate esterification rather than oxidation may contribute to impaired stimulus-secretion coupling. Consistent with this, 2-bromopalmitate, a non-oxidisable palmitate analogue, inhibited GSIS as effectively as palmitate. Conclusions: Our results exclude changes in ceramide content or mitochondrial fatty acid handling as factors initiating palmitate-induced defects in insulin release from MIN6 beta cells, but suggest that reduced CaMKII and ERK activation associated with palmitate overload may contribute to impaired stimulus-induced insulin secretion.	[Watson, Maria L.; Macrae, Katherine; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland; [Marley, Anna E.] AstraZeneca, CVGI, Macclesfield, Cheshire, England	University of Dundee; AstraZeneca	Watson, ML (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008	Hundal, Hari/0000-0002-7621-4932	Biotechnology and Biological Sciences Research Council-AstraZeneca; European Commission [LSHM-CT-20004-005272]; Diabetes United Kingdom; AstraZeneca	Biotechnology and Biological Sciences Research Council-AstraZeneca(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)AstraZeneca); European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes United Kingdom(Diabetes UK); AstraZeneca(AstraZeneca)	MW and KM have been supported by Biotechnology and Biological Sciences Research Council-AstraZeneca CASE scholarships. The authors are grateful for financial support from the European Commission (contract LSHM-CT-20004-005272) and Diabetes United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, AM, is an employee of AstraZeneca and two of the other authors, MW and KM, have been supported by funds from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderwald C, 2007, EUR J CLIN INVEST, V37, P774, DOI 10.1111/j.1365-2362.2007.01858.x; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beha A, 2006, AM J PHYSIOL-ENDOC M, V290, pE989, DOI 10.1152/ajpendo.00459.2005; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; DA SX, 2003, BIOCHEM J, V371, P761; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Gertow K, 2006, EUR J CLIN NUTR, V60, P1406, DOI 10.1038/sj.ejcn.1602471; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Mynatt RL, 2009, DIABETES-METAB RES, V25, pS45, DOI 10.1002/dmrr.987; Newsholme P, 2010, ADV EXP MED BIOL, V654, P91, DOI 10.1007/978-90-481-3271-3_6; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Thorens B, 2003, PFLUG ARCH EUR J PHY, V445, P482, DOI 10.1007/s00424-002-0954-2; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Tuunanen Helena, 2008, Curr Cardiol Rep, V10, P142, DOI 10.1007/s11886-008-0024-2; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Yoshikawa H, 2001, METABOLISM, V50, P613, DOI 10.1053/meta.2001.22565; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, DIABETES, V44, P394, DOI 10.2337/diabetes.44.4.394	53	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25975	10.1371/journal.pone.0025975	http://dx.doi.org/10.1371/journal.pone.0025975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998735	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900085
J	Wong, HE; Kwon, I				Wong, H. Edward; Kwon, Inchan			Xanthene Food Dye, as a Modulator of Alzheimer's Disease Amyloid-beta Peptide Aggregation and the Associated Impaired Neuronal Cell Function	PLOS ONE			English	Article							MTT FORMAZAN EXOCYTOSIS; MASS-PER-LENGTH; A-BETA; IN-VIVO; NEUROBLASTOMA-CELLS; FIBRILLAR OLIGOMERS; COMMON MECHANISM; TOXICITY; INHIBITORS; REDUCTION	Background: Alzheimer's disease (AD) is the most common form of dementia. AD is a degenerative brain disorder that causes problems with memory, thinking and behavior. It has been suggested that aggregation of amyloid-beta peptide (A beta) is closely linked to the development of AD pathology. In the search for safe, effective modulators, we evaluated the modulating capabilities of erythrosine B (ER), a Food and Drug Administration (FDA)-approved red food dye, on A beta aggregation and A beta-associated impaired neuronal cell function. Methodology/Principal Findings: In order to evaluate the modulating ability of ER on A beta aggregation, we employed transmission electron microscopy (TEM), thioflavin T (ThT) fluorescence assay, and immunoassays using A beta-specific antibodies. TEM images and ThT fluorescence of A beta samples indicate that protofibrils are predominantly generated and persist for at least 3 days. The average length of the ER-induced protofibrils is inversely proportional to the concentration of ER above the stoichiometric concentration of A beta monomers. Immunoassay results using A beta-specific antibodies suggest that ER binds to the N-terminus of A beta and inhibits amyloid fibril formation. In order to evaluate A beta-associated toxicity we determined the reducing activity of SH-SY5Y neuroblastoma cells treated with A beta aggregates formed in the absence or in the presence of ER. As the concentration of ER increased above the stoichiometric concentration of A beta, cellular reducing activity increased and A beta-associated reducing activity loss was negligible at 500 mu M ER. Conclusions/Significance: Our findings show that ER is a novel modulator of A beta aggregation and reduces A beta-associated impaired cell function. Our findings also suggest that xanthene dye can be a new type of small molecule modulator of A beta aggregation. With demonstrated safety profiles and blood-brain permeability, ER represents a particularly attractive aggregation modulator for amyloidogenic proteins associated with neurodegenerative diseases.	[Wong, H. Edward; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA; [Kwon, Inchan] Univ Virginia, Inst Aging, Charlottesville, VA USA	University of Virginia; University of Virginia	Wong, HE (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.	ik4t@virginia.edu			National Institutes of Neurological Disorders and Stroke [R21NS069946]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069946] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Neurological Disorders and Stroke (R21NS069946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P813, DOI 10.1016/0278-6915(90)90054-Q; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; GARDNER DF, 1987, TOXICOL APPL PHARM, V91, P299, DOI 10.1016/0041-008X(87)90052-4; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hertel C, 1996, J NEUROCHEM, V67, P272; Hirohashi T, 1997, J PHARMACOL EXP THER, V280, P813; Hu Y, 2010, CHEMBIOCHEM, V11, P2409, DOI 10.1002/cbic.201000435; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LEVINE H, 1999, QUANTIFICATION BETA, P274; LEVITAN H, 1984, BRAIN RES, V322, P131, DOI 10.1016/0006-8993(84)91191-0; Liu YB, 1997, J NEUROCHEM, V69, P2285; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Moss MA, 2004, MOL PHARMACOL, V66, P592; Nishimura S, 2003, PHARMACOL TOXICOL, V93, P29, DOI 10.1034/j.1600-0773.2003.930104.x; Olivieri G, 2003, NEUROSCIENCE, V120, P659, DOI 10.1016/S0306-4522(03)00342-7; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Qi W, 2008, BIOTECHNOL BIOENG, V100, P1214, DOI 10.1002/bit.21846; Qi W, 2009, BIOCHEMISTRY-US, V48, P8908, DOI 10.1021/bi9006397; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Sarracino R, 2010, COLEC MONOGRAF ACAD, P1; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shin HJ, 2000, BBA-PROTEIN STRUCT M, V1481, P139, DOI 10.1016/S0167-4838(00)00106-0; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Wang SSS, 2001, J BIOL CHEM, V276, P42027, DOI 10.1074/jbc.M102834200; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	46	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25752	10.1371/journal.pone.0025752	http://dx.doi.org/10.1371/journal.pone.0025752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998691	gold, Green Published			2022-12-25	WOS:000295966900051
J	Kershner, J; Samhouri, JF; James, CA; Levin, PS				Kershner, Jessi; Samhouri, Jameal F.; James, C. Andrew; Levin, Phillip S.			Selecting Indicator Portfolios for Marine Species and Food Webs: A Puget Sound Case Study	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; ECOLOGICAL INDICATORS; ECOSYSTEM APPROACH; MANAGEMENT; FRAMEWORK; CONSERVATION; BIODIVERSITY; DIVERSITY; INDEXES; IMPACT	Ecosystem-based management (EBM) has emerged as a promising approach for maintaining the benefits humans want and need from the ocean, yet concrete approaches for implementing EBM remain scarce. A key challenge lies in the development of indicators that can provide useful information on ecosystem status and trends, and assess progress towards management goals. In this paper, we describe a generalized framework for the methodical and transparent selection of ecosystem indicators. We apply the framework to the second largest estuary in the United States - Puget Sound, Washington - where one of the most advanced EBM processes is currently underway. Rather than introduce a new method, this paper integrates a variety of familiar approaches into one step-by-step approach that will lead to more consistent and reliable reporting on ecosystem condition. Importantly, we demonstrate how a framework linking indicators to policy goals, as well as a clearly defined indicator evaluation and scoring process, can result in a portfolio of useful and complementary indicators based on the needs of different users (e. g., policy makers and scientists). Although the set of indicators described in this paper is specific to marine species and food webs, we provide a general approach that could be applied to any set of management objectives or ecological system.	[Kershner, Jessi] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Samhouri, Jameal F.; Levin, Phillip S.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [James, C. Andrew] Univ Washington, Ctr Urban Waters, Tacoma, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Tacoma	Kershner, J (corresponding author), EcoAdapt, Bainbridge Isl, WA USA.	jessikershner@gmail.com			Puget Sound Partnership; U.S. Environmental Protection Agency	Puget Sound Partnership; U.S. Environmental Protection Agency(United States Environmental Protection Agency)	We gratefully acknowledge funding from the Puget Sound Partnership and the U.S. Environmental Protection Agency (Dr. Samhouri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Caro T. M, 2010, CONSERVATION PROXY I; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Conservation Measures Partnership, 2007, OP STAND PRACT CONS; Cury PM, 2005, ICES J MAR SCI, V62, P577, DOI 10.1016/j.icesjms.2004.10.007; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Doren RF, 2009, ECOL INDIC, V9, pS2, DOI 10.1016/j.ecolind.2008.08.009; Essington T, 2010, BIOPHYSICAL CONDITIO; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harwell MA, 1999, BIOSCIENCE, V49, P543, DOI 10.2307/1313475; Heiman K, 2005, BIOSCIENCE, V55, P548, DOI 10.1641/0006-3568(2005)055[0548:SINS]2.0.CO;2; Heinz H.J, 2013, STATE NATIONS ECOSYS; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Jackson LE, 2000, EPA620R99005US OFF R; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Jorgensen S.E., 2005, HDB ECOLOGICAL INDIC; Kurtz Janis C., 2001, Ecological Indicators, V1, P49, DOI 10.1016/S1470-160X(01)00004-8; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin P. S., 2010, STANFORD J LAW SCI P, V2, P36; Levin PS, 2010, DEV EXECUTIVE DASHBO; Levin PS, 2010, PUGET SOUND SCI UPDA; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Mardle S., 1999, MARINE RESOURCE EC, V1999, P41; McElhany P, 2000, NMFSNWFSC42 NOAA; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; OCONNOR JS, 1986, ENVIRON MANAGE, V10, P335, DOI 10.1007/BF01867257; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; ONeill T.K., 2008, ENV INDICATORS PUGET; Orians GH, 2009, ANNU REV ENV RESOUR, V34, P375, DOI 10.1146/annurev.environ.020608.151439; Pacala S, 2002, MG POP BIOL, V33, P169; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Patrick WS, 2010, FISH B-NOAA, V108, P305; *PEW OC COMM, 2003, AM LIV OC CHART COUR; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pirrone N, 2005, REG ENVIRON CHANGE, V5, P111, DOI 10.1007/s10113-004-0092-9; Powers JE, 2010, MAR POLICY, V34, P723, DOI 10.1016/j.marpol.2009.11.009; Puget Sound Action Team, 2007, 9 PUG SOUND ASS MON; Puget Sound Partnership, 2010, 2009 STAT SOUND REP; Puget Sound Partnership, 2010, STRAT SCI PLAN; Puget Sound Partnership, 2009, ID EC COMP THEIR IND; Puget Sound Partnership, 2008, PUG SOUND ACT AG PRO; RAPPORT D, 1990, ENVIRON MONIT ASSESS, V15, P273, DOI 10.1007/BF00394894; RAPPORT DJ, 1985, AM NAT, V125, P617, DOI 10.1086/284368; Recchia C, 2009, DRAFT N CENTRAL COAS; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rothaus DP, 2008, CAN J FISH AQUAT SCI, V65, P2703, DOI 10.1139/F08-168; Ruckelshaus M.H., 2007, SOUND SCI SYNTHESIZI; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Samhouri JF, MARINE POLI IN PRESS; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shin Y-J, 2010, ICES J MARINE SCI, V67; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steele K, 2009, RISK ANAL, V29, P26, DOI 10.1111/j.1539-6924.2008.01130.x; U.S. Environmental Protection Agency, 2002, FRAM ASS REP EC COND; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	72	80	81	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25248	10.1371/journal.pone.0025248	http://dx.doi.org/10.1371/journal.pone.0025248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991305	gold, Green Published, Green Submitted			2022-12-25	WOS:000295963300007
J	Kelly, AD; Breitkopf, SB; Yuan, M; Goldsmith, J; Spentzos, D; Asara, JM				Kelly, Andrew D.; Breitkopf, Susanne B.; Yuan, Min; Goldsmith, Jeffrey; Spentzos, Dimitrios; Asara, John M.			Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma	PLOS ONE			English	Article							MASS-SPECTROMETRY; CANCER; CELLS; METABOANALYST	The relatively new field of onco-metabolomics attempts to identify relationships between various cancer phenotypes and global metabolite content. Previous metabolomics studies utilized either nuclear magnetic resonance spectroscopy or gas chromatography/mass spectrometry, and analyzed metabolites present in urine and serum. However, direct metabolomic assessment of tumor tissues is important for determining altered metabolism in cancers. In this respect, the ability to obtain reliable data from archival specimens is desirable and has not been reported to date. In this feasibility study, we demonstrate the analysis of polar metabolites extracted directly from ten formalin-fixed, paraffin-embedded (FFPE) specimens, including five soft tissue sarcomas and five paired normal samples. Using targeted liquid chromatography-tandem mass spectrometry (LC/MS/MS) via selected reaction monitoring (SRM), we detect an average of 106 metabolites across the samples with excellent reproducibility and correlation between different sections of the same specimen. Unsupervised hierarchical clustering and principal components analysis reliably recovers a priori known tumor and normal tissue phenotypes, and supervised analysis identifies candidate metabolic markers supported by the literature. In addition, we find that diverse biochemical processes are well-represented in the list of detected metabolites. Our study supports the notion that reliable and broadly informative metabolomic data may be acquired from FFPE soft tissue sarcoma specimens, a finding that is likely to be extended to other malignancies.	[Kelly, Andrew D.; Spentzos, Dimitrios] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Sarcoma Program, Boston, MA 02215 USA; [Breitkopf, Susanne B.; Yuan, Min; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Goldsmith, Jeffrey] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Spentzos, Dimitrios; Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kelly, AD (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Sarcoma Program, Boston, MA 02215 USA.	jasara@bidmc.harvard.edu		Kelly, Andrew/0000-0002-5338-7689	National Institutes of Health/National Cancer Institute [1 K22 CA138716-01A2, 5 P01 CA120964-05, 5 P30 CA006516-46]; Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE [P30CA006516, K22CA138716, P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute 1 K22 CA138716-01A2 Award (DS), 5 P01 CA120964-05 (JA), and 5 P30 CA006516-46 (JA). The authors would also like to acknowledge a donation by Dr. Richard and Virginia Clemmer to the sarcoma program at Beth Israel Deaconess Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Davis VW, 2011, J SURG ONCOL, V103, P451, DOI 10.1002/jso.21831; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lei Z, 2011, J BIOL CHEM IN PRESS; Locasale JW, 2011, NAT GENET IN PRESS; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Mishur RJ, 2011, MASS SPECTR IN PRESS; Naderi EH, 2009, BLOOD, V114, P608, DOI 10.1182/blood-2009-02-204883; Naderi S, 2005, MOL BIOL CELL, V16, P1527, DOI 10.1091/mbc.E04-06-0501; Safa M, 2011, J RECEPT SIG TRANSD, V31, P256, DOI 10.3109/10799893.2011.578140; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	19	57	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25357	10.1371/journal.pone.0025357	http://dx.doi.org/10.1371/journal.pone.0025357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984915	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000026
J	Metz, SW; Feenstra, F; Villoing, S; van Hulten, MC; van Lent, JW; Koumans, J; Vlak, JM; Pijlman, GP				Metz, Stefan W.; Feenstra, Femke; Villoing, Stephane; van Hulten, Marielle C.; van Lent, Jan W.; Koumans, Joseph; Vlak, Just M.; Pijlman, Gorben P.			Low Temperature-Dependent Salmonid Alphavirus Glycoprotein Processing and Recombinant Virus-Like Particle Formation	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; EQUINE ENCEPHALITIS-VIRUS; NUCLEAR POLYHEDROSIS-VIRUS; SWINE-FEVER VIRUS; PANCREAS DISEASE; ATLANTIC SALMON; SPODOPTERA-FRUGIPERDA; NUCLEOCAPSID PROTEIN; BACULOVIRUS VECTORS; SLEEPING-DISEASE	Pancreas disease (PD) and sleeping disease (SD) are important viral scourges in aquaculture of Atlantic salmon and rainbow trout. The etiological agent of PD and SD is salmonid alphavirus (SAV), an unusual member of the Togaviridae (genus Alphavirus). SAV replicates at lower temperatures in fish. Outbreaks of SAV are associated with large economic losses of similar to 17 to 50 million $/year. Current control strategies rely on vaccination with inactivated virus formulations that are cumbersome to obtain and have intrinsic safety risks. In this research we were able to obtain non-infectious virus-like particles (VLPs) of SAV via expression of recombinant baculoviruses encoding SAV capsid protein and two major immunodominant viral glycoproteins, E1 and E2 in Spodoptera frugiperda Sf9 insect cells. However, this was only achieved when a temperature shift from 27 degrees C to lower temperatures was applied. At 27 degrees C, precursor E2 (PE2) was misfolded and not processed by host furin into mature E2. Hence, E2 was detected neither on the surface of infected cells nor as VLPs in the culture fluid. However, when temperatures during protein expression were lowered, PE2 was processed into mature E2 in a temperature-dependent manner and VLPs were abundantly produced. So, temperature shift-down during synthesis is a prerequisite for correct SAV glycoprotein processing and recombinant VLP production.	[Metz, Stefan W.; Feenstra, Femke; van Lent, Jan W.; Vlak, Just M.; Pijlman, Gorben P.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Villoing, Stephane] Intervet Norbio, Bergen, Norway; [van Hulten, Marielle C.; Koumans, Joseph] Intervet Int BV, Boxmeer, Netherlands	Wageningen University & Research; Merck & Company; Intervet International B.V.	Metz, SW (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	gorben.pijlman@wur.nl	Metz, Stefan/J-1974-2019	Metz, Stefan/0000-0002-9249-2844; Pijlman, Gorben/0000-0001-9301-0408	Intervet International	Intervet International(Merck & CompanyIntervet International B.V.)	Intervet International provided limited funding to GP to compensate consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2007, J VIROL, V81, P3866, DOI 10.1128/JVI.02075-06; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Benmansour A, 1997, DEV BIOLOGICALS, V90, P279; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; BOUCHER P, 1995, DIS AQUAT ORGAN, V22, P19, DOI 10.3354/dao022019; Boucher P, 1996, J FISH DIS, V19, P303, DOI 10.1111/j.1365-2761.1996.tb00708.x; Bouma A, 1999, VET MICROBIOL, V66, P101, DOI 10.1016/S0378-1135(99)00003-6; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desvignes L, 2002, FISH SHELLFISH IMMUN, V12, P77, DOI 10.1006/fsim.2001.0356; FROST P, 1995, J GEN VIROL, V76, P1165, DOI 10.1099/0022-1317-76-5-1165; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Hodgson LA, 1999, VACCINE, V17, P1151, DOI 10.1016/S0264-410X(98)00335-1; HOUGHTON G, 1995, DIS AQUAT ORGAN, V22, P193, DOI 10.3354/dao022193; HOUGHTON G, 1994, DIS AQUAT ORGAN, V18, P109, DOI 10.3354/dao018109; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; Karlsson M., 2010, APPL INNOVATION MANA, P1; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kuhn R, 2007, FIELDS VIROLOGY, P1001; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Lopez-Doriga MV, 2001, FISH SHELLFISH IMMUN, V11, P505, DOI 10.1006/fsim.2000.0330; Makela AR, 2006, ADV VIRUS RES, V68, P91, DOI 10.1016/S0065-3527(06)68003-2; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; McLoughlin MF, 1996, DIS AQUAT ORGAN, V26, P117, DOI 10.3354/dao026117; Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353; Metz SW, 2011, J INVERTEBR PATHOL, V107, pS16, DOI 10.1016/j.jip.2011.05.002; MICHEL MR, 1990, J VIROL, V64, P5123, DOI 10.1128/JVI.64.10.5123-5131.1990; Mitchell C, 1997, VIRUS RES, V47, P67, DOI 10.1016/S0168-1702(96)01408-6; Moriette C, 2006, J VIROL, V80, P4088, DOI 10.1128/JVI.80.8.4088-4098.2006; Moriette C, 2005, J GEN VIROL, V86, P3119, DOI 10.1099/vir.0.81030-0; Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229; NELSON RT, 1995, DIS AQUAT ORGAN, V22, P25, DOI 10.3354/dao022025; OKERBLOM C, 1989, J VIROL, V63, P1256, DOI 10.1128/JVI.63.3.1256-1264.1989; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Paavonen J, 2008, ANN MED, V40, P162, DOI 10.1080/07853890701802404; Parker MD, 2010, J VIROL, V84, P12683, DOI 10.1128/JVI.01345-10; Petterson E, 2009, J FISH DIS, V32, P477, DOI 10.1111/j.1365-2761.2009.01038.x; Pijlman GP, 2002, J VIROL, V76, P5605, DOI 10.1128/JVI.76.11.5605-5611.2002; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; SAIJO T, 2010, VIROL J, V7, P327; Sjoberg M, 2011, J VIROL, V85, P5644, DOI 10.1128/JVI.00130-11; Snow M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-56; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P8472, DOI 10.1128/AEM.71.12.8472-8480.2005; van Oers MM, 2001, J BIOTECHNOL, V86, P31, DOI 10.1016/S0168-1656(00)00403-X; van Oers MM, 2006, ADV VIRUS RES, V68, P193, DOI 10.1016/S0065-3527(06)68006-8; VANLENT JWM, 1990, ARCH VIROL, V111, P103, DOI 10.1007/BF01310508; Vialard J E, 1995, Methods Mol Biol, V39, P1; VLAK JM, 1979, J INVERTEBR PATHOL, V34, P110, DOI 10.1016/0022-2011(79)90089-2; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; Westenberg M, 2002, J VIROL, V76, P178, DOI 10.1128/JVI.76.1.178-184.2002; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WRIGHT KE, 1989, VIROLOGY, V171, P417, DOI 10.1016/0042-6822(89)90610-7; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	60	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25816	10.1371/journal.pone.0025816	http://dx.doi.org/10.1371/journal.pone.0025816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991361	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000077
J	Srivastava, RK; Rahman, Q; Kashyap, MP; Lohani, M; Pant, AB				Srivastava, Ritesh Kumar; Rahman, Qamar; Kashyap, Mahendra Pratap; Lohani, Mohtashim; Pant, Aditya Bhushan			Ameliorative Effects of Dimetylthiourea and N-Acetylcysteine on Nanoparticles Induced Cyto-Genotoxicity in Human Lung Cancer Cells-A549	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; WALL CARBON NANOTUBES; OXIDATIVE STRESS; OXIDE NANOPARTICLES; MEDIATED APOPTOSIS; SURFACE-CHEMISTRY; ASBESTOS; TOXICITY; ACTIVATION; IMPACT	We study the ameliorative potential of dimetylhiourea (DMTU), an OH radical trapper and N-acetylcysteine (NAC), a glutathione precursor/H2O2 scavenger against titanium dioxide nanoparticles (TiO2-NPs) and multi-walled carbon nanotubes (MWCNTs) induced cyto-genotoxicity in cultured human lung cancer cells-A549. Cytogenotoxicity was induced by exposing the cells to selected concentrations (10 and 50 mu g/ml) of either of TiO2-NPs or MWCNTs for 24 h . Anti-cytogenotoxicity effects of DMTU and NAC were studied in two groups, i.e., treatment of 30 minutes prior to toxic insult (short term exposure), while the other group received DMTU and NAC treatment during nanoparticles, exposure, i.e., 24 h (long term exposure). Investigations were carried out for cell viability, generation of reactive oxygen specie (ROS), micronuclei (MN), and expression of markers of oxidative stress (HSP27, CYP2E1), genotoxicity (P-53) and CYP2E1 dependent n-nitrosodimethylamine-demethylase (NDMA-d) activity. In general, the treatment of both DMTU and NAC was found to be effective significantly against TiO2-NPs and MWCNTs induced cytogenotoxicity in A549 cells. Long-term treatment of DMTU and NAC during toxic insults has shown better prevention than short-term pretreatment. Although, cells responded significantly to both DMTU and NAC, but responses were chemical specific. In part, TiO(2-)NPs induced toxic responses were mediated through OH" radicals generation and reduction in the antioxidant defense system. While in the case of MWCNTs, adverse effects were primarily due to altering/hampering the enzymatic antioxidant system. Data indicate the applicability of human lung cancer cells-A549 as a pre-screening tool to identify he target specific prophylactic and therapeutic potential of drugs candidate molecules against nanoparticles induced cellular damages.	[Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] CSIR, New Delhi, India; [Rahman, Qamar; Lohani, Mohtashim] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Integral University	Srivastava, RK (corresponding author), Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Rahman, Qamar/AFJ-9953-2022; Kashyap, Mahendra/G-4305-2011; Lohani, Mohtashim/AAR-3394-2021; Rahman, Qamar/AAF-7026-2022; Srivastava, Ritesh/V-6029-2019	Kashyap, Mahendra/0000-0001-7924-4793; Lohani, Mohtashim/0000-0001-9414-4539	Council of Scientific & Industrial Research, New Delhi [SIP-08]	Council of Scientific & Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Financial support was received from the Council of Scientific & Industrial Research, New Delhi, (SIP-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Barillet S, 2010, TOXICOL LETT, V198, P324, DOI 10.1016/j.toxlet.2010.07.009; Bhattacharya K, 2005, MUTAT RES-FUND MOL M, V579, P6, DOI 10.1016/j.mrfmmm.2005.02.022; Bhattacharya K, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-17; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Dopp E, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-9; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Fubini B, 2010, NANOTOXICOLOGY, V4, P347, DOI 10.3109/17435390.2010.509519; Gillissen A, 1997, RESP MED, V91, P159, DOI 10.1016/S0954-6111(97)90052-4; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Kapoor N, 2006, LIFE SCI, V79, P1514, DOI 10.1016/j.lfs.2006.04.023; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kashyap MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017757; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kong SJ, 2008, ENVIRON MOL MUTAGEN, V49, P399, DOI 10.1002/em.20399; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; McVicker BL, 2009, WORLD J GASTROENTERO, V15, P2609, DOI 10.3748/wjg.15.2609; Mroz RM, 2008, EUR RESPIR J, V31, P241, DOI 10.1183/09031936.00006707; Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Pacurari M, 2010, J TOXICOL ENV HEAL A, V73, P378, DOI 10.1080/15287390903486527; Pant AB, 2001, HUM EXP TOXICOL, V20, P412, DOI 10.1191/096032701682692919; Patlolla A, 2010, ETHNIC DIS, V20, P65; Patlolla AK, 2010, ENVIRON TOXICOL, V25, P608, DOI 10.1002/tox.20621; Poser I, 2004, MUTAT RES-GEN TOX EN, V559, P19, DOI 10.1016/j.mrgentox.2003.12.006; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Rahman Q, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110797; RAJU PA, 1994, AIDS RES HUM RETROV, V10, P961, DOI 10.1089/aid.1994.10.961; Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Srivastava RK, 2010, TOXICOL IND HEALTH, V26, P575, DOI 10.1177/0748233710374464; Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370; Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001; Tirmenstein MA, 2000, CHEM-BIOL INTERACT, V127, P201, DOI 10.1016/S0009-2797(00)00180-0; Trouiller B, 2009, CANCER RES, V69, P8784, DOI 10.1158/0008-5472.CAN-09-2496; Tsuji T, 2009, TOXICOL APPL PHARM, V234, P202, DOI 10.1016/j.taap.2008.09.031; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yin H, 2010, LANGMUIR, V26, P15399, DOI 10.1021/la101033n	44	27	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25767	10.1371/journal.pone.0025767	http://dx.doi.org/10.1371/journal.pone.0025767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980536	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600054
J	Racanelli, V; Brunetti, C; De Re, V; Caggiari, L; De Zorzi, M; Leone, P; Perosa, F; Vacca, A; Dammacco, F				Racanelli, Vito; Brunetti, Claudia; De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Leone, Patrizia; Perosa, Federico; Vacca, Angelo; Dammacco, Franco			Antibody V-h Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; B-CELLS; MIXED CRYOGLOBULINEMIA; ANTIGEN SELECTION; NEUTRALIZING ANTIBODIES; SOMATIC HYPERMUTATION; CLONAL EXPANSION; VIRAL CLEARANCE; HCV; RISK	Despite the production of neutralizing antibodies to hepatitis C virus (HCV), many patients fail to clear the virus and instead develop chronic infection and long-term complications. To understand how HCV infection perturbs the antibody repertoire and to identify molecular features of antibody genes associated with either viral clearance or chronic infection, we sequenced the V(D)J region of naive and memory B cells of 6 persons who spontaneously resolved an HCV infection (SR), 9 patients with a newly diagnosed chronically evolving infection (CE), and 7 healthy donors. In both naive and memory B cells, the frequency of use of particular antibody gene subfamilies and segments varied among the three clinical groups, especially between SR and CE. Compared to CE, SR antibody genes used fewer VH, D and JH gene segments in naive B cells and fewer VH segments in memory B cells. SR and CE groups significantly differed in the frequency of use of 7 gene segments in naive B cell clones and 3 gene segments in memory clones. The nucleotide mutation rates were similar among groups, but the pattern of replacement and silent mutations in memory B cell clones indicated greater antigen selection in SR than CE. Greater clonal evolution of SR than CE memory B cells was revealed by analysis of phylogenetic trees and CDR3 lengths. Pauciclonality of the peripheral memory B cell population is a distinguishing feature of persons who spontaneously resolved an HCV infection. This finding, previously considered characteristic only of patients with HCV-associated lymphoproliferative disorders, suggests that the B cell clones potentially involved in clearance of the virus may also be those susceptible to abnormal expansion.	[Racanelli, Vito; Brunetti, Claudia; Leone, Patrizia; Perosa, Federico; Vacca, Angelo; Dammacco, Franco] Univ Bari, Sch Med, Dept Internal Med & Clin Oncol, Bari, Italy; [De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela] IRCCS Natl Canc Inst, Expt & Clin Pharmacol Unit, Ctr Riferimento Oncol, Aviano, PN, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Aviano (CRO)	Racanelli, V (corresponding author), Univ Bari, Sch Med, Dept Internal Med & Clin Oncol, Bari, Italy.	v.racanelli@dimo.uniba.it	DE RE, VALLI/AAA-1374-2019; Dammacco, Franco/ABG-5728-2020; Racanelli, Vito/J-8511-2018; De Re, Valli/K-4121-2016; CAGGIARI, LAURA/Q-6125-2019; Vacca, Angelo/AAC-9558-2022; De Zorzi, Mariangela/AAA-8832-2019	DE RE, VALLI/0000-0001-6100-9373; Dammacco, Franco/0000-0003-2149-5471; Racanelli, Vito/0000-0002-8639-1940; De Re, Valli/0000-0001-6100-9373; CAGGIARI, LAURA/0000-0003-1651-6653; Vacca, Angelo/0000-0002-4567-8216; De Zorzi, Mariangela/0000-0002-3794-270X; Perosa, Federico/0000-0002-4072-4244	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	The study was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro, Milan, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; BAHLER DW, 1992, CANCER RES, V52, pS5547; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Chapel HM, 2001, CLIN IMMUNOL, V99, P320, DOI 10.1006/clim.2001.5036; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; De Re V, 2006, RHEUMATOLOGY, V45, P685, DOI 10.1093/rheumatology/kei278; De Re V, 2000, INT J CANCER, V87, P211, DOI 10.1002/1097-0215(20000715)87:2&lt;211::AID-IJC9&gt;3.0.CO;2-8; De Re V, 2000, BLOOD, V96, P3578; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FRANZIN F, 1995, BRIT J HAEMATOL, V90, P548, DOI 10.1111/j.1365-2141.1995.tb05582.x; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Ivanovski M, 1998, BLOOD, V91, P2433, DOI 10.1182/blood.V91.7.2433.2433_2433_2442; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Libra M, 2005, J PATHOL, V206, P87, DOI 10.1002/path.1754; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Magalini AR, 1998, J PATHOL, V185, P86; Matsuo K, 2004, CANCER SCI, V95, P745, DOI 10.1111/j.1349-7006.2004.tb03256.x; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Miqueu P, 2007, MOL IMMUNOL, V44, P1057, DOI 10.1016/j.molimm.2006.06.026; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Racanelli V, 2003, TRENDS IMMUNOL, V24, P456, DOI 10.1016/S1471-4906(03)00178-9; Racanelli V, 2001, J IMMUNOL, V167, P21, DOI 10.4049/jimmunol.167.1.21; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rasul I, 1999, HEPATOLOGY, V29, P543, DOI 10.1002/hep.510290224; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sansonno D, 2005, LANCET INFECT DIS, V5, P227, DOI 10.1016/S1473-3099(05)70053-0; Sansonno D, 1998, J IMMUNOL, V160, P3594; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; Strasak AM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-15; Uchiyama M, 2003, J CLIN PATHOL, V56, P778, DOI 10.1136/jcp.56.10.778; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Yu MYW, 2004, P NATL ACAD SCI USA, V101, P7705, DOI 10.1073/pnas.0402458101; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800; Zuckerman E, 2001, BRIT J HAEMATOL, V112, P364, DOI 10.1046/j.1365-2141.2001.02573.x	48	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25606	10.1371/journal.pone.0025606	http://dx.doi.org/10.1371/journal.pone.0025606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980500	gold, Green Published, Green Submitted			2022-12-25	WOS:000295936900079
J	Trotter, EW; Rolfe, MD; Hounslow, AM; Craven, CJ; Williamson, MP; Sanguinetti, G; Poole, RK; Green, J				Trotter, Eleanor W.; Rolfe, Matthew D.; Hounslow, Andrea M.; Craven, C. Jeremy; Williamson, Michael P.; Sanguinetti, Guido; Poole, Robert K.; Green, Jeffrey			Reprogramming of Escherichia coli K-12 Metabolism during the Initial Phase of Transition from an Anaerobic to a Micro-Aerobic Environment	PLOS ONE			English	Article							OXYGEN AVAILABILITY; TRANSCRIPTION; ACTIVATION; EXPRESSION; OPERON; PDHR	Background: Many bacteria undergo transitions between environments with differing O-2 availabilities as part of their natural lifestyles and during biotechnological processes. However, the dynamics of adaptation when bacteria experience changes in O-2 availability are understudied. The model bacterium and facultative anaerobe Escherichia coli K-12 provides an ideal system for exploring this process. Methods and Findings: Time-resolved transcript profiles of E. coli K-12 during the initial phase of transition from anaerobic to micro-aerobic conditions revealed a reprogramming of gene expression consistent with a switch from fermentative to respiratory metabolism. The changes in transcript abundance were matched by changes in the abundances of selected central metabolic proteins. A probabilistic state space model was used to infer the activities of two key regulators, FNR (O-2 sensing) and PdhR (pyruvate sensing). The model implied that both regulators were rapidly inactivated during the transition from an anaerobic to a micro-aerobic environment. Analysis of the external metabolome and protein levels suggested that the cultures transit through different physiological states during the process of adaptation, characterized by the rapid inactivation of pyruvate formate-lyase (PFL), a slower induction of pyruvate dehydrogenase complex (PDHC) activity and transient excretion of pyruvate, consistent with the predicted inactivation of PdhR and FNR. Conclusion: Perturbation of anaerobic steady-state cultures by introduction of a limited supply of O-2 combined with time-resolved transcript, protein and metabolite profiling, and probabilistic modeling has revealed that pyruvate (sensed by PdhR) is a key metabolic signal in coordinating the reprogramming of E. coli K-12 gene expression by working alongside the O-2 sensor FNR during transition from anaerobic to micro-aerobic conditions.	[Trotter, Eleanor W.; Rolfe, Matthew D.; Hounslow, Andrea M.; Craven, C. Jeremy; Williamson, Michael P.; Poole, Robert K.; Green, Jeffrey] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Sheffield; University of Edinburgh	Trotter, EW (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Williamson, Mike/0000-0001-5572-1903	Biotechnology and Biological Sciences Research Council UK [BB/E019943/1]; SysMO initiative; BBSRC [BB/E019943/1, BB/F003463/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003463/1, BB/E019943/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SysMO initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Biotechnology and Biological Sciences Research Council UK (grant number BB/E019943/1, bbsrc.ac.uk) and the SysMO initiative (www.sysmo.net) for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Asif HMS, 2010, BIOINFORMATICS, V26, P2635, DOI 10.1093/bioinformatics/btq469; Bock A., 1996, ESCHERICHIA COLI SAL, V2, P262; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Evans CGT, 1970, METHOD MICROBIOL, V2, P278; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guest John R., 1996, P317; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; KESSLER D, 1992, J BIOL CHEM, V267, P18073; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marshall FA, 2001, MOL MICROBIOL, V39, P747, DOI 10.1046/j.1365-2958.2001.02262.x; Ogasawara H, 2007, J BACTERIOL, V189, P5534, DOI 10.1128/JB.00229-07; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; QUAIL MA, 1995, MOL MICROBIOL, V15, P519, DOI 10.1111/j.1365-2958.1995.tb02265.x; Reyes-Ramirez F, 2006, FEMS MICROBIOL LETT, V255, P262, DOI 10.1111/j.1574-6968.2005.00077.x; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wyborn NR, 2002, MICROBIOL-SGM, V148, P1015, DOI 10.1099/00221287-148-4-1015	25	44	45	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25501	10.1371/journal.pone.0025501	http://dx.doi.org/10.1371/journal.pone.0025501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980479	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295933700040
J	Whipple, CA; Young, AL; Korc, M				Whipple, C. A.; Young, A. L.; Korc, M.			A Kras(G12D)-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis	ONCOGENE			English	Article						pancreatic cancer; glypican-1; proliferation; angiogenesis; tumor microenvironment	FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE; CARCINOMA CELLS; K-RAS; EXPRESSION; PROGRESSION; ADENOCARCINOMA; PROTEOGLYCAN; CHEMOTHERAPY; METASTASIS	Pancreatic ductal adenocarcinomas (PDACs) exhibit multiple molecular alterations and overexpress heparin-binding growth factors (HBGFs) and glypican-1 (GPC1), a heparan sulfate proteoglycan that promotes efficient signaling by HBGFs. It is not known, however, whether GPC1 has a role in genetic mouse models of PDAC. Therefore, we generated a GPC1 null mouse that combines pancreas-specific Cre-mediated activation of oncogenic Kras (Kras(G12D)) with deletion of a conditional INK4A/Arf allele (Pdx1-Cre; LSL-Kras(G12D); INK4A/Arf(lox/lox); GPC1(-/-) mice). By comparison with Pdx1-Cre; LSL-Kras(G12D); INK4A/Arf(lox/lox) mice that were wild type for GPC1, the Pdx1-Cre; LSL-Kras(G12D); INK4A/Arf(lox/lox); GPC1(-/-) mice exhibited attenuated pancreatic tumor growth and invasiveness, decreased cancer cell proliferation and mitogen-activated protein kinase activation. These mice also exhibited suppressed angiogenesis in conjunction with decreased expression of messenger RNAs encoding several pro-angiogenic factors and molecules, including vascular endothelial growth factor-A (VEGF-A), SRY-box containing gene (SOX17), chemokine C-X3-C motif ligand 1 (CX3CL1) and integrin beta 3 (ITGB3). Moreover, pancreatic cancer cells isolated from the tumors of GPC1(-/-) mice were not as invasive in response to fibroblast growth factor-2 (FGF-2) as cancer cells isolated from wild-type mice, and formed smaller tumors that exhibited an attenuated metastatic potential. Similarly, VEGF-A and FGF-2 did not enhance the migration of hepatic endothelial cells and immortalized murine embryonic fibroblasts isolated from GPC1 null mice. These data demonstrate in an oncogenic Kras-driven genetic mouse model of PDAC that tumor growth, angiogenesis and invasion are enhanced by GPC1, and suggest that suppression of GPC1 may be an important component of therapeutic strategies in PDAC. Oncogene (2012) 31, 2535-2544; doi:10.1038/onc.2011.430; published online 26 September 2011	[Korc, M.] Dartmouth Hitchcock Med Ctr, Dept Med, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Whipple, C. A.; Young, A. L.; Korc, M.] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Whipple, C. A.; Young, A. L.; Korc, M.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Dartmouth College	Korc, M (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Med, Norris Cotton Canc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	murray.korc@dartmouth.edu			US Public Health Service [CA-R37-075059]; National Cancer Institute [F32 CA-144579]; NATIONAL CANCER INSTITUTE [R01CA075059, F32CA144579, R37CA075059] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Daniel Longnecker (Dartmouth Medical School) for his expert assistance in the evaluation of pancreatic tumor pathology. This work was supported by two US Public Health Service Grant (CA-R37-075059) awarded to MK. CAW was supported by a Ruth L Kirschstein National Research Service Award, F32 CA-144579 from the National Cancer Institute.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Arnold NB, 2004, CANCER RES, V64, P3599, DOI 10.1158/0008-5472.CAN-03-2999; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Berman B, 1999, J BIOL CHEM, V274, P36132, DOI 10.1074/jbc.274.51.36132; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Cepko CP, 1996, RETROVIRUS INFECT CE, P91411; CHANG SC, 1990, J NUTR, V120, P1228, DOI 10.1093/jn/120.10.1228; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Cheng N, 2002, MOL CANCER RES, V1, P2; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Kleeff J, 1999, PANCREAS, V19, P281, DOI 10.1097/00006676-199910000-00009; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Korc M, 2003, Mol Cancer, V2, P8, DOI 10.1186/1476-4598-2-8; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Li AH, 2011, TRANSL ONCOL, V4, P20, DOI 10.1593/tlo.10184; Matsuda K, 2001, CANCER RES, V61, P5562; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Preis M, 2010, CANCER BIOL THER, V9, P754, DOI 10.4161/cbt.9.10.11534; Rowland-Goldsmith MA, 2002, MOL CANCER THER, V1, P161; Rowland-Goldsmith MA, 2001, CLIN CANCER RES, V7, P2931; Schneider Gunter, 2003, Mol Cancer, V2, P15, DOI 10.1186/1476-4598-2-15; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Suyama E, 2003, P NATL ACAD SCI USA, V100, P5616, DOI 10.1073/pnas.1035850100; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; Vilar E, 2007, ENDOCR-RELAT CANCER, V14, P221, DOI 10.1677/ERC-06-0074; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	46	57	63	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	20					2535	2544		10.1038/onc.2011.430	http://dx.doi.org/10.1038/onc.2011.430			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21996748	Green Accepted			2022-12-25	WOS:000304191800004
J	Schneider, DJ; Wu, MH; Le, TT; Cho, SH; Brenner, MB; Blackburn, MR; Agarwal, SK				Schneider, Daniel J.; Wu, Minghua; Le, Thuy T.; Cho, Seo-Hee; Brenner, Michael B.; Blackburn, Michael R.; Agarwal, Sandeep K.			Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition	FASEB JOURNAL			English	Article						macrophage; extracellular matrix; lung; alveolar; fibroblast	GROWTH-FACTOR-BETA; GENE-EXPRESSION; N-CADHERIN; CELLS; TGF-BETA-1; INFLAMMATION; MECHANISMS; DISEASE; DIFFERENTIATION; MYOFIBROBLASTS	Pulmonary fibrosis, characterized by excess deposition of extracellular matrix by myofibroblasts, is a serious component of chronic lung diseases. Cadherin-11 (CDH11) is increased in wound healing and fibrotic skin. We hypothesized that CDH11 is increased in pulmonary fibrosis and contributes its development. CDH11 expression was assessed in lung tissue from idiopathic pulmonary fibrosis patients. The role of CDH11 in lung fibrosis was determined using the bleomycin model of pulmonary fibrosis, and in vitro analyses were performed on A549 cells during the process of epithelial to mesenchymal transition (EMT). Immunohistochemical studies demonstrated CDH11 expression on fibroblasts, epithelial cells, and alveolar macrophages of patients with pulmonary fibrosis and mice given bleomycin. Interestingly, CDH11-deficient mice had decreased fibrotic endpoints in the bleomycin model of pulmonary fibrosis compared to wild-type mice. Furthermore, anti-CDH11-neutralizing monoclonal antibodies successfully treated established pulmonary fibrosis induced by bleomycin. TGF-beta levels were reduced in bronchoalveolar lavage (BAL) fluid, BAL cells, and primary alveolar macrophages from CDH11-deficient mice. Mechanistic studies demonstrated that TGF-beta up-regulated CDH11 expression on A549 cells, and inhibition of CDH11 expression using siRNA reduced TGF-beta -induced EMT. Together, these results identify CDH11 as a novel therapeutic target for pulmonary fibrosis. Schneider, D. J., Wu, M., Le, T. T., Cho, S.-H., Brenner, M. B., Blackburn, M. R., Agarwal, S. K. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF beta production and epithelial to mesenchymal transition. FASEB J. 26, 503-512 (2012). www.fasebj.org	[Schneider, Daniel J.; Le, Thuy T.; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX USA; [Wu, Minghua; Agarwal, Sandeep K.] Univ Texas Hlth Sci Ctr, Div Rheumatol & Clin Immunogenet, Dept Internal Med, Houston, TX USA; [Cho, Seo-Hee] Univ Texas Hlth Sci Ctr, Dept Pediat, Pediat Res Ctr, Houston, TX USA; [Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Agarwal, SK (corresponding author), Baylor Coll Med, Dept Med, Sect Allergy Immunol & Rheumatol, Biol Inflammat Ctr, 1 Baylor Plaza,Suite 672E,MS BCM285, Houston, TX 77030 USA.	skagarwa@bcm.edu		Blackburn, Michael/0000-0002-1394-9966	U.S. National Institutes of Health (NIH) [HL095401, HL70952]; NIH [TL1RR024147, 5T32AR052283-03, K08AR054404]; Scleroderma Foundation; Synovex Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095401, R01HL070952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054404, T32AR052283] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; Synovex Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) grants HL095401 and HL70952 (M. R. B), NIH training awards TL1RR024147 (D.J.S.) and 5T32AR052283-03 (M. W.), and NIH grant K08AR054404 and a Scleroderma Foundation New Investigator Award (S. K. A.). The authors declare that M. B. B. owns equity options and has received consulting fees from Synovex Corporation.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Borchers A, 2001, DEVELOPMENT, V128, P3049; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Forino M, 2006, INT J EXP PATHOL, V87, P197, DOI 10.1111/j.1365-2613.2006.00479.x; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Homer RJ, 2002, AM J PHYSIOL-LUNG C, V283, pL52, DOI 10.1152/ajplung.00438.2001; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; Jeffery PK, 1999, CLIN EXP ALLERGY, V29, P14, DOI 10.1046/j.1365-2222.1999.00004.x-i2; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; Katzenstein ALA, 2002, AM J SURG PATHOL, V26, P1567, DOI 10.1097/00000478-200212000-00004; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kiener HP, 2009, ARTHRITIS RHEUM-US, V60, P1305, DOI 10.1002/art.24453; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pishvaian MJ, 1999, CANCER RES, V59, P947; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Reneker LW, 2010, BRAIN RES BULL, V81, P287, DOI 10.1016/j.brainresbull.2009.10.019; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schneider DJ, 2010, FASEB J, V24, P70, DOI 10.1096/fj.09-140772; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Takao S, 2000, Hum Cell, V13, P15; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xiao YQ, 2008, J IMMUNOL, V181, P3575, DOI 10.4049/jimmunol.181.5.3575; Yu Q, 2000, GENE DEV, V14, P163; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	63	106	113	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					503	512		10.1096/fj.11-186098	http://dx.doi.org/10.1096/fj.11-186098			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	21990376	Green Published			2022-12-25	WOS:000300485700004
J	Wang, SA; Li, HY; Hsu, TI; Chen, SH; Wu, CJ; Chang, WC; Hung, JJ				Wang, Shao-An; Li, Hao-Yi; Hsu, Tsung-I; Chen, Shu-Hui; Wu, Chin-Jen; Chang, Wen-Chang; Hung, Jan-Jong			Heat Shock Protein 90 Stabilizes Nucleolin to Increase mRNA Stability in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; BINDING PROTEIN; HSP90; CELLS; RECEPTORS; EXPRESSION; CANCER; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION	Most studies on heat shock protein 90 (Hsp90) have focused on the involvement of Hsp90 in the interphase, whereas the role of this protein in the nucleus during mitosis remains largely unclear. In this study, we found that the level of the acetylated form of Hsp90 decreased dramatically during mitosis, which indicates more chaperone activity during mitosis. We thus probed proteins that interacted with Hsp90 by liquid chromatography/mass spectrometry (LC/MS) and found that nucleolin was one of those interacting proteins during mitosis. The nucleolin level decreased upon geldanamycin treatment, and Hsp90 maintained the cyclin-dependent kinase 1 (CDK1) activity to phosphorylate nucleolin at Thr-641/707. Mutation of Thr641/707 resulted in the destabilization of nucleolin in mitosis. We globally screened the level of mitotic mRNAs and found that 229 mRNAs decreased during mitosis in the presence of geldanamycin. Furthermore, a bioinformatics tool and an RNA immunoprecipitation assay found that 16 mRNAs, including cadherin and Bcl-xl, were stabilized through the recruitment of nucleolin to the 3' -untranslated regions (3'-UTRs) of those genes. Overall, strong correlations exist between the up-regulation of Hsp90, nucleolin, and the mRNAs related to tumorigenesis of the lung. Our findings thus indicate that nucleolin stabilized by Hsp90 contributes to the lung tumorigenesis by increasing the level of many tumor-related mRNAs during mitosis.	[Wang, Shao-An; Li, Hao-Yi; Hsu, Tsung-I; Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct Res, Coll Sci, Tainan 701, Taiwan; [Chen, Shu-Hui; Wu, Chin-Jen] Natl Cheng Kung Univ, Coll Sci, Dept Chem, Tainan 701, Taiwan; [Hung, Jan-Jong] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Hsu, Tsung-I; Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw	Hsu, Tsung-I/AAK-9942-2020	Hsu, Tsung-I/0000-0002-7524-7740; Wang, Shao-an/0000-0002-5473-4195	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan [NSC 99-2320-B-006-031-MY3, NSC 100-2321-B-006-011]	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan	This work was supported by the National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan, Grants NSC 99-2320-B-006-031-MY3 and NSC 100-2321-B-006-011.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; ALCAIDE JRC, 2006, CLIN TRANSL ONCOL, V8, P148; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; CAIZERGUESFERRER M, 1989, GENE DEV, V3, P324, DOI 10.1101/gad.3.3.324; Chen CY, 2000, GENE DEV, V14, P1236; Citri A, 2004, CELL CYCLE, V3, P51; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; ERARD M, 1990, EUR J BIOCHEM, V191, P19, DOI 10.1111/j.1432-1033.1990.tb19088.x; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Garfinkel Mark D, 2004, Methods Mol Biol, V287, P151; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 1999, J CELL SCI, V112, P761; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Katafiasz BJ, 2003, J BIOL CHEM, V278, P27513, DOI 10.1074/jbc.M304119200; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mazzucchelli R, 2004, ANAL QUANT CYTOL, V26, P127; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rothstein TL, 2000, CELL RES, V10, P245, DOI 10.1038/sj.cr.7290053; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schulz S, 2006, J HISTOCHEM CYTOCHEM, V54, P1015, DOI 10.1369/jhc.6A6966.2006; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Steinman RA, 2007, LEUKEMIA, V21, P1158, DOI 10.1038/sj.leu.2404656; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang SA, 2009, J MOL BIOL, V387, P1106, DOI 10.1016/j.jmb.2009.02.040; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130	56	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43816	43829		10.1074/jbc.M111.310979	http://dx.doi.org/10.1074/jbc.M111.310979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998300	Green Published, hybrid			2022-12-25	WOS:000298402300024
J	de Souza, AR; Zago, M; Pollock, SJ; Sime, PJ; Phipps, RP; Baglole, CJ				de Souza, Angela Rico; Zago, Michela; Pollock, Stephen J.; Sime, Patricia J.; Phipps, Richard P.; Baglole, Carolyn J.			Genetic Ablation of the Aryl Hydrocarbon Receptor Causes Cigarette Smoke-induced Mitochondrial Dysfunction and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; HUMAN LUNG FIBROBLASTS; CELL-DEATH; QUANTITATIVE-DETERMINATION; DECREASED EXPRESSION; OXIDATIVE STRESS; HEME OXYGENASE-1; IN-VITRO; T-CELL; INDUCTION	Cigarette smoke is the primary risk factor for chronic obstructive pulmonary disease (COPD). Alterations in the balance between apoptosis and proliferation are involved in the etiology of COPD. Fibroblasts and epithelial cells are sensitive to the oxidative properties of cigarette smoke, and whose loss may precipitate the development of COPD. Fibroblasts express the aryl hydrocarbon receptor (AhR), a transcription factor that attenuates pulmonary inflammation and may also regulate apoptosis. We hypothesized the AhR would prevent apoptosis caused by cigarette smoke. Using genetically deleted in vitro AhR expression models and an established method of cigarette smoke exposure, we report that AhR expression regulates fibroblasts proliferation and prevents morphological features of apoptosis, including membrane blebbing and chromatin condensation caused by cigarette smoke extract (CSE). Absence of AhR expression results in cleavage of PARP, lamin, and caspase-3. Mitochondrial dysfunction, including cytochrome c release, was associated with loss of AhR expression, indicating activation of the intrinsic apoptotic cascade. Heightened sensitivity of AhR-deficient fibroblasts was not the result of alterations in GSH, Nrf2, or HO-1 expression. Instead, AhR(-/-) cells had significantly less MnSOD and CuZn-SOD expression, enzymes that protects against oxidative stress. The ability of the AhR to suppress apoptosis was not restricted to fibroblasts, as siRNA-mediated knockdown of the AhR in lung epithelial cells also increased sensitivity to smoke-induced apoptosis. Collectively, these results suggest that cigarette smoke induced loss of lung structural support (i.e. fibroblasts, epithelial cells) caused by aberrations in AhR expression may explain why some smokers develop lung diseases such as COPD.	[de Souza, Angela Rico; Zago, Michela] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H2X 2P2, Canada; [Zago, Michela; Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; [Pollock, Stephen J.; Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [Sime, Patricia J.] Univ Rochester, Dept Med, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14642 USA	McGill University; McGill University; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Baglole, CJ (corresponding author), 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	Carolyn.baglole@McGill.ca		Pollock, Stephen/0000-0002-2091-1675	National Institutes of Health [HL075432, HL088325, HL04492, ES01247]; American Thoracic Society; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075432, R01HL088325, K08HL004492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075432, HL088325, HL04492, and ES01247, an American Thoracic Society Research Grant, the Department of Medicine at McGill University, and the Research Institute of the McGill University Health Centre.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Eltom SE, 1998, CARCINOGENESIS, V19, P1437, DOI 10.1093/carcin/19.8.1437; Emmert SW, 2010, BIOORG MED CHEM LETT, V20, P2675, DOI 10.1016/j.bmcl.2010.01.044; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Joseph A, 2008, FREE RADICAL BIO MED, V45, P1143, DOI 10.1016/j.freeradbiomed.2008.07.006; Karaflou M, 2008, MINI-REV MED CHEM, V8, P912, DOI 10.2174/138955708785132765; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lehmann GM, 2011, AM J PATHOL, V178, P1556, DOI 10.1016/j.ajpath.2010.12.025; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Loo DT, 1998, METHOD CELL BIOL, V57, P251; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Mulligan RM, 2009, AM J RHINOL ALLERGY, V23, pE1, DOI 10.2500/ajra.2009.23.3400; Nagata K, 2007, RESP MED, V101, P800, DOI 10.1016/j.rmed.2006.07.017; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niittynen M, 2008, TOXICOLOGY, V250, P132, DOI 10.1016/j.tox.2008.06.014; Ohnishi K, 1998, LAB INVEST, V78, P1077; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Padilla J, 2002, CLIN IMMUNOL, V103, P22, DOI 10.1006/clim.2001.5181; Park Jeong-Woong, 2007, COPD, V4, P347, DOI 10.1080/15412550701603775; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Peraza MA, 2006, J APPL TOXICOL, V26, P356, DOI 10.1002/jat.1149; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; Rogers RJ, 2001, J BIOL CHEM, V276, P20419, DOI 10.1074/jbc.M008915200; Ryu DY, 1999, J BIOCHEM MOL TOXIC, V13, P249, DOI 10.1002/(SICI)1099-0461(1999)13:5<249::AID-JBT4>3.0.CO;2-L; Sampsonas F, 2006, CURR MED CHEM, V13, P2857, DOI 10.2174/092986706778521922; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Scovassi AI, 2009, ANN NY ACAD SCI, V1171, P12, DOI 10.1111/j.1749-6632.2009.04707.x; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tanaka KI, 2011, J PHARMACOL EXP THER, V338, P810, DOI 10.1124/jpet.111.179051; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weydert C, 2003, MOL CANCER THER, V2, P361; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Zavitz CCJ, 2008, CELL IMMUNOL, V253, P38, DOI 10.1016/j.cellimm.2008.04.012; Zhivotosky B., 2001, CURR PROTOC CELL BIO	74	66	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43214	43228		10.1074/jbc.M111.258764	http://dx.doi.org/10.1074/jbc.M111.258764			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21984831	hybrid, Green Published			2022-12-25	WOS:000298351300042
J	Capyk, JK; Casabon, I; Gruninger, R; Strynadka, NC; Eltis, LD				Capyk, Jenna K.; Casabon, Israeel; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.			Activity of 3-Ketosteroid 9 alpha-Hydroxylase (KshAB) Indicates Cholesterol Side Chain and Ring Degradation Occur Simultaneously in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS DSM43269; ERYTHROPOLIS SQ1; MONOOXYGENASE; MACROPHAGES; IDENTIFICATION; DEHYDROGENASE; PERSISTENCE; OXYGENASE; REQUIRES; ENZYMES	Mycobacterium tuberculosis (Mtb), a significant global pathogen, contains a cholesterol catabolic pathway. Although the precise role of cholesterol catabolism in Mtb remains unclear, the Rieske monooxygenase in this pathway, 3-ketosteroid 9 alpha-hydroxylase (KshAB), has been identified as a virulence factor. To investigate the physiological substrate of KshAB, a rhodococcal acyl-CoA synthetase was used to produce the coenzyme A thioesters of two cholesterol derivatives: 3-oxo-23,24-bisnorchol-4-en-22-oic acid (forming 4-BNC-CoA) and 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid (forming 1,4-BNC-CoA). The apparent specificity constant (k(cat)/K-m) of KshAB for the CoA thioester substrates was 20-30 times that for the corresponding 17-keto compounds previously proposed as physiological substrates. The apparent K-mO2 was 90 +/- 10 mu M in the presence of 1,4-BNC-CoA, consistent with the value for two other cholesterol catabolic oxygenases. The Delta(1) ketosteroid dehydrogenase KstD acted with KshAB to cleave steroid ring B with a specific activity eight times greater for a CoA thioester than the corresponding ketone. Finally, modeling 1,4-BNC-CoA into the KshA crystal structure suggested that the CoA moiety, binds in a pocket at the mouth of the active site channel and could contribute to substrate specificity. These results indicate that the physiological substrates of KshAB are CoA thioester intermediates of cholesterol side chain degradation and that side chain and ring degradation occur concurrently in Mtb. This finding has implications for steroid metabolites potentially released by the pathogen during infection and for the design of inhibitors for cholesterol-degrading enzymes. The methodologies and rhodococcal enzymes used to generate thioesters will facilitate the further study of cholesterol catabolism.	[Capyk, Jenna K.; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Capyk, Jenna K.; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israeel; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mai.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institutes for Health Research; Natural Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Canadian Institutes for Health Research (to L. D. E.).; Recipient of a studentship from Natural Science and Engineering Research Council.	Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Birkenmaier A, 2007, J BACTERIOL, V189, P7165, DOI 10.1128/JB.00665-07; Brzostek A, 2005, MICROBIOL-SGM, V151, P2393, DOI 10.1099/mic.0.27953-0; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrusma M, 2009, APPL ENVIRON MICROB, V75, P5300, DOI 10.1128/AEM.00066-09; Petrusma M, 2011, J BACTERIOL, V193, P3931, DOI 10.1128/JB.00274-11; PULLEYBLANK D, 1983, MOL BIOL REP, V9, P191, DOI 10.1007/BF00775367; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Geize R, 2008, APPL ENVIRON MICROB, V74, P7197, DOI 10.1128/AEM.00888-08; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wilbrink MH, 2011, APPL ENVIRON MICROB, V77, P4455, DOI 10.1128/AEM.00380-11; WORLD HEALTH ORGANIZATION-WHO, 2010, GLOBAL OBSERVATORY E, V2; Yam KC, 2010, MICROBIOL MONOGR, V16, P133, DOI 10.1007/978-3-642-12937-7_6; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	36	65	72	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40717	40724		10.1074/jbc.M111.289975	http://dx.doi.org/10.1074/jbc.M111.289975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21987574	hybrid, Green Published			2022-12-25	WOS:000297315400032
J	Tromans, JM; Harris, M; Stringer, SM				Tromans, James Matthew; Harris, Mitchell; Stringer, Simon Maitland			A Computational Model of the Development of Separate Representations of Facial Identity and Expression in the Primate Visual System	PLOS ONE			English	Article							INVARIANT OBJECT RECOGNITION; MULTIPLE STIMULI PRESENT; SELF-ORGANIZATION; NEURONS; CORTEX; ORIENTATION; CONNECTIONS; INFORMATION; INHIBITION; ACTIVATION	Experimental studies have provided evidence that the visual processing areas of the primate brain represent facial identity and facial expression within different subpopulations of neurons. For example, in non-human primates there is evidence that cells within the inferior temporal gyrus (TE) respond primarily to facial identity, while cells within the superior temporal sulcus (STS) respond to facial expression. More recently, it has been found that the orbitofrontal cortex (OFC) of non-human primates contains some cells that respond exclusively to changes in facial identity, while other cells respond exclusively to facial expression. How might the primate visual system develop physically separate representations of facial identity and expression given that the visual system is always exposed to simultaneous combinations of facial identity and expression during learning? In this paper, a biologically plausible neural network model, VisNet, of the ventral visual pathway is trained on a set of carefully-designed cartoon faces with different identities and expressions. The VisNet model architecture is composed of a hierarchical series of four Self-Organising Maps (SOMs), with associative learning in the feedforward synaptic connections between successive layers. During learning, the network develops separate clusters of cells that respond exclusively to either facial identity or facial expression. We interpret the performance of the network in terms of the learning properties of SOMs, which are able to exploit the statistical indendependence between facial identity and expression.	[Tromans, James Matthew; Harris, Mitchell; Stringer, Simon Maitland] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, Oxon, England	University of Oxford	Tromans, JM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, Oxon, England.	james.tromans@psy.ox.ac.uk			The Economic and Social Research Council	The Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by The Economic and Social Research Council via a studentship awarded to J.M. Tromans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednar JA, 2006, NEUROCOMPUTING, V69, P1272, DOI 10.1016/j.neucom.2005.12.090; Bosking WH, 1997, J NEUROSCI, V17, P2112; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calder AJ, 2001, VISION RES, V41, P1179, DOI 10.1016/S0042-6989(01)00002-5; Choe Y, 1998, NEUROCOMPUTING, V21, P139, DOI 10.1016/S0925-2312(98)00040-X; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; Fox CJ, 2009, NEUROIMAGE, V44, P569, DOI 10.1016/j.neuroimage.2008.09.011; GARY GC, 2002, P 24 ANN C COGN SCI, P238; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; Hertz JA, 2018, INTRO THEORY NEURAL; Higgins IV, 2011, VISION RES, V51, P553, DOI 10.1016/j.visres.2011.01.016; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Rolls ET, 2006, EXP BRAIN RES, V170, P74, DOI 10.1007/s00221-005-0191-y; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SIROSH J, 1994, BIOL CYBERN, V71, P65, DOI 10.1007/BF00198912; Stringer SM, 2008, NEURAL NETWORKS, V21, P888, DOI 10.1016/j.neunet.2007.11.004; Stringer SM, 2007, NETWORK-COMP NEURAL, V18, P161, DOI 10.1080/09548980701556055; Stringer SM, 2002, NEURAL COMPUT, V14, P2585, DOI 10.1162/089976602760407982; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Stringer SM, 2000, NEURAL NETWORKS, V13, P305, DOI 10.1016/S0893-6080(00)00017-4; TROMANS JM, 2011, LEARNING SEPAR UNPUB; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001; WALLIS G, 1993, LEARNING INVARIANT R, V2, P1087; WALLIS G, 1997, INVARIANT FACE OBJEC; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Xu XK, 2010, J VISION, V10, DOI 10.1167/10.14.36	38	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25616	10.1371/journal.pone.0025616	http://dx.doi.org/10.1371/journal.pone.0025616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998673	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700014
J	Holman, RM; Carson, V; Janssen, I				Holman, Rebecca M.; Carson, Valerie; Janssen, Ian			Does the Fractionalization of Daily Physical Activity (Sporadic vs. Bouts) Impact Cardiometabolic Risk Factors in Children and Youth?	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK; ADOLESCENTS; POPULATION; FREQUENCY; HEALTH	Objective: Children and youth accumulate their daily moderate-to-vigorous physical activity (MVPA) in bouts (i.e., >= 5 consecutive minutes) and in a sporadic manner (i.e., <5 consecutive minutes). The study objective was to determine, within children and youth, whether MVPA accumulated in bouts is more strongly associated with cardiometabolic risk factors than an equivalent volume of MVPA accumulated sporadically. Methods: Participants consisted of 2754 children and youth aged 6-19 years from the 2003-2006 National Health and Nutrition Examination Survey, a representative cross-sectional study. Bouts and sporadic MVPA were measured objectively over 7 days using Actigraph accelerometers. Thresholds of 5 and 10 consecutive minutes were used to differentiate between bouts and sporadic MVPA. A high cardiometabolic risk factor score (CRS) was created based on measures of waist circumference, non-high-density lipoprotein cholesterol, C-reactive protein, and systolic blood pressure. Associations were examined using logistic regression and controlled for covariates (sex, age, ethnicity, socioeconomic status, dietary fat and sodium, smoking, and accelerometry wear time). Results: The odds of a high CRS decreased in a dose-response for both the sporadic and bout MVPA measures. Relative to quartile 1, the odds ratio (95% confidence interval) for a high CRS in quartile 4 was 0.25 (0.10-0.60) for sporadic MVPA, 0.17 (0.09-0.34) for >= 5 minute bouts of MVPA, and 0.19 (0.11-0.34) for >= 10 minute bouts of MVPA. The sporadic and bout MVPA measures had a similar ability to distinguish between participants with high and normal CRS. Relative to 0 minutes of MVPA, an equivalent number of minutes of sporadic MVPA and bouts of MVPA had an almost identical odds ratio for a high CRS. The findings were consistent for 5 and 10 minute bout thresholds. Conclusions: The relations between sporadic MVPA and bouts of MVPA with cardiometabolic risk factors were remarkably similar in children and youth.	[Holman, Rebecca M.; Carson, Valerie; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Holman, RM (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	ian.janssen@queenu.ca	Carson, Valerie/ABG-2853-2021; Janssen, Ian/B-7700-2009	Carson, Valerie/0000-0002-3009-3282; Janssen, Ian/0000-0003-2159-3012	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was supported by a research grant from the Heart and Stroke Foundation of Ontario. VC was supported by a doctoral scholarship from the Canadian Institutes of Health Research. IJ was supported by a Canada Research Chair and an Early Researcher Award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Colley Rachel, 2010, Health Rep, V21, P63; Cook Stephen, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.051; Eston RG, 1998, J APPL PHYSIOL, V84, P362, DOI 10.1152/jappl.1998.84.1.362; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gardner CD, 2000, AM J CARDIOL, V86, P299, DOI 10.1016/S0002-9149(00)00918-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Liu J, 2009, APPL PHYSIOL NUTR ME, V34, P136, DOI 10.1139/H08-149; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; McGuire KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020503; Moliner-Urdiales D, 2009, INT J OBESITY, V33, P1126, DOI 10.1038/ijo.2009.139; Oliveira AC, 2008, OBESITY, V16, P1094, DOI 10.1038/oby.2008.43; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rowlands AV, 2007, J SPORT SCI MED, V6, P270; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; U.S. Census Bureau Population Division Fertility Family Statistics Branch, 2004, CURR POP SURV DEF EX; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; *US DEP HHS, 2005, US DEP AGR DIET GUID; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	30	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25733	10.1371/journal.pone.0025733	http://dx.doi.org/10.1371/journal.pone.0025733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998688	gold, Green Published, Green Submitted			2022-12-25	WOS:000295966900049
J	Magnee, MJCM; Lamme, VAF; de Sain-van der Velden, MGM; Vorstman, JAS; Kemner, C				Magnee, Maurice J. C. M.; Lamme, Victor A. F.; de Sain-van der Velden, Monique G. M.; Vorstman, Jacob A. S.; Kemner, Chantal			Proline and COMT Status Affect Visual Connectivity in Children with 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; FIGURE-GROUND SEGREGATION; VELOCARDIOFACIAL SYNDROME; CHROMOSOME 22Q11; SPECTRUM DISORDERS; SCHIZOPHRENIA; BRAIN; ADULTS; AUTISM; PERCEPTION	Background: Individuals with the 22q11.2 deletion syndrome (22q11DS) are at increased risk for schizophrenia and Autism Spectrum Disorders (ASDs). Given the prevalence of visual processing deficits in these three disorders, a causal relationship between genes in the deleted region of chromosome 22 and visual processing is likely. Therefore, 22q11DS may represent a unique model to understand the neurobiology of visual processing deficits related with ASD and psychosis. Methodology: We measured Event-Related Potentials (ERPs) during a texture segregation task in 58 children with 22q11DS and 100 age-matched controls. The C1 component was used to index afferent activity of visual cortex area V1; the texture negativity wave provided a measure for the integrity of recurrent connections in the visual cortical system. COMT genotype and plasma proline levels were assessed in 22q11DS individuals. Principal Findings: Children with 22q11DS showed enhanced feedforward activity starting from 70 ms after visual presentation. ERP activity related to visual feedback activity was reduced in the 22q11DS group, which was seen as less texture negativity around 150 ms post presentation. Within the 22q11DS group we further demonstrated an association between high plasma proline levels and aberrant feedback/feedforward ratios, which was moderated by the COMT 158 genotype. Conclusions: These findings confirm the presence of early visual processing deficits in 22q11DS. We discuss these in terms of dysfunctional synaptic plasticity in early visual processing areas, possibly associated with deviant dopaminergic and glutamatergic transmission. As such, our findings may serve as a promising biomarker related to the development of schizophrenia among 22q11DS individuals.	[Magnee, Maurice J. C. M.; Vorstman, Jacob A. S.; Kemner, Chantal] Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Lamme, Victor A. F.] Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; [de Sain-van der Velden, Monique G. M.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [de Sain-van der Velden, Monique G. M.] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands; [Magnee, Maurice J. C. M.; Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Magnee, MJCM (corresponding author), Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	M.J.C.M.Magnee@umcutrecht.nl			Netherlands Organization for Scientific Research [402-01-094]; Utrecht University; European Research Council	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council(European Research Council (ERC)European Commission)	The work described was supported by an Innovational Research Incentives grant (VIDI-scheme, 402-01-094) of The Netherlands Organization for Scientific Research, a Neuroscience and Cognition Utrecht grant from Utrecht University to Chantal Kemner and an European Research Council advanced investigator grant to Victor Lamme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, BIOL PSYCHIAT, V63, P49, DOI 10.1016/j.biopsych.2007.02.022; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Baker KD, 2005, BRIT J PSYCHIAT, V186, P115, DOI 10.1192/bjp.186.2.115; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Campbell LE, 2006, BRAIN, V129, P1218, DOI 10.1093/brain/awl066; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cohen SM, 1997, BRAIN RES, V769, P333, DOI 10.1016/S0006-8993(97)00721-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Feinstein C, 2002, BIOL PSYCHIAT, V51, P312, DOI 10.1016/S0006-3223(01)01231-8; Fine SE, 2005, J AUTISM DEV DISORD, V35, P461, DOI 10.1007/s10803-005-5036-9; Foxe JJ, 2008, BRAIN TOPOGR, V21, P11, DOI 10.1007/s10548-008-0063-4; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jolij J, 2007, NEUROREPORT, V18, P39, DOI 10.1097/01.wnr.0000236863.46952.a6; Kates WR, 2001, BIOL PSYCHIAT, V49, P677, DOI 10.1016/S0006-3223(00)01002-7; Lajiness-O'Neill RR, 2005, CHILD NEUROPSYCHOL, V11, P55, DOI 10.1080/09297040590911202; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1992, VISION RES, V32, P797, DOI 10.1016/0042-6989(92)90022-B; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lepage N, 1997, CLIN CHEM, V43, P2397; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mansour A M, 1987, J Pediatr Ophthalmol Strabismus, V24, P263; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Niklasson L, 2001, GENET MED, V3, P79, DOI 10.1097/00125817-200101000-00017; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; van Amelsvoort T, 2004, ARCH GEN PSYCHIAT, V61, P1085, DOI 10.1001/archpsyc.61.11.1085; Van Amelsvoort T, 2006, BRIT J PSYCHIAT, V189, P560, DOI 10.1192/bjp.bp.105.019876; Vandenbroucke MWG, 2008, BRAIN, V131, P1013, DOI 10.1093/brain/awm321; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wang PP, 2000, DEV MED CHILD NEUROL, V42, P422, DOI 10.1017/S0012162200000785	54	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25882	10.1371/journal.pone.0025882	http://dx.doi.org/10.1371/journal.pone.0025882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998713	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900067
J	Manente, AG; Pinton, G; Tavian, D; Lopez-Rodas, G; Brunelli, E; Moro, L				Manente, Arcangela Gabriella; Pinton, Giulia; Tavian, Daniela; Lopez-Rodas, Gerardo; Brunelli, Elisa; Moro, Laura			Coordinated Sumoylation and Ubiquitination Modulate EGF Induced EGR1 Expression and Stability	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-SURVIVAL; A EGR-1; GROWTH; INDUCTION; APOPTOSIS; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION	Background: Human early growth response-1 (EGR1) is a member of the zing-finger family of transcription factors induced by a range of molecular and environmental stimuli including epidermal growth factor (EGF). In a recently published paper we demonstrated that integrin/EGFR cross-talk was required for Egr1 expression through activation of the Erk1/2 and PI3K/Akt/Forkhead pathways. EGR1 activity and stability can be influenced by many different post-translational modifications such as acetylation, phosphorylation, ubiquitination and the recently discovered sumoylation. The aim of this work was to assess the influence of sumoylation on EGF induced Egr1 expression and/or stability. Methods: We modulated the expression of proteins involved in the sumoylation process in ECV304 cells by transient transfection and evaluated Egr1 expression in response to EGF treatment at mRNA and protein levels. Results: We demonstrated that in ECV304 cells Egr1 was transiently induced upon EGF treatment and a fraction of the endogenous protein was sumoylated. Moreover, SUMO-1/Ubc9 over-expression stabilized EGF induced ERK1/2 phosphorylation and increased Egr1 gene transcription. Conversely, in SUMO-1/Ubc9 transfected cells, EGR1 protein levels were strongly reduced. Data obtained from protein expression and ubiquitination analysis, in the presence of the proteasome inhibitor MG132, suggested that upon EGF stimuli EGR1 sumoylation enhanced its turnover, increasing ubiquitination and proteasome mediated degradation. Conclusions: Here we demonstrate that SUMO-1 modification improving EGR1 ubiquitination is involved in the modulation of its stability upon EGF mediated induction.	[Manente, Arcangela Gabriella; Pinton, Giulia; Brunelli, Elisa; Moro, Laura] Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy; [Tavian, Daniela] Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy; [Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem, Valencia, Spain	University of Eastern Piedmont Amedeo Avogadro; Catholic University of the Sacred Heart; University of Valencia	Manente, AG (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy.	moro@pharm.unipmn.it	Moro, Laura/ABF-2175-2020; Pinton, Giulia/ABF-2199-2020; tavian, daniela/AAE-4584-2020; LOPEZ-RODAS, GERARDO/I-1349-2015	LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Moro, Laura/0000-0003-3421-2522; Pinton, Giulia/0000-0003-0496-0378	Italian Ministry for Research; Ministerio de Ciencia y Tecnologia [BFU2007-63120]	Italian Ministry for Research(Ministry of Education, Universities and Research (MIUR)); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Italian Ministry for Research to LM and by Ministerio de Ciencia y Tecnologia (BFU2007-63120) to GL-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Bae MH, 2002, BBA-MOL CELL RES, V1592, P163, DOI 10.1016/S0167-4889(02)00310-5; Bae SK, 1999, CANCER RES, V59, P5989; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Blume A, 2009, BRAIN RES, V1302, P34, DOI 10.1016/j.brainres.2009.09.047; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; CAO XM, 1993, J BIOL CHEM, V268, P16949; CAO XM, 1992, J BIOL CHEM, V267, P12991; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, P1; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Huang RP, 1998, CELL DEATH DIFFER, V5, P96, DOI 10.1038/sj.cdd.4400322; HUANG RP, 1995, ONCOGENE, V10, P467; Jeong SH, 2010, EXP DERMATOL, V19, pE206, DOI 10.1111/j.1600-0625.2009.01050.x; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Liu CT, 1998, CANCER GENE THER, V5, P3; Liu T, 2005, BRIT J CANCER, V93, P310, DOI 10.1038/sj.bjc.6602700; Mayer SI, 2009, J CELL SCI, V122, P3340, DOI 10.1242/jcs.048272; MITEVA M, 2010, SUMOYLATION SIGNAL P; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; PYU J, 2009, EMBO J, V28, P21; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; SUKHATME VP, 1991, AM J KIDNEY DIS, V17, P615, DOI 10.1016/S0272-6386(12)80333-7; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Tang KF, 2010, BBA-GEN SUBJECTS, V1800, P380, DOI 10.1016/j.bbagen.2009.11.009; Teutschbein J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-386; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	41	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25676	10.1371/journal.pone.0025676	http://dx.doi.org/10.1371/journal.pone.0025676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998680	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900043
J	Ashley, JW; Shi, ZQ; Zhao, HB; Li, XS; Kesterson, RA; Feng, X				Ashley, Jason W.; Shi, Zhenqi; Zhao, Haibo; Li, Xingsheng; Kesterson, Robert A.; Feng, Xu			Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional Osteoclasts	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MACROSIALIN MOUSE CD68; VESICULAR TRAFFICKING; SURFACE EXPRESSION; KUPFFER CELLS; MACROPHAGES; RESORPTION; RECEPTOR; PROTEIN; IDENTIFICATION	CD68 is a member of the lysosome associated membrane protein (LAMP) family that is restricted in its expression to cells of the monocyte/macrophage lineage. This lineage restriction includes osteoclasts, and, while previous studies of CD68 in macrophages and dendritic cells have proposed roles in lipid metabolism, phagocytosis, and antigen presentation, the expression and function of CD68 in osteoclasts have not been explored. In this study, we investigated the expression and localization of CD68 in macrophages and osteoclasts in response to the monocyte/macrophage-colony stimulating factor (M-CSF) and the receptor activator of NF-kappa B ligand (RANKL). We found that M-CSF stimulates CD68 expression and RANKL alters the apparent molecular weight of CD68 as measured by Western immunoblotting. In addition, we explored the significance of CD68 expression in osteoclasts by generating mice that lack expression of CD68. These mice have increased trabecular bone, and in vitro assessment of CD68(-/-) osteoclasts revealed that, in the absence of CD68, osteoclasts demonstrate an accumulation of intracellular vesicle-like structures, and do not efficiently resorb bone. These findings demonstrate a role for CD68 in the function of osteoclasts, and future studies will determine the mechanistic nature of the defects seen in CD68(-/-) osteoclasts.	[Ashley, Jason W.; Shi, Zhenqi; Feng, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zhao, Haibo] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Li, Xingsheng] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ashley, JW (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	xufeng@uab.edu	Zhao, Haibo/ABG-9729-2021; Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; ZHAO, HAIBO/0000-0003-0836-7555	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR47830]; University of Alabama at Birmingham's Center for Metabolic Bone Disease [T32 AR047512-09]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047512, R01AR047830] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Alabama at Birmingham's Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grant number AR47830 (to XF) from National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and a training fellowship (to JWA) from the University of Alabama at Birmingham's Center for Metabolic Bone Disease (T32 AR047512-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakangas A, 2002, CALCIFIED TISSUE INT, V70, P40, DOI 10.1007/s002230010047; ATHANASOU NA, 1991, J CLIN PATHOL, V44, P664, DOI 10.1136/jcp.44.8.664; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; de Beer MC, 2003, J LIPID RES, V44, P674, DOI 10.1194/jlr.M200444-JLR200; Gough PJ, 2003, BLOOD, V101, P485, DOI 10.1182/blood-2002-07-2131; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Hall SL, 2007, MOL THER, V15, P1881, DOI 10.1038/sj.mt.6300258; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kurushima H, 2000, J LEUKOCYTE BIOL, V67, P104, DOI 10.1002/jlb.67.1.104; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Li S, 2011, J LIPID RES, V52, P1542; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P1414; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Pavlos NJ, 2005, MOL CELL BIOL, V25, P5253, DOI 10.1128/MCB.25.12.5253-5269.2005; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RAMPRASAD MP, 1995, P NATL ACAD SCI USA, V92, P9580, DOI 10.1073/pnas.92.21.9580; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Taylor R, 2011, J PATHOL, V225, P195, DOI 10.1002/path.2869; TOMITA M, 1994, HEPATOLOGY, V20, P317, DOI 10.1002/hep.1840200208; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; vanderKooij MA, 1997, ARTERIOSCL THROM VAS, V17, P3107, DOI 10.1161/01.ATV.17.11.3107; VanVelzen AG, 1997, BIOCHEM J, V322, P411; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Zeibig S, 2011, CIRC RES, V108, P695, DOI 10.1161/CIRCRESAHA.111.240515; Zhao HB, 2006, J BONE MINER RES, V21, P456, DOI 10.1359/JBMR.051204; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	42	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25838	10.1371/journal.pone.0025838	http://dx.doi.org/10.1371/journal.pone.0025838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991369	Green Submitted, gold, Green Published			2022-12-25	WOS:000295943000083
J	Kottler, B; Lampin-Saint-Amaux, A; Comas, D; Preat, T; Goguel, V				Kottler, Benjamin; Lampin-Saint-Amaux, Aurelie; Comas, Daniel; Preat, Thomas; Goguel, Valerie			Debra, a Protein Mediating Lysosomal Degradation, Is Required for Long-Term Memory in Drosophila	PLOS ONE			English	Article							OLFACTORY MEMORY; MUSHROOM BODY; GENE-EXPRESSION; CONSOLIDATED MEMORY; SYNAPTIC PLASTICITY; MELANOGASTER; UBIQUITIN; BODIES; PROTEASOME; NEURONS	A central goal of neuroscience is to understand how neural circuits encode memory and guide behavior changes. Many of the molecular mechanisms underlying memory are conserved from flies to mammals, and Drosophila has been used extensively to study memory processes. To identify new genes involved in long-term memory, we screened Drosophila enhancer-trap P(Gal4) lines showing Gal4 expression in the mushroom bodies, a specialized brain structure involved in olfactory memory. This screening led to the isolation of a memory mutant that carries a P-element insertion in the debra locus. debra encodes a protein involved in the Hedgehog signaling pathway as a mediator of protein degradation by the lysosome. To study debra's role in memory, we achieved debra overexpression, as well as debra silencing mediated by RNA interference. Experiments conducted with a conditional driver that allowed us to specifically restrict transgene expression in the adult mushroom bodies led to a long-term memory defect. Several conclusions can be drawn from these results: i) debra levels must be precisely regulated to support normal long-term memory, ii) the role of debra in this process is physiological rather than developmental, and iii) debra is specifically required for long-term memory, as it is dispensable for earlier memory phases. Drosophila long-term memory is the only long-lasting memory phase whose formation requires de novo protein synthesis, a process underlying synaptic plasticity. It has been shown in several organisms that regulation of proteins at synapses occurs not only at translation level of but also via protein degradation, acting in remodeling synapses. Our work gives further support to a role of protein degradation in long-term memory, and suggests that the lysosome plays a role in this process.	[Kottler, Benjamin; Lampin-Saint-Amaux, Aurelie; Comas, Daniel; Preat, Thomas; Goguel, Valerie] ESPCI, CNRS, Neurobiol Unit, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Kottler, B (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	valerie.goguel@espci.fr	Kottler, Benjamin/K-4073-2014; KOTTLER, Benjamin/ABC-5926-2020	Kottler, Benjamin/0000-0002-4551-5791; Preat, Thomas/0000-0001-9976-1763	Agence Nationale pour la Recherche; Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale; Ministry of Research; European Marie Curie Program	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); European Marie Curie Program(European Commission)	This work was supported by the Agence Nationale pour la Recherche, the Fondation Bettencourt-Schueller and the Fondation pour la Recherche Medicale (to TP). BK was supported by the Ministry of Research and by the Fondation pour la Recherche Medicale, and DC was supported by the European Marie Curie Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Berry J, 2008, PROG BRAIN RES, V169, P293, DOI 10.1016/S0079-6123(07)00018-0; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Boquet I, 2000, J NEUROBIOL, V42, P33; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabaud MA, 2009, CURR BIOL, V19, P1654, DOI 10.1016/j.cub.2009.08.017; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Copf T, 2011, P NATL ACAD SCI USA, V108, P8059, DOI 10.1073/pnas.1012919108; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Deshapriya RMC, 2007, ZOOL SCI, V24, P21, DOI 10.2108/zsj.24.21; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Khokhar A, 2008, GENETICS, V178, P1283, DOI 10.1534/genetics.106.065912; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Merlo E, 2007, NEUROSCIENCE, V147, P46, DOI 10.1016/j.neuroscience.2007.04.022; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Preat T, 1998, J NEUROSCI, V18, P8534; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Rodriguez-Ortiz CJ, 2011, NEUROBIOL LEARN MEM, V95, P311, DOI 10.1016/j.nlm.2010.12.010; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Szuperak M, 2005, GENE EXPR PATTERNS, V5, P717, DOI 10.1016/j.modgep.2005.02.004; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tseng ASK, 2002, GENETICS, V162, P229; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	54	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25902	10.1371/journal.pone.0025902	http://dx.doi.org/10.1371/journal.pone.0025902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991383	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000093
J	Alessandri, AL; Duffin, R; Leitch, AE; Lucas, CD; Sheldrake, TA; Dorward, DA; Hirani, N; Pinho, V; de Sousa, LP; Teixeira, MM; Lyons, JF; Haslett, C; Rossi, AG				Alessandri, Ana L.; Duffin, Rodger; Leitch, Andrew E.; Lucas, Christopher D.; Sheldrake, Tara A.; Dorward, David A.; Hirani, Nik; Pinho, Vanessa; de Sousa, Lirlandia Pires; Teixeira, Mauro M.; Lyons, John F.; Haslett, Christopher; Rossi, Adriano G.			Induction of Eosinophil Apoptosis by the Cyclin-Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; GRANULOCYTE APOPTOSIS; R-ROSCOVITINE; IN-VITRO; MACROPHAGE PHAGOCYTOSIS; NEUTROPHIL APOPTOSIS; AIRWAY INFLAMMATION; CASPASE INHIBITOR; CELL APOPTOSIS; TNF-ALPHA	Background: Eosinophils not only defend the body against parasitic infection but are also involved in pathological inflammatory allergic diseases such as asthma, allergic rhinitis and contact dermatitis. Clearance of apoptotic eosinophils by macrophages is a key process responsible for driving the resolution of eosinophilic inflammation and can be defective in allergic diseases. However, enhanced resolution of eosinophilic inflammation by deliberate induction of eosinophil apoptosis using pharmacological agents has not been previously demonstrated. Here we investigated the effect of a novel cyclin-dependent kinase inhibitor drug, AT7519, on human and mouse eosinophil apoptosis and examined whether it could enhance the resolution of a murine model of eosinophil-dominant inflammation in vivo. Methodology/Principal Findings: Eosinophils from blood of healthy donors were treated with AT7519 and apoptosis assessed morphologically and by flow-cytometric detection of annexin-V/propidium iodide staining. AT7519 induced eosinophil apoptosis in a concentration dependent manner. Therapeutic administration of AT7519 in eosinophil-dominant allergic inflammation was investigated using an established ovalbumin-sensitised mouse model of allergic pleurisy. Following ovalbumin challenge AT7519 was administered systemically at the peak of pleural inflammation and inflammatory cell infiltrate, apoptosis and evidence of macrophage phagocytosis of apoptotic eosinophils assessed at appropriate time points. Administration of AT7519 dramatically enhanced the resolution of allergic pleurisy via direct induction of eosinophil apoptosis without detriment to macrophage clearance of these cells. This enhanced resolution of inflammation was shown to be caspase-dependent as the effects of AT7519 were reduced by treatment with a broad spectrum caspase inhibitor (z-vad-fmk). Conclusions: Our data show that AT7519 induces human eosinophil apoptosis and enhances the resolution of a murine model of allergic pleurisy by inducing caspase-dependent eosinophil apoptosis and enhancing macrophage ingestion of apoptotic eosinophils. These findings demonstrate the utility of cyclin-dependent kinase inhibitors such as AT7519 as potential therapeutic agents for the treatment of eosinophil dominant allergic disorders.	[Alessandri, Ana L.; Duffin, Rodger; Leitch, Andrew E.; Lucas, Christopher D.; Sheldrake, Tara A.; Dorward, David A.; Hirani, Nik; Haslett, Christopher; Rossi, Adriano G.] Univ Edinburgh, Ctr Inflammat Res, Med Res Council, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Pinho, Vanessa; de Sousa, Lirlandia Pires; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Lyons, John F.] Astex Therapeut, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; Universidade Federal de Minas Gerais; Astex Pharmaceuticals	Alessandri, AL (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Med Res Council, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	rodger.duffin@ed.ac.uk	Dorward, David/K-8669-2012; Pinho, Vanessa/AAR-1686-2021; pinho, vanessa/AAC-8437-2020; Pinho, Vanessa/GXM-8532-2022; Teixeira, Mauro M/A-4587-2008	Dorward, David/0000-0002-4658-8829; pinho, vanessa/0000-0003-1038-2324; Teixeira, Mauro M/0000-0002-6944-3008; Sousa, Lirlandia/0000-0002-1042-9762; Duffin, Rodger/0000-0002-3425-9745; Lucas, Christopher/0000-0002-7523-0295	Medical Research Council [G0601481]; Wellcome Trust [WT082181, WT094415]; Chief Scientist Office (Scotland) [ETM/86]; MRC [G0901697, G0701740, G0601481] Funding Source: UKRI; Medical Research Council [G0701740, G9900991B, G0901697] Funding Source: researchfish; Chief Scientist Office [ETM/86] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office (Scotland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was funded by a Medical Research Council grant (G0601481) and Wellcome Trust grants (WT082181) and (WT094415). ALA is currently funded through a Chief Scientist Office (Scotland) awarded research grant: ETM/86. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; Brazil TJ, 2005, CLIN EXP ALLERGY, V35, P854, DOI 10.1111/j.1365-2222.2005.02231.x; Brode S, 2010, THORAX, V65, P1116, DOI 10.1136/thx.2009.124909; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Duffin R, 2009, FEBS LETT, V583, P2540, DOI 10.1016/j.febslet.2009.07.017; Duncan CJA, 2003, EUR RESPIR J, V22, P484, DOI 10.1183/09031936.03.00109803a; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Farahi N, 2011, CLIN EXP ALLERGY, V41, P673, DOI 10.1111/j.1365-2222.2010.03680.x; Fitzpatrick AM, 2008, J ALLERGY CLIN IMMUN, V121, P1372, DOI 10.1016/j.jaci.2008.03.008; Fujihara S, 2002, EUR J IMMUNOL, V32, P457, DOI 10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; HASLETT C, 1985, AM J PATHOL, V119, P101; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kuwano K, 2001, AM J PHYSIOL-LUNG C, V280, pL316, DOI 10.1152/ajplung.2001.280.2.L316; Leitch AE, 2008, MUCOSAL IMMUNOL, V1, P350, DOI 10.1038/mi.2008.31; Leitch AE, 2009, BRIT J PHARMACOL, V158, P1004, DOI 10.1111/j.1476-5381.2009.00402.x; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; MAHADEVAN D, 2011, ANN ONCOL, V16; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Mersmann J, 2008, RESUSCITATION, V79, P468, DOI 10.1016/j.resuscitation.2008.07.008; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Persson C, 2010, THORAX, V65, P1111, DOI 10.1136/thx.2009.133363; Pinho V, 2005, J LEUKOCYTE BIOL, V77, P800, DOI 10.1189/jlb.0704386; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Santo L, 2010, ONCOGENE, V29, P2325, DOI 10.1038/onc.2009.510; Senderowicz AM, 2003, CANCER BIOL THER, V2, pS84; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simon HU, 2001, IMMUNOL REV, V179, P156, DOI 10.1034/j.1600-065X.2001.790115.x; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h	52	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25683	10.1371/journal.pone.0025683	http://dx.doi.org/10.1371/journal.pone.0025683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984938	gold, Green Published, Green Submitted			2022-12-25	WOS:000295941300048
J	Leache, AD				Leache, Adam D.			Multi-Locus Estimates of Population Structure and Migration in a Fence Lizard Hybrid Zone	PLOS ONE			English	Article							SCELOPORUS-UNDULATUS; GENUS SCELOPORUS; GENOTYPE DATA; DNA POLYMORPHISM; SPECIES GROUP; INFERENCE; GENETICS; MODEL	A hybrid zone between two species of lizards in the genus Sceloporus (S. cowlesi and S. tristichus) on the Mogollon Rim in Arizona provides a unique opportunity to study the processes of lineage divergence and merging. This hybrid zone involves complex interactions between 2 morphologically and ecologically divergent subspecies, 3 chromosomal groups, and 4 mitochondrial DNA (mtDNA) clades. The spatial patterns of divergence between morphology, chromosomes and mtDNA are discordant, and determining which of these character types (if any) reflects the underlying population-level lineages that are of interest has remained impeded by character conflict. The focus of this study is to estimate the number of populations interacting in the hybrid zone using multi-locus nuclear data, and to then estimate the migration rates and divergence time between the inferred populations. Multi-locus estimates of population structure and gene flow were obtained from 12 anonymous nuclear loci sequenced for 93 specimens of Sceloporus. Population structure estimates support two populations, and this result is robust to changes to the prior probability distribution used in the Bayesian analysis and the use of spatially-explicit or non-spatial models. A coalescent analysis of population divergence suggests that gene flow is high between the two populations, and that the timing of divergence is restricted to the Pleistocene. The hybrid zone is more accurately described as involving two populations belonging to S. tristichus, and the presence of S. cowlesi mtDNA haplotypes in the hybrid zone is an anomaly resulting from mitochondrial introgression.	[Leache, Adam D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Leache, Adam D.] Univ Washington, Burke Museum, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Leache, AD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	leache@uw.edu			National Science Foundation [DEB-0508929, DBI-0805455]; Chang-Lin Tien Graduate Fellowship in Biodiversity	National Science Foundation(National Science Foundation (NSF)); Chang-Lin Tien Graduate Fellowship in Biodiversity	Funding was provided by the National Science Foundation (DEB-0508929 and DBI-0805455) and the Chang-Lin Tien Graduate Fellowship in Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; COLE CJ, 1972, SYST ZOOL, V21, P357, DOI 10.2307/2412428; Falush D, 2003, GENETICS, V164, P1567; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Leache AD, 2009, CYTOGENET GENOME RES, V127, P166, DOI 10.1159/000293285; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Leache AD, 2007, MOL ECOL, V16, P5216, DOI 10.1111/j.1365-294X.2007.03556.x; Leache AD, 2007, MOL ECOL, V16, P1035, DOI 10.1111/j.1365-294X.2006.03194.x; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Li N, 2003, GENETICS, V165, P2213; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Pritchard JK, 2000, GENETICS, V155, P945; Rosenblum EB, 2007, MOL ECOL NOTES, V7, P113, DOI 10.1111/j.1471-8286.2006.01547.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SITES JW, 1992, B AM MUS NAT HIST, P1; Smith Hobart M., 1992, Bulletin of the Maryland Herpetological Society, V28, P123; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TAJIMA F, 1989, GENETICS, V123, P597	23	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25827	10.1371/journal.pone.0025827	http://dx.doi.org/10.1371/journal.pone.0025827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980539	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600057
J	Lee, KH; Miller, CR; Nagel, AC; Wichman, HA; Joyce, P; Ytreberg, FM				Lee, Kuo Hao; Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.; Joyce, Paul; Ytreberg, F. Marty			First-Step Mutations for Adaptation at Elevated Temperature Increase Capsid Stability in a Virus	PLOS ONE			English	Article							PREDICTING PROTEIN STABILITY; INDUCED STRUCTURAL-CHANGES; STRANDED-DNA VIRUS; FREE-ENERGY; SCAFFOLDING PROTEINS; MOLECULAR-DYNAMICS; FUNCTIONAL IMPLICATIONS; ATOMIC-STRUCTURE; EVOLUTION; BACTERIOPHAGE-PHI-X174	The relationship between mutation, protein stability and protein function plays a central role in molecular evolution. Mutations tend to be destabilizing, including those that would confer novel functions such as host-switching or antibiotic resistance. Elevated temperature may play an important role in preadapting a protein for such novel functions by selecting for stabilizing mutations. In this study, we test the stability change conferred by single mutations that arise in a G4-like bacteriophage adapting to elevated temperature. The vast majority of these mutations map to interfaces between viral coat proteins suggesting they affect protein-protein interactions. We assess their effects by estimating thermodynamic stability using molecular dynamic simulations and measuring kinetic stability using experimental decay assays. The results indicate that most, though not all, of the observed mutations are stabilizing.	[Lee, Kuo Hao; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83843 USA; [Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.; Joyce, Paul] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Joyce, Paul] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Lee, Kuo Hao; Miller, Craig R.; Nagel, Anna C.; Wichman, Holly A.; Joyce, Paul; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Lee, KH (corresponding author), Univ Idaho, Dept Phys, Moscow, ID 83843 USA.	ytreberg@uidaho.edu	Lee, Kuo Hao/H-9929-2019; Miller, Craig/GWQ-5012-2022		National Institutes of Health [P20RR016448-07S1, R01GM076040]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant P20RR016448-07S1 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Computational resources were provided by the Institute for Bioinformatics and Evolutionary Studies at University of Idaho. CRM and ACN were partially supported by grant R01GM076040 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Andricioaei I, 1996, PHYS REV E, V53, pR3055, DOI 10.1103/PhysRevE.53.R3055; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bernal RA, 2003, J MOL BIOL, V325, P11, DOI 10.1016/S0022-2836(02)01201-9; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherwa JE, 2008, J VIROL, V82, P5774, DOI 10.1128/JVI.02758-07; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; den Otter WK, 2000, J CHEM PHYS, V112, P7283, DOI 10.1063/1.481329; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dokland T, 1999, J MOL BIOL, V288, P595, DOI 10.1006/jmbi.1999.2699; EKECHUKWU MC, 1995, J BACTERIOL, V177, P829, DOI 10.1128/jb.177.3.829-830.1995; FANE BA, 1993, GENETICS, V134, P1003; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ILAG LL, 1994, J MOL BIOL, V244, P291, DOI 10.1006/jmbi.1994.1730; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; McKenna R, 1996, J MOL BIOL, V256, P736, DOI 10.1006/jmbi.1996.0121; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Michel J, 2008, J MED CHEM, V51, P6654, DOI 10.1021/jm800524s; Miller CR, 2011, GENETICS, V187, P185, DOI 10.1534/genetics.110.121400; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rader AJ, 2005, STRUCTURE, V13, P413, DOI 10.1016/j.str.2004.12.015; Reddy VS, 1998, BIOPHYS J, V74, P546, DOI 10.1016/S0006-3495(98)77813-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schafer H, 2002, PROTEINS, V46, P215, DOI 10.1002/prot.1166; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; van Vlijmen HWT, 1998, J MOL BIOL, V275, P295, DOI 10.1006/jmbi.1997.1418; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Ytreberg FM, 2006, COMP FREE ENERGY MET, V125, P184114, DOI [10.1063/1.2378907, DOI 10.1063/1.2378907]; Zhou RH, 2008, J PHYS CHEM B, V112, P15813, DOI 10.1021/jp805529z; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	55	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25640	10.1371/journal.pone.0025640	http://dx.doi.org/10.1371/journal.pone.0025640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980515	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600043
J	Sun, JP; Glass, NL				Sun, Jianping; Glass, N. Louise			Identification of the CRE-1 Cellulolytic Regulon in Neurospora crassa	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; SECRETORY PHOSPHOLIPASES A(2); JECORINA TRICHODERMA-REESEI; CELL WALL DEGRADATION; ASPERGILLUS-NIDULANS; HYPOCREA-JECORINA; ETHANOL REGULON; BINDING-SITES; SACCHAROMYCES-CEREVISIAE; DNA-BINDING	Background: In filamentous ascomycete fungi, the utilization of alternate carbon sources is influenced by the zinc finger transcription factor CreA/CRE-1, which encodes a carbon catabolite repressor protein homologous to Mig1 from Saccharomyces cerevisiae. In Neurospora crassa, deletion of cre-1 results in increased secretion of amylase and beta-galactosidase. Methodology/Principal Findings: Here we show that a strain carrying a deletion of cre-1 has increased cellulolytic activity and increased expression of cellulolytic genes during growth on crystalline cellulose (Avicel). Constitutive expression of cre-1 complements the phenotype of a N. crassa Delta cre-1 strain grown on Avicel, and also results in stronger repression of cellulolytic protein secretion and enzyme activity. We determined the CRE-1 regulon by investigating the secretome and transcriptome of a Delta cre-1 strain as compared to wild type when grown on Avicel versus minimal medium. Chromatin immunoprecipitation-PCR of putative target genes showed that (CRE-1 binds to only some adjacent 5'-SYGGRG-3' motifs, consistent with previous findings in other fungi, and suggests that unidentified additional regulatory factors affect CRE-1 binding to promoter regions. Characterization of 30 mutants containing deletions in genes whose expression level increased in a Delta cre-1 strain under cellulolytic conditions identified novel genes that affect cellulase activity and protein secretion. Conclusions/Significance:Our data provide comprehensive information on the CRE-1 regulon in N. crassa and contribute to deciphering the global role of carbon catabolite repression in filamentous ascomycete fungi during plant cell wall deconstruction.	[Sun, Jianping; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sun, JP (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Lglass@berkeley.edu	Glass, N. Louise/ABA-7303-2021		Energy Biosciences Institute to NLG	Energy Biosciences Institute to NLG	This work was supported by a grant from the Energy Biosciences Institute to NLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bruno KS, 1996, EMBO J, V15, P5772, DOI 10.1002/j.1460-2075.1996.tb00963.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chulkin AM, MOL BIOL MOSK, V44, P677; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Cziferszky A, 2003, FUNGAL GENET BIOL, V40, P166, DOI 10.1016/S1087-1845(03)00082-3; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; David H, 2005, MICROBIOL-SGM, V151, P2209, DOI 10.1099/mic.0.27787-0; de Vries RP, 1999, RES MICROBIOL, V150, P281; de Vries RP, 2002, MOL GENET GENOMICS, V268, P96, DOI 10.1007/s00438-002-0729-7; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Ebbole DJ, 1998, FUNGAL GENET BIOL, V25, P15, DOI 10.1006/fgbi.1998.1088; ENTIAN KD, 1984, J BACTERIOL, V158, P29, DOI 10.1128/JB.158.1.29-35.1984; ESPESO EA, 1994, FEBS LETT, V342, P43, DOI 10.1016/0014-5793(94)80581-4; FELENBOK B, 1988, GENE, V73, P385, DOI 10.1016/0378-1119(88)90503-3; FILLINGER S, 1995, FEBS LETT, V368, P547, DOI 10.1016/0014-5793(95)00736-S; Forment JV, 2006, J BIOL CHEM, V281, P8339, DOI 10.1074/jbc.M508198200; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Granata F, 2003, INT ARCH ALLERGY IMM, V131, P153, DOI 10.1159/000071481; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Kato M, 1996, BIOSCI BIOTECH BIOCH, V60, P1776, DOI 10.1271/bbb.60.1776; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; KULMBURG P, 1993, MOL MICROBIOL, V7, P847, DOI 10.1111/j.1365-2958.1993.tb01175.x; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Mach RL, 1996, MOL MICROBIOL, V21, P1273, DOI 10.1046/j.1365-2958.1996.00094.x; Mach-Aigner AR, 2008, APPL ENVIRON MICROB, V74, P6554, DOI 10.1128/AEM.01143-08; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mathieu M, 2000, MOL MICROBIOL, V36, P123, DOI 10.1046/j.1365-2958.2000.01833.x; MATHIEU M, 1994, EMBO J, V13, P4022, DOI 10.1002/j.1460-2075.1994.tb06718.x; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Mogensen J, 2006, FUNGAL GENET BIOL, V43, P593, DOI 10.1016/j.fgb.2006.03.003; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Nakari-Setala T, 2009, APPL ENVIRON MICROB, V75, P4853, DOI 10.1128/AEM.00282-09; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Orejas M, 1999, MOL MICROBIOL, V31, P177, DOI 10.1046/j.1365-2958.1999.01157.x; PICKETT M, 1987, GENE, V51, P217, DOI 10.1016/0378-1119(87)90310-6; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Roy P, 2008, FUNGAL GENET BIOL, V45, P657, DOI 10.1016/j.fgb.2007.10.016; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruijter GJG, 1996, FEMS MICROBIOL LETT, V139, P223, DOI 10.1111/j.1574-6968.1996.tb08206.x; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Ruijter GJG, 1997, MICROBIOL-UK, V143, P2991, DOI 10.1099/00221287-143-9-2991; SAKAGUCHI M, 1991, J BIOCHEM-TOKYO, V109, P799, DOI 10.1093/oxfordjournals.jbchem.a123460; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schroder K, 1999, EMBO J, V18, P4804, DOI 10.1093/emboj/18.17.4804; Seidl V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-327; Smith KM, EUKARYOT CELL, P1549; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Strauss J, 1999, MOL MICROBIOL, V32, P169, DOI 10.1046/j.1365-2958.1999.01341.x; Sun JP, 2011, PROTEIN EXPRES PURIF, V75, P147, DOI 10.1016/j.pep.2010.08.016; Takashima S, 1996, FEMS MICROBIOL LETT, V145, P361, DOI 10.1016/S0378-1097(96)00432-6; Tamayo EN, 2008, FUNGAL GENET BIOL, V45, P984, DOI 10.1016/j.fgb.2008.03.002; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Tian CG, 2007, EUKARYOT CELL, V6, P1018, DOI 10.1128/EC.00078-07; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Townsend JP, 2002, GENOME BIOL, V3; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; VANDERVEEN P, 1995, MICROBIOL-UK, V141, P2301, DOI 10.1099/13500872-141-9-2301; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3; Ziv C, 2008, FUNGAL GENET BIOL, V45, P103, DOI 10.1016/j.fgb.2007.05.005	85	151	158	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25654	10.1371/journal.pone.0025654	http://dx.doi.org/10.1371/journal.pone.0025654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980519	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600046
J	Sun, Z; Cao, X; Jiang, MM; Qiu, Y; Zhou, H; Chen, L; Qin, B; Wu, H; Jiang, F; Chen, J; Liu, J; Dai, Y; Chen, HF; Hu, QY; Wu, Z; Zeng, JZ; Yao, XS; Zhang, XK				Sun, Z.; Cao, X.; Jiang, M-M; Qiu, Y.; Zhou, H.; Chen, L.; Qin, B.; Wu, H.; Jiang, F.; Chen, J.; Liu, J.; Dai, Y.; Chen, H-F; Hu, Q-Y; Wu, Z.; Zeng, J-Z; Yao, X-S; Zhang, X-K			Inhibition of beta-catenin signaling by nongenomic action of orphan nuclear receptor Nur77	ONCOGENE			English	Article						Nur77; beta-catenin; nongenomic; cardenolide; cancer	COLON-CANCER CELLS; GENE-EXPRESSION; BREAST-CANCER; RXR-ALPHA; NGFI-B; APOPTOSIS; WNT; DEGRADATION; PATHWAY; PROTEIN	Dysregulation of beta-catenin turnover due to mutations of its regulatory proteins including adenomatous polyposis coli (APC) and p53 is implicated in the pathogenesis of cancer. Thus, intensive effort is being made to search for alternative approaches to reduce abnormally activated beta-catenin in cancer cells. Nur77, an orphan member of the nuclear receptor superfamily, has a role in the growth and apoptosis of cancer cells. Here, we reported that Nur77 could inhibit transcriptional activity of beta-catenin by inducing beta-catenin degradation via proteasomal degradation pathway that is glycogen synthase kinase 3 beta and Siah-1 independent. Nur77 induction of beta-catenin degradation required both the N-terminal region of Nur77, which was involved in Nur77 ubiquitination, and the C-terminal region, which was responsible for beta-catenin binding. Nur77/DDBD, a Nur77 mutant lacking its DNA-binding domain, resided in the cytoplasm, interacted with beta-catenin, and induced beta-catenin degradation, demonstrating that Nur77-mediated beta-catenin degradation was independent of its DNA binding and transactivation, and might occur in the cytoplasm. In addition, we reported our identification of two digitalis-like compounds (DLCs), H-9 and ATE-i2-b4, which potently induced Nur77 expression and beta-catenin degradation in SW620 colon cancer cells expressing mutant APC protein in vitro and in animals. DLC-induced Nur77 protein was mainly found in the cytoplasm, and inhibition of Nur77 nuclear export by the CRM1-dependent nuclear export inhibitor leptomycin B or Jun N-terminal kinase inhibitor prevented the effect of DLC on inducing beta-catenin degradation. Together, our results demonstrate that beta-catenin can be degraded by cytoplasmic Nur77 through their interaction and identify H-9 and ATE-i2-b4 as potent activators of the Nur77-mediated pathway for beta-catenin degradation. Oncogene (2012) 31, 2653-2667; doi:10.1038/onc.2011.448; published online 10 October 2011	[Dai, Y.; Yao, X-S] Jinan Univ, Inst Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China; [Dai, Y.; Yao, X-S] Jinan Univ, Inst Nat Prod, Guangzhou 510632, Guangdong, Peoples R China; [Sun, Z.; Qiu, Y.; Zhou, H.; Chen, L.; Qin, B.; Wu, H.; Jiang, F.; Liu, J.; Chen, H-F; Wu, Z.; Zeng, J-Z] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Cao, X.; Zhou, H.; Chen, J.; Liu, J.; Hu, Q-Y; Zhang, X-K] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Jiang, M-M] Guangdong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Guangdong Pharmaceutical University	Yao, XS (corresponding author), Jinan Univ, Inst Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China.	yaoxinsheng@vip.tom.com; xzhang@sanfordburnham.org	Wu, Hua/W-4204-2019; Wu, Z/G-3993-2010; Zeng, JZ/G-3377-2010; Chen, HF/G-3376-2010		National Institutes of Health [CA140980, GM089927]; US Army Medical Research and Material Command; Xiamen University; National Natural Science Foundation of China (NSFC) [30971445, NSCF-81001373]; NSFC/Hong Kong Research Grants Council (RGC) [30931160431]; Natural Science Foundation of Fujian Province [2009J01198]; NATIONAL CANCER INSTITUTE [R01CA140980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Xiamen University(Xiamen University); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC/Hong Kong Research Grants Council (RGC)(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Zhuohua Zhang for providing beta-catenin expression vectors and TOPFLASH reporter plasmid. This work is in part supported by grants from the National Institutes of Health (CA140980, GM089927), the US Army Medical Research and Material Command, the 985 Project from Xiamen University, the National Natural Science Foundation of China (NSFC; 30971445 and NSCF-81001373) and NSFC/Hong Kong Research Grants Council (RGC; 30931160431) and the Natural Science Foundation of Fujian Province (2009J01198).	Camacho CP, 2009, CLIN ENDOCRINOL, V70, P475, DOI 10.1111/j.1365-2265.2008.03349.x; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Chtarbova S, 2002, BIOCHEM J, V367, P723, DOI 10.1042/BJ20020699; Dawson MI, 2001, CANCER RES, V61, P4723; Dillard AC, 2008, NUTR CANCER, V60, P97, DOI 10.1080/01635580701586754; Dillard AC, 2007, MOL CARCINOGEN, V46, P315, DOI 10.1002/mc.20280; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hutchinson DA, 2007, P NATL ACAD SCI USA, V104, P2265, DOI 10.1073/pnas.0610785104; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jiang MM, 2008, CHEM PHARM BULL, V56, P1005, DOI 10.1248/cpb.56.1005; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kitagawa H, 2007, MOL CELL BIOL, V27, P7486, DOI 10.1128/MCB.00409-07; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Safe S, 2008, CANCER LETT, V269, P326, DOI 10.1016/j.canlet.2008.04.021; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Steyn PS, 1998, NAT PROD REP, V15, P397; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Wilson AJ, 2003, CANCER RES, V63, P5401; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P700, DOI 10.2741/2094; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Wu Q, 1997, MOL CELL BIOL, V17, P6598, DOI 10.1128/MCB.17.11.6598; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69; Zhao HY, 2010, J ASIAN NAT PROD RES, V12, P793, DOI 10.1080/10286020.2010.505187; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	61	42	45	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	21					2653	2667		10.1038/onc.2011.448	http://dx.doi.org/10.1038/onc.2011.448			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21986938	Green Accepted			2022-12-25	WOS:000304523500005
J	Satyanarayana, A; Klarmann, KD; Gavrilova, O; Keller, JR				Satyanarayana, Ande; Klarmann, Kimberly D.; Gavrilova, Oksana; Keller, Jonathan R.			Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis	FASEB JOURNAL			English	Article						PGC1a; UCP1; adipogenesis; brown adipose tissue; thermogenesis	WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; IN-VIVO; MELANOCORTIN SYSTEM; HEPATIC STEATOSIS; INDUCED OBESITY; LEAN PHENOTYPE; DEFICIENT MICE; KNOCKOUT MICE; BROWN FAT	Obesity is a major health concern that contributes to the development of diabetes, hyperlipidemia, coronary artery disease, and cancer. Id proteins are helix-loop-helix transcription factors that regulate the proliferation and differentiation of cells from multiple tissues, including adipocytes. We screened mouse tissues for the expression of Id1 and found that Id1 protein is highly expressed in brown adipose tissue (BAT) and white adipose tissue (WAT), suggesting a role for Id1 in adipogenesis and cell metabolism. Id1(-/-) mice are viable but show a significant reduction in fat mass (P<0.005) over the life of the animal that was not due to decreased number of adipocytes. Analysis of Id1(-/-) mice revealed higher energy expenditure, increased lipolysis, and fatty acid oxidation, resulting in reduced triglyceride accumulation in WAT compared to Id1(+/+) mice. Serum levels of triglycerides (193.9 +/- 32.2 vs. 86.5 +/- 33.8, P<0.0005), cholesterol (189.4 +/- 33.8 vs. 110.6 +/- 8.23, P<0.0005) and leptin (1263 +/- 835 vs. 222 +/- 260, P<0.005) were significantly lower in aged Id1(-/-) mice compared to Id1(+/+) mice. Id1-deficient mice have higher resting (P<0.005) and total (P<0.05) O-2 consumption and lower respiratory exchange ratio (P<0.005), confirming that Id1(-/-) mice use a higher proportion of lipid as an energy source for the increased energy expenditure. The expression of PGC1 alpha and UCP1 were 2- to 3-fold up-regulated in Id1(-/-) BAT, suggesting that loss of Id1 increases thermogenesis. As a consequence of higher energy expenditure and reduced fat mass, Id1(-/-) mice displayed enhanced insulin sensitivity. Id1 deficiency protected mice against age-and high-fat-diet-induced adiposity, insulin resistance, and hepatosteatosis. Our findings suggest that Id1 plays a critical role in the regulation of energy homeostasis and could be a potential target in the treatment of insulin resistance and fatty liver disease.-Satyanarayana, A., Klarmann, K. D., Gavrilova, 1 O., Keller, J. R. Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet-induced insulin resistance and hepatosteatosis. FASEB J. 26, 309-323 (2012). www.fasebj.org	[Satyanarayana, Ande; Klarmann, Kimberly D.; Keller, Jonathan R.] NCI, Basic Res Program, SAIC Frederick, Ctr Canc Res, Frederick, MD 21701 USA; [Gavrilova, Oksana] Natl Inst Diabet Digest & Kidney Dis, Mouse Metab Core Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Keller, JR (corresponding author), Inst Frederick, Basic Res Program, SAIC Frederick, Ctr Canc Res, Bldg 560-12-03,1050 Boyles St, Frederick, MD 21702 USA.	kellerjo@mail.nih.gov	Keller, Jonathan R./O-6677-2018		National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Robert Benezra (Memorial Sloan-Kettering Cancer Center, New York, NY, USA) for providing the Id1-knockout mice. The authors thank Steven Stull and Juanita Mercado for animal care; Tatyana Chanturiya and William Jou for technical help; and Roberta Smith and the Pathology/Histotechnology Laboratory, NCI-Frederick, for tissue sectioning and staining. This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The authors declare no competing financial interests.	Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; ATRENS DM, 1993, BRAIN RES, V630, P238, DOI 10.1016/0006-8993(93)90662-7; Baggio Laurie L, 2002, Treat Endocrinol, V1, P117, DOI 10.2165/00024677-200201020-00005; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Budhiraja S, 2009, FUND CLIN PHARMACOL, V23, P149, DOI 10.1111/j.1472-8206.2009.00667.x; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chen M, 2010, CELL METAB, V11, P320, DOI 10.1016/j.cmet.2010.02.013; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; D'Agostino D, 2002, J BIOL CHEM, V277, P7170, DOI 10.1074/jbc.M108328200; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Florez-Duquet M, 1998, PHYSIOL REV, V78, P339, DOI 10.1152/physrev.1998.78.2.339; FOLEY JE, 1980, DIABETOLOGIA, V19, P234, DOI 10.1007/BF00275275; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Guesdon B, 2010, BEHAV BRAIN RES, V207, P14, DOI 10.1016/j.bbr.2009.09.032; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hulver MW, 2004, P NUTR SOC, V63, P375, DOI 10.1079/PNS2004351; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Iwen KAH, 2008, J ENDOCRINOL, V196, P465, DOI 10.1677/JOE-07-0299; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kanzaki M, 2001, CELL BIOCHEM BIOPHYS, V35, P191, DOI 10.1385/CBB:35:2:191; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kim A, 2010, MOL NUTR FOOD RES, V54, P1361, DOI 10.1002/mnfr.200900317; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Klaus S, 1997, BIOESSAYS, V19, P215, DOI 10.1002/bies.950190307; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Murad JM, 2010, J BIOL CHEM, V285, P24164, DOI 10.1074/jbc.M110.128744; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Ordovas JM, 1999, CURR OPIN LIPIDOL, V10, P15, DOI 10.1097/00041433-199902000-00004; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Su PY, 2011, J PHARMACOL EXP THER, V337, P822, DOI 10.1124/jpet.111.178970; Suh HC, 2008, ONCOGENE, V27, P5612, DOI 10.1038/onc.2008.175; Sun L, 2008, P NATL ACAD SCI USA, V105, P3339, DOI 10.1073/pnas.0800165105; Szekely Miklos, 2010, Front Biosci (Schol Ed), V2, P1009; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Tomimoto S, 2008, J PHARMACOL SCI, V107, P41, DOI 10.1254/jphs.FP0072173; Verty ANA, 2010, ENDOCRINOLOGY, V151, P4236, DOI 10.1210/en.2009-1235; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wielinga PY, 2010, PHYSIOL BEHAV, V101, P45, DOI 10.1016/j.physbeh.2010.04.012; Wilding JPH, 2002, DIABETIC MED, V19, P619, DOI 10.1046/j.1464-5491.2002.00790.x; Ye JM, 2001, AM J PHYSIOL-ENDOC M, V280, pE562, DOI 10.1152/ajpendo.2001.280.4.E562; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	75	29	29	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					309	323		10.1096/fj.11-190892	http://dx.doi.org/10.1096/fj.11-190892			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21990377	Green Published, Bronze			2022-12-25	WOS:000299202200031
J	Harris, C; Herker, E; Farese, RV; Ott, M				Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie			Hepatitis C Virus Core Protein Decreases Lipid Droplet Turnover A MECHANISM FOR CORE-INDUCED STEATOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; AMINO-ACID SUBSTITUTIONS; HEPATOCELLULAR-CARCINOMA; DIACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL BIOSYNTHESIS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; LIVER STEATOSIS; TRANSGENIC MICE; GENOTYPE	Steatosis is a frequent complication of hepatitis C virus infection. In mice, this condition is recapitulated by the expression of a single viral protein, the nucleocapsid core. Core localizes to the surface of lipid droplets (LDs) in infected liver cells through a process dependent on host diacylglycerol acyltransferase 1 (DGAT1), an enzyme that synthesizes triglycerides in the endoplasmic reticulum. Whether DGAT1 also plays a role in core-induced steatosis is uncertain. Here, we show that mouse embryonic fibroblasts isolated from DGAT1(-/-) mice are protected from core-induced steatosis, as are livers of DGAT1(-/-) mice expressing core, demonstrating that the steatosis is DGAT1-dependent. Surprisingly, core expression did not increase DGAT1 activity or triglyceride synthesis, thus excluding the possibility that core activates DGAT1 to cause steatosis. Instead, we find that DGAT1-dependent localization of core to LDs is a prerequisite for the steatogenic properties of the core. Using biochemical and immunofluorescence microscopy techniques, we show that the turnover of lipids in core-coated droplets is decreased, providing a physiological mechanism for core-induced steatosis. Our results support a bipartite model in which core first requires DGAT1 to gain access to LDs, and then LD-localized core interferes with triglyceride turnover, thus stabilizing lipid droplets and leading to steatosis.	[Herker, Eva; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Harris, Charles; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/B-9699-2014; Herker, Eva/AAQ-1944-2021	Herker, Eva/0000-0001-9644-2484; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R56 AI085056, R01-DK056084]; NIDDK [DK081680]; NCRR [CO6 RR-018928]; Hellman Family Foundation; University of California, San Francisco [P30 DK026743]; Liver Center; Human Frontiers Science Program; J. David Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081680, P30DK026743, R01DK056084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hellman Family Foundation; University of California, San Francisco(University of California System); Liver Center; Human Frontiers Science Program(Human Frontier Science Program); J. David Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56 AI085056 (to M. O.) and R01-DK056084 (to R. V. F.), Grant DK081680 (Mentored Clinical Scientist Research Career Development Award) from NIDDK (to C. H.), and Grant CO6 RR-018928 from NCRR (to Gladstone animal facilities). This work was also supported by the Hellman Family Foundation (to M. O.), Pilot/Feasibility Grant P30 DK026743 from the University of California, San Francisco, Liver Center (to C. H. and E. H.), fellowship from the Human Frontiers Science Program (to E. H.), and the J. David Gladstone Institutes.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Sanyal AJ, 2011, LIVER INT, V31, P23, DOI 10.1111/j.1478-3231.2010.02397.x; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sumida Y, 2011, J GASTROEN HEPATOL, V26, P836, DOI 10.1111/j.1440-1746.2010.06568.x; Tachi Y, 2010, LIVER INT, V30, P554, DOI 10.1111/j.1478-3231.2009.02164.x; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang CB, 2009, AM J PHYSIOL-ENDOC M, V296, pE862, DOI 10.1152/ajpendo.90651.2008	51	63	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42615	42625		10.1074/jbc.M111.285148	http://dx.doi.org/10.1074/jbc.M111.285148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21984835	Green Published, hybrid			2022-12-25	WOS:000298180900069
J	Levic, S; Bouleau, Y; Dulon, D				Levic, Snezana; Bouleau, Yohan; Dulon, Didier			Developmental Acquisition of a Rapid Calcium-Regulated Vesicle Supply Allows Sustained High Rates of Exocytosis in Auditory Hair Cells	PLOS ONE			English	Article							DEPENDENT EXOCYTOSIS; AFFERENT SYNAPSE; RELEASE SITES; OTOFERLIN; REPLENISHMENT; RESPONSES; CHANNELS; INNERVATION; MATURATION; DEPLETION	Auditory hair cells (HCs) have the remarkable property to indefinitely sustain high rates of synaptic vesicle release during ongoing sound stimulation. The mechanisms of vesicle supply that allow such indefatigable exocytosis at the ribbon active zone remain largely unknown. To address this issue, we characterized the kinetics of vesicle recruitment and release in developing chick auditory HCs. Experiments were done using the intact chick basilar papilla from E10 (embryonic day 10) to P2 (two days post-hatch) by monitoring changes in membrane capacitance and Ca2+ currents during various voltage stimulations. Compared to immature pre-hearing HCs (E10-E12), mature post-hearing HCs (E18-P2) can steadily mobilize a larger readily releasable pool (RRP) of vesicles with faster kinetics and higher Ca2+ efficiency. As assessed by varying the inter-pulse interval of a 100 ms paired-pulse depolarization protocol, the kinetics of RRP replenishment were found much faster in mature HCs. Unlike mature HCs, exocytosis in immature HCs showed large depression during repetitive stimulations. Remarkably, when the intracellular concentration of EGTA was raised from 0.5 to 2 mM, the paired-pulse depression level remained unchanged in immature HCs but was drastically increased in mature HCs, indicating that the Ca2+ sensitivity of the vesicle replenishment process increases during maturation. Concomitantly, the immunoreactivity of the calcium sensor otoferlin and the number of ribbons at the HC plasma membrane largely increased, reaching a maximum level at E18-P2. Our results suggest that the efficient Ca2+-dependent vesicle release and supply in mature HCs essentially rely on the concomitant engagement of synaptic ribbons and otoferlin at the plasma membrane.	[Levic, Snezana] INSERM, Equipe Neurophysiol Synapse Audit, U587, Unite Mixte Rech, Bordeaux, France; Univ Pellegrin, Cent Hosp, Univ Victor Segalen, Inst Neurosci Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Levic, S (corresponding author), INSERM, Equipe Neurophysiol Synapse Audit, U587, Unite Mixte Rech, Bordeaux, France.	snezana.levic@inserm.fr; didier.dulon@inserm.fr	DULON, Didier/I-7881-2016	DULON, Didier/0000-0003-1541-6861; Levic, Snezana/0000-0002-6171-896X	INSERM (Institut National de la Santeet de la Recherche Medicale); University of Bordeaux Segalen; Fondation Voir et Entendre	INSERM (Institut National de la Santeet de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Bordeaux Segalen; Fondation Voir et Entendre	This work was supported by INSERM (Institut National de la Santeet de la Recherche Medicale), the University of Bordeaux Segalen and the Fondation Voir et Entendre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, J NEUROSCI, V30, P15866, DOI 10.1523/JNEUROSCI.2891-10.2010; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Beurg M, 2010, J NEUROSCI, V30, P13281, DOI 10.1523/JNEUROSCI.2528-10.2010; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cho S, 2011, J NEUROSCI, V31, P5682, DOI 10.1523/JNEUROSCI.5453-10.2011; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193, DOI 10.1113/jphysiol.1978.sp012228; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; JOHNSON SL, 2005, CELL, V563, P177; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Jones TA, 2001, J NEUROSCI, V21, P8129, DOI 10.1523/JNEUROSCI.21-20-08129.2001; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; Kiang NYS, 1965, DISCHARGE PATTERNS S; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; MANLEY GA, 1987, SCIENCE, V237, P655, DOI 10.1126/science.3603046; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; REBILLARD G, 1981, BRAIN RES, V229, P15, DOI 10.1016/0006-8993(81)90741-1; REBILLARD M, 1983, ACTA OTO-LARYNGOL, V96, P379, DOI 10.3109/00016488309132723; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Schnee ME, 2011, NEURON, V70, P326, DOI 10.1016/j.neuron.2011.01.031; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Walsh Edward J., 1992, P161; WALSH EJ, 1987, HEARING RES, V28, P97, DOI 10.1016/0378-5955(87)90157-2; WHITEHEAD MC, 1985, NEUROSCIENCE, V14, P255, DOI 10.1016/0306-4522(85)90177-0; ZAMPINI V, 2010, CELL, V588, P187	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25714	10.1371/journal.pone.0025714	http://dx.doi.org/10.1371/journal.pone.0025714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998683	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700015
J	Schonfeld-Dado, E; Segal, M				Schonfeld-Dado, Eldi; Segal, Menahem			Activity Deprivation Induces Neuronal Cell Death: Mediation by Tissue-Type Plasminogen Activator	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MECHANISMS; APOPTOSIS; STROKE	Spontaneous activity is an essential attribute of neuronal networks and plays a critical role in their development and maintenance. Upon blockade of activity with tetrodotoxin (TTX), neurons degenerate slowly and die in a manner resembling neurodegenerative diseases-induced neuronal cell death. The molecular cascade leading to this type of slow cell death is not entirely clear. Primary post-natal cortical neurons were exposed to TTX for up to two weeks, followed by molecular, biochemical and immunefluorescence analysis. The expression of the neuronal marker, neuron specific enolase (NSE), was down-regulated, as expected, but surprisingly, there was a concomitant and striking elevation in expression of tissue-type plasminogen activator (tPA). Immunofluorescence analysis indicated that tPA was highly elevated inside affected neurons. Transfection of an endogenous tPA inhibitor, plasminogen activator inhibitor-1 (PAI-1), protected the TTX-exposed neurons from dying. These results indicate that tPA is a pivotal player in slowly progressing activity deprivation-induced neurodegeneration.	[Schonfeld-Dado, Eldi; Segal, Menahem] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schonfeld-Dado, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eldis@stanford.edu	SEGAL, MENAHEM/K-1577-2012		Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was funded by the Israel Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Corredor RG, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055001; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fishbein I, 2007, CEREB CORTEX, V17, P1292, DOI 10.1093/cercor/bhl037; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavin MP, 2001, J NEUROSCI RES, V63, P388, DOI 10.1002/1097-4547(20010301)63:5<388::AID-JNR1033>3.0.CO;2-T; Flavin MP, 2000, GLIA, V29, P347, DOI 10.1002/(SICI)1098-1136(20000215)29:4<347::AID-GLIA5>3.3.CO;2-#; Gabriel C, 2002, FASEB J, V16, P277, DOI 10.1096/fj.02-0403fje; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Ho-Tin-Noe B, 2009, MOL CELL NEUROSCI, V42, P288, DOI 10.1016/j.mcn.2009.08.001; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Schonfeld-Dado E, 2009, J NEURAL TRANSM, V116, P1363, DOI 10.1007/s00702-009-0256-3; Schonfeld-Dado E, 2009, J NEUROCHEM, V110, P1203, DOI 10.1111/j.1471-4159.2009.06204.x; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Tabuchi A, 2008, BIOL PHARM BULL, V31, P327, DOI 10.1248/bpb.31.327; Takahashi H, 2005, NEUROSCI LETT, V381, P189, DOI 10.1016/j.neulet.2005.02.031; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25919	10.1371/journal.pone.0025919	http://dx.doi.org/10.1371/journal.pone.0025919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998719	Green Submitted, Green Published, gold			2022-12-25	WOS:000295968700025
J	Wahl-Jensen, V; Cann, JA; Rubins, KH; Huggins, JW; Fisher, RW; Johnson, AJ; de Kok-Mercado, F; Larsen, T; Raymond, JL; Hensley, LE; Jahrling, PB				Wahl-Jensen, Victoria; Cann, Jennifer A.; Rubins, Kathleen H.; Huggins, John W.; Fisher, Robert W.; Johnson, Anthony J.; de Kok-Mercado, Fabian; Larsen, Thomas; Raymond, Jo Lynne; Hensley, Lisa E.; Jahrling, Peter B.			Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus	PLOS ONE			English	Article							GLOBAL ERADICATION; SMALLPOX; PREGNANCY; HISTOLOGY; MOUSEPOX	Smallpox, caused by variola virus (VARV), is a devastating human disease that affected millions worldwide until the virus was eradicated in the 1970 s. Subsequent cessation of vaccination has resulted in an immunologically naive human population that would be at risk should VARV be used as an agent of bioterrorism. The development of antivirals and improved vaccines to counter this threat would be facilitated by the development of animal models using authentic VARV. Towards this end, cynomolgus macaques were identified as adequate hosts for VARV, developing ordinary or hemorrhagic smallpox in a dose-dependent fashion. To further refine this model, we performed a serial sampling study on macaques exposed to doses of VARV strain Harper calibrated to induce ordinary or hemorrhagic disease. Several key differences were noted between these models. In the ordinary smallpox model, lymphoid and myeloid hyperplasias were consistently found whereas lymphocytolysis and hematopoietic necrosis developed in hemorrhagic smallpox. Viral antigen accumulation, as assessed immunohistochemically, was mild and transient in the ordinary smallpox model. In contrast, in the hemorrhagic model antigen distribution was widespread and included tissues and cells not involved in the ordinary model. Hemorrhagic smallpox developed only in the presence of secondary bacterial infections - an observation also commonly noted in historical reports of human smallpox. Together, our results support the macaque model as an excellent surrogate for human smallpox in terms of disease onset, acute disease course, and gross and histopathological lesions.	[Wahl-Jensen, Victoria; Cann, Jennifer A.; Johnson, Anthony J.; de Kok-Mercado, Fabian; Jahrling, Peter B.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21701 USA; [Rubins, Kathleen H.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Huggins, John W.; Fisher, Robert W.; Larsen, Thomas; Raymond, Jo Lynne; Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Massachusetts Institute of Technology (MIT); Whitehead Institute	Wahl-Jensen, V (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21701 USA.	jahrlingp@niaid.nih.gov	; Wahl, Victoria/K-9267-2015	Larsen, Thomas/0000-0002-3609-9490; Hensley, Lisa/0000-0003-1188-4342; Wahl, Victoria/0000-0002-6588-4308	U.S. Department of Homeland Security for the management for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC) [HSHQDC-07-C-00020]; National Institute of Allergy and Infectious Diseases [HHSN27220020000161]	U.S. Department of Homeland Security for the management for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part under agreement no. HSHQDC-07-C-00020 awarded by the U.S. Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The principal authors (WWJ and JAC) are employees of Battelle Memorial Institute under its prime contract with National Institute of Allergy and Infectious Diseases # HHSN27220020000161.	Gonzalez DA, 2010, IMMUNOL LETT, V133, P6, DOI 10.1016/j.imlet.2010.07.001; BRAS G, 1952, Doc Med Geogr Trop, V4, P303; Councilman W T, 1905, Public Health Pap Rep, V31, P218; Councilman WT, 1904, J MED RES, V11, P12; DAMON IK, 2007, FIELDS VIROLOGY, P2948; FENNER F, 1982, REV INFECT DIS, V4, P916; Fenner F, 1977, Prog Med Virol, V23, P1; FENNER F, 1980, MED J AUSTRALIA, V1, P455, DOI 10.5694/j.1326-5377.1980.tb135034.x; FENNER F, 1993, HIST PHIL LIFE SCI, V15, P397; FENNER F, 1988, CLIN FEATURES SMALLP, P1; Food and Drug Administration HHS, 2002, Fed Regist, V67, P37988; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hopkins Donald R., 2002, GREATEST KILLER SMAL, DOI [10.7208/chicago/9780226189529.001.0001, DOI 10.7208/CHICAGO/9780226189529.001.0001]; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Karupiah G, 1998, VET IMMUNOL IMMUNOP, V63, P105, DOI 10.1016/S0165-2427(98)00086-5; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Lillie RD, 1930, ARCH PATHOL, V10, P241; NIEMIALTOWSKI MG, 1994, ACTA VIROL, V38, P299; Ostensen M, 1999, ANN NY ACAD SCI, V876, P131, DOI 10.1111/j.1749-6632.1999.tb07630.x; Prophet E.B., 1992, LAB METHODS HISTOTEC, P25; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Rao AR, 1972, SMALLPOX; ROBERTS JA, 1962, BRIT J EXP PATHOL, V43, P451; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zelicoff AP, 2003, CRIT REV MICROBIOL, V29, P97, DOI 10.1080/713610418	28	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24832	10.1371/journal.pone.0024832	http://dx.doi.org/10.1371/journal.pone.0024832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998632	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700005
J	Alphey, N; Alphey, L; Bonsall, MB				Alphey, Nina; Alphey, Luke; Bonsall, Michael B.			A Model Framework to Estimate Impact and Cost of Genetics-Based Sterile Insect Methods for Dengue Vector Control	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MOSQUITO-BORNE DISEASES; MARK-RELEASE-RECAPTURE; HEMORRHAGIC-FEVER; ECONOMIC-IMPACT; LATIN-AMERICA; BODY-SIZE; POPULATION; THAILAND; CULICIDAE	Vector-borne diseases impose enormous health and economic burdens and additional methods to control vector populations are clearly needed. The Sterile Insect Technique (SIT) has been successful against agricultural pests, but is not in large-scale use for suppressing or eliminating mosquito populations. Genetic RIDL technology (Release of Insects carrying a Dominant Lethal) is a proposed modification that involves releasing insects that are homozygous for a repressible dominant lethal genetic construct rather than being sterilized by irradiation, and could potentially overcome some technical difficulties with the conventional SIT technology. Using the arboviral disease dengue as an example, we combine vector population dynamics and epidemiological models to explore the effect of a program of RIDL releases on disease transmission. We use these to derive a preliminary estimate of the potential cost-effectiveness of vector control by applying estimates of the costs of SIT. We predict that this genetic control strategy could eliminate dengue rapidly from a human community, and at lower expense (approximately US$ 2 similar to 30 per case averted) than the direct and indirect costs of disease (mean US$ 86-190 per case of dengue). The theoretical framework has wider potential use; by appropriately adapting or replacing each component of the framework (entomological, epidemiological, vector control bio-economics and health economics), it could be applied to other vector-borne diseases or vector control strategies and extended to include other health interventions.	[Alphey, Nina; Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Alphey, Nina; Alphey, Luke] Oxitec Ltd, Oxford, England	University of Oxford	Alphey, N (corresponding author), Univ Oxford, Dept Zool, Math Ecol Res Grp, S Parks Rd, Oxford OX1 3PS, England.	nina.alphey@zoo.ox.ac.uk	Alphey, Nina/A-1734-2010	Alphey, Nina/0000-0002-1458-2406; Alphey, Luke/0000-0002-2916-3802; Bonsall, Michael/0000-0003-0250-0423	Royal Society; UK Biotechnology and Biological Sciences Research Council [BB/C512702/1, BBS/S/J/2005/12055, BB/H01814X/1]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; Oxitec Ltd.; University of Oxford; Biotechnology and Biological Sciences Research Council [BB/H01814X/1, BB/C512702/1] Funding Source: researchfish; BBSRC [BB/H01814X/1] Funding Source: UKRI	Royal Society(Royal Society of London); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxitec Ltd.; University of Oxford; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society (University Research Fellowship to MBB), the UK Biotechnology and Biological Sciences Research Council (BB/C512702/1, BBS/S/J/2005/12055, BB/H01814X/1), by a grant to the Regents of the University of California from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by internal funds of Oxitec Ltd. Oxitec provided salary and other support for the research program of LA as an employee of the company, and financial support to NA through the University of Oxford under a collaborative PhD studentship agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs:http://royalsociety.org/, http://www.bbsrc.ac.uk/, http://www.grandchallenges.org/, http://www.oxitec.com/.	Alphey L., 2007, TRANSGENICS MANAGEME; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2011, J THEOR BIOL, V270, P42, DOI 10.1016/j.jtbi.2010.11.016; [Anonymous], 2011, B WORLD HEALTH ORGAN, V89, P476, DOI 10.2471/BLT.11.030711; [Anonymous], US FED RES H10 FOR E; [Anonymous], WHO GLOB BURD DIS 20; [Anonymous], WORLD POP PROSP 2008; [Anonymous], WHO FACT SHEET NO 11; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; DAY JF, 1994, J MED ENTOMOL, V31, P611, DOI 10.1093/jmedent/31.4.611; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Dyck V.A., 2006, STERILE INSECT TECHN; DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355; Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Fine P. E. M., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Science Research Report, 25), P121; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; (IAEA) International Atomic Energy Agency, 2008, MOD BUS PLAN STER IN; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Lenhart A, 2010, AM J TROP MED HYG, V83, P138; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; May RM, 2007, TRENDS ECOL EVOL, V22, P497, DOI 10.1016/j.tree.2007.08.009; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Statistical Office of Thailand, 1996, 1995 1996 SURV POP C; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; SLOSEK J, 1986, SOC SCI MED, V23, P249, DOI 10.1016/0277-9536(86)90345-X; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stainton KC, DEV FEMALE LET UNPUB; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Torres JR, 2007, CAD SAUDE PUBLICA, V23, pS23, DOI 10.1590/S0102-311X2007001300004; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; United Nations Population Division, 2006, WORLD MORT REP 2005; US Office of Management and Budget, 2008, BUDG US GOV HIST TAB; Vasan S, 2008, SCI REPORT INNOVATIV; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; WHO-TDR, 2007, TDRSWG08160 WHO; Wight A, 2009, THIRST BLOOD GROWS D; World Bank, 1993, WORLD DEV REP 1992 I; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	68	61	64	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25384	10.1371/journal.pone.0025384	http://dx.doi.org/10.1371/journal.pone.0025384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998654	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900023
J	Oidovsambuu, O; Nyamsuren, G; Liu, SA; Goring, W; Engel, W; Adham, IM				Oidovsambuu, Odgerel; Nyamsuren, Gunsmaa; Liu, Shuai; Goering, Wolfgang; Engel, Wolfgang; Adham, Ibrahim M.			Adhesion Protein VSIG1 Is Required for the Proper Differentiation of Glandular Gastric Epithelia	PLOS ONE			English	Article							IMMUNOGLOBULIN SUPERFAMILY; A33 ANTIGEN; MOUSE; ENDODERM; CELLS; MICE; MOLECULE; STOMACH; CLONING; TESTIS	VSIG1, a cell adhesion protein of the immunoglobulin superfamily, is preferentially expressed in stomach, testis, and certain gastric, esophageal and ovarian cancers. Here, we describe the expression patterns of three alternatively spliced isoforms of mouse Vsig1 during pre- and postnatal development of stomach and potential function of Vsig1 in differentiation of gastric epithelia. We show that isoforms Vsig1A and Vsig1B, which differ in the 3'untranslated region, are expressed in the early stages of stomach development. Immunohistochemical analysis revealed that VSIG1 is restricted to the adherens junction of the glandular epithelium. The shorter transcript Vsig1C is restricted to the testis, encodes an N-terminal truncated protein and is presumably regulated by an internal promoter, which is located upstream of exon 1b. To determine whether the 59 flanking region of exon 1a specifically targets the expression of Vsig1 to stomach epithelia, we generated and analyzed transgenic mice. The 4.8-kb fragment located upstream of exon 1a was sufficient to direct the expression of the reporter gene to the glandular epithelia of transgenic stomach. To determine the role of VSIG1 during the development of stomach epithelia, an X-linked Vsig1 was inactivated in embryonic stem cells (ESCs). Although Vsig1(-/Y) ESCs were only able to generate low coat color chimeric mice, no male chimeras transmitted the targeted allele to their progeny suggesting that the high contribution of Vsig1(-/Y) cells leads to the lethality of chimeric embryos. Analysis of chimeric stomachs revealed the differentiation of VSIG1-null cells into squamous epithelia inside the glandular region. These results suggest that VSIG1 is required for the establishment of glandular versus squamous epithelia in the stomach.	[Oidovsambuu, Odgerel; Nyamsuren, Gunsmaa; Liu, Shuai; Goering, Wolfgang; Engel, Wolfgang; Adham, Ibrahim M.] Univ Gottingen, Inst Human Genet, D-3400 Gottingen, Germany	University of Gottingen	Oidovsambuu, O (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-3400 Gottingen, Germany.	iadham@gwdg.de	Oidovsambuu, Odgerel/AHE-0868-2022	Oidovsambuu, Odgerel/0000-0001-6872-3385				Beck F, 2003, DEV BIOL, V255, P399, DOI 10.1016/S0012-1606(02)00096-9; CHO C, 1997, TECHNICAL TIPS ONLIN, V1, P20; CUMBINER BM, 2000, J CELL BIOL, V148, P399; DUAN HJ, 1993, CELL MOL BIOL, V39, P309; FUKUMACHI H, 1979, ANAT EMBRYOL, V157, P151; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Heath JK, 1997, P NATL ACAD SCI USA, V94, P469, DOI 10.1073/pnas.94.2.469; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Johnstone CN, 2000, AM J PHYSIOL-GASTR L, V279, pG500, DOI 10.1152/ajpgi.2000.279.3.G500; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; Kim E, 2010, MOL CELLS, V30, P443, DOI 10.1007/s10059-010-0138-4; Kim SK, 2000, GENE DEV, V14, P1866; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Nagamatsu G, 2006, MOL CELL BIOL, V26, P8498, DOI 10.1128/MCB.01502-06; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Scanlan Matthew J, 2006, Cancer Immun, V6, P2; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Wurst W., 1993, Gene targeting: a practical approach., P33	25	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25908	10.1371/journal.pone.0025908	http://dx.doi.org/10.1371/journal.pone.0025908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991385	Green Submitted, Green Published, gold			2022-12-25	WOS:000295963300030
J	Gan, XB; Duan, YC; Xiong, XQ; Li, P; Cui, BP; Gao, XY; Zhu, GQ				Gan, Xian-Bing; Duan, Yang-Can; Xiong, Xiao-Qing; Li, Peng; Cui, Bai-Ping; Gao, Xing-Ya; Zhu, Guo-Qing			Inhibition of Cardiac Sympathetic Afferent Reflex and Sympathetic Activity by Baroreceptor and Vagal Afferent Inputs in Chronic Heart Failure	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS MEDIATE; ANG-II; HYDROGEN-PEROXIDE; AT(1) RECEPTORS; NERVE ACTIVITY; RATS; BAROREFLEX; ACTIVATION; RESPONSES; PATHWAY	Background: Cardiac sympathetic afferent reflex (CSAR) contributes to sympathetic activation and angiotensin II (Ang II) in paraventricular nucleus (PVN) augments the CSAR in vagotomized (VT) and baroreceptor denervated (BD) rats with chronic heart failure (CHF). This study was designed to determine whether it is true in intact (INT) rats with CHF and to determine the effects of cardiac and baroreceptor afferents on the CSAR and sympathetic activity in CHF. Methodology/Principal Findings: Sham-operated (Sham) or coronary ligation-induced CHF rats were respectively subjected to BD+VT, VT, cardiac sympathetic denervation (CSD) or INT. Under anesthesia, renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded, and the CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Either CSAR or the responses of RSNA, MAP and CSAR to Ang II in PVN were enhanced in CHF rats treated with BD+VT, VT or INT. Treatment with VT or BD+VT potentiated the CSAR and the CSAR responses to Ang II in both Sham and CHF rats. Treatment with CSD reversed the capsaicin-induced RSNA and MAP changes and the CSAR responses to Ang II in both Sham and CHF rats, and reduced the RSNA and MAP responses to Ang II only in CHF rats. Conclusions: The CSAR and the CSAR responses to Ang II in PVN are enhanced in intact CHF rats. Baroreceptor and vagal afferent activities inhibit CSAR and the CSAR responses to Ang II in intact Sham and CHF rats.	[Gan, Xian-Bing; Duan, Yang-Can; Xiong, Xiao-Qing; Li, Peng; Cui, Bai-Ping; Gao, Xing-Ya; Zhu, Guo-Qing] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Gan, Xian-Bing; Xiong, Xiao-Qing; Zhu, Guo-Qing] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Peoples R China; [Duan, Yang-Can] Jining Med Univ, Dept Med Ultrasound, Affiliated Hosp, Jining, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jining Medical University	Gan, XB (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China.	gqzhucn@njmu.edu.cn		Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science fund [30670768, 30870908]	Chinese National Natural Science fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science fund (30670768 & 30870908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuaje F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009661; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; BARBER MJ, 1984, CIRC RES, V55, P532, DOI 10.1161/01.RES.55.4.532; Chen AD, 2011, EXP PHYSIOL, V96, P94, DOI 10.1113/expphysiol.2010.054353; Dans AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013694; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Gao L, 2005, HYPERTENSION, V45, P1173, DOI 10.1161/01.HYP.0000168056.66981.c2; Gao L, 2004, AM J PHYSIOL-HEART C, V286, pH1706, DOI 10.1152/ajpheart.01097.2003; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Guo ZL, 2004, BRAIN RES, V1006, P36, DOI 10.1016/j.brainres.2004.01.057; Han Y, 2005, BRAIN RES, V1058, P82, DOI 10.1016/j.brainres.2005.07.055; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; HUANG HS, 1995, AM J PHYSIOL-HEART C, V268, pH2114, DOI 10.1152/ajpheart.1995.268.5.H2114; Kuenzli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009946; Ma R, 1999, AM J PHYSIOL-HEART C, V277, pH15, DOI 10.1152/ajpheart.1999.277.1.H15; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Schultz HD, 2001, ANN NY ACAD SCI, V940, P59; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Wang HJ, 2005, AUTON NEUROSCI-BASIC, V121, P56, DOI 10.1016/j.autneu.2005.07.003; Wang W, 2000, Heart Fail Rev, V5, P57; Xu B, 2011, EXP PHYSIOL, V96, P295, DOI 10.1113/expphysiol.2010.055475; Yoshimoto M, 2008, AM J PHYSIOL-HEART C, V295, pH2447, DOI 10.1152/ajpheart.00958.2008; Yu Y, 2007, PFLUG ARCH EUR J PHY, V454, P551, DOI 10.1007/s00424-007-0256-9; Zhang Y, 2006, BRAIN RES, V1082, P132, DOI 10.1016/j.brainres.2006.01.113; Zheng H, 2009, AM J PHYSIOL-REG I, V297, pR1364, DOI 10.1152/ajpregu.00149.2009; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhong MK, 2008, EUR J NEUROSCI, V27, P3226, DOI 10.1111/j.1460-9568.2008.06261.x; Zhou LM, 2010, PFLUG ARCH EUR J PHY, V459, P681, DOI 10.1007/s00424-010-0793-5; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2002, BASIC RES CARDIOL, V97, P320, DOI 10.1007/s00395-002-0353-z; Zhu GQ, 2002, AM J PHYSIOL-HEART C, V282, pH2039, DOI 10.1152/ajpheart.00854.2001; Zhu GQ, 2009, EXP PHYSIOL, V94, P785, DOI 10.1113/expphysiol.2008.046565; Zucker Irving H, 2002, Heart Fail Monit, V3, P2	38	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25784	10.1371/journal.pone.0025784	http://dx.doi.org/10.1371/journal.pone.0025784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991351	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000069
J	Dellagi, K; Rollot, O; Temmam, S; Salez, N; Guernier, V; Pascalis, H; Gerardin, P; Fianu, A; Lapidus, N; Naty, N; Tortosa, P; Boussaid, K; Jaffar-Banjee, MC; Filleul, L; Flahault, A; Carrat, F; Favier, F; de Lamballerie, X				Dellagi, Koussay; Rollot, Olivier; Temmam, Sarah; Salez, Nicolas; Guernier, Vanina; Pascalis, Herve; Gerardin, Patrick; Fianu, Adrian; Lapidus, Nathanael; Naty, Nadege; Tortosa, Pablo; Boussaid, Karim; Jaffar-Banjee, Marie-Christine; Filleul, Laurent; Flahault, Antoine; Carrat, Fabrice; Favier, Francois; de Lamballerie, Xavier			Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009	PLOS ONE			English	Article							ANTIBODY-RESPONSES; RISK-FACTORS; H1N1 VIRUS; SEROCONVERSION; SURVEILLANCE; EMERGENCE	Background: To date, there is little information that reflects the true extent of spread of the pH1N1/2009v influenza pandemic at the community level as infection often results in mild or no clinical symptoms. This study aimed at assessing through a prospective study, the attack rate of pH1N1/2009 virus in Reunion Island and risk factors of infection, during the 2009 season. Methodology/Principal Findings: A serosurvey was conducted during the 2009 austral winter, in the frame of a prospective population study. Pairs of sera were collected from 1687 individuals belonging to 772 households, during and after passage of the pandemic wave. Antibodies to pH1N1/2009v were titered using the hemagglutination inhibition assay (HIA) with titers >= 1/40 being considered positive. Seroprevalence during the first two weeks of detection of pH1N1/2009v in Reunion Island was 29.8% in people under 20 years of age, 35.6% in adults (20-59 years) and 73.3% in the elderly (>= 60 years) (P<0.0001). Baseline corrected cumulative incidence rates, were 42.9%, 13.9% and 0% in these age groups respectively (P<0.0001). A significant decline in antibody titers occurred soon after the passage of the epidemic wave. Seroconversion rates to pH1N1/2009 correlated negatively with age: 63.2%, 39.4% and 16.7%, in each age group respectively (P<0.0001). Seroconversion occurred in 65.2% of individuals who were seronegative at inclusion compared to 6.8% in those who were initially seropositive. Conclusions: Seroincidence of pH1N1/2009v infection was three times that estimated from clinical surveillance, indicating that almost two thirds of infections occurring at the community level have escaped medical detection. People under 20 years of age were the most affected group. Pre-epidemic titers >= 1/40 prevented seroconversion and are likely protective against infection. A concern was raised about the long term stability of the antibody responses.	[Dellagi, Koussay; Temmam, Sarah; Guernier, Vanina; Pascalis, Herve; Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, GIS CRVOI, St Denis, Reunion, France; [Dellagi, Koussay; Guernier, Vanina; Pascalis, Herve] IRD, Marseille, France; [Rollot, Olivier; Gerardin, Patrick; Fianu, Adrian; Naty, Nadege; Boussaid, Karim; Favier, Francois] Ctr Hosp Reg, Ctr Invest Clin Epidemiol Clin CIC EC La Reunion, INSERM CHR Univ URMLR, St Pierre, Reunion, France; [Temmam, Sarah] Univ Lyon, CNRS, Ecol Microbienne UMR 5557, Lyon, France; [Salez, Nicolas; de Lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents, UMR S 190, Marseille, France; [Lapidus, Nathanael; Carrat, Fabrice] Univ Paris 06, INSERM, Epidemiol Malad Infect & Modelisat UMR S 70, Paris, France; [Tortosa, Pablo] Univ La Reunion, Chaire Mixte CNRS INEE, St Denis, Reunion, France; [Jaffar-Banjee, Marie-Christine] Ctr Hosp Reg, Dept Microbiol, St Denis, Reunion, France; [Filleul, Laurent] Cellule Interreg Epidemiol CIRE Reunion Mayotte I, St Denis, Reunion, France; [Flahault, Antoine] EHESP, Paris, France	Institut de Recherche pour le Developpement (IRD); Centre Hospitalier Annecy Genevois; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of La Reunion; Centre Hospitalier Annecy Genevois; CHU Reunion; Ecole des Hautes Etudes en Sante Publique (EHESP)	Dellagi, K (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, GIS CRVOI, St Denis, Reunion, France.	koussay.dellagi@ird.fr	Pascalis, Herve/F-5726-2014; Pascalis, Herve/M-9410-2019; Guernier, Vanina/AAX-3772-2020; Carrat, Fabrice/AAU-8480-2020; TEMMAM, Sarah/AAX-3717-2021; Lapidus, N./AAT-4479-2020	Pascalis, Herve/0000-0002-6822-7311; Guernier, Vanina/0000-0002-0960-3874; Carrat, Fabrice/0000-0002-8672-7918; TEMMAM, Sarah/0000-0003-3655-9220; Lapidus, N./0000-0002-4837-1068; Abid, sayda/0000-0003-2488-1431; Tortosa, Pablo/0000-0002-7928-7264	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI	This study was supported by funds from CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund), INSERM/IMMI and CRVOI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Booy R, 2011, MED J AUSTRALIA, V194, P19, DOI 10.5694/j.1326-5377.2011.tb04139.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cire Ocean Indien, 2010, POINT EP; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delangue J, 2012, CLIN MICROBIOL INFEC, V18, P177, DOI 10.1111/j.1469-0691.2011.03545.x; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Gerardin P, 2011, BMC MED IN PRESS; Gerardin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010896; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huo XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017995; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kumar S, 2010, VIRUSES-BASEL, V2, P782, DOI 10.3390/v2040782; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Lemaitre M, 2010, CLIN MICROBIOL INFEC, DOI [10.1111/11469-0691.2010.03352.x, DOI 10.1111/11469-0691.2010.03352.X]; Lim WY, 2011, EMERG INFECT DIS, V17, P1455, DOI 10.3201/eid1708.101270; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Renault Philippe, 2010, PLoS Curr, V2, pRRN1145; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	46	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25738	10.1371/journal.pone.0025738	http://dx.doi.org/10.1371/journal.pone.0025738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980532	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295939600052
J	Zeineldin, M; Cunningham, J; McGuinness, W; Alltizer, P; Cowley, B; Blanchat, B; Xu, W; Pinson, D; Neufeld, KL				Zeineldin, M.; Cunningham, J.; McGuinness, W.; Alltizer, P.; Cowley, B.; Blanchat, B.; Xu, W.; Pinson, D.; Neufeld, K. L.			A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression	ONCOGENE			English	Article						adenomatous polyposis coli; polyp; Wnt; nuclear; mouse model; NLS	ADENOMATOUS POLYPOSIS-COLI; BETA-CATENIN; SUBCELLULAR-LOCALIZATION; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN; GENE; MUTATION; MICE; DNA; PHOSPHORYLATION	Mutation of the tumor suppressor adenomatous polyposis coli (APC) is considered an initiating step in the genesis of the vast majority of colorectal cancers. APC inhibits the Wnt-signaling pathway by targeting the proto-oncogene beta-catenin for destruction by cytoplasmic proteasomes. In the presence of a Wnt signal, or in the absence of functional APC, beta-catenin can serve as a transcription cofactor for genes required for cell proliferation such as cyclin-D1 and c-Myc. In cultured cells, APC shuttles between the nucleus and the cytoplasm, with nuclear APC implicated in the inhibition of Wnt target gene expression. Adopting a genetic approach to evaluate the functions of nuclear APC in the context of a whole organism, we generated a mouse model with mutations that inactivate the nuclear localization signals (NLSs) of Apc (Apc(mNLS)). Apc(mNLS/mNLS) mice are viable and fractionation of mouse embryonic fibroblasts (MEFs) isolated from these mice revealed a significant reduction in nuclear Apc as compared with Apc(+/+) MEFs. The levels of Apc and beta-catenin protein were not significantly altered in small intestinal epithelia from Apc(mNLS/mNLS) mice. Compared with Apc(+/+) mice, Apc(mNLS/mNLS) mice showed increased proliferation in epithelial cells from the jejunum, ileum and colon. These same tissues from Apc(mNLS/mNLS) mice showed more mRNA from three genes upregulated in response to canonical Wnt signal, c-Myc, axin-2 and cyclin-D1, and less mRNA from Hath-1, which is downregulated in response to Wnt. These observations suggest a role for nuclear Apc in the inhibition of canonical Wnt signaling and the control of epithelial proliferation in intestinal tissue. Furthermore, we found Apc(Min/+) mice, which harbor a mutation that truncates Apc, to have an increased polyp size and multiplicity if they also carry the Apc(mNLS) allele. Taken together, this analysis of the novel Apc(mNLS) mouse model supports a role for nuclear Apc in the control of Wnt target genes, intestinal epithelial cell proliferation and polyp formation. Oncogene (2012) 31, 2423-2437; doi: 10.1038/onc.2011.434; published online 26 September 2011	[Zeineldin, M.; McGuinness, W.; Alltizer, P.; Blanchat, B.; Neufeld, K. L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Cowley, B.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Xu, W.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Pinson, D.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; Utah System of Higher Education; University of Utah; University of Virginia; University of Kansas; University of Kansas Medical Center	Neufeld, KL (corresponding author), Univ Kansas, Dept Mol Biosci, 7049 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	klneuf@ku.edu	Zeineldin, Maged/AAU-1040-2021	Neufeld, Kristi/0000-0003-3653-9385	National Cancer Institute [RO1 CA10922];  [5P20 RR15563]; NATIONAL CANCER INSTITUTE [R01CA109220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by RO1 CA10922 from the National Cancer Institute and 5P20 RR15563. We extend our gratitude to Alan Godwin, Kirk Thomas and Mario Capecchi for advice on the generation of the knock-in mouse and for the lambda phage library, and the tACE-Cre-Neo<SUP>r</SUP>- and Tk<SUP>HSV</SUP>-containing constructs. We thank Marc Roth, Areli Monarrez, Ashrita Abraham and Travis Friesen for technical assistance; the staff at the University of Kansas Animal Care Unit for excellent mouse husbandry and David Davido for critical reading of the manuscript. We also thank Reka Nagy and Drs Andras Nagy, Janet Rossant and Wanda Abramow-Newerly (Mount Sinai Hospital) for the mouse R1 ES cells.	Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Fagman H, 2003, ONCOGENE, V22, P6013, DOI 10.1038/sj.onc.1206731; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Magnus HA, 1937, J PATHOL BACTERIOL, V44, P389, DOI 10.1002/path.1700440214; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Neufeld KL, 1997, P NATL ACAD SCI USA, V94, P3034, DOI 10.1073/pnas.94.7.3034; Neufeld KL, 2000, EMBO REP, V1, P519; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Sena P, 2006, CANCER LETT, V241, P203, DOI 10.1016/j.canlet.2005.10.011; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Taketo MM, 2006, CANCER SCI, V97, P355, DOI 10.1111/j.1349-7006.2006.00190.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang Y, 2008, MOL BIOL CELL, V19, P4076, DOI 10.1091/mbc.E07-12-1296; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-75; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001	50	22	23	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2423	2437		10.1038/onc.2011.434	http://dx.doi.org/10.1038/onc.2011.434			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996741	Green Submitted, Green Accepted			2022-12-25	WOS:000303985300005
J	Lund, LM; Kerr, JP; Lupinetti, J; Zhang, YH; Russell, MA; Bloch, RJ; Bond, M				Lund, Linda M.; Kerr, Jaclyn P.; Lupinetti, Jenna; Zhang, Yinghua; Russell, Mary A.; Bloch, Robert J.; Bond, Meredith			Synemin isoforms differentially organize cell junctions and desmin filaments in neonatal cardiomyocytes	FASEB JOURNAL			English	Article						Z disk; sarcolemma; intermediate filaments; rat	HEART-MUSCLE CELLS; CULTURED CARDIAC MYOCYTES; MICE LACKING DESMIN; INTERMEDIATE-FILAMENTS; PROTEIN SYNEMIN; SKELETAL-MUSCLE; AREA COMPOSITA; INTERCALATED DISKS; PLECTIN ISOFORMS; ALPHA-SYNEMIN	Intermediate filaments (IFs) in cardiomyocytes consist primarily of desmin, surround myofibrils at Z disks, and transmit forces from the contracting myofilaments to the cell surface through costameres at the sarcolemma and desmosomes at intercalated disks. Synemin is a type IV IF protein that forms filaments with desmin and also binds alpha-actinin and vinculin. Here we examine the roles and expression of the alpha and beta forms of synemin in developing rat cardiomyocytes. Quantitative PCR showed low levels of expression for both synemin mRNAs, which peaked at postnatal day 7. Synemin was concentrated at sites of cell-cell adhesion and at Z disks in neonatal cardiomyocytes. Overexpression of the individual isoforms showed that alpha-synemin preferentially localized to cell-cell junctions, whereas beta-synemin was primarily at the level of Z disks. An siRNA targeted to both synemin isoforms reduced protein expression in cardiomyocytes by 70% and resulted in a failure of desmin to align with Z disks and disrupted cell-cell junctions, with no effect on sarcomeric organization. Solubility assays showed that beta-synemin was soluble and interacted with sarcomeric alpha-actinin by coimmunoprecipitation, while alpha-synemin and desmin were insoluble. We conclude that beta-synemin mediates the association of desmin IFs with Z disks, whereas alpha-synemin stabilizes junctional complexes between cardiomyocytes.-Lund, L. M., Kerr, J. P., Lupinetti, J., Zhang, Y., Russell, M. A., Bloch, R. J., Bond, M. Synemin isoforms differentially organize cell junctions and desmin filaments in neonatal cardiomyocytes. FASEB J. 26, 137-148 (2012). www.fasebj.org	[Lund, Linda M.; Kerr, Jaclyn P.; Lupinetti, Jenna; Zhang, Yinghua; Bloch, Robert J.; Bond, Meredith] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Russell, Mary A.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Lund, LM (corresponding author), Univ Maryland, Dept Physiol, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	llund001@umaryland.edu		Russell, Mary A/0000-0001-5677-8194; Kerr, Jaclyn/0000-0002-1416-276X	U.S. National Institutes of Health [NIH RO1-02520711, NIH RO1 AR055928RO1]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055928] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Shirley Gaa and Dr. Terry B. Rogers for preparations of cardiomyocytes, Gloria Vives-Rodriguez for technical assistance, and Maureen O'Donnell for help with TaqMan assays and data analysis. This work was supported by U.S. National Institutes of Health grants NIH RO1-02520711 (to M.B.) and NIH RO1 AR055928RO1 (to R.J.B.) and by The Muscular Dystrophy Association (R.J.B.).	BECKER B, 1995, BIOCHEM BIOPH RES CO, V213, P796, DOI 10.1006/bbrc.1995.2200; Bellin RM, 1999, J BIOL CHEM, V274, P29493, DOI 10.1074/jbc.274.41.29493; Bellin RM, 2001, J BIOL CHEM, V276, P32330, DOI 10.1074/jbc.M104005200; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bilak SR, 1998, ARCH BIOCHEM BIOPHYS, V355, P63, DOI 10.1006/abbi.1998.0702; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; Herrmann H, 2003, CELL MOL LIFE SCI, V60, P1607, DOI 10.1007/s00018-003-3004-0; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Hirako Y, 2003, CELL TISSUE RES, V313, P195, DOI 10.1007/s00441-003-0732-2; Izmiryan A, 2010, NEUROCHEM RES, V35, P881, DOI 10.1007/s11064-009-0111-9; Izmiryan A, 2009, EXP CELL RES, V315, P769, DOI 10.1016/j.yexcr.2008.12.009; Jing RF, 2005, GLIA, V50, P107, DOI 10.1002/glia.20158; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Khanamiryan L, 2008, BIOCHEMISTRY-US, V47, P9531, DOI 10.1021/bi800912w; Kim HD, 1996, ANAT RECORD, V246, P271, DOI 10.1002/(SICI)1097-0185(199610)246:2<271::AID-AR13>3.0.CO;2-L; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Lovering RM, 2011, AM J PHYSIOL-CELL PH, V300, pC803, DOI 10.1152/ajpcell.00394.2010; LU MH, 1992, J CELL BIOL, V117, P1007, DOI 10.1083/jcb.117.5.1007; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Mizuno Y, 2004, MUSCLE NERVE, V30, P337, DOI 10.1002/mus.20111; Mizuno Y, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-8; O'Neill A, 2002, MOL BIOL CELL, V13, P2347, DOI 10.1091/mbc.01-12-0576; Pieperhoff S, 2010, EUR J CELL BIOL, V89, P365, DOI 10.1016/j.ejcb.2009.11.025; Rezniczek GA, 2003, HUM MOL GENET, V12, P3181, DOI 10.1093/hmg/ddg345; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; SANDOVAL IV, 1983, J BIOL CHEM, V258, P2568; Shiraishi I, 1997, J MOL CELL CARDIOL, V29, P2041, DOI 10.1006/jmcc.1997.0438; SMOLICH JJ, 1995, REPROD FERT DEVELOP, V7, P451, DOI 10.1071/RD9950451; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Sun N, 2008, BIOCHEM J, V409, P657, DOI 10.1042/BJ20071188; Titeux M, 2001, EUR J BIOCHEM, V268, P6435, DOI 10.1046/j.0014-2956.2001.02594.x; Tokuyasu D., 1985, ANN NY ACAD SCI, V455, P200; TOKUYASU KT, 1983, J CELL BIOL, V96, P1727, DOI 10.1083/jcb.96.6.1727; TOKUYASU KT, 1983, J CELL BIOL, V96, P1736, DOI 10.1083/jcb.96.6.1736; Ursitti JA, 2004, J BIOL CHEM, V279, P41830, DOI 10.1074/jbc.M400128200; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wright G, 2002, AM J PHYSIOL-HEART C, V282, pH872, DOI 10.1152/ajpheart.00256.2001	48	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					137	148		10.1096/fj.10-179408	http://dx.doi.org/10.1096/fj.10-179408			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21982947	Green Published			2022-12-25	WOS:000299202200015
J	Muir, P; Schwartz, Z; Malek, S; Kreines, A; Cabrera, SY; Buote, NJ; Bleedorn, JA; Schaefer, SL; Holzman, G; Hao, ZL				Muir, Peter; Schwartz, Zeev; Malek, Sarah; Kreines, Abigail; Cabrera, Sady Y.; Buote, Nicole J.; Bleedorn, Jason A.; Schaefer, Susan L.; Holzman, Gerianne; Hao, Zhengling			Contralateral Cruciate Survival in Dogs with Unilateral Non-Contact Cranial Cruciate Ligament Rupture	PLOS ONE			English	Article							INFLAMMATORY STIFLE ARTHRITIS; TIBIAL PLATEAU ANGLE; SYNOVIAL-FLUID; BACTERIAL LOAD; CANINE OSTEOARTHRITIS; RISK-FACTORS; JOINT; DOXYCYCLINE; DISEASE; IDENTIFICATION	Background: Non-contact cranial cruciate ligament rupture (CrCLR) is an important cause of lameness in client-owned dogs and typically occurs without obvious injury. There is a high incidence of bilateral rupture at presentation or subsequent contralateral rupture in affected dogs. Although stifle synovitis increases risk of contralateral CrCLR, relatively little is known about risk factors for subsequent contralateral rupture, or whether therapeutic intervention may modify this risk. Methodology/Principal Findings: We conducted a longitudinal study examining survival of the contralateral CrCL in client-owned dogs with unilateral CrCLR in a large baseline control population (n = 380), and a group of dogs that received disease-modifying therapy with arthroscopic lavage, intra-articular hyaluronic acid and oral doxycycline (n = 16), and were followed for one year. Follow-up in treated dogs included analysis of mobility, radiographic evaluation of stifle effusion and arthritis, and quantification of biomarkers of synovial inflammation. We found that median survival of the contralateral CrCL was 947 days. Increasing tibial plateau angle decreased contralateral ligament survival, whereas increasing age at diagnosis increased survival. Contralateral ligament survival was reduced in neutered dogs. Our disease-modifying therapy did not significantly influence contralateral ligament survival. Correlative analysis of clinical and biomarker variables with development of subsequent contralateral rupture revealed few significant results. However, increased expression of T lymphocyte-associated genes in the index unstable stifle at diagnosis was significantly related to development of subsequent non-contact contralateral CrCLR. Conclusion: Subsequent contralateral CrCLR is common in client-owned dogs, with a median ligament survival time of 947 days. In this naturally occurring model of non-contact cruciate ligament rupture, cranial tibial translation is preceded by development of synovial inflammation. However, treatment with arthroscopic lavage, intra-articular hyaluronic acid and oral doxycycline does not significantly influence contralateral CrCL survival.	[Muir, Peter; Schwartz, Zeev; Malek, Sarah; Kreines, Abigail; Bleedorn, Jason A.; Schaefer, Susan L.; Holzman, Gerianne; Hao, Zhengling] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Cabrera, Sady Y.] VCA W Angeles Anim Hosp, Dept Surg, Los Angeles, CA USA; [Buote, Nicole J.] Calif Anim Hosp Inc, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Fiumefreddo, Andrea/T-2977-2019; Bleedorn, Jason A/AAE-2115-2019; Muir, Peter/AAH-8057-2021; Malek, Sarah/AAT-5214-2020	Bleedorn, Jason A/0000-0003-2987-7722; Muir, Peter/0000-0003-0028-6005; Malek, Sarah/0000-0001-8809-8388	American Kennel Club Canine Health Foundation	American Kennel Club Canine Health Foundation	This work was supported by the American Kennel Club Canine Health Foundation (www.akcchf.org). The contents of this publication are solely the responsibility of the authors and do not necessarily reflect the views of the Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Ayral X, 1996, BRIT J RHEUMATOL, V35, P14; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Boissier MC, 2009, JOINT BONE SPINE, V76, P10, DOI 10.1016/j.jbspin.2008.08.002; Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Clements DN, 2011, VET COMP ORTHOPAED, V24, P262, DOI [10.3415/VCOT-11-03-0048, 10.3415/VCOT-11-03-008]; Comerford EJ, 2005, J ORTHOP RES, V23, P61, DOI 10.1016/j.orthres.2004.05.016; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; de Bruin T, 2007, J VET MED A, V54, P292, DOI 10.1111/j.1439-0442.2007.00977.x; de Bruin T, 2007, AM J VET RES, V68, P283, DOI 10.2460/ajvr.68.3.283; de Rooster H, 2000, AM J VET RES, V61, P1456, DOI 10.2460/ajvr.2000.61.1456; De Rooster H, 2006, VET SURG, V35, P769, DOI 10.1111/j.1532-950X.2006.00221.x; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Dreitz MJ, 1999, VET IMMUNOL IMMUNOP, V69, P113, DOI 10.1016/S0165-2427(99)00047-1; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Faldyna M, 2004, ACTA VET BRNO, V73, P73, DOI 10.2754/avb200473010073; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fu X, 2009, J ORTHOP RES, V27, P91, DOI 10.1002/jor.20720; GALLOWAY RH, 1995, J AM ANIM HOSP ASSOC, V31, P289, DOI 10.5326/15473317-31-4-289; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Guerrero TG, 2007, AM J VET RES, V68, P1332, DOI 10.2460/ajvr.68.12.1332; Hayashi K, 2004, J AM ANIM HOSP ASSOC, V40, P385, DOI 10.5326/0400385; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Hiraoka N, 2011, J ORTHOP RES, V29, P354, DOI 10.1002/jor.21240; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Klocke NW, 2005, AM J VET RES, V66, P493, DOI 10.2460/ajvr.2005.66.493; Kobayashi S, 2006, J ORTHOP RES, V24, P1509, DOI 10.1002/jor.20183; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; Maccoux LJ, 2007, VET IMMUNOL IMMUNOP, V118, P59, DOI 10.1016/j.vetimm.2007.04.006; Miur P, 2007, MICROB PATHOGENESIS, V42, P47, DOI 10.1016/j.micpath.2006.10.002; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2005, VET SURG, V34, P239, DOI 10.1111/j.1532-950X.2005.00036.x; Muir P, 2011, VET SURG, V40, P753, DOI 10.1111/j.1532-950X.2011.00867.x; Muir P, 2010, VET MICROBIOL, V141, P127, DOI 10.1016/j.vetmic.2009.08.015; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NASH RA, 1991, IMMUNOGENETICS, V33, P396, DOI 10.1007/BF00216700; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schwartz Z, 2011, VET MICROBIOL, V148, P308, DOI 10.1016/j.vetmic.2010.09.011; Short AD, 2009, VET IMMUNOL IMMUNOP, V128, P137, DOI 10.1016/j.vetimm.2008.10.301; Smith GN, 1996, ARTHRITIS RHEUM, V39, P235, DOI 10.1002/art.1780390209; Smith MM, 2008, RHEUMATOLOGY, V47, P1172, DOI 10.1093/rheumatology/ken219; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; Toth A P, 2001, J Gend Specif Med, V4, P25; Wang YS, 2007, VET IMMUNOL IMMUNOP, V118, P186, DOI 10.1016/j.vetimm.2007.05.010; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2009, AM J VET RES, V70, P1013, DOI 10.2460/ajvr.70.8.1013; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Wilke VL, 2002, J AM VET MED ASSOC, V221, P1426, DOI 10.2460/javma.2002.221.1426; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Ying BW, 2011, MOL BIOL REP, V38, P379, DOI 10.1007/s11033-010-0119-x; YU LP, 1991, J RHEUMATOL, V18, P1450; YU LP, 1992, ARTHRITIS RHEUM, V35, P1150, DOI 10.1002/art.1780351007	67	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25331	10.1371/journal.pone.0025331	http://dx.doi.org/10.1371/journal.pone.0025331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998650	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900019
J	Peralvarez-Marin, A; Tae, H; Board, PG; Casarotto, MG; Dulhunty, AF; Samso, M				Peralvarez-Marin, Alex; Tae, HanShen; Board, Philip G.; Casarotto, Marco G.; Dulhunty, Angela F.; Samso, Montserrat			3D Mapping of the SPRY2 Domain of Ryanodine Receptor 1 by Single-Particle Cryo-EM	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; MONOCLONAL FAB FRAGMENT; SKELETAL-MUSCLE; 3-DIMENSIONAL RECONSTRUCTION; DIHYDROPYRIDINE RECEPTOR; CRYOELECTRON MICROSCOPY; SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAINS; UCSF CHIMERA; RYR1	The type 1 skeletal muscle ryanodine receptor (RyR1) is principally responsible for Ca2+ release from the sarcoplasmic reticulum and for the subsequent muscle contraction. The RyR1 contains three SPRY domains. SPRY domains are generally known to mediate protein-protein interactions, however the location of the three SPRY domains in the 3D structure of the RyR1 is not known. Combining immunolabeling and single-particle cryo-electron microscopy we have mapped the SPRY2 domain (S1085-V1208) in the 3D structure of RyR1 using three different antibodies against the SPRY2 domain. Two obstacles for the image processing procedure; limited amount of data and signal dilution introduced by the multiple orientations of the antibody bound in the tetrameric RyR1, were overcome by modifying the 3D reconstruction scheme. This approach enabled us to ascertain that the three antibodies bind to the same region, to obtain a 3D reconstruction of RyR1 with the antibody bound, and to map SPRY2 to the periphery of the cytoplasmic domain of RyR1. We report here the first 3D localization of a SPRY2 domain in any known RyR isoform.	[Peralvarez-Marin, Alex; Samso, Montserrat] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Spain; [Tae, HanShen; Board, Philip G.; Casarotto, Marco G.; Dulhunty, Angela F.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Autonomous University of Barcelona; Australian National University; John Curtin School of Medical Research; Virginia Commonwealth University	Peralvarez-Marin, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.	msamso@vcu.edu	Dulhunty, Angela/AAO-5421-2020; Tae, Han-Shen/AAA-1904-2020; Peralvarez-Marin, Alex/AAH-4305-2020; Peralvarez-Marin, Alex/A-8958-2017	Tae, Han-Shen/0000-0001-8961-7194; Peralvarez-Marin, Alex/0000-0002-3457-0875; Casarotto, Marco/0000-0002-0571-7671; Dulhunty, Angela/0000-0001-9493-4944; Samso, Montserrat/0000-0002-2788-3283	Brigham and Women's Hospital Biomedical Research Institute; Australian National Health and the Medical Research Council [471418]; European Commission (Marie Curie Action) [PIOF-GA-2009-237120]	Brigham and Women's Hospital Biomedical Research Institute; Australian National Health and the Medical Research Council; European Commission (Marie Curie Action)(European CommissionEuropean Commission Joint Research Centre)	The authors want to thank the Brigham and Women's Hospital Biomedical Research Institute (to MS), the Australian National Health and the Medical Research Council (471418 to AD, MC and PB), and the European Commission (Marie Curie Action PIOF-GA-2009-237120 to AP-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BOARD PG, 1987, P NATL ACAD SCI USA, V84, P2377, DOI 10.1073/pnas.84.8.2377; BOISSET N, 1993, J STRUCT BIOL, V111, P234, DOI 10.1006/jsbi.1993.1053; BOISSET N, 1995, J STRUCT BIOL, V115, P16, DOI 10.1006/jsbi.1995.1025; Casarotto MG, 2006, CLIN EXP PHARMACOL P, V33, P1114, DOI 10.1111/j.1440-1681.2006.04501.x; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4717, DOI 10.1021/bi00437a031; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; Harlow E, 1988, ANTIBODIES LAB MANUU; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Kimura T, 2007, BIOCHEM J, V401, P317, DOI 10.1042/BJ20060686; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Perez CF, 2003, J BIOL CHEM, V278, P39644, DOI 10.1074/jbc.M305160200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; RADERMACHER M, 1992, BIOPHYS J, V61, P936, DOI 10.1016/S0006-3495(92)81900-8; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sandin S, 2004, STRUCTURE, V12, P409, DOI 10.1016/j.str.2004.02.011; Sencer S, 2001, J BIOL CHEM, V276, P38237; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tae H, 2011, CHANNELS, V5, P148, DOI 10.4161/chan.5.2.14407; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; Treves S, 2002, CELL CALCIUM, V31, P1, DOI 10.1054/ceca.2001.0252; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yamazawa T, 1997, J BIOL CHEM, V272, P8161, DOI 10.1074/jbc.272.13.8161; Yao SG, 2006, PROTEIN SCI, V15, P2761, DOI 10.1110/ps.062477806	44	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25813	10.1371/journal.pone.0025813	http://dx.doi.org/10.1371/journal.pone.0025813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998699	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900056
J	Zou, Q; Yao, X; Feng, J; Yin, ZN; Flavell, R; Hu, YX; Zheng, GX; Jin, J; Kang, YM; Wu, B; Liang, XX; Feng, CC; Liu, H; Li, WY; Wang, XZ; Wen, YM; Wang, B				Zou, Qiang; Yao, Xin; Feng, Jin; Yin, Zhinan; Flavell, Richard; Hu, Yanxin; Zheng, Guoxing; Jin, Jin; Kang, Youmin; Wu, Bing; Liang, Xiaoxuan; Feng, Congcong; Liu, Hu; Li, Weiyi; Wang, Xianzheng; Wen, Yumei; Wang, Bin			Praziquantel Facilitates IFN-gamma-Producing CD8(+) T Cells (Tc1) and IL-17-Producing CD8(+) T Cells (Tc17) Responses to DNA Vaccination in Mice	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CONTACT HYPERSENSITIVITY RESPONSES; DELAYED-TYPE HYPERSENSITIVITY; VACCINIA VIRUS; SCHISTOSOMA-MANSONI; IMMUNE-RESPONSES; TRANSGENIC MICE; HOST-DEFENSE; INFECTION; ANTIGEN	Background: CD8(+) cytotoxic T lymphocytes (CTLs) are crucial for eliminating hepatitis B virus (HBV) infected cells. DNA vaccination, a novel therapeutic strategy for chronic virus infection, has been shown to induce CTL responses. However, accumulated data have shown that CTLs could not be effectively induced by HBV DNA vaccination. Methodology/principal Findings: Here, we report that praziquantel (PZQ), an anti-schistoma drug, could act as an adjuvant to overcome the lack of potent CTL responses by HBV DNA vaccination in mice. PZQ in combination with HBV DNA vaccination augmented the induction of CD8(+) T cell-dependent and HBV-specific delayed hypersensitivity responses (DTH) in C57BL/6 mice. Furthermore, the induced CD8(+) T cells consisted of both Tc1 and Tc17 subtypes. By using IFN-gamma knockout (KO) mice and IL-17 KO mice, both cytokines were found to be involved in the DTH. The relevance of these findings to HBV immunization was established in HBsAg transgenic mice, in which PZQ also augmented the induction of HBV-specific Tc1 and Tc17 cells and resulted in reduction of HBsAg positive hepatocytes. Adoptive transfer experiments further showed that PZQ-primed CD8(+) T cells from wild type mice, but not the counterpart from IFN-gamma KO or IL-17 KO mice, resulted in elimination of HBsAg positive hepatocytes. Conclusions/Significance: Our results suggest that PZQ is an effective adjuvant to facilitate Tc1 and Tc17 responses to HBV DNA vaccination, inducing broad CD8(+) T cell-based immunotherapy that breaks tolerance to HBsAg.	[Zou, Qiang; Jin, Jin; Kang, Youmin; Wu, Bing; Liang, Xiaoxuan; Feng, Congcong; Liu, Hu; Li, Weiyi; Wang, Xianzheng; Wang, Bin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Yao, Xin; Wen, Yumei; Wang, Bin] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH, Shanghai 200433, Peoples R China; [Feng, Jin] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Flavell, Richard] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Hu, Yanxin] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zheng, Guoxing] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Yao, Xin; Wen, Yumei; Wang, Bin] Fudan Univ, Shanghai Med Coll, MOE, Shanghai 200433, Peoples R China	China Agricultural University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Yale University; China Agricultural University; University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Fudan University	Zou, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	bwang3@cau.edu.cn	YAO, XIN/G-5370-2014; wen, yu/AAJ-7482-2021	Jin, Jin/0000-0001-7887-5972; Kang, Youmin/0000-0003-2597-6117	National Key Technology Research & Development Program of China [2004BA519A39, 2006BAD06A06]; National Nature Science Foundation [30771602]; National Mega Grand Program on Key Infectious Diseases of China [2008ZX10001-012]	National Key Technology Research & Development Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Mega Grand Program on Key Infectious Diseases of China	This work was supported in part by National Key Technology Research & Development Program of China (2004BA519A39 and 2006BAD06A06), National Nature Science Foundation (30771602) and National Mega Grand Program on Key Infectious Diseases of China (2008ZX10001-012) to B.Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1994, J IMMUNOL, V152, P3245; Brignone C, 2007, J IMMUNOL, V179, P4202, DOI 10.4049/jimmunol.179.6.4202; BRINDLEY PJ, 1987, J IMMUNOL, V139, P215; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; FERRARI C, 1990, J IMMUNOL, V145, P3442; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Kienzle N, 2002, J IMMUNOL, V168, P1672, DOI 10.4049/jimmunol.168.4.1672; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Kosinska AD, 2010, HEPAT RES TREAT; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Martins-Leite P, 2008, ANTIMICROB AGENTS CH, V52, P2780, DOI 10.1128/AAC.00173-08; Nair S, 2001, HEPATOLOGY, V34, P1021, DOI 10.1053/jhep.2001.28459; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; Sallberg M, 1998, HUM GENE THER, V9, P1719, DOI 10.1089/hum.1998.9.12-1719; Schirmbeck R, 2003, EUR J IMMUNOL, V33, P3342, DOI 10.1002/eji.200324403; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Yang KJ, 2008, J IMMUNOL, V180, P6159, DOI 10.4049/jimmunol.180.9.6159; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhang XL, 2005, J VIROL, V79, P15289, DOI 10.1128/JVI.79.24.15289-15301.2005; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zou Q, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/562356; Zou Q, 2010, VACCINE, V28, P2032, DOI 10.1016/j.vaccine.2009.10.101	52	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25525	10.1371/journal.pone.0025525	http://dx.doi.org/10.1371/journal.pone.0025525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998665	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900032
J	Annesley, SJ; Bago, R; Bosnar, MH; Filic, V; Marinovic, M; Weber, I; Mehta, A; Fisher, PR				Annesley, Sarah J.; Bago, Ruzica; Bosnar, Maja Herak; Filic, Vedrana; Marinovic, Maja; Weber, Igor; Mehta, Anil; Fisher, Paul R.			Dictyostelium discoideum Nucleoside Diphosphate Kinase C Plays a Negative Regulatory Role in Phagocytosis, Macropinocytosis and Exocytosis	PLOS ONE			English	Article							PATHWAYS MEDIATING CHEMOTAXIS; HEPATOCYTE GROWTH-FACTOR; FLUID-PHASE PINOCYTOSIS; X-RAY-STRUCTURE; TUMOR-METASTASIS; GENE-EXPRESSION; CELL-ADHESION; BREAST-CANCER; SOCIAL AMEBA; NM23	Nucleoside diphosphate kinases (NDPKs) are ubiquitous phosphotransfer enzymes responsible for producing most of the nucleoside triphosphates except for ATP. This role is important for the synthesis of nucleic acids and proteins and the metabolism of sugars and lipids. Apart from this housekeeping role NDPKs have been shown to have many regulatory functions in diverse cellular processes including proliferation and endocytosis. Although the protein has been shown to have a positive regulatory role in clathrin-and dynamin-mediated micropinocytosis, its roles in macropinocytosis and phagocytosis have not been studied. The additional non-housekeeping roles of NDPK are often independent of enzyme activity but dependent on the expression level of the protein. In this study we altered the expression level of NDPK in the model eukaryotic organism Dictyostelium discoideum through antisense inhibition and overexpression. We demonstrate that NDPK levels affect growth, endocytosis and exocytosis. In particular we find that Dictyostelium NDPK negatively regulates endocytosis in contrast to the positive regulatory role identified in higher eukaryotes. This can be explained by the differences in types of endocytosis that have been studied in the different systems - phagocytosis and macropinocytosis in Dictyostelium compared with micropinocytosis in mammalian cells. This is the first report of a role for NDPK in regulating macropinocytosis and phagocytosis, the former being the major fluid phase uptake mechanism for macrophages, dendritic cells and other (non dendritic) cells exposed to growth factors.	[Annesley, Sarah J.; Bago, Ruzica; Fisher, Paul R.] La Trobe Univ, Dept Microbol, Bundoora, Vic 3086, Australia; [Bago, Ruzica; Bosnar, Maja Herak] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Filic, Vedrana; Marinovic, Maja; Weber, Igor] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Mehta, Anil] Ninewells Hosp, Div Med Sci, Dundee DD1 9SY, Scotland; [Mehta, Anil] Univ Dundee, Sch Med, Dundee, Scotland	La Trobe University; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Dundee; University of Dundee	Annesley, SJ (corresponding author), La Trobe Univ, Dept Microbol, Bundoora, Vic 3086, Australia.	P.Fisher@latrobe.edu.au	Weber, Igor/J-3947-2012; Filić, Vedrana/ABH-5748-2020; Annesley, Sarah/K-6985-2019; Bosnar, Maja Herak/AAN-6122-2020; Fisher, Paul/F-2870-2011	Weber, Igor/0000-0003-4296-3166; Filić, Vedrana/0000-0001-6597-1607; Annesley, Sarah/0000-0002-7604-3985; Fisher, Paul/0000-0003-1884-6306	Thyne Reid Memorial Trusts; Australian Research Council; Wellcome Trust [WT086370MA]	Thyne Reid Memorial Trusts; Australian Research Council(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants to PRF from the Thyne Reid Memorial Trusts and the Australian Research Council, and to AM from Wellcome Trust WT086370MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren MAE, 2004, MOL CANCER RES, V2, P387; Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; Annesley SJ, 2011, N-S ARCH PHARMACOL, V384, P341, DOI 10.1007/s00210-011-0615-0; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; BARSAGI D, 1987, J CELL PHYSIOL, P69; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Barth C, 1998, PLASMID, V39, P141, DOI 10.1006/plas.1997.1326; BAZARI WL, 1982, CELL MOTIL CYTOSKEL, V2, P471, DOI 10.1002/cm.970020506; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Bosnar MH, 2008, CROAT CHEM ACTA, V81, P183; Buczynski G, 1997, MOL BIOL CELL, V8, P1343, DOI 10.1091/mbc.8.7.1343; Caligo MA, 1997, INT J CANCER, V74, P102, DOI 10.1002/(SICI)1097-0215(19970220)74:1<102::AID-IJC18>3.0.CO;2-H; CHERFILS J, 1994, BIOCHEMISTRY-US, V33, P9062, DOI 10.1021/bi00197a006; Chubb JR, 2000, J CELL SCI, V113, P709; Cipollini G, 1997, INT J CANCER, V73, P297, DOI 10.1002/(SICI)1097-0215(19971009)73:2<297::AID-IJC22>3.0.CO;2-B; Clarke M, 1990, CALCIUM INTRACELLULA, P375; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Dumontier M, 2000, J CELL SCI, V113, P2253; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fisher Paul R., 2006, V346, P137; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Hacker U, 1997, J CELL SCI, V110, P105; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Kang Y, 2007, BIOCHEM BIOPH RES CO, V359, P76, DOI 10.1016/j.bbrc.2007.05.090; Kapetanovich L, 2005, MOL BIOL CELL, V16, P835, DOI 10.1091/mbc.e04-09-0785; Karlsson A, 1996, J BIOL CHEM, V271, P19928, DOI 10.1074/jbc.271.33.19928; Khosla M, 2000, J CELL SCI, V113, P1427; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; KLEIN G, 1986, BIOCHEM BIOPH RES CO, V138, P1146, DOI 10.1016/S0006-291X(86)80402-8; Kotsifas M, 2002, J MUSCLE RES CELL M, V23, P839, DOI 10.1023/A:1024444215766; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; LACOMBE ML, 1991, EUR J CANCER, V27, P1302, DOI 10.1016/0277-5379(91)90101-I; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Lombardi D, 2001, CELL DEATH DIFFER, V8, P470, DOI 10.1038/sj.cdd.4400842; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maniak M, 2002, INT REV CYTOL, V221, P257; Maselli A, 2002, MICROBIOL-SGM, V148, P413, DOI 10.1099/00221287-148-2-413; MELKI R, 1992, BIOCHEM BIOPH RES CO, V187, P65, DOI 10.1016/S0006-291X(05)81459-7; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; MORERA S, 1994, BIOCHEMISTRY-US, V33, P459, DOI 10.1021/bi00168a010; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; MORERA S, 1994, J MOL BIOL, V243, P873, DOI 10.1006/jmbi.1994.1689; Narayanan R, 2003, J BIOENERG BIOMEMBR, V35, P49, DOI 10.1023/A:1023441806530; NELLEN W, 1984, MOL CELL BIOL, V4, P2890, DOI 10.1128/MCB.4.12.2890; Noegel AA, 2000, J CELL SCI, V113, P759; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Postel EH, 2009, MOL CELL BIOCHEM, V329, P45, DOI 10.1007/s11010-009-0110-9; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Sager R, 1997, P NATL ACAD SCI USA, V94, P952, DOI 10.1073/pnas.94.3.952; SASTREGARAU X, 1992, INT J CANCER, V50, P533, DOI 10.1002/ijc.2910500406; SAWAN A, 1994, J PATHOL, V172, P27, DOI 10.1002/path.1711720107; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SELLAM O, 1995, MOL MICROBIOL, V16, P79, DOI 10.1111/j.1365-2958.1995.tb02393.x; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Srinivasan S, 2001, PROTEOMICS, V1, P1119, DOI 10.1002/1615-9861(200109)1:9<1119::AID-PROT1119>3.3.CO;2-O; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; TROLL H, 1993, J BIOL CHEM, V268, P25469; Veithen A, 1996, J CELL SCI, V109, P2005; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wilczynska Z, 1997, BIOCHEM BIOPH RES CO, V234, P39, DOI 10.1006/bbrc.1997.6574; WILCZYNSKA Z, 1994, PLASMID, V32, P182, DOI 10.1006/plas.1994.1054; Wilkins A, 2000, CURR BIOL, V10, P1427, DOI 10.1016/S0960-9822(00)00797-1; Willard SS, 2006, EUR J CELL BIOL, V85, P897, DOI 10.1016/j.ejcb.2006.06.003; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zhou KM, 1998, J CELL SCI, V111, P283; ZICHA D, 1991, J CELL SCI, V99, P769	91	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26024	10.1371/journal.pone.0026024	http://dx.doi.org/10.1371/journal.pone.0026024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991393	Green Submitted, gold, Green Published			2022-12-25	WOS:000295963300034
J	Bikadi, Z; Hazai, I; Malik, D; Jemnitz, K; Veres, Z; Hari, P; Ni, ZL; Loo, TW; Clarke, DM; Hazai, E; Mao, QC				Bikadi, Zsolt; Hazai, Istvan; Malik, David; Jemnitz, Katalin; Veres, Zsuzsa; Hari, Peter; Ni, Zhanglin; Loo, Tip W.; Clarke, David M.; Hazai, Eszter; Mao, Qingcheng			Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein	PLOS ONE			English	Article							PASSIVE PERMEABILITY; BINDING-SITE; CLASSIFICATION; IDENTIFICATION; RESISTANCE; INHIBITORS; ACCURACY; DOXORUBICIN; ABSORPTION; GENOMICS	Human P-glycoprotein (P-gp) is an ATP-binding cassette multidrug transporter that confers resistance to a wide range of chemotherapeutic agents in cancer cells by active efflux of the drugs from cells. P-gp also plays a key role in limiting oral absorption and brain penetration and in facilitating biliary and renal elimination of structurally diverse drugs. Thus, identification of drugs or new molecular entities to be P-gp substrates is of vital importance for predicting the pharmacokinetics, efficacy, safety, or tissue levels of drugs or drug candidates. At present, publicly available, reliable in silico models predicting P-gp substrates are scarce. In this study, a support vector machine (SVM) method was developed to predict P-gp substrates and P-gp-substrate interactions, based on a training data set of 197 known P-gp substrates and non-substrates collected from the literature. We showed that the SVM method had a prediction accuracy of approximately 80% on an independent external validation data set of 32 compounds. A homology model of human P-gp based on the X-ray structure of mouse P-gp as a template has been constructed. We showed that molecular docking to the P-gp structures successfully predicted the geometry of P-gp-ligand complexes. Our SVM prediction and the molecular docking methods have been integrated into a free web server (http://pgp.althotas.com), which allows the users to predict whether a given compound is a P-gp substrate and how it binds to and interacts with P-gp. Utilization of such a web server may prove valuable for both rational drug design and screening.	[Bikadi, Zsolt; Hazai, Istvan; Malik, David; Hazai, Eszter] Virtua Drug Ltd, Budapest, Hungary; [Jemnitz, Katalin; Veres, Zsuzsa] Hungary Acad Sci, Chem Res Ctr, Budapest, Hungary; [Hari, Peter] Delta Serv Ltd, Budapest, Hungary; [Loo, Tip W.; Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ni, Zhanglin; Mao, Qingcheng] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA	Hungarian Academy of Sciences; University of Toronto; University of Washington; University of Washington Seattle	Bikadi, Z (corresponding author), Virtua Drug Ltd, Budapest, Hungary.	qmao@u.washington.edu	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188; Jemnitz, Katalin/0000-0003-1943-3108	Hungarian State; European Union [KMOP-1.1.1-09/1-2009-0044]; National Cancer Institute of Canada through the Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; National Institutes of Health [GM073715]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073715] Funding Source: NIH RePORTER	Hungarian State; European Union(European Commission); National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hungarian State and the European Union (European Regional Development Fund), under the aegis of New Hungary Development Plan (KMOP-1.1.1-09/1-2009-0044). Dr. Clarke is the holder of the Canada Research Chair in Membrane Biology and the research was supported by grants from the National Cancer Institute of Canada through the Canadian Cancer Society (Grant 19074) and from the Canadian Institutes of Health Research (Grant 25043). Dr. Mao gratefully acknowledges financial support by the National Institutes of Health Grant (GM073715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2001, PHARMACEUT RES, V18, P1660, DOI 10.1023/A:1013358126640; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balimane PV, 2004, EUR J PHARM BIOPHARM, V58, P99, DOI 10.1016/j.ejpb.2004.02.014; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Cabrera MA, 2006, J PHARM SCI-US, V95, P589, DOI 10.1002/jps.20449; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Eytan GD, 1997, EUR J BIOCHEM, V248, P104, DOI 10.1111/j.1432-1033.1997.00104.x; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Huang JP, 2007, J CHEM INF MODEL, V47, P1638, DOI 10.1021/ci700083n; Kaiser D, 2007, J MED CHEM, V50, P1698, DOI 10.1021/jm060604z; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Lima PDC, 2006, J CHEM INF MODEL, V46, P1245, DOI 10.1021/ci0504317; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Luts J, 2010, ANAL CHIM ACTA, V665, P129, DOI 10.1016/j.aca.2010.03.030; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Noble W.S., 2004, KERNEL METHODS COMPU, P71; Penzotti JE, 2002, J MED CHEM, V45, P1737, DOI 10.1021/jm0255062; Perloff MD, 2003, PHARMACEUT RES, V20, P1177, DOI 10.1023/A:1025092829696; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauna ZE, 2007, J BIOENERG BIOMEMBR, V39, P481, DOI 10.1007/s10863-007-9115-9; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Susanto M, 2002, PHARM RES-DORDR, V19, P457, DOI 10.1023/A:1015191511817; Tarcsay A, 2011, FUTURE MED CHEM, V3, P297, DOI [10.4155/FMC.10.276, 10.4155/fmc.10.276]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; van der Sandt ICJ, 2000, EUR J PHARM SCI, V11, P207, DOI 10.1016/S0928-0987(00)00097-X; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Varma MVS, 2005, MOL PHARMACEUT, V2, P12, DOI 10.1021/mp0499196; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Wang Z, 2011, J CHEM INF MODEL; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1497, DOI 10.1021/ci049971e; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Zhang L, 2007, INT J PHARMACEUT, V343, P98, DOI 10.1016/j.ijpharm.2007.05.017; Zsila F, 2011, BIOINFORMATICS	48	83	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25815	10.1371/journal.pone.0025815	http://dx.doi.org/10.1371/journal.pone.0025815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991360	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000295963300022
J	James, PMA; Coltman, DW; Murray, BW; Hamelin, RC; Sperling, FAH				James, Patrick M. A.; Coltman, Dave W.; Murray, Brent W.; Hamelin, Richard C.; Sperling, Felix A. H.			Spatial Genetic Structure of a Symbiotic Beetle-Fungal System: Toward Multi-Taxa Integrated Landscape Genetics	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE HOPK; BARK BEETLES; MYCANGIAL FUNGI; RANGE EXPANSION; CLIMATE-CHANGE; COLEOPTERA; FOREST; COMMUNITY; ECOLOGY	Spatial patterns of genetic variation in interacting species can identify shared features that are important to gene flow and can elucidate co-evolutionary relationships. We assessed concordance in spatial genetic variation between the mountain pine beetle (Dendroctonus ponderosae) and one of its fungal symbionts, Grosmanniaclavigera, in western Canada using neutral genetic markers. We examined how spatial heterogeneity affects genetic variation within beetles and fungi and developed a novel integrated landscape genetics approach to assess reciprocal genetic influences between species using constrained ordination. We also compared landscape genetic models built using Euclidean distances based on allele frequencies to traditional pair-wise Fst. Both beetles and fungi exhibited moderate levels of genetic structure over the total study area, low levels of structure in the south, and more pronounced fungal structure in the north. Beetle genetic variation was associated with geographic location while that of the fungus was not. Pinevolume and climate explained beetle genetic variation in the northern region of recent outbreak expansion. Reciprocal genetic relationships were only detectedin the south where there has been alonger history of beetle infestations. The Euclidean distance and Fst-based analyses resulted in similar models in the north and over the entire study area, but differences between methods in the south suggest that genetic distances measures should be selected based on ecological and evolutionary contexts. The integrated landscape genetics framework we present is powerful, general, and can be applied to other systems to quantify the biotic and abiotic determinants of spatial genetic variation within and among taxa.	[James, Patrick M. A.; Coltman, Dave W.; Sperling, Felix A. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Murray, Brent W.] Univ No British Columbia, Nat Resources & Environm Studies Inst, Prince George, BC V2L 5P2, Canada; [Hamelin, Richard C.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Hamelin, Richard C.] Nat Resources Canada, Quebec City, PQ, Canada	University of Alberta; University of Northern British Columbia; University of British Columbia; Natural Resources Canada	James, PMA (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	patrick.ma.james@umontreal.ca	Lundquist, John/B-6433-2012; Coltman, David W/A-4453-2012; Sperling, Felix A.H./H-8376-2012; Murray, Brent/F-5031-2012; Hamelin, Richard/F-7006-2010	Coltman, David W/0000-0002-1268-2307; Sperling, Felix A.H./0000-0001-5148-4226; Hamelin, Richard/0000-0003-4006-532X	Government of Alberta [AAET/AFRI-859-G07]; Genome Canada; Genome Alberta; Genome British Columbia; University of Alberta	Government of Alberta; Genome Canada(Genome Canada); Genome Alberta; Genome British Columbia; University of Alberta(University of Alberta)	Funding for this research was provided through grants from the Government of Alberta (AAET/AFRI-859-G07) to DWC, and FAHS and from Genome Canada, Genome Alberta, and Genome British Columbia for the TRIA1 and TRIA2 Projects (http://www.thetriaproject.ca) to DWC, BM, RH and FAHS. PMAJ was also supported by a Killam Post-Doctoral Fellowship at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 1999, EVOLUTION, V53, P818, DOI 10.1111/j.1558-5646.1999.tb05375.x; Amman GD, 1973, INT171 NAT RES CAN; Anderson B, 2004, EVOLUTION, V58, P1730, DOI 10.1111/j.0014-3820.2004.tb00457.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; BERRYMAN AA, 1972, BIOSCIENCE, V22, P598, DOI 10.2307/1296206; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Bleiker KP, 2009, CAN ENTOMOL, V141, P503, DOI 10.4039/n09-034; Cardoza YJ, 2008, ENVIRON ENTOMOL, V37, P956, DOI 10.1603/0046-225X(2008)37[956:MSAFMN]2.0.CO;2; Carroll AL, 2004, PACIF FOR C, V399, P223; Davis CS, 2009, MOL ECOL RESOUR, V9, P1071, DOI 10.1111/j.1755-0998.2009.02579.x; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fall A, 2007, ECOSYSTEMS, V10, P448, DOI 10.1007/s10021-007-9038-7; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Hopping G. R., 1945, FOREST CHRON, V21, P1; Jackson PL, 2008, CAN J FOREST RES, V38, P2313, DOI 10.1139/X08-066; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Logan J, 1999, ENV ENTOMOLOGY, V28; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Nealis V, 2008, BCX417 NAT RES CAN; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roe AD, 2011, MOL ECOL, V20, P584, DOI 10.1111/j.1365-294X.2010.04953.x; SAFRANYIK L, 1989, J APPL ENTOMOL, V108, P498, DOI 10.1111/j.1439-0418.1989.tb00484.x; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Six DL, 2007, MICROB ECOL, V54, P112, DOI 10.1007/s00248-006-9178-x; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2004, SYMBIOSIS, V37, P207; Six DL, 1999, ANN ENTOMOL SOC AM, V92, P159, DOI 10.1093/aesa/92.2.159; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; ter Braak CJF, 1987, DATA ANAL COMMUNITY; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Tsui CKM, 2009, MOL ECOL RESOUR, V9, P1501, DOI 10.1111/j.1755-0998.2009.02717.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S, 1943, GENETICS, V28, P114; Yemshanov D, ENV MONITOR IN PRESS	59	57	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25359	10.1371/journal.pone.0025359	http://dx.doi.org/10.1371/journal.pone.0025359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991309	gold, Green Submitted, Green Published			2022-12-25	WOS:000295963300011
J	Nogaro, SI; Hafalla, JC; Walther, B; Remarque, EJ; Tetteh, KKA; Conway, DJ; Riley, EM; Walther, M				Nogaro, Sarah I.; Hafalla, Julius C.; Walther, Brigitte; Remarque, Edmond J.; Tetteh, Kevin K. A.; Conway, David J.; Riley, Eleanor M.; Walther, Michael			The Breadth, but Not the Magnitude, of Circulating Memory B Cell Responses to P. falciparum Increases with Age/Exposure in an Area of Low Transmission	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; APICAL MEMBRANE ANTIGEN-1; MALARIA-ENDEMIC AREA; PLASMODIUM-FALCIPARUM; SERUM ANTIBODIES; ACQUIRED-IMMUNITY; NATURAL-SELECTION; GAMBIAN CHILDREN; INDIVIDUALS; RECOGNITION	Background: Malaria caused by Plasmodium falciparum remains a major cause of death in sub-Saharan Africa. Immunity against symptoms of malaria requires repeated exposure, suggesting either that the parasite is poorly immunogenic or that the development of effective immune responses to malaria may be impaired. Methods: We carried out two age-stratified cross-sectional surveys of anti-malarial humoral immune responses in a Gambian village where P. falciparum malaria transmission is low and sporadic. Circulating antibodies and memory B cells (MBC) to four malarial antigens were measured using ELISA and cultured B cell ELISpot. Findings and Conclusions: The proportion of individuals with malaria-specific MBC and antibodies, and the average number of antigens recognised by each individual, increased with age but the magnitude of these responses did not. Malaria-specific antibody levels did not correlate with either the prevalence or median number of MBC, indicating that these two assays are measuring different aspects of the humoral immune response. Among those with immunological evidence of malaria exposure (defined as a positive response to at least one malarial antigen either by ELISA or ELISPOT), the median number of malaria-specific MBC was similar to median numbers of diphtheria-specific MBC, suggesting that the circulating memory cell pool for malaria antigens is of similar size to that for other antigens.	[Nogaro, Sarah I.; Walther, Brigitte; Conway, David J.; Walther, Michael] MRC Labs, Banjul, Gambia; [Nogaro, Sarah I.; Hafalla, Julius C.; Riley, Eleanor M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Gj Rijswijk, Netherlands; [Tetteh, Kevin K. A.; Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nogaro, SI (corresponding author), MRC Labs, Banjul, Gambia.	Michael.Walther@nih.gov	Riley, Eleanor M/C-8960-2013; Tetteh, Kevin/GYQ-9704-2022; Remarque, Ed/AAE-8643-2020; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Tetteh, Kevin/0000-0003-2733-0037; Riley, Eleanor/0000-0003-3447-3570; Conway, David/0000-0002-8711-3037	Medical Research Council (UK), The Gambia; Wellcome Trust [079920]; Royal Society (UK); MRC [MC_U190097907, MC_U190081993, MC_U190081986] Funding Source: UKRI; Medical Research Council [MC_U190081993, MC_U190097907, MC_U190081986] Funding Source: researchfish	Medical Research Council (UK), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society (UK)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK), The Gambia. J.C.H. was a recipient of a Wellcome Trust Visiting Fellowship (grant reference number 079920) and is currently supported by a University Research Fellowship from The Royal Society (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V67, P343, DOI 10.1016/0166-6851(94)90026-4; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902; GREENWOOD BM, 1974, LANCET, V1, P435; GREENWOOD BM, 1975, NATURE, V257, P592, DOI 10.1038/257592a0; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; OSIER FH, 2011, INFECT IMMU IN PRESS, P1; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; RAMASAMY R, 1994, AM J TROP MED HYG, V50, P537, DOI 10.4269/ajtmh.1994.50.537; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; UNICEF, 2011, INF COUNTR; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; World Health Organization/UNICEF, 2009, REV NAT IMM COV 1980	53	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25582	10.1371/journal.pone.0025582	http://dx.doi.org/10.1371/journal.pone.0025582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991321	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000295963300013
J	Mechtcheriakova, D; Sobanov, Y; Holtappels, G; Bajna, E; Svoboda, M; Jaritz, M; Bachert, C; Jensen-Jarolim, E				Mechtcheriakova, Diana; Sobanov, Yury; Holtappels, Gabriele; Bajna, Erika; Svoboda, Martin; Jaritz, Markus; Bachert, Claus; Jensen-Jarolim, Erika			Activation-Induced Cytidine Deaminase (AID)-Associated Multigene Signature to Assess Impact of AID in Etiology of Diseases with Inflammatory Component	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; LARGE B-CELLS; NASAL POLYPS; T-CELLS; MONOCLONAL-ANTIBODY; EXPRESSION; GENE; IGE; HYPERMUTATION; PAX5	Activation-induced cytidine deaminase (AID) is expressed in B cells within germinal centers and is critically involved in class switch recombination and somatic hypermutation of immunoglobulin loci. Functionally active AID can additionally be detected within ectopic follicular structures developed at sites of chronic inflammation. Furthermore, AID may target non-Ig genes in B-and non-B-cell background. Therefore, AID-associated effects are of increasing interest in disease areas such as allergy, inflammation, autoimmunity, and cancer. Pathway-or disease-relevant multigene signatures have attracted substantial attention for therapeutic target proposal, diagnostic tools, and monitoring of therapy response. To delineate the impact of AID in etiology of multifactorial diseases, we designed the AID-associated 25-gene signature. Chronic rhinosinusitis with nasal polyps was used as an inflammation-driven airway disease model; high levels of IgE have been previously shown to be present within polyp tissue. Expression levels of 16 genes were found to be modulated in polyps including AID, IgG and IgE mature transcripts which reflect AID activity; clustering algorithm revealed an AID-specific gene signature for the disease state with nasal polyp. Complementary, AID-positive ectopic lymphoid structures were detected within polyp tissues by in situ immunostaining. Our data demonstrate the class switch recombination and somatic hypermutation events likely taking place locally in the airways and in addition to the previously highlighted markers and/or targets as IL5 and IgE suggest novel candidate genes to be considered for treatment of nasal polyposis including among others IL13 and CD23. Thus, the algorithm presented herein including the multigene signature approach, analysis of co-regularities and creation of AID-associated functional network gives an integrated view of biological processes and might be further applied to assess role of altered AID expression in etiology of other diseases, in particular, aberrant immunity and cancer.	[Mechtcheriakova, Diana; Sobanov, Yury; Bajna, Erika; Svoboda, Martin; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, B-9000 Ghent, Belgium; [Jaritz, Markus] Res Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; Ghent University; Ghent University Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Mechtcheriakova, D (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	diana.mechtcheriakova@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Bachert, Claus/J-8825-2012	Jensen-Jarolim, Erika/0000-0003-4019-5765; Mechtcheriakova, Diana/0000-0002-8737-3592; Jaritz, Markus/0000-0002-9326-2047	Austrian Science Fund (FWF) [539, APP22441FW]; Flemish Scientific Research Board (FWO) [A12/5-HB-KH3, G.0436.04]; Austrian Science Fund (FWF) [P 22441] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Flemish Scientific Research Board (FWO)(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by The Austrian Science Fund (FWF;539 http://www.fwf.ac.at/) APP22441FW to DM, and by the Flemish Scientific Research Board (FWO) A12/5-HB-KH3 and G.0436.04 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2344; Bonnefoy J Y, 1997, Int Rev Immunol, V16, P113, DOI 10.3109/08830189709045705; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; Byrd JC, 2010, BLOOD, V115, P489, DOI 10.1182/blood-2009-08-237727; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Dinkel A, 1997, J IMMUNOL, V159, P2678; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ewart MA, 2002, GENES IMMUN, V3, P158, DOI 10.1038/sj.gene.6363848; Fokkens W, 2007, RHINOLOGY, V45, P97; Gevaert P, 2008, J ALLERGY CLIN IMMUN, V121, P797, DOI 10.1016/j.jaci.2008.01.062; Gevaert P, 2005, ALLERGY, V60, P71, DOI 10.1111/j.1398-9995.2004.00621.x; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Huvenne W, 2009, CURR ALLERGY ASTHM R, V9, P213, DOI 10.1007/s11882-009-0031-4; Iacobucci I, 2010, LEUKEMIA, V24, P66, DOI 10.1038/leu.2009.197; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kijimoto-Ochiai S, 2002, CELL MOL LIFE SCI, V59, P648, DOI 10.1007/s00018-002-8455-1; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kothapalli NR, 2011, CURR OPIN IMMUNOL, V23, P184, DOI 10.1016/j.coi.2010.12.009; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lewis Christina C, 2009, J Allergy Clin Immunol, V123, P795, DOI 10.1016/j.jaci.2009.01.003; Liu T, 2011, CLIN EXP IMMUNOL, V163, P59, DOI 10.1111/j.1365-2249.2010.04278.x; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Marafioti T, 2003, BLOOD, V102, P2868, DOI 10.1182/blood-2003-03-0692; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Moldenhauer G, 2006, BLOOD, V107, P2470, DOI 10.1182/blood-2005-06-2502; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Naclerio RM, 2010, INT J GEN MED, V3, P47; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Patadia M, 2010, AM J RHINOL ALLERGY, V24, P11, DOI 10.2500/ajra.2010.24.3386; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Rawstron A., 2006, CURR PROTOC CYTOM, V23; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; Simon HU, 1997, J IMMUNOL, V158, P3902; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Thomson CW, 2006, J IMMUNOL, V177, P2250, DOI 10.4049/jimmunol.177.4.2250; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Zele T, 2007, CLIN EXP ALLERGY, V37, P1840, DOI 10.1111/j.1365-2222.2007.02838.x; Van Zele T, 2009, LARYNGOSCOPE, V119, P1753, DOI 10.1002/lary.20484; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Visan I, 2003, EUR J IMMUNOL, V33, P1163, DOI 10.1002/eji.200323747; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wu XS, 2008, BLOOD, V112, P4675, DOI 10.1182/blood-2008-03-145995; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	80	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25611	10.1371/journal.pone.0025611	http://dx.doi.org/10.1371/journal.pone.0025611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984922	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000046
J	Rands, SA; Whitney, HM				Rands, Sean A.; Whitney, Heather M.			Field Margins, Foraging Distances and Their Impacts on Nesting Pollinator Success	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; AGRICULTURAL LANDSCAPES; BUMBLEBEES HYMENOPTERA; EUROPEAN LANDSCAPE; BEE; HEDGEROWS; CONSERVATION; BOMBUS; BIODIVERSITY; DIVERSITY	The areas of wild land around the edges of agricultural fields are a vital resource for many species. These include insect pollinators, to whom field margins provide both nest sites and important resources (especially when adjacent crops are not in flower). Nesting pollinators travel relatively short distances from the nest to forage: most species of bee are known to travel less than two kilometres away. In order to ensure that these pollinators have sufficient areas of wild land within reach of their nests, agricultural landscapes need to be designed to accommodate the limited travelling distances of nesting pollinators. We used a spatially-explicit modelling approach to consider whether increasing the width of wild strips of land within the agricultural landscape will enhance the amount of wild resources available to a nesting pollinator, and if it would impact differently on pollinators with differing foraging strategies. This was done both by creating field structures with a randomised geography, and by using landscape data based upon the British agricultural landscape. These models demonstrate that enhancing field margins should lead to an increase in the availability of forage to pollinators that nest within the landscape. With the exception of species that only forage within a very short range of their nest (less than 125 m), a given amount of field margin manipulation should enhance the proportion of land available to a pollinator for foraging regardless of the distance over which it normally travels to find food. A fixed amount of field edge manipulation should therefore be equally beneficial for both longer-distance nesting foragers such as honeybees, and short-distance foragers such as solitary bees.	[Rands, Sean A.] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England; [Whitney, Heather M.] Univ Bristol, Sch Biol Sci, Bristol BS18 7DU, Avon, England	University of Bristol; University of Bristol	Rands, SA (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X; Whitney, Heather/0000-0001-6450-8266	ERC [260920]	ERC(European Research Council (ERC)European Commission)	HMW was supported by an ERC Starting Grant (#260920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2008, APPL VEG SCI, V11, P375, DOI 10.3170/2008-7-18486; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Baudry J, 2000, J ENVIRON MANAGE, V60, P7, DOI 10.1006/jema.2000.0358; Baudry J, 2000, LANDSCAPE URBAN PLAN, V50, P119, DOI 10.1016/S0169-2046(00)00084-0; BEDFORD SE, 1994, AGR ECOSYST ENVIRON, V48, P295, DOI 10.1016/0167-8809(94)90111-2; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Beil M, 2008, APIDOLOGIE, V39, P456, DOI 10.1051/apido:2008021; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blackwell G, 2008, NEW ZEAL J AGR RES, V51, P473, DOI 10.1080/00288230809510478; Boutin C, 2002, BIODIVERS CONSERV, V11, P1, DOI 10.1023/A:1014023326658; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Buddle CM, 2004, AM MIDL NAT, V151, P15, DOI 10.1674/0003-0031(2004)151[0015:GSAIRF]2.0.CO;2; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Carvell C, 2004, BIOL CONSERV, V118, P327, DOI 10.1016/j.biocon.2003.09.012; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Davies ZG, 2007, LANDSCAPE ECOL, V22, P333, DOI 10.1007/s10980-006-9064-4; DENNIS P, 1992, AGR ECOSYST ENVIRON, V40, P95, DOI 10.1016/0167-8809(92)90086-Q; Dramstad WE, 1996, J INSECT BEHAV, V9, P163, DOI 10.1007/BF02213863; Elliott SE, 2009, ENVIRON ENTOMOL, V38, P748, DOI 10.1603/022.038.0327; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; FORMAN RTT, 1984, ENVIRON MANAGE, V8, P495, DOI 10.1007/BF01871575; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; FOWLES AP, 1996, PROVISIONAL CHECKLIS, V2; Franzen M, 2009, J INSECT CONSERV, V13, P89, DOI 10.1007/s10841-007-9123-4; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gaucherel C, 2006, ECOL MODEL, V194, P233, DOI 10.1016/j.ecolmodel.2005.10.026; Gaucherel C, 2006, ECOL MODEL, V197, P159, DOI 10.1016/j.ecolmodel.2006.02.044; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2009, BUMBLEBEES BEHAV ECO, V2nd; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Grashof-Bokdam CJ, 2005, LANDSCAPE ECOL, V20, P417, DOI 10.1007/s10980-004-5646-1; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hannon LE, 2009, BIOL CONSERV, V142, P2140, DOI 10.1016/j.biocon.2009.04.014; Jongman RHG, 2002, LANDSCAPE URBAN PLAN, V58, P211, DOI 10.1016/S0169-2046(01)00222-5; Karanja R. H. N., 2010, Journal of Pollination Ecology, V2, P7; Kells AR, 2001, J INSECT CONSERV, V5, P283, DOI 10.1023/A:1013307822575; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Kuhn-Neto B, 2009, APIDOLOGIE, V40, P472, DOI 10.1051/apido/2009007; Kurz WA, 2000, COMPUT ELECTRON AGR, V27, P227, DOI 10.1016/S0168-1699(00)00109-5; Larsson M, 2007, BIOL CONSERV, V134, P405, DOI 10.1016/j.biocon.2006.08.030; Le Ber F, 2009, ECOL MODEL, V220, P3536, DOI 10.1016/j.ecolmodel.2009.06.019; Leon MC, 2006, AGROFOREST SYST, V68, P15, DOI 10.1007/s10457-005-5831-5; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Marshall EJP, 2002, AGR ECOSYST ENVIRON, V89, P1, DOI 10.1016/S0167-8809(01)00314-0; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Maudsley MJ, 2000, J ENVIRON MANAGE, V60, P65, DOI 10.1006/jema.2000.0362; McCollin D, 2000, J ENVIRON MANAGE, V60, P77, DOI 10.1006/jema.2000.0363; MEEUS JHA, 1995, LANDSCAPE URBAN PLAN, V31, P57, DOI 10.1016/0169-2046(94)01036-8; MEEUS JHA, 1990, LANDSCAPE URBAN PLAN, V18, P289, DOI 10.1016/0169-2046(90)90016-U; MEEUS JHA, 1993, SCI TOTAL ENVIRON, V129, P171, DOI 10.1016/0048-9697(93)90169-7; Mucher CA, 2010, ECOL INDIC, V10, P87, DOI 10.1016/j.ecolind.2009.03.018; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; Olson DM, 2007, J APPL ECOL, V44, P13, DOI 10.1111/j.1365-2664.2006.01241.x; Orians G.H., 1979, P155; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rands SA, 2000, J THEOR BIOL, V202, P161, DOI 10.1006/jtbi.1999.1048; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Rands SA, 2010, ECOL MODEL, V221, P1310, DOI 10.1016/j.ecolmodel.2010.01.014; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Rudner M, 2007, ENVIRON MODELL SOFTW, V22, P177, DOI 10.1016/j.envsoft.2005.07.016; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Saura S, 2000, LANDSCAPE ECOL, V15, P661, DOI 10.1023/A:1008107902848; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Steffan-Dewenter I, 2008, J APPL ECOL, V45, P737, DOI 10.1111/j.1365-2664.2008.01483.x; TSCHARNTKE T, AGR ECOSYST IN PRESS; Varchola JM, 2001, AGR ECOSYST ENVIRON, V83, P153, DOI 10.1016/S0167-8809(00)00249-8; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x; Zuria I, 2006, HUM ECOL, V34, P53, DOI 10.1007/s10745-005-9002-0	85	39	42	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25971	10.1371/journal.pone.0025971	http://dx.doi.org/10.1371/journal.pone.0025971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991390	gold, Green Submitted, Green Published			2022-12-25	WOS:000295943000097
J	Shin, J; Epperson, K; Yanjanin, NM; Albus, J; Borgenheimer, L; Bott, N; Brennan, E; Castellanos, D; Cheng, M; Clark, M; Devany, M; Ensslin, C; Farivari, N; Fernando, S; Gabriel, L; Gallardo, R; Castleman, M; Gutierrez, O; Herschel, A; Hodge, S; Horst, A; Howard, M; James, E; Jones, L; Kearns, M; Kelly, M; Kim, C; Kiser, K; Klazura, G; Knoedler, C; Kolbus, E; Lange, L; Lee, J; Li, E; Lu, W; Luttrell, A; Ly, E; McKeough, K; McSorley, B; Miller, C; Mitchell, S; Moon, A; Moser, K; O'Brien, S; Olivieri, P; Patzwahl, A; Pereira, M; Pymento, C; Ramelb, E; Ramos, B; Raya, T; Riney, S; Roberts, G; Robertshaw, M; Rudolf, F; Rund, S; Sansone, S; Schwartz, L; Shay, R; Siu, E; Spear, T; Tan, C; Truong, M; Uddin, M; VanTrieste, J; Veloz, O; White, E; Porter, FD; Haldar, K				Shin, Jenny; Epperson, Katrina; Yanjanin, Nicole M.; Albus, Jennifer; Borgenheimer, Laura; Bott, Natalie; Brennan, Erin; Castellanos, Daniel; Cheng, Melissa; Clark, Michael; Devany, Margaret; Ensslin, Courtney; Farivari, Nina; Fernando, Shanik; Gabriel, Lauren; Gallardo, Rani; Castleman, Moriah; Gutierrez, Olimpia; Herschel, Allison; Hodge, Sarah; Horst, Anne; Howard, Mary; James, Evan; Jones, Lindsey; Kearns, Mary; Kelly, Mary; Kim, Christine; Kiser, Kinzie; Klazura, Gregory; Knoedler, Chris; Kolbus, Emily; Lange, Lauren; Lee, Joan; Li, Eileena; Lu, Wei; Luttrell, Andrew; Ly, Emily; McKeough, Katherine; McSorley, Brianna; Miller, Catherine; Mitchell, Sean; Moon, Abbey; Moser, Kevin; O'Brien, Shane; Olivieri, Paula; Patzwahl, Aaron; Pereira, Marie; Pymento, Craig; Ramelb, Erin; Ramos, Bryce; Raya, Teresa; Riney, Stephen; Roberts, Geoff; Robertshaw, Mark; Rudolf, Frannie; Rund, Samuel; Sansone, Stephanie; Schwartz, Lindsay; Shay, Ryan; Siu, Edwin; Spear, Timothy; Tan, Catherine; Marisa Truong; Uddin, Mairaj; VanTrieste, Jennifer; Veloz, Omar; White, Elizabeth; Porter, Forbes D.; Haldar, Kasturi			Defining Natural History: Assessment of the Ability of College Students to Aid in Characterizing Clinical Progression of Niemann-Pick Disease, Type C	PLOS ONE			English	Article								Niemann-Pick Disease, type C (NPC) is a fatal, neurodegenerative, lysosomal storage disorder. It is a rare disease with broad phenotypic spectrum and variable age of onset. These issues make it difficult to develop a universally accepted clinical outcome measure to assess urgently needed therapies. To this end, clinical investigators have defined emerging, disease severity scales. The average time from initial symptom to diagnosis is approximately 4 years. Further, some patients may not travel to specialized clinical centers even after diagnosis. We were therefore interested in investigating whether appropriately trained, community-based assessment of patient records could assist in defining disease progression using clinical severity scores. In this study we evolved a secure, step wise process to show that pre-existing medical records may be correctly assessed by non-clinical practitioners trained to quantify disease progression. Sixty-four undergraduate students at the University of Notre Dame were expertly trained in clinical disease assessment and recognition of major and minor symptoms of NPC. Seven clinical records, randomly selected from a total of thirty seven used to establish a leading clinical severity scale, were correctly assessed to show expected characteristics of linear disease progression. Student assessment of two new records donated by NPC families to our study also revealed linear progression of disease, but both showed accelerated disease progression, relative to the current severity scale, especially at the later stages. Together, these data suggest that college students may be trained in assessment of patient records, and thus provide insight into the natural history of a disease.	[Shin, Jenny; Epperson, Katrina; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Yanjanin, Nicole M.; Porter, Forbes D.] NICHD, Program Dev Endocrinol & Genet, NIH, DHHS, Bethesda, MD USA; [Albus, Jennifer; Borgenheimer, Laura; Bott, Natalie; Brennan, Erin; Castellanos, Daniel; Cheng, Melissa; Clark, Michael; Devany, Margaret; Ensslin, Courtney; Farivari, Nina; Fernando, Shanik; Gabriel, Lauren; Gallardo, Rani; Castleman, Moriah; Gutierrez, Olimpia; Herschel, Allison; Hodge, Sarah; Horst, Anne; Howard, Mary; James, Evan; Jones, Lindsey; Kearns, Mary; Kelly, Mary; Kim, Christine; Kiser, Kinzie; Klazura, Gregory; Knoedler, Chris; Kolbus, Emily; Lange, Lauren; Lee, Joan; Li, Eileena; Lu, Wei; Luttrell, Andrew; Ly, Emily; McKeough, Katherine; McSorley, Brianna; Miller, Catherine; Mitchell, Sean; Moon, Abbey; Moser, Kevin; O'Brien, Shane; Olivieri, Paula; Patzwahl, Aaron; Pereira, Marie; Pymento, Craig; Ramelb, Erin; Ramos, Bryce; Raya, Teresa; Riney, Stephen; Roberts, Geoff; Robertshaw, Mark; Rudolf, Frannie; Rund, Samuel; Sansone, Stephanie; Schwartz, Lindsay; Shay, Ryan; Siu, Edwin; Spear, Timothy; Tan, Catherine; Marisa Truong; Uddin, Mairaj; VanTrieste, Jennifer; Veloz, Omar; White, Elizabeth] NPC Consortium Community Based Assessment Patient, Cape Town, South Africa	University of Notre Dame; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shin, J (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014; Rund, Samuel SC/AAH-5724-2019; Mitchell, Sean M/AAJ-6000-2020	Rund, Samuel SC/0000-0002-1701-7787; Mitchell, Sean M/0000-0002-0584-3256; Siu, Edwin/0000-0003-1046-2279; , Helen Catherine (Miller) Wilbur/0000-0001-5330-5084; Castellanos, Daniel/0000-0003-1188-5257; Vater, Laura/0000-0002-5920-9576; Keenan, Anne/0000-0001-5601-2682; Shin, Jenny/0000-0002-5650-8044	University of Notre Dame; NICHD; Office of Rare Diseases; Dana's Angels Research Trust	University of Notre Dame; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Rare Diseases; Dana's Angels Research Trust	The work was supported in part by funds to KH (start-up funds from the University of Notre Dame), to FDP (intramural research program of NICHD and via a Bench to Bedside Grant from the Office of Rare Diseases), and to NY (Ara Parseghian Medical Research Foundation, http://www.parseghian.org/, and Dana's Angels Research Trust, www.DanasAngels.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Imrie J, 2007, J INHERIT METAB DIS, V30, P51, DOI 10.1007/s10545-006-0384-7; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pineda M, 2009, MOL GENET METAB, V98, P243, DOI 10.1016/j.ymgme.2009.07.003; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969	6	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e23666	10.1371/journal.pone.0023666	http://dx.doi.org/10.1371/journal.pone.0023666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984891	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000001
J	Zhang, X; Ramirez, BE; Liao, XB; Diekwisch, TGH				Zhang, Xu; Ramirez, Benjamin E.; Liao, Xiubei; Diekwisch, Thomas G. H.			Amelogenin Supramolecular Assembly in Nanospheres Defined by a Complex Helix-Coil-PPII Helix 3D-Structure	PLOS ONE			English	Article							BOVINE TOOTH ENAMEL; TORSION ANGLE; PROTEINS; PH; HYDROXYAPATITE; MATRIX; AGGREGATION; DYNAMICS; PROGRAM; DISPLAY	Tooth enamel, the hardest material in the human body, is formed within a self-assembled matrix consisting mostly of amelogenin proteins. Here we have determined the complete mouse amelogenin structure under physiological conditions and defined interactions between individual domains. NMR spectroscopy revealed four major amelogenin structural motifs, including an N-terminal assembly of four alpha-helical segments (S9-V19, T21-P33, Y39-W45, V53-Q56), an elongated random coil region interrupted by two 3(10) helices (similar to P60-Q117), an extended proline-rich PPII-helical region (P118-L165), and a charged hydrophilic C-terminus (L165-D180). HSQC experiments demonstrated ipsilateral interactions between terminal domains of individual amelogenin molecules, i.e. N-terminal interactions with corresponding N-termini and C-terminal interactions with corresponding C-termini, while the central random coil domain did not engage in interactions. Our HSQC spectra of the full-length amelogenin central domain region completely overlapped with spectra of the monomeric Amel-M fragment, suggesting that the central amelogenin coil region did not involve in assembly, even in assembled nanospheres. This finding was confirmed by analytical ultracentrifugation experiments. We conclude that under conditions resembling those found in the developing enamel protein matrix, amelogenin molecules form complex 3D-structures with N-terminal alpha-helix-like segments and C-terminal PPII-helices, which self-assemble through ipsilateral interactions at the N-terminus of the molecule.	[Zhang, Xu; Diekwisch, Thomas G. H.] Univ Illinois, Brodie Lab Craniofacial Genet, Coll Dent, Chicago, IL 60607 USA; [Ramirez, Benjamin E.; Liao, Xiubei] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhang, X (corresponding author), Univ Illinois, Brodie Lab Craniofacial Genet, Coll Dent, Chicago, IL 60607 USA.	xiubei@uic.edu; tomdkw@uic.edu		Diekwisch, Thomas GH/0000-0003-3356-9677	NIDCR [DE13378, DE18900]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018900, R01DE013378] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding by NIDCR grants DE13378 and DE18900 to TD is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichmayer B, 2010, BIOMACROMOLECULES, V11, P369, DOI 10.1021/bm900983b; AOBA T, 1987, CALCIFIED TISSUE INT, V41, P281, DOI 10.1007/BF02555230; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Buchko GW, 2008, BIOCHEMISTRY-US, V47, P13215, DOI 10.1021/bi8018288; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; DIEKWISCH T, 1993, DEVELOPMENT, V117, P471; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin TQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000262; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lakshminarayanan R, 2010, J BIOL CHEM, V285, P40593, DOI 10.1074/jbc.M110.131136; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Moradian-Oldak J, 1998, J STRUCT BIOL, V122, P320, DOI 10.1006/jsbi.1998.4008; Moradian-Oldak J, 2002, CONNECT TISSUE RES, V43, P450, DOI 10.1080/03008200290000835; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; NIKIFORUK G, 1965, J DENT RES, V44, P1119, DOI 10.1177/00220345650440061101; Paine ML, 2004, CELLS TISSUES ORGANS, V176, P7, DOI 10.1159/000075023; Renugopalakrishnan V, 2002, J PEPT SCI, V8, P139, DOI 10.1002/psc.378; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; SOGAH GDY, 1976, J AM CHEM SOC, V98, P3038; Tan J, 1998, CONNECT TISSUE RES, V38, P215, DOI 10.3109/03008209809017039; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; ZHENG SD, 1987, BIOPOLYMERS, V26, P1809, DOI 10.1002/bip.360261012	33	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24952	10.1371/journal.pone.0024952	http://dx.doi.org/10.1371/journal.pone.0024952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984897	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000007
J	Benner, J; Daniel, H; Spanier, B				Benner, Jacqueline; Daniel, Hannelore; Spanier, Britta			A Glutathione Peroxidase, Intracellular Peptidases and the TOR Complexes Regulate Peptide Transporter PEPT-1 in C-elegans	PLOS ONE			English	Article							P70 S6 KINASE; CAENORHABDITIS-ELEGANS; MAMMALIAN TARGET; FAT STORAGE; LEUKOTRIENE-A(4) HYDROLASE; GENE-EXPRESSION; NA+/H+ EXCHANGE; RAPAMYCIN MTOR; LIFE-SPAN; HYDROPEROXIDE	The intestinal peptide transporter PEPT-1 in Caenorhabditis elegans is a rheogenic H+-dependent carrier responsible for the absorption of di- and tripeptides. Transporter-deficient pept-1(lg601) worms are characterized by impairments in growth, development and reproduction and develop a severe obesity like phenotype. The transport function of PEPT-1 as well as the influx of free fatty acids was shown to be dependent on the membrane potential and on the intracellular pH homeostasis, both of which are regulated by the sodium-proton exchanger NHX-2. Since many membrane proteins commonly function as complexes, there could be proteins that possibly modulate PEPT-1 expression and function. A systematic RNAi screening of 162 genes that are exclusively expressed in the intestine combined with a functional transport assay revealed four genes with homologues existing in mammals as predicted PEPT-1 modulators. While silencing of a glutathione peroxidase surprisingly caused an increase in PEPT-1 transport function, silencing of the ER to Golgi cargo transport protein and of two cytosolic peptidases reduced PEPT-1 transport activity and this even corresponded with lower PEPT-1 protein levels. These modifications of PEPT-1 function by gene silencing of homologous genes were also found to be conserved in the human epithelial cell line Caco-2/TC7 cells. Peptidase inhibition, amino acid supplementation and RNAi silencing of targets of rapamycin (TOR) components in C. elegans supports evidence that intracellular peptide hydrolysis and amino acid concentration are a part of a sensing system that controls PEPT-1 expression and function and that involves the TOR complexes TORC1 and TORC2.	[Benner, Jacqueline; Daniel, Hannelore; Spanier, Britta] Tech Univ Munich, Abt Biochem, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Benner, J (corresponding author), Tech Univ Munich, Abt Biochem, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany.	spanier@wzw.tum.de	Daniel, Hannelore/B-8982-2009; Elgeti, Dana/H-8859-2015	Wallwitz, Jacqueline/0000-0002-7335-362X; Elgeti, Dana/0000-0002-4295-4983	Deutsche Forschungsgemeinschaft (DFG) [SP965/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the grant SP965/2-1 by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ban H, 2004, INT J MOL MED, V13, P537; Bao YP, 1997, FEBS LETT, V410, P210, DOI 10.1016/S0014-5793(97)00591-7; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P705, DOI 10.1159/000185554; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DANIEL H, 1994, FASEB J, V8, P753, DOI 10.1096/fasebj.8.10.8050675; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Davies DR, 2009, J MED CHEM, V52, P4694, DOI 10.1021/jm900259h; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Gilbert ER, 2008, J ANIM SCI, V86, P2135, DOI 10.2527/jas.2007-0826; Girotti AW, 1998, J LIPID RES, V39, P1529; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P248, DOI 10.1042/BST0370248; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697, DOI 10.1152/ajpgi.2001.281.3.G697; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kennedy DJ, 2002, PFLUG ARCH EUR J PHY, V445, P139, DOI 10.1007/s00424-002-0910-1; LENNEY JF, 1990, BIOL CHEM H-S, V371, P167, DOI 10.1515/bchm3.1990.371.1.167; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Mertl M, 2008, AM J PHYSIOL-CELL PH, V295, pC1332, DOI 10.1152/ajpcell.00241.2008; Morgan EL, 2005, DEV COMP IMMUNOL, V29, P53, DOI 10.1016/j.dci.2004.05.001; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; ORNING L, 1994, J BIOL CHEM, V269, P11269; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Rubio-Aliaga I, 2002, TRENDS PHARMACOL SCI, V23, P434, DOI 10.1016/S0165-6147(02)02072-2; Rudberg PC, 2002, P NATL ACAD SCI USA, V99, P4215, DOI 10.1073/pnas.072090099; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Thwaites DT, 1999, J CLIN INVEST, V104, P629, DOI 10.1172/JCI7192; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57	69	36	51	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25624	10.1371/journal.pone.0025624	http://dx.doi.org/10.1371/journal.pone.0025624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980510	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900082
J	Li, L; Eldredge, LC; Quach, DH; Honasoge, A; Gruner, K; Tourtellotte, WG				Li, Lin; Eldredge, Laurie C.; Quach, David H.; Honasoge, Avinash; Gruner, Katherine; Tourtellotte, Warren G.			Egr3 Dependent Sympathetic Target Tissue Innervation in the Absence of Neuron Death	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MICE LACKING; IN-VIVO; SYSTEM; NGF; OVEREXPRESSION; SPECIFICATION; HYPERPLASIA; REQUIREMENT; MIGRATION	Nerve Growth Factor (NGF) is a target tissue derived neurotrophin required for normal sympathetic neuron survival and target tissue innervation. NGF signaling regulates gene expression in sympathetic neurons, which in turn mediates critical aspects of neuron survival, axon extension and terminal axon branching during sympathetic nervous system (SNS) development. Egr3 is a transcription factor regulated by NGF signaling in sympathetic neurons that is essential for normal SNS development. Germline Egr3-deficient mice have physiologic dysautonomia characterized by apoptotic sympathetic neuron death and abnormal innervation to many target tissues. The extent to which sympathetic innervation abnormalities in the absence of Egr3 is caused by altered innervation or by neuron death during development is unknown. Using Bax-deficient mice to abrogate apoptotic sympathetic neuron death in vivo, we show that Egr3 has an essential role in target tissue innervation in the absence of neuron death. Sympathetic target tissue innervation is abnormal in many target tissues in the absence of neuron death, and like NGF, Egr3 also appears to effect target tissue innervation heterogeneously. In some tissues, such as heart, spleen, bowel, kidney, pineal gland and the eye, Egr3 is essential for normal innervation, whereas in other tissues such as lung, stomach, pancreas and liver, Egr3 appears to have little role in innervation. Moreover, in salivary glands and heart, two tissues where Egr3 has an essential role in sympathetic innervation, NGF and NT-3 are expressed normally in the absence of Egr3 indicating that abnormal target tissue innervation is not due to deregulation of these neurotrophins in target tissues. Taken together, these results clearly demonstrate a role for Egr3 in mediating sympathetic target tissue innervation that is independent of neuron survival or neurotrophin deregulation.	[Li, Lin; Tourtellotte, Warren G.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Div Neuropathol, Chicago, IL 60611 USA; [Tourtellotte, Warren G.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Li, L (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Div Neuropathol, Chicago, IL 60611 USA.	warren@northwestern.edu			NIH [R01-NS040748, K02-NS046468, K26-RR026099, F30-NS047775, F31-NS066721]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, K26RR026099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788, R01NS040748, K02NS046468, F31NS066721, F30NS047775] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD010945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01-NS040748, K02-NS046468 and K26-RR026099 (WGT). LCE was supported by NIH grant F30-NS047775 and DHQ was supported by NIH grant F31-NS066721. http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; HASSANKHANI A, 1995, DEV BIOL, V169, P309, DOI 10.1006/dbio.1995.1146; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; Kawasaki T, 2002, DEVELOPMENT, V129, P671; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Rohrer H, 2003, DRUG NEWS PERSPECT, V16, P589, DOI 10.1358/dnp.2003.16.9.829341; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757	28	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25696	10.1371/journal.pone.0025696	http://dx.doi.org/10.1371/journal.pone.0025696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980528	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900092
J	Piccione, EC; Lieu, TJ; Gentile, CF; Williams, TR; Connolly, AJ; Godwin, AK; Koong, AC; Wong, AJ				Piccione, E. C.; Lieu, T. J.; Gentile, C. F.; Williams, T. R.; Connolly, A. J.; Godwin, A. K.; Koong, A. C.; Wong, A. J.			A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors	ONCOGENE			English	Article						EGFR; GRP78; ER stress; unfolded protein response; transcription	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEINS; HUMAN-BRAIN TUMORS; CELL LUNG-CANCER; EGF-RECEPTOR; ER STRESS; NUCLEAR-LOCALIZATION; MALIGNANT GLIOMAS; OXIDATIVE STRESS	The epidermal growth factor receptor (EGFR) is essential to multiple physiological and neoplastic processes via signaling by its tyrosine kinase domain and subsequent activation of transcription factors. EGFR overexpression and alteration, including point mutations and structural variants, contribute to oncogenesis in many tumor types. In this study, we identified an in-frame splice variant of the EGFR called mini-LEEK (mLEEK) that is more broadly expressed than the EGFR and is overexpressed in several cancers. Unlike previously characterized EGFR variants, mLEEK lacks the extracytoplasmic, transmembrane and tyrosine kinase domains. mLEEK localizes in the nucleus and functions as a transcription factor to regulate target genes involved in the cellular response to endoplasmic reticulum (ER) stress, including the master regulator of the unfolded protein response (UPR) pathways, molecular chaperone GRP78/Bip. We demonstrated that mLEEK regulates GRP78 transcription through direct interaction with a cis-regulatory element within the gene promoter. Several UPR pathways were interrogated and mLEEK expression was found to attenuate the induction of all pathways upon ER stress. Conversely, knockdown of mLEEK resulted in caspase-mediated cell death and sensitization to ER stress. These findings indicate that mLEEK levels determine cellular responses to unfavorable conditions that cause ER stress. This information, along with the overexpression of mLEEK in tumors, suggests unique strategies for therapeutic intervention. Furthermore, the identification of mLEEK expands the known mechanisms by which the EGFR gene contributes to oncogenesis and represents the first link between two previously disparate areas in cancer cell biology: EGFR signaling and the UPR.	[Piccione, E. C.; Lieu, T. J.; Gentile, C. F.; Williams, T. R.; Wong, A. J.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Piccione, E. C.; Lieu, T. J.; Gentile, C. F.; Williams, T. R.; Wong, A. J.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Connolly, A. J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Godwin, A. K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Koong, A. C.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of Kansas; University of Kansas Medical Center; Stanford University	Wong, AJ (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, 1201 Welch Rd,MSLS P105, Stanford, CA 94305 USA.	ajwong@stanford.edu		Piccione, Emilio/0000-0001-7754-7395; Koong, Albert/0000-0001-9824-1643; Lieu, Tiffany/0000-0001-7430-4064	NIH from NINDS [F31 NS056581, R01 CA69495, R01 CA096539, R01 CA124832]; Ovarian SPORE at FCCC [P50 CA083638]; National Brain Tumor Foundation; California Breast Cancer Program [15IB-0080]; NATIONAL CANCER INSTITUTE [R01CA124832, R01CA096539, R01CA069495, R01CA140323, P50CA083638, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056581] Funding Source: NIH RePORTER	NIH from NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ovarian SPORE at FCCC; National Brain Tumor Foundation; California Breast Cancer Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R Nitta, G Li, S Mitra, C Del Vecchio and M Holgado-Madruga for comments. We thank K Mori, K Kokame, R Prywes and G Nolan for reagents. This work was supported by the NIH under Ruth L Kirschstein National Research Service Award F31 NS056581 from the NINDS to ECP, the Ovarian SPORE at FCCC (P50 CA083638) to AKG and AJW, NIH Grants R01 CA69495, R01 CA096539 and R01 CA124832, as well as a research grant from the National Brain Tumor Foundation and Grant 15IB-0080 from the California Breast Cancer Program to AJW.	Allen TD, 2000, J CELL SCI, V113, P1651; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHANG SC, 1989, MOL CELL BIOL, V9, P2153, DOI 10.1128/MCB.9.5.2153; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Eley G, 1998, GENE CHROMOSOME CANC, V23, P248, DOI 10.1002/(SICI)1098-2264(199811)23:3<248::AID-GCC7>3.0.CO;2-1; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; HALEY J, 1987, ONCOGENE RES, V1, P375; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Kandul NP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-67; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lawson B, 1998, J CELL PHYSIOL, V174, P170, DOI 10.1002/(SICI)1097-4652(199802)174:2<170::AID-JCP4>3.3.CO;2-A; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; LIBERMANN TA, 1984, CANCER RES, V44, P753; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2005, CANCER RES, V65, P338; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MALDEN LT, 1988, CANCER RES, V48, P2711; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Moscatello DK, 1996, ONCOGENE, V13, P85; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pedersen MW, 2005, J CELL BIOCHEM, V96, P412, DOI 10.1002/jcb.20554; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Pedersen MW, 2001, BRIT J CANCER, V85, P1211, DOI 10.1054/bjoc.2001.2053; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Roy M, 2008, RNA, V14, P2261, DOI 10.1261/rna.1024908; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xie W, 1997, ANTICANCER RES, V17, P2627; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	68	11	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	24					2953	2967		10.1038/onc.2011.465	http://dx.doi.org/10.1038/onc.2011.465			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	960LD	21986942	Green Accepted			2022-12-25	WOS:000305388400005
J	Cheriyath, V; Kuhns, MA; Jacobs, BS; Evangelista, P; Elson, P; Downs-Kelly, E; Tubbs, R; Borden, EC				Cheriyath, V.; Kuhns, M. A.; Jacobs, B. S.; Evangelista, P.; Elson, P.; Downs-Kelly, E.; Tubbs, R.; Borden, E. C.			G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer	ONCOGENE			English	Article						G1P3; breast cancer; hyperplasia; apoptosis; tamoxifen resistance; interferon-stimulated genes	GENE-EXPRESSION; PROGNOSTIC MARKER; IMMUNE CELLS; APOPTOSIS; MORPHOGENESIS; INFLAMMATION; SIGNATURE; FAMILY; BCL2; IDENTIFICATION	Hormonally regulated survival factors can have an important role in breast cancer. Here we elucidate G1P3, a survival protein induced by interferons (IFNs), as a target of estrogen signaling and a contributor to poor outcomes in estrogen receptor-positive (ER+) breast cancer. Compared with normal breast tissue, G1P3 was upregulated in the malignant epithelium (50 x higher) and was induced by estrogen ex vivo. In accord with its overexpression in early stages of breast cancer (hyperplasia and ductal carcinoma in situ), in morphogenesis assays G1P3 enhanced the survival of MCF10A acinar luminal cells causing hyperplasia by suppressing detachment-induced loss of mitochondrial potential and apoptosis (anoikis). In cells undergoing anoikis, G1P3 attenuated the induction of Bim protein, a proapoptotic member of the Bcl-2 family and reversed the downmodulation of Bcl-2 protein. Downregulation of G1P3 induced spontaneous apoptosis in BT-549 breast cancer cells and significantly reduced the growth of ER+ breast cancer cell MCF7 (P <= 0.01), further suggesting its prosurvival activity. In agreement with its induction by estrogen, G1P3 antagonized tamoxifen, an inhibitor of ER in MCF7 cells. More importantly, elevated expression of G1P3 was significantly associated with decreased relapse-free and overall survival in ER+ breast cancer patients (P <= 0.01). Our studies suggest that elevated expression of G1P3 may perturb canonical tumor-suppressing activity of IFNs partly by affecting the balance of pro- and antiapoptotic members of Bcl-2 family proteins, leading to breast cancer development and resistance to therapies. Oncogene (2012) 31, 2222-2236; doi:10.1038/onc.2011.393; published online 26 September 2011	[Cheriyath, V.; Kuhns, M. A.; Jacobs, B. S.; Evangelista, P.; Borden, E. C.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Elson, P.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Downs-Kelly, E.; Tubbs, R.] Cleveland Clin, Dept Mol Pathol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Cheriyath, V (corresponding author), Cleveland Clin Fdn, Taussig Canc Inst, 9500 Euclid Ave,Mailcode R40, Cleveland, OH 44195 USA.	venu_cheriyath@tamu-commerce.edu; bordene@ccf.org			Clinical and Translational Science Collaborative (CTSC); NCI [CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Clinical and Translational Science Collaborative (CTSC); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study is supported by a Clinical and Translational Science Collaborative (CTSC) award to VC and by NCI CA043703 to ECB. We thank Drs Thomas Budd and Joseph Crowe and Mrs Joanne Lyons for their help in procuring biopsies. Our sincere thanks to Dr Judith Drazba, director of the Cleveland Clinic Imaging Core, Dr John Peterson and Eric Diskin for their kind help with the confocal and light microscopy. We thank Linda Vargo for preparing the specimens for in situ hybridization. We gratefully acknowledge Dr Aejaz Nasir at Eli Lilly and Dr Tim Huang at the Ohio State University for helpful discussions. We also thank Dr George Stark and Dr Thomas Budd at the Cleveland Clinic for critical reading of the manuscript.	Anderson LR, 2010, ONCOGENE, V29, P527, DOI 10.1038/onc.2009.362; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Bani MR, 2004, MOL CANCER THER, V3, P111; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Bharadwaj S, 2005, ONCOGENE, V24, P8291, DOI 10.1038/sj.onc.1208993; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cheriyath V, 2010, J INTERFERON CYTOKIN, V31, P173; Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Eroles P, 2010, CLIN TRANSL ONCOL, V12, P246, DOI 10.1007/s12094-010-0500-1; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Luszczek W, 2010, MOL CANCER THER, V9, P2309, DOI 10.1158/1535-7163.MCT-10-0309; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Mailleux AA, 2008, M S-MED SCI, V24, P246, DOI 10.1051/medsci/2008243246; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Parker N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-8; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Radisky ES, 2007, REV ENDOCR METAB DIS, V8, P279, DOI 10.1007/s11154-007-9037-1; RASMUSSEN UB, 1993, CANCER RES, V53, P4096; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Sorbello V, 2003, INT J BIOL MARKER, V18, P123, DOI 10.1177/172460080301800205; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Swan EA, 2003, ORAL ONCOL, V39, P648, DOI 10.1016/S1368-8375(03)00049-6; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Thomadaki H, 2008, CONNECT TISSUE RES, V49, P261, DOI 10.1080/03008200802147829; Thomadaki H, 2007, CANCER LETT, V247, P48, DOI 10.1016/j.canlet.2006.03.016; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zhang HP, 1999, RECURSIVE PARTITIONI	62	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2222	2236		10.1038/onc.2011.393	http://dx.doi.org/10.1038/onc.2011.393			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21996729				2022-12-25	WOS:000303415900010
J	Chun, Y; Park, B; Koh, W; Lee, S; Cheon, Y; Kim, R; Che, L; Lee, S				Chun, Younghwa; Park, Byoungwoo; Koh, Wansoo; Lee, Sunhee; Cheon, Yeongmi; Kim, Raehyung; Che, Lihua; Lee, Soojin			New Centromeric Component CENP-W Is an RNA-associated Nuclear Matrix Protein That Interacts with Nucleophosmin/B23 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME BIOGENESIS; NUCLEOLUS; CANCER; KINETOCHORE; COMPLEX; CELLS; IDENTIFICATION; CHROMATIN; DYNAMICS; CUG2	CENP-W was originally identified as a putative oncogene, cancer-upregulated gene 2 (CUG2) that was commonly up-regulated in many cancer tissues. Recently, CENP-W has also been identified as a new centromeric component that interacts with CENP-T. As a complex with CENP-T, CENP-W plays crucial roles in assembly of the functional kinetochore complex. In this study, the subnuclear localization of CENP-W was extensively analyzed using various approaches. We found that ectopically expressed CENP-W primarily accumulated in the nucleolus and remained substantially associated with the nucleolus in stable cells. The following fractionation study also showed that CENP-W is associated with RNA as well as DNA. Moreover, a considerable amount of CENP-W was found in the nuclear mesh-like structure, nuclear matrix, possibly indicating that CENP-W participates in diverse subnuclear activities. Finally, biochemical affinity binding analysis revealed that CENP-W specifically interacts with the nucleolar phosphoprotein, nucleophosmin (B23). Depletion of cellular B23 by siRNA treatment induced a dramatic decrease of CENP-W stability and severe mislocalization during prophase. Our data proposed that B23 may function in the assembly of the kinetochore complex by interacting with CENP-W during interphase.	[Chun, Younghwa; Park, Byoungwoo; Koh, Wansoo; Lee, Sunhee; Cheon, Yeongmi; Kim, Raehyung; Che, Lihua; Lee, Soojin] Chungnam Natl Univ, Dept Mol Biol & Microbiol, Taejon 305764, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Mol Biol & Microbiol, Taejon 305764, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Korean Government; National Research Foundation [20100005431]; Ministry for Health, Welfare and Family Affairs [A080588-21]	Korean Government(Korean Government); National Research Foundation; Ministry for Health, Welfare and Family Affairs	This work was supported by grants funded by Korean Government, the Basic Science Research Program through National Research Foundation (Grant 20100005431), and the Korea Healthcare Technology R and D Project through the Ministry for Health, Welfare and Family Affairs (Grant A080588-21).	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Biggiogera M, 2008, DIFFERENTIATION, V76, P57, DOI 10.1111/j.1432-0436.2007.00211.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; FEUERSTEIN N, 1987, J IMMUNOL, V139, P1818; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; He D, 1995, INT REV CYTOL, V162B, P1; He D, 1996, J CELL SCI, V109, P2693; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurg R, 2005, J VIROL, V79, P10528, DOI 10.1128/JVI.79.16.10528-10539.2005; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Leonhardt H, 1995, INT REV CYTOL, V162B, P303; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8; Pluta AF, 1996, J BIOL CHEM, V271, P18767, DOI 10.1074/jbc.271.31.18767; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Sjakste N, 2004, EXP ONCOL, V26, P170; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Szebeni A, 1999, PROTEIN SCI, V8, P905; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weng JJ, 2005, BIOCHEM BIOPH RES CO, V335, P826, DOI 10.1016/j.bbrc.2005.07.150; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149	42	23	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42758	42769		10.1074/jbc.M111.228411	http://dx.doi.org/10.1074/jbc.M111.228411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002061	Green Published, hybrid			2022-12-25	WOS:000298180900082
J	Li, ZG; Xie, WB; Escano, CS; Asico, LD; Xie, QY; Jose, PA; Chen, SY				Li, Zuguo; Xie, Wei-Bing; Escano, Crisanto S.; Asico, Laureano D.; Xie, Qiyun; Jose, Pedro A.; Chen, Shi-You			Response Gene to Complement 32 Is Essential for Fibroblast Activation in Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE-DIFFERENTIATION; CHRONIC KIDNEY-DISEASE; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; DIABETIC-NEPHROPATHY; TUBULAR CELLS; SMAD3	Response gene to complement 32 (RGC-32) is a downstream target of transforming growth factor-beta (TGE-beta). TGE-beta is known to play a pathogenic role in renal fibrosis. In this study, we investigated RGC-32 function in renal fibrosis following unilateral ureteral obstruction (UUO) in mice, a model of progressive tubulointerstitial fibrosis. RGC-32 is normally expressed only in blood vessels of mouse kidney. However, UUO induces RGC-32 expression in renal interstitial cells at the early stage of kidney injury, suggesting that RGC-32 is involved in interstitial fibroblast activation. Indeed, expression of smooth muscle alpha-actin (alpha-SMA), an indicator of fibroblast activation, is limited to the interstitial cells at the early stage, and became apparent later in both interstitial and tubular cells. RGC-32 knockdown by shRNA significantly inhibits UUO-induced renal structural damage, alpha-SMA expression and collagen deposition, suggesting that RGC-32 is essential for the onset of renal interstitial fibrosis. In vitro studies indicate that RGC-32 mediates TGF-beta-induced fibroblast activation. Mechanistically, RGC-32 interacts with Smad3 and enhances Smad3 binding to the Smad binding element in alpha-SMA promoter as demonstrated by DNA affinity assay. In the chromatin setting, Smad3, but not Smad2, binds to alpha-SMA promoter in fibroblasts. RGC-32 appears to be essential for Smad3 interaction with the promoters of fibroblast activation-related genes in vivo. Functionally, RGC-32 is crucial for Smad3-mediated alpha-SMA promoter activity. Taken together, we identify RGC-32 as a novel fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.	[Li, Zuguo; Xie, Wei-Bing; Xie, Qiyun; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Escano, Crisanto S.; Asico, Laureano D.; Jose, Pedro A.] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Washington, DC 20010 USA; [Jose, Pedro A.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA	University System of Georgia; University of Georgia; Children's National Health System; Georgetown University	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Asico, Laureano/AAM-6321-2020		National Institutes of Health [HL093429, HL107526, DK39308, HL23081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL093429, R37HL023081, R01HL023081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants HL093429 and HL107526 (to S. Y. C.) and DK39308 and HL23081 (to P. A. J.) from the National Institutes of Health.	Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; DIAMOND JR, 1995, AM J KIDNEY DIS, V26, P133, DOI 10.1016/0272-6386(95)90166-3; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Guo BL, 2005, KIDNEY INT, V68, P972, DOI 10.1111/j.1523-1755.2005.00491.x; Guo X, 2011, AM J PHYSIOL-CELL PH, V300, pC1415, DOI 10.1152/ajpcell.00204.2010; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; HEWITSON TD, 1995, AM J NEPHROL, V15, P111, DOI 10.1159/000168813; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Jernigan S. M., 2000, EXPT INSIGHTS MECH T; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Klahr S, 2003, J NEPHROL, V16, P179; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schnaper HW, 2006, J AM SOC NEPHROL, V17, P1777, DOI 10.1681/ASN.2006030267; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	44	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41323	41330		10.1074/jbc.M111.259184	http://dx.doi.org/10.1074/jbc.M111.259184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990365	Green Published, hybrid			2022-12-25	WOS:000298057500019
J	Nina, PB; Morrisey, JM; Ganesan, SM; Ke, HJ; Pershing, AM; Mather, MW; Vaidya, AB				Nina, Praveen Balabaskaran; Morrisey, Joanne M.; Ganesan, Suresh M.; Ke, Hangjun; Pershing, April M.; Mather, Michael W.; Vaidya, Akhil B.			ATP Synthase Complex of Plasmodium falciparum DIMERIC ASSEMBLY IN MITOCHONDRIAL MEMBRANES AND RESISTANCE TO GENETIC DISRUPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; TETRAHYMENA-PYRIFORMIS; MAMMALIAN MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; ELECTRON-TRANSPORT; YEAST; CRISTAE; GENOME; SUPERCOMPLEXES; DEHYDROGENASE	The rotary nanomotor ATP synthase is a central player in the bioenergetics of most organisms. Yet the role of ATP synthase in malaria parasites has remained unclear, as blood stages of Plasmodium falciparum appear to derive ATP largely through glycolysis. Also, genes for essential subunits of the F-O sector of the complex could not be detected in the parasite genomes. Here, we have used molecular genetic and immunological tools to investigate the localization, complex formation, and functional significance of predicted ATP synthase subunits in P. falciparum. We generated transgenic P. falciparum lines expressing seven epitope-tagged canonical ATP synthase subunits, revealing localization of all but one of the subunits to the mitochondrion. Blue native gel electrophoresis of P. falciparum mitochondrial membranes suggested the molecular mass of the ATP synthase complex to be greater than 1 million daltons. This size is consistent with the complex being assembled as a dimer in a manner similar to the complexes observed in other eukaryotic organisms. This observation also suggests the presence of previously unknown subunits in addition to the canonical subunits in P. falciparum ATP synthase complex. Our attempts to disrupt genes encoding beta and gamma subunits were unsuccessful, suggesting an essential role played by the ATP synthase complex in blood stages of P. falciparum. These studies suggest that, despite some unconventional features and its minimal contribution to ATP synthesis, P. falciparum ATP synthase is localized to the parasite mitochondrion, assembled as a large dimeric complex, and is likely essential for parasite survival.	[Nina, Praveen Balabaskaran; Morrisey, Joanne M.; Ganesan, Suresh M.; Ke, Hangjun; Pershing, April M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Vaidya, AB (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, 2900 Queen Ln, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu		Mather, Michael/0000-0002-1062-0137; Balabaskaran Nina, Praveen/0000-0003-4096-0738	National Institutes of Health [AI28398]; Drexel University College of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398, R22AI028398, R01AI053148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drexel University College of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI28398 (to A. B. V.). This work was also supported by Drexel University College of Medicine.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRYANT C, 1964, AM J TROP MED HYG, V13, P515, DOI 10.4269/ajtmh.1964.13.515; CONKLIN KA, 1972, COMP BIOCHEM PHYSIOL, V41, P45, DOI 10.1016/0305-0491(72)90006-5; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; KILPATRICK L, 1977, BIOCHIM BIOPHYS ACTA, V462, P515, DOI 10.1016/0005-2728(77)90098-6; KOBAYASHI S, 1965, J BIOCHEM, V58, P444, DOI 10.1093/oxfordjournals.jbchem.a128224; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Krungkrai Jerapan, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P636; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Mogi T, 2009, MITOCHONDRION, V9, P443, DOI 10.1016/j.mito.2009.08.004; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NISHI A, 1962, BIOCHIM BIOPHYS ACTA, V65, P419, DOI 10.1016/0006-3002(62)90443-2; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 2004, FEBS LETT, V570, P93, DOI 10.1016/j.febslet.2004.06.032; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sherman Irwin W., 1998, P135; St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TURNER G, 1971, J GEN MICROBIOL, V65, P359, DOI 10.1099/00221287-65-3-359; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; Vaidya Akhil B., 2004, Current Drug Targets - Infectious Disorders, V4, P11, DOI 10.2174/1568005043480907; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xing SL, 2011, CELL BIOL INT, V35, P81, DOI 10.1042/CBI20090441; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	68	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41312	41322		10.1074/jbc.M111.290973	http://dx.doi.org/10.1074/jbc.M111.290973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984828	Green Published, hybrid			2022-12-25	WOS:000298057500018
J	Zhang, NG; Panigrahi, AK; Mao, QL; Pati, D				Zhang, Nenggang; Panigrahi, Anil K.; Mao, Qilong; Pati, Debananda			Interaction of Sororin Protein with Polo-like Kinase 1 Mediates Resolution of Chromosomal Arm Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; ANAPHASE-PROMOTING COMPLEX; BOX DOMAIN; PHOSPHORYLATION DYNAMICS; CELL-DIVISION; PROPHASE; CLEAVAGE; BINDING; PLK1; WAPL	Unlike in budding yeast, sister chromatid cohesion in vertebrate cells is resolved in two steps: cohesin complexes are removed from sister chromatid arms during prophase via phosphorylation, whereas centromeric cohesins are removed at anaphase by Separase. Phosphorylation of cohesin subunit SA2 by polo-like kinase 1 (Plk1) is required for the removal of cohesins at prophase, but how Plk1 is recruited to phosphorylate SA2 during prophase is currently not known. Here we report that Sororin, a cohesin-interacting protein essential for sister chromatid cohesion, plays a novel role in the resolution of sister chromatid arms by direct interaction with Plk1. We identified an evolutionarily conserved motif ((STP)-P-159) on Sororin, which was phosphorylated by Cdk1/cyclin B and bound to the polo box domain of Plk1. Mutating Thr(159) into alanine prevented the interaction of Plk1 and Sororin and inhibited the resolution of chromosomal arm cohesion. We propose that Sororin is phosphorylated by Cdk1/cyclin B at prophase and acts as a docking protein to bring Plk1 into proximity with SA2, resulting in the phosphorylation of SA2 and the removal of cohesin complexes from chromosomal arms.	[Zhang, Nenggang; Panigrahi, Anil K.; Mao, Qilong; Pati, Debananda] Baylor Coll Med, Dept Pediat Hematol Oncol, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center	Zhang, NG (corresponding author), Baylor Coll Med, Dept Pediat Hematol Oncol, Texas Childrens Canc & Hematol Ctr, 1102 Bates Ave,Suite 1220, Houston, TX 77030 USA.	nzhang@bcm.edu; pati@bcm.edu			National Institutes of Health, NCI [1RO1 CA109478, 1RO1 CA109330]; Simmons Family Foundation; NATIONAL CANCER INSTITUTE [R01CA109478, R01CA109330] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simmons Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 CA109478 and 1RO1 CA109330 from the NCI (to D. P.). This work was also supported by a 2008 Virginia and L. E. Simmons Family Foundation collaborative research award (to D. P.).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Freshney R. I., 2000, CULTURE ANIMAL CELLS, P456; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nguyen MH, 2010, CANCER RES, V70, P5337, DOI 10.1158/0008-5472.CAN-09-4372; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Wu FM, 2011, J BIOL CHEM, V286, P3579, DOI 10.1074/jbc.M110.196758; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	45	38	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41826	41837		10.1074/jbc.M111.305888	http://dx.doi.org/10.1074/jbc.M111.305888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987589	Green Published, hybrid			2022-12-25	WOS:000298057500065
J	De Ridder, D; Vanneste, S; Congedo, M				De Ridder, Dirk; Vanneste, Sven; Congedo, Marco			The Distressed Brain: A Group Blind Source Separation Analysis on Tinnitus	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; ACTIVITY FLUCTUATIONS; CINGULATE CORTEX; VERBAL MEMORY; RESTING-STATE; PAIN; PERCEPTION; MECHANISMS; REGIONS	Background: Tinnitus, the perception of a sound without an external sound source, can lead to variable amounts of distress. Methodology: In a group of tinnitus patients with variable amounts of tinnitus related distress, as measured by the Tinnitus Questionnaire (TQ), an electroencephalography (EEG) is performed, evaluating the patients' resting state electrical brain activity. This resting state electrical activity is compared with a control group and between patients with low (N = 30) and high distress (N = 25). The groups are homogeneous for tinnitus type, tinnitus duration or tinnitus laterality. A group blind source separation (BSS) analysis is performed using a large normative sample (N = 84), generating seven normative components to which high and low tinnitus patients are compared. A correlation analysis of the obtained normative components' relative power and distress is performed. Furthermore, the functional connectivity as reflected by lagged phase synchronization is analyzed between the brain areas defined by the components. Finally, a group BSS analysis on the Tinnitus group as a whole is performed. Conclusions: Tinnitus can be characterized by at least four BSS components, two of which are posterior cingulate based, one based on the subgenual anterior cingulate and one based on the parahippocampus. Only the subgenual component correlates with distress. When performed on a normative sample, group BSS reveals that distress is characterized by two anterior cingulate based components. Spectral analysis of these components demonstrates that distress in tinnitus is related to alpha and beta changes in a network consisting of the subgenual anterior cingulate cortex extending to the pregenual and dorsal anterior cingulate cortex as well as the ventromedial prefrontal cortex/orbitofrontal cortex, insula, and parahippocampus. This network overlaps partially with brain areas implicated in distress in patients suffering from pain, functional somatic syndromes and posttraumatic stress disorder, and might therefore represent a specific distress network.	[De Ridder, Dirk; Vanneste, Sven] Univ Antwerp Hosp, TRI, Antwerp, Belgium; [De Ridder, Dirk; Vanneste, Sven] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Congedo, Marco] Grenoble Univ, Natl Ctr Sci Res, Team ViBS Vis & Brain Signal Proc, GIPSA Lab, Grenoble, France	University of Antwerp; University of Antwerp; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	De Ridder, D (corresponding author), Univ Antwerp Hosp, TRI, Antwerp, Belgium.	dirk.de.ridder@uza.be		Vanneste, Sven/0000-0003-1513-5752				ALSTER J, 1993, BIOL PSYCHIAT, V34, P84, DOI 10.1016/0006-3223(93)90260-K; Axelsson Alf, 2000, Noise Health, V2, P47; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; BEARD AW, 1965, J PSYCHOSOM RES, V9, P29, DOI 10.1016/0022-3999(65)90008-5; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; CLARK WW, 1991, J ACOUST SOC AM, V90, P175, DOI 10.1121/1.401285; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Congedo M, 2010, INT J PSYCHOPHYSIOL; Congedo M., 2002, EUREKA VERSION 3 0 C; Congedo M, 2010, BRAIN TOPOGR, V23, P134, DOI 10.1007/s10548-009-0113-6; Congedo M, 2008, CLIN NEUROPHYSIOL, V119, P2677, DOI 10.1016/j.clinph.2008.09.007; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dille MF, 2010, J AM ACAD AUDIOL, V21, P409, DOI 10.3766/jaaa.21.6.6; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; ELITHORN A, 1954, P ROY SOC MED, V46, P832; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; GOEBEL G, 1994, HNO, V42, P166; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Meeus O, 2007, B-ENT, P11; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moller A., 1994, NEUROTOLOGY, P153; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Stern J, 2006, NEUROIMAGE, V31, P721, DOI 10.1016/j.neuroimage.2005.12.042; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2011, CLIN NEUROPHYSIOL; Vanneste S, 2010, B ENT; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Waldorp LJ, 2005, IEEE T BIO-MED ENG, V52, P414, DOI 10.1109/TBME.2004.842982; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	72	96	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24273	10.1371/journal.pone.0024273	http://dx.doi.org/10.1371/journal.pone.0024273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NO	21998628	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700004
J	Lindstrom, ES; Ostman, O				Lindstrom, Eva S.; Ostman, Orjan			The Importance of Dispersal for Bacterial Community Composition and Functioning	PLOS ONE			English	Article							BIODIVERSITY; PRODUCTIVITY; IMMIGRATION; DIVERSITY	We conducted a metacommunity experiment to investigate the role of dispersal for bacterial community composition (BCC) and function of freshwater bacteria. Bacteria were dispersed from a common source pool into three different lake communities in their natural lake water. The experiment was conducted in dialysis bags to enable a decoupling between a change in the local environment and dispersal. BCC was determined by terminal restriction fragment length polymorphism (tRFLP) of the 16S rRNA gene. We show that the greatest changes in BCC occurred between 10% and 43% of dispersal of standing stock per day. Functioning, measured as growth rate, was also affected by dispersal in all three communities but the qualitative pattern differed between communities, sometimes showing a hump-shaped relationship to dispersal and sometimes decreasing with increasing dispersal. In all waters, functioning was related to BCC. Our results show that dispersal does affect BCC and functioning but that high dispersal rates are needed. Further, the effect of dispersal on BCC and function seem to depend on the quality of the habitat to which bacteria disperse into.	[Lindstrom, Eva S.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden; [Ostman, Orjan] Uppsala Univ, Dept Ecol & Genet Populat Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Lindstrom, ES (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	Eva.Lindstrom@ebc.uu.se	LindstrÃm, Eva/H-5930-2016; Östman, Örjan/ABF-8714-2020	LindstrÃm, Eva/0000-0001-8920-3071; Östman, Örjan/0000-0002-1930-0148	Swedish Research Council [2009-5172, 2005-5307, 2007-5932]; Olsson-Borgh foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Olsson-Borgh foundation	This study was financed by a grant from the Olsson-Borgh foundation to the authors, and by one grant each to both authors from the Swedish Research Council (contract number 2009-5172 (ESL), 2005-5307 and 2007-5932 (OO)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bertilsson S, 2007, ISME J, V1, P532, DOI 10.1038/ismej.2007.64; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Hillebrand H., 2009, ECOL LETT, V12, P1; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Nelson CE, 2009, LIMNOL OCEANOGR, V54, P1292, DOI 10.4319/lo.2009.54.4.1292; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Sobek S, 2003, GLOBAL CHANGE BIOL, V9, P630, DOI 10.1046/j.1365-2486.2003.00619.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wu FC, 2003, BIOGEOCHEMISTRY, V65, P245, DOI 10.1023/A:1026074318377	35	65	65	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25883	10.1371/journal.pone.0025883	http://dx.doi.org/10.1371/journal.pone.0025883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998714	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700024
J	Merhi, F; Tang, RP; Piedfer, M; Mathieu, J; Bombarda, I; Zaher, M; Kolb, JP; Billard, C; Bauvois, B				Merhi, Faten; Tang, Ruoping; Piedfer, Marion; Mathieu, Julie; Bombarda, Isabelle; Zaher, Murhaf; Kolb, Jean-Pierre; Billard, Christian; Bauvois, Brigitte			Hyperforin Inhibits Akt1 Kinase Activity and Promotes Caspase-Mediated Apoptosis Involving Bad and Noxa Activation in Human Myeloid Tumor Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FACTOR-KAPPA-B; HYPERICUM-PERFORATUM; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIINFLAMMATORY COMPOUNDS; DOWN-REGULATION; GENE-PRODUCTS; PLANT-ORIGIN; DNA-DAMAGE; IN-VITRO	Background: The natural phloroglucinol hyperforin HF displays anti-inflammatory and anti-tumoral properties of potential pharmacological interest. Acute myeloid leukemia (AML) cells abnormally proliferate and escape apoptosis. Herein, the effects and mechanisms of purified HF on AML cell dysfunction were investigated in AML cell lines defining distinct AML subfamilies and primary AML cells cultured ex vivo. Methodology and Results: HF inhibited in a time-and concentration-dependent manner the growth of AML cell lines (U937, OCI-AML3, NB4, HL-60) by inducing apoptosis as evidenced by accumulation of sub-G1 population, phosphatidylserine externalization and DNA fragmentation. HF also induced apoptosis in primary AML blasts, whereas normal blood cells were not affected. The apoptotic process in U937 cells was accompanied by downregulation of antiapoptotic Bcl-2, upregulation of pro-apoptotic Noxa, mitochondrial membrane depolarization, activation of procaspases and cleavage of the caspase substrate PARP-1. The general caspase inhibitor Z-VAD-fmk and the caspase-9- and -3-specific inhibitors, but not caspase-8 inhibitor, significantly attenuated apoptosis. HF-mediated apoptosis was associated with dephosphorylation of active Akt1 (at Ser(473)) and Akt1 substrate Bad (at Ser(136)) which activates Bad pro-apoptotic function. HF supppressed the kinase activity of Akt1, and combined treatment with the allosteric Akt1 inhibitor Akt-I-VIII significantly enhanced apoptosis of U937 cells. Significance: Our data provide new evidence that HF's pro-apoptotic effect in AML cells involved inhibition of Akt1 signaling, mitochondria and Bcl-2 members dysfunctions, and activation of procaspases -9/-3. Combined interruption of mitochondrial and Akt1 pathways by HF may have implications for AML treatment.	[Merhi, Faten; Tang, Ruoping; Piedfer, Marion; Zaher, Murhaf; Kolb, Jean-Pierre; Billard, Christian; Bauvois, Brigitte] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM U872, Paris, France; [Tang, Ruoping] Hop St Antoine, AP HP, Dept Hematol, F-75571 Paris, France; [Mathieu, Julie] Hop St Louis, INSERM U685, Paris, France; [Bombarda, Isabelle] Univ Paul Cezanne, CNRS, ISM2 AD2M, UMR 6263, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Merhi, F (corresponding author), Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM U872, Paris, France.	brigitte.bauvois@crc.jussieu.fr	Bauvois, Brigitte/F-6776-2013	Bauvois, Brigitte/0000-0002-1751-6922	Institut National de la Sante et de la Recherche Medicale; Ligue contre le Cancer (Comite de Paris; Servier Institute (Neuilly-sur-Seine, France); Societe Francaise d'Hematologie (Paris, France)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue contre le Cancer (Comite de Paris(Ligue nationale contre le cancer); Servier Institute (Neuilly-sur-Seine, France); Societe Francaise d'Hematologie (Paris, France)	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale and the Ligue contre le Cancer (Comite de Paris. Faten Merhi was funded by Servier Institute (Neuilly-sur-Seine, France) and Societe Francaise d'Hematologie (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva EA, 2007, INT J CANCER, V121, P2615, DOI 10.1002/ijc.22974; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bailly C, 2009, BIOCHEM PHARMACOL, V77, P1447, DOI 10.1016/j.bcp.2008.12.013; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bauvois B, 1996, EXP CELL RES, V222, P209, DOI 10.1006/excr.1996.0026; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Calixto Joao B., 2004, Planta Medica, V70, P93, DOI 10.1055/s-2004-815483; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Cilloni D, 2007, HAEMATOLOGICA, V92, P1224, DOI 10.3324/haematol.11199; Cristobal I, 2011, LEUKEMIA, V25, P606, DOI 10.1038/leu.2010.294; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Dalle S, 2011, CURR MOL PHARM; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Decker RH, 2002, CANCER BIOL THER, V1, P136, DOI 10.4161/cbt.58; Dell'Aica I, 2007, CLIN CHIM ACTA, V381, P69, DOI 10.1016/j.cca.2007.02.022; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Feisst C, 2009, CELL MOL LIFE SCI, V66, P2759, DOI 10.1007/s00018-009-0078-3; Fourneron JD, 2006, PHYTOCHEM ANALYSIS, V17, P71, DOI 10.1002/pca.888; Giles FJ, 2005, CURR MOL MED, V5, P653, DOI 10.2174/156652405774641034; Griffith TN, 2010, CURR MED CHEM, V17, P391, DOI 10.2174/092986710790226156; Guan LY, 2008, BMB REP, V41, P745, DOI 10.5483/BMBRep.2008.41.10.745; Hers I, 2011, CELL SIGNAL IN PRESS; Hostanska K, 2003, EUR J PHARM BIOPHARM, V56, P121, DOI 10.1016/S0939-6411(03)00046-8; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; KIM YR, 1991, LEUKEMIA RES, V15, P409, DOI 10.1016/0145-2126(91)90050-4; King ME, 2007, ONCOLOGIST, V12, P14, DOI 10.1634/theoncologist.12-S2-14; Komeno Y, 2009, J CELL PHYSIOL, V219, P529, DOI 10.1002/jcp.21739; LANOTTE M, 1991, BLOOD, V77, P1080; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu JY, 2011, CHEM-BIOL INTERACT, V190, P91, DOI 10.1016/j.cbi.2011.02.026; Lorusso G, 2009, EUR J CANCER, V45, P1474, DOI 10.1016/j.ejca.2009.01.014; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2007, EUR J HISTOCHEM, V51, P125; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Mason KD, 2006, BLOOD REV, V20, P71, DOI 10.1016/j.blre.2005.08.002; Mathieu J, 2005, ONCOGENE, V24, P7145, DOI 10.1038/sj.onc.1208889; Medina MA, 2006, LIFE SCI, V79, P105, DOI 10.1016/j.lfs.2005.12.027; Meuillet EJ, 2011, CURR MED CH IN PRESS; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Newcomb EW, 2004, ANTI-CANCER DRUG, V15, P411, DOI 10.1097/01.cad.0000127332.06439.47; Park C, 2008, TOXICOL APPL PHARM, V227, P219, DOI 10.1016/j.taap.2007.10.003; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Plesa C, 2008, CANCER-AM CANCER SOC, V112, P572, DOI 10.1002/cncr.23219; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Qin JZ, 2004, MOL CANCER THER, V3, P895; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Quiney C, 2006, LEUKEMIA, V20, P1519, DOI 10.1038/sj.leu.2404301; Quiney C, 2006, LEUKEMIA, V20, P491, DOI 10.1038/sj.leu.2404098; Quiney C, 2007, LEUKEMIA LYMPHOMA, V48, P1587, DOI 10.1080/10428190701474332; Rosato RR, 2007, MOL CANCER THER, V6, P692, DOI 10.1158/1535-7163.MCT-06-0562; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schulz HU, 2005, ARZNEIMITTELFORSCH, V55, P15; Sedlacek HH, 2001, CRIT REV ONCOL HEMAT, V38, P139, DOI 10.1016/S1040-8428(00)00124-4; Song G, 2010, CURR CANCER DRUG TAR, V10, P584, DOI 10.2174/156800910791859515; Sonneveld P, 2001, BEST PRACT RES CL HA, V14, P211, DOI 10.1053/beha.2000.0124; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Stock Wendy, 2006, Hematology Am Soc Hematol Educ Program, P185; Stoddart A, 2011, ONCOGENE; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Takada Y, 2004, J BIOL CHEM, V279, P4750, DOI 10.1074/jbc.M304546200; Takada Y, 2008, MOL PHARMACOL, V73, P1549, DOI 10.1124/mol.107.041350; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wurglics M, 2006, CLIN PHARMACOKINET, V45, P449, DOI 10.2165/00003088-200645050-00002; Yamamoto M, 1999, LEUKEMIA, V13, P595, DOI 10.1038/sj.leu.2401372; Zaher M, 2009, LEUKEMIA, V23, P594, DOI 10.1038/leu.2008.239; Zanoli P, 2004, CNS DRUG REV, V10, P203; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	80	44	45	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25963	10.1371/journal.pone.0025963	http://dx.doi.org/10.1371/journal.pone.0025963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998731	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700027
J	Bouletreau, S; Cucherousset, J; Villeger, S; Masson, R; Santoul, F				Bouletreau, Stephanie; Cucherousset, Julien; Villeger, Sebastien; Masson, Remi; Santoul, Frederic			Colossal Aggregations of Giant Alien Freshwater Fish as a Potential Biogeochemical Hotspot	PLOS ONE			English	Article							CATFISH SILURUS-GLANIS; PHOSPHORUS; ECOLOGY	The ubiquity and fascinating nature of animal aggregations are widely recognised. We report here consistent and previously undocumented occurences of aggregations of a giant alien freshwater fish, the Wels catfish (Silurus glanis). Aggregative groups were on average composed of 25 (+/- 10 SD, ranging from 15 to 44) adults with estimated average total biomass of 651 kg (386 - 1132) and biomass density of 23 kg m(-2) (14 - 40). Aggregations always occurred within the same location. No foraging, reproductive or anti-predator behaviour were observed during the aggregations. A mass-balance model estimated that these colossal aggregations of an alien species can locally release, through excretion only, up to 70 mg P m(-2) h(-1) and 400 mg N m(-2) h(-1), potentially representing the highest biogeochemical hotspots reported in freshwater ecosystems and another unexpected ecological effect of alien species.	[Bouletreau, Stephanie; Masson, Remi; Santoul, Frederic] Univ Toulouse, UPS, INP, UMR EcoLab Lab Ecol Fonct & Environm 5245, Toulouse, France; [Bouletreau, Stephanie; Santoul, Frederic] CNRS, EcoLab, Toulouse, France; [Cucherousset, Julien; Villeger, Sebastien] CNRS, UPS, ENFA, UMR EDB Lab Evolut & Divers Biol 5174, Toulouse, France; [Cucherousset, Julien; Villeger, Sebastien] Univ Toulouse, UPS, UMR EDB 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Bouletreau, S (corresponding author), Univ Toulouse, UPS, INP, UMR EcoLab Lab Ecol Fonct & Environm 5245, Toulouse, France.	santoul@cict.fr	Villéger, Sébastien/AAW-9949-2021; Cucherousset, Julien/B-5709-2011; Bouletreau, Stephanie/T-2915-2019; Villéger, Sébastien/C-6272-2011	Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178; Santoul, Frederic/0000-0002-2932-2172; Bouletreau, Stephanie/0000-0002-0094-0196; Cucherousset, Julien/0000-0003-0533-9479				Alp A, 2011, REV FISH BIOL FISHER, V21, P283, DOI 10.1007/s11160-010-9168-4; Britton JR, 2007, FISHERIES MANAG ECOL, V14, P263, DOI 10.1111/j.1365-2400.2007.00554.x; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; DAVIS JA, 1978, T AM FISH SOC, V107, P862, DOI 10.1577/1548-8659(1978)107<862:COSEAA>2.0.CO;2; Groves TDD, 1979, FISH PHYSL, VVII; Hanson P. C., 1997, WISCUT97001 U WISC S; Krause J, 2002, LIVING GROUPS; Krone R, 2008, CORAL REEFS, V27, P619, DOI 10.1007/s00338-008-0365-8; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; NAKASHIMA BS, 1980, CAN J FISH AQUAT SCI, V37, P1540, DOI 10.1139/f80-199; NAKASHIMA BS, 1980, CAN J FISH AQUAT SCI, V37, P679, DOI 10.1139/f80-085; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PENCZAK T, 1985, HYDROBIOLOGIA, V120, P159, DOI 10.1007/BF00032137; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Schaus MH, 1997, LIMNOL OCEANOGR, V42, P1386, DOI 10.4319/lo.1997.42.6.1386; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220	20	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25732	10.1371/journal.pone.0025732	http://dx.doi.org/10.1371/journal.pone.0025732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998687	Green Submitted, gold, Green Published			2022-12-25	WOS:000295966900048
J	Ferrara, F; Listwan, P; Waldo, GS; Bradbury, ARM				Ferrara, Fortunato; Listwan, Pawel; Waldo, Geoffrey S.; Bradbury, Andrew R. M.			Fluorescent Labeling of Antibody Fragments Using Split GFP	PLOS ONE			English	Article							LINKED IMMUNOSORBENT-ASSAY; RECOMBINANT-ANTIBODIES; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; FUSION PROTEINS; PHAGE; PHOSPHATASE; LIBRARIES; AFFINITY; ANTIGEN	Antibody fragments are easily isolated from in vitro selection systems, such as phage and yeast display. Lacking the Fc portion of the antibody, they are usually labeled using small peptide tags recognized by antibodies. In this paper we present an efficient method to fluorescently label single chain Fvs (scFvs) using the split green fluorescent protein (GFP) system. A 13 amino acid tag, derived from the last beta strand of GFP (termed GFP11), is fused to the C terminus of the scFv. This tag has been engineered to be non-perturbing, and we were able to show that it exerted no effect on scFv expression or functionality when compared to a scFv without the GFP11 tag. Effective functional fluorescent labeling is demonstrated in a number of different assays, including fluorescence linked immunosorbant assays, flow cytometry and yeast display. Furthermore, we were able to show that this split GFP system can be used to determine the concentration of scFv in crude samples, as well an estimate of antibody affinity, without the need for antibody purification. We anticipate this system will be of widespread interest in antibody engineering and in vitro display systems.	[Ferrara, Fortunato; Listwan, Pawel; Waldo, Geoffrey S.; Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Ferrara, F (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.	amb@lanl.gov	Ferrara, Fortunato/AAD-5947-2019	Bradbury, Andrew/0000-0002-5567-8172; Ferrara, Fortunato/0000-0002-4615-035X	NIH [P50GM085273, R01-HG004852-01A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the NIH (P50GM085273 and R01-HG004852-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; Casey JL, 2000, PROTEIN ENG, V13, P445, DOI 10.1093/protein/13.6.445; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; England P, 1999, J IMMUNOL, V162, P2129; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Griep RA, 1999, J IMMUNOL METHODS, V230, P121, DOI 10.1016/S0022-1759(99)00131-3; Han ZZ, 2004, COMB CHEM HIGH T SCR, V7, P55, DOI 10.2174/138620704772884823; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; HARPER M, 1987, MOL IMMUNOL, V24, P97, DOI 10.1016/0161-5890(87)90081-2; HAWKINS RE, 1993, J MOL BIOL, V234, P958, DOI 10.1006/jmbi.1993.1650; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; Lindner P, 1997, BIOTECHNIQUES, V22, P140, DOI 10.2144/97221rr01; Listwan Pawel, 2010, Journal of Structural and Functional Genomics, V11, P41, DOI 10.1007/s10969-009-9077-8; Listwan Pawel, 2009, Journal of Structural and Functional Genomics, V10, P47, DOI 10.1007/s10969-008-9049-4; MAGNUSSON KE, 1987, IMMUNOL INVEST, V16, P227, DOI 10.3109/08820138709030578; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Morino K, 2001, J IMMUNOL METHODS, V257, P175, DOI 10.1016/S0022-1759(01)00462-8; Muller BH, 1999, J IMMUNOL METHODS, V227, P177, DOI 10.1016/S0022-1759(99)00071-X; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Oelschlaeger P, 2002, ANAL BIOCHEM, V309, P27, DOI 10.1016/S0003-2697(02)00290-7; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Pavoor TV, 2009, P NATL ACAD SCI US; Pluckthun A, 1990, Behring Inst Mitt, P48; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; REIMANN KA, 1994, CYTOMETRY, V17, P102, DOI 10.1002/cyto.990170113; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Siegel RW, 2003, NAT BIOTECHNOL; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; VanAntwerp JJ, 1998, J MOL RECOGNIT, V11, P10, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<10::AID-JMR381>3.0.CO;2-H; VANDYKE MW, 1992, GENE, V111, P99, DOI 10.1016/0378-1119(92)90608-R; Velappan N, 2008, J IMMUNOL METHODS, V336, P135, DOI 10.1016/j.jim.2008.04.007; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wingren C, 2007, PROTEOMICS, V7, P3055, DOI 10.1002/pmic.200700025	47	12	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25727	10.1371/journal.pone.0025727	http://dx.doi.org/10.1371/journal.pone.0025727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998685	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900046
J	Rampersad, RR; Tarrant, TK; Vallanat, CT; Quintero-Matthews, T; Weeks, MF; Esserman, DA; Clark, J; Di Padova, F; Patel, DD; Fong, AM; Liu, P				Rampersad, Rishi R.; Tarrant, Teresa K.; Vallanat, Christopher T.; Quintero-Matthews, Tatiana; Weeks, Michael F.; Esserman, Denise A.; Clark, Jennifer; Di Padova, Franco; Patel, Dhavalkumar D.; Fong, Alan M.; Liu, Peng			Enhanced Th17-Cell Responses Render CCR2-Deficient Mice More Susceptible for Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-HELPER-CELLS; SYNOVIAL INFLAMMATION; RHEUMATOID-ARTHRITIS; CC-CHEMOKINE; BONE-MARROW; INTERLEUKIN-17; EXPRESSION; IL-17; INDUCTION	CCR2 is considered a proinflammatory mediator in many inflammatory diseases such as rheumatoid arthritis. However, mice lacking CCR2 develop exacerbated collagen-induced arthritis. To explore the underlying mechanism, we investigated whether autoimmune-associated Th17 cells were involved in the pathogenesis of the severe phenotype of autoimmune arthritis. We found that Th17 cells were expanded approximately 3-fold in the draining lymph nodes of immunized CCR2(-/-) mice compared to WT controls (p = 0.017), whereas the number of Th1 cells and regulatory T cells are similar between these two groups of mice. Consistently, levels of the Th17 cell cytokine IL-17A and Th17 cell-associated cytokines, IL-6 and IL-1 beta were approximately 2-6-fold elevated in the serum and 22-28-fold increased in the arthritic joints in CCR2(-/-) mice compared to WT mice (p = 0.04, 0.0004, and 0.01 for IL-17, IL-6, and IL-1 beta, respectively, in the serum and p = 0.009, 0.02, and 0.02 in the joints). Furthermore, type II collagen-specific antibodies were significantly increased, which was accompanied by B cell and neutrophil expansion in CCR2(-/-) mice. Finally, treatment with an anti-IL-17A antibody modestly reduced the disease severity in CCR2(-/-) mice. Therefore, we conclude that while we detect markedly enhanced Th17-cell responses in collagen-induced arthritis in CCR2-deficient mice and IL-17A blockade does have an ameliorating effect, factors additional to Th17 cells and IL-17A also contribute to the severe autoimmune arthritis seen in CCR2 deficiency. CCR2 may have a protective role in the pathogenesis of autoimmune arthritis. Our data that monocytes were missing from the spleen while remained abundant in the bone marrow and joints of immunized CCR2(-/-) mice suggest that there is a potential link between CCR2-expressing monocytes and Th17 cells during autoimmunity.	[Rampersad, Rishi R.; Tarrant, Teresa K.; Vallanat, Christopher T.; Quintero-Matthews, Tatiana; Weeks, Michael F.; Patel, Dhavalkumar D.; Fong, Alan M.; Liu, Peng] Univ N Carolina, Dept Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA; [Esserman, Denise A.] Univ N Carolina, Dept Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC USA; [Esserman, Denise A.; Clark, Jennifer] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Di Padova, Franco; Patel, Dhavalkumar D.] Novartis Inst BioMed Res, Basel, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Novartis	Rampersad, RR (corresponding author), Univ N Carolina, Dept Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA.	liupz@med.unc.edu		Tarrant, Teresa/0000-0003-4067-5363	Arthritis Foundation; North Carolina Translational and Clinical Science (NC TraCS) Institute; home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA); NIH [HL077406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077406] Funding Source: NIH RePORTER	Arthritis Foundation; North Carolina Translational and Clinical Science (NC TraCS) Institute; home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an Arthritis Foundation Postdoctoral Fellowship, a pilot grant from the North Carolina Translational and Clinical Science (NC TraCS) Institute, home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA), and NIH grant HL077406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Bruhl H, 2001, CLIN EXP IMMUNOL, V126, P551, DOI 10.1046/j.1365-2249.2001.01679.x; Chabaud M, 2001, ARTHRITIS RHEUM, V44, P1293, DOI 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ferber IA, 1996, J IMMUNOL, V156, P5; Fujii H, 2001, ARTHRITIS RHEUM, V63, P96; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Genovese MC, 1929, ARTHRITIS RHEUM, V62, P929; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jerath MR, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-14; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kato H, 1917, CTS-CLIN TRANSL SCI, V3, P319; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Rampersad RR, 2009, SCAND J RHEUMATOL, V38, P445, DOI 10.3109/03009740902895743; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tarrant Teresa K, 2006, Pathophysiology, V13, P1, DOI 10.1016/j.pathophys.2005.11.001; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	52	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25833	10.1371/journal.pone.0025833	http://dx.doi.org/10.1371/journal.pone.0025833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991368	Green Published, Green Submitted, gold			2022-12-25	WOS:000295963300024
J	Celotto, AM; Chiu, WK; Van Voorhies, W; Palladino, MJ				Celotto, Alicia M.; Chiu, Wai Kan; Van Voorhies, Wayne; Palladino, Michael J.			Modes of Metabolic Compensation during Mitochondrial Disease Using the Drosophila Model of ATP6 Dysfunction	PLOS ONE			English	Article							ESCHERICHIA-COLI; LEIGH-SYNDROME; RESPIRATORY-CHAIN; SYNTHASE; SUBUNIT; DNA; MUTATION; DISORDERS; MUTANTS; MTDNA	Numerous mitochondrial DNA mutations cause mitochondrial encephalomyopathy: a collection of related diseases for which there exists no effective treatment. Mitochondrial encephalomyopathies are complex multisystem diseases that exhibit a relentless progression of severity, making them both difficult to treat and study. The pathogenic and compensatory metabolic changes that are associated with chronic mitochondrial dysfunction are not well understood. The Drosophila ATP6(1) mutant models human mitochondrial encephalomyopathy and allows the study of metabolic changes and compensation that occur throughout the lifetime of an affected animal. ATP6(1) animals have a nearly complete loss of ATP synthase activity and an acute bioenergetic deficit when they are asymptomatic, but surprisingly we discovered no chronic bioenergetic deficit in these animals during their symptomatic period. Our data demonstrate dynamic metabolic compensatory mechanisms that sustain normal energy availability and activity despite chronic mitochondrial complex V dysfunction resulting from an endogenous mutation in the mitochondrial DNA. ATP6(1) animals compensate for their loss of oxidative phosphorylation through increases in glycolytic flux, ketogenesis and Kreb's cycle activity early during pathogenesis. However, succinate dehydrogenase activity is reduced and mitochondrial supercomplex formation is severely disrupted contributing to the pathogenesis seen in ATP6(1) animals. These studies demonstrate the dynamic nature of metabolic compensatory mechanisms and emphasize the need for time course studies in tractable animal systems to elucidate disease pathogenesis and novel therapeutic avenues.	[Celotto, Alicia M.; Chiu, Wai Kan; Palladino, Michael J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Celotto, Alicia M.; Chiu, Wai Kan; Palladino, Michael J.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA; [Van Voorhies, Wayne] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New Mexico State University	Celotto, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	amc41@pitt.edu			National Institutes of Health (NIH) [R01 AG025046, AG027453]; U.S. National Cancer Institute [NCI U56 CA96286]; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025046, R01AG027453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) R01 AG025046 and AG027453 to Dr. Palladino and U.S. National Cancer Institute (NCI U56 CA96286) to Dr. Van Voorhies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya A, 1993, MITOCHONDRIAL DNA AS; Ashmore LJ, 2009, HUM GENET, V126, P431, DOI 10.1007/s00439-009-0673-2; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264; Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637; Celotto AM, 2006, GENETICS, V174, P1237, DOI 10.1534/genetics.106.063206; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chakrapani A, 1998, J INHERIT METAB DIS, V21, P685, DOI 10.1023/A:1005401121344; D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880; Di Donato S, 2000, J INHERIT METAB DIS, V23, P247, DOI 10.1023/A:1005684029429; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Forester BP, 2010, NMR BIOMED, V23, P242, DOI 10.1002/nbm.1444; GANETZKY B, 1982, GENETICS, V100, P597; GASNIER F, 1993, ANAL BIOCHEM, V212, P173, DOI 10.1006/abio.1993.1309; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Goyon V, 2008, J BIOL CHEM, V283, P9749, DOI 10.1074/jbc.M800204200; HARTZOG PE, 1993, J BACTERIOL, V175, P1337, DOI 10.1128/JB.175.5.1337-1343.1993; HARTZOG PE, 1993, J BIOL CHEM, V268, P12250; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; LINTS FA, 1968, EXP GERONTOL, V3, P341, DOI 10.1016/0531-5565(68)90047-8; Lopez-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616; Matthews RT, 1998, J NEUROSCI, V18, P156; MORRISON JF, 1957, BIOCHEM J, V65, P143, DOI 10.1042/bj0650143; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nation JL, 2008, INS PHYS BIOCH, P509; Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Palladino MJ, 2002, GENETICS, V161, P1197; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rantamaki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P99, DOI 10.1016/S0005-2728(98)00160-1; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Seigle JL, 2008, GENETICS, V179, P855, DOI 10.1534/genetics.108.087551; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Van Voorhies W, 2003, EXP GERONTOL, V38, P343, DOI 10.1016/S0531-5565(02)00272-3; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Van Voorhies WA, 2002, FREE RADICAL BIO MED, V33, P587; Van Voorhies WA, 2008, J INSECT PHYSIOL, V54, P1132, DOI 10.1016/j.jinsphys.2008.04.022; Viant MR, 2001, J CHROMATOGR B, V765, P107, DOI 10.1016/S0378-4347(01)00428-5; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; Vilarinho L, 2001, J INHERIT METAB DIS, V24, P883, DOI 10.1023/A:1013908728445; Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Xue XF, 2009, J AGR FOOD CHEM, V57, P4500, DOI 10.1021/jf900853q; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Zsurka G, 2010, J BIOENERG BIOMEMBR, V42, P443, DOI 10.1007/s10863-010-9314-7	72	43	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25823	10.1371/journal.pone.0025823	http://dx.doi.org/10.1371/journal.pone.0025823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991365	Green Published, gold			2022-12-25	WOS:000295943000081
J	Ma, HL; Zhao, HM; Liu, Z; Zhao, J				Ma, Haoli; Zhao, Heming; Liu, Zhi; Zhao, Jie			The Phytocyanin Gene Family in Rice (Oryza sativa L.): Genome-Wide Identification, Classification and Transcriptional Analysis	PLOS ONE			English	Article							ARABINOGALACTAN PROTEIN GENE; EXPRESSION ANALYSIS; EARLY NODULIN; ARABIDOPSIS; STRESS; GERMINATION; EVOLUTION; OXYGEN; PLANTS; MOTIFS	Background: Phytocyanins (PCs) are plant-specific blue copper proteins involved in electron transport, and a large number of known PCs are considered to be chimeric arabinogalactan proteins (AGPs). To date there has not been a genome-wide overview of the OsPC gene family. Therefore, as the first step and a useful strategy to elucidate the functions of OsPCs, there is an urgent need for a thorough genome-wide analysis of this gene family. Methodology/Principal Findings: In this study, a total of 62 OsPC genes were identified through a comprehensive bioinformatics analysis of the rice (Oryza sativa L.) genome. Based on phylogeny and motif constitution, the family of OsPCs was classified into three subclasses: uclacyanin-like proteins (OsUCLs), stellacyanin-like proteins (OsSCLs) and early nodulin-like proteins (OsENODLs). Structure and glycosylation prediction indicated that 46 OsPCs were glycosylphosphatigylinositolanchored proteins and 38 OsPCs were chimeric AGPs. Gene duplication analysis revealed that chromosomal segment and tandem duplications contributed almost equally to the expansion of this gene family, and duplication events were mostly happened in the OsUCL subfamily. The expression profiles of OsPC genes were analyzed at different stages of vegetative and reproductive development and under abiotic stresses. It revealed that a large number of OsPC genes were abundantly expressed in the various stages of development. Moreover, 17 genes were regulated under the treatments of abiotic stresses. Conclusions/Significance: The genome-wide identification and expression analysis of OsPC genes should facilitate research in this gene family and give new insights toward elucidating their functions in higher plants.	[Ma, Haoli; Zhao, Heming; Liu, Zhi; Zhao, Jie] Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Ma, HL (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China.	jzhao@whu.edu.cn			National Natural Science Foundation of China [30821064, 31170171]; Major State Basic Research Program of China [2007CB108704]; Ministry of Education of China [20090141110035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (30821064; 31170171, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Program of China (2007CB108704, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm) and the Special Doctoral Program Funds of the Ministry of Education of China (20090141110035, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Borner GHH, 2003, PLANT PHYSIOL, V132, P568, DOI 10.1104/pp.103.021170; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Ezaki B, 2001, PLANT PHYSIOL, V127, P918, DOI 10.1104/pp.010399; Fruhling M, 2000, PLANT SCI, V160, P67, DOI 10.1016/S0168-9452(00)00362-9; Greene EA, 1998, PLANT MOL BIOL, V36, P775, DOI 10.1023/A:1005916821224; Hene L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-333; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Khan JA, 2007, PLANT PHYSIOL, V143, P1576, DOI 10.1104/pp.106.092296; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Lalanne E, 2004, PLANT CELL, V16, P229, DOI 10.1105/tpc.014407; Levitin B, 2008, PLANT J, V56, P351, DOI 10.1111/j.1365-313X.2008.03607.x; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Mashiguchi K, 2004, PLANT CELL PHYSIOL, V45, P1817, DOI 10.1093/pcp/pch208; Mashiguchi K, 2009, BIOSCI BIOTECH BIOCH, V73, P2452, DOI 10.1271/bbb.90407; Miller JD, 1999, PLANT PHYSIOL, V120, P1015, DOI 10.1104/pp.120.4.1015; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Schultz CJ, 2004, J BIOL CHEM, V279, P45503, DOI 10.1074/jbc.M407594200; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Stears RL, 2000, PHYSIOL GENOMICS, V3, P93, DOI 10.1152/physiolgenomics.2000.3.2.93; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yoshizaki M, 2000, BIOCHEM BIOPH RES CO, V268, P466, DOI 10.1006/bbrc.2000.2130; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304	45	42	47	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25184	10.1371/journal.pone.0025184	http://dx.doi.org/10.1371/journal.pone.0025184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984902	Green Submitted, gold, Green Published			2022-12-25	WOS:000295943000013
J	Aberg, UWN; Saarinen, N; Abrahamsson, A; Nurmi, T; Engblom, S; Dabrosin, C				Aberg, Ulrika W. Nilsson; Saarinen, Niina; Abrahamsson, Annelie; Nurmi, Tarja; Engblom, Sofia; Dabrosin, Charlotta			Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LIQUID-CHROMATOGRAPHY; POSTMENOPAUSAL WOMEN; CANCER; ESTRADIOL; ENDOSTATIN; MICRODIALYSIS; PREVENTION; LIGNANS; CELLS	The incidence of breast cancer is increasing in the Western world and there is an urgent need for studies of the mechanisms of sex steroids in order to develop novel preventive strategies. Diet modifications may be among the means for breast cancer prevention. Angiogenesis, key in tumor progression, is regulated by the balance between pro-and anti-angiogenic factors, which are controlled in the extracellular space. Sampling of these molecules at their bioactive compartment is therefore needed. The aims of this study were to explore if tamoxifen, one of the most used anti-estrogen treatments for breast cancer affected some of the most important endogenous angiogenesis regulators, vascular endothelial growth factor (VEGF), angiogenin, and endostatin in normal breast tissue in vivo and if a diet supplementation with flaxseed had similar effects as tamoxifen in the breast. Microdialysis was used for in situ sampling of extracellular proteins in normal breast tissue of women before and after six weeks of tamoxifen treatment or before and after addition of 25 g/day of ground flaxseed to the diet or in control women. We show significant correlations between estradiol and levels of VEGF, angiogenin, and endostatin in vivo, which was verified in ex vivo breast tissue culture. Moreover, tamoxifen decreased the levels of VEGF and angiogenin in the breast whereas endostatin increased significantly. Flaxseed did not alter VEGF or angiogenin levels but similar to tamoxifen the levels of endostatin increased significantly. We conclude that one of the mechanisms of tamoxifen in normal breast tissue include tipping of the angiogenic balance into an anti-angiogenic state and that flaxseed has limited effects on the pro-angiogenic factors whereas the anti-angiogenic endostatin may be modified by diet. Further studies of diet modifications for breast cancer prevention are warranted.	[Aberg, Ulrika W. Nilsson; Saarinen, Niina; Abrahamsson, Annelie; Engblom, Sofia; Dabrosin, Charlotta] Linkoping Univ, Fac Hlth Sci, Div Oncol, Dept Clin & Expt Med, Linkoping, Sweden; [Abrahamsson, Annelie; Engblom, Sofia; Dabrosin, Charlotta] Cty Council Ostergotland, Dept Oncol, Linkoping, Sweden; [Saarinen, Niina] Univ Turku, Turku, Finland; [Nurmi, Tarja] Univ Eastern Finland, Kuopio, Finland	Linkoping University; City Council Ostergotland; University of Turku; University of Eastern Finland	Aberg, UWN (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Oncol, Dept Clin & Expt Med, Linkoping, Sweden.	charlotta.dabrosin@liu.se		Saarinen, Niina/0000-0003-3531-378X	Swedish Cancer Society; Swedish Research Counsil; Ekhaga Foundation; Academy of Finland [114526, 115459]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Counsil; Ekhaga Foundation; Academy of Finland(Academy of Finland)	This study was supported by Swedish Cancer Society (CD); Swedish Research Counsil (CD); Ekhaga Foundation (CD); Academy of Finland #114526 (TN); Academy of Finland #115459 (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Bendrik C, 2008, CANCER RES, V68, P3405, DOI 10.1158/0008-5472.CAN-08-0295; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brooks JD, 2004, AM J CLIN NUTR, V79, P318; Clarke M, 1998, LANCET, V351, P1451; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Dabrosin C, 2005, CLIN CANCER RES, V11, P8036, DOI 10.1158/1078-0432.CCR-05-0977; Dabrosin C, 2005, FRONT BIOSCI-LANDMRK, V10, P1329, DOI 10.2741/1622; Dabrosin C, 2003, INT J CANCER, V107, P535, DOI 10.1002/ijc.11398; Dabrosin C, 2003, BREAST CANCER RES TR, V80, P193, DOI 10.1023/A:1024575103524; Dabrosin C, 2003, J CLIN ENDOCR METAB, V88, P2695, DOI 10.1210/jc.2002-021584; Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353; Dabrosin C, 2001, SCAND J CLIN LAB INV, V61, P269, DOI 10.1080/00365510152378987; Dabrosin C, 1997, J CLIN ENDOCR METAB, V82, P1382, DOI 10.1210/jc.82.5.1382; Dabrosin C, 1997, CLIN SCI, V92, P493, DOI 10.1042/cs0920493; Dabrosin C, 2005, J ENDOCRINOL, V187, P103, DOI 10.1677/joe.1.06163; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Folkman J, 1992, Semin Cancer Biol, V3, P65; Garvin S, 2003, CANCER RES, V63, P8742; Garvin S, 2006, CELL TISSUE RES, V325, P245, DOI 10.1007/s00441-006-0159-7; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Hyder SM, 2000, CANCER RES, V60, P3183; Jungestrom MB, 2007, CLIN CANCER RES, V13, P1061, DOI 10.1158/1078-0432.CCR-06-1651; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kulke MH, 2006, J CLIN ONCOL, V24, P3555, DOI 10.1200/JCO.2006.05.6762; Lindahl G, 2011, CANCER RES, V71, P51, DOI 10.1158/0008-5472.CAN-10-2289; Nilsson UW, 2006, CANCER RES, V66, P4789, DOI 10.1158/0008-5472.CAN-05-4012; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; Nurmi T, 1999, ANAL BIOCHEM, V274, P110, DOI 10.1006/abio.1999.4247; Nurmi T, 2003, J CHROMATOGR B, V798, P101, DOI 10.1016/j.jchromb.2003.09.018; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Penalvo JL, 2004, ANAL BIOCHEM, V332, P384, DOI 10.1016/j.ab.2004.05.046; Penttinen-Damdimopoulou PE, 2009, MOL NUTR FOOD RES, V53, P996, DOI 10.1002/mnfr.200800487; Pike MC, 2004, ONCOGENE, V23, P6379, DOI 10.1038/sj.onc.1207899; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936, DOI 10.1152/ajpendo.1998.274.5.E936; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saarinen NM, 2010, INT J CANCER, V127, P737, DOI 10.1002/ijc.25052; SAARINEN NM, 2008, BROMACOLOGY PHARM FO, P1; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Thompson LU, 2005, CLIN CANCER RES, V11, P3828, DOI 10.1158/1078-0432.CCR-04-2326; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Zorick TS, 2001, EUR J HUM GENET, V9, P811, DOI 10.1038/sj.ejhg.5200721	51	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25720	10.1371/journal.pone.0025720	http://dx.doi.org/10.1371/journal.pone.0025720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984941	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300051
J	Rodriguez, S; Eriksson, M				Rodriguez, Sofia; Eriksson, Maria			Low and High Expressing Alleles of the LMNA Gene: Implications for Laminopathy Disease Development	PLOS ONE			English	Article							LAMIN-A; MUTATIONS; MICE	Today, there are at least a dozen different genetic disorders caused by mutations within the LMNA gene, and collectively, they are named laminopathies. Interestingly, the same mutation can cause phenotypes with different seventies or even different disorders and might, in some cases, be asymptomatic. We hypothesized that one possible contributing mechanism this phenotypic variability could be the existence of high and low expressing alleles in the LMNA locus. To investigate this hypothesis, we developed an allele-specific absolute quantification method for lamin A and lamin C transcripts using he polymorphic rs4641(C/T) LMNA coding SNP. The contribution of each allele to the total transcript level was investigated in nine informative human primary dermal fibroblast cultures from Hutchinson-Gilford progeria syndrome (HGPS) and unaffected controls. Our results show differential expression of the two alleles. The C allele is more frequently expressed and accounts for similar to 70% of the lamin A and lamin C transcripts. Analysis of samples from six patients with Hutchinson-Gilford progeria syndrome showed that the c.1824C>T, p.G608G mutation is located in both the C and the T allele which might account for the variability in phenotype seen among HGPS patients. Our method should be useful for further studies of human samples with mutations in the LMNA gene and to increase the understanding of the link between genotype and phenotype in laminopathies.	[Rodriguez, Sofia; Eriksson, Maria] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Rodriguez, S (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Maria.Eriksson.2@ki.se			Swedish Medical Research Council; Gun and Bertil Stohne foundation; Torsten and Ragnar Soderberg foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gun and Bertil Stohne foundation; Torsten and Ragnar Soderberg foundation	This study was supported by grants from the Swedish Medical Research Council, the Gun and Bertil Stohne foundation, and the Torsten and Ragnar Soderberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; Becane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x; FURUKAWA K, 1994, EXP CELL RES, V212, P426, DOI 10.1006/excr.1994.1164; LIN F, 1993, J BIOL CHEM, V268, P16321; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Rozen S, 2000, Methods Mol Biol, V132, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; van der Kooi AJ, 2002, NEUROLOGY, V59, P620, DOI 10.1212/WNL.59.4.620; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146; Yang SH, 2008, J BIOL CHEM, V283, P7094, DOI 10.1074/jbc.M708138200	18	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25472	10.1371/journal.pone.0025472	http://dx.doi.org/10.1371/journal.pone.0025472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980471	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600027
J	Wang, HG; Wang, C; Pitt, GS				Wang, Hong-Gang; Wang, Chuan; Pitt, Geoffrey S.			Rem2-Targeted shRNAs Reduce Frequency of Miniature Excitatory Postsynaptic Currents without Altering Voltage-Gated Ca2+ Currents	PLOS ONE			English	Article							SMALL G-PROTEIN; CALCIUM-CHANNELS; SYNAPSE DEVELOPMENT; RAS FAMILY; GEM; GTPASES; REM2; INACTIVATION; CALMODULIN; MODULATION	Ca2+ influx through voltage-gated Ca2+ channels (VGCCs) plays important roles in neuronal cell development and function. Rem2 is a member of the RGK ((R) under bar ad, (R) under bar em, (R) under bar em2, (G) under bar em/(K) under bar ir) subfamily of small GTPases that confers potent inhibition upon VGCCs. The physiologic roles of RGK proteins, particularly in the brain, are poorly r understood. Rem2 was implicated in synaptogenesis through an RNAi screen and proposed to regulate Ca2+ homeostasis in neurons. To test this hypothesis and uncover physiological roles for Rem2 in the brain, we investigated the molecular mechanisms by which Rem2 knockdown affected synaptogenesis and Ca2+ homeostasis in cultured rat hippocampal neurons. Expression of a cocktail of shRNAs targeting rat Rem2 (rRem2) reduced the frequency of miniature excitatory postsynaptic currents (mEPSCs) measured 10 d after transfection (14 d in vitro), but did not affect mEPSC amplitude. VGCC current amplitude, after rRem2-targeted knockdown was not different from that in control cells, however, a either 4 or 10 d Po transfection. Co-expression of a human Rem2 that was insensitive to the shRNAs targeting rRem2 was unable to prevent the reduction in mEPSC frequency after rRem2-targeted knockdown. Over-expression of rRem2 resulted in 50% reduction in VGCC current, but neither the mEPSC frequency nor amplitude was affected. Taken together, the observed effects upon synaptogenesis after shRNA treatment are more likely due to mechanisms other than modulation of VGCCs and Ca2+ homeostasis, and may be independent of Rem2. In addition, our results reveal a surprising lack of contribution of VGCCs to synaptogenesis during early development in cultured hippocampal neurons.	[Wang, Hong-Gang] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA	Duke University; Duke University	Wang, HG (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA.	geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [R01 HL71165, R01 HL088089]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088089, R01HL071165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (R01 HL71165 and R01 HL088089). GSP is supported by an Established Investigator Award from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; BASARSKY TA, 1994, HIPPOCAMPAL SYNAPTOG, P6402; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Opatowsky Y, 2006, FEBS LETT, V580, P5959, DOI 10.1016/j.febslet.2006.09.067; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; van Daalen E, 2009, EUR CHILD ADOLES PSY, V18, P663, DOI 10.1007/s00787-009-0025-8; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Wang H., 2007, Autonomic & Autacoid Pharmacology, V27, P1, DOI 10.1111/j.1474-8673.2006.00381.x; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25741	10.1371/journal.pone.0025741	http://dx.doi.org/10.1371/journal.pone.0025741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980534	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600053
J	Rosa, RD; Santini, A; Fievet, J; Bulet, P; Destoumieux-Garzon, D; Bachere, E				Rosa, Rafael D.; Santini, Adrien; Fievet, Julie; Bulet, Philippe; Destoumieux-Garzon, Delphine; Bachere, Evelyne			Big Defensins, a Diverse Family of Antimicrobial Peptides That Follows Different Patterns of Expression in Hemocytes of the Oyster Crassostrea gigas	PLOS ONE			English	Article							MOLECULAR-CLONING; GENE; INVERTEBRATE; CONVERTASE; RESISTANCE; SEQUENCE; PROTEIN; NOV.	Background: Big defensin is an antimicrobial peptide composed of a highly hydrophobic N-terminal region and a cationic C-terminal region containing six cysteine residues involved in three internal disulfide bridges. While big defensin sequences have been reported in various mollusk species, few studies have been devoted to their sequence diversity, gene organization and their expression in response to microbial infections. Findings: Using the high-throughput Digital Gene Expression approach, we have identified in Crassostrea gigas oysters several sequences coding for big defensins induced in response to a Vibrio infection. We showed that the oyster big defensin family is composed of three members (named Cg-BigDef1, Cg-BigDef2 and Cg-BigDef3) that are encoded by distinct genomic sequences. All Cg-BigDefs contain a hydrophobic N-terminal domain and a cationic C-terminal domain that resembles vertebrate beta-defensins. Both domains are encoded by separate exons. We found that big defensins form a group predominantly present in mollusks and closer to vertebrate defensins than to invertebrate and fungi CS alpha beta-containing defensins. Moreover, we showed that Cg-BigDefs are expressed in oyster hemocytes only and follow different patterns of gene expression. While Cg-BigDef3 is non-regulated, both Cg-BigDef1 and Cg-BigDef2 transcripts are strongly induced in response to bacterial challenge. Induction was dependent on pathogen associated molecular patterns but not damage-dependent. The inducibility of Cg-BigDef1 was confirmed by HPLC and mass spectrometry, since ions with a molecular mass compatible with mature Cg-BigDef1 (10.7 kDa) were present in immune-challenged oysters only. From our biochemical data, native Cg-BigDef1 would result from the elimination of a prepropeptide sequence and the cyclization of the resulting N-terminal glutamine residue into a pyroglutamic acid. Conclusions: We provide here the first report showing that big defensins form a family of antimicrobial peptides diverse not only in terms of sequences but also in terms of genomic organization and regulation of gene expression.	[Rosa, Rafael D.; Santini, Adrien; Fievet, Julie; Bachere, Evelyne] IFREMER, CNRS, Univ Montpellier 2, IRD, Montpellier, France; [Rosa, Rafael D.; Santini, Adrien; Destoumieux-Garzon, Delphine; Bachere, Evelyne] Univ Montpellier I, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Bulet, Philippe] UJF Grenoble, AGIM, FRE 3405, CNRS EPHE 1, La Tronche, France; AGIM, Plateforme BioPk Archamps, Archamps, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rosa, RD (corresponding author), IFREMER, CNRS, Univ Montpellier 2, IRD, Montpellier, France.	ebachere@ifremer.fr	Destoumieux-Garzón, Delphine/O-3328-2014; BUELT, PHILIPPE/C-8451-2014; BULET, Philippe/C-8557-2014; Rosa, Rafael Diego/L-6944-2019; Bachere, Evelyne/O-6117-2014	Destoumieux-Garzón, Delphine/0000-0002-8793-9138; BULET, Philippe/0000-0001-9016-265X; Rosa, Rafael Diego/0000-0002-4076-3163; 	IFREMER; CNRS; CNPq-Brazil	IFREMER; CNRS(Centre National de la Recherche Scientifique (CNRS)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received financial support from IFREMER and CNRS. RDR was supported by a doctoral funding from CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kouno T, 2008, BIOCHEMISTRY-US, V47, P10611, DOI 10.1021/bi800957n; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; NAGLE GT, 1995, DNA CELL BIOL, V14, P431, DOI 10.1089/dna.1995.14.431; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Rabel D, 2004, J BIOL CHEM, V279, P14853, DOI 10.1074/jbc.M313608200; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Spijker S, 1999, J NEUROBIOL, V41, P399, DOI 10.1002/(SICI)1097-4695(19991115)41:3<399::AID-NEU8>3.0.CO;2-Z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson FL, 2003, SYST APPL MICROBIOL, V26, P65, DOI 10.1078/072320203322337326; VALORE EV, 1992, BLOOD, V79, P1538; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480	43	84	86	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25594	10.1371/journal.pone.0025594	http://dx.doi.org/10.1371/journal.pone.0025594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980497	Green Published, gold			2022-12-25	WOS:000295936900078
J	Beekman, JM; Vervoort, SJ; Dekkers, F; van Vessem, ME; Vendelbosch, S; Brugulat-Panes, A; van Loosdregt, J; Braat, AK; Coffer, PJ				Beekman, J. M.; Vervoort, S. J.; Dekkers, F.; van Vessem, M. E.; Vendelbosch, S.; Brugulat-Panes, A.; van Loosdregt, J.; Braat, A. K.; Coffer, P. J.			Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output	ONCOGENE			English	Article						Sox4; syntenin; proteasomal degradation; metastasis	PROTEIN-DEGRADATION; CANCER METASTASIS; ADAPTER PROTEIN; KAPPA-B; CELLS; GENE; MDA-9/SYNTENIN; UBIQUITIN; MICE; DIFFERENTIATION	The transcription factor Sox4 is aberrantly expressed in many human tumors and can modulate tumorigenesis and metastases of murine tumors in vivo. However, mechanisms that control Sox4 function remain poorly defined. It has recently been observed that DNA damage increases Sox4 protein expression independently of Sox4 mRNA levels, suggesting an as yet undefined post-transcriptional mechanism regulating Sox4 expression and functionality. Here, we show that Sox4 protein is rapidly degraded by the proteasome as indicated by pharmacological inhibition with Mg132 and epoxymycin. Sox4 half-life was found to be less than 1 h as evident by inhibition of protein synthesis using cycloheximide. Ectopic expression of Sox4 deletion mutants revealed that the C-terminal 33 residues of Sox4 were critical in modulating its degradation in a polyubiquitin-independent manner. Syntenin, a Sox4 binding partner, associates with this domain and was found to stabilize Sox4 expression. Syntenin-induced stabilization of Sox4 correlated with Sox4-syntenin relocalization to the nucleus, where both proteins accumulate. Syntenin overexpression or knockdown in human tumor cell lines was found to reciprocally modulate Sox4 protein expression and transcriptional activity implicating its role as a regulator of Sox4. Taken together, our data demonstrate that the Sox4 C-terminal domain regulates polyubiquitin-independent proteasomal degradation of Sox4 that can be modulated by interaction with syntenin. As aberrant Sox4 expression has been found associated with many human cancers, modulation of Sox4 proteasomal degradation may impact oncogenesis and metastatic properties of tumors. Oncogene (2012) 31, 2668-2679; doi:10.1038/onc.2011.445; published online 10 October 2011	[Beekman, J. M.; van Vessem, M. E.; Vendelbosch, S.; Brugulat-Panes, A.; van Loosdregt, J.; Braat, A. K.; Coffer, P. J.] Univ Med Ctr Utrecht, Dept Immunol, NL-3584 EA Utrecht, Netherlands; [Beekman, J. M.; Vervoort, S. J.; Dekkers, F.; Coffer, P. J.] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Wilhelmina Childrens Hosp, NL-3584 EA Utrecht, Netherlands; [Vervoort, S. J.; Coffer, P. J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 EA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, KC 02-085-2,Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014; Coffer, Paul/AAF-7970-2020; Vervoort, Stephin/AAP-7854-2020	Beekman, Jeffrey M/0000-0003-4886-3756; van Loosdregt, Jorg/0000-0003-1411-3754; Vervoort, Stephin/0000-0001-7459-126X; Brugulat Panes, Anna/0000-0003-4102-1417				Asher G, 2006, ISR MED ASSOC J, V8, P229; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Beekman JM, 2009, BLOOD, V114, P3917, DOI 10.1182/blood-2009-03-208850; Beekman JM, 2004, P NATL ACAD SCI USA, V101, P10392, DOI 10.1073/pnas.0401217101; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fietta P, 2010, RIV BIOL-BIOL FORUM, V103, P29; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Hunt SMN, 1999, BIOL REPROD, V61, P476, DOI 10.1095/biolreprod61.2.476; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Kruger E, 2001, BIOCHIMIE, V83, P289, DOI 10.1016/S0300-9084(01)01241-X; Kwak J., 2010, BIOCHIM BIOPHYS ACTA, V1809, P88; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Malki S, 2010, INT J BIOCHEM CELL B, V42, P411, DOI 10.1016/j.biocel.2009.09.020; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Sarkar D, 2004, PHARMACOL THERAPEUT, V104, P101, DOI 10.1016/j.pharmthera.2004.08.004; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Ziegler EC, 2005, SCI STKE, V2005, P1	50	34	36	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	21					2668	2679		10.1038/onc.2011.445	http://dx.doi.org/10.1038/onc.2011.445			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21986941				2022-12-25	WOS:000304523500006
J	Shibata, T; Kimura, Y; Mukai, A; Mori, H; Ito, S; Asaka, Y; Oe, S; Tanaka, H; Takahashi, T; Uchida, K				Shibata, Takahiro; Kimura, Yuuki; Mukai, Akihiro; Mori, Hitoshi; Ito, Sohei; Asaka, Yukio; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi; Uchida, Koji			Transthiocarbamoylation of Proteins by Thiolated Isothiocyanates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; TRANSCRIPTION FACTOR; PANCREATIC-CANCER; GLUTATHIONE; SULFORAPHANE; APOPTOSIS; CELLS; IDENTIFICATION; METABOLITES; ACTIVATION	Isothiocyanates, membrane-permeable electrophiles that form adducts with thiols, have been suggested to have important medical benefits. Here we shed light on isothiocyanate-thiol conjugates and studied their electrophilic potential transferring an isothiocyanate moiety to cellular proteins. When we examined the effect of sulfhydryl molecules on cellular response induced by 6-methylsulfinylhexyl isothiocyanate (6-HITC), an analog of sulforaphane isolated from broccoli, we observed significant induction of heme oxygenase-1 by 6-HITC even in the presence of N-acetyl-L-cysteine or glutathione (GSH). In addition, the authentic 6-HITC-beta-mercaptoethanol (6-HITC-ME) conjugate markedly up-regulated the enzyme expression, suggesting the electrophilic potential of thiolated isothiocyanates. To gain a chemical insight into the cellular response induced by thiolated isothiocyanates, we studied the occurrence of transthiocarbamoylation of sulfhydryl molecules by 6-HITC-ME and observed that, upon incubation of 6-HITC-ME with GSH, a single product corresponding to the GSH conjugate of 6-HITC was generated. To test the functional ability of thiolated isothiocyanates to thiocarbamoylate proteins in living cells, we designed a novel probe, combining an isothiocyanate-reactive group and an alkyne functionality, and revealed that the transthiocarbamoylation of proteins occurred in the cells upon exposure to 6-HITC-ME. The target of thiocarbamoylation included heat shock protein 90 beta (Hsp90 beta), a chaperone ATPase of the Hsp90 family implicated in protein maturation and targeting. To identify the sites of the Hsp90 beta modification, we utilized nano-LC/MALDI-TOF MS/MS and suggested that a thiol group on the peptide containing Cys-521 reacted with 6-HITC, resulting in a covalent adduct in a 6-HITC-treated recombinant Hsp90 beta in vitro. The site-selective binding to Cys-521 was supported by in silico modeling. Further study on the thiocarbamoylation of Hsp90 beta suggested that the formation of 6-HITC-Hsp90 beta conjugate might cause activation of heat shock factor-1, rapidly signaling a potential heat shock response. These data suggest that thiolated isothiocyanates are an active metabolite that could contribute to cellular responses through transthiocarbamoylation of cellular proteins.	[Shibata, Takahiro; Kimura, Yuuki; Mukai, Akihiro; Mori, Hitoshi; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Asaka, Yukio; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan	Nagoya University; University of Shizuoka; Tokyo Institute of Technology	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan [20117007]	Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan (Grant 20117007, to K. U.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adams J, 2000, ONCOGENE, V19, P6687, DOI 10.1038/sj.onc.1204088; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Baillie T A, 1994, Adv Pharmacol, V27, P163, DOI 10.1016/S1054-3589(08)61032-7; BAILLIE TA, 1991, ACCOUNTS CHEM RES, V24, P264, DOI 10.1021/ar00009a003; BRUGGEMAN IM, 1986, TOXICOL APPL PHARM, V83, P349, DOI 10.1016/0041-008X(86)90312-1; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Depree JA, 1998, FOOD RES INT, V31, P329, DOI 10.1016/S0963-9969(98)00105-7; DIDOMENICO BJ, 1982, P NATL ACAD SCI-BIOL, V79, P6181, DOI 10.1073/pnas.79.20.6181; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEE HP, 1989, INT J CANCER, V43, P1007, DOI 10.1002/ijc.2910430609; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MEHTA RG, 1995, CARCINOGENESIS, V16, P399, DOI 10.1093/carcin/16.2.399; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Nakajima M, 2001, DRUG METAB DISPOS, V29, P1110; OLSEN GW, 1991, CANCER CAUSE CONTROL, V2, P291, DOI 10.1007/BF00051668; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; ZHENG GQ, 1992, J MED CHEM, V35, P185, DOI 10.1021/jm00079a025	45	38	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42150	42161		10.1074/jbc.M111.308049	http://dx.doi.org/10.1074/jbc.M111.308049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998322	Green Published, hybrid			2022-12-25	WOS:000298180900026
J	Dixit, A; Verkhivker, GM				Dixit, Anshuman; Verkhivker, Gennady M.			The Energy Landscape Analysis of Cancer Mutations in Protein Kinases	PLOS ONE			English	Article							C-TERMINAL TAIL; ALLOSTERIC TRANSITIONS; MOLECULAR-DYNAMICS; CONFORMATIONAL TRANSITIONS; CATALYTIC DOMAIN; ADENYLATE KINASE; EGF RECEPTOR; NORMAL-MODES; DIHYDROFOLATE-REDUCTASE; BIOLOGICAL NANOMACHINES	The growing interest in quantifying the molecular basis of protein kinase activation and allosteric regulation by cancer mutations has fueled computational studies of allosteric signaling in protein kinases. In the present study, we combined computer simulations and the energy landscape analysis of protein kinases to characterize the interplay between oncogenic mutations and locally frustrated sites as important catalysts of allostetric kinase activation. While structurally rigid kinase core constitutes a minimally frustrated hub of the catalytic domain, locally frustrated residue clusters, whose interaction networks are not energetically optimized, are prone to dynamic modulation and could enable allosteric conformational transitions. The results of this study have shown that the energy landscape effect of oncogenic mutations may be allosteric eliciting global changes in the spatial distribution of highly frustrated residues. We have found that mutation-induced allosteric signaling may involve a dynamic coupling between structurally rigid (minimally frustrated) and plastic (locally frustrated) clusters of residues. The presented study has demonstrated that activation cancer mutations may affect the thermodynamic equilibrium between kinase states by allosterically altering the distribution of locally frustrated sites and increasing the local frustration in the inactive form, while eliminating locally frustrated sites and restoring structural rigidity of the active form. The energy landsape analysis of protein kinases and the proposed role of locally frustrated sites in activation mechanisms may have useful implications for bioinformatics-based screening and detection of functional sites critical for allosteric regulation in complex biomolecular systems.	[Dixit, Anshuman] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Computat Sci, Orange, CA USA; [Verkhivker, Gennady M.] Chapman Univ, Crean Sch Hlth & Life Sci, Schmid Coll Sci & Technol, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Kansas; Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Dixit, A (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.	gverkhiv@ucsd.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	The University of Kansas	The University of Kansas	This work is partly supported by funding from The University of Kansas. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Banavali NK, 2007, PROTEINS, V67, P1096, DOI 10.1002/prot.21334; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutet Emmanuel, 2007, V406, P89; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129; Chen J, 2007, J MOL BIOL, V374, P250, DOI 10.1016/j.jmb.2007.08.047; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Dixit A, 2011, PLOS COMPUT IN PRESS; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dixit A, 2009, BIOPHYS J, V96, P858, DOI 10.1016/j.bpj.2008.10.041; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hyeon C, 2006, P NATL ACAD SCI USA, V103, P18939, DOI 10.1073/pnas.0608759103; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Isin B, 2008, BIOPHYS J, V95, P789, DOI 10.1529/biophysj.107.120691; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar S, 2000, PROTEIN SCI, V9, P10; Latzer J, 2008, BIOCHEMISTRY-US, V47, P2110, DOI 10.1021/bi701350v; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Li WF, 2011, P NATL ACAD SCI USA, V108, P3504, DOI 10.1073/pnas.1018983108; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Liu T, 2007, P NATL ACAD SCI USA, V104, P4347, DOI 10.1073/pnas.0607132104; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Ma L, 2007, J AM CHEM SOC, V129, P10261, DOI 10.1021/ja073059f; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mustafa M, 2011, PROTEINS, V79, P99, DOI 10.1002/prot.22862; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Onaran HO, 2009, CURR PROTEIN PEPT SC, V10, P110, DOI 10.2174/138920309787847644; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plotkin SS, 2002, Q REV BIOPHYS, V35, P205, DOI 10.1017/S0033583502003785; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sherry ST, 1999, GENOME RES, V9, P677; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Stan G, 2007, P NATL ACAD SCI USA, V104, P8803, DOI 10.1073/pnas.0700607104; Stenberg KAE, 2000, NUCLEIC ACIDS RES, V28, P369, DOI 10.1093/nar/28.1.369; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Whitford PC, 2008, HFSP J, V2, P61, DOI 10.2976/1.2894846; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360; Yanga S, 2008, EXP CELL RES, V314, P413, DOI 10.1016/j.yexcr.2007.09.002; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270; Zheng WJ, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-45; Zheng WJ, 2009, BIOPHYS J, V96, P2128, DOI [10.1016/j.bpj.2008.12.3897, 10.1016/j.bpj.200X.12.3X97]; Zheng WJ, 2009, CURR PROTEIN PEPT SC, V10, P128, DOI 10.2174/138920309787847608; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x; Zhou XB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-40; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928	171	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26071	10.1371/journal.pone.0026071	http://dx.doi.org/10.1371/journal.pone.0026071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998754	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700037
J	Italia, JL; Sharp, A; Carter, KC; Warn, P; Kumar, MNVR				Italia, Jagdishbhai L.; Sharp, Andrew; Carter, Katharine C.; Warn, Peter; Kumar, M. N. V. Ravi			Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome (R) or Fungizone (TM)	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; CELL TRANSPLANTATION; MURINE MODEL; THERAPY; FORMULATION; DIFFUSION	Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70-90%) in immunocompromised patients. Amphotericin B (AMB), a polyene antibiotic with broad spectrum antifungal activity appears to be a choice of treatment but is available only as an intravenous formulation; development of an oral formulation would be beneficial as well as economical. Methodology: Poly(lactide-co-glycolode) (PLGA) nanoparticles encapsulating AMB (AMB-NPs) were developed for oral administration. The AMB-NPs were 113 +/- 20 nm in size with similar to 70% entrapment efficiency at 30% AMB w/w of polymer. The in vivo therapeutic efficacy of oral AMB-NPs was evaluated in neutropenic murine models of disseminated and invasive pulmonary aspergillosis. AMB-NPs exhibited comparable or superior efficacy to that of Ambisome (R) or Fungizone (TM) administered parenterally indicating potential of NPs as carrier for oral delivery. Conclusions: The present investigation describes an efficient way of producing AMB-NPs with higher AMB pay-load and entrapment efficiency employing DMSO as solvent and ethanol as non-solvent. The developed oral formulation was highly efficacious in murine models of disseminated aspergillosis as well as an invasive pulmonary aspergillosis, which is refractory to treatment with IP Fungizone (TM) and responds only modestly to AmBisome (R).	[Italia, Jagdishbhai L.; Carter, Katharine C.; Kumar, M. N. V. Ravi] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Sharp, Andrew; Warn, Peter] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	University of Strathclyde; University of Manchester	Italia, JL (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	peter.warn@manchester.ac.uk; mnvrkumar@strath.ac.uk			University of Strathclyde	University of Strathclyde	The study was funded by startup funds from University of Strathclyde (www.strath.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann E, 1998, ADV DRUG DELIVER REV, V34, P171, DOI 10.1016/S0169-409X(98)00039-8; Annaloro C, 2009, J ANTIMICROB CHEMOTH, V63, P625, DOI 10.1093/jac/dkn549; Bhardwaj V, 2005, J BIOMED NANOTECHNOL, V1, P235, DOI 10.1166/jbn.2005.033; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Delmas G, 2002, ANTIMICROB AGENTS CH, V46, P2704, DOI 10.1128/AAC.46.8.2704-2707.2002; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Egger SS, 2010, BONE MARROW TRANSPL, V45, P1197, DOI 10.1038/bmt.2009.325; Erjavec Z, 2009, CLIN MICROBIOL INFEC, V15, P625, DOI 10.1111/j.1469-0691.2009.02929.x; Galindo-Rodriguez S, 2004, PHARM RES-DORDR, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Hirvonen J., 2002, AAPS PHARMSCITECH, V3, P52; Italia JL, 2009, PHARM RES-DORDR, V26, P1324, DOI 10.1007/s11095-009-9841-2; Kayser O, 2003, INT J PHARM, V254, P73, DOI 10.1016/S0378-5173(02)00686-5; Lehrnbecher T, 2010, J INFECTION, V61, P259, DOI 10.1016/j.jinf.2010.06.018; Murakami H, 2000, POWDER TECHNOL, V107, P137, DOI 10.1016/S0032-5910(99)00182-5; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Risovic V, 2007, DRUG DEV IND PHARM, V33, P703, DOI 10.1080/03639040601077349; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Singh UK, 2010, J TROP PEDIATRICS, V56, P321, DOI 10.1093/tropej/fmp132; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Warn PA, 2010, INT J ANTIMICROB AG, V35, P146, DOI 10.1016/j.ijantimicag.2009.09.029; Wasan EK, 2009, INT J PHARMACEUT, V372, P76, DOI 10.1016/j.ijpharm.2009.01.003; Xiong JY, 2005, J PHYS CHEM B, V109, P13877, DOI 10.1021/jp0446480	25	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25744	10.1371/journal.pone.0025744	http://dx.doi.org/10.1371/journal.pone.0025744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998690	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295968700017
J	Riedel, TJ; Johnson, LC; Knight, J; Hantgan, RR; Holmes, RP; Lowther, WT				Riedel, Travis J.; Johnson, Lynnette C.; Knight, John; Hantgan, Roy R.; Holmes, Ross P.; Lowther, W. Todd			Structural and Biochemical Studies of Human 4-hydroxy-2-oxoglutarate Aldolase: Implications for Hydroxyproline Metabolism in Primary Hyperoxaluria	PLOS ONE			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; CRYSTAL-STRUCTURE; QUATERNARY STRUCTURE; 2-KETO-4-HYDROXYGLUTARATE ALDOLASE; 4-HYDROXY-2-KETOGLUTARATE ALDOLASE; DIRECTED EVOLUTION; GLYOXYLATE; SUBSTRATE; OXALATE; ENZYME	Background: 4-hydroxy-2-oxoglutarate (HOG) aldolase is a unique enzyme in the hydroxyproline degradation pathway catalyzing the cleavage of HOG to pyruvate and glyoxylate. Mutations in this enzyme are believed to be associated with the excessive production of oxalate in primary hyperoxaluria type 3 (PH3), although no experimental data is available to support this hypothesis. Moreover, the identity, oligomeric state, enzymatic activity, and crystal structure of human HOGA have not been experimentally determined. Methodology/Principal Findings: In this study human HOGA (hHOGA) was identified by mass spectrometry of the mitochondrial enzyme purified from bovine kidney. hHOGA performs a retro-aldol cleavage reaction reminiscent of the trimeric 2-keto-3-deoxy-6-phosphogluconate aldolases. Sequence comparisons, however, show that HOGA is related to the tetrameric, bacterial dihydrodipicolinate synthases, but the reaction direction is reversed. The 1.97 A resolution crystal structure of hHOGA bound to pyruvate was determined and enabled the modeling of the HOG-Schiff base intermediate and the identification of active site residues. Kinetic analyses of site-directed mutants support the importance of Lys196 as the nucleophile, Tyr168 and Ser77 as components of a proton relay, and Asn78 and Ser198 as unique residues that facilitate substrate binding. Conclusions/Significance: The biochemical and structural data presented support that hHOGA utilizes a type I aldolase reaction mechanism, but employs novel residue interactions for substrate binding. A mapping of the PH3 mutations identifies potential rearrangements in either the active site or the tetrameric assembly that would likely cause a loss in activity. Altogether, these data establish a foundation to assess mutant forms of hHOGA and how their activity could be pharmacologically restored.	[Riedel, Travis J.; Johnson, Lynnette C.; Hantgan, Roy R.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Riedel, Travis J.; Johnson, Lynnette C.; Hantgan, Roy R.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Knight, John; Holmes, Ross P.] Wake Forest Sch Med, Div Urol, Dept Surg, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Riedel, TJ (corresponding author), Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA.	tlowther@wakehealth.edu	Knight, John/J-8739-2012	Knight, John/0000-0002-9683-8064; Holmes, Ross/0000-0002-8994-0159	The Oxalosis and Hyperoxaluria Foundation; National Institutes of Health [DK54468, DK73732, DK074945]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083527, R21DK074945, R01DK073732, R01DK054468] Funding Source: NIH RePORTER	The Oxalosis and Hyperoxaluria Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by The Oxalosis and Hyperoxaluria Foundation and the National Institutes of Health (Grants DK54468, DK73732 and DK074945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AISAKA K, 1991, BIOCHEM J, V276, P541, DOI 10.1042/bj2760541; ANDERSON M, 1985, ARCH BIOCHEM BIOPHYS, V236, P82, DOI 10.1016/0003-9861(85)90608-3; Belostotsky R, 2010, AM J HUM GENET, V87, P392, DOI 10.1016/j.ajhg.2010.07.023; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheriyan M, 2007, PROTEIN SCI, V16, P2368, DOI 10.1110/ps.073042907; Coulter-Mackie MB, 2006, KIDNEY INT, V70, P1891, DOI 10.1038/sj.ki.5001987; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DEKKER EE, 1992, J BIOL CHEM, V267, P10507; Devenish SRA, 2008, ACTA CRYSTALLOGR F, V64, P1092, DOI 10.1107/S1744309108033654; Dobson RCJ, 2005, BIOCHEMISTRY-US, V44, P13007, DOI 10.1021/bi051281w; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dobson RCJ, 2009, BIOCHIMIE, V91, P1036, DOI 10.1016/j.biochi.2009.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; GOLDSTONE A, 1962, J BIOL CHEM, V237, P3476; GRADY SR, 1981, BIOCHEMISTRY-US, V20, P2497, DOI 10.1021/bi00512a021; Griffiths JS, 2004, BIOORGAN MED CHEM, V12, P4067, DOI 10.1016/j.bmc.2004.05.034; Guo BBB, 2009, BIOCHEM BIOPH RES CO, V380, P802, DOI 10.1016/j.bbrc.2009.01.169; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kivirikko K I, 1970, Int Rev Connect Tissue Res, V5, P93; Knight J, 2006, KIDNEY INT, V70, P1929, DOI 10.1038/sj.ki.5001906; KOBES RD, 1966, BIOCHEM BIOPH RES CO, V25, P329, DOI 10.1016/0006-291X(66)90781-9; KRAMER DN, 1959, ANAL CHEM, V31, P250, DOI 10.1021/ac60146a028; Lawrence MC, 1997, J MOL BIOL, V266, P381, DOI 10.1006/jmbi.1996.0769; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; MAITRA U, 1963, J BIOL CHEM, V238, P3660; MAITRA U, 1964, J BIOL CHEM, V239, P1485; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monico CG, 2011, CLIN J AM SOC NEPHRO, V6, P2289, DOI 10.2215/CJN.02760311; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muscroft-Taylor AC, 2010, ARCH BIOCHEM BIOPHYS, V503, P202, DOI 10.1016/j.abb.2010.08.009; NEIMS AH, 1962, J BIOL CHEM, V237, pP976; Pauluhn A, 2008, PROTEINS, V72, P35, DOI 10.1002/prot.21890; Pearce FG, 2008, BIOCHEMISTRY-US, V47, P12108, DOI 10.1021/bi801094t; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phang J. M., 2001, METABOLIC MOL BASES, P1821; Poore RE, 1997, AM J PHYSIOL-CELL PH, V272, pC289, DOI 10.1152/ajpcell.1997.272.1.C289; ROSSO RG, 1967, J BIOL CHEM, V242, P5524; RUFFO A, 1962, BIOCHEM J, V85, P588, DOI 10.1042/bj0850588; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; SCHOLTZ JM, 1984, BIOORG CHEM, V12, P229, DOI 10.1016/0045-2068(84)90006-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; VALLE D, 1979, J CLIN INVEST, V64, P1365, DOI 10.1172/JCI109593; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walters MJ, 2008, BIOORGAN MED CHEM, V16, P710, DOI 10.1016/j.bmc.2007.10.043; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4	58	42	45	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26021	10.1371/journal.pone.0026021	http://dx.doi.org/10.1371/journal.pone.0026021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998747	gold, Green Published, Green Submitted			2022-12-25	WOS:000295968700032
J	Deraz, EM; Kudo, Y; Yoshida, M; Obayashi, M; Tsunematsu, T; Tani, H; Siriwardena, SBSM; Kiekhaee, MR; Qi, GY; Iizuka, S; Ogawa, I; Campisi, G; Lo Muzio, L; Abiko, Y; Kikuchi, A; Takata, T				Deraz, Elsayed Mohamed; Kudo, Yasusei; Yoshida, Maki; Obayashi, Mariko; Tsunematsu, Takaaki; Tani, Hirotaka; Siriwardena, Samadarani B. S. M.; Kiekhaee, Mohammad Reza; Qi, Guangying; Iizuka, Shinji; Ogawa, Ikuko; Campisi, Giuseppina; Lo Muzio, Lorenzo; Abiko, Yoshimitsu; Kikuchi, Akira; Takata, Takashi			MMP-10/Stromelysin-2 Promotes Invasion of Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; MATRIX METALLOPROTEINASES; ORAL-CANCER; GASTRIC-CANCER; EXPRESSION; WNT5A; PERIOSTIN; TARGET; GENES	Background: Periostin, IFN-induced transmembrane protein 1 (IFITM1) and Wingless-type MMTV integration site family, member 5B (Wnt-5b) were previously identified as the invasion promoted genes of head and neck squamous cell carcinoma (HNSCC) by comparing the gene expression profiles between parent and a highly invasive clone. We have previously reported that Periostin and IFITM1 promoted the invasion of HNSCC cells. Here we demonstrated that Wnt-5b overexpression promoted the invasion of HNSCC cells. Moreover, stromelysin-2 (matrix metalloproteinase-10; MMP-10) was identified as a common up-regulated gene among Periostin, IFITM1 and Wnt-5b overexpressing HNSCC cells by using microarray data sets. In this study, we investigated the roles of MMP-10 in the invasion of HNSCC. Methods and Findings: We examined the expression of MMP-10 in HNSCC cases by immunohistochemistry. High expression of MMP-10 was frequently observed and was significantly correlated with the invasiveness and metastasis in HNSCC cases. Next, we examined the roles of MMP-10 in the invasion of HNSCC cells in vitro. Ectopic overexpression of MMP-10 promoted the invasion of HNSCC cells, and knockdown of MMP-10 suppressed the invasion of HNSCC cells. Moreover, MMP-10 knockdown suppressed Periostin and Wnt-5b-promoted invasion. Interestingly, MMP-10 overexpression induced the decreased p38 activity and MMP-10 knockdown induced the increased p38 activity. In addition, treatment with a p38 inhibitor SB203580 in HNSCC cells inhibited the invasion. Conclusions: These results suggest that MMP-10 plays an important role in the invasion and metastasis of HNSCC, and that invasion driven by MMP-10 is partially associated with p38 MAPK inhibition. We suggest that MMP-10 can be used as a marker for prediction of metastasis in HNSCC.	[Deraz, Elsayed Mohamed; Kudo, Yasusei; Yoshida, Maki; Obayashi, Mariko; Tsunematsu, Takaaki; Tani, Hirotaka; Siriwardena, Samadarani B. S. M.; Kiekhaee, Mohammad Reza; Qi, Guangying; Iizuka, Shinji; Takata, Takashi] Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Campisi, Giuseppina] Univ Palermo, Dept Stomatol Sci, Palermo, Italy; [Lo Muzio, Lorenzo] Univ Foggia, Dept Surg Sci, Foggia, Italy; [Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Dept Biochem, Tokyo, Japan; [Takata, Takashi] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka, Japan	Hiroshima University; Hiroshima University; University of Palermo; University of Foggia; Nihon University; Osaka University	Deraz, EM (corresponding author), Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Muzio, Lorenzo Lo/C-8533-2011	Muzio, Lorenzo Lo/0000-0003-4633-4893; Kudo, Yasusei/0000-0002-0392-7720; campisi, giuseppina/0000-0002-9443-0495	Ministry of Education, Science and Culture of Japan; Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research [23659858] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was funded in part by the Ministry of Education, Science and Culture of Japan grants-in-aid (Y. Kudo and T. Takata) and Kurozumi Memorial Foundation grant (Y. Kudo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Han X, 2002, CONNECT TISSUE RES, V43, P63; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Hickson JA, 2006, CANCER RES, V66, P2264, DOI 10.1158/0008-5472.CAN-05-3676; Howell GMS, 2005, HEAD NECK-J SCI SPEC, V27, P710, DOI 10.1002/hed.20222; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; JACOBSSON PA, 1973, ACTA RADIOL THER PHY, V12, P1; Japan Society for Head and Neck Cancer, 2005, GEN RUL CLIN PATH ST; Kawata R, 2002, ACTA OTO-LARYNGOL, V122, P101, DOI 10.1080/00016480252775823; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Kudo Y, 2003, ORAL ONCOL, V39, P515, DOI 10.1016/S1368-8375(03)00015-0; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Madlener H, 1997, GENE, V202, P75, DOI 10.1016/S0378-1119(97)00456-3; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neville BW, 1995, EPITHELIAL PTHOLOGY, P295; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; SAARIALHOKERE UK, 1994, J CLIN INVEST, V94, P79, DOI 10.1172/JCI117351; Saitoh T, 2002, INT J MOL MED, V10, P345; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; STOCKER W, 1995, PROTEIN SCI, V4, P823; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yen CY, 2009, BIOMARKERS, V14, P244, DOI 10.1080/13547500902829375	45	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25438	10.1371/journal.pone.0025438	http://dx.doi.org/10.1371/journal.pone.0025438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998657	Green Published, gold			2022-12-25	WOS:000295966900026
J	Pan, N; Jiang, W; Sun, H; Miao, FQ; Qiu, J; Jin, H; Xu, JH; Shi, Q; Xie, W; Zhang, JQ				Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Qiu, Jie; Jin, Hui; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong			KIR and HLA Loci Are Associated with Hepatocellular Carcinoma Development in Patients with Hepatitis B Virus Infection: A Case-Control Study	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTOR; MHC CLASS-I; INHIBITORY RECEPTORS; TRANSGENIC MICE; LIVER-INJURY; RECOGNITION; GENE; GENOTYPES; KIR2DS4	Background: Natural killer (NK) cells activation has been reported to contribute to inflammation and liver injury during hepatitis B virus (HBV) infection both in transgenic mice and in patients. However, the role of NK cells in the process of HBV-associated hepatocellular carcinoma (HCC) development has not been addressed. Killer cell immunoglobulin-like receptors (KIRs) are involved in regulating NK cell activation through recognition of specific human leukocyte antigen (HLA) class I allotypes. Methodology/Principal Findings: To investigate whether KIR and HLA genes could influence the risk of HBV-associated HCC development, 144 HBV-infected patients with HCC and 189 well-matched HBV infectors with chronic hepatitis or cirrhosis as non-HCC controls were enrolled in this study. The presence of 12 loci of KIR was detected individually. HLA-A, -B, -C loci were genotyped with high-resolution. HLA-C group 1 homozygote (OR = 2.02; p= 0.005), HLA-Bw4-80I (OR = 2.67; p = 2.0E-04) and combination of full-length form and 22 bp-deleted form of KIR2DS4 (KIR2DS4/1D) (OR = 1.89; p = 0.017) were found associated with HCC incidence. When the combined effects of these three genetic factors were evaluated, more risk factors were observed correlating with higher odds ratios for HCC incidence (P trend = 7.4E-05). Because all the risk factors we found have been reported to result in high NK cell functional potential by previous studies, our observations suggest that NK cell activation may contribute to HBV-associated HCC development. Conclusions/Significance: In conclusion, this study has identified significant associations that suggest an important role for NK cells in HCC incidence in HBV-infected patients. Our study is useful for HCC surveillance and has implications for novel personalized therapy strategy development aiming at HCC prevention in HBV-infected patients.	[Pan, Ning; Miao, Fengqin; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Sch Med, Dept Immunol & Pathogen Biol, Nanjing, Jiangsu Provinc, Peoples R China; [Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Qiu, Jie; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Inst Life Sci, Nanjing, Jiangsu Provinc, Peoples R China; [Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Sch Med, Dept Med Genet, Nanjing, Jiangsu Provinc, Peoples R China; [Jin, Hui] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu Provinc, Peoples R China; [Qiu, Jie] Southeast Univ, Affiliated Hosp 2, Nanjing, Jiangsu Provinc, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Zhang, JQ (corresponding author), Southeast Univ, Sch Med, Dept Immunol & Pathogen Biol, Nanjing, Jiangsu Provinc, Peoples R China.	wei.xie@seu.edu.cn; zhjq@seu.edu.cn	JIN, HUI/AAA-8732-2019; Jin, Hui/GXG-2296-2022	Pan, Ning/0000-0001-8795-6926; Jiang, Wei/0000-0002-6119-3331	National Natural Science Foundation [30571703]; National Natural Science Foundation for Distinguished Young Scholars of China [30325017]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work is funded by National Natural Science Foundation (30571703) and National Natural Science Foundation for Distinguished Young Scholars of China (30325017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen YY, 2007, J HEPATOL, V47, P183, DOI 10.1016/j.jhep.2007.02.020; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn Paul P J, 2003, Methods Mol Biol, V210, P191; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Jiang W, 2008, TISSUE ANTIGENS, V71, P479, DOI 10.1111/j.1399-0039.2008.01028.x; Kafrouni MI, 2001, J IMMUNOL, V167, P1566, DOI 10.4049/jimmunol.167.3.1566; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Katz G, 2004, J IMMUNOL, V173, P1819, DOI 10.4049/jimmunol.173.3.1819; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kovacic MB, 2005, CANCER EPIDEM BIOMAR, V14, P2673, DOI 10.1158/1055-9965.EPI-05-0229; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Miao F, 2010, TISSUE ANTIGENS, V75, P737, DOI 10.1111/j.1399-0039.2010.01456.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Rani M, 2009, B WORLD HEALTH ORGAN, V87, P707, DOI 10.2471/BLT.08.059220; Shamliyan TA, 2009, ANN INTERN MED, V150, P111, DOI 10.7326/0003-4819-150-2-200901200-00101; Stern M, 2008, BLOOD, V112, P708, DOI 10.1182/blood-2008-02-137521; Winter CC, 1998, J IMMUNOL, V161, P571; Yao GB, 1996, GUT, V38, pS39, DOI 10.1136/gut.38.Suppl_2.S39; Yin Xiao-lin, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1416; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	44	35	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25682	10.1371/journal.pone.0025682	http://dx.doi.org/10.1371/journal.pone.0025682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998681	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900044
J	Sharlow, ER; Wilson, GM; Close, D; Leimgruber, S; Tandon, M; Reed, RB; Shun, TY; Wang, QJ; Wipf, P; Lazo, JS				Sharlow, Elizabeth R.; Wilson, Gabriela Mustata; Close, David; Leimgruber, Stephanie; Tandon, Manuj; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane; Wipf, Peter; Lazo, John S.			Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity	PLOS ONE			English	Article							PROTEIN-KINASE-D; ENDOTHELIAL-CELLS; C-MU; GROWTH; CANCER; POTENT; DISEASE; D2; PHOSPHORYLATION; IMPLEMENTATION	Protein kinase D (PKD) is a novel family of serine/threonine kinases regulated by diacylglycerol, which is involved in multiple cellular processes and various pathological conditions. The limited number of cell-active, selective inhibitors has historically restricted biochemical and pharmacological studies of PKD. We now markedly expand the PKD1 inhibitory chemotype inventory with eleven additional novel small molecule PKD1 inhibitors derived from our high throughput screening campaigns. The in vitro IC(50)s for these eleven compounds ranged in potency from 0.4 to 6.1 mu M with all of the evaluated compounds being competitive with ATP. Three of the inhibitors (CID 1893668, (1Z)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one; CID 2011756, 5-(3-chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide; CID 5389142, (6Z)-6-[4-(3-aminopropylamino)-6-methyl-1H-pyrimidin-2-ylidene]cyclohexa-2,4-dien-1-one) inhibited phorbol ester-induced endogenous PKD1 activation in LNCaP prostate cancer cells in a concentration-dependent manner. The specificity of these compounds for PKD1 inhibitory activity was supported by kinase assay counter screens as well as by bioinformatics searches. Moreover, computational analyses of these novel cell-active PKD1 inhibitors indicated that they were structurally distinct from the previously described cell-active PKD1 inhibitors while computational docking of the new cell-active compounds in a highly conserved ATP-binding cleft suggests opportunities for structural modification. In summary, we have discovered novel PKD1 inhibitors with in vitro and cell-based inhibitory activity, thus successfully expanding the structural diversity of small molecule inhibitors available for this important pharmacological target.	[Sharlow, Elizabeth R.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lazo, John S.] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Wilson, Gabriela Mustata] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Wilson, Gabriela Mustata; Close, David; Leimgruber, Stephanie; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane; Wipf, Peter] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Close, David; Leimgruber, Stephanie; Tandon, Manuj; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sharlow, ER (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	ers7g@virginia.edu	Wipf, Peter/AAG-1771-2021; Reed, Robyn/P-4381-2014; Mustata Wilson, Gabriela/GPW-8746-2022; Wang, Qiming Jane/B-6064-2012	Wipf, Peter/0000-0001-7693-5863; Reed, Robyn/0000-0003-2141-0490; Mustata Wilson, Gabriela/0000-0003-3090-9242; Wang, Qiming Jane/0000-0002-9502-4851	National Institutes of Health [R03DA24898, R01CA142580, R01CA129127, U54MH074411]; Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE [R01CA129127, R01CA142580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants R03DA24898, R01CA142580, R01CA129127 and U54MH074411 as well as the Fiske Drug Discovery Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Besirli CG, 2006, J NEUROCHEM, V99, P218, DOI 10.1111/j.1471-4159.2006.04116.x; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2008, NAT PROTOC, V3, P1350, DOI 10.1038/nprot.2008.111; Sharlow ER, 2007, ASSAY DRUG DEV TECHN, V5, P723, DOI 10.1089/adt.2007.102; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Thrower EC, 2011, AM J PHYSIOL-GASTR L, V300, pG120, DOI 10.1152/ajpgi.00300.2010; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003	37	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25134	10.1371/journal.pone.0025134	http://dx.doi.org/10.1371/journal.pone.0025134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998636	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295966900009
J	Kozubowski, L; Thompson, JW; Cardenas, ME; Moseley, MA; Heitman, J				Kozubowski, Lukasz; Thompson, J. Will; Cardenas, Maria E.; Moseley, M. Arthur; Heitman, Joseph			Association of Calcineurin with the COPI Protein Sec28 and the COPII Protein Sec13 Revealed by Quantitative Proteomics	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; CRYPTOCOCCUS-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; HEAT-STRESS; GLUTAMATE-DEHYDROGENASE; CANDIDA-ALBICANS; GENE-EXPRESSION; LATE GOLGI	Calcineurin is a calcium-calmodulin-dependent serine/threonine specific protein phosphatase operating in key cellular processes governing responses to extracellular cues. Calcineurin is essential for growth at high temperature and virulence of the human fungal pathogen Cryptococcus neoformans but the underlying mechanism is unknown. We performed a mass spectrometry analysis to identify proteins that associate with the calcineurin A catalytic subunit (Cna1) in C. neoformans cells grown under non-stress and high temperature stress conditions. A novel prioritization strategy for mass spectrometry data from immunoprecipitation experiments identified putative substrates and proteins potentially operating with calcineurin in common pathways. Cna1 co-purified with proteins involved in membrane trafficking including the COPI component Sec28 and the COPII component Sec13. The association of Cna1 with Sec28 and Sec13 was confirmed by co-immunoprecipitation. Cna1 exhibited a dramatic change in subcellular localization during high temperature stress from diffuse cytoplasmic to ER-associated puncta and the mother-bud neck and co-localized with Sec28 and Sec13.	[Kozubowski, Lukasz; Cardenas, Maria E.; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Thompson, J. Will; Moseley, M. Arthur] Duke Univ, Duke Prote Core Facil, Med Ctr, Durham, NC USA	Duke University; Duke University	Kozubowski, L (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.	Lukasz.kozubowski@duke.edu	Heitman, Joseph/ABC-6006-2021		National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01 AI42159]; NATIONAL CANCER INSTITUTE [R01CA154499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042159, R01AI050438] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institutes of Health/National Institute of Allergy and Infectious Diseases R01 AI42159 grant (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Bartz R, 2008, EMBO J, V27, P948, DOI 10.1038/emboj.2008.36; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Fox DS, 2001, MOL MICROBIOL, V39, P835, DOI 10.1046/j.1365-2958.2001.02295.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; HEMENWAY CS, 1995, GENETICS, V141, P833; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; KHALEKUMAR A, 1993, J BACTERIOL, V175, P6052, DOI 10.1128/JB.175.18.6052-6055.1993; KMETZSCH L, EUKARYOT CELL, V9, P1798; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; PETERS J, 1979, J BACTERIOL, V137, P1134, DOI 10.1128/JB.137.3.1134-1139.1979; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; SONG HO, MOL CELLS, V30, P255; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; SUN T, J NEUROSCI, V30, P11838; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; Tokheim AM, 2006, PROTEINS, V64, P28, DOI 10.1002/prot.20996; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vermeulen M, 2008, CURR OPIN BIOTECH, V19, P331, DOI 10.1016/j.copbio.2008.06.001; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WEST M, J CELL BIOL, V193, P333; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001	64	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25280	10.1371/journal.pone.0025280	http://dx.doi.org/10.1371/journal.pone.0025280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984910	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000021
J	Veninga, H; Hoek, RM; de Vos, AF; de Bruin, AM; An, FQ; van der Poll, T; van Lier, RAW; Medof, ME; Hamann, J				Veninga, Henrike; Hoek, Robert M.; de Vos, Alex F.; de Bruin, Alex M.; An, Feng-Qi; van der Poll, Tom; van Lier, Rene A. W.; Medof, M. Edward; Hamann, Jorg			A Novel Role for CD55 in Granulocyte Homeostasis and Anti-Bacterial Host Defense	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; TRANSMEMBRANE RECEPTOR CD97; T-CELL IMMUNITY; BONE-MARROW; MOUSE CD97; C. ELEGANS; FACTOR DAF; COMPLEMENT; MICE; SUSCEPTIBILITY	Background: In addition to its complement-regulating activity, CD55 is a ligand of the adhesion class G protein-coupled receptor CD97; however, the relevance of this interaction has remained elusive. We previously showed that mice lacking a functional CD97 gene have increased numbers of granulocytes. Methodology/Results: Here, we demonstrate that CD55-deficient mice display a comparable phenotype with about two-fold more circulating granulocytes in the blood stream, the marginated pool, and the spleen. This granulocytosis was independent of increased complement activity. Augmented numbers of Gr-1-positive cells in cell cycle in the bone marrow indicated a higher granulopoietic activity in mice lacking either CD55 or CD97. Concomitant with the increase in blood granulocyte numbers, Cd55(-/-) mice challenged with the respiratory pathogen Streptococcus pneumoniae developed less bacteremia and died later after infection. Conclusions: Collectively, these data suggest that complement-independent interaction of CD55 with CD97 is functionally relevant and involved in granulocyte homeostasis and host defense.	[Veninga, Henrike; Hoek, Robert M.; de Bruin, Alex M.; van Lier, Rene A. W.; Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [An, Feng-Qi; Medof, M. Edward] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Case Western Reserve University	Veninga, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.veninga@vumc.nl		Hamann, Jorg/0000-0002-9448-1727; van Lier, Rene/0000-0002-3201-7144; Veninga, Henrike/0000-0001-8731-0615	Netherlands Organization for Scientific Research (NWO) [814.02.012]; Landsteiner Foundation for Bloodtransfusion Research (LSBR) [0310]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Bloodtransfusion Research (LSBR)	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO 814.02.012) and the Landsteiner Foundation for Bloodtransfusion Research (LSBR 0310) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Gray JX, 1996, J IMMUNOL, V157, P5438; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hoek RM, 2010, ARTHRITIS RHEUM-US, V62, P1036, DOI 10.1002/art.27347; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; Lea S, 2002, BIOCHEM SOC T, V30, P1014, DOI 10.1042/bst0301014; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Li L, 2001, BRIT J CANCER, V84, P80, DOI 10.1054/bjoc.2000.1570; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lin F, 2002, J CLIN INVEST, V110, P1269, DOI 10.1172/JCI200216086; Lin F, 2001, IMMUNOLOGY, V104, P215, DOI 10.1046/j.1365-2567.2001.01287.x; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; NICHOLSONWELLER A, 1994, J LAB CLIN MED, V123, P485; Perianayagam MC, 2004, EUR J CLIN INVEST, V34, P50, DOI 10.1111/j.1365-2362.2004.01273.x; Qian YM, 1999, IMMUNOLOGY, V98, P303; Sogabe H, 2001, J IMMUNOL, V167, P2791, DOI 10.4049/jimmunol.167.5.2791; Steimel A, 2010, DEVELOPMENT, V137, P3663, DOI 10.1242/dev.054320; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; TERSTAPPEN LWMM, 1992, J LEUKOCYTE BIOL, V52, P652, DOI 10.1002/jlb.52.6.652; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; van Pel M, 2008, HAEMATOL-HEMATOL J, V93, P1137, DOI 10.3324/haematol.12838; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Wang T, 2007, INFECT IMMUN, V75, P1144, DOI 10.1128/IAI.00869-06; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24431	10.1371/journal.pone.0024431	http://dx.doi.org/10.1371/journal.pone.0024431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984892	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000002
J	Willis, C; Wang, CK; Osman, A; Simon, A; Pickering, D; Mulvenna, J; Riboldi-Tunicliffe, A; Jones, MK; Loukas, A; Hofmann, A				Willis, Charlene; Wang, Conan K.; Osman, Asiah; Simon, Anne; Pickering, Darren; Mulvenna, Jason; Riboldi-Tunicliffe, Alan; Jones, Malcolm K.; Loukas, Alex; Hofmann, Andreas			Insights into the Membrane Interactions of the Saposin-Like Proteins Na-SLP-1 and Ac-SLP-1 from Human and Dog Hookworm	PLOS ONE			English	Article							NK-LYSIN; ANCYLOSTOMA-CANINUM; CRYSTAL-STRUCTURE; LIPID-BINDING; ENTAMOEBA-HISTOLYTICA; DEGRADATION; GRANULYSIN; PEPTIDES	Saposin-like proteins (SAPLIPs) from soil-transmitted helminths play pivotal roles in host-pathogen interactions and have a high potential as targets for vaccination against parasitic diseases. We have identified two non-orthologous SAPLIPs from human and dog hookworm, Na-SLP-1 and Ac-SLP-1, and solved their three-dimensional crystal structures. Both proteins share the property of membrane binding as monitored by liposome co-pelleting assays and monolayer adsorption. Neither SAPLIP displayed any significant haemolytic or bactericidal activity. Based on the structural information, as well as the results from monolayer adsorption, we propose models of membrane interactions for both SAPLIPs. Initial membrane contact of the monomeric Na-SLP-1 is most likely by electrostatic interactions between the membrane surface and a prominent basic surface patch. In case of the dimeric Ac-SLP-1, membrane interactions are most likely initiated by a unique tryptophan residue that has previously been implicated in membrane interactions in other SAPLIPs.	[Willis, Charlene; Jones, Malcolm K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Wang, Conan K.; Osman, Asiah; Hofmann, Andreas] Griffith Univ, Struct Chem Program, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Simon, Anne] Univ Lyon 1, CNRS, ICBMS, UMR 5246, F-69622 Villeurbanne, France; [Pickering, Darren; Mulvenna, Jason; Loukas, Alex] James Cook Univ, Cairns, Qld, Australia; [Riboldi-Tunicliffe, Alan] Australian Synchrotron, Clayton, Vic, Australia; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Hofmann, Andreas] Univ Melbourne, Dept Vet Sci, Melbourne, Vic 3010, Australia; [Loukas, Alex; Hofmann, Andreas] Queensland Trop Hlth Alliance, Townsville, Qld, Australia	QIMR Berghofer Medical Research Institute; Griffith University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; James Cook University; University of Queensland; University of Melbourne	Willis, C (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	a.hofmann@griffith.edu.au	Loukas, Alex/B-7355-2014; Wang, Conan K/D-1481-2010; Osman, Asiah/AAK-5173-2021; SIMON, Anne/D-6046-2011; Hofmann, Andreas/B-9515-2008; Mulvenna, Jason/H-7110-2014; Willis, Charlene/U-1344-2017; Jones, Malcolm K/A-1097-2009; Hofmann, Andreas/M-9870-2019	Loukas, Alex/0000-0002-0896-8441; Wang, Conan K/0000-0002-7973-7632; Hofmann, Andreas/0000-0003-4408-5467; Mulvenna, Jason/0000-0003-3521-8061; Jones, Malcolm K/0000-0002-0035-6141; Hofmann, Andreas/0000-0003-4408-5467	Rebecca L. Cooper Foundation; James Kirby Foundation (AH); National Health & Medical Research Counci	Rebecca L. Cooper Foundation; James Kirby Foundation (AH); National Health & Medical Research Counci	The support from the Australian Synchrotron in form of beam time is gratefully acknowledged. The authors are further grateful for partial support of this study by the Rebecca L. Cooper Foundation and the James Kirby Foundation (AH). C. Willis and C. Wang are National Health and Medical Research Council (NHMRC) Postdoctoral Fellows. AL is an NHMRC Senior Research Fellow. Funding support was from an National Health & Medical Research Council program grant awarded to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; Andreu D, 1999, BIOCHEM J, V344, P845, DOI 10.1042/0264-6021:3440845; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Braunewell KH, 2010, AUST J CHEM, V63, P350, DOI 10.1071/CH09355; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bruhn H, 2001, BBA-BIOMEMBRANES, V1514, P14, DOI 10.1016/S0005-2736(01)00345-5; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; de Silva A, 2003, AM J CLIN NUTR, V77, P234, DOI 10.1093/ajcn/77.1.234; DELANO, 2002, W PYMOL MOL GRAPHICS; Don TA, 2007, PARASITOLOGY, V134, P427, DOI 10.1017/S003118200600148X; Don TA, 2004, INT J PARASITOL, V34, P1029, DOI 10.1016/j.ijpara.2004.04.013; Espino AM, 2004, J PARASITOL, V90, P876, DOI 10.1645/GE-215R; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Hofmann A, 2003, METHOD ENZYMOL, V372, P186; Hofmann A, 2002, BIOINFORMATICS, V18, P209, DOI 10.1093/bioinformatics/18.1.209; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2002, BIOCHEM BIOPH RES CO, V296, P1238, DOI 10.1016/S0006-291X(02)02062-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Piatigorsky J, 2001, P NATL ACAD SCI USA, V98, P12362, DOI 10.1073/pnas.231310698; QI XY, 1994, J BIOL CHEM, V269, P16746; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Ranjit N, 2006, INT J PARASITOL, V36, P701, DOI 10.1016/j.ijpara.2006.01.015; Rasband W., 2005, IMAGEJ VERSION 1 30; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; Ruysschaert JM, 1998, FEBS LETT, V425, P341, DOI 10.1016/S0014-5793(98)00261-0; Sandhoff K, 1996, TRENDS CELL BIOL, V6, P98, DOI 10.1016/0962-8924(96)80999-8; Torres D, 2006, INFECT IMMUN, V74, P4932, DOI 10.1128/IAI.00442-06; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104	48	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25369	10.1371/journal.pone.0025369	http://dx.doi.org/10.1371/journal.pone.0025369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991310	Green Published, Green Accepted, gold			2022-12-25	WOS:000295943000027
J	Basile, KJ; Abel, EV; Aplin, AE				Basile, K. J.; Abel, E. V.; Aplin, A. E.			Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells	ONCOGENE			English	Article						RAF inhibitor; ERK1/2; FOXD3; chemotherapeutic resistance	BRAF MUTATIONS; NEURAL CREST; SELF-RENEWAL; STEM-CELLS; KINASE; CANCER; INHIBITION; PLURIPOTENCY; REQUIREMENT; APOPTOSIS	Melanoma cells driven by mutant v-raf murine sarcoma viral oncogene homolog B1 (B-RAF) are highly resistant to chemotherapeutic treatments. Recent phase 1 results with PLX4032/RG7204/vemurafenib, which selectively inhibits B-RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)1/2 signaling in mutant B-RAF cells, has given encouragement to this struggling field. Nearly all patients in the phase 1-3 studies saw at least some response and the overall response rates ranged from 48 and 81%. However, despite initial tumor shrinkage, most responders in the trial experienced tumor relapse over time. These findings indicate that both intrinsic and acquired resistance may affect the clinical efficacy of PLX4032. It is critical to optimize PLX4032 activity to improve response rates and understand why some patients with the B-RAF mutation do not respond. We have previously shown that the stemness factor, Forkhead box D3 (FOXD3), is upregulated following inhibition of B-RAF-MEK signaling in mutant B-RAF melanoma cells. Here, we show that upregulation of FOXD3 following treatment with PLX4032 and PLX4720 (the non-clinical tool compound for PLX4032) confers resistance to cell death. Small interfering RNA-mediated knockdown of FOXD3 significantly enhanced the cell death response after PLX4032/4720 treatment in mutant B-RAF melanoma cell lines. Additionally, upregulation of FOXD3 after PLX4720 treatment was attenuated in non-adherent conditions and correlated with enhanced cell death. Ectopic expression of FOXD3 in non-adherent cells significantly reduced cell death in response to PLX4720 treatment. Together, these data indicate that upregulation of FOXD3 is an adaptive response to RAF inhibitors that promotes a state of drug resistance. Oncogene (2012) 31, 2471-2479; doi: 10.1038/onc.2011.424; published online 26 September 2011	[Basile, K. J.; Abel, E. V.; Aplin, A. E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Aplin, A. E.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Aplin, AE (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, 233 S 10th St,BLSB 524, Philadelphia, PA 19107 USA.	Andrew.Aplin@KimmelCancerCenter.Org			National Institutes of Health [GM067893, CA125103]; American Cancer Society [RSG-08-03-01-CSM]; Joanna M Nicolay Melanoma Foundation; National Cancer Institute [1P30CA56036]; NATIONAL CANCER INSTITUTE [R01CA160495, P30CA056036, R01CA125103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Joanna M Nicolay Melanoma Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Gideon Bollag (Plexxikon, Berkeley, CA, USA) for providing PLX4720, Dr Meenhard Herlyn (Wistar Institute, Philadelphia, PA, USA) for WM melanoma cell lines, and Dr Fred Kaplan for critical comments on this paper. This work was supported by National Institutes of Health (GM067893, CA125103), American Cancer Society (RSG-08-03-01-CSM) and a Joanna M Nicolay Melanoma Foundation scholarship. The Kimmel Cancer Center is supported by National Cancer Institute Support Grant 1P30CA56036.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Aplin AE, 2011, J INVEST DERMATOL, V131, P1817, DOI 10.1038/jid.2011.147; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Ribas A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8509; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smalley KSM, 2010, NEW ENGL J MED, V363, P876, DOI 10.1056/NEJMe1005370; Sutton J, 1996, J BIOL CHEM, V271, P23126, DOI 10.1074/jbc.271.38.23126; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665	33	48	48	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2471	2479		10.1038/onc.2011.424	http://dx.doi.org/10.1038/onc.2011.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996740	Green Accepted			2022-12-25	WOS:000303985300009
J	Clunes, LA; Davies, CM; Coakley, RD; Aleksandrov, AA; Henderson, AG; Zeman, KL; Worthington, EN; Gentzsch, M; Kreda, SM; Cholon, D; Bennett, WD; Riordan, JR; Boucher, RC; Tarran, R				Clunes, Lucy A.; Davies, Catrin M.; Coakley, Raymond D.; Aleksandrov, Andrei A.; Henderson, Ashley G.; Zeman, Kirby L.; Worthington, Erin N.; Gentzsch, Martina; Kreda, Silvia M.; Cholon, Deborah; Bennett, William D.; Riordan, John R.; Boucher, Richard C.; Tarran, Robert			Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration	FASEB JOURNAL			English	Article						aggresome; chronic bronchitis; ion channel; lung disease	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOCYTIC TRAFFICKING; AGGRESOME FORMATION; MUCUS CLEARANCE; IN-VITRO; PROTEASOME; INFLAMMATION; DEGRADATION; VIVO	Cigarette smoke (CS) exposure induces mucus obstruction and the development of chronic bronchitis (CB). While many of these responses are determined genetically, little is known about the effects CS can exert on pulmonary epithelia at the protein level. We, therefore, tested the hypothesis that CS exerts direct effects on the CFTR protein, which could impair airway hydration, leading to the mucus stasis characteristic of both cystic fibrosis and CB. In vivo and in vitro studies demonstrated that CS rapidly decreased CFTR activity, leading to airway surface liquid (ASL) volume depletion (i.e., dehydration). Further studies revealed that CS induced internalization of CFTR. Surprisingly, CS-internalized CFTR did not colocalize with lysosomal proteins. Instead, the bulk of CFTR shifted to a detergent-resistant fraction within the cell and colocalized with the intermediate filament vimentin, suggesting that CS induced CFTR movement into an aggresome-like, perinuclear compartment. To test whether airway dehydration could be reversed, we used hypertonic saline (HS) as an osmolyte to rehydrate ASL. HS restored ASL height in CS-exposed, dehydrated airway cultures. Similarly, inhaled HS restored mucus transport and increased clearance in patients with CB. Thus, we propose that CS exposure rapidly impairs CFTR function by internalizing CFTR, leading to ASL dehydration, which promotes mucus stasis and a failure of mucus clearance, leaving smokers at risk for developing CB. Furthermore, our data suggest that strategies to rehydrate airway surfaces may provide a novel form of therapy for patients with CB.-Clunes, L. A., Davies, C. M., Coakley, R. D., Aleksandrov, A. A., Henderson, A. G., Zeman, K. L., Worthington, E. N., Gentzsch, M., Kreda, S. M., Cholon, D., Bennett, W. D., Riordan, J. R., Boucher, R. C., Tarran, R. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 26, 533-545 (2012). www.fasebj.org	[Clunes, Lucy A.; Davies, Catrin M.; Coakley, Raymond D.; Aleksandrov, Andrei A.; Henderson, Ashley G.; Zeman, Kirby L.; Worthington, Erin N.; Gentzsch, Martina; Kreda, Silvia M.; Cholon, Deborah; Bennett, William D.; Riordan, John R.; Boucher, Richard C.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7125 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	robert_tarran@med.unc.edu	Gentzsch, Martina/AAY-1815-2021	Gentzsch, Martina/0000-0002-9435-0321	Cystic Fibrosis Foundation; U.S. National Institutes of Health (NIH) [5R01DK051870, 5R01DK051619]; NIH [HL084934, HL34332]; British American Tobacco; Novartis Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934, R13HL034332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870, R01DK051619] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British American Tobacco; Novartis Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the UNC CF Center Tissue and Histology Cores for isolating cells from donor lungs and for sectioning cultures, respectively. The assistance of L. A. Aleksandrov, J. E. Rasmussen, and M. J. Watson is gratefully acknowledged. R. D. C., M. G., and S. K. were funded by the Cystic Fibrosis Foundation. A. A. A., M. G., and J. R. were funded by the U.S. National Institutes of Health (NIH; 5R01DK051870, 5R01DK051619). R. C. B. was funded by NIH HL084934 and HL34332. R. T. was funded by NIH HL084934, a British American Tobacco research grant, and a Novartis Institute biomedical research grant.	Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; BARTON AD, 1976, J LAB CLIN MED, V88, P423; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Brody JS, 2011, ANNU REV PHYSIOL, V73, P437, DOI 10.1146/annurev-physiol-012110-142219; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chmiel JF, 2007, CLIN CHEST MED, V28, P331, DOI 10.1016/j.ccm.2007.02.002; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; French BA, 2001, EXP MOL PATHOL, V71, P241, DOI 10.1006/exmp.2001.2401; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gerald Lynn B, 2002, J Cardiopulm Rehabil, V22, P234, DOI 10.1097/00008483-200207000-00004; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; Hill AT, 2000, AM J MED, V109, P288, DOI 10.1016/S0002-9343(00)00507-6; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Incalzi R A, 1989, Compr Gerontol A, V3 Suppl, P65; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Leikauf GD, 2002, CHEST, V121, p166S, DOI 10.1378/chest.121.5_suppl.166S; MORTENSEN J, 1994, EUR J NUCL MED, V21, P953; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Olzmann JA, 2008, CURR MED CHEM, V15, P47; PUCHELLE E, 1979, SCAND J RESPIR DIS, V60, P307; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; RUBIN BK, 1992, AM REV RESPIR DIS, V145, P545, DOI 10.1164/ajrccm/145.3.545; Sawyer K, 2007, J APPL PHYSIOL, V102, P1380, DOI 10.1152/japplphysiol.00269.2006; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Sethi S, 2000, CHEST, V117, p286S, DOI 10.1378/chest.117.5_suppl_1.286S; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Svartengren M, 2005, EUR RESPIR J, V26, P609, DOI 10.1183/09031936.05.00002105; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Taylor L, 2006, PEDIATR PULM, V41, P839, DOI 10.1002/ppul.20451; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH	48	183	187	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					533	545		10.1096/fj.11-192377	http://dx.doi.org/10.1096/fj.11-192377			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	21990373	Green Published			2022-12-25	WOS:000300485700007
J	Lee, KK; Pessi, A; Gui, L; Santoprete, A; Talekar, A; Moscona, A; Porotto, M				Lee, Kelly K.; Pessi, Antonello; Gui, Long; Santoprete, Alessia; Talekar, Aparna; Moscona, Anne; Porotto, Matteo			Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROXIMAL REGION; RECEPTOR-BINDING; CONFORMATIONAL CHANGE; ENTRY INHIBITORS; MEDIATED FUSION; VIRAL FUSION; A VIRUSES; PARAMYXOVIRUS; MECHANISM; POTENCY	We previously described fusion-inhibitory peptides that are targeted to the cell membrane by cholesterol conjugation and potently inhibit enveloped viruses that fuse at the cell surface, including HIV, parainfluenza, and henipaviruses. However, for viruses that fuse inside of intracellular compartments, fusion-inhibitory peptides have exhibited very low antiviral activity. We propose that for these viruses, too, membrane targeting via cholesterol conjugation may yield potent compounds. Here we compare the activity of fusion-inhibitory peptides derived from the influenza hemagglutinin (HA) and show that although the unconjugated peptides are inactive, the cholesterol-conjugated compounds are effective inhibitors of infectivity and membrane fusion. We hypothesize that the cholesterol moiety, by localizing the peptides to the target cell membrane, allows the peptides to follow the virus to the intracellular site of fusion. The cholesterol-conjugated peptides trap HA in a transient intermediate state after fusion is triggered but before completion of the refolding steps that drive the merging of the viral and cellular membranes. These results provide proof of concept for an antiviral strategy that is applicable to intracellularly fusing viruses, including known and emerging viral pathogens.	[Talekar, Aparna; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Talekar, Aparna; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Lee, Kelly K.; Gui, Long] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Lee, Kelly K.; Gui, Long] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Pessi, Antonello] PeptiPharma, I-00040 Rome, Italy	Cornell University; Cornell University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lee, KK (corresponding author), H-172J,Hlth Sci Bldg, Seattle, WA 98195 USA.	kklee@u.washington.edu; map2028@med.cornell.edu		POROTTO, Matteo/0000-0003-3866-9220; Gui, Long/0000-0002-2629-0689	NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease [U54AI057158]; National Institutes of Health [R01AI076335, R01AI31971, R21AI090354, R21EBO11707, R00GM080352]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI031971, R01AI076335, R21AI090354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080352, R00GM080352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease Research Grant U54AI057158 (to M. P.), Principal Investigator of Center of Excellence Grant W. I. Lipkin (to A. M.), National Institutes of Health Grants R01AI076335, R01AI31971, and R21AI090354 (to A. M.); R21EBO11707 (to M. P.); and R00GM080352 (to K. K. L.).	Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Harrison C, 2009, NAT REV DRUG DISCOV, V8, P276, DOI 10.1038/nrd2856; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Leikina E, 2002, EMBO J, V21, P5701, DOI 10.1093/emboj/cdf559; Miller EH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207084; Mirsaliotis A, 2008, J VIROL, V82, P4965, DOI 10.1128/JVI.02458-07; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P1171, DOI 10.1093/nar/24.6.1171; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Noah E, 2008, BIOCHEMISTRY-US, V47, P6782, DOI 10.1021/bi7023139; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Park HE, 2003, NAT STRUCT BIOL, V10, P1048, DOI 10.1038/nsb1012; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Porotto M, 2009, J VIROL, V83, P6947, DOI 10.1128/JVI.00416-09; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Rojek JM, 2008, CELL MICROBIOL, V10, P828, DOI 10.1111/j.1462-5822.2007.01113.x; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Veiga AS, 2007, FEBS J, V274, P5096, DOI 10.1111/j.1742-4658.2007.06029.x; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; WHARTON SA, 1995, EMBO J, V14, P240, DOI 10.1002/j.1460-2075.1995.tb06997.x; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	48	69	70	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42141	42149		10.1074/jbc.M111.254243	http://dx.doi.org/10.1074/jbc.M111.254243			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994935	hybrid, Green Published			2022-12-25	WOS:000298180900025
J	Tan, BZ; Jiang, FL; Tan, MY; Yu, DJ; Huang, H; Shen, YR; Soong, TW				Tan, Bao Zhen; Jiang, Fengli; Tan, Ming Yeong; Yu, Dejie; Huang, Hua; Shen, Yiru; Soong, Tuck Wah			Functional Characterization of Alternative Splicing in the C Terminus of L-type Ca(V)1.3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; CA2+ CHANNELS; IDENTIFICATION; CALMODULIN; MODULATION; PROTEINS; SUBUNITS	Ca(V)1.3 channels are unique among the high voltage-activated Ca2+ channel family because they activate at the most negative potentials and display very rapid calcium-dependent inactivation. Both properties are of crucial importance in neurons of the suprachiasmatic nucleus and substantia nigra, where the influx of Ca2+ ions at subthreshold membrane voltages supports pace-making function. Previously, alternative splicing in the Ca(V)1.3C terminus gives rise to a long (Ca(V)1.3(42)) and a short form (Ca(V)1.3(42A)), resulting in a pronounced activation at more negative voltages and faster inactivation in the latter. It was further shown that the C-terminal modulator in the Ca(V)1.3(42) isoforms modulates calmodulin binding to the IQ domain. Using splice variant-specific antibodies, we determined that protein localization of both splice variants in different brain regions were similar. Using the transcript-scanning method, we further identified alternative splicing at four loci in the C terminus of Ca(V)1.3 channels. Alternative splicing of exon 41 removes the IQ motif, resulting in a truncated Ca(V)1.3 protein with diminished inactivation. Splicing of exon 43 causes a frameshift and exhibits a robust inactivation of similar intensity to Ca(V)1.3(42A). Alternative splicing of exons 44 and 48 are in-frame, altering interaction of the distal modulator with the IQ domain and tapering inactivation slightly. Thus, alternative splicing in the C terminus of Ca(V)1.3 channels modulates its electrophysiological properties, which could in turn alter neuronal firing properties and functions.	[Tan, Bao Zhen; Jiang, Fengli; Tan, Ming Yeong; Yu, Dejie; Huang, Hua; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Tan, Bao Zhen; Huang, Hua; Soong, Tuck Wah] Natl Univ Singapore, NUS Grad Sch Integrat Engn & Sci, Singapore 117597, Singapore; [Shen, Yiru; Soong, Tuck Wah] Natl Neurosci Inst, Singapore 308433, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI)	Soong, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Tuluc, Petronel/C-2527-2011	Huang, Hua/0000-0002-7421-3696	National Institutes of Health [RO1DC00276]; Singapore Biomedical Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DC00276 and the Singapore Biomedical Research Council.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Gamelli AE, 2011, HIPPOCAMPUS, V21, P133, DOI 10.1002/hipo.20728; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mittman S, 1999, NEUROSCI LETT, V274, P143, DOI 10.1016/S0304-3940(99)00716-8; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Soong TW, 2002, J NEUROSCI, V22, P10142; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	33	60	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42725	42735		10.1074/jbc.M111.265207	http://dx.doi.org/10.1074/jbc.M111.265207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998309	Green Published, hybrid			2022-12-25	WOS:000298180900079
J	Lee, YS; Tresguerres, M; Hess, K; Marmorstein, LY; Levin, LR; Buck, J; Marmorstein, AD				Lee, Yong S.; Tresguerres, Martin; Hess, Kenneth; Marmorstein, Lihua Y.; Levin, Lonny R.; Buck, Jochen; Marmorstein, Alan D.			Regulation of Anterior Chamber Drainage by Bicarbonate-sensitive Soluble Adenylyl Cyclase in the Ciliary Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS-HUMOR SECRETION; MICE; GLAUCOMA; EPITHELIUM; CELLS	Glaucoma is a leading cause of blindness affecting as many as 2.2 million Americans. All current glaucoma treatment strategies aim to reduce intraocular pressure (LOP). LOP results from the resistance to drainage of aqueous humor (AH) produced by the ciliary body in a process requiring bicarbonate. Once secreted into the anterior chamber, AH drains from the eye via two pathways: uveoscleral and pressure-dependent or conventional outflow (C). Modulation of "inflow" and "outflow" pathways is thought to occur via distinct, local mechanisms. Mice deficient in the bicarbonate channel bestrophin-2 (Best2), however, exhibit a lower IOP despite an increase in AH production. Best2 is expressed uniquely in nonpigmented ciliary epithelial (NPE) cells providing evidence for a bicarbonate-dependent communicative pathway linking inflow and outflow. Here, we show that bicarbonate-sensitive soluble adenylyl cyclase (sAC) is highly expressed in the ciliary body in NPE cells, but appears to be absent from drainage tissues. Pharmacologic inhibition of sAC in mice causes a significant increase in LOP due to a decrease in C, with no effect on inflow. In mice deficient in sAC IOP is elevated, and C, is decreased relative to wild-type mice. Pharmacologic inhibition of sAC did not alter LOP or C, in sAC-deficient mice. Based on these data we propose that the ciliary body can regulate C, and that sAC serves as a critical sensor of bicarbonate in the ciliary body regulating the secretion of substances into the AH that govern outflow facility independent of pressure.	[Marmorstein, Alan D.] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA; [Marmorstein, Lihua Y.] Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85719 USA; [Tresguerres, Martin; Hess, Kenneth; Levin, Lonny R.; Buck, Jochen] Weill Cornell Coll Med, Dept Pharmacol, New York, NY 10065 USA	University of Arizona; University of Arizona; University of Arizona; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Marmorstein, AD (corresponding author), Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, POB 245216, Tucson, AZ 85719 USA.	amarmorstein@eyes.arizona.edu	Tresguerres, Martin/J-8628-2012; Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Tresguerres, Martin/0000-0002-7090-9266; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [EY13160, GM62328]; American Health Assistance Foundation; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013160, R56EY013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13160 and GM62328. This work was also supported by the American Health Assistance Foundation and an unrestricted grant from Research to Prevent Blindness (to the Department of Ophthalmology and Vision Science at the University of Arizona).	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; Do CW, 2004, J MEMBRANE BIOL, V200, P1, DOI 10.1007/s00232-004-0688-5; Dunn TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007877; Escribano J, 2002, MOL VIS, V8, P315; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; Sugrue MF, 1996, J OCUL PHARMACOL TH, V12, P363, DOI 10.1089/jop.1996.12.363; Sugrue MF, 2000, PROG RETIN EYE RES, V19, P87, DOI 10.1016/S1350-9462(99)00006-3; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Sun Xing Cai, 2004, BMC Physiol, V4, P8, DOI 10.1186/1472-6793-4-8; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; Zhang YW, 2010, MOL VIS, V16, P200; Zhang YW, 2009, INVEST OPHTH VIS SCI, V50, P765, DOI 10.1167/iovs.08-2501	28	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41353	41358		10.1074/jbc.M111.284679	http://dx.doi.org/10.1074/jbc.M111.284679			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994938	Green Published, hybrid			2022-12-25	WOS:000298057500022
J	Sebens, S; Bauer, I; Geismann, C; Grage-Griebenow, E; Ehlers, S; Kruse, ML; Arlt, A; Schafer, H				Sebens, Susanne; Bauer, Iris; Geismann, Claudia; Grage-Griebenow, Evelin; Ehlers, Stefan; Kruse, Marie-Luise; Arlt, Alexander; Schaefer, Heiner			Inflammatory Macrophages Induce Nrf2 Transcription Factor-dependent Proteasome Activity in Colonic NCM460 Cells and Thereby Confer Anti-apoptotic Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; ANTIOXIDANT RESPONSE; MOLECULAR-MECHANISMS; ULCERATIVE-COLITIS; ADAPTIVE RESPONSE; CANCER; ACTIVATION; EXPRESSION; SUBUNIT; PATHWAY	Adaptation of epithelial cells to persistent oxidative stress plays an important role in inflammation-associated carcinogenesis. This adaptation process involves activation of Nrf2 (nuclear factor-E2-related factor-2), which has been recently shown to contribute to carcinogenesis through the induction of proteasomal gene expression and proteasome activity. To verify this possible link between inflammation, oxidative stress, and Nr12-dependent proteasome activation, we explored the impact of inflammatory (M1) macrophages on the human colon epithelial cell line NCM460. Transwell cocultures with macrophages differentiated from granulocyte monocyte-colony-stimulating factor-treated monocytes led to an increased activity of Nrf2 in NCM460 cells along with an elevated proteasome activity. This higher proteasome activity resulted from Nrf2-dependent induction of proteasomal gene expression, as shown for the 19 and 20 S subunit proteins S5a and alpha 5, respectively. These effects of macrophage coculture were preceded by an increase of reactive oxygen species in cocultured NCM460 cells and could be blocked by catalase or by the reactive oxygen species scavenger Tiron, whereas transient treatment of NCM460 cells with H2O2 similarly led to Nrf2-dependent proteasome activation. Through the Nrf2-dependent increase of proteasomal gene expression and proteasome activity, the sensitivity of NCM460 cells to tumor necrosis factor-related apoptosis-inducing ligand-or irinotecan-induced apoptosis declined. These findings indicate that inflammatory conditions such as the presence of M1 macrophages and the resulting oxidative stress are involved in the Nrf2-dependent gain of proteasome activity in epithelial cells, e.g. colonocytes, giving rise of greater resistance to apoptosis. This mechanism might contribute to inflammation-associated carcinogenesis, e.g. of the colon.	[Sebens, Susanne; Bauer, Iris; Geismann, Claudia; Grage-Griebenow, Evelin; Kruse, Marie-Luise; Arlt, Alexander; Schaefer, Heiner] Univ Klinikum Schleswig Holstein, Dept Internal Med 1, Lab Mol Gastroenterol & Hepatol, Kiel, Germany; [Sebens, Susanne; Grage-Griebenow, Evelin] Univ Klinikum Schleswig Holstein, Inst Expt Med, Kiel, Germany; [Ehlers, Stefan] Res Ctr Borstel, Leibniz Ctr Med & Biosci, Div Mol Inflammat Med, Borstel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel	Schafer, H (corresponding author), Dept Internal Med, I Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Schäfer, Heiner/C-1055-2011; Ehlers, Stefan/B-4075-2010; Arlt, Alexander/G-7308-2019; Geismann, Claudia/AAX-8158-2021; Sebens, Susanne/C-1222-2010	Arlt, Alexander/0000-0002-6160-1059; Geismann, Claudia/0000-0003-0640-9256; 	Deutsche Forschungsgemeinschaft [SCHA677/9-1]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA677/9-1 and the Cluster of Excellence "Inflammation at Interfaces."	Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Arisawa T, 2008, HEPATO-GASTROENTEROL, V55, P394; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt A, 2007, BIOCHEM J, V402, P367, DOI 10.1042/BJ20061072; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bedard K, 2007, PHYSIOL REV, V87, P245; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Du ZX, 2011, J CLIN ENDOCR METAB, V96, pE763, DOI 10.1210/jc.2010-2642; Ebert B, 2011, CHEM-BIOL INTERACT, V191, P239, DOI 10.1016/j.cbi.2010.12.026; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Grimm S, 2010, AMINO ACIDS IN PRESS; Han YH, 2009, ONCOL REP, V21, P253, DOI 10.3892/or_00000216; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hellwinkel OJC, 2011, PROSTATE CANCER P D, V14, P38, DOI 10.1038/pcan.2010.48; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Rushworth SA, 2011, CANCER RES, V71, P1999, DOI 10.1158/0008-5472.CAN-10-3018; Schaedler S, 2010, J BIOL CHEM, V285, P41074, DOI 10.1074/jbc.M110.145862; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Visconti R, 2009, CURR OPIN DRUG DISC, V12, P240; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Xie YM, 2010, CANCER METAST REV, V29, P687, DOI 10.1007/s10555-010-9255-y; Zhao CR, 2010, CANCER EPIDEMIOL, V34, P523, DOI 10.1016/j.canep.2010.06.012	65	32	35	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40911	40921		10.1074/jbc.M111.274902	http://dx.doi.org/10.1074/jbc.M111.274902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990354	Green Published, hybrid			2022-12-25	WOS:000297315400051
J	Avnir, Y; Turjeman, K; Tulchinsky, D; Sigal, A; Kizelsztein, P; Tzemach, D; Gabizon, A; Barenholz, Y				Avnir, Yuval; Turjeman, Keren; Tulchinsky, Deborah; Sigal, Alex; Kizelsztein, Pablo; Tzemach, Dina; Gabizon, Alberto; Barenholz, Yechezkel			Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids	PLOS ONE			English	Article							GLATIRAMER ACETATE; DELIVERY; MODEL; METHYLPREDNISOLONE; PHARMACOKINETICS; DOXORUBICIN; MECHANISMS; DRUGS; MICE; ENCEPHALOMYELITIS	We report here the design, development and performance of a novel formulation of liposome- encapsulated glucocorticoids (GCs). A highly efficient (>90%) and stable GC encapsulation was obtained based on a transmembrane calcium acetate gradient driving the active accumulation of an amphipathic weak acid GC pro-drug into the intraliposome aqueous compartment, where it forms a GC-calcium precipitate. We demonstrate fabrication principles that derive from the physicochemical properties of the GC and the liposomal lipids, which play a crucial role in GC release rate and kinetics. These principles allow fabrication of formulations that exhibit either a fast, second-order (t(1/2) similar to 1 h), or a slow, zero-order release rate (t(1/2) similar to 50 h) kinetics. A high therapeutic efficacy was found in murine models of experimental autoimmune encephalomyelitis (EAE) and hematological malignancies.	[Avnir, Yuval; Turjeman, Keren; Tulchinsky, Deborah; Sigal, Alex; Kizelsztein, Pablo; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel; [Tzemach, Dina; Gabizon, Alberto] Shaare Zedek Med Ctr, Expt Oncol Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Avnir, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel.	yb@cc.huji.ac.il	Gabizon, Alberto/C-6171-2009		Barenholz Fund	Barenholz Fund	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. The other support was the Hebrew University regular support system. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hai A, 2007, BONE MARROW TRANSPL, V40, P881, DOI 10.1038/sj.bmt.1705819; Abraham SA, 2004, J CONTROL RELEASE, V96, P449, DOI 10.1016/j.jconrel.2004.02.017; *ACS, 2006, SCIFINDER SCHOL SOFT; ANDERSON BD, 1981, J PHARM SCI, V70, P181, DOI 10.1002/jps.2600700217; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Avnir Y, 2008, ARTHRITIS RHEUM-US, V58, P119, DOI 10.1002/art.23230; Banciu M, 2008, J STEROID BIOCHEM, V111, P101, DOI 10.1016/j.jsbmb.2008.05.004; Barenholz Y, 2003, J LIPOSOME RES, V13, P1, DOI 10.1081/LPR-120017482; Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Barenholz Y., 2007, LIPOSOME TECHNOLOGY, V2, P1; Blanchette F, 2008, J NEUROL, V255, P26, DOI 10.1007/s00415-008-1005-5; Breimer DD, 1999, J CONTROL RELEASE, V62, P3, DOI 10.1016/S0168-3659(99)00060-7; Buttmann Mathias, 2007, Expert Rev Neurother, V7, P227, DOI 10.1586/14737175.7.3.227; Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022; Chang PL, 1999, TRENDS BIOTECHNOL, V17, P78, DOI 10.1016/S0167-7799(98)01250-5; Charmandari E, 2010, NEONATAL PEDIAT PHAR, P760; CHEMIN C, 2008, BIOCH BIOPHYS ACTA; Ciccone A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006264.pub2; Clerc S, 1995, BBA-BIOMEMBRANES, V1240, P257, DOI 10.1016/0005-2736(95)00214-6; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Dubois EFL, 2005, CURR RESPIR MED REV, V1, P103, DOI 10.2174/1573398052953604; Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028; GABIZON A, 1980, BRIT J CANCER, V42, P551, DOI 10.1038/bjc.1980.279; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Garbuzenko O, 2005, LANGMUIR, V21, P2560, DOI 10.1021/la0479105; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; KALEDIN VI, 1981, J NATL CANCER I, V66, P881; Kluza E, 2011, J CONTROL RELEASE, V151, P10, DOI 10.1016/j.jconrel.2010.11.031; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; LASIC DD, 1995, BBA-BIOMEMBRANES, V1239, P145, DOI 10.1016/0005-2736(95)00159-Z; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MCKAY LI, 2000, CANC MED, P730; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Metselaar Josbert M, 2005, Expert Opin Drug Deliv, V2, P465, DOI 10.1517/17425247.2.3.465; Moreau T, 2009, J NEUROL SCI, V277, pS12, DOI 10.1016/S0022-510X(09)70005-X; MUKERJEE P, 1971, 36 NSRDS NBS, P8; MUNSHI NC, 2001, CANC PRINCIPLES PRAC, P2465; Peleg-Shulman T, 2001, BBA-BIOMEMBRANES, V1510, P278, DOI 10.1016/S0005-2736(00)00359-X; RANADE VV, 1990, J CLIN PHARMACOL, V30, P871, DOI 10.1002/j.1552-4604.1990.tb03566.x; Rousseau V, 1999, EXP BRAIN RES, V125, P255, DOI 10.1007/s002210050681; Samuni AM, 1997, FREE RADICAL BIO MED, V22, P1165, DOI 10.1016/S0891-5849(96)00509-6; Schleimer RP, 2003, MIDDLETONS ALLERGY P, P870; Schmidt J, 2003, BRAIN, V126, P1895, DOI 10.1093/brain/awg176; Schroeder A, 2007, LANGMUIR, V23, P4019, DOI 10.1021/la0631668; SHAW IH, 1976, BIOCHEM J, V158, P473, DOI 10.1042/bj1580473; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Shmeeda H, 2003, METHOD ENZYMOL, V367, P272; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; SMITH MD, 1979, J CHROMATOGR, V164, P129, DOI 10.1016/S0378-4347(00)81182-2; Stein W., 2012, TRANSPORT DIFFUSION; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Wasserman V, 2007, LANGMUIR, V23, P1937, DOI 10.1021/la060218k; WHITHAM RH, 1991, J IMMUNOL, V146, P101; WILLIAMS BD, 1987, ANN RHEUM DIS, V46, P314, DOI 10.1136/ard.46.4.314; Wong JP, 2003, J CONTROL RELEASE, V92, P265, DOI 10.1016/S0168-3659(03)00358-4; Yetgin S, 1998, LEUKEMIA RES, V22, P485, DOI 10.1016/S0145-2126(98)00003-4; Ziemssen T, 2007, INT REV NEUROBIOL, V79, P537, DOI 10.1016/S0074-7742(07)79024-4; Zucker D, 2010, J CONTROL RELEASE, V146, P326, DOI 10.1016/j.jconrel.2010.05.024; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	66	51	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25721	10.1371/journal.pone.0025721	http://dx.doi.org/10.1371/journal.pone.0025721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998684	Green Published, gold, Green Submitted			2022-12-25	WOS:000295968700016
J	Tao, LZ; Li, XF; Zhang, LL; Tian, JY; Li, XB; Sun, X; Li, XF; Jiang, L; Zhang, XJ; Chen, JZ				Tao, Lizhen; Li, Xiaofeng; Zhang, Lingling; Tian, Jiyu; Li, Xiaobing; Sun, Xin; Li, Xuefen; Jiang, Lin; Zhang, Xiaojun; Chen, Jianzong			Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; POLYGONUM-MULTIFLORUM; PARKINSONS-DISEASE; 6-HYDROXYDOPAMINE-INDUCED APOPTOSIS; NEURODEGENERATIVE DISORDERS; OXIDATIVE STRESS; NEUROTOXICITY; 6-OHDA; PEROXYNITRITE; BRAIN	Oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease. The molecule, 2,3,5,4'-tetrahydr-oxystilbene-2-O-beta-D-glucoside (TSG), is a potent antioxidant derived from the Chinese herb, Polygonum multiflorum Thunb. In this study, we investigated the protective effect of TSG against 6-hydroxydopamine-induced apoptosis in rat adrenal pheochromocytoma PC12 cells and the possible mechanisms. Our data demonstrated that TSG significantly reversed the 6-hydroxydopamine-induced decrease in cell viability, prevented 6-hydroxydopamine-induced changes in condensed nuclei and decreased the percentage of apoptotic cells in a dose-dependent manner. In addition, TSG slowed the accumulation of intracellular reactive oxygen species and nitric oxide, counteracted the overexpression of inducible nitric oxide syntheses as well as neuronal nitric oxide syntheses, and also reduced the level of protein-bound 3-nitrotyrosine. These results demonstrate that the protective effects of TSG on rat adrenal pheochromocytoma PC12 cells are mediated, at least in part, by the ROS-NO pathway. Our results indicate that TSG may be effective in providing protection against neurodegenerative diseases associated with oxidative stress.	[Tao, Lizhen; Li, Xiaofeng; Zhang, Lingling; Tian, Jiyu; Li, Xiaobing; Sun, Xin; Li, Xuefen; Jiang, Lin; Chen, Jianzong] Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China; [Zhang, Xiaojun] Fourth Mil Med Univ, Dept Math & Phys, Sch Biomed Engn, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Tao, LZ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China.	zy04310@fmmu.edu.cn; jzchen57@fmmu.edu.cn	zhang, lingling/HDM-2189-2022	Zhang, Lingling/0000-0002-6272-7171	National Natural Science Foundation of China [30772743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the funding support from National Natural Science Foundation of China (No. 30772743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus JS, 2000, FREE RADICAL BIO MED, V29, P1085, DOI 10.1016/S0891-5849(00)00350-6; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bharath S, 2002, NEUROTOXICOLOGY, V23, P479, DOI 10.1016/S0161-813X(02)00035-9; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Chan YC, 2003, AM J CHINESE MED, V31, P171, DOI 10.1142/S0192415X03000862; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Chung KKK, 2010, NITRIC OXIDE-BIOL CH, V22, P290, DOI 10.1016/j.niox.2010.02.002; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004; Feng L, 2008, INT J DEV NEUROSCI, V26, P323, DOI 10.1016/j.ijdevneu.2008.01.003; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gatto EM, 1999, J NEUROL SCI, V165, P66, DOI 10.1016/S0022-510X(99)00079-9; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Gorman AM, 2005, BIOCHEM BIOPH RES CO, V327, P801, DOI 10.1016/j.bbrc.2004.12.066; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Guo SH, 2005, FREE RADICAL BIO MED, V39, P682, DOI 10.1016/j.freeradbiomed.2005.04.022; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hornykiewicz O, 1987, Adv Neurol, V45, P19; JELLINGER KA, 1993, ADV NEUROL, V60, P267; Ju MS, 2010, TOXICOL IN VITRO, V24, P759, DOI 10.1016/j.tiv.2009.12.026; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Li X, 2005, PHARMACOL BIOCHEM BE, V82, P345, DOI 10.1016/j.pbb.2005.09.004; Li XB, 2010, NEUROSCI LETT, V483, P1, DOI 10.1016/j.neulet.2010.07.027; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Luo HB, 2009, NEUROSCI BULL, V25, P391, DOI 10.1007/s12264-009-0601-4; Mayo JC, 1999, BRAIN RES, V818, P221, DOI 10.1016/S0006-8993(98)01262-1; Nie GJ, 2002, ARCH BIOCHEM BIOPHYS, V397, P84, DOI 10.1006/abbi.2001.2636; Padiglia A, 1997, BIOCHEM PHARMACOL, V53, P1065, DOI 10.1016/S0006-2952(96)00716-2; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Smith MP, 2007, NEUROSCI LETT, V412, P259, DOI 10.1016/j.neulet.2006.11.017; Tatton WG, 2002, J PHARMACOL EXP THER, V301, P753, DOI 10.1124/jpet.301.2.753; Tian LL, 2008, INT J BIOCHEM CELL B, V40, P409, DOI 10.1016/j.biocel.2007.08.005; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; WALKINSHAW G, 1994, NEUROSCIENCE, V63, P975, DOI 10.1016/0306-4522(94)90566-5; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Watanabe H, 2004, EUR NEUROPSYCHOPHARM, V14, P93, DOI 10.1016/S0924-977X(03)00065-8; Yamada K, 1997, BRAIN RES BULL, V43, P573, DOI 10.1016/S0361-9230(96)00336-X; Yang Xiuwei, 1996, Zhongguo Zhongyao Zazhi, V21, P48; Yao S, 2006, J CHROMATOGR A, V1115, P64, DOI 10.1016/j.chroma.2006.02.071; Ye Shaojian, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P13; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhang YD, 2007, J COMB CHEM, V9, P9, DOI 10.1021/cc0601231	53	55	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26055	10.1371/journal.pone.0026055	http://dx.doi.org/10.1371/journal.pone.0026055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998750	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700035
J	Lepore, AC; O'Donnell, J; Kim, AS; Williams, T; Tuteja, A; Rao, MS; Kelley, LL; Campanelli, JT; Maragakis, NJ				Lepore, Angelo C.; O'Donnell, John; Kim, Andrew S.; Williams, Timothy; Tuteja, Alicia; Rao, Mahendra S.; Kelley, Linda L.; Campanelli, James T.; Maragakis, Nicholas J.			Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1(G93A) Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; TRANSGENIC RAT MODEL; FAMILIAL ALS; CELL GRAFTS; STEM-CELLS; DEGENERATION; ASTROCYTES; SURVIVAL; MICE	Cellular abnormalities are not limited to motor neurons in amyotrophic lateral sclerosis (ALS). There are numerous observations of astrocyte dysfunction in both humans with ALS and in SOD1(G93A) rodents, a widely studied ALS model. The present study therapeutically targeted astrocyte replacement in this model via transplantation of human Glial-Restricted Progenitors (hGRPs), lineage-restricted progenitors derived from human fetal neural tissue. Our previous findings demonstrated that transplantation of rodent-derived GRPs into cervical spinal cord ventral gray matter (in order to target therapy to diaphragmatic function) resulted in therapeutic efficacy in the SOD1(G93A) rat. Those findings demonstrated the feasibility and efficacy of transplantation-based astrocyte replacement for ALS, and also show that targeted multi-segmental cell delivery to cervical spinal cord is a promising therapeutic strategy, particularly because of its relevance to addressing respiratory compromise associated with ALS. The present study investigated the safety and in vivo survival, distribution, differentiation, and potential efficacy of hGRPs in the SOD1(G93A) mouse. hGRP transplants robustly survived and migrated in both gray and white matter and differentiated into astrocytes in SOD1(G93A) mice spinal cord, despite ongoing disease progression. However, cervical spinal cord transplants did not result in motor neuron protection or any therapeutic benefits on functional outcome measures. This study provides an in vivo characterization of this glial progenitor cell and provides a foundation for understanding their capacity for survival, integration within host tissues, differentiation into glial subtypes, migration, and lack of toxicity or tumor formation.	[Lepore, Angelo C.] Thomas Jefferson Univ, Coll Med, Dept Neurosci, Philadelphia, PA 19107 USA; [O'Donnell, John; Kim, Andrew S.; Williams, Timothy; Tuteja, Alicia; Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rao, Mahendra S.] Life Technol, Carlsbad, CA USA; [Kelley, Linda L.] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Rao, Mahendra S.; Campanelli, James T.] Q Therapeut, Salt Lake City, UT USA; [Campanelli, James T.] Univ Utah, Dept Neurol, Salt Lake City, UT USA	Jefferson University; Johns Hopkins University; Thermo Fisher Scientific; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lepore, AC (corresponding author), Thomas Jefferson Univ, Coll Med, Dept Neurosci, Philadelphia, PA 19107 USA.	nmaragak@jhmi.edu		O'Donnell, John/0000-0002-0774-9028	National Institutes of Health (NIH) [F32-NS059155, NIH U01 NS062713]; The Robert Packard Center for Lou Gehrig's Disease (ALS) Research; Muscular Dystrophy Association; The Maryland Stem Cell Research Fund; Q Therapeutics Inc.; The ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS062713, F32NS059155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert Packard Center for Lou Gehrig's Disease (ALS) Research; Muscular Dystrophy Association(Muscular Dystrophy Association); The Maryland Stem Cell Research Fund; Q Therapeutics Inc.; The ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by: National Institutes of Health (NIH) F32-NS059155 (AL), NIH U01 NS062713 (NM, JC, LK), The Robert Packard Center for Lou Gehrig's Disease (ALS) Research (NM), Muscular Dystrophy Association (NM), The ALS Association (NM), The Maryland Stem Cell Research Fund (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JC and MR have a financial interest and are associated with Q Therapeutics Inc., which provided the hGRPs for transplantation. MR is the Vice President for Research, Regenerative Medicine and Stem Cells at Life Technologies. Q Therapeutics, Inc. has patents on hGRPs and is currently developing these for potential clinical study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Campanelli James T, 2008, BMC Dev Biol, V8, P102, DOI 10.1186/1471-213X-8-102; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Lepore AC, 2007, NEUROCHEM INT, V50, P966, DOI 10.1016/j.neuint.2006.09.005; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Lepore AC, 2007, BRAIN RES, V1185, P256, DOI 10.1016/j.brainres.2007.09.034; Lepore AC, 2010, NEUROBIOL DIS, V39, P252, DOI 10.1016/j.nbd.2010.03.021; Llado J, 2006, NEUROBIOL DIS, V21, P110, DOI 10.1016/j.nbd.2005.06.019; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Mitsumoto H, 1998, AMYOTROPHIC LATERAL, Vxxv; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Papadeas ST, 2009, CURR OPIN BIOTECH, V20, P545, DOI 10.1016/j.copbio.2009.09.003; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sandrock RW, 2010, REGEN MED, V5, P381, DOI 10.2217/RME.10.24; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	39	87	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25968	10.1371/journal.pone.0025968	http://dx.doi.org/10.1371/journal.pone.0025968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998733	Green Published, gold			2022-12-25	WOS:000295966900083
J	Novick, I; Vaadia, E				Novick, Itai; Vaadia, Eilon			Just Do It: Action-Dependent Learning Allows Sensory Prediction	PLOS ONE			English	Article							POSTERIOR PARIETAL; INTERNAL-MODELS; MOTOR CONTROL; ADAPTATION; CORTEX; SPECIFICITY; PRINCIPLES; STATE	Sensory-motor learning is commonly considered as a mapping process, whereby sensory information is transformed into the motor commands that drive actions. However, this directional mapping, from inputs to outputs, is part of a loop; sensory stimuli cause actions and vice versa. Here, we explore whether actions affect the understanding of the sensory input that they cause. Using a visuo-motor task in humans, we demonstrate two types of learning-related behavioral effects. Stimulus-dependent effects reflect stimulus-response learning, while action-dependent effects reflect a distinct learning component, allowing the brain to predict the forthcoming sensory outcome of actions. Together, the stimulus-dependent and the action-dependent learning components allow the brain to construct a complete internal representation of the sensory-motor loop.	[Novick, Itai; Vaadia, Eilon] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Edmond & Lily Safra Ctr Brain Sci, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Novick, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Edmond & Lily Safra Ctr Brain Sci, IL-91010 Jerusalem, Israel.	itain@ekmd.huji.ac.il			US-Israel Binational Science Foundation; Israeli Science foundation; Rosetrees Trust; Ida Baruch fund	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Science foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Ida Baruch fund	This work was supported in part by the US-Israel Binational Science Foundation, by the Israeli Science foundation, and special contributions by the Rosetrees Trust and the Ida Baruch fund. EV is the Jack H. Skirball Chair of Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lalazar H, 2008, CURR OPIN NEUROBIOL, V18, P573, DOI 10.1016/j.conb.2008.11.003; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Paz R, 2004, J PHYSIOL-PARIS, V98, P331, DOI 10.1016/j.jphysparis.2005.09.005; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Tanaka H, 2009, J NEUROPHYSIOL, V102, P2921, DOI 10.1152/jn.90834.2008; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26020	10.1371/journal.pone.0026020	http://dx.doi.org/10.1371/journal.pone.0026020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998746	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900092
J	Veyrac, A; Reibel, S; Sacquet, J; Mutin, M; Camdessanche, JP; Kolattukudy, P; Honnorat, J; Jourdan, F				Veyrac, Alexandra; Reibel, Sophie; Sacquet, Joelle; Mutin, Mireille; Camdessanche, Jean-Philippe; Kolattukudy, Pappachan; Honnorat, Jerome; Jourdan, Francois			CRMP5 Regulates Generation and Survival of Newborn Neurons in Olfactory and Hippocampal Neurogenic Areas of the Adult Mouse Brain	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-1; DENDRITIC DEVELOPMENT; CELL-PROLIFERATION; EXPRESSION; MICE; SYSTEM; FAMILY; DEATH; BULB; FOREBRAIN	The Collapsin Response Mediator Proteins (CRMPs) are highly expressed in the developing brain, and in adult brain areas that retain neurogenesis, ie: the olfactory bulb (OB) and the dentate gyrus (DG). During brain development, CRMPs are essentially involved in signaling of axon guidance and neurite outgrowth, but their functions in the adult brain remain largely unknown. CRMP5 has been initially identified as the target of auto-antibodies involved in paraneoplasic neurological diseases and further implicated in a neurite outgrowth inhibition mediated by tubulin binding. Interestingly, CRMP5 is also highly expressed in adult brain neurogenic areas where its functions have not yet been elucidated. Here we observed in both neurogenic areas of the adult mouse brain that CRMP5 was present in proliferating and post-mitotic neuroblasts, while they migrate and differentiate into mature neurons. In CRMP5(-/-) mice, the lack of CRMP5 resulted in a significant increase of proliferation and neurogenesis, but also in an excess of apoptotic death of granule cells in the OB and DG. These findings provide the first evidence that CRMP5 is involved in the generation and survival of newly generated neurons in areas of the adult brain with a high level of activity-dependent neuronal plasticity.	[Veyrac, Alexandra; Sacquet, Joelle; Jourdan, Francois] Univ Lyon 1, Team Neuroplast & Neuropathol Olfactory Percept, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292, F-69365 Lyon, France; [Reibel, Sophie; Mutin, Mireille; Camdessanche, Jean-Philippe; Honnorat, Jerome] Univ Lyon 1, Team Neurooncol & Neuroinflammat, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292,Fac Laennec, F-69365 Lyon, France; [Kolattukudy, Pappachan] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; State University System of Florida; University of Central Florida	Veyrac, A (corresponding author), Univ Lyon 1, Team Neuroplast & Neuropathol Olfactory Percept, Lyon Neurosci Res Ctr, INSERM,U1028,CNRS,UMR 5292, F-69365 Lyon, France.	jourdan@olfac.univ-lyon1.fr	Veyrac, Alexandra/G-8313-2017; Camdessanché, Jean-Philippe/N-9652-2017; kolattukudy, pappachan e/A-1350-2012; Honnorat, jerome/G-6394-2017	Camdessanché, Jean-Philippe/0000-0002-5282-6707; Honnorat, jerome/0000-0002-4721-5952; VEYRAC, Alexandra/0000-0002-8063-4016	CNRS (Centre National de la Recherche Scientifique); INSERM 5 Institut National de la Recherche Medicale; French Research Ministry through Universite Claude Bernard Lyon 1	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM 5 Institut National de la Recherche Medicale; French Research Ministry through Universite Claude Bernard Lyon 1	Funding for this work was obtained from the French academic institutions CNRS (Centre National de la Recherche Scientifique), INSERM 5 Institut National de la Recherche Medicale and French Research Ministry through Universite Claude Bernard Lyon 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Auvergnon N, 2009, BRAIN RES, V1261, P1, DOI 10.1016/j.brainres.2009.01.006; Bath KG, 2012, DEV PSYCHOBIOL, V54, P578, DOI 10.1002/dev.20546; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Duplan L, 2010, J NEUROSCI, V30, P785, DOI 10.1523/JNEUROSCI.5411-09.2010; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Honnorat J, 1999, EUR J NEUROSCI, V11, P4226, DOI 10.1046/j.1460-9568.1999.00864.x; Honnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; HOWARD C, 1998, UNBIASED STEREOLOGY, P41; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Inatome R, 2000, J BIOL CHEM, V275, P27291; McLaughlin D, 2008, NEUROSCI LETT, V432, P117, DOI 10.1016/j.neulet.2007.12.011; Meyronet D, 2008, AM J SURG PATHOL, V32, P1699, DOI 10.1097/PAS.0b013e31817dc37c; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; Petreanu L, 2002, J NEUROSCI, V22, P6106; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veyrac A, 2005, EXP NEUROL, V194, P444, DOI 10.1016/j.expneurol.2005.03.004; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Veyrac A, 2011, FASEB J, V25, P1048, DOI 10.1096/fj.10-172635; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	33	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e23721	10.1371/journal.pone.0023721	http://dx.doi.org/10.1371/journal.pone.0023721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991301	Green Submitted, Green Published, gold			2022-12-25	WOS:000295963300002
J	Chisti, MJ; Salam, MA; Smith, JH; Ahmed, T; Ashraf, H; Bardhan, PK; Pietroni, MAC				Chisti, Mohammod J.; Salam, Mohammed A.; Smith, Jonathan Harvey; Ahmed, Tahmeed; Ashraf, Hasan; Bardhan, Pradip K.; Pietroni, Mark A. C.			Impact of Lack of Breast Feeding during Neonatal Age on the Development of Clinical Signs of Pneumonia and Hypoxemia in Young Infants with Diarrhea	PLOS ONE			English	Article							MALNOURISHED CHILDREN; LUNG-FUNCTION; RISK-FACTORS; MORTALITY; BANGLADESH; CHILDHOOD; INFECTION; MADAGASCAR; MANAGEMENT; INITIATION	Background: Hypoxemia is a grave sequel of pneumonia, and an important predictor of a fatal outcome. Pneumonia in the neonatal period is often associated with lack of breast feeding. However, there is no published report on the impact of the cessation of breast feeding in the neonatal period on the development of pneumonia and hypoxemia. The purpose of our study was to assess the impact of non-breast feeding or stopping breast feeding during the neonatal period (henceforth to be referred to as non-breast fed) on clinical features of pneumonia and hypoxemia in 0-6-month-old infants with diarrhea admitted to an urban hospital in Bangladesh. Methods: We prospectively enrolled all infants (n = 107) aged 0 to 6 months who were admitted to the Special Care Ward (SCW) of the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR,B) with diarrhea and pneumonia from September 2007 through December 2007. We compared the clinical features of pneumonia and hypoxemia of breast fed infants (n = 34) with those who were non-breast fed (n = 73). Results: The median (inter-quartile range) duration of hypoxemia (hours) in non-breast-feds was longer than breast-fed infants [0.0 (0.0, 12.0) vs. 12.0 (0.0, 21.75); p = 0.021]. After adjusting for potential confounders such as inability to drink, fever, head nodding, cyanosis, grunting respiration, and lower chest wall in drawing, the non-breast-fed infants with pneumonia along with diarrhea had a higher probability of cough (OR 9.09; CI 1.34-61.71; p = 0.024), hypoxemia (OR 3.32; CI 1.23-8.93; p = 0.017), and severe undernutrition (OR 3.42; CI 1.29-9.12; p = 0.014). Conclusions and Significance: Non-breast feeding or cessation of breast feeding during the neonatal period may substantially increase the incidence of severe malnutrition, incidence of cough, and both the incidence and duration of hypoxemia in young infants presenting with pneumonia and diarrhea. The findings emphasize the paramount importance of the continuation of breast feeding in the neonatal period and early infancy.	[Chisti, Mohammod J.; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Nutr Programme, Dhaka 1000, Bangladesh; [Chisti, Mohammod J.; Smith, Jonathan Harvey; Bardhan, Pradip K.; Pietroni, Mark A. C.] Int Ctr Diarrhoeal Dis Res, Execut Directors Div, Dhaka 1000, Bangladesh; [Smith, Jonathan Harvey] UCL, Inst Child Hlth, Portex Dept Paediat Anaesthesia, London, England	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of London; University College London	Chisti, MJ (corresponding author), Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Nutr Programme, GPO Box 128, Dhaka 1000, Bangladesh.	chisti@icddrb.org	Chisti, Mohammod J/A-7216-2018; Smith, Jonathan/S-9476-2019	Smith, Jonathan/0000-0002-0295-6773	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) [Gr-00233]; Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B); Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR,B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Baker EJ, 2006, J HEALTH POPUL NUTR, V24, P530; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brady JP, 2000, J TROP PEDIATRICS, V46, P200, DOI 10.1093/tropej/46.4.200; BROWN KH, 1992, ACTA PAEDIATR, V81, P127, DOI 10.1111/j.1651-2227.1992.tb12386.x; Castro-Rodriguez JA, 2008, ALLERGOL IMMUNOPATH, V36, P3, DOI 10.1157/13115664; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Chisti MJ, 2007, ACTA PAEDIATR, V96, P693, DOI 10.1111/j.1651-2227.2007.00192.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P444, DOI 10.1097/INF.0b013e3181cb4608; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Guilbert TW, 2007, AM J RESP CRIT CARE, V176, P843, DOI 10.1164/rccm.200610-1507OC; Kelly D, 2000, P NUTR SOC, V59, P177, DOI 10.1017/S0029665100000197; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Libster R, 2009, PEDIATR INFECT DIS J, V28, P131, DOI 10.1097/INF.0b013e31818a8a82; Lopez-Alarcon M, 2004, ADV EXP MED BIOL, V554, P371; Major Vicki, 2002, J Okla State Med Assoc, V95, P711; MAJUMDER AK, 1991, J BIOSOC SCI, V23, P297, DOI 10.1017/S0021932000019362; MARQUIS GS, 1993, AM J CLIN NUTR, V57, P218, DOI 10.1093/ajcn/57.2.218; Montgomery-Downs HE, 2007, PEDIATRICS, V120, P1030, DOI 10.1542/peds.2007-0722; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Nagel G, 2009, EUR RESPIR J, V33, P993, DOI 10.1183/09031936.00075708; Ogawa J, 2004, EARLY HUM DEV, V77, P67, DOI 10.1016/j.earlhumdev.2004.01.005; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; RAVELOMANANA N, 1995, EUR J CLIN NUTR, V49, P91; Ryan AS, 2006, WOMEN HEALTH ISS, V16, P243, DOI 10.1016/j.whi.2006.08.001; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; World Health Organization, 1990, AC RESP INF CHILDR C; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	31	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25817	10.1371/journal.pone.0025817	http://dx.doi.org/10.1371/journal.pone.0025817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991362	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000078
J	Chua, KYL; Seemann, T; Harrison, PF; Monagle, S; Korman, TM; Johnson, PDR; Coombs, GW; Howden, BO; Davies, JK; Howden, BP; Stinear, TP				Chua, Kyra Y. L.; Seemann, Torsten; Harrison, Paul F.; Monagle, Shaun; Korman, Tony M.; Johnson, Paul D. R.; Coombs, Geoffrey W.; Howden, Brian O.; Davies, John K.; Howden, Benjamin P.; Stinear, Timothy P.			The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMPLETE GENOME SEQUENCE; VANCOMYCIN RESISTANCE; NECROTIZING PNEUMONIA; SKIN INFECTIONS; STRAINS; EVOLUTION; EPIDEMIC; DETERMINANTS; INSIGHTS	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 has spread rapidly across North America, and CA-MRSA is also increasing in Australia. However, the dominant Australian CA-MRSA strain, ST93-IV [2B] appears distantly related to USA300 despite strikingly similar clinical and epidemiological profiles. Here, we compared the virulence of a recent Australian ST93 isolate (JKD6159) to other MRSA, including USA300, and found that JKD6159 was the most virulent in a mouse skin infection model. We fully sequenced the genome of JKD6159 and confirmed that JKD6159 is a distinct clone with 7616 single nucleotide polymorphisms (SNPs) distinguishing this strain from all other S. aureus genomes. Despite its high virulence there were surprisingly few virulence determinants. However, genes encoding a-hemolysin, Panton-Valentine leukocidin (PVL) and alpha-type phenol soluble modulins were present. Genome comparisons revealed 32 additional CDS in JKD6159 but none appeared to encode new virulence factors, suggesting that this clone's enhanced pathogenicity could lie within subtler genome changes, such as SNPs within regulatory genes. To investigate the role of accessory genome elements in CA-MRSA epidemiology, we next sequenced three additional Australian non-ST93 CA-MRSA strains and compared them with JKD6159, 19 completed S. aureus genomes and 59 additional S. aureus genomes for which unassembled genome sequence data was publicly available (82 genomes in total). These comparisons showed that despite its distinctive genotype, JKD6159 and other CA-MRSA clones (including USA300) share a conserved repertoire of three notable accessory elements (SSCmecIV, PVL prophage, and pMW2). This study demonstrates that the genetically distinct ST93 CA-MRSA from Australia is highly virulent. Our comparisons of geographically and genetically diverse CA-MRSA genomes suggest that apparent convergent evolution in CA-MRSA may be better explained by the rapid dissemination of a highly conserved accessory genome from a common source.	[Chua, Kyra Y. L.; Davies, John K.; Howden, Benjamin P.; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Seemann, Torsten; Harrison, Paul F.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3168, Australia; [Chua, Kyra Y. L.; Johnson, Paul D. R.; Howden, Benjamin P.] Austin Hlth, Austin Ctr Infect Res, Dept Infect Dis, Heidelberg, Vic, Australia; [Howden, Benjamin P.] Austin Hlth, Dept Microbiol, Heidelberg, Vic, Australia; [Korman, Tony M.] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia; [Monagle, Shaun] Eastern Hlth, Dept Anat Pathol, Box Hill, Vic, Australia; [Coombs, Geoffrey W.] Royal Perth Hosp, Dept Microbiol & Infect Dis, PathWest Lab Med WA, Perth, WA, Australia; [Howden, Brian O.] Microsurg Consultants, Blackburn, Australia	Monash University; University of Melbourne; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Royal Perth Hospital; University of Western Australia	Chua, KYL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	Benjamin.Howden@austin.org.au; tstinear@unimelb.edu.au	Harrison, Paul/V-6978-2019; Seemann, Torsten/B-2318-2010; Korman, Tony M/I-3099-2013	Harrison, Paul/0000-0002-3980-268X; Seemann, Torsten/0000-0001-6046-610X; Korman, Tony M/0000-0002-6155-8353; Howden, Benjamin/0000-0003-0237-1473; Stinear, Timothy/0000-0003-0150-123X; Chua, Kyra Yu Lin/0000-0001-8826-7137; Coombs, Geoffrey/0000-0003-1635-6506	National Health and Medical Research Council of Australia [1008656]; CASS Foundation; Austin Hospital Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CASS Foundation; Austin Hospital Medical Research Foundation	This research was supported by the National Health and Medical Research Council of Australia Project Grant 1008656, the CASS Foundation and the Austin Hospital Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Howden BP, 2008, ANTIMICROB AGENTS CH, V52, P3755, DOI 10.1128/AAC.01613-07; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Peleg AY, 2005, EUR J CLIN MICROBIOL, V24, P384, DOI 10.1007/s10096-005-1329-3; Rasband W., 2006, IMAGEJ; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25887	10.1371/journal.pone.0025887	http://dx.doi.org/10.1371/journal.pone.0025887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991381	Green Published, gold			2022-12-25	WOS:000295943000092
J	Hill, PJ; Stritzker, J; Scadeng, M; Geissinger, U; Haddad, D; Basse-Lusebrink, TC; Gbureck, U; Jakob, P; Szalay, AA				Hill, Philip J.; Stritzker, Jochen; Scadeng, Miriam; Geissinger, Ulrike; Haddad, Daniel; Basse-Luesebrink, Thomas C.; Gbureck, Uwe; Jakob, Peter; Szalay, Aladar A.			Magnetic Resonance Imaging of Tumors Colonized with Bacterial Ferritin-Expressing Escherichia coli	PLOS ONE			English	Article							BLOOD-BRAIN BARRIER; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; TRANSGENE REPORTER; SUGAR-TRANSPORT; BREAST-TUMORS; MRI REPORTER; IRON-UPTAKE; THERAPY; PROTEINS	Background: Recent studies have shown that human ferritin can be used as a reporter of gene expression for magnetic resonance imaging (MRI). Bacteria also encode three classes of ferritin-type molecules with iron accumulation properties. Methods and Findings: Here, we investigated whether these bacterial ferritins can also be used as MRI reporter genes and which of the bacterial ferritins is the most suitable reporter. Bacterial ferritins were overexpressed in probiotic E. coli Nissle 1917. Cultures of these bacteria were analyzed and those generating highest MRI contrast were further investigated in tumor bearing mice. Among members of three classes of bacterial ferritin tested, bacterioferritin showed the most promise as a reporter gene. Although all three proteins accumulated similar amounts of iron when overexpressed individually, bacterioferritin showed the highest contrast change. By site-directed mutagenesis we also show that the heme iron, a unique part of the bacterioferritin molecule, is not critical for MRI contrast change. Tumor-specific induction of bacterioferritin-expression in colonized tumors resulted in contrast changes within the bacteria-colonized tumors. Conclusions: Our data suggest that colonization and gene expression by live vectors expressing bacterioferritin can be monitored by MRI due to contrast changes.	[Hill, Philip J.; Stritzker, Jochen; Geissinger, Ulrike; Szalay, Aladar A.] Genelux Corp, San Diego, CA 92109 USA; [Hill, Philip J.] Univ Nottingham, Sch Biosci, Leicester, Leics, England; [Hill, Philip J.] Univ Wurzburg, Sch Med, Virchow Ctr, Wurzburg, Germany; [Stritzker, Jochen; Szalay, Aladar A.] Bioctr, Inst Biochem, Wurzburg, Germany; [Stritzker, Jochen; Szalay, Aladar A.] Inst Mol Infect Biol, Wurzburg, Germany; [Haddad, Daniel; Basse-Luesebrink, Thomas C.; Jakob, Peter] Inst Expt Phys V, Wurzburg, Germany; [Haddad, Daniel; Basse-Luesebrink, Thomas C.; Jakob, Peter] MRB Res Ctr, Wurzburg, Germany; [Scadeng, Miriam] Univ Calif San Diego, Ctr Funct MRI, La Jolla, CA 92093 USA; [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany	University of Nottingham; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg	Hill, PJ (corresponding author), Genelux Corp, San Diego, CA 92109 USA.	aaszalay@genelux.com	hill, phil/AAQ-1081-2020; Gbureck, Uwe/G-1430-2012	hill, phil/0000-0002-2250-1397; Jakob, Peter/0000-0002-3481-5545; Scadeng, Miriam/0000-0002-9593-2956	Research and Development Division of Genelux Corporation, San Diego, United States of America; Service Grant; Genelux Corp.; Research and Development Division of Genelux Corporation	Research and Development Division of Genelux Corporation, San Diego, United States of America; Service Grant; Genelux Corp.; Research and Development Division of Genelux Corporation	This research was supported by the Research and Development Division of Genelux Corporation, San Diego, United States of America, and a Service Grant to the University of Wurzburg, Germany. PJH was supported by a grant received from Genelux Corp.; JS and AAS are employees and shareholders of Genelux Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The research was supported by the Research and Development Division of Genelux Corporation and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corporation. PJH was supported by a grant received from Genelux Corporation; JS and AAS are employees and shareholders of Genelux Corporation. PJH, JS and AAS are co-inventors of the patents "Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders'' (US 7820184 B2 and US 7763420 B2). There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All of the other authors declare that they have no conflicts of interest.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; ANDREWS SC, 1991, BIOCHIM BIOPHYS ACTA, V1078, P111, DOI 10.1016/0167-4838(91)90099-L; ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; Aung W, 2009, GENE THER, V16, P830, DOI 10.1038/gt.2009.55; Benoit MR, 2009, CLIN CANCER RES, V15, P5170, DOI 10.1158/1078-0432.CCR-08-3206; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; BRADER P, 2008, CLIN CAN RES; Brooks RA, 1998, MAGN RESON MED, V40, P227, DOI 10.1002/mrm.1910400208; BUSCHIAZZO PM, 1970, AM J PHYSIOL, V219, P1505, DOI 10.1152/ajplegacy.1970.219.5.1505; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; EIDELBERG E, 1967, J PHYSIOL-LONDON, V191, P47, DOI 10.1113/jphysiol.1967.sp008236; FOLEY JE, 1978, AM J PHYSIOL, V234, pE112, DOI 10.1152/ajpendo.1978.234.2.E112; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Gossuin Y, 2004, NMR BIOMED, V17, P427, DOI 10.1002/nbm.903; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; GROSSMAN MJ, 1992, P NATL ACAD SCI USA, V89, P2419, DOI 10.1073/pnas.89.6.2419; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Harrison PM, 1998, MET IONS BIOL SYST, V35, P435; Hasegawa S, 2010, MAGN RESON MED SCI, V9, P37, DOI 10.2463/mrms.9.37; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; HUDSON AJ, 1993, EUR J BIOCHEM, V218, P985, DOI 10.1111/j.1432-1033.1993.tb18457.x; Kim HS, 2010, CANCER RES, V70, P7315, DOI 10.1158/0008-5472.CAN-10-0241; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Liu J, 2009, TISSUE ENG PART C-ME, V15, P739, DOI 10.1089/ten.TEC.2008.0678; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Ono K, 2009, BIOCHEM BIOPH RES CO, V388, P589, DOI 10.1016/j.bbrc.2009.08.055; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; RIEDEL CU, 2007, APPL ENV MICROBIOL; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Soghomonyan SA, 2005, CANCER GENE THER, V12, P101, DOI 10.1038/sj.cgt.7700779; STRITZKER J, 2007, INT J MED MICROBIOL; Stritzker Jochen, 2010, Bioeng Bugs, V1, P139, DOI 10.4161/bbug.1.2.10286; Stritzker J, 2010, INT J MED MICROBIOL, V300, P449, DOI 10.1016/j.ijmm.2010.02.004; Taniguchi S, 2010, CANCER SCI, V101, P1925, DOI 10.1111/j.1349-7006.2010.01628.x; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; TRIKHA J, 1994, PROTEINS, V18, P107, DOI 10.1002/prot.340180204; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Vymazal J, 1996, MAGN RESON MED, V36, P61, DOI 10.1002/mrm.1910360111; VYMAZAL J, 1992, MAGNET RESON MED, V27, P368, DOI 10.1002/mrm.1910270218; Wall DM, 2010, ONCOTARGET, V1, P721; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	56	19	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25409	10.1371/journal.pone.0025409	http://dx.doi.org/10.1371/journal.pone.0025409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984917	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000029
J	Kanamori-Katayama, M; Kaiho, A; Ishizu, Y; Okamura-Oho, Y; Hino, O; Abe, M; Kishimoto, T; Sekihara, H; Nakamura, Y; Suzuki, H; Forrest, ARR; Hayashizaki, Y				Kanamori-Katayama, Mutsumi; Kaiho, Ai; Ishizu, Yuri; Okamura-Oho, Yuko; Hino, Okio; Abe, Masaaki; Kishimoto, Takumi; Sekihara, Hisahiko; Nakamura, Yukio; Suzuki, Harukazu; Forrest, Alistair R. R.; Hayashizaki, Yoshihide			LRRN4 and UPK3B Are Markers of Primary Mesothelial Cells	PLOS ONE			English	Article							MEGAKARYOCYTE POTENTIATING FACTOR; MALIGNANT MESOTHELIOMA; GENE-EXPRESSION; MOLECULAR-CLONING; ESTABLISHMENT; IDENTIFICATION; DIAGNOSIS; ASBESTOS; CANCER; DIFFERENTIATION	Background: Mesothelioma is a highly malignant tumor that is primarily caused by occupational or environmental exposure to asbestos fibers. Despite worldwide restrictions on asbestos usage, further cases are expected as diagnosis is typically 2040 years after exposure. Once diagnosed there is a very poor prognosis with a median survival rate of 9 months. Considering this the development of early pre clinical diagnostic markers may help improve clinical outcomes. Methodology: Microarray expression arrays on mesothelium and other tissues dissected from mice were used to identify candidate mesothelial lineage markers. Candidates were further tested by qRTPCR and in-situ hybridization across a mouse tissue panel. Two candidate biomarkers with the potential for secretion, uroplakin 3B (UPK3B), and leucine rich repeat neuronal 4 (LRRN4) and one commercialized mesothelioma marker, mesothelin (MSLN) were then chosen for validation across a panel of normal human primary cells, 16 established mesothelioma cell lines, 10 lung cancer lines, and a further set of 8 unrelated cancer cell lines. Conclusions: Within the primary cell panel, LRRN4 was only detected in primary mesothelial cells, but MSLN and UPK3B were also detected in other cell types. MSLN was detected in bronchial epithelial cells and alveolar epithelial cells and UPK3B was detected in retinal pigment epithelial cells and urothelial cells. Testing the cell line panel, MSLN was detected in 15 of the 16 mesothelioma cells lines, whereas LRRN4 was only detected in 8 and UPK3B in 6. Interestingly MSLN levels appear to be upregulated in the mesothelioma lines compared to the primary mesothelial cells, while LRRN4 and UPK3B, are either lost or down-regulated. Despite the higher fraction of mesothelioma lines positive for MSLN, it was also detected at high levels in 2 lung cancer lines and 3 other unrelated cancer lines derived from papillotubular adenocarcinoma, signet ring carcinoma and transitional cell carcinoma.	[Kanamori-Katayama, Mutsumi; Kaiho, Ai; Ishizu, Yuri; Suzuki, Harukazu; Forrest, Alistair R. R.; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, OMICs Sci Ctr, Kanagawa, Japan; [Okamura-Oho, Yuko] RIKEN Adv Sci Inst, Adv Computat Sci Dept, Wako, Saitama, Japan; [Hino, Okio; Abe, Masaaki] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan; [Kishimoto, Takumi] Japan Labor Hlth & Welf Org Okayama Rosai Hosp, Dept Resp Med, Okayama, Japan; [Sekihara, Hisahiko] Japan Labour Hlth & Welf Org, Kawasaki, Kanagawa, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan	RIKEN; RIKEN; Juntendo University; RIKEN	Kanamori-Katayama, M (corresponding author), RIKEN Yokohama Inst, OMICs Sci Ctr, Kanagawa, Japan.	alistair.forrest@gmail.com; rgscerg@gsc.riken.jp	Hayashizaki, Yoshihide/N-6590-2015; Suzuki, Harukazu/N-9553-2015; Nakamura, Yukio/A-5263-2016	Suzuki, Harukazu/0000-0002-8087-0836; Nakamura, Yukio/0000-0001-8056-4946; Forrest, Alistair/0000-0003-4543-1675	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology to the RIKEN Omics Science Center to Yoshihide Hayashizaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameille Jacques, 2004, Rev Prat, V54, P1649; AMIN KM, 1995, AM J PATHOL, V146, P344; Aoe K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e12007; ARMSTRONG BK, 1984, MED J AUSTRALIA, V141, P86, DOI 10.5694/j.1326-5377.1984.tb132709.x; Bando T, 2005, MOL CELL BIOL, V25, P4166, DOI 10.1128/MCB.25.10.4166-4175.2005; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMIN H, 2009, J CLIN ONCOL, V27; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chen Y, 2003, CANCER RES, V63, P1927; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eba S, 2009, Kyobu Geka, V62, P598; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gordon GJ, 2002, CANCER RES, V62, P4963; Hagiwara Y, 2008, CANCER SCI, V99, P666, DOI 10.1111/j.1349-7006.2008.00731.x; HILL ID, 1966, P ROY SOC MED, V59, P59, DOI 10.1177/003591576605900126; Ichikawa M, 2005, NEUROBIOL DIS, V19, P378, DOI 10.1016/j.nbd.2005.01.021; Ishikawa K, 2009, PATHOL INT, V59, P161, DOI 10.1111/j.1440-1827.2009.02344.x; Ivanov SV, 2009, INT J CANCER, V124, P589, DOI 10.1002/ijc.23949; JASANI B, 1985, VIRCHOWS ARCH A, V406, P441, DOI 10.1007/BF00710235; Jirsova K, 2010, EXP EYE RES, V91, P623, DOI 10.1016/j.exer.2010.08.002; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Ladou J, 2010, ENVIRON HEALTH PERSP, V118, P897, DOI 10.1289/ehp.1002285; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Li Zhong-Qian, 2007, Expert Opin Med Diagn, V1, P137, DOI 10.1517/17530059.1.1.137; Liu CC, 2006, NUCLEIC ACIDS RES, V34, P4069, DOI 10.1093/nar/gkl583; Liu ZW, 2004, ANTICANCER RES, V24, P599; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Mazieres J, 2005, INT J CANCER, V117, P326, DOI 10.1002/ijc.21160; MCNULTY JC, 1962, MED J AUSTRALIA, V2, P953, DOI 10.5694/j.1326-5377.1962.tb24396.x; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Phelps RM, 1996, J CELL BIOCHEM, P32; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; SELIKOFF IJ, 1980, CANCER, V46, P2736, DOI 10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L; SHEIBANI K, 1991, AM J SURG PATHOL, V15, P779, DOI 10.1097/00000478-199108000-00008; Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Suzuki H, 2004, FEBS LETT, V573, P214, DOI 10.1016/j.febslet.2004.07.068; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; VERSNEL M, 2002, HUMAN CELL CULTURE; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; WAGNER J C, 1960, Br J Ind Med, V17, P260; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; YUNG S, 1995, AM J PATHOL, V146, P520	51	52	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25391	10.1371/journal.pone.0025391	http://dx.doi.org/10.1371/journal.pone.0025391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984916	Green Submitted, gold, Green Published			2022-12-25	WOS:000295943000028
J	Lin, Y; Son, H; Lee, J; Min, K; Choi, GJ; Kim, JC; Lee, YW				Lin, Yang; Son, Hokyoung; Lee, Jungkwan; Min, Kyunghun; Choi, Gyung Ja; Kim, Jin-Cheol; Lee, Yin-Won			A Putative Transcription Factor MYT1 Is Required for Female Fertility in the Ascomycete Gibberella zeae	PLOS ONE			English	Article							FUSARIUM-GRAMINEARUM; FUNCTIONAL ANALYSES; HEAD-BLIGHT; C-MYB; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; BINDING PROTEIN; GENE; WHEAT; DIFFERENTIATION	Gibberella zeae is an important pathogen of major cereal crops. The fungus produces ascospores that forcibly discharge from mature fruiting bodies, which serve as the primary inocula for disease epidemics. In this study, we characterized an insertional mutant Z39P105 with a defect in sexual development and identified a gene encoding a putative transcription factor designated as MYT1. This gene contains a Myb DNA-binding domain and is conserved in the subphylum Pezizomycotina of Ascomycota. The MYT1 protein fused with green fluorescence protein localized in nuclei, which supports its role as a transcriptional regulator. The MYT1 deletion mutant showed similar phenotypes to the wild-type strain in vegetative growth, conidia production and germination, virulence, and mycotoxin production, but had defect in female fertility. A mutant overexpressing MYT1 showed earlier germination, faster mycelia growth, and reduced mycotoxin production compared to the wild-type strain, suggesting that improper MYT1 expression affects the expression of genes involved in the cell cycle and secondary metabolite production. This study is the first to characterize a transcription factor containing a Myb DNA-binding domain that is specific to sexual development in G. zeae.	[Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lin, Yang; Son, Hokyoung; Min, Kyunghun; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Lee, Jungkwan] Dong A Univ, Dept Appl Biol, Pusan, South Korea; [Choi, Gyung Ja; Kim, Jin-Cheol] Korea Res Inst Chem Technol, Biol Funct Res Team, Taejon 305606, South Korea	Seoul National University (SNU); Seoul National University (SNU); Dong A University; Korea Research Institute of Chemical Technology (KRICT)	Lin, Y (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	lee2443@snu.ac.kr		Min, Kyunghun/0000-0002-2682-4660; Son, Hokyoung/0000-0001-5080-7951	National Research Foundation of Korea (NRF); Korean government (MEST) [2010-0001826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2010-0001826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Desjardins AE, 2004, APPL ENVIRON MICROB, V70, P2437, DOI 10.1128/AEM.70.4.2437-2444.2004; DESJARDINS AE, FUSARIUM MYCOTOXINS; Dill-Macky R, 2000, PLANT DIS, V84, P71, DOI 10.1094/PDIS.2000.84.1.71; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DYER PS, 1992, BIOL REV, V67, P421, DOI 10.1111/j.1469-185X.1992.tb01189.x; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Hong SY, 2010, FUNGAL GENET BIOL, V47, P364, DOI 10.1016/j.fgb.2010.01.005; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kwon SJ, 2009, VIRUS RES, V144, P96, DOI 10.1016/j.virusres.2009.04.004; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee J, 2010, BIOCHEM BIOPH RES CO, V401, P48, DOI 10.1016/j.bbrc.2010.09.005; Lee J, 2009, APPL ENVIRON MICROB, V75, P3289, DOI 10.1128/AEM.02287-08; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee SH, 2006, FUNGAL GENET BIOL, V43, P295, DOI 10.1016/j.fgb.2005.12.007; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Leslie JF, 1996, GENETICS, V144, P557; Lipsick JS, 1996, ONCOGENE, V13, P223; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Park J, 2008, NUCLEIC ACIDS RES, V36, pD562, DOI 10.1093/nar/gkm758; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; RAJU NB, 1986, MYCOLOGIA, V78, P901, DOI 10.2307/3807428; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rodriguez-Sanchez L, 2011, J CELL SCI, V124, P25, DOI 10.1242/jcs.070987; Sambrook J, 2001, MOL CLONING LAB MANU; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Shen WC, 1998, GENETICS, V148, P1031; Shim WB, 2006, MOL PLANT MICROBE IN, V19, P725, DOI 10.1094/MPMI-19-0725; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Trail F, 2000, MYCOLOGIA, V92, P130, DOI 10.2307/3761457; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	62	21	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25586	10.1371/journal.pone.0025586	http://dx.doi.org/10.1371/journal.pone.0025586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984921	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000043
J	Pons, E; Navarro, A; Ollitrault, P; Pena, L				Pons, Elsa; Navarro, Antonio; Ollitrault, Patrick; Pena, Leandro			Pollen Competition as a Reproductive Isolation Barrier Represses Transgene Flow between Compatible and Co-Flowering Citrus Genotypes	PLOS ONE			English	Article							GENE FLOW; MATING PATTERNS; RISK-ASSESSMENT; TUBE GROWTH; FRUIT-SET; DISPERSAL; POPULATION; L.; HYBRIDIZATION; NEIGHBORHOOD	Background/Objective: Despite potential benefits granted by genetically modified (GM) fruit trees, their release and commercialization raises concerns about their potential environmental impact, and the transfer via pollen of transgenes to cross-compatible cultivars is deemed to be the greatest source for environmental exposure. Information compiled from field trials on GM trees is essential to propose measures to minimize the transgene dispersal. We have conducted a field trial of seven consecutive years to investigate the maximum frequency of pollen-mediated crop-to-crop transgene flow in a citrus orchard, and its relation to the genetic, phenological and environmental factors involved. Methodology/Principal Findings: Three different citrus genotypes carrying the uidA (GUS) tracer marker gene (pollen donors) and a non-GM self-incompatible contiguous citrus genotype (recipient) were used in conditions allowing natural entomophilous pollination to occur. The examination of 603 to 2990 seeds per year showed unexpectedly low frequencies (0.17-2.86%) of transgene flow. Paternity analyses of the progeny of subsets of recipient plants using 10 microsatellite (SSR) loci demonstrated a higher mating competence of trees from another non-GM pollen source population that greatly limited the mating chance of the contiguous cross-compatible and flowering-synchronized transgenic pollen source. This mating superiority could be explained by a much higher pollen competition capacity of the non-GM genotypes, as was confirmed through mixed-hand pollinations. Conclusions/Significance: Pollen competition strongly contributed to transgene confinement. Based on this finding, suitable isolation measures are proposed for the first time to prevent transgene outflow between contiguous plantings of citrus types that may be extendible to other entomophilous transgenic fruit tree species.	[Pons, Elsa; Navarro, Antonio; Ollitrault, Patrick; Pena, Leandro] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain; [Ollitrault, Patrick] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Ameliorat Genet Especes Multiplicat Vegetat, Montpellier, France	Instituto Valenciano de Investigaciones Agrarias (IVIA); CIRAD	Pons, E (corresponding author), Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	lpenya@ivia.es	Pons Bayarri, Elsa/J-5403-2016; Peña, Leandro/F-9089-2014	Pons Bayarri, Elsa/0000-0002-2736-9276; Peña, Leandro/0000-0002-9853-366X; Ollitrault, Patrick/0000-0002-9456-5517	Fondo Europeo de Desarrollo Regional (FEDER) [AGL2009-08052]; Ministerio de Ciencia e Innovacion (MICINN)	Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant AGL2009-08052, co-financed by the Fondo Europeo de Desarrollo Regional (FEDER) and the Ministerio de Ciencia e Innovacion (MICINN). Elsa Pons was a recipient of a PhD fellowship from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti M., 1997, Fruits (Paris), V52, P287; Aldridge G, 2006, AM J BOT, V93, P903, DOI 10.3732/ajb.93.6.903; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Aleza P, 2011, ANN BOT-LONDON, V108, P37, DOI 10.1093/aob/mcr099; Bock Anne-Katrin, 2002, SCENARIOS COEXISTENC; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Cameron JW, 1968, CITRUS IND, V1, P325; CAMPBELL DR, 1985, EVOLUTION, V39, P418, DOI [10.2307/2408374, 10.1111/j.1558-5646.1985.tb05678.x]; Carney SE, 1996, EVOLUTION, V50, P1871, DOI [10.2307/2410745, 10.1111/j.1558-5646.1996.tb03574.x]; Cervera M, 2000, THEOR APPL GENET, V100, P670, DOI 10.1007/s001220051338; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Coart E, 2003, MOL ECOL, V12, P845, DOI 10.1046/j.1365-294X.2003.01778.x; Cottrell JE, 2009, HEREDITY, V103, P118, DOI 10.1038/hdy.2009.39; Cuenca J, 2010, HEREDITY IN PRESS; Darwin C., 1877, DIFFERENT FORMS FLOW; de Jong TJ, 2005, ACTA OECOL, V28, P331, DOI 10.1016/j.actao.2005.07.001; DEGANI C, 1995, J AM SOC HORTIC SCI, V120, P523, DOI 10.21273/JASHS.120.3.523; DEGANI C, 1990, HORTSCIENCE, V25, P471, DOI 10.21273/HORTSCI.25.4.471; Delph LF., 1998, SPERM COMPETITION SE, P149, DOI [10.1016/B978-012100543-6/50030-1, DOI 10.1016/B978-012100543-6/50030-1]; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; FREE JB, 1960, J ANIM ECOL, V29, P385, DOI 10.2307/2211; Froelicher Y, 2008, MOL ECOL RESOUR, V8, P119, DOI 10.1111/j.1471-8286.2007.01893.x; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Howard DJ, 1998, ENDLESS FORMS, P279; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jackson JF, 1996, SEX PLANT REPROD, V9, P367, DOI 10.1007/BF02441958; Jia HJ, 2008, J INTEGR PLANT BIOL, V50, P203, DOI 10.1111/j.1744-7909.2007.00382.x; Jorgensen RB, 2005, BIOL SCI SER, P113; Kijas JMH, 1997, THEOR APPL GENET, V94, P701, DOI 10.1007/s001220050468; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; LEVIN DA, 1969, EVOLUTION, V23, P560, DOI 10.1111/j.1558-5646.1969.tb03541.x; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BaoRong, 2009, Biodiversity Science, V17, P362, DOI 10.3724/SP.J.1003.2009.09132; LUBY JJ, 1995, THEOR APPL GENET, V90, P1133, DOI 10.1007/BF00222933; MARSHALL DL, 1991, ANNU REV ECOL SYST, V22, P37, DOI 10.1146/annurev.es.22.110191.000345; Mateu, 2003, REV EPIDEM MED PREV, V1, P8; Matsumoto S, 2008, SCI HORTIC-AMSTERDAM, V117, P151, DOI 10.1016/j.scienta.2008.03.025; MCGARVEY P, 1991, BIOTECHNIQUES, V11, P428; MOFFETT J O, 1974, American Bee Journal, V114, P21; Mulas M., 2008, Informatore Agrario, V64, P57; National Research Council, 2010, STRAT PLANN FLOR CIT; Niesenbaum RA, 1997, SEX PLANT REPROD, V10, P101, DOI 10.1007/s004970050074; NRC (National Research Council), 2000, GEN MOD PESTPR PLANT; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Pena L, 2008, COMPENDIUM TRANSGENI, P1; Ricroch A, 2009, CR BIOL, V332, P861, DOI 10.1016/j.crvi.2009.07.001; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1995, AM J BOT, V82, P515, DOI 10.2307/2445699; Saeglitz C, 2000, MOL ECOL, V9, P2035, DOI 10.1046/j.1365-294X.2000.01109.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SNOW AA, 1994, AM NAT, V144, pS69, DOI 10.1086/285653; Soost R. K., 1975, Advances in fruit breeding. Subtropical fruits., P507; Wallace HM, 2002, HORTSCIENCE, V37, P84, DOI 10.21273/HORTSCI.37.1.84; Wallace HM, 1999, J HORTIC SCI BIOTECH, V74, P82, DOI 10.1080/14620316.1999.11511077; Waser N.M., 1983, P277; Williams JH, 1999, P NATL ACAD SCI USA, V96, P9201, DOI 10.1073/pnas.96.16.9201; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437	63	10	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25810	10.1371/journal.pone.0025810	http://dx.doi.org/10.1371/journal.pone.0025810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991359	Green Published, gold			2022-12-25	WOS:000295943000076
J	Rai, MF; Graeve, T; Twardziok, S; Schmidt, MFG				Rai, Muhammad Farooq; Graeve, Thomas; Twardziok, Sven; Schmidt, Michael F. G.			Evidence for Regulated Interleukin-4 Expression in Chondrocyte-Scaffolds under In Vitro Inflammatory Conditions	PLOS ONE			English	Article							NF-KAPPA-B; ARTICULAR-CARTILAGE; GENE-TRANSFER; OSTEOARTHRITIS; CYTOKINES; IL-4; ARTHRITIS; MEDIATORS; RECEPTOR; DEFECTS	Objective: To elucidate the anti-inflammatory and anabolic effects of regulated expression of IL-4 in chondrocyte-scaffolds under in vitro inflammatory conditions. Methods: Mature articular chondrocytes from dogs (n = 3) were conditioned through transient transfection using pcDNA3.1. cIL-4 (constitutive) or pCOX-2. cIL-4 (cytokine-responsive) plasmids. Conditioned cells were seeded in alginate microspheres and rat-tail collagen type I matrix (CaReS (R)) to generate two types of tissue-engineered 3-dimensional scaffolds. Inflammatory arthritis was simulated in the packed chondrocytes through exogenous addition of recombinant canine (rc) IL-1 beta (100 ng/ml) plus rcTNF alpha (50 ng/ml) in culture media for 96 hours. Harvested cells and culture media were analyzed by various assays to monitor the anti-inflammatory and regenerative (anabolic) properties of cIL-4. Results: cIL-4 was expressed from COX-2 promoter exclusively on the addition of rcIL-1 beta and rcTNF alpha while its expression from CMV promoter was constitutive. The expressed cIL-4 downregulated the mRNA expression of IL-1 beta, TNF alpha, IL-6, iNOS and COX-2 in the cells and inhibited the production of NO and PGE(2) in culture media. At the same time, it up-regulated the expression of IGF-1, IL-1ra, COL2a1 and aggrecan in conditioned chondrocytes in both scaffolds along with a diminished release of total collagen and sGAG into the culture media. An increased amount of cIL-4 protein was detected both in chondrocyte cell lysate and in concentrated culture media. Neutralizing anti-cIL-4 antibody assay confirmed that the anti-inflammatory and regenerative effects seen are exclusively driven by cIL-4. There was a restricted expression of IL-4 under COX-2 promoter possibly due to negative feedback loop while it was over-expressed under CMV promoter (undesirable). Furthermore, the anti-inflammatory/anabolic outcomes from both scaffolds were reproducible and the therapeutic effects of cIL-4 were both scaffold-and promoter-independent. Conclusions: Regulated expression of therapeutic candidate gene(s) coupled with suitable scaffold(s) could potentially serve as a useful tissue-engineering tool to devise future treatment strategies for osteoarthritis.	[Rai, Muhammad Farooq; Graeve, Thomas; Schmidt, Michael F. G.] Free Univ Berlin, Inst Immunol & Mol Biol, Dept Vet Med, Berlin, Germany; Amedrix GmbH, Esslingen, Germany; [Twardziok, Sven] Charite, Inst Mol Biol & Bioinformat, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rai, MF (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Sch Med,Barnes Jewish Hosp, St Louis, MO 63130 USA.	schmidt.mfg@vetmed.fu-berlin.de	Farooq, Muhammad/ABE-6335-2021	Rai, Muhammad Farooq/0000-0003-4826-4331; Twardziok, Sven/0000-0002-0326-5704	Freie Universitat Berlin, Germany; DFG [Schm 442/11-2]	Freie Universitat Berlin, Germany; DFG(German Research Foundation (DFG))	This study was supported through Freie Universitat Berlin, Germany albeit the initiating work was funded by the DFG through project Schm 442/11-2 to MFGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CaReS matrix were provided by Amedrix Esslingen, Germany.	Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; Andereya S, 2007, Z ORTHOP UNFALLCHIR, V145, P139, DOI 10.1055/s-2007-965181; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Dare EV, 2009, TISSUE ENG PT A, V15, P2285, DOI 10.1089/ten.tea.2008.0228; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Garvican ER, 2010, J ORTHOP RES, V28, P370, DOI 10.1002/jor.21001; GENG Y, 1995, J IMMUNOL, V155, P796; Geurts J, 2007, GENE THER, V14, P1632, DOI 10.1038/sj.gt.3303022; Goldring MB, 1999, CONNECT TISSUE RES, V40, P1, DOI 10.3109/03008209909005273; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hardingham T, 2002, ARTHRITIS RES THER, V4, pS63, DOI 10.1186/ar561; Hegemann N, 2005, VET COMP ORTHOPAED, V18, P67, DOI 10.1055/s-0038-1632931; Hennerbichler A, 2008, ARCH ORTHOP TRAUM SU, V128, P61, DOI 10.1007/s00402-007-0360-5; Jovanovic D, 1998, OSTEOARTHR CARTILAGE, V6, P40, DOI 10.1053/joca.1997.0091; Lubberts E, 1999, J IMMUNOL, V163, P4546; Madry H, 2003, J GENE MED, V5, P502, DOI 10.1002/jgm.368; Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688; Manna SK, 1998, J BIOL CHEM, V273, P33333, DOI 10.1074/jbc.273.50.33333; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Nuki G, 1999, OSTEOARTHRITIS CLIN, P101; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pelletier JP, 2000, ARTHRITIS ALLIED CON, P2195; Rachakonda PS, 2008, CYTOKINE, V44, P179, DOI 10.1016/j.cyto.2008.07.470; Rachakonda PS, 2008, ARTHRITIS RHEUM-US, V58, P2088, DOI 10.1002/art.23598; Rai MF, 2008, CYTOKINE, V42, P8, DOI 10.1016/j.cyto.2008.02.004; Rai MF, 2009, RES VET SCI, V87, P399, DOI 10.1016/j.rvsc.2009.04.008; Relic B, 2001, J IMMUNOL, V166, P2775, DOI 10.4049/jimmunol.166.4.2775; Salter DM, 2002, BIORHEOLOGY, V39, P97; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schulz RM, 2008, BIO-MED MATER ENG, V18, pS55; SEITZ M, 1994, BRIT J RHEUMATOL, V33, P613; Studer RK, 2004, OSTEOARTHR CARTILAGE, V12, P863, DOI 10.1016/j.joca.2004.07.005; Van den Berg Wim B, 2002, Curr Rheumatol Rep, V4, P232; Watanabe S, 2000, MOL THER, V2, P147, DOI 10.1006/mthe.2000.0111; Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams CJ, 1999, OSTEOARTHRITIS CLIN, P134; Wondimu A, 2001, CYTOKINE, V16, P88, DOI 10.1006/cyto.2001.0953; Woods JM, 2001, J IMMUNOL, V166, P1214, DOI 10.4049/jimmunol.166.2.1214; Yanez JA, 2008, J MED SCI, V8, P98	50	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25749	10.1371/journal.pone.0025749	http://dx.doi.org/10.1371/journal.pone.0025749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991344	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000063
J	Dong, GY; Xu, C; Wang, CM; Wu, B; Luo, J; Zhang, H; Nolte, DL; Deliberto, TJ; Duan, MX; Ji, GJ; He, HX				Dong, Guoying; Xu, Cong; Wang, Chengmin; Wu, Bin; Luo, Jing; Zhang, Hong; Nolte, Dale Louis; Deliberto, Thomas Jude; Duan, Mingxing; Ji, Guangju; He, Hongxuan			Reassortant H9N2 Influenza Viruses Containing H5N1-Like PB1 Genes Isolated from Black-Billed Magpies in Southern China	PLOS ONE			English	Article							A VIRUSES; MOLECULAR CHARACTERIZATION; AVIAN INFLUENZA; HONG-KONG; PHYLOGENETIC ANALYSIS; HUMAN INFECTION; MAINLAND CHINA; H5N1; EVOLUTION; DUCKS	H9N2 influenza A viruses have become endemic in different types terrestrial poultry and wild birds in Asia, and are occasionally transmitted to humans and pigs. To evaluate he role of black-billed magpies (Pica pica) in the evolution of influenza A virus, we conducted two epidemic surveys on avian influenza viruses in wild black-billed magpies in Guangxi, China in 2005 and characterized three isolated black-billed magpie H9N2 viruses (BbM viruses). Phylogenetic analysis indicated that three BbM viruses were almost identical with 99.7 to 100% nucleotide homology in their whole genomes, and were reassortants containing BJ94-like (Ck/BJ/1/94) HA, NA, M, and NS genes, SH/F/98-like (Ck/SH/F/98) PB2, PA, and NP genes, and H5N1-like (Ck/YN/1252/03, clade 1) PB1 genes. Genetic analysis showed that BbM viruses were most likely the result of multiple reassortments between co-circulating H9N2-like and H5N1-like viruses, and were genetically different from other H9N2 viruses because of the existence of H5N1-like PB1 genes. Genotypical analysis revealed that BbM viruses evolved from diverse sources and belonged to a novel genotype (B46) discovered in our recent study. Molecular analysis suggested that BbM viruses were likely low pathogenic reassortants. However, results of our pathogenicity study demonstrated that BbM viruses replicated efficiently in chickens and a mammalian mouse model but were not lethal for infected chickens and mice. Antigenic analysis showed that BbM viruses were antigenic heterologous with the H9N2 vaccine strain. Our study is probably the first report to document and characterize H9N2 influenza viruses isolated from black-billed magpies in southern China. Our results suggest that black-billed magpies were susceptible to H9N2 influenza viruses, which raise concerns over possible transmissions of reassortant H9N2 viruses among poultry and wild birds.	[Dong, Guoying; Wang, Chengmin; Wu, Bin; Luo, Jing; Zhang, Hong; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Xu, Cong] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China; [Nolte, Dale Louis; Deliberto, Thomas Jude] USDA, Natl Wildlife Dis Program, USDA APHIS Wildlife Serv, Ft Collins, CO USA; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Southwest University - China; United States Department of Agriculture (USDA); Tsinghua University	Dong, GY (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	gj28@ibp.ac.cn; hehx@ioz.ac.cn		Zhang, Hong/0000-0002-3930-6731; Ji, Guangju/0000-0001-8626-3490	science & technology support project of the eleventh-five-year plan of China [2009BAI83B01]; National Key Basic Research and Development Program of China [2007BC109103]; Chinese Academy of Sciences [KSCX2-YW-N-063]; NWDP USDA-IOZ CAS [0760621234]	science & technology support project of the eleventh-five-year plan of China; National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NWDP USDA-IOZ CAS	This work was supported by grants from the science & technology support project of the eleventh-five-year plan of China (2009BAI83B01), the National Key Basic Research and Development Program of China (Grant No. 2007BC109103), the Knowledge Innovation Project of the Chinese Academy of Sciences (Grant No. KSCX2-YW-N-063) and NWDP USDA-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen H, 2003, VACCINE, V21, P4430, DOI 10.1016/S0264-410X(03)00430-4; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kwon HJ, 2006, AVIAN PATHOL, V35, P309, DOI 10.1080/03079450600821166; Lee DCW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-71; Lee YJ, 2007, VIROLOGY, V359, P313, DOI 10.1016/j.virol.2006.09.025; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JH, 2003, VIRUS GENES, V27, P291, DOI 10.1023/A:1026304117797; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu B, 2009, CHINESE SCI BULL, V54, P2179, DOI 10.1007/s11434-009-0421-y; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	40	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25808	10.1371/journal.pone.0025808	http://dx.doi.org/10.1371/journal.pone.0025808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980538	Green Published, gold			2022-12-25	WOS:000295939600056
J	Renner, M; Domanov, Y; Sandrin, F; Izeddin, I; Bassereau, P; Triller, A				Renner, Marianne; Domanov, Yegor; Sandrin, Fanny; Izeddin, Ignacio; Bassereau, Patricia; Triller, Antoine			Lateral Diffusion on Tubular Membranes: Quantification of Measurements Bias	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; NONPLANAR FORM; PROTEINS; DYNAMICS; TRACKING; TRAJECTORIES; MICROSCOPY; RECEPTORS; MOLECULES; VESICLES	Single Particle Tracking (SPT) is a powerful technique for analysis of the lateral diffusion of the lipid and protein components of biological membranes. In neurons, SPT allows the study of the real-time dynamics of receptors for neurotransmitters that diffuse continuously in and out synapses. In the simplest case where the membrane is flat and is parallel to the focal plane of the microscope the analysis of diffusion from SPT data is relatively straightforward. However, in most biological samples the membranes are carved, which complicates analysis and may lead to erroneous conclutions as for the mode of lateral diffusion. Here we considered the case of lateral diffusion in tubular membranes, such as axons, dendrites or the neck of dendritic spines. Monte Carlo simulations allowed us to evaluate the error in diffusion coefficient (D) calculation if the curvature is not taken into account. The underestimation is determined by the diameter of the tubular surface, the frequency of image acquisition and the degree of mobility itself. We found that projected trajectories give estimates that are 25 to 50% lower than the real D in case of 2D-SPT over the tubular surface. The use of 3D-SPT improved the measurements if the frequency of image acquisition was fast enough in relation to the mobility of the molecules and the diameter of the tube. Nevertheless, the calculation of D from the components of displacements in the axis of he tubular structure gave accurate estimate of D, free of geometrical artefacts. We show the application of this approach to analyze the diffusion of a lipid on model tubular membranes and of a membrane-bound GFP on neurites from cultured rat hippocampal neuron.	[Renner, Marianne; Sandrin, Fanny; Izeddin, Ignacio; Triller, Antoine] Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, IBENS, U1024,UMR8197, Paris, France; [Domanov, Yegor; Sandrin, Fanny; Bassereau, Patricia] Univ Paris 06, Ctr Natl Rech Sci, Membrane & Cell Funct Grp, Inst Curie,Ctr Rech,UMR168, Paris, France; [Izeddin, Ignacio] IBENS, Lab Kastler Brossel, Dept Phys, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Renner, M (corresponding author), Ctr Natl Rech Sci, Inst Natl Sante & Rech Med, IBENS, U1024,UMR8197, Paris, France.	patricia.bassereau@curie.fr; triller@biologie.ens.fr	Izeddin, Ignacio/H-2628-2013; Renner, Marianne/H-5315-2011; Bassereau, Patricia/P-8657-2018	Izeddin, Ignacio/0000-0002-8476-3915; Renner, Marianne/0000-0002-8727-6581; Bassereau, Patricia/0000-0002-8544-6778; Domanov, Yegor/0000-0003-1531-6457; TRILLER, Antoine/0000-0002-7530-1233	Agence Nationale de la Recherche [ANR-Neur-043-02, ANR-08-Blan-0282-02]; Fondation Pierre-Gilles de Gennes; Marie Curie Actions; Netherlands Organisation for Scientific Research (NWO)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes; Marie Curie Actions(European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Agence Nationale de la Recherche ANR-Neur-043-02 and ANR-08-Blan-0282-02, Fondation Pierre-Gilles de Gennes, Marie Curie Actions, and Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZENBUD BM, 1985, BIOPHYS J, V48, P543, DOI 10.1016/S0006-3495(85)83811-X; AIZENBUD BM, 1982, BIOPHYS J, V38, P287, DOI 10.1016/S0006-3495(82)84560-8; Almeida P.F.F, 1995, HDB BIOL PHYS STRUCT, V1, P305; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Berglund AJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011917; Cuvelier D, 2005, EUROPHYS LETT, V71, P1015, DOI 10.1209/epl/i2005-10173-4; Daniels DR, 2007, LANGMUIR, V23, P6667, DOI 10.1021/la0635000; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Fournier JB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018103; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Long BR, 2010, BIOPHYS J, V98, P1712, DOI 10.1016/j.bpj.2009.12.4299; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wieser S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822890	29	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25731	10.1371/journal.pone.0025731	http://dx.doi.org/10.1371/journal.pone.0025731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980531	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600051
J	Germain, M; Saut, N; Greliche, N; Dina, C; Lambert, JC; Perret, C; Cohen, W; Oudot-Mellakh, T; Antoni, G; Alessi, MC; Zelenika, D; Cambien, F; Tiret, L; Bertrand, M; Dupuy, AM; Letenneur, L; Lathrop, M; Emmerich, J; Amouyel, P; Tregouet, DA; Morange, PE				Germain, Marine; Saut, Noemie; Greliche, Nicolas; Dina, Christian; Lambert, Jean-Charles; Perret, Claire; Cohen, William; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Alessi, Marie-Christine; Zelenika, Diana; Cambien, Francois; Tiret, Laurence; Bertrand, Marion; Dupuy, Anne-Marie; Letenneur, Luc; Lathrop, Mark; Emmerich, Joseph; Amouyel, Philippe; Tregouet, David-Alexandre; Morange, Pierre-Emmanuel			Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; SUSCEPTIBILITY LOCUS; PLASMA-LEVELS; PROTEIN-C; RISK; THROMBOEMBOLISM; POLYMORPHISMS; EPIDEMIOLOGY; TOOL	Background: Venous Thrombosis (VT) is a common multifactorial disease associated with a major public health burden. Genetics factors are known to contribute to the susceptibility of the disease but how many genes are involved and their contribution to VT risk still remain obscure. We aimed to identify genetic variants associated with VT risk. Methodology/Principal Findings: We conducted a genome-wide association study (GWAS) based on 551,141 SNPs genotyped in 1,542 cases and 1,110 controls. Twelve SNPs reached the genome-wide significance level of 2.0x10(-8) and encompassed four known VT-associated loci, ABO, F5, F11 and FGG. By means of haplotype analyses, we also provided novel arguments in favor of a role of HIVEP1, PROCR and STAB2, three loci recently hypothesized to participate in the susceptibility to VT. However, no novel VT-associated loci came out of our GWAS. Using a recently proposed statistical methodology, we also showed that common variants could explain about 35% of the genetic variance underlying VT susceptibility among which 3% could be attributable to the main identified VT loci. This analysis additionally suggested that the common variants left to be identified are not uniformly distributed across the genome and that chromosome 20, itself, could contribute to similar to 7% of the total genetic variance. Conclusions/Significance: This study might also provide a valuable source of information to expand our understanding of biological mechanisms regulating quantitative biomarkers for VT.	[Germain, Marine; Greliche, Nicolas; Perret, Claire; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] INSERM, UMR S 937, Paris, France; [Germain, Marine; Greliche, Nicolas; Perret, Claire; Oudot-Mellakh, Tiphaine; Antoni, Guillemette; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] Univ Paris 06, ICAN Inst, Paris, France; [Saut, Noemie; Cohen, William; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] INSERM, UMR S 626, F-13258 Marseille, France; [Saut, Noemie; Cohen, William; Alessi, Marie-Christine; Morange, Pierre-Emmanuel] Univ Mediterranee, Marseille, France; [Dina, Christian] Inst Thorax, Nantes, France; [Dina, Christian] CNRS, ERL3147, Nantes, France; [Dina, Christian] INSERM, UMR S 915, Nantes, France; [Lambert, Jean-Charles; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Lille, France; [Zelenika, Diana; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, Inst Genom, Evry, France; [Bertrand, Marion] Univ Paris 06, INSERM, UMR S 708, Paris, France; [Dupuy, Anne-Marie] Hop Colombiere, INSERM, U888, Montpellier, France; [Letenneur, Luc] INSERM, U897, Bordeaux, France; [Letenneur, Luc] Univ Victor Segalen, Bordeaux, France; [Emmerich, Joseph] Univ Paris 05, Hop Europeen Georges Pompidou, INSERM, Med Vasc HTA,U765, Paris, France; [Amouyel, Philippe] CHRU Lille, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille	Germain, M (corresponding author), INSERM, UMR S 937, Paris, France.	david.tregouet@upmc.fr; pierre.morange@ap-hm.fr	Cambien, Francois/AAP-9751-2020; lambert, jean-charles/F-8787-2013; Greliche, Nicolas/P-4180-2015; Dina, Christian R/D-3535-2015; Morange, Pierre/T-9070-2019; Tregouet, David-Alexandre/E-3961-2016; ALESSI, Marie-christine/AAK-3582-2020; Lambert, jean-charles/A-9553-2014; Trégouët, David-Alexandre/P-9210-2019; LETENNEUR, Luc/T-4424-2019	lambert, jean-charles/0000-0003-0829-7817; Greliche, Nicolas/0000-0003-0683-2257; Dina, Christian R/0000-0002-7722-7348; Morange, Pierre/0000-0002-9065-722X; ALESSI, Marie-christine/0000-0003-3927-5792; Lambert, jean-charles/0000-0003-0829-7817; Trégouët, David-Alexandre/0000-0001-9084-7800; LETENNEUR, Luc/0000-0002-3274-937X; Germain, Marine/0000-0002-8489-8916; Amouyel, Philippe/0000-0001-9088-234X; dupuy, anne marie/0000-0001-6538-3944	Agence Nationale pour la Recherche [ANR-07-MRAR-021]; Program Hospitalier de recherche Clinique [PHRC2009 RENOVA-TV, PHRC 20002]; Fondation pour la Recherche Medicale; Fondation de France; Leducq Foundation; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon; Ministry of Research-Inserm; Eisai	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Program Hospitalier de recherche Clinique; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Leducq Foundation(Leducq Foundation); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon(Region Occitanie); Ministry of Research-Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Eisai(Eisai Co Ltd)	M.G. was supported by grants funded by the Agence Nationale pour la Recherche (Project ANR-07-MRAR-021) and the Program Hospitalier de recherche Clinique (PHRC2009 RENOVA-TV). T.O.M. was supported by a grant from the Fondation pour la Recherche Medicale. The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique and the FARIVE study by grants from the Fondation pour la Recherche Medicale, the Program Hospitalier de recherche Clinique (PHRC 20002; PHRC2009 RENOVA-TV), the Fondation de France, and the Leducq Foundation. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale and La Region Ile de France. The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen -Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C-Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, the Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme 'Cohorts and collection of biological material'. The Lille Genopole received an unconditional grant from Eisai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Antoni G, 2010, J THROMB HAEMOST, V8, P2671, DOI 10.1111/j.1538-7836.2010.04092.x; Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Coombes R, 2005, BRIT MED J, V330, P559, DOI 10.1136/bmj.330.7491.559-c; de Willige SU, 2009, THROMB HAEMOSTASIS, V101, P1078, DOI 10.1160/TH08-12-0813; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Folsom AR, 2002, ARTERIOSCL THROM VAS, V22, P1018, DOI 10.1161/01.ATV.0000017470.08363.AB; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Larsen TB, 2003, EPIDEMIOLOGY, V14, P328, DOI 10.1097/00001648-200305000-00013; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; MacDougall DA, 2006, AM J HEALTH-SYST PH, V63, pS5, DOI 10.2146/ajhp060388; MANTEL N, 1959, J NATL CANCER I, V22, P719; Morange PE, 2011, J THROMB HAEMOST, V9, P229, DOI 10.1111/j.1538-7836.2010.04082.x; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Prandoni P, 2004, BMJ-BRIT MED J, V329, P484, DOI 10.1136/bmj.38167.684444.3A; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2011, BLOOD, V117, P6007, DOI 10.1182/blood-2010-10-315473; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Tang WH, 2010, BLOOD, V116, P5032, DOI 10.1182/blood-2010-05-283739; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	43	105	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25581	10.1371/journal.pone.0025581	http://dx.doi.org/10.1371/journal.pone.0025581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980494	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000295933700044
J	Leung, JY; Andrechek, ER; Cardiff, RD; Nevins, JR				Leung, J. Y.; Andrechek, E. R.; Cardiff, R. D.; Nevins, J. R.			Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence	ONCOGENE			English	Article						mouse; mammary; EMT; MYC; cancer	EPITHELIAL-MESENCHYMAL TRANSITIONS; HUMAN BREAST; GENOME; IDENTIFICATION; TUMORIGENESIS; INACTIVATION; CANCERS; MODELS; CELLS; EMT	A hallmark of human cancer is heterogeneity, reflecting the complex series of changes resulting in the activation of oncogenes coupled with inactivation of tumor suppressor genes. Breast cancer is no exception and indeed, many studies have revealed considerable complexity and heterogeneity in the population of primary breast tumors and substantial changes in a recurrent breast tumor that has acquired metastatic properties and drug resistance. We have made use of a Myc-inducible transgenic mouse model of breast cancer in which elimination of Myc activity following tumor development initially leads to a regression of a subset of tumors generally followed by de novo Myc-independent growth. We have observed that tumors that grow independent of Myc expression have gene profiles that are distinct from the primary tumors with characteristics indicative of an epithelial-mesenchymal transition (EMT) phenotype. Phenotypic analyses of Myc-independent tumors confirm the acquisition of an EMT phenotype suggested to be associated with invasive and migratory properties in human cancer cells. Further genomic analyses reveal mouse mammary tumors growing independent of myc have a higher probability of exhibiting a gene signature similar to that observed for human 'tumor-initiating' cells. Collectively, the data reveal genetic alterations that underlie tumor progression and an escape from Myc-dependent growth in a transgenic mouse model that can provide insights to what occurs in human cancers as they acquire drug resistance and metastatic properties. Oncogene (2012) 31, 2545-2554; doi:10.1038/onc.2011.433; published online 26 September 2011	[Leung, J. Y.; Nevins, J. R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; [Andrechek, E. R.] Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA; [Cardiff, R. D.] Univ Calif Davis, Dept Pathol & Lab Med, Ctr Comparat Med, Davis, CA 95616 USA; [Nevins, J. R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Michigan State University; University of California System; University of California Davis; Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, 101 Sci Dr,Box 3382, Durham, NC 27710 USA.	j.nevins@duke.edu		Andrechek, Eran/0000-0002-8680-3423	NIH [CA104663, CA112952]; National Cancer Institute's Mouse Models of Human Cancers Consortium [U01 CA141541, U01 CA141582]; JRN from the National Cancer Institute [RO1-CA104663, U54-CA112952]; NATIONAL CANCER INSTITUTE [U54CA112952, U01CA141582, R01CA104663, U01CA141541, R01CA106520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's Mouse Models of Human Cancers Consortium; JRN from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MTB/TOM mouse was a kind gift from Lewis A Chodosh. We thank Kenichiro Fujiwara for his assistance in animal husbandry and Rachel E Rempel for her helpful advice. We are grateful to Kaye Culler for her assistance with the manuscript. This work was supported by grants from the NIH (CA104663, CA112952) and grants U01 CA141541 and U01 CA141582 from the National Cancer Institute's Mouse Models of Human Cancers Consortium (RDC). We also thank Ms Katie Bell and Judith Walls of the CCM MMPL for their excellent immunohistochemistry. This work was also supported by grants from the JRN (RO1-CA104663 and U54-CA112952) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Cardiff RD, 2010, J MAMMARY GLAND BIOL, V15, P225, DOI 10.1007/s10911-010-9184-y; Carvalho CM, 2008, J AM STAT ASSOC, V103, P1438, DOI 10.1198/016214508000000869; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Damonte P, 2007, LAB INVEST, V87, P1218, DOI 10.1038/labinvest.3700683; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Lucas J, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1436; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nicolini A, 2011, CURR PHARM BIOTECHNO, V12, P196, DOI 10.2174/138920111794295657; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Radaelli E, 2009, FUTURE ONCOL, V5, P1113, DOI [10.2217/fon.09.93, 10.2217/FON.09.93]; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358	31	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	20					2545	2554		10.1038/onc.2011.433	http://dx.doi.org/10.1038/onc.2011.433			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	944ID	21996730	Green Accepted			2022-12-25	WOS:000304191800005
J	Xie, Q; Cvekl, A				Xie, Qing; Cvekl, Ales			The Orchestration of Mammalian Tissue Morphogenesis through a Series of Coherent Feed-forward Loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY NETWORKS; FACTOR C-MAF; FIBER CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR PAX6; EMBRYONIC STEM-CELLS; PAIRED DOMAIN; LENS DEVELOPMENT; DNA-BINDING; MOUSE LENS; NASAL DEVELOPMENT	Tissue morphogenesis requires intricate temporal and spatial control of gene expression that is executed through specific gene regulatory networks (GRNs). GRNs are comprised from individual subcircuits of different levels of complexity. An important question is to elucidate the mutual relationship between those genes encoding DNA-binding factors that trigger the subcircuit with those that play major "later" roles during terminal differentiation via expression of specific genes that constitute the phenotype of individual tissues. The ocular lens is a classical model system to study tissue morphogenesis. Pax6 is essential for both lens placode formation and subsequent stages of lens morphogenesis, whereas c-Maf controls terminal differentiation of lens fibers, including regulation of crystallins, key lens structural proteins required for its transparency and refraction. Here, we show that Pax6 directly regulates c-Maf expression during lens development. A 1.3-kb c-Maf promoter with a 1.6-kb upstream enhancer (CR1) recapitulated the endogenous c-Maf expression pattern in lens and retinal pigmented epithelium. ChIP assays revealed binding of Pax6 and c-Maf to multiple regions of the c-Maf locus in lens chromatin. To predict functional Pax6-binding sites, nine novel variants of Pax6 DNA-binding motifs were identified and characterized. Two of these motifs predicted a pair of Pax6-binding sites in the CR1. Mutagenesis of these Pax6-binding sites inactivated transgenic expression in the lens but not in retinal pigmented epithelium. These data establish a novel regulatory role for Pax6 during lens development, link together the Pax6/c-Maf/crystallin regulatory network, and suggest a novel type of GRN subcircuit that controls a major part of embryonic lens development.	[Xie, Qing; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cvekl, A (corresponding author), 1300 Morris Pk Ave,Ullmann 123, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu	Cvekl, Ales/B-2427-2013		National Institutes of Health [EY012200, EY014237, EY014237S7]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014237, R01EY012200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012200, EY014237, and EY014237S7. This work was also supported by an unrestricted grant from Research to Prevent Blindness.	Ali RR, 2011, NATURE, V472, P42, DOI 10.1038/472042a; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; Chen Q, 2002, J BIOL CHEM, V277, P24081, DOI 10.1074/jbc.M201821200; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Civil A, 2002, NUCLEIC ACIDS RES, V30, P975, DOI 10.1093/nar/30.4.975; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Cvekl A, 2010, HEREDITY, V105, P135, DOI 10.1038/hdy.2010.16; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Dressler GR, 2009, ORGANOGENESIS, V5, P73, DOI 10.4161/org.5.2.8930; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Duncan MK, 2000, J CELL SCI, V113, P3173; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Gunhaga L, 2011, PHILOS T R SOC B, V366, P1193, DOI 10.1098/rstb.2010.0175; Harada T, 2007, GENE DEV, V21, P367, DOI 10.1101/gad.1504307; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jun S, 1996, DEVELOPMENT, V122, P2639; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kozmikova I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014650; Kusakabe M, 2011, BLOOD, V118, P1374, DOI 10.1182/blood-2010-08-300400; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Liu SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017904; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Medina-Martinez O, 2007, DEVELOPMENT, V134, P1455, DOI 10.1242/dev.000117; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Rani A, 2011, J IMMUNOL, V187, P3721, DOI 10.4049/jimmunol.1002354; Ring BZ, 2000, DEVELOPMENT, V127, P307; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114	80	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43259	43271		10.1074/jbc.M111.264580	http://dx.doi.org/10.1074/jbc.M111.264580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998302	Green Published, hybrid			2022-12-25	WOS:000298351300046
J	Soty, M; Visa, M; Soriano, S; Carmona, MD; Nadal, A; Novials, A				Soty, Maud; Visa, Montse; Soriano, Sergi; del Carmen Carmona, Maria; Nadal, Angel; Novials, Anna			Involvement of ATP-sensitive Potassium (K-ATP) Channels in the Loss of Beta-cell Function Induced by Human Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; STIMULATED INSULIN-SECRETION; ENDOPLASMIC-RETICULUM STRESS; HUMAN PANCREATIC-ISLETS; COMMON MECHANISM; MITOCHONDRIAL DYSFUNCTION; MEMBRANE DISRUPTION; DIABETES-MELLITUS; OLIGOMERS IMPLIES; FIBRIL FORMATION	Islet amyloid polypeptide (IAPP) is a major component of amyloid deposition in pancreatic islets of patients with type 2 diabetes. It is known that IAPP can inhibit glucose-stimulated insulin secretion; however, the mechanisms of action have not yet been established. In the present work, using a rat pancreatic beta-cell line, INS1E, we have created an in vitro model that stably expressed human IAPP gene (hIAPP cells). These cells showed intracellular oligomers and a strong alteration of glucose-stimulated insulin and IAPP secretion, Taking advantage of this model, we investigated the mechanism by which IAPP altered beta-cell secretory response and contributed to the development of type 2 diabetes. We have measured the intracellular Ca2+ mobilization in response to different secretagogues as well as mitochondrial metabolism. The study of calcium signals in hIAPP cells demonstrated an absence of response to glucose and also to tolbutamide, indicating a defect in ATP-sensitive potassium (K-ATP) channels. Interestingly, hIAPP showed a greater maximal respiratory capacity than control cells. These data were confirmed by an increased mitochondrial membrane potential in hIAPP cells under glucose stimulation, leading to an elevated reactive oxygen species level as compared with control cells. We concluded that the hIAPP overexpression inhibits insulin and IAPP secretion in response to glucose affecting the activity of K-ATP channels and that the increased mitochondrial metabolism is a compensatory response to counteract the secretory defect of beta-cells.	[Novials, Anna] Hosp Clin Barcelona, IDIBAPS, Diabets & Obes Lab, CEK, E-08036 Barcelona, Spain; [Soriano, Sergi; Nadal, Angel] Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Spain; [Soty, Maud; Visa, Montse; Soriano, Sergi; Nadal, Angel; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Novials, A (corresponding author), Hosp Clin Barcelona, IDIBAPS, Diabets & Obes Lab, CEK, Planta 5,Calle Rossello 149-153, E-08036 Barcelona, Spain.	anovials@clinic.ub.es	Nadal, Angel/G-6721-2014; Soriano, Sergi/M-5255-2017; Visa, Montse/AAQ-8529-2021	Nadal, Angel/0000-0003-4178-2152; Soriano, Sergi/0000-0001-9844-7027; Novials, Anna/0000-0003-0465-2949	Fondo de Investigaciones Sanitarias (FIS) [PI08/0088]; Sarda Farriol Research Program; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion)	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Sarda Farriol Research Program; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Fondo de Investigaciones Sanitarias (FIS) Grant PI08/0088, the Sarda Farriol Research Program, and CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), which is an initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion).	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ahren B, 1998, DIABETOLOGIA, V41, P1374, DOI 10.1007/s001250051079; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BETSHOLTZ C, 1990, DIABETES, V39, P118, DOI 10.2337/diabetes.39.1.118; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; CLARK A, 1987, LANCET, V2, P231; COORDT MC, 1995, P SOC EXP BIOL MED, V209, P213; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Gasa R, 1997, AM J PHYSIOL-ENDOC M, V272, pE543, DOI 10.1152/ajpendo.1997.272.4.E543; Gasa R, 1997, REGUL PEPTIDES, V68, P99, DOI 10.1016/S0167-0115(96)02109-X; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Gloyn AL, 2005, HUM MOL GENET, V14, P925, DOI 10.1093/hmg/ddi086; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hiddinga HJ, 1999, AM J PATHOL, V154, P1077, DOI 10.1016/S0002-9440(10)65360-6; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Novials A, 2004, DIABETOLOGIA, V47, P1167, DOI 10.1007/s00125-004-1439-y; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; Pertusa JAG, 2002, DIABETES, V51, P2552, DOI 10.2337/diabetes.51.8.2552; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Ronner P, 2001, DIABETES, V50, P291, DOI 10.2337/diabetes.50.2.291; SALAS M, 1995, DIABETES METAB, V21, P269; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Sohal R S, 1985, Basic Life Sci, V35, P75; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235; Zhao HL, 2009, TRANSL RES, V153, P24, DOI 10.1016/j.trsl.2008.10.009; Zhu TH, 2011, DIABETES-METAB RES, V27, P28, DOI 10.1002/dmrr.1140; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	60	28	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40857	40866		10.1074/jbc.M111.232801	http://dx.doi.org/10.1074/jbc.M111.232801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984830	Green Published, hybrid			2022-12-25	WOS:000297315400046
J	Gotoh, K; Ito, Y; Maruo, S; Takada, K; Mizuno, T; Teranishi, M; Nakata, S; Nakashima, T; Iwata, S; Goshima, F; Nakamura, S; Kimura, H				Gotoh, Kensei; Ito, Yoshinori; Maruo, Seiji; Takada, Kenzo; Mizuno, Terukazu; Teranishi, Masaaki; Nakata, Seiichi; Nakashima, Tsutomu; Iwata, Seiko; Goshima, Fumi; Nakamura, Shigeo; Kimura, Hiroshi			Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants	PLOS ONE			English	Article							HUMAN LYMPHOID-TISSUE; TIME PCR ASSAY; HUMAN CD34(+) CELLS; B-CELL; EBV INFECTION; LYMPHOPROLIFERATIVE DISEASE; QUANTITATIVE-ANALYSIS; IMMUNE-RESPONSES; MOUSE MODEL; EX-VIVO	Epstein-Barr virus (EBV) may cause a variety of virus-associated diseases, but no antiviral agents have yet been developed against this virus. Animal models are thus indispensable for the pathological analysis of EBV-related infections and the elucidation of therapeutic methods. To establish a model system for the study of EBV infection, we tested the ability of B95-8 virus and recombinant EBV expressing enhanced green fluorescent protein (EGFP) to replicate in human lymphoid tissue. Human tonsil tissues that had been surgically removed during routine tonsillectomy were sectioned into small blocks and placed on top of collagen sponge gels in culture medium at the air-interface, then a cell-free viral suspension was directly applied to the top of each tissue block. Increasing levels of EBV DNA in culture medium were observed after 12-15 days through 24 days post-infection in tissue models infected with B95-8 and EGFP-EBV. Expression levels of eight EBV-associated genes in cells collected from culture medium were increased during culture. EBV-encoded small RNA-positive cells were detected in the interfollicular areas in paraffin-embedded sections. Flow cytometric analyses revealed that most EGFP(+) cells were CD3(-) CD56(-) CD19(+) HLA-DR(+), and represented both naive (immunoglobulin D(+)) and memory (CD27(+)) B cells. Moreover, EBV replication in this model was suppressed by acyclovir treatment in a dose-dependent manner. These data suggest that this model has potential for use in the pathological analysis of local tissues at the time of primary infection, as well as for screening novel antiviral agents.	[Gotoh, Kensei; Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Maruo, Seiji; Takada, Kenzo] Hokkaido Univ, Dept Tumor Virol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Mizuno, Terukazu; Teranishi, Masaaki; Nakata, Seiichi; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4648601, Japan; [Iwata, Seiko; Goshima, Fumi; Kimura, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi 4648601, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan	Nagoya University; Hokkaido University; Nagoya University; Nagoya University; Nagoya University	Gotoh, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan.	yoshi-i@med.nagoya-u.ac.jp	Maruo, Seiji/A-4288-2012; Teranishi, Masaaki/I-1956-2012; Nakashima, Tsutomu/B-8259-2012; Kimura, Hiroshi/I-2246-2012; GOSHIMA, Fumi/I-7241-2014; Takada, Kenzo/A-6666-2012; Ito, Yoshinori/A-7591-2016	Nakashima, Tsutomu/0000-0003-3930-9120; Kimura, Hiroshi/0000-0001-8063-5660; 	Japan Society for the Promotion of Science [20591276]; Health and Labour Science Research [22091401]; Grants-in-Aid for Scientific Research [23591564, 21591384] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (20591276) to YI and from Health and Labour Science Research (22091401) to YI and HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAN B, 2007, FIELDS VIROLOGY, P2655; ALLAUDEEN HS, 1982, ANTIVIR RES, V2, P123, DOI 10.1016/0166-3542(82)90014-6; ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Chaganti S, 2009, BLOOD, V113, P6372, DOI 10.1182/blood-2008-08-175828; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Condit R. C., 2007, FIELDS VIROLOGY, V1, P25; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Glushakova S, 1998, NAT MED, V4, P346, DOI 10.1038/nm0398-346; Grivel JC, 2003, J VIROL, V77, P8280, DOI 10.1128/JVI.77.15.8280-8289.2003; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Islas-Ohlmayer M, 2004, J VIROL, V78, P13891, DOI 10.1128/JVI.78.24.13891-13900.2004; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Iwata S, 2010, J GEN VIROL, V91, P42, DOI 10.1099/vir.0.013482-0; Johannessen I, 1999, REV MED VIROL, V9, P263, DOI 10.1002/(SICI)1099-1654(199910/12)9:4<263::AID-RMV256>3.0.CO;2-D; Johnston Andrew, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0708s86; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kimura H, 2009, J INFECT DIS, V200, P1078, DOI 10.1086/605610; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Laichalk LL, 2002, IMMUNITY, V16, P745, DOI 10.1016/S1074-7613(02)00318-7; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Long MC, 2003, ANTIVIR RES, V58, P149, DOI 10.1016/S0166-3542(02)00210-3; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Nakamura S, 1999, AM J SURG PATHOL, V23, P363, DOI 10.1097/00000478-199904000-00001; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Takashima K, 2008, J MED VIROL, V80, P455, DOI 10.1002/jmv.21102; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trempat P, 2002, J VIROL, V76, P11139, DOI 10.1128/JVI.76.21.11139-11142.2002; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Woodford NL, 2004, COMPARATIVE MED, V54, P209; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502	44	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25490	10.1371/journal.pone.0025490	http://dx.doi.org/10.1371/journal.pone.0025490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998663	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900030
J	Liu, G; Yang, YP; Yang, SZ; Banerjee, S; De Freitas, A; Friggeri, A; Davis, KI; Abraham, E				Liu, Gang; Yang, Yanping; Yang, Shanzhong; Banerjee, Sami; De Freitas, Andressa; Friggeri, Arnaud; Davis, Kasey I.; Abraham, Edward			The Receptor for Urokinase Regulates TLR2 Mediated Inflammatory Responses in Neutrophils	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; KAPPA-B ACTIVATION; INTERLEUKIN-1 RECEPTOR; KRINGLE DOMAIN; DEFICIENT MICE; LIPOPOLYSACCHARIDE; INVOLVEMENT; EFFEROCYTOSIS; JNK	The urokinase-type plasminogen activator receptor (uPAR), a glycosylphosphatidylinositol (GPI) anchored membrane protein, regulates urokinase (uPA) protease activity, chemotaxis, cell-cell interactions, and phagocytosis of apoptotic cells. uPAR expression is increased in cytokine or bacteria activated cell populations, including macrophages and monocytes. However, it is unclear if uPAR has direct involvement in the response of inflammatory cells, such as neutrophils and macrophages, to Toll like receptor (TLR) stimulation. In this study, we found that uPAR is required for optimal neutrophil activation after TLR2, but not TLR4 stimulation. We found that the expression of TNF-alpha and IL-6 induced by TLR2 engagement in uPAR-/-neutrophils was less than that in uPAR+/+ (WT) neutrophils. Pretreatment of neutrophils with PIPLC, which cleaves GPI moieties, significantly decreased TLR2 induced expression of TNF-alpha in WT neutrophils, but demonstrated only marginal effects on TNF-alpha expression in PAM treated uPAR-/- neutrophils. I kappa B-alpha degradation and NF-kappa B activation were not different in uPAR-/-or WT neutrophils after TLR2 stimulation. However, uPAR is required for optimal p38 MAPK activation after TLR2 engagement. Consistent with the in vitro findings that uPAR modulates TLR2 engagement induced neutrophil activation, we found that pulmonary and systemic inflammation induced by TLR2, but not TLR4 stimulation is reduced in uPAR-/-mice compared to WT counterparts. Therefore, our data suggest that neutrophil associated uPAR could be a potential target for treating acute inflammation, sepsis, and organ injury related to severe bacterial and other microbial infections in which TLR2 engagement plays a major role.	[Liu, Gang; Yang, Yanping; Yang, Shanzhong; Banerjee, Sami; De Freitas, Andressa; Friggeri, Arnaud; Abraham, Edward] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Davis, Kasey I.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Friggeri, Arnaud] CHU Amiens, Amiens, France; [Friggeri, Arnaud] INSERM, ERI 12, Amiens, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm)	Liu, G (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	eabraham@uab.edu	Friggeri, Arnaud/AAE-7644-2020; de Freitas, Andressa/B-7264-2012	Friggeri, Arnaud/0000-0003-4687-2173; de Freitas, Andressa/0000-0001-8453-7742; Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [HL76206, GM87748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105473, R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants HL76206 and GM87748 to Edward Abraham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Abraham E, 2006, J IMMUNOL, V176, P7753, DOI 10.4049/jimmunol.176.12.7753; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bhandary YP, 2008, AM J RESP CRIT CARE; Briassouli P, 2010, CIRC RES, V107, P374, DOI 10.1161/CIRCRESAHA.109.213629; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Coleman JL, 2003, INFECT IMMUN, V71, P5556, DOI 10.1128/IAI.71.10.5556-5564.2003; D'mello V, 2009, J BIOL CHEM, V284, P17030, DOI 10.1074/jbc.M109.010066; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koay MA, 2002, AM J RESP CELL MOL, V26, P572, DOI 10.1165/ajrcmb.26.5.4748; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kwak SH, 2006, THROMB HAEMOSTASIS, V95, P829, DOI 10.1160/TH05-12-0782; Kwak SH, 2005, J LEUKOCYTE BIOL, V78, P937, DOI 10.1189/jlb.0305158; Lee YB, 2000, CYTOKINE, V12, P874, DOI 10.1006/cyto.2000.0688; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Park YJ, 2009, BLOOD, V114, P860, DOI 10.1182/blood-2008-12-193524; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; van Zoelen MAD, 2009, AM J PATHOL, V174, P2182, DOI 10.2353/ajpath.2009.080914; Waltz DA, 2000, AM J RESP CELL MOL, V22, P316, DOI 10.1165/ajrcmb.22.3.3713; Wang XQ, 2006, J IMMUNOL, V177, P5550, DOI 10.4049/jimmunol.177.8.5550; Wiersinga WJ, 2010, J IMMUNOL, V184, P3079, DOI 10.4049/jimmunol.0901008; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25843	10.1371/journal.pone.0025843	http://dx.doi.org/10.1371/journal.pone.0025843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998707	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900063
J	Resch, S; Korenromp, E; Stover, J; Blakley, M; Krubiner, C; Thorien, K; Hecht, R; Atun, R				Resch, Stephen; Korenromp, Eline; Stover, John; Blakley, Matthew; Krubiner, Carleigh; Thorien, Kira; Hecht, Robert; Atun, Rifat			Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; HIV/AIDS; HIV; IMPACT; MORTALITY; IMPROVEMENTS; PERFORMANCE; EMPLOYMENT	Since the early 2000s, aid organizations and developing country governments have invested heavily in AIDS treatment. By 2010, more than five million people began receiving antiretroviral therapy (ART) - yet each year, 2.7 million people are becoming newly infected and another two million are dying without ever having received treatment. As the need for treatment grows without commensurate increase in the amount of available resources, it is critical to assess the health and economic gains being realized from increasingly large investments in ART. This study estimates total program costs and compares them with selected economic benefits of ART, for the current cohort of patients whose treatment is cofinanced by the Global Fund to Fight AIDS, Tuberculosis and Malaria. At end 2011, 3.5 million patients in low and middle income countries will be receiving ART through treatment programs cofinanced by the Global Fund. Using 2009 ART prices and program costs, we estimate that the discounted resource needs required for maintaining this cohort are $14.2 billion for the period 2011-2020. This investment is expected to save 18.5 million life-years and return $12 to $34 billion through increased labor productivity, averted orphan care, and deferred medical treatment for opportunistic infections and end-of-life care. Under alternative assumptions regarding the labor productivity effects of HIV infection, AIDS disease, and ART, the monetary benefits range from 81 percent to 287 percent of program costs over the same period. These results suggest that, in addition to the large health gains generated, the economic benefits of treatment will substantially offset, and likely exceed, program costs within 10 years of investment.	[Resch, Stephen] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Korenromp, Eline; Blakley, Matthew; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline] Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Stover, John] Futures Inst, Glastonbury, CT USA; [Krubiner, Carleigh; Thorien, Kira; Hecht, Robert] Results Dev Inst, Washington, DC USA; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London	Resch, S (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 665 Huntington Ave, Boston, MA 02115 USA.	stephen_resch@harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983	Global Fund to Fight AIDS, Tuberculosis and Malaria	Global Fund to Fight AIDS, Tuberculosis and Malaria	Funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund commissioned the study, provided the data for analysis, and staff co-authored the paper.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Becker G. S., 2003, 9765 NAT BUR EC RES; Beegle K, 2007, ORPHANHOOD LONG RUN; Bell C, 2004, MACROECONOMICS HIV A; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bollinger L, 2007, FINANACIAL RESOURCES; Booysen FL, 2003, SOC SCI MED, V56, P2391, DOI 10.1016/S0277-9536(02)00243-5; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Coetzee C, 2008, S AFR J ECON, V76, pS75, DOI 10.1111/j.1813-6982.2008.00166.x; Cuddington J T, 1995, J Afr Econ, V4, P1; Eholie S., 2003, EC AIDS ACCESS HIV A, P329; Foster C, 2000, AIDS, V14, pS275; Fox MP, 2010, AIDS CARE, V22, P137, DOI 10.1080/09540120903038366; Fox MP, 2004, TROP MED INT HEALTH, V9, P318, DOI 10.1111/j.1365-3156.2004.01207.x; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gold MR, 1996, COST EFFECTIVENESS H; Goldstein MPG-Z J, 2009, ANN WORLD BANK C DEV; Haacker M, 2010, SOCIOECONOMIC DIMENS; Haacker M, 2004, MACROECONOMICS HIV A; Habyarimana J, 2007, HIV AIDS ARV TREATM; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; International Labour Organization, 2009, LABORSTA LAB STAT DA; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Jamison D.T., 2001, EFFECT AIDS EPIDEMIC; Jeffries K, 2006, EC IMPACT HIV AIDS B; [Joint United Nations Programme on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2009, AIDS EP UPD NOV 2009; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Larson BA, 2008, AIDS, V22, P421, DOI 10.1097/QAD.0b013e3282f3cc0c; Larson BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-240; Linnemayr S, 2011, J AFR ECON, V20, P505, DOI 10.1093/jae/ejr014; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; MUIRHEAD D, 2006, 16 INT AIDS C TOR CA; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Renaud-Thery F, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/749041; Rosen S, 2008, AIDS, V22, pS131, DOI 10.1097/01.aids.0000327634.92844.91; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Sgombich X, 2006, 16 INT AIDS C TOR CA; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2007, HEALTH POLICY PLANN, V22, P21, DOI 10.1093/heapol/czl033; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; Tan-Torres ET, 2003, MAKING CHOICES HLTH; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOB FUND RES REP 20; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, FIN HLTH IMP CONT SU; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, PRIC QUAL REP SYST; THIRUMURTHY H, 2008, 17 INT AIDS C MEX CI; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; Thirumurthy H, 2011, AIDS, V25, P239, DOI 10.1097/QAD.0b013e328341b928; Thurlow J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-18; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Tsai AC, 2009, AIDS CARE, V21, P59, DOI 10.1080/09540120802068811; [UNAIDS UNICEF USAID], 2004, CHILDR BRINK JOINT R; UNAIDS, 2009, AIDS EP UPD NOV 2009; UNAIDS, 2010, GLOB REP UNAIDS REP; van Zyl A, 2009, COSTBENEFIT ANAL EMP; Ventelou B, 2008, AIDS, V22, P107, DOI 10.1097/QAD.0b013e3282f1d49f; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; WHO, 2010, ANT THER HIV INF AD; World Bank, 2009, WORLD DEV IND ONL 8; World Health Organization, 2010, WHO CHOICE COST EFF; World Health Organization, 2009, GLOB PRIC REP MECH; World Health Organization HIV/AIDS Programme, 2009, RAP ADV ANT THER HIV; [World Health Organization HIV/AIDS Programme UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Yamano T, 2004, WORLD DEV, V32, P91, DOI 10.1016/j.worlddev.2003.07.004; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	70	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25310	10.1371/journal.pone.0025310	http://dx.doi.org/10.1371/journal.pone.0025310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998648	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900017
J	Beaulieu, A; Poncin, G; Belaid-Choucair, Z; Humblet, C; Bogdanovic, G; Lognay, G; Boniver, J; Defresne, MP				Beaulieu, Aurore; Poncin, Geraldine; Belaid-Choucair, Zakia; Humblet, Chantal; Bogdanovic, Gordana; Lognay, Georges; Boniver, Jacques; Defresne, Marie-Paule			Leptin Reverts Pro-Apoptotic and Antiproliferative Effects of alpha-Linolenic Acids in BCR-ABL Positive Leukemic Cells: Involvement of PI3K Pathway	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BONE-MARROW ADIPOCYTES; SATURATED FATTY-ACIDS; PROSTATE-CANCER RISK; SIGNALING PATHWAY; PROLIFERATION; EXPRESSION; RECEPTOR; STEM; AKT	It is suspected that bone marrow (BM) microenvironmental factors may influence the evolution of chronic myeloid leukaemia (CML). In this study, we postulated that adipocytes and lipids could be involved in the progression of CML. To test this hypothesis, adipocytes were co-cultured with two BCR-ABL positive cell lines (PCMDS and K562). T cell (Jurkat) and stroma cell (HS-5) lines were used as controls. In the second set of experiments, leukemic cell lines were treated with stearic, oleic, linoleic or a-linolenic acids in presence or absence of leptin. Survival, proliferation, leptin production, OB-R isoforms (OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of treatment. Our results showed that adipocytes induced a decrease of CML proliferation and an increase in lipid accumulation in leukemic cells. In addition, CML cell lines induced adipocytes cell death. Chromatography analysis showed that BM microenvironment cells were full of saturated (SFA) and monounsaturated (MUFA) fatty acids, fatty acids that protect tumor cells against external agents. Stearic acid increased Bcl-2 expression in PCMDS, whereas oleic and linoleic acids had no effects. In contrast, a-linolenic acid decreased the proliferation and the survival of CML cell lines as well as BCL-2 and OB-R expression. The effect of a-linolenic acids seemed to be due to PI3K pathway and Bcl-2 inhibition. Leptin production was detected in the co-culture medium. In the presence of leptin, the effect of a-linolenic acid on proliferation, survival, OB-R and BCl-2 expression was reduced.	[Beaulieu, Aurore; Poncin, Geraldine; Humblet, Chantal; Boniver, Jacques; Defresne, Marie-Paule] Univ Liege, Dept Cytol Histol & Pathol Anat Giga R, Liege, Belgium; [Belaid-Choucair, Zakia] Univ Paris 05, CNRS, UMR 8147, Hop Necker, F-75270 Paris, France; [Bogdanovic, Gordana] Inst Oncol Sremska Kamenica, Sremska Kamenica, Serbia; [Lognay, Georges] Univ Liege, Dept Analyt Chem, Gembloux, Belgium	University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Liege	Beaulieu, A (corresponding author), Univ Liege, Dept Cytol Histol & Pathol Anat Giga R, Liege, Belgium.	abeaulieu@ulg.ac.be	Bogdanovic, Gordana M/E-2869-2019	Bogdanovic, Gordana M/0000-0003-4024-108X	Fonds National de la Recherche Scientifique [FNRS 7452809F]; GIGA-Cell Imaging; Flow Cytometry platform; FACS CantoII (Becton Dickinson, France)	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); GIGA-Cell Imaging; Flow Cytometry platform; FACS CantoII (Becton Dickinson, France)	This work was supported by the Fonds National de la Recherche Scientifique (FNRS 7452809F)http://www1.frs-fnrs.be/. Dr. Beaulieu, Dr. Poncin, and Dr. Belaid-Choucair are Televie (FNRS) fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We also thank the GIGA-Cell Imaging and Flow Cytometry platform for support with FACS CantoII (Becton Dickinson, France).	ALEXE DM, 2006, LEPTIN, P201; Anand M, 1998, HEMATOL ONCOL, V16, P143; Behan JW, 2009, CANCER RES, V69, P7867, DOI 10.1158/0008-5472.CAN-09-0800; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Cantoni O, 2008, METHOD ENZYMOL, V441, P73, DOI 10.1016/S0076-6879(08)01205-6; Carayol M, 2010, CANCER CAUSE CONTROL, V21, P347, DOI 10.1007/s10552-009-9465-1; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Couplan Elodie, 2009, Biotechnology Journal, V4, P1190, DOI 10.1002/biot.200800229; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; deGraffenried LA, 2003, ANN ONCOL, V14, P1051, DOI 10.1093/annonc/mdg291; Deshimaru Ryota, 2005, Keio Journal of Medicine, V54, P150, DOI 10.2302/kjm.54.150; Di Benedetto R, 2009, J FOOD LIPIDS, V16, P382, DOI 10.1111/j.1745-4522.2009.01153.x; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005; EAVES AC, 1986, P NATL ACAD SCI USA, V83, P5306, DOI 10.1073/pnas.83.14.5306; FINSTAD HS, 1994, BLOOD, V84, P3799, DOI 10.1182/blood.V84.11.3799.bloodjournal84113799; Finstad HS, 1998, BIOCHEM J, V336, P451, DOI 10.1042/bj3360451; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frater JL, 2003, AM J CLIN PATHOL, V119, P833, DOI 10.1309/A4RGP4LF12GGH8MW; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Ghalaut VS, 2006, CLIN CHIM ACTA, V366, P239, DOI 10.1016/j.cca.2005.10.022; GILBERT S, 1983, CANCER, V51, P1428; Gullicksen PS, 2003, APOPTOSIS, V8, P327, DOI 10.1023/A:1024112716024; GUPTA PK, 2004, LEUKEMIA MJAFI, V60, P297; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hayhoe FGJ., 1994, HAEMATOLOGICAL CYTOC; HIRATA J, 1989, ACTA HAEMATOL-BASEL, V82, P35; Kim JY, 2009, ANN NY ACAD SCI, V1171, P190, DOI 10.1111/j.1749-6632.2009.04897.x; Kim JY, 2010, ONCOL REP, V23, P1369, DOI 10.3892/or_00000773; KUTO F, 1984, ULTRASTRUCT PATHOL, V6, P307, DOI 10.3109/01913128409018589; Laharrague P, 2000, EUR CYTOKINE NETW, V11, P634; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; LICHTMAN MA, 2011, NATURE IN PRESS; MAYANI H, 2008, LEUKEMIA RES, V33, P624; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Mouzaki A, 2009, CYTOKINE, V48, P203, DOI 10.1016/j.cyto.2009.07.006; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Pardini RS, 2006, CHEM-BIOL INTERACT, V162, P89, DOI 10.1016/j.cbi.2006.05.012; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; Sloma I, 2010, LEUKEMIA, V24, P1823, DOI 10.1038/leu.2010.159; SOEL DW, 2008, BIOCHEM BIOPH RES CO, V377, P508; Strom SS, 2009, CANCER EPIDEM BIOMAR, V18, P1501, DOI 10.1158/1055-9965.EPI-09-0028; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Uddin S, 2010, LEUKEMIA LYMPHOMA, V51, P1305, DOI 10.3109/10428191003802365; Uddin S, 2010, ENDOCR-RELAT CANCER, V17, P191, DOI 10.1677/ERC-09-0153; VITOLS S, 1990, P NATL ACAD SCI USA, V87, P2598, DOI 10.1073/pnas.87.7.2598; Vondracek J, 2001, EUR J PHARMACOL, V424, P1, DOI 10.1016/S0014-2999(01)01124-4; Yamamoto K, 2011, ANAL BIOANAL CHEM, V400, P1829, DOI 10.1007/s00216-011-4864-z	56	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25651	10.1371/journal.pone.0025651	http://dx.doi.org/10.1371/journal.pone.0025651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991326	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000050
J	Gan, L; Schwengberg, S; Denecke, B				Gan, Lin; Schwengberg, Silke; Denecke, Bernd			MicroRNA Profiling during Cardiomyocyte-Specific Differentiation of Murine Embryonic Stem Cells Based on Two Different miRNA Array Platforms	PLOS ONE			English	Article							GENE-EXPRESSION; BIOLOGY; MOUSE; LINES	MicroRNA (miRNA) plays a critical role in a wide variety of biological processes. Profiling miRNA expression during differentiation of embryonic stem cells will help to understand the regulation pathway of differentiation, which in turn may elucidate disease mechanisms. The identified miRNAs could then serve as a new group of possible therapeutic targets. In the present paper, miRNA expression profiles were determined during cardiomyocyte-specific differentiation and maturation of murine embryonic stem (ES) cells. For this purpose a homogeneous cardiomyocyte population was generated from a transgenic murine ES cell line. Two high throughput array platforms (Affymetrix and Febit) were used for miRNA profiling in order to compare the effect of the platforms on miRNA profiling as well as to increase the validity of target miRNA identification. Four time points (i.e. day 0, day 12, day 19 and day 26) were chosen for the miRNA profiling study, which corresponded to different stages during cardiomyocyte-specific differentiation and maturation. Fifty platform and preprocessing method-independent miRNAs were identified as being regulated during the differentiation and maturation processes. The identification of these miRNAs is an important step for characterizing and understanding the events involved in cardiomyocyte-specific differentiation of ES cells and may also highlight candidate target molecules for therapeutic purposes.	[Gan, Lin; Denecke, Bernd] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res IZKF Aachen, Aachen, Germany; [Schwengberg, Silke] Axiogenesis AG, Cologne, Germany	RWTH Aachen University	Gan, L (corresponding author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res IZKF Aachen, Aachen, Germany.	bernd.denecke@rwth-aachen.de			Interdisciplinary Centre for Clinical Research Aachen, Rheinisch Westfalische Technische Hochschule (RWTH) Aachen [VVB-110e]	Interdisciplinary Centre for Clinical Research Aachen, Rheinisch Westfalische Technische Hochschule (RWTH) Aachen	This work was supported by the Interdisciplinary Centre for Clinical Research Aachen within the Rheinisch Westfalische Technische Hochschule (RWTH) Aachen -grant#VVB-110e, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Silke Schwengberg is an employee of Axiogenesis AG (www.axiogenesis.com). Axiogenesis AG provided all cell culture material used in this study, including the cells. Axiogenesis AG had no role in study design, data collection and analysis, or manuscript preparation, but endorsed the decision to publish after reviewing the manuscript.	Barone AD, 2001, NUCLEOS NUCLEOT NUCL, V20, P525, DOI 10.1081/NCN-100002328; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glaser T, 2008, J NEUROL SCI, V265, P47, DOI 10.1016/j.jns.2007.09.018; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huber W, 2002, BIOINFORMATICS, V18, pS96; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Katsumoto K, 2010, DEV GROWTH DIFFER, V52, P115, DOI 10.1111/j.1440-169X.2009.01160.x; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Liang Y, 2009, CRIT REV EUKAR GENE, V19, P289, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.30; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minard ME, 2009, GENESIS, V47, P559, DOI 10.1002/dvg.20534; Murray P, 2004, PHILOS T R SOC B, V359, P1009, DOI 10.1098/rstb.2003.1460; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Rowe C, 2010, J PROTEOME RES, V9, P2658, DOI 10.1021/pr1001687; Sachinidis A, 2003, CARDIOVASC RES, V58, P278, DOI 10.1016/S0008-6363(03)00248-7; Smyth G, 2002, STAT APPL GENETICS M; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Team RDC, 2019, R LANG ENV STAT COMP; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang YL, 2009, CURR OPIN MOL THER, V11, P292; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Zeineddine D, 2005, METH MOLEC MED, V112, P175; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang Y, 2009, HUM GENE THER, V20, P1687, DOI 10.1089/hum.2009.057; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25809	10.1371/journal.pone.0025809	http://dx.doi.org/10.1371/journal.pone.0025809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991358	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000075
J	Mitchell, L; Lau, A; Lambert, JP; Zhou, H; Fong, Y; Couture, JF; Figeys, D; Baetz, K				Mitchell, Leslie; Lau, Andrea; Lambert, Jean-Philippe; Zhou, Hu; Fong, Ying; Couture, Jean-Francois; Figeys, Daniel; Baetz, Kristin			Regulation of Septin Dynamics by the Saccharomyces cerevisiae Lysine Acetyltransferase NuA4	PLOS ONE			English	Article							HISTONE H4 ACETYLATION; GENETIC INTERACTION NETWORK; CELL-CYCLE; BUDDING YEAST; MORPHOGENESIS CHECKPOINT; FUNCTIONAL DISSECTION; CHITIN SYNTHASE-2; PROTEIN COMPLEXES; DELETION MUTANTS; DNA	In the budding yeast Saccharomyces cerevisiae, the lysine acetyltransferase NuA4 has been linked to a host of cellular processes through the acetylation of histone and non-histone targets. To discover proteins regulated by NuA4-dependent acetylation, we performed genome-wide synthetic dosage lethal screens to identify genes whose overexpression is toxic to non-essential NuA4 deletion mutants. The resulting genetic network identified a novel link between NuA4 and septin proteins, a group of highly conserved GTP-binding proteins that function in cytokinesis. We show that acetyltransferase-deficient NuA4 mutants have defects in septin collar formation resulting in the development of elongated buds through the Swe1-dependent morphogenesis checkpoint. We have discovered multiple sites of acetylation on four of the five yeast mitotic septins, Cdc3, Cdc10, Cdc12 and Shs1, and determined that NuA4 can acetylate three of the four in vitro. In vivo we find that acetylation levels of both Shs1 and Cdc10 are reduced in a catalytically inactive esa1 mutant. Finally, we determine that cells expressing a Shs1 protein with decreased acetylation in vivo have defects in septin localization that are similar to those observed in NuA4 mutants. These findings provide the first evidence that yeast septin proteins are acetylated and that NuA4 impacts septin dynamics.	[Mitchell, Leslie; Lau, Andrea; Lambert, Jean-Philippe; Zhou, Hu; Fong, Ying; Couture, Jean-Francois; Figeys, Daniel; Baetz, Kristin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Mitchell, L (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	kbaetz@uottawa.ca	Baetz, Kristin/E-6859-2013	Mitchell, Leslie/0000-0001-7869-9817; Figeys, Daniel/0000-0002-5373-7546; Lambert, Jean-Philippe/0000-0002-0833-1221	Canadian Cancer Society [20309]; Ontario Government; Canada Research Chair (CRC) in Chemical and Functional Genomics	Canadian Cancer Society(Canadian Cancer Society (CCS)); Ontario Government; Canada Research Chair (CRC) in Chemical and Functional Genomics(Canada Research Chairs)	This research is funded by the Canadian Cancer Society (grant # 20309) and an Early Researcher Award from the Ontario Government to K. B. K. B. is a Canada Research Chair (CRC) in Chemical and Functional Genomics. D. F. is a CRC in Proteomics and Systems Biology and J.F.C. is a CRC in Structural Biology and Epigenetics. L. M. was supported by a Canada Institute for Health Research Ph.D. scholarship. A. L. was supported by a Natural Sciences and Engineering Research Council of Canada M.Sc Scholarship. J.-P.L. was supported by an Ontario Graduate Scholarship. http://www.cihr-irsc.gc.ca/.http://www.nserc-crsng.gc.ca/.http://www.hrsdc.gc.ca/eng/workplaceskills/foreign_workers/reschair.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Baetz K, 2006, CELL CYCLE, V5, P592, DOI 10.4161/cc.5.6.2583; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2004, EUKARYOT CELL, V3, P847, DOI 10.1128/EC.3.4.847-854.2004; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197; Hoke SM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-46; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; KROGAN NJ, 2004, P NATL ACAD SCI US; Kroll ES, 1996, GENETICS, V143, P95; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ruault M, 2006, GENETICS, V174, P1135, DOI 10.1534/genetics.106.059873; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; SIKORSKI RS, 1989, GENETICS, V122, P19; SILVERMAN SJ, 1988, P NATL ACAD SCI USA, V85, P4735, DOI 10.1073/pnas.85.13.4735; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Stoynova L, 2004, BIOTECHNIQUES, V36, P402, DOI 10.2144/04363BM05; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	77	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25336	10.1371/journal.pone.0025336	http://dx.doi.org/10.1371/journal.pone.0025336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984913	Green Submitted, gold, Green Published			2022-12-25	WOS:000295943000024
J	Kim, S; Sandler, DP; Carswell, G; Weinberg, CR; Taylor, JA				Kim, Sangmi; Sandler, Dale P.; Carswell, Gleta; Weinberg, Clarice R.; Taylor, Jack A.			Reliability and Short-Term Intra-Individual Variability of Telomere Length Measurement Using Monochrome Multiplexing Quantitative PCR	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; CELLS; MEN	Background: Studies examining the association between telomere length and cancer risk have often relied on measurement of telomere length from a single blood draw using a real-time PCR technique. We examined the reliability of telomere length measurement using sequential samples collected over a 9-month period. Methods and Findings: Relative telomere length in peripheral blood was estimated using a single tube monochrome multiplex quantitative PCR assay in blood DNA samples from 27 non-pregnant adult women ( aged 35 to 74 years) collected in 7 visits over a 9-month period. A linear mixed model was used to estimate the components of variance for telomere length measurements attributed to variation among women and variation between time points within women. Mean telomere length measurement at any single visit was not significantly different from the average of 7 visits. Plates had a significant systematic influence on telomere length measurements, although measurements between different plates were highly correlated. After controlling for plate effects, 64% of the remaining variance was estimated to be accounted for by variance due to subject. Variance explained by time of visit within a subject was minor, contributing 5% of the remaining variance. Conclusion: Our data demonstrate good short-term reliability of telomere length measurement using blood from a single draw. However, the existence of technical variability, particularly plate effects, reinforces the need for technical replicates and balancing of case and control samples across plates.	[Kim, Sangmi; Sandler, Dale P.; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Carswell, Gleta; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA; [Weinberg, Clarice R.] Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kim, S (corresponding author), Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	kims3@niehs.nih.gov	taylor, jack a/C-7154-2019	taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; Weinberg, Clarice/0000-0002-7713-8556	National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES044005, Z01 ES049033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102245, Z01ES044005, Z01ES049033, ZIAES044005, ZIAES049032] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES044005 and Z01 ES049033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Ferre F, 1992, PCR Methods Appl, V2, P1; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Hornsby PJ, 2010, PFLUG ARCH EUR J PHY, V459, P291, DOI 10.1007/s00424-009-0723-6; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kim S, 2011, CANCER CAUSE CONTROL, V22, P1061, DOI 10.1007/s10552-011-9778-8; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	29	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25774	10.1371/journal.pone.0025774	http://dx.doi.org/10.1371/journal.pone.0025774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984947	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300057
J	Sandoval, JM; Arenas, FA; Vasquez, CC				Sandoval, Juan M.; Arenas, Felipe A.; Vasquez, Claudio C.			Glucose-6-Phosphate Dehydrogenase Protects Escherichia coli from Tellurite-Mediated Oxidative Stress	PLOS ONE			English	Article							REACTIVE OXYGEN; SOXRS REGULON; SALMONELLA-TYPHIMURIUM; GLUTATHIONE-REDUCTASE; POTASSIUM TELLURITE; SUPEROXIDE STRESS; CELL-DEATH; IN-VIVO; DEHYDROGENASE; ANTIOXIDANT	The tellurium oxyanion tellurite induces oxidative stress in most microorganisms. In Escherichia coli, tellurite exposure results in high levels of oxidized proteins and membrane lipid peroxides, inactivation of oxidation-sensitive enzymes and reduced glutathione content. In this work, we show that tellurite-exposed E. coli exhibits transcriptional activation of the zwf gene, encoding glucose 6-phosphate dehydrogenase (G6PDH), which in turn results in augmented synthesis of reduced nicotinamide adenine dinucleotide phosphate (NADPH). Increased zwf transcription under tellurite stress results mainly from reactive oxygen species (ROS) generation and not from a depletion of cellular glutathione. In addition, the observed increase of G6PDH activity was paralleled by accumulation of glucose-6-phosphate (G6P), suggesting a metabolic flux shift toward the pentose phosphate shunt. Upon zwf overexpression, bacterial cells also show increased levels of antioxidant molecules (NADPH, GSH), better-protected oxidation-sensitive enzymes and decreased amounts of oxidized proteins and membrane lipids. These results suggest that by increasing NADPH content, G6PDH plays an important role in E. coli survival under tellurite stress.	[Sandoval, Juan M.; Arenas, Felipe A.; Vasquez, Claudio C.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile	Universidad de Santiago de Chile	Sandoval, JM (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile.	claudio.vasquez@usach.cl		Appanna, Vasu/0000-0002-0138-5665	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica) [1090097]; Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile); MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior), Chile; CONICYT (Comision Nacional de Ciencia y Tecnologia)	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile); MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior), Chile; CONICYT (Comision Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grants # 1090097 from Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica) and Dicyt (Direccion de Investigacion Cientifica y Tecnologica)-USACH (Universidad de Santiago de Chile) to C. C. V. J.M.S. was supported by a doctoral fellowship from MECESUP (Mejoramiento de la Calidad y Equidad de la Educacion Superior) UCH407, Chile. F. A. A. received doctoral fellowships from CONICYT (Comision Nacional de Ciencia y Tecnologia) and from MECESUP UCH607, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASNIS RE, 1955, J BIOL CHEM, V213, P77; Beriault R, 2007, BIOMETALS, V20, P165, DOI 10.1007/s10534-006-9024-0; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0; Castro ME, 2008, BIOCHEM BIOPH RES CO, V375, P91, DOI 10.1016/j.bbrc.2008.07.119; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; CHIONG M, 1988, J BACTERIOL, V170, P3269, DOI 10.1128/jb.170.7.3269-3273.1988; Contreras ND, 2010, ARCH MICROBIOL, V192, P969, DOI 10.1007/s00203-010-0624-2; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fuentes DE, 2007, J BACTERIOL, V189, P8953, DOI 10.1128/JB.01252-07; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Griffith KL, 2004, J MOL BIOL, V344, P1, DOI 10.1016/j.jmb.2004.09.007; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Hasan MR, 2010, J BIOL CHEM, V285, P19135, DOI 10.1074/jbc.M109.074310; HEBER UW, 1967, BIOCHIM BIOPHYS ACTA, V109, P390; HERRERA G, 2003, CURR PROTOC CYTOM; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; JOHNSON RM, 1994, BLOOD, V83, P1117; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Liochev SI, 1999, J BIOL CHEM, V274, P9479, DOI 10.1074/jbc.274.14.9479; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Lundberg BE, 1999, INFECT IMMUN, V67, P436, DOI 10.1128/IAI.67.1.436-438.1999; Lushchak VI, 2001, AM J PHYSIOL-REG I, V280, pR100, DOI 10.1152/ajpregu.2001.280.1.R100; Miller JH, 1972, EXPT MOL GENETICS, P201; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Murakami K, 2006, ARCH MICROBIOL, V186, P385, DOI 10.1007/s00203-006-0153-1; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Petrat F, 2003, J BIOL CHEM, V278, P3298, DOI 10.1074/jbc.M204230200; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Rungrassamee W, 2008, ARCH MICROBIOL, V190, P41, DOI 10.1007/s00203-008-0361-y; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Sambrook J., 2002, MOL CLONING LAB MANU; Sandoval JM, 2010, BIOMETALS, V23, P623, DOI 10.1007/s10534-010-9316-2; Semchyshyn H, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1238, DOI 10.1007/s10541-005-0253-6; SILIPRANDI D, 1973, FEBS LETT, V29, P101, DOI 10.1016/0014-5793(73)80535-6; SILIPRANDI D, 1971, BIOCHEM BIOPH RES CO, V45, P1071, DOI 10.1016/0006-291X(71)90446-3; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	57	52	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25573	10.1371/journal.pone.0025573	http://dx.doi.org/10.1371/journal.pone.0025573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984934	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300044
J	Fazzi, R; Pacini, S; Carnicelli, V; Trombi, L; Montali, M; Lazzarini, E; Petrini, M				Fazzi, Rita; Pacini, Simone; Carnicelli, Vittoria; Trombi, Luisa; Montali, Marina; Lazzarini, Edoardo; Petrini, Mario			Mesodermal Progenitor Cells (MPCs) Differentiate into Mesenchymal Stromal Cells (MSCs) by Activation of Wnt5/Calmodulin Signalling Pathway	PLOS ONE			English	Article							HUMAN BONE-MARROW; ADULT STEM-CELLS; IDENTIFICATION; PROLIFERATION; PLURIPOTENCY; EXPRESSION; EXPANSION; NICHE; SERUM; WNTS	Background: Mesenchymal Stromal Cells (MSCs) remain poorly characterized because of the absence of manifest physical, phenotypic, and functional properties in cultured cell populations. Despite considerable research on MSCs and their clinical application, the biology of these cells is not fully clarified and data on signalling activation during mesenchymal differentiation and proliferation are controversial. The role of Wnt pathways is still debated, partly due to culture heterogeneity and methodological inconsistencies. Recently, we described a new bone marrow cell population isolated from MSC cultures that we named Mesodermal Progenitor Cells (MPCs) for their mesenchymal and endothelial differentiation potential. An optimized culture method allowed the isolation from human adult bone marrow of a highly pure population of MPCs (more than 97%), that showed the distinctive SSEA-4(+)CD105(+)CD90(neg) phenotype and not expressing MSCA-1 antigen. Under these selective culture conditions the percentage of MSCs (SSEA-4(neg)CD105(+)CD90(bright) and MSCA-1(+)), in the primary cultures, resulted lower than 2%. Methodology/Principal Finding: We demonstrate that MPCs differentiate to MSCs through an SSEA-4(+)CD105(+)CD90(bright) early intermediate precursor. Differentiation paralleled the activation of Wnt5/Calmodulin signalling by autocrine/paracrine intense secretion of Wnt5a and Wnt5b (p<0.05 vs uncondictioned media), which was later silenced in late MSCs (SSEA-4(neg)). We found the inhibition of this pathway by calmidazolium chloride specifically blocked mesenchymal induction (ID50 = 0.5 mu M, p<0.01), while endothelial differentiation was unaffected. Conclusion:The present study describes two different putative progenitors (early and kite MSCs) that, together with already described MPCs, could be co-isolated and expanded in different percentages depending on the culture conditions. These results suggest that some modifications to the widely accepted MSC nomenclature are required.	[Fazzi, Rita; Pacini, Simone; Trombi, Luisa; Montali, Marina; Lazzarini, Edoardo; Petrini, Mario] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy; [Carnicelli, Vittoria] Univ Pisa, Dipartimento Sci Uomo & Ambiente, Pisa, Italy	University of Pisa; University of Pisa	Fazzi, R (corresponding author), Univ Pisa, Div Hematol, Dept Oncol Transplants & New Adv Med, Pisa, Italy.	simone.pacini@do.unipi.it	Pacini, Simone/H-3318-2019; Lazzarini, Edoardo/J-8459-2018	Pacini, Simone/0000-0003-1701-6001; Lazzarini, Edoardo/0000-0001-6369-5442; Montali, Marina/0000-0001-8804-4320	Department of Oncology; Transplants and New Advances in Medicine, University of Pisa	Department of Oncology; Transplants and New Advances in Medicine, University of Pisa	The work was exclusively supported by institutional funds of the Department of Oncology, Transplants and New Advances in Medicine, University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Noggle SA, 2005, STEM CELL REV, V1, P111, DOI 10.1385/SCR:1:2:111; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Petrini M, 2009, STEM CELLS DEV, V18, P857, DOI 10.1089/scd.2008.0291; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poloni A, 2009, CYTOTHERAPY, V11, P153, DOI 10.1080/14653240802582125; Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Suda T, 2008, CELL, V132, P729, DOI 10.1016/j.cell.2008.02.017; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trombi L, 2009, STEM CELLS DEV, V18, P1227, DOI 10.1089/scd.2009.0054; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	33	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25600	10.1371/journal.pone.0025600	http://dx.doi.org/10.1371/journal.pone.0025600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980498	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600037
J	Reimann, K; Krishnamoorthy, G; Wier, WG; Wangemann, P				Reimann, Katrin; Krishnamoorthy, Gayathri; Wier, Withrow Gil; Wangemann, Philine			Gender Differences in Myogenic Regulation along the Vascular Tree of the Gerbil Cochlea	PLOS ONE			English	Article							KCNJ10 PROTEIN EXPRESSION; BLOOD-FLOW; NITRIC-OXIDE; STRIA-VASCULARIS; ISCHEMIA; ARTERY; AUTOREGULATION; ESTROGEN; HOMEOSTASIS; ISOFLURANE	Regulation of cochlear blood flow is critical for hearing due to its exquisite sensitivity to ischemia and oxidative stress. Many forms of hearing loss such as sensorineural hearing loss and presbyacusis may involve or be aggravated by blood flow males being more susceptible. Autoregulation of cochlear blood flow has been demonstrated in some animal models in vivo, suggesting that similar to the brain, blood vessels supplying the cochlea have the ability to control flow within normal limits, despite variations in systemic blood pressure. Here, we investigated myogenic regulation in the cochlear blood supply of the Mongolian gerbil, a widely used animal model in hearing research. The cochlear blood supply originates at the basilar artery, followed by the anterior inferior cerebellar artery, and inside the inner ear, by the spiral modiolar artery and female gerbils were isolated and pressurized using a concentric pipette system. Diameter changes in response to increasing luminal pressures were recorded by laser scanning microscopy. Our results show that cochlear vessels from male and female gerbils exhibit myogenic regulation but with important differences. Whereas in male gerbils, both spiral modiolar arteries and radiating arterioles exhibited pressure-dependent tone, in females, only radiating arterioles had this property. Male spiral modiolar arteries responded more to L-NNA than female spiral modiolar arteries, suggesting that NO-dependent mechanisms play a bigger role in the myogenic regulation of male than female gerbil cochlear vessels.	[Reimann, Katrin; Krishnamoorthy, Gayathri; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Wier, Withrow Gil] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Kansas State University; University System of Maryland; University of Maryland Baltimore	Reimann, K (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wier, Withrow/AAE-2451-2020; Wangemann, Philine/N-2826-2013	Krishnamoorthy, Gayathri/0000-0002-2208-3244; Natarajan, Gayathri/0000-0001-7654-5013	NIH [R01-DC04280, R01-HL-091969, P20-RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants: NIH-R01-DC04280 to PW, NIH-R01-HL-091969 to WGW, and NIH-P20-RR017686 to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1988, AM J OTOLARYNG, V9, P278, DOI 10.1016/S0196-0709(88)80036-X; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Boettcher FA, 2002, J ACOUST SOC AM, V112, P2948, DOI 10.1121/1.1513364; BRECHTELSBAUER PB, 1994, HEARING RES, V77, P38, DOI 10.1016/0378-5955(94)90251-8; BROWN JN, 1994, AM J PHYSIOL, V266, pH458, DOI 10.1152/ajpheart.1994.266.2.H458; Cipolla MJ, 2008, MICROCIRCULATION, V15, P495, DOI 10.1080/10739680801986742; Cipolla MJ, 2008, MICROCIRCULATION, P1; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; Gladwin MT, 2006, ADV EXP MED BIOL, V588, P189; de Segura IAG, 2009, LAB ANIM-UK, V43, P239, DOI 10.1258/la.2008.006065; GOODWIN PC, 1984, HEARING RES, V15, P215, DOI 10.1016/0378-5955(84)90030-3; Gratton M A, 1996, Hear Res, V102, P181, DOI 10.1016/S0378-5955(96)90017-9; HATA R, 1994, J NEUROL SCI, V121, P79, DOI 10.1016/0022-510X(94)90160-0; HAYASHI K, 1995, HYPERTENSION, V25, P1212, DOI 10.1161/01.HYP.25.6.1212; HONRUBIA V, 1969, J ACOUST SOC AM, V46, P388, DOI 10.1121/1.1911701; KAWAKAMI M, 1991, EUR ARCH OTO-RHINO-L, V248, P471, DOI 10.1007/BF00627636; KILBOURN RG, 1994, BIOCHEM BIOPH RES CO, V199, P155, DOI 10.1006/bbrc.1994.1208; Knot HJ, 1999, AM J PHYSIOL-HEART C, V276, pH961, DOI 10.1152/ajpheart.1999.276.3.H961; MARCUS DC, 1978, LARYNGOSCOPE, V88, P1825; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; OHLSEN KA, 1992, HEARING RES, V58, P19, DOI 10.1016/0378-5955(92)90004-7; PEARSON JD, 1995, J ACOUST SOC AM, V97, P1196, DOI 10.1121/1.412231; PRAZMA J, 1990, ARCH OTOLARYNGOL, V116, P932; Preckel MP, 1998, ANESTH ANALG, V87, P1002, DOI 10.1097/00000539-199811000-00004; QUIRK WS, 1989, HEARING RES, V41, P53, DOI 10.1016/0378-5955(89)90178-0; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; ROBINSON D W, 1988, British Journal of Audiology, V22, P5, DOI 10.3109/03005368809077793; SHAPIRO HM, 1971, AM J PHYSIOL, V221, P279, DOI 10.1152/ajplegacy.1971.221.1.279; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Skarsgard P, 1997, AM J PHYSIOL-HEART C, V273, pH2248, DOI 10.1152/ajpheart.1997.273.5.H2248; SOHMER H, 1989, HEARING RES, V40, P87, DOI 10.1016/0378-5955(89)90102-0; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; Vaquez BYS, 2008, AM J RESP CELL MOL, V38, P135, DOI 10.1165/rcmb.2007-0081OC; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wangemann P, 1998, HEARING RES, V115, P113, DOI 10.1016/S0378-5955(97)00184-6; Wangemann P, 2005, HEARING RES, V209, P91, DOI 10.1016/j.heares.2005.06.011; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wellman GC, 1996, CIRC RES, V79, P1024, DOI 10.1161/01.RES.79.5.1024	40	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25659	10.1371/journal.pone.0025659	http://dx.doi.org/10.1371/journal.pone.0025659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980520	gold, Green Published, Green Submitted			2022-12-25	WOS:000295939600047
J	Tornavaca, O; Sarro, E; Pascual, G; Bardaji, B; Montero, MA; Salcedo, MT; Plana, M; Lopez-Hellin, J; Itarte, E; Meseguer, A				Tornavaca, Olga; Sarro, Eduard; Pascual, Gloria; Bardaji, Beatriz; Angeles Montero, M.; Teresa Salcedo, M.; Plana, Maria; Lopez-Hellin, Joan; Itarte, Emilio; Meseguer, Anna			KAP Degradation by Calpain Is Associated with CK2 Phosphorylation and Provides a Novel Mechanism for Cyclosporine A-Induced Proximal Tubule Injury	PLOS ONE			English	Article							CELL-SPECIFIC EXPRESSION; PROTEIN-KINASE CK2; THYROID-HORMONE; MESSENGER-RNA; KIDNEY INJURY; MEDIATED DEGRADATION; PEST SEQUENCES; B-ALPHA; NEPHROTOXICITY; GENE	The use of cyclosporine A (CsA) is limited by its severe nephrotoxicity that includes reversible vasoconstrictor effects and proximal tubule cell injury, the latter associated whith chronic kidney disease progression. The mechanisms of CsA-induced tubular injury, mainly on the S3 segment, have not been completely elucidated. Kidney androgen-regulated protein (KAP) is exclusively expressed in kidney proximal tubule cells, interacts with the CsA-binding protein cyclophilin B and its expression diminishes in kidneys of CsA-treated mice. Since we reported that KAP protects against CsA toxicity in cultured proximal tubule cells, we hypothesized that low KAP levels found in kidneys of CsA-treated mice might correlate with proximal tubule cell injury. To test this hypothesis, we used KAP Tg mice developed in our laboratory and showed that these mice are more resistant to CsA-induced tubular injury than control littermates. Furthermore, we found that calpain, which was activated by CsA in cell cultures and kidney, is involved in KAP degradation and observed that phosphorylation of serine and threonine residues found in KAP PEST sequences by protein kinase CK2 enhances KAP degradation by calpain. Moreover, we also observed that CK2 inhibition protected against CsA-induced cytotoxicity. These findings point to a novel mechanism for CsA-induced kidney toxicity that might be useful in developing therapeutic strategies aimed at preventing tubular cell damage while maintaining the immunosuppressive effects of CsA.	[Tornavaca, Olga; Sarro, Eduard; Pascual, Gloria; Bardaji, Beatriz; Lopez-Hellin, Joan; Meseguer, Anna] Hosp Univ Vall dHebron, Inst Recerca Vall dHebron, Ctr Invest Bioquim & Biol Mol CIBBIM, Barcelona, Spain; [Sarro, Eduard; Plana, Maria; Itarte, Emilio] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim Biociencies, Bellaterra, Spain; [Angeles Montero, M.; Teresa Salcedo, M.] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Meseguer, Anna] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim Med, Bellaterra, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Tornavaca, O (corresponding author), Hosp Univ Vall dHebron, Inst Recerca Vall dHebron, Ctr Invest Bioquim & Biol Mol CIBBIM, Barcelona, Spain.	ameseguer@ir.vhebron.net	Lopez-Hellin, Joan/M-2234-2014; Itarte, Emilio/Q-6246-2019; Montero, Angeles/AAQ-1696-2021; Sarró Tauler, Eduard/M-1660-2014; Angulo, Gloria Pascual/AAA-7668-2019; Navarro, Anna Meseguer/M-2222-2014; Itarte, Emilio/K-5275-2014; Plana Coll, Maria/L-3414-2014; Salcedo, Maria-Teresa/N-7091-2014	Lopez-Hellin, Joan/0000-0001-7286-3882; Montero, Angeles/0000-0002-2381-6833; Sarró Tauler, Eduard/0000-0001-7723-2916; Angulo, Gloria Pascual/0000-0003-3810-6647; Navarro, Anna Meseguer/0000-0003-3833-2249; Itarte, Emilio/0000-0002-9366-5807; Plana Coll, Maria/0000-0001-5808-9229; Bardaji de Quixano, Beatriz/0000-0001-7456-355X; Salcedo, Maria-Teresa/0000-0002-4822-5060	Ministerio de Ciencia e Innovacion [SAF2005-05167, BFU2009-10189]; Instituto de Salud Carlos III [FIS PI081351]; Fundacio La Marato de TV3 [002230, 002231]; Fundacion Senefro; Fundacion Mutua Madrilena; Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo; Fundacio Institut de Recerca Vall d'Hebron	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacio La Marato de TV3; Fundacion Senefro; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo; Fundacio Institut de Recerca Vall d'Hebron	This study was supported in part by grants (SAF2005-05167 to A. M and BFU2009-10189 to E. I.) from Ministerio de Ciencia e Innovacion; grant FIS PI081351 from Instituto de Salud Carlos III to A. M.; Fundacio La Marato de TV3 (grants 002230 and 002231) to A. M. and E. I.; Fundacion Senefro to A. M. and Fundacion Mutua Madrilena to A. M. Fellow funding was as follows: Dr. Olga Tornavaca was supported by the Red Nacional de Investigacion en Trasplantes del Instituto de Salud Carlos III; Beatriz Bardaji by Fundacion Renal Inigo Alvarez de Toledo and Gloria Pascual by Fundacio Institut de Recerca Vall d'Hebron. Dr. Meseguer's research group holds the "Quality'' mention from the Generalitat de Catalunya (Expediente 2009 SGR 75). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BATLLE DC, 1990, KIDNEY INT, V37, P21, DOI 10.1038/ki.1990.3; BENNETT WM, 1994, MINER ELECTROL METAB, V20, P214; Blomgren K, 2004, J BIOL CHEM, V13, P10191; BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Cebrian C, 2001, J BIOL CHEM, V276, P29410, DOI 10.1074/jbc.M102916200; Cheng CH, 2002, FEBS LETT, V516, P191, DOI 10.1016/S0014-5793(02)02563-2; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; da Costa MC, 2003, NEPHROL DIAL TRANSPL, V18, P2262, DOI 10.1093/ndt/gfg343; Edelstein CL, 1996, KIDNEY INT, V50, P1150, DOI 10.1038/ki.1996.422; EDELSTEIN CL, 1995, P NATL ACAD SCI USA, V92, P7662, DOI 10.1073/pnas.92.17.7662; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Inserte J, 2004, CARDIOVASC RES, V64, P105, DOI 10.1016/j.cardiores.2004.06.001; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2003, BIOCHEM J, V375, P623, DOI 10.1042/BJ20030915; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MESEGUER A, 1987, MOL ENDOCRINOL, V1, P535, DOI 10.1210/mend-1-8-535; MESEGUER A, 1989, MOL ENDOCRINOL, V3, P962, DOI 10.1210/mend-3-6-962; MESEGUER A, 1990, MOL ENDOCRINOL, V4, P1240, DOI 10.1210/mend-4-8-1240; MESEGUER A, 1992, MOL CELL ENDOCRINOL, V89, P153, DOI 10.1016/0303-7207(92)90221-Q; MIHATSCH MJ, 1988, TRANSPLANT P, V20, P759; MIHATSCH MJ, 1986, CLIN NEPHROL, V25, pS2; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; MURRAY BM, 1985, KIDNEY INT, V28, P767, DOI 10.1038/ki.1985.196; MYERS BD, 1984, NEW ENGL J MED, V311, P699, DOI 10.1056/NEJM198409133111103; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Perez-Rojas J, 2007, AM J PHYSIOL-RENAL, V292, pF131, DOI 10.1152/ajprenal.00147.2006; Rasband W.S., 1997, IMAGE J; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Schnellmann RG, 1998, RENAL FAILURE, V20, P679, DOI 10.3109/08860229809045162; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; SOLE E, 1994, ENDOCRINOLOGY, V135, P2120, DOI 10.1210/en.135.5.2120; Sole E, 1996, MOL CELL ENDOCRINOL, V119, P147, DOI 10.1016/0303-7207(96)03603-9; Soler M, 2002, BIOCHEM J, V366, P757, DOI 10.1042/BJ20011807; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; SUZUKI S, 1987, TRANSPLANTATION, V44, P363, DOI 10.1097/00007890-198709000-00008; Teixido N, 2006, MOL ENDOCRINOL, V20, P389, DOI 10.1210/me.2005-0229; TOOLE JJ, 1979, CELL, V17, P441, DOI 10.1016/0092-8674(79)90170-3; Tornavaca O, 2009, CIRCULATION, V119, P1908, DOI 10.1161/CIRCULATIONAHA.108.808543; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; WILSON PD, 1991, CELL BIOL INT REP, V15, P1243, DOI 10.1016/0309-1651(91)90096-2; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Wu MJ, 2004, J CELL PHYSIOL, V200, P395, DOI 10.1002/jcp.20028; Yanagawa T, 1997, BIOCHEM BIOPH RES CO, V241, P157, DOI 10.1006/bbrc.1997.7783	55	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25746	10.1371/journal.pone.0025746	http://dx.doi.org/10.1371/journal.pone.0025746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980535	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900095
J	Cheli, Y; Giuliano, S; Fenouille, N; Allegra, M; Hofman, V; Hofman, P; Bahadoran, P; Lacour, JP; Tartare-Deckert, S; Bertolotto, C; Ballotti, R				Cheli, Y.; Giuliano, S.; Fenouille, N.; Allegra, M.; Hofman, V.; Hofman, P.; Bahadoran, P.; Lacour, J-P; Tartare-Deckert, S.; Bertolotto, C.; Ballotti, R.			Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells	ONCOGENE			English	Article						metastasis; MITF; mesenchymal transition; hypoxia; Bhlhb2; differentiation	EPITHELIAL-MESENCHYMAL TRANSITION; LESS-THAN-OR-EQUAL-TO-1 MM; CYCLE PROGRESSION; GENE-EXPRESSION; STEM-CELLS; IN-VITRO; DIFFERENTIATION; GROWTH; SPARC; DEC1	Melanomas are very aggressive neoplasms with notorious resistance to therapeutics. It was recently proposed that the remarkable phenotypic plasticity of melanoma cells allows for the rapid development of both resistance to chemotherapeutic drugs and invasive properties. Indeed, the capacity of melanoma cells to form distant metastases is the main cause of mortality in melanoma patients. Therefore, the identification of the mechanism controlling melanoma phenotype is of paramount importance. In the present report, we show that deletion of microphthalmia-associated transcription factor (MITF), the master gene in melanocyte differentiation, is sufficient to increase the metastatic potential of mouse and human melanoma cells. MITF silencing also increases fibronectin and Snail, two mesenchymal markers that might explain the increased invasiveness in vitro and in vivo. Furthermore, ablation of this population by Forskolin-induced differentiation or MITF-forced expression significantly decreases tumour and metastasis formation, suggesting that eradication of low-MITF cells might improve melanoma treatment. Moreover, we demonstrate that a hypoxic microenvironment decreases MITF expression through an indirect, hypoxia-inducible factor 1 (HIF1)alpha-dependant transcriptional mechanism, and increases the tumourigenic and metastatic properties of melanoma cells. We identified Bhlhb2, a new factor in melanoma biology, as the mediator of hypoxia/HIF1 alpha inhibitory effect on MITF expression. Our results reveal a hypoxia-HIF1 alpha-BHLHB2-MITF cascade controlling the phenotypic plasticity in melanoma cells and favouring metastasis development. Targeting this pathway might be helpful in the design of new anti-melanoma therapies. Oncogene (2012) 31, 2461-2470; doi:10.1038/onc.2011.425; published online 26 September 2011	[Ballotti, R.] INSERM, Equipe Labellisee Ligue Contre Canc, Ctr Mediterraneen Med Mol, Team 1,Equipe 1,U895, F-06204 Nice 3, France; [Cheli, Y.; Giuliano, S.; Fenouille, N.; Allegra, M.; Hofman, P.; Bahadoran, P.; Lacour, J-P; Tartare-Deckert, S.; Bertolotto, C.; Ballotti, R.] Univ Nice Sophia Antipolis, UFR Med, Nice, France; [Hofman, V.; Hofman, P.] ERI21 EA 4319, Nice, France; [Hofman, V.; Hofman, P.] Human Biobank, Nice, France; [Bahadoran, P.; Lacour, J-P; Tartare-Deckert, S.; Bertolotto, C.; Ballotti, R.] CHU NICE, Dept Dermatol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Ballotti, R (corresponding author), INSERM, Equipe Labellisee Ligue Contre Canc, Ctr Mediterraneen Med Mol, Team 1,Equipe 1,U895, 151 Route St Antoine de Ginestiere, F-06204 Nice 3, France.	ballotti@unice.fr	Hofman, Paul/P-7654-2018; Bertolotto, Corine/AAF-6634-2021; Fenouille, Nina/AAI-1027-2021; CHELI, Yann/O-5783-2016; TARTARE-DECKERT, Sophie/P-6057-2015	Hofman, Paul/0000-0003-0431-9353; Bertolotto, Corine/0000-0001-6971-7753; veronique, HOFMAN/0000-0003-0943-1627; CHELI, Yann/0000-0001-9839-4332; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; BALLOTTI, Robert/0000-0002-7322-4908; Bahadoran, Philippe/0000-0002-2481-0556	'Fondation de France'; Societe Francaise de Dermatologie; ARC	'Fondation de France'(Fondation de France); Societe Francaise de Dermatologie; ARC(Australian Research Council)	We thank Giorgetti-Peraldi Sophie, Regazzetti Claire and Karine Bille for their help. Bhlhb2 reporter plasmid and expression vector were a kind gift from Dr S Egan (Toronto, Canada). This work was supported by the 'Fondation de France', and Societe Francaise de Dermatologie. YC has been supported by ARC's fellowships. The authors greatly acknowledge the C3M Imaging core facility (microscopy and imaging platform Cote d'Azur, MICA) and the C3M animal room facility.	AGARWAL KC, 1983, INT J CANCER, V32, P801, DOI 10.1002/ijc.2910320622; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bedrosian I, 2000, ANN SURG ONCOL, V7, P262, DOI 10.1007/s10434-000-0262-z; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Botton T, 2009, J INVEST DERMATOL, V129, P1208, DOI 10.1038/jid.2008.346; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Corsetti RL, 2000, ANN SURG ONCOL, V7, P456, DOI 10.1007/s10434-000-0456-4; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Eichhoff OM, 2010, MELANOMA RES, V20, P349, DOI 10.1097/CMR.0b013e32833bd89e; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; King R, 2001, AM J SURG PATHOL, V25, P51, DOI 10.1097/00000478-200101000-00005; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; SHAW HM, 1987, ARCH SURG-CHICAGO, V122, P1147; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059	40	135	141	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	19					2461	2470		10.1038/onc.2011.425	http://dx.doi.org/10.1038/onc.2011.425			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996743				2022-12-25	WOS:000303985300008
J	Llanos, S; Royer, C; Lu, M; Bergamaschi, D; Lee, WH; Lu, X				Llanos, Susana; Royer, Christophe; Lu, Min; Bergamaschi, Daniele; Lee, Wen Hwa; Lu, Xin			Inhibitory Member of the Apoptosis-stimulating Proteins of the p53 Family (iASPP) Interacts with Protein Phosphatase 1 via a Noncanonical Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPP; E2F; REGION	Background: Regulatory subunits confer substrate specificity to protein phosphatases. Results: iASPP, unlike ASPP2, interacts with protein phosphatase 1 (PP1) via a noncanonical binding motif within its SH3 domain. Conclusion: iASPP is a new PP1-binding partner. Significance: The identification of all ASPP family members as PP1-binding partners extends our understanding of how PP1 activity may be regulated in vivo.	[Llanos, Susana; Royer, Christophe; Lu, Min; Bergamaschi, Daniele; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford OX3 7DQ, England; [Llanos, Susana] Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain; [Bergamaschi, Daniele] Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, Blizard Inst, London E1 2AT, England; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	Ludwig Institute for Cancer Research; University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); University of London; Queen Mary University London; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Old Rd,Campus Res Bldg, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk	lu, min/E-5407-2014; Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013; , Susana/AAA-9282-2019	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Lu, Xin/0000-0002-6587-1152; Royer, Christophe/0000-0002-9882-7676; Bergamaschi, Daniele/0000-0002-3955-1091	Ludwig Institute for Cancer Research; Structural Genomics Consortium (SGC); Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation, Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Pfizer; Wellcome Trust	Ludwig Institute for Cancer Research; Structural Genomics Consortium (SGC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Ludwig Institute for Cancer Research.; Supported by the Structural Genomics Consortium (SGC). The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, Pfizer, and the Wellcome Trust.	Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; HELPS NR, 1994, FEBS LETT, V340, P93, DOI 10.1016/0014-5793(94)80179-7; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	22	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43039	43044		10.1074/jbc.M111.270751	http://dx.doi.org/10.1074/jbc.M111.270751			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998301	hybrid, Green Published			2022-12-25	WOS:000298351300024
J	Misra, J; Chanda, D; Kim, DK; Li, TG; Koo, SH; Back, SH; Chiang, JYL; Choi, HS				Misra, Jagannath; Chanda, Dipanjan; Kim, Don-kyu; Li, Tiangang; Koo, Seung-Hoi; Back, Sung-Hoon; Chiang, John Y. L.; Choi, Hueng-Sik			Curcumin Differentially Regulates Endoplasmic Reticulum Stress through Transcriptional Corepressor SMILE (Small Heterodimer Partner-interacting Leucine Zipper Protein)-mediated Inhibition of CREBH (cAMP Responsive Element-binding Protein H)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; HEPATIC GLUCONEOGENESIS; CREB/ATF-FAMILY; GENE-EXPRESSION; CELLS; KINASE; ZHANGFEI; LKB1; ATF6; PHOSPHORYLATION	Curcumin (diferuloylmethane), a major active component of turmeric (Curcuma longa), is a natural polyphenolic compound. Herein the effect of curcumin on endoplasmic reticulum (ER) stress responsive gene expression was investigated. We report that curcumin induces transcriptional corepressor small heterodimer partner-interacting leucine zipper protein (SMILE) gene expression through liver kinase B1 (LKB1)/adenosine monophosphate-activated kinase (AMPK) signaling pathway and represses ER stress-responsive gene transcription in an ER-bound transcription factor specific manner. cAMP responsive element-binding protein H (CREBH) and activating transcription factor 6 (ATF6) are both ER-bound bZIP family transcription factors that are activated upon ER stress. Of interest, we observed that both curcumin treatment and SMILE overexpression only represses CREBH-mediated transactivation of the target gene but not ATF6-mediated transactivation. Knockdown of endogenous SMILE significantly releases the inhibitory effect of curcumin on CREBH transactivation. Intrinsic repressive activity of SMILE is observed in the Gal4 fusion system, and the intrinsic repressive domain is mapped to the C terminus of SMILE spanning amino acid residues 203-269, corresponding to the basic region leucine zipper (bZIP) domain. In vivo interaction assay revealed that through its bZIP domain, SMILE interacts with CREBH and inhibits its transcriptional activity. Interestingly, we observed that SMILE does not interact with ATF6. Furthermore, competition between SMILE and the coactivator peroxisome proliferator-activated receptor alpha (PGC1 alpha) on CREBH transactivation has been demonstrated in vitro and in vivo. Finally, chromatin immunoprecipitation assays revealed that curcumin decreases the binding of PGC-1 alpha and CREBH on target gene promoter in a SMILE-dependent manner. Overall, for the first time we suggest a novel phenomenon that the curcumin/LKB1/AMPK/SMILE/PGC1 alpha pathway differentially regulates ER stress-mediated gene transcription.	[Misra, Jagannath; Chanda, Dipanjan; Kim, Don-kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Back, Sung-Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Northeast Ohio Medical University (NEOMED); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); University of Ulsan; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Ctr Nucl Receptor Signals, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015; Misra, Jagannath/AAW-8774-2021	Chiang, John Y. L./0000-0001-9360-7650; Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Misra, Jagannath/0000-0001-9713-0298	National Institutes of Health [DK58379, DK44442]; Korean Ministry of Education, Science, and Technology [20110018305]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea [20100019512]; Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442, R01DK058379, R56DK044442, R37DK058379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58379 and DK44442 (to J. Y. L. C.). This work was supported by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science, and Technology, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Korea Healthcare Technology R&D Project Grant A100588, and National Research Foundation of Korea Future-based Technology Development Program (BIO Fields) Grant 20100019512, funded by the Ministry of Education, Science, and Technology (to H.-S. C.).	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Gomez G, 2007, BIOCHEM BIOPH RES CO, V364, P561, DOI 10.1016/j.bbrc.2007.10.024; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Howells LM, 2007, ACTA PHARMACOL SIN, V28, P1274, DOI 10.1111/j.1745-7254.2007.00690.x; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lim HW, 2009, BIOCHEM BIOPH RES CO, V389, P187, DOI 10.1016/j.bbrc.2009.08.121; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Pizzo P, 2010, J CELL MOL MED, V14, P970, DOI [10.1111/j.1582-4934.2008.00681.x, 10.1111/j.1582-4934.2009.00681.x]; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	38	37	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41972	41984		10.1074/jbc.M111.274514	http://dx.doi.org/10.1074/jbc.M111.274514			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994947	Green Published, hybrid			2022-12-25	WOS:000298180900008
J	Gu, Y; Runyan, C; Shoemaker, A; Surani, MA; Wylie, C				Gu, Ying; Runyan, Christopher; Shoemaker, Amanda; Surani, M. Azim; Wylie, Christopher			Membrane-Bound Steel Factor Maintains a High Local Concentration for Mouse Primordial Germ Cell Motility, and Defines the Region of Their Migration	PLOS ONE			English	Article							C-KIT LIGAND; GROWTH-FACTOR; GENE-PRODUCT; MUTANT MICE; PROLIFERATION; SURVIVAL; CULTURE; FORMS; TRANSMEMBRANE; SPECIFICATION	Steel factor, the protein product of the Steel locus in the mouse, is a multifunctional signal for the primordial germ cell population. We have shown previously that its expression accompanies the germ cells during migration to the gonads, forming a "travelling niche'' that controls their survival, motility, and proliferation. Here we show that these functions are distributed between the alternatively spliced membrane-bound and soluble forms of Steel factor. The germ cells normally migrate as individuals from E7.5 to E11.5, when they aggregate together in the embryonic gonads. Movie analysis of Steel-dickie mutant embryos, which make only the soluble form, at E7.5, showed that the germ cells fail to migrate normally, and undergo "premature aggregation'' in the base of the allantois. Survival and directionality of movement is not affected. Addition of excess soluble Steel factor to Steel-dickie embryos rescued germ cell motility, and addition of Steel factor to germ cells in vitro showed that a fourfold higher dose was required to increase motility, compared to survival. These data show that soluble Steel factor is sufficient for germ cell survival, and suggest that the membrane-bound form provides a higher local concentration of Steel factor that controls the balance between germ cell motility and aggregation. This hypothesis was tested by addition of excess soluble Steel factor to slice cultures of E11.5 embryos, when migration usually ceases, and the germ cells aggregate. This reversed the aggregation process, and caused increased motility of the germ cells. We conclude that the two forms of Steel factor control different aspects of germ cell behavior, and that membrane-bound Steel factor controls germ cell motility within a "motility niche'' that moves through the embryo with the germ cells. Escape from this niche causes cessation of motility and death by apoptosis of the ectopic germ cells.	[Gu, Ying; Shoemaker, Amanda; Wylie, Christopher] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Gu, Ying] Univ Cincinnati, Mol & Dev Biol Grad Program, Sch Med, Cincinnati, OH USA; [Runyan, Christopher] Cincinnati Childrens Hosp, Med Ctr, Div Plast Surg, Cincinnati, OH USA; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon, Inst Canc & Dev Biol, Cambridge, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cambridge	Gu, Y (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	Christopher.Wylie@cchmc.org	Runyan, Christopher/AAE-5656-2019	Runyan, Christopher/0000-0002-3985-7250; Surani, Azim/0000-0002-8640-4318	National Institutes of Health [1R01HD060578-01]; Albert J. Ryan Foundation; Cincinnati Children's Hospital Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060578] Funding Source: NIH RePORTER; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert J. Ryan Foundation; Cincinnati Children's Hospital Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported in part by funding from National Institutes of Health (1R01HD060578-01), the Albert J. Ryan Foundation, and the Cincinnati Children's Hospital Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Bendel-Stenzel MR, 2000, MECH DEVELOP, V91, P143, DOI 10.1016/S0925-4773(99)00287-7; Bennett D, 1956, J MORPHOL, V98, P57; BESMER P, 1993, DEVELOPMENT, P125; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Friel J, 2002, GROWTH FACTORS, V20, P35, DOI 10.1080/08977190290022211; GALLI SJ, 1992, ANN NY ACAD SCI, V664, P69, DOI 10.1111/j.1749-6632.1992.tb39750.x; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; Gu Y, 2009, DEVELOPMENT, V136, P1295, DOI 10.1242/dev.030619; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IEMURA A, 1994, AM J PATHOL, V144, P321; KINASHI T, 1994, BLOOD, V83, P1033; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCCOSHEN JA, 1975, EXPERIENTIA, V31, P589, DOI 10.1007/BF01932475; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	30	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25984	10.1371/journal.pone.0025984	http://dx.doi.org/10.1371/journal.pone.0025984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998739	Green Published, Green Submitted, gold			2022-12-25	WOS:000295968700030
J	Gomez-Benito, M; Loayza-Puch, F; Vrielink, JO; Odero, MD; Agami, R				Gomez-Benito, Maria; Loayza-Puch, Fabricio; Vrielink, Joachim Oude; Odero, Maria D.; Agami, Reuven			3'UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene	PLOS ONE			English	Article							11Q23 CHROMOSOMAL TRANSLOCATIONS; TARGET MESSENGER-RNA; CELLS; TRANSFORMATION; MICRORNAS; LET-7	Translocations involving the Mixed Lineage Leukemia (MLL) gene generate in-frame fusions of MLL with more than 50 different partner genes (PGs). Common to all MLL translocations is the exchange not only of coding regions, but also of MLL and PG 3'-untranslated regions (3'UTRs). As a result, the MLL-PG fusion is normally highly expressed and considered the main driver of leukemia development, whereas the function of the PG-MLL fusions in leukemic disease is unclear. As 3'UTRs have been recognized as determinant regions for regulation of gene expression, we hypothesized that loss of the MLL 3'UTR could have a role in generating high MLL-PG levels and leukemia development. Here, we first tested the MLL-PG and PG-MLL mRNA levels in different leukemic cells and tumours and uncovered differential expression that indicates strong repression by the MLL-3'UTR. Reporter assays confirmed that the 3'UTR of MLL, but not of its main PGs, harbours a region that imposes a strong gene silencing effect. Gene suppression by the MLL 3'UTR was largely microRNA independent and did not affect mRNA stability, but inhibited transcription. This effect can at least partially be attributed to a tighter interaction of the MLL 3'UTR with RNA polymerase II than PG 3'UTRs, affecting its phosphorylation state. Altogether, our findings indicate that MLL translocations relieve oncogenic MLL-PG fusions from the repressive MLL 3'UTR, contributing to higher activity of these genes and leukaemia development.	[Gomez-Benito, Maria; Loayza-Puch, Fabricio; Vrielink, Joachim Oude; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Gomez-Benito, Maria; Odero, Maria D.] Ctr Appl Med Res, Pamplona, Spain; [Agami, Reuven] Ctr Biomed Genet, Utrecht, Netherlands	Netherlands Cancer Institute; University of Navarra	Gomez-Benito, M (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022; Odero/ABG-9860-2020	Odero/0000-0002-8858-2054; Agami, Reuven/0000-0002-2848-2473; Loayza-Puch, Fabricio/0000-0002-2999-8594	European Research Council [58196]; Horizon-NWO (Dutch Science Organization) [59140]; Spanish Ministry of Health (instituto de Salud Carlos III)	European Research Council(European Research Council (ERC)European Commission); Horizon-NWO (Dutch Science Organization); Spanish Ministry of Health (instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government)	This work was supported by the European Research Council (miReg number 58196) and Horizon-NWO (Dutch Science Organization) to RA; number 59140; and by the Spanish Ministry of Health (instituto de Salud Carlos III) fellowship to MG-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Burmeister T, 2010, BLOOD, V115, P4627, DOI 10.1182/blood-2010-03-275214; CIERPICKI T, NAT STRUCT MOL BIOL, V17, P62; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Keefe JG, 2010, J MOL DIAGN, V12, P441, DOI 10.2353/jmoldx.2010.090214; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lahortiga I, 2004, GENE CHROMOSOME CANC, V40, P179, DOI 10.1002/gcc.20033; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martin ME, 2003, CANCER CELL, V4, P197, DOI 10.1016/S1535-6108(03)00214-9; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9	24	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25449	10.1371/journal.pone.0025449	http://dx.doi.org/10.1371/journal.pone.0025449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998658	gold, Green Submitted, Green Published			2022-12-25	WOS:000295966900027
J	Chen, CS; Smits, C; Dodson, GG; Shevtsov, MB; Merlino, N; Gollnick, P; Antson, AA				Chen, Chao-Sheng; Smits, Callum; Dodson, Guy G.; Shevtsov, Mikhail B.; Merlino, Natalie; Gollnick, Paul; Antson, Alfred A.			How to Change the Oligomeric State of a Circular Protein Assembly: Switch from 11-Subunit to 12-Subunit TRAP Suggests a General Mechanism	PLOS ONE			English	Article							BINDING ATTENUATION PROTEIN; CRYSTAL-STRUCTURE; BACILLUS-HALODURANS; RNA; BIOSYNTHESIS; REFINEMENT; SEQUENCE; OPERON; MTRB	Background: Many critical cellular functions are performed by multisubunit circular protein oligomers whose internal geometry has evolved to meet functional requirements. The subunit number is arguably the most critical parameter of a circular protein assembly, affecting the internal and external diameters of the assembly and often impacting on the protein's function. Although accurate structural information has been obtained for several circular proteins, a lack of accurate information on alternative oligomeric states has prevented engineering such transitions. In this study we used the bacterial transcription regulator TRAP as a model system to investigate the features that define the oligomeric state of a circular protein and to question how the subunit number could be manipulated. Methodology/Principal Findings: We find that while Bacillus subtilis and Bacillus stearothermophilus TRAP form 11-subunit oligomers, the Bacillus halodurans TRAP exclusively forms 12-subunit assemblies. Significantly, the two states of TRAP are related by a simple rigid body rotation of individual subunits around inter-subunit axes. We tested if such a rotation could be induced by insertion or deletion mutations at the subunit interface. Using wild type 11-subunit TRAP, we demonstrate that removal of five C-terminal residues at the outer side of the inter-subunit axis or extension of an amino acid side chain at the opposite, inner side, increased the subunit number from 11 to 12. Our findings are supported by crystal structures of TRAP oligomers and by native mass spectrometry data. Conclusions/Significance: The subunit number of the TRAP oligomer can be manipulated by introducing deletion or addition mutations at the subunit interface. An analysis of available and emerging structural data on alternative oligomeric states indicates that the same principles may also apply to the subunit number of other circular assemblies suggesting that the deletion/addition approach could be used generally to engineer transitions between different oligomeric states.	[Chen, Chao-Sheng; Smits, Callum; Dodson, Guy G.; Shevtsov, Mikhail B.; Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Shevtsov, Mikhail B.] Univ Portsmouth, Portsmouth, Hants, England; [Merlino, Natalie; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	University of York - UK; University of Portsmouth; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chen, CS (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	fred@ysbl.york.ac.uk	Shevtsov, Mikhail B/I-1823-2014; Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Shevtsov, Mikhail/0000-0001-8160-2967	Wild Fund award; National Institutes of Health [RO1GM62750]; National Science Foundation [1019960]; Wellcome Trust [081916]; Diamond Light Source; Direct For Biological Sciences [1019960] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062750] Funding Source: NIH RePORTER	Wild Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Diamond Light Source; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wild Fund award (to C-SC), by National Institutes of Health grant RO1GM62750 and National Science Foundation Molecular and Cellular Biology grant 1019960 (both to PG) and by Wellcome Trust fellowship 081916 (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Sam Hart and Johan Turkenburg for help in collecting the X-ray data. We acknowledge support of the Diamond Light Source and we also thank ESRF for providing access to beamlines.	Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1992, J BACTERIOL, V174, P2059, DOI 10.1128/JB.174.7.2059-2064.1992; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Green BN, 2001, J MOL BIOL, V309, P553, DOI 10.1006/jmbi.2001.4704; Heddle JG, 2006, STRUCTURE, V14, P925, DOI 10.1016/j.str.2006.03.013; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; McCammon MG, 2004, J AM CHEM SOC, V126, P5950, DOI 10.1021/ja0317170; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naidoo N, 2008, J MOL BIOL, V377, P1357, DOI 10.1016/j.jmb.2008.01.007; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sallai L, 2005, J STRUCT BIOL, V151, P160, DOI 10.1016/j.jsb.2005.05.006; Shrive AK, 2009, J MOL BIOL, V386, P1240, DOI 10.1016/j.jmb.2009.01.008; Szigeti R, 2004, J BACTERIOL, V186, P818, DOI 10.1128/JB.186.3.818-828.2004; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Young HS, 2003, BIOPHYS J, V84, P571, DOI [10.1016/s0006-3495(03)74877-2, 10.1016/S0006-3495(03)74877-2]	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25296	10.1371/journal.pone.0025296	http://dx.doi.org/10.1371/journal.pone.0025296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984911	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000022
J	Wan, XW; Nardi, F; Zhang, B; Liu, YH				Wan, Xuanwu; Nardi, Francesco; Zhang, Bin; Liu, Yinghong			The Oriental Fruit Fly, Bactrocera dorsalis, in China: Origin and Gradual Inland Range Expansion Associated with Population Growth	PLOS ONE			English	Article							SAN-FRANCISCO BAY; GENETIC-STRUCTURE; OLIVE FLY; MICROSATELLITE MARKERS; MITOCHONDRIAL GENOME; DIPTERA; TEPHRITIDAE; CALIFORNIA; SPARTINA; INTRODUCTIONS	The oriental fruit fly, Bactrocera dorsalis, expanded throughout mainland China in the last century to become one of the most serious pests in the area, yet information on this process are fragmentary. Three mitochondrial genes (nad1, cytb and nad5) were used to infer the genetic diversity, population structure and demographic history of the oriental fruit fly from its entire distribution range in China. High levels of genetic diversity, as well as a significant correspondence between genetic and geographic distances, suggest that the invasion process might have been gradual, with no associated genetic bottlenecks. Three population groups could be identified, nevertheless the overall genetic structure was weak. The effective number of migrants between populations, estimated using the coalescent method, suggested asymmetric gene flow from the costal region of Guangdong to most inland regions. The demographic analysis indicates the oriental fruit fly underwent a recent population expansion in the Central China. We suggest the species originated in the costal region facing the South China Sea and gradually expanded to colonize mainland China, expanding here to high population numbers.	[Wan, Xuanwu; Zhang, Bin; Liu, Yinghong] Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China; [Nardi, Francesco] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Southwest University - China; University of Siena	Wan, XW (corresponding author), Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022; Nardi, Francesco/E-5516-2011	Nardi, Francesco/0000-0003-0271-9855	National Basic Research Program of China [2009CB125903]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (2009CB125903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Aketarawong N, 2006, MOL ECOL NOTES, V6, P1138, DOI 10.1111/j.1471-8286.2006.01463.x; Alaoui A, 2010, INT J AGRIC BIOL, V12, P291; Anttila CK, 2000, MOL ECOL, V9, P765, DOI 10.1046/j.1365-294x.2000.00935.x; Augustinos AA, 2005, GENETICA, V125, P231, DOI 10.1007/s10709-005-8692-y; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Baker DA, 2003, MOL ECOL, V12, P3303, DOI 10.1046/j.1365-294X.2003.02010.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Chen LianGen, 2010, Acta Agriculturae Shanghai, V26, P99; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Daehler CC, 1997, AM J BOT, V84, P607, DOI 10.2307/2445896; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Elfekih S, 2010, J APPL ENTOMOL, V134, P647, DOI 10.1111/j.1439-0418.2009.01500.x; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Grapputo A, 2006, ITAL J ZOOL, V73, P67, DOI 10.1080/11250000500502111; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; He M, 1997, ANN ENTOMOL SOC AM, V90, P825, DOI 10.1093/aesa/90.6.825; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang Fan, 2001, Acta Agriculturae Universitatis Jiangxiensis, V23, P259; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JH, 2007, ENTOMOL SCI, V10, P11, DOI 10.1111/j.1479-8298.2006.00194.x; MANTEL N, 1967, CANCER RES, V27, P209; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller NJ, 2009, ENVIRON ENTOMOL, V38, P274, DOI 10.1603/022.038.0134; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Muraji M, 2008, APPL ENTOMOL ZOOL, V43, P609, DOI 10.1303/aez.2008.609; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schmitt T, 2005, BIOL CONSERV, V123, P11, DOI 10.1016/j.biocon.2004.09.018; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Siedchlag AC, 2010, MOL PHYLOGENET EVOL, V56, P622, DOI 10.1016/j.ympev.2010.04.027; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Suarez NM, 2009, MOL PHYLOGENET EVOL, V53, P556, DOI 10.1016/j.ympev.2009.07.018; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; Wang S. Q., 2009, PLANT PROTECTION HUB, V3, P5; Wang X J., 1996, ACTA ZOOTAXONOMICA S, V21, P53; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Yuan M., 2008, J ANHUI AGR SCI, V22, P9619; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; [周国梁 ZHOU GuoLiang], 2007, [生态学报, Acta Ecologica Sinica], V27, P3362	62	46	52	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25238	10.1371/journal.pone.0025238	http://dx.doi.org/10.1371/journal.pone.0025238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984907	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000018
J	Xiao, PJ; Peng, ZY; Huang, L; Li, Y; Chen, XH				Xiao, Ping-Jie; Peng, Zheng-Yu; Huang, Lu; Li, Ya; Chen, Xian-Hua			Dephosphorylated NSSR1 Is Induced by Androgen in Mouse Epididymis and Phosphorylated NSSR1 Is Increased during Sperm Maturation	PLOS ONE			English	Article							PRE-MESSENGER-RNA; TYROSINE PHOSPHORYLATION; SPLICING REPRESSOR; MINOR SPLICEOSOME; ACROSOME REACTION; RAT RETINA; EXPRESSION; PROTEIN; SRP38; LOCALIZATION	NSSR1 (Neural salient serine/arginine rich protein 1, alternatively SRp38) is a newly identified RNA splicing factor and predominantly expressed in neural tissues. Here, by Western blot analysis and immunofluorescent staining, we showed that the expression of dephosphorylated NISSR1 increased significantly during development of the caput epididymis. In adult mice, phosphorylated NISSR1 was mainly expressed in the apical side of epithelial cells, and dephosphorylated NSSR1 in caput epididymis was upregulated in a testosterone dependent manner. In addition, subcellular immunoreactive distribution of NSSR1 varied in different regions of the epididymis. With respect to the sperm, phosphorylated NSSR1 was detected in the mid-piece of the tail as well as the acrosome. Furthermore, NSSR1 was released from the sperm head during the capacitation and acrosome reaction. These findings for the first time provide the evidence for the potential roles of NSSR1 in sperm maturation and fertilization.	[Xiao, Ping-Jie; Peng, Zheng-Yu; Li, Ya; Chen, Xian-Hua] Fudan Univ, Inst Brain Sci, Lab Genom Physiol, Shanghai 200433, Peoples R China; [Xiao, Ping-Jie; Peng, Zheng-Yu; Li, Ya; Chen, Xian-Hua] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Peng, Zheng-Yu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Lu] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Xiao, PJ (corresponding author), Fudan Univ, Inst Brain Sci, Lab Genom Physiol, Shanghai 200433, Peoples R China.	xhchen@fudan.edu.cn	XIAO, PING-JIE/E-6399-2012; Huang, Lu/E-4250-2014; Xiao, Pingjie/G-4045-2012		National Foundation of Natural Sciences of China [30770661, 30971464, 81030020]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Key project [07DJ14005]; Research Fund for the Doctoral Program of Higher Education of China [20070246053]	National Foundation of Natural Sciences of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Key project; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Foundation of Natural Sciences of China (No. 30770661, 30971464, 81030020), the Shanghai Leading Academic Discipline Project (No. B111), the Shanghai Key project (No. 07DJ14005), and Research Fund for the Doctoral Program of Higher Education of China (20070246053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Cherry J, 2006, IN VIVO, V20, P17; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Cooper TG, 1996, ANDROLOGIA, V28, P57; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; HERAS MAD, 1987, J REPROD FERTIL, V79, P9, DOI 10.1530/jrf.0.0790009; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Johnson PM, 2007, REPRODUCTION, V134, P739, DOI 10.1530/REP-07-0363; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Komatsu M, 1999, GENES CELLS, V4, P593, DOI 10.1046/j.1365-2443.1999.00286.x; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Ling IF, 2010, HUM MUTAT, V31, P702, DOI 10.1002/humu.21244; Liu L, 2004, NEUROREPORT, V15, P823, DOI 10.1097/00001756-200404090-00017; Liu L, 2003, NEUROREPORT, V14, P1847, DOI 10.1097/00001756-200310060-00018; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Peng ZY, 2007, NEUROREPORT, V18, P1641, DOI 10.1097/WNR.0b013e3282f0b542; Peng ZY, 2009, NEUROCHEM RES, V34, P1083, DOI 10.1007/s11064-008-9878-3; Peng ZY, TUMOUR BIOL, V32, P359; Roberts KP, 2006, MOL CELL ENDOCRINOL, V250, P122, DOI 10.1016/j.mce.2005.12.034; Roberts KP, 2001, J ANDROL, V22, P157; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Steitz JA, 2008, P NATL ACAD SCI USA, V105, P8485, DOI 10.1073/pnas.0804024105; TALBOT P, 1976, J EXP ZOOL, V198, P383, DOI 10.1002/jez.1401980312; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Wilhelm B, 2008, HISTOCHEM CELL BIOL, V129, P331, DOI 10.1007/s00418-007-0362-y; Xao PJ, 2007, MOL REPROD DEV, V74, P1363, DOI 10.1002/mrd.20719	39	4	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25667	10.1371/journal.pone.0025667	http://dx.doi.org/10.1371/journal.pone.0025667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980524	Green Submitted, gold, Green Published			2022-12-25	WOS:000295939600048
J	Gomez-Posada, JC; Aivar, P; Alberdi, A; Alaimo, A; Etxeberria, A; Fernandez-Orth, J; Zamalloa, T; Roura-Ferrer, M; Villace, P; Areso, P; Casis, O; Villarroel, A				Gomez-Posada, Juan Camilo; Aivar, Paloma; Alberdi, Araitz; Alaimo, Alessandro; Etxeberria, Ainhoa; Fernandez-Orth, Juncal; Zamalloa, Teresa; Roura-Ferrer, Meritxell; Villace, Patricia; Areso, Pilar; Casis, Oscar; Villarroel, Alvaro			Kv7 Channels Can Function without Constitutive Calmodulin Tethering	PLOS ONE			English	Article							GO POTASSIUM CHANNELS; K+ CHANNELS; SURFACE EXPRESSION; HUMAN ETHER; TRAFFICKING; BINDING; INHIBITION; KCNQ2/KCNQ3; SUPPRESSION; MODULATION	M-channels are voltage-gated potassium channels composed of Kv7.2-7.5 subunits that serve as important regulators of neuronal excitability. Calmodulin binding is required for Kv7 channel function and mutations in Kv7.2 that disrupt calmodulin binding cause Benign Familial Neonatal Convulsions (BFNC), a dominantly inherited human epilepsy. On the basis that Kv7.2 mutants deficient in calmodulin binding are not functional, calmodulin has been defined as an auxiliary subunit of Kv7 channels. However, we have identified a presumably phosphomimetic mutation S511D that permits calmodulin-independent function. Thus, our data reveal that constitutive tethering of calmodulin is not required for Kv7 channel function.	[Gomez-Posada, Juan Camilo; Aivar, Paloma; Alberdi, Araitz; Alaimo, Alessandro; Etxeberria, Ainhoa; Fernandez-Orth, Juncal; Zamalloa, Teresa; Roura-Ferrer, Meritxell; Villace, Patricia; Villarroel, Alvaro] Univ Basque Country Euskal Herriko Unibersitatea, Consejo Super Invest Cient, Unidad Biofis, Leioa, Spain; [Casis, Oscar] Univ Basque Country, Dept Fisiol, Leioa, Spain; [Areso, Pilar] Univ Basque Country, Dept Farmacol, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Basque Country	Gomez-Posada, JC (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	gbxvimua@ehu.es	Villarroel, Alvaro/H-5580-2015; Messier, Claude/A-2322-2008; Zamalloa, Teresa/AGT-7311-2022; Alaimo, Alessandro/C-6334-2016; Arco, Mariangeles/C-6181-2016	Messier, Claude/0000-0002-4791-1763; Zamalloa, Teresa/0000-0001-8050-496X; Alaimo, Alessandro/0000-0002-5888-6268; Arco, Mariangeles/0000-0002-0993-7460; CASIS SAENZ, OSCAR/0000-0002-6219-3317	Fondo de Investigaciones Sanitarias [PI071316]; Spanish Ministry of Education [BFU2009-07581, SAF2006-1450]; Spanish Ion Channel Initiative [CSD2008-00005]; Fondo Social Europeo; Funeacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Ministry of Education(Spanish Government); Spanish Ion Channel Initiative; Fondo Social Europeo(European Social Fund (ESF)European Commission); Funeacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the VII European framework program managed by the Fondo de Investigaciones Sanitarias (PI071316), from the Spanish Ministry of Education (BFU2009-07581 and SAF2006-1450), and by the Spanish Ion Channel Initiative Consolider Project (CSD2008-00005). J.C.G-P. held an I3P CSIC Fellowship co-financed by the Fondo Social Europeo. A.A and A.E. were partially funded by Funeacion Biofisica Bizkaia. P.A. held a Formacion de Personal Investigador Fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hughes S, 2007, PFLUG ARCH EUR J PHY, V455, P115, DOI 10.1007/s00424-007-0259-6; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	37	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25508	10.1371/journal.pone.0025508	http://dx.doi.org/10.1371/journal.pone.0025508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980481	Green Published, gold			2022-12-25	WOS:000295936900073
J	Kim, TM; Ramirez, V; Barrera-Chimal, J; Bobadilla, NA; Park, PJ; Vaidya, VS				Kim, Tae-Min; Ramirez, Victoria; Barrera-Chimal, Jonatan; Bobadilla, Norma A.; Park, Peter J.; Vaidya, Vishal S.			Gene Expression Analysis Reveals the Cell Cycle and Kinetochore Genes Participating in Ischemia Reperfusion Injury and Early Development in Kidney	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LIVER DEVELOPMENT; SET ENRICHMENT; BIOMARKERS; REGENERATION; RAT; ISCHEMIA/REPERFUSION; MOLECULE-1; PROTEINS; PATTERNS	Background: The molecular mechanisms that mediate the ischemia-reperfusion (I/R) injury in kidney are not completely understood. It is also largely unknown whether such mechanisms overlap with those governing the early development of kidney. Methodology/Principal Findings: We performed gene expression analysis to investigate the transcriptome changes during regeneration after I/R injury in the rat (0 hr, 6 hr, 24 hr, and 120 hr after reperfusion) and early development of mouse kidney (embryonic day 16 p. c. and postnatal 1 and 7 day). Pathway analysis revealed a wide spectrum of molecular functions that may participate in the regeneration and developmental processes of kidney as well as the functional association between them. While the genes associated with cell cycle, immunity, inflammation, and apoptosis were globally activated during the regeneration after I/R injury, the genes encoding various transporters and metabolic enzymes were down-regulated. We also observed that these injury-associated molecular functions largely overlap with those of early kidney development. In particular, the up-regulation of kinases and kinesins with roles in cell division was common during regeneration and early developmental kidney as validated by real-time PCR and immunohistochemistry. Conclusions: In addition to the candidate genes whose up-regulation constitutes an overlapping expression signature between kidney regeneration and development, this study lays a foundation for studying the functional relationship between two biological processes.	[Kim, Tae-Min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02163 USA; [Ramirez, Victoria; Vaidya, Vishal S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; [Barrera-Chimal, Jonatan; Bobadilla, Norma A.] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Ramirez, Victoria; Barrera-Chimal, Jonatan; Bobadilla, Norma A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nefrol & Metab Mineral, Mexico City, DF, Mexico; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Harvard T.H. Chan School of Public Health	Kim, TM (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02163 USA.	vvaidya@partners.org	Barrera-Chimal, Jonatan/AAC-1380-2020; Ramirez, Victoria/I-8087-2012	Ramirez, Victoria/0000-0002-2782-1381; Park, Peter/0000-0001-9378-960X; Barrera-Chimal, JONATAN/0000-0002-0711-5092	National Institutes of Environmental Health Sciences [ES016723]; National Institute of General Medical Sciences [R01 GM082798]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Vaidya laboratory is supported by National Institutes of Environmental Health Sciences' Pathway to Independence Grant [ES016723]. TMK and PJP are supported by a grant from National Institute of General Medical Sciences (R01 GM082798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Kelley-Loughnane N, 2002, HEPATOLOGY, V35, P525, DOI 10.1053/jhep.2002.31351; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Lu Y, 2009, BIOINFORMATICS, V25, P1476, DOI 10.1093/bioinformatics/btp247; Maeshima A, 2002, J AM SOC NEPHROL, V13, P2850, DOI 10.1097/01.ASN.0000035086.93977.E9; Perco P, 2007, TRANSPL INT, V20, P2, DOI 10.1111/j.1432-2277.2006.00376.x; Ramirez V, 2004, CELL STRESS CHAPERON, V9, P198, DOI 10.1379/CSC-22R.1; Rensen WM, 2009, ONCOGENE, V28, P1748, DOI 10.1038/onc.2009.24; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; WITZGALL R, 1993, MOL CELL BIOL, V13, P1933, DOI 10.1128/MCB.13.3.1933; Yoshida T, 2002, BIOCHEM BIOPH RES CO, V291, P787, DOI 10.1006/bbrc.2002.6535; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005	35	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25679	10.1371/journal.pone.0025679	http://dx.doi.org/10.1371/journal.pone.0025679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980527	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900091
J	Mika, JT; Krasnikov, V; van den Bogaart, G; de Haan, F; Poolman, B				Mika, Jacek T.; Krasnikov, Victor; van den Bogaart, Geert; de Haan, Foppe; Poolman, Bert			Evaluation of Pulsed-FRAP and Conventional-FRAP for Determination of Protein Mobility in Prokaryotic Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; DIFFUSION; GROWTH	Background: Macromolecule mobility is often quantified with Fluorescence Recovery After Photobleaching (FRAP). Throughout literature a wide range of diffusion coefficients for GFP in the cytoplasm of Escherichia coli (3 to 14 mu m(2)/s) is reported using FRAP-based approaches. In this study, we have evaluated two of these methods: pulsed-FRAP and "conventional''-FRAP. Principal Findings: To address the question whether the apparent discrepancy in the diffusion data stems from methodological differences or biological variation, we have implemented and compared the two techniques on bacteria grown and handled in the same way. The GFP diffusion coefficients obtained under normal osmotic conditions and upon osmotic upshift were very similar for the different techniques. Conclusions: Our analyses indicate that the wide range of values reported for the diffusion coefficient of GFP in live cells are due to experimental conditions and/or biological variation rather than methodological differences.	[Mika, Jacek T.] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	University of Groningen; University of Groningen	Mika, JT (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; van den Bogaart, Geert/GLV-3283-2022; van den Bogaart, Geert/A-1089-2014; Poolman, Bert/D-1882-2012	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; 	SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC); Nederlandse Wetenschappelijke Organisatie (NWO) [700.56.302]	SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nederlandse Wetenschappelijke Organisatie (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge financial support from SysMo via the Biotechnology and Biological Sciences Research Council (BBSRC)-funded KosmoBac programme coordinated by Ian R. Booth (Aberdeen) and Nederlandse Wetenschappelijke Organisatie (NWO) (top-subsidy grant 700.56.302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ENGLISH BP, 2010, TRACKING INDIVIDUAL; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009; MIKA JT, 2010, MOL MICROBIOL; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; NENNINGER A, 2010, J BACTERIOL; Slade KM, 2009, J PHYS CHEM B, V113, P4837, DOI 10.1021/jp810642d; Slade KM, 2009, BIOCHEMISTRY-US, V48, P5083, DOI 10.1021/bi9004107; van den Bogaart G, 2007, MOL MICROBIOL, V64, P858, DOI 10.1111/j.1365-2958.2007.05705.x; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994	16	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25664	10.1371/journal.pone.0025664	http://dx.doi.org/10.1371/journal.pone.0025664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980523	Green Submitted, Green Published, gold			2022-12-25	WOS:000295936900089
J	Li, W; Melton, DW				Li, W.; Melton, D. W.			Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance	ONCOGENE			English	Article						chemotherapy; DNA damage; DUSP6 phosphatase; nucleotide excision repair; XPF	NUCLEOTIDE EXCISION-REPAIR; ACTIVATED PROTEIN-KINASES; OVARIAN-CANCER CELLS; SIGNALING PATHWAY; OXIDATIVE STRESS; RESISTANCE; INHIBITION; APOPTOSIS; PHOSPHATASES; GROWTH	The incidence of malignant melanoma is growing rapidly worldwide and there is still no effective therapy for metastatic disease. Melanoma is the second most common cancer among young adults in the UK, where incidence rates have more than quadrupled since the 1970s. Increased expression of a number of DNA repair genes has been reported in melanoma and this likely contributes to its extreme resistance to conventional DNA-damaging chemotherapeutics. One such chemotherapeutic that is effective against a range of other cancers, but not melanoma, is cisplatin. The DNA repair proteins ERCC1 and XPF are needed to remove cisplatin-induced DNA damage and we have investigated the response of these proteins to cisplatin in melanoma. The expression of both genes is induced by cisplatin. Use of a MEK inhibitor showed that ERCC1, but not XPF induction was regulated by the mitogen-activated protein kinase (MAPK) pathway, with reduction in expression of DUSP6, the phosphatase that inactivates the extracellular signal-regulated kinase (ERK), being particularly important. DUSP6 overexpression prevented cisplatin induction of both ERCC1 and XPF, resulting in increased sensitivity to cisplatin. A novel ERCC1 mRNA was found that initiated upstream of the normal transcription initiation site, and was strongly regulated by both cisplatin and the MAPK pathway and its role in cisplatin resistance merits further study. The cisplatin induction of ERCC1 and XPF provides important insights into the resistance of melanoma to DNA-damaging chemotherapeutics, which is one of the major obstacles to melanoma treatment. Oncogene (2012) 31, 2412-2422; doi: 10.1038/onc.2011.426; published online 26 September 2011	[Li, W.; Melton, D. W.] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Melton, DW (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, MRC Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	David.Melton@ed.ac.uk		li, weiling/0000-0001-6681-9156	China Scholarship Council/University of Edinburgh; Charon Fund	China Scholarship Council/University of Edinburgh(China Scholarship Council); Charon Fund	The cisplatin colony-forming assay was carried out by Ann-Marie Ritchie. We are grateful to Professor Toru Furukawa (Tohoku University School of Medicine, Japan), who kindly provided the DUSP6 plasmid. WL was supported by a China Scholarship Council/University of Edinburgh Scholarship. This work was supported by the Charon Fund.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; BROWN R, 1993, INT J CANCER, V55, P678, DOI 10.1002/ijc.2910550428; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Cancer Research UK, 2020, PANCR CANC STAT CANC, P1; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Ciuffreda L, 2009, NEOPLASIA, V11, P720, DOI 10.1593/neo.09398; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Ferry KV, 2000, BIOCHEM PHARMACOL, V60, P1305, DOI 10.1016/S0006-2952(00)00441-X; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Gozdz A, 2008, J NEUROCHEM, V106, P2056, DOI 10.1111/j.1471-4159.2008.05550.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Jansen B, 1997, CANCER RES, V57, P362; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee-Kwon W, 1998, BIOCHEM J, V331, P591, DOI 10.1042/bj3310591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Mirmohammadsadegh A, 2007, J INVEST DERMATOL, V127, P2207, DOI 10.1038/sj.jid.5700870; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oliveria SA, 2006, ARCH DIS CHILD, V91, P131, DOI 10.1136/adc.2005.086918; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rosell Rafael, 2003, Cancer Control, V10, P297; Selfridge J, 2010, DNA REPAIR, V9, P653, DOI 10.1016/j.dnarep.2010.02.018; Shahzad MMK, 2009, DRUG RESIST UPDATE, V12, P148, DOI 10.1016/j.drup.2009.09.001; Song L, 2011, TRANSGENIC RES, V20, P109, DOI 10.1007/s11248-010-9396-3; Stecca C, 1998, BIOCHEM PHARMACOL, V55, P941, DOI 10.1016/S0006-2952(97)00448-6; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; VANDUIN M, 1987, NUCLEIC ACIDS RES, V15, P9195, DOI 10.1093/nar/15.22.9195; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Winter AG, 2005, ONCOGENE, V24, P2110, DOI 10.1038/sj.onc.1208400; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yacoub A, 2003, RADIAT RES, V159, P439, DOI 10.1667/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2	51	70	72	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	19					2412	2422		10.1038/onc.2011.426	http://dx.doi.org/10.1038/onc.2011.426			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996734				2022-12-25	WOS:000303985300004
J	Manser, C; Guillot, F; Vagnoni, A; Davies, J; Lau, KF; McLoughlin, DM; De Vos, KJ; Miller, CCJ				Manser, C.; Guillot, F.; Vagnoni, A.; Davies, J.; Lau, K-F; McLoughlin, D. M.; De Vos, K. J.; Miller, C. C. J.			Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo	ONCOGENE			English	Article						glycogen synthase kinase-3 beta; protein phosphatase-1C; transforming growth factor-beta; amyotrophic lateral sclerosis; Alzheimer's disease; axonal transport	GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN PHOSPHATASE-1; TGF-BETA; MYOSIN-VI; GENE-EXPRESSION; IDENTIFICATION; INACTIVATION; INHIBITOR; TRANSPORT; BRAIN	A recent genome-wide association study identified the gene encoding lemur tyrosine kinase-2 (LMTK2) as a susceptibility gene for prostate cancer. The identified genetic alteration is within intron 9, but the mechanisms by which LMTK2 may impact upon prostate cancer are not clear because the functions of LMTK2 are poorly understood. Here, we show that LMTK2 regulates a known pathway that controls phosphorylation of kinesin-1 light chain-2 (KLC2) by glycogen synthase kinase-3 beta (GSK3b). KLC2 phosphorylation by GSK3 beta induces the release of cargo from KLC2. LMTK2 signals via protein phosphatase-1C (PP1C) to increase inhibitory phosphorylation of GSK3 beta on serine-9 that reduces KLC2 phosphorylation and promotes binding of the known KLC2 cargo Smad2. Smad2 signals to the nucleus in response to transforming growth factor-beta (TGF beta) receptor stimulation and transport of Smad2 by kinesin-1 is required for this signalling. We show that small interfering RNA loss of LMTK2 not only reduces binding of Smad2 to KLC2, but also inhibits TGF beta-induced Smad2 signalling. Thus, LMTK2 may regulate the activity of kinesin-1 motor function and Smad2 signalling. Oncogene (2012) 31, 2773-2782; doi: 10.1038/onc.2011.437; published online 26 September 2011	[Manser, C.; Guillot, F.; Vagnoni, A.; Davies, J.; Lau, K-F; McLoughlin, D. M.; De Vos, K. J.; Miller, C. C. J.] Kings Coll London, Dept Neurosci P037, MRC Ctr Neurodegenerat Res, Inst Psychiat, London SE5 8AF, England; [Lau, K-F] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [McLoughlin, D. M.] St Patricks Hosp, Trinity Coll Inst Neurosci, Dept Psychiat, Dublin, Ireland	University of London; King's College London; Chinese University of Hong Kong; Trinity College Dublin	Miller, CCJ (corresponding author), Kings Coll London, Dept Neurosci P037, MRC Ctr Neurodegenerat Res, Inst Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	chris.miller@kcl.ac.uk	Miller, Christopher/H-5733-2012; De Vos, Kurt/D-8380-2011	De Vos, Kurt/0000-0003-2161-6309; Miller, Christopher/0000-0002-5130-1845; , Florence/0000-0002-8491-4269; Lau, Kwok-Fai/0000-0002-0193-1152; Vagnoni, Alessio/0000-0003-2947-9193; McLoughlin, Declan/0000-0003-4574-2799	Wellcome Trust; MRC; MNDA; BBSRC; MRC [G0501573] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506913/1] Funding Source: researchfish; Medical Research Council [G0501573] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MNDA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust, MRC, MNDA and BBSRC. We thank Caroline Hill (Cancer Research UK London Research Institute) for EGFP-Smad2 plasmid, Peter ten Dijke (Leiden University Medical Centre) for Smad2 reporter plasmids, Folma Buss (University of Cambridge UK) for LMTK2 antibody and Manuel Mayr (KCL London) for assistance with analyses of Pro-Q labelling.	Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FitzGerald LM, 2009, CLIN CANCER RES, V15, P3231, DOI 10.1158/1078-0432.CCR-08-2190; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guidato S, 1998, J NEUROCHEM, V70, P335; Guo CY, 2002, J BIOL CHEM, V277, P41756, DOI 10.1074/jbc.M207519200; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Kawa S, 2006, P NATL ACAD SCI USA, V103, P19344, DOI 10.1073/pnas.0603603103; Kesavapany S, 2003, J NEUROSCI, V23, P4975; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Martin K, 2003, PROTEOMICS, V3, P1244, DOI 10.1002/pmic.200300445; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McLoughlin DM, 1996, FEBS LETT, V397, P197; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Murakami M, 2009, GENES CELLS, V14, P469, DOI 10.1111/j.1365-2443.2009.01283.x; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman-Roblick R, 2008, ONCOGENE, V27, P4854, DOI 10.1038/onc.2008.124; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Su AI, 2001, CANCER RES, V61, P7388; Su SC, 2011, ANNU REV CE IN PRESS; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Wang H, 2006, MOL CELL PROTEOMICS, V5, P2124, DOI 10.1074/mcp.M600188-MCP200; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	59	36	36	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	22					2773	2782		10.1038/onc.2011.437	http://dx.doi.org/10.1038/onc.2011.437			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	952DB	21996745	Green Accepted, Green Published			2022-12-25	WOS:000304769000007
J	Shih, MC; Chen, JY; Wu, YC; Jan, YH; Yang, BM; Lu, PJ; Cheng, HC; Huang, MS; Yang, CJ; Hsiao, M; Lai, JM				Shih, M-C; Chen, J-Y; Wu, Y-C; Jan, Y-H; Yang, B-M; Lu, P-J; Cheng, H-C; Huang, M-S; Yang, C-J; Hsiao, M.; Lai, J-M			TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer	ONCOGENE			English	Article						TOPK; AKT; PTEN; migration; prognosis marker; lung adenocarcinoma	ORIGINATED PROTEIN-KINASE; PDZ-BINDING KINASE; MITOTIC KINASE; DISEASE RECURRENCE; EXPRESSION; PTEN; PHOSPHORYLATION; SURVIVAL; PBK/TOPK; INVASION	We integrated four gene expression profile data sets, namely two different pair-matched stage I lung adenocarcinoma data sets, secondary metastatic tumors vs benign tumors and lung tumor metastasizes to the brain, and we identified one kinase, T-LAK Cell-Originated Protein Kinase (TOPK), as a putative gene that promotes metastasis. To delineate the role of TOPK in lung cancer, we showed that overexpression of TOPK, but not a catalytically inactive form of TOPK, can enhance the migration and invasion of lung fibroblasts or cells with low TOPK expression. In addition, TOPK-induced cell migration was shown to be a PI3K/AKT-dependent event. TOPK concurrently promoted AKT phosphorylation at Ser(473) and decreased the phosphatase and tensin homolog (PTEN) levels, whereas TOPK knockdown had the reverse effects. LY294002, a PI3K inhibitor, did not inhibit the TOPK-induced decrease in PTEN, and co-expression of PTEN significantly reduced TOPK-induced AKT phosphorylation in a dose-dependent manner; these results indicate that the TOPK-mediated PTEN decrease has an upstream role in regulating PI3K/AKT-stimulated migration. Using immunohistochemical analysis of lung cancer tissue samples, we showed that a high TOPK expression level correlates strongly with reduced overall and disease-free survivals. Moreover, an inverse correlation between TOPK and PTEN expression was present and is consistent with the biochemical findings. Finally, a combination of high TOPK and low PTEN expression was inversely correlated with overall and disease-free survivals, independent of other pathologic staging factors. Our results suggest that TOPK is a potential therapeutic target in lung cancer that promotes cell migration by modulating a PI3K/PTEN/AKT-dependent signaling pathway; they also suggest that high TOPK expression, either alone or in combination with a low level of PTEN, may serve as a prognostic marker for lung cancer. Oncogene (2012) 31, 2389-2400; doi: 10.1038/onc.2011.419; published online 26 September 2011	[Shih, M-C; Chen, J-Y; Yang, B-M; Lai, J-M] Fu Jen Catholic Univ, Coll Sci & Engn, Dept Life Sci, New Taipei City 24205, Taiwan; [Wu, Y-C] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Jan, Y-H; Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lu, P-J; Cheng, H-C] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Huang, M-S; Yang, C-J] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Fu Jen Catholic University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lai, JM (corresponding author), Fu Jen Catholic Univ, Coll Sci & Engn, Dept Life Sci, 510 Zhongzheng Rd, New Taipei City 24205, Taiwan.	jmlai@mail.fju.edu.tw	Lai, Jin-Mei/AAM-4119-2020; Hsiao, Michael/U-6238-2019	Hsiao, Michael/0000-0001-8529-9213; Jan, Yi-Hua/0000-0001-7344-7602	National Science Council (Taiwan) [NSC95-2311-B-030-002-MY3, NSC99-2627-B-030-001]; Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH100-TD-C-111-007]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Center of Excellence for Cancer Research at Taipei Veterans General Hospital(Taipei Veterans General Hospital)	We thank Dr Chi-Ying F Huang (Yang-Ming University, Taipei, Taiwan) for providing lung cancer microarray data. This work was supported by grants from National Science Council (Taiwan) (NSC95-2311-B-030-002-MY3 and NSC99-2627-B-030-001) to JM Lai and Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH100-TD-C-111-007) to YC Wu.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Akca H, 2011, LUNG CANCER, V73, P302, DOI 10.1016/j.lungcan.2011.01.012; AlKattan K, 1997, EUR J CARDIO-THORAC, V12, P380, DOI 10.1016/S1010-7940(97)00198-X; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Hung JJ, 2009, THORAX, V64, P192, DOI 10.1136/thx.2007.094912; Kratz JR, 2009, CLIN LUNG CANCER, V10, P151, DOI 10.3816/CLC.2009.n.021; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zlobec I, 2010, BRIT J CANCER, V102, P151, DOI 10.1038/sj.bjc.6605452; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	33	134	138	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2389	2400		10.1038/onc.2011.419	http://dx.doi.org/10.1038/onc.2011.419			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21996732				2022-12-25	WOS:000303985300002
J	Narayanan, S; Arthanari, H; Wolfe, MS; Wagner, G				Narayanan, Saravanakumar; Arthanari, Haribabu; Wolfe, Michael S.; Wagner, Gerhard			Molecular Characterization of Disrupted in Schizophrenia-1 Risk Variant S704C Reveals the Formation of Altered Oligomeric Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR PROLIFERATION; CORTICAL DEVELOPMENT; NEURONAL MIGRATION; NEURITE OUTGROWTH; DISC1; ASSOCIATION; BINDING; PROTEIN; GENES; NUDEL	DISC1 ((D) under bar isrupted (i) under barn schizophrenia-(1) under bar) plays essential roles in neuronal proliferation, neuronal migration and axon guidance and has been implicated in schizophrenia and related psychiatric disorders. DISC1 forms a functional complex with nuclear distribution element-like protein-1 (NDEL1), a key component that regulates microtubule organization during cell division and neuronal migration. DISC1 polymorphisms at the binding interface of DISC1-NDEL1 complex have been implicated in schizophrenia. However, it is unknown how schizophrenia risk polymorphisms perturb its interaction with NDEL1 and how they change the inherent biochemical properties of DISC1. Here, we characterize the oligomerization and binding property of DISC1 and its natural schizophrenia risk variant, S704C. Our results show that DISC1 forms octamers via dimers as building blocks and directly interacts with tetramers of NDEL1. The schizophrenia risk variant S704C affects the formation of octamers of DISC1 and exhibits higher-order self-oligomerization. However, the observed formation of new oligomeric species did not influence its binding with NDEL1. These results suggest that the improper oligomeric assembly of DISC1-S704C may underlie the observed phenotypic variation due to the polymorphism.	[Narayanan, Saravanakumar; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wolfe, Michael S.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Bldg C1,Rm 107,240 Longwood Ave, Boston, MA 02115 USA.	Gerhard_wagner@hms.harvard.edu		Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health [P01-GM047467]; Foundation for Neurologic Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Neurologic Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant P01-GM047467. M. S. W. acknowledges the funding from the Foundation for Neurologic Diseases.	Bakken TE, 2011, ARCH GEN PSYCHIAT, V68, P781, DOI 10.1001/archgenpsychiatry.2011.81; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Di Giorgio A, 2008, EUR J NEUROSCI, V28, P2129, DOI 10.1111/j.1460-9568.2008.06482.x; Eastwood SL, 2010, HUM MOL GENET, V19, P2487, DOI 10.1093/hmg/ddq130; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mathieson I, 2011, MOL PSYCHIAT; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Nicodemus KK, 2010, HUM GENET, V127, P441, DOI 10.1007/s00439-009-0782-y; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sawa A, 2005, SCIENCE, V310, P1128, DOI 10.1126/science.1121114; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Taylor Ian A, 2004, Methods Mol Biol, V261, P119; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Young-Pearse TL, 2010, J NEUROSCI, V30, P10431, DOI 10.1523/JNEUROSCI.1445-10.2010	35	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44266	44276		10.1074/jbc.M111.271593	http://dx.doi.org/10.1074/jbc.M111.271593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998303	Green Published, hybrid			2022-12-25	WOS:000298402300066
J	DeRouchey, JE; Rau, DC				DeRouchey, Jason E.; Rau, Donald C.			Role of Amino Acid Insertions on Intermolecular Forces between Arginine Peptide Condensed DNA Helices IMPLICATIONS FOR PROTAMINE-DNA PACKAGING IN SPERM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; NUCLEOPROTAMINE STRUCTURE; HYDRATION FORCES; COMPLEXES; FRAGMENTATION; AGGREGATION; SPERMATOZOA; POLYAMINES; MOLECULES; CHROMATIN	In spermatogenesis, chromatin histones are replaced by arginine-rich protamines to densely compact DNA in sperm heads. Tight packaging is considered necessary to protect the DNA from damage. To better understand the nature of the forces condensing protamine-DNA assemblies and their dependence on amino acid content, the effect of neutral and negatively charged amino acids on DNA-DNA intermolecular forces was studied using model peptides containing six arginines. We have previously observed that the neutral amino acids in salmon protamine decrease the net attraction between protamine-DNA helices compared with the equivalent homo-arginine peptide. Using osmotic stress coupled with x-ray scattering, we have investigated the component attractive and repulsive forces that determine the net attraction and equilibrium interhelical distance as a function of the chemistry, position, and number of the amino acid inserted. Neutral amino acids inserted into hexa-arginine increase the short range repulsion while only slightly affecting longer range attraction. The amino acid content alone of salmon protamine is enough to rationalize the forces that package DNA in sperm heads. Inserting a negatively charged amino acid into hexa-arginine dramatically weakens the net attraction. Both of these observations have biological implications for protamine-DNA packaging in sperm heads.	[DeRouchey, Jason E.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Rau, Donald C.] NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	DeRouchey, JE (corresponding author), Univ Kentucky, Dept Chem, 125 Chem Phys Bldg, Lexington, KY 40506 USA.	derouchey@uky.edu	DeRouchey, Jason/C-5907-2011	DeRouchey, Jason/0000-0002-3624-4432	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Eunice Kennedy Shriver Intramural Research Program.	Andrabi SMH, 2007, J ASSIST REPROD GEN, V24, P561, DOI 10.1007/s10815-007-9177-y; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Blanc NS, 2001, J STRUCT BIOL, V134, P76, DOI 10.1006/jsbi.2001.4365; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Brewer LR, 2011, INTEGR BIOL-UK, V3, P540, DOI 10.1039/c0ib00128g; Castillo J, 2011, J ANDROL, V32, P324, DOI 10.2164/jandrol.110.011015; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; DeRouchey J, 2005, EUR PHYS J E, V16, P17, DOI 10.1140/epje/e2005-00003-4; DeRouchey J, 2010, BIOPHYS J, V99, P2608, DOI 10.1016/j.bpj.2010.08.028; FEUGHELMAN M, 1955, NATURE, V175, P834, DOI 10.1038/175834a0; FITA I, 1983, J MOL BIOL, V167, P157, DOI 10.1016/S0022-2836(83)80039-4; GREEN GR, 1994, MOL REPROD DEV, V37, P255, DOI 10.1002/mrd.1080370303; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; Kornyshev AA, 1999, PHYS REV LETT, V82, P4138, DOI 10.1103/PhysRevLett.82.4138; Kornyshev AA, 2007, REV MOD PHYS, V79, P943, DOI 10.1103/RevModPhys.79.943; LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.pc.44.100193.002101; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; MUDD CP, 1987, REV SCI INSTRUM, V58, P2110, DOI 10.1063/1.1139472; Muratori M, 2006, FRONT BIOSCI-LANDMRK, V11, P1491, DOI 10.2741/1898; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; PERREAULT SD, 1984, DEV BIOL, V101, P160, DOI 10.1016/0012-1606(84)90126-X; Prieto MC, 1997, BIOCHEMISTRY-US, V36, P11944, DOI 10.1021/bi971061l; Qiu XY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.228101; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Raspaud E, 1998, BIOPHYS J, V74, P381, DOI 10.1016/S0006-3495(98)77795-1; RAU DC, 1992, BIOPHYS J, V61, P246, DOI 10.1016/S0006-3495(92)81831-3; Raukas E, 1999, BIOESSAYS, V21, P440, DOI 10.1002/(SICI)1521-1878(199905)21:5<440::AID-BIES11>3.0.CO;2-V; SCHELLMAN JA, 1984, J MOL BIOL, V175, P313, DOI 10.1016/0022-2836(84)90351-6; STANLEY C, 2011, CURR OPIN C IN PRESS; SUAU P, 1977, J MOL BIOL, V117, P909, DOI 10.1016/S0022-2836(77)80005-3; SUWALSKY M, 1972, BIOPOLYMERS, V11, P2223, DOI 10.1002/bip.1972.360111103; Teif VB, 2005, BIOPHYS J, V89, P2574, DOI 10.1529/biophysj.105.063909; TODD BA, 2007, WILEY ENCY CHEM BIOL; Todd BA, 2008, BIOPHYS J, V94, P4775, DOI 10.1529/biophysj.107.127332; Vilfan ID, 2004, J BIOL CHEM, V279, P20088, DOI 10.1074/jbc.M312777200; WIDOM J, 1983, BIOPOLYMERS, V22, P1595, DOI 10.1002/bip.360220612	42	21	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41985	41992		10.1074/jbc.M111.295808	http://dx.doi.org/10.1074/jbc.M111.295808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994948	Green Published, hybrid			2022-12-25	WOS:000298180900009
J	Bartoszewski, R; Brewer, JW; Rab, A; Crossman, DK; Bartoszewska, S; Kapoor, N; Fuller, C; Collawn, JF; Bebok, Z				Bartoszewski, Rafal; Brewer, Joseph W.; Rab, Andras; Crossman, David K.; Bartoszewska, Sylwia; Kapoor, Niren; Fuller, Cathy; Collawn, James F.; Bebok, Zsuzsa			The Unfolded Protein Response (UPR)-activated Transcription Factor X-box-binding Protein 1 (XBP1) Induces MicroRNA-346 Expression That Targets the Human Antigen Peptide Transporter 1 (TAP1) mRNA and Governs Immune Regulatory Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; MAMMALIAN-CELLS; CHAIN; DECAY	To identify endoplasmic reticulum (ER) stress-induced microRNAs (miRNA) that govern ER protein influx during the adaptive phase of unfolded protein response, we performed miRNA microarray profiling and analysis in human airway epithelial cells following ER stress induction using proteasome inhibition or tunicamycin treatment. We identified miR-346 as the most significantly induced miRNA by both classic stressors. miR-346 is encoded within an intron of the glutamate receptor ionotropic delta-1 gene (GRID1), but its ER stress-associated expression is independent of GRID1. We demonstrated that the spliced X-box-binding protein-1 (sXBP1) is necessary and sufficient for ER stress-associated miR-346 induction, revealing a novel role for this unfolded protein response-activated transcription factor. In mRNA profiling arrays, we identified 21 mRNAs that were reduced by both ER stress and miR-346. The target genes of miR-346 regulate immune responses and include the major histocompatibility complex (MHC) class I gene products, interferon-induced genes, and the ER antigen peptide transporter 1 (TAP1). Although most of the repressed mRNAs appear to be indirect targets because they lack specific seeding sites for miR-346, we demonstrate that the human TAP1 mRNA is a direct target of miR-346. The human TAP1 mRNA 3'-UTR contains a 6-mer canonical seeding site for miR-346. Importantly, the ER stress-associated reduction in human TAP1 mRNA and protein levels could be reversed with an miR-346 antagomir. Because TAP function is necessary for proper MHC class I-associated antigen presentation, our results provide a novel mechanistic explanation for reduced MHC class I-associated antigen presentation that was observed during ER stress.	[Bartoszewski, Rafal; Rab, Andras; Bartoszewska, Sylwia; Collawn, James F.; Bebok, Zsuzsa] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Crossman, David K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Kapoor, Niren; Fuller, Cathy] Univ Alabama Birmingham, Dept Physiol, Birmingham, AL 35294 USA; [Brewer, Joseph W.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama	Bartoszewski, R (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 350, Birmingham, AL 35294 USA.	rafalbar@uab.edu; bebok@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021; Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019	Rab, András/0000-0003-2154-0017; Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; Crossman, David/0000-0002-0981-169X; Collawn, James/0000-0002-2528-2759	National Institutes of Health [HL076587, GM61970, DK060065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065, R01DK037206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076587 (to Z. B.), GM61970 (to J. W. B.), and DK060065 (to J. F. C.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Applied Biosystems, 2004, REL QUANT APPL BIOS; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Hui-Ju, 2004, Mol Diagn, V8, P245, DOI 10.2165/00066982-200408040-00006; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; NEEFJES JJ, 1993, CURR OPIN IMMUNOL, V5, P27, DOI 10.1016/0952-7915(93)90077-6; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tardif KD, 2003, J VIROL, V77, P11644, DOI 10.1128/JVI.77.21.11644-11650.2003; Thompson LH, 2010, CELL CYCLE, V9, P4213, DOI 10.4161/cc.9.20.13543; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Ulianich L., 2011, BIOCHIM BIOPHYS ACTA, V1812, P431; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	57	104	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41862	41870		10.1074/jbc.M111.304956	http://dx.doi.org/10.1074/jbc.M111.304956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	22002058	Green Published, hybrid			2022-12-25	WOS:000298057500068
J	Ruminski, DJ; Webb, CHT; Riccitelli, NJ; Luptak, A				Ruminski, Dana J.; Webb, Chiu-Ho T.; Riccitelli, Nathan J.; Luptak, Andrej			Processing and Translation Initiation of Non-long Terminal Repeat Retrotransposons by Hepatitis Delta Virus (HDV)-like Self-cleaving Ribozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-LTR RETROTRANSPOSON; RIBOSOMAL-RNA GENES; DROSOPHILA-MELANOGASTER; REVERSE-TRANSCRIPTASE; CATALYTIC CORE; HAMMERHEAD RIBOZYMES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; SATELLITE DNA; HDV RIBOZYME	Many non-long terminal repeat (non-LTR) retrotransposons lack internal promoters and are co-transcribed with their host genes. These transcripts need to be liberated before inserting into new loci. Using structure-based bioinformatics, we show that several classes of retrotransposons in phyla-spanning arthropods, nematodes, and chordates utilize self-cleaving ribozymes of the hepatitis delta virus (HMI) family for processing their 5' termini Ribozyme-terminated retrotransposons include rDNA-specific R2, R4, and R6, telomere-specific SAW, and Baggins and RTE. The self-scission of the R2 ribozyme is strongly modulated by the insertion site sequence in the rDNA, with the most common insertion sequences promoting faster processing. The ribozymes also promote translation initiation of downstream open reading frames in vitro and in vivo. In some organisms HDV-like and hammerhead ribozymes appear to be dedicated to processing long and short interspersed elements, respectively. HDV-like ribozymes serve several distinct functions in non-LTR retrotransposition, including 5' processing, translation initiation, and potentially trans-templating.	[Ruminski, Dana J.; Webb, Chiu-Ho T.; Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Riccitelli, Nathan J.; Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luptak, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	aluptak@ucl.edu			National Institutes of Health [GM094929]; University of California, Irvine; Pew Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Irvine(University of California System); Pew Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094929. This work was also supported by the University of California, Irvine, and the Pew Trusts.	BEEN MD, 1992, BIOCHEMISTRY-US, V31, P11843, DOI 10.1021/bi00162a024; Belfort Marlene, 2002, P761; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blesa D, 2001, MOL BIOL EVOL, V18, P585, DOI 10.1093/oxfordjournals.molbev.a003839; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Burke WD, 2002, MOL BIOL EVOL, V19, P619, DOI 10.1093/oxfordjournals.molbev.a004121; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; BURKE WD, 1995, NUCLEIC ACIDS RES, V23, P4628, DOI 10.1093/nar/23.22.4628; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Cech T. R., 1993, RNA WORLD; Chadalavada DM, 2000, J MOL BIOL, V301, P349, DOI 10.1006/jmbi.2000.3953; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; Duhamel J, 1996, NUCLEIC ACIDS RES, V24, P3911, DOI 10.1093/nar/24.20.3911; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; EPSTEIN LM, 1987, CELL, V48, P535, DOI 10.1016/0092-8674(87)90204-2; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; George JA, 1999, INSECT MOL BIOL, V8, P3, DOI 10.1046/j.1365-2583.1999.810003.x; Ghesini S, 2011, J MOL EVOL, V72, P296, DOI 10.1007/s00239-011-9430-y; GREEN B, 1993, MOL BIOL EVOL, V10, P732; Han JS, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-15; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; JAMRICH M, 1984, EMBO J, V3, P1541, DOI 10.1002/j.1460-2075.1984.tb02008.x; Jeong S, 2003, BIOCHEMISTRY-US, V42, P7727, DOI 10.1021/bi034627g; Jimenez RM, 2011, J BIOL CHEM, V286, P7737, DOI 10.1074/jbc.C110.209288; Kamoshita N, 2009, MOL CELL, V35, P181, DOI 10.1016/j.molcel.2009.05.024; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; KIDD SJ, 1981, J MOL BIOL, V151, P645, DOI 10.1016/0022-2836(81)90428-9; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2003, MOL BIOL EVOL, V20, P351, DOI 10.1093/molbev/msg031; Kubo Y, 2001, MOL BIOL EVOL, V18, P848, DOI 10.1093/oxfordjournals.molbev.a003866; Kurzynska-Kokorniak A, 2007, J MOL BIOL, V374, P322, DOI 10.1016/j.jmb.2007.09.047; Legiewicz M, 2006, NUCLEIC ACIDS RES, V34, P1270, DOI 10.1093/nar/gkl018; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; LONG EO, 1981, MOL GEN GENET, V182, P377, DOI 10.1007/BF00293925; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luptak A., 2007, RIBOZYMES RNA CATALY, P130; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; McFarlane CT, 2009, CONSERV GENET RESOUR, V1, P377, DOI 10.1007/s12686-009-9087-7; Mourier Tobias, 2009, Briefings in Functional Genomics & Proteomics, V8, P493, DOI 10.1093/bfgp/elp036; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nishikawa F, 1999, NUCLEIC ACIDS RES, V27, P403, DOI 10.1093/nar/27.2.403; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Rezende-Teixeira P, 2009, CHROMOSOME RES, V17, P455, DOI 10.1007/s10577-009-9038-x; Riccitelli NJ, 2010, METHODS, V52, P133, DOI 10.1016/j.ymeth.2010.06.005; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Warren AM, 1997, MOL GEN GENET, V254, P505, DOI 10.1007/s004380050445; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yang J, 1999, P NATL ACAD SCI USA, V96, P7847, DOI 10.1073/pnas.96.14.7847; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	74	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41286	41295		10.1074/jbc.M111.297283	http://dx.doi.org/10.1074/jbc.M111.297283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994949	Green Published, hybrid			2022-12-25	WOS:000298057500016
J	Tortosa, E; Montenegro-Venegas, C; Benoist, M; Hartel, S; Gonzalez-Billault, C; Esteban, JA; Avila, J				Tortosa, Elena; Montenegro-Venegas, Carolina; Benoist, Marion; Hartel, Steffen; Gonzalez-Billault, Christian; Esteban, Jose A.; Avila, Jesus			Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN DEVELOPMENT; ACTIN DYNAMICS; RHO-GTPASES; POSTSYNAPTIC DENSITIES; HIPPOCAMPAL-NEURONS; LIM-KINASE; MORPHOLOGICAL PLASTICITY; CYTOSKELETAL DYNAMICS; MOLECULAR-MECHANISMS; PROTEOMIC ANALYSIS	Microtubule-associated protein 1B (MAP1B) is prominently expressed during early stages of neuronal development, and it has been implicated in axonal growth and guidance. MAP 1B expression is also found in the adult brain in areas of significant synaptic plasticity. Here, we demonstrate that MAP 1B is present in dendritic spines, and we describe a decrease in the density of mature dendritic spines in neurons of MAP1B-deficient mice that was accompanied by an increase in the number of immature filopodia-like protrusions. Although these neurons exhibited normal passive membrane properties and action potential firing, AMPA receptor-mediated synaptic currents were significantly diminished. Moreover, we observed a significant decrease in Rac1 activity and an increase in RhoA activity in the postsynaptic densities of adult MAP1B(+/-) mice when compared with wild type controls. MAP1B(+/-) fractions also exhibited a decrease in phosphorylated cofilin Taken together, these results indicate a new and important role for MAP1B in the formation and maturation of dendritic spines, possibly through the regulation of the actin cytoskeleton. This activity of MAP1B could contribute to the regulation of synaptic activity and plasticity in the adult brain.	[Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam, Dept Biol, Santiago, Chile; [Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Inst Cell Dynam & Biotechnol, Santiago, Chile; [Tortosa, Elena; Montenegro-Venegas, Carolina; Benoist, Marion; Esteban, Jose A.] Univ Autonoma Madrid, Dept Neurosci, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Hartel, Steffen] Univ Chile, Lab Sci Image Anal SCIANLab, Santiago 1027, Chile; [Tortosa, Elena; Avila, Jesus] Ctr Enfermedades Neurodegenerativas CIBERNED, Madrid 28031, Spain	Universidad de Chile; Universidad de Chile; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Chile; CIBERNED	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam, Dept Biol, Santiago, Chile.	chrgonza@uchile.cl	Binacua, Elena Tortosa/AAA-1114-2020; Härtel, Steffen/AAA-2336-2020; Avila, Jesus/I-2610-2015; Gonzalez-Billault, Christian/P-2393-2019; Esteban, Jose/L-4944-2014	Härtel, Steffen/0000-0002-8913-1757; Avila, Jesus/0000-0002-6288-0571; Esteban, Jose/0000-0002-3759-3300; Tortosa, Elena/0000-0003-3910-2314				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; AVILA J, 1994, INT J DEV BIOL, V38, P13; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cueille N, 2007, BRAIN RES BULL, V71, P610, DOI 10.1016/j.brainresbull.2006.12.003; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Dehmelt L, 2005, GENOME BIOL, V6; DENNY JB, 1991, J NEUROCYTOL, V20, P627, DOI 10.1007/BF01187065; Diaz-Nido J., 1990, J NEUROCHEM, V54, P211; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DiTella MC, 1996, J CELL SCI, V109, P467; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; FISCHER I, 1990, J NEUROCHEM, V55, P328, DOI 10.1111/j.1471-4159.1990.tb08855.x; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C., 2001, BIO CELL, V12, P2087; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Gu Jiaping, 2009, Open Neurosci J, V3, P128; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kawakami SI, 2003, CELL MOL NEUROBIOL, V23, P887, DOI 10.1023/B:CEMN.0000005317.79634.27; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MATUS A, 1986, ANN NY ACAD SCI, V466, P167, DOI 10.1111/j.1749-6632.1986.tb38393.x; MATUS A, 1991, J CELL SCI, P61; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Moreno FJ, 1999, MOL CELL BIOCHEM, V191, P201, DOI 10.1023/A:1006836211318; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Pedrotti B, 1996, FEBS LETT, V388, P131, DOI 10.1016/0014-5793(96)00520-0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pilpel Y, 2004, EUR J NEUROSCI, V19, P3151, DOI 10.1111/j.0953-816X.2004.03380.x; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; RIEDERER BM, 1990, EUR J MORPHOL, V28, P347; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; TUCKER RP, 1988, J COMP NEUROL, V271, P44, DOI 10.1002/cne.902710106; TUCKER RP, 1987, DEVELOPMENT, V101, P535; ULLOA L, 1994, GLIA, V10, P266, DOI 10.1002/glia.440100405; ULLOA L, 1993, J NEUROCHEM, V61, P961, DOI 10.1111/j.1471-4159.1993.tb03609.x; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VIERECK C, 1989, J NEUROSCI, V9, P3547; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	82	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40638	40648		10.1074/jbc.M111.271320	http://dx.doi.org/10.1074/jbc.M111.271320			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984824	Green Published, hybrid			2022-12-25	WOS:000297315400025
J	Giangreco, I; Lattanzi, G; Nicolotti, O; Catto, M; Laghezza, A; Leonetti, F; Stefanachi, A; Carotti, A				Giangreco, Ilenia; Lattanzi, Gianluca; Nicolotti, Orazio; Catto, Marco; Laghezza, Antonio; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo			Insights into the Complex Formed by Matrix Metalloproteinase-2 and Alloxan Inhibitors: Molecular Dynamics Simulations and Free Energy Calculations	PLOS ONE			English	Article							SELECTIVE-INHIBITION; COLLAGENASE; BINDING; DOMAIN	Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, homeostatic regulation, innate immunity, impaired delivery of pro-apoptotic ligands, and the release and cleavage of cell-surface receptors. Hence, the development of potent and selective inhibitors targeting these enzymes continues to be eagerly sought. In this paper, a number of alloxan-based compounds, initially conceived to bias other therapeutically relevant enzymes, were rationally modified and successfully repurposed to inhibit MMP-2 (also named gelatinase A) in the nanomolar range. Importantly, the alloxan core makes its debut as zinc binding group since it ensures a stable tetrahedral coordination of the catalytic zinc ion in concert with the three histidines of the HExxHxxGxxH metzincin signature motif, further stabilized by a hydrogen bond with the glutamate residue belonging to the same motif. The molecular decoration of the alloxan core with a biphenyl privileged structure allowed to sample the deep S-1' specificity pocket of MMP-2 and to relate the high affinity towards this enzyme with the chance of forming a hydrogen bond network with the backbone of Leu116 and Asn147 and the side chains of Tyr144, Thr145 and Arg149 at the bottom of the pocket. The effect of even slight structural changes in determining the interaction at the S-1' subsite of MMP-2 as well as the nature and strength of the binding is elucidated via molecular dynamics simulations and free energy calculations. Among the herein presented compounds, the highest affinity (pIC(50) = 7.06) is found for BAM, a compound exhibiting also selectivity (>20) towards MMP2, as compared to MMP-9, the other member of the gelatinases.	[Giangreco, Ilenia; Nicolotti, Orazio; Catto, Marco; Laghezza, Antonio; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo] Univ Bari Aldo Moro, Dipartimento Farmacochim, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Dipartimento Sci Med Base, Bari, Italy; [Lattanzi, Gianluca; Nicolotti, Orazio; Carotti, Angelo] Univ Bari Aldo Moro, Ctr Ric Tires, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Ist Nazl Fis Nucl, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro	Giangreco, I (corresponding author), Univ Bari Aldo Moro, Dipartimento Farmacochim, Bari, Italy.	gl.lattanzi@gmail.com; nicolotti@farmchim.uniba.it	Lattanzi, Gianluca/E-1753-2011; Laghezza, Antonio/F-7420-2014; Nicolotti, Orazio/F-3209-2012; Giangreco, Ilenia/AAF-6203-2020; Lattanzi, Gianluca/AAA-3173-2019; LATTANZI, GIOVANNA/P-8214-2015	Lattanzi, Gianluca/0000-0002-0808-6457; Nicolotti, Orazio/0000-0001-6533-5539; Lattanzi, Gianluca/0000-0002-0808-6457; LATTANZI, GIOVANNA/0000-0002-7103-8722; STEFANACHI, Angela/0000-0002-9430-7972; Leonetti, Francesco/0000-0003-2043-7464; Laghezza, Antonio/0000-0001-6221-6155; CATTO, Marco/0000-0002-8411-304X; Giangreco, Ilenia/0000-0002-3345-0230	University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori)	University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori)	The authors acknowledge financial support from the University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, CHEMMEDCHEM, V3, P812, DOI 10.1002/cmdc.200700290; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Altomare C, 1998, J MED CHEM, V41, P3812, DOI 10.1021/jm981005y; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blagg JA, 2005, BIOORG MED CHEM LETT, V15, P1807, DOI 10.1016/j.bmcl.2005.02.038; Brandstetter H, 2001, J BIOL CHEM, V276, P17405, DOI 10.1074/jbc.M007475200; CancerGrid STREP project, CANCERGRID STREP PRO; Case D.A., 2022, AMBER 2020; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Conejo-Garcia A, 2011, J MED CHEM, V54, P2627, DOI 10.1021/jm101299d; CORINA website, CORINA; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Diaz N, 2008, PROTEINS, V72, P50, DOI 10.1002/prot.21894; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng YQ, 2002, BBA-PROTEINS PROTEOM, V1598, P10, DOI 10.1016/S0167-4838(02)00307-2; Foley LH, 2001, BIOORG MED CHEM LETT, V11, P969, DOI 10.1016/S0960-894X(01)00104-4; Frisch G.W., 2016, GAUSSIAN 16 REVISION; Giangreco I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-500; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Hemmings FJ, 2001, RHEUMATOLOGY, V40, P537, DOI 10.1093/rheumatology/40.5.537; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Nicolescu AC, 2009, BIOCHEM BIOPH RES CO, V387, P646, DOI 10.1016/j.bbrc.2009.07.080; Nicolotti O, 2007, J CHEM INF MODEL, V47, P2439, DOI 10.1021/ci700119r; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Pisani L, 2009, J MED CHEM, V52, P6685, DOI 10.1021/jm9010127; Pospisil P, 2003, J RECEPT SIG TRANSD, V23, P361, DOI 10.1081/RRS-120026975; Radmer RJ, 1997, J COMPUT CHEM, V18, P902, DOI 10.1002/(SICI)1096-987X(199705)18:7<902::AID-JCC4>3.0.CO;2-V; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; SIMONSON T, 1993, MOL PHYS, V80, P441, DOI 10.1080/00268979300102371; Stefanachi A, 2011, J MED CHEM, V54, P1613, DOI 10.1021/jm101120u; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang J, 2011, N SUBSTITUTED HOMOPI; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yan YL, 2009, BIOORG MED CHEM LETT, V19, P1970, DOI 10.1016/j.bmcl.2009.02.044	47	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25597	10.1371/journal.pone.0025597	http://dx.doi.org/10.1371/journal.pone.0025597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998672	Green Submitted, Green Published, gold			2022-12-25	WOS:000295966900036
J	Hiratsuka, M; Uno, N; Ueda, K; Kurosaki, H; Imaoka, N; Kazuki, K; Ueno, E; Akakura, Y; Katoh, M; Osaki, M; Kazuki, Y; Nakagawa, M; Yamanaka, S; Oshimura, M				Hiratsuka, Masaharu; Uno, Narumi; Ueda, Kana; Kurosaki, Hajime; Imaoka, Natsuko; Kazuki, Kanako; Ueno, Etsuya; Akakura, Yutaro; Katoh, Motonobu; Osaki, Mitsuhiko; Kazuki, Yasuhiro; Nakagawa, Masato; Yamanaka, Shinya; Oshimura, Mitsuo			Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EXPRESSION; GENERATION; INDUCTION; DIFFERENTIATION; FIBROBLASTS; VIRUS; NANOG; SOX2; HAC	Human artificial chromosomes (HACs) have unique characteristics as gene-delivery vectors, including episomal transmission and transfer of multiple, large transgenes. Here, we demonstrate the advantages of HAC vectors for reprogramming mouse embryonic fibroblasts (MEFs) into induced pluripotent stem (iPS) cells. Two HAC vectors (iHAC1 and iHAC2) were constructed. Both carried four reprogramming factors, and iHAC2 also encoded a p53-knockdown cassette. iHAC1 partially reprogrammed MEFs, and iHAC2 efficiently reprogrammed MEFs. Global gene expression patterns showed that the iHACs, unlike other vectors, generated relatively uniform iPS cells. Under non-selecting conditions, we established iHAC-free iPS cells by isolating cells that spontaneously lost iHAC2. Analyses of pluripotent markers, teratomas and chimeras confirmed that these iHAC-free iPS cells were pluripotent. Moreover, iHAC-free iPS cells with a re-introduced HAC encoding Herpes Simplex virus thymidine kinase were eliminated by ganciclovir treatment, indicating that the HAC safeguard system functioned in iPS cells. Thus, the HAC vector could generate uniform, integration-free iPS cells with a built-in safeguard system.	[Hiratsuka, Masaharu; Oshimura, Mitsuo] Tottori Univ, Fac Med, Sch Life Sci, Div Mol & Cell Genet,Dept Mol & Cellular Biol, Yonago, Tottori 683, Japan; [Uno, Narumi; Ueda, Kana; Kurosaki, Hajime; Imaoka, Natsuko; Ueno, Etsuya; Akakura, Yutaro; Osaki, Mitsuhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Kazuki, Kanako; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Katoh, Motonobu] Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cellular Biol,Div Human Genome Sci, Yonago, Tottori 683, Japan; [Nakagawa, Masato; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Oshimura, Mitsuo] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tottori University; Tottori University; Tottori University; Tottori University; Kyoto University; Japan Science & Technology Agency (JST)	Hiratsuka, M (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Div Mol & Cell Genet,Dept Mol & Cellular Biol, Yonago, Tottori 683, Japan.	oshimura@med.tottori-u.ac.jp	Narumi, Uno/AAP-3936-2021	Narumi, Uno/0000-0002-4218-1167	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by the Core Research for Evolutional Science and Technology (CREST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jst.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Iida Y, 2010, DNA RES, V17, P293, DOI 10.1093/dnares/dsq020; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kakeda M, 2005, GENE THER, V12, P852, DOI 10.1038/sj.gt.3302483; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kazuki Y, 2008, GENE THER, V15, P617, DOI 10.1038/sj.gt.3303091; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; Rudd MK, 2003, MOL CELL BIOL, V23, P7689, DOI 10.1128/MCB.23.21.7689-7697.2003; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	39	52	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25961	10.1371/journal.pone.0025961	http://dx.doi.org/10.1371/journal.pone.0025961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998730	Green Published, gold, Green Submitted			2022-12-25	WOS:000295966900081
J	Kalinkat, G; Rall, BC; Vucic-Pestic, O; Brose, U				Kalinkat, Gregor; Rall, Bjoern Christian; Vucic-Pestic, Olivera; Brose, Ulrich			The Allometry of Prey Preferences	PLOS ONE			English	Article							FUNCTIONAL-RESPONSE; FOOD WEBS; BODY-SIZE; PREDATOR INTERFERENCE; INTERACTION STRENGTHS; ECOLOGICAL NETWORKS; STABILITY; CONSTRAINTS; POPULATION; BEHAVIOR	The distribution of weak and strong non-linear feeding interactions (i.e., functional responses) across the links of complex food webs is critically important for their stability. While empirical advances have unravelled constraints on single-prey functional responses, their validity in the context of complex food webs where most predators have multiple prey remain uncertain. In this study, we present conceptual evidence for the invalidity of strictly density-dependent consumption as the null model in multi-prey experiments. Instead, we employ two-prey functional responses parameterised with allometric scaling relationships of the functional response parameters that were derived from a previous single-prey functional response study as novel null models. Our experiments included predators of different sizes from two taxonomical groups (wolf spiders and ground beetles) simultaneously preying on one small and one large prey species. We define compliance with the null model predictions (based on two independent single-prey functional responses) as passive preferences or passive switching, and deviations from the null model as active preferences or active switching. Our results indicate active and passive preferences for the larger prey by predators that are at least twice the size of the larger prey. Moreover, our approach revealed that active preferences increased significantly with the predator-prey body-mass ratio. Together with prior allometric scaling relationships of functional response parameters, this preference allometry may allow estimating the distribution of functional response parameters across the myriads of interactions in natural ecosystems.	[Kalinkat, Gregor; Vucic-Pestic, Olivera] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Kalinkat, Gregor; Rall, Bjoern Christian; Brose, Ulrich] Univ Gottingen, Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Technical University of Darmstadt; University of Gottingen	Kalinkat, G (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	kalinkat@bio.tu-darmstadt.de	Rall, Björn C./G-1508-2013; Brose, Ulrich/AAT-7547-2020; Kalinkat, Gregor/H-5401-2013; Brose, Ulrich/I-3488-2014	Rall, Björn C./0000-0002-3191-8389; Brose, Ulrich/0000-0001-9156-583X; Kalinkat, Gregor/0000-0003-3529-5681; Chiaradia, Andre/0000-0002-6178-4211	German Research Foundation [BR 2315/6, BR 2315/13]	German Research Foundation(German Research Foundation (DFG))	Funding has been provided by the German Research Foundation (BR 2315/6, BR 2315/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljetlawi AA, 2004, J ANIM ECOL, V73, P239, DOI 10.1111/j.0021-8790.2004.00800.x; [Anonymous], 2010, R LANG ENV STAT COMP; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Brose U, 2008, J ANIM ECOL, V77, P1072, DOI 10.1111/j.1365-2656.2008.01408.x; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carnicer J, 2008, ECOL LETT, V11, P802, DOI 10.1111/j.1461-0248.2008.01195.x; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; COLTON TF, 1987, ECOLOGY, V68, P900, DOI 10.2307/1938361; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; Elliott JM, 2006, FRESHWATER BIOL, V51, P913, DOI 10.1111/j.1365-2427.2006.01549.x; Elliott JM, 2004, FRESHWATER BIOL, V49, P709, DOI 10.1111/j.1365-2427.2004.01222.x; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Galarowicz TL, 2005, CAN J FISH AQUAT SCI, V62, P2330, DOI 10.1139/F05-148; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOUDE ED, 1980, ENVIRON BIOL FISH, V5, P315, DOI 10.1007/BF00005186; Hubbell Stephen P., 2001, V32, pi; HUGHES RN, 1993, J ANIM ECOL, V62, P341, DOI 10.2307/5365; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Koen-Alonso Mariano, 2007, P1; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKee MH, 1997, FRESHWATER BIOL, V38, P193, DOI 10.1046/j.1365-2427.1997.00205.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Murdoch W.W., 1975, ADV ECOL RES, V9, P1, DOI DOI 10.1016/S0065-2504(08)60288-3; MURDOCH WW, 1973, J APPL ECOL, V10, P335; MURDOCH WW, 1975, ECOLOGY, V56, P1094, DOI 10.2307/1936149; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pervez A, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rall BC, 2008, OIKOS, V117, P202, DOI 10.1111/j.2007.0030-1299.15491.x; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Rall BC, 2011, OIKOS, V120, P483, DOI 10.1111/j.1600-0706.2010.18860.x; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Royama T., 1971, Researches Popul Ecol Kyoto Univ, V1, P1; Skalski GT, 2001, ECOLOGY, V82, P3083; Smout S, 2007, MAR ECOL PROG SER, V341, P277, DOI 10.3354/meps341277; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPITZE K, 1985, ECOLOGY, V66, P938, DOI 10.2307/1940556; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; THOMPSON DJ, 1975, J ANIM ECOL, V44, P907, DOI 10.2307/3727; Valdovinos FS, 2010, ECOL LETT, V13, P1546, DOI 10.1111/j.1461-0248.2010.01535.x; Vonesh JR, 2005, ECOLOGY, V86, P1580, DOI 10.1890/04-0535; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Vucic-Pestic O, 2010, J ANIM ECOL, V79, P249, DOI 10.1111/j.1365-2656.2009.01622.x; Wahlstrom E, 2000, OECOLOGIA, V123, P138, DOI 10.1007/s004420050999; Williams RJ, 2004, EUR PHYS J B, V38, P297, DOI 10.1140/epjb/e2004-00122-1	66	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25937	10.1371/journal.pone.0025937	http://dx.doi.org/10.1371/journal.pone.0025937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998724	Green Published, gold			2022-12-25	WOS:000295966900076
J	Murphy, TF; Lesse, AJ; Kirkham, C; Zhong, HC; Sethi, S; Munson, RS				Murphy, Timothy F.; Lesse, Alan J.; Kirkham, Charmaine; Zhong, Huachun; Sethi, Sanjay; Munson, Robert S., Jr.			A Clonal Group of Nontypeable Haemophilus influenzae with Two IgA Proteases Is Adapted to Infection in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HUMAN RESPIRATORY-TRACT; OTITIS-MEDIA; HEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSE; BACTERIAL PATHOGENS; CHRONIC-BRONCHITIS; ANTIGENIC DRIFT; STRAINS; DIVERSITY	Strains of nontypeable Haemophilus influenzae show enormous genetic heterogeneity and display differential virulence potential in different clinical settings. The igaB gene, which encodes a newly identified IgA protease, is more likely to be present in the genome of COPD strains of H. influenzae than in otitis media strains. Analysis of igaB and surrounding sequences in the present study showed that H. influenzae likely acquired igaB from Neisseria meningitidis and that the acquisition was accompanied by a similar to 20 kb genomic inversion that is present only in strains that have igaB. As part of a long running prospective study of COPD, molecular typing of H. influenzae strains identified a clonally related group of strains, a surprising observation given the genetic heterogeneity that characterizes strains of nontypeable H. influenzae. Analysis of strains by 5 independent methods (polyacrylamide gel electrophoresis, multilocus sequence typing, igaB gene sequences, P2 gene sequences, pulsed field gel electrophoresis) established the clonal relationship among the strains. Analysis of 134 independent strains collected prospectively from a cohort of adults with COPD demonstrated that similar to 10% belonged to the clonal group. We conclude that a clonally related group of strains of nontypeable H. influenzae that has two IgA1 protease genes (iga and igaB) is adapted for colonization and infection in COPD. This observation has important implications in understanding population dynamics of H. influenzae in human infection and in understanding virulence mechanisms specifically in the setting of COPD.	[Murphy, Timothy F.; Lesse, Alan J.; Kirkham, Charmaine] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA; [Sethi, Sanjay] SUNY Buffalo, Dept Med, Div Pulm & Crit Care Med, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Lesse, Alan J.] SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA; [Lesse, Alan J.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Kirkham, Charmaine] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Lesse, Alan J.; Sethi, Sanjay] Vet Affairs Western New York Healthcare Syst, Buffalo, NY USA; [Zhong, Huachun; Munson, Robert S., Jr.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Zhong, Huachun; Munson, Robert S., Jr.] Ohio State Univ, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Murphy, TF (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA.	murphyt@buffalo.edu	Munson, Jr, Robert/E-3710-2011	Munson, Jr, Robert/0000-0002-3204-3019; Murphy, Timothy/0000-0002-3496-2641	National Institutes of Health [AI19741]; Department of Veterans Affairs;  [N01-AI-30040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI19741 (TFM), the Department of Veterans Affairs (TFM, SS), and a subcontract of N01-AI-30040 (RSM; PI, Michael Apicella). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1982, INFECT IMMUN, V36, P535, DOI 10.1128/IAI.36.2.535-540.1982; BELL J, 1994, INFECT IMMUN, V62, P2639, DOI 10.1128/IAI.62.6.2639-2643.1994; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; DUIM B, 1993, MICROB PATHOGENESIS, V14, P451, DOI 10.1006/mpat.1993.1044; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Erwin AL, 2008, J BACTERIOL, V190, P1473, DOI 10.1128/JB.01207-07; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Fernaays MM, 2006, INFECT IMMUN, V74, P5860, DOI 10.1128/IAI.00796-06; Fernaays MM, 2006, INFECT IMMUN, V74, P3366, DOI 10.1128/IAI.01904-05; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gilsdorf JR, 1998, INFECT IMMUN, V66, P5053, DOI 10.1128/IAI.66.11.5053-5059.1998; GROENEVELD K, 1990, AM REV RESPIR DIS, V141, P1316, DOI 10.1164/ajrccm/141.5_Pt_1.1316; GROENEVELD K, 1989, INFECT IMMUN, V57, P3038, DOI 10.1128/IAI.57.10.3038-3044.1989; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Hiltke TJ, 2002, J INFECT DIS, V185, P627, DOI 10.1086/339362; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; LaCross NC, 2008, J CLIN MICROBIOL, V46, P3817, DOI 10.1128/JCM.00940-08; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; MUNSON RS, 1983, J CLIN INVEST, V72, P677, DOI 10.1172/JCI111017; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; O'Neill JM, 2003, J CLIN MICROBIOL, V41, P3064, DOI 10.1128/JCM.41.7.3064-3069.2003; Ostberg KL, 2009, MUCOSAL IMMUNOL, V2, P63, DOI 10.1038/mi.2008.70; Peerbooms PGH, 2002, J CLIN MICROBIOL, V40, P2832, DOI 10.1128/JCM.40.8.2832-2836.2002; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Sethi S, 2004, AM J RESP CRIT CARE, V169, P448, DOI 10.1164/rccm.200308-1181OC; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Weiser LN, 2000, TRENDS MICROBIOL, V8, P433, DOI 10.1016/S0966-842X(00)01839-4; Xie JP, 2006, J CLIN MICROBIOL, V44, P4316, DOI 10.1128/JCM.01331-06; Yi KC, 1997, J INFECT DIS, V176, P1247, DOI 10.1086/514119	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25923	10.1371/journal.pone.0025923	http://dx.doi.org/10.1371/journal.pone.0025923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998721	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900073
J	Yuan, DS				Yuan, Daniel S.			Dithizone Staining of Intracellular Zinc: An Unexpected and Versatile Counterscreen for Auxotrophic Marker Genes in Saccharomyces cerevisiae	PLOS ONE			English	Article							FLUORESCENT SENSORS; CELL BIOLOGY; YEAST; MUTANTS; PROTEIN; TRANSPORTER; GENOME; IDENTIFICATION; DEFICIENCY; ENRICHMENT	Auxotrophic marker genes such as URA3, LEU2, and HIS3 in Saccharomyces cerevisiae have long been used to select cells that have been successfully transformed with recombinant DNA. A longstanding challenge in working with these genes is that counterselection procedures are often lacking. This paper describes the unexpected discovery of a simple plate assay that imparts a bright red stain to cells experiencing nutritional stress from the lack of a marker gene. The procedure specifically stains a zinc-rich vesicular compartment analogous to the zinc-rich secretory vesicles found in insulin-secreting pancreatic islet cells and glutamate-secreting neurons. Staining was greatly diminished in zap1 mutants, which lack a homeostatic activator of zinc uptake, and in cot1 zrc1 double mutants, which lack the two yeast homologs of mammalian vesicle-specific zinc export proteins. Only one of 93 strains with temperature-sensitive alleles of essential genes exhibited an increase in dithizone staining at its non-permissive temperature, indicating that staining is not simply a sign of growth-arrested or dying cells. Remarkably, the procedure works with most commonly used marker genes, highlights subtle defects, uses no reporter constructs or expensive reagents, requires only a few hours of incubation, yields visually striking results without any instrumentation, and is not toxic to the cells. Many potential applications exist for dithizone staining, both as a versatile counterscreen for auxotrophic marker genes and as a powerful new tool for the genetic analysis of a biomedically important vesicular organelle.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Yuan, DS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	dyuan@jhmi.edu			discretionary laboratory funds of Jef Boeke	discretionary laboratory funds of Jef Boeke	Recent work was generously supported by discretionary laboratory funds of Jef Boeke and by Beverly Wendland. Funding sources had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; BOTSTEIN D, 1982, MOL BIOL YEAST SACCH, P607; Brachmann CB, 1998, YEAST, V14, P115; Carbon John, 1993, P375; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Corbacho I, 2011, ANTON LEEUW INT J G, V99, P591, DOI 10.1007/s10482-010-9530-5; Cuesta R, 1998, GENETICS, V148, P1007; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haase H, 2002, BIOCHEM BIOPH RES CO, V296, P923, DOI 10.1016/S0006-291X(02)02017-X; HENRY SA, 1975, MOL GEN GENET, V143, P5, DOI 10.1007/BF00269415; HIBBARD P. L., 1937, Industrial and Engineering Chemistry. Analytical edition, V9, P127, DOI 10.1021/ac50107a009; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HORN P, 1966, J BACTERIOL, V91, P1388, DOI 10.1128/JB.91.3.1388-.1966; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kissler HJ, 2010, CLIN TRANSPLANT, V24, P236, DOI 10.1111/j.1399-0012.2009.01052.x; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Liebhafsky HA, 1937, J AM CHEM SOC, V59, P1966, DOI 10.1021/ja01289a051; LITTLEWOOD BS, 1973, MUTAT RES, V17, P315, DOI 10.1016/0027-5107(73)90003-1; MAWBY A, 1972, J INORG NUCL CHEM, V34, P109, DOI 10.1016/0022-1902(72)80367-1; MCCAMMON MT, 1982, MOL GEN GENET, V186, P295, DOI 10.1007/BF00331865; MIDDELHOVEN WJ, 1976, J BACTERIOL, V128, P851, DOI 10.1128/JB.128.3.851-852.1976; NAGAI S, 1963, J BACTERIOL, V86, P299, DOI 10.1128/JB.86.2.299-302.1963; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; ONO BI, 1991, APPL ENVIRON MICROB, V57, P3183, DOI 10.1128/AEM.57.11.3183-3186.1991; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; PARADKAR RP, 1994, ANAL CHEM, V66, P2752, DOI 10.1021/ac00089a024; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shima C, 1996, ANAL BIOCHEM, V236, P173, DOI 10.1006/abio.1996.0148; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slattery MG, 2008, EUKARYOT CELL, V7, P358, DOI 10.1128/EC.00334-07; SNOW R, 1966, NATURE, V211, P206, DOI 10.1038/211206a0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YOUNG JD, 1976, MUTAT RES, V35, P423, DOI 10.1016/0027-5107(76)90204-9; Yuan DS, 2000, GENETICS, V156, P45; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25830	10.1371/journal.pone.0025830	http://dx.doi.org/10.1371/journal.pone.0025830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998704	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900061
J	Advani, A; Connelly, KA; Yuen, DA; Zhang, YL; Advani, SL; Trogadis, J; Kabir, MG; Shachar, E; Kuliszewski, MA; Leong-Poi, H; Stewart, DJ; Gilbert, RE				Advani, Andrew; Connelly, Kim A.; Yuen, Darren A.; Zhang, Yanling; Advani, Suzanne L.; Trogadis, Judy; Kabir, M. Golam; Shachar, Etai; Kuliszewski, Michael A.; Leong-Poi, Howard; Stewart, Duncan J.; Gilbert, Richard E.			Fluorescent Microangiography Is a Novel and Widely Applicable Technique for Delineating the Renal Microvasculature	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; REMNANT KIDNEY MODEL; AMINOPEPTIDASE-P; POTENTIAL ROLE; CELLS; PROGRESSION; INJURY; MICROCIRCULATION; REGRESSION; REDUCTION	Rarefaction of the renal microvasculature correlates with declining kidney function. However, current technologies commonly used for its evaluation are limited by their reliance on endothelial cell antigen expression and assessment in two dimensions. We set out to establish a widely applicable and unbiased optical sectioning method to enable three dimensional imaging and reconstruction of the renal microvessels based on their luminal filling. The kidneys of subtotally nephrectomized (SNx) rats and their sham-operated counterparts were subjected to either routine two-dimensional immunohistochemistry or the novel technique of fluorescent microangiography (FMA). The latter was achieved by perfusion of the kidney with an agarose suspension of fluorescent polystyrene microspheres followed by optical sectioning of 200 mm thick cross-sections using a confocal microscope. The fluorescent microangiography method enabled the three-dimensional reconstruction of virtual microvascular casts and confirmed a reduction in both glomerular and peritubular capillary density in the kidneys of SNx rats, despite an overall increase in glomerular volume. FMA is an uncomplicated technique for evaluating the renal microvasculature that circumvents many of the limitations imposed by conventional analysis of two-dimensional tissue sections.	[Advani, Andrew; Connelly, Kim A.; Yuen, Darren A.; Zhang, Yanling; Advani, Suzanne L.; Trogadis, Judy; Kabir, M. Golam; Shachar, Etai; Kuliszewski, Michael A.; Leong-Poi, Howard; Gilbert, Richard E.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Stewart, Duncan J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute	Advani, A (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	advania@smh.ca; richard.gilbert@utoronto.ca	Connelly, Kim A/S-5160-2017	Connelly, Kim A/0000-0002-1031-3137	CIHR [MOP-97791]; Heart and Stroke Foundation of Ontario; KRESCENT postdoctoral fellowship	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); KRESCENT postdoctoral fellowship	These studies were supported by CIHR grant MOP-97791 to Dr. Advani and a CIHR Team Grant to Dr. Gilbert. Dr. Advani is a Canadian Diabetes Association Clinician Scientist, Dr. Gilbert is a Canada Research Chair in Diabetes Complications and this work was supported thanks, in part, to the Canadian Diabetes Association and the Canada Research Chair Program. Dr. Connelly and Dr. Leong-Poi are supported by Clinician Scientist Awards from the Heart and Stroke Foundation of Ontario. Dr. Yuen is supported by a KRESCENT postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Antiga L, 2001, MICROVASC RES, V62, P346, DOI 10.1006/mvre.2001.2351; Bertram JF, 1995, INT REV CYTOL, V161, P111; Dutly AE, 2006, LAB INVEST, V86, P409, DOI 10.1038/labinvest.3700399; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fogo AB, 2005, CURR OPIN NEPHROL HY, V14, P201, DOI 10.1097/01.mnh.0000165883.08675.ab; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Haylor J, 1996, NEPHROL DIAL TRANSPL, V11, P643, DOI 10.1093/oxfordjournals.ndt.a027353; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kosugi T, 2010, AM J PHYSIOL-RENAL, V298, pF609, DOI 10.1152/ajprenal.00377.2009; Lasch J, 1998, BIOL CHEM, V379, P705, DOI 10.1515/bchm.1998.379.6.705; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; MILLER PL, 1990, J CLIN INVEST, V85, P1119, DOI 10.1172/JCI114543; Mondy WL, 2009, TISSUE ENG PART C-ME, V15, P729, DOI [10.1089/ten.tec.2008.0583, 10.1089/ten.TEC.2008.0583]; Nagaoka T, 2006, INVEST OPHTH VIS SCI, V47, P1113, DOI 10.1167/iovs.05-0218; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Pillebout E, 2001, AM J PATHOL, V159, P547, DOI 10.1016/S0002-9440(10)61726-9; Prior HM, 1998, CARDIOVASC RES, V37, P780, DOI 10.1016/S0008-6363(97)00237-X; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Scruggs BS, 2011, AM J PATHOL, V178, P1891, DOI 10.1016/j.ajpath.2010.12.029; Sharman JE, 2009, HYPERTENSION, V54, P1092, DOI 10.1161/HYPERTENSIONAHA.109.135525; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Terayama H, 2011, J TISSUE ENG REGEN M, V5, P32, DOI 10.1002/term.285; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	28	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e24695	10.1371/journal.pone.0024695	http://dx.doi.org/10.1371/journal.pone.0024695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984894	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000004
J	Giraudo, M; Califano, J; Hilliou, F; Tran, T; Taquet, N; Feyereisen, R; Le Goff, G				Giraudo, Maeva; Califano, Jerome; Hilliou, Frederique; Tran, Trang; Taquet, Nathalie; Feyereisen, Rene; Le Goff, Gaelle			Effects of Hormone Agonists on Sf9 Cells, Proliferation and Cell Cycle Arrest	PLOS ONE			English	Article							NONSTEROIDAL ECDYSONE AGONIST; BEETLE TRIBOLIUM-CASTANEUM; INSECT GROWTH-REGULATORS; VACUOLAR H+-ATPASE; RED FLOUR BEETLE; JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; METHOPRENE-TOLERANT; MICROARRAY DATA; V-ATPASE	Methoxyfenozide and methoprene are two insecticides that mimic the action of the main hormones involved in the control of insect growth and development, 20-hydroxyecdysone and juvenile hormone. We investigated their effect on the Spodoptera frugiperda Sf9 cell line. Methoxyfenozide was more toxic than methoprene in cell viability tests and more potent in the inhibition of cellular proliferation. Cell growth arrest occurred in the G2/M phase after a methoprene treatment and more modestly in G1 after methoxyfenozide treatment. Microarray experiments and real-time quantitative PCR to follow the expression of nuclear receptors ultraspiracle and ecdysone receptor were performed to understand the molecular action of these hormone agonists. Twenty-six genes were differentially expressed after methoxyfenozide treatment and 55 genes after methoprene treatment with no gene in common between the two treatments. Our results suggest two different signalling pathways in Sf9 cells.	[Giraudo, Maeva; Califano, Jerome; Hilliou, Frederique; Tran, Trang; Taquet, Nathalie; Feyereisen, Rene; Le Goff, Gaelle] Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale 1301, CNRS,UMR 6243, Sophia Antipolis, France; [Giraudo, Maeva] Univ Clermont Ferrand, CNRS, UMR 6023, Aubiere, France; [Califano, Jerome] Dept Affaires Reglementaires, Grasse, France; [Tran, Trang] Lanaud Gest Pole Lanaud, Boisseuil, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Giraudo, M (corresponding author), Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale 1301, CNRS,UMR 6243, Sophia Antipolis, France.	legoff@sophia.inra.fr	Feyereisen, René/I-3140-2012; Feyereisen, René/Y-7514-2019; Legoff, Gaelle/B-7501-2015; Giraudo, Maeva/GVS-6750-2022; Hilliou, Frédérique/T-5714-2019; Giraudo, Maeva/ABE-4328-2021	Feyereisen, René/0000-0002-9560-571X; Feyereisen, René/0000-0002-9560-571X; Legoff, Gaelle/0000-0003-1973-7136; Giraudo, Maeva/0000-0003-4296-146X; hilliou, frederique/0000-0002-3020-2987	Agence Nationale pour la Recherche [ANR 06BLAN0346]; Institut National de la Recherche Agronomique; region Provence Alpes Cote d'Azur	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National de la Recherche Agronomique; region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur)	We thank Agence Nationale pour la Recherche (ANR 06BLAN0346) for funding. M. Giraudo was supported by a PhD fellowship from Institut National de la Recherche Agronomique and region Provence Alpes Cote d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; ATMANN F, 1999, GLYCOCONJ J, V2, P109; Auzoux-Bordenave S, 2005, INSECT BIOCHEM MOLEC, V35, P1033, DOI 10.1016/j.ibmb.2005.04.004; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Crissman H A, 1975, Methods Cell Biol, V9, P179, DOI 10.1016/S0091-679X(08)60076-X; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Decombel L, 2005, ARCH INSECT BIOCHEM, V58, P145, DOI 10.1002/arch.20048; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fallon AM, 2010, J INSECT PHYSIOL, V56, P1396, DOI 10.1016/j.jinsphys.2010.03.016; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerenday A, 2004, J INSECT PHYSIOL, V50, P831, DOI 10.1016/j.jinsphys.2004.06.005; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HENRICK CA, 1973, J AGR FOOD CHEM, V21, P354, DOI 10.1021/jf60187a043; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; Jones G, 2001, INSECT BIOCHEM MOLEC, V32, P33, DOI 10.1016/S0965-1748(01)00077-7; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; Mikitani K, 1996, BIOCHEM BIOPH RES CO, V227, P427, DOI 10.1006/bbrc.1996.1524; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Mosallanejad H, 2010, J INSECT PHYSIOL, V56, P1973, DOI 10.1016/j.jinsphys.2010.08.022; Mottier V, 2004, INSECT BIOCHEM MOLEC, V34, P51, DOI 10.1016/j.ibmb.2003.09.003; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Oberlander H, 2000, J INSECT PHYSIOL, V46, P259, DOI 10.1016/S0022-1910(99)00178-X; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; QUACK S, 1995, EUR J ENTOMOL, V92, P341; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SILHACEK DL, 1990, ARCH INSECT BIOCHEM, V15, P201, DOI 10.1002/arch.940150402; Smagghe G, 2002, INSECT BIOCHEM MOLEC, V32, P187, DOI 10.1016/S0965-1748(01)00109-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STAAL GB, 1975, ANNU REV ENTOMOL, V20, P417, DOI 10.1146/annurev.en.20.010175.002221; STEVENS B, 1980, CELL, V22, P675, DOI 10.1016/0092-8674(80)90543-7; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Swevers L, 2008, INSECT BIOCHEM MOLEC, V38, P825, DOI 10.1016/j.ibmb.2008.06.001; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Willis DK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6601; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; WING KD, 1988, SCIENCE, V241, P467, DOI 10.1126/science.3393913; Yang YH, 2003, INST MATH S, V40, P403; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	64	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25708	10.1371/journal.pone.0025708	http://dx.doi.org/10.1371/journal.pone.0025708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991338	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000058
J	Hakuno, F; Yamauchi, Y; Kaneko, G; Yoneyama, Y; Nakae, J; Chida, K; Kadowaki, T; Yamanouchi, K; Nishihara, M; Takahashi, SI				Hakuno, Fumihiko; Yamauchi, Yoko; Kaneko, Gen; Yoneyama, Yosuke; Nakae, Jun; Chida, Kazuhiro; Kadowaki, Tatsuhiko; Yamanouchi, Keitaro; Nishihara, Masugi; Takahashi, Shin-Ichiro			Constitutive Expression of Insulin Receptor Substrate (IRS)-1 Inhibits Myogenic Differentiation through Nuclear Exclusion of Foxo1 in L6 Myoblasts	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSCRIPTION FACTOR FKHR; MUSCLE DIFFERENTIATION; SIGNALING PATHWAYS; ADULT MYOGENESIS; TYROSINE KINASE; IRS PROTEINS; DEGRADATION; CELLS; SYSTEM	Insulin-like growth factors (IGFs) are well known to play essential roles in enhancement of myogenic differentiation. In this report we showed that initial IGF-I signal activation but long-term IGF-1 signal termination are required for myogenic differentiation. L6 myoblast stably transfected with myc-epitope tagged insulin receptor substrate-1, myc-IRS-1 (L6-mIRS1) was unable to differentiate into myotubes, indicating that IRS-1 constitutive expression inhibited myogenesis. To elucidate the molecular mechanisms underlying myogenic inhibition, IGF-I signaling was examined. IGF-I treatment of control L6 cells for 18 h resulted in a marked suppression of IGF-I stimulated IRS-1 association with the p85 PI 3-kinase and suppression of activation of Akt that correlated with a down regulation of IRS-1 protein. L6-mIRS1 cells, in contrast, had sustained high levels of IRS-1 protein following 18 h of IGF-I treatment with persistent p85 PI 3-kinase association with IRS-1, Akt phosphorylation and phosphorylation of the downstream Akt substrate, Foxo1. Consistent with Foxo1 phosphorylation, Foxo1 protein was excluded from the nuclei in L6-mIRS1 cells, whereas Foxo1 was localized in the nuclei in control L6 cells during induction of differentiation. In addition, L6 cells stably expressing a dominant-interfering form of Foxo1, Delta 256Foxo1 (L6-Delta 256Foxo1) were unable to differentiate into myotubes. Together, these data demonstrate that IGF-I regulation of Foxo1 nuclear localization is essential for the myogenic program in L6 cells but that persistent activation of IGF-1 signaling pathways results in a negative feedback to prevent myogenesis.	[Hakuno, Fumihiko; Kaneko, Gen; Yoneyama, Yosuke; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Dept Anim Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Yamauchi, Yoko; Kadowaki, Tatsuhiko] Nagoya Univ, Dept Bioengn Sci, Grad Sch Bioagr Sci, Aichi, Japan; [Nakae, Jun] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol,Shinjuku Ku, Tokyo, Japan; [Yamanouchi, Keitaro; Nishihara, Masugi] Univ Tokyo, Dept Vet Med Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Nagoya University; Keio University; University of Tokyo	Hakuno, F (corresponding author), Univ Tokyo, Dept Anim Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp	Yamanouchi, Keitaro/R-5003-2019; Kaneko/B-3359-2008	Kaneko/0000-0003-4295-5123; Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010	Ministry of Education, Science and Culture of Japan [11460126, 16208028, 2248030, 21580345]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [21580345] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research [to S-IT, (B)(2) #11460126 and (A)(2) #16208028 and #2248030, and to FH, (C) #21580345] from the Ministry of Education, Science and Culture of Japan (http://www.jsps.go.jp/english/e-grants/grants.html), and was supported partially by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to FH and KY) and the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S-IT) (http://brain.naro.affrc.go.jp/tokyo/marumoto/inv_up/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Conejo R, 2002, ONCOGENE, V21, P3739, DOI 10.1038/sj.onc.1205469; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hribal ML, 2000, J CLIN ENDOCR METAB, V85, P2004, DOI 10.1210/jc.85.5.2004; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lim MJ, 2007, MOL ENDOCRINOL, V21, P2282, DOI 10.1210/me.2007-0114; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Miller MG, 2003, BIOCHEM BIOPH RES CO, V310, P796, DOI 10.1016/j.bbrc.2003.09.080; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Suzue N, 2006, J BONE MINER RES, V21, P722, DOI 10.1359/JBMR.060207; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	46	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25655	10.1371/journal.pone.0025655	http://dx.doi.org/10.1371/journal.pone.0025655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991327	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000051
J	Kumar, A; Chen, T; Pakkanen, S; Kantele, A; Soderlund-Venermo, M; Hedman, K; Franssila, R				Kumar, Arun; Chen, Tingting; Pakkanen, Sari; Kantele, Anu; Soderlund-Venermo, Maria; Hedman, Klaus; Franssila, Rauli			T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; INTERFERON-GAMMA; IFN-GAMMA; IMMUNE-RESPONSE; TUMOR-GROWTH; B-CELLS; CARCINOMA; INTERLEUKIN-10; ANTIBODIES; CANCER	The newly discovered Merkel Cell Polyomavirus (MCPyV) resides in approximately 80% of Merkel cell carcinomas (MCC). Causal role of MCPyV for this rare and aggressive skin cancer is suggested by monoclonal integration and truncation of large T (LT) viral antigen in MCC cells. The mutated MCPyV has recently been found in highly purified leukemic cells from patients with chronic lymphocytic leukemia (CLL), suggesting a pathogenic role also in CLL. About 50-80% of adults display MCPyV-specific antibodies. The humoral immunity does not protect against the development of MCC, as neutralizing MCPyV antibodies occur in higher levels among MCC patients than healthy controls. Impaired T-cell immunity has been linked with aggressive MCC behavior. Therefore, cellular immunity appears to be important in MCPyV infection surveillance. In order to elucidate the role of MCPyV-specific Th-cell immunity, peripheral blood mononuclear cells (PBMC) of healthy adults were stimulated with MCPyV VP1 virus-like particles (VLPs), using human bocavirus (HBoV) VLPs and Candida albicans antigen as positive controls. Proliferation, IFN-gamma, IL-13 and IL-10 responses were examined in 15 MCPyV-seropositive and 15 seronegative volunteers. With the MCPyV antigen, significantly stronger Th-cell responses were found in MCPyV-seropositive than MCPyV-seronegative subjects, whereas with the control antigens, the responses were statistically similar. The most readily detectable cytokine was IFN-gamma. The MCPyV antigen tended to induce stronger IFN-gamma responses than HBoV VLP antigen. Taken together, MCPyV-specific Th-cells elicit vigorous IFN-gamma responses. IFN-gamma being a cytokine with major antiviral and tumor suppressing functions, Th-cells are suggested to be important mediators of MCPyV-specific immune surveillance.	[Kumar, Arun; Chen, Tingting; Soderlund-Venermo, Maria; Hedman, Klaus; Franssila, Rauli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Pakkanen, Sari; Kantele, Anu] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Cent Hosp, Div Infect Dis, Helsinki, Finland; [Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Kumar, A (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	arun.kumar@helsinki.fi	Söderlund-Venermo, Maria/AAX-2112-2020; Kumar, Arun/C-9466-2013; Hedman, Klaus/D-5379-2009; Chen, Tingting/I-8274-2019; Kantele, Anu/AAS-4131-2021	Chen, Tingting/0000-0002-2227-3208; Kantele, Anu/0000-0002-0004-1000; Pakkanen, Sari/0000-0003-4522-5337; Hedman, Klaus/0000-0003-1779-7960; Kumar, Arun/0000-0003-4483-7585	Helsinki University Central Hospital; Medical Society of Finland; Academy of Finland [1122539]; Clinical Chemistry Research Foundation; Orion-Farmos Research Foundation; University of Helsinki; Sigrid Juselius Foundation	Helsinki University Central Hospital; Medical Society of Finland; Academy of Finland(Academy of Finland); Clinical Chemistry Research Foundation; Orion-Farmos Research Foundation; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by the Helsinki University Central Hospital Research and Education Fund, the Medical Society of Finland, the Academy of Finland (project 1122539), the Clinical Chemistry Research Foundation Grant (A. Kumar), the Orion-Farmos Research Foundation Grant (A. Kumar), the University of Helsinki Funds Grant (A. Kumar), and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2010, J CUTAN PATHOL, V37, P28, DOI 10.1111/j.1600-0560.2009.01352.x; Arany I, 1998, J Cutan Med Surg, V2, P138; Beatty GL, 2001, IMMUNOL RES, V24, P201, DOI 10.1385/IR:24:2:201; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Berman RM, 1996, J IMMUNOL, V157, P231; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chaouchi N, 1996, BLOOD, V87, P1022, DOI 10.1182/blood.V87.3.1022.bloodjournal8731022; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2008, EMERG INFECT DIS, V14, P1491, DOI 10.3201/eid1409.080651; Franssila R, 2004, VACCINE, V22, P3809, DOI 10.1016/j.vaccine.2003.06.003; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Hemmer B, 1998, J IMMUNOL, V160, P3631; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Kaufman HL, 1999, J IMMUNOTHER, V22, P489, DOI 10.1097/00002371-199911000-00003; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Koljonen V, 2009, BRIT J CANCER, V101, P1444, DOI 10.1038/sj.bjc.6605306; Kornacker M, 2006, INT J CANCER, V119, P1377, DOI 10.1002/ijc.21994; Kumar A, 2011, SCAND J IMMUNOL, V73, P135, DOI 10.1111/j.1365-3083.2010.02483.x; Kundu N, 1996, JNCI-J NATL CANCER I, V88, P536, DOI 10.1093/jnci/88.8.536; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Ma HL, 2004, INT IMMUNOL, V16, P1009, DOI 10.1093/intimm/dxh105; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mertz KD, 2010, J INVEST DERMATOL, V130, P1146, DOI 10.1038/jid.2009.392; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Pantulu ND, 2010, BLOOD, V116, P5280, DOI 10.1182/blood-2010-02-269829; Paolini F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-103; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Paulson KG, 2011, J CLIN ONCOL, V29, P1539, DOI 10.1200/JCO.2010.30.6308; Paulson KG, 2010, CANCER RES, V70, P8388, DOI 10.1158/0008-5472.CAN-10-2128; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Posavad CM, 2003, J IMMUNOL, V170, P4380, DOI 10.4049/jimmunol.170.8.4380; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Teman CJ, 2011, LEUKEMIA RES, V35, P689, DOI 10.1016/j.leukres.2011.01.032; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zaninoni A, 2003, EXP HEMATOL, V31, P185, DOI 10.1016/S0301-472X(02)01046-9; Zheng LM, 1996, J EXP MED, V184, P579, DOI 10.1084/jem.184.2.579	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25751	10.1371/journal.pone.0025751	http://dx.doi.org/10.1371/journal.pone.0025751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991346	gold, Green Published, Green Submitted			2022-12-25	WOS:000295943000065
J	Liu, R; Hu, JJ				Liu, Rong; Hu, Jianjun			Computational Prediction of Heme-Binding Residues by Exploiting Residue Interaction Network	PLOS ONE			English	Article							PROTEIN STRUCTURES; KEY RESIDUES; CONSERVATION; RECOGNITION; CENTRALITY; DIVERSITY; FAMILIES; VIEW	Computational identification of heme-binding residues is beneficial for predicting and designing novel heme proteins. Here we proposed a novel method for heme-binding residue prediction by exploiting topological properties of these residues in the residue interaction networks derived from three-dimensional structures. Comprehensive analysis showed that key residues located in heme-binding regions are generally associated with the nodes with higher degree, closeness and betweenness, but lower clustering coefficient in the network. HemeNet, a support vector machine (SVM) based predictor, was developed to identify heme-binding residues by combining topological features with existing sequence and structural features. The results showed that incorporation of network-based features significantly improved the prediction performance. We also compared the residue interaction networks of heme proteins before and after heme binding and found that the topological features can well characterize the heme-binding sites of apo structures as well as those of holo structures, which led to reliable performance improvement as we applied HemeNet to predicting the binding residues of proteins in the heme-free state. HemeNet web server is freely accessible at http://mleg.cse.sc.edu/hemeNet/.	[Liu, Rong; Hu, Jianjun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Liu, R (corresponding author), Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.	jianjunh@cse.sc.edu			National Science Foundation [BIO-DBI-0845381]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Career Award (Grant BIO-DBI-0845381). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; [Anonymous], LIBSVM LIB SUPPORT V; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bikiel DE, 2006, PHYS CHEM CHEM PHYS, V8, P5611, DOI 10.1039/b611741b; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; DIJKSTRA KE, 1959, NUMER MATH, V1, P269; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; GUENGERICH FP, 1984, ACCOUNTS CHEM RES, V17, P9, DOI 10.1021/ar00097a002; Illingworth CJR, 2010, J COMPUT CHEM, V31, P2677, DOI 10.1002/jcc.21561; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schneider S, 2007, NAT PROD REP, V24, P621, DOI 10.1039/b604186h; SMITH A, 1993, J BIOL CHEM, V268, P7365; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Terwilliger NB, 1998, J EXP BIOL, V201, P1085; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591	35	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25560	10.1371/journal.pone.0025560	http://dx.doi.org/10.1371/journal.pone.0025560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991319	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000040
J	Tjondrokoesoemo, A; Park, KH; Ferrante, C; Komazaki, S; Lesniak, S; Brotto, M; Ko, JK; Zhou, JS; Weisleder, N; Ma, JJ				Tjondrokoesoemo, Andoria; Park, Ki Ho; Ferrante, Christopher; Komazaki, Shinji; Lesniak, Sebastian; Brotto, Marco; Ko, Jae-Kyun; Zhou, Jingsong; Weisleder, Noah; Ma, Jianjie			Disrupted Membrane Structure and Intracellular Ca2+ Signaling in Adult Skeletal Muscle with Acute Knockdown of Bin1	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; TUMOR-SUPPRESSOR; OSMOTIC-STRESS; RELEASE; SPARKS; FIBERS; AMPHIPHYSIN; CHANNELS; DEPOLARIZATION	Efficient intracellular Ca2+ ([Ca2+]i) homeostasis in skeletal muscle requires intact triad junctional complexes comprised of t-tubule invaginations of plasma membrane and terminal cisternae of sarcoplasmic reticulum. Bin1 consists of a specialized BAR domain that is associated with t-tubule development in skeletal muscle and involved in tethering the dihydropyridine receptors (DHPR) to the t-tubule. Here, we show that Bin1 is important for Ca2+ homeostasis in adult skeletal muscle. Since systemic ablation of Bin1 in mice results in postnatal lethality, in vivo electroporation mediated transfection method was used to deliver RFP-tagged plasmid that produced short -hairpin (sh) RNA targeting Bin1 (shRNA-Bin1) to study the effect of Bin1 knockdown in adult mouse FDB skeletal muscle. Upon confirming the reduction of endogenous Bin1 expression, we showed that shRNA-Bin1 muscle displayed swollen t-tubule structures, indicating that Bin1 is required for the maintenance of intact membrane structure in adult skeletal muscle. Reduced Bin1 expression led to disruption of t-tubule structure that was linked with alterations to intracellular Ca2+ release. Voltage-induced Ca2+ released in isolated single muscle fibers of shRNA-Bin1 showed that both the mean amplitude of Ca2+ current and SR Ca2+ transient were reduced when compared to the shRNA-control, indicating compromised coupling between DHPR and ryanodine receptor 1. The mean frequency of osmotic stress induced Ca2+ sparks was reduced in shRNA-Bin1, indicating compromised DHPR activation. ShRNA-Bin1 fibers also displayed reduced Ca2+ sparks' amplitude that was attributed to decreased total Ca2+ stores in the shRNA-Bin1 fibers. Human mutation of Bin1 is associated with centronuclear myopathy and SH3 domain of Bin1 is important for sarcomeric protein organization in skeletal muscle. Our study showing the importance of Bin1 in the maintenance of intact t-tubule structure and ([Ca2+]i) homeostasis in adult skeletal muscle could provide mechanistic insight on the potential role of Bin1 in skeletal muscle contractility and pathology of myopathy.	[Tjondrokoesoemo, Andoria; Park, Ki Ho; Ferrante, Christopher; Lesniak, Sebastian; Ko, Jae-Kyun; Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama, Japan; [Brotto, Marco] Univ Missouri, Muscle Biol Res Grp, Kansas City, MO 64110 USA; [Zhou, Jingsong] Rush Univ, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Saitama Medical University; University of Missouri System; University of Missouri Kansas City; Rush University	Tjondrokoesoemo, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	weisleno@umdnj.edu	Park, Ki Ho/N-8153-2017; Weisleder, Noah L/A-7098-2013	Park, Ki Ho/0000-0002-6193-9826; Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	National Institutes of Health (NIH) [AG28614, HL69000, AR054793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057404, R00AR054793, K99AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants to Dr. Ma (AG28614 and HL69000) and Dr. Weileder (AR054793). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; DiFranco M, 2009, J VIS EXP; Fernando P, 2009, J BIOL CHEM, V284, P27674, DOI 10.1074/jbc.M109.029538; Glund S, 2009, ENDOCRINOLOGY, V150, P600, DOI 10.1210/en.2008-1204; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; JIMENEZMORENO R, 2010, PFLUGERS ARCH; Launikonis BS, 2006, J GEN PHYSIOL, V128, P45, DOI 10.1085/jgp.200609545; Lee EH, 2004, AM J PHYSIOL-CELL PH, V286, pC179, DOI 10.1152/ajpcell.00176.2003; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pickering JD, 2009, J GEN PHYSIOL, V133, P511, DOI 10.1085/jgp.200910191; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Shirokova N, 1998, J PHYSIOL-LONDON, V512, P377, DOI 10.1111/j.1469-7793.1998.377be.x; Teichmann MDH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003644; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; TOUSSAINT A, 2010, ACTA NEUROPATHOL; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Weisleder N, 2007, CELL CALCIUM, V42, P548, DOI 10.1016/j.ceca.2007.01.009; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Weisleder N, 2006, ACTA PHARMACOL SIN, V27, P791, DOI 10.1111/j.1745-7254.2006.00384.x; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319	36	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25740	10.1371/journal.pone.0025740	http://dx.doi.org/10.1371/journal.pone.0025740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984944	Green Submitted, Green Published, gold			2022-12-25	WOS:000295941300054
J	Miller, DL; Budde, MW; Roth, MB				Miller, Dana L.; Budde, Mark W.; Roth, Mark B.			HIF-1 and SKN-1 Coordinate the Transcriptional Response to Hydrogen Sulfide in Caenorhabditis elegans	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ISCHEMIA-REPERFUSION INJURY; ANIMATION-LIKE STATE; OXIDATIVE STRESS; LIFE-SPAN; LONGEVITY; PROTEINS	Hydrogen sulfide (H2S) has dramatic physiological effects on animal that are associated with improved survival. C. elegan grown in H2S are long-lived and thermotolerant. To identify mechanisms by which adaptation to H2S effects physiological functions, we have measured transcriptional responses to H2S exposure. Using microarray analysis we observe rapid changes in the abundance of specific mRNAs. The number and magnitude of transcriptional changes increased with the duration of H2S exposure. Functional annotation suggests that genes associated with protein homeostasis are upregulated upon prolonged exposure to H2S. Previous work has shown that the hypoxia-inducible transcription factor, HIF-1 is required for survival in H2S. In fact, we show that hif-1 requried for most, if not all, early transcriptional changes in H2S. Moreover, our data demonstrate that SKN-1, the C. elegans homologue of NRF2, also contribute to H2S-dependent changes in transcription. We show that these results are functionally important, as skn-1 is essential to survive exposure to H2S. Our results suggest a model in which HIF-1 and SKN-1 coordinate a broad transcriptional response to H2S that culminates in a global reorganization of protein homeostasis networks.	[Miller, Dana L.] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; [Miller, Dana L.; Budde, Mark W.; Roth, Mark B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Budde, Mark W.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Miller, DL (corresponding author), Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA.	dlm16@uw.edu; mroth@fhcrc.org		Miller, Dana/0000-0003-3983-0493	National Institutes of Health [K99/R00 AG033050]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE ON AGING [R00AG033050, K99AG033050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant K99/R00 AG033050 to Dana L Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Microarray experiments and analysis were performed with the expert assistance of Dr. Jeff Delrow (FHCRC DNA Array Facility), and Dr. Jerry Davison (FHCRC Computational Biology) provided valuable assistance with data analysis. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BOWERMAN B, 1992, DEVELOPMENT, V116, P1113; BRENNER S, 1974, GENETICS, V77, P71; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Budde MW, 2011, GENETICS; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morrison ML, 2008, J TRAUMA, V65, P183, DOI 10.1097/TA.0b013e3181507579; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Robertson SM, 2004, DEV BIOL, V276, P493, DOI 10.1016/j.ydbio.2004.09.015; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Simon F, 2008, SHOCK, V30, P359, DOI 10.1097/SHK.0b013e3181674185; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348	40	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25476	10.1371/journal.pone.0025476	http://dx.doi.org/10.1371/journal.pone.0025476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980473	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600029
J	Wan, CY; Bazen, L; Baars, R; Libenson, A; Zipse, L; Zuk, J; Norton, A; Schlaug, G				Wan, Catherine Y.; Bazen, Loes; Baars, Rebecca; Libenson, Amanda; Zipse, Lauryn; Zuk, Jennifer; Norton, Andrea; Schlaug, Gottfried			Auditory-Motor Mapping Training as an Intervention to Facilitate Speech Output in Non-Verbal Children with Autism: A Proof of Concept Study	PLOS ONE			English	Article							MELODIC INTONATION THERAPY; MIRROR NEURON SYSTEM; FOLLOW-UP; SPECTRUM DISORDERS; LANGUAGE; MUSIC; REPRESENTATION; IMITATION; SPEAKING; NETWORK	Although up to 25% of children with autism are non-verbal, there are very few interventions that can reliably produce significant improvements in speech output. Recently, a novel intervention called Auditory-Motor Mapping Training (AMMT) has been developed, which aims to promote speech production directly by training he association between sounds and articulatory actions using intonation and bimanual motor activities. AMMT capitalizes on the inherent musical strengths of children with autism, and offers activities that they intrinsically enjoy. It also engages and potentially stimulates a network of brain regions that may be dysfunctional in autism. Here we report an initial efficacy study to provide 'proof of concept' for AMMT. Six non-verbal children with autism participated. Prior to treatment, the children had no intelligible words. They each received 40 individual sessions of AMMT 5 times per week, over an 8-week period. Probe assessments were conducted periodically during baseline, therapy, and follow-up sessions. After therapy, all children showed significant improvements in their ability to articulate words and phrases, with generalization to items that were not practiced during therapy sessions. Because these children had no or minimal vocal output prior to treatment, the acquisition of speech sounds and word approximations through AMMT represents a critical step in expressive language development in children with autism.	[Wan, Catherine Y.; Bazen, Loes; Baars, Rebecca; Libenson, Amanda; Zuk, Jennifer; Norton, Andrea; Schlaug, Gottfried] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mus & Neuroimaging Lab,Dept Neurol, Boston, MA 02215 USA; [Zipse, Lauryn] MGH Inst Hlth Profess, Dept Commun Sci & Disorders, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wan, CY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mus & Neuroimaging Lab,Dept Neurol, Boston, MA 02215 USA.	cwan@bidmc.harvard.edu		Zuk, Jennifer/0000-0001-9113-3973	The Nancy Lurie Marks Family Foundation; Deborah Munroe Noonan Memorial Research Fund; National Institutes of Health (NIH) [1RO1 DC008796, 3RO1DC008796-02S1, RO1DC009823-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009823, R01DC008796] Funding Source: NIH RePORTER	The Nancy Lurie Marks Family Foundation; Deborah Munroe Noonan Memorial Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by The Nancy Lurie Marks Family Foundation (Dr. Schlaug) and the Deborah Munroe Noonan Memorial Research Fund (Dr. Wan). Dr. Schlaug also acknowledges additional support from the National Institutes of Health (NIH) (1RO1 DC008796, 3RO1DC008796-02S1, RO1DC009823-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1973, ARCH NEUROL-CHICAGO, V29, P130, DOI 10.1001/archneur.1973.00490260074018; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; BIJOU SW, 1989, ADV CHILD DEV BEHAV, V21, P221, DOI 10.1016/S0065-2407(08)60288-8; Francis K, 2005, DEV MED CHILD NEUROL, V47, P493, DOI 10.1017/S0012162205000952; Hadjikhani N., 2007, PROGR AUTISM RES, P151; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Hoelzley P., 1993, CANADIAN J MUSIC THE, V1, P54; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; KEITH RL, 1975, BRAIN LANG, V2, P483, DOI 10.1016/S0093-934X(75)80085-X; Koegel RL, 2009, J AUTISM DEV DISORD, V39, P1587, DOI 10.1007/s10803-009-0765-9; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lord C, 2006, ARCH GEN PSYCHIAT, V63, P694, DOI 10.1001/archpsyc.63.6.694; Lord C, 2004, DEV LANGUAGE DISORDE, P1; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; MILLER SB, 1979, J CLIN PSYCHIAT, V40, P201; MONSEN RB, 1976, J SPEECH HEAR RES, V19, P279, DOI 10.1044/jshr.1902.279; Mullen E.M., 1995, MULLENS SCALES EARLY; Newmeyer AJ, 2007, CLIN PEDIATR, V46, P604, DOI 10.1177/0009922807299545; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Pickett E, 2009, COGN BEHAV NEUROL, V22, P1, DOI 10.1097/WNN.0b013e318190d185; Rogers SJ, 2006, J AUTISM DEV DISORD, V36, P1007, DOI 10.1007/s10803-006-0142-x; Schlaug G, 2008, MUSIC PERCEPT, V25, P315, DOI 10.1525/MP.2008.25.4.315; Schlosser RW, 2008, AM J SPEECH-LANG PAT, V17, P212, DOI 10.1044/1058-0360(2008/021); Schopler E, CHILDHOOD AUTISM RAT, V2nd; Sherer MR, 2005, J CONSULT CLIN PSYCH, V73, P525, DOI 10.1037/0022-006X.73.3.525; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; Smith T, 2007, J AUTISM DEV DISORD, V37, P354, DOI 10.1007/s10803-006-0173-3; SPARKS R, 1974, Cortex, V10, P303; Turner LM, 2006, AUTISM, V10, P243, DOI 10.1177/1362361306063296; Uozumi T, 2004, NEUROLOGY, V62, P757, DOI 10.1212/01.WNL.0000113731.75479.25; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; Wan CY, 2010, FUTUR NEUROL, V5, P797, DOI 10.2217/FNL.10.55; Wan CY, 2010, BRAIN RES BULL, V82, P161, DOI 10.1016/j.brainresbull.2010.04.010; Wan CY, 2010, MUSIC PERCEPT, V27, P287, DOI 10.1525/MP.2010.27.4.287; Warner-Czyz AD, 2010, J SPEECH LANG HEAR R, V53, P2, DOI 10.1044/1092-4388(2009/0163); Wigram T., 2002, BRIT J MUSIC THER, V16, P11, DOI [10.1177/135945750201600104, DOI 10.1177/135945750201600104]; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Williams K.T., 2007, EVT 2 EXPRESSIVE VOC	48	71	73	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25505	10.1371/journal.pone.0025505	http://dx.doi.org/10.1371/journal.pone.0025505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834DM	21980480	Green Published, Green Submitted, gold			2022-12-25	WOS:000295939600032
J	Gomez, ND; Safeukui, I; Adelani, AA; Tewari, R; Reddy, JK; Rao, S; Holder, A; Buffet, P; Mohandas, N; Haldar, K				Gomez, Noe D.; Safeukui, Innocent; Adelani, Aanuoluwa A.; Tewari, Rita; Reddy, Janardan K.; Rao, Sam; Holder, Anthony; Buffet, Pierre; Mohandas, Narla; Haldar, Kasturi			Deletion of a Malaria Invasion Gene Reduces Death and Anemia, in Model Hosts	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-7; HIGH-EFFICIENCY TRANSFECTION; PLASMODIUM-FALCIPARUM; ERYTHROPOIESIS; DESTRUCTION; SUPPRESSION; INFECTIONS; ANTIBODIES; VIRULENCE; SELECTION	Malaria parasites induce complex cellular and clinical phenotypes, including anemia, cerebral malaria and death in a wide range of mammalian hosts. Host genes and parasite 'toxins' have been implicated in malarial disease, but the contribution of parasite genes remains to be fully defined. Here we assess disease in BALB/c mice and Wistar rats infected by the rodent malaria parasite Plasmodium berghei with a gene knock out for merozoite surface protein (MSP) 7. MSP7 is not essential for infection but in P. falciparum, it enhances erythrocyte invasion by 20%. In vivo, as compared to wild type, the P. berghei Delta msp7 mutant is associated with an abrogation of death and a decrease from 3% to 2% in peak, circulating parasitemia. The Delta msp7 mutant is also associated with less anemia and modest increase in the size of follicles in the spleen. Together these data show that deletion of a single parasite invasion ligand modulates blood stage disease, as measured by death and anemia. This work is the first to assess the contribution of a gene present in all plasmodial species in severe disease.	[Gomez, Noe D.; Safeukui, Innocent; Adelani, Aanuoluwa A.; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Gomez, Noe D.; Reddy, Janardan K.; Rao, Sam] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Tewari, Rita] Univ Nottingham, Ctr Genet & Genom, Sch Biol, Nottingham NG7 2RD, England; [Holder, Anthony] MRC Natl Inst Med Res, Div Parasitol, London, England; [Buffet, Pierre] Univ Paris 06, INSERM, UMR S945, Paris, France; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	University of Notre Dame; Northwestern University; Feinberg School of Medicine; University of Nottingham; MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; New York Blood Center	Gomez, ND (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Adelani, Aanuoluwa/J-8964-2012; Adelani, Aanuoluwa/I-4385-2015; Tewari, Rita/M-5698-2014; Haldar, Kasturi/C-6685-2014; Holder, Anthony A/A-7554-2013; Buffet, Pierre A/O-6189-2017	Adelani, Aanuoluwa/0000-0002-8763-1010; Holder, Anthony A/0000-0002-8490-6058; Buffet, Pierre A/0000-0003-4010-929X; Tewari, Rita/0000-0003-3943-1847	National Institutes of Health [F31 HL09277, P01HL078826]; UK MRC [U117532067]; MRC [G0900109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER; Medical Research Council [MC_U117532067, G0900109] Funding Source: researchfish; MRC [MC_U117532067] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported in part by grants from the National Institutes of Health F31 HL09277 (NG) and P01HL078826 (KH, AH, NM, PB). RT is holder of an MRC Investigator Award (G0900109) and AH is funded in part by the UK MRC (U117532067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awandare GA, 2009, J INFECT DIS, V200, P629, DOI 10.1086/600894; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Carvalho TG, 2005, CURR ISSUES MOL BIOL, V7, P39, DOI 10.21775/cimb.007.039; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Lamb TJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-68; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; Thawan N, 2009, HAEMATOL-HEMATOL J, V94, P195, DOI 10.3324/haematol.13422; Wang L, 2003, PARASITE IMMUNOL, V25, P403, DOI 10.1111/j.1365-3024.2003.00647.x; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77	30	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25477	10.1371/journal.pone.0025477	http://dx.doi.org/10.1371/journal.pone.0025477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980474	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900070
J	Courtial, N; Smink, JJ; Kuvardina, ON; Leutz, A; Gothert, JR; Lausen, J				Courtial, Nadine; Smink, Jeske J.; Kuvardina, Olga N.; Leutz, Achim; Goethert, Joachim R.; Lausen, Joern			Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP	FASEB JOURNAL			English	Article						hematopoiesis; transcription; gene regulation	MICROPHTHALMIA TRANSCRIPTION FACTOR; GENE-EXPRESSION; STEM-CELLS; BONE; SCL; NFATC1; HEMATOPOIESIS; PU.1; MEGAKARYOPOIESIS; DEGRADATION	The balance between bone-forming osteoblasts and bone-resorbing osteoclasts is crucial to bone homeostasis, an equilibrium that is disturbed in many bone diseases. The transcription factor Tal1 is involved in the establishment of hematopoietic stem cells in the embryo and is a master regulator of hematopoietic gene expression in the adult. Here, we show that Tal1 is expressed in osteoclasts and that loss of Tal1 in osteoclast progenitors leads to altered expression of >1200 genes. We found that DC-STAMP, a key regulator of osteoclast cell fusion, is a direct target gene of Tal1 and show that Tal1 represses DC-STAMP expression by counteracting the activating function of the transcription factors PU. 1 and MITF. The identification of Tal1 as a factor involved in cell fusion contributes to the understanding of osteoclast-associated diseases, including osteoporosis.-Courtial, N., Smink, J. J., Kuvardina, O. N., Leutz, A., Gothert, J. R., Lausen, J. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J. 26, 523-532 (2012). www.fasebj.org	[Courtial, Nadine; Kuvardina, Olga N.; Lausen, Joern] Inst Biomed Res, D-60596 Frankfurt, Germany; [Smink, Jeske J.; Leutz, Achim] Max Delbruck Ctr Mol Med, Berlin, Germany; [Smink, Jeske J.; Leutz, Achim] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Goethert, Joachim R.] Univ Duisburg Essen, Dept Hematol, Essen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen	Lausen, J (corresponding author), Inst Biomed Res, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	lausen@em.uni-frankfurt.de	Leutz, Achim/K-9643-2013	Leutz, Achim/0000-0001-8259-927X; Gothert, Joachim/0000-0001-8957-6732	LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/55.004, III L 4-518/17004]; Elsbeth-Bonhoff-Stiftung (Berlin)	LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst; Elsbeth-Bonhoff-Stiftung (Berlin)	The authors thank Takeshi Miyamoto (Keio University School of Medicine, Tokyo, Japan), Dr. Nicholas Meadows (University of Queensland, Brisbane, QLD, Australia), and Dr. Manuel Grez (Georg-Speyer-Haus, Frankfurt, Germany) for providing material. J.L. is supported by the LOEWE initiative Onkogene Signaltransduktion Frankfurt and the LOEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst, III L 4-518/55.004 and III L 4-518/17004). This work was supported by a grant to J.L. from the Elsbeth-Bonhoff-Stiftung (Berlin).	Anract P, 1998, INT ORTHOP, V22, P19, DOI 10.1007/s002640050201; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bloor AJC, 2002, J HEMATOTH STEM CELL, V11, P195, DOI 10.1089/152581602753658402; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Gekas C, 2009, BLOOD, V113, P3461, DOI 10.1182/blood-2008-07-167577; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; Ida-Yonemochi H, 2004, EUR J ORAL SCI, V112, P148, DOI 10.1111/j.0909-8836.2004.00109.x; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Mensah K. A., J CELL PHYSL, V223, P76; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Pimanda JE, 2006, MOL CELL BIOL, V26, P2615, DOI 10.1128/MCB.26.7.2615-2625.2006; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Smink JJ, 2003, OSTEOARTHR CARTILAGE, V11, P864, DOI 10.1016/S1063-4584(03)00187-0; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Terme JM, 2009, BLOOD, V113, P6695, DOI 10.1182/blood-2008-07-166835; Tsuneto M, 2005, STEM CELLS, V23, P134, DOI 10.1634/stemcells.2004-0154; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Yamane T, 2000, EXP HEMATOL, V28, P833, DOI 10.1016/S0301-472X(00)00175-2; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	58	32	33	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					523	532		10.1096/fj.11-190850	http://dx.doi.org/10.1096/fj.11-190850			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	21990371				2022-12-25	WOS:000300485700006
J	Zheng, ZX; Li, L; Liu, XY; Wang, DL; Tu, B; Wang, LN; Wang, HY; Zhu, WG				Zheng, Zhixing; Li, Lian; Liu, Xiangyu; Wang, Donglai; Tu, Bo; Wang, Lina; Wang, Haiying; Zhu, Wei-Guo			5-Aza-2 '-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins	FASEB JOURNAL			English	Article						MDM2; histone modification	INHIBIT CELL-PROLIFERATION; TUMOR-SUPPRESSOR GENE; LUNG-CANCER CELLS; RETINOBLASTOMA PROTEIN; DNA-DAMAGE; PHOSPHATASE 2A; HISTONE DEACETYLASE; MDM2; METHYLATION; P53	Not only does 5-aza-2'-deoxycytidine (5-aza-CdR) induce the reexpression of silenced genes through the demethylation of CpG islands, but it increases the expression of unmethylated genes. However, the mechanism by which 5-aza-CdR activates the expression of genes is not completely understood. Here, we report that the pRb pocket proteins pRb, p107, and p130 were degraded in various cancer cell lines in response to 5-aza-CdR treatment, and this effect was dependent on the proteasome pathway. Mouse double minute 2 (MDM2) played a critical role in this 5-aza-CdR-induced degradation of pRb. Furthermore, PP2A phosphatase-induced MDM2 dephosphorylation at S260 was found to be essential for MDM2 binding to pRb in the presence of 5-aza-CdR. pRb degradation resulted in the significant reexpression of several genes, including methylated CDKN2A, RASFF1A, and unmethylated CDKN2D. Finally, knockdown of pRb pocket proteins by either RNAi or 5-aza-CdR treatment induced a significant decrease in the recruitment of SUV39H1 and an increase in the enrichment of KDM3B and KDM4A to histones around the promoter of RASFF1A and thus reduced H3K9 di- and trimethylation, by which RASFF1A expression is activated. Our data reveal a novel mechanism by which 5-aza-CdR induces the expression of both methylated and unmethylated genes by degrading pRb pocket proteins.-Zheng, Z., Li, L., Liu, X., Wang, D., Tu, B., Wang, L., Wang, H., Zhu, W.-G. 5-Aza-2'-deoxycytidine reactivates gene expression via degradation of pRb pocket proteins. FASEB J. 26, 449-459 (2012). www.fasebj.org	[Zhu, Wei-Guo] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; Peking Univ, Peking Univ Tsiinghua Univ Joint Ctr Life Sci, Beijing 100191, Peoples R China	Peking University; Peking University	Zhu, WG (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xuanyuan Rd, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn	zhu, wei-guo/E-1334-2012; liu, xiangyu/D-8213-2014	Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Natural Science Foundation of China [90919030, 31070691, 31071117, 30921062]; Ministry of Education of China; Ministry of Science and Technology of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study is supported by National Natural Science Foundation of China grants 90919030, 31070691, 31071117, 30921062; 111 Project from the Ministry of Education of China; and grants from the Ministry of Science and Technology of China.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chai GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002445; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; GLAZER RI, 1984, MOL PHARMACOL, V26, P381; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; JUVEN T, 1993, ONCOGENE, V8, P3411; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Link PA, 2008, CANCER RES, V68, P9358, DOI 10.1158/0008-5472.CAN-08-1860; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meek DW, 2003, MOL CANCER RES, V1, P1017; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; VESELY J, 1977, CANCER RES, V37, P3684; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970	48	19	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					449	459		10.1096/fj.11-190025	http://dx.doi.org/10.1096/fj.11-190025			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21990374				2022-12-25	WOS:000299202200044
J	Costa, R; Speretta, E; Crowther, DC; Cardoso, I				Costa, Rita; Speretta, Elena; Crowther, Damian C.; Cardoso, Isabel			Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-PEPTIDE; PARKINSONS-DISEASE; MOUSE MODEL; A-BETA; HUNTINGTONS-DISEASE; LATERAL-SCLEROSIS; RAT MODEL; IN-VITRO; MINOCYCLINE; TETRACYCLINES	Therapies for Alzheimer disease that reduce the production of pathogenic amyloid beta (A beta) peptides have been associated with a range of unwanted effects. For this reason, alternative strategies that promote the clearance of the peptide by preventing its aggregation and deposition in the brain have been favored. In this context we have studied doxycycline, a member of the tetracycline family of antibiotics that has shown neuroprotective effects in a number of models of neurodegenerative disease. We investigated the neuroprotective potential of doxycycline in a Drosophila model of A beta toxicity and sought to correlate any effects with the aggregation state of the peptide. We found that administration of doxycycline to A beta 42-expressing flies did not improve their lifespan but was able to slow the progression of their locomotor deficits. We also measured the rough eye phenotype of transgenic flies expressing the E22G variant of A beta 42 and showed that doxycycline administration partially rescued the toxicity of A beta in the developing eye. We correlated these in vivo effects with in vitro observations using transmission electron microscopy, dynamic light scattering, and thioflavin T binding. We found that doxycycline prevents A beta fibrillization and favors the generation of smaller, non-amyloid structures that were nontoxic as determined by the lack of caspase 3 activation in a neuroblastoma cell line. Our confirmation that doxycycline can prevent amyloid beta toxicity both in vitro and in vivo supports its therapeutic potential in AD.	[Costa, Rita; Cardoso, Isabel] IBMC, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Speretta, Elena; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Speretta, Elena; Crowther, Damian C.] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Cardoso, Isabel] Escola Super Tecnol Saude Porto, Inst Politecn Porto, P-4400330 Vila Nova De Gaia, Portugal	Universidade do Porto; University of Cambridge; University of Cambridge; Polytechnic Institute of Porto	Cardoso, I (corresponding author), IBMC, Mol Neurobiol Unit, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	icardoso@ibmc.up.pt	Costa, Ana Rita AR/G-6341-2016; Cardoso, Isabel/K-3903-2013	Costa, Ana Rita AR/0000-0002-2855-0472; Cardoso, Isabel/0000-0003-2472-7055; Speretta, Elena/0000-0003-1506-7438	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/64593/2006]; FCT [SFRH/BD/41799/2007]; MRC [G0700990]; POCI (Programa Operacional Ciencia e Inovacao); MRC [MC_G1000734] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0700990] Funding Source: researchfish	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); POCI (Programa Operacional Ciencia e Inovacao); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) Grants POCI/SAU-NEU/64593/2006 and POCI 2010 (Programa Operacional Ciencia e Inovacao 2010) and with the participation of the European Communitarian Fund FEDER. This work was also supported by FCT PhD Scholarship SFRH/BD/41799/2007 (to R. C.) and by MRC Grant G0700990 (to D. C. C.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Airoldi C, 2011, ORG BIOMOL CHEM, V9, P463, DOI 10.1039/c0ob00303d; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Corti O, 1999, P NATL ACAD SCI USA, V96, P12120, DOI 10.1073/pnas.96.21.12120; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Epis R, 2008, EUR J PHARMACOL, V597, P51, DOI 10.1016/j.ejphar.2008.09.001; Faust K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-109; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Franco C, 2006, AM J PATHOL, V168, P1697, DOI 10.2353/ajpath.2006.050613; Freeman M, 1997, DEVELOPMENT, V124, P261; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Kelly KJ, 2004, AM J PHYSIOL-RENAL, V287, pF760, DOI 10.1152/ajprenal.00050.2004; KLEIN NC, 1995, MED CLIN N AM, V79, P789, DOI 10.1016/S0025-7125(16)30039-6; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Thomas M, 2003, CLIN NEUROPHARMACOL, V26, P18, DOI 10.1097/00002826-200301000-00005; Tickoo S, 2002, CURR OPIN PHARMACOL, V2, P555, DOI 10.1016/S1471-4892(02)00206-0; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	45	58	62	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41647	41655		10.1074/jbc.M111.274548	http://dx.doi.org/10.1074/jbc.M111.274548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21998304	Green Published, hybrid			2022-12-25	WOS:000298057500049
J	Januchowski-Hartley, SR; Pearson, RG; Puschendorf, R; Rayner, T				Januchowski-Hartley, Stephanie R.; Pearson, Richard G.; Puschendorf, Robert; Rayner, Thomas			Fresh Waters and Fish Diversity: Distribution, Protection and Disturbance in Tropical Australia	PLOS ONE			English	Article							ADAPTIVE REGRESSION SPLINES; GREAT-BARRIER-REEF; SPECIES DISTRIBUTIONS; RIVER CONSERVATION; AREAS; MODELS; QUEENSLAND; NETWORKS; BASIN; BIODIVERSITY	Background: Given the globally poor protection of fresh waters for their intrinsic ecological values, assessments are needed to determine how well fresh waters and supported fish species are incidentally protected within existing terrestrial protected-area networks, and to identify their vulnerability to human-induced disturbances. To date, gaps in data have severely constrained any attempt to explore the representation of fresh waters in tropical regions. Methodology and Results: We determined the distribution of fresh waters and fish diversity in the Wet Tropics of Queensland, Australia. We then used distribution data of fresh waters, fish species, human-induced disturbances, and the terrestrial protected-area network to assess the effectiveness of terrestrial protected areas for fresh waters and fish species. We also identified human-induced disturbances likely to influence the effectiveness of freshwater protection and evaluated the vulnerability of fresh waters to these disturbances within and outside protected areas. The representation of fresh waters and fish species in the protected areas of the Wet Tropics is poor: 83% of stream types defined by order, 75% of wetland types, and 89% of fish species have less than 20% of their total Wet Tropics length, area or distribution completely within IUCN category II protected areas. Numerous disturbances affect fresh waters both within and outside of protected areas despite the high level of protection afforded to terrestrial areas in the Wet Tropics (>60% of the region). High-order streams and associated wetlands are influenced by the greatest number of human-induced disturbances and are also the least protected. Thirty-two percent of stream length upstream of protected areas has at least one human-induced disturbance present. Conclusions/Significance: We demonstrate the need for greater consideration of explicit protection and off-reserve management for fresh waters and supported biodiversity by showing that, even in a region where terrestrial protection is high, it does not adequately capture fresh waters.	[Januchowski-Hartley, Stephanie R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Pearson, Richard G.; Puschendorf, Robert] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Rayner, Thomas] Univ New S Wales, Australian Wetlands & Rivers Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	James Cook University; James Cook University; University of New South Wales Sydney	Januchowski-Hartley, SR (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	stephierenee@gmail.com	Januchowski, Stephanie/F-1636-2011; Pearson, Richard/GQH-2760-2022; Puschendorf, Robert/B-6280-2011	Puschendorf, Robert/0000-0002-8105-171X; Januchowski-Hartley, Stephanie/0000-0002-1661-917X; Pearson, Richard/0000-0001-6047-031X	Atherton Tablelands Environmental Trust, James Cook University	Atherton Tablelands Environmental Trust, James Cook University	This work was funded by Atherton Tablelands Environmental Trust Fund, James Cook University (http://www.jcu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Abellan P, 2007, AQUAT CONSERV, V17, P361, DOI 10.1002/aqc.778; [Anonymous], C PART CONV BIOL DIV; Bainbridge ZT, 2009, MAR FRESHWATER RES, V60, P1081, DOI 10.1071/MF08333; Boyero L, 2009, J N AM BENTHOL SOC, V28, P397, DOI 10.1899/08-146.1; Daam MA, 2010, ECOTOXICOLOGY, V19, P24, DOI 10.1007/s10646-009-0402-6; *DERM, 2009, QUEENSL WETL MAPP CL; *DERM, 2008, PROT AR QUEENSL EST; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; Hughes RM, 2011, J N AM BENTHOL SOC, V30, P103, DOI 10.1899/09-174.1; Januchowski SR, 2010, INT J GEOGR INF SCI, V24, P1327, DOI 10.1080/13658811003591680; Januchowski-Hartley SR, 2011, BIOL INVASIONS, V13, P1241, DOI 10.1007/s10530-011-9960-7; Keith P, 2000, BIOL CONSERV, V92, P265, DOI 10.1016/S0006-3207(99)00041-5; LAWRENCE DJ, 2011, CONSERVAITO IN PRESS, DOI DOI 10.1111/J.1755-263X.2011.00185.X; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Linke S, 2008, J APPL ECOL, V45, P1486, DOI 10.1111/j.1365-2664.2008.01520.x; Linke S, 2007, FRESHWATER BIOL, V52, P918, DOI 10.1111/j.1365-2427.2006.01690.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Maidment D.R., 2002, ARC HYDRO GIS WATER; Mancini L, 2005, BIODIVERS CONSERV, V14, P351, DOI 10.1007/s10531-004-5355-8; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McJannet D, 2007, HYDROL PROCESS, V21, P3549, DOI 10.1002/hyp.6576; Nel JL, 2007, DIVERS DISTRIB, V13, P341, DOI 10.1111/j.1472-4642.2007.00308.x; Nel JL, 2009, BIOL CONSERV, V142, P1605, DOI 10.1016/j.biocon.2009.02.031; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Pearson Richard G., 2005, P470; Pusey B.J., 2008, LIVING DYNAMIC TROPI, P150; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Sanchez-Arguello R, 2010, ANN LIMNOL-INT J LIM, V46, P149, DOI 10.1051/limn/2010019; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Stork NE, 2008, LIVING DYNAMIC TROPI, P4, DOI DOI 10.1002/9781444300321; SYDES T, 2009, CROSS REGIONAL HYMEN; Thieme M, 2007, BIOL CONSERV, V135, P484, DOI 10.1016/j.biocon.2006.10.054; Turak E, 2011, MAR FRESHWATER RES, V62, P300, DOI 10.1071/MF09297; Turak E, 2011, FRESHWATER BIOL, V56, P39, DOI 10.1111/j.1365-2427.2009.02394.x; Vorosmarty CJ, 2010, NATURE, V468, P334, DOI 10.1038/nature09549; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P61, DOI 10.1899/0887-3593(2006)25[61:NVINSE]2.0.CO;2; Witte C., 2006, MAPPING LAND USE QUE	48	22	23	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25846	10.1371/journal.pone.0025846	http://dx.doi.org/10.1371/journal.pone.0025846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998708	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000295968700022
J	Liu, Y; Xue, JY; Wang, B; Li, LB; Qiu, YL				Liu, Yang; Xue, Jia-Yu; Wang, Bin; Li, Libo; Qiu, Yin-Long			The Mitochondrial Genomes of the Early Land Plants Treubia lacunosa and Anomodon rugelii: Dynamic and Conservative Evolution	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE-CLUSTER; DNA-SEQUENCE; GREEN-ALGA; NAD7 GENE; RECOMBINATION; ORGANIZATION; CHLOROPLAST; LIVERWORTS; INTRONS	Early land plant mitochondrial genomes captured important changes of mitochondrial genome evolution when plants colonized land. The chondromes of seed plants show several derived characteristics, e. g., large genome size variation, rapid intra-genomic rearrangement, abundant introns, and highly variable levels of RNA editing. On the other hand, the chondromes of charophytic algae are still largely ancestral in these aspects, resembling those of early eukaryotes. When the transition happened has been a long-standing question in studies of mitochondrial genome evolution. Here we report complete mitochondrial genome sequences from an early-diverging liverwort, Treubia lacunosa, and a late-evolving moss, Anomodon rugelii. The two genomes, 151,983 and 104,239 base pairs in size respectively, contain standard sets of protein coding genes for respiration and protein synthesis, as well as nearly full sets of rRNA and tRNA genes found in the chondromes of the liverworts Marchantia polymorpha and Pleurozia purpurea and the moss Physcomitrella patens. The gene orders of these two chondromes are identical to those of the other liverworts and moss. Their intron contents, with all cis-spliced group I or group II introns, are also similar to those in the previously sequenced liverwort and moss chondromes. These five chondromes plus the two from the hornworts Phaeoceros laevis and Megaceros aenigmaticus for the first time allowed comprehensive comparative analyses of structure and organization of mitochondrial genomes both within and across the three major lineages of bryophytes. These analyses led to the conclusion that the mitochondrial genome experienced dynamic evolution in genome size, gene content, intron acquisition, gene order, and RNA editing during the origins of land plants and their major clades. However, evolution of this organellar genome has remained rather conservative since the origin and initial radiation of early land plants, except within vascular plants.	[Liu, Yang; Xue, Jia-Yu; Wang, Bin; Li, Libo; Qiu, Yin-Long] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Xue, Jia-Yu] Nanjing Univ, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; Nanjing University	Liu, Y (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	ylqiu@umich.edu	liu, yang/H-6324-2011; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Wang, Bin/A-8639-2013	Wang, Bin/0000-0003-2481-735X; Xue, Jia-Yu/0000-0002-7128-9935; Liu, Yang/0000-0002-5942-839X	NSF [DEB 0531689, 0332298]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants DEB 0531689 and 0332298 to YLQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Berner R. A., 2001, PLANTS INVADE LAND E, P173; BLAND MM, 1986, MOL GEN GENET, V204, P8, DOI 10.1007/BF00330180; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Crosby MR, 1999, CHECKLIST MOSSES TRO; Dombrovska O, 2004, MOL PHYLOGENET EVOL, V32, P246, DOI 10.1016/j.ympev.2003.12.013; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duff RJ, 2004, MONOG SYST BOTAN, V98, P41; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Forrest LL, 2006, BRYOLOGIST, V109, P303, DOI 10.1639/0007-2745(2006)109[303:UTEHOT]2.0.CO;2; Gagliardi D, 2004, ADV PHOTO RESPIRAT, V17, P55; Goffinet B, 2001, ANN BOT-LONDON, V87, P191, DOI 10.1006/anbo.2000.1318; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grewe F, 2010, NUCL ACIDS IN PRESS; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Groth-Malonek M, 2007, INT J PLANT SCI, V168, P709, DOI 10.1086/513472; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Hernick LV, 2008, REV PALAEOBOT PALYNO, V148, P154, DOI 10.1016/j.revpalbo.2007.09.002; Hoffmann M, 1999, MOL GEN GENET, V261, P537, DOI 10.1007/s004380050998; Jobson RW, 2011, J MOL EVOL, V72, P204, DOI 10.1007/s00239-010-9416-1; Jobson RW, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-43; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Knoop V, 2010, PLANT MITOCHONDRIA, P3; Kobayashi Y, 1997, MOL GEN GENET, V256, P589, DOI 10.1007/PL00008616; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, GENOMICS CH IN PRESS; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1988, PHILOS T ROY SOC B, V319, P149, DOI 10.1098/rstb.1988.0039; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; MISHLER BD, 1984, BRITTONIA, V36, P406, DOI 10.2307/2806602; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Odahara M, 2009, PLANT CELL, V21, P1182, DOI 10.1105/tpc.108.064709; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; PALMER JD, 1992, CURR GENET, V21, P125, DOI 10.1007/BF00318471; Qiu Y-L, 2011, J SYST EVOL IN PRESS; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; SCHUSTER W, 1994, ANNU REV PLANT PHYS, V45, P61, DOI 10.1146/annurev.pp.45.060194.000425; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Turmel M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-137; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Villarreal JC, 2010, BRYOLOGIST, V113, P106, DOI 10.1639/0007-2745-113.1.106; Wahrmund U, 2008, J MOL EVOL, V66, P621, DOI 10.1007/s00239-008-9114-4; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Qiu YL, 2008, J SYST EVOL, V46, P287, DOI [10.3724/SP.J.1002.2008.08035, 10.1111/j.1439-0469.2008.00465.x]	81	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25836	10.1371/journal.pone.0025836	http://dx.doi.org/10.1371/journal.pone.0025836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998706	gold, Green Published, Green Submitted			2022-12-25	WOS:000295966900062
J	Settles, M; Etzrodt, M; Kosanke, K; Schiemann, M; Zimmermann, A; Meier, R; Braren, R; Huber, A; Rummeny, EJ; Weissleder, R; Swirski, FK; Wildgruber, M				Settles, Marcus; Etzrodt, Martin; Kosanke, Katja; Schiemann, Matthias; Zimmermann, Alexander; Meier, Reinhard; Braren, Rickmer; Huber, Armin; Rummeny, Ernst J.; Weissleder, Ralph; Swirski, Filip K.; Wildgruber, Moritz			Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles	PLOS ONE			English	Article							MR CONTRAST AGENTS; BLOOD MONOCYTES; DENDRITIC CELLS; IN-VITRO; DISEASE; USPIO; INFLAMMATION; ENDOTHELIUM; EXPRESSION; METASTASES	Objective: To explore the capacity of human CD14(+)CD16(++) and CD14(++)CD16(-) monocytes to phagocyte iron-oxide nanoparticles in vitro. Methods: Human monocytes were labeled with four different magnetic nanoparticle preparations (Ferumoxides, SHU 555C, CLIO-680, MION-48) exhibiting distinct properties and cellular uptake was quantitatively assessed by flow cytometry, fluorescence microscopy, atomic absorption spectrometry and Magnetic Resonance Imaging (MRI). Additionally we determined whether cellular uptake of the nanoparticles resulted in phenotypic changes of cell surface markers. Results: Cellular uptake differed between the four nanoparticle preparations. However for each nanoparticle tested, CD14(++)CD16(-) monocytes displayed a significantly higher uptake compared to CD14(+)CD16(++) monocytes, this resulted in significantly lower T1 and T2 relaxation times of these cells. The uptake of iron-oxide nanoparticles further resulted in a remarkable shift of expression of cell surface proteins indicating that the labeling procedure affects the phenotype of CD14(+)CD16(++) and CD14(++)CD16(-) monocytes differently. Conclusion: Human monocyte subsets internalize different magnetic nanoparticle preparations differently, resulting in variable loading capacities, imaging phenotypes and likely biological properties.	[Settles, Marcus; Kosanke, Katja; Meier, Reinhard; Braren, Rickmer; Huber, Armin; Rummeny, Ernst J.; Wildgruber, Moritz] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany; [Etzrodt, Martin; Weissleder, Ralph; Swirski, Filip K.; Wildgruber, Moritz] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Schiemann, Matthias] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Mikrobiol Immunol & Hyg, D-8000 Munich, Germany; [Schiemann, Matthias] Helmholtzzentrum Munchen, Clin Cooperat Grp Antigen Specif Immunotherapy, Munich, Germany; [Zimmermann, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Gefasschirurg, D-8000 Munich, Germany	Technical University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Settles, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany.	moritz.wildgruber@tum.de	Swirski, Filip/AAF-1340-2019; Etzrodt, Martin/P-3325-2015; Braren, Rickmer/U-3254-2018; Meier, Reinhard/B-2882-2014	Etzrodt, Martin/0000-0003-1928-3904; Braren, Rickmer/0000-0001-6039-6957; Meier, Reinhard/0000-0002-2169-4780; /0000-0003-0828-4143; Swirski, Filip/0000-0002-3163-9152; Zimmermann, Alexander/0000-0003-0635-8591	NHLBI NIH HHS [R01 HL095612] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Brochet B, 2006, NEUROIMAGE, V32, P266, DOI 10.1016/j.neuroimage.2006.03.028; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; DENKLEEF JJEI, 1987, MAGN RESON MED, V5, P513, DOI 10.1002/mrm.1910050602; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; FINGERLE G, 1993, BLOOD, V82, P3170; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guimaraes AR, 2011, MOL IMAGING BIOL, V13, P314, DOI 10.1007/s11307-010-0357-2; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Henning TD, 2007, EUR RADIOL, V17, P1226, DOI 10.1007/s00330-006-0522-9; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Metz S, 2004, EUR RADIOL, V14, P1851, DOI 10.1007/s00330-004-2405-2; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Persigehl T, 2007, RADIOLOGY, V244, P449, DOI 10.1148/radiol.2442060371; Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Seneterre E, 1996, RADIOLOGY, V200, P785, DOI 10.1148/radiology.200.3.8756932; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wildgruber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005663; Wunderbaldinger P, 2002, ACAD RADIOL, V9, pS304, DOI 10.1016/S1076-6332(03)80210-6; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	42	28	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25197	10.1371/journal.pone.0025197	http://dx.doi.org/10.1371/journal.pone.0025197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984904	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000015
J	Gabbe, BJ; Harrison, JE; Lyons, RA; Jolley, D				Gabbe, Belinda J.; Harrison, James E.; Lyons, Ronan A.; Jolley, Damien			Modelling Long Term Disability following Injury: Comparison of Three Approaches for Handling Multiple Injuries	PLOS ONE			English	Article							MAJOR TRAUMA; HEALTH STATES; REGISTRY; MORTALITY; OUTCOMES; WORK; COMORBIDITY; PREDICTORS; RETURN; ICD	Background: Injury is a leading cause of the global burden of disease (GBD). Estimates of non-fatal injury burden have been limited by a paucity of empirical outcomes data. This study aimed to (i) establish the 12-month disability associated with each GBD 2010 injury health state, and (ii) compare approaches to modelling the impact of multiple injury health states on disability as measured by the Glasgow Outcome Scale - Extended (GOS-E). Methods: 12-month functional outcomes for 11,337 survivors to hospital discharge were drawn from the Victorian State Trauma Registry and the Victorian Orthopaedic Trauma Outcomes Registry. ICD-10 diagnosis codes were mapped to the GBD 2010 injury health states. Cases with a GOS-E score >6 were defined as "recovered.'' A split dataset approach was used. Cases were randomly assigned to development or test datasets. Probability of recovery for each health state was calculated using the development dataset. Three logistic regression models were evaluated: a) additive, multivariable; b) "worst injury;'' and c) multiplicative. Models were adjusted for age and comorbidity and investigated for discrimination and calibration. Findings: A single injury health state was recorded for 46% of cases (1-16 health states per case). The additive (C-statistic 0.70, 95% CI: 0.69, 0.71) and "worst injury" (C-statistic 0.70; 95% CI: 0.68, 0.71) models demonstrated higher discrimination than the multiplicative (C-statistic 0.68; 95% CI: 0.67, 0.70) model. The additive and "worst injury" models demonstrated acceptable calibration. Conclusions: The majority of patients survived with persisting disability at 12-months, highlighting the importance of improving estimates of non-fatal injury burden. Additive and "worst" injury models performed similarly. GBD 2010 injury states were moderately predictive of recovery 1-year post-injury. Further evaluation using additional measures of health status and functioning and comparison with the GBD 2010 disability weights will be needed to optimise injury states for future GBD studies.	[Gabbe, Belinda J.; Jolley, Damien] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA 5001, Australia; [Lyons, Ronan A.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Monash University; Flinders University South Australia; Swansea University	Gabbe, BJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu	Lyons, Ronan/G-7741-2012; Harrison, James/B-8958-2009	Lyons, Ronan/0000-0001-5225-000X; Harrison, James/0000-0001-9893-8491; Gabbe, Belinda/0000-0001-7096-7688	Victorian State Trauma Registry is a Department of Health (Victoria); Transport Accident Commission; Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission; National Health and Medical Research Council of Australia [465103]	Victorian State Trauma Registry is a Department of Health (Victoria); Transport Accident Commission; Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Victorian State Trauma Registry is a Department of Health (Victoria) and Transport Accident Commission funded initiative. The Victorian Orthopaedic Trauma Outcomes Registry is funded by the Institute for Safety, Compensation and Recovery Research and the Transport Accident Commission. Prof. Belinda Gabbe was supported by a Career Development Award (465103) from the National Health and Medical Research Council of Australia during the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Currens JAB, 2000, INJURY, V31, P93, DOI 10.1016/S0020-1383(99)00244-2; Dale W, 2008, MED DECIS MAKING, V28, P102, DOI 10.1177/0272989X07309639; Davie G, 2008, INJURY PREV, V14, P250, DOI 10.1136/ip.2007.017640; Edwards ER, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2005.02.027; FLANAGAN W, 2006, POPUL HLTH METR, V4; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Hanmer J, 2010, J CLIN EPIDEMIOL, V63, P331, DOI 10.1016/j.jclinepi.2009.06.013; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; LOPEZ A, 2005, GLOBAL HLTH, V1, DOI DOI 10.1186/1744-8603-1181-1185; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Mathers C., 1999, BURDEN DIS INJURY AU; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Willis CD, 2010, ANZ J SURG, V80, P802, DOI 10.1111/j.1445-2197.2010.05432.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25862	10.1371/journal.pone.0025862	http://dx.doi.org/10.1371/journal.pone.0025862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984951	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300062
J	Hollander, FA; Van Dyck, H; Martin, GS; Titeux, N				Hollander, Franck A.; Van Dyck, Hans; Martin, Gilles San; Titeux, Nicolas			Maladaptive Habitat Selection of a Migratory Passerine Bird in a Human-Modified Landscape	PLOS ONE			English	Article							ECOLOGICAL TRAPS; POPULATION-DYNAMICS; REPRODUCTIVE-PERFORMANCE; SOCIAL INFORMATION; LANIUS-COLLURIO; CONSERVATION; QUALITY; FITNESS; ARRIVAL; GREAT	In human-altered environments, organisms may preferentially settle in poor-quality habitats where fitness returns are lower relative to available higher-quality habitats. Such ecological trapping is due to a mismatch between the cues used during habitat selection and the habitat quality. Maladaptive settlement decisions may occur when organisms are time-constrained and have to rapidly evaluate habitat quality based on incomplete knowledge of the resources and conditions that will be available later in the season. During a three-year study, we examined settlement decision-making in the long-distance migratory, open-habitat bird, the Red-backed shrike (Lanius collurio), as a response to recent land-use changes. In Northwest Europe, the shrikes typically breed in open areas under a management regime of extensive farming. In recent decades, Spruce forests have been increasingly managed with large-size cutblocks in even-aged plantations, thereby producing early-successional vegetation areas that are also colonised by the species. Farmland and open areas in forests create mosaics of two different types of habitats that are now occupied by the shrikes. We examined redundant measures of habitat preference (order of settlement after migration and distribution of dominant individuals) and several reproductive performance parameters in both habitat types to investigate whether habitat preference is in line with habitat quality. Territorial males exhibited a clear preference for the recently created open areas in forests with higher-quality males settling in this habitat type earlier. Reproductive performance was, however, higher in farmland, with higher nest success, offspring quantity, and quality compared to open areas in forests. The results showed strong among-year consistency and we can therefore exclude a transient situation. This study demonstrates a case of maladaptive habitat selection in a farmland bird expanding its breeding range to human-created open habitats in plantations. We discuss the reasons that could explain this decision-making and the possible consequences for the population dynamics and persistence.	[Hollander, Franck A.; Van Dyck, Hans; Martin, Gilles San] Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium; [Titeux, Nicolas] Gabriel Lippmann Publ Res Ctr, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg	Universite Catholique Louvain	Hollander, FA (corresponding author), Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	titeux@lippmann.lu	San Martin, Gilles/B-7827-2015; Titeux, Nicolas/G-4723-2016; Titeux, Nicolas/AAD-4439-2019	San Martin, Gilles/0000-0002-0434-9416; Titeux, Nicolas/0000-0002-7719-7417; Titeux, Nicolas/0000-0002-7719-7417	Belgian National Fund of Scientific Research	Belgian National Fund of Scientific Research(Fonds de la Recherche Scientifique - FNRS)	The study was funded by the Belgian National Fund of Scientific Research (FRIA PhD-grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Antczak M, 2009, ETHOL ECOL EVOL, V21, P127, DOI 10.1080/08927014.2009.9522501; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Becker PH, 2008, P NATL ACAD SCI USA, V105, P12349, DOI 10.1073/pnas.0804179105; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Choi YS, 2010, ZOOL STUD, V49, P398; de Warnaffe GD, 2008, BIODIVERS CONSERV, V17, P1041, DOI 10.1007/s10531-008-9364-x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GEBHARDTHENRICH S, 1998, CAUSES GROWTH VARIAT; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; HANSSON L, 1994, LANDSCAPE ECOL, V9, P105; Hels T, 2002, ECOGRAPHY, V25, P303, DOI 10.1034/j.1600-0587.2002.250307.x; Hromada M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003930; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; JAKOBER H, 1989, J ORNITHOL, V130, P247, DOI 10.1007/BF01649759; Jakober H, 2000, J ORNITHOL, V141, P408, DOI 10.1007/BF01651570; JAKOBER H, 1983, J ORNITHOL, V124, P29, DOI 10.1007/BF01650659; Jose S, 2008, AGROFORESTRY DESIGN, DOI 10.1007/978-1-4020-6572-9; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kristan WB, 2003, OIKOS, V103, P457; Lefranc N., 1997, SHRIKES GUIDE SHRIKE; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Marshall MR, 2004, ECOLOGY, V85, P432, DOI 10.1890/02-0548; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nocera JJ, 2009, ECOGRAPHY, V32, P143, DOI 10.1111/j.1600-0587.2008.05614.x; Olsson Viking, 1995, Ornis Svecica, V5, P101; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; Acuna MP, 2011, BIOL CONSERV, V144, P1577, DOI 10.1016/j.biocon.2011.02.003; Pfister L., 2005, ATLAS CLIMATIQUE GRA; Pidgeon AM, 2006, BIOL CONSERV, V132, P199, DOI 10.1016/j.biocon.2006.03.024; Pulliam H. R., 1996, POPULATION DYNAMICS; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Schaub M., 2011, OECOLOGIA IN PRESS; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schmidt KA, 2010, OIKOS, V119, P245, DOI 10.1111/j.1600-0706.2009.17824.x; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 2011, CONSERV BIOL, V25, P48, DOI 10.1111/j.1523-1739.2010.01571.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Soderstrom B, 2001, IBIS, V143, P561, DOI 10.1111/j.1474-919X.2001.tb04883.x; Soderstrom B, 2011, J ORNITHOL, V152, P313, DOI 10.1007/s10336-010-0587-8; STAMPS JA, 2001, HABITAT SELECTION DI; Storch D, 1999, EVOL ECOL, V13, P591, DOI 10.1023/A:1006765422475; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tarof SA, 2005, P ROY SOC B-BIOL SCI, V272, P1121, DOI 10.1098/rspb.2005.3053; Thomson RL, 2006, ECOGRAPHY, V29, P507; TITEUX N, 2010, SERIE FAUNE FLORE HA, V5; Titeux N, 2007, BIOL CONSERV, V138, P207, DOI 10.1016/j.biocon.2007.04.019; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; Wilson JD, 2009, ECOL BIODIVERS CONS, P1; [No title captured]	71	57	62	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25703	10.1371/journal.pone.0025703	http://dx.doi.org/10.1371/journal.pone.0025703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984940	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300050
J	Wang, L; Wu, ZQ; Bystriakova, N; Ansell, SW; Xiang, QP; Heinrichs, J; Schneider, H; Zhang, XC				Wang, Li; Wu, Zhi-Qiang; Bystriakova, Nadia; Ansell, Stephen W.; Xiang, Qiao-Ping; Heinrichs, Jochen; Schneider, Harald; Zhang, Xian-Chun			Phylogeography of the Sino-Himalayan Fern Lepisorus clathratus on "The Roof of the World"	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; TAXONOMIC REVISION; DNA HAPLOTYPES; CHLOROPLAST; QUATERNARY; MITOCHONDRIAL; HISTORY; POLYPODIACEAE; COLONIZATION; GLACIATION	Background: The Qinghai-Tibetan Plateau (QTP) and its southern and southeastern mountain ranges, Himalaya-Hengduan Mountains (HHM), are one of the most extensive habitats for alpine plants in the world. How ferns occurring in QTP and HHM changed their distribution ranges in response to Quaternary climatic oscillations remains almost unknown. Methodology and Results: We employed sequences of two chloroplast DNA regions, rps4-trnS and trnL-trnF, to reconstruct phylogeography of the Sino-Himalayan fern Lepisorus clathratus, occurring mainly in the QTP and HHM. Individuals of this species have either dehiscent or indehiscent sporangia with the latter evolved from the plesiomorphic dehiscent forms. Based on a range-wide sampling, we detected 27 cpDNA haplotypes that were divided into five groups by network analyses. Populations in the Hengduan Mountains possess the highest genetic diversity, while a single haplogroup is detected across the north-central region. A distinct phylogeographical subdivision was detected between the Hengduan Mountains and north-central region by AMOVA analysis. The haplogroup distribution pattern, coalescence and AMOVA analysis suggest that a long term survival area (refugia) of the species was located in the Hengduan Mountains during glaciations, with probable range expansions into north-central regions during interglacial periods. Populations with indehiscent sporangium can carry private haplotypes and are inclined to maintain genetic homogeneity. One group with indehiscent sporangia most likely survived in situ on the QTP during glaciations. Conclusions/Significance: This study for the first time sheds light on the response of alpine ferns in the QTP and HHM to the Quaternary climatic oscillations.	[Wang, Li; Wu, Zhi-Qiang; Xiang, Qiao-Ping; Zhang, Xian-Chun] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China; [Wang, Li; Heinrichs, Jochen; Schneider, Harald] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Wang, Li; Bystriakova, Nadia; Ansell, Stephen W.; Schneider, Harald] Nat Hist Museum, Dept Bot, London SW7 5BD, England; [Wang, Li; Wu, Zhi-Qiang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; University of Gottingen; Natural History Museum London; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	h.schneider@nhm.ac.uk; zhangxc@ibcas.ac.cn	Wu, Zhiqiang/CAG-6688-2022; , wuzhiqiang/C-7843-2017; Schneider, Harald/B-6681-2008	Wu, Zhiqiang/0000-0002-4238-7317; , wuzhiqiang/0000-0002-4238-7317; Schneider, Harald/0000-0002-4548-7268	National Natural Science Foundation of China [31070196, 30770166, 13183A1001]; Chinese Academy of Sciences Foundation [91136G1001]; Deutsche Forschungsgemeinschaft (DFG) [SCHN 785/2-2]; DAAD-CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DAAD-CAS	This project is financially supported by the National Natural Science Foundation of China Grant (NSFC No. 31070196, No. 30770166 and No. 13183A1001), Chinese Academy of Sciences Foundation 91136G1001, the Deutsche Forschungsgemeinschaft (DFG Grant SCHN 785/2-2), and a scholarship granted to L. Wang by the DAAD-CAS Joint Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise J.C., 2004, MOL MARKERS NATURAL; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; BROWNSEY PJ, 1977, EVOLUTION, V31, P294, DOI 10.1111/j.1558-5646.1977.tb01010.x; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; CHING R-C, 1980, Acta Botanica Yunnanica, V2, P67; CHING RC, 1983, ACTA BOT YUNNAN, V2, P382; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehlers J, 2004, QUATERNARY GLACIAT 3; *ESRI, 1999, ARCMAP VERS 9 3; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fraser- Jenkins C. R., 2008, TAXONOMIC REVISION 3; Fraser-Jenkins C.R., 1992, PAKISTAN SYST, V5, P85; Fraser-Jenkins CR., 1997, NEW SPECIES SYNDROME; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall T.A., 1999, BIOEDIT USER FRIENDL; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HIJMANS RJ, 2005, DIVA GIS VSN 7 1 7 2; HUSON DH, 2008, ESTIMATING PHYLOGENE; Ingold C. T., 1939, SPORE DISCHARGE LAND; KRAMER K U, 1977, Gardens' Bulletin (Singapore), V30, P79; Kuhle M., 1988, GeoJournal, V17, P457; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Lin YX, 1996, BULL BOT RES, V16, P3; LIN YX, 2000, FLORA CHINA, P32; Liu QR, 2008, J SYST EVOL, V46, P906, DOI 10.3724/SP.J.1002.2008.08036; MADDISON DR, 2002, MACCLADE 4 ANAL PHYL; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; NADOT S, 1995, MOL PHYLOGENET EVOL, V4, P257, DOI 10.1006/mpev.1995.1024; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Owen LA, 2005, QUATERNARY SCI REV, V24, P1391, DOI 10.1016/j.quascirev.2004.10.014; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qi XP, 2009, J SYST EVOL, V47, P581, DOI 10.1111/j.1759-6831.2009.00056.x; Schafer JM, 2002, EARTH PLANET SC LETT, V194, P287, DOI 10.1016/S0012-821X(01)00573-8; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Smith AR, 2002, AM FERN J, V92, P131, DOI 10.1640/0002-8444(2002)092[0131:IROTTF]2.0.CO;2; SOLTIS DE, 1992, AM J BOT, V79, P97, DOI 10.2307/2445202; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1995, GENETICS, V140, P767; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang W. T., 1993, VASCULAR PLANTS HENG, V1; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu, 1988, J JPN BOT, V63, P297; Wu C.-Y., 1980, VEGETATION CHINA; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XC, 2002, ACTA PHYTOTAXON SIN, V41, P401; Zwickl D., 2006, GARLI GENETIC ALGORI	68	59	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25896	10.1371/journal.pone.0025896	http://dx.doi.org/10.1371/journal.pone.0025896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984953	Green Published, gold, Green Submitted			2022-12-25	WOS:000295941300064
J	Wong, KKL; Abbott, D				Wong, Kelvin Kian Loong; Abbott, Derek			Automatic Target Recognition Based on Cross-Plot	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; IMAGE RETRIEVAL; OBJECT RECOGNITION; SHAPE; SEGMENTATION; DESCRIPTORS; ALGORITHM; PLANE	Automatic target recognition that relies on rapid feature extraction of real-time target from photo-realistic imaging will enable efficient identification of target patterns. To achieve this objective, Cross-plots of binary patterns are explored as potential signatures for the observed target by high-speed capture of the crucial spatial features using minimal computational resources. Target recognition was implemented based on the proposed pattern recognition concept and tested rigorously for its precision and recall performance. We conclude that Cross-plotting is able to produce a digital fingerprint of a target that correlates efficiently and effectively to signatures of patterns having its identity in a target repository.	[Wong, Kelvin Kian Loong] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia; [Wong, Kelvin Kian Loong; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Royal Melbourne Institute of Technology (RMIT); University of Adelaide	Wong, KKL (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Bundoora, Vic, Australia.	k.wong@rmit.edu.au	Abbott, Derek/E-8352-2011; Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105				Arya S, 1998, J ACM, V45, P891, DOI 10.1145/293347.293348; BARUCH O, 1988, PATTERN RECOGN, V21, P581, DOI 10.1016/0031-3203(88)90031-3; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Bieniek A, 1998, CONNECTED COMPONENT; BKP Horn, 1988, ROBOT VISION; BRIGO D, 1998, IEEE T AUTOMATIC CON, V68, P181; Burroughs C, 2001, SANDIA LAB NEWS SAND, V53, P6; DUDANI SA, 1977, IEEE T COMPUT, V26, P39, DOI 10.1109/TC.1977.5009272; ElBadawy O., 2002, INT J IMAGE GRAPHICS, V2, P375; Falconer K., 2014, FRACTAL GEOMETRY MAT; Fukunaga K, 1990, INTRO STAT PATTERN R; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Greenacre M, 2003, J APPL STAT, V30, P1101, DOI 10.1080/0266476032000107132; KERVRANN C, 1995, IEEE T IMAGE PROCESS, V4, P856, DOI 10.1109/83.388090; Khan JF, 2009, APPL OPTICS, V48, P464, DOI 10.1364/AO.48.000464; Kliot M, 1998, COMPUT VIS IMAGE UND, V71, P182, DOI 10.1006/cviu.1998.0709; Lam CP, 1996, World Patent Information, V18, P249, Patent No. 18249249; Landry JW, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031303; Lee L, 1999, MEASURES DISTRIBUTIO, P25; LEONARD J, 1990, COMPUT CHEM ENG, V14, P337, DOI 10.1016/0098-1354(90)87070-6; Li S, 2009, IEEE T SYST MAN CY A, V39, P227, DOI 10.1109/TSMCA.2008.2007988; Ling HB, 2007, IEEE T PATTERN ANAL, V29, P286, DOI 10.1109/TPAMI.2007.41; Ling HB, 2005, PROC CVPR IEEE, P719; Lu GJ, 1997, J INFORM SCI, V23, P119, DOI 10.1177/016555159702300203; Mehtre BM, 1997, INFORM PROCESS MANAG, V33, P319, DOI 10.1016/S0306-4573(96)00069-6; Messer K., 1999, BMVC99. Proceedings of the 10th British Machine Vision Conference, P443; Mori G, 2005, IEEE T PATTERN ANAL, V27, P1832, DOI 10.1109/TPAMI.2005.220; NIBLACK W, 1993, P SOC PHOTO-OPT INS, V1908, P173; Oakley JP, 1996, P SOC PHOTO-OPT INS, V2666, P266, DOI 10.1117/12.234751; Oncel AO, 2002, B SEISMOL SOC AM, V92, P339, DOI 10.1785/0120000844; Pan J.-Y., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P405, DOI 10.1145/584792.584859; Park JA, 2003, IEICE T COMMUN, VE86B, P3662; Persoon E, 1997, IEEE T SYST MAN CYB, V7, P170; Petrakis EGM, 2002, IMAGE VISION COMPUT, V20, P59, DOI 10.1016/S0262-8856(01)00077-4; Safar M, 2002, SHAPE ANAL RETRIEVAL; Sajjanhar A, 1997, AUST COMPUT J, V29, P131; SAMET H, 1981, J ACM, V28, P487, DOI 10.1145/322261.322267; Sang N, 1996, P SOC PHOTO-OPT INS, V2666, P259, DOI 10.1117/12.234750; SCHETTINI R, 1994, PATTERN RECOGN LETT, V15, P1089, DOI 10.1016/0167-8655(94)90124-4; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; Shen DG, 1999, PATTERN RECOGN, V32, P151, DOI 10.1016/S0031-3203(98)00137-X; Silbert LE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051302; Stimets RW, 1996, SPIE IMAGE VIDEO PRO, P2; Tao Y., 1999, 7 SPIE S STOR RETR I, P631; Tepper M, 2009, LECT NOTES COMPUT SC, V5856, P129, DOI 10.1007/978-3-642-10268-4_15; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; TRAHANIAS PE, 1992, PATTERN RECOGN, V25, P1277, DOI 10.1016/0031-3203(92)90141-5; Trier OD, 1996, PATTERN RECOGN, V29, P641, DOI 10.1016/0031-3203(95)00118-2; Wang Y, 2002, INT J IMAGE GRAPHICS, V2, P361; Wong KKL, 2003, 2 WORKSH CONJ 9 ACM; Wu JK, 1994, LECT NOTES COMPUTER, V819, P109; Zaharia T, 2003, 5 ACM SIGMM INT WORK, P39; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949; Zhang DS, 2002, SIGNAL PROCESS-IMAGE, V17, P825, DOI 10.1016/S0923-5965(02)00084-X; Zhang H, 1992, ACM SE REG C RAL N C, P437; Zhuang Y, 2001, J COMPUT PHYS, V171, P79, DOI 10.1006/jcph.2001.6771	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2011	6	9							e25621	10.1371/journal.pone.0025621	http://dx.doi.org/10.1371/journal.pone.0025621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834DM	21980508	Green Published, gold, Green Submitted			2022-12-25	WOS:000295939600042
J	Hogins, J; Crawford, DC; Zorumski, CF; Mennerick, S				Hogins, Joshua; Crawford, Devon C.; Zorumski, Charles F.; Mennerick, Steven			Excitotoxicity Triggered by Neurobasal Culture Medium	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; AMINO-ACIDS; NEUROPSYCHIATRIC DISORDERS; GLUTAMATE NEUROTOXICITY; GLUCOSE DEPRIVATION; NERVOUS-SYSTEM; L-CYSTEINE; MECHANISMS	Neurobasal defined culture medium has been optimized for survival of rat embryonic hippocampal neurons and is now widely used for many types of primary neuronal cell culture. Therefore, we were surprised that routine medium exchange with serum-and supplement-free Neurobasal killed as many as 50% of postnatal hippocampal neurons after a 4 h exposure at day in vitro 12-15. Minimal Essential Medium (MEM), in contrast, produced no significant toxicity. Detectable Neurobasal-induced neuronal death occurred with as little as 5 min exposure, measured 24 h later. D-2-Amino-5-phosphonovalerate (D-APV) completely prevented Neurobasal toxicity, implicating direct or indirect N-methyl-D-aspartate (NMDA) receptor-mediated neuronal excitotoxicity. Whole-cell recordings revealed that Neurobasal but not MEM directly activated D-APVsensitive currents similar in amplitude to those gated by 1 mu M glutamate. We hypothesized that L-cysteine likely mediates the excitotoxic effects of Neurobasal incubation. Although the original published formulation of Neurobasal contained only 10 mu M L-cysteine, commercial recipes contain 260 mu M, a concentration in the range reported to activate NMDA receptors. Consistent with our hypothesis, 260 mu M L-cysteine in bicarbonate-buffered saline gated NMDA receptor currents and produced toxicity equivalent to Neurobasal. Although NMDA receptor-mediated depolarization and Ca2+ influx may support survival of young neurons, NMDA receptor agonist effects on development and survival should be considered when employing Neurobasal culture medium.	[Hogins, Joshua; Crawford, Devon C.; Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zorumski, Charles F.; Mennerick, Steven] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Crawford, Devon C.] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hogins, J (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	menneris@wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Crawford, Devon/0000-0002-9354-4976	Bantly Foundation; National Institutes of Health [DA07261, NS066611, MH07791, AA017413, MH078823, NS52823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261] Funding Source: NIH RePORTER	Bantly Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the Bantly Foundation and the following National Institutes of Health grants: DA07261 (to JH), NS066611 (to DCC), MH07791 (to CFZ), AA017413 (to CFZ), MH078823 (to SM) and NS52823 (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Crawford DC, 2011, J NEUROSCI, V31, P979, DOI 10.1523/JNEUROSCI.4960-10.2011; Croucher MJ, 2001, BRIT J PHARMACOL, V133, P815, DOI 10.1038/sj.bjp.0704138; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; GUSTAFSSON B, 1990, PROG BRAIN RES, V83, P223; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; IZUMI Y, 1992, NEUROSCI LETT, V137, P245, DOI 10.1016/0304-3940(92)90414-3; Janaky R, 2000, NEUROCHEM RES, V25, P1397, DOI 10.1023/A:1007616817499; Mathisen GA, 1996, NEUROCHEM RES, V21, P293, DOI 10.1007/BF02531643; MATTSON MP, 1991, BRAIN RES, V565, P94, DOI 10.1016/0006-8993(91)91740-R; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mennerick S, 1996, J PHYSIOL-LONDON, V490, P405, DOI 10.1113/jphysiol.1996.sp021154; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2007, J NEUROSCI, V27, P9846, DOI 10.1523/JNEUROSCI.2803-07.2007; NUNN PB, 1991, SCIENCE, V251, P1619, DOI 10.1126/science.1859531; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; OLNEY JW, 1990, SCIENCE, V248, P596, DOI 10.1126/science.2185543; PAN ZZ, 1993, NEURON, V11, P85; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Shanker G, 2001, J NEUROSCI RES, V66, P998, DOI 10.1002/jnr.10066; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Tang XC, 2003, ANN NY ACAD SCI, V1003, P472, DOI 10.1196/annals.1300.056; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; WEISS JH, 1988, SCIENCE, V241, P973, DOI 10.1126/science.3136549; Zorumski CF, 1996, J PHYSIOL-LONDON, V494, P465, DOI 10.1113/jphysiol.1996.sp021506; ZORUMSKI CF, 1993, PHARMACOL THERAPEUT, V59, P145, DOI 10.1016/0163-7258(93)90043-D	42	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25633	10.1371/journal.pone.0025633	http://dx.doi.org/10.1371/journal.pone.0025633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21980512	Green Published, Green Submitted, gold			2022-12-25	WOS:000295936900084
J	Kallay, LM; Brett, CL; Tukaye, DN; Wemmer, MA; Chyou, A; Odorizzi, G; Rao, R				Kallay, Laura M.; Brett, Christopher L.; Tukaye, Deepali N.; Wemmer, Megan A.; Chyou, Anthony; Odorizzi, Greg; Rao, Rajini			Endosomal Na+ (K+)/H+ Exchanger Nhx1/Vps44 Functions Independently and Downstream of Multivesicular Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GTPASE-ACTIVATING PROTEIN; ESCRT COMPLEXES; VESICLE TRAFFICKING; CANDIDA-ALBICANS; VACUOLE FUSION; MEMBRANE; PATHWAY; PH; COMPARTMENT	The multivesicular body (MVB) is an endosomal intermediate containing intralumenal vesicles destined for membrane protein degradation in the lysosome. In Saccharomyces cerevisiae, the MVB pathway is composed of 17 evolutionarily conserved ESCRT (endosomal sorting complex required for transport) genes grouped by their vacuole protein sorting Class E mutant phenotypes. Only one integral membrane protein, the endosomal Na+ (K+)/H+ exchanger Nhx1/Vps44, has been assigned to this class, but its role in the MVB pathway has not been directly tested. Herein, we first evaluated the link between Nhx1 and the ESCRT proteins and then used an unbiased phenomics approach to probe the cellular role of Nhx1. Select ESCRT mutants (vps36 Delta, vps20 Delta, snf7 Delta, and bro1 Delta) with defects in cargo packaging and intralumenal vesicle formation shared multiple growth phenotypes with nhx1 Delta. However, analysis of cellular trafficking and ultrastructural examination by electron microscopy revealed that nhx1 Delta cells retain the ability to sort cargo into intralumenal vesicles. In addition, we excluded a role for Nhx1 in Snf7/Bro1-mediated cargo deubiquitylation and Rim101 response to pH stress. Genetic epistasis experiments provided evidence that NHX1 and ESCRT genes function in parallel. A genome-wide screen for single gene deletion mutants that phenocopy nhx1 Delta yielded a limited gene set enriched for endosome fusion function, including Rab signaling and actin cytoskeleton reorganization. In light of these findings and the absence of the so-called Class E compartment in nhx1 Delta, we eliminated a requirement for Nhx1 in MVB formation and suggest an alternative post-ESCRT role in endosomal membrane fusion.	[Kallay, Laura M.; Brett, Christopher L.; Tukaye, Deepali N.; Chyou, Anthony; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Brett, Christopher L.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Wemmer, Megan A.; Odorizzi, Greg] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Johns Hopkins University; Concordia University - Canada; University of Colorado System; University of Colorado Boulder	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao1@jhmi.edu		Odorizzi, Greg/0000-0002-1143-1098	National Institutes of Health [DK054214, GM065505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 (to R. R.) and GM065505 (to G. O.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dewar H, 2002, MOL BIOL CELL, V13, P3646, DOI 10.1091/mbc.E02-05-0262; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; LI RJ, 1997, CELL BIOL, V136, P649; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	59	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44067	44077		10.1074/jbc.M111.282319	http://dx.doi.org/10.1074/jbc.M111.282319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998311	Green Published, hybrid			2022-12-25	WOS:000298402300047
J	Garbers, C; Thaiss, W; Jones, GW; Waetzig, GH; Lorenzen, I; Guilhot, F; Lissilaa, R; Ferlin, WG; Grotzinger, J; Jones, SA; Rose-John, S; Scheller, J				Garbers, Christoph; Thaiss, Wolfgang; Jones, Gareth W.; Waetzig, Georg H.; Lorenzen, Inken; Guilhot, Florence; Lissilaa, Rami; Ferlin, Walter G.; Groetzinger, Joachim; Jones, Simon A.; Rose-John, Stefan; Scheller, Juergen			Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BIOLOGICAL FUNCTION; DESIGNER CYTOKINE; EPITHELIAL-CELLS; TH17 CELLS; IL-6; INFLAMMATION; RESPONSES; BLOCKADE; CANCER	Background: IL-6 trans-signaling plays a critical role in chronic inflammation and cancer. Results: The trans-signaling inhibitor sgp130(Fc) also inhibits classic signaling depending on IL-6/sIL-6R ratios. Conclusion: The additional function of sgp130(Fc) suggests that in vivo only low therapeutic concentrations guarantee blockade of trans-signaling but not classic signaling. Significance: The demonstration that the trans-signaling inhibitor can also inhibit classic signaling is central for the field of IL-6 biology.	[Garbers, Christoph; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Thaiss, Wolfgang; Lorenzen, Inken; Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Jones, Gareth W.; Jones, Simon A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Waetzig, Georg H.] CONARIS Res Inst AG, D-20498 Kiel, Germany; [Guilhot, Florence; Lissilaa, Rami; Ferlin, Walter G.] NovImmune SA, CH-1228 Geneva, Switzerland	Heinrich Heine University Dusseldorf; University of Kiel; Cardiff University; NovImmune SA	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010; Waetzig, Georg/AAV-7486-2021; Garbers, Christoph/D-9932-2015; Thaiss, Wolfgang/ABH-9299-2020; Jones, Simon Arnett/Q-7017-2018	Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; Jones, Gareth/0000-0002-0125-4841; Guilhot, Francois/0000-0001-7222-487X; Jones, Simon Arnett/0000-0001-7297-9711	Deutsche Forschungsgemeinschaft [SFB877, A1, A2]; Cluster of Excellence "Inflammation at Interfaces"; Versus Arthritis [18286] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Versus Arthritis(Versus Arthritis)	This work was funded by Deutsche Forschungsgemeinschaft Grant SFB877 of Projects A1 and A2 and by the Cluster of Excellence "Inflammation at Interfaces."	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; CASTELL JV, 1988, EUR J BIOCHEM, V177, P357, DOI 10.1111/j.1432-1033.1988.tb14384.x; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dominitzki S, 2007, J IMMUNOL, V179, P2041, DOI 10.4049/jimmunol.179.4.2041; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Gaillard JP, 1999, EUR CYTOKINE NETW, V10, P337; GAILLARD JP, 1993, EUR J IMMUNOL, V23, P820, DOI 10.1002/eji.1830230408; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Melton L, 2008, NAT BIOTECHNOL, V26, P957, DOI 10.1038/nbt0908-957; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Mitsuyama K, 2006, GUT, V55, P1263, DOI 10.1136/gut.2005.079343; Montero-Julian FA, 2001, CELL MOL BIOL, V47, P583; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; Muller-Newen G, 1998, J IMMUNOL, V161, P6347; Peters M, 1997, J EXP MED, V185, P755, DOI 10.1084/jem.185.4.755; Peters M, 1998, J IMMUNOL, V161, P3575; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SATO K, 1993, CANCER RES, V53, P851; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	45	116	122	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42959	42970		10.1074/jbc.M111.295758	http://dx.doi.org/10.1074/jbc.M111.295758			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21990364	hybrid, Green Published			2022-12-25	WOS:000298351300017
J	Cheetham, J; MacCallum, DM; Doris, KS; Dantas, AD; Scorfield, S; Odds, F; Smith, DA; Quinn, J				Cheetham, Jill; MacCallum, Donna M.; Doris, Kathryn S.; Dantas, Alessandra da Silva; Scorfield, Susan; Odds, Frank; Smith, Deborah A.; Quinn, Janet			MAPKKK-independent Regulation of the Hog1 Stress-activated Protein Kinase in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; FISSION YEAST; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTIONAL RESPONSE; CHLAMYDOSPORE FORMATION; SIGNALING PATHWAYS; MITOTIC REGULATOR; IN-VIVO	The Hog1 stress-activated protein kinase regulates both stress responses and morphogenesis in Candida albicans and is essential for the virulence of this major human pathogen. Stress-induced Hog1 phosphorylation is regulated by the upstream MAPKK, Pbs2, which in turn is regulated by the MAPKKK, Ssk2. Here, we have investigated the role of phosphorylation of Hog1 and Pbs2 in Hog1-mediated processes in C. albicans. Mutation of the consensus regulatory phosphorylation sites of Hog1 (Thr-174/Tyr-176) and Pbs2 (Ser-355/Thr-359), to non-phosphorylatable residues, resulted in strains that phenocopied hog1 Delta and pbs2 Delta cells. Consistent with this, stress-induced phosphorylation of Hog1 was abolished in cells expressing non-phosphorylatable Pbs2 (Pbs2(A)A). However, mutation of the consensus sites of Pbs2 to phosphomimetic residues (Pbs2(DD)) failed to constitutively activate Hog1. Furthermore, Ssk2-independent stress-induced Hog1 activation was observed in Pbs2(DD) cells. Collectively, these data reveal a previously uncharacterized MAPKKK-independent mechanism of Hog1 activation in response to stress. Although Pbs2(DD) cells did not exhibit high basal levels of Hog1 phosphorylation, overexpression of an N-terminal truncated form of Ssk2 did result in constitutive Hog1 activation, which was further increased upon stress. Significantly, both Pbs2(AA) and Pbs2(DD) cells displayed impaired stress resistance and attenuated virulence in a mouse model of disease, whereas only Pbs2(AA) cells exhibited the morphological defects associated with loss of Hog1 function. This indicates that Hog1 mediates C. albicans virulence by conferring stress resistance rather than regulating morphogenesis.	[Cheetham, Jill; Doris, Kathryn S.; Dantas, Alessandra da Silva; Scorfield, Susan; Smith, Deborah A.; Quinn, Janet] Newcastle Univ, Fac Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [MacCallum, Donna M.; Odds, Frank] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen AB25 2ZD, Scotland	Newcastle University - UK; University of Aberdeen	Quinn, J (corresponding author), Newcastle Univ, Fac Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	janet.quinn@ncl.ac.uk	da Silva Dantas, Alessandra/B-9151-2015; Quinn, Janet/AAR-9957-2021; MacCallum, Donna M./D-7897-2011	MacCallum, Donna M./0000-0003-4833-0378; Quinn, Janet/0000-0002-8732-7676	Biotechnology and Biological Sciences Research Council; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.	ALFA CE, 1993, METHOD CELL BIOL, V37, P201, DOI 10.1016/S0091-679X(08)60251-4; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; MacCallum DM, 2010, ANTIMICROB AGENTS CH, V54, P1476, DOI 10.1128/AAC.01645-09; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; PIPER PW, 1988, NUCLEIC ACIDS RES, V16, P1333, DOI 10.1093/nar/16.4.1333; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Samejima I, 1998, MOL BIOL CELL, V9, P2325, DOI 10.1091/mbc.9.8.2325; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shieh JC, 1998, MOL BIOL CELL, V9, P311, DOI 10.1091/mbc.9.2.311; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; Vylkova S, 2007, EUKARYOT CELL, V6, P1876, DOI 10.1128/EC.00039-07; Walker LA, 2009, FUNGAL GENET BIOL, V46, P210, DOI 10.1016/j.fgb.2008.10.012; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	54	40	51	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42002	42016		10.1074/jbc.M111.265231	http://dx.doi.org/10.1074/jbc.M111.265231			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994942	hybrid, Green Published			2022-12-25	WOS:000298180900011
J	Wortmann, A; He, YW; Christensen, ME; Linn, M; Lumley, JW; Pollock, PM; Waterhouse, NJ; Hooper, JD				Wortmann, Andreas; He, Yaowu; Christensen, Melinda E.; Linn, Mayla; Lumley, John W.; Pollock, Pamela M.; Waterhouse, Nigel J.; Hooper, John D.			Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; SIGNAL-TRANSDUCTION; PKC-DELTA; CARCINOMA-CELLS; GROWTH-FACTOR; CANCER-CELLS; PHOSPHORYLATION; MIGRATION; BINDING; FAK	Reciprocal interactions between Src family kinases (SFKs) and focal adhesion kinase (FAK) are critical during changes in cell attachment. Recently it has been recognized that another SFK substrate, CUB-domain-containing protein 1 (CDCP1), is differentially phosphorylated during these events. However, the molecular processes underlying SFK-mediated phosphorylation of CDCP1 are poorly understood. Here we identify a novel mechanism in which FAK tyrosine 861 and CDCP1-Tyr-734 compete as SFK substrates and demonstrate cellular settings in which SFKs switch between these sites. Our results show that stable CDCP1 expression induces robust SFK-mediated phosphorylation of CDCP1-Tyr-734 with concomitant loss of p-FAK-Tyr-861 in adherent HeLa cells. SFK substrate switching in these cells is dependent on the level of expression of CDCP1 and is also dependent on CDCP1-Tyr-734 but is independent of CDCP1-Tyr-743 and -Tyr-762. In HeLa CDCP1 cells, engagement of SFKs with CDCP1 is accompanied by an increase in phosphorylation of Src-Tyr-416 and a change in cell morphology to a fibroblastic appearance dependent on CDCP1-Tyr-734. SFK switching between FAK-Tyr-861 and CDCP1-Tyr-734 also occurs during changes in adhesion of colorectal cancer cell lines endogenously expressing these two proteins. Consistently, increased p-FAK-Tyr-861 levels and a more epithelial morphology are seen in colon cancer SW480 cells silenced for CDCP1. Unlike protein kinase C delta, FAK does not appear to form a trimeric complex with Src and CDCP1. These data demonstrate novel aspects of the dynamics of SFK-mediated cell signaling that may be relevant during cancer progression.	[Wortmann, Andreas; He, Yaowu; Christensen, Melinda E.; Waterhouse, Nigel J.; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld 4101, Australia; [Wortmann, Andreas; Linn, Mayla; Pollock, Pamela M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Lumley, John W.] Wesley Med Ctr, Auchenflower, Qld 4066, Australia	Mater Research; Queensland University of Technology (QUT); Wesley Hospital	Hooper, JD (corresponding author), Mater Med Res Inst, Aubigny Pl, Brisbane, Qld 4101, Australia.	jhooper@mmri.mater.org.au	Waterhouse, Nigel/B-2498-2012; Wortmann, Dr Andreas/D-2074-2012; Waterhouse, Nigel/I-9813-2016; Hooper, John/C-1481-2016	Hooper, John/0000-0003-1054-8486; Pollock, Pamela/0000-0001-8420-1026; HE, Yaowu/0000-0002-7828-263X	National Health and Medical Research Council of Australia [339732]; Cancer Council Queensland; Wesley Research Institute [2008/06]; Cancer and Bowel Research Trust; Australian Research Council [FT0991446]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Wesley Research Institute; Cancer and Bowel Research Trust; Australian Research Council(Australian Research Council)	This work was supported by a National Health and Medical Research Council of Australia Fellowship 339732 (to J. D. H.), a Cancer Council Queensland grant (to J. D. H.), Wesley Research Institute Grant 2008/06 (to J. D. H.), a Ph.D. scholarship from the Cancer and Bowel Research Trust (to A. W.), and an Australian Research Council Futures Fellowship FT0991446 (to N. J. W.).	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; BROOKS PC, 1993, J CELL BIOL, V122, P1351, DOI 10.1083/jcb.122.6.1351; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Myoui A, 2003, CANCER RES, V63, P5028; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Playford MP, 2008, EXP CELL RES, V314, P3187, DOI 10.1016/j.yexcr.2008.08.010; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sedelies KA, 2008, CELL DEATH DIFFER, V15, P708, DOI 10.1038/sj.cdd.4402300; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Spassov DS, 2011, CELL CYCLE, V10, P1225, DOI 10.4161/cc.10.8.15343; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000; Yadav SS, 2007, CANCER LETT, V257, P116, DOI 10.1016/j.canlet.2007.07.012; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013	56	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42303	42315		10.1074/jbc.M111.227462	http://dx.doi.org/10.1074/jbc.M111.227462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994943	hybrid, Green Published			2022-12-25	WOS:000298180900040
J	Li, YM; Jaramillo-Lambert, A; Hao, J; Yang, Y; Zhu, WG				Li, Yongming; Jaramillo-Lambert, Aimee; Hao, Jing; Yang, Yi; Zhu, Wenge			The Stability of Histone Acetyltransferase General Control Non-derepressible (Gcn) 5 Is Regulated by Cullin4-RING E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-ASSOCIATED PROTEIN; DNA-DAMAGE RESPONSE; HUMAN STAGA COMPLEX; CELL-CYCLE; S-PHASE; REQUIRES TRRAP; REPLICATION; ACETYLATION; DEGRADATION; DESTRUCTION	Histone acetyltransferases play important roles in the regulation of chromatin structure and gene transcription. As one of the most important histone acetyltransferases, general control non-derepressible (Gcn) 5 has been linked to diverse cellular processes and tumorigenesis as well. We have recently identified a functional link between Gcn5 and acidic nucleoplasmic DNA-binding protein 1 (And-1) that is elevated in multiple cancer cells and is essential for Gcn5 protein stability. However, the mechanism by which And-1 regulates Gcn5 protein stability remains unknown. Here we show that the ablation of Cullin4-RING E3 ubiquitin ligase (CRL4) leads to the stabilization of Gcn5 in cells with depleted And-1, and Cdc10-dependent transcript 2 (Cdt2) serves as a substrate receptor protein of CRL4. Overexpression of Cdt2 reduces the Gcn5 protein levels, and CRLCdt2 is sufficient to ubiquitinate Gcn5 both in vivo and in vitro. And-1 stabilizes Gcn5 by impairing the interaction between Gcn5 and CRLCdt2 and thereby preventing Gcn5 ubiquitination and degradation. The degradation of Gcn5 is not dependent on proliferating cell nuclear antigen, an important player involved in CRLCdt2-mediated protein degradation. Thus, CRLCdt2 and And-1 play an essential role in the regulation of Gcn5 protein stability. This study provides us with the mechanistic basis to develop alternative approaches to inhibit Gcn5 activity for cancer therapy.	[Li, Yongming; Jaramillo-Lambert, Aimee; Hao, Jing; Yang, Yi; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	bcmwxz@gwumc.edu	li, yong/HDN-3885-2022	Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [4R00CA136555]; NATIONAL CANCER INSTITUTE [R00CA136555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 4R00CA136555 (to W. Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Li Y., 2011, ONCOGENE        0704, DOI DOI 10.1038/ONC.2011.261; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Rekowski MV, 2010, BBA-GENE REGUL MECH, V1799, P760, DOI 10.1016/j.bbagrm.2010.05.006; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	42	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41344	41352		10.1074/jbc.M111.290767	http://dx.doi.org/10.1074/jbc.M111.290767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987584	Green Published, hybrid			2022-12-25	WOS:000298057500021
J	Moumen, A; Virard, I; Raoul, C				Moumen, Anice; Virard, Isabelle; Raoul, Cedric			Accumulation of Wildtype and ALS-Linked Mutated VAPB Impairs Activity of the Proteasome	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; ENDOPLASMIC-RETICULUM; ER STRESS; LIVING CELLS; PROTEIN AGGREGATION; QUALITY-CONTROL; MOUSE MODEL; MUTANT; UBIQUITIN	Cellular homeostasis relies on a tight control of protein synthesis, folding and degradation, in which the endoplasmic reticulum (ER) quality control and the ubiquitin proteasome system (UPS) have an instrumental function. ER stress and aberrant accumulation of misfolded proteins represent a pathological signature of amyotrophic lateral sclerosis (ALS), a fatal paralytic disorder caused by the selective degeneration of motoneurons in the brain and spinal cord. Mutations in the ER-resident protein VAPB have been associated with familial forms of the disease. ALS-linked mutations cause VAPB to form cytoplasmic aggregates. We previously demonstrated that viral-mediated expression of both wildtype and mutant human VAPB (hVAPB) leads to an ER stress response that contributes to the selective death of motoneurons. However, the mechanisms behind ER stress, defective UPS and hVAPB-associated motoneuron degeneration remain elusive. Here, we show that the overexpression of wildtype and mutated hVAPB, which is found to be less stable than the wildtype protein, leads to the abnormal accumulation of ubiquitin and ubiquitin-like protein conjugates in non-human primate cells. We observed that overexpression of both forms of hVAPB elicited an ER stress response. Treatment of wildtype and mutated hVAPB expressing cells with the ER stress inhibitor salubrinal diminished the burden of ubiquitinated proteins, suggesting that ER stress contributes to the impairment of proteasome function. We also found that both wildtype and mutated hVAPB can associate with the 20S proteasome, which was found to accumulate at the ER with wildtype hVAPB or in mutant hVAPB aggregates. Our results suggest that ER stress and corruption of the proteasome function might contribute to the aberrant protein homeostasis associated with hVAPB.	[Moumen, Anice; Virard, Isabelle; Raoul, Cedric] INMED, Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France; [Moumen, Anice; Virard, Isabelle; Raoul, Cedric] Univ Aix Marseille 2, UMR Aix Marseille 2 S901, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Moumen, A (corresponding author), INMED, Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France.	cedric.raoul@inserm.fr	Raoul, Cedric/H-6517-2016	Raoul, Cedric/0000-0003-0561-6851; Virard, Isabelle/0000-0002-3980-0078	Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); American ALS Association (ALSA); Conseil General des Bouches-du-Rhone	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); American ALS Association (ALSA); Conseil General des Bouches-du-Rhone(Region Provence-Alpes-Cote d'Azur)	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association Francaise contre les Myopathies (AFM), the American ALS Association (ALSA) and the Conseil General des Bouches-du-Rhone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; GKOGKAS C, 2008, HUM MOL GENET; Gkogkas C, 2011, J NEUROCHEM, V117, P286, DOI 10.1111/j.1471-4159.2011.07201.x; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Matias AC, 2010, BIOCHEM SOC T, V38, P29, DOI 10.1042/BST0380029; Mendonca DMF, 2006, NEUROSCI LETT, V404, P315, DOI 10.1016/j.neulet.2006.06.009; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Piao YS, 2003, BRAIN PATHOL, V13, P10; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tagawa A, 2007, ACTA NEUROPATHOL, V113, P205, DOI 10.1007/s00401-006-0151-z; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	58	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26066	10.1371/journal.pone.0026066	http://dx.doi.org/10.1371/journal.pone.0026066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998752	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900093
J	Muto, J; Naidu, NN; Yamasaki, K; Pineau, N; Breton, L; Gallo, RL				Muto, Jun; Naidu, Nandita Natasha; Yamasaki, Kenshi; Pineau, Nathalie; Breton, Lionel; Gallo, Richard L.			Exogenous Addition of a C-Xylopyranoside Derivative Stimulates Keratinocyte Dermatan Sulfate Synthesis and Promotes Migration	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE; SEQUENCE; OLIGOSACCHARIDES; BIOSYNTHESIS; PROTEOGLYCAN; FGFR2-IIIB; RECEPTORS; BINDING; FGF10	As C-Xyloside has been suggested to be an initiator of glycosaminoglycan (GAG) synthesis, and GAGs such as Dermatan sulfate (DS) are potent enhancers of fibroblast growth factor (FGF) - 10 action, we investigated if a C-Xylopyranoside derivative, (C-beta-D-xylopyranoside-2-hydroxy-propane, C-Xyloside), could promote DS production by cultured normal human keratinocytes, how this occurs and if C-Xyloside could also stimulate FGF-dependent cell migration and proliferation. C-Xyloside-treated keratinocytes greatly increased secretion of total sulfated GAGs. Majority of the induced GAG was chondroitin sulfate/dermatan sulfate (CS/DS) of which the major secreted GAG was DS. Cells lacking xylosyltransferase enzymatic activity demonstrated that C-Xyloside was able to stimulate GAG synthesis without addition to core proteins. Consistent with the observed increase in DS, keratinocytes treated with C-Xyloside showed enhanced migration in response to FGF-10 and secreted into their culture media GAGs that promoted FGF-10-dependent cellular proliferation. These results indicate that C-Xyloside may enhance epithelial repair by serving as an initiator of DS synthesis.	[Muto, Jun; Yamasaki, Kenshi; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Muto, Jun; Yamasaki, Kenshi; Gallo, Richard L.] Vet Affairs San Diego Hlth Care Syst, San Diego, CA USA; [Pineau, Nathalie; Breton, Lionel] LOreal Rech, Clichy, France	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; L'Oreal Group	Muto, J (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Yamasaki, Kenshi/C-8905-2018	Gallo, Richard L/0000-0002-1401-7861; Yamasaki, Kenshi/0000-0002-5495-4956	L'Oreal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER	L'Oreal(L'Oreal Group); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by an investigator initiated grant from L'Oreal. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Lee PHA, 2004, J BIOL CHEM, V279, P48640, DOI 10.1074/jbc.M407241200; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Sakai S, 2002, ANAL BIOCHEM, V302, P169, DOI 10.1006/abio.2001.5545; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337	23	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25480	10.1371/journal.pone.0025480	http://dx.doi.org/10.1371/journal.pone.0025480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998662	Green Published, Green Submitted, gold			2022-12-25	WOS:000295966900029
J	King, CM; Hentges, ST				King, Connie M.; Hentges, Shane T.			Relative Number and Distribution of Murine Hypothalamic Proopiomelanocortin Neurons Innervating Distinct Target Sites	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; NUCLEUS TRACTUS SOLITARIUS; RAT ARCUATE NUCLEUS; BETA-ENDORPHIN; ALPHA-MSH; PARAVENTRICULAR NUCLEUS; GENE-EXPRESSION; FOOD-INTAKE; BRAIN-STEM; MELANOCORTIN RECEPTOR	Proopiomelanocortin (POMC) neurons send projections widely throughout the brain consistent with their role in regulating numerous homeostatic processes and mediating analgesia and reward. Recent data suggest that POMC neurons located in the rostral and caudal extents of the arcuate nucleus of the hypothalamus may mediate selective actions, however it is not clear if POMC neurons in these regions of the arcuate nucleus innervate specific target sites. In the present study, fluorescent microspheres and cholera toxin B were used to retrogradely label POMC neurons in POMC-DsRed transgenic mice. The number and location of POMC cells projecting to the supraoptic nucleus, periaqueductal gray, ventral tegmental area, paraventricular nucleus, lateral hypothalamic nucleus, amygdala and the dosal vagal complex was determined. Tracer injected unilaterally labeled POMC neurons in both sides of the arcuate nucleus. While the total number of retrogradely labeled cells in the arcuate nucleus varied by injection site, less than 10% of POMC neurons were labeled with tracer injected into any target area. Limited target sites appear to be preferentially innervated by POMC neurons that reside in the rostral or caudal extremes of the arcuate nucleus, whereas the majority of target sites are innervated by diffusely distributed POMC neurons. The modest number of cells projecting to each target site indicates that relatively few POMC neurons may mediate potent and specific physiologic responses and therefore disturbed signaling in a very few POMC neurons may have significant consequences.	[King, Connie M.; Hentges, Shane T.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	King, CM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	hentgess@colostate.edu	Hentges, Shane T/B-9747-2012		National Institutes of Health [R01DK0798749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health (R01DK0798749 to STH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barna I, 1997, BRAIN RES BULL, V42, P353, DOI 10.1016/S0361-9230(96)00298-5; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; BUNEL DT, 1990, BRAIN RES, V513, P299, DOI 10.1016/0006-8993(90)90471-M; Caquineau C, 2006, J NEUROENDOCRINOL, V18, P685, DOI 10.1111/j.1365-2826.2006.01465.x; CHEUNG S, 1995, NEUROENDOCRINOLOGY, V62, P283, DOI 10.1159/000127015; CHOWENBREED JA, 1989, ENDOCRINOLOGY, V124, P2875, DOI 10.1210/endo-124-6-2875; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Coll AP, 2007, CLIN SCI, V113, P171, DOI 10.1042/CS20070105; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; DENNIS M, 1983, LIFE SCI, V33, P49, DOI 10.1016/0024-3205(83)90441-1; Douglas AJ, 2002, J NEUROENDOCRINOL, V14, P768, DOI 10.1046/j.1365-2826.2002.00837.x; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Ellacott KLJ, 2006, ENDOCRINOLOGY, V147, P3190, DOI 10.1210/en.2005-0877; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; ESKAY RL, 1979, BRAIN RES, V178, P55, DOI 10.1016/0006-8993(79)90087-8; Fekete C, 2000, J NEUROSCI, V20, P1550; FINLEY JCW, 1981, NEUROENDOCRINOLOGY, V33, P28, DOI 10.1159/000123197; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; HUGHES AM, 1987, NEUROSCIENCE, V23, P1063, DOI 10.1016/0306-4522(87)90181-3; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; KAPCALA LP, 1986, BRAIN RES, V364, P350, DOI 10.1016/0006-8993(86)90847-4; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Klusa V, 1998, NEUROPEPTIDES, V32, P573, DOI 10.1016/S0143-4179(98)90088-9; Kokare DM, 2010, NEUROPHARMACOLOGY, V58, P1009, DOI 10.1016/j.neuropharm.2010.01.006; LAM MP, 2011, PSYCHOPHARMACOLOGY B; Li SJ, 1996, J NEUROSCI, V16, P5182; Lindblom J, 2001, NEUROREPORT, V12, P2155, DOI 10.1097/00001756-200107200-00022; LUPPI PH, 1987, BRAIN RES, V402, P339, DOI 10.1016/0006-8993(87)90041-2; Maolood N, 2010, J NEUROENDOCRINOL, V22, P75, DOI 10.1111/j.1365-2826.2009.01946.x; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; MILLINGTON WR, 1984, PEPTIDES, V5, P841, DOI 10.1016/0196-9781(84)90033-0; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; ODONOHUE TL, 1979, BRAIN RES, V176, P101, DOI 10.1016/0006-8993(79)90873-4; ODONOHUE TL, 1982, PEPTIDES, V3, P353, DOI 10.1016/0196-9781(82)90098-5; Ohgami Y, 2010, BRAIN RES, V1366, P38, DOI 10.1016/j.brainres.2010.10.010; Palkovits M, 1999, FRONT NEUROENDOCRIN, V20, P270, DOI 10.1006/frne.1999.0186; PALKOVITS M, 1987, NEUROPEPTIDES, V9, P123, DOI 10.1016/0143-4179(87)90051-5; PELLETIER G, 1993, ANN NY ACAD SCI, V680, P246, DOI 10.1111/j.1749-6632.1993.tb19688.x; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Priest CA, 2000, NEUROENDOCRINOLOGY, V72, P293, DOI 10.1159/000054598; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Roth-Deri I, 2008, PROG NEUROBIOL, V86, P1, DOI 10.1016/j.pneurobio.2008.06.003; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Sabatier N, 2003, J NEUROSCI, V23, P10351; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Vrang N, 1999, J Neurosci, V19, pRC5; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Yang J, 2007, REGUL PEPTIDES, V142, P29, DOI 10.1016/j.regpep.2007.01.006; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001; YOSHIDA M, 1988, ARCH HISTOL CYTOL, V51, P175, DOI 10.1679/aohc.51.175; Zheng HY, 2010, AM J PHYSIOL-REG I, V298, pR720, DOI 10.1152/ajpregu.00619.2009; Zheng HY, 2005, AM J PHYSIOL-REG I, V289, pR247, DOI 10.1152/ajpregu.00869.2004	68	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25864	10.1371/journal.pone.0025864	http://dx.doi.org/10.1371/journal.pone.0025864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991375	Green Submitted, gold, Green Published			2022-12-25	WOS:000295963300027
J	Wang, MH; Marinotti, O; Vardo-Zalik, A; Boparai, R; Yan, GY				Wang, Mei-Hui; Marinotti, Osvaldo; Vardo-Zalik, Anne; Boparai, Rajni; Yan, Guiyun			Genome-Wide Transcriptional Analysis of Genes Associated with Acute Desiccation Stress in Anopheles gambiae	PLOS ONE			English	Article							DRY SEASON; DROSOPHILA-MELANOGASTER; MALARIA TRANSMISSION; DNA-REPAIR; CHROMOSOMAL INVERSION; OXIDATIVE STRESS; PEA APHID; EXPRESSION; ADAPTATION; RESISTANCE	Malaria transmission in sub-Saharan Africa varies seasonally in intensity. Outbreaks of malaria occur after the beginning of the rainy season, whereas, during the dry season, reports of the disease are less frequent. Anopheles gambiae mosquitoes, the main malaria vector, are observed all year long but their densities are low during the dry season that generally lasts several months. Aestivation, seasonal migration, and local adaptation have been suggested as mechanisms that enable mosquito populations to persist through the dry season. Studies of chromosomal inversions have shown that inversions 2La, 2Rb, 2Rc, 2Rd, and 2Ru are associated with various physiological changes that confer aridity resistance. However, little is known about how phenotypic plasticity responds to seasonally dry conditions. This study examined the effects of desiccation stress on transcriptional regulation in An. gambiae. We exposed female An. gambiae G3 mosquitoes to acute desiccation and conducted a genome-wide analysis of their transcriptomes using the Affymetrix Plasmodium/Anopheles Genome Array. The transcription of 248 genes (1.7% of all transcripts) was significantly affected in all experimental conditions, including 96 with increased expression and 152 with decreased expression. In general, the data indicate a reduction in the metabolic rate of mosquitoes exposed to desiccation. Transcripts accumulated at higher levels during desiccation are associated with oxygen radical detoxification, DNA repair and stress responses. The proportion of transcripts within 2La and 2Rs (2Rb, 2Rc, 2Rd, and 2Ru) (67/248, or 27%) is similar to the percentage of transcripts located within these inversions (31%). These data may be useful in efforts to elucidate the role of chromosomal inversions in aridity tolerance. The scope of application of the anopheline genome demonstrates that examining transcriptional activity in relation to genotypic adaptations greatly expands the number of candidate regions involved in the desiccation response in this important malaria vector.	[Wang, Mei-Hui; Boparai, Rajni; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Vardo-Zalik, Anne] Penn State Univ, Dept Biol, York, PA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wang, MH (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	meihuiw@uci.edu		Marinotti, Osvaldo/0000-0002-7173-7160	National Institutes of Health [R01 AI050243, R21 AI078463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243, R21AI078463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by grants from the National Institutes of Health (R01 AI050243 and R21 AI078463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; [Anonymous], 2008, WORLD MAL REP 2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit JB, 2007, J EXP BIOL, V210, P217, DOI 10.1242/jeb.02630; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Boubriak I, 1997, SEED SCI RES, V7, P97, DOI 10.1017/S0960258500003433; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P37, DOI 10.1017/S0007485300051993; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cortes T, 2008, GENE, V408, P146, DOI 10.1016/j.gene.2007.10.030; CREWSOYEN AE, 1993, AM J TROP MED HYG, V49, P341, DOI 10.4269/ajtmh.1993.49.341; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gray EM, 2005, AM J TROP MED HYG, V73, P553, DOI 10.4269/ajtmh.2005.73.553; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; HADLEY NF, 1979, SCIENCE, V203, P367, DOI 10.1126/science.203.4378.367; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Ibrahima B, 2010, PLOS ONE, V5; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-456; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lighton JRB, 1996, ANNU REV ENTOMOL, V41, P309, DOI 10.1146/annurev.en.41.010196.001521; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupu A, 2004, MUTAGENESIS, V19, P383, DOI 10.1093/mutage/geh045; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morris ER, 2006, PLANT PHYSIOL, V141, P932, DOI 10.1104/pp.106.076893; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ADV EXP MED BIOL, V673, P184; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sharakhova MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-91; Somvanshi VS, 2008, MOL BIOCHEM PARASIT, V158, P65, DOI 10.1016/j.molbiopara.2007.11.012; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Venn J, 1880, LONDON EDINBURGH DUB, V10, P1, DOI [DOI 10.1080/14786448008626877, 10.1080/14786448008626877]; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Willis J.H., 2005, P79; Xia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010592; Yakob L, 2010, T ROY SOC TROP MED H, V104, P669, DOI 10.1016/j.trstmh.2010.07.014; Yoshida H, 2009, IUBMB LIFE, V61, P871, DOI 10.1002/iub.229	64	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26011	10.1371/journal.pone.0026011	http://dx.doi.org/10.1371/journal.pone.0026011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991392	Green Published, gold			2022-12-25	WOS:000295963300033
J	El-Kassaby, YA; Cappa, EP; Liewlaksaneeyanawin, C; Klapste, J; Lstiburek, M				El-Kassaby, Yousry A.; Cappa, Eduardo P.; Liewlaksaneeyanawin, Cherdsak; Klapste, Jaroslav; Lstiburek, Milan			Breeding without Breeding: Is a Complete Pedigree Necessary for Efficient Breeding?	PLOS ONE			English	Article							QUANTITATIVE INHERITANCE; MICROSATELLITE LOCI; INFERENCES; SUCCESS; PROGENY; COEFFICIENTS; MARKERS	Complete pedigree information is a prerequisite for modern breeding and the ranking of parents and offspring for selection and deployment decisions. DNA fingerprinting and pedigree reconstruction can substitute for artificial matings, by allowing parentage delineation of naturally produced offspring. Here, we report on the efficacy of a breeding concept called 'Breeding without Breeding" (BwB) that circumvents artificial matings, focusing instead on a subset of randomly sampled, maternally known but paternally unknown offspring to delineate their paternal parentage. We then generate the information needed to rank those offspring and their paternal parents, using a combination of complete (full-sib: FS) and incomplete (half-sib: HS) analyses of the constructed pedigrees. Using a random sample of wind-pollinated offspring from 15 females (seed donors), growing in a 41-parent western larch population, BwB is evaluated and compared to two commonly used testing methods that rely on either incomplete (maternal half-sib, open-pollinated: OP) or complete (FS) pedigree designs. BwB produced results superior to those from the incomplete design and virtually identical to those from the complete pedigree methods. The combined use of complete and incomplete pedigree information permitted evaluating all parents, both maternal and paternal, as well as all offspring, a result that could not have been accomplished with either the OP or FS methods alone. We also discuss the optimum experimental setting, in terms of the proportion of fingerprinted offspring, the size of the assembled maternal and paternal half-sib families, the role of external gene flow, and selfing, as well as the number of parents that could be realistically tested with BwB.	[El-Kassaby, Yousry A.; Liewlaksaneeyanawin, Cherdsak; Klapste, Jaroslav] Univ British Columbia, Dept Forest Sci, Fac Forestry, Vancouver, BC V6T 1W5, Canada; [Cappa, Eduardo P.] Inst Recursos Biol, INTA, Buenos Aires, DF, Argentina; [Lstiburek, Milan] Czech Univ Life Sci Prague, Dept Dendrol & Forest Tree Breeding, Fac Forestry & Wood Sci, Prague, Czech Republic	University of British Columbia; Instituto Nacional de Tecnologia Agropecuaria (INTA); Czech University of Life Sciences Prague	El-Kassaby, YA (corresponding author), Univ British Columbia, Dept Forest Sci, Fac Forestry, Vancouver, BC V6T 1W5, Canada.	y.el-kassaby@ubc.ca	Klapste, Jaroslav/B-6668-2016; Lstiburek, Milan/G-5669-2010; Lstiburek, Milan/AAE-4280-2022; El-Kassaby, Yousry A/K-9856-2016	Klapste, Jaroslav/0000-0001-5504-3735; Lstiburek, Milan/0000-0002-6304-6669; Lstiburek, Milan/0000-0002-6304-6669; El-Kassaby, Yousry A/0000-0002-4887-8977	Natural Sciences and Engineering Research Council of Canada; Johnson's Family Forest Biotechnology Endowment	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Johnson's Family Forest Biotechnology Endowment	This study is supported by the Natural Sciences and Engineering Research Council of Canada - Discovery and IRC Grants and the Johnson's Family Forest Biotechnology Endowment to YAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard RW, PRINCIPLES PLANT BRE; ASKEW GR, 1994, THEOR APPL GENET, V88, P267, DOI 10.1007/BF00225908; BURDON R D, 1971, New Zealand Journal of Forestry Science, V1, P174; Cappa EP, 2011, SILVAE GENET, V60, P25, DOI 10.1515/sg-2011-0004; Chen C, 2009, MOL ECOL RESOUR, V9, P843, DOI 10.1111/j.1755-0998.2008.02289.x; COTTERILL PP, 1986, SILVAE GENET, V35, P212; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Doerksen TK, 2010, TREE GENET GENOMES, V6, P591, DOI 10.1007/s11295-010-0274-1; El-Kassaby YA, 2006, LOW INPUT BREEDING G, P43; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; ELKASSABY YA, 1993, CAN J FOREST RES, V23, P1096, DOI 10.1139/x93-139; Falconer D., INTRO QUANTITATIVE G, V4th; Funda T, 2011, CAN J FOREST RES, V41, P380, DOI 10.1139/X10-190; Gilmour A. R., ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Hansen OK, 2010, TREE GENET GENOMES, V6, P345, DOI 10.1007/s11295-009-0253-6; Henderson CR, APPL LINEAR MODELS A; International Seed Testing Association, 1993, SEED SCI TECHNOL S, V21, p1B259; Isoda K, 2006, MOL ECOL NOTES, V6, P664, DOI 10.1111/j.1471-8286.2006.01291.x; Gaspar MJ, 2009, TREE GENET GENOMES, V5, P609, DOI 10.1007/s11295-009-0213-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Khasa PD, 2000, GENOME, V43, P439, DOI 10.1139/gen-43-3-439; Lambeth C, 2001, THEOR APPL GENET, V103, P930, DOI 10.1007/s001220100627; Lynch M, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; NAMKOONG G, 1966, FOREST SCI, V12, P8; Namkoong G, TECH B USDA; Namkoong G, MONOGRAPH THEOR APPL, V11; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Ritland K, 2004, FOREST ECOL MANAG, V197, P171, DOI 10.1016/j.foreco.2004.05.012; Ronningen K, WORLD ANIMAL SCI, P187; Squillace A. E., 1974, Silvae Genetica, V23, P149; Stern K, GENETICS FOREST ECOS; WHITE T.L., FOREST GENETICS	36	68	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25737	10.1371/journal.pone.0025737	http://dx.doi.org/10.1371/journal.pone.0025737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991342	Green Published, Green Submitted, gold			2022-12-25	WOS:000295943000061
J	Hoey, AS; Pratchett, MS; Cvitanovic, C				Hoey, Andrew S.; Pratchett, Morgan S.; Cvitanovic, Christopher			High Macroalgal Cover and Low Coral Recruitment Undermines the Potential Resilience of the World's Southernmost Coral Reef Assemblages	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; HERBIVOROUS FISHES; RANGE SHIFTS; PHASE-SHIFTS; PATTERNS; IMPACTS; NORTHWESTERN; MORTALITY; ABUNDANCE	Coral reefs are under increasing pressure from anthropogenic and climate-induced stressors. The ability of reefs to reassemble and regenerate after disturbances (i.e., resilience) is largely dependent on the capacity of herbivores to prevent macroalgal expansion, and the replenishment of coral populations through larval recruitment. Currently there is a paucity of this information for higher latitude, subtropical reefs. To assess the potential resilience of the benthic reef assemblages of Lord Howe Island (31 degrees 32'S, 159 degrees 04'E), the worlds' southernmost coral reef, we quantified the benthic composition, densities of juvenile corals (as a proxy for coral recruitment), and herbivorous fish communities. Despite some variation among habitats and sites, benthic communities were dominated by live scleractinian corals (mean cover 37.4%) and fleshy macroalgae (20.9%). Live coral cover was higher than in most other subtropical reefs and directly comparable to lower latitude tropical reefs. Juvenile coral densities (0.8 ind.m(-2)), however, were 5-200 times lower than those reported for tropical reefs. Overall, macroalgal cover was negatively related to the cover of live coral and the density of juvenile corals, but displayed no relationship with herbivorous fish biomass. The biomass of herbivorous fishes was relatively low (204 kg.ha(-1)), and in marked contrast to tropical reefs was dominated by macroalgal browsing species (84.1%) with relatively few grazing species. Despite their extremely low biomass, grazing fishes were positively related to both the density of juvenile corals and the cover of bare substrata, suggesting that they may enhance the recruitment of corals through the provision of suitable settlement sites. Although Lord Howe Islands' reefs are currently coral-dominated, the high macroalgal cover, coupled with limited coral recruitment and low coral growth rates suggest these reefs may be extremely susceptible to future disturbances.	[Hoey, Andrew S.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Hoey, Andrew S.; Pratchett, Morgan S.; Cvitanovic, Christopher] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	King Abdullah University of Science & Technology; James Cook University	Hoey, AS (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	andrew.hoey@kaust.edu.sa	Hoey, Andrew S/B-5457-2015; Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459; Cvitanovic, Christopher/0000-0002-2565-3396; Hoey, Andrew/0000-0002-4261-5594	Australian Government Department of Sustainability, Environment, Water, Population and Communities; Australian Research Council Centre of Excellence for Coral Reef Studies	Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	Financial support was provided by the Australian Government Department of Sustainability, Environment, Water, Population and Communities, and the Australian Research Council Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Choat J.H., 1991, P120; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CHOAT JH, 2006, REPORT ECOLOGICAL SU; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Edgar GJ, 2010, AQUAT CONSERV, V20, P378, DOI 10.1002/aqc.1075; Emslie MJ, 2010, CORAL REEFS, V29, P705, DOI 10.1007/s00338-010-0619-0; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Glassom D, 2006, MAR ECOL PROG SER, V318, P111, DOI 10.3354/meps318111; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; HARRIOTT VJ, 1992, CORAL REEFS, V11, P215, DOI 10.1007/BF00301996; HARRIOTT VJ, 1995, AQUAT CONSERV, V5, P179, DOI 10.1002/aqc.3270050303; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Kleypas JA, 1999, AM ZOOL, V39, P146; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; PAYRI CE, 1984, BOT MAR, V27, P327, DOI 10.1515/botm.1984.27.7.327; POLUNIN NVC, 1992, J EXP MAR BIOL ECOL, V164, P1, DOI 10.1016/0022-0981(92)90132-T; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; TRIBBLE GW, 1986, CORAL REEFS, V4, P151, DOI 10.1007/BF00427936; Valentine JP, 2010, CORAL REEFS, V29, P399, DOI 10.1007/s00338-010-0610-9; VERON JEN, 1979, AUST J MAR FRESH RES, V30, P203, DOI 10.1071/MF9790203; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	68	84	84	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25824	10.1371/journal.pone.0025824	http://dx.doi.org/10.1371/journal.pone.0025824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991366	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000082
J	Hollen, LI; Bell, MBV; Russell, A; Niven, F; Ridley, AR; Radford, AN				Hollen, Linda I.; Bell, Matthew B. V.; Russell, Alexis; Niven, Fraser; Ridley, Amanda R.; Radford, Andrew N.			Calling by Concluding Sentinels: Coordinating Cooperation or Revealing Risk?	PLOS ONE			English	Article							WATCHMANS SONG HYPOTHESIS; BREEDING PIED BABBLER; SELFISH SENTINELS; SOCIAL BIRD; VIGILANCE; BEHAVIOR; PREDATION; HABITAT; URGENCY; SAFE	Efficient cooperation requires effective coordination of individual contributions to the cooperative behaviour. Most social birds and mammals involved in cooperation produce a range of vocalisations, which may be important in regulating both individual contributions and the combined group effort. Here we investigate the role of a specific call in regulating cooperative sentinel behaviour in pied babblers (Turdoides bicolor). 'Fast-rate chuck' calls are often given by sentinels as they finish guard bouts and may potentially coordinate the rotation of individuals as sentinels, minimising time without a sentinel, or may signal the presence or absence of predators, regulating the onset of the subsequent sentinel bout. We ask (i) when fast-rate chuck calls are given and (ii) what effect they have on the interval between sentinel bouts. Contrary to expectation, we find little evidence that these calls are involved in regulating the pied babbler sentinel system: observations revealed that their utterance is influenced only marginally by wind conditions and not at all by habitat, while observations and experimental playback showed that the giving of these calls has no effect on inter-bout interval. We conclude that pied babblers do not seem to call at the end of a sentinel bout to maximise the efficiency of this cooperative act, but may use vocalisations at this stage to influence more individually driven behaviours.	[Hollen, Linda I.; Radford, Andrew N.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bell, Matthew B. V.] Univ Cambridge, Dept Zool, Cambridge, England; [Russell, Alexis; Niven, Fraser] Pied Babbler Res Project, Vanzylsrus, No Cape, South Africa; [Ridley, Amanda R.] Univ Cape Town, Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa	University of Bristol; University of Cambridge; University of Cape Town	Hollen, LI (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	linda.hollen@bristol.ac.uk	Ridley, Amanda/D-2636-2011; Bell, Matthew/B-6353-2013; Ridley, Amanda/B-5759-2009	Ridley, Amanda/0000-0001-5886-0992; Radford, Andrew N/0000-0001-5470-3463	Magdalene College, Cambridge; CoE at the Fitzpatrick Institute; Biotechnology and Biological Sciences Research Council (BBSRC); Marie Curie Fellowship; Percy Fitzpatrick Institute of African Ornithology in Cape Town; Biotechnology and Biological Sciences Research Council [BB/C520555/2, BB/C520555/1] Funding Source: researchfish	Magdalene College, Cambridge; CoE at the Fitzpatrick Institute; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Fellowship(European Commission); Percy Fitzpatrick Institute of African Ornithology in Cape Town; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Dr. Hollen was funded by a Marie Curie Fellowship, Dr. Bell was supported by a Junior Research Fellowship from Magdalene College, Cambridge, Dr. Ridley by the CoE at the Fitzpatrick Institute, and Dr. Radford by a Biotechnology and Biological Sciences Research Council (BBSRC) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr and Mrs Kotze, the Kalahari Research Trust, Tim Clutton-Brock and Marta Manser for access to land and logistics; the Northern Cape Conservation Authority for research permission; the Percy Fitzpatrick Institute of African Ornithology in Cape Town for funding to maintain the Pied Babbler Project; Krystyna Golabek, Martha Nelson-Flower and Nichola Raihani for habituation help; Rachel Smith and Alex Thompson for help locating groups and obtaining call recordings; and Isa-Rita Russo and Martha Nelson-Flower for molecular sexing.	[Anonymous], 2010, R LANG ENV STAT COMP; Baayen RH, 2010, LANGUAGER DATA SETS; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bednekoff PA, 2003, ETHOLOGY, V109, P895, DOI 10.1046/j.0179-1613.2003.00926.x; Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Bednekoff PA, 2008, ETHOLOGY, V114, P313, DOI 10.1111/j.1439-0310.2008.01467.x; Bell MBV, 2010, P ROY SOC B-BIOL SCI, V277, P3223, DOI 10.1098/rspb.2010.0643; Bell MBV, 2009, P ROY SOC B-BIOL SCI, V276, P2997, DOI 10.1098/rspb.2009.0276; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; GASTON AJ, 1977, ANIM BEHAV, V25, P828, DOI 10.1016/0003-3472(77)90036-7; Griesser M, 2009, BEHAV ECOL, V20, P709, DOI 10.1093/beheco/arp045; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; Hollen LI, 2008, CURR BIOL, V18, P576, DOI 10.1016/j.cub.2008.02.078; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 1999, P ROY SOC B-BIOL SCI, V266, P1013, DOI 10.1098/rspb.1999.0737; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; METCALFE NB, 1984, ANIM BEHAV, V32, P981, DOI 10.1016/S0003-3472(84)80210-9; Nelson-Flower MJ, 2011, BEHAV ECOL, V22, P559, DOI 10.1093/beheco/arr018; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Radford AN, 2008, ANIM BEHAV, V75, P519, DOI 10.1016/j.anbehav.2007.05.016; Radford AN, 2007, BIOLOGY LETT, V3, P249, DOI 10.1098/rsbl.2007.0110; Radford AN, 2006, CURR BIOL, V16, P1700, DOI 10.1016/j.cub.2006.06.053; Radford AN, 2011, EVOLUTION, V65, P900, DOI 10.1111/j.1558-5646.2010.01180.x; Radford AN, 2009, P ROY SOC B-BIOL SCI, V276, P2437, DOI 10.1098/rspb.2009.0187; Raihani NJ, 2007, ANIM BEHAV, V74, P1303, DOI 10.1016/j.anbehav.2007.02.025; RASA OAE, 1986, ETHOLOGY, V71, P340, DOI 10.1111/j.1439-0310.1986.tb00598.x; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; Ridley AR, 2010, BIOL LETTERS, V6, P445, DOI 10.1098/rsbl.2010.0023; Townsend SW, 2011, BEHAV ECOL SOCIOBIOL, V65, P1927, DOI 10.1007/s00265-011-1202-6; WICKLER W, 1985, Z TIERPSYCHOL, V69, P250; Wright J, 2001, ANIM BEHAV, V62, P973, DOI 10.1006/anbe.2001.1838; Wright J, 2001, J ANIM ECOL, V70, P1070, DOI 10.1046/j.0021-8790.2001.00565.x; [No title captured]; [No title captured]	37	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25010	10.1371/journal.pone.0025010	http://dx.doi.org/10.1371/journal.pone.0025010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21984898	Green Published, gold, Green Submitted			2022-12-25	WOS:000295943000008
J	Kong, XQ; Ouyang, SS; Liang, ZJ; Lu, JY; Chen, L; Shen, BR; Li, DH; Zheng, MY; Li, KK; Luo, C; Jiang, HL				Kong, Xiangqian; Ouyang, Sisheng; Liang, Zhongjie; Lu, Junyan; Chen, Liang; Shen, Bairong; Li, Donghai; Zheng, Mingyue; Li, Keqin Kathy; Luo, Cheng; Jiang, Hualiang			Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study	PLOS ONE			English	Article							MONOAMINE-OXIDASE-A; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; POLYAMINE OXIDASE; STRUCTURAL BASIS; AMINE OXIDATION; PH-DEPENDENCE; SUBSTRATE; INSIGHTS; COMPLEX	Lysine-specific demethylase 1 (LSD1), the first identified histone demethylase, is a flavin-dependent amine oxidase which specifically demethylates mono-or dimethylated H3K4 and H3K9 via a redox process. It participates in a broad spectrum of biological processes and is of high importance in cell proliferation, adipogenesis, spermatogenesis, chromosome segregation and embryonic development. To date, as a potential drug target for discovering anti-tumor drugs, the medical significance of LSD1 has been greatly appreciated. However, the catalytic mechanism for the rate-limiting reductive half-reaction in demethylation remains controversial. By employing a combined computational approach including molecular modeling, molecular dynamics (MD) simulations and quantum mechanics/molecular mechanics (QM/MM) calculations, the catalytic mechanism of dimethylated H3K4 demethylation by LSD1 was characterized in details. The three-dimensional (3D) model of the complex was composed of LSD1, CoREST, and histone substrate. A 30-ns MD simulation of the model highlights the pivotal role of the conserved Tyr761 and lysine-water-flavin motif in properly orienting flavin adenine dinucleotide (FAD) with respect to substrate. The synergy of the two factors effectively stabilizes the catalytic environment and facilitated the demethylation reaction. On the basis of the reasonable consistence between simulation results and available mutagenesis data, QM/MM strategy was further employed to probe the catalytic mechanism of the reductive half-reaction in demethylation. The characteristics of the demethylation pathway determined by the potential energy surface and charge distribution analysis indicates that this reaction belongs to the direct hydride transfer mechanism. Our study provides insights into the LSD1 mechanism of reductive half-reaction in demethylation and has important implications for the discovery of regulators against LSD1 enzymes.	[Kong, Xiangqian; Ouyang, Sisheng; Liang, Zhongjie; Lu, Junyan; Chen, Liang; Zheng, Mingyue; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Shen, Bairong; Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Li, Donghai] Nanjing Univ, Sch Life Sci, Jiangsu Diabet Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Li, Keqin Kathy] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Jiang, Hualiang] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Soochow University - China; Nanjing University; Chinese Academy of Sciences; Shanghai Jiao Tong University; East China University of Science & Technology	Kong, XQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	kli@epigenetic.us; cluo@mail.shcnc.ac.cn	Zheng, Mingyue/HHZ-4062-2022; Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019; Kong, Xiangqian/J-4500-2017; Liang, Zhongjie/F-2108-2019; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/AAJ-8027-2020	Zheng, Mingyue/0000-0002-3323-3092; Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531; Kong, Xiangqian/0000-0002-9596-7825; Liang, Zhongjie/0000-0003-0763-5407; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Lu, Junyan/0000-0002-9211-0746	State Key Program of Basic Research of China [2009CB918502]; National Natural Science Foundation of China [20972174, 21021063, 31000323, 91029704]; Shanghai Committee of Science and Technology [10410703900]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100091120023]; Chinese Academy of Sciences [XDA01040305]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors gratefully acknowledge financial support from the State Key Program of Basic Research of China grant (2009CB918502), the National Natural Science Foundation of China grants (20972174, 21021063, 31000323 and 91029704), Shanghai Committee of Science and Technology grants (10410703900), Specialized Research Fund for the Doctoral Program of Higher Education of China (20100091120023) and the Chinese Academy of Sciences (XDA01040305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2011, STRUCTURE, V19, P212, DOI 10.1016/j.str.2011.01.001; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Brinkley DW, 2005, J AM CHEM SOC, V127, P15720, DOI 10.1021/ja056025l; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dunn RV, 2008, FEBS J, V275, P3850, DOI 10.1111/j.1742-4658.2008.06532.x; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Forneris F, 2009, FEBS J, V276, P4304, DOI 10.1111/j.1742-4658.2009.07142.x; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frisch M.J., 2003, GAUSSIAN 03 REVISION; Gaweska H, 2009, BIOCHEMISTRY-US, V48, P5440, DOI 10.1021/bi900499w; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurtz KA, 2000, J AM CHEM SOC, V122, P12896, DOI 10.1021/ja002528+; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Polticelli F, 2005, BIOCHEMISTRY-US, V44, P16108, DOI 10.1021/bi050983i; Pozzi MH, 2010, ARCH BIOCHEM BIOPHYS, V498, P83, DOI 10.1016/j.abb.2010.04.015; Pozzi MH, 2009, BIOCHEMISTRY-US, V48, P12305, DOI 10.1021/bi901694s; Pozzi MH, 2009, BIOCHEMISTRY-US, V48, P1508, DOI 10.1021/bi802227m; Raghavachari K, 2000, THEOR CHEM ACC, V103, P361, DOI 10.1007/s002149900065; Ralph EC, 2005, BIOCHEMISTRY-US, V44, P3074, DOI 10.1021/bi047716h; Ralph EC, 2007, BIOCHEMISTRY-US, V46, P7655, DOI 10.1021/bi700482h; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SILVERMAN RB, 1995, ACCOUNTS CHEM RES, V28, P335, DOI 10.1021/ar00056a003; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Svensson M, 1996, J CHEM PHYS, V105, P3654, DOI 10.1063/1.472235; Tilocca A, 2002, BIOCHEMISTRY-US, V41, P14111, DOI 10.1021/bi020309q; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Vreven T, 2001, J CHEM PHYS, V115, P62, DOI 10.1063/1.1376127; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2000, J COMPUT CHEM, V21, P1419, DOI 10.1002/1096-987X(200012)21:16<1419::AID-JCC1>3.0.CO;2-C; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yuan HL, 2011, BIOCHEMISTRY-US, V50, P770, DOI 10.1021/bi101837u	79	28	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25444	10.1371/journal.pone.0025444	http://dx.doi.org/10.1371/journal.pone.0025444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984927	gold, Green Submitted, Green Published			2022-12-25	WOS:000295941300031
J	Rick, IP; Mehlis, M; Bakker, TCM				Rick, Ingolf P.; Mehlis, Marion; Bakker, Theo C. M.			Male Red Ornamentation Is Associated with Female Red Sensitivity in Sticklebacks	PLOS ONE			English	Article							SEXUAL SELECTION; MATE-CHOICE; GASTEROSTEUS-ACULEATUS; ARTIFICIAL SELECTION; SENSORY DRIVE; SPECTRAL SENSITIVITY; GENETIC CORRELATION; MATING PREFERENCES; OPTOMOTOR RESPONSE; COLOR PATTERNS	Sexual selection theory proposes correlated evolutionary changes in mating preferences and secondary sexual characters based on a positive genetic correlation between preference and the preferred trait. Empirical work has provided support for a genetic covariation between female preference and male attractiveness in several taxa. Here, we study parent and offspring visual traits in threespine sticklebacks, Gasterosteus aculeatus. While focusing on the proximate basis of mating preferences, we compare the red breeding coloration of males, which strongly contributes to female choice, with their daughters' red sensitivity measured by optomotor response thresholds. We show that the red color expression of fathers correlates well with their daughters' red sensitivity. Given that a within-population genetic correlation between signal and preference was experimentally confirmed for the red coloration in sticklebacks, our results indicate a proximate mechanism in terms of perceptual sensitivity being involved in the co-evolution of female preferences and male mating signals.	[Rick, Ingolf P.; Mehlis, Marion; Bakker, Theo C. M.] Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany	University of Bonn	Rick, IP (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, D-5300 Bonn, Germany.	irick@evolution.uni-bonn.de	Bakker, Theo/AAI-3587-2020; Rick, Ingolf P/AAP-2531-2020; Rick, Ingolf P/C-1387-2010	Rick, Ingolf P/0000-0001-8072-6933; 				Allison JD, 2008, J EVOLUTION BIOL, V21, P1666, DOI 10.1111/j.1420-9101.2008.01595.x; Andersson Malte, 1994; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Bakker TCM, 1999, NATURE, V401, P234, DOI 10.1038/45727; BAKKER TCM, 1993, MAR BEHAV PHYSIOL, V23, P287; BAKKER TCM, 1991, BEHAV ECOL SOCIOBIOL, V29, P205, DOI 10.1007/BF00166402; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Baugh AT, 2009, BEHAV ECOL, V20, P1153, DOI 10.1093/beheco/arp120; Bleiweiss R, 2007, EVOLUTION, V61, P2861, DOI 10.1111/j.1558-5646.2007.00217.x; BOAKE CRB, 1991, TRENDS ECOL EVOL, V6, P225, DOI 10.1016/0169-5347(91)90027-U; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; BREDEN F, 1994, HEREDITY, V73, P291, DOI 10.1038/hdy.1994.136; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; BUTLIN RK, 1989, BIOL J LINN SOC, V37, P237, DOI 10.1111/j.1095-8312.1989.tb01902.x; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2000, BEHAV ECOL SOCIOBIOL, V49, P57, DOI 10.1007/s002650000267; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cronin TW, 2001, NATURE, V411, P547, DOI 10.1038/35079184; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; Flamarique IN, 2005, J COMP PHYSIOL A, V191, P37, DOI 10.1007/s00359-004-0573-9; FLEISHMAN LJ, 1988, ANIM BEHAV, V36, P1420, DOI 10.1016/S0003-3472(88)80212-4; Fukamachi S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-64; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gray DA, 1999, EVOLUTION, V53, P848, DOI [10.2307/2640724, 10.1111/j.1558-5646.1999.tb05378.x]; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Griggio M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-261; Heckel G, 2002, CONSERV GENET, V3, P79, DOI 10.1023/A:1014255027870; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kraak SBM, 1999, BEHAV ECOL, V10, P696, DOI 10.1093/beheco/10.6.696; Kroger RHH, 2003, J EXP BIOL, V206, P1643, DOI 10.1242/jeb.00337; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCLENNAN DA, 1990, CAN J ZOOL, V68, P482, DOI 10.1139/z90-071; McLennan Deborah A., 2007, P179; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Montgomerie R., 2006, BIRD COLORATION, P90; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; Rick IP, 2008, NATURWISSENSCHAFTEN, V95, P631, DOI 10.1007/s00114-008-0365-0; Rick IP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-189; Ronnestad I, 1998, COMP BIOCHEM PHYS A, V119, P787, DOI 10.1016/S1095-6433(98)01017-4; Rowe MP, 2004, J COMP PHYSIOL A, V190, P241, DOI 10.1007/s00359-004-0493-8; Rowland William J., 1994, P297; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shand J, 2008, J EXP BIOL, V211, P1495, DOI 10.1242/jeb.012047; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Toomey MB, 2010, J EXP BIOL, V213, P1709, DOI 10.1242/jeb.041004; Uetz GW, 2007, BEHAV ECOL SOCIOBIOL, V61, P631, DOI 10.1007/s00265-006-0293-y; Von Helversen D, 2004, ANIM BEHAV, V68, P131, DOI 10.1016/j.anbehav.2003.10.020; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wiley C, 2010, EVOLUTION, V64, P2238, DOI 10.1111/j.1558-5646.2010.01007.x; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; ZIMMERMAN WF, 1971, SCIENCE, V171, P1167, DOI 10.1126/science.171.3976.1167	77	30	30	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25554	10.1371/journal.pone.0025554	http://dx.doi.org/10.1371/journal.pone.0025554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21984930	Green Submitted, gold, Green Published			2022-12-25	WOS:000295941300040
J	Krishnan, B; Genzer, KM; Pollandt, SW; Liu, J; Gallagher, JP; Shinnick-Gallagher, P				Krishnan, Balaji; Genzer, Kathy M.; Pollandt, Sebastian W.; Liu, Jie; Gallagher, Joel P.; Shinnick-Gallagher, Patricia			Dopamine-Induced Plasticity, Phospholipase D (PLD) Activity and Cocaine-Cue Behavior Depend on PLD-Linked Metabotropic Glutamate Receptors in Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CORTICOTROPIN-RELEASING-FACTOR; CONDITIONED PLACE PREFERENCE; SELF-ADMINISTRATION BEHAVIOR; BASOLATERAL AMYGDALA; SEEKING BEHAVIOR; PREFRONTAL CORTEX; EXCITOTOXIC LESIONS; NEURITE OUTGROWTH; MESSENGER-RNA	Cocaine-cue associations induce synaptic plasticity with long lasting molecular and cellular changes in the amygdala, a site crucial for cue-associated memory mechanisms. The underlying neuroadaptations can include marked alterations in signaling via dopamine (DA) receptors (DRs) and metabotropic glutamate (Glu) receptors (mGluRs). Previously, we reported that DR antagonists blocked forms of synaptic plasticity in amygdala slices of Sprague-Dawley rats withdrawn from repeated cocaine administration. In the present study, we investigated synaptic plasticity induced by exogenous DA and its dependence on mGluR signaling and a potential role for phospholipase D (PLD) as a downstream element linked to mGluR and DR signaling. Utilizing a modified conditioned place preference (CPP) paradigm as a functional behavioral measure, we studied the neurophysiological effects after two-weeks to the last cocaine conditioning. We recorded, electrophysiologically, a DR-induced synaptic potentiation in the basolateral to lateral capsula central amygdala (BLA-lcCeA) synaptic pathway that was blocked by antagonists of group I mGluRs, particularly, the PLD-linked mGluR. In addition, we observed 2-2.5 fold increase in PLD expression and 3.7-fold increase in basal PLD enzyme activity. The enhanced PLD activity could be further stimulated (9.3 fold) by a DA D1-like (D1/5R) receptor agonist, and decreased to control levels by mGluR1 and PLD-linked mGluR antagonists. Diminished CPP was observed by infusion of a PLD-linked mGluR antagonist, PCCG-13, in the amygdala 15 minutes prior to testing, two weeks after the last cocaine injection. These results imply a functional interaction between D1/5Rs, group I mGluRs via PLD in the amygdala synaptic plasticity associated with cocaine-cues.	[Krishnan, Balaji; Genzer, Kathy M.; Pollandt, Sebastian W.; Liu, Jie; Gallagher, Joel P.; Shinnick-Gallagher, Patricia] Univ Texas Med Branch Galveston, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Liu, Jie] Columbia Univ, Presbyterian Hosp, Dept Anesthesiol, New York, NY USA	University of Texas System; University of Texas Medical Branch Galveston; Columbia University; NewYork-Presbyterian Hospital	Krishnan, B (corresponding author), Univ Texas Med Branch Galveston, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	bakrishn@utmb.edu	Pollandt, Sebastian/I-8055-2019; Krishnan, Balaji/M-9914-2019	Pollandt, Sebastian/0000-0003-1540-7439; Krishnan, Balaji/0000-0003-2074-4165	National Institutes of Health [DA017727, DA017727-06S1]; NRSA F32 Ruth L. Kirschstein postdoctoral grant [DA023316]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017727, F32DA023316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA F32 Ruth L. Kirschstein postdoctoral grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant DA017727 to PSG, DA017727-06S1 to JL, and by NRSA F32 Ruth L. Kirschstein postdoctoral grant DA023316 to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1992, J BIOL CHEM, V267, P13361; Albani-Torregrossa S, 1999, MOL PHARMACOL, V55, P699; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Attucci S, 2001, NEUROCHEM RES, V26, P1151, DOI 10.1023/A:1012327007733; Backstrom P, 2006, NEUROPSYCHOPHARMACOL, V31, P778, DOI 10.1038/sj.npp.1300845; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; BOSS V, 1992, J NEUROCHEM, V59, P2340; BOSS V, 1994, MOL PHARMACOL, V45, P1177; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5; BROWN EE, 1993, PSYCHOPHARMACOLOGY, V113, P123, DOI 10.1007/BF02244344; BROWN EE, 1992, J NEUROSCI, V12, P4112; Buffalari DM, 2010, CURR TOP BEHAV NEURO, V3, P73, DOI 10.1007/7854_2009_18; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; CAINE SB, 1995, BRAIN RES, V692, P47; CALLAHAN PM, 1995, PHARMACOL BIOCHEM BE, V51, P759, DOI 10.1016/0091-3057(95)00027-T; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CARR GD, 1989, NEUROLOGICAL BASIS R, P284; CHARIFSON PS, 1989, J MED CHEM, V32, P2050, DOI 10.1021/jm00129a006; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; FIBIGER HC, 1992, CIBA F SYMP, V166, P96; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Fu Y, 2007, J NEUROPHYSIOL, V97, P937, DOI 10.1152/jn.00349.2006; Fuchs RA, 2002, BRAIN RES, V929, P15, DOI 10.1016/S0006-8993(01)03366-2; Gardiner TW, 1999, CONTEMP TOP LAB ANIM, V38, P56; Goffin D, 2008, J NEUROCHEM, V107, P964, DOI 10.1111/j.1471-4159.2008.05679.x; Gorbatyuk OS, 2010, MOL THER, V18, P1758, DOI 10.1038/mt.2010.137; Goussakov I, 2006, EUR J NEUROSCI, V23, P239, DOI 10.1111/j.1460-9568.2005.04538.x; Grimm JW, 2002, BEHAV PHARMACOL, V13, P379, DOI 10.1097/00008877-200209000-00011; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; HALL RA, 2004, RECEPTOR BIOCH METHO, P165; Hayakawa K, 1999, NEUROSCI LETT, V265, P127, DOI 10.1016/S0304-3940(99)00228-1; HOLLER T, 1993, J NEUROCHEM, V61, P1569, DOI 10.1111/j.1471-4159.1993.tb13659.x; HOLLER T, 1994, BIOCHEM PHARMACOL, V47, P411, DOI 10.1016/0006-2952(94)90033-7; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Hurd YL, 2000, BEHAV BRAIN RES, V116, P177, DOI 10.1016/S0166-4328(00)00271-0; Hurd YL, 1997, EUR J NEUROSCI, V9, P2541, DOI 10.1111/j.1460-9568.1997.tb01683.x; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kantak KM, 2002, J NEUROSCI, V22, P1126, DOI 10.1523/JNEUROSCI.22-03-01126.2002; Kawasaki S, 2008, NEUROSCI RES, V60, P147, DOI 10.1016/j.neures.2007.10.003; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kim M, 2010, ACTA HISTOCHEM, V112, P81, DOI 10.1016/j.acthis.2008.09.004; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Klein J, 1997, NEUROPHARMACOLOGY, V36, P305, DOI 10.1016/S0028-3908(97)00024-5; KOBAYASHI M, 1987, J NEUROCHEM, V48, P1597, DOI 10.1111/j.1471-4159.1987.tb05707.x; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krishnan B, 2010, EUR J NEUROSCI, V31, P1027, DOI 10.1111/j.1460-9568.2010.07148.x; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Kruzich PJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-14-j0002.2001; LAURIER LG, 1994, BRAIN RES, V634, P31, DOI 10.1016/0006-8993(94)90255-0; Le Vasseur M, 2008, NEUROSCIENCE, V151, P28, DOI 10.1016/j.neuroscience.2007.09.071; Li YQ, 2008, J NEUROSCI, V28, P13248, DOI 10.1523/JNEUROSCI.3027-08.2008; Liu J, 2004, J NEUROSCI, V24, P4020, DOI 10.1523/JNEUROSCI.5531-03.2004; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lu L, 2007, BIOL PSYCHIAT, V61, P591, DOI 10.1016/j.biopsych.2006.04.011; Luedtke RR, 1999, J NEUROIMMUNOL, V101, P170, DOI 10.1016/S0165-5728(99)00142-3; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maggos CE, 1997, SYNAPSE, V26, P55, DOI 10.1002/(SICI)1098-2396(199705)26:1<55::AID-SYN6>3.0.CO;2-D; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUMOTO M, 1988, J PHYSIOL-LONDON, V407, P199, DOI 10.1113/jphysiol.1988.sp017410; McGinty JF, 2008, J NEUROCHEM, V104, P1440, DOI 10.1111/j.1471-4159.2008.05240.x; MCGREGOR A, 1993, BRAIN RES, V624, P245, DOI 10.1016/0006-8993(93)90084-Z; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Mottola DM, 1996, J MED CHEM, V39, P285, DOI 10.1021/jm9502100; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Oliveira TG, 2010, BBA-MOL CELL BIOL L, V1801, P799, DOI 10.1016/j.bbalip.2010.04.004; Orozco-Cabal L, 2008, J NEUROSCI, V28, P529, DOI 10.1523/JNEUROSCI.2666-07.2008; Otani S, 1999, J NEUROSCI, V19, P9788; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Pape HC, 2005, NEURON, V48, P877, DOI 10.1016/j.neuron.2005.12.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PellegriniGiampietro DE, 1996, BRIT J PHARMACOL, V118, P1035, DOI 10.1111/j.1476-5381.1996.tb15503.x; Pellicciari R, 1999, J MED CHEM, V42, P2716, DOI 10.1021/jm990128v; PENG X, 2011, ACTA PHYSL OXF; Poisik OV, 2007, EUR J NEUROSCI, V26, P852, DOI 10.1111/j.1460-9568.2007.05710.x; Pollandt S, 2006, EUR J NEUROSCI, V24, P1733, DOI 10.1111/j.1460-9568.2006.05049.x; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rico MJ, 2004, J NEUROPHYSIOL, V91, P2385, DOI 10.1152/jn.01140.2003; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rouillon C, 2008, BRAIN RES, V1198, P44, DOI 10.1016/j.brainres.2008.01.025; Royer S, 1999, J NEUROSCI, V19, P10575; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Schmidt K, 2011, EUR J NEUROSCI, V34, P177, DOI 10.1111/j.1460-9568.2011.07769.x; Schotanus SM, 2008, NEUROPHARMACOLOGY, V54, P837, DOI 10.1016/j.neuropharm.2007.12.012; SCIBILIA RJ, 1992, SYNAPSE, V11, P146, DOI 10.1002/syn.890110208; See RE, 2003, ANN NY ACAD SCI, V985, P294; See RE, 2001, PSYCHOPHARMACOLOGY, V154, P301, DOI 10.1007/s002130000636; Senogles SE, 2000, MOL PHARMACOL, V58, P455, DOI 10.1124/mol.58.2.455; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shimosato K, 2000, PHARMACOL BIOCHEM BE, V66, P285, DOI 10.1016/S0091-3057(00)00185-4; Shinomura T, 2000, BRIT J PHARMACOL, V131, P1011, DOI 10.1038/sj.bjp.0703651; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Tran-Nguyen LTL, 1998, NEUROPSYCHOPHARMACOL, V19, P48; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Voulalas PJ, 2005, J NEUROSCI, V25, P3763, DOI 10.1523/JNEUROSCI.4574-04.2005; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; Watanabe H, 2004, J NEUROCHEM, V89, P142, DOI 10.1111/j.1471-4159.2004.02308.x; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WILSON JM, 1994, BRAIN RES, V668, P39, DOI 10.1016/0006-8993(94)90508-8; Xie XH, 2010, PSYCHOPHARMACOLOGY, V208, P1, DOI 10.1007/s00213-009-1700-7; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zhang Y, 2005, J NEUROSCI, V25, P1797, DOI 10.1523/jneurosci.4850-04.2005; Zhang Y, 2004, GLIA, V46, P74, DOI 10.1002/glia.10322	131	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25639	10.1371/journal.pone.0025639	http://dx.doi.org/10.1371/journal.pone.0025639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980514	gold, Green Submitted, Green Published			2022-12-25	WOS:000295933700049
J	Lo, PK; Kanojia, D; Liu, X; Singh, UP; Berger, FG; Wang, Q; Chen, H				Lo, P-K; Kanojia, D.; Liu, X.; Singh, U. P.; Berger, F. G.; Wang, Q.; Chen, H.			CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGF beta signaling	ONCOGENE			English	Article						tumor-initiating cells; Her2/neu; mammary tumor; CD49f; CD61; ESA	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; STEM-CELLS; II RECEPTOR; EXPRESSION; MOUSE; GLAND; TUMORIGENESIS; POPULATION; TGF-BETA-1	Human epidermal growth factor receptor 2 (HER2)/Neu is overexpressed in 20-30% of breast cancers and associated with aggressive phenotypes and poor prognosis. For deciphering the role of HER2/Neu in breast cancer, mouse mammary tumor virus (MMTV)-Her2/neu transgenic mice that develop mammary tumors resembling human HER2-subtype breast cancer have been established. Several recent studies have revealed that HER2/Neu is overexpressed in and regulates self renewal of breast tumor-initiating cells (TICs). However, in the MMTV-Her2/neu transgenic mouse model, the identity of TICs remains elusive, despite previous studies showing supportive evidence for existence of TICs in Her2/neu-induced mammary tumors. Through systematic screening and characterization, we identified that surface markers CD49f, CD61 and ESA were aberrantly overexpressed in Her2-overexpressing mammary tumor cells. Analysis of these markers and CD24 detected anomalous expansion of the luminal progenitor population in preneoplastic mammary glands of Her2/neu transgenic mice, indicating that aberrant luminal progenitors originated in Her2-induced mammary tumors. The combined markers, CD49f and CD61, further delineated the CD49f(high)CD61(high)-sorted fraction as a TIC-enriched population, which displayed increased tumorsphere formation ability, enhanced tumorigenicity both in vitro and in vivo and drug resistance to pacitaxel and doxorubicin. Moreover, the TIC-enriched population manifested increased transforming growth factor-beta (TGF beta) signaling and exhibited gene expression signatures of stemness, TGF beta signaling and epithelial-to-mesenchymal transition. Our findings that self-renewal and clonogenicity of TICs were suppressed by pharmacologically inhibiting the TGF beta signaling further indicate that the TGF beta pathway is vital for maintenance of the TIC population. Finally, we showed that the integrin-beta 3 (CD61) signaling pathway was required for sustaining active TGF beta signaling and self-renewal of TICs. We for the first time developed a technique to highly enrich TICs from mammary tumors of Her2/neu transgenic mice, unraveled their properties and identified the cooperative integrin-beta 3-TGF beta signaling axis as a potential therapeutic target for HER2-induced TICs. Oncogene (2012) 31, 2614-2626; doi:10.1038/onc.2011.439; published online 26 September 2011	[Lo, P-K; Kanojia, D.; Berger, F. G.; Chen, H.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Lo, P-K; Kanojia, D.; Berger, F. G.; Wang, Q.; Chen, H.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Liu, X.] Univ S Carolina, Dept Math, Columbia, SC 29208 USA; [Singh, U. P.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Wang, Q.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, H (corresponding author), Univ S Carolina, Dept Biol Sci, 715 Sumter St,PSC621, Columbia, SC 29208 USA.	hchen@biol.sc.edu	Kanojia, Deepak/G-5120-2014; chen, hexin/F-1714-2011	Kanojia, Deepak/0000-0003-4295-4972; Wang, Qian/0000-0002-2149-384X; Singh, Udai/0000-0002-7048-4325	Elsa U Pardee Cancer Foundation [B94AFFAA]; American Cancer Society [RSG-10-067-01-TBE]; NIH [3P20RR017698-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	Elsa U Pardee Cancer Foundation; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Marai M Pena, Celestia Davis, Sara Johnson and Andrea Daamen for experimental assistance. This work was supported by the Elsa U Pardee Cancer Foundation grant (B94AFFAA), the American Cancer Society Research Award (RSG-10-067-01-TBE) to HC and NIH grant (3P20RR017698-08) to HC and QW.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Chen HX, 2010, PROTEOMICS, V10, P3800, DOI 10.1002/pmic.201000297; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gu Y.B., 2011, J BIOTECH RES, V3, P7; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanker L, 2010, BREAST CANCER RES TR, V122, P765, DOI 10.1007/s10549-009-0608-6; HYNES NE, 1985, MOL CELL BIOL, V5, P268, DOI 10.1128/MCB.5.1.268; Ishikawa Toshihisa, 2009, J Exp Ther Oncol, V8, P5; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kveiborg M., 2001, Journal of Endocrinology, V169, P549, DOI 10.1677/joe.0.1690549; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Welm B, 2003, CELL PROLIFERAT, V36, P17, DOI 10.1046/j.1365-2184.36.s.1.3.x; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang C, 2007, EXP CELL RES, V313, P1240, DOI 10.1016/j.yexcr.2007.01.011	38	149	155	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	21					2614	2626		10.1038/onc.2011.439	http://dx.doi.org/10.1038/onc.2011.439			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	948SS	21996747	Green Accepted			2022-12-25	WOS:000304523500002
J	Santana, SE; Geipel, I; Dumont, ER; Kalka, MB; Kalko, EKV				Santana, Sharlene E.; Geipel, Inga; Dumont, Elizabeth R.; Kalka, Margareta B.; Kalko, Elisabeth K. V.			All You Can Eat: High Performance Capacity and Plasticity in the Common Big-Eared Bat, Micronycteris microtis (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							BITE FORCE; FOOD HARDNESS; DIET; ECHOLOCATION; INSECTIVORY; ASSEMBLAGE; EVOLUTION; BEHAVIOR; FOREST; SIZE	Ecological specialization and resource partitioning are expected to be particularly high in the species-rich communities of tropical vertebrates, yet many species have broader ecological niches than expected. In Neotropical ecosystems, Neotropical leaf-nosed bats (Phyllostomidae) are one of the most ecologically and functionally diverse vertebrate clades. Resource partitioning in phyllostomids might be achieved through differences in the ability to find and process food. We selected Micronycteris microtis, a very small (5-7 g) animalivorous phyllostomid, to explore whether broad resource use is associated with specific morphological, behavioral and performance traits within the phyllostomid radiation. We documented processing of natural prey and measured bite force in free-ranging M. microtis and other sympatric phyllostomids. We found that M. microtis had a remarkably broad diet for prey size and hardness. For the first time, we also report the consumption of vertebrates (lizards), which makes M. microtis the smallest carnivorous bat reported to date. Compared to other phyllostomids, M. microtis had the highest bite force for its size and cranial shape and high performance plasticity. Bite force and cranial shape appear to have evolved rapidly in the M. microtis lineage. High performance capacity and high efficiency in finding motionless prey might be key traits that allow M. microtis, and perhaps other species, to successfully co-exist with other gleaning bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Geipel, Inga; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kalka, Margareta B.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian Tropical Research Institute	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD; NSF [IOB 0447616]; European Union	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NSF(National Science Foundation (NSF)); European Union(European Commission)	S.E.S. was supported by University of Massachusetts Graduate School Fellowship and travel funds from the Institute of Experimental Ecology, University of Ulm; M.B.K. by a DAAD fellowship; E.R.D. by a NSF grant (IOB 0447616); and G.G. and E.K.V.K. by the European Union project ChiRoPing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Bumrungsri S, 2007, BIOTROPICA, V39, P241, DOI 10.1111/j.1744-7429.2006.00245.x; Dondini G, 2000, J ZOOL, V251, P233, DOI 10.1111/j.1469-7998.2000.tb00606.x; Dumont ER, 1999, J ZOOL, V248, P219, DOI 10.1017/S0952836999006093; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; FREEMAN PW, 1984, BIOL J LINN SOC, V21, P387, DOI 10.1111/j.1095-8312.1984.tb01601.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; Geipel I, 2007, PREY DETECTION NEOTR; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Giannini NP, 2005, ACTA CHIROPTEROL, V7, P131, DOI 10.3161/1733-5329(2005)7[131:TGSOAL]2.0.CO;2; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 2004, BAT ECHOLOCATION RES, P63; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1998, P197; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Paradis E., 2006, APE ANAL PHYLOGENETI; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Santana SE, 2011, BIOL J LINN SOC, V102, P1, DOI 10.1111/j.1095-8312.2010.01551.x; Santana SE, 2010, FUNCT ECOL, V24, P776, DOI 10.1111/j.1365-2435.2010.01703.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS N.B., 1998, B AM MUSEUM NATURAL, V237; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; van de Sand M, 2004, OKOLOGIE VERHALTEN N; Wetterer AL, 2000, B AM MUS NAT HIST, P4, DOI 10.1206/0003-0090(2000)248<0001:POPBMC>2.0.CO;2; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	43	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28584	10.1371/journal.pone.0028584	http://dx.doi.org/10.1371/journal.pone.0028584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	21991371	gold, Green Published			2022-12-25	WOS:000298171400110
J	Santana, SE; Dial, TO; Eiting, TP; Alfaro, ME				Santana, Sharlene E.; Dial, Thomas O.; Eiting, Thomas P.; Alfaro, Michael E.			Roosting Ecology and the Evolution of Pelage Markings in Bats	PLOS ONE			English	Article							FRUIT-EATING BATS; DISRUPTIVE COLORATION; SPERM COMPETITION; ECHOLOCATION; STRIPES; CRYPSIS; DISCRIMINATION; CHIROPTERA; CAMOUFLAGE; PATTERNS	Multiple lineages of bats have evolved striking facial and body pelage makings, including spots, stripes and countershading. Although researchers have hypothesized that these markings mainly evolved for crypsis, this idea has never been tested in a quantitative and comparative context. We present the first comparative study integrating data on roosting ecology (roost type and colony size) and pelage coloration patterns across bats, and explore the hypothesis that the evolution of bat pelage markings is associated with roosting ecologies that benefit from crypsis. We find that lineages that roost in the vegetation have evolved pelage markings, especially stripes and neck collars, which may function in crypsis through disruptive coloration and a type of countershading that might be unique to bats. We also demonstrate that lineages that live in larger colonies and are larger in size tend not to have pelage markings, possibly because of reduced predation pressures due to the predator dilution effect and a lower number of potential predators. Although social functions for pelage color patterns are also possible, our work provides strong support for the idea that roosting ecology has driven the evolution of pelage markings in bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.; Dial, Thomas O.; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Eiting, Thomas P.] Univ Massachusetts, Amherst, MA 01003 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Amherst	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	Center for Society and Genetics; National Science Foundation [0918748]	Center for Society and Genetics; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a Center for Society and Genetics (http://socgen.ucla.edu) Postdoctoral Fellowship to SES and National Science Foundation grant 0918748 to MEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Baron G, 1996, COMP NEUROBIOLOGY CH; Bates P, 1998, BATS INDIAN SUBCONTI; Behrens RR, 2009, PHILOS T R SOC B, V364, P497, DOI 10.1098/rstb.2008.0250; Bonaccorso FJ, 1998, BATS PAPUA NEW GUINE; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2011, EVOL ECOL, V25, P1231, DOI 10.1007/s10682-011-9479-5; Caro T, 2010, BEHAV ECOL, V21, P78, DOI 10.1093/beheco/arp165; Caro Tim, 2005, pXIII; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Cott H.B., 1940, ADAPTIVE COLORATION; Csorba G., 2003, HORSESHOE BATS WORLD; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DEFANIS E, 1995, ANIM BEHAV, V49, P835; EDMUNDS M, 1994, BIOL J LINN SOC, V51, P447, DOI 10.1006/bijl.1994.1034; Edmunds M., 1974, DEFENCE ANIMALS; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Ewer RF, 1997, CARNIVORES; Fenton BM, 2008, KOEDOE AFRICAN PROTE, V35, P49; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frey JK, 2006, J MAMMAL, V87, P1175, DOI 10.1644/05-MAMM-A-374R2.1; Garnett Stephen, 1999, Australian Zoologist, V31, P38; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hodgkison R, 2003, J TROP ECOL, V19, P667, DOI 10.1017/S0266467403006060; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Hutson A, 2001, MICROCHIROPTERAN BAT; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kamilar JM, 2011, J ZOOL, V283, P227, DOI 10.1111/j.1469-7998.2010.00765.x; KILTIE RA, 1989, ANIM BEHAV, V38, P542, DOI 10.1016/S0003-3472(89)80048-X; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Majerus M, 1998, MELANISM EVOLUTION A; Marshall Justin, 2011, P186; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Nowak RM, 1994, WALKERS BATS WORLD; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Plumpton D.L., 1992, Mammalian Species, P1, DOI 10.2307/3504230; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reid F., 2009, FIELD GUIDE MAMMALS, V2nd; Safi K, 2003, ANIM BEHAV, V65, P363, DOI 10.1006/anbe.2003.2067; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; Stankowich T, 2011, EVOLUTION, V65, P3090, DOI 10.1111/j.1558-5646.2011.01334.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoner CJ, 2003, BEHAV ECOL, V14, P823, DOI 10.1093/beheco/arg072; TAYLOR PJ, 2000, BATS SO AFRICA; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; WICKLER W, 1976, Z TIERPSYCHOL, V40, P345; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	68	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25845	10.1371/journal.pone.0025845	http://dx.doi.org/10.1371/journal.pone.0025845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991371	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000084
